Citrus Sinensis ID: 005859
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 673 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.707 | 0.749 | 0.292 | 2e-62 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.851 | 0.480 | 0.294 | 6e-62 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.791 | 0.843 | 0.282 | 2e-57 | |
| Q6R2K1 | 699 | Protein STRUBBELIG-RECEPT | no | no | 0.918 | 0.884 | 0.271 | 2e-56 | |
| Q6R2J8 | 703 | Protein STRUBBELIG-RECEPT | no | no | 0.904 | 0.866 | 0.263 | 3e-55 | |
| Q0WVM4 | 634 | Probable LRR receptor-lik | no | no | 0.699 | 0.742 | 0.282 | 8e-55 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.780 | 0.822 | 0.282 | 9e-55 | |
| C0LGU5 | 614 | Probable LRR receptor-lik | no | no | 0.778 | 0.853 | 0.271 | 1e-54 | |
| C0LGF4 | 591 | LRR receptor-like serine/ | no | no | 0.716 | 0.815 | 0.296 | 1e-54 | |
| Q9LP77 | 655 | Probable inactive recepto | no | no | 0.820 | 0.842 | 0.284 | 4e-54 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 240 bits (613), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 163/557 (29%), Positives = 263/557 (47%), Gaps = 81/557 (14%)
Query: 124 NLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGD 183
NLSG + S IGN+TNLQ + L N +TGNIP ++G L KL L L N TG IP +L
Sbjct: 92 NLSGTLSSSIGNLTNLQTVLLQNNYITGNIPHEIGKLMKLKTLDLSTNNFTGQIPFTLSY 151
Query: 184 LGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAA 243
L L ++ N+L G +P LAN+ +L LD+ N+ SG VP +L + F N+
Sbjct: 152 SKNLQYLRVNNNSLTGTIPSSLANMTQLTFLDLSYNNLSGPVPRSLAKT---FNVMGNSQ 208
Query: 244 LCGTGFTNLKNCTASDHPTPGKPEPFEPNGLSTKDIPESAKLPANCGQPGCSSPA-RRPH 302
+C TG K+C + +P+P + N Q S +
Sbjct: 209 ICPTGTE--KDCNGT------QPKPMS--------------ITLNSSQNKSSDGGTKNRK 246
Query: 303 TGVFVGVIAVFIILTVTGLFTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVCRRNSSPLI 362
V GV + L + G W+RRR K FD ++ +E+C N
Sbjct: 247 IAVVFGVSLTCVCLLIIGFGFLLWWRRRHNKQVLFFD-----INEQNKEEMCLGNLR--- 298
Query: 363 SLEYSNGWDPLAKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKGI 422
FN +E++ AT FS NL+GK F YKG
Sbjct: 299 ----------------------------RFNFKELQSATSNFSSKNLVGKGGFGNVYKGC 330
Query: 423 LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDF 482
L DGS++AVK + + E +F L++++ H NL L G C + E L+Y +
Sbjct: 331 LHDGSIIAVKRLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTS--SERLLVYPY 388
Query: 483 VPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK-RPGLVHPNLSAEKVLIH 541
+ NG++ L ++ VL+W TR + G +G+ YLH + P ++H ++ A +L+
Sbjct: 389 MSNGSVASRLK----AKPVLDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLD 444
Query: 542 RRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQI 601
+ ++ D GL KLL + +G++APEY +TG+ +EK+D++ FG+++ ++
Sbjct: 445 DYFEAVVGDFGLAKLLDHEESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 504
Query: 602 LSG------------KCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCT 649
++G + +I + ++ + K+E +D +L+ + E + Q+AL CT
Sbjct: 505 ITGLRALEFGKAANQRGAILDWVKKLQQEKKLEQIVDKDLKSNYDRIEVEEMVQVALLCT 564
Query: 650 HESPSHRPSIENVMQEL 666
P HRP + V++ L
Sbjct: 565 QYLPIHRPKMSEVVRML 581
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (610), Expect = 6e-62, Method: Compositional matrix adjust.
Identities = 182/617 (29%), Positives = 299/617 (48%), Gaps = 44/617 (7%)
Query: 67 VANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLS 126
+ ISL LSGEIPA++ L +LT L L NAL G IPKE+ + +L L L N L+
Sbjct: 606 LVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLN 665
Query: 127 GKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGM 186
G IP G + +L L L NKL G +P LG+L++L+ + L +N L+G + + L +
Sbjct: 666 GHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEK 725
Query: 187 LMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAALCG 246
L+ L + N G +P +L N+ +LE LD+ N SG +P + L
Sbjct: 726 LVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKI------------CGLPN 773
Query: 247 TGFTNL-KNCTASDHPTPGKPEPFEPNGLSTKDIPESAKLPANCGQPGCSSPARRPHTGV 305
F NL KN + P+ G + LS + ++C G + G+
Sbjct: 774 LEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIEGTKLRSAWGIAGL 833
Query: 306 FVGVIAVFIILTVTGLFTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVCRRNSSPLISLE 365
+G + + + V L + +R KQ+ + R+ ++K +N L L
Sbjct: 834 MLG-FTIIVFVFVFSLRRWAMTKRVKQR------DDPERMEESRLKGFVDQN---LYFLS 883
Query: 366 YSNGWDPLAKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKGILRD 425
S +PL+ + F Q +L+ L ++ AT FS+ N++G F YK L
Sbjct: 884 GSRSREPLSINIA--MFEQPLLK---VRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPG 938
Query: 426 GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPN 485
VAVK +++ + + EF+ ++ L +KH NL SL G C E L+Y+++ N
Sbjct: 939 EKTVAVKKLSEAKTQGNR-EFMAEMETLGKVKHPNLVSLLGYCSFS--EEKLLVYEYMVN 995
Query: 486 GNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYL-HGKRPGLVHPNLSAEKVLIHRRY 544
G+L L + G +VL+W+ R+ + G A+G+++L HG P ++H ++ A +L+ +
Sbjct: 996 GSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDF 1055
Query: 545 NPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSG 604
P ++D GL +L++ + GY+ PEY + R T K D+Y+FG+I+ ++++G
Sbjct: 1056 EPKVADFGLARLISACESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTG 1115
Query: 605 KCSITP------------FTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHES 652
K P + Q K D IDP L + L QIA+ C E+
Sbjct: 1116 KEPTGPDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLAET 1175
Query: 653 PSHRPSIENVMQELSSI 669
P+ RP++ +V++ L I
Sbjct: 1176 PAKRPNMLDVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 224 bits (571), Expect = 2e-57, Method: Compositional matrix adjust.
Identities = 175/620 (28%), Positives = 283/620 (45%), Gaps = 87/620 (14%)
Query: 67 VANISLQGKGLSGEIPAAVGGLKSLTGLY--LHFNALNGVIPKEIASLS----ELSDLYL 120
+++ +L G++ E+ A V L Y L +N V P +S +S L L
Sbjct: 22 ISSATLSPTGVNYEVTALVAVKNELNDPYKVLENWDVNSVDPCSWRMVSCTDGYVSSLDL 81
Query: 121 NVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPAS 180
+LSG + +IGN+T LQ + L N +TG IP +G L KL L L N TG IPAS
Sbjct: 82 PSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQSLDLSNNSFTGEIPAS 141
Query: 181 LGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDN 240
LG+L L L L+ N+L G P L+ + L ++DI N+ SG++P R F+
Sbjct: 142 LGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSLPKVSART---FKVIG 198
Query: 241 NAALCGTGFTNLKNCTASDHPTPGKPEPFEPNGLSTKDIPESAKLPANC-GQPGCSSPAR 299
NA +CG + NC+A +PE LP + + G +
Sbjct: 199 NALICGP--KAVSNCSA---------------------VPEPLTLPQDGPDESGTRTNGH 235
Query: 300 RPHTGVFVGVIAVFIILTVTGLFTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVCRRNSS 359
A F + +G+F + YRR KQ + + D +S +K
Sbjct: 236 HVALAFAASFSAAFFVFFTSGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKR------- 288
Query: 360 PLISLEYSNGWDPLAKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATY 419
+ +E+ AT F+ N+LG+ + Y
Sbjct: 289 --------------------------------YTFKELRSATNHFNSKNILGRGGYGIVY 316
Query: 420 KGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479
KG L DG++VAVK + + E +F ++ ++ H NL LRG C S E L+
Sbjct: 317 KGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSN--QERILV 374
Query: 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK-RPGLVHPNLSAEKV 538
Y ++PNG++ L E L+W+ R + G A+G+ YLH + P ++H ++ A +
Sbjct: 375 YPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANI 434
Query: 539 LIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIV 598
L+ + ++ D GL KLL +G++APEY +TG+ +EK+D++ FG+++
Sbjct: 435 LLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 494
Query: 599 FQILSG------------KCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIAL 646
++++G K + + ++ + K++ ID +L KF E + Q+AL
Sbjct: 495 LELITGQKALDFGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVAL 554
Query: 647 HCTHESPSHRPSIENVMQEL 666
CT +PSHRP + VM+ L
Sbjct: 555 LCTQFNPSHRPKMSEVMKML 574
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6R2K1|SRF5_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 5 OS=Arabidopsis thaliana GN=SRF5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (562), Expect = 2e-56, Method: Compositional matrix adjust.
Identities = 196/723 (27%), Positives = 311/723 (43%), Gaps = 105/723 (14%)
Query: 5 LYVLTLFLSVTYTLSSTS--EVDILMHIKDSLDPENRLLTSWAPNADPCSSDSFDGVACD 62
L +++L ++VT + T EV L + SL+ ++L A DPC DS++GV C
Sbjct: 8 LVIVSLAITVTLLQAKTDNQEVSALNVMFTSLNSPSKLKGWKANGGDPCE-DSWEGVKC- 65
Query: 63 ENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNV 122
+ V + L G L G + LKSLT L N L G IP ++ +++L +
Sbjct: 66 KGSSVTELQLSGFELGGSRGYLLSNLKSLTTFDLSKNNLKGNIPYQLPP--NIANLDFSE 123
Query: 123 NNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLG 182
N L G +P + M NLQ + L NKL G +P L KL L N+L+G +P S
Sbjct: 124 NELDGNVPYSLSQMKNLQSINLGQNKLNGELPDMFQKLSKLETLDFSLNKLSGKLPQSFA 183
Query: 183 DLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNA 242
+L L +L L N G + V L N+ ++ L++ +N F G +P LK D ++
Sbjct: 184 NLTSLKKLHLQDNRFTGDINV-LRNL-AIDDLNVEDNQFEGWIPNELK--------DIDS 233
Query: 243 ALCGTGFTNLKNCTASDHPTPGKPEPFEPNGLSTKDIPESAKLPANCGQPGCSSPARRPH 302
L G +D T P P P G + K + G ++
Sbjct: 234 LLTG----------GNDWSTETAPPP--PPG-----VKYGRKSSGSKDGGGITAGTGMVI 276
Query: 303 TGVFVGVIAVFIILTVTGLFTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVCRRNSSPLI 362
G +GV+ + I+L ++K + F + D+ T + K + S+ +
Sbjct: 277 AGACLGVLVLIIVL-------IALVSKKKSSLSPHFIDEDNSHHTPKFKSLTSHGSAQEL 329
Query: 363 SLEYSNGWDPLAKGQSGN---------GFSQEVLESFM---------------------- 391
+++ N + G SG+ G V M
Sbjct: 330 RVDFGNDYKDGKSGDSGDENIHRIGSKGLKHYVSSRVMSFTDTEFANKLNAKRTTSTRSA 389
Query: 392 --FNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKG 449
F L +++ AT FS NLLG+ S Y+ DG +AVK I T S + E +
Sbjct: 390 VEFELSDLQSATANFSPGNLLGEGSIGRVYRAKYSDGRTLAVKKIDSTLFDSGKSEGITP 449
Query: 450 LKI-LTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRI 508
+ + L+ ++H+N+A L G C +G L+Y++ NG+L + L L K L W TR+
Sbjct: 450 IVMSLSKIRHQNIAELVGYCSEQGHN--MLVYEYFRNGSLHEFLHLSDCFSKPLTWNTRV 507
Query: 509 SVIKGIAKGISYLHGK-RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLK 567
+ G A+ + YLH P ++H N+ + +L+ NP LSD GL K L+
Sbjct: 508 RIALGTARAVEYLHEACSPSVMHKNIKSSNILLDADLNPRLSDYGLSKF--------YLR 559
Query: 568 ASAAM--GYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF-------------- 611
S + GY APE +T KSD+Y+FG+++ ++L+G+ PF
Sbjct: 560 TSQNLGEGYNAPEARDPSAYTPKSDVYSFGVVMLELLTGRV---PFDGEKPRPERSLVRW 616
Query: 612 -TRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
T Q + + + DP L G + S I C P RP + V++ L ++
Sbjct: 617 ATPQLHDIDALSNIADPALHGLYPPKSLSRFADIIALCVQVEPEFRPPMSEVVEALVRMV 676
Query: 671 GSS 673
S
Sbjct: 677 QRS 679
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q6R2J8|SRF8_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 8 OS=Arabidopsis thaliana GN=SRF8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 217 bits (552), Expect = 3e-55, Method: Compositional matrix adjust.
Identities = 189/718 (26%), Positives = 309/718 (43%), Gaps = 109/718 (15%)
Query: 7 VLTLFL------SVTYTLSSTSEVDILMHIKDSLDPENRLLTSWAPNA-DPCSSDSFDGV 59
VL LF+ SV ++ S+V L + SL+ ++L T+W DPC +S+ G+
Sbjct: 11 VLLLFIASISGFSVVRCVTDPSDVQALQVLYTSLNSPSQL-TNWKNGGGDPCG-ESWKGI 68
Query: 60 ACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLY 119
C E V I + G+SG + + LKSL L + N+++ +P ++
Sbjct: 69 TC-EGSAVVTIDISDLGVSGTLGYLLSDLKSLRKLDVSGNSIHDTLPYQLPP-------- 119
Query: 120 LNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPA 179
NL L L N L+GN+P + ++ LS + + N LT +I
Sbjct: 120 ------------------NLTSLNLARNNLSGNLPYSISAMGSLSYMNVSGNSLTMSIGD 161
Query: 180 SLGDLGMLMRLDLSFNNLFGPVPVK-----------------------LANVPKLEVLDI 216
D L LDLS NN G +P L+ +P L+ L++
Sbjct: 162 IFADHKSLATLDLSHNNFSGDLPSSLSTVSTLSVLYVQNNQLTGSIDVLSGLP-LKTLNV 220
Query: 217 RNNSFSGNVPPALKRLNGGFQYDNNAALCGTGFTNLKNCTASDHPTPGKPEPFEPNGLST 276
NN F+G++P L + YD N+ F N+ P P+P P
Sbjct: 221 ANNHFNGSIPKELSSIQ-TLIYDGNS------FDNV----------PASPQPERPG---K 260
Query: 277 KDIPESAKLPANCGQPGCSSPARRPHTGVFVGVIAVFIILTVTGLFTFTWY---RRRKQK 333
K+ P +K P + S + GV G+ VF L V G+ Y ++K+K
Sbjct: 261 KETPSGSKKPKIGSEEKSSDSGKGLSGGVVTGI--VFGSLFVAGIIALVLYLCLHKKKRK 318
Query: 334 IGNAFDNSDSRL---STDQVKEVCRRNSSPLISLEYSNGWDPLAKGQSGNGFSQEV---L 387
+ + S L T +V+E ++ + + L+ S NG + +
Sbjct: 319 VRGSTRASQRSLPLSGTPEVQEQRVKSVASVADLKSSPAEKVTVDRVMKNGSISRIRSPI 378
Query: 388 ESFMFNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCK-SDEGEF 446
+ + + ++ AT FS+ N++G+ S Y+ +G ++A+K I + +E F
Sbjct: 379 TASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPNGKIMAIKKIDNAALSLQEEDNF 438
Query: 447 LKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWAT 506
L+ + ++ L+H N+ L G C G+ L+Y++V NGNL L L W
Sbjct: 439 LEAVSNMSRLRHPNIVPLAGYCTE--HGQRLLVYEYVGNGNLDDTLHTNDDRSMNLTWNA 496
Query: 507 RISVIKGIAKGISYLHGK-RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSM 565
R+ V G AK + YLH P +VH N + +L+ NP LSDSGL L +
Sbjct: 497 RVKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELNPHLSDSGLAALTPNTERQVS 556
Query: 566 LKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE--- 622
+ + GY APE+ +G +T KSD+Y FG+++ ++L+G+ + +R AE S V
Sbjct: 557 TQVVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTGRKPLDS-SRTRAEQSLVRWAT 615
Query: 623 ----------DFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+DP+L G + S I C P RP + V+Q+L ++
Sbjct: 616 PQLHDIDALSKMVDPSLNGMYPAKSLSRFADIIALCIQPEPEFRPPMSEVVQQLVRLV 673
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 215 bits (548), Expect = 8e-55, Method: Compositional matrix adjust.
Identities = 157/556 (28%), Positives = 258/556 (46%), Gaps = 85/556 (15%)
Query: 124 NLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGD 183
+LSG + IGN+TNL+ + L N ++G IP ++ SL KL L L N+ +G IP S+
Sbjct: 85 SLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQTLDLSNNRFSGEIPGSVNQ 144
Query: 184 LGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAA 243
L L L L+ N+L GP P L+ +P L LD+ N+ G VP R F N
Sbjct: 145 LSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGPVPKFPART---FNVAGNPL 201
Query: 244 LCGTGFTNLKNCTASDHPTPGKPEPFEPNGLSTKDIPESAKLPANCGQPGCSSPARRPHT 303
+C + C+ S +P S L ++ G+ R
Sbjct: 202 ICKNSLPEI--CSGSISASP-----------------LSVSLRSSSGR-------RTNIL 235
Query: 304 GVFVGVIAVFIILTVTGLFTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVCRRNSSPLIS 363
V +GV F + + L F WYR++++++ + + + L+
Sbjct: 236 AVALGVSLGFAVSVILSL-GFIWYRKKQRRL--------------TMLRISDKQEEGLLG 280
Query: 364 LEYSNGWDPLAKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKGIL 423
L GN L SF F E+ AT FS ++LG F Y+G
Sbjct: 281 L--------------GN------LRSFTF--RELHVATDGFSSKSILGAGGFGNVYRGKF 318
Query: 424 RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFV 483
DG+VVAVK + + S +F L++++ H NL L G C S E L+Y ++
Sbjct: 319 GDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRLIGYCASSS--ERLLVYPYM 376
Query: 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK-RPGLVHPNLSAEKVLIHR 542
NG++ L ++ L+W TR + G A+G+ YLH + P ++H ++ A +L+
Sbjct: 377 SNGSVASRLK----AKPALDWNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDE 432
Query: 543 RYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQIL 602
+ ++ D GL KLL + +G++APEY +TG+ +EK+D++ FG+++ +++
Sbjct: 433 YFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 492
Query: 603 SG------------KCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTH 650
+G K ++ + R+ + KVE+ +D L + E + Q+AL CT
Sbjct: 493 TGMRALEFGKSVSQKGAMLEWVRKLHKEMKVEELVDRELGTTYDRIEVGEMLQVALLCTQ 552
Query: 651 ESPSHRPSIENVMQEL 666
P+HRP + V+Q L
Sbjct: 553 FLPAHRPKMSEVVQML 568
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 215 bits (548), Expect = 9e-55, Method: Compositional matrix adjust.
Identities = 187/662 (28%), Positives = 284/662 (42%), Gaps = 137/662 (20%)
Query: 23 EVDILMHIKDSLDPENRLLTSWAPNA-DPCSSDSFDGVACDENGRVANISLQGKGLSGEI 81
EV LM IK SL + +L +W +A DPCS + V C V + + LSG +
Sbjct: 41 EVQALMDIKASLHDPHGVLDNWDRDAVDPCS---WTMVTCSSENFVIGLGTPSQNLSGTL 97
Query: 82 PAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQV 141
+ I +L+ L + L NN+ GKIP++IG +T L+
Sbjct: 98 SPS------------------------ITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLET 133
Query: 142 LQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPV 201
L L N G IP +G L+ L L L N L+G P SL ++ L LDLS+NNL GPV
Sbjct: 134 LDLSDNFFHGEIPFSVGYLQSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSGPV 193
Query: 202 PVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAALCGTGFTNLKNCTASDHP 261
P A F N +C TG
Sbjct: 194 PRFAAKT---------------------------FSIVGNPLICPTG------------- 213
Query: 262 TPGKPEPFEPNGLSTKDIPESAKLPANCGQPGCSSPARRPHTGVFVG--VIAVFIILTVT 319
EP+ T IP S L G P + +R + VG V V +I
Sbjct: 214 -------TEPDCNGTTLIPMSMNL-NQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAV 265
Query: 320 GLFTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVCRRNSSPLISLEYSNGWDPLAKGQSG 379
GL F W+R+R + FD D N +SL G
Sbjct: 266 GL--FLWWRQRHNQ-NTFFDVKDG-------------NHHEEVSL--------------G 295
Query: 380 NGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSC 439
N L F F E++ AT FS NLLGK + YKGIL D +VVAVK +
Sbjct: 296 N------LRRFGF--RELQIATNNFSSKNLLGKGGYGNVYKGILGDSTVVAVKRLKDGGA 347
Query: 440 KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSE 499
E +F +++++ H NL L G C ++ E L+Y ++ NG++ + ++
Sbjct: 348 LGGEIQFQTEVEMISLAVHRNLLRLYGFCITQ--TEKLLVYPYMSNGSVASRMK----AK 401
Query: 500 KVLEWATRISVIKGIAKGISYLHGK-RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558
VL+W+ R + G A+G+ YLH + P ++H ++ A +L+ ++ D GL KLL
Sbjct: 402 PVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLD 461
Query: 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSG------------KC 606
+G++APEY +TG+ +EK+D++ FG+++ ++++G K
Sbjct: 462 HQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTGQRAFEFGKAANQKG 521
Query: 607 SITPFTRQAAESSKVEDFIDPNLEGKFSVSEA--SNLGQIALHCTHESPSHRPSIENVMQ 664
+ + ++ + K+E +D L K S E + ++AL CT P HRP + V++
Sbjct: 522 VMLDWVKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALLCTQYLPGHRPKMSEVVR 581
Query: 665 EL 666
L
Sbjct: 582 ML 583
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGU5|Y5457_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g45780 OS=Arabidopsis thaliana GN=At5g45780 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 215 bits (547), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 180/662 (27%), Positives = 289/662 (43%), Gaps = 138/662 (20%)
Query: 23 EVDILMHIKDSLDPENRLLTSWAPNA-DPCSSDSFDGVACDENGRVANISLQGKGLSGEI 81
EV LM +K+ + E +L+ W N+ DPC+ ++ V C G V ++ + KGL
Sbjct: 39 EVAALMSVKNKMKDEKEVLSGWDINSVDPCT---WNMVGCSSEGFVVSLEMASKGL---- 91
Query: 82 PAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQV 141
SG + + IG +T+L
Sbjct: 92 --------------------------------------------SGILSTSIGELTHLHT 107
Query: 142 LQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPV 201
L L N+LTG IP++LG L +L L L N+ +G IPASLG L L L LS N L G V
Sbjct: 108 LLLQNNQLTGPIPSELGQLSELETLDLSGNRFSGEIPASLGFLTHLNYLRLSRNLLSGQV 167
Query: 202 PVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAALCGTGFTNLKNCTASDHP 261
P +A + L LD+ N+ SG P + ++ NA LCG L C+ +
Sbjct: 168 PHLVAGLSGLSFLDLSFNNLSGPTPNISAK---DYRIVGNAFLCGPASQEL--CSDA--- 219
Query: 262 TPGKPEPFEPNGLSTKDIPESAKLPANCGQPGCSSPARRPHTGVFVGVIAVFIILTVTGL 321
TP + GLS KD + L + G++ FII +
Sbjct: 220 TPVR----NATGLSEKDNSKHHSLVLSFA----------------FGIVVAFIISLMFLF 259
Query: 322 FTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVCRRNSSPLISLEYSNGWDPLAKGQSGNG 381
F W+R SRLS V++
Sbjct: 260 FWVLWHR--------------SRLSRSHVQQ----------------------------D 277
Query: 382 FSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKS 441
+ E+ F+ E++ AT FS N+LG+ F YKG L +G+VVAVK + K +
Sbjct: 278 YEFEIGHLKRFSFREIQTATSNFSPKNILGQGGFGMVYKGYLPNGTVVAVKRL-KDPIYT 336
Query: 442 DEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKV 501
E +F ++++ H NL L G C + E L+Y ++PNG++ L G +
Sbjct: 337 GEVQFQTEVEMIGLAVHRNLLRLFGFCMTP--EERMLVYPYMPNGSVADRLRDNYGEKPS 394
Query: 502 LEWATRISVIKGIAKGISYLHGK-RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560
L+W RIS+ G A+G+ YLH + P ++H ++ A +L+ + ++ D GL KLL
Sbjct: 395 LDWNRRISIALGAARGLVYLHEQCNPKIIHRDVKAANILLDESFEAIVGDFGLAKLLDQR 454
Query: 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSG------------KCSI 608
+G++APEY +TG+ +EK+D++ FG+++ ++++G K I
Sbjct: 455 DSHVTTAVRGTIGHIAPEYLSTGQSSEKTDVFGFGVLILELITGHKMIDQGNGQVRKGMI 514
Query: 609 TPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSS 668
+ R + + +D +L+G+F + ++AL CT P+ RP + V++ L
Sbjct: 515 LSWVRTLKAEKRFAEMVDRDLKGEFDDLVLEEVVELALLCTQPHPNLRPRMSQVLKVLEG 574
Query: 669 II 670
++
Sbjct: 575 LV 576
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGF4|FEI1_ARATH LRR receptor-like serine/threonine-protein kinase FEI 1 OS=Arabidopsis thaliana GN=FEI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 214 bits (546), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 168/566 (29%), Positives = 259/566 (45%), Gaps = 84/566 (14%)
Query: 118 LYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAI 177
L L + + G +P IG + +L++L L N L G IPT LG+ L + LQ N TG I
Sbjct: 79 LNLTYHKIMGPLPPDIGKLDHLRLLMLHNNALYGAIPTALGNCTALEEIHLQSNYFTGPI 138
Query: 178 PASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQ 237
PA +GDL L +LD+S N L GP+P L + KL ++ NN G +P + GF
Sbjct: 139 PAEMGDLPGLQKLDMSSNTLSGPIPASLGQLKKLSNFNVSNNFLVGQIPS--DGVLSGFS 196
Query: 238 ---YDNNAALCGTGFTNLKNCTASDHPTPGKPEPFEPNGLSTKDIPESAKLPANCGQPGC 294
+ N LCG K+ G P +G + K N G+
Sbjct: 197 KNSFIGNLNLCG------KHVDVVCQDDSGNPSSHSQSGQNQK---------KNSGKLLI 241
Query: 295 SSPARRPHTGVFVGVIAVFIILTVTGLFTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVC 354
S+ A VG + + ++ G F + +K+G ++K
Sbjct: 242 SASAT-------VGALLLVALMCFWGCFLY-------KKLGKV-----------EIKS-- 274
Query: 355 RRNSSPLISLEYSNGWDPLAKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSS 414
LAK G ++ +++ + + +E +++G
Sbjct: 275 ------------------LAKDVGGGASIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGG 316
Query: 415 FSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRG 474
F YK + DG V A+K I K + D F + L+IL S+KH L +LRG C S
Sbjct: 317 FGTVYKLAMDDGKVFALKRILKLNEGFDRF-FERELEILGSIKHRYLVNLRGYCNSPTSK 375
Query: 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK-RPGLVHPNL 533
L+YD++P G+L + L E G + L+W +R+++I G AKG+SYLH P ++H ++
Sbjct: 376 --LLLYDYLPGGSLDEALH-ERGEQ--LDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDI 430
Query: 534 SAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYA 593
+ +L+ +SD GL KLL D+ + GYLAPEY +GR TEK+D+Y+
Sbjct: 431 KSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYS 490
Query: 594 FGMIVFQILSGK-----------CSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLG 642
FG++V ++LSGK ++ + + + D +DPN EG + L
Sbjct: 491 FGVLVLEVLSGKRPTDASFIEKGLNVVGWLKFLISEKRPRDIVDPNCEG-MQMESLDALL 549
Query: 643 QIALHCTHESPSHRPSIENVMQELSS 668
IA C SP RP++ V+Q L S
Sbjct: 550 SIATQCVSPSPEERPTMHRVVQLLES 575
|
Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (542), Expect = 4e-54, Method: Compositional matrix adjust.
Identities = 185/650 (28%), Positives = 304/650 (46%), Gaps = 98/650 (15%)
Query: 50 PCSSDSFDGVACDENGRVANISLQGKGLSGEIPAAV-GGLKSLTGLYLHFNALNGVIPKE 108
PC+ + GV C+ N RV + L G LSG+IP + G L L L L NAL+G +PK+
Sbjct: 61 PCN---WAGVKCESN-RVTALRLPGVALSGDIPEGIFGNLTQLRTLSLRLNALSGSLPKD 116
Query: 109 IASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLAL 168
+++ S L LYL N SG+IP + ++++L L L N TG I + +L KL L L
Sbjct: 117 LSTSSNLRHLYLQGNRFSGEIPEVLFSLSHLVRLNLASNSFTGEISSGFTNLTKLKTLFL 176
Query: 169 QYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPA 228
+ NQL+G+IP DL + + + FN + NNS +G++P
Sbjct: 177 ENNQLSGSIP----DLDLPL---VQFN--------------------VSNNSLNGSIPKN 209
Query: 229 LKRLNGGFQYDN--NAALCGTGFTNLKNC----TASDHPTPGKPEPFEPNGLSTKDIPES 282
L+R F+ D+ +LCG LK C T PT G P+ +++ +
Sbjct: 210 LQR----FESDSFLQTSLCGKP---LKLCPDEETVPSQPTSGGNRT-PPSVEGSEEKKKK 261
Query: 283 AKLPANCGQPGCSSPARRPHTGVFVGVIAVFIILTVTGLFTFTWYRRRKQKIGNAFDNSD 342
KL G+ +G + F ++ L R++ K A D S
Sbjct: 262 NKLSGGA------------IAGIVIGCVVGFALIV---LILMVLCRKKSNKRSRAVDIST 306
Query: 343 SRLSTDQV---KEVCRRNSSPLISLEYSNGWDPLAKGQSGNGFSQEVLESF-----MFNL 394
+ ++ KE + +S + K GNG + + L F +F+L
Sbjct: 307 IKQQEPEIPGDKEAVDNGNVYSVSAAAAAAMTGNGKASEGNGPATKKLVFFGNATKVFDL 366
Query: 395 EEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILT 454
E++ RA+ A +LGK +F YK +L +VVAVK + K +D+ EF + ++++
Sbjct: 367 EDLLRAS-----AEVLGKGTFGTAYKAVLDAVTVVAVKRL-KDVMMADK-EFKEKIELVG 419
Query: 455 SLKHENLASLRGICCSKGRGECFLIYDFVPNGNL--LQHLDLEAGSEKVLEWATRISVIK 512
++ HENL LR S R E L+YDF+P G+L L H + AG L W R +
Sbjct: 420 AMDHENLVPLRAYYFS--RDEKLLVYDFMPMGSLSALLHGNRGAGRSP-LNWDVRSRIAI 476
Query: 513 GIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAM 572
G A+G+ YLH + H N+ + +L+ + ++ +SD GL +L+ S + A
Sbjct: 477 GAARGLDYLHSQGTSTSHGNIKSSNILLTKSHDAKVSDFGLAQLVGS----SATNPNRAT 532
Query: 573 GYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKC-----------SITPFTRQAAESSKV 621
GY APE T R ++K D+Y+FG+++ ++++GK + + + A
Sbjct: 533 GYRAPEVTDPKRVSQKGDVYSFGVVLLELITGKAPSNSVMNEEGVDLPRWVKSVARDEWR 592
Query: 622 EDFIDPNLEGKFSVSEA--SNLGQIALHCTHESPSHRPSIENVMQELSSI 669
+ D L + E + + Q+ L CT + P RP + V++++ ++
Sbjct: 593 REVFDSELLSLATDEEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENL 642
|
Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 673 | ||||||
| 224127374 | 644 | predicted protein [Populus trichocarpa] | 0.942 | 0.984 | 0.755 | 0.0 | |
| 225453949 | 677 | PREDICTED: probable LRR receptor-like se | 0.995 | 0.989 | 0.719 | 0.0 | |
| 147798550 | 702 | hypothetical protein VITISV_012898 [Viti | 0.991 | 0.950 | 0.716 | 0.0 | |
| 225455531 | 681 | PREDICTED: leucine-rich repeat receptor- | 0.988 | 0.976 | 0.669 | 0.0 | |
| 255541284 | 627 | leucine rich repeat receptor kinase, put | 0.900 | 0.966 | 0.683 | 0.0 | |
| 15225456 | 691 | putative leucine-rich repeat transmembra | 0.958 | 0.933 | 0.669 | 0.0 | |
| 255562812 | 648 | leucine rich repeat receptor kinase, put | 0.873 | 0.907 | 0.704 | 0.0 | |
| 449526527 | 679 | PREDICTED: probable leucine-rich repeat | 0.985 | 0.976 | 0.631 | 0.0 | |
| 356530961 | 683 | PREDICTED: probable leucine-rich repeat | 0.953 | 0.939 | 0.650 | 0.0 | |
| 449432257 | 691 | PREDICTED: probable LRR receptor-like se | 0.991 | 0.965 | 0.620 | 0.0 |
| >gi|224127374|ref|XP_002320058.1| predicted protein [Populus trichocarpa] gi|222860831|gb|EEE98373.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 982 bits (2538), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 485/642 (75%), Positives = 541/642 (84%), Gaps = 8/642 (1%)
Query: 28 MHIKDSLDPENRLLTSWAPNADPCSSDSFDGVACDENGRVANISLQGKGLSGEIPAAVGG 87
M IK SLDP+NRLLTSW N DPCS SF+GVAC+E G VANISLQGKGL G+IPAA+GG
Sbjct: 1 MEIKASLDPQNRLLTSWETNKDPCSG-SFEGVACNELGHVANISLQGKGLLGQIPAALGG 59
Query: 88 LKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYN 147
LKSLTGLYLHFNALNGVIPKEIA LSELSDLYLNVNNLSG+IP +GNM+NLQVLQLCYN
Sbjct: 60 LKSLTGLYLHFNALNGVIPKEIAELSELSDLYLNVNNLSGEIPPHVGNMSNLQVLQLCYN 119
Query: 148 KLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLAN 207
KLTG+IPTQLGSL KLSVLALQYNQLTGAIPASLGDL +L RLDLSFN LFGP+PVKLA
Sbjct: 120 KLTGSIPTQLGSLEKLSVLALQYNQLTGAIPASLGDLELLSRLDLSFNGLFGPIPVKLAK 179
Query: 208 VPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAALCGTGFTNLKNCTASDHPTPGKPE 267
P L LDIRNNS SGN+PPALKRL GFQY NN LCG GF+NL+ C SD P +PE
Sbjct: 180 APLLHSLDIRNNSLSGNIPPALKRLTTGFQYGNNPDLCGVGFSNLETCATSD---PNRPE 236
Query: 268 PFEPNGLSTKDIPESAKLPANCGQPGCSSPARRPHTGVFVGVIAVFIILTVTGLFTFTWY 327
P EP + KDIPESA P+ C + CS+ ++ P G+ GVI VFI ++VTGL F+W+
Sbjct: 237 PSEPRVATEKDIPESAN-PSYCSKSDCSNLSKTPRYGIIFGVIGVFIAMSVTGLLMFSWH 295
Query: 328 RRRKQKIGNAFDNSDSRLSTDQVKEVCRRNSSPLISLEYSNGWDPLAKGQSGNGFSQEVL 387
RRRKQKIG+A D D RLSTDQ KEV RR++SPLISLEY NGWDPLA G+S +GFSQEVL
Sbjct: 296 RRRKQKIGSALDTFDGRLSTDQAKEVSRRSASPLISLEYPNGWDPLAIGRSKSGFSQEVL 355
Query: 388 ESFMFNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFL 447
ESFMFNLEEVERATQCFSE NLLGKS+FSA YKGILRDGSVVA+KCI KTSCKSDE +FL
Sbjct: 356 ESFMFNLEEVERATQCFSEMNLLGKSNFSAIYKGILRDGSVVAIKCITKTSCKSDEADFL 415
Query: 448 KGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATR 507
KGLKILTSLKHENL LRG CCSKGRGECFLIYDFVPNGNL+Q+LD++ GS KVLEW+TR
Sbjct: 416 KGLKILTSLKHENLVRLRGFCCSKGRGECFLIYDFVPNGNLVQYLDVKDGSGKVLEWSTR 475
Query: 508 ISVIKGIAKGISYLH---GKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFS 564
IS+I GIAKGI++LH G + LVH N+SAEKV I R YNP+LSDSGLHKLLADD+VFS
Sbjct: 476 ISIINGIAKGIAHLHVSKGNKHALVHQNISAEKVFIDRWYNPMLSDSGLHKLLADDLVFS 535
Query: 565 MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF 624
MLKASAAMGYLAPEYTTTGRFTEKSD+YAFG+IV QILSGK +IT T AAE+ K EDF
Sbjct: 536 MLKASAAMGYLAPEYTTTGRFTEKSDVYAFGIIVLQILSGKRNITQLTHHAAEACKFEDF 595
Query: 625 IDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQEL 666
ID LEG FS SEA+ LG+IAL CT+ESP+HRP++E VMQEL
Sbjct: 596 IDAKLEGNFSESEAAKLGRIALCCTNESPNHRPTMETVMQEL 637
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225453949|ref|XP_002279998.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 978 bits (2529), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/680 (71%), Positives = 551/680 (81%), Gaps = 10/680 (1%)
Query: 1 MSFSLY----VLTLFLSVTYTLSSTSEVDILMHIKDSLDPENRLLTSWAPNADPCSSDSF 56
M SLY +L L L+ LSS E+ +LM +K SLDPENR L+SW + DPCS DSF
Sbjct: 1 MGLSLYLLSFILALHLNYPQALSSNPELRVLMAMKASLDPENRFLSSWTSDNDPCS-DSF 59
Query: 57 DGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELS 116
+GVAC+E G V NISLQGKGL G+IP + LKSL+GL+LHFN+L G IPKEI++L+ELS
Sbjct: 60 EGVACNEYGHVVNISLQGKGLMGQIPKEIAELKSLSGLFLHFNSLYGEIPKEISALAELS 119
Query: 117 DLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGA 176
DLYLNVNNLSG I IGNM+NLQVLQLCYNKLTG IPTQLGSL+KLSVLALQ N+LTGA
Sbjct: 120 DLYLNVNNLSGVIHPGIGNMSNLQVLQLCYNKLTGGIPTQLGSLKKLSVLALQSNELTGA 179
Query: 177 IPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGF 236
IPASLGDL ML RLDLSFNNLFGP+PVKLAN P LE+LDIRNN+ SGNVP ALKRLN GF
Sbjct: 180 IPASLGDLEMLTRLDLSFNNLFGPIPVKLANAPMLEILDIRNNTLSGNVPQALKRLNDGF 239
Query: 237 QYDNNAALCGTGFTNLKNCTASDHPTPGKPEPFEPNGLSTKDIPESAKLPANCGQPGCSS 296
QY NN +LCG GF L C+ASD P +PEPF PNG +PESA L +C + CS+
Sbjct: 240 QYRNNPSLCGDGFLALDVCSASDQLNPNRPEPFGPNGTDKNGLPESANLQPDCSKTHCST 299
Query: 297 PARRPHTGVFVGVIAVFIILTVTGLFTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVCRR 356
P++ + GVI V + LTV+GLF F+WYRRRKQKIG+AFD SDSRLSTDQVKEV R+
Sbjct: 300 PSKTSQIAIVCGVIGVIVALTVSGLFAFSWYRRRKQKIGSAFDASDSRLSTDQVKEVYRK 359
Query: 357 NSSPLISLEYSNGWDPLAKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFS 416
++SPLISLEYS+GWDPL GQSGNGFSQEV S MFNLE+VE ATQ FS+ NLLGKS+FS
Sbjct: 360 SASPLISLEYSHGWDPL--GQSGNGFSQEVPGSVMFNLEDVESATQYFSDLNLLGKSNFS 417
Query: 417 ATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476
A YKGILRDGSVVA+KCIAK SCKSDE EFLKGLK L SLKHENL LRG CCSKGRGEC
Sbjct: 418 AIYKGILRDGSVVAIKCIAKISCKSDEAEFLKGLKTLASLKHENLVRLRGFCCSKGRGEC 477
Query: 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP---GLVHPNL 533
FLIYDFVPNGNLLQ+LD+ S KVLEW+TRIS+I GIAKGI YLHGK+ LVH N+
Sbjct: 478 FLIYDFVPNGNLLQYLDVTDNSGKVLEWSTRISIINGIAKGIGYLHGKKGNKCALVHQNI 537
Query: 534 SAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYA 593
SAEKVLI + YNPLLSDSGLHKLLADDIVFS LKA+AAMGYLAPEYTTTGRFTEKSD+YA
Sbjct: 538 SAEKVLIDQHYNPLLSDSGLHKLLADDIVFSTLKATAAMGYLAPEYTTTGRFTEKSDVYA 597
Query: 594 FGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESP 653
FGMIVFQILSGK I TR AES + EDFID NL GKFS SEA+ LG+IAL CTH+SP
Sbjct: 598 FGMIVFQILSGKRKIAHLTRNGAESGRFEDFIDANLAGKFSESEAAKLGKIALLCTHDSP 657
Query: 654 SHRPSIENVMQELSSIIGSS 673
SHRP+IENVMQEL+ ++ S
Sbjct: 658 SHRPAIENVMQELNDLVSPS 677
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147798550|emb|CAN72186.1| hypothetical protein VITISV_012898 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 972 bits (2513), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 485/677 (71%), Positives = 546/677 (80%), Gaps = 10/677 (1%)
Query: 1 MSFSLYVLTLFLSVTY----TLSSTSEVDILMHIKDSLDPENRLLTSWAPNADPCSSDSF 56
M SLY+L+ L++ LSS E+ +LM +K SLDPENR L+SW + DPCS DSF
Sbjct: 1 MGLSLYLLSFILALXLNYPQALSSNPELRVLMAMKASLDPENRFLSSWTSDNDPCS-DSF 59
Query: 57 DGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELS 116
+GVAC+E G V NISLQGKGL G+IP + LKSL+GL+LHFN+L G IPKEI++L+ELS
Sbjct: 60 EGVACNEYGHVVNISLQGKGLMGQIPKEIAELKSLSGLFLHFNSLXGEIPKEISALAELS 119
Query: 117 DLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGA 176
DLYLNVNNLSG I IGNM+NLQVLQLCYNKLTG IPTQLGSL+KLSVLALQ N+LTGA
Sbjct: 120 DLYLNVNNLSGVIHPGIGNMSNLQVLQLCYNKLTGGIPTQLGSLKKLSVLALQSNELTGA 179
Query: 177 IPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGF 236
IPASLGDL ML RLDLSFNNLFGP+PVKLAN P LE+LDIRNN+ SGNVP ALKRLN GF
Sbjct: 180 IPASLGDLEMLTRLDLSFNNLFGPIPVKLANAPMLEILDIRNNTLSGNVPQALKRLNDGF 239
Query: 237 QYDNNAALCGTGFTNLKNCTASDHPTPGKPEPFEPNGLSTKDIPESAKLPANCGQPGCSS 296
QY NN LCG GF L C+ASD P +PEPF PNG +PESA L +C + CS+
Sbjct: 240 QYRNNPGLCGDGFLALDVCSASDQLNPNRPEPFGPNGTDKNGLPESANLQPDCSKTHCST 299
Query: 297 PARRPHTGVFVGVIAVFIILTVTGLFTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVCRR 356
P++ GVI V TV+GLF F+WYRRRKQKIG+AFD SDSRLSTDQVKEV R+
Sbjct: 300 PSKTSQIAXVCGVIGVIXAFTVSGLFAFSWYRRRKQKIGSAFDASDSRLSTDQVKEVYRK 359
Query: 357 NSSPLISLEYSNGWDPLAKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFS 416
++SPLISLEYS+GWDPL GQSGNGFSQEV SFMFNLE+VE ATQ FS+ NLLGKS+FS
Sbjct: 360 SASPLISLEYSHGWDPL--GQSGNGFSQEVPGSFMFNLEDVESATQYFSDLNLLGKSNFS 417
Query: 417 ATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476
A YKGILRDGSVVA+KCIAK SCKSDE EFLKGLK L SLKHENL LRG CCSKGRGEC
Sbjct: 418 AIYKGILRDGSVVAIKCIAKISCKSDEAEFLKGLKTLASLKHENLVRLRGFCCSKGRGEC 477
Query: 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP---GLVHPNL 533
FLIYDFVPNGNLLQ+LD+ S KVLEW+TRIS+I GIAKGI YLHGK+ LVH N+
Sbjct: 478 FLIYDFVPNGNLLQYLDVTDNSGKVLEWSTRISIINGIAKGIGYLHGKKGNKCALVHQNI 537
Query: 534 SAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYA 593
SAEKVLI + YNPLLSDSGLHKLLADDIVFS LKA+AAMGYLAPEYTTTGRFTEKSD+YA
Sbjct: 538 SAEKVLIDQHYNPLLSDSGLHKLLADDIVFSTLKATAAMGYLAPEYTTTGRFTEKSDVYA 597
Query: 594 FGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESP 653
FGMIVFQILSGK I T AES + EDFID NL GKFS SEA+ LG+IAL C H+SP
Sbjct: 598 FGMIVFQILSGKRKIAHLTHNGAESGRFEDFIDANLAGKFSESEAAKLGKIALLCIHDSP 657
Query: 654 SHRPSIENVMQELSSII 670
SHRP+IENVMQEL+ ++
Sbjct: 658 SHRPAIENVMQELNDLL 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455531|ref|XP_002267632.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2318), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 452/675 (66%), Positives = 533/675 (78%), Gaps = 10/675 (1%)
Query: 1 MSFSLYVLTLF----LSVTYTLSSTSEVDILMHIKDSLDPENRLLTSWAPNADPCSSDSF 56
M+ S +V TLF L V + TSE+ LM IK +LDP N L+SW N DPC SF
Sbjct: 1 MAISAFVSTLFIFFTLQVPLLVHGTSELRSLMVIKSTLDPHNLFLSSWTINGDPCDG-SF 59
Query: 57 DGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELS 116
+GVAC+E G+VANISLQGKGL+G++ A+ GLK LTGLYLH+N+L G IP EIA+L++LS
Sbjct: 60 EGVACNERGQVANISLQGKGLTGKLSPAIAGLKHLTGLYLHYNSLYGEIPVEIANLTQLS 119
Query: 117 DLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGA 176
DLYLNVNNLSG IP+++G M LQVLQLCYN+LTG+IPTQLGSL+KLSVLALQ NQLTGA
Sbjct: 120 DLYLNVNNLSGTIPAELGKMATLQVLQLCYNQLTGSIPTQLGSLKKLSVLALQSNQLTGA 179
Query: 177 IPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGF 236
IPASLGDLGML+RLDLSFN LFG +P +LA+V LEVLDIRNN+ SG +PPALKRLNGGF
Sbjct: 180 IPASLGDLGMLVRLDLSFNRLFGSIPRRLADVVSLEVLDIRNNTLSGKIPPALKRLNGGF 239
Query: 237 QYDNNAALCGTGFTNLKNCTASDHPTPGKPEPFEP--NGLSTKDIPESAKLPANCGQPGC 294
QY NNA LCG GF+ LK C + D +PEP+ N ST DIPE+A + +C + C
Sbjct: 240 QYKNNARLCGDGFSYLKVCNSLDLTNQSRPEPYGAGSNTQSTGDIPETANVQLHCDKAHC 299
Query: 295 SSPARRPHTGVFVGVIAVFIILTVTGLFTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVC 354
S+P++ H V VG++ V I L+ G+ +F YRRRKQK+G++FD SDSRLSTDQ KEV
Sbjct: 300 SNPSKSSHAPVVVGMVVVTIALSAIGILSFAQYRRRKQKLGSSFDISDSRLSTDQGKEVY 359
Query: 355 RRNSSPLISLEYSNGWDPLAKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSS 414
R+N SPL+SLEYSNGWDPLA G++ GF QEV +SF FNLEEVE ATQ FSE NLLGKS+
Sbjct: 360 RKNGSPLVSLEYSNGWDPLADGRNYGGFPQEVFQSFRFNLEEVESATQHFSEVNLLGKSN 419
Query: 415 FSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRG 474
FSA YKGILRDGS+VA+K I KTSCKS++ EFLKGL ILTSL+HENL LRG+CCSKGRG
Sbjct: 420 FSAIYKGILRDGSLVAIKSINKTSCKSEDAEFLKGLNILTSLRHENLVRLRGLCCSKGRG 479
Query: 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHG---KRPGLVHP 531
ECFLIYDF+PNGNLL +LDL+ G KVLEW+TR+S+I GIAKGI YLHG +P LVH
Sbjct: 480 ECFLIYDFIPNGNLLSYLDLKDGDSKVLEWSTRVSMISGIAKGIEYLHGYKLNKPALVHQ 539
Query: 532 NLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDI 591
N+SAEKVLI +R NPLLSDSGLHKLL DDIVFS LKASAAMGYLAPEYTTTGRFTEKSD+
Sbjct: 540 NISAEKVLIDQRLNPLLSDSGLHKLLTDDIVFSALKASAAMGYLAPEYTTTGRFTEKSDL 599
Query: 592 YAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHE 651
YAFG++VFQILSGK T AE+ + +DFID NL G+FS EA+ L +IAL CTHE
Sbjct: 600 YAFGVLVFQILSGKRKFTSSIHLGAETCRFQDFIDANLHGRFSEYEAAKLARIALMCTHE 659
Query: 652 SPSHRPSIENVMQEL 666
SP RPS+E V+ EL
Sbjct: 660 SPIERPSMETVIHEL 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255541284|ref|XP_002511706.1| leucine rich repeat receptor kinase, putative [Ricinus communis] gi|223548886|gb|EEF50375.1| leucine rich repeat receptor kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 890 bits (2300), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 452/661 (68%), Positives = 513/661 (77%), Gaps = 55/661 (8%)
Query: 10 LFLSVTYTLSSTSEVDILMHIKDSLDPENRLLTSWAPNADPCSSDSFDGVACDENGRVAN 69
+FLS TLSS +E+++LM IK SLDP NR LTSW PN +PCS SF+GVAC+ G VAN
Sbjct: 13 VFLS--QTLSSPTELELLMQIKASLDPNNRFLTSWEPNTNPCSG-SFEGVACNGQGNVAN 69
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
ISLQGKGLSG+IPAA+GGLKSLTGLYLHFNALNG IPKEIA L+ELSDLYLNVNNLSG+I
Sbjct: 70 ISLQGKGLSGQIPAALGGLKSLTGLYLHFNALNGEIPKEIAELTELSDLYLNVNNLSGEI 129
Query: 130 PSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMR 189
PSQIGNM+NLQVLQLCYNKLTG+IPTQLGSLRKL+VLALQYNQLT AIPASLGDL L R
Sbjct: 130 PSQIGNMSNLQVLQLCYNKLTGSIPTQLGSLRKLNVLALQYNQLTSAIPASLGDLKFLTR 189
Query: 190 LDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAALCGTGF 249
LDLSFN LFG VPVKLA+ P L+VLDIRNNS SGN+P AL+RL+ GFQYDNN LCG GF
Sbjct: 190 LDLSFNGLFGSVPVKLASAPMLQVLDIRNNSLSGNLPAALRRLDNGFQYDNNPDLCGIGF 249
Query: 250 TNLKNCTASDHPTPGKPEPFEPNGLSTKDIPESAKLPANCGQPGCSSPARRPHTGVFVGV 309
NL+ CTAS + P +PEPF+PNG +DIPESA +NCGQ CS+ ++ P G+ GV
Sbjct: 250 PNLETCTASGNLNPNRPEPFKPNGTLQRDIPESANFTSNCGQTHCSNSSKNPQFGIIFGV 309
Query: 310 IAVFIILTVTGLFTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVCRRNSSPLISLEYSNG 369
I VFI+LT+ LFTFTWYRR+KQKIG+AFD SD RLSTDQ KEV R+++SPLISLEYSNG
Sbjct: 310 IGVFIVLTIIVLFTFTWYRRQKQKIGSAFDASDGRLSTDQAKEVYRKSASPLISLEYSNG 369
Query: 370 WDPLAKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVV 429
WDPLA GQ+ NG SQE LESFMFNLEEVERATQCFSE NLLGKS+F ATYKGILRDGSVV
Sbjct: 370 WDPLAIGQNKNGLSQEFLESFMFNLEEVERATQCFSEVNLLGKSNFCATYKGILRDGSVV 429
Query: 430 AVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLL 489
AVKCI KTSCKSDE +FLKGLKILTSLKHENL N NLL
Sbjct: 430 AVKCITKTSCKSDEADFLKGLKILTSLKHENL-----------------------NENLL 466
Query: 490 QHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK---RPGLVHPNLSAEKVLIHRRYNP 546
Q+LD++ G+E+VLEW+TR+S+I GIAKGI YLHG + L H N+SAEKV+I R
Sbjct: 467 QYLDVKEGTERVLEWSTRVSIINGIAKGIGYLHGNKGSKRALFHQNISAEKVIIDIR--- 523
Query: 547 LLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKC 606
AAMGYLAPEYTTTGRFTEKSD+Y+FGMIV QILSGK
Sbjct: 524 -----------------------AAMGYLAPEYTTTGRFTEKSDVYSFGMIVLQILSGKR 560
Query: 607 SITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQEL 666
+IT R A ES KVE FID LEGKFS EA LG++AL CTHESP RP++E V++E+
Sbjct: 561 NITAMIRHAVESCKVELFIDAKLEGKFSELEAIELGKLALLCTHESPDQRPTVETVLREV 620
Query: 667 S 667
S
Sbjct: 621 S 621
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15225456|ref|NP_182059.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] gi|2583120|gb|AAB82629.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|224589551|gb|ACN59309.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|330255447|gb|AEC10541.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 872 bits (2252), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/660 (66%), Positives = 521/660 (78%), Gaps = 15/660 (2%)
Query: 25 DILMHIKDSLDPENRLLTSWAPNADPCSSDSFDGVACDENGRVANISLQGKGLSGEIPAA 84
DIL+ IK SLDPE R LTSW P+ADPCSS SFDGVACD N RVANISLQG GL+G IP +
Sbjct: 28 DILLDIKSSLDPEKRFLTSWTPDADPCSSGSFDGVACDGNRRVANISLQGMGLTGTIPPS 87
Query: 85 VGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144
+G L SLTGLYLHFN+L G IPK+I++L L+DLYLNVNNLSG+IP IGN+ NLQV+QL
Sbjct: 88 IGLLTSLTGLYLHFNSLTGHIPKDISNLPLLTDLYLNVNNLSGEIPPLIGNLDNLQVIQL 147
Query: 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVK 204
CYNKL+G+IPTQ GSL+K++VLALQYNQL+GAIPASLGD+ L RLDLSFNNLFGPVPVK
Sbjct: 148 CYNKLSGSIPTQFGSLKKITVLALQYNQLSGAIPASLGDIDTLTRLDLSFNNLFGPVPVK 207
Query: 205 LANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAALCGTGFTNLKNCTASDHPTPG 264
LA P LEVLDIRNNSFSG VP ALKRLN GFQY NN LCG GFT+LK CT + P P
Sbjct: 208 LAGAPLLEVLDIRNNSFSGFVPSALKRLNNGFQYSNNHGLCGDGFTDLKACTGLNGPNPN 267
Query: 265 KPEPFEPNGLSTKDI-PESAKLP-ANC--GQPGC-SSPARRPHTGVFVGVIAVFIILTVT 319
+P+P P +T D+ PESA L +NC GC S + G+ +G+I + + +
Sbjct: 268 RPDPTNPTNFTTVDVKPESADLQRSNCSNNNGGCSSKSLKSSPLGIVMGLIGSILAVAIF 327
Query: 320 GLFTFTWYRRRKQKIGNAFDNSDSRLSTD-QVKEVCRR-NSSPLISLEYSNGWDPLAKGQ 377
G TFTWYRRRKQKIG++ D D R+ST+ KEV RR +SSPLISLEY++GWDPL +GQ
Sbjct: 328 GGSTFTWYRRRKQKIGSSLDAMDGRISTEYNFKEVSRRKSSSPLISLEYASGWDPLGRGQ 387
Query: 378 SGN---GFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCI 434
S N SQEV ESFMFNLEE+ERATQ FSE NLLGKS+ S+ YKGILRDGSV A+KCI
Sbjct: 388 SSNNNSALSQEVFESFMFNLEEIERATQSFSEINLLGKSNVSSVYKGILRDGSVAAIKCI 447
Query: 435 AKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDL 494
AK+SCKSDE EFLKGLK+LT LKHENLA LRG CCSKGRGECFLIY+FVPNGNLLQ+LD+
Sbjct: 448 AKSSCKSDESEFLKGLKMLTLLKHENLARLRGFCCSKGRGECFLIYEFVPNGNLLQYLDV 507
Query: 495 EAGSEKVLEWATRISVIKGIAKGISYLHGK---RPGLVHPNLSAEKVLIHRRYNPLLSDS 551
+ + +VLEWATR+S+I GIA+GI YLHG+ +P +VH NLSAEK+LI YNP L+DS
Sbjct: 508 KDETGEVLEWATRVSIINGIARGIVYLHGENGNKPAIVHQNLSAEKILIDHWYNPSLADS 567
Query: 552 GLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
GLHKL DDIVFS LKASAAMGYLAPEY TTGRFT+KSD+YAFGMI+ QILSGK I+
Sbjct: 568 GLHKLFTDDIVFSKLKASAAMGYLAPEYITTGRFTDKSDVYAFGMILLQILSGKSKISHL 627
Query: 612 T-RQAAESSKV-EDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSI 669
QA ES ++ EDF+DPNL F EA+ L ++ L CTHES + RPS+E+V+QEL+++
Sbjct: 628 MILQAVESGRLNEDFMDPNLRKNFPEVEAAQLARLGLLCTHESSNQRPSMEDVIQELNNL 687
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255562812|ref|XP_002522411.1| leucine rich repeat receptor kinase, putative [Ricinus communis] gi|223538296|gb|EEF39903.1| leucine rich repeat receptor kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 867 bits (2239), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/613 (70%), Positives = 486/613 (79%), Gaps = 25/613 (4%)
Query: 58 GVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSD 117
GVAC+ G VANISLQGKGLSG+I + +IPKEIA L+ELSD
Sbjct: 52 GVACNGQGNVANISLQGKGLSGQITGCSRWAQEFD-----------LIPKEIAQLTELSD 100
Query: 118 LYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAI 177
LY NVNNLS +IP QIGNM+NLQVLQLCYNKLTG+IPTQLGSLRKL+VLALQYNQLT AI
Sbjct: 101 LYPNVNNLSAEIPRQIGNMSNLQVLQLCYNKLTGSIPTQLGSLRKLNVLALQYNQLTSAI 160
Query: 178 PASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQ 237
PASLGDL L RLDLSFN LFG VPVKLA P L+VLDIRNNS SGN+P AL+RL+ GFQ
Sbjct: 161 PASLGDLKFLTRLDLSFNGLFGSVPVKLATAPMLQVLDIRNNSLSGNLPAALRRLDNGFQ 220
Query: 238 YDNNAALCGTGFTNLKNCTASDHPTPGKPEPFEPNGLSTKDIPESAKLPANCGQPGCSSP 297
YDNN +CG GF NL+ CTAS + P +PEPF+PNG +DIPESA +NCGQ CS+
Sbjct: 221 YDNNPDVCGIGFPNLETCTASGNLNPNRPEPFKPNGTLQRDIPESANFTSNCGQTHCSNS 280
Query: 298 ARRPHTGVFVGVIAVFIILTVTGLFTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVCRRN 357
++ P G+ GVI VFI+LT+ +FTFTWY R+KQKIG+AFD SD RLSTDQ K+
Sbjct: 281 SKNPQFGIIFGVIGVFIVLTIIVIFTFTWYCRQKQKIGSAFDASDGRLSTDQAKK----- 335
Query: 358 SSPLISLEYSNGWDPLAKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSA 417
LEYSNGWDPLA GQ+ NG SQE LESFMFNLEEVERATQCFSE NLLGKS+F A
Sbjct: 336 ------LEYSNGWDPLAIGQNKNGLSQEFLESFMFNLEEVERATQCFSEVNLLGKSNFCA 389
Query: 418 TYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477
TYKGILRDGSVVAVKCI KTSCKSDE +FLKGLKILTSLKHENL LRG CCSKGRGECF
Sbjct: 390 TYKGILRDGSVVAVKCITKTSCKSDEADFLKGLKILTSLKHENLVRLRGFCCSKGRGECF 449
Query: 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK---RPGLVHPNLS 534
LIYDFV NGNLLQ+LD++ G+E+VLEW+TR+S+I GIAKGI YLHG + L H N+S
Sbjct: 450 LIYDFVQNGNLLQYLDVKEGTERVLEWSTRVSIINGIAKGIGYLHGNKGSKRALFHQNIS 509
Query: 535 AEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAF 594
AEKV I RYNPLLSDSGLHKLLADDIVFS+LKASAAMGYLAPEYTTTGRFTEKSD+Y+F
Sbjct: 510 AEKVFIDIRYNPLLSDSGLHKLLADDIVFSILKASAAMGYLAPEYTTTGRFTEKSDVYSF 569
Query: 595 GMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPS 654
GMIV QILSGK +IT A ES KVE FID LEGKFS EA LG++AL CTHESP
Sbjct: 570 GMIVLQILSGKRNITAMILHAVESCKVELFIDAKLEGKFSELEAIELGKLALLCTHESPD 629
Query: 655 HRPSIENVMQELS 667
RP++E V++E+S
Sbjct: 630 QRPTVETVLREVS 642
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449526527|ref|XP_004170265.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 861 bits (2225), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/671 (63%), Positives = 521/671 (77%), Gaps = 8/671 (1%)
Query: 1 MSFSLYVLTLFLSVTYTLSSTSEVDILMHIKDSLDPENRLLTSWAPNADPCSSDSFDGVA 60
+SF L +F+S + E+ LM +K +LDP+N+ L SW N DPCSS F+G+
Sbjct: 5 ISFFLISFLIFISNPLGILGNEELQALMDLKAALDPDNQYLASWTANGDPCSS--FEGIG 62
Query: 61 CDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYL 120
C+E G+V N+SLQGKGLSG++ A+ GLK LTGLYLH+N+L G IPKEIA+L+ LSDLYL
Sbjct: 63 CNEKGQVTNMSLQGKGLSGKLSPAIAGLKHLTGLYLHYNSLFGDIPKEIANLTLLSDLYL 122
Query: 121 NVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPAS 180
NVNN SG+IPS+IGNM +LQVLQLCYN+L+G+IPTQL SL+KL+V+ALQ NQLTGAIPAS
Sbjct: 123 NVNNFSGEIPSEIGNMESLQVLQLCYNQLSGSIPTQLSSLKKLTVIALQTNQLTGAIPAS 182
Query: 181 LGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDN 240
LG L +L+R+DLS N+LFG VP +LA+ P LEVLD+RNN+ SGNVPPALKRLN GF Y+N
Sbjct: 183 LGRLDLLVRVDLSSNHLFGSVPSRLADAPSLEVLDVRNNTLSGNVPPALKRLNEGFLYEN 242
Query: 241 NAALCGTGFTNLKNCTASDHPTPGKPEPF--EPNGLSTKDIPESAKLPANCGQPGCSSPA 298
N LCG GF +LK+C S H +PEPF + T+DIPE+A + C C S +
Sbjct: 243 NLGLCGVGFPSLKDCAGSSHVNQNQPEPFAGSAGSMPTRDIPETANVQLPCNHTRCPSSS 302
Query: 299 RRPHTGVFVGVIAVFIILTVTGLFTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVCRRNS 358
+ + + VGV+ V I L+ G+ TFT YRRRKQK+G++FD D RLSTDQ K R+N
Sbjct: 303 KSRNASI-VGVVVVTIALSAIGILTFTQYRRRKQKLGSSFDICDHRLSTDQAKATYRKNG 361
Query: 359 SPLISLEYSNGWDPLAKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSAT 418
SPL+SLEY+NGWDPLA GQ + F+QEV +SF FNLEEVE ATQ FSE NLLGKS+FSAT
Sbjct: 362 SPLVSLEYANGWDPLADGQGLSIFAQEVFQSFRFNLEEVETATQYFSEVNLLGKSNFSAT 421
Query: 419 YKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478
YKGILRDGSVVAVK I KTSCKS+E EFLKGL +LTSL+HENL LRG CCS+GRGECFL
Sbjct: 422 YKGILRDGSVVAVKSICKTSCKSEEAEFLKGLNLLTSLRHENLVRLRGFCCSRGRGECFL 481
Query: 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLH---GKRPGLVHPNLSA 535
IYDFVPNGNLL++LD++ G +VLEW+TR+S+I+GIAKG++YLH +P LVH N+SA
Sbjct: 482 IYDFVPNGNLLRYLDVKDGDGQVLEWSTRVSIIRGIAKGVAYLHKNEANKPALVHQNISA 541
Query: 536 EKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFG 595
EKVLI +R+NPLLSDSGL KLL +DIVFS LKASAA GYLAPEYTTTGRFTE+SD+YAFG
Sbjct: 542 EKVLIDQRFNPLLSDSGLQKLLTNDIVFSELKASAARGYLAPEYTTTGRFTERSDVYAFG 601
Query: 596 MIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSH 655
++VFQILSG IT R AAE+ + + +D L G+F EA+ L +IAL CTHES S
Sbjct: 602 VLVFQILSGTRKITSSLRGAAEACRYTELLDSKLHGRFFEYEAAKLCRIALLCTHESQSE 661
Query: 656 RPSIENVMQEL 666
RPS+E ++QEL
Sbjct: 662 RPSMEAIVQEL 672
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356530961|ref|XP_003534047.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 861 bits (2225), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/650 (65%), Positives = 518/650 (79%), Gaps = 8/650 (1%)
Query: 23 EVDILMHIKDSLDPENRLLTSWAPNADPCSSDSFDGVACDENGRVANISLQGKGLSGEIP 82
E+ L+ +K SLDPE L+SW + PC SF+GVAC+E G+VAN+SLQGKGLSG++
Sbjct: 29 ELRTLLDLKSSLDPEGHFLSSWTIDGTPCGG-SFEGVACNEKGQVANVSLQGKGLSGKLS 87
Query: 83 AAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVL 142
A+ GLK LTGLYLH+N+L G IP+E+A+L+ELSDLYLNVN+LSG+IP +IG M +LQVL
Sbjct: 88 PAIAGLKHLTGLYLHYNSLYGEIPRELANLTELSDLYLNVNHLSGEIPPEIGMMESLQVL 147
Query: 143 QLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVP 202
QLCYN+LTG+IPTQL L+KLSVLALQ NQ GAIPASLGDLGMLMRLDLS NNLFG +P
Sbjct: 148 QLCYNQLTGSIPTQLSDLKKLSVLALQSNQFAGAIPASLGDLGMLMRLDLSSNNLFGSIP 207
Query: 203 VKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAALCGTGFTNLKNCTASDHPT 262
KLA++P L+VLD+ NN+ SGNVPPALKRL GF +++N LCG GF++LK CTASDH
Sbjct: 208 TKLADLPLLQVLDVHNNTLSGNVPPALKRLEEGFVFEHNVGLCGVGFSSLKACTASDHAN 267
Query: 263 PGKPEPFEPN--GLSTKDIPESAKLPANCGQPGCSSPAR-RPHTGVFVGVIAVFIILTVT 319
+PEP+ GLS +DIPE+A + C C +P+R + + VG++ V I ++
Sbjct: 268 LTRPEPYGAGVGGLS-RDIPETANVKLPCNTTQCRNPSRSKQAASITVGIVLVTIAVSAI 326
Query: 320 GLFTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVCRRNSSPLISLEYSNGWDPLAKGQSG 379
G+FTFT YRRRKQK+G+ FD S+ RLSTDQ K + R+N SPL+SLEYSNGWDPLA G++
Sbjct: 327 GIFTFTMYRRRKQKLGSTFDISEGRLSTDQAKSIYRKNGSPLVSLEYSNGWDPLADGKNV 386
Query: 380 NGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSC 439
NG Q++ +SF FNLEEVE ATQ FSE NLLGKS+FSATYKG+LRDGSVVAVK I+KTSC
Sbjct: 387 NGDRQDMFQSFRFNLEEVESATQYFSELNLLGKSNFSATYKGVLRDGSVVAVKSISKTSC 446
Query: 440 KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSE 499
KSDE EFLKGL ILTSL++ENL LRG CCS+GRGECFL+YDFV NGNL +LD++ G
Sbjct: 447 KSDEAEFLKGLNILTSLRNENLVRLRGFCCSRGRGECFLVYDFVSNGNLSCYLDVKEGDG 506
Query: 500 KVLEWATRISVIKGIAKGISYLH---GKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556
+VLEW+TR+S++KGIAKGI+YLH K+ LVH N+SAEKVLI +RYNPLLSDSGL+KL
Sbjct: 507 EVLEWSTRVSIVKGIAKGIAYLHAYKAKKQALVHQNISAEKVLIDQRYNPLLSDSGLYKL 566
Query: 557 LADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA 616
L +DIVFS LK SAA GYLAPEYTTTGRFTEKSD+YAFG+++FQIL+GK IT R AA
Sbjct: 567 LTNDIVFSALKGSAAKGYLAPEYTTTGRFTEKSDVYAFGVLLFQILTGKQKITSAMRLAA 626
Query: 617 ESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQEL 666
ES K +FIDPNL GKF EA+ L ++AL C+HESP RPS+E ++QEL
Sbjct: 627 ESFKFPEFIDPNLHGKFFEYEAAKLARMALLCSHESPFERPSMEAIVQEL 676
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449432257|ref|XP_004133916.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g34110-like [Cucumis sativus] gi|449480066|ref|XP_004155789.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g34110-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 857 bits (2215), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/675 (62%), Positives = 511/675 (75%), Gaps = 8/675 (1%)
Query: 2 SFSLYVLTLFLSVTYTLSSTSEVDILMHIKDSLDPENRLLTSWAPNADPCSSDSFDGVAC 61
S + + L S + +S ++E+ LM IK SLDP + LLTSW P+++PC F+GVAC
Sbjct: 7 SLLISIFFLVFSSPFAISESTELSTLMSIKASLDPHSTLLTSWNPSSNPCGG-YFEGVAC 65
Query: 62 DENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLN 121
+E G+V NISLQG GLSG IP+AV GL+SLTGLYLHFNAL G IPKEIASL++L+DLYLN
Sbjct: 66 NEQGKVVNISLQGMGLSGNIPSAVAGLRSLTGLYLHFNALVGEIPKEIASLNQLTDLYLN 125
Query: 122 VNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASL 181
VN LSG+IP +IGNM NLQVLQLCYNKLTG IP+Q+G+++ L+VLALQYNQLTGAIPASL
Sbjct: 126 VNQLSGEIPFEIGNMANLQVLQLCYNKLTGGIPSQVGNMKVLNVLALQYNQLTGAIPASL 185
Query: 182 GDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNN 241
G+L L RL+LS N FGP+PV LA+ P LEV ++ NNS +GNVPP KRL F Y NN
Sbjct: 186 GNLTALTRLNLSNNKFFGPIPVILADAPALEVFNVENNSLTGNVPPGFKRLKEKFMYLNN 245
Query: 242 AALCGTGFTNLKNCTASDHPTPGKPEPFEP----NGLSTKDIPESAKLPANCGQPGCSSP 297
+LCG GF +L C+ P +PEPF P N S +DIPESA L +NC CS
Sbjct: 246 PSLCGVGFQDLNPCSKLKSLNPSRPEPFLPQLPGNDHSARDIPESANLGSNCNGGNCSRQ 305
Query: 298 ARRPHTGVFVGVIAVFIILTVTGLFTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVCRRN 357
++ GV +GVI VF + GL TF+WYRR + K G+ + R+ T QV+EV RRN
Sbjct: 306 SKSSRVGVALGVIGVFAAFSAIGLATFSWYRRNEHKFGSTSNGISRRIITSQVREVYRRN 365
Query: 358 SSPLISLEYSNGWDPLAKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSA 417
+SPLI+LEYSNGWDPLAK Q G+ S+E+ +SFMFNLE+VERATQCFS++NLLG+++FSA
Sbjct: 366 ASPLINLEYSNGWDPLAKDQGGSASSREIFKSFMFNLEDVERATQCFSKSNLLGRNNFSA 425
Query: 418 TYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477
YKG LRDGSVVA+KCI KTSCKSDE EFLKGLKIL S+ HENL RG+CCSK RGEC+
Sbjct: 426 LYKGKLRDGSVVAIKCIGKTSCKSDEAEFLKGLKILISMNHENLVKFRGLCCSKDRGECY 485
Query: 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLH---GKRPGLVHPNLS 534
LIYDF NG L+Q+LD GS KVL+W+TR+S+I GIAKG+ YLH GK+P L+H N+S
Sbjct: 486 LIYDFAANGTLMQYLDDSNGSGKVLDWSTRVSIICGIAKGLGYLHRKIGKKPALIHQNIS 545
Query: 535 AEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAF 594
A+KVLI YNPLLSDSGLHKLLADDI+FSMLK SAA+GYL PEYTTTGRFTEKSDIYAF
Sbjct: 546 ADKVLIDANYNPLLSDSGLHKLLADDIIFSMLKVSAALGYLPPEYTTTGRFTEKSDIYAF 605
Query: 595 GMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPS 654
GMIV Q++SGK SI E + EDFID LEG+F SEA+ LG++A+ CTHE P
Sbjct: 606 GMIVLQVISGKTSIMKLNYNTIELRQFEDFIDSKLEGRFLESEAAKLGKLAVICTHEYPE 665
Query: 655 HRPSIENVMQELSSI 669
RP+I+ V++EL +
Sbjct: 666 LRPTIDVVVEELEEM 680
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 673 | ||||||
| TAIR|locus:2050877 | 691 | AT2G45340 [Arabidopsis thalian | 0.989 | 0.963 | 0.640 | 9.2e-226 | |
| TAIR|locus:2153097 | 680 | AT5G51560 [Arabidopsis thalian | 0.976 | 0.966 | 0.582 | 8.2e-202 | |
| TAIR|locus:2132634 | 688 | AT4G22730 [Arabidopsis thalian | 0.979 | 0.957 | 0.518 | 1.2e-182 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.430 | 0.304 | 0.331 | 1.8e-61 | |
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.413 | 0.268 | 0.347 | 1.5e-59 | |
| TAIR|locus:2181017 | 951 | AT5G01950 [Arabidopsis thalian | 0.407 | 0.288 | 0.329 | 1.6e-59 | |
| TAIR|locus:2206179 | 592 | FEI1 "FEI 1" [Arabidopsis thal | 0.429 | 0.488 | 0.333 | 1.6e-59 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.401 | 0.427 | 0.316 | 1.2e-58 | |
| TAIR|locus:2171973 | 614 | AT5G45780 [Arabidopsis thalian | 0.407 | 0.446 | 0.302 | 3.1e-58 | |
| TAIR|locus:2033379 | 685 | AT1G66830 [Arabidopsis thalian | 0.858 | 0.843 | 0.269 | 6.1e-58 |
| TAIR|locus:2050877 AT2G45340 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2179 (772.1 bits), Expect = 9.2e-226, P = 9.2e-226
Identities = 437/682 (64%), Positives = 520/682 (76%)
Query: 4 SLYVLTLFLSVTYTLSSTS-EVDILMHIKDSLDPENRLLTSWAPNADPCSSDSFDGVACD 62
+L+++ F ++ LSS+S E+DIL+ IK SLDPE R LTSW P+ADPCSS SFDGVACD
Sbjct: 6 TLFLILFFFFLSSALSSSSSELDILLDIKSSLDPEKRFLTSWTPDADPCSSGSFDGVACD 65
Query: 63 ENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNV 122
N RVANISLQG GL+G IP ++G L SLTGLYLHFN+L G IPK+I++L L+DLYLNV
Sbjct: 66 GNRRVANISLQGMGLTGTIPPSIGLLTSLTGLYLHFNSLTGHIPKDISNLPLLTDLYLNV 125
Query: 123 NNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPAXXX 182
NNLSG+IP IGN+ NLQV+QLCYNKL+G+IPTQ GSL+K++VLALQYNQL+GAIPA
Sbjct: 126 NNLSGEIPPLIGNLDNLQVIQLCYNKLSGSIPTQFGSLKKITVLALQYNQLSGAIPASLG 185
Query: 183 XXXXXXXXXXXFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNA 242
FNNLFGPVPVKLA P LEVLDIRNNSFSG VP ALKRLN GFQY NN
Sbjct: 186 DIDTLTRLDLSFNNLFGPVPVKLAGAPLLEVLDIRNNSFSGFVPSALKRLNNGFQYSNNH 245
Query: 243 ALCGTGFTNLKNCTASDHPTPGKPEPFEPNGLSTKDI-PESAKLP-ANCGQP--GCSSPA 298
LCG GFT+LK CT + P P +P+P P +T D+ PESA L +NC GCSS +
Sbjct: 246 GLCGDGFTDLKACTGLNGPNPNRPDPTNPTNFTTVDVKPESADLQRSNCSNNNGGCSSKS 305
Query: 299 RRPHTXXXXXXXXXXX-XLTVTGLFTFTWYRRRKQKIGNAFDNSDSRLSTD-QVKEVCRR 356
+ + + G TFTWYRRRKQKIG++ D D R+ST+ KEV RR
Sbjct: 306 LKSSPLGIVMGLIGSILAVAIFGGSTFTWYRRRKQKIGSSLDAMDGRISTEYNFKEVSRR 365
Query: 357 -NSSPLISLEYSNGWDPLAKGQSGNG---FSQEVLESFMFNLEEVERATQCFSEANLLGK 412
+SSPLISLEY++GWDPL +GQS N SQEV ESFMFNLEE+ERATQ FSE NLLGK
Sbjct: 366 KSSSPLISLEYASGWDPLGRGQSSNNNSALSQEVFESFMFNLEEIERATQSFSEINLLGK 425
Query: 413 SSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKG 472
S+ S+ YKGILRDGSV A+KCIAK+SCKSDE EFLKGLK+LT LKHENLA LRG CCSKG
Sbjct: 426 SNVSSVYKGILRDGSVAAIKCIAKSSCKSDESEFLKGLKMLTLLKHENLARLRGFCCSKG 485
Query: 473 RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK---RPGLV 529
RGECFLIY+FVPNGNLLQ+LD++ + +VLEWATR+S+I GIA+GI YLHG+ +P +V
Sbjct: 486 RGECFLIYEFVPNGNLLQYLDVKDETGEVLEWATRVSIINGIARGIVYLHGENGNKPAIV 545
Query: 530 HPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKS 589
H NLSAEK+LI YNP L+DSGLHKL DDIVFS LKASAAMGYLAPEY TTGRFT+KS
Sbjct: 546 HQNLSAEKILIDHWYNPSLADSGLHKLFTDDIVFSKLKASAAMGYLAPEYITTGRFTDKS 605
Query: 590 DIYAFGMIVFQILSGKCSITPFT-RQAAESSKV-EDFIDPNLEGKFSVSEASNLGQIALH 647
D+YAFGMI+ QILSGK I+ QA ES ++ EDF+DPNL F EA+ L ++ L
Sbjct: 606 DVYAFGMILLQILSGKSKISHLMILQAVESGRLNEDFMDPNLRKNFPEVEAAQLARLGLL 665
Query: 648 CTHESPSHRPSIENVMQELSSI 669
CTHES + RPS+E+V+QEL+++
Sbjct: 666 CTHESSNQRPSMEDVIQELNNL 687
|
|
| TAIR|locus:2153097 AT5G51560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1953 (692.5 bits), Expect = 8.2e-202, P = 8.2e-202
Identities = 390/670 (58%), Positives = 483/670 (72%)
Query: 5 LYVLTLFLSVTYTLSSTSEVDILMHIKDSLDPENRLLTSWAPNADPCSSDSFDGVACDEN 64
L +L L S T E+ LM +K LDPE++ L SW+ N D C F+GV CD
Sbjct: 13 LPLLFLHFSNQVMAEITDELATLMEVKTELDPEDKHLASWSVNGDLCKD--FEGVGCDWK 70
Query: 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNN 124
GRV+NISLQGKGLSG+I +G LK LTGL+LH+NAL G IP+E+ +LSEL+DLYLNVNN
Sbjct: 71 GRVSNISLQGKGLSGKISPNIGKLKHLTGLFLHYNALVGDIPRELGNLSELTDLYLNVNN 130
Query: 125 LSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPAXXXXX 184
LSG+IPS IG M LQVLQLCYN LTG+IP +L SLRKLSVLALQ N+LTGAIPA
Sbjct: 131 LSGEIPSNIGKMQGLQVLQLCYNNLTGSIPRELSSLRKLSVLALQSNKLTGAIPASLGDL 190
Query: 185 XXXXXXXXXFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAAL 244
+N+LFG VP KLA+ P L VLDIRNNS +GNVPP LKRLN GF ++NN L
Sbjct: 191 SALERLDLSYNHLFGSVPGKLASPPLLRVLDIRNNSLTGNVPPVLKRLNEGFSFENNLGL 250
Query: 245 CGTGFTNLKNCTASDHPTPGKPEPFEPN--GLSTKDIPESAKLPANCGQPGCSSPARRPH 302
CG F+ LK+C + P +P+P+ G ++DIPESA L + C C++P +
Sbjct: 251 CGAEFSPLKSCNGT---APEEPKPYGATVFGFPSRDIPESANLRSPCNGTNCNTPPKSHQ 307
Query: 303 TXXXXXXXXXXXXLTVTGLFTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVCRRNS-SPL 361
L+ + FT YRRRKQK+ ++ SD+RL+T V R+N+ SPL
Sbjct: 308 GAILIGLVVSTIALSAISILLFTHYRRRKQKLSTTYEMSDNRLNT--VGGGFRKNNGSPL 365
Query: 362 ISLEYSNGWDPLAKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKG 421
SLEY+NGWDPL+ ++ + F+QEV++SF FNLEEVE ATQ FSE NLLG+S+FSATYKG
Sbjct: 366 ASLEYTNGWDPLSDNRNLSVFAQEVIQSFRFNLEEVETATQYFSEVNLLGRSNFSATYKG 425
Query: 422 ILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481
ILRDGS VA+K +KTSCKS+E EFLKGL +L SLKHENL+ LRG CCS+GRGECFLIYD
Sbjct: 426 ILRDGSAVAIKRFSKTSCKSEEPEFLKGLNMLASLKHENLSKLRGFCCSRGRGECFLIYD 485
Query: 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLH---GKRPGLVHPNLSAEKV 538
F PNGNLL +LDL+ G VL+W+TR+S+ KGIAKGI+YLH G +P LVH N+SAEKV
Sbjct: 486 FAPNGNLLSYLDLKDGDAHVLDWSTRVSIAKGIAKGIAYLHSYKGSKPALVHQNISAEKV 545
Query: 539 LIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIV 598
LI +RY+PLLS+SGLH LL +DIVFS LK SAAMGYLAPEYTTTGRFTEK+D+YAFG++V
Sbjct: 546 LIDQRYSPLLSNSGLHTLLTNDIVFSALKDSAAMGYLAPEYTTTGRFTEKTDVYAFGILV 605
Query: 599 FQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPS 658
FQI+SGK + + E+ + D+IDPNL+G+F EA+ L +IA CTHESP RPS
Sbjct: 606 FQIISGKQKVRHLVKLGTEACRFNDYIDPNLQGRFFEYEATKLARIAWLCTHESPIERPS 665
Query: 659 IENVMQELSS 668
+E V+ EL +
Sbjct: 666 VEAVVHELGN 675
|
|
| TAIR|locus:2132634 AT4G22730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1772 (628.8 bits), Expect = 1.2e-182, P = 1.2e-182
Identities = 352/679 (51%), Positives = 467/679 (68%)
Query: 5 LYVLTLFLSVTYTLSSTSEVDILMHIKDSLDPENRLLTSWAPNADPCSSDSFDGVACDEN 64
L +L++FL+ + +E+ LM +K SLDPEN+LL SW N DPC SF+G+AC+++
Sbjct: 9 LILLSIFLATPSNVRGNAELKALMELKSSLDPENKLLRSWTFNGDPCDG-SFEGIACNQH 67
Query: 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNN 124
+VANISLQGK L G++ AV LK L+GLYLH+N+L+G IP+EI +L+ELSDLYLNVNN
Sbjct: 68 LKVANISLQGKRLVGKLSPAVAELKCLSGLYLHYNSLSGEIPQEITNLTELSDLYLNVNN 127
Query: 125 LSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPAXXXXX 184
SG+IP+ IG+M LQV+ LC N LTG IP +GSL+KL+VL+LQ+N+LTG +P
Sbjct: 128 FSGEIPADIGSMAGLQVMDLCCNSLTGKIPKNIGSLKKLNVLSLQHNKLTGEVPWTLGNL 187
Query: 185 XXXXXXXXXFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAAL 244
FNNL G +P LAN+P+L+ LD+RNN+ SG VPP LK+LNG FQ++NN L
Sbjct: 188 SMLSRLDLSFNNLLGLIPKTLANIPQLDTLDLRNNTLSGFVPPGLKKLNGSFQFENNTGL 247
Query: 245 CGTGFTNLKNCTASDHPTPGKPEPFEPNGLSTK-----DIPESAKLPANCGQPGCS-SPA 298
CG F +L+ C+A D+ + P + T +IPES L +C Q C S +
Sbjct: 248 CGIDFPSLRACSAFDNANNIEQFKQPPGEIDTDKSALHNIPESVYLQKHCNQTHCKKSSS 307
Query: 299 RRPHTXXXXXXXXXXXXLTVTGLFTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVCRRNS 358
+ P L G+ TF YRRRKQKI N + S+ RLSTDQ KE +
Sbjct: 308 KLPQVALISSVITVTITLIGAGILTFFRYRRRKQKISNTPEFSEGRLSTDQQKEF---RA 364
Query: 359 SPLISLEYSNGWDPLAKGQSGNGFSQE-----VLESFMFNLEEVERATQCFSEANLLGKS 413
SPL+SL Y+ WDPL ++G FSQE V SF FNLE++E ATQCFSEANLL ++
Sbjct: 365 SPLVSLAYTKEWDPLGDSRNGAEFSQEPHLFVVNSSFRFNLEDIESATQCFSEANLLSRN 424
Query: 414 SFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGR 473
SF++ +KG+LRDGS VA++ I +SCK++E EF+ GLK+L+SL HENL LRG CCS+GR
Sbjct: 425 SFTSVFKGVLRDGSPVAIRSINISSCKNEEVEFMNGLKLLSSLSHENLVKLRGFCCSRGR 484
Query: 474 GECFLIYDFVPNGNLLQHLDL-EAGSEKVLEWATRISVIKGIAKGISYLHG----KRPGL 528
GECFLIYDF G L LDL E + VL W+ RIS+IKGIAKGI+YLHG K+P +
Sbjct: 485 GECFLIYDFASKGKLSNFLDLQERETNLVLAWSARISIIKGIAKGIAYLHGSDQQKKPTI 544
Query: 529 VHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEK 588
VH N+S EK+L+ ++NPL++DSGLH LLADD+VFS LK SAAMGYLAPEY TTG+FTEK
Sbjct: 545 VHRNISVEKILLDEQFNPLIADSGLHNLLADDMVFSALKTSAAMGYLAPEYVTTGKFTEK 604
Query: 589 SDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHC 648
+DI+AFG+I+ QILSGK +T R AAE+ + FID +L +F EA+ + +I + C
Sbjct: 605 TDIFAFGVIILQILSGKLMLTSSLRNAAENGEHNGFIDEDLREEFDKPEATAMARIGISC 664
Query: 649 THESPSHRPSIENVMQELS 667
T E P++RP+IE +++ ++
Sbjct: 665 TQEIPNNRPNIETLLENIN 683
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 460 (167.0 bits), Expect = 1.8e-61, Sum P(2) = 1.8e-61
Identities = 101/305 (33%), Positives = 168/305 (55%)
Query: 374 AKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKC 433
+K Q F L F+L +++ AT F AN +G+ F YKG L DG+++AVK
Sbjct: 594 SKSQMEKDFKSLELMIASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQ 653
Query: 434 IAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLD 493
++ T K EFL + ++++L H NL L G CC +G G+ L+Y+FV N +L + L
Sbjct: 654 LS-TGSKQGNREFLNEIGMISALHHPNLVKLYG-CCVEG-GQLLLVYEFVENNSLARALF 710
Query: 494 LEAGSEKVLEWATRISVIKGIAKGISYLHGK-RPGLVHPNLSAEKVLIHRRYNPLLSDSG 552
++ L+W TR + G+A+G++YLH + R +VH ++ A VL+ ++ NP +SD G
Sbjct: 711 GPQETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFG 770
Query: 553 LHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCS----- 607
L KL +D + + GY+APEY G T+K+D+Y+FG++ +I+ G+ +
Sbjct: 771 LAKLDEEDSTHISTRIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERS 830
Query: 608 ------ITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIEN 661
+ + E + + + +DP L +++ EA + QIA+ CT P RPS+
Sbjct: 831 KNNTFYLIDWVEVLREKNNLLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSE 890
Query: 662 VMQEL 666
V++ L
Sbjct: 891 VVKML 895
|
|
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 445 (161.7 bits), Expect = 1.5e-59, Sum P(2) = 1.5e-59
Identities = 104/299 (34%), Positives = 169/299 (56%)
Query: 387 LESFMFNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEF 446
L++ F L++++RAT F N +G+ F YKG+L DG +AVK ++ S K EF
Sbjct: 650 LQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKS-KQGNREF 708
Query: 447 LKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKV---LE 503
+ + ++++L+H NL L G CC +G+ E L+Y+++ N +L + L G+EK L+
Sbjct: 709 VTEIGMISALQHPNLVKLYG-CCIEGK-ELLLVYEYLENNSLARAL---FGTEKQRLHLD 763
Query: 504 WATRISVIKGIAKGISYLHGK-RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV 562
W+TR V GIAKG++YLH + R +VH ++ A VL+ N +SD GL KL ++
Sbjct: 764 WSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENT 823
Query: 563 FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCS-----------ITPF 611
+ + +GY+APEY G T+K+D+Y+FG++ +I+SGK + + +
Sbjct: 824 HISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDW 883
Query: 612 TRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
E + + +DP+L FS EA + IAL CT+ SP+ RP + +V+ L I
Sbjct: 884 AYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLQGKI 942
|
|
| TAIR|locus:2181017 AT5G01950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 398 (145.2 bits), Expect = 1.6e-59, Sum P(2) = 1.6e-59
Identities = 98/297 (32%), Positives = 165/297 (55%)
Query: 392 FNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLK 451
F+ +E+ AT FS + L+G+ + Y+G+L D +V A+K + S + ++ EFL ++
Sbjct: 614 FSFKELAEATDDFSSSTLVGRGGYGKVYRGVLSDNTVAAIKRADEGSLQGEK-EFLNEIE 672
Query: 452 ILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVI 511
+L+ L H NL SL G C + E L+Y+F+ NG L L + G E L + RI V
Sbjct: 673 LLSRLHHRNLVSLIGYCDEES--EQMLVYEFMSNGTLRDWLSAK-GKES-LSFGMRIRVA 728
Query: 512 KGIAKGISYLHGK-RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL---LAD--DI---V 562
G AKGI YLH + P + H ++ A +L+ +N ++D GL +L L D D+ V
Sbjct: 729 LGAAKGILYLHTEANPPVFHRDIKASNILLDPNFNAKVADFGLSRLAPVLEDEEDVPKHV 788
Query: 563 FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITP---FTRQ---AA 616
++++ + GYL PEY T + T+KSD+Y+ G++ ++L+G +I+ R+ A
Sbjct: 789 STVVRGTP--GYLDPEYFLTHKLTDKSDVYSIGVVFLELLTGMHAISHGKNIVREVKTAE 846
Query: 617 ESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
+ + ID +E +S+ +AL C+H+SP RP + V++EL S++ +S
Sbjct: 847 QRDMMVSLIDKRME-PWSMESVEKFAALALRCSHDSPEMRPGMAEVVKELESLLQAS 902
|
|
| TAIR|locus:2206179 FEI1 "FEI 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 417 (151.9 bits), Expect = 1.6e-59, Sum P(2) = 1.6e-59
Identities = 103/309 (33%), Positives = 164/309 (53%)
Query: 373 LAKGQSGNGFSQEVLESFM-FNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAV 431
LAK G G S + + ++ +++ + + +E +++G F YK + DG V A+
Sbjct: 275 LAK-DVGGGASIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGGFGTVYKLAMDDGKVFAL 333
Query: 432 KCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQH 491
K I K + D F + L+IL S+KH L +LRG C S L+YD++P G+L +
Sbjct: 334 KRILKLNEGFDRF-FERELEILGSIKHRYLVNLRGYCNSPTSK--LLLYDYLPGGSLDEA 390
Query: 492 LDLEAGSEKVLEWATRISVIKGIAKGISYLHGK-RPGLVHPNLSAEKVLIHRRYNPLLSD 550
L +E G + L+W +R+++I G AKG+SYLH P ++H ++ + +L+ +SD
Sbjct: 391 LHVERGEQ--LDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNILLDGNLEARVSD 448
Query: 551 SGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGK----- 605
GL KLL D+ + GYLAPEY +GR TEK+D+Y+FG++V ++LSGK
Sbjct: 449 FGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDA 508
Query: 606 ------CSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSI 659
++ + + + D +DPN EG + L IA C SP RP++
Sbjct: 509 SFIEKGLNVVGWLKFLISEKRPRDIVDPNCEG-MQMESLDALLSIATQCVSPSPEERPTM 567
Query: 660 ENVMQELSS 668
V+Q L S
Sbjct: 568 HRVVQLLES 576
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 411 (149.7 bits), Expect = 1.2e-58, Sum P(2) = 1.2e-58
Identities = 92/291 (31%), Positives = 160/291 (54%)
Query: 392 FNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLK 451
+ +E+ AT F+ N+LG+ + YKG L DG++VAVK + + E +F ++
Sbjct: 289 YTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVE 348
Query: 452 ILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVI 511
++ H NL LRG C S E L+Y ++PNG++ L E L+W+ R +
Sbjct: 349 TISLALHRNLLRLRGFCSSNQ--ERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIA 406
Query: 512 KGIAKGISYLHGK-RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL--ADDIVFSMLKA 568
G A+G+ YLH + P ++H ++ A +L+ + ++ D GL KLL D V + ++
Sbjct: 407 VGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG 466
Query: 569 SAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESS--------- 619
+ +G++APEY +TG+ +EK+D++ FG+++ ++++G+ ++ F R A +
Sbjct: 467 T--VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALD-FGRSAHQKGVMLDWVKKL 523
Query: 620 ----KVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQEL 666
K++ ID +L KF E + Q+AL CT +PSHRP + VM+ L
Sbjct: 524 HQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKML 574
|
|
| TAIR|locus:2171973 AT5G45780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 392 (143.0 bits), Expect = 3.1e-58, Sum P(2) = 3.1e-58
Identities = 89/294 (30%), Positives = 160/294 (54%)
Query: 392 FNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLK 451
F+ E++ AT FS N+LG+ F YKG L +G+VVAVK + K + E +F ++
Sbjct: 288 FSFREIQTATSNFSPKNILGQGGFGMVYKGYLPNGTVVAVKRL-KDPIYTGEVQFQTEVE 346
Query: 452 ILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVI 511
++ H NL L G C + E L+Y ++PNG++ L G + L+W RIS+
Sbjct: 347 MIGLAVHRNLLRLFGFCMTPE--ERMLVYPYMPNGSVADRLRDNYGEKPSLDWNRRISIA 404
Query: 512 KGIAKGISYLHGK-RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL--ADDIVFSMLKA 568
G A+G+ YLH + P ++H ++ A +L+ + ++ D GL KLL D V + ++
Sbjct: 405 LGAARGLVYLHEQCNPKIIHRDVKAANILLDESFEAIVGDFGLAKLLDQRDSHVTTAVRG 464
Query: 569 SAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSG------------KCSITPFTRQAA 616
+ +G++APEY +TG+ +EK+D++ FG+++ ++++G K I + R
Sbjct: 465 T--IGHIAPEYLSTGQSSEKTDVFGFGVLILELITGHKMIDQGNGQVRKGMILSWVRTLK 522
Query: 617 ESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+ + +D +L+G+F + ++AL CT P+ RP + V++ L ++
Sbjct: 523 AEKRFAEMVDRDLKGEFDDLVLEEVVELALLCTQPHPNLRPRMSQVLKVLEGLV 576
|
|
| TAIR|locus:2033379 AT1G66830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 511 (184.9 bits), Expect = 6.1e-58, Sum P(2) = 6.1e-58
Identities = 170/630 (26%), Positives = 290/630 (46%)
Query: 6 YVLTLFLSVTYTLSSTSEVDILMHIKDSLDPEN-RLLTSW-APNADPCSSDSFDGVACDE 63
++LT F ++ +L+ L+ K S+ ++ + T+W + +++PCS + GV C+
Sbjct: 10 FILTHFFAIATSLNDQGLA--LLSFKQSIQNQSDSVFTNWNSSDSNPCS---WQGVTCNY 64
Query: 64 NGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVN 123
+ RV +I L K LSG + ++G L SL + L N G +P E+ L L L L+ N
Sbjct: 65 DMRVVSIRLPNKRLSGSLDPSIGSLLSLRHINLRDNDFQGKLPVELFGLKGLQSLVLSGN 124
Query: 124 NLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPAXXXX 183
+ SG +P +IG++ +L L L N G+I L +KL L L N +G +P
Sbjct: 125 SFSGFVPEEIGSLKSLMTLDLSENSFNGSISLSLIPCKKLKTLVLSKNSFSGDLPTGLGS 184
Query: 184 XXXXXXXXX-XFNNLFGPVPVKLANVPKLE-VLDIRNNSFSGNVPPALKRLNGGFQYD-- 239
FN L G +P + ++ L+ LD+ +N FSG +P +L L D
Sbjct: 185 NLVHLRTLNLSFNRLTGTIPEDVGSLENLKGTLDLSHNFFSGMIPTSLGNLPELLYVDLS 244
Query: 240 -NNAALCGTGFTNLKNCTASDHPTPGKPEPFEPNGLSTKDIPESAKLPANCGQPGCSSPA 298
NN + F L N P + PF GL K I S + N
Sbjct: 245 YNNLSGPIPKFNVLLNAG----PNAFQGNPFLC-GLPIK-ISCSTR---NTQVVPSQLYT 295
Query: 299 RRPHTXXXXXXXXXXXXLTVTGLF----TFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVC 354
RR + TV G+ F +Y R+ +A N D T + E
Sbjct: 296 RRANHHSRLCIILTATGGTVAGIIFLASLFIYYLRK----ASARANKDQNNRTCHINEKL 351
Query: 355 RRNSSP-LISLEYSNGWDPLAKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKS 413
++ + P + + N + F+L+++ +A+ A LLGKS
Sbjct: 352 KKTTKPEFLCFKTGNSESETLDENKNQQVFMPMDPEIEFDLDQLLKAS-----AFLLGKS 406
Query: 414 SFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGR 473
YK +L +G ++AV+ + + EFL ++ + +KH N+ +L+ C S
Sbjct: 407 RIGLVYKVVLENGLMLAVRRLEDKGWLRLK-EFLADVEAMAKIKHPNVLNLKACCWSPE- 464
Query: 474 GECFLIYDFVPNGNLLQHLDLEAGSE--KVLEWATRISVIKGIAKGISYLHGKRPG-LVH 530
E LIYD++PNG+L + GS K L W R+ +++GIAKG++Y+H P VH
Sbjct: 465 -EKLLIYDYIPNGDLGSAIQGRPGSVSCKQLTWTVRLKILRGIAKGLTYIHEFSPKRYVH 523
Query: 531 PNLSAEKVLIHRRYNPLLSDSGLHKLL--ADDI----VFSMLKASAAMG----YLAPEYT 580
+++ +L+ P +S GL +++ + DI + M +S + Y APE
Sbjct: 524 GHINTSNILLGPNLEPKVSGFGLGRIVDTSSDIRSDQISPMETSSPILSRESYYQAPEAA 583
Query: 581 TT-GRFTEKSDIYAFGMIVFQILSGKCSIT 609
+ + ++K D+Y+FG+++ ++++GK ++
Sbjct: 584 SKMTKPSQKWDVYSFGLVILEMVTGKSPVS 613
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_Genewise1_v1.C_LG_XIV0762 | hypothetical protein (645 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 673 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-46 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-32 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-32 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-32 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-30 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-27 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-26 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-25 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-19 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-18 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-16 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-13 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-12 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-12 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-12 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-11 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-11 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-11 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-11 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-10 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-10 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-09 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-09 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-08 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-08 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-07 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-07 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-07 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-07 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-07 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-06 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-05 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-04 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-04 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-04 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-04 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-04 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.001 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.001 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 0.001 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 0.001 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 0.001 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 0.001 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 0.001 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 0.002 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 0.002 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 0.002 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.002 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 0.002 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 0.002 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.003 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.003 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.003 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 0.003 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 0.003 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.004 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.004 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 1e-46
Identities = 172/618 (27%), Positives = 263/618 (42%), Gaps = 123/618 (19%)
Query: 77 LSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNM 136
L G I + + SL L L N G +P S L +L L+ N SG +P ++G++
Sbjct: 440 LQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSL 498
Query: 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNN 196
+ L L+L NKL+G IP +L S +KL L L +NQL+G IPAS ++ +L +LDLS N
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558
Query: 197 LFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAALCGTGFTNLKNCT 256
L G +P L NV L ++I +N G++P G F N +A+ G N+ C
Sbjct: 559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPST-----GAFLAINASAVAG----NIDLCG 609
Query: 257 ASDHPTPGKPEPFEPNGLSTKDIPESAKLPANCGQPGCSSPARRPHTGVFVG-VIAVFII 315
G P C + P ++ + F++
Sbjct: 610 GD----------------------------TTSGLPPCKRVRKTPSWWFYITCTLGAFLV 641
Query: 316 LTVTGLFTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVCRRNSSPLISLEYSNG-WDPLA 374
L + F F + R R N+ L +E +G W+
Sbjct: 642 LALVA-FGFVFIRGR--------------------------NNLELKRVENEDGTWELQF 674
Query: 375 KGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCI 434
F +V +S + E N++ + A+YKG + + +
Sbjct: 675 -------FDSKVSKSIT-----INDILSSLKEENVISRGKKGASYKGKSIKNGM---QFV 719
Query: 435 AKTSCKSD---EGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQH 491
K + E + L+H N+ L G+C S+ +LI++++ NL +
Sbjct: 720 VKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCRSEK--GAYLIHEYIEGKNLSEV 773
Query: 492 LDLEAGSEKVLEWATRISVIKGIAKGISYLHGK-RPGLVHPNLSAEKVLIHRRYNPLLSD 550
L + L W R + GIAK + +LH + P +V NLS EK++I + P L
Sbjct: 774 L-------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR- 825
Query: 551 SGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKC---- 606
L LL D +SA Y+APE T TEKSDIY FG+I+ ++L+GK
Sbjct: 826 LSLPGLLCTD--TKCFISSA---YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880
Query: 607 ------SITPFTRQAAESSKVEDFIDPNLEGKFSVS-----EASNLGQIALHCTHESPSH 655
SI + R ++ +IDP++ G SV+ E NL ALHCT P+
Sbjct: 881 EFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNL---ALHCTATDPTA 937
Query: 656 RPSIENVMQELSSIIGSS 673
RP +V++ L S SS
Sbjct: 938 RPCANDVLKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 3e-35
Identities = 86/267 (32%), Positives = 130/267 (48%), Gaps = 50/267 (18%)
Query: 10 LFLSVTYTLSSTSEVDILMHIKDSLDPENRLLTSWAPNADPCSSDSFDGVACDENGRVAN 69
FL + +++ E+++L+ K S++ + L++W +AD C + G+ C+ + RV +
Sbjct: 17 FFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSSADVCL---WQGITCNNSSRVVS 73
Query: 70 ISLQGKG------------------------LSGEIPAAV-------------------- 85
I L GK LSG IP +
Sbjct: 74 IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGS 133
Query: 86 ---GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVL 142
G + +L L L N L+G IP +I S S L L L N L GKIP+ + N+T+L+ L
Sbjct: 134 IPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFL 193
Query: 143 QLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVP 202
L N+L G IP +LG ++ L + L YN L+G IP +G L L LDL +NNL GP+P
Sbjct: 194 TLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253
Query: 203 VKLANVPKLEVLDIRNNSFSGNVPPAL 229
L N+ L+ L + N SG +PP++
Sbjct: 254 SSLGNLKNLQYLFLYQNKLSGPIPPSI 280
|
Length = 968 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 70/266 (26%), Positives = 130/266 (48%), Gaps = 23/266 (8%)
Query: 410 LGKSSFSATYKGILRDGSV-----VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASL 464
LG+ +F YKG L+ VAVK + + + + EFL+ +I+ L H N+ L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK 524
G+C + ++ +++P G+LL + L K L + +S IA+G+ YL K
Sbjct: 67 LGVCTEEEPL--MIVMEYMPGGDLLDY--LRKNRPKELSLSDLLSFALQIARGMEYLESK 122
Query: 525 RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGR 584
+H +L+A L+ +SD GL + L DD + + + ++APE G+
Sbjct: 123 N--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 585 FTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS---N 640
FT KSD+++FG+++++I + G+ P+ + +V +++ +G +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGE---EPYPGMSNA--EVLEYLK---KGYRLPKPPNCPPE 232
Query: 641 LGQIALHCTHESPSHRPSIENVMQEL 666
L ++ L C E P RP+ +++ L
Sbjct: 233 LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 4e-32
Identities = 74/164 (45%), Positives = 101/164 (61%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
++L L G+IP +G +KSL +YL +N L+G IP EI L+ L+ L L NNL+G I
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252
Query: 130 PSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMR 189
PS +GN+ NLQ L L NKL+G IP + SL+KL L L N L+G IP + L L
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEI 312
Query: 190 LDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233
L L NN G +PV L ++P+L+VL + +N FSG +P L + N
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN 356
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 4e-32
Identities = 72/163 (44%), Positives = 101/163 (61%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
+ L G L G+IP ++ L SL L L N L G IP+E+ + L +YL NNLSG+I
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228
Query: 130 PSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMR 189
P +IG +T+L L L YN LTG IP+ LG+L+ L L L N+L+G IP S+ L L+
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLIS 288
Query: 190 LDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232
LDLS N+L G +P + + LE+L + +N+F+G +P AL L
Sbjct: 289 LDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
|
Length = 968 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 4e-32
Identities = 71/277 (25%), Positives = 129/277 (46%), Gaps = 34/277 (12%)
Query: 408 NLLGKSSFSATYKGILRDGS----VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463
LG+ +F YKG L+ VAVK + + + + + +FLK +++ L H N+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHL-----DLEAGSEKVLEWATRISVIKGIAKGI 518
L G+C + +L+ +++ G+LL +L + + L +S IAKG+
Sbjct: 61 LLGVCTEE--EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 519 SYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAM--GYLA 576
YL K+ VH +L+A L+ +SD GL + + DD + K + ++A
Sbjct: 119 EYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRK-KTGGKLPIRWMA 175
Query: 577 PEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPF-TRQAAESSKVEDFIDPNLEGKF- 633
PE G FT KSD+++FG+++++I + G TP+ E V +++ +G
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGA---TPYPGLSNEE---VLEYL---RKGYRL 226
Query: 634 ----SVSEASNLGQIALHCTHESPSHRPSIENVMQEL 666
+ L ++ L C P RP+ +++ L
Sbjct: 227 PKPEYCPDE--LYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 9e-32
Identities = 68/269 (25%), Positives = 126/269 (46%), Gaps = 30/269 (11%)
Query: 410 LGKSSFSATYKGILRDGSV-----VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASL 464
LG+ +F YKG L+ VAVK + + + + EFL+ +I+ L H N+ L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK 524
G+C + +++ +++ G+LL +L + L + +S IA+G+ YL K
Sbjct: 67 LGVCTEEEPL--YIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 525 RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTT 581
+H +L+A L+ +SD GL + L DD + ++APE
Sbjct: 122 N--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD---DYYRKRGGKLPIRWMAPESLK 176
Query: 582 TGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS- 639
G+FT KSD+++FG+++++I + G+ P+ + +V +++ G +
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGE---QPY--PGMSNEEVLEYLK---NGYRLPQPPNC 228
Query: 640 --NLGQIALHCTHESPSHRPSIENVMQEL 666
L + L C E P RP+ +++ L
Sbjct: 229 PPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 55/195 (28%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 410 LGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGIC 468
LG+ F Y + G VA+K I K S E L+ ++IL L H N+ L G+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGL 528
+ +L+ ++ G+L L E L + ++ I +G+ YLH G+
Sbjct: 61 --EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN--GI 113
Query: 529 VHPNLSAEKVLIHRR-YNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPE-YTTTGRFT 586
+H +L E +L+ L+D GL KLL + Y+APE G ++
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLL-TSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 587 EKSDIYAFGMIVFQI 601
EKSDI++ G+I++++
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-29
Identities = 69/156 (44%), Positives = 94/156 (60%)
Query: 77 LSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNM 136
LSGEIP +G SL L L N L G IP + +L+ L L L N L G+IP ++G M
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQM 211
Query: 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNN 196
+L+ + L YN L+G IP ++G L L+ L L YN LTG IP+SLG+L L L L N
Sbjct: 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNK 271
Query: 197 LFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232
L GP+P + ++ KL LD+ +NS SG +P + +L
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQL 307
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-29
Identities = 67/153 (43%), Positives = 93/153 (60%)
Query: 77 LSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNM 136
L+G IP+++G LK+L L+L+ N L+G IP I SL +L L L+ N+LSG+IP + +
Sbjct: 248 LTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQL 307
Query: 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNN 196
NL++L L N TG IP L SL +L VL L N+ +G IP +LG L LDLS NN
Sbjct: 308 QNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNN 367
Query: 197 LFGPVPVKLANVPKLEVLDIRNNSFSGNVPPAL 229
L G +P L + L L + +NS G +P +L
Sbjct: 368 LTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-27
Identities = 65/156 (41%), Positives = 88/156 (56%)
Query: 77 LSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNM 136
LSG IP ++ L+ L L L N+L+G IP+ + L L L+L NN +GKIP + ++
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
Query: 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNN 196
LQVLQL NK +G IP LG L+VL L N LTG IP L G L +L L N+
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNS 391
Query: 197 LFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232
L G +P L L + +++NSFSG +P +L
Sbjct: 392 LEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKL 427
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 66/265 (24%), Positives = 113/265 (42%), Gaps = 25/265 (9%)
Query: 410 LGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKG-LKILTSLKHENLASLRGI 467
LG SF YK + G +VAVK + K S KS + + + ++IL L H N+ L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG 527
K +L+ ++ G+L +L L + I +G+ YLH G
Sbjct: 67 FEDKDH--LYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSN--G 118
Query: 528 LVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI-VFSMLKASAAMGYLAPEYTTTGR-F 585
++H +L E +L+ ++D GL K L + + Y+APE G +
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTP--WYMAPEVLLGGNGY 176
Query: 586 TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE------AS 639
K D+++ G+I++++L+GK PF+ + I L E +
Sbjct: 177 GPKVDVWSLGVILYELLTGK---PPFSGENILDQLQ--LIRRILGPPLEFDEPKWSSGSE 231
Query: 640 NLGQIALHCTHESPSHRPSIENVMQ 664
+ C ++ PS RP+ E ++Q
Sbjct: 232 EAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 26/206 (12%)
Query: 410 LGKSSFSATYKGILR-DGS----VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASL 464
LG +F YKG+ +G VA+K + + + E L ++ S+ H ++ L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 465 RGICCSKGRGECFLIYDFVPNGNLL----QHLDLEAGSEKVLEWATRISVIKGIAKGISY 520
GIC S + LI +P G LL H D GS+ +L W +I AKG+SY
Sbjct: 75 LGICLSS---QVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQI------AKGMSY 124
Query: 521 LHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAM---GYLAP 577
L KR LVH +L+A VL+ + ++D GL KLL D+ A ++A
Sbjct: 125 LEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL--DVDEKEYHAEGGKVPIKWMAL 180
Query: 578 EYTTTGRFTEKSDIYAFGMIVFQILS 603
E +T KSD++++G+ V+++++
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 107 bits (271), Expect = 3e-26
Identities = 68/277 (24%), Positives = 124/277 (44%), Gaps = 45/277 (16%)
Query: 410 LGKSSFSATYKGILRDGS-----VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASL 464
LG+ +F YKG L+ VAVK + + + + + EFL+ I+ L H N+ L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK 524
G+C +++ +++P G+LL L + L + + IAKG+ YL K
Sbjct: 67 LGVC--TQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLESK 121
Query: 525 RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTT 581
VH +L+A L+ +SD GL + + +D K ++APE
Sbjct: 122 N--FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD--YYRKRGGGKLPIKWMAPESLK 177
Query: 582 TGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID-----------PNL 629
G+FT KSD+++FG+++++I + G+ P+ + +V + ++ P
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGE---QPY--PGMSNEEVLELLEDGYRLPRPENCP-- 230
Query: 630 EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQEL 666
L ++ L C P RP+ ++++L
Sbjct: 231 ---------DELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-25
Identities = 69/181 (38%), Positives = 91/181 (50%), Gaps = 3/181 (1%)
Query: 52 SSDSFDGVACDENGRVAN---ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKE 108
+S+ G E G++ + I L LSGEIP +GGL SL L L +N L G IP
Sbjct: 196 ASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSS 255
Query: 109 IASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLAL 168
+ +L L L+L N LSG IP I ++ L L L N L+G IP + L+ L +L L
Sbjct: 256 LGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHL 315
Query: 169 QYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPA 228
N TG IP +L L L L L N G +P L L VLD+ N+ +G +P
Sbjct: 316 FSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEG 375
Query: 229 L 229
L
Sbjct: 376 L 376
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 69/264 (26%), Positives = 113/264 (42%), Gaps = 25/264 (9%)
Query: 408 NLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRG 466
LG+ SF Y + G +VA+K I K K D L+ +KIL LKH N+ L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVL-EWATRISVIKGIAKGISYLHGKR 525
+ + + +L+ ++ G+L L L E R ++ I + YLH K
Sbjct: 65 VFEDE--DKLYLVMEYCEGGDLFDLLK----KRGRLSEDEAR-FYLRQILSALEYLHSK- 116
Query: 526 PGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRF 585
G+VH +L E +L+ + L+D GL + L + + Y+APE +
Sbjct: 117 -GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPE--YMAPEVLLGKGY 173
Query: 586 TEKSDIYAFGMIVFQILSGKCSITPF-----TRQAAESSKVEDFIDPNLEGKFSVSEASN 640
+ DI++ G+I++++L+GK PF + + P E S EA +
Sbjct: 174 GKAVDIWSLGVILYELLTGK---PPFPGDDQLLELFKKIGKPKPPFPPPEWDIS-PEAKD 229
Query: 641 LGQIALHCTHESPSHRPSIENVMQ 664
L I + P R + E +Q
Sbjct: 230 L--I-RKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-24
Identities = 64/166 (38%), Positives = 95/166 (57%), Gaps = 2/166 (1%)
Query: 61 CDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYL 120
C +G + + L L GEIP ++G +SL + L N+ +G +P E L + L +
Sbjct: 377 CS-SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDI 435
Query: 121 NVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPAS 180
+ NNL G+I S+ +M +LQ+L L NK G +P GS ++L L L NQ +GA+P
Sbjct: 436 SNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRK 494
Query: 181 LGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVP 226
LG L LM+L LS N L G +P +L++ KL LD+ +N SG +P
Sbjct: 495 LGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIP 540
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-24
Identities = 63/149 (42%), Positives = 77/149 (51%)
Query: 77 LSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNM 136
LSGEIP V L++L L+L N G IP + SL L L L N SG+IP +G
Sbjct: 296 LSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH 355
Query: 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNN 196
NL VL L N LTG IP L S L L L N L G IP SLG L R+ L N+
Sbjct: 356 NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNS 415
Query: 197 LFGPVPVKLANVPKLEVLDIRNNSFSGNV 225
G +P + +P + LDI NN+ G +
Sbjct: 416 FSGELPSEFTKLPLVYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 6e-23
Identities = 71/273 (26%), Positives = 136/273 (49%), Gaps = 14/273 (5%)
Query: 398 ERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK 457
ER + F+ LG F ++G+ ++ VA+K + K+ + +F K ++ L L+
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKIL-KSDDLLKQQDFQKEVQALKRLR 60
Query: 458 HENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKG 517
H++L SL +C S G ++I + + G+LL L G +VL A+ I + +A+G
Sbjct: 61 HKHLISLFAVC-SVGE-PVYIITELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEG 116
Query: 518 ISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAP 577
++YL + +H +L+A +L+ ++D GL +L+ +D V+ + AP
Sbjct: 117 MAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKED-VYLSSDKKIPYKWTAP 173
Query: 578 EYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636
E + G F+ KSD+++FG++++++ + G+ P+ + +V D I
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQV---PY--PGMNNHEVYDQITAGYRMPCPAK 228
Query: 637 EASNLGQIALHCTHESPSHRPSIENVMQELSSI 669
+ +I L C P RPS + + +EL +I
Sbjct: 229 CPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 70/281 (24%), Positives = 132/281 (46%), Gaps = 25/281 (8%)
Query: 396 EVERATQCFSEANLLGKSSFSATYKGIL-RDGSVVAVKCIAKTSCKSDEGEFLKGLKILT 454
E+ER + + LG + Y+G+ + VAVK + + + + +E FLK ++
Sbjct: 2 EMERTD--ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMK 57
Query: 455 SLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKV-----LEWATRIS 509
+KH NL L G+C + ++I +F+ GNLL +L E ++V L AT+I
Sbjct: 58 EIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQI- 113
Query: 510 VIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKAS 569
+ + YL K +H +L+A L+ + ++D GL +L+ D + A
Sbjct: 114 -----SSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 166
Query: 570 AAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNL 629
+ + APE +F+ KSD++AFG+++++I + S P + S+V + ++
Sbjct: 167 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP----GIDLSQVYELLEKGY 222
Query: 630 EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+ + ++ C +PS RPS + Q ++
Sbjct: 223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 63/265 (23%), Positives = 115/265 (43%), Gaps = 20/265 (7%)
Query: 409 LLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGIC 468
+GK +F YKG+L+ + VAVK T + +FL+ +IL H N+ L G+C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGL 528
K +++ + VP G+LL L + V + + A G+ YL K
Sbjct: 62 VQK--QPIYIVMELVPGGSLLTFLRKKKNRLTV---KKLLQMSLDAAAGMEYLESK--NC 114
Query: 529 VHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG-----YLAPEYTTTG 583
+H +L+A L+ +SD G+ + + S + + APE G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEG----GIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 584 RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQ 643
R+T +SD++++G+++++ S TP+ + + + + I+ + +
Sbjct: 171 RYTSESDVWSYGILLWETFSL--GDTPYPGMS--NQQTRERIESGYRMPAPQLCPEEIYR 226
Query: 644 IALHCTHESPSHRPSIENVMQELSS 668
+ L C P +RPS + EL
Sbjct: 227 LMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 2e-21
Identities = 55/150 (36%), Positives = 83/150 (55%)
Query: 77 LSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNM 136
+G+IP A+ L L L L N +G IPK + + L+ L L+ NNL+G+IP + +
Sbjct: 320 FTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS 379
Query: 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNN 196
NL L L N L G IP LG+ R L + LQ N +G +P+ L ++ LD+S NN
Sbjct: 380 GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNN 439
Query: 197 LFGPVPVKLANVPKLEVLDIRNNSFSGNVP 226
L G + + ++P L++L + N F G +P
Sbjct: 440 LQGRINSRKWDMPSLQMLSLARNKFFGGLP 469
|
Length = 968 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 72/261 (27%), Positives = 127/261 (48%), Gaps = 18/261 (6%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
LG F G R VA+K I + S DE F++ K++ L HE L L G+C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE--FIEEAKVMMKLSHEKLVQLYGVC- 68
Query: 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLV 529
+K R +++ +++ NG LL +L K + + + + K + +G++YL K+ +
Sbjct: 69 TKQR-PIYIVTEYMSNGCLLNYL---REHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FI 122
Query: 530 HPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKS 589
H +L+A L+ + +SD GL + + DD S + + + + PE +F+ KS
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 590 DIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHC 648
D++AFG++++++ S GK P+ R +S+ + + L + + I C
Sbjct: 183 DVWAFGVLMWEVYSLGK---MPYER--FNNSETVEKVSQGLRLYRPHLASEKVYAIMYSC 237
Query: 649 THESPSHRPSIENVMQELSSI 669
HE RP+ + Q LSSI
Sbjct: 238 WHEKAEERPTFQ---QLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 69/270 (25%), Positives = 124/270 (45%), Gaps = 31/270 (11%)
Query: 409 LLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSD-----EGEFLKGLKILTSLKHENLAS 463
LLGK +F +KG L+D + VAVK +CK D + +FL +IL H N+
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVK-----TCKEDLPQELKIKFLSEARILKQYDHPNIVK 56
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHG 523
L G+C R +++ + VP G+ L L + K + + ++ A G++YL
Sbjct: 57 LIGVCTQ--RQPIYIVMELVPGGDFLSFLRKKKDELK-TKQLVKFAL--DAAAGMAYLES 111
Query: 524 KRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG 583
K +H +L+A L+ +SD G+ + D I S + + APE G
Sbjct: 112 K--NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYG 169
Query: 584 RFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS--- 639
R++ +SD++++G+++++ S G C T Q A +E + +S
Sbjct: 170 RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE---------QVEKGYRMSCPQKCP 220
Query: 640 -NLGQIALHCTHESPSHRPSIENVMQELSS 668
++ ++ C P +RP + +EL++
Sbjct: 221 DDVYKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 62/257 (24%), Positives = 118/257 (45%), Gaps = 13/257 (5%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
LG F + G R VA+K I + + D+ F++ K++ L H NL L G+C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD--FIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLV 529
+ F++ +++ NG LL +L + L + + + + + YL + G +
Sbjct: 70 K--QRPIFIVTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEYL--ESNGFI 122
Query: 530 HPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKS 589
H +L+A L+ +SD GL + + DD S + + PE RF+ KS
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKS 182
Query: 590 DIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCT 649
D+++FG++++++ S P+ R + +S+V + + + + I C
Sbjct: 183 DVWSFGVLMWEVFS--EGKMPYERFS--NSEVVESVSAGYRLYRPKLAPTEVYTIMYSCW 238
Query: 650 HESPSHRPSIENVMQEL 666
HE P RP+ + ++ +L
Sbjct: 239 HEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 70/284 (24%), Positives = 128/284 (45%), Gaps = 32/284 (11%)
Query: 408 NLLGKSSFSATYKG---ILRD--GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLA 462
LG+ F L D G VAVK + + + +F + ++IL +L HEN+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 463 SLRGICCSKGRGECFLIYDFVPNGNL---LQHLDLEAGSEKVLEWATRISVIKGIAKGIS 519
+G+C G LI +++P+G+L LQ + +++L ++++ I KG+
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ------ICKGMD 123
Query: 520 YLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD---IVFSMLKASAAMGYLA 576
YL +R +H +L+A +L+ +SD GL K+L +D S Y A
Sbjct: 124 YLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-A 180
Query: 577 PEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITP---FTRQ---AAESSKVEDFIDPNL 629
PE T +F+ SD+++FG+ ++++ + G S +P F R A V ++
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240
Query: 630 EGKFSVSEASNLG----QIALHCTHESPSHRPSIENVMQELSSI 669
EG+ + + + C P RPS +++ + +
Sbjct: 241 EGE-RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 62/262 (23%), Positives = 119/262 (45%), Gaps = 19/262 (7%)
Query: 409 LLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGIC 468
+GK F G R G VAVKC+ S + FL ++T+L+H NL L G+
Sbjct: 13 TIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA--FLAEASVMTTLRHPNLVQLLGVV 69
Query: 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGL 528
+++ +++ G+L+ +L + V+ A ++ + +G+ YL K
Sbjct: 70 LQGN--PLYIVTEYMAKGSLVDYL--RSRGRAVITLAQQLGFALDVCEGMEYLEEKN--F 123
Query: 529 VHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEK 588
VH +L+A VL+ +SD GL A + + + APE +F+ K
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGL----AKEASQGQDSGKLPVKWTAPEALREKKFSTK 179
Query: 589 SDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALH 647
SD+++FG+++++I S G+ P+ R + V ++ + + ++
Sbjct: 180 SDVWSFGILLWEIYSFGR---VPYPRIPLK--DVVPHVEKGYRMEAPEGCPPEVYKVMKD 234
Query: 648 CTHESPSHRPSIENVMQELSSI 669
C P+ RP+ + + ++L+ I
Sbjct: 235 CWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 59/205 (28%), Positives = 109/205 (53%), Gaps = 19/205 (9%)
Query: 409 LLGKSSFSATYK---GILRD--GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463
LGK +F + L+D G VVAVK + ++ + +F + ++IL SL+H+N+
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR-DFEREIEILKSLQHDNIVK 69
Query: 464 LRGICCSKGRGECFLIYDFVPNGNL---LQHLDLEAGSEKVLEWATRISVIKGIAKGISY 520
+G+C S GR L+ +++P G+L LQ K+L +A++ I KG+ Y
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ------ICKGMEY 123
Query: 521 LHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLK--ASAAMGYLAPE 578
L KR VH +L+ +L+ + D GL K+L D + ++ + + + APE
Sbjct: 124 LGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181
Query: 579 YTTTGRFTEKSDIYAFGMIVFQILS 603
T +F+ SD+++FG++++++ +
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 65/261 (24%), Positives = 119/261 (45%), Gaps = 32/261 (12%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
LG F + G + VAVK + + FL+ +I+ L+H+ L L +C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVC- 70
Query: 470 SKGRGE-CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGL 528
E +++ +++ G+LL L G + L + + IA+G++YL +
Sbjct: 71 --SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP--QLVDMAAQIAEGMAYLESRN--Y 124
Query: 529 VHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEK 588
+H +L+A +L+ ++D GL +L+ DD + A + + APE GRFT K
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIK 184
Query: 589 SDIYAFGMIVFQILS-GKCSITPF----TRQAAESSKVEDFIDPNLEGKFSVSEASN--- 640
SD+++FG+++ +I++ G+ P+ R+ E +E + + N
Sbjct: 185 SDVWSFGILLTEIVTYGRV---PYPGMTNREVLE----------QVERGYRMPRPPNCPE 231
Query: 641 -LGQIALHCTHESPSHRPSIE 660
L + L C + P RP+ E
Sbjct: 232 ELYDLMLQCWDKDPEERPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 6e-19
Identities = 63/271 (23%), Positives = 125/271 (46%), Gaps = 39/271 (14%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
LG F + G R VA+K I + + ++ F++ K++ L H L L G+C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEED--FIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 470 SKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYLHGKRPG 527
+ +++ +F+ NG LL +L G S+ +L +S+ + + +G+ YL +R
Sbjct: 70 Q--QKPLYIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQDVCEGMEYL--ERNS 120
Query: 528 LVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTE 587
+H +L+A L+ +SD G+ + + DD S A + + PE +++
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 588 KSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQ--- 643
KSD+++FG++++++ + GK PF +++ N E +S L +
Sbjct: 181 KSDVWSFGVLMWEVFTEGK---MPFEKKS------------NYEVVEMISRGFRLYRPKL 225
Query: 644 -------IALHCTHESPSHRPSIENVMQELS 667
+ C HE P RP+ +++ ++
Sbjct: 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 408 NLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKG-LKILTSLKHENLASLR 465
LLG+ SF + Y + +D G ++AVK + + +E E L+ ++IL+SL+H N+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 466 GICCSKGRGECFLIYDFVPNGNLLQHLDLEAG-SEKVLEWATRISVIKGIAKGISYLHGK 524
G + + + ++V G+L L E V+ + I +G++YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI-----RKYTRQILEGLAYLHSN 120
Query: 525 RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTT 581
G+VH ++ +L+ L+D G K L D + G ++APE
Sbjct: 121 --GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR--GTPYWMAPEVIR 176
Query: 582 TGRFTEKSDIYAFGMIVFQILSGK 605
+ +DI++ G V ++ +GK
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 65/253 (25%), Positives = 121/253 (47%), Gaps = 16/253 (6%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
LG F ++G+ + + VAVK + + D +FL +I+ L+H L L +C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 470 SKGRGE-CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGL 528
E +++ + + G+LL++L AG + L+ I + +A G++YL +
Sbjct: 72 ---LEEPIYIVTELMKYGSLLEYLQGGAG--RALKLPQLIDMAAQVASGMAYLEAQN--Y 124
Query: 529 VHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEK 588
+H +L+A VL+ ++D GL +++ +DI + A + + APE RF+ K
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 589 SDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALH 647
SD+++FG+++ +I++ G+ T +++V +D L I L
Sbjct: 185 SDVWSFGILLTEIVTYGRMPYPGMT-----NAEVLQQVDQGYRMPCPPGCPKELYDIMLD 239
Query: 648 CTHESPSHRPSIE 660
C E P RP+ E
Sbjct: 240 CWKEDPDDRPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 7e-18
Identities = 62/265 (23%), Positives = 126/265 (47%), Gaps = 27/265 (10%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
+G F + G + VA+K I + S+E +F++ +++ L H L L G+C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEE-DFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLV 529
R L+++F+ +G L +L + G T + + + +G++YL + ++
Sbjct: 70 E--RSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYL--ESSNVI 122
Query: 530 HPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKS 589
H +L+A L+ +SD G+ + + DD S + + +PE + +++ KS
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 590 DIYAFGMIVFQILS-GKCSITPFTRQAAESSKVED------FIDPNLEGKFSVSEASNLG 642
D+++FG++++++ S GK TP+ + + S VE P L + ++
Sbjct: 183 DVWSFGVLMWEVFSEGK---TPYENR-SNSEVVETINAGFRLYKPRLASQ-------SVY 231
Query: 643 QIALHCTHESPSHRPSIENVMQELS 667
++ HC E P RPS ++ +L+
Sbjct: 232 ELMQHCWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 67/275 (24%), Positives = 119/275 (43%), Gaps = 35/275 (12%)
Query: 410 LGKSSFSATYKGILR--DGSV--VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLR 465
LG +F + KG+ G VAVK + + + + EFL+ ++ L H + L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 466 GICCSKGRGECF-LIYDFVPNGNLLQHL--DLEAGSEKVLEWATRISVIKGIAKGISYLH 522
G+C +GE L+ + P G LL++L E + E A + +A G++YL
Sbjct: 63 GVC----KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLE 112
Query: 523 GKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL-ADDIVFSMLKASAA----MGYLAP 577
K VH +L+A VL+ R+ +SD G+ + L A +A+ A + + AP
Sbjct: 113 SKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS---DYYRATTAGRWPLKWYAP 167
Query: 578 EYTTTGRFTEKSDIYAFGMIVFQILS--GKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635
E G+F+ KSD++++G+ +++ S K P+ + ++V ++
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAK----PY--GEMKGAEVIAMLESGERLPRPE 221
Query: 636 SEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+ I L C P RP+ +
Sbjct: 222 ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-18
Identities = 59/179 (32%), Positives = 83/179 (46%), Gaps = 28/179 (15%)
Query: 19 SSTSEVDILMHIKDSLDPENRLLTSWAPNADPCSSDS--FDGVACDENGRVANISLQGKG 76
+ EV L +K SL R W N DPC + G C + + G G
Sbjct: 369 TLLEEVSALQTLKSSLGLPLRF--GW--NGDPCVPQQHPWSGADCQFDSTKGKWFIDGLG 424
Query: 77 LSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNM 136
L + GL+ G IP +I+ L L + L+ N++ G IP +G++
Sbjct: 425 LDNQ------GLR-------------GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSI 465
Query: 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFN 195
T+L+VL L YN G+IP LG L L +L L N L+G +PA+LG G L+ SFN
Sbjct: 466 TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG--GRLLH-RASFN 521
|
Length = 623 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 68/264 (25%), Positives = 123/264 (46%), Gaps = 19/264 (7%)
Query: 410 LGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGIC 468
+G+ +F + G LR D + VAVK +T + +FL+ +IL H N+ L G+C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGL 528
K +++ + V G+ L L E KV E I +++ A G+ YL K
Sbjct: 63 TQKQ--PIYIVMELVQGGDFLTFLRTEGPRLKVKEL---IQMVENAAAGMEYLESKH--C 115
Query: 529 VHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSM--LKASAAMGYLAPEYTTTGRFT 586
+H +L+A L+ + +SD G+ + D + S +K + + APE GR++
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK-QIPVKWTAPEALNYGRYS 174
Query: 587 EKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE--ASNLGQI 644
+SD+++FG+++++ S P+ + + ++ + I+ + E + ++
Sbjct: 175 SESDVWSFGILLWEAFS--LGAVPYANLSNQQTR--EAIEQG--VRLPCPELCPDAVYRL 228
Query: 645 ALHCTHESPSHRPSIENVMQELSS 668
C P RPS V QEL S
Sbjct: 229 MERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 58/204 (28%), Positives = 107/204 (52%), Gaps = 20/204 (9%)
Query: 409 LLGKSSFSATYKGI-LRDGSVV----AVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463
+LG +F YKGI + +G V A+K + +T+ EF+ I+ S+ H +L
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEA---GSEKVLEWATRISVIKGIAKGISY 520
L G+C S L+ +P+G LL ++ GS+ +L W + IAKG+ Y
Sbjct: 74 LLGVCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMY 124
Query: 521 LHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL-ADDIVFSMLKASAAMGYLAPEY 579
L +R LVH +L+A VL+ + ++D GL +LL D+ ++ + ++A E
Sbjct: 125 LEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 580 TTTGRFTEKSDIYAFGMIVFQILS 603
+FT +SD++++G+ ++++++
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 61/275 (22%), Positives = 125/275 (45%), Gaps = 19/275 (6%)
Query: 403 CFSEANLLGKSSFSATYKGIL----RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKH 458
++ ++G F ++GIL R VA+K + + +FL I+ H
Sbjct: 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65
Query: 459 ENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGI 518
N+ L G+ +K + +I +++ NG L ++L G + + +++GIA G+
Sbjct: 66 HNIIRLEGVV-TKFK-PAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRGIAAGM 120
Query: 519 SYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD--IVFSMLKASAAMGYLA 576
YL VH +L+A +L++ +SD GL ++L DD ++ + + A
Sbjct: 121 KYLSDM--NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178
Query: 577 PEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635
PE +FT SD+++FG+++++++S G+ + + + F P +
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA-----PM 233
Query: 636 SEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
S + Q+ L C + + RP +++ L ++
Sbjct: 234 DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 17/181 (9%)
Query: 429 VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNL 488
VAVKC+ +FLK I+ SL HENL L G+ + ++ + P G+L
Sbjct: 26 VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTH---PLMMVTELAPLGSL 82
Query: 489 LQHLDLEAGSE----KVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY 544
L L +A + ++A + IA G+ YL KR +H +L+A +L+
Sbjct: 83 LDRLRKDALGHFLISTLCDYAVQ------IANGMRYLESKR--FIHRDLAARNILLASDD 134
Query: 545 NPLLSDSGLHKLL--ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQIL 602
+ D GL + L +D + APE T F+ SD++ FG+ ++++
Sbjct: 135 KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMF 194
Query: 603 S 603
+
Sbjct: 195 T 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 64/251 (25%), Positives = 118/251 (47%), Gaps = 13/251 (5%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
LG+ F + G + VA+K + K S E FL+ +++ L+HE L L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLV 529
+ +++ +++ G+LL L E G K L + + IA G++Y+ +R V
Sbjct: 72 EE---PIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYV--ERMNYV 124
Query: 530 HPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKS 589
H +L A +L+ ++D GL +L+ D+ + A + + APE GRFT KS
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 590 DIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCT 649
D+++FG+++ + L+ K + P+ + +V D ++ +L + C
Sbjct: 185 DVWSFGILLTE-LTTKGRV-PYPGMV--NREVLDQVERGYRMPCPPECPESLHDLMCQCW 240
Query: 650 HESPSHRPSIE 660
+ P RP+ E
Sbjct: 241 RKEPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 62/252 (24%), Positives = 118/252 (46%), Gaps = 14/252 (5%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
LG F + G + + VAVK + K S + FL+ ++ +L+H+ L L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVT 71
Query: 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLV 529
+ ++I +++ G+LL L + G + +L I IA+G++Y+ +R +
Sbjct: 72 KEE--PIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYI--ERKNYI 125
Query: 530 HPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKS 589
H +L A VL+ ++D GL +++ D+ + A + + APE G FT KS
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 590 DIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHC 648
D+++FG+++++I++ GK + S+ + P +E + L I C
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRME-----NCPDELYDIMKTC 240
Query: 649 THESPSHRPSIE 660
E RP+ +
Sbjct: 241 WKEKAEERPTFD 252
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 409 LLGKSSFSATYKGI-LRDGSV----VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463
LLG F +KGI + +G VA+K I S + E + + SL H +
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGS---EKVLEWATRISVIKGIAKGISY 520
L GIC L+ P G+LL H+ S +++L W +I AKG+ Y
Sbjct: 74 LLGICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYY 124
Query: 521 LHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL-ADDIVFSMLKASAAMGYLAPEY 579
L R +VH NL+A +L+ ++D G+ LL DD + + + ++A E
Sbjct: 125 LEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182
Query: 580 TTTGRFTEKSDIYAFGMIVFQILS 603
GR+T +SD++++G+ V++++S
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 79.8 bits (195), Expect = 7e-16
Identities = 66/277 (23%), Positives = 118/277 (42%), Gaps = 30/277 (10%)
Query: 409 LLGKSSFSATYKGILRDGSVVAVKCIAK--TSCKSDEGEFLKGLKILTSLKHENLASLRG 466
LG+ SF Y RD +VA+K +AK S + FL+ ++IL SL H ++
Sbjct: 7 KLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN-IVKL 63
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
+ G +L+ ++V G+L L G + L + + ++ I + YLH K
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKI-GRKGPLSESEALFILAQILSALEYLHSK-- 120
Query: 527 GLVHPNLSAEKVLIHRRYNPL-LSDSGLHKLLADDIVFSMLKASAA-----MGYLAPEY- 579
G++H ++ E +L+ R + L D GL KLL D S + A + GY+APE
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 580 --TTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE----------DFIDP 627
+ + SDI++ G+ ++++L+G PF + S+ + +
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGL---PPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 628 NLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664
L + + + P +R S + +
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-16
Identities = 62/214 (28%), Positives = 86/214 (40%), Gaps = 66/214 (30%)
Query: 120 LNVNN--LSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAI 177
L ++N L G IP+ I + +LQ + L N + GNIP LGS+ L VL L YN G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 178 PASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQ 237
P SLG L L L+L+ N+L G VP L + SF+
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRL------LHRASFN--------------- 521
Query: 238 YDNNAALCGTGFTNLKNCTASDHPTPGKPEPFEPNGLSTKDIPESAKLPANCGQPGCSSP 297
+ +NA LCG PG CG P S
Sbjct: 522 FTDNAGLCG---------------IPGLRA---------------------CG-PHLSVG 544
Query: 298 ARRPHTGVFVGVIAVFIILTVTGLFTFTWYRRRK 331
A+ G+ GV F+ L + + W++RR+
Sbjct: 545 AK---IGIAFGVSVAFLFLVICAMC---WWKRRQ 572
|
Length = 623 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 70/272 (25%), Positives = 124/272 (45%), Gaps = 43/272 (15%)
Query: 424 RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFV 483
G VAVK + S + + K ++IL +L HEN+ +GIC G LI +F+
Sbjct: 31 NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90
Query: 484 PNGNLLQHLDLEAGS---EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI 540
P+G+L ++L ++ L++A + I KG+ YL G R VH +L+A VL+
Sbjct: 91 PSGSLKEYLPRNKNKINLKQQLKYAVQ------ICKGMDYL-GSR-QYVHRDLAARNVLV 142
Query: 541 HRRYNPLLSDSGLHKLLADDIVFSMLK--ASAAMGYLAPEYTTTGRFTEKSDIYAFGMIV 598
+ + D GL K + D + +K + + + APE +F SD+++FG+ +
Sbjct: 143 ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTL 202
Query: 599 FQILSGKCSITPFTRQAAESSKVEDF---IDPNLEGKFSVSEASN--------------- 640
+++L T +ESS + F I P G+ +V+
Sbjct: 203 YELL---------TYCDSESSPMTLFLKMIGPT-HGQMTVTRLVRVLEEGKRLPRPPNCP 252
Query: 641 --LGQIALHCTHESPSHRPSIENVMQELSSII 670
+ Q+ C PS R + +N+++ +I+
Sbjct: 253 EEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 60/251 (23%), Positives = 115/251 (45%), Gaps = 13/251 (5%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
LG F + G + VAVK + K S E FL+ +I+ L+H+ L L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPES-FLEEAQIMKKLRHDKLVQLYAVV- 70
Query: 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLV 529
+++ +++ G+LL L + G + L+ + + +A G++Y+ +R +
Sbjct: 71 --SEEPIYIVTEYMSKGSLLDFL--KDGEGRALKLPNLVDMAAQVAAGMAYI--ERMNYI 124
Query: 530 HPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKS 589
H +L + +L+ ++D GL +L+ D+ + A + + APE GRFT KS
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 590 DIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCT 649
D+++FG+++ ++++ P +VE +S L ++ L C
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPIS----LHELMLQCW 240
Query: 650 HESPSHRPSIE 660
+ P RP+ E
Sbjct: 241 KKDPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 68/277 (24%), Positives = 125/277 (45%), Gaps = 27/277 (9%)
Query: 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGE----FLKGLKILTSLKHENLAS 463
++GK F Y G L D + C K+ + + E FLK I+ H N+ S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHG 523
L GIC G ++ ++ +G+L + E + V + I +AKG+ YL
Sbjct: 61 LLGICLPS-EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKGMEYLAS 116
Query: 524 KRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAA---MGYLAPEYT 580
K+ VH +L+A ++ + ++D GL + + D +S+ + A + ++A E
Sbjct: 117 KK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 581 TTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPN--LEGKFSVSE- 637
T +FT KSD+++FG+++++++ TR A V+ F L+G+ +
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELM---------TRGAPPYPDVDSFDITVYLLQGRRLLQPE 225
Query: 638 --ASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672
L ++ L C H P RP+ ++ + I +
Sbjct: 226 YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFST 262
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 63/265 (23%), Positives = 117/265 (44%), Gaps = 27/265 (10%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
+GK F G R G+ VAVKCI + FL ++T L+H NL L G+
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLV 529
+ +G +++ +++ G+L+ +L + VL + + + + YL V
Sbjct: 70 EE-KGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN--NFV 124
Query: 530 HPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKS 589
H +L+A VL+ +SD GL K + + + + APE +F+ KS
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 590 DIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN----LGQI 644
D+++FG+++++I S G+ P+ R + + P +E + + + +
Sbjct: 181 DVWSFGILLWEIYSFGR---VPYPRIPLKD------VVPRVEKGYKMDAPDGCPPVVYDV 231
Query: 645 ALHCTHESPSHRPSIENVMQELSSI 669
C H + RPS + ++L I
Sbjct: 232 MKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-15
Identities = 47/131 (35%), Positives = 71/131 (54%), Gaps = 2/131 (1%)
Query: 52 SSDSFDGVACDENG--RVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEI 109
+ + F G D G R+ N+ L SG +P +G L L L L N L+G IP E+
Sbjct: 460 ARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDEL 519
Query: 110 ASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQ 169
+S +L L L+ N LSG+IP+ M L L L N+L+G IP LG++ L + +
Sbjct: 520 SSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNIS 579
Query: 170 YNQLTGAIPAS 180
+N L G++P++
Sbjct: 580 HNHLHGSLPST 590
|
Length = 968 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 64/271 (23%), Positives = 125/271 (46%), Gaps = 24/271 (8%)
Query: 404 FSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENL 461
F N +GK SF +K + + D V A+K I + + + E + ++L L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 462 ASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYL 521
+R +G+ ++ ++ NG+L + L ++ G + R + I G+++L
Sbjct: 62 --IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QILLGLAHL 117
Query: 522 HGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPE 578
H K+ ++H ++ + + + N + D G+ KLL+D+ F A+ +G YL+PE
Sbjct: 118 HSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF----ANTIVGTPYYLSPE 171
Query: 579 YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF--TRQAAESSKVEDFIDPNLEGKFSVS 636
+ EKSD++A G+++++ +GK PF Q A K+ + P + +S
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK---HPFDANNQGALILKIIRGVFPPVSQMYS-- 226
Query: 637 EASNLGQIALHCTHESPSHRPSIENVMQELS 667
L Q+ C + RP +++ S
Sbjct: 227 --QQLAQLIDQCLTKDYRQRPDTFQLLRNPS 255
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 61/255 (23%), Positives = 115/255 (45%), Gaps = 21/255 (8%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
LG F + G + VA+K + + S + FL ++ L+H L L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA--FLAEANLMKQLQHPRLVRLYAVVT 71
Query: 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLV 529
+ ++I +++ NG+L+ L G + L I + IA+G++++ +R +
Sbjct: 72 ---QEPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFI--ERKNYI 124
Query: 530 HPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKS 589
H +L A +L+ ++D GL +L+ D+ + A + + APE G FT KS
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 590 DIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN----LGQIA 645
D+++FG+++ +I++ + R + I NLE + + N L ++
Sbjct: 185 DVWSFGILLTEIVT-------YGRIPYPGMTNPEVIQ-NLERGYRMPRPDNCPEELYELM 236
Query: 646 LHCTHESPSHRPSIE 660
C E P RP+ E
Sbjct: 237 RLCWKEKPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 67/274 (24%), Positives = 120/274 (43%), Gaps = 32/274 (11%)
Query: 409 LLGKSSFSATYKGI-LRDGS----VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463
+LG +F YKGI + DG VA+K + + + E L ++ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEA---GSEKVLEWATRISVIKGIAKGISY 520
L GIC + L+ +P G LL ++ GS+ +L W +I AKG+SY
Sbjct: 74 LLGICLTS---TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSY 124
Query: 521 LHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL-ADDIVFSMLKASAAMGYLAPEY 579
L R LVH +L+A VL+ + ++D GL +LL D+ + + ++A E
Sbjct: 125 LEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 580 TTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639
RFT +SD++++G+ V+++++ F + + + D LE + +
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT-------FGAKPYDGIPAREIPDL-LEKGERLPQPP 234
Query: 640 N----LGQIALHCTHESPSHRPSIENVMQELSSI 669
+ I + C RP ++ E S +
Sbjct: 235 ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 61/258 (23%), Positives = 119/258 (46%), Gaps = 15/258 (5%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
LG+ F + G + VA+K + K E FL+ +I+ L+H+ L L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLV 529
+ +++ +F+ G+LL L + G K L+ + + IA G++Y+ +R +
Sbjct: 72 EE---PIYIVTEFMGKGSLLDFL--KEGDGKYLKLPQLVDMAAQIADGMAYI--ERMNYI 124
Query: 530 HPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKS 589
H +L A +L+ ++D GL +L+ D+ + A + + APE GRFT KS
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 590 DIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHC 648
D+++FG+++ ++++ G+ + + P +G +L ++ C
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGC-----PESLHELMKLC 239
Query: 649 THESPSHRPSIENVMQEL 666
+ P RP+ E + L
Sbjct: 240 WKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 408 NLLGKSSFSATYKG----ILRDGS---VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHEN 460
N LG +F Y+G IL GS VAVK + K + ++ EFLK ++++ H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 461 LASLRGICCSKGRGECFLIYDFVPNGNLLQHL---DLEAGSEKVLEWATRISVIKGIAKG 517
+ L G+C ++I + + G+LL +L +E +L + + +AKG
Sbjct: 61 IVKLLGVCLLN--EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 518 ISYLHGKRPGLVHPNLSAEKVLI-----HRRYNPLLSDSGLHKLLADDIVFSMLKASAAM 572
YL +H +L+A L+ + D G LA DI S
Sbjct: 119 CVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFG----LARDIYKSDYYRKEGE 172
Query: 573 G-----YLAPEYTTTGRFTEKSDIYAFGMIVFQILS 603
G ++APE G+FT +SD+++FG+++++IL+
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 62/265 (23%), Positives = 119/265 (44%), Gaps = 37/265 (13%)
Query: 426 GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF-LIYDFVP 484
G +VAVK + + + + + K + IL +L HEN+ +G CCS+ G+ LI ++VP
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKG-CCSEQGGKGLQLIMEYVP 91
Query: 485 NGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY 544
G+L +L + L A + + I +G++YLH + +H +L+A VL+
Sbjct: 92 LGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDR 144
Query: 545 NPLLSDSGLHKLLADDIVFSMLK--ASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQIL 602
+ D GL K + + + ++ + + + A E +F+ SD+++FG+ ++++L
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
Query: 603 SGKC--SITPFTRQAAESSKVEDFIDPN------------LEGKFSVSEASNLGQ----I 644
+ C +P K E+ I P LE + N Q +
Sbjct: 205 T-HCDSKQSP-------PKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYIL 256
Query: 645 ALHCTHESPSHRPSIENVMQELSSI 669
+C RP+ +++ L +
Sbjct: 257 MKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 62/220 (28%), Positives = 111/220 (50%), Gaps = 27/220 (12%)
Query: 394 LEEVERATQCFSEANLLGKSSFSATYKGI-LRDGS----VVAVKCIAKTSCKSDEGEFLK 448
L+E E F + +LG +F YKG+ + +G VA+K + + + E L
Sbjct: 4 LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 58
Query: 449 GLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLL----QHLDLEAGSEKVLEW 504
++ S+ + ++ L GIC + LI +P G LL +H D GS+ +L W
Sbjct: 59 EAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNW 114
Query: 505 ATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL-ADDIVF 563
+I AKG++YL +R LVH +L+A VL+ + ++D GL KLL AD+ +
Sbjct: 115 CVQI------AKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY 166
Query: 564 SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS 603
+ ++A E +T +SD++++G+ V+++++
Sbjct: 167 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 58/252 (23%), Positives = 114/252 (45%), Gaps = 15/252 (5%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
LG F + + VAVK + S + FL ++ +L+H+ L L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAVVT 71
Query: 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLV 529
+ ++I +F+ G+LL L + GS++ L I IA+G++++ + +
Sbjct: 72 ---KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR--NYI 124
Query: 530 HPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKS 589
H +L A +L+ ++D GL +++ D+ + A + + APE G FT KS
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 590 DIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHC 648
D+++FG+++ +I++ G+ P+ + +V ++ + L I + C
Sbjct: 185 DVWSFGILLMEIVTYGR---IPYP--GMSNPEVIRALERGYRMPRPENCPEELYNIMMRC 239
Query: 649 THESPSHRPSIE 660
P RP+ E
Sbjct: 240 WKNRPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 58/219 (26%), Positives = 109/219 (49%), Gaps = 25/219 (11%)
Query: 404 FSEANLLGKSSFSATYKGIL------RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK 457
F E LG+ +F YKG L + VA+K + + + + EF + ++++ L+
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66
Query: 458 HENLASLRGICCSKGRGECFLIYDFVPNGNLLQHL-------DLEAGSE-----KVLEWA 505
H N+ L G+C +K + C L ++++ +G+L + L D+ A S L+ +
Sbjct: 67 HPNIVCLLGVC-TKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124
Query: 506 TRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL-ADDIVFS 564
+ + IA G+ YL VH +L+A L+ +SD GL + + + D
Sbjct: 125 DFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182
Query: 565 MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS 603
K+ + ++ PE G+FT +SDI++FG+++++I S
Sbjct: 183 QSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 18/218 (8%)
Query: 409 LLGKSSFSATYKGI---LRDGSV-VAVKCIAKTSCKSDEGE-FLKGLKILTSLKHENLAS 463
+G+ F Y+G+ + + VAVK K E FL+ I+ H ++
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVK-TCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHG 523
L G+ +++ + P G L +L + S L+ A+ I ++ ++YL
Sbjct: 72 LIGVITEN---PVWIVMELAPLGELRSYLQVNKYS---LDLASLILYSYQLSTALAYLES 125
Query: 524 KRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG 583
KR VH +++A VL+ L D GL + L D+ + K + ++APE
Sbjct: 126 KR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 584 RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV 621
RFT SD++ FG+ +++IL + PF Q +++ V
Sbjct: 184 RFTSASDVWMFGVCMWEILM--LGVKPF--QGVKNNDV 217
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 69/280 (24%), Positives = 124/280 (44%), Gaps = 23/280 (8%)
Query: 404 FSEANL-----LGKSSFS----ATYKGILRDG--SVVAVKCIAKTSCKSDEGEFLKGLKI 452
F +NL LG+ F A KGI +G ++V VK + KT ++ + EF + L +
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 453 LTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHL-----DLEAGSEKVLEWATR 507
L H+N+ L G+C + ++I ++ G+L Q L E L +
Sbjct: 62 FRKLSHKNVVRLLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119
Query: 508 ISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLK 567
+++ IA G+ +L R VH +L+A L+ + +S L K + + + +
Sbjct: 120 VALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN 177
Query: 568 ASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDP 627
A + +LAPE F+ KSD+++FG++++++ + PF + E +
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQ--GELPFYGLSDEEV-LNRLQAG 234
Query: 628 NLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELS 667
LE S L ++ C +P RPS ++ L
Sbjct: 235 KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 58/245 (23%), Positives = 116/245 (47%), Gaps = 15/245 (6%)
Query: 429 VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNL 488
VA+K + + +FL I+ H N+ L G+ +K + ++ +++ NG+L
Sbjct: 35 VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-TKSK-PVMIVTEYMENGSL 92
Query: 489 LQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLL 548
L G V++ + +++GIA G+ YL G VH +L+A +L++ +
Sbjct: 93 DAFLRKHDGQFTVIQL---VGMLRGIASGMKYLSDM--GYVHRDLAARNILVNSNLVCKV 147
Query: 549 SDSGLHKLLADD--IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GK 605
SD GL ++L DD ++ + + APE +FT SD++++G+++++++S G+
Sbjct: 148 SDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 207
Query: 606 CSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQE 665
+ Q + E + P + + L Q+ L C + + RP E ++
Sbjct: 208 RPYWEMSNQDVIKAIEEGYRLPA-----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSI 262
Query: 666 LSSII 670
L +I
Sbjct: 263 LDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 66/277 (23%), Positives = 123/277 (44%), Gaps = 21/277 (7%)
Query: 403 CFSEANLLGKSSFSATYKGIL----RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKH 458
C ++G F +G L + VA+K + + +FL I+ H
Sbjct: 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 64
Query: 459 ENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGI 518
N+ L G+ +K R +I +F+ NG L L G V++ + +++GIA G+
Sbjct: 65 PNIIHLEGVV-TKSR-PVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGM 119
Query: 519 SYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD----IVFSMLKASAAMGY 574
YL VH +L+A +L++ +SD GL + L DD S L + +
Sbjct: 120 KYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177
Query: 575 LAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKF 633
APE +FT SD++++G+++++++S G+ + Q ++ +D+ P
Sbjct: 178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP----- 232
Query: 634 SVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+ + L Q+ L C + + RP ++ L +I
Sbjct: 233 PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 72/275 (26%), Positives = 132/275 (48%), Gaps = 29/275 (10%)
Query: 410 LGKSSF----SATYKGILRDGSV--VAVKCIAKTSCKSDEGEFLKG-LKILTSL-KHENL 461
LG +F AT G+ + +V VAVK + K + S E E L LKI++ L HEN+
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKML-KPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 462 ASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYL 521
+L G C+ G G +I ++ G+LL L E L +S +AKG+++L
Sbjct: 102 VNLLG-ACTIG-GPILVITEYCCYGDLLNFL--RRKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 522 HGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAM--GYLAPEY 579
K +H +L+A VL+ + D GL + + +D + ++K +A + ++APE
Sbjct: 158 ASK--NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY-VVKGNARLPVKWMAPES 214
Query: 580 TTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE-- 637
+T +SD++++G+++++I S P+ +S F EG + +++
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFS--LGSNPYPGMPVDSK----FYKLIKEG-YRMAQPE 267
Query: 638 --ASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+ + I C P RP+ + ++Q + +
Sbjct: 268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 52/194 (26%), Positives = 96/194 (49%), Gaps = 15/194 (7%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
+G+ F A +G G VAVK I C FL+ ++T L H+NL L G+
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNI---KCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLV 529
G +++ + + GNL+ L + + + S+ +A+G+ YL K+ LV
Sbjct: 70 HNG---LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL--DVAEGMEYLESKK--LV 122
Query: 530 HPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKS 589
H +L+A +L+ +SD GL ++ + + S L + APE +F+ KS
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK----WTAPEALKHKKFSSKS 178
Query: 590 DIYAFGMIVFQILS 603
D++++G++++++ S
Sbjct: 179 DVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 17/211 (8%)
Query: 404 FSEANLLGKSSFSATYKGILRDGSV-VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLA 462
EA+ L S A + D V VAVK + + + +FLK +KIL+ L N+A
Sbjct: 23 LCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82
Query: 463 SLRGICCSKGRGECFLIYDFVPNGNLLQHL-------DLEAGSEKVLEWATRISVIKGIA 515
L G+C +I +++ NG+L Q L A + K L ++T + + IA
Sbjct: 83 RLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIA 140
Query: 516 KGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK-LLADDIVFSMLKASAAMG- 573
G+ YL VH +L+ L+ + Y ++D G+ + L + D + ++ A +
Sbjct: 141 SGMRYLESLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD--YYRVQGRAPLPI 196
Query: 574 -YLAPEYTTTGRFTEKSDIYAFGMIVFQILS 603
++A E G+FT KSD++AFG+ +++IL+
Sbjct: 197 RWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 57/264 (21%), Positives = 124/264 (46%), Gaps = 28/264 (10%)
Query: 424 RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLIYDF 482
++ VAVK + + + D + + ++++ + KH+N+ +L G C G ++I ++
Sbjct: 45 KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEY 102
Query: 483 VPNGNLLQHL------------DLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVH 530
GNL ++L D+ ++ + + +S +A+G+ YL ++ +H
Sbjct: 103 ASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIH 160
Query: 531 PNLSAEKVLIHRRYNPLLSDSGLHKLLAD-DIVFSMLKASAAMGYLAPEYTTTGRFTEKS 589
+L+A VL+ ++D GL + + + D + ++APE +T +S
Sbjct: 161 RDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 220
Query: 590 DIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIAL--- 646
D+++FG+++++I + S P VE+ EG A+ ++ +
Sbjct: 221 DVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLLKEGHRMDKPANCTNELYMMMR 273
Query: 647 HCTHESPSHRPSIENVMQELSSII 670
C H PSHRP+ + ++++L I+
Sbjct: 274 DCWHAIPSHRPTFKQLVEDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 428 VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGN 487
+VAVK + + K+ +FLK +KIL+ LK N+ L G+C + +I +++ NG+
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDE--DPLCMITEYMENGD 105
Query: 488 LLQHL---------------DLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPN 532
L Q L A + +++ + V IA G+ YL VH +
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL--SSLNFVHRD 163
Query: 533 LSAEKVLIHRRYNPLLSDSGLHK-LLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDI 591
L+ L+ ++D G+ + L A D +A + ++A E G+FT SD+
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDV 223
Query: 592 YAFGMIVFQILSGKCSITPFTRQAAE 617
+AFG+ +++IL C P+ E
Sbjct: 224 WAFGVTLWEILM-LCKEQPYGELTDE 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 69/273 (25%), Positives = 123/273 (45%), Gaps = 19/273 (6%)
Query: 410 LGKSSFSATYKGIL-RDGSV--VAVKCIAKTSCKSDEGE-FLKGLKILTSLKHENLASLR 465
LG+ F + +G L +D S+ VAVK + C E E FL + H N+ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 466 GICCSKGRGECF----LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISV--IKGIAKGIS 519
G+C E + +I F+ +G+L L + T++ V + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 520 YLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLK-ASAAMGYLAPE 578
YL K +H +L+A +++ N ++D GL K + + + + A + ++A E
Sbjct: 127 YLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184
Query: 579 YTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637
+T KSD+++FG+ +++I + G+ TP+ E+S++ D++ K
Sbjct: 185 SLADRVYTTKSDVWSFGVTMWEIATRGQ---TPYP--GVENSEIYDYLRQGNRLKQPPDC 239
Query: 638 ASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
L + C +P RPS E + EL +
Sbjct: 240 LDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 7e-13
Identities = 61/270 (22%), Positives = 115/270 (42%), Gaps = 38/270 (14%)
Query: 410 LGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGIC 468
LG+ S YK + G + A+K I + + L+ LK L S + + G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 469 CSKGRGECFLIYDFVPNGNLLQHLD-LEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG 527
+G E ++ +++ G+L L + E VL + R I KG+ YLH KR
Sbjct: 69 YKEG--EISIVLEYMDGGSLADLLKKVGKIPEPVLAYIAR-----QILKGLDYLHTKR-H 120
Query: 528 LVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTTTGR 584
++H ++ +LI+ + ++D G+ K+L + ++ + + +G Y++PE
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLEN----TLDQCNTFVGTVTYMSPERIQGES 176
Query: 585 FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFID----------PNLEGKFS 634
++ +DI++ G+ + + GK PF F + P+L +
Sbjct: 177 YSYAADIWSLGLTLLECALGKF---PF-----LPPGQPSFFELMQAICDGPPPSLPAEEF 228
Query: 635 VSEASNLGQIALHCTHESPSHRPSIENVMQ 664
E + I+ C + P RPS ++Q
Sbjct: 229 SPEFRDF--IS-ACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 60/264 (22%), Positives = 122/264 (46%), Gaps = 30/264 (11%)
Query: 427 SVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLIYDFVPN 485
VAVK + + D + + ++++ + KH+N+ +L G+C +G ++I ++
Sbjct: 45 VTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG--PLYVIVEYAAK 102
Query: 486 GNLLQHL------------DLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNL 533
GNL + L D+ E+ L + +S +A+G+ YL +R +H +L
Sbjct: 103 GNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDL 160
Query: 534 SAEKVLIHRRYNPLLSDSGLHKLLAD-DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIY 592
+A VL+ ++D GL + + D D + ++APE +T +SD++
Sbjct: 161 AARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVW 220
Query: 593 AFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN----LGQIALHC 648
+FG+++++I + S P VE+ EG + + SN L + C
Sbjct: 221 SFGILMWEIFTLGGSPYP-------GIPVEELFKLLREGH-RMDKPSNCTHELYMLMREC 272
Query: 649 THESPSHRPSIENVMQELSSIIGS 672
H P+ RP+ + +++ L ++ +
Sbjct: 273 WHAVPTQRPTFKQLVEALDKVLAA 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 67/280 (23%), Positives = 116/280 (41%), Gaps = 20/280 (7%)
Query: 404 FSEANLLGKSSFSATYKGILR--DGSV--VAVKCIAKTSCKSDEGE-FLKGLKILTSLKH 458
+LG+ F + +G L DGS VAVK + E E FL + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 459 ENLASLRGICCSKGRGECF----LIYDFVPNGNLLQHL---DLEAGSEKVLEWATRISVI 511
N+ L G+C + +I F+ +G+L L L EK L T + +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK-LPLQTLLKFM 119
Query: 512 KGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL-HKLLADDIVFSMLKASA 570
IA G+ YL + +H +L+A ++ ++D GL K+ + D A
Sbjct: 120 VDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 571 AMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLE 630
+ ++A E +T KSD++AFG+ +++I + TP+ E+ ++ D++
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR--GQTPYP--GVENHEIYDYLRHGNR 233
Query: 631 GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
K L + C P RP+ + + L +I+
Sbjct: 234 LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 52/235 (22%), Positives = 90/235 (38%), Gaps = 52/235 (22%)
Query: 409 LLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLK----------ILTSLK 457
++G+ SFS + A+K + K L K +LT L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDK--------RQLIKEKKVKYVKIEKEVLTRLN 59
Query: 458 -HENLASLRGICCSKGRGECFLIYDFVPNGNLLQHL-DLEAGSEKVLEWATRISVIKGIA 515
H + L + + + ++ PNG LLQ++ + EK + I
Sbjct: 60 GHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF-----YAAEIL 112
Query: 516 KGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG-- 573
+ YLH K G++H +L E +L+ + + ++D G K+L + K A
Sbjct: 113 LALEYLHSK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 574 -----------------YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
Y++PE + SD++A G I++Q+L+GK PF
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK---PPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 67/279 (24%), Positives = 125/279 (44%), Gaps = 29/279 (10%)
Query: 410 LGKSSFSATYKGIL-----RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASL 464
LG+ +F YKG L +VA+K + + GEF + ++ L H N+ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQ-------HLDLEAGSEK------VLEWATRISVI 511
G+ ++ + C L ++++ G+L + H D+ S++ L+ + +
Sbjct: 73 LGVV-TQEQPVCML-FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 512 KGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK-LLADDIVFSMLKASA 570
IA G+ YL VH +L+A +LI + + +SD GL + + + D K+
Sbjct: 131 IQIAAGMEYLSSHF--FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 571 AMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNL 629
+ ++ PE G+F+ SDI++FG+++++I S G F+ Q +V + +
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-----EVIEMVRKRQ 243
Query: 630 EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSS 668
S + + C E PS RP +++ L S
Sbjct: 244 LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 56/249 (22%), Positives = 104/249 (41%), Gaps = 25/249 (10%)
Query: 429 VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY-DFVPNGN 487
VA+ + FL L H N+ L G+ RG +I +++ NG
Sbjct: 36 VAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT---RGNTMMIVTEYMSNGA 92
Query: 488 LLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPL 547
L L G + + ++ G+A G+ YL G VH L+A KVL++ + +
Sbjct: 93 LDSFLRKHEGQLVAGQL---MGMLPGLASGMKYL--SEMGYVHKGLAAHKVLVNS--DLV 145
Query: 548 LSDSGLHKLLADDI--VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGK 605
SG +L D +++ + + + + APE F+ SD+++FG+++++++S
Sbjct: 146 CKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS-- 203
Query: 606 CSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN----LGQIALHCTHESPSHRPSIEN 661
+ + +D I +E F + N L Q+ L C + RP
Sbjct: 204 -----YGERPYWDMSGQDVIKA-VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQ 257
Query: 662 VMQELSSII 670
+ LS ++
Sbjct: 258 IHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 63/279 (22%), Positives = 125/279 (44%), Gaps = 26/279 (9%)
Query: 408 NLLGKSSFSATYKG-ILRDGSVV--AVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLAS 463
+++G+ +F K I +DG + A+K + + + K D +F L++L L H N+ +
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLD----LEA--------GSEKVLEWATRISVI 511
L G C + RG +L ++ P+GNLL L LE + L +
Sbjct: 73 LLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 512 KGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAA 571
+A+G+ YL K+ +H +L+A +L+ Y ++D GL + ++
Sbjct: 131 ADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLP 186
Query: 572 MGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEG 631
+ ++A E +T SD++++G+++++I+S TP+ + LE
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--LGGTPYCGMTCAELYEKLPQGYRLEK 244
Query: 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+ + + + C E P RPS ++ L+ ++
Sbjct: 245 PLNCDD--EVYDLMRQCWREKPYERPSFAQILVSLNRML 281
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 62/267 (23%), Positives = 122/267 (45%), Gaps = 27/267 (10%)
Query: 410 LGKSSFSATYKGI--LRDGSV-VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRG 466
LG +F KG+ +R + VA+K + + KS E ++ +I+ L + + + G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
+C ++ L+ + G L + L +G + + + + ++ ++ G+ YL GK
Sbjct: 63 VCEAEA---LMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEGK-- 114
Query: 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL-ADDIVFSMLKASAA----MGYLAPEYTT 581
VH +L+A VL+ ++ +SD GL K L ADD S KA +A + + APE
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYAPECIN 171
Query: 582 TGRFTEKSDIYAFGMIVFQILS--GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639
+F+ +SD++++G+ +++ S K P+ + + +V FI+
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQK----PYKKM--KGPEVMSFIEQGKRLDCPAECPP 225
Query: 640 NLGQIALHCTHESPSHRPSIENVMQEL 666
+ + C RP+ V + +
Sbjct: 226 EMYALMKDCWIYKWEDRPNFAKVEERM 252
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 3e-12
Identities = 51/195 (26%), Positives = 85/195 (43%), Gaps = 13/195 (6%)
Query: 403 CFSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENL 461
F +GK F YK R G VA+K I S + E + + ++IL KH N+
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKE-KIINEIQILKKCKHPNI 59
Query: 462 ASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYL 521
+ E +++ +F G+L DL + + L + V K + KG+ YL
Sbjct: 60 VKY--YGSYLKKDELWIVMEFCSGGSLK---DLLKSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 522 HGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV-FSMLKASAAMGYLAPEYT 580
H G++H ++ A +L+ L D GL L+D +M+ ++APE
Sbjct: 115 HSN--GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVI 169
Query: 581 TTGRFTEKSDIYAFG 595
+ K+DI++ G
Sbjct: 170 NGKPYDYKADIWSLG 184
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 47/212 (22%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 408 NLLGKSSFSATYKGILRDGSV---VAVKCIAKTSCKSDEGEFLKGLKILTSLKHE-NLAS 463
+++G+ +F K ++ + A+K + + + K D +F L++L L H N+ +
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLD------------LEAGSEKVLEWATRISVI 511
L G C + RG +L ++ P+GNLL L + + L +
Sbjct: 61 LLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 512 KGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAA 571
+A+G+ YL K+ +H +L+A +L+ Y ++D GL + ++
Sbjct: 119 ADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLP 174
Query: 572 MGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS 603
+ ++A E +T SD++++G+++++I+S
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 46/219 (21%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 410 LGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463
LG+ +F + G D +VAVK + +T+ +F + ++LT+ +HEN+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 464 LRGICCSKGRGEC-FLIYDFVPNGNL----------LQHLDLEAGSEKVLEWATRISVIK 512
G+C G+ ++++++ +G+L L L + + +
Sbjct: 73 FYGVC---TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 513 GIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV---FSMLKAS 569
IA G+ YL + VH +L+ L+ + D G+ + D+ + +
Sbjct: 130 QIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGH 183
Query: 570 AAMG--YLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GK 605
+ ++ PE +FT +SD+++FG+++++I + GK
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 50/212 (23%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 408 NLLGKSSFSATYKGILR-DGSVV--AVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLAS 463
+++G+ +F + +++ DG + A+K + + + ++D +F L++L L H N+ +
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLD------------LEAGSEKVLEWATRISVI 511
L G C + RG ++ ++ P GNLL L E G+ L +
Sbjct: 68 LLGAC--ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 512 KGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAA 571
+A G+ YL K+ +H +L+A VL+ ++D GL + +++
Sbjct: 126 SDVATGMQYLSEKQ--FIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGRLP 181
Query: 572 MGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS 603
+ ++A E +T KSD+++FG+++++I+S
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 5e-12
Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSC-KSDEGEFLKGLK-ILTSLKHENLASLRG 466
LGK SF +D G + A+K + K K E E + IL+ + H + L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
+ + +L+ ++ P G L HL E + E R I + YLH
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKE---GRFSEERARF-YAAEIVLALEYLHSL-- 112
Query: 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTTTG 583
G+++ +L E +L+ + L+D GL K L+ + + + G YLAPE
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE----GSRTNTFCGTPEYLAPEVLLGK 168
Query: 584 RFTEKSDIYAFGMIVFQILSGKCSITPFT 612
+ + D ++ G++++++L+GK PF
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK---PPFY 194
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 20/224 (8%)
Query: 404 FSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSD--EGEFLK---GLKILTSLKH 458
+++ +LGK ++ Y G+ G ++AVK + + E E+ K + +L SLKH
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 459 ENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLD-LEAGSEKVLEWATRISVIKGIAKG 517
N+ G C F+ +FVP G++ L+ E V T K I G
Sbjct: 62 VNIVQYLGTCLDDNTISIFM--EFVPGGSISSILNRFGPLPEPVFCKYT-----KQILDG 114
Query: 518 ISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA----DDIVFSMLKASAAMG 573
++YLH +VH ++ V++ L D G + LA +MLK+
Sbjct: 115 VAYLHNN--CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172
Query: 574 Y-LAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA 616
Y +APE + KSDI++ G VF++ +GK + R AA
Sbjct: 173 YWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA 216
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 71/279 (25%), Positives = 129/279 (46%), Gaps = 20/279 (7%)
Query: 404 FSEANLLGKSSFSATYKGILR--DGSV--VAVKCI-AKTSCKSDEGEFLKGLKILTSLKH 458
F+ +LGK F + + L+ DGS VAVK + A SD EFL+ + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 459 ENLASLRGICC---SKGRGEC-FLIYDFVPNGNLLQHLDLEAGSEK--VLEWATRISVIK 512
N+ L G+ +KGR +I F+ +G+L L + E+ L T + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 513 GIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL-HKLLADDIVFSMLKASAA 571
IA G+ YL K +H +L+A +++ ++D GL K+ + D +
Sbjct: 121 DIASGMEYLSSK--NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178
Query: 572 MGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLE 630
+ +LA E +T SD++AFG+ +++I++ G+ TP+ E+S++ +++
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ---TPYA--GVENSEIYNYLIKGNR 233
Query: 631 GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSI 669
K ++ ++ C P RPS +++ +L I
Sbjct: 234 LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 53/198 (26%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 428 VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGN 487
+VAVK + + + K+ +FLK +KI++ LK N+ L +C + +I +++ NG+
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITS--DPLCMITEYMENGD 105
Query: 488 LLQHL-------DLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI 540
L Q L E + ++T I + IA G+ YL VH +L+ L+
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL--NFVHRDLATRNCLV 163
Query: 541 HRRYNPLLSDSGLHK-LLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVF 599
+ Y ++D G+ + L + D +A + +++ E G+FT SD++AFG+ ++
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223
Query: 600 QILSGKCSITPFTRQAAE 617
+IL+ C P+++ + E
Sbjct: 224 EILT-LCKEQPYSQLSDE 240
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 25/227 (11%)
Query: 396 EVERATQCFSEANLLGKSSFSATYKGIL------RDGSVVAVKCIAKTSCKSDEGEFLKG 449
E+ +T F E LG+ F YKG L VA+K + + EF
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 450 LKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDL-----EAGS------ 498
+ + L+H N+ L G+ + +I+ + + +L + L + + GS
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQ--PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116
Query: 499 -EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK-L 556
+ LE A + ++ IA G+ +L +VH +L+ VL+ + N +SD GL + +
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 557 LADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS 603
A D M + + +++PE G+F+ SDI+++G++++++ S
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 52/194 (26%), Positives = 95/194 (48%), Gaps = 14/194 (7%)
Query: 428 VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGN 487
+VAVK + K+ +FLK +KI++ LK+ N+ L G+C S +I +++ NG+
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD--DPLCMITEYMENGD 103
Query: 488 LLQHLD--------LEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVL 539
L Q L A + + A + + IA G+ YL VH +L+ L
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL--NFVHRDLATRNCL 161
Query: 540 IHRRYNPLLSDSGLHK-LLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIV 598
+ Y ++D G+ + L + D +A + ++A E G+FT SD++AFG+ +
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 599 FQILSGKCSITPFT 612
+++ + C P++
Sbjct: 222 WEMFT-LCKEQPYS 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 62/272 (22%), Positives = 120/272 (44%), Gaps = 24/272 (8%)
Query: 408 NLLGKSSFSATYKGILRDGS----VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463
++G F +G L+ VA+K + S +FL I+ H N+
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHG 523
L G+ +K R +I +++ NG+L + L G + +++GIA G+ YL
Sbjct: 70 LEGVV-TKSR-PVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGMKYL-- 122
Query: 524 KRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD-DIVFSMLKASAAMGYLAPEYTTT 582
VH +L+A +L++ +SD GL + L D + ++ + + APE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182
Query: 583 GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE----A 638
+FT SD+++FG+++++++S + + +D I +E + +
Sbjct: 183 RKFTSASDVWSFGIVMWEVMS-------YGERPYWDMSNQDVIK-AVEDGYRLPPPMDCP 234
Query: 639 SNLGQIALHCTHESPSHRPSIENVMQELSSII 670
S L Q+ L C + + RP+ ++ L +I
Sbjct: 235 SALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 4e-11
Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 54/280 (19%)
Query: 408 NLLGKSSFSATYKG-ILRDGSVVAVKCIAKTSCKSDEGEF-LKGLKILTSLKHENLASLR 465
+GK SF Y DG + +K I ++ E E L +KIL L H N+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 466 GICCSKGRGECFL-------IYDFVPNGNLLQHLDLEAGS------EKVLEWATRISVIK 512
E F + ++ G+L Q + + E++L+W ++
Sbjct: 66 ---------ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL---- 112
Query: 513 GIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAM 572
+ YLH ++ ++H ++ + + + L D G+ K+L+ ++ A +
Sbjct: 113 --CLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS----TVDLAKTVV 164
Query: 573 G---YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNL 629
G YL+PE + KSDI++ G +++++ + K PF E + + L
Sbjct: 165 GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLK---HPF-----EGENLLELALKIL 216
Query: 630 EGKF-----SVSEASNLGQIALHCTHESPSHRPSIENVMQ 664
+G++ S S L + + P RPSI ++Q
Sbjct: 217 KGQYPPIPSQYS--SELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 62/268 (23%), Positives = 123/268 (45%), Gaps = 24/268 (8%)
Query: 402 QCFSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHEN 460
+ F++ +GK SF +KGI R VVA+K I + + + + + +L+
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 461 LASLRGICCSKGRG-ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGIS 519
+ G S +G + ++I +++ G+ L L AG + AT ++K I KG+
Sbjct: 64 VTKYYG---SYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIAT---MLKEILKGLD 115
Query: 520 YLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLA 576
YLH ++ +H ++ A VL+ + + L+D G+ L D + +K + +G ++A
Sbjct: 116 YLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTD----TQIKRNTFVGTPFWMA 169
Query: 577 PEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636
PE + K+DI++ G+ ++ G+ + + P L G+FS
Sbjct: 170 PEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-LFLIPKNNPPTLTGEFS-- 226
Query: 637 EASNLGQIALHCTHESPSHRPSIENVMQ 664
+ C ++ PS RP+ + +++
Sbjct: 227 --KPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 64/276 (23%), Positives = 124/276 (44%), Gaps = 38/276 (13%)
Query: 410 LGKSSFSATYKGILRD--------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENL 461
LG+ +F+ +KGI R+ + V +K + K+ E F + +++ L H++L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSE-SFFEAASMMSQLSHKHL 61
Query: 462 ASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYL 521
G+C E ++ ++V G+L +L + + + W ++ V K +A + +L
Sbjct: 62 VLNYGVCV--CGDESIMVQEYVKFGSLDTYLK-KNKNLINISW--KLEVAKQLAWALHFL 116
Query: 522 HGKRPGLVHPNLSAEKVLIHRRY-----NP---LLSDSGLH-KLLADDIVFSMLKASAAM 572
K GL H N+ A+ VL+ R NP LSD G+ +L +I+ +
Sbjct: 117 EDK--GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP----- 169
Query: 573 GYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEG 631
++ PE + + +D ++FG +++I SG P + A +S K F + +
Sbjct: 170 -WVPPECIENPQNLSLAADKWSFGTTLWEIFSG--GDKPLS--ALDSQKKLQFYEDRHQ- 223
Query: 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQELS 667
+ + L + C P RPS ++++L+
Sbjct: 224 -LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 60/263 (22%), Positives = 121/263 (46%), Gaps = 30/263 (11%)
Query: 429 VAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLIYDFVPNGN 487
VAVK + + + D + + ++++ + KH+N+ +L G C G ++I ++ GN
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGN 110
Query: 488 LLQHL------------DLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSA 535
L ++L + E+ L + +S +A+G+ YL K+ +H +L+A
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAA 168
Query: 536 EKVLIHRRYNPLLSDSGLHKLLAD-DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAF 594
VL+ ++D GL + + D + ++APE +T +SD+++F
Sbjct: 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228
Query: 595 GMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN----LGQIALHCTH 650
G+++++I + S P VE+ EG + + SN L + C H
Sbjct: 229 GVLLWEIFTLGGSPYP-------GVPVEELFKLLKEGH-RMDKPSNCTNELYMMMRDCWH 280
Query: 651 ESPSHRPSIENVMQELSSIIGSS 673
PS RP+ + ++++L I+ +
Sbjct: 281 AVPSQRPTFKQLVEDLDRILALT 303
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 52/208 (25%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 404 FSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKG-LKILTSLKHENL 461
+ +L+G+ +F YKG+ L G VA+K I+ K + + + + +L +LKH N+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 462 ASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAG-SEKVLEWATRISVIKGIAKGISY 520
G + ++I ++ NG+L Q + E ++ + + +G++Y
Sbjct: 62 VKYIG--SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV-----AVYVYQVLQGLAY 114
Query: 521 LHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAP 577
LH + G++H ++ A +L + L+D G+ L D S AS G ++AP
Sbjct: 115 LHEQ--GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV---SKDDASVV-GTPYWMAP 168
Query: 578 EYTTTGRFTEKSDIYAFGMIVFQILSGK 605
E + SDI++ G V ++L+G
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 69/267 (25%), Positives = 112/267 (41%), Gaps = 30/267 (11%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVK--CIAKTSCKSDE--GEFLKGLKILTSLKHENLAS 463
LLG SF + Y+G+ L DG AVK +A E + + + +L+ L+H N+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHL-DLEAGSEKVLEWATRISVIKGIAKGISYLH 522
G + FL + VP G+L + L + E V+ TR I G+ YLH
Sbjct: 67 YLGTEREEDNLYIFL--ELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLH 119
Query: 523 GKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEY-TT 581
+ VH ++ +L+ L+D G+ K + + K S ++APE
Sbjct: 120 DR--NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY--WMAPEVIAQ 175
Query: 582 TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA----ESSKVEDFIDPNLEGKFSVSE 637
G + +DI++ G V ++ +GK + AA SK I +L E
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLS-----DE 230
Query: 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664
A + L C PS RP+ +++
Sbjct: 231 AKDF---ILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 58/259 (22%), Positives = 118/259 (45%), Gaps = 28/259 (10%)
Query: 429 VAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLIYDFVPNGN 487
VAVK + + D + + ++++ + KH+N+ +L G C G +++ ++ GN
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG--PLYVLVEYASKGN 104
Query: 488 LLQHL------------DLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSA 535
L ++L D E+ L + +S +A+G+ YL ++ +H +L+A
Sbjct: 105 LREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAA 162
Query: 536 EKVLIHRRYNPLLSDSGLHKLLAD-DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAF 594
VL+ ++D GL + + + D + ++APE +T +SD+++F
Sbjct: 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222
Query: 595 GMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS---NLGQIALHCTHE 651
G+++++I + S P VE+ EG A+ L I C H
Sbjct: 223 GVLLWEIFTLGGSPYP-------GIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHA 275
Query: 652 SPSHRPSIENVMQELSSII 670
PS RP+ + ++++L ++
Sbjct: 276 VPSQRPTFKQLVEDLDRVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 48/217 (22%), Positives = 97/217 (44%), Gaps = 37/217 (17%)
Query: 410 LGKSSFSATYKGILRD------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463
LG+ SF Y+G+ + + VA+K + + + + EFL ++ ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHL-----DLEAGS-------EKVLEWATRISVI 511
L G+ S G+ ++ + + G+L +L + E +K ++ A I
Sbjct: 74 LLGVV-STGQ-PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI--- 128
Query: 512 KGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFS--MLKAS 569
A G++YL K+ VH +L+A ++ + D G+ DI + K
Sbjct: 129 ---ADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGM----TRDIYETDYYRKGG 179
Query: 570 AAM---GYLAPEYTTTGRFTEKSDIYAFGMIVFQILS 603
+ ++APE G FT KSD+++FG++++++ +
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 64/279 (22%), Positives = 122/279 (43%), Gaps = 38/279 (13%)
Query: 415 FSATYKGI--LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSK 471
A G+ + S VAVK + + + D + + ++++ + KH+N+ +L G+C
Sbjct: 29 VKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC--T 86
Query: 472 GRGECFLIYDFVPNGNLLQHL------------DLEAGSEKVLEWATRISVIKGIAKGIS 519
G +++ ++ +GNL L D E+ L +S +A+G+
Sbjct: 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGME 146
Query: 520 YLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYL---- 575
+L K+ +H +L+A VL+ + ++D GL A DI G L
Sbjct: 147 FLASKK--CIHRDLAARNVLVTEDHVMKIADFGL----ARDIHHIDYYRKTTNGRLPVKW 200
Query: 576 -APEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKF- 633
APE +T +SD+++FG+++++I + S P VE+ EG
Sbjct: 201 MAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP-------GIPVEELFKLLKEGYRM 253
Query: 634 --SVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+ L + C HE PS RP+ + ++++L ++
Sbjct: 254 EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 68/302 (22%), Positives = 120/302 (39%), Gaps = 59/302 (19%)
Query: 396 EVERATQCFSEANLLGKSSFSATYKGIL--RDGSV----VAVKCIAKTSCKSDEGEFLKG 449
EV R + LG +F Y+G+ RDG VAVK + ++ + DE +FL
Sbjct: 2 EVPRD--SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLME 59
Query: 450 LKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLE---AGSEKVLEWAT 506
I++ H+N+ L G+ R F++ + + G+L L L
Sbjct: 60 ALIMSKFNHQNIVRLIGVSFE--RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKD 117
Query: 507 RISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL-------LAD 559
+ + +AKG YL +H +++A N LL+ G ++ +A
Sbjct: 118 LLFCARDVAKGCKYLEENH--FIHRDIAAR--------NCLLTCKGPGRVAKIADFGMAR 167
Query: 560 DIVFS--MLKASAAM---GYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQ 614
DI + K AM ++ PE G FT K+D+++FG+++++I S P+ +
Sbjct: 168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS--LGYMPYPGR 225
Query: 615 AAESSKVEDFIDPNLEGKFSVSEASNLG----------QIALHCTHESPSHRPSIENVMQ 664
N E V+ L +I C +P RP+ +++
Sbjct: 226 ------------TNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILE 273
Query: 665 EL 666
+
Sbjct: 274 RI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 62/286 (21%), Positives = 131/286 (45%), Gaps = 33/286 (11%)
Query: 398 ERATQCFSEANLLGKSSFSATY----KGILRDG--SVVAVKCIAKTSCKSDEGEFLKGLK 451
E+ T LG+ SF Y KG+++D + VA+K + + + + EFL
Sbjct: 6 EKITMSRE----LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 452 ILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHL-----DLEAGSEKVLEWAT 506
++ ++ L G+ S+G+ +I + + G+L +L ++E +
Sbjct: 62 VMKEFNCHHVVRLLGVV-SQGQ-PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 507 RISVIKG-IAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK-LLADDIVFS 564
++ + G IA G++YL+ + VH +L+A ++ + + D G+ + + D
Sbjct: 120 KMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177
Query: 565 MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF 624
K + +++PE G FT SD+++FG+++++I + + P+ Q + +V F
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT--LAEQPY--QGMSNEQVLRF 233
Query: 625 IDPNLEGKFSVSEASN----LGQIALHCTHESPSHRPSIENVMQEL 666
+ +EG + + N L ++ C +P RPS ++ +
Sbjct: 234 V---MEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 67/291 (23%), Positives = 121/291 (41%), Gaps = 35/291 (12%)
Query: 410 LGKSSFSATYKGIL-----RDG-SVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463
LG+ F K R G + VAVK + + + S+ + L +L + H ++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHL--------------------DLEAGSEKVLE 503
L G C G LI ++ G+L L L+ E+ L
Sbjct: 68 LYGACSQD--GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 504 WATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK-LLADDIV 562
IS I++G+ YL + LVH +L+A VL+ +SD GL + + +D
Sbjct: 126 MGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 563 FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE 622
K + ++A E +T +SD+++FG+++++I++ P+ A E
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--LGGNPYPGIAPERLFNL 241
Query: 623 DFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
+E + SE + + L C + P RP+ ++ +EL ++ S
Sbjct: 242 LKTGYRMERPENCSEE--MYNLMLTCWKQEPDKRPTFADISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 54/211 (25%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVK-----CIAKTSCKSDEG--EFLKG-LKILTSLKHE 459
L+G SF + Y G+ G ++AVK ++ +S + L + +L L+HE
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 460 NLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGIS 519
N+ G FL Y VP G++ L+ E+ L R + ++ I KG++
Sbjct: 67 NIVQYLGSSLDADHLNIFLEY--VPGGSVAALLNNYGAFEETL---VR-NFVRQILKGLN 120
Query: 520 YLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKAS-----AAMGY 574
YLH + G++H ++ +L+ + +SD G+ K L + + + + ++ +
Sbjct: 121 YLHNR--GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 575 LAPEYTTTGRFTEKSDIYAFGMIVFQILSGK 605
+APE +T K+DI++ G +V ++L+GK
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 64/271 (23%), Positives = 122/271 (45%), Gaps = 37/271 (13%)
Query: 404 FSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKH---E 459
+ L+G+ ++ A Y+G + G VVA+K I + D + + + +L+ L+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 460 NLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVI-KGIAKGI 518
N+ G KG ++I ++ G++ + +EK ISVI + + +
Sbjct: 63 NITKYYG-SYLKGP-RLWIIMEYAEGGSVRTLMKAGPIAEKY------ISVIIREVLVAL 114
Query: 519 SYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YL 575
Y+H + G++H ++ A +L+ N L D G+ LL + K S +G ++
Sbjct: 115 KYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ----NSSKRSTFVGTPYWM 168
Query: 576 APEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFI----DPNLE 630
APE T G+ + K+DI++ G+ ++++ +G P++ ++ + I P LE
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGN---PPYSDV--DAFRAMMLIPKSKPPRLE 223
Query: 631 GK-FSVSEASNLGQIALHCTHESPSHRPSIE 660
+S L + C E P R S E
Sbjct: 224 DNGYSKL----LREFVAACLDEEPKERLSAE 250
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 61/258 (23%), Positives = 106/258 (41%), Gaps = 26/258 (10%)
Query: 419 YKGILRDGSVVAVKCIAK--TSCKSDEGEFLKGLKILTSLKHENLASLRG----ICCSKG 472
YKGI + V+ ++ K K +K L + N+ + G I
Sbjct: 37 YKGIFNNKEVI-IRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 473 RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPN 532
R LI ++ G L + LD EK L + T++ + KG+ L+ K + N
Sbjct: 96 RLS--LILEYCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLY-KYTNKPYKN 148
Query: 533 LSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT--GRFTEKSD 590
L++ L+ Y + GL K+L+ K M Y + + +T K D
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSS----PPFKNVNFMVYFSYKMLNDIFSEYTIKDD 204
Query: 591 IYAFGMIVFQILSGKCSITPFTRQAAESSKVED-FIDPNLEGKFSVSEASNLGQIALHCT 649
IY+ G+++++I +GK PF + + ++ D I+ N K + + I CT
Sbjct: 205 IYSLGVVLWEIFTGK---IPF--ENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACT 259
Query: 650 HESPSHRPSIENVMQELS 667
RP+I+ ++ LS
Sbjct: 260 SHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 4e-10
Identities = 64/271 (23%), Positives = 122/271 (45%), Gaps = 30/271 (11%)
Query: 402 QCFSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHEN 460
+ F++ +GK SF +KGI R VVA+K I + + + + + +L+
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 461 LASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISY 520
+ G + ++I +++ G+ L L E G + AT +++ I KG+ Y
Sbjct: 64 VTKYYGSYLKDTK--LWIIMEYLGGGSALDLL--EPGPLDETQIAT---ILREILKGLDY 116
Query: 521 LHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAP 577
LH ++ +H ++ A VL+ L+D G+ L D + +K + +G ++AP
Sbjct: 117 LHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTD----TQIKRNTFVGTPFWMAP 170
Query: 578 EYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFI----DPNLEGKF 633
E + K+DI++ G+ ++ G+ P + KV I P LEG +
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGE---PPHSE--LHPMKVLFLIPKNNPPTLEGNY 225
Query: 634 SVSEASNLGQIALHCTHESPSHRPSIENVMQ 664
S L + C ++ PS RP+ + +++
Sbjct: 226 S----KPLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 4e-10
Identities = 51/208 (24%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 410 LGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEF----LKGLKILTSLKHENLASL 464
+G+ ++ YK + G +VA+K K ++++ F ++ +K+L L+H N+ L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALK---KIRMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAK----GISY 520
+ I SKG+G +++++++ + L L L++ K E S IK K G+ Y
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHD--LTGL-LDSPEVKFTE-----SQIKCYMKQLLEGLQY 115
Query: 521 LHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEY- 579
LH G++H ++ +LI+ L+D GL + + Y PE
Sbjct: 116 LHSN--GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 580 --TTTGRFTEKSDIYAFGMIVFQILSGK 605
T R+ + D+++ G I+ ++ GK
Sbjct: 174 LGAT--RYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 47/202 (23%), Positives = 93/202 (46%), Gaps = 12/202 (5%)
Query: 410 LGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGIC 468
+G + + Y I L + VA+K I C++ E K ++ ++ H N+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY--- 65
Query: 469 CSKGRGEC-FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG 527
S G+ +L+ ++ G+LL + + L+ A +V+K + KG+ YLH G
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLL-DIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--SNG 122
Query: 528 LVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTTTGR 584
+H ++ A +L+ + ++D G+ LAD + +G ++APE
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 585 -FTEKSDIYAFGMIVFQILSGK 605
+ K+DI++FG+ ++ +G
Sbjct: 183 GYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 61/271 (22%), Positives = 121/271 (44%), Gaps = 30/271 (11%)
Query: 402 QCFSEANLLGKSSFSATYKGIL-RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHEN 460
+ F++ +GK SF YKGI R VVA+K I + + + + + +L+
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 461 LASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISY 520
+ G + ++I +++ G+ L L LE ++++ I KG+ Y
Sbjct: 64 ITRYYGSYLKGTK--LWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDY 116
Query: 521 LHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAP 577
LH +R +H ++ A VL+ + + L+D G+ L D + +K + +G ++AP
Sbjct: 117 LHSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTD----TQIKRNTFVGTPFWMAP 170
Query: 578 EYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFI----DPNLEGKF 633
E + K+DI++ G+ ++ G+ P + +V I P LEG++
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGE---PPNSD--LHPMRVLFLIPKNSPPTLEGQY 225
Query: 634 SVSEASNLGQIALHCTHESPSHRPSIENVMQ 664
S + C ++ P RP+ + +++
Sbjct: 226 S----KPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 64/279 (22%), Positives = 108/279 (38%), Gaps = 49/279 (17%)
Query: 410 LGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKG-LKILTSLKHENLASL--R 465
+GK SF K DG ++ K I + E + L + IL LKH N+ R
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 466 GI------------CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKG 513
I C G D L+Q E +E ++
Sbjct: 68 IIDRSNQTLYIVMEYCEGG--------DL---AQLIQKCKKERKY---IEEEFIWRILTQ 113
Query: 514 IAKGISYLHGKRPG---LVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASA 570
+ + H + ++H +L + + N L D GL K+L D F A
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF----AKT 169
Query: 571 AMG---YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFT--RQAAESSKVEDFI 625
+G Y++PE + EKSDI++ G +++++ + PFT Q +SK+++
Sbjct: 170 YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS---PPFTARNQLQLASKIKEGK 226
Query: 626 DPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664
+ ++S S L ++ + P RPS E ++Q
Sbjct: 227 FRRIPYRYS----SELNEVIKSMLNVDPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 45/218 (20%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 403 CFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENL 461
E + LG+ + + K L++ G + A+K I + + L+ L+I S K +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 462 ASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRIS------VIKGIA 515
G + + ++ G+L ++ +KV + RI + + +
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSL------DSIYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 516 KGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG-- 573
KG+SYLH ++ ++H ++ +L+ R+ L D G+ + ++V S+ A G
Sbjct: 116 KGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGV----SGELVNSL--AGTFTGTS 167
Query: 574 -YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITP 610
Y+APE ++ SD+++ G+ + ++ + P
Sbjct: 168 FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPP 205
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 410 LGKSSFSATYKGILRD------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463
LG+ SF Y+G RD + VAVK + +++ + EFL ++ ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHL-DLEAGSEK-----VLEWATRISVIKGIAKG 517
L G+ SKG+ ++ + + +G+L +L L +E I + IA G
Sbjct: 74 LLGVV-SKGQ-PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 518 ISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK-LLADDIVFSMLKASAAMGYLA 576
++YL+ K+ VH +L+A ++ + + D G+ + + D K + ++A
Sbjct: 132 MAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 577 PEYTTTGRFTEKSDIYAFGMIVFQILS 603
PE G FT SD+++FG+++++I S
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 56/272 (20%), Positives = 129/272 (47%), Gaps = 42/272 (15%)
Query: 410 LGKSSFSATYKGIL----RDGSVVAVK--CIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463
+G+ SF K IL DG +K I+K S K E E K + +L+++KH N+
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKERE-ESRKEVAVLSNMKHPNIVQ 63
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGS----EKVLEWATRISVIKGIAKGIS 519
+ + G +++ D+ G+L + ++ + G +++L+W +I + +
Sbjct: 64 YQE--SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL------ALK 115
Query: 520 YLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLA 576
++H ++ ++H ++ ++ + + + L D G+ ++L ++ A +G YL+
Sbjct: 116 HVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS----TVELARTCIGTPYYLS 169
Query: 577 PEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKF--- 633
PE + KSDI+A G +++++ + K A E+ +++ + + G +
Sbjct: 170 PEICENRPYNNKSDIWALGCVLYEMCTLK--------HAFEAGNMKNLVLKIIRGSYPPV 221
Query: 634 SVSEASNLGQIALHCTHESPSHRPSIENVMQE 665
S + +L + +P RPS+ +++++
Sbjct: 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 52/221 (23%), Positives = 84/221 (38%), Gaps = 36/221 (16%)
Query: 404 FSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHEN 460
F ++GK +F RD + A+K + K C K L +IL L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 461 LASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISY 520
L +L +L+ D + G+L HL + K E + + + I + Y
Sbjct: 62 LVNLWYSFQD--EENMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICE-IVLALEY 115
Query: 521 LHGKRPGLVHPNLSAEKVLIHRRYNP---LLSDSGLHKLLADDIVFSMLKA-------SA 570
LH K +IHR P LL + G H + D + + + S
Sbjct: 116 LHSKG-------------IIHRDIKPDNILLDEQG-HVHITDFNIATKVTPDTLTTSTSG 161
Query: 571 AMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
GY+APE ++ D ++ G+ ++ L GK P+
Sbjct: 162 TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK---RPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 49/151 (32%), Positives = 81/151 (53%), Gaps = 6/151 (3%)
Query: 80 EIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNL 139
+P+ + L +L L L FN L+ +PK +++LS L++L L+ N +S +P +I ++ L
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSAL 211
Query: 140 QVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFG 199
+ L L N + + + L +L+ LS L L N+L +P S+G+L L LDLS N +
Sbjct: 212 EELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS 269
Query: 200 PVPVKLANVPKLEVLDIRNNSFSGNVPPALK 230
L ++ L LD+ NS S +P
Sbjct: 270 ISS--LGSLTNLRELDLSGNSLSNALPLIAL 298
|
Length = 394 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 59/274 (21%), Positives = 115/274 (41%), Gaps = 46/274 (16%)
Query: 409 LLGKSSFSATYK-GILRDGSVVAVKCIAKTSCKSDEGE-FLKGLKILTSLKHENLASLRG 466
LGK S+ + YK L D A+K + S E E + ++IL S+ H N+ S +
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK- 65
Query: 467 ICCSKGRGECFL-------IYDFVPNGNLLQHLDLEAGSEKVLE----WATRISVIKGIA 515
E FL + ++ P G+L + + K++ W I +
Sbjct: 66 --------EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ----LL 113
Query: 516 KGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG-- 573
+G+ LH + ++H +L + +L+ + D G+ K+L ++ A +G
Sbjct: 114 RGLQALHEQ--KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM------AKTQIGTP 165
Query: 574 -YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE--SSKVEDFIDPNLE 630
Y+APE ++ KSDI++ G +++++ + PF ++ + KV+ P +
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA---PPFEARSMQDLRYKVQRGKYPPIP 222
Query: 631 GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664
+S +L P RP+ + ++
Sbjct: 223 PIYS----QDLQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 51/225 (22%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 451 KILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAG----SEKVLEWAT 506
++L+ LKH N+ + R G +++ F G+L L + G +V+EW
Sbjct: 51 QLLSQLKHPNIVAYRE-SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV 109
Query: 507 RISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSML 566
+I A + YLH K ++H +L + V + R + D G+ ++L + M
Sbjct: 110 QI------AMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--CDM- 158
Query: 567 KASAAMG---YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVED 623
AS +G Y++PE + + KSD++A G V+++ + + A + +
Sbjct: 159 -ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT--------LKHAFNAKDMNS 209
Query: 624 FIDPNLEGKF---SVSEASNLGQIALHCTHESPSHRPSIENVMQE 665
+ +EGK + LG++ + P RPS+++++++
Sbjct: 210 LVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 55/273 (20%), Positives = 115/273 (42%), Gaps = 33/273 (12%)
Query: 409 LLGKSSFSATYKGILRD---GSVVAVKCIAKTSCKSDEGE-------FLKGLKILTSLKH 458
LG +FS+ Y+ RD G+++AVK + T ++ E K ++++ L H
Sbjct: 7 QLGTGAFSSCYQA--RDVKTGTLMAVKQV--TYVRNTSSEQEEVVEALRKEIRLMARLNH 62
Query: 459 ENLASLRGICCSKGRGECFLIYDFVPNGNLLQHL-DLEAGSEKVLEWATRISVIKGIAKG 517
++ + G C F+ +++ G++ L A E V+ I+ + + +G
Sbjct: 63 PHIIRMLGATCEDSHFNLFV--EWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRG 115
Query: 518 ISYLHGKRPGLVHPNLSAEKVLIHRRYNPL-LSDSGLHKLLADDIVFSMLKASAAMG--- 573
+SYLH + ++H ++ +LI L ++D G LA + +G
Sbjct: 116 LSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173
Query: 574 YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKF 633
++APE ++ D+++ G ++ ++ + K P+ + + F +
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK---PPWNAEKHSNHLALIFKIASATTAP 230
Query: 634 SVSEASNLG--QIALHCTHESPSHRPSIENVMQ 664
S+ E + G + L C P RP +++
Sbjct: 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 42/132 (31%), Positives = 70/132 (53%), Gaps = 4/132 (3%)
Query: 88 LKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYN 147
L +LT L L N + + P S L +L L+ N + +PS + N+ NL+ L L +N
Sbjct: 115 LTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173
Query: 148 KLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLAN 207
L+ ++P L +L L+ L L N+++ +P + L L LDLS N++ + L+N
Sbjct: 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSN 230
Query: 208 VPKLEVLDIRNN 219
+ L L++ NN
Sbjct: 231 LKNLSGLELSNN 242
|
Length = 394 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 46/210 (21%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 415 FSATYKGIL--RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKG 472
F A G+L ++VAVK + + + + +F + ++ H N+ L G+C + G
Sbjct: 22 FQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC-AVG 80
Query: 473 RGECFLIYDFVPNGNL--------------LQHLDLEAGSEKV----LEWATRISVIKGI 514
+ C L+++++ G+L L H A + L ++ + K +
Sbjct: 81 KPMC-LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQV 139
Query: 515 AKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL-HKLLADDIVFSMLKASAAMG 573
A G++YL ++ VH +L+ L+ ++D GL + + D + + +
Sbjct: 140 AAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR 197
Query: 574 YLAPEYTTTGRFTEKSDIYAFGMIVFQILS 603
++ PE R+T +SD++A+G+++++I S
Sbjct: 198 WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 54/262 (20%), Positives = 114/262 (43%), Gaps = 26/262 (9%)
Query: 410 LGKSSF-SATYKGILRDGSVVAVKCIAKTSCKSDEGEF-LKGLKILTSLKHENLASLRGI 467
LGK +F AT D S+V K + T E L + IL+ L+H N+ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG 527
+ ++ G L + + G ++ E + + I +SY+H + G
Sbjct: 68 FMDDN--TLLIEMEYANGGTLYDKIVRQKG--QLFEEEMVLWYLFQIVSAVSYIH--KAG 121
Query: 528 LVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTTTGR 584
++H ++ + + + L D G+ K+L + +SM A +G Y++PE +
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE--YSM--AETVVGTPYYMSPELCQGVK 177
Query: 585 FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE---ASNL 641
+ KSDI+A G +++++L+ ++ +++ + + ++G ++ +S L
Sbjct: 178 YNFKSDIWALGCVLYELLT--------LKRTFDATNPLNLVVKIVQGNYTPVVSVYSSEL 229
Query: 642 GQIALHCTHESPSHRPSIENVM 663
+ + P RP+ + V+
Sbjct: 230 ISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 21/203 (10%)
Query: 410 LGKSSFSATYKGIL---RDGSVVAVKCIAKTSCKSDEG---EFLKGLKILTSLKHENLAS 463
LG +F KG+ + VAVK + + +D E L+ ++ L + +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVR 60
Query: 464 LRGICCSKGRGECF-LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLH 522
+ GIC E + L+ + G L + L ++ V E ++ ++ G+ YL
Sbjct: 61 MIGIC----EAESWMLVMELAELGPLNKFL---QKNKHVTE-KNITELVHQVSMGMKYL- 111
Query: 523 GKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAA--MGYLAPEYT 580
+ VH +L+A VL+ ++ +SD GL K L D + K + + APE
Sbjct: 112 -EETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170
Query: 581 TTGRFTEKSDIYAFGMIVFQILS 603
+F+ KSD+++FG+++++ S
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 21/221 (9%)
Query: 450 LKILTSLKHENLASLRGICCSKGRGECFL--IYDFVPNGNLLQHLD-LEAGSEKVLEWAT 506
+++L +L+HE + G C + R E L +++P G++ L A +E V T
Sbjct: 55 IQLLKNLQHERIVQYYG--CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYT 112
Query: 507 RISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSML 566
R I +G+SYLH +VH ++ +L N L D G K L I S
Sbjct: 113 R-----QILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICMSGT 164
Query: 567 KASAAMG---YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVED 623
+ G +++PE + + K+D+++ G V ++L+ K + AA
Sbjct: 165 GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ 224
Query: 624 FIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664
+P L S S + L C HRPS E +++
Sbjct: 225 PTNPQLP-----SHISEHARDFLGCIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 32/158 (20%), Positives = 77/158 (48%), Gaps = 15/158 (9%)
Query: 452 ILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAG----SEKVLEWATR 507
+L +KH N+ + + + G +++ ++ G+L+Q + L+ G + +L+W +
Sbjct: 51 LLAKMKHPNIVAFKE--SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ 108
Query: 508 ISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLK 567
+ + G+ ++H KR ++H ++ ++ + + + L D G +LL ++
Sbjct: 109 MCL------GVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY 160
Query: 568 ASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGK 605
Y+ PE + KSDI++ G I++++ + K
Sbjct: 161 VGTPY-YVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 43/192 (22%), Positives = 96/192 (50%), Gaps = 17/192 (8%)
Query: 424 RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFV 483
+D +VAVK + K + +S +F + ++LT L+H+++ G+C ++GR ++++++
Sbjct: 33 QDKMLVAVKAL-KEASESARQDFQREAELLTVLQHQHIVRFYGVC-TEGR-PLLMVFEYM 89
Query: 484 PNGNLLQHLDLEAGSEKVLE-----------WATRISVIKGIAKGISYLHGKRPGLVHPN 532
+G+L + L K+L +++ IA G+ YL VH +
Sbjct: 90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRD 147
Query: 533 LSAEKVLIHRRYNPLLSDSGLHK-LLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDI 591
L+ L+ + + D G+ + + + D + + ++ PE +FT +SDI
Sbjct: 148 LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDI 207
Query: 592 YAFGMIVFQILS 603
++FG+++++I +
Sbjct: 208 WSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 67/284 (23%), Positives = 130/284 (45%), Gaps = 45/284 (15%)
Query: 408 NLLGKSSFSATYKGILRDGSV-----VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLA 462
+LL + +F + GIL D V VK + + + L+ +L L H+N+
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 463 SLRGICCSKGRGECFLIYDFVPNGNLLQHL----DLEAGSEKVLEWATRISVIKG--IAK 516
+ +C + F++Y ++ GNL L EA + + L +T+ V IA
Sbjct: 72 PILHVC-IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL--STQQLVHMAIQIAC 128
Query: 517 GISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK-LLADDIVFSML--KASAAMG 573
G+SYLH + G++H +++A +I ++D+ L + L D + L + +
Sbjct: 129 GMSYLHKR--GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD--YHCLGDNENRPVK 184
Query: 574 YLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDP----- 627
++A E ++ SD+++FG++++++++ G+ TP+ VE IDP
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMTLGQ---TPY---------VE--IDPFEMAA 230
Query: 628 NLEGKFSVSEASN----LGQIALHCTHESPSHRPSIENVMQELS 667
L+ + +++ N L + C P RPS ++Q L+
Sbjct: 231 YLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 59/264 (22%), Positives = 117/264 (44%), Gaps = 25/264 (9%)
Query: 410 LGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGIC 468
LG + K + R G ++AVK I ++ + + L+ L IL + G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAGS--EKVLEWATRISVIKGIAKGISYLHGKRP 526
+ G + + +++ G+L + L G E++L +I+V + KG++YLH K
Sbjct: 69 YNNG--DISICMEYMDGGSLDKILKEVQGRIPERIL---GKIAV--AVLKGLTYLHEKH- 120
Query: 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFT 586
++H ++ +L++ R L D G+ L + + + + S+ Y+APE ++
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSS---YMAPERIQGNDYS 177
Query: 587 EKSDIYAFGMIVFQILSGKCSITPFTRQAAES-----SKVEDFIDPNL-EGKFSVSEASN 640
KSDI++ G+ + ++ +G+ P + + + P L GKFS
Sbjct: 178 VKSDIWSLGLSLIELATGRFPY-PPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236
Query: 641 LGQIALHCTHESPSHRPSIENVMQ 664
+ C + P RPS + +++
Sbjct: 237 VNL----CLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 3e-07
Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 43/219 (19%)
Query: 404 FSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLA 462
F+ +GK SF YK I R VVA+K I + + + + ++ L+ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 463 SLRGICCSKGRGECFL-------IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVI-KGI 514
G FL I ++ G+ L L E I+ I + +
Sbjct: 63 KYYG---------SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETY------IAFILREV 107
Query: 515 AKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD-----DIVFSMLKAS 569
G+ YLH + +H ++ A N LLS+ G KL AD + +M K +
Sbjct: 108 LLGLEYLHEEG--KIHRDIKAA--------NILLSEEGDVKL-ADFGVSGQLTSTMSKRN 156
Query: 570 AAMG---YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGK 605
+G ++APE + EK+DI++ G+ ++ G+
Sbjct: 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 54/235 (22%), Positives = 93/235 (39%), Gaps = 53/235 (22%)
Query: 408 NLLGKSSFSATYKGI-LRDGSVVAVKCIA-----KTSCKSDEGEFLKGLKILTSLKHENL 461
N +G +F Y + L G ++AVK I + K E +K+L LKH NL
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADE----MKVLELLKHPNL 61
Query: 462 ASLRGI------------CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRIS 509
G+ CS G + + + +G +L E V+ T
Sbjct: 62 VKYYGVEVHREKVYIFMEYCSGGT-----LEELLEHGRILD--------EHVIRVYT--- 105
Query: 510 VIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD--DIVFSMLK 567
+ +G++YLH G+VH ++ + + L D G L + + ++
Sbjct: 106 --LQLLEGLAYLHSH--GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQ 161
Query: 568 --ASAAMGYLAPEYTTTGRFTEK---SDIYAFGMIVFQILSGKCSITPFTRQAAE 617
A Y+APE T G+ +DI++ G +V ++ +GK P++ E
Sbjct: 162 SLAGTPA-YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK---RPWSELDNE 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 49/202 (24%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 409 LLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
LG+ S+ + YK I ++ G VVA+K + + D E +K + IL + G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIVKYYG- 65
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVI-KGIAKGISYLHGKRP 526
K + +++ ++ G++ D+ + K L I+ I KG+ YLH +
Sbjct: 66 SYFKN-TDLWIVMEYCGAGSVS---DIMKITNKTLTEE-EIAAILYQTLKGLEYLHSNK- 119
Query: 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTTTG 583
+H ++ A +L++ L+D G+ L D +M K + +G ++APE
Sbjct: 120 -KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD----TMAKRNTVIGTPFWMAPEVIQEI 174
Query: 584 RFTEKSDIYAFGMIVFQILSGK 605
+ K+DI++ G+ ++ GK
Sbjct: 175 GYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 43/197 (21%), Positives = 96/197 (48%), Gaps = 32/197 (16%)
Query: 478 LIYDFVPNGNLLQHLDLEAGS----EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNL 533
++ ++ P G L +++ S + +L + +I + + ++H K ++H +L
Sbjct: 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILL------ALHHVHTKL--ILHRDL 127
Query: 534 SAEKVLIHRRYNPL-LSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTTTGRFTEKS 589
+ +L+ + + + D G+ K+L+ S KA +G Y++PE + +KS
Sbjct: 128 KTQNILLDKHKMVVKIGDFGISKILS-----SKSKAYTVVGTPCYISPELCEGKPYNQKS 182
Query: 590 DIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS-VSE--ASNLGQIAL 646
DI+A G +++++ S K +A E++ + + + G F+ +S+ + +L Q+ L
Sbjct: 183 DIWALGCVLYELASLK--------RAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLIL 234
Query: 647 HCTHESPSHRPSIENVM 663
+ PS RP + +M
Sbjct: 235 SMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 15/162 (9%)
Query: 447 LKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWAT 506
L+ +K+L L+HEN+ +L+ KGR +L++++V LL+ L+ G L
Sbjct: 48 LREVKVLRQLRHENIVNLKEAFRRKGR--LYLVFEYVER-TLLELLEASPGG---LPPDA 101
Query: 507 RISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSML 566
S I + + I+Y H ++H ++ E +L+ L D G + L +
Sbjct: 102 VRSYIWQLLQAIAYCHSH--NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159
Query: 567 KASAAMGYLAPE----YTTTGRFTEKSDIYAFGMIVFQILSG 604
A Y APE T G+ D++A G I+ ++L G
Sbjct: 160 DYVATRWYRAPELLVGDTNYGK---PVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 39/190 (20%), Positives = 90/190 (47%), Gaps = 15/190 (7%)
Query: 424 RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFV 483
+D +VAVK + K + + +F + ++LT+L+HE++ G+C ++++++
Sbjct: 33 QDKILVAVKTL-KDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD--PLIMVFEYM 89
Query: 484 PNGNLLQHLDL---------EAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLS 534
+G+L + L E L + + + + IA G+ YL + VH +L+
Sbjct: 90 KHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLA 147
Query: 535 AEKVLIHRRYNPLLSDSGLHK-LLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYA 593
L+ + D G+ + + + D + ++ PE +FT +SD+++
Sbjct: 148 TRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 207
Query: 594 FGMIVFQILS 603
G+++++I +
Sbjct: 208 LGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 60/268 (22%), Positives = 123/268 (45%), Gaps = 35/268 (13%)
Query: 410 LGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTS-LKHENLASLRGI 467
+G+ SF Y + D +K I T E E K IL + +KH N+ +
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAG----SEKVLEWATRISVIKGIAKGISYLHG 523
GR F++ ++ G+L++ ++ + G +++L W +IS+ G+ ++H
Sbjct: 68 FQENGR--LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHD 119
Query: 524 KRPGLVHPNLSAEKVLIHRR-YNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEY 579
++ ++H ++ ++ + + + L D G+ + L D SM A +G YL+PE
Sbjct: 120 RK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND----SMELAYTCVGTPYYLSPEI 173
Query: 580 TTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKF---SVS 636
+ K+DI++ G +++++ + K PF E + + + +G F S +
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLK---HPF-----EGNNLHQLVLKICQGYFAPISPN 225
Query: 637 EASNLGQIALHCTHESPSHRPSIENVMQ 664
+ +L + SP RPSI ++++
Sbjct: 226 FSRDLRSLISQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 482 FVPNGNLLQHLDLEAGSE----KVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEK 537
FV +L + EA E KVL I +AKG+ +L ++ +H +L+A
Sbjct: 152 FVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARN 209
Query: 538 VLIHRRYNPLLSDSGLHK-LLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGM 596
+L+ + D GL + + D A + ++APE +T +SD+++FG+
Sbjct: 210 ILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 269
Query: 597 IVFQILSGKCSITP-------FTRQAAESSKVE--DFIDPNLEGKFSVSEASNLGQIALH 647
++++I S S P F R+ E +++ D+ P + Q L
Sbjct: 270 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY------------QTMLD 317
Query: 648 CTHESPSHRPSIENVMQELSSIIGSS 673
C H PS RP+ +++ L +++ ++
Sbjct: 318 CWHGEPSQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 62/281 (22%), Positives = 123/281 (43%), Gaps = 45/281 (16%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKC--IAKTSCKSDEGEFLKGLKILTS-------LKH 458
L+GK ++ Y + + G ++AVK + T + +K L S L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 459 ENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGI 518
N+ G + ++VP G++ L E+ L R + + +G+
Sbjct: 68 LNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL---VR-FFTEQVLEGL 121
Query: 519 SYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV--FSMLKASAAMGYLA 576
+YLH K G++H +L A+ +L+ +SD G+ K +DDI + ++ ++A
Sbjct: 122 AYLHSK--GILHRDLKADNLLVDADGICKISDFGISKK-SDDIYDNDQNMSMQGSVFWMA 178
Query: 577 PEYTTTGR--FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF-------IDP 627
PE + ++ K DI++ G +V ++ +G+ P++ + A ++ + I P
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR---RPWSDEEAIAAMFKLGNKRSAPPIPP 235
Query: 628 NLEGKFSVSEASNLGQIALH----CTHESPSHRPSIENVMQ 664
++ + NL +AL C +P +RP+ ++Q
Sbjct: 236 DV--------SMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 52/243 (21%), Positives = 94/243 (38%), Gaps = 54/243 (22%)
Query: 398 ERATQCFSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEF---------- 446
ER Q LG+ ++ K G +VA+K + +D +
Sbjct: 8 ERYIQK---GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64
Query: 447 ---LKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGS-EKVL 502
L+ LKI+ +KHEN+ L + DF+ NL+ +D+ A +KV+
Sbjct: 65 FTTLRELKIMNEIKHENIMGLVDVYVEG---------DFI---NLV--MDIMASDLKKVV 110
Query: 503 EWATRIS------VIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556
+ R++ ++ I G++ LH +H +LS + I+ + ++D GL +
Sbjct: 111 DRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARR 168
Query: 557 LADDIVFSMLKASAAMG-------------YLAPEYTT-TGRFTEKSDIYAFGMIVFQIL 602
L M Y APE ++ D+++ G I ++L
Sbjct: 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228
Query: 603 SGK 605
+GK
Sbjct: 229 TGK 231
|
Length = 335 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 44/196 (22%), Positives = 94/196 (47%), Gaps = 24/196 (12%)
Query: 424 RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE-CFLIYDF 482
+D +VAVK + K + +F + ++LT+L+HE++ G+C G G+ +++++
Sbjct: 33 KDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQHEHIVKFYGVC---GDGDPLIMVFEY 88
Query: 483 VPNGNLLQHL--------------DLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGL 528
+ +G+L + L +A E L + + + IA G+ YL +
Sbjct: 89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGE--LGLSQMLHIASQIASGMVYLASQH--F 144
Query: 529 VHPNLSAEKVLIHRRYNPLLSDSGLHK-LLADDIVFSMLKASAAMGYLAPEYTTTGRFTE 587
VH +L+ L+ + D G+ + + + D + ++ PE +FT
Sbjct: 145 VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT 204
Query: 588 KSDIYAFGMIVFQILS 603
+SD+++FG+I+++I +
Sbjct: 205 ESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 3e-06
Identities = 25/60 (41%), Positives = 28/60 (46%)
Query: 138 NLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNL 197
NL+ L L N+LT L L VL L N LT P + L L LDLS NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 39/147 (26%), Positives = 68/147 (46%), Gaps = 11/147 (7%)
Query: 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEK 537
LI D+V G L HL E E R+ I I + +LH + G+++ ++ E
Sbjct: 82 LILDYVNGGELFTHL---YQREHFTESEVRV-YIAEIVLALDHLH--QLGIIYRDIKLEN 135
Query: 538 VLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGR--FTEKSDIYAFG 595
+L+ + +L+D GL K + + Y+APE G + D ++ G
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLG 195
Query: 596 MIVFQILSGKCSITPFTRQAAESSKVE 622
++ F++L+G S PFT ++S+ E
Sbjct: 196 VLTFELLTG-AS--PFTVDGEQNSQSE 219
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 409 LLGKSSFSATYKGILR-DGSVVAVKCIAK-TSCKSDEGEFLKGLKILTSLKHENLASLRG 466
+LGK SF L+ G AVK + K D+ E K + +L EN
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
C + + F + +F+ G+L+ H+ + + L AT + I G+ +LH K
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFD--LYRATFYAA--EIVCGLQFLHSK-- 115
Query: 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTTTG 583
G+++ +L + V++ R + ++D G+ K + VF +AS G Y+APE
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCK----ENVFGDNRASTFCGTPDYIAPEILQGL 171
Query: 584 RFTEKSDIYAFGMIVFQILSGKCSITPF 611
++T D ++FG++++++L G+ +PF
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQ---SPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 68/272 (25%), Positives = 117/272 (43%), Gaps = 29/272 (10%)
Query: 410 LGKSSFSATYKGILR-------DGSVVAVKCIAKT--SCKSDEGEFLKGLKILTSLKHEN 460
LG+ +F+ YKG+LR G V + K S D F + +++ L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 461 LASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISY 520
L L G+C R E ++ ++V G L L E + L W ++ V K +A + Y
Sbjct: 63 LVKLYGVCV---RDENIMVEEYVKFGPLDVFLHREKNNVS-LHW--KLDVAKQLASALHY 116
Query: 521 LHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAP 577
L K LVH N+ + +L+ RY KL I ++L + ++AP
Sbjct: 117 LEDK--KLVHGNVCGKNILV-ARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAP 173
Query: 578 EYTTTGR--FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635
E G+ T +D ++FG + +I CS SS+ E F + + +
Sbjct: 174 ECIRNGQASLTIAADKWSFGTTLLEI----CSNGEEPLSTLSSSEKERFYQD--QHRLPM 227
Query: 636 SEASNLGQIALHCTHESPSHRPSIENVMQELS 667
+ + L + C P+ RPS ++++L+
Sbjct: 228 PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 61/279 (21%), Positives = 119/279 (42%), Gaps = 31/279 (11%)
Query: 398 ERATQCFSEANLLGKSSFSATY-KGILRDGSVVAVKCIAKTSCKSDEG--EFLKGLKILT 454
E + F++ +G SF A Y +R VVA+K ++ + +S+E + +K +K L
Sbjct: 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80
Query: 455 SLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGI 514
+KH N +G C +L+ ++ L DL +K L+ ++ G
Sbjct: 81 RIKHPNSIEYKG--CYLREHTAWLVMEYC----LGSASDLLEVHKKPLQEVEIAAITHGA 134
Query: 515 AKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG- 573
+G++YLH ++H ++ A +L+ L+D G + + A++ +G
Sbjct: 135 LQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIAS--------PANSFVGT 184
Query: 574 --YLAPEYTTT---GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPN 628
++APE G++ K D+++ G+ ++ K P A S+ I N
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK---PPLFNMNAMSALYH--IAQN 239
Query: 629 LEGKFSVSEASN-LGQIALHCTHESPSHRPSIENVMQEL 666
+E S+ C + P RP+ E +++ +
Sbjct: 240 ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 5e-06
Identities = 48/229 (20%), Positives = 93/229 (40%), Gaps = 34/229 (14%)
Query: 456 LKHENLASL--RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKG 513
L H N+ +L G G F ++++VP L + L ++ L ++
Sbjct: 35 LYHPNIVALLDSGEA---PPGLLFAVFEYVPGRTLREVL----AADGALPAGETGRLMLQ 87
Query: 514 IAKGISYLHGKRPGLVHPNLSAEKVLIHR---RYNPLLSDSGLHKLLAD--DIVFSMLKA 568
+ ++ H G+VH +L + +++ + R + + D G+ LL D + L
Sbjct: 88 VLDALACAH--NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTR 145
Query: 569 SAAM----GYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA---ESSKV 621
+ + Y APE T SD+YA+G+I + L+G+ + + + S V
Sbjct: 146 TTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPV 205
Query: 622 EDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHR----PSIENVMQEL 666
+ + P + G LGQ+ ++ P R P++ + L
Sbjct: 206 DVSLPPWIAGH-------PLGQVLRKALNKDPRQRAASAPALAERFRAL 247
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 44/199 (22%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 410 LGKSSFSATYKGI-LRDGSVVAVKCIA-KTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
+G+ ++ YK G +VA+K I + + L+ +K+L L H N+ L +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG 527
KG +L+++F+ + +L + + ++ L + S + + +G+++ H G
Sbjct: 67 FRHKGD--LYLVFEFM-DTDLYKLIK---DRQRGLPESLIKSYLYQLLQGLAFCH--SHG 118
Query: 528 LVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRF-T 586
++H +L E +LI+ L+D GL + + Y APE + +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP-YTHYVVTRWYRAPELLLGDKGYS 177
Query: 587 EKSDIYAFGMIVFQILSGK 605
DI++ G I ++LS +
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 40/133 (30%), Positives = 59/133 (44%), Gaps = 26/133 (19%)
Query: 111 SLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLT-------------------- 150
+L L L LN+N L I + +TNL L L N +T
Sbjct: 91 NLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSD 149
Query: 151 ---GNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLAN 207
++P+ L +L L L L +N L+ +P L +L L LDLS N + +P ++
Sbjct: 150 NKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIEL 207
Query: 208 VPKLEVLDIRNNS 220
+ LE LD+ NNS
Sbjct: 208 LSALEELDLSNNS 220
|
Length = 394 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 50/220 (22%), Positives = 89/220 (40%), Gaps = 43/220 (19%)
Query: 404 FSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEG-------EFLKGLKILTS 455
+ E +G+ ++ YK L G VA+K + S+EG E + LK L S
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR--VPLSEEGIPLSTLRE-IALLKQLES 57
Query: 456 LKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLD------LEAGSEKVLEWATRIS 509
+H N+ L +C + V +H+D L + L T
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLT-LV-----FEHVDQDLATYLSKCPKPGLPPETIKD 111
Query: 510 VIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKAS 569
+++ + +G+ +LH R +VH +L + +L+ ++D GL ++ + F M S
Sbjct: 112 LMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIYS----FEMALTS 165
Query: 570 --AAMGYLAPE------YTTTGRFTEKSDIYAFGMIVFQI 601
+ Y APE Y T D+++ G I ++
Sbjct: 166 VVVTLWYRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 57/218 (26%), Positives = 93/218 (42%), Gaps = 17/218 (7%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGL--KILTSLKHENLASLRG 466
LGK F ++ G + A K + K K +GE + KIL + + SL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
+K + L+ + G+L H+ E A I I G+ +LH +R
Sbjct: 61 AFETKD--DLCLVMTLMNGGDLKYHI--YNVGEPGFPEARAIFYAAQIICGLEHLHQRR- 115
Query: 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAM-GYLAPEYTTTGRF 585
+V+ +L E VL+ N +SD GL L +K A GY+APE +
Sbjct: 116 -IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGRAGTPGYMAPEVLQGEVY 171
Query: 586 TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVED 623
D +A G ++++++G+ +PF RQ E + E+
Sbjct: 172 DFSVDWFALGCTLYEMIAGR---SPF-RQRKEKVEKEE 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 35/148 (23%), Positives = 72/148 (48%), Gaps = 13/148 (8%)
Query: 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKG-IAKGISYLHGKRPGLVHPNLSAE 536
LI D++ G L HL S++ + + G I + +LH + G+++ ++ E
Sbjct: 82 LILDYINGGELFTHL-----SQRERFKEQEVQIYSGEIVLALEHLH--KLGIIYRDIKLE 134
Query: 537 KVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGR--FTEKSDIYAF 594
+L+ + +L+D GL K +D V + Y+AP+ G + D ++
Sbjct: 135 NILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSM 194
Query: 595 GMIVFQILSGKCSITPFTRQAAESSKVE 622
G++++++L+G +PFT ++S+ E
Sbjct: 195 GVLMYELLTGA---SPFTVDGEKNSQAE 219
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 409 LLGKSSFSATYKGILR-DGSVVAVKCIAK-TSCKSDEGEFLKGLKILTSLKHENLASLRG 466
+LGK SF L+ G + AVK + K + D+ E K + SL + +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
CC + F + +FV G+L+ H+ S + E R + I + +LH K
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAE-ITSALMFLHDK-- 115
Query: 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTTTG 583
G+++ +L + VL+ + L+D G+ K + +F+ S G Y+APE
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGIFNGKTTSTFCGTPDYIAPEILQEM 171
Query: 584 RFTEKSDIYAFGMIVFQILSGKCSITPF 611
+ D +A G++++++L G PF
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGH---APF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 409 LLGKSSFSATYKGILRD---GSVVAVKCIAKTS--CKSDEGEFLKGLKILTSLKHENLAS 463
LLGK +F ++R+ G A+K + K K + L ++L + +H L S
Sbjct: 2 LLGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVL-EWATRISVIKGIAKGISYLH 522
L+ +K R CF++ ++V G L HL E+V E TR + I + YLH
Sbjct: 60 LKYSFQTKDR-LCFVM-EYVNGGELFFHLS----RERVFSEDRTRFYGAE-IVSALDYLH 112
Query: 523 GKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT 582
+ +V+ +L E +++ + + ++D GL K D +M YLAPE
Sbjct: 113 SGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKTFCGTPEYLAPEVLED 169
Query: 583 GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE 617
+ D + G+++++++ G+ PF Q E
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR---LPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 59/228 (25%), Positives = 107/228 (46%), Gaps = 40/228 (17%)
Query: 391 MFNLEEVERATQCFSEANLLGKSSFSATYKGILRD---GSVVAVKCIAKTSCKSDEG--- 444
M E+VE+ G+ ++ YK RD +A+K I + DEG
Sbjct: 1 MDQYEKVEKI----------GEGTYGVVYKA--RDRVTNETIALKKIRLE--QEDEGVPS 46
Query: 445 EFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEW 504
++ + +L ++H N+ L+ + S+ R +L+++++ LDL+ + ++
Sbjct: 47 TAIREISLLKEMQHGNIVRLQDVVHSEKR--LYLVFEYL-------DLDLKKHMDSSPDF 97
Query: 505 ATRISVIKG----IAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPL-LSDSGLHKLLAD 559
A +IK I +GI+Y H R ++H +L + +LI RR N L L+D GL + A
Sbjct: 98 AKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLAR--AF 153
Query: 560 DI-VFSMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGK 605
I V + + Y APE R ++ DI++ G I ++++ K
Sbjct: 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 4e-05
Identities = 20/59 (33%), Positives = 24/59 (40%)
Query: 115 LSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQL 173
L L L+ N L+ + NL+VL L N LT P L L L L N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 39/167 (23%), Positives = 73/167 (43%), Gaps = 27/167 (16%)
Query: 451 KILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAG---SEKVLEWATR 507
++L + H + L + +++ ++VP G L +L +G + L +A+
Sbjct: 53 RVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLR-NSGRFSNSTGLFYASE 109
Query: 508 ISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLK 567
I + YLH K +V+ +L E +L+ + + L+D G K L D +
Sbjct: 110 ------IVCALEYLHSK--EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-------R 154
Query: 568 ASAAMG---YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
G YLAPE + + D +A G++++++L G PF
Sbjct: 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG---YPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 65/281 (23%), Positives = 116/281 (41%), Gaps = 46/281 (16%)
Query: 410 LGKSSFSATYKGILRD---------GSVVAVKCIAKT---SCKSDEGEFLKGLKILTSLK 457
LG+ + + Y GIL +K I K S + F + ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 458 HENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKG 517
H+++ L G+C E ++ +FV G L L + S+ VL + V K +A
Sbjct: 63 HKHIVLLYGVCVRDV--ENIMVEEFVEFGPL--DLFMHRKSD-VLTTPWKFKVAKQLASA 117
Query: 518 ISYLHGKRPGLVHPNLSAEKVLIHR-----RYNPL--LSDSGLHKLLADDIVFSMLKASA 570
+SYL K LVH N+ + +L+ R P LSD G+ V S +
Sbjct: 118 LSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPGI-----PITVLSRQECVE 170
Query: 571 AMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQI-LSGKCSITPFT-RQAAESSKVEDFIDP 627
+ ++APE + + +D ++FG +++I +G+ P + AE +
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGE---IPLKDKTLAEKERF------ 221
Query: 628 NLEGKFSVSEAS--NLGQIALHCTHESPSHRPSIENVMQEL 666
EG+ + S L + HC + P+ RP +M+++
Sbjct: 222 -YEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 30/128 (23%), Positives = 57/128 (44%), Gaps = 11/128 (8%)
Query: 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAE 536
+L+ +++ G+ + G +WA + I + G+ LH + G++H ++ E
Sbjct: 73 YLVMEYLNGGDCASLIKTLGGLP--EDWAKQ--YIAEVVLGVEDLHQR--GIIHRDIKPE 126
Query: 537 KVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGM 596
+LI + + L+D GL + K YLAPE + SD ++ G
Sbjct: 127 NLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGC 181
Query: 597 IVFQILSG 604
++F+ L G
Sbjct: 182 VIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 32/226 (14%)
Query: 409 LLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLK-GLKILTSLKHENLASLRG 466
++G+ F Y D G + A+KC+ K K +GE L +I+ SL
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI- 59
Query: 467 ICCSKGRGE----CFLIYDFVPNGNLLQHLDLEA-GSEKVLE-WATRISVIKGIAKGISY 520
+C + CF I D + G+L HL SEK + +AT I + G+ +
Sbjct: 60 VCMTYAFHTPDKLCF-ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEH 112
Query: 521 LHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAM---GYLAP 577
+H + +V+ +L +L+ + +SD G LA D FS K A++ GY+AP
Sbjct: 113 MHNRF--VVYRDLKPANILLDEHGHVRISDLG----LACD--FSKKKPHASVGTHGYMAP 164
Query: 578 EYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE 622
E G + +D ++ G ++F++L G +PF RQ K E
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGH---SPF-RQHKTKDKHE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 39/119 (32%), Positives = 64/119 (53%), Gaps = 24/119 (20%)
Query: 447 LKGLKILTSLKHENLASLRGICCSKG------RGECFLIYDFVPNGNLLQHLDLEAG--S 498
L+ +KIL LKHEN+ +L IC +K +G +L+++F +H DL AG S
Sbjct: 59 LREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFC------EH-DL-AGLLS 110
Query: 499 EKVLEWATRISVIKGIAK----GISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL 553
K +++ +S IK + K G+ Y+H R ++H ++ A +LI + L+D GL
Sbjct: 111 NKNVKFT--LSEIKKVMKMLLNGLYYIH--RNKILHRDMKAANILITKDGILKLADFGL 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 41/195 (21%), Positives = 86/195 (44%), Gaps = 19/195 (9%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
LG +F YK ++ + A I + + + +F+ + IL+ KH N+ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLV 529
+ + +++ +F G L + LE E+ L V + + + +++LH + ++
Sbjct: 73 YENK--LWILIEFCDGGA-LDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK--VI 125
Query: 530 HPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTTTGRFT 586
H +L A +L+ + L+D G+ ++ K +G ++APE F
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKS----TLQKRDTFIGTPYWMAPEVVACETFK 181
Query: 587 E-----KSDIYAFGM 596
+ K+DI++ G+
Sbjct: 182 DNPYDYKADIWSLGI 196
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 30/152 (19%), Positives = 69/152 (45%), Gaps = 10/152 (6%)
Query: 452 ILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVI 511
+L ++ H ++ ++ S C ++ + + +L +L + L + +
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGA-ITCMVLPHY--SSDLYTYLTKRSRP---LPIDQALIIE 163
Query: 512 KGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAA 571
K I +G+ YLH +R ++H ++ E + I+ + D G + F L +
Sbjct: 164 KQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVE 221
Query: 572 MGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS 603
APE ++ K+DI++ G+++F++L+
Sbjct: 222 TN--APEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 51/202 (25%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 410 LGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLK---ILTSLKHENLASLR 465
LG+ S++ YKGI R +G +VA+K I S K++EG ++ +L LKH N+ L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVI---SMKTEEGVPFTAIREASLLKGLKHANIVLLH 69
Query: 466 GICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
I +K +++++ + +L Q++ G + + R+ + + + +G++Y+HG+
Sbjct: 70 DIIHTK--ETLTFVFEYM-HTDLAQYMIQHPGG--LHPYNVRLFMFQ-LLRGLAYIHGQH 123
Query: 526 PGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG-- 583
++H +L + +LI L+D GL + A I + + P G
Sbjct: 124 --ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVLLGAT 179
Query: 584 RFTEKSDIYAFGMIVFQILSGK 605
++ DI+ G I ++L G+
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 33/129 (25%), Positives = 66/129 (51%), Gaps = 13/129 (10%)
Query: 489 LQHLDLEAGS-EKVLEWATRI------SVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIH 541
++H+D GS ++VL+ A RI V + +G++YL K ++H ++ +L++
Sbjct: 82 MEHMD--GGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ-IMHRDVKPSNILVN 138
Query: 542 RRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQI 601
R L D G+ L D + S + + Y++PE ++ +SDI++ G+ + ++
Sbjct: 139 SRGEIKLCDFGVSGQLIDSMANSFVGTRS---YMSPERLQGTHYSVQSDIWSMGLSLVEL 195
Query: 602 LSGKCSITP 610
G+ I P
Sbjct: 196 AIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 49/255 (19%), Positives = 103/255 (40%), Gaps = 27/255 (10%)
Query: 429 VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNL 488
V VK + ++ ++ FL+ ++ L H N+ G C L+ +F P G+L
Sbjct: 25 VVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES--IPYLLVLEFCPLGDL 82
Query: 489 LQHLDLEAGSEKVL-EWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPL 547
+L G + + + +A G+ +LH + +H +L+ + +
Sbjct: 83 KNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--QADFIHSDLALRNCQLTADLSVK 140
Query: 548 LSDSGL-HKLLADDIVFSMLKASAAMGYLAPEYTT-------TGRFTEKSDIYAFGMIVF 599
+ D GL + +D + + + +LAPE T+KS+I++ G+ ++
Sbjct: 141 IGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMW 200
Query: 600 QILSGKCSITPFTRQAAESSKVEDFID-------PNLEGKFSVSEASNLGQIALHCTHES 652
++ + + P+ + E + + P L+ K+S ++ C
Sbjct: 201 ELFTA--ADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYS----DRWYEVMQFCWL-D 253
Query: 653 PSHRPSIENVMQELS 667
P RP+ E V + L+
Sbjct: 254 PETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 409 LLGKSSFSATY---KGILRD-GSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLAS 463
+LG+ SF + K D G + A+K + K + K D IL + H +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISV---IKGIAKGISY 520
L + G+ +LI DF+ G+L L S++V+ T V + +A + +
Sbjct: 63 LH--YAFQTEGKLYLILDFLRGGDLFTRL-----SKEVM--FTEEDVKFYLAELALALDH 113
Query: 521 LHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAP 577
LH G+++ +L E +L+ + L+D GL K D KA + G Y+AP
Sbjct: 114 LHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH----EKKAYSFCGTVEYMAP 167
Query: 578 EYTTTGRFTEKSDIYAFGMIVFQILSG 604
E T+ +D ++FG+++F++L+G
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 38/212 (17%)
Query: 409 LLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGL-----KILTSLKHENLA 462
L+G+ S+ K ++ G +VA+K +S++ + +K + ++L L+HENL
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF----LESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 463 SLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLH 522
+L + K R +L+++FV + +L DLE L+ + + I +GI + H
Sbjct: 64 NLIEVFRRKKR--LYLVFEFVDH-TVLD--DLEK-YPNGLDESRVRKYLFQILRGIEFCH 117
Query: 523 GKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA------DDIVFSMLKASAAMGYLA 576
++H ++ E +L+ + L D G + LA D V A Y A
Sbjct: 118 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-------ATRWYRA 168
Query: 577 PEY----TTTGRFTEKSDIYAFGMIVFQILSG 604
PE T GR DI+A G +V ++L+G
Sbjct: 169 PELLVGDTKYGR---AVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 42/168 (25%), Positives = 77/168 (45%), Gaps = 26/168 (15%)
Query: 507 RISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSML 566
RI+V + KG++YL + ++H ++ +L++ R L D G+ L + I + +
Sbjct: 99 RIAV--AVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV 154
Query: 567 KASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGK----------CSITPFTRQAA 616
+A Y+APE + ++ SD+++ G+ ++ G+ S+ P Q
Sbjct: 155 GTNA---YMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL--QLL 209
Query: 617 ESSKVEDFIDPNL-EGKFSVSEASNLGQIALHCTHESPSHRPSIENVM 663
+ ED P L G+FS + Q C + P RP+ EN+M
Sbjct: 210 QCIVDED--PPVLPVGQFSEKFVHFITQ----CMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 40/161 (24%), Positives = 76/161 (47%), Gaps = 12/161 (7%)
Query: 447 LKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNG--NLLQHLDLEAGSEKVLEW 504
L+ LK+L +LK EN+ L+ + RG+ +L++++V LL+ + EKV
Sbjct: 48 LRELKMLRTLKQENIVELKE--AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-- 103
Query: 505 ATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFS 564
S I + K I + H + +VH ++ E +LI L D G + L++ +
Sbjct: 104 ----SYIYQLIKAIHWCH--KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157
Query: 565 MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGK 605
+ A Y +PE + + D+++ G I+ ++ G+
Sbjct: 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 23/216 (10%)
Query: 410 LGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLK--ILTSLKHENLASLR 465
+GK SF + DG AVK + K + K E + + + +L ++KH L L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 466 GICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
+ + + + D+V G L HL E E R + IA + YLH
Sbjct: 63 YSFQTADK--LYFVLDYVNGGELFFHLQRE---RSFPEPRARFYAAE-IASALGYLHSLN 116
Query: 526 PGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTTT 582
+++ +L E +L+ + + +L+D GL K + I S S G YLAPE
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSK-TTSTFCGTPEYLAPEVLRK 170
Query: 583 GRFTEKSDIYAFGMIVFQILSGKCSITPF-TRQAAE 617
+ D + G +++++L G + PF +R AE
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG---LPPFYSRDTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 40/158 (25%), Positives = 78/158 (49%), Gaps = 18/158 (11%)
Query: 489 LQHLDLEAGS-EKVLEWATRI------SVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIH 541
++H+D GS ++VL+ A RI V + KG++YL K ++H ++ +L++
Sbjct: 82 MEHMD--GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVN 138
Query: 542 RRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQI 601
R L D G+ L D + S + + Y++PE ++ +SDI++ G+ + ++
Sbjct: 139 SRGEIKLCDFGVSGQLIDSMANSFVGTRS---YMSPERLQGTHYSVQSDIWSMGLSLVEM 195
Query: 602 LSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639
G+ I P ++ ++E +EG + SE S
Sbjct: 196 AIGRYPIPP-----PDAKELELMFGCPVEGDPAESETS 228
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 54/225 (24%), Positives = 100/225 (44%), Gaps = 20/225 (8%)
Query: 404 FSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGE--FLKGLKILTSLKHEN 460
F + +LGK F +R G + A K + K K +GE L +IL +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 461 LASLRGICCSKGRGECFLIYDFVPNGNLLQHLDL--EAGSEKVLEWATRISVIKGIAKGI 518
+ SL + + L+ + G+L H+ EAG E+ + I G+
Sbjct: 62 VVSL--AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEE----GRAVFYAAEICCGL 115
Query: 519 SYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKAS-AAMGYLAP 577
LH +R +V+ +L E +L+ + +SD GL + + +K +GY+AP
Sbjct: 116 EDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKGRVGTVGYMAP 170
Query: 578 EYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE 622
E R+T D +A G +++++++G+ +PF ++ + + E
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQ---SPFQQRKKKIKREE 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 55/229 (24%), Positives = 99/229 (43%), Gaps = 27/229 (11%)
Query: 404 FSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGE--FLKGLKILTSLKHEN 460
F + +LGK F +R G + A K + K K +GE L +IL + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 461 LASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGS-----EKVLEWATRISVIKGIA 515
+ +L + + L+ + G+L H+ G+ E+ L +A I
Sbjct: 62 VVNL--AYAYETKDALCLVLTIMNGGDLKFHI-YNMGNPGFEEERALFYAAEILC----- 113
Query: 516 KGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLH-KLLADDIVFSMLKASAAMGY 574
G+ LH R V+ +L E +L+ + +SD GL K+ + + + +GY
Sbjct: 114 -GLEDLH--RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGY 167
Query: 575 LAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVED 623
+APE R+T D + G ++++++ G+ +PF R E K E+
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ---SPF-RGRKEKVKREE 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 44/171 (25%), Positives = 79/171 (46%), Gaps = 24/171 (14%)
Query: 482 FVPNGN---LLQHLDLEAGS-EKVLEWATRI------SVIKGIAKGISYLHGKRPGLVHP 531
F +G ++H+D GS ++VL+ A RI + + +G++YL K ++H
Sbjct: 68 FYSDGEISICMEHMD--GGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH-KIMHR 124
Query: 532 NLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTTTGRFTEK 588
++ +L++ R L D G+ L D SM A++ +G Y++PE +T +
Sbjct: 125 DVKPSNILVNSRGEIKLCDFGVSGQLID----SM--ANSFVGTRSYMSPERLQGTHYTVQ 178
Query: 589 SDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639
SDI++ G+ + ++ G+ I P A E + E K S S
Sbjct: 179 SDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVS 227
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 5e-04
Identities = 52/211 (24%), Positives = 97/211 (45%), Gaps = 36/211 (17%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGI 467
LG +F + Y ++ G +VA+K + K +E L+ +K L L H N+ L+ +
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAG---SEKVLEWATRISVIKGIAKGISYLHGK 524
+ E + +++++ GNL Q + G SE V+ S+I I +G++++H
Sbjct: 67 F--RENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR-----SIIYQILQGLAHIH-- 116
Query: 525 RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPE--- 578
+ G H +L E +L+ ++D G LA +I S + + Y APE
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFG----LAREIR-SRPPYTDYVSTRWYRAPEILL 171
Query: 579 ----YTTTGRFTEKSDIYAFGMIVFQILSGK 605
Y++ DI+A G I+ ++ + +
Sbjct: 172 RSTSYSS------PVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 38/165 (23%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 514 IAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASA--A 571
+A+G+ +L ++ +H +L+A +L+ + D GL + + D + + K A
Sbjct: 182 VARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLP 238
Query: 572 MGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEG 631
+ ++APE +T +SD+++FG+++++I S S P + E+F EG
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID------EEFCRRLKEG 292
Query: 632 ------KFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+++ E + I L C H +P RP+ +++ L ++
Sbjct: 293 TRMRAPEYATPE---IYSIMLDCWHNNPEDRPTFSELVEILGDLL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 6e-04
Identities = 21/60 (35%), Positives = 27/60 (45%)
Query: 162 KLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSF 221
L L L N+LT + L L LDLS NNL P + +P L LD+ N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 60/243 (24%), Positives = 102/243 (41%), Gaps = 37/243 (15%)
Query: 409 LLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLK-GLKILTSLKHENLASLRG 466
++G+ F Y D G + A+KC+ K K +GE L +I+ SL
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF-- 58
Query: 467 ICCSKGRGE-----CFLIYDFVPNGNLLQHLDLEA--GSEKVLEWATRISVIKGIAKGIS 519
I C F I D + G+L HL ++ +A I + G+
Sbjct: 59 IVCMSYAFHTPDKLSF-ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL------GLE 111
Query: 520 YLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAM---GYLA 576
++H + +V+ +L +L+ + +SD G LA D FS K A++ GY+A
Sbjct: 112 HMHNR--FVVYRDLKPANILLDEHGHVRISDLG----LACD--FSKKKPHASVGTHGYMA 163
Query: 577 PEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPF----TRQAAESSKVEDFIDPNLEG 631
PE G + +D ++ G ++F++L G +PF T+ E ++ + L
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH---SPFRQHKTKDKHEIDRMTLTMAVELPD 220
Query: 632 KFS 634
FS
Sbjct: 221 SFS 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 62/273 (22%), Positives = 104/273 (38%), Gaps = 40/273 (14%)
Query: 410 LGKSSFSATYKGI-LRDGSVVAVKCI---------AKTSCKSDEGEFLKGLKILTSLKHE 459
+GK FS YK I L DG VVA+K + A+ C LK + +L L H
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDC-------LKEIDLLKQLDHP 62
Query: 460 N----LASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIA 515
N LAS E ++ + G+L + + ++++ T +
Sbjct: 63 NVIKYLASF------IENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 516 KGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYL 575
+ ++H KR ++H ++ V I L D GL + + + Y+
Sbjct: 117 SALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-YM 173
Query: 576 APEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE----SSKVEDFIDPNLEG 631
+PE + KSDI++ G +++++ +PF K+E P L
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM---AALQSPFYGDKMNLYSLCKKIEKCDYPPLPA 230
Query: 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664
E +L C + P RP I V+Q
Sbjct: 231 DHYSEELRDLVSR---CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 49/217 (22%), Positives = 91/217 (41%), Gaps = 17/217 (7%)
Query: 409 LLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGL----KILTSLKHENLAS 463
LLG+ +F Y D G +AVK + + + + L ++L +L+H+ +
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLD-LEAGSEKVLEWATRISVIKGIAKGISYLH 522
G + + +++P G++ L A +E V TR I +G+SYLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR-----QILQGVSYLH 123
Query: 523 GKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEY 579
+VH ++ +L N L D G K + I S + G +++PE
Sbjct: 124 SNM--IVHRDIKGANILRDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGTPYWMSPEV 180
Query: 580 TTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA 616
+ + K+D+++ V ++L+ K + AA
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA 217
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 55/229 (24%), Positives = 94/229 (41%), Gaps = 58/229 (25%)
Query: 404 FSEANLLGKSSFSATYKGILRD---GSVVAVKCIAKTSCKSDEGEFLKGLK---ILTSLK 457
F + N +G+ ++ Y+ RD G +VA+K + +G + L+ +L +L+
Sbjct: 9 FEKLNRIGEGTYGIVYRA--RDTTSGEIVALKKVRMD--NERDGIPISSLREITLLLNLR 64
Query: 458 HENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATR---ISVIKGI 514
H N+ L+ + K FL+ ++ DL + +L+ S +K +
Sbjct: 65 HPNIVELKEVVVGKHLDSIFLVMEYCEQ-------DLAS----LLDNMPTPFSESQVKCL 113
Query: 515 A----KGISYLHGKRPGLVHPNLSAEKVLIHRRY---NPLLSDSGLHKLLAD-------- 559
+G+ YLH E +IHR N LL+D G K +AD
Sbjct: 114 MLQLLRGLQYLH-------------ENFIIHRDLKVSNLLLTDKGCLK-IADFGLARTYG 159
Query: 560 DIVFSMLKASAAMGYLAPEY---TTTGRFTEKSDIYAFGMIVFQILSGK 605
M + Y APE TT +T D++A G I+ ++L+ K
Sbjct: 160 LPAKPMTPKVVTLWYRAPELLLGCTT--YTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 8e-04
Identities = 46/210 (21%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 410 LGKSSFSATYKGILRDGSV---VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRG 466
+G+ ++ YK +DG A+K I T + + +L LKH N+ SL+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA---CREIALLRELKHPNVISLQK 65
Query: 467 ICCSKGRGECFLIYDFVPNG--NLLQHLDLEAGSEKVLEWATRI--SVIKGIAKGISYLH 522
+ S + +L++D+ + ++++ ++K ++ + S++ I GI YLH
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 523 GKRPGLVHPNLSAEKVLIH----RRYNPLLSDSGLHKLLADDI--VFSMLKASAAMGYLA 576
++H +L +L+ R ++D G +L + + + Y A
Sbjct: 126 AN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 577 PEYTTTGR-FTEKSDIYAFGMIVFQILSGK 605
PE R +T+ DI+A G I ++L+ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 35/168 (20%), Positives = 78/168 (46%), Gaps = 26/168 (15%)
Query: 514 IAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASA--A 571
+A+G+ +L ++ +H +L+A +L+ + D GL + + D + + K SA
Sbjct: 183 VARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARLP 239
Query: 572 MGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITP-------FTRQAAESSKVE-- 622
+ ++APE +T +SD+++FG+++++I S S P F ++ + +++
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAP 299
Query: 623 DFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+ P + I L C P RP+ +++ L ++
Sbjct: 300 ENATPEIYR------------IMLACWQGDPKERPTFSALVEILGDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 45/210 (21%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 410 LGKSSFSATYKGILRDGS---VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRG 466
+G+ ++ YK +DG A+K I T + + +L LKH N+ +L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA---CREIALLRELKHPNVIALQK 65
Query: 467 ICCSKGRGECFLIYDFVPNG--NLLQHLDLEAGSEKVLEWATRI--SVIKGIAKGISYLH 522
+ S + +L++D+ + ++++ ++K ++ + S++ I GI YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 523 GKRPGLVHPNLSAEKVLIH----RRYNPLLSDSGLHKLLADDI--VFSMLKASAAMGYLA 576
++H +L +L+ R ++D G +L + + + Y A
Sbjct: 126 AN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 577 PEYTTTGR-FTEKSDIYAFGMIVFQILSGK 605
PE R +T+ DI+A G I ++L+ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 48/188 (25%), Positives = 79/188 (42%), Gaps = 24/188 (12%)
Query: 505 ATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK--------L 556
+S+ I I Y+H K G++H +L + +L+ ++ D G L
Sbjct: 113 GAFLSIFHKICATIEYVHSK--GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDL 170
Query: 557 LADD-----IVFS-MLKASAAMG---YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCS 607
L D I +S M +G Y+APE +E +DIYA G+I++Q+L+
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLS-- 228
Query: 608 ITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHR-PSIENVMQEL 666
P+ R+ D I +E L QIA+ P+ R S++ + Q+L
Sbjct: 229 -FPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL 287
Query: 667 SSII-GSS 673
+ GS
Sbjct: 288 EPHLQGSP 295
|
Length = 932 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 51/222 (22%), Positives = 95/222 (42%), Gaps = 34/222 (15%)
Query: 409 LLGKSSFSATYKGILR-DGSVVAVKCIAK-TSCKSDEGEFLKGLKILTSLKHENLASLRG 466
+LGK SF + L+ A+K + K D+ E K + SL E+
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHL------DLEAGSEKVLEWATRISVIKGIAKGISY 520
C + + F + +++ G+L+ H+ DL + E I G+ +
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE----------IICGLQF 111
Query: 521 LHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK--LLADDIVFSMLKASAAMG---YL 575
LH K G+V+ +L + +L+ + ++D G+ K +L D K G Y+
Sbjct: 112 LHSK--GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD------AKTCTFCGTPDYI 163
Query: 576 APEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE 617
APE ++ D ++FG++++++L G+ +PF E
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQ---SPFHGHDEE 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 36.9 bits (86), Expect = 0.001
Identities = 17/43 (39%), Positives = 24/43 (55%), Gaps = 5/43 (11%)
Query: 22 SEVDILMHIKDSL-DPENRLLTSWAPNA-DPCSSDSFDGVACD 62
+ D L+ K SL + L+SW P++ DPC S+ GV CD
Sbjct: 3 DDRDALLAFKSSLNGDPSGALSSWNPSSSDPC---SWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 17/217 (7%)
Query: 409 LLGKSSFSATYKGILRD-GSVVAVKCIA---KTSCKSDEGEFLK-GLKILTSLKHENLAS 463
LLG+ +F Y D G +AVK + ++ S E L+ +++L +L HE +
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHL-DLEAGSEKVLEWATRISVIKGIAKGISYLH 522
G + + +P G++ L A +E V TR I +G+SYLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR-----QILEGVSYLH 123
Query: 523 GKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFS---MLKASAAMGYLAPEY 579
+VH ++ +L N L D G K L I S M + +++PE
Sbjct: 124 SNM--IVHRDIKGANILRDSVGNVKLGDFGASKRL-QTICLSGTGMKSVTGTPYWMSPEV 180
Query: 580 TTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA 616
+ + K+DI++ G V ++L+ K F AA
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA 217
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 27/210 (12%)
Query: 409 LLGKSSFSATYKGILRD-GSVVAVKCI--------AKTSCKSDEGEFLKGLKILTSLKHE 459
LLG+ +F Y D G +AVK + K + E E +++L +L+HE
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECE----IQLLKNLQHE 64
Query: 460 NLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLE-AGSEKVLEWATRISVIKGIAKGI 518
+ G C + + +++P G++ L A +E V TR I +G+
Sbjct: 65 RIVQYYG--CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-----QILEGV 117
Query: 519 SYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YL 575
YLH +VH ++ +L N L D G K L I S + G ++
Sbjct: 118 EYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICSSGTGMKSVTGTPYWM 174
Query: 576 APEYTTTGRFTEKSDIYAFGMIVFQILSGK 605
+PE + + K+D+++ G V ++L+ K
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 31/214 (14%)
Query: 410 LGKSSFS----ATYKGILRDGSVVAVKCIAKTSCKS-DEGEFLKGLK----ILTSLKHEN 460
LG+ F A YK G + A+K + K + DE E L K S +H
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 461 LASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISY 520
L +L C + + ++ G+L+ H+ + SE + V+ G+ Y
Sbjct: 64 LVNL--FACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVL-----GLQY 116
Query: 521 LHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAP 577
LH +V+ +L + +L+ ++D GL K + + F + S G +LAP
Sbjct: 117 LHEN--KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGD-RTSTFCGTPEFLAP 170
Query: 578 EYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
E T +T D + G++++++L G+ PF
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGES---PF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 50/210 (23%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 409 LLGKSSFSATYKGILRDGS-VVAVKCIAKTSCKSD---EGEFLKGLKILTSLKHENLASL 464
+LGK SF L+ + A+K + K D E ++ + + +H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK 524
C + + F + +++ G+L+ H+ S + E R + I G+ +LH K
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQ---SSGRFDEARARFYAAE-IICGLQFLHKK 115
Query: 525 RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTT 581
G+++ +L + VL+ + + ++D G+ K + KAS G Y+APE
Sbjct: 116 --GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN----MNGEGKASTFCGTPDYIAPEILK 169
Query: 582 TGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
++ E D ++FG++++++L G+ +PF
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQ---SPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 31/109 (28%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 514 IAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG 573
I GI +LH +V+ ++ E VL+ + N LSD GL L D ++ + + G
Sbjct: 104 ITCGILHLHSM--DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNG 159
Query: 574 YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE 622
Y+APE ++ D +A G ++++++G+ TPF + +K E
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR---TPFKDHKEKVAKEE 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 35/146 (23%), Positives = 68/146 (46%), Gaps = 10/146 (6%)
Query: 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEK 537
LI D+V G + HL + E R + I + +LH + G+V+ ++ E
Sbjct: 82 LILDYVSGGEMFTHL---YQRDNFSEDEVRFYSGE-IILALEHLH--KLGIVYRDIKLEN 135
Query: 538 VLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYT-TTGRFTEKSDIYAFGM 596
+L+ + +L+D GL K + + Y+APE G + D ++ G+
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGI 195
Query: 597 IVFQILSGKCSITPFTRQAAESSKVE 622
++F++L+G +PFT + +++ E
Sbjct: 196 LIFELLTGA---SPFTLEGERNTQSE 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 16/198 (8%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKT-SCKSDEGEFLKGLKILTSLKHENLASLRGIC 468
+G + + L G VA+K I K S + LK+L L+HEN+ SL I
Sbjct: 20 MGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIF 78
Query: 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGL 528
S + + + + + G L L L + LE + I +G+ Y+H G+
Sbjct: 79 ISP-LEDIYFVTELL--GTDLHRL-LTSRP---LEKQFIQYFLYQILRGLKYVHSA--GV 129
Query: 529 VHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT-GRFTE 587
VH +L +LI+ + + D GL ++ M + Y APE T ++
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLARIQDP----QMTGYVSTRYYRAPEIMLTWQKYDV 185
Query: 588 KSDIYAFGMIVFQILSGK 605
+ DI++ G I ++L GK
Sbjct: 186 EVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 0.002
Identities = 40/161 (24%), Positives = 73/161 (45%), Gaps = 37/161 (22%)
Query: 410 LGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEG---EFLKGLKILTSLKHENLASLR 465
LG+ ++ YK + G +VA+K I +EG L+ + +L LKH N+ L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRL--DNEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 466 GICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIA----KGISYL 521
+ ++ + +L++++ +L ++LD G L ++IK I +G++Y
Sbjct: 65 DVIHTERK--LYLVFEYCDM-DLKKYLDKRPG---PLS----PNLIKSIMYQLLRGLAYC 114
Query: 522 HGKRPGLVHPNLSAEKVLIHRRYNP---LLSDSGLHKLLAD 559
H R ++HR P L++ G+ K LAD
Sbjct: 115 HSHR-------------ILHRDLKPQNILINRDGVLK-LAD 141
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 32/150 (21%), Positives = 62/150 (41%), Gaps = 23/150 (15%)
Query: 510 VIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKAS 569
+ + +G++YL+ ++H ++ +L++ R L D G+ L + I + + S
Sbjct: 108 IAVAVVEGLTYLYNVHR-IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTS 166
Query: 570 AAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNL 629
Y++PE G++T KSD+++ G+ + ++ GK PF N+
Sbjct: 167 T---YMSPERIQGGKYTVKSDVWSLGISIIELALGK---FPFA-------------FSNI 207
Query: 630 EGKFSVSEASNLGQIALHC-THESPSHRPS 658
+ L L E P PS
Sbjct: 208 DDDGQDDPMGILD--LLQQIVQEPPPRLPS 235
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 63/260 (24%), Positives = 103/260 (39%), Gaps = 39/260 (15%)
Query: 424 RDGSVVAVKCIAK-----TSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRG---E 475
RDG VA+K + SCK + LK+L KH+N+ S I E
Sbjct: 23 RDGKRVALKKMPNVFQNLVSCK----RVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE 78
Query: 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISV--IK----GIAKGISYLHGKRPGLV 529
+++ + L DL K++ +S +K I +G+ YLH G++
Sbjct: 79 IYVVTE-------LMQSDLH----KIIVSPQPLSSDHVKVFLYQILRGLKYLHSA--GIL 125
Query: 530 HPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGR-FTEK 588
H ++ +L++ + D GL ++ D M + Y APE R +T
Sbjct: 126 HRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSA 185
Query: 589 SDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHC 648
DI++ G I ++L + QA + D I +L G S+ + + A
Sbjct: 186 VDIWSVGCIFAELLGRRILF-----QAQSPIQQLDLI-TDLLGTPSLEAMRSACEGARAH 239
Query: 649 THESPSHRPSIENVMQELSS 668
P H+P V+ LSS
Sbjct: 240 ILRGP-HKPPSLPVLYTLSS 258
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 34/145 (23%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGL 528
C + FL+ ++V G+L+ H+ + K+ E R + I +++LH + G+
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQ---RKLPEEHARFYAAE-ICIALNFLHER--GI 117
Query: 529 VHPNLSAEKVLIHRRYNPLLSDSGLHK--LLADDIVFSMLKASAAMGYLAPEYTTTGRFT 586
++ +L + VL+ + L+D G+ K L D + Y+APE +
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTF---CGTPNYIAPEILRGEEYG 174
Query: 587 EKSDIYAFGMIVFQILSGKCSITPF 611
D +A G+++F++++G+ +PF
Sbjct: 175 FSVDWWALGVLMFEMMAGR---SPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 34/145 (23%), Positives = 70/145 (48%), Gaps = 14/145 (9%)
Query: 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGL 528
C + F + ++V G+L+ H+ + K+ E R + I+ ++YLH + G+
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAE-ISLALNYLHER--GI 117
Query: 529 VHPNLSAEKVLIHRRYNPLLSDSGLHK--LLADDIVFSMLKASAAMGYLAPEYTTTGRFT 586
++ +L + VL+ + L+D G+ K L D + Y+APE +
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF---CGTPNYIAPEILRGEDYG 174
Query: 587 EKSDIYAFGMIVFQILSGKCSITPF 611
D +A G+++F++++G+ +PF
Sbjct: 175 FSVDWWALGVLMFEMMAGR---SPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 56/273 (20%), Positives = 104/273 (38%), Gaps = 44/273 (16%)
Query: 410 LGKSSFSATYKGI-LRDGSVVAVKCI---------AKTSCKSDEGEFLKGLKILTSLKHE 459
+G+ FS Y+ L DG VA+K + A+ C +K + +L L H
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADC-------IKEIDLLKQLNHP 62
Query: 460 NLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGIS 519
N+ E ++ + G+L + + ++++ T + +
Sbjct: 63 NVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 520 YLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG------ 573
++H +R ++H ++ V I L D GL + + K +AA
Sbjct: 121 HMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSS-------KTTAAHSLVGTPY 171
Query: 574 YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE----SSKVEDFIDPNL 629
Y++PE + KSDI++ G +++++ + + +PF K+E P L
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQ---SPFYGDKMNLYSLCKKIEQCDYPPL 228
Query: 630 EGKFSVSEASNLGQIALHCTHESPSHRPSIENV 662
E L Q+ C + P RP I V
Sbjct: 229 PSDHYSEE---LRQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 44/221 (19%)
Query: 409 LLGKSSFS----ATYKGILRDGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSL--KHENL 461
+LGK SF A KG + AVK + K + D+ E K + +L KH L
Sbjct: 2 VLGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 462 ASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYL 521
L C + + F + ++V G+L+ H+ S + E R + I G+ +L
Sbjct: 59 TQLH--SCFQTKDRLFFVMEYVNGGDLMFHIQ---RSGRFDEPRARFYAAE-IVLGLQFL 112
Query: 522 HGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG-------- 573
H + G+++ +L + VL+ DS H +AD F M K G
Sbjct: 113 HER--GIIYRDLKLDNVLL---------DSEGHIKIAD---FGMCKEGILGGVTTSTFCG 158
Query: 574 ---YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
Y+APE + + D +A G++++++L+G+ +PF
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ---SPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 409 LLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKIL-TSLKHENLASL 464
++GK SF + + AVK + K + K +E + +L ++KH L L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK 524
+ + + + D++ G L HL E LE R + IA + YLH
Sbjct: 62 HFSFQTADK--LYFVLDYINGGELFYHLQRE---RCFLEPRARFYAAE-IASALGYLHSL 115
Query: 525 RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKAS--AAMGYLAPEYTTT 582
+V+ +L E +L+ + + +L+D GL K ++I + ++ YLAPE
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLHK 170
Query: 583 GRFTEKSDIYAFGMIVFQILSGKCSITPF-TRQAAE 617
+ D + G +++++L G + PF +R AE
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG---LPPFYSRNTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 36/162 (22%), Positives = 79/162 (48%), Gaps = 14/162 (8%)
Query: 514 IAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK-LLADDIVFSMLKASAAM 572
+A+G+ +L K VH +L+A VL+ + + D GL + ++ D S +
Sbjct: 246 VARGMEFLASK--NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 573 GYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGK 632
++APE +T SD++++G+++++I S TP+ +S+ F + ++
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFS--LGGTPYPGMIVDST----FYN-KIKSG 356
Query: 633 FSVSEASNLGQ----IALHCTHESPSHRPSIENVMQELSSII 670
+ +++ + Q I + C + P RPS ++ + S++
Sbjct: 357 YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 22/213 (10%)
Query: 409 LLGKSSFSATYKGILR-DGSVVAVKCI-AKTSCKSDEGEFLKGLK--ILTSLKHENLASL 464
++GK SF + DGS AVK + KT K E + + +L +LKH L L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK 524
+ + + + D+V G L HL E LE R + +A I YLH
Sbjct: 62 H--YSFQTAEKLYFVLDYVNGGELFFHLQRE---RCFLEPRARFYAAE-VASAIGYLHSL 115
Query: 525 RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTT 581
+++ +L E +L+ + + +L+D GL K + V S G YLAPE
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTFCGTPEYLAPEVLR 169
Query: 582 TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQ 614
+ D + G +++++L G + PF +
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYG---LPPFYSR 199
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 673 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.71 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.62 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.6 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.59 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.56 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.49 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.44 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.36 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.3 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.28 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.27 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.26 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.25 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.24 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.22 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.18 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.18 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.18 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.15 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.14 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.11 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.08 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.08 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.07 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.01 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.01 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.93 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.91 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.88 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.84 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.84 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.83 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.81 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.76 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.76 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.75 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.66 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.62 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.53 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.51 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.47 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.42 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.41 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.41 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.36 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.35 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.31 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.28 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.28 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.28 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.27 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.26 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.18 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-65 Score=610.06 Aligned_cols=258 Identities=31% Similarity=0.531 Sum_probs=204.2
Q ss_pred cCHHHHHHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEec
Q 005859 392 FNLEEVERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCS 470 (673)
Q Consensus 392 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 470 (673)
++++++. ..|...+.||+|+||.||+|+.. ++..||||++..... ...+|++++++++|||||+++|+|..
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~ 754 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRS 754 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEc
Confidence 3445543 35777889999999999999974 689999998865321 12356889999999999999999965
Q ss_pred CCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcC-CCCcccCCcCCCCeEecCCCCeeec
Q 005859 471 KGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK-RPGLVHPNLSAEKVLIHRRYNPLLS 549 (673)
Q Consensus 471 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~ivHrDlk~~NILl~~~~~~kl~ 549 (673)
. +..++||||+++|+|.++++ .++|..+.+|+.|||+||+|||+. .++|+||||||+||+++.++.+++.
T Consensus 755 ~--~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~ 825 (968)
T PLN00113 755 E--KGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR 825 (968)
T ss_pred C--CCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE
Confidence 4 67899999999999999995 288999999999999999999963 5589999999999999999988876
Q ss_pred cccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHh----h------hhcc
Q 005859 550 DSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQ----A------AESS 619 (673)
Q Consensus 550 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~----~------~~~~ 619 (673)
||.+.....+ ....++..|||||++.+..++.|+|||||||++|||+||+.||...... . ....
T Consensus 826 -~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 899 (968)
T PLN00113 826 -LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC 899 (968)
T ss_pred -eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc
Confidence 6655433221 1235788999999999999999999999999999999999998542110 0 0011
Q ss_pred chhhhcCCcCCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 620 KVEDFIDPNLEG--KFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 620 ~~~~~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
.....+++.+.. .....+..++.+++.+||+.||++||||+||+++|+++.++
T Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 223334444432 23455667889999999999999999999999999999774
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-55 Score=459.58 Aligned_cols=276 Identities=38% Similarity=0.757 Sum_probs=237.3
Q ss_pred ccccCHHHHHHHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEE
Q 005859 389 SFMFNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGIC 468 (673)
Q Consensus 389 ~~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 468 (673)
...|+++|++.+|++|+..+.||+|+||.||+|.+.+|+.||||++....... ..+|.+|++++.+++|||+|+++|||
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 35799999999999999999999999999999999999999999887654322 56799999999999999999999999
Q ss_pred ecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhc-CCCCcccCCcCCCCeEecCCCCee
Q 005859 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHG-KRPGLVHPNLSAEKVLIHRRYNPL 547 (673)
Q Consensus 469 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~ivHrDlk~~NILl~~~~~~k 547 (673)
.+.+. +.+||||||++|+|.++|+..... .++|..|++||.++|+||+|||+ +.|.||||||||+|||||+++++|
T Consensus 141 ~e~~~-~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LEGGE-HRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ecCCc-eEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 76532 589999999999999999864332 78999999999999999999999 556799999999999999999999
Q ss_pred eccccccccccC-cchhhhhcc-CCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhh-----------Hh
Q 005859 548 LSDSGLHKLLAD-DIVFSMLKA-SAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFT-----------RQ 614 (673)
Q Consensus 548 l~DfGla~~~~~-~~~~~~~~~-~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~-----------~~ 614 (673)
|+|||+|+.... ... .... .||.+|+|||++..+..++|+|||||||+|+|++||+.|.+... ..
T Consensus 218 lsDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred ccCccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 999999977654 221 1112 79999999999999999999999999999999999998765321 11
Q ss_pred hhhccchhhhcCCcCC-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 615 AAESSKVEDFIDPNLE-GKFSV-SEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 615 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
......+.+++|+.+. ..++. .+...+..++.+|++.+|.+||+|.||+++|+.+.
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 2223367889999987 55554 67888999999999999999999999999997764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-51 Score=423.23 Aligned_cols=255 Identities=27% Similarity=0.515 Sum_probs=213.6
Q ss_pred cccccCCcceEEEEEEcCCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCCC
Q 005859 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNG 486 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~g 486 (673)
+.||+|+||+||+|.++....||||++...... ...++|.+|+.+|.+++|||||+++|+|... +...++|||||++|
T Consensus 47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~-~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP-PGSLCIVTEYMPGG 125 (362)
T ss_pred hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-CCceEEEEEeCCCC
Confidence 459999999999999975555999999865422 1256899999999999999999999999654 22689999999999
Q ss_pred ChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC-CeeeccccccccccCcchhhh
Q 005859 487 NLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY-NPLLSDSGLHKLLADDIVFSM 565 (673)
Q Consensus 487 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~~ 565 (673)
+|.++++.. ....+++..+++++.|||+||.|||++.| ||||||||+|||++.++ ++||+|||+++...... ...
T Consensus 126 sL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~ 201 (362)
T KOG0192|consen 126 SLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSM 201 (362)
T ss_pred cHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccceeecccc-ccc
Confidence 999999853 34679999999999999999999999844 99999999999999997 99999999998776532 234
Q ss_pred hccCCCCCccCCcccc--CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHH
Q 005859 566 LKASAAMGYLAPEYTT--TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQ 643 (673)
Q Consensus 566 ~~~~gt~~y~aPE~~~--~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 643 (673)
+...||+.|||||++. ...|+.|+|||||||+||||+||+.||............+.. ..+...+..++..+..
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~----~~Rp~~p~~~~~~l~~ 277 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG----GLRPPIPKECPPHLSS 277 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc----CCCCCCCccCCHHHHH
Confidence 4468999999999999 568999999999999999999999999876553333333333 3333444457789999
Q ss_pred HHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 644 IALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 644 l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
+|.+||+.||++||++.+++..|+.+..
T Consensus 278 l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 278 LMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred HHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 9999999999999999999999998764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=400.18 Aligned_cols=257 Identities=20% Similarity=0.354 Sum_probs=215.9
Q ss_pred ccCHHHHHHHhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEe
Q 005859 391 MFNLEEVERATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469 (673)
Q Consensus 391 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 469 (673)
.+++.|++.. +.||+|..|+|||++++. ++.+|+|++.........+++.+|++++++.+||+||.+||.|+
T Consensus 75 ~i~~~dle~~-------~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLERL-------GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhhh-------hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 3566777654 579999999999999874 88999999965554555689999999999999999999999998
Q ss_pred cCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeec
Q 005859 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLS 549 (673)
Q Consensus 470 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~ 549 (673)
.+.. +..|+||||++|+|.+++... +.+++...-+|+.+|++||.|||+.+ +||||||||+|||++..|.+||+
T Consensus 148 ~~~~-~isI~mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~-~IIHRDIKPsNlLvNskGeVKic 221 (364)
T KOG0581|consen 148 SNGE-EISICMEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER-KIIHRDIKPSNLLVNSKGEVKIC 221 (364)
T ss_pred eCCc-eEEeehhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc-CeeeccCCHHHeeeccCCCEEec
Confidence 7643 799999999999999998632 45899999999999999999999732 79999999999999999999999
Q ss_pred cccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChh-hHhhhhccchhhhcCCc
Q 005859 550 DSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF-TRQAAESSKVEDFIDPN 628 (673)
Q Consensus 550 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~-~~~~~~~~~~~~~~~~~ 628 (673)
|||.++.+.+. .....+||..|||||.+.+..|+.++||||||++++|+++|+.||.+. .....+...+..+++..
T Consensus 222 DFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p 298 (364)
T KOG0581|consen 222 DFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP 298 (364)
T ss_pred cccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC
Confidence 99999988765 234578999999999999999999999999999999999999999774 11122333444444422
Q ss_pred CCCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 629 LEGKFSV-SEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 629 ~~~~~~~-~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
. +..+. .+++++++++..|+++||.+||+++|+++
T Consensus 299 p-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 299 P-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred C-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2 23344 47899999999999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=416.63 Aligned_cols=263 Identities=25% Similarity=0.483 Sum_probs=226.0
Q ss_pred cccCHHHHHHHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEe
Q 005859 390 FMFNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469 (673)
Q Consensus 390 ~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 469 (673)
+.+.-+++... +.||+|.||+||.|.+.....||+|.++... ...++|.+|+++|++|+|+|||+++|+|.
T Consensus 201 wei~r~~l~l~-------~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 201 WEIPREELKLI-------RELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred eeecHHHHHHH-------HHhcCCccceEEEEEEcCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence 44555665544 5799999999999999888899999998763 45578999999999999999999999996
Q ss_pred cCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeec
Q 005859 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLS 549 (673)
Q Consensus 470 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~ 549 (673)
.+ +.++||||||+.|+|.++|+.. .+..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+
T Consensus 272 ~~--~piyIVtE~m~~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~--~~IHRDLAARNiLV~~~~~vKIs 345 (468)
T KOG0197|consen 272 KQ--EPIYIVTEYMPKGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESK--NYIHRDLAARNILVDEDLVVKIS 345 (468)
T ss_pred cC--CceEEEEEecccCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhC--CccchhhhhhheeeccCceEEEc
Confidence 64 4699999999999999999852 345688999999999999999999998 69999999999999999999999
Q ss_pred cccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCc
Q 005859 550 DSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPN 628 (673)
Q Consensus 550 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 628 (673)
|||+||...++.+.......-.+.|.|||.+..++++.|||||||||+||||+| |+.||........ .+.+...
T Consensus 346 DFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev-----~~~le~G 420 (468)
T KOG0197|consen 346 DFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV-----LELLERG 420 (468)
T ss_pred ccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH-----HHHHhcc
Confidence 999999777776655555566788999999999999999999999999999999 9999877655433 2333444
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 629 LEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 629 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
.+-..|..++.++.++|..||+.+|++||||+.+...|+++...
T Consensus 421 yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 421 YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 44456777889999999999999999999999999999988764
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-48 Score=419.30 Aligned_cols=263 Identities=21% Similarity=0.397 Sum_probs=222.2
Q ss_pred cCCccccccccCCcceEEEEEEcC------CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
.+.+..+.||+|+||+||+|+..+ .+.||||.++.......+++|.+|+++|+.++|||||+++|+|... +.
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~--~P 563 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG--DP 563 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC--Ce
Confidence 344455679999999999999543 4689999999877555778999999999999999999999999665 67
Q ss_pred EEEEEeecCCCChhhhhccccC----------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAG----------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN 545 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~ 545 (673)
.++|+|||..|||.++|..... ...+++..+.+.||.|||.||+||-+++ +|||||..+|+||.++..
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGENLV 641 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceeccceE
Confidence 8999999999999999964321 1234889999999999999999999974 999999999999999999
Q ss_pred eeeccccccccccCcchhhhh-ccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhh
Q 005859 546 PLLSDSGLHKLLADDIVFSML-KASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVED 623 (673)
Q Consensus 546 ~kl~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~ 623 (673)
+||+|||++|..-...++... ...-.++|||||.+..++||++||||||||+|||++| |+.||....+.+...
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe----- 716 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE----- 716 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH-----
Confidence 999999999976554444433 4455789999999999999999999999999999999 999998887654432
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcCC
Q 005859 624 FIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673 (673)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~ 673 (673)
.+...-.-..++.++.++++||..||+.+|++||+++||-..|+++.+.|
T Consensus 717 ~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 717 CIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 22222224678889999999999999999999999999999999987754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=381.88 Aligned_cols=248 Identities=23% Similarity=0.380 Sum_probs=198.2
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.+|...+.||+|+||+||+|+++. +..||||.+.+... +...+....|+++|++++|||||++++++.. ++.+|+|
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~--~~~i~lV 87 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED--DDFIYLV 87 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec--CCeEEEE
Confidence 467777889999999999999875 89999999987742 3345667899999999999999999999955 4799999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC------CCeeeccccc
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR------YNPLLSDSGL 553 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~------~~~kl~DfGl 553 (673)
||||.||||.+|++. .+.+++++++.++.|+|.||++||++ +||||||||.||||+.. -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~--~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN--NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999999984 34699999999999999999999998 79999999999999865 3579999999
Q ss_pred cccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCC
Q 005859 554 HKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 554 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (673)
||.+..... ....+|++.|||||++..++|+.|+|+||.|+++||+++|+.||........... +. .+..+....
T Consensus 162 AR~L~~~~~--a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~-~~--k~~~~~~~~ 236 (429)
T KOG0595|consen 162 ARFLQPGSM--AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLY-IK--KGNEIVPVL 236 (429)
T ss_pred hhhCCchhH--HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH-Hh--ccccccCch
Confidence 999986543 3457899999999999999999999999999999999999999975443322210 00 111222233
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 005859 634 SVSEASNLGQIALHCTHESPSHRPSIENV 662 (673)
Q Consensus 634 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev 662 (673)
+........+++..-++.+|.+|-++.+-
T Consensus 237 ~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~ 265 (429)
T KOG0595|consen 237 PAELSNPLRELLISLLQRNPKDRISFEDF 265 (429)
T ss_pred hhhccCchhhhhhHHHhcCccccCchHHh
Confidence 33334445566666666666666655543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=368.19 Aligned_cols=260 Identities=18% Similarity=0.290 Sum_probs=213.5
Q ss_pred CCccccccccCCcceEEEEE-EcCCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+|.+.+.||+|+||+|||+. ..+|..||.|.+.-.... ..+++...|+.+|++|+|||||++++.-...+....+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46667889999999999998 557999999999855432 3457889999999999999999999854444444589999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCC--cccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG--LVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~--ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
|||+.|||.+.++..+..++.+++..+++++.|++.||.++|+.-|. |+||||||.||+|+.+|.+|++|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999986666677899999999999999999999994445 9999999999999999999999999999998
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
.+... ....+||+.||+||.+.+..|+.||||||+||++|||..-+.||.+..-. .....+.. ....+-+....+
T Consensus 180 s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~-~L~~KI~q---gd~~~~p~~~YS 254 (375)
T KOG0591|consen 180 SKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL-SLCKKIEQ---GDYPPLPDEHYS 254 (375)
T ss_pred chhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH-HHHHHHHc---CCCCCCcHHHhh
Confidence 76543 34578999999999999999999999999999999999999999764221 11112222 222222336678
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQELS 667 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 667 (673)
.++..|+..|+..||+.||+...+++.+.
T Consensus 255 ~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 255 TDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred hHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 89999999999999999998555555444
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=380.04 Aligned_cols=253 Identities=19% Similarity=0.318 Sum_probs=205.1
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC------cHHHHHHHHHHHhccCCCCceeEeeEEecCCC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS------DEGEFLKGLKILTSLKHENLASLRGICCSKGR 473 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 473 (673)
.+.|...+.||+|+||.|-+|..+ +|+.||||++.+..... ......+|+++|++|+|||||++++++.. +
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~--~ 248 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV--P 248 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--C
Confidence 456777899999999999999855 59999999998754322 12335799999999999999999999954 4
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC---CCeeecc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR---YNPLLSD 550 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~---~~~kl~D 550 (673)
+..|+|||||+||+|.+.+- ..+.+.+.....++.|++.|+.|||+. ||+||||||+|||+..+ ..+||+|
T Consensus 249 ds~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~--GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQ--GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred CceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHc--CcccccCCcceEEeccCCcceEEEecc
Confidence 77899999999999999986 335677888899999999999999998 99999999999999766 7899999
Q ss_pred ccccccccCcchhhhhccCCCCCccCCccccCCC---CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCC
Q 005859 551 SGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGR---FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDP 627 (673)
Q Consensus 551 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 627 (673)
||+|+...... -+...+||+.|.|||++.+.. +..|+|+||+||+||-+++|..||.+........+++.... -
T Consensus 323 FGlAK~~g~~s--fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~-y 399 (475)
T KOG0615|consen 323 FGLAKVSGEGS--FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR-Y 399 (475)
T ss_pred cchhhccccce--ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc-c
Confidence 99999887543 355689999999999998654 34589999999999999999999976533221111111111 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 628 NLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 628 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...+..+...+++..++|.++|..||++|||++|+++
T Consensus 400 ~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 400 AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1222445667889999999999999999999999985
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=391.01 Aligned_cols=248 Identities=22% Similarity=0.376 Sum_probs=212.3
Q ss_pred cCCccccccccCCcceEEEEEE-cCCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGIL-RDGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
.+|...++||+|+|+.+|+++. ..|+.||+|++.+... ...++...+||+|.++|+|||||+++++|.+ .+.+||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED--s~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED--SNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec--CCceEE
Confidence 5799999999999999999997 6799999999988543 3345788999999999999999999999954 588999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
|.|+|++|+|.++++ ..+++++.+++.+.+||+.||.|||+. +|+|||||-.|++|++++++||+|||+|..+.
T Consensus 96 vLELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~--~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 96 VLELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL--GIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EEEecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc--CceecccchhheeecCcCcEEecccceeeeec
Confidence 999999999999997 346799999999999999999999998 79999999999999999999999999999887
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
.+... ....+||+-|+|||++....++..+||||+||+||-|++|++||....-...... +.... -.+|...+
T Consensus 170 ~~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~----Ik~~~--Y~~P~~ls 242 (592)
T KOG0575|consen 170 YDGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNK----IKLNE--YSMPSHLS 242 (592)
T ss_pred Ccccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHH----HHhcC--cccccccC
Confidence 55433 3357899999999999999999999999999999999999999976432222211 11111 12344566
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+..+||.++|+.||.+|||+++|+.
T Consensus 243 ~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 243 AEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 88999999999999999999999985
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=395.09 Aligned_cols=258 Identities=22% Similarity=0.419 Sum_probs=223.2
Q ss_pred cCCccccccccCCcceEEEEEEcC----CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD----GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
....+.++||.|.||+||+|+++- ...||||.++.....+.+.+|+.|+.||.+++||||+++.|+... ...++
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk--s~PvM 706 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK--SKPVM 706 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec--CceeE
Confidence 345678899999999999999764 347999999988777788899999999999999999999999854 46799
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
||.|||++|+|..+|+.+. ..+++-+...+.++||.||+||-+. ++|||||.++|||++.+...||+|||++|.+
T Consensus 707 IiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm--~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM--NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred EEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc--CchhhhhhhhheeeccceEEEeccccceeec
Confidence 9999999999999998654 3589999999999999999999998 7999999999999999999999999999988
Q ss_pred cCcchhhhhc--cCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 558 ADDIVFSMLK--ASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 558 ~~~~~~~~~~--~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
.++.....+. ..-.++|.|||.+...+++.+||||||||+|||.++ |.+||.++.++........ ..+-..+
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~-----gyRLPpP 856 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ-----GYRLPPP 856 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh-----ccCCCCC
Confidence 7665222222 233468999999999999999999999999999888 9999999877655443322 2333456
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.+++..+.+||..||++|-.+||+|.+|+..|++++.
T Consensus 857 mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 857 MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 6788999999999999999999999999999999985
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=363.41 Aligned_cols=243 Identities=20% Similarity=0.289 Sum_probs=204.2
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCC--CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCK--SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
-++|+..++||+|+||+||.++.++ ++.+|+|++++...- .+.+....|..||.+++||.||+++..| ++.+..|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF--Qt~~kLy 101 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF--QTEEKLY 101 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec--ccCCeEE
Confidence 3578899999999999999999765 899999999887542 3456788999999999999999998877 6678999
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+|+||+.||.|..+|. .+..+++..+.-++..|+.||.|||++ |||||||||+|||||.+|+++|+|||+++..
T Consensus 102 lVld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~--gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSK--GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEEeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhC--CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 9999999999999997 345699999999999999999999998 8999999999999999999999999999965
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
..... .....+||+.|||||++.+..|+..+|.||+||++|||++|..||............... . ....+...
T Consensus 176 ~~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~----k-~~~~p~~l 249 (357)
T KOG0598|consen 176 LKDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG----K-LPLPPGYL 249 (357)
T ss_pred ccCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC----c-CCCCCccC
Confidence 44322 233479999999999999999999999999999999999999999775544333322221 1 11222334
Q ss_pred HHHHHHHHHHccccCCCCCC
Q 005859 638 ASNLGQIALHCTHESPSHRP 657 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RP 657 (673)
+.+.++++.+.+..||++|-
T Consensus 250 s~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 250 SEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CHHHHHHHHHHhccCHHHhc
Confidence 57889999999999999995
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=409.51 Aligned_cols=261 Identities=26% Similarity=0.460 Sum_probs=218.7
Q ss_pred CCccccccccCCcceEEEEEEcC--Cc----EEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 403 CFSEANLLGKSSFSATYKGILRD--GS----VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
.....+.||+|.||.||+|.+.+ |. .||||.+++.....+..+|.+|..+|++++|||||+++|+|.+. ...
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--~~~ 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--GPP 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC--CCc
Confidence 34556789999999999999765 43 49999998877666778999999999999999999999999774 668
Q ss_pred EEEEeecCCCChhhhhccccC---CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAG---SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL 553 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGl 553 (673)
+|++|||++|||..+|+..+. ....++..+.+.++.|||+|++||+++ .+|||||.++|+||++...+||+|||+
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~--~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK--HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC--CCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999986532 245689999999999999999999998 599999999999999999999999999
Q ss_pred cccccCcchhhhhcc-CCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCC
Q 005859 554 HKLLADDIVFSMLKA-SAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEG 631 (673)
Q Consensus 554 a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 631 (673)
|+.+.+..++..... .-..+|||||.+..+.++.|+|||||||+|||++| |..||....+.......+.. . +-
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g----g-RL 923 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG----G-RL 923 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC----C-cc
Confidence 996554444333322 44578999999999999999999999999999999 88898776544332212211 1 34
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 632 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
+.+..++..++++|..||+.+|++||++..+++.+.++++.
T Consensus 924 ~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 924 DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 56778889999999999999999999999999999988753
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=369.34 Aligned_cols=262 Identities=24% Similarity=0.380 Sum_probs=218.8
Q ss_pred hcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
.......++||+|.||+|..|....+..||||.++....+..+.+|.+|+++|.+++|||||+++|+|..+ +..++|+
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D--ePicmI~ 614 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD--DPLCMIT 614 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC--CchHHHH
Confidence 34456677899999999999999888999999999888777778999999999999999999999999776 5688999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc-C
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA-D 559 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~-~ 559 (673)
|||++|+|.+++...... .++-....+|+.|||.||+||.+. ++||||+.++|+|+|+++++||+|||+++-+- .
T Consensus 615 EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~--nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL--NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh--chhhccccccceeecCcccEEecCcccccccccC
Confidence 999999999999754322 245566788999999999999998 69999999999999999999999999999554 3
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh--CCCCCChhhHhhhhccchhhhcC-Cc--CCCCCC
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS--GKCSITPFTRQAAESSKVEDFID-PN--LEGKFS 634 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t--G~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~~ 634 (673)
+.+....+.+-.++|||||.+.-++++.++|||+|||++||+++ ...||....+....+.. .++.+ +. .....+
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~-~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENA-GEFFRDQGRQVVLSRP 769 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhh-hhhcCCCCcceeccCC
Confidence 44444455667889999999999999999999999999999887 77898877665443322 22222 21 222446
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQELSSI 669 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i 669 (673)
..++..++++|.+||..|.++||+++++...|++.
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 67889999999999999999999999999888764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=378.83 Aligned_cols=268 Identities=22% Similarity=0.408 Sum_probs=212.3
Q ss_pred CHHHHHHHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecC
Q 005859 393 NLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSK 471 (673)
Q Consensus 393 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 471 (673)
+.++++..-+.+.....||+|+||+||+|++. ..||||+++..... ...+.|.+|+.++++-+|.||+-+.|||..+
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 34555555555566778999999999999986 46999999876533 2347899999999999999999999999653
Q ss_pred CCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccc
Q 005859 472 GRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDS 551 (673)
Q Consensus 472 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~Df 551 (673)
.. .||+.+|+|-+|+.+++.. +..|+..+.+.||.|||+||.|||.+ +|||||||+.||++++++++||+||
T Consensus 461 --~~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK--~IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 461 --PL-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK--NIIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred --ce-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh--hhhhhhccccceEEccCCcEEEecc
Confidence 43 8999999999999999854 35699999999999999999999998 7999999999999999999999999
Q ss_pred cccccccC-cchhhhhccCCCCCccCCccccCC---CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCC
Q 005859 552 GLHKLLAD-DIVFSMLKASAAMGYLAPEYTTTG---RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDP 627 (673)
Q Consensus 552 Gla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 627 (673)
|++..... ..........|..-|||||++..+ .|++.+||||||+|+|||+||..||............-.....+
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~p 612 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMP 612 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCc
Confidence 99864321 111122334578889999998743 58999999999999999999999997332222111111111112
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 628 NLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 628 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.. ......++.++.+|+..||.+++++||.+.+|+..|+.++.
T Consensus 613 d~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 613 DL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 21 12345677899999999999999999999999999988865
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=364.86 Aligned_cols=254 Identities=24% Similarity=0.407 Sum_probs=203.6
Q ss_pred CCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 403 CFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
++...+.||+|+||.||++...+ |...|||.+...... ..+.+.+|+++|++++|||||+++|.....+...+++.||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccch-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45667899999999999999765 999999998765322 2567899999999999999999999754332236889999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC-CCCeeeccccccccccC-
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR-RYNPLLSDSGLHKLLAD- 559 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~-~~~~kl~DfGla~~~~~- 559 (673)
|+++|+|.+++....+ .+++..+.++.+||++||+|||++ |||||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~--g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK--GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC--CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999975432 599999999999999999999987 8999999999999999 79999999999987763
Q ss_pred -cchhhhhccCCCCCccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 560 -DIVFSMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 560 -~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
..........||+.|||||++..+. ...++||||+||++.||+||+.||..+... ....+...... ..+..+...
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~--~~~~~~ig~~~-~~P~ip~~l 248 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE--AEALLLIGRED-SLPEIPDSL 248 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch--HHHHHHHhccC-CCCCCCccc
Confidence 2112234567999999999999643 345999999999999999999998764111 11111111111 222556667
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
+.+..+++.+|++.||++||||+++++.
T Consensus 249 s~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 249 SDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 7899999999999999999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=367.09 Aligned_cols=257 Identities=18% Similarity=0.296 Sum_probs=207.4
Q ss_pred cCCccccccccCCcceEEEEEE-cCCcEEEEEEecccCCCCc-HHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGIL-RDGSVVAVKCIAKTSCKSD-EGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
+.|+..+.||+|.||.||||+. .+|+.||+|+++....+.+ ..-..+||.||++|+||||+++.++.++.....+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4566678899999999999995 4699999999987653332 3456799999999999999999999988766789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
+|||++ ||.-++.. ..-.|+..++..++.|++.||+|+|++ ||+|||||.+|||||.+|.+||+|||+|+++..
T Consensus 197 FeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~--gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR--GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc--CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999976 88888762 235699999999999999999999998 899999999999999999999999999998877
Q ss_pred cchhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh----------------
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE---------------- 622 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~---------------- 622 (673)
......+..+.|.+|+|||++.+. .|+.++|+||.||||.||++|+..|.+..+......++.
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 666667788899999999999975 599999999999999999999987765433222111110
Q ss_pred --hhcCCcCC--C---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 623 --DFIDPNLE--G---KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 623 --~~~~~~~~--~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+.+... . +.....+....+|+..+|..||.+|.|+.++++
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00111100 0 001123567789999999999999999999874
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=368.75 Aligned_cols=256 Identities=20% Similarity=0.323 Sum_probs=205.5
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCeEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~l 478 (673)
.++|...+.||.|+||.||+|+-. +|..||||++++.....++-.-+||++.|++++ |||||++.+++.+.++ ..++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEee
Confidence 456788899999999999999955 599999999988765545555689999999998 9999999999977643 8999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
|||||+ -+|+++++.+ ++.+++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||.+.
T Consensus 88 VfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~--GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH--GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc--CcccccCChhheEecccceeEecccccccccc
Confidence 999995 4999999743 57899999999999999999999987 99999999999999999999999999999876
Q ss_pred CcchhhhhccCCCCCccCCcccc-CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhcc-----------------c
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTT-TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESS-----------------K 620 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~-----------------~ 620 (673)
... ..+..+.|.+|+|||++. .+.|+.+.|+||+|||++|+.+-+.-|.+..+.....+ .
T Consensus 162 Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 SKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 543 345677899999999876 56699999999999999999998765644322211110 0
Q ss_pred h---hhhcCCcCCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 621 V---EDFIDPNLEG----KFSVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 621 ~---~~~~~~~~~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
+ ..+.-|...+ ..-...+.++.+++.+|+++||.+|||+.|+++.
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0 1111111111 1112256789999999999999999999999864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=376.80 Aligned_cols=265 Identities=22% Similarity=0.383 Sum_probs=207.7
Q ss_pred HhcCCccccccccCCcceEEEEEEc------CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCC
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKG 472 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 472 (673)
..++|.+.+.||+|+||.||+|... +++.||||++...........+.+|++++.++ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 3467888899999999999999742 25689999987654333446799999999999 899999999988543
Q ss_pred CCeEEEEEeecCCCChhhhhccccCC------------------------------------------------------
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAGS------------------------------------------------------ 498 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~~------------------------------------------------------ 498 (673)
.+..++||||+++|+|.+++......
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 34688999999999999998642110
Q ss_pred ----ccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh-hhhccCCCCC
Q 005859 499 ----EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF-SMLKASAAMG 573 (673)
Q Consensus 499 ----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~ 573 (673)
...+++..+.+++.||++||+|||+. ||+||||||+|||+++++.+||+|||+++........ ......++..
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHC--CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 13488899999999999999999987 8999999999999999999999999999865432211 1222345678
Q ss_pred ccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccC
Q 005859 574 YLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHES 652 (673)
Q Consensus 574 y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~ 652 (673)
|+|||++.+..++.++|||||||++|||+| |..||............+.. ......+...+..+.+++.+||+.|
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~d 317 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD----GTRMRAPENATPEIYRIMLACWQGD 317 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc----CCCCCCCCCCCHHHHHHHHHHccCC
Confidence 999999998899999999999999999997 99998653221111111111 1111123345578999999999999
Q ss_pred CCCCCCHHHHHHHHHHhhc
Q 005859 653 PSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 653 p~~RPs~~evl~~L~~i~~ 671 (673)
|++|||+.|+++.|++++.
T Consensus 318 p~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 318 PKERPTFSALVEILGDLLQ 336 (338)
T ss_pred hhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=369.79 Aligned_cols=250 Identities=25% Similarity=0.430 Sum_probs=213.0
Q ss_pred cccccCHHHHHHHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeE
Q 005859 388 ESFMFNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467 (673)
Q Consensus 388 ~~~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 467 (673)
+.+.++|++|.. .+-||.|+.|.||+|+++ ++.||||+++.-. ..+|+-|++|+||||+.|.|+
T Consensus 117 e~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGV 180 (904)
T KOG4721|consen 117 ELWEIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGV 180 (904)
T ss_pred hhccCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeee
Confidence 346777888754 357999999999999996 6889999876432 246899999999999999999
Q ss_pred EecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCee
Q 005859 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPL 547 (673)
Q Consensus 468 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~k 547 (673)
|.. ....+||||||+.|-|.++|+ .+.+++......+..+||.||+|||.+ .|||||||+-||||..+..+|
T Consensus 181 Ctq--sPcyCIiMEfCa~GqL~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h--KIIHRDLKSPNiLIs~~d~VK 252 (904)
T KOG4721|consen 181 CTQ--SPCYCIIMEFCAQGQLYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH--KIIHRDLKSPNILISYDDVVK 252 (904)
T ss_pred ecC--CceeEEeeeccccccHHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh--hHhhhccCCCceEeeccceEE
Confidence 954 367889999999999999997 345688888889999999999999997 499999999999999999999
Q ss_pred eccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCC
Q 005859 548 LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDP 627 (673)
Q Consensus 548 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 627 (673)
|+|||.++...+. ......+||..|||||++....+++|+||||||||||||+||..||.+....+ ++..+-..
T Consensus 253 IsDFGTS~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIwGVGsN 326 (904)
T KOG4721|consen 253 ISDFGTSKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWGVGSN 326 (904)
T ss_pred eccccchHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEEeccCC
Confidence 9999999877654 24456789999999999999999999999999999999999999997654433 33344444
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 005859 628 NLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELS 667 (673)
Q Consensus 628 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 667 (673)
.+.-..+..++..+.-|+..||+..|.+||+|++++..|+
T Consensus 327 sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 327 SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 4555667788899999999999999999999999998876
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=343.26 Aligned_cols=253 Identities=20% Similarity=0.284 Sum_probs=196.5
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCc-HHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSD-EGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
+.|+...++|+|+||+||||+.++ |+.||||++........ .+-.++|+++|++++|+|+|.++++|.. ....++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--krklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--KRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--cceeEEE
Confidence 457778899999999999999886 99999999976542222 3457899999999999999999999954 4789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
+|||+..=|. -|.. ...-++.....+|+.|+++|+.|+|++ +||||||||+||||+.++.+|++|||+|+.+..
T Consensus 80 FE~~dhTvL~-eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~--n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 80 FEYCDHTVLH-ELER---YPNGVPSELVKKYLYQLLKAIHFCHKN--NCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred eeecchHHHH-HHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhc--CeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 9999874444 3432 223478889999999999999999988 799999999999999999999999999998874
Q ss_pred cchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhc--------------------
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAES-------------------- 618 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~-------------------- 618 (673)
.. ...+..+.|.+|+|||.+.+ .+|...+||||.||++.||+||..-|.+..+.....
T Consensus 154 pg-d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 PG-DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred Cc-chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 22 23456778999999999987 579999999999999999999986554432211100
Q ss_pred cchhhhcCCcCC------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 619 SKVEDFIDPNLE------GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 619 ~~~~~~~~~~~~------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+..+.-|... ..+ .....-+.+++..|++.||++|++.++++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 011111111111 111 223456889999999999999999999873
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=352.41 Aligned_cols=258 Identities=19% Similarity=0.328 Sum_probs=210.8
Q ss_pred hcCCccccccccCCcceEEEEEE-cCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGIL-RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.+.|+..+.||.|..++||+|+. +.+..||||++.-..+..+.+.+.+|+..|+.++||||++++..|..+ ...|+|
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~--~~LWvV 102 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD--SELWVV 102 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec--ceeEEe
Confidence 35688889999999999999994 458999999999888777778999999999999999999999988665 789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|.||.+|++.+++...-. .-+++..+..|.+++++||.|||.+ |.||||||+.||||+++|.+||+|||.+..+.+
T Consensus 103 mpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~--G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN--GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred ehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc--CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 999999999999975432 3488999999999999999999988 899999999999999999999999999776544
Q ss_pred cchh---hhhccCCCCCccCCccccC--CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcC----CcCC
Q 005859 560 DIVF---SMLKASAAMGYLAPEYTTT--GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFID----PNLE 630 (673)
Q Consensus 560 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~----~~~~ 630 (673)
...+ .....+|++.|||||++.. ..|+.|+|||||||+..||++|..||..+.........+..-.. ....
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence 3221 1144589999999999543 45999999999999999999999999877655433222221110 0111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 631 GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 631 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+........+++++..|++.||++|||++++++
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1222334568999999999999999999999874
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=368.26 Aligned_cols=267 Identities=24% Similarity=0.402 Sum_probs=228.2
Q ss_pred HHHHHHHhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCC
Q 005859 394 LEEVERATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKG 472 (673)
Q Consensus 394 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 472 (673)
+++++-..-+..-.++||-|.||.||.|.|+. .-.||||.++.. ....++|++|+.+|+.++|||+|+++|+|..+
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED--tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E- 335 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE- 335 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc--chhHHHHHHHHHHHHhhcCccHHHHhhhhccC-
Confidence 45565555566677899999999999999986 668999999876 35678999999999999999999999999765
Q ss_pred CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccc
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSG 552 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfG 552 (673)
...|||+|||.+|+|.+||+.. .+..++--..+.+|.||+.||+||..+ ++|||||.++|+|+.++..+||+|||
T Consensus 336 -pPFYIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk--nFIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 336 -PPFYIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred -CCeEEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh--hhhhhhhhhhhccccccceEEeeccc
Confidence 5589999999999999999843 334567777889999999999999987 69999999999999999999999999
Q ss_pred ccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCC
Q 005859 553 LHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEG 631 (673)
Q Consensus 553 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 631 (673)
+++++..+.+.......-.+.|.|||.+....++.|+|||+|||+|||+.| |..||.+.... ++.+.+....+-
T Consensus 411 LsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-----qVY~LLEkgyRM 485 (1157)
T KOG4278|consen 411 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYGLLEKGYRM 485 (1157)
T ss_pred hhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-----HHHHHHhccccc
Confidence 999998887655544455678999999999999999999999999999999 88888664322 344444455555
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcCC
Q 005859 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673 (673)
Q Consensus 632 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~ 673 (673)
+.++.|++.+++||+.||+++|++||++.|+.+.++.++++|
T Consensus 486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 667888999999999999999999999999999999998864
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=356.46 Aligned_cols=261 Identities=21% Similarity=0.321 Sum_probs=209.4
Q ss_pred ccCHHHHHHHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCc--HHHHHHHHHHHhccCCCCceeEeeEE
Q 005859 391 MFNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSD--EGEFLKGLKILTSLKHENLASLRGIC 468 (673)
Q Consensus 391 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~ 468 (673)
.++.+++. ......||+|++|.||+|.+ +|+.||||.+........ .+.|.+|+++|++++||||++++|++
T Consensus 14 ~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~ 87 (283)
T PHA02988 14 CIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI 87 (283)
T ss_pred ecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeE
Confidence 44566662 23346799999999999998 688999999976532211 35788999999999999999999998
Q ss_pred ec--CCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCe
Q 005859 469 CS--KGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNP 546 (673)
Q Consensus 469 ~~--~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~ 546 (673)
.+ .+....++||||+++|+|.+++.. ...++|..+.+++.|++.||+|||+.. +++||||||+|||+++++.+
T Consensus 88 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~-~~~Hrdlkp~nill~~~~~~ 162 (283)
T PHA02988 88 IDIVDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT-NKPYKNLTSVSFLVTENYKL 162 (283)
T ss_pred EecccCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC-CCCCCcCChhhEEECCCCcE
Confidence 76 444578999999999999999973 346899999999999999999999742 68999999999999999999
Q ss_pred eeccccccccccCcchhhhhccCCCCCccCCccccC--CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhh
Q 005859 547 LLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT--GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF 624 (673)
Q Consensus 547 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~ 624 (673)
||+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||+||+.||...............
T Consensus 163 kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~- 237 (283)
T PHA02988 163 KIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK- 237 (283)
T ss_pred EEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-
Confidence 999999998664422 23457889999999976 67999999999999999999999999765433222111111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 625 IDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
......+..++..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 238 ---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 238 ---NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ---CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1112233345678999999999999999999999999998764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=373.86 Aligned_cols=253 Identities=23% Similarity=0.436 Sum_probs=207.9
Q ss_pred ccccccCCcceEEEEEEcC--C--cE-EEEEEeccc--CCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 407 ANLLGKSSFSATYKGILRD--G--SV-VAVKCIAKT--SCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++||+|+||+||+|+++. + .. ||||..+.. .......+|++|+++|++++|||||+++|++..+ ...++|
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~--~Pl~iv 239 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE--EPLMLV 239 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--CccEEE
Confidence 3689999999999999764 2 23 899988752 2234457899999999999999999999999765 568999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
||+|.||+|.++|.... ..++..++++++.|+|.||+|||++ ++|||||.++|+|++.++.+||+|||+++.-..
T Consensus 240 mEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k--~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK--NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC--CCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 99999999999998432 3599999999999999999999998 699999999999999999999999999876542
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
-. .......-...|+|||.+..+.|+.++|||||||++||+++ |..||.+............. ..+-..+...+
T Consensus 315 ~~-~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~----~~r~~~~~~~p 389 (474)
T KOG0194|consen 315 YV-MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN----GYRMPIPSKTP 389 (474)
T ss_pred ee-eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc----CccCCCCCCCH
Confidence 11 11112235678999999999999999999999999999999 88899887665444433232 22233344667
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
..+..++.+||..+|++||+|.++.+.|+.+..
T Consensus 390 ~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 390 KELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred HHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 888999999999999999999999999998864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=363.75 Aligned_cols=253 Identities=19% Similarity=0.301 Sum_probs=210.5
Q ss_pred HHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCC
Q 005859 398 ERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSL-KHENLASLRGICCSKGR 473 (673)
Q Consensus 398 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 473 (673)
++..++|...+.||+|+|++||+|+.. .++.+|||++.+... +...+...+|-.+|.+| .||.||+++-.|. +.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ--D~ 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ--DE 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEee--cc
Confidence 344568888999999999999999965 499999999987543 22234577889999999 8999999988884 44
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL 553 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGl 553 (673)
...|+|+||+++|+|.++|+. ...|++...+.++.+|+.||+|||++ |||||||||+|||||+||++||+|||.
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~--GIIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSN--GIIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred cceEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhc--CceeccCChhheeEcCCCcEEEeeccc
Confidence 779999999999999999983 35699999999999999999999998 999999999999999999999999999
Q ss_pred cccccCcchh----------h--hhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch
Q 005859 554 HKLLADDIVF----------S--MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV 621 (673)
Q Consensus 554 a~~~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~ 621 (673)
|+.+.+.... . ....+||..|.+||++..+..+..+|+|+|||++|.|+.|+.||.+..+-....+
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk-- 298 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK-- 298 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH--
Confidence 9987643211 1 1347899999999999999999999999999999999999999987644333222
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 622 EDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+++ +.-++++..++.+.+|+.+.|..||.+|+|..+|-+
T Consensus 299 --I~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 299 --IQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred --HHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 221 122455556688999999999999999999988764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=366.01 Aligned_cols=250 Identities=15% Similarity=0.279 Sum_probs=210.4
Q ss_pred hcCCccccccccCCcceEEEEEE-cCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGIL-RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
...|..-..||+|+.|.||.++. .+++.||||++.... ...++-.++|+.+|+..+|+|||++++.|... ++.++|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVG--DELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhccc--ceeEEE
Confidence 45677778899999999999984 458999999998765 34556789999999999999999999988665 789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
||||+||+|.+.+. ...+++.++..|++++++||+|||.+ ||+|||||.+|||++.++.+||+|||++..+..
T Consensus 349 MEym~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~--gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHAR--GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EeecCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHhc--ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 99999999999986 34589999999999999999999998 899999999999999999999999999988876
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
... ....-+||++|||||++....|++|+||||||++.+||+-|+.||.......... .+..--. .+-..++..+.
T Consensus 422 ~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly-LIa~ng~--P~lk~~~klS~ 497 (550)
T KOG0578|consen 422 EQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGT--PKLKNPEKLSP 497 (550)
T ss_pred ccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH-HHhhcCC--CCcCCccccCH
Confidence 543 3445689999999999999999999999999999999999999986432221111 1111111 22234566778
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+.+++.+||+.|+++||++.|+|+
T Consensus 498 ~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 498 ELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHHHHHHhhcchhcCCCHHHHhc
Confidence 9999999999999999999999985
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=359.95 Aligned_cols=261 Identities=25% Similarity=0.431 Sum_probs=222.7
Q ss_pred HHHhcCCccccccccCCcceEEEEEEcC---C--cEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCC
Q 005859 398 ERATQCFSEANLLGKSSFSATYKGILRD---G--SVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKG 472 (673)
Q Consensus 398 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 472 (673)
+..++.....+.||+|.||.||+|.+.+ | -.||||..+......+.+.|+.|.-+|+.++|||||+++|+|.+
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-- 462 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-- 462 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec--
Confidence 3334445556789999999999999654 2 36999998876655667899999999999999999999999965
Q ss_pred CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccc
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSG 552 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfG 552 (673)
...+||||.++.|.|.+||... ...++......++.||+.||+|||+. .+|||||.++|||+.....+|++|||
T Consensus 463 -~P~WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk--rfVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK--RFVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred -cceeEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh--chhhhhhhhhheeecCcceeeecccc
Confidence 4689999999999999999854 34688899999999999999999998 59999999999999999999999999
Q ss_pred ccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCC
Q 005859 553 LHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEG 631 (673)
Q Consensus 553 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 631 (673)
++|.+.++.++..+...-.+.|||||.+...+++.++|||-|||.|||++. |..||....+.... ..+...-+.
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-----~~iEnGeRl 611 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-----GHIENGERL 611 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-----EEecCCCCC
Confidence 999999988877777777889999999999999999999999999999987 99999776443222 112222333
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 632 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
..++.|++.++.++.+||+++|.+||++.|+...|+.+++
T Consensus 612 P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 612 PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 5677888999999999999999999999999999998875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=360.61 Aligned_cols=248 Identities=19% Similarity=0.333 Sum_probs=204.9
Q ss_pred HhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC----CcHHHHHHHHHHHhccC-CCCceeEeeEEecCCC
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK----SDEGEFLKGLKILTSLK-HENLASLRGICCSKGR 473 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 473 (673)
..++|...+.||+|+||+||.|+.. ++..||||.+.+.... ...+.+.+|+.++++++ ||||+++++++...
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-- 92 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-- 92 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC--
Confidence 3567888999999999999999865 5899999977664211 23456678999999998 99999999999554
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC-CCeeecccc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR-YNPLLSDSG 552 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~-~~~kl~DfG 552 (673)
...++||||+.+|+|.+++.. ...+.+..+.+++.|++.|++|+|++ ||+||||||+|||+|.+ +++||+|||
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~--gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR--GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred CeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC--CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 679999999999999999974 34588899999999999999999988 89999999999999999 999999999
Q ss_pred cccccc-CcchhhhhccCCCCCccCCccccCCC-CC-cchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcC
Q 005859 553 LHKLLA-DDIVFSMLKASAAMGYLAPEYTTTGR-FT-EKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNL 629 (673)
Q Consensus 553 la~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 629 (673)
++.... .+ ......+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||........... +.....
T Consensus 167 ~s~~~~~~~--~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k----i~~~~~ 240 (370)
T KOG0583|consen 167 LSAISPGED--GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK----IRKGEF 240 (370)
T ss_pred cccccCCCC--CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH----HhcCCc
Confidence 999873 22 2345678999999999999877 86 789999999999999999999987433322222 111111
Q ss_pred CCCCCHHH-HHHHHHHHHHccccCCCCCCCHHHHH
Q 005859 630 EGKFSVSE-ASNLGQIALHCTHESPSHRPSIENVM 663 (673)
Q Consensus 630 ~~~~~~~~-~~~l~~l~~~Cl~~~p~~RPs~~evl 663 (673)
.++... +.++..++.+|+..||.+|+|+.+|+
T Consensus 241 --~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 241 --KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred --cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 122222 68899999999999999999999998
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=349.08 Aligned_cols=258 Identities=22% Similarity=0.374 Sum_probs=206.3
Q ss_pred hcCCccccccccCCcceEEEEEEc----CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR----DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
.++|+..+.||+|+||.||+|.+. .+..||+|.++..........|.+|+.++++++||||+++++++.. .+..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR--GNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CCCc
Confidence 346888899999999999999864 3668999999765433344679999999999999999999999854 4678
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ |++||||||+||+++.++.+|++|||.+..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~--~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM--GYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC--CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 9999999999999998642 24689999999999999999999987 799999999999999999999999998765
Q ss_pred ccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
.............++..|+|||.+.+..++.++|||||||++||+++ |+.||.......... .+.+. .....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~-~~~~~----~~~~~~~ 231 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIK-AVEDG----FRLPAPR 231 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-HHHCC----CCCCCCC
Confidence 43322212222335678999999999999999999999999999775 999986543322111 11111 1112234
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
.++..+.+++.+||+.+|++||+++++++.|++++
T Consensus 232 ~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~~ 266 (266)
T cd05064 232 NCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266 (266)
T ss_pred CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhhC
Confidence 45678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=354.24 Aligned_cols=248 Identities=19% Similarity=0.373 Sum_probs=209.4
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
.|...+.||+|.||.||||... .++.||+|++.....+.+.++..+|+.+|.+++++||.++||.+... ..++++||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g--~~LwiiMe 91 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG--TKLWIIME 91 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec--ccHHHHHH
Confidence 4666788999999999999965 48999999998876666667899999999999999999999999775 66899999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
||.||++.+.+.. ...+++..+.-|++++..|+.|||.+ +.+|||||+.|||+..+|.+|++|||++..+....
T Consensus 92 y~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~--~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 92 YCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE--KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc--ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 9999999999972 33446777777899999999999998 69999999999999999999999999998887765
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 641 (673)
... ...+||+.|||||++....|+.|+||||+|++.+||++|..|+...... .+.-.+....++......+..+
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-----rvlflIpk~~PP~L~~~~S~~~ 239 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-----RVLFLIPKSAPPRLDGDFSPPF 239 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-----eEEEeccCCCCCccccccCHHH
Confidence 544 5678999999999999889999999999999999999999998765432 1111222222333334566789
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 005859 642 GQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 642 ~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
++++..|++.||+.||++.++++
T Consensus 240 kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 240 KEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred HHHHHHHhhcCcccCcCHHHHhh
Confidence 99999999999999999999985
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=356.51 Aligned_cols=247 Identities=18% Similarity=0.337 Sum_probs=208.5
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
++|.+.+.||+|+||.||||+-+. .+.||+|.+.+... +++.+...+|++|+++++|||||.++++| ++..+.++|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf--Et~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF--ETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh--cccceEEEE
Confidence 578888999999999999999664 88999999987542 33446789999999999999999999999 556899999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
+||+.| +|.++|.+ ...++++.+..|+.|+..||.|||+. +|+|||+||.|||++..+.+|++|||+|+.+..
T Consensus 80 te~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~--rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN--RILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred ehhhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc--CcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 999976 99999973 35699999999999999999999998 699999999999999999999999999998876
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
+.. ..+...||+.|||||.+.++.|+..+|.||+||++||+++|++||....-.. .+..+.... ..++...+.
T Consensus 153 ~t~-vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~----Lv~~I~~d~--v~~p~~~S~ 225 (808)
T KOG0597|consen 153 NTS-VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ----LVKSILKDP--VKPPSTASS 225 (808)
T ss_pred Cce-eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH----HHHHHhcCC--CCCcccccH
Confidence 543 3456789999999999999999999999999999999999999986532211 122222111 123446678
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+..++...+.+||.+|.|-.+++.
T Consensus 226 ~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 226 SFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHHHHHHHHhhcChhhcccHHHHhc
Confidence 8999999999999999999888764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=355.20 Aligned_cols=262 Identities=23% Similarity=0.357 Sum_probs=202.7
Q ss_pred cCCccccccccCCcceEEEEEEcC-----------------CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-----------------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASL 464 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 464 (673)
++|...+.||+|+||.||+|.+++ +..||+|.+..........+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467888899999999999998542 347999998765433345679999999999999999999
Q ss_pred eeEEecCCCCeEEEEEeecCCCChhhhhccccC---------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcc
Q 005859 465 RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAG---------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLV 529 (673)
Q Consensus 465 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~iv 529 (673)
++++... +..++||||+++|+|.+++..... ....++|..+.+++.||+.||+|||+. ||+
T Consensus 85 ~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--~iv 160 (304)
T cd05096 85 LGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--NFV 160 (304)
T ss_pred EEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--Ccc
Confidence 9999654 668999999999999998854211 123578899999999999999999987 799
Q ss_pred cCCcCCCCeEecCCCCeeeccccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh--CCC
Q 005859 530 HPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS--GKC 606 (673)
Q Consensus 530 HrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t--G~~ 606 (673)
||||||+|||+++++.+||+|||+++........ ......++..|+|||++..+.++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865433211 1122345778999999988889999999999999999987 556
Q ss_pred CCChhhHhhhhccchhhhcCC---cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 607 SITPFTRQAAESSKVEDFIDP---NLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 607 p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
||........... ....... ......+..++..+.+++.+||+.||++|||+.+|.+.|++
T Consensus 241 p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDEQVIEN-AGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHHHHHHH-HHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 7654432221111 1111110 11111233456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=365.97 Aligned_cols=262 Identities=22% Similarity=0.371 Sum_probs=205.1
Q ss_pred HhcCCccccccccCCcceEEEEEE------cCCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCC
Q 005859 400 ATQCFSEANLLGKSSFSATYKGIL------RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKG 472 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 472 (673)
..++|...+.||+|+||+||+|+. .++..||||+++........+.+.+|+++++.+ +||||++++++|...
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~- 111 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG- 111 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC-
Confidence 345688889999999999999973 235689999997554334456789999999999 899999999999554
Q ss_pred CCeEEEEEeecCCCChhhhhccccC-------------------------------------------------------
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAG------------------------------------------------------- 497 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------- 497 (673)
+..++||||+++|+|.+++.....
T Consensus 112 -~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 112 -GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred -CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 678999999999999999864221
Q ss_pred ----------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 498 ----------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 498 ----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
....++|..+++++.||++||+|||+. ||+||||||+|||+++++.+||+|||+++......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 012478999999999999999999987 89999999999999999999999999998665432
Q ss_pred hhh-hhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 562 VFS-MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 562 ~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
... .....++..|+|||.+.+..++.++|||||||++|||+| |..||............+ ........+...+.
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 344 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI----KEGYRMLSPECAPS 344 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH----HhCccCCCCCCCCH
Confidence 211 112234567999999999899999999999999999998 888886532221111111 11111112223356
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQELSSI 669 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i 669 (673)
++.+++.+||+.||++||++.||++.|++.
T Consensus 345 ~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 345 EMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=322.63 Aligned_cols=255 Identities=20% Similarity=0.274 Sum_probs=200.9
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCc-HHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSD-EGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.+|...+.||+|.||.||+|+.. +|+.||||+++....+.. .....+|++.|+.++|+||+.++++|- ..+...||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~--~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFP--HKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhcc--CCCceEEE
Confidence 35777889999999999999954 599999999988754322 357899999999999999999999994 44678899
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
+|||+. ||+..++. +...++..++..++.++++|++|+|.+ .|+||||||.|+|++.+|.+||+|||+|+.+..
T Consensus 80 fEfm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~--~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK--WILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred EEeccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh--hhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 999964 99999974 446799999999999999999999998 699999999999999999999999999998875
Q ss_pred cchhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc-----------------h
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK-----------------V 621 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~-----------------~ 621 (673)
... ..+..+.|.+|+|||.+.+. .|+..+||||.|||+.||+-|..-|.+..+....... +
T Consensus 154 p~~-~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 154 PNR-IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred CCc-ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 432 23344778999999998865 5999999999999999999886444332221111110 1
Q ss_pred hhhc-----CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 622 EDFI-----DPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 622 ~~~~-----~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
.++. .+......-..++.++.+++..++.+||.+|+|+.|++++
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1110 1111111223445677999999999999999999999864
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=365.91 Aligned_cols=265 Identities=21% Similarity=0.372 Sum_probs=207.4
Q ss_pred HHhcCCccccccccCCcceEEEEEEc------CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecC
Q 005859 399 RATQCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSK 471 (673)
Q Consensus 399 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 471 (673)
...++|+..+.||+|+||.||+|+.. ++..||||++...........+.+|+++++.+ +|||||+++++|..
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~- 113 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH- 113 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC-
Confidence 34457888899999999999999842 24579999997654333346788999999999 89999999999854
Q ss_pred CCCeEEEEEeecCCCChhhhhccccC------------------------------------------------------
Q 005859 472 GRGECFLIYDFVPNGNLLQHLDLEAG------------------------------------------------------ 497 (673)
Q Consensus 472 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------ 497 (673)
.+..++||||+++|+|.+++.....
T Consensus 114 -~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 114 -GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred -CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 4678999999999999998853210
Q ss_pred ------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhhh
Q 005859 498 ------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSM 565 (673)
Q Consensus 498 ------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 565 (673)
....+++..+++++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+++..........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK--NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC--CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 113478899999999999999999987 899999999999999999999999999986544322111
Q ss_pred -hccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHH
Q 005859 566 -LKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQ 643 (673)
Q Consensus 566 -~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 643 (673)
....++..|||||++....++.++|||||||++|||++ |+.||........ .............+...+.++.+
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~ 346 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK----FYKMVKRGYQMSRPDFAPPEIYS 346 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH----HHHHHHcccCccCCCCCCHHHHH
Confidence 12234567999999998899999999999999999997 9999865432111 11111111111222234578999
Q ss_pred HHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 644 IALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 644 l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
++.+||+.||++|||+.+|+++|+++++
T Consensus 347 li~~cl~~dp~~RPs~~~l~~~l~~~~~ 374 (374)
T cd05106 347 IMKMCWNLEPTERPTFSQISQLIQRQLG 374 (374)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHHhC
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=343.73 Aligned_cols=257 Identities=16% Similarity=0.262 Sum_probs=207.2
Q ss_pred HHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC-------------cHHHHHHHHHHHhccCCCCcee
Q 005859 398 ERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS-------------DEGEFLKGLKILTSLKHENLAS 463 (673)
Q Consensus 398 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~H~niv~ 463 (673)
.+.-+.|+..+.||+|.||+|-+|+.. +++.||||++.+..... ..+...+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 344578999999999999999999965 59999999997643211 1147889999999999999999
Q ss_pred EeeEEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC
Q 005859 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR 543 (673)
Q Consensus 464 l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~ 543 (673)
++++..+...+..|||+|||..|.+...-. ....++..++++|++++..||+|||.+ |||||||||+|+||+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Q--giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQ--GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhc--CeeccccchhheEEcCC
Confidence 999998888889999999999988864332 222399999999999999999999988 89999999999999999
Q ss_pred CCeeeccccccccccCc----chhhhhccCCCCCccCCccccCCC----CCcchhHHHHHHHHHHHHhCCCCCChhhHhh
Q 005859 544 YNPLLSDSGLHKLLADD----IVFSMLKASAAMGYLAPEYTTTGR----FTEKSDIYAFGMIVFQILSGKCSITPFTRQA 615 (673)
Q Consensus 544 ~~~kl~DfGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~ 615 (673)
|.+||+|||.+...... ........+||+.|||||...++. .+.+.||||+||+||.|+.|++||.+.....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 99999999999866321 122334578999999999998743 3578999999999999999999998765444
Q ss_pred hhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 616 AESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...+ ++...+.-....+....+.+|+.++|++||++|.+..+|..
T Consensus 327 l~~K----Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 327 LFDK----IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred HHHH----HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 3333 33333322222345688999999999999999999988853
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=328.61 Aligned_cols=237 Identities=19% Similarity=0.283 Sum_probs=203.1
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCC--CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCK--SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|+..+.||.|+||.|..++.+. |..+|+|++.+...- .+.+...+|.++|+.+.||.++++++.+.+ .+..|+
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d--~~~lym 121 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD--NSNLYM 121 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc--CCeEEE
Confidence 356677899999999999999764 889999999875431 233567889999999999999999998854 488999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||++||.|..+++. ...+++..++.+|.||+.||+|||+. +|++|||||+|||+|.+|.+||.|||+|+.+.
T Consensus 122 vmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~--~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL--DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc--CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 9999999999999973 35699999999999999999999998 79999999999999999999999999999887
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
.. ....+||+.|+|||.++...|..++|.|||||++|||+.|..||..........+++.. . -.+|....
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~----~--v~fP~~fs 265 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG----K--VKFPSYFS 265 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC----c--ccCCcccC
Confidence 64 33578999999999999999999999999999999999999999876654443333322 2 13556667
Q ss_pred HHHHHHHHHccccCCCCC
Q 005859 639 SNLGQIALHCTHESPSHR 656 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~R 656 (673)
.++.+|+.+.++.|-.+|
T Consensus 266 ~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 266 SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHHHHHHHhhhhHhh
Confidence 889999999999999998
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=353.07 Aligned_cols=255 Identities=18% Similarity=0.287 Sum_probs=202.2
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|+..+.||+|+||.||+++.. +|..||+|.+...........+.+|++++++++||||+++++++... +..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEEEEE
Confidence 357889999999999999999976 48899999987643223346799999999999999999999998654 689999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 82 MEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred eecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 999999999999963 245889999999999999999999853 699999999999999999999999999976643
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc-------------------
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK------------------- 620 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~------------------- 620 (673)
.. .....|+..|+|||++.+..++.++|||||||++|||+||+.||............
T Consensus 157 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred cc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence 22 22346889999999999888999999999999999999999998643211110000
Q ss_pred -----------------------hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 621 -----------------------VEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 621 -----------------------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
...+.............+.++.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000011245689999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=339.03 Aligned_cols=252 Identities=22% Similarity=0.393 Sum_probs=203.2
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
++|+..+.||+|+||.||++.++++..+|+|.+.... ....+|.+|++++++++||||+++++++.. .+..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEcc--CCCEEEEEE
Confidence 3577788999999999999999888899999886542 345689999999999999999999999854 467899999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+++|+|.++++... ..+++..++.++.|++.||+|||+. ||+||||||+||++++++.+||+|||.++......
T Consensus 80 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 80 FMENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN--SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred cCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC--CccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 999999999987432 3589999999999999999999987 89999999999999999999999999998664433
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
........++..|+|||++....++.++||||||+++|||++ |+.||............ .... ....+...+..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i-~~~~----~~~~~~~~~~~ 229 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI-SRGF----RLYRPKLASMT 229 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCC----CCCCCCCCCHH
Confidence 222223345568999999988889999999999999999999 88888654322211111 1110 11112233467
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQELS 667 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~~L~ 667 (673)
+.+++.+||+.+|++||+++++++.|.
T Consensus 230 ~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 230 VYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=330.07 Aligned_cols=255 Identities=15% Similarity=0.263 Sum_probs=202.6
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCc-HHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSD-EGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
.|+..+.|++|+||.||+|+.+ +++.||+|+++....+.. .-.-++||.+|.+++|||||.+..+....+-+.+|+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 4666788999999999999966 489999999987642222 23568999999999999999999999888778899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
|||+. ||..+++.. ...+...+...++.|+++|++|||.. .|+|||||++|+|+...|.+||+|||+||.+...
T Consensus 157 e~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~--wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN--WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc--eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 99976 999999743 24688899999999999999999987 6999999999999999999999999999988765
Q ss_pred chhhhhccCCCCCccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch-----------hhhcC--
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV-----------EDFID-- 626 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~-----------~~~~~-- 626 (673)
. ...+..+.|.+|+|||.+.+.+ |+++.|+||+|||+.||++++.-|.+.........++ ..+..
T Consensus 231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 3 2456678899999999998755 9999999999999999999986665432221111111 11000
Q ss_pred ------------CcCCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 627 ------------PNLEGKFSVS-EASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 627 ------------~~~~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..++..+... ..+.-.+++...+.+||.+|.|++|.++
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0111112111 2366789999999999999999999874
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=359.35 Aligned_cols=266 Identities=23% Similarity=0.363 Sum_probs=209.3
Q ss_pred HHhcCCccccccccCCcceEEEEEEcC------CcEEEEEEecccCCCCcHHHHHHHHHHHhccC-CCCceeEeeEEecC
Q 005859 399 RATQCFSEANLLGKSSFSATYKGILRD------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGICCSK 471 (673)
Q Consensus 399 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 471 (673)
...++|.+.+.||+|+||.||+|+... +..||||++.........+.+.+|+++++++. |||||+++++|..
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~- 112 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK- 112 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc-
Confidence 345678888999999999999998532 34799999976543444568999999999996 9999999999954
Q ss_pred CCCeEEEEEeecCCCChhhhhccccC------------------------------------------------------
Q 005859 472 GRGECFLIYDFVPNGNLLQHLDLEAG------------------------------------------------------ 497 (673)
Q Consensus 472 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------ 497 (673)
.+..++|||||++|+|.++++....
T Consensus 113 -~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 113 -SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred -CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 4779999999999999998864210
Q ss_pred --------------------------------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeE
Q 005859 498 --------------------------------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVL 539 (673)
Q Consensus 498 --------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NIL 539 (673)
....+++..+.+++.|+++||+|||+. +|+||||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivH~dikp~Nil 269 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK--NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChHhEE
Confidence 012478889999999999999999987 7999999999999
Q ss_pred ecCCCCeeeccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhh
Q 005859 540 IHRRYNPLLSDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAE 617 (673)
Q Consensus 540 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~ 617 (673)
+++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.........
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~ 349 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence 99999999999999986543221 11222346678999999998889999999999999999997 88888653221111
Q ss_pred ccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 618 SSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
...+.. ......+...+.++.+++.+||+.||++||++.+|.++|++++.+
T Consensus 350 ~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~~ 400 (400)
T cd05105 350 YNKIKS----GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLPS 400 (400)
T ss_pred HHHHhc----CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcCC
Confidence 111111 111122334567899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=346.37 Aligned_cols=251 Identities=19% Similarity=0.289 Sum_probs=200.2
Q ss_pred CccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC--CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 404 FSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK--SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
|+..+.||+|+||+||+|... +|+.||+|.+...... .....+.+|++++++++|+||+++++++.. .+..++||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~~~~lv~ 79 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET--KDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CCeEEEEE
Confidence 677889999999999999965 5899999998754322 223467899999999999999999998854 46799999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++|+|.+++... ....+++..+..++.|++.||+|||+. ||+||||||+|||+++++.+||+|||+++.....
T Consensus 80 e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~--~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 80 TIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE--RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC--CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999999887532 223589999999999999999999987 8999999999999999999999999999875433
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||.................. ....++...+.+
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~ 231 (285)
T cd05631 156 E--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--DQEEYSEKFSED 231 (285)
T ss_pred C--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc--ccccCCccCCHH
Confidence 2 123356899999999999999999999999999999999999998753221111111111111 111233445678
Q ss_pred HHHHHHHccccCCCCCCC-----HHHHHH
Q 005859 641 LGQIALHCTHESPSHRPS-----IENVMQ 664 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs-----~~evl~ 664 (673)
+.+|+.+||+.||++||+ ++++++
T Consensus 232 ~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 232 AKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred HHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 899999999999999997 788775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=352.87 Aligned_cols=265 Identities=22% Similarity=0.372 Sum_probs=207.2
Q ss_pred hcCCccccccccCCcceEEEEEEc------CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGR 473 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 473 (673)
.++|++.+.||+|+||.||+|... +++.||+|++.........+.+.+|++++.++ +||||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-G 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-C
Confidence 346888899999999999999742 25789999987543223345688899999999 899999999988644 3
Q ss_pred CeEEEEEeecCCCChhhhhccccCC-------------------------------------------------------
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGS------------------------------------------------------- 498 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~------------------------------------------------------- 498 (673)
...+++|||+++|+|.+++......
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5688999999999999988532110
Q ss_pred --ccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcch-hhhhccCCCCCcc
Q 005859 499 --EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV-FSMLKASAAMGYL 575 (673)
Q Consensus 499 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~ 575 (673)
...++|..+.+++.||+.||+|||+. ||+||||||+||++++++.+||+|||+++.+..... .......++..|+
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~--~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 13689999999999999999999987 899999999999999999999999999987643221 1122334567899
Q ss_pred CCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCC
Q 005859 576 APEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPS 654 (673)
Q Consensus 576 aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~ 654 (673)
|||++.+..++.++|||||||++|||++ |+.||............+.. ......+...+.++.+++.+||+.+|+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE----GTRMRAPEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc----cCCCCCCccCCHHHHHHHHHHccCChh
Confidence 9999999999999999999999999998 99888643211111111111 111122234457899999999999999
Q ss_pred CCCCHHHHHHHHHHhhcC
Q 005859 655 HRPSIENVMQELSSIIGS 672 (673)
Q Consensus 655 ~RPs~~evl~~L~~i~~~ 672 (673)
+||++.||++.|+++++.
T Consensus 319 ~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 319 DRPTFSELVEILGDLLQE 336 (337)
T ss_pred hCcCHHHHHHHHHHHHhc
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=339.41 Aligned_cols=256 Identities=23% Similarity=0.412 Sum_probs=207.2
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
.+|...+.||+|+||.||+|...+ ++.||+|.+... .....++.+|++++++++||||+++++++... +..++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCC--CCcEEEE
Confidence 347778899999999999999764 889999988654 23456799999999999999999999998544 6789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++... ....+++..++.++.|+++||+|||+. |++||||||+||++++++.+||+|||+++.....
T Consensus 82 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~--~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 82 EFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC--CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 999999999998643 224589999999999999999999987 8999999999999999999999999999876544
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
..........+..|+|||.+.+..++.++|||||||++|||+| |..||.......... ... .......+...+.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~-~~~----~~~~~~~~~~~~~ 232 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLE----KGYRMERPEGCPP 232 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHH----CCCCCCCCCCCCH
Confidence 3222222234567999999998899999999999999999998 888886532221111 111 1122233444567
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
++.+++.+||+.||++||++.+++++|+.++
T Consensus 233 ~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 233 KVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 8999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=343.10 Aligned_cols=259 Identities=23% Similarity=0.417 Sum_probs=206.8
Q ss_pred cCCccccccccCCcceEEEEEEcC-C-----cEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-G-----SVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
++|+..+.||+|+||.||+|.... + ..||+|.+..........+|.+|++++++++||||+++++++.. .+.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK--EQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC--CCc
Confidence 357778899999999999998643 2 57999998755433334678999999999999999999999854 367
Q ss_pred EEEEEeecCCCChhhhhccccC------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAG------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR 543 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~ 543 (673)
.+++|||+++|+|.+++..... ....+++..++.++.|++.||+|||+. ||+||||||+||+++++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~--~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH--HFVHRDLAARNCLVGEG 160 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccccccceEEEcCC
Confidence 8999999999999999864311 114588999999999999999999987 79999999999999999
Q ss_pred CCeeeccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccch
Q 005859 544 YNPLLSDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKV 621 (673)
Q Consensus 544 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~ 621 (673)
+.+||+|||+++....... .......++..|+|||.+....++.++|||||||++|||+| |..||..........
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~--- 237 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE--- 237 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---
Confidence 9999999999986543221 12223446778999999988889999999999999999998 999987643322111
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 005859 622 EDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSI 669 (673)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i 669 (673)
.+........+...+.++.+++.+||+.||++||++.||++.|+++
T Consensus 238 --~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 238 --MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred --HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1111112223445678899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=349.78 Aligned_cols=257 Identities=23% Similarity=0.374 Sum_probs=204.4
Q ss_pred cCCccccccccCCcceEEEEEEcC-Cc----EEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GS----VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
.+|+..+.||+|+||.||+|++.. +. .||+|.+.........+++.+|+.+++.++||||++++|+|.. +..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---~~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---CCc
Confidence 468889999999999999998643 43 4899998754333445689999999999999999999999864 346
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++|+||+++|+|.+++... ...+++..+++++.||+.||+|||+. ||+||||||+|||+++++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~--~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 84 QLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER--RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc--CeeccccchhheEecCCCcEEEcccccccc
Confidence 7999999999999999743 23588999999999999999999987 899999999999999999999999999987
Q ss_pred ccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 557 LADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 557 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
....... ......++..|+|||++....++.++|||||||++|||+| |+.||........ ............+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-----~~~~~~~~~~~~~ 233 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-----SSILEKGERLPQP 233 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-----HHHHhCCCCCCCC
Confidence 6543221 1122234567999999999899999999999999999998 9999865432211 1111111111122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
..++.++.+++.+||+.+|++||++.+++..|.++..
T Consensus 234 ~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 234 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 3345678999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=338.48 Aligned_cols=257 Identities=23% Similarity=0.414 Sum_probs=207.3
Q ss_pred cCCccccccccCCcceEEEEEEcC----CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD----GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
++|+..+.||+|+||+||+|.+.. ...||||.+..........+|.+|+.++++++||||+++++++.. .+..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CCceE
Confidence 568889999999999999999753 458999988765434445679999999999999999999999854 36789
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++++|.+++.... ..+++..+++++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 82 iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~--~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 82 IITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEM--NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999997432 3689999999999999999999987 7999999999999999999999999999877
Q ss_pred cCcc-hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 558 ADDI-VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 558 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
.... ........++..|+|||.+....++.++||||||+++|||++ |..||.............. ......+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~ 231 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-----GYRLPPPM 231 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc-----CCCCCCCC
Confidence 5211 111122334578999999998889999999999999999998 9999865443322111111 11112233
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
..+..+.+++.+||+.+|++||++.||++.|++++
T Consensus 232 ~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 232 DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 45678899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.58 Aligned_cols=256 Identities=22% Similarity=0.394 Sum_probs=207.2
Q ss_pred hcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
.++|+..+.||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++.. .+..++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTK--EEPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCcEEEE
Confidence 35688889999999999999998888899999886542 245689999999999999999999998854 46789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++|+|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~--~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 81 EYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK--NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred ecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999998643 234588999999999999999999987 7999999999999999999999999999876543
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
.........++..|+|||++....++.++|||||||++|||+| |+.||........... +...... ......+.
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~~~~~~~----~~~~~~~~ 231 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA-LQRGYRM----PRMENCPD 231 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH-HHcCCCC----CCCCCCCH
Confidence 3222223345678999999988889999999999999999999 9989865432221111 1111111 11223456
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQELSSI 669 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i 669 (673)
++.+++.+||+.+|++||+++++.+.|+++
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 232 ELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=337.76 Aligned_cols=256 Identities=24% Similarity=0.436 Sum_probs=207.9
Q ss_pred hcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
.++|...+.||+|+||.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++... +..++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 80 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE--EPIYIVT 80 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecC--CCeeeee
Confidence 45688889999999999999998778899999987543 3456899999999999999999999988544 6789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++.... ...+++..+..++.|++.|++|||+. ||+||||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 81 ELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ--NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred ecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 9999999999996432 24689999999999999999999987 8999999999999999999999999999877543
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
..........+..|+|||++.+..++.++||||||+++|||+| |+.||............ .. ......+...+.
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~----~~~~~~~~~~~~ 231 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-DQ----GYRMPCPPGCPK 231 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-Hc----CCCCCCCCcCCH
Confidence 2222222223457999999998889999999999999999999 99888654332221111 11 111122334557
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQELSSI 669 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i 669 (673)
.+.+++.+||+.+|++||+++++++.|+++
T Consensus 232 ~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 232 ELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=343.28 Aligned_cols=250 Identities=29% Similarity=0.532 Sum_probs=194.0
Q ss_pred cccccccCCcceEEEEEEc-----CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 406 EANLLGKSSFSATYKGILR-----DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 406 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
..+.||.|.||.||+|.+. .+..|+||.+.........++|.+|++.+++++||||++++|++... +..++||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~--~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN--EPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS--SSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccc--ccccccc
Confidence 3568999999999999987 25689999996644333467899999999999999999999999743 5589999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++|+|.+++... ....+++..+.+|+.||++||+|||+. +|+|+||+++||++++++.+||+|||+++.....
T Consensus 81 e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~--~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN--NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp E--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT--TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccccc--ccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccc
Confidence 999999999999854 235689999999999999999999997 7999999999999999999999999999876322
Q ss_pred c-hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 561 I-VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 561 ~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
. ............|+|||.+....++.++||||||+++|||+| |+.||.......... .+.+.. ....+..++
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~-~~~~~~----~~~~~~~~~ 231 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIE-KLKQGQ----RLPIPDNCP 231 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHH-HHHTTE----ETTSBTTSB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccc----cceeccchh
Confidence 1 111222345678999999998889999999999999999999 778876653322111 111111 122333456
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQEL 666 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L 666 (673)
..+.+++.+||+.||++||+|.++++.|
T Consensus 232 ~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 232 KDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 7899999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=344.29 Aligned_cols=253 Identities=20% Similarity=0.263 Sum_probs=204.8
Q ss_pred HhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
..++|+....||+|+||.||.|+-++ |..+|+|++++... ..+.+..+.|-.+|...++|+||+++..| ++.+..
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF--QD~~~L 216 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF--QDKEYL 216 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe--cCCCee
Confidence 45789999999999999999999765 99999999988643 23345678899999999999999999888 566899
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
||||||++|||+..+|. ....|++..+..++.+++.|++-||.. |+|||||||+|+|||..|++||+|||++..
T Consensus 217 YLiMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~--gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL--GYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc--CcccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999997 346799999999999999999999987 899999999999999999999999999864
Q ss_pred ccCc-----------------------ch-----hh------------------hhccCCCCCccCCccccCCCCCcchh
Q 005859 557 LADD-----------------------IV-----FS------------------MLKASAAMGYLAPEYTTTGRFTEKSD 590 (673)
Q Consensus 557 ~~~~-----------------------~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~s~ksD 590 (673)
+... .. .. ....+||+-|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 3210 00 00 01247999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHH
Q 005859 591 IYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPS---IENVM 663 (673)
Q Consensus 591 VwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~evl 663 (673)
.||+|||||||+.|-+||..........+++.-- ..+.-........+..+||.+|+. ||++|-. +.||-
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr--~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR--ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh--hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 9999999999999999998766655544332211 011111112334789999999999 9999964 55553
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=342.34 Aligned_cols=262 Identities=22% Similarity=0.378 Sum_probs=207.6
Q ss_pred CCccccccccCCcceEEEEEEcC------CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 403 CFSEANLLGKSSFSATYKGILRD------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
+|...+.||+|+||.||+|+... ...||+|.+.........+++.+|++++++++||||+++++.+... +..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--GPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CCc
Confidence 46778899999999999998532 3579999887654333346789999999999999999999998544 678
Q ss_pred EEEEeecCCCChhhhhcccc--------------------CCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCC
Q 005859 477 FLIYDFVPNGNLLQHLDLEA--------------------GSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAE 536 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~ 536 (673)
++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~ivH~dikp~ 156 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM--KLVHRDLAAR 156 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC--Ceehhhhhhh
Confidence 99999999999999986321 1123588999999999999999999987 8999999999
Q ss_pred CeEecCCCCeeeccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHh
Q 005859 537 KVLIHRRYNPLLSDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQ 614 (673)
Q Consensus 537 NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~ 614 (673)
||++++++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||+| |+.||......
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999986543221 11222345678999999988889999999999999999999 99888654322
Q ss_pred hhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcCC
Q 005859 615 AAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673 (673)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~ 673 (673)
... +..........+...+.++.+++.+||+.+|++||+++|+++.|++++++|
T Consensus 237 ~~~-----~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~~ 290 (290)
T cd05045 237 RLF-----NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVKS 290 (290)
T ss_pred HHH-----HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhcC
Confidence 211 111111122223345578999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=340.33 Aligned_cols=260 Identities=21% Similarity=0.378 Sum_probs=204.9
Q ss_pred CccccccccCCcceEEEEEE-----cCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 404 FSEANLLGKSSFSATYKGIL-----RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
|...+.||+|+||+||++.. .+++.||+|.+...........|.+|++++++++||||+++++++........++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37788999999999988653 2478999999876543334567899999999999999999999987655567899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. ||+||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC--CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999863 2489999999999999999999987 79999999999999999999999999998765
Q ss_pred Ccchhh--hhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhh----------ccchhhhcC
Q 005859 559 DDIVFS--MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE----------SSKVEDFID 626 (673)
Q Consensus 559 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~----------~~~~~~~~~ 626 (673)
...... .....++..|+|||.+....++.++||||||+++|||+||+.|+......... .....+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 432111 11223556799999998888999999999999999999999887543211000 001111111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 627 PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 627 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
.......+...+.++.+++.+||+.+|++|||++++++.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111223445678999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=313.36 Aligned_cols=268 Identities=21% Similarity=0.316 Sum_probs=214.7
Q ss_pred HhcCCccccccccCCcceEEEEE-EcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCC---CCe
Q 005859 400 ATQCFSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKG---RGE 475 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---~~~ 475 (673)
..++|.+.+.||+|||+.||.++ ..+++.+|+|++.-.. ..+.+..++|++..++++||||++++++...+. ..+
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 35689999999999999999998 5678999999997665 456678999999999999999999998876432 347
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.||+++|...|+|.+.+......+..+++.+.+.|+.+|++||++||+..|+++||||||.|||+.+++.+++.|||.+.
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 89999999999999999866556678999999999999999999999987789999999999999999999999999987
Q ss_pred cccCcch--------hhhhccCCCCCccCCccccC---CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhh
Q 005859 556 LLADDIV--------FSMLKASAAMGYLAPEYTTT---GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF 624 (673)
Q Consensus 556 ~~~~~~~--------~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~ 624 (673)
...-... .......-|..|+|||.+.- ...++++|||||||+||+|+.|..||....... ......+
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G--gSlaLAv 255 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG--GSLALAV 255 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC--CeEEEee
Confidence 5431110 01122346788999999863 346899999999999999999999987643311 1111111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 625 IDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
..+.+.-......++.+.+++.+|++.||.+||++.+++..++.++
T Consensus 256 ~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 256 QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1212111111226788999999999999999999999999998875
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=350.80 Aligned_cols=247 Identities=21% Similarity=0.321 Sum_probs=206.9
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
-|+..+.||+|+-|.|-.|++. +|+.+|||++.+... ......+.+|+-+|+-+.||||+++|+++.. ..+.|+|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~~~lylv 90 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--KQHLYLV 90 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc--CceEEEE
Confidence 4566788999999999999965 599999999987632 2234568899999999999999999999954 5889999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
.||+++|.|++++-. +..+++.++.+++.||+.|+.|+|.. +|+|||+||+|+|||..+++||+|||+|..-..
T Consensus 91 lEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~--~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF--NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh--cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 999999999999973 45689999999999999999999997 699999999999999999999999999987665
Q ss_pred cchhhhhccCCCCCccCCccccCCCCC-cchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFT-EKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
+.. ....||++.|.|||++.+..|+ .++||||.|||||-|+||+.||++..-.... .++.... -+++...+
T Consensus 165 gkl--LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LL----lKV~~G~--f~MPs~Is 236 (786)
T KOG0588|consen 165 GKL--LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLL----LKVQRGV--FEMPSNIS 236 (786)
T ss_pred Ccc--ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHH----HHHHcCc--ccCCCcCC
Confidence 542 3457899999999999999985 8999999999999999999999854322111 1111111 13456667
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
.++.+|+.+|+..||++|.|++||++.
T Consensus 237 ~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 237 SEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHHHHHHHHHhccCccccccHHHHhhC
Confidence 899999999999999999999999863
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=346.68 Aligned_cols=245 Identities=18% Similarity=0.237 Sum_probs=200.2
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|+..+.||+|+||.||+|... +++.||+|++..... ....+.+.+|++++++++||||+++++++.+ .+..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEEE
Confidence 36888899999999999999976 589999999865421 1234568899999999999999999998854 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ ||+||||||+|||+++++.+||+|||+++...
T Consensus 79 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 79 LMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK--EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred EEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 9999999999999863 24588999999999999999999987 89999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
... ....|++.|+|||++.+..++.++|||||||++|||+||+.||.......... .+.... ..++...+
T Consensus 153 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~----~i~~~~--~~~~~~~~ 222 (291)
T cd05612 153 DRT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE----KILAGK--LEFPRHLD 222 (291)
T ss_pred CCc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCC--cCCCccCC
Confidence 432 23468899999999998889999999999999999999999986543222111 111111 12233345
Q ss_pred HHHHHHHHHccccCCCCCCC-----HHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPS-----IENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 664 (673)
..+.+++.+||+.||.+||+ ++|+++
T Consensus 223 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 223 LYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred HHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 68899999999999999995 888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=342.61 Aligned_cols=255 Identities=18% Similarity=0.257 Sum_probs=199.1
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
++|++.+.||+|+||.||+|+.+. ++.||+|++..... ....+.+.+|++++++++||||+++++++.. .+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEEEE
Confidence 468889999999999999999864 88999999876432 2234678899999999999999999999854 4789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||++++.+..+.. ....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~--~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 79 FEYVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN--DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred EecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 99999877765443 224588999999999999999999987 799999999999999999999999999987654
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc-----------h-------
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK-----------V------- 621 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~-----------~------- 621 (673)
..........++..|+|||++.+..++.++|||||||++|||++|+.||............ .
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 3322233456889999999999888999999999999999999999998653221110000 0
Q ss_pred --hhhcCCcCCC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 622 --EDFIDPNLEG------KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 622 --~~~~~~~~~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.....+.... ......+..+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 011124567999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=347.43 Aligned_cols=254 Identities=19% Similarity=0.296 Sum_probs=200.0
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|+..+.||+|+||.||++... ++..||+|.+...........+.+|++++++++||||+++++++... +..++|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC--CEEEEE
Confidence 367889999999999999999976 48899999887653233346789999999999999999999999664 789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+.. +|+||||||+|||+++++.+||+|||+++....
T Consensus 82 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 82 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC-CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 999999999999963 245889999999999999999999742 699999999999999999999999999876543
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhcc-------c------------
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESS-------K------------ 620 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~-------~------------ 620 (673)
.. .....++..|+|||++.+..++.++|||||||++|||++|+.||........... .
T Consensus 157 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred hc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence 21 2234688899999999988899999999999999999999999864321110000 0
Q ss_pred ---------------------hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 621 ---------------------VEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 621 ---------------------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...+.............+.++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 00000000000000113467899999999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=351.17 Aligned_cols=242 Identities=19% Similarity=0.292 Sum_probs=195.8
Q ss_pred cccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecC
Q 005859 408 NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVP 484 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~ 484 (673)
+.||+|+||.||+++.. +|+.||||++..... ......+.+|++++++++||||+++++++.. .+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCCC
Confidence 36999999999999975 589999999976432 2233567899999999999999999998854 478999999999
Q ss_pred CCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhh
Q 005859 485 NGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFS 564 (673)
Q Consensus 485 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 564 (673)
+|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++....... .
T Consensus 79 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~--~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~ 151 (323)
T cd05571 79 GGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC--DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-T 151 (323)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC--CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-c
Confidence 9999999863 34689999999999999999999987 899999999999999999999999999875432211 1
Q ss_pred hhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHH
Q 005859 565 MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQI 644 (673)
Q Consensus 565 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 644 (673)
.....|++.|+|||++.+..++.++|||||||++|||+||+.||............ .... ..++...+.++.++
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~----~~~~--~~~p~~~~~~~~~l 225 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI----LMEE--IRFPRTLSPEAKSL 225 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH----HcCC--CCCCCCCCHHHHHH
Confidence 23356899999999999989999999999999999999999998654322211111 1111 12333456788999
Q ss_pred HHHccccCCCCCC-----CHHHHHH
Q 005859 645 ALHCTHESPSHRP-----SIENVMQ 664 (673)
Q Consensus 645 ~~~Cl~~~p~~RP-----s~~evl~ 664 (673)
+.+||+.||++|| ++.++++
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 226 LAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHccCCHHHcCCCCCCCHHHHHc
Confidence 9999999999999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=342.74 Aligned_cols=264 Identities=21% Similarity=0.406 Sum_probs=209.5
Q ss_pred HHhcCCccccccccCCcceEEEEEEcC------CcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecC
Q 005859 399 RATQCFSEANLLGKSSFSATYKGILRD------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSK 471 (673)
Q Consensus 399 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 471 (673)
...++|+..+.||+|+||.||++...+ ...||+|.+..........++.+|+++++++ +||||+++++++..
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~- 87 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ- 87 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC-
Confidence 344568888999999999999998643 3689999987654333345788999999999 89999999999854
Q ss_pred CCCeEEEEEeecCCCChhhhhcccc------------CCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeE
Q 005859 472 GRGECFLIYDFVPNGNLLQHLDLEA------------GSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVL 539 (673)
Q Consensus 472 ~~~~~~lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NIL 539 (673)
.+..++||||+++|+|.++++... .....+++..+++++.|++.||+|||+. +|+||||||+||+
T Consensus 88 -~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--~ivH~dlkp~Nil 164 (293)
T cd05053 88 -EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK--KCIHRDLAARNVL 164 (293)
T ss_pred -CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC--CccccccceeeEE
Confidence 467899999999999999986421 2235689999999999999999999987 8999999999999
Q ss_pred ecCCCCeeeccccccccccCcchhh-hhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhh
Q 005859 540 IHRRYNPLLSDSGLHKLLADDIVFS-MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAE 617 (673)
Q Consensus 540 l~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~ 617 (673)
+++++.+||+|||+++.+....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.........
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 9999999999999998765432211 122334567999999988889999999999999999998 88888654322111
Q ss_pred ccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 618 SSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
. ..........+...+..+.+++.+||+.||++|||+.|+++.|++++.
T Consensus 245 ~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~~ 293 (293)
T cd05053 245 K-----LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRMLT 293 (293)
T ss_pred H-----HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhhC
Confidence 1 111111222334456789999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=352.56 Aligned_cols=247 Identities=20% Similarity=0.326 Sum_probs=191.1
Q ss_pred CccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEee
Q 005859 404 FSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDF 482 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~ 482 (673)
|+..+.||+|+||.||+|+.. +++.||||++...........+.+|++++++++|+||+++++++.. .+..++||||
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~ 153 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQVLLEF 153 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--CCeEEEEEec
Confidence 344568999999999999976 5899999998655433334678999999999999999999999854 4788999999
Q ss_pred cCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcch
Q 005859 483 VPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV 562 (673)
Q Consensus 483 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 562 (673)
+++|+|.+.. ..++..+..++.||+.||+|||+. ||+||||||+|||+++++.+||+|||+++.......
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR--HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC--CEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986533 245677888999999999999987 899999999999999999999999999987653321
Q ss_pred hhhhccCCCCCccCCccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 563 FSMLKASAAMGYLAPEYTTT-----GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 563 ~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
......|+..|+|||++.. ...+.++|||||||++|||++|+.||...... .+........ .......+...
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~-~~~~~~~~~~~ 300 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLMCAIC-MSQPPEAPATA 300 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHh-ccCCCCCCCcc
Confidence 1233568999999998753 22456899999999999999999998632110 0111111110 11111223345
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
+.++.+++.+||+.||++|||+.|+++.
T Consensus 301 ~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 301 SREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 6789999999999999999999999863
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=341.90 Aligned_cols=255 Identities=19% Similarity=0.310 Sum_probs=196.7
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|...+.||+|+||.||+|+.. +++.||||++...........+.+|++++++++||||+++++++.. .+..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeEEEE
Confidence 357889999999999999999976 5889999999765433344567899999999999999999999854 4688999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||++ ++|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+|||+++++.+||+|||+++....
T Consensus 82 ~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 82 FEYVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR--YILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred EECCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 99995 6888887632 24588899999999999999999987 899999999999999999999999999875433
Q ss_pred cchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhc-------------
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFI------------- 625 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~------------- 625 (673)
.. .......++..|+|||++.+ ..++.++||||+||++|||+||+.||....+.......+....
T Consensus 156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 156 PS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred CC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 21 12233567889999999875 4589999999999999999999999965322111100000000
Q ss_pred ----CCc-CCCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 626 ----DPN-LEGKFS---------VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 626 ----~~~-~~~~~~---------~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+. .....+ ...+..+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000 000000 012356889999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=333.77 Aligned_cols=261 Identities=17% Similarity=0.264 Sum_probs=208.0
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|++.+.||+|+||.||+|+.. +++.||||.+..... ......+.+|++++++++||||+++++++... +..++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED--NELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--CeEEE
Confidence 46888999999999999999965 589999998865322 12235688999999999999999999998654 67899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++.........+++..+..++.|+++||+|||+. ||+||||||+||+++.++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC--CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 9999999999998864333345688999999999999999999987 89999999999999999999999999988765
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
.... ......++..|+|||.+.+..++.++||||||+++|||+||+.||....... ......+.............+
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08228 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--FSLCQKIEQCDYPPLPTEHYS 234 (267)
T ss_pred chhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH--HHHHHHHhcCCCCCCChhhcC
Confidence 4322 1223457888999999988889999999999999999999999985432110 001111111111122233456
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQELSSI 669 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i 669 (673)
..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 235 ~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 235 EKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 7899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=351.37 Aligned_cols=245 Identities=18% Similarity=0.284 Sum_probs=200.3
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|...+.||+|+||.||+|+... ++.||+|++..... ....+.+.+|++++++++||||+++++++.. .+..++
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 95 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRVYF 95 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEEEE
Confidence 468888999999999999999764 89999999975421 2234578899999999999999999999855 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||+++++.+||+|||+++...
T Consensus 96 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK--DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 9999999999999863 24588899999999999999999987 89999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
... ....|++.|+|||++.+..++.++|||||||++|||+||+.||.......... .+..... .++...+
T Consensus 170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~----~i~~~~~--~~p~~~~ 239 (329)
T PTZ00263 170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE----KILAGRL--KFPNWFD 239 (329)
T ss_pred CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH----HHhcCCc--CCCCCCC
Confidence 432 23468999999999999889999999999999999999999986543222111 1111111 1222345
Q ss_pred HHHHHHHHHccccCCCCCCC-----HHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPS-----IENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 664 (673)
..+.+++.+||+.||.+||+ ++++++
T Consensus 240 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 240 GRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 67899999999999999996 677663
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=332.60 Aligned_cols=250 Identities=25% Similarity=0.426 Sum_probs=202.1
Q ss_pred CCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEee
Q 005859 403 CFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDF 482 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~ 482 (673)
+|...+.||+|+||.||+|..+++..+|+|.+.... ....+|.+|++++++++||||+++++++.. .+..++||||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~ 80 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK--QRPIFIVTEY 80 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCceEEEEec
Confidence 466778999999999999998877889999886543 345678999999999999999999999854 4678999999
Q ss_pred cCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcch
Q 005859 483 VPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV 562 (673)
Q Consensus 483 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 562 (673)
+++++|.+++.... ..+++..++.++.|++.||+|||+. ||+||||||+||++++++.+||+|||+++...+...
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 81 MANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN--GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC--CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 99999999986432 3589999999999999999999987 799999999999999999999999999986654322
Q ss_pred hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHH
Q 005859 563 FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641 (673)
Q Consensus 563 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 641 (673)
.......++..|+|||.+.+..++.++||||||+++|||+| |+.||.......... ...... ....+...+.++
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~ 230 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE-SVSAGY----RLYRPKLAPTEV 230 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH-HHHcCC----cCCCCCCCCHHH
Confidence 22222234457999999998899999999999999999999 888886543322211 111111 112223356789
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHH
Q 005859 642 GQIALHCTHESPSHRPSIENVMQEL 666 (673)
Q Consensus 642 ~~l~~~Cl~~~p~~RPs~~evl~~L 666 (673)
.+++.+||+.+|++|||+.|+++.|
T Consensus 231 ~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 231 YTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHHhcCChhhCcCHHHHHHHh
Confidence 9999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=333.01 Aligned_cols=252 Identities=25% Similarity=0.429 Sum_probs=202.9
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
++|...+.||+|+||+||+|...++..||+|.+.... ....+|.+|+.++++++||||+++++++... +..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ--RPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccC--CCcEEEEE
Confidence 3567788999999999999998877789999987543 3456799999999999999999999998544 56899999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+++|+|.+++... ...+++..++.++.||+.||+|||+. ||+|+||||+||++++++.+||+|||.++......
T Consensus 80 ~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 80 YMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK--QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred cCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 99999999998642 23589999999999999999999987 89999999999999999999999999988665433
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
........++..|+|||++.+..++.++|||||||++|||+| |+.||............. ..... ..+...+..
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~ 229 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRL----YRPHLASEK 229 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-cCCCC----CCCCCCCHH
Confidence 222222335567999999988889999999999999999999 998986543322211111 11111 112234578
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQELS 667 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~~L~ 667 (673)
+.+++.+||+.+|.+||++.++++.|+
T Consensus 230 ~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 230 VYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=338.39 Aligned_cols=258 Identities=20% Similarity=0.375 Sum_probs=205.8
Q ss_pred cCCccccccccCCcceEEEEEEcC------CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
++|...+.||+|+||.||+|+..+ ++.||||.+.........+.+.+|++++++++||||+++++++... ..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG--DP 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC--CC
Confidence 457778899999999999998643 4789999987654333457899999999999999999999998654 67
Q ss_pred EEEEEeecCCCChhhhhcccc----------CCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC
Q 005859 476 CFLIYDFVPNGNLLQHLDLEA----------GSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN 545 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~ 545 (673)
.++||||+++|+|.+++.... .....+++..+..++.|++.|++|||+. ||+||||||+||+++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~--~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ--HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC--CeeccccccceEEEcCCCe
Confidence 899999999999999997432 1234588999999999999999999987 8999999999999999999
Q ss_pred eeeccccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhh
Q 005859 546 PLLSDSGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVED 623 (673)
Q Consensus 546 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~ 623 (673)
+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||...........
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~---- 236 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC---- 236 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----
Confidence 999999999765332211 1122345678999999999999999999999999999999 9999865432221111
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 624 FIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
+. .......+...+..+.+++.+||+.||++||++.||++.|++
T Consensus 237 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 IT-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11 111112233456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=338.69 Aligned_cols=260 Identities=19% Similarity=0.353 Sum_probs=203.7
Q ss_pred HhcCCccccccccCCcceEEEEEEc------CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGR 473 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 473 (673)
.+++|+..+.||+|+||.||+|... .+..||||.+..........+|.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--G 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--C
Confidence 4567999999999999999999853 2567999988654322344578999999999999999999999844 4
Q ss_pred CeEEEEEeecCCCChhhhhccccCC------ccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCee
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGS------EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPL 547 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~k 547 (673)
...++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. |++||||||+||++++++.+|
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCcchheEEEcCCCCEE
Confidence 6789999999999999998643211 23468889999999999999999987 899999999999999999999
Q ss_pred eccccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhc
Q 005859 548 LSDSGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFI 625 (673)
Q Consensus 548 l~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~ 625 (673)
|+|||+++........ ......++..|+|||++.++.++.++|||||||++|||++ |..||........... ..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~----~~ 235 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF----VM 235 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HH
Confidence 9999998765432211 1112345678999999998889999999999999999999 6778765432211111 11
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 626 DPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
.... ...+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 236 ~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 EGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111 12233445789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=329.48 Aligned_cols=246 Identities=18% Similarity=0.335 Sum_probs=206.5
Q ss_pred cCCccccccccCCcceEEEEEE-cCCcEEEEEEecccCCCCc--HHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGIL-RDGSVVAVKCIAKTSCKSD--EGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
-+|++.+.||+|.||+|-+++. ..|+.||||.+++...+.. .-.+.+|++||+.|+||||+.+|++| ++.+.+.|
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF--ENkdKIvi 130 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF--ENKDKIVI 130 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh--cCCceEEE
Confidence 4577788999999999999985 5699999999988764332 34678999999999999999999999 55688999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||..+|.|++|+.. ...+++.++.++++||..|+.|+|.+ +++|||||-+|||+|.++++||+|||++-++.
T Consensus 131 vMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn--rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN--RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc--cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 9999999999999973 35699999999999999999999987 79999999999999999999999999999887
Q ss_pred CcchhhhhccCCCCCccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRF-TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
++.. ....+|++-|.+||++.+..| .+.+|-||+||+||-|+-|..||++...... +.++-..... ....
T Consensus 205 ~~kf--LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l----vrQIs~GaYr---EP~~ 275 (668)
T KOG0611|consen 205 DKKF--LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL----VRQISRGAYR---EPET 275 (668)
T ss_pred cccH--HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH----HHHhhccccc---CCCC
Confidence 7653 446789999999999999888 5899999999999999999999988643321 1111111111 1123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+....-||++|+..+|++|.|+.+|..
T Consensus 276 PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 276 PSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred CchHHHHHHHHHhcCcccchhHHHHhh
Confidence 456778999999999999999999864
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=336.52 Aligned_cols=256 Identities=24% Similarity=0.384 Sum_probs=200.1
Q ss_pred CCccccccccCCcceEEEEEEc-CCc----EEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGS----VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
+|+..+.||+|+||+||+|.+. +++ .|++|.+..........++..|+.++++++||||+++++++.. ...+
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~~~ 84 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---ASLQ 84 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---CccE
Confidence 5677789999999999999964 344 4777777543322233567888889999999999999998742 3467
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+++||+++|+|.+++... ...+++..+..++.||+.||+|||+. |++||||||+||++++++.+||+|||+++..
T Consensus 85 ~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~--~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH--RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC--CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 899999999999999743 24589999999999999999999987 7999999999999999999999999999866
Q ss_pred cCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 558 ADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 558 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
..... .......++..|+|||.+.++.++.++|||||||++||++| |+.||........ .+.+........+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~ 234 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-----PDLLEKGERLAQPQ 234 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-----HHHHHCCCcCCCCC
Confidence 43221 11223446678999999998899999999999999999998 9988865432211 11111111111122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.++..+.+++.+||..||++|||+.|+++.|..+.+
T Consensus 235 ~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 235 ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 244678889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=349.79 Aligned_cols=252 Identities=19% Similarity=0.248 Sum_probs=202.8
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|++.+.||+|+||.||+|+..+ ++.||||++..... ......+.+|++++..++||||+++++++.. .+..++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--DEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--CCEEEE
Confidence 368889999999999999999774 89999999976432 1234578899999999999999999999854 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 79 v~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 79 AMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL--GYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred EEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 9999999999999963 34588999999999999999999987 89999999999999999999999999998654
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc--hhhhcCCcCCCCCCHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK--VEDFIDPNLEGKFSVS 636 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 636 (673)
. ......|++.|+|||++.+..++.++|||||||++|||++|+.||............ ................
T Consensus 153 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 228 (333)
T cd05600 153 T----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFN 228 (333)
T ss_pred c----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccc
Confidence 3 223456899999999999889999999999999999999999998654322211111 0111111111111123
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 637 EASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
.+.++.+++.+||..+|.+||+++++++.
T Consensus 229 ~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 229 LSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 45788999999999999999999999853
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=335.92 Aligned_cols=258 Identities=24% Similarity=0.470 Sum_probs=210.4
Q ss_pred HHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 399 RATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 399 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
.+..+|...+.||+|+||.||+|...+++.||+|.+.... .....++.+|++++++++||||+++++++... +..++
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 79 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVG--EPVYI 79 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecC--CCeEE
Confidence 3455688889999999999999999889999999987653 23456789999999999999999999998544 67899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++.... ...+++..+.+++.|++.||+|||+. ||+||||||+||++++++.+||+|||.+....
T Consensus 80 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~--~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 80 ITELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ--NSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred EEeecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 999999999999997432 34689999999999999999999987 89999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
..... .....++..|+|||.+....++.++||||||+++|||++ |+.||........... .. .......+..+
T Consensus 156 ~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~-~~----~~~~~~~~~~~ 229 (261)
T cd05148 156 EDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ-IT----AGYRMPCPAKC 229 (261)
T ss_pred Ccccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH-HH----hCCcCCCCCCC
Confidence 43222 223345678999999988889999999999999999998 8888865432221111 11 11112223455
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQELSSI 669 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i 669 (673)
+..+.+++.+||+.||++|||++++++.|+.+
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 230 PQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 67899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=349.69 Aligned_cols=244 Identities=19% Similarity=0.307 Sum_probs=206.0
Q ss_pred HhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCe
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGE 475 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 475 (673)
..++|....+||+|+||+|+++..+. ++.+|||++++... ..+.+..+.|.+|+.-. +||.+++++..| +++++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT~~~ 443 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF--QTKEH 443 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc--ccCCe
Confidence 44678899999999999999999875 88999999998754 33446788898988887 599999999888 66799
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.|+||||+.|||+..+.+ ...+++..+..||..|+.||+|||++ |||+||||-+|||||.+|.+||+|||+++
T Consensus 444 l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~--~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN--GIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc--CceeeecchhheEEcccCcEEeccccccc
Confidence 999999999999655543 35699999999999999999999998 89999999999999999999999999998
Q ss_pred cccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 556 LLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
....... .....+||+.|||||++.+..|+.++|.|||||+||||+.|..||.+.........++.+ ...+|.
T Consensus 517 e~m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d------~~~yP~ 589 (694)
T KOG0694|consen 517 EGMGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND------EVRYPR 589 (694)
T ss_pred ccCCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------CCCCCC
Confidence 6543222 455689999999999999999999999999999999999999999876554444333322 123455
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH
Q 005859 636 SEASNLGQIALHCTHESPSHRPSI 659 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~ 659 (673)
-.+.+...|+.+.+..+|++|-.+
T Consensus 590 ~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 590 FLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred cccHHHHHHHHHHhccCcccccCC
Confidence 567889999999999999999765
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=311.04 Aligned_cols=248 Identities=20% Similarity=0.328 Sum_probs=207.8
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|++.+.||+|.||.||.|+.+. +-.||+|++.+... ..-..++.+|++|-+.|+||||.++|+++.+. ...|+
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~--~riyL 99 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS--KRIYL 99 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc--ceeEE
Confidence 568888999999999999999765 78999999987643 23357899999999999999999999999665 77999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
++||.++|+++..|... ....++......++.|+|.|+.|+|.+ +|+||||||+|+|++..+..||+|||.+....
T Consensus 100 ilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k--~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC--CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999743 335688888899999999999999987 69999999999999999999999999987654
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
.+ .....+||.-|.+||+..+..++.++|+|++||+.||++.|..||......... .++.... -.++...+
T Consensus 176 ~~---kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etY----krI~k~~--~~~p~~is 246 (281)
T KOG0580|consen 176 SN---KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETY----KRIRKVD--LKFPSTIS 246 (281)
T ss_pred CC---CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHH----HHHHHcc--ccCCcccC
Confidence 32 234568999999999999999999999999999999999999999765422221 2221111 12344556
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+.++|.+|+..+|.+|.+..|+++
T Consensus 247 ~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 247 GGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred hhHHHHHHHHhccCccccccHHHHhh
Confidence 78999999999999999999999875
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=351.58 Aligned_cols=265 Identities=21% Similarity=0.351 Sum_probs=207.0
Q ss_pred HHhcCCccccccccCCcceEEEEEEcC------CcEEEEEEecccCCCCcHHHHHHHHHHHhccC-CCCceeEeeEEecC
Q 005859 399 RATQCFSEANLLGKSSFSATYKGILRD------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGICCSK 471 (673)
Q Consensus 399 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 471 (673)
...++|...+.||+|+||.||+|++.. ++.||+|++.........+.+.+|+++|.++. |||||+++++|..
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~- 112 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK- 112 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc-
Confidence 334457778899999999999998642 46899999976543333457899999999997 9999999999955
Q ss_pred CCCeEEEEEeecCCCChhhhhccccC------------------------------------------------------
Q 005859 472 GRGECFLIYDFVPNGNLLQHLDLEAG------------------------------------------------------ 497 (673)
Q Consensus 472 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------ 497 (673)
.+..++||||+++|+|.++++....
T Consensus 113 -~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 113 -GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred -CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 3678999999999999999864311
Q ss_pred ----------------------------------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCC
Q 005859 498 ----------------------------------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEK 537 (673)
Q Consensus 498 ----------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~N 537 (673)
....+++....+|+.|++.||+|||+. +|+||||||+|
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrdlkp~N 269 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK--NCVHRDLAARN 269 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC--CcCcccCCcce
Confidence 113478888999999999999999987 89999999999
Q ss_pred eEecCCCCeeeccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhh
Q 005859 538 VLIHRRYNPLLSDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQA 615 (673)
Q Consensus 538 ILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~ 615 (673)
||+++++.+||+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |+.||.......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986543221 11122346778999999998889999999999999999998 888875432211
Q ss_pred hhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 616 AESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.. .+.+........+...+.++.+++.+||+.+|++||+++||++.|++++.
T Consensus 350 ~~----~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~~ 401 (401)
T cd05107 350 QF----YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLLT 401 (401)
T ss_pred HH----HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhC
Confidence 11 11111111112233446789999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=338.65 Aligned_cols=254 Identities=17% Similarity=0.293 Sum_probs=196.8
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|...+.||+|+||.||+|+.+ +++.||+|++...........+.+|++++++++||||+++++++.. .+..++||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEEEE
Confidence 46888899999999999999976 4889999999765433344578899999999999999999999854 46789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||++ |+|.+++... ...+++..+..++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 83 EYLD-SDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR--KILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred eCCC-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 9997 5999888632 23578999999999999999999987 8999999999999999999999999999765432
Q ss_pred chhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc-------------------
Q 005859 561 IVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK------------------- 620 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~------------------- 620 (673)
.. ......++..|+|||++.+ ..++.++||||+||++|||+||+.||............
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 157 TK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred Cc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 21 1223457889999999875 46899999999999999999999998653221111000
Q ss_pred -hhhhcCCcCCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 621 -VEDFIDPNLEGK----FSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 621 -~~~~~~~~~~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
......+..... .....+.++.+++.+|++.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000110000 01123467889999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=347.85 Aligned_cols=239 Identities=20% Similarity=0.278 Sum_probs=193.1
Q ss_pred cccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCCC
Q 005859 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNG 486 (673)
Q Consensus 410 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~g 486 (673)
||+|+||.||+|+..+ ++.||+|++..... ......+.+|++++++++||||+++++++.. .+..++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCCC
Confidence 6999999999999764 88999999875421 2234578899999999999999999998854 47899999999999
Q ss_pred ChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhhhh
Q 005859 487 NLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSML 566 (673)
Q Consensus 487 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 566 (673)
+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++....... ...
T Consensus 79 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~ 151 (312)
T cd05585 79 ELFHHLQR----EGRFDLSRARFYTAELLCALENLHKF--NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTN 151 (312)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC--CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccc
Confidence 99999863 24589999999999999999999987 899999999999999999999999999986433221 223
Q ss_pred ccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHH
Q 005859 567 KASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIAL 646 (673)
Q Consensus 567 ~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 646 (673)
...||+.|+|||++.+..++.++|||||||++|||+||+.||.......... .+.... ..++...+.++.+++.
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~----~~~~~~--~~~~~~~~~~~~~li~ 225 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYR----KILQEP--LRFPDGFDRDAKDLLI 225 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHH----HHHcCC--CCCCCcCCHHHHHHHH
Confidence 4568999999999999899999999999999999999999986543222111 111111 1233445578899999
Q ss_pred HccccCCCCCCC---HHHHH
Q 005859 647 HCTHESPSHRPS---IENVM 663 (673)
Q Consensus 647 ~Cl~~~p~~RPs---~~evl 663 (673)
+||+.||++||+ +.|++
T Consensus 226 ~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 226 GLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHcCCCHHHcCCCCCHHHHH
Confidence 999999999985 55554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=338.42 Aligned_cols=248 Identities=17% Similarity=0.240 Sum_probs=196.1
Q ss_pred cccCCcceEEEEEEc-CCcEEEEEEecccCCCC--cHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCCC
Q 005859 410 LGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS--DEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNG 486 (673)
Q Consensus 410 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~g 486 (673)
||+|+||+||++... +++.||+|.+....... ..+.+..|++++++++||||+++.+++.. .+..++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCCC
Confidence 699999999999965 58899999987543221 23567889999999999999999998854 46789999999999
Q ss_pred ChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhhhh
Q 005859 487 NLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSML 566 (673)
Q Consensus 487 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 566 (673)
+|.+++.........+++..+..++.||+.||+|||+. ||+||||||+||++++++.+||+|||+++....... ...
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 155 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK 155 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence 99988754333345689999999999999999999987 899999999999999999999999999976644321 122
Q ss_pred ccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHH
Q 005859 567 KASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIAL 646 (673)
Q Consensus 567 ~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 646 (673)
...|+..|+|||++.+..++.++|||||||++|||++|+.||.................... ...+...+..+.+++.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~ 233 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS--VTYPDKFSPASKSFCE 233 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC--CCCcccCCHHHHHHHH
Confidence 34688999999999999999999999999999999999999865322111111111111111 1233445678999999
Q ss_pred HccccCCCCCC-----CHHHHHH
Q 005859 647 HCTHESPSHRP-----SIENVMQ 664 (673)
Q Consensus 647 ~Cl~~~p~~RP-----s~~evl~ 664 (673)
+||+.||++|| +++++++
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 234 ALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHhcCCHHHhcCCCCCCHHHHhc
Confidence 99999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=331.12 Aligned_cols=256 Identities=22% Similarity=0.401 Sum_probs=206.2
Q ss_pred hcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
.++|...+.||+|+||.||+|+..+...||+|.+.... ...++|.+|++++++++||||+++++++.. +..++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEECC---CCcEEEE
Confidence 35688889999999999999998777789999987543 345679999999999999999999998732 4578999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||.++.....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~--~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 80 EYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC--CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999999999743 224579999999999999999999987 7999999999999999999999999999866543
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
.........++..|+|||+..+..++.++||||||+++|||+| |+.||............ . .......+...+.
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~-~----~~~~~~~~~~~~~ 230 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-E----RGYRMPCPPECPE 230 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH-h----cCCCCCCccccCH
Confidence 3222222345677999999988889999999999999999999 78787654322211111 1 1111122344567
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
.+.+++.+||+.||++||++.++++.|+..+
T Consensus 231 ~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 231 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 8899999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.75 Aligned_cols=249 Identities=26% Similarity=0.456 Sum_probs=198.0
Q ss_pred cccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCCC
Q 005859 408 NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNG 486 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~g 486 (673)
+.||+|+||.||+|+.. +++.||+|.+...........+.+|++++++++||||+++++++.. .+..++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeeccCC
Confidence 36999999999999975 5899999988654323334679999999999999999999999855 46789999999999
Q ss_pred ChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhhh-
Q 005859 487 NLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSM- 565 (673)
Q Consensus 487 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~- 565 (673)
+|.+++... ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++..........
T Consensus 79 ~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~--~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 79 DFLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK--HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred cHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC--CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 999998632 23588999999999999999999987 799999999999999999999999999876543221111
Q ss_pred hccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHH
Q 005859 566 LKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQI 644 (673)
Q Consensus 566 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 644 (673)
.....+..|+|||.+.++.++.++|||||||++|||++ |..||.......... ..........+...+..+.++
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l 228 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-----AIEQGVRLPCPELCPDAVYRL 228 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH-----HHHcCCCCCCcccCCHHHHHH
Confidence 11123456999999998889999999999999999998 888876543321111 111111223334456789999
Q ss_pred HHHccccCCCCCCCHHHHHHHHHH
Q 005859 645 ALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 645 ~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
+.+||+.+|++|||+.+++++|++
T Consensus 229 i~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 229 MERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred HHHHcCCChhhCcCHHHHHHHHhC
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=336.79 Aligned_cols=258 Identities=24% Similarity=0.425 Sum_probs=203.1
Q ss_pred cCCccccccccCCcceEEEEEE-----cCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGIL-----RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
.+|+..+.||+|+||+||+|.. .++..||+|.+...........+.+|++++++++||||+++++++... +..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE--QPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--Cce
Confidence 3567778999999999999984 246789999997544333346788999999999999999999998544 678
Q ss_pred EEEEeecCCCChhhhhccccC-------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC
Q 005859 477 FLIYDFVPNGNLLQHLDLEAG-------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR 543 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~ 543 (673)
++||||+++|+|.+++..... ....+++...+.++.|++.||+|||++ ||+||||||+||+++++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--~i~H~dlkp~nili~~~ 160 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH--FFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc--CeehhccccceEEEcCC
Confidence 999999999999999853211 123588999999999999999999987 89999999999999999
Q ss_pred CCeeeccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccch
Q 005859 544 YNPLLSDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKV 621 (673)
Q Consensus 544 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~ 621 (673)
+.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~----- 235 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV----- 235 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-----
Confidence 9999999999986543221 11222335667999999988889999999999999999999 8888865432211
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 622 EDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
.+.++.......+...+.++.+++.+||+.||++||++.+|.+.|.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 IEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111112333456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.51 Aligned_cols=262 Identities=24% Similarity=0.414 Sum_probs=203.3
Q ss_pred cCCccccccccCCcceEEEEEEc-----CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-----DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
++|+..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46788899999999999999853 47899999986543 2334678999999999999999999998866555678
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+||++++++.+||+|||+++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~--~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK--RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999998632 23589999999999999999999987 899999999999999999999999999987
Q ss_pred ccCcchhh--hhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhh----c-------cchhh
Q 005859 557 LADDIVFS--MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE----S-------SKVED 623 (673)
Q Consensus 557 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~----~-------~~~~~ 623 (673)
........ .....++..|+|||++.+..++.++|||||||++|||++|..|+......... . ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 65432111 11122345699999998888999999999999999999987664322111000 0 00011
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 005859 624 FIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSI 669 (673)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i 669 (673)
..........+...+.++.+++.+||+.+|++|||+.||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111111112234457899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=337.62 Aligned_cols=263 Identities=19% Similarity=0.349 Sum_probs=207.3
Q ss_pred hcCCccccccccCCcceEEEEEEc------CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRG 474 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 474 (673)
..+|.+.+.||+|+||+||++... ++..+|+|.+.... ......+.+|++++++++||||+++++++.. .+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVE--GD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 356888899999999999999842 24578999886543 2334679999999999999999999999855 46
Q ss_pred eEEEEEeecCCCChhhhhcccc---------CCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEA---------GSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN 545 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~ 545 (673)
..++||||+++++|.+++.... .....+++..++.++.|++.||+|||++ ||+||||||+||++++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~--~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ--HFVHRDLATRNCLVGENLL 158 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeecccCcceEEEccCCc
Confidence 7899999999999999986432 1223589999999999999999999987 8999999999999999999
Q ss_pred eeeccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhh
Q 005859 546 PLLSDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVED 623 (673)
Q Consensus 546 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~ 623 (673)
+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||+| |+.||...............
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~ 238 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999986543221 11122335678999999998889999999999999999999 88888654322211111111
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcCC
Q 005859 624 FIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673 (673)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~ 673 (673)
. ....+...+.++.+++.+||+.||.+|||+.||++.|+++..+|
T Consensus 239 ----~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 239 ----R-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred ----C-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 1 11112234567999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=346.31 Aligned_cols=242 Identities=19% Similarity=0.304 Sum_probs=195.2
Q ss_pred cccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecC
Q 005859 408 NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVP 484 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~ 484 (673)
+.||+|+||.||+++.. +|+.||+|++..... ......+.+|++++++++||||+++++++.. .+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCCC
Confidence 36999999999999965 589999999976431 2233567889999999999999999998854 478999999999
Q ss_pred CCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhh
Q 005859 485 NGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFS 564 (673)
Q Consensus 485 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 564 (673)
+|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++....... .
T Consensus 79 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 151 (323)
T cd05595 79 GGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T 151 (323)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-c
Confidence 9999988863 24689999999999999999999987 899999999999999999999999999875422211 1
Q ss_pred hhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHH
Q 005859 565 MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQI 644 (673)
Q Consensus 565 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 644 (673)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||............. .... ..+...+.++.++
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~----~~~~--~~p~~~~~~~~~l 225 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL----MEEI--RFPRTLSPEAKSL 225 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh----cCCC--CCCCCCCHHHHHH
Confidence 223568999999999998899999999999999999999999986543322111111 1111 1233445788999
Q ss_pred HHHccccCCCCCC-----CHHHHHH
Q 005859 645 ALHCTHESPSHRP-----SIENVMQ 664 (673)
Q Consensus 645 ~~~Cl~~~p~~RP-----s~~evl~ 664 (673)
+.+||+.||++|| ++.++++
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 226 LAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHccCCHHHhCCCCCCCHHHHHc
Confidence 9999999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=330.79 Aligned_cols=249 Identities=21% Similarity=0.394 Sum_probs=198.9
Q ss_pred ccccCCcceEEEEEEc---CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCC
Q 005859 409 LLGKSSFSATYKGILR---DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPN 485 (673)
Q Consensus 409 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~ 485 (673)
.||+|+||.||+|.+. ++..||+|++.........+.|.+|++++++++||||+++++++.. +..++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeCCC
Confidence 3899999999999864 3557999998765433344679999999999999999999998732 467899999999
Q ss_pred CChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh--
Q 005859 486 GNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF-- 563 (673)
Q Consensus 486 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-- 563 (673)
|+|.+++... ...+++..+++++.|++.||+|||++ |++||||||+||+++.++.+||+|||+++........
T Consensus 79 ~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 79 GPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK--NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc--CeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 9999998632 34689999999999999999999987 8999999999999999999999999999865433211
Q ss_pred hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHH
Q 005859 564 SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLG 642 (673)
Q Consensus 564 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 642 (673)
......++..|+|||++....++.++|||||||++||+++ |+.||......... ..+........+..++.++.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~ 228 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-----SFIEQGKRLDCPAECPPEMY 228 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-----HHHHCCCCCCCCCCCCHHHH
Confidence 1112223567999999988889999999999999999997 99998654332211 11111112233445568899
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 643 QIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 643 ~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
+++.+||+.+|++||++.+|.+.|+.++
T Consensus 229 ~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 229 ALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 9999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=330.42 Aligned_cols=253 Identities=21% Similarity=0.420 Sum_probs=204.6
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
++|++.+.||+|+||.||+|...++..||+|.+.... ...+.|.+|+.++++++||||+++++++.. +..++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv~e 80 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT--MSPESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYIVTE 80 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC--CCHHHHHHHHHHHHhcCCCceEEEEeEECC---CCcEEEEE
Confidence 4677788999999999999998888899999987643 345679999999999999999999998732 45789999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+++++|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~--~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 81 YMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM--NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred ecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999998743 224589999999999999999999987 79999999999999999999999999998765432
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
........++..|+|||++.+..++.++||||||+++|||++ |+.||.......... .+ ........+...+..
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~ 231 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLE----QV-ERGYRMPCPQDCPIS 231 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HH-HcCCCCCCCCcCCHH
Confidence 222222334567999999988889999999999999999999 888886543221111 11 111122233445678
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
+.+++.+||+.+|++|||++++.+.|++
T Consensus 232 ~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 232 LHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=336.55 Aligned_cols=264 Identities=20% Similarity=0.340 Sum_probs=210.2
Q ss_pred HhcCCccccccccCCcceEEEEEEcC-----CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCC
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRD-----GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRG 474 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 474 (673)
..++|...+.||+|+||.||+|...+ +..|++|.+.........+.+.+|+.++++++||||+++++++... ..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~ 82 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GE 82 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CC
Confidence 35678888999999999999999765 6889999887544333456789999999999999999999988654 45
Q ss_pred eEEEEEeecCCCChhhhhccccCC----ccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGS----EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSD 550 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~D 550 (673)
..++++||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR--GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC--CEeecccCHhhEEEcCCCcEEECC
Confidence 678999999999999998653221 14689999999999999999999987 799999999999999999999999
Q ss_pred ccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCc
Q 005859 551 SGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPN 628 (673)
Q Consensus 551 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 628 (673)
||+++.+...... ......++..|+|||++....++.++|||||||++||+++ |+.||.......... .... .
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~----~ 235 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA-YLKD----G 235 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHH-HHHc----C
Confidence 9999865432211 1112335667999999988889999999999999999999 999986543221111 1111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 629 LEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 629 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.....+..++.++.+++.+||+.||++|||+.++++.|+++.+
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 236 YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111223345789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.50 Aligned_cols=266 Identities=23% Similarity=0.392 Sum_probs=206.0
Q ss_pred hcCCccccccccCCcceEEEEEE------cCCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCC
Q 005859 401 TQCFSEANLLGKSSFSATYKGIL------RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGR 473 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 473 (673)
.++|...+.||+|+||+||+|.. .+++.||||+++..........+.+|++++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-C
Confidence 35688889999999999999973 247899999997654333446788999999999 789999999988644 3
Q ss_pred CeEEEEEeecCCCChhhhhccccC--------------------------------------------------------
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAG-------------------------------------------------------- 497 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 497 (673)
...++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467899999999999999864211
Q ss_pred -------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcch-hhhhccC
Q 005859 498 -------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV-FSMLKAS 569 (673)
Q Consensus 498 -------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~ 569 (673)
....+++..+.+++.|+++||+|||+. ||+||||||+||++++++.+||+|||+++....... .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 012478899999999999999999987 899999999999999999999999999986543221 1112233
Q ss_pred CCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHc
Q 005859 570 AAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHC 648 (673)
Q Consensus 570 gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~C 648 (673)
++..|+|||.+.+..++.++||||||+++|||++ |..||............+.. ......+...+.++.+++.+|
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~c 318 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE----GTRMRAPDYTTPEMYQTMLDC 318 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc----cCCCCCCCCCCHHHHHHHHHH
Confidence 5567999999988889999999999999999997 88888543211111111111 111111222346789999999
Q ss_pred cccCCCCCCCHHHHHHHHHHhhcCC
Q 005859 649 THESPSHRPSIENVMQELSSIIGSS 673 (673)
Q Consensus 649 l~~~p~~RPs~~evl~~L~~i~~~~ 673 (673)
|+.||++|||+.||++.|+.+++.+
T Consensus 319 l~~~p~~Rps~~eil~~l~~~~~~~ 343 (343)
T cd05103 319 WHGEPSQRPTFSELVEHLGNLLQAN 343 (343)
T ss_pred ccCChhhCcCHHHHHHHHHHHHhcC
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=349.65 Aligned_cols=245 Identities=18% Similarity=0.240 Sum_probs=199.9
Q ss_pred cCCccccccccCCcceEEEEEEcC--CcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD--GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
++|...+.||+|+||.||+|..+. +..||+|++..... ....+.+.+|+++++.++||||+++++++... +..+
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~~ 107 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE--SYLY 107 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC--CEEE
Confidence 468888999999999999998654 36899999875422 22345788999999999999999999999554 7899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 108 lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL--NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999999963 34589999999999999999999987 8999999999999999999999999999876
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
... .....||+.|+|||++.+..++.++|||||||++|||+||+.||........... +..... .++...
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~----i~~~~~--~~p~~~ 251 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK----ILEGII--YFPKFL 251 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH----HhcCCC--CCCCCC
Confidence 432 2235689999999999988899999999999999999999999975433221111 111111 123334
Q ss_pred HHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRP-----SIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 664 (673)
+..+.+++.+|++.||++|+ +++++++
T Consensus 252 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 252 DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 56788999999999999995 8888865
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.96 Aligned_cols=261 Identities=19% Similarity=0.358 Sum_probs=206.7
Q ss_pred cCCccccccccCCcceEEEEEEc------CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 402 QCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
.+|...+.||+|+||.||+|... ++..|++|.+.... ....+.+.+|++++++++||||+++++++.. .+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGD--GDP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc--CCc
Confidence 35777889999999999999843 35578999886543 2334678999999999999999999999854 467
Q ss_pred EEEEEeecCCCChhhhhccccC------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAG------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR 543 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~ 543 (673)
.++||||+++++|.+++..... ....+++..++.++.|++.||+|||++ ||+||||||+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ--HFVHRDLATRNCLVGAN 159 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC--CeeecccCcceEEEccC
Confidence 8999999999999999964321 123589999999999999999999987 89999999999999999
Q ss_pred CCeeeccccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccch
Q 005859 544 YNPLLSDSGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKV 621 (673)
Q Consensus 544 ~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~ 621 (673)
+.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||+| |+.||...........
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~-- 237 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC-- 237 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--
Confidence 99999999999765432211 1123345678999999998899999999999999999999 9999865433221111
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 622 EDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
. ........+...+..+.+++.+||+.+|++||++++|+++|+++..+
T Consensus 238 --~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 238 --I-TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred --H-hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1 11111122333567899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=332.34 Aligned_cols=253 Identities=19% Similarity=0.287 Sum_probs=196.1
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCC---eEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRG---ECF 477 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~---~~~ 477 (673)
-.|...+++|.|+||.||+|...+ ++.||||++.... +.-.+|+++|++++|||||++.-+|...... ...
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 356667899999999999999765 7899999886543 2334799999999999999999888765444 345
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC-CCeeecccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR-YNPLLSDSGLHKL 556 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~-~~~kl~DfGla~~ 556 (673)
+|||||+. +|.++++.....+..++.-.+.-+..|+.+||+|||+. ||+||||||.|+|+|.+ +.+||+|||.|+.
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~--~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH--GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc--CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 89999976 99999875433445677777888999999999999996 89999999999999976 8999999999998
Q ss_pred ccCcchhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhc-----------------
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAES----------------- 618 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~----------------- 618 (673)
+..+.. .....-|..|+|||.+.+. .|+.+.||||.|||+.||+-|+.-|.+........
T Consensus 176 L~~~ep--niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 176 LVKGEP--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eccCCC--ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 876543 2334567889999999875 59999999999999999999987675432111000
Q ss_pred -cchhhhcCCcCCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 619 -SKVEDFIDPNLEGK-----FSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 619 -~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
....+...+.+... +....+++..+++.++++++|.+|.++.|++.
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 00111122222211 23445688999999999999999999999874
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=362.62 Aligned_cols=262 Identities=15% Similarity=0.216 Sum_probs=208.4
Q ss_pred HHHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCC-
Q 005859 397 VERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGR- 473 (673)
Q Consensus 397 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~- 473 (673)
.....++|.+.+.||+|+||+||+|+.. +|+.||||++...... .....+.+|+.++..++|+||+++++.+.....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3445578999999999999999999865 5899999998765322 234568899999999999999999887654322
Q ss_pred -----CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeee
Q 005859 474 -----GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLL 548 (673)
Q Consensus 474 -----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl 548 (673)
...++||||+++|+|.+++.........+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~--~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK--HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEeCCCCEEE
Confidence 136899999999999999975444446789999999999999999999987 8999999999999999999999
Q ss_pred ccccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCC
Q 005859 549 SDSGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDP 627 (673)
Q Consensus 549 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 627 (673)
+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||...............
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~---- 260 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG---- 260 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC----
Confidence 999999876432211 123456899999999999989999999999999999999999999754322211111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 628 NLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 628 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
. ....+...+.++.+++.+||+.||++||++.++++.
T Consensus 261 ~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 R-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred C-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 112233456789999999999999999999999763
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=357.23 Aligned_cols=260 Identities=18% Similarity=0.260 Sum_probs=209.9
Q ss_pred hcCCccccccccCCcceEEEEEEcCC-cEEEEEEecccCCCCcHHHHHHHHHHHhccC-CCCceeEeeE-Eec---CC-C
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDG-SVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGI-CCS---KG-R 473 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~-~~~---~~-~ 473 (673)
..++.+.+.|.+|||+.||.|....+ ..+|+|++-... +.+.+...+|+++|++|+ |+|||.+++. ... .. .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~d-e~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVND-EEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCC-HHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 34567788999999999999998775 999999987652 455678899999999996 9999999993 221 11 2
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL 553 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGl 553 (673)
-+++|.||||++|.|-+++..+.. ..|++.++++|+.|+++|+++||..+|+|||||||-+||||+.++..||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 478999999999999999975432 339999999999999999999999999999999999999999999999999999
Q ss_pred cccccCcc--------hhhhhccCCCCCccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh
Q 005859 554 HKLLADDI--------VFSMLKASAAMGYLAPEYTT---TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE 622 (673)
Q Consensus 554 a~~~~~~~--------~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~ 622 (673)
|.-..... .........|+.|+|||++. +..+++|+||||+||+||.|+-...||......+
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------- 265 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------- 265 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-------
Confidence 86432111 01112345789999999875 5668999999999999999999999997642221
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 623 DFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
++.....-.....++..+.+||..||+.||++||++-+|+..+.++.+
T Consensus 266 -Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 266 -ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred -EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 122222111224678899999999999999999999999999988865
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=328.28 Aligned_cols=247 Identities=26% Similarity=0.478 Sum_probs=199.4
Q ss_pred ccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCCCCh
Q 005859 409 LLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNL 488 (673)
Q Consensus 409 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~gsL 488 (673)
+||+|+||.||+|...+++.||+|.+...........|.+|++++++++||||+++++++... +..++||||+++|+|
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR--QPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC--CccEEEEECCCCCcH
Confidence 689999999999998889999999987654333345789999999999999999999998554 678999999999999
Q ss_pred hhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhhhhcc
Q 005859 489 LQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKA 568 (673)
Q Consensus 489 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 568 (673)
.+++... ...+++..+..++.|++.||.|||+. |++||||||+||++++++.+|++|||++..............
T Consensus 80 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~--~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 80 LSFLRKK---KDELKTKQLVKFALDAAAGMAYLESK--NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC--CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 9998632 23578999999999999999999987 899999999999999999999999999876544322222223
Q ss_pred CCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHH
Q 005859 569 SAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALH 647 (673)
Q Consensus 569 ~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 647 (673)
.++..|+|||++.+..++.++||||||+++||+++ |..||.......... .+.. ......+...+..+.+++.+
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~li~~ 229 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE-QVEK----GYRMSCPQKCPDDVYKVMQR 229 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-HHHc----CCCCCCCCCCCHHHHHHHHH
Confidence 34567999999998889999999999999999999 998986543222111 1111 11112233456789999999
Q ss_pred ccccCCCCCCCHHHHHHHHH
Q 005859 648 CTHESPSHRPSIENVMQELS 667 (673)
Q Consensus 648 Cl~~~p~~RPs~~evl~~L~ 667 (673)
||+.+|++||++.|++++|.
T Consensus 230 ~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 230 CWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HcccCcccCCCHHHHHHHhc
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=331.71 Aligned_cols=259 Identities=23% Similarity=0.371 Sum_probs=200.8
Q ss_pred ccccccccCCcceEEEEEEcC-Cc--EEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCC----CCeE
Q 005859 405 SEANLLGKSSFSATYKGILRD-GS--VVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKG----RGEC 476 (673)
Q Consensus 405 ~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~~ 476 (673)
.+.+.||+|+||.||+|+..+ +. .||+|.++.... ....+.+.+|++++++++||||+++++++.... ....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999999765 33 689998876432 223467899999999999999999999875422 2356
Q ss_pred EEEEeecCCCChhhhhcccc--CCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEA--GSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLH 554 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla 554 (673)
++||||+++|+|.+++.... .....+++..+..++.|++.||+|||++ ||+||||||+|||+++++.+||+|||++
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK--SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC--CeeccccchhheEEcCCCCEEECCCCcc
Confidence 89999999999998874322 1234589999999999999999999987 8999999999999999999999999999
Q ss_pred ccccCcchhh-hhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCC
Q 005859 555 KLLADDIVFS-MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGK 632 (673)
Q Consensus 555 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (673)
+......... .....++..|+|||+..+..++.++||||||+++|||++ |+.||.......... .+. . .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~-~~~---~-~~~~~ 234 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD-YLR---Q-GNRLK 234 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHH---c-CCCCC
Confidence 8765432211 122235668999999998889999999999999999999 788886533221111 111 1 11111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 633 FSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 633 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
.+...+..+.+++.+||+.||++|||+.++++.|++++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 22344567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=330.69 Aligned_cols=254 Identities=23% Similarity=0.388 Sum_probs=206.5
Q ss_pred hcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
.++|...++||+|+||.||+|..++++.||+|.+.... ....++.+|+.++++++||||+++++++.. +..++||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~ 79 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYIIT 79 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEEEE
Confidence 45688889999999999999998889999999987543 345689999999999999999999998732 5689999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++|+|.+++.... ...+++..+..++.|++.||+|||+. |++||||||+||++++++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~--~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 80 EYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK--NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC--CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 9999999999986432 34689999999999999999999987 8999999999999999999999999999876533
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
.........++..|+|||++....++.++||||||+++||+++ |+.||.......... .+... .....+...+.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~----~~~~~~~~~~~ 230 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ-NLERG----YRMPRPDNCPE 230 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH-HHHcC----CCCCCCCCCCH
Confidence 2222223345678999999988889999999999999999999 999986543222111 11111 11122233456
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
++.+++.+||+.+|++||+++++++.|+.
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 231 ELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 89999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=315.89 Aligned_cols=252 Identities=20% Similarity=0.309 Sum_probs=206.3
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++.|++.+.||+|.|+.||++... +|+.+|+|.+..... ..+.+++.+|++|.+.|+|||||++.+.+. +....|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~--~~~~~yl 87 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--EESFHYL 87 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc--ccceeEE
Confidence 345777789999999999999865 599999998875433 345678999999999999999999999884 3478899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC---CCeeeccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR---YNPLLSDSGLHK 555 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~---~~~kl~DfGla~ 555 (673)
|+|+|+||+|..-+-. +..+++..+-.++.||+++|.|+|.+ ||||||+||+|+|+... --+|++|||+|.
T Consensus 88 vFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n--~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSN--GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc--CceeccCChhheeeeeccCCCceeecccceEE
Confidence 9999999999866642 25688999999999999999999998 79999999999999533 357999999999
Q ss_pred cccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 556 LLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
.+.++. .....+||++|||||++...+|+..+|||+-||+||-++.|..||.+.......+.+...-.| ..+....
T Consensus 162 ~l~~g~--~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd--~~~~~w~ 237 (355)
T KOG0033|consen 162 EVNDGE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD--YPSPEWD 237 (355)
T ss_pred EeCCcc--ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC--CCCcccC
Confidence 887432 344678999999999999999999999999999999999999999874433333333222222 2233344
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...++.++|+++|+..||++|.|+.|.++
T Consensus 238 ~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 238 TVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 56688999999999999999999999864
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=336.62 Aligned_cols=259 Identities=21% Similarity=0.404 Sum_probs=203.4
Q ss_pred cCCccccccccCCcceEEEEEEcC-Cc--EEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GS--VVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~ 477 (673)
++|+..+.||+|+||.||+|..++ +. .+++|.++........+.+.+|++++.++ +||||+++++++.. .+..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcce
Confidence 468888999999999999999764 33 47888886533233446789999999999 79999999999854 46789
Q ss_pred EEEeecCCCChhhhhccccC------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC
Q 005859 478 LIYDFVPNGNLLQHLDLEAG------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN 545 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~ 545 (673)
+||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. ||+||||||+|||+++++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~--~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK--QFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCcCCcceEEECCCCe
Confidence 99999999999999964321 113588999999999999999999987 8999999999999999999
Q ss_pred eeeccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhh
Q 005859 546 PLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDF 624 (673)
Q Consensus 546 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~ 624 (673)
+||+|||++....... .......+..|+|||++....++.++|||||||++|||+| |..||...........
T Consensus 158 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~----- 230 (297)
T cd05089 158 SKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK----- 230 (297)
T ss_pred EEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-----
Confidence 9999999986432211 1111223457999999988889999999999999999998 9999865432221111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 625 IDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.........+...+..+.+++.+||+.+|.+||++.++++.|+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 231 LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111112233455788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=336.06 Aligned_cols=256 Identities=18% Similarity=0.288 Sum_probs=195.4
Q ss_pred cCCccccccccCCcceEEEEEEc--CCcEEEEEEecccCCC-CcHHHHHHHHHHHhcc---CCCCceeEeeEEecC---C
Q 005859 402 QCFSEANLLGKSSFSATYKGILR--DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSL---KHENLASLRGICCSK---G 472 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~---~ 472 (673)
++|...+.||+|+||+||+|+.. +++.||+|.+...... .....+.+|+++++++ +||||++++++|... .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 3688999998754322 2234567788777765 699999999988532 2
Q ss_pred CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccc
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSG 552 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfG 552 (673)
....++||||++ ++|.+++... ....+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~--~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 356899999996 6999988643 224589999999999999999999987 89999999999999999999999999
Q ss_pred ccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhh--------
Q 005859 553 LHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF-------- 624 (673)
Q Consensus 553 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~-------- 624 (673)
+++...... ......++..|+|||.+....++.++|||||||++|||++|+.||................
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 156 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred ceEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 998665431 2234468899999999988889999999999999999999999986543221111111000
Q ss_pred ----------cCCcCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 625 ----------IDPNLEG---KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 625 ----------~~~~~~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+.... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000 001123467789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=335.42 Aligned_cols=264 Identities=20% Similarity=0.345 Sum_probs=206.4
Q ss_pred HhcCCccccccccCCcceEEEEEEcC------CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRD------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGR 473 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 473 (673)
..++|++.+.||+|+||.||+|..++ +..||+|.+...........+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG-- 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 45678999999999999999997542 4589999886543333345788999999999999999999998544
Q ss_pred CeEEEEEeecCCCChhhhhccccC------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCee
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAG------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPL 547 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~k 547 (673)
+..++||||+++|+|.+++..... .....++..+..++.|++.||+|||++ +|+||||||+||++++++.+|
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK--KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CCcCCCCChheEEEcCCCcEE
Confidence 678999999999999999964321 123467788899999999999999987 899999999999999999999
Q ss_pred eccccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhc
Q 005859 548 LSDSGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFI 625 (673)
Q Consensus 548 l~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~ 625 (673)
++|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||......... ..+.
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~----~~~~ 235 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL----KFVM 235 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHH
Confidence 9999999865432211 1122334677999999998889999999999999999999 78787653222111 1111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 626 DPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
+... ...+...+..+.+++.+||+.||++|||+.++++.|++.+..
T Consensus 236 ~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 236 DGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred cCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 1111 122334457899999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=345.16 Aligned_cols=242 Identities=20% Similarity=0.314 Sum_probs=195.6
Q ss_pred cccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecC
Q 005859 408 NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVP 484 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~ 484 (673)
+.||+|+||.||+++.. +|+.||+|++.+... ......+.+|+++++.++||||+++++++.. .+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEEEeCCC
Confidence 36899999999999965 489999999976432 2234578899999999999999999998854 478999999999
Q ss_pred CCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhh
Q 005859 485 NGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFS 564 (673)
Q Consensus 485 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 564 (673)
+|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||+++++.+||+|||+++....... .
T Consensus 79 ~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 151 (328)
T cd05593 79 GGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG--KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-T 151 (328)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC--CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-c
Confidence 9999988863 34689999999999999999999987 899999999999999999999999999875432211 2
Q ss_pred hhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHH
Q 005859 565 MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQI 644 (673)
Q Consensus 565 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 644 (673)
.....|++.|+|||++.+..++.++|||||||++|||+||+.||........... +... ...++...+.++.++
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~----~~~~--~~~~p~~~~~~~~~l 225 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----ILME--DIKFPRTLSADAKSL 225 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH----hccC--CccCCCCCCHHHHHH
Confidence 2335689999999999988999999999999999999999999865432211111 1111 112233445788999
Q ss_pred HHHccccCCCCCC-----CHHHHHH
Q 005859 645 ALHCTHESPSHRP-----SIENVMQ 664 (673)
Q Consensus 645 ~~~Cl~~~p~~RP-----s~~evl~ 664 (673)
+.+||+.||++|| ++.|+++
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 226 LSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 9999999999997 8898875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=331.02 Aligned_cols=254 Identities=20% Similarity=0.285 Sum_probs=192.7
Q ss_pred ccccCCcceEEEEEEcC---CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCC
Q 005859 409 LLGKSSFSATYKGILRD---GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPN 485 (673)
Q Consensus 409 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~ 485 (673)
.||+|+||.||+|...+ +..+|+|.++..........+.+|+.++++++||||+++++++.+ ....++||||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEEEEECCCC
Confidence 58999999999998654 457999988765433334578999999999999999999999854 4668999999999
Q ss_pred CChhhhhccccC-CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh-
Q 005859 486 GNLLQHLDLEAG-SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF- 563 (673)
Q Consensus 486 gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~- 563 (673)
|+|.+++..... .....++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC--CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999999974322 123567888889999999999999987 7999999999999999999999999999754432211
Q ss_pred hhhccCCCCCccCCccccCC-------CCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 564 SMLKASAAMGYLAPEYTTTG-------RFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 564 ~~~~~~gt~~y~aPE~~~~~-------~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
......++..|+|||++... .++.++||||||+++|||++ |+.||......................+....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence 12234467789999998642 35789999999999999996 99998654333221111111111111112222
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQELS 667 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 667 (673)
..+..+.+++..|| .+|++|||++||++.|+
T Consensus 238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 34567889999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.10 Aligned_cols=246 Identities=22% Similarity=0.365 Sum_probs=206.4
Q ss_pred ccccccCCcceEEEEEEcC-CcEEEEEEeccc---CCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEee
Q 005859 407 ANLLGKSSFSATYKGILRD-GSVVAVKCIAKT---SCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDF 482 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~ 482 (673)
..+||+|+|-+||||.... |..||--.++.. ......+.|..|+.+|+.|+|||||++|.+|.+.......+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 3569999999999999764 888875444322 222334789999999999999999999999988877788899999
Q ss_pred cCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC-CCeeeccccccccccCcc
Q 005859 483 VPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR-YNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 483 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~-~~~kl~DfGla~~~~~~~ 561 (673)
|..|+|+.|+... +.++......+++||++||.|||++.|+|||||||++||+|+.+ |.+||+|.|+|.......
T Consensus 125 ~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999999743 45788899999999999999999999999999999999999865 799999999999887653
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 641 (673)
. ....||+.|||||++. ..|++.+||||||+.|+||+|+.+||....+.+...+.+...+.|.- +.....+++
T Consensus 201 a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s---l~kV~dPev 273 (632)
T KOG0584|consen 201 A---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA---LSKVKDPEV 273 (632)
T ss_pred c---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH---hhccCCHHH
Confidence 2 2368999999999997 78999999999999999999999999887776665555555544432 223335789
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 005859 642 GQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 642 ~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
++||.+|+.. .++|||+.|+++
T Consensus 274 r~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 274 REFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHHHHHhcC-chhccCHHHHhh
Confidence 9999999999 899999999985
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=337.64 Aligned_cols=259 Identities=22% Similarity=0.413 Sum_probs=202.2
Q ss_pred cCCccccccccCCcceEEEEEEcC-Cc--EEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GS--VVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~ 477 (673)
++|+..+.||+|+||.||+|..++ +. .+|+|.+...........+.+|++++.++ +||||+++++++.. .+..+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCCce
Confidence 467888899999999999999754 44 46788776543233446788999999999 89999999999854 46789
Q ss_pred EEEeecCCCChhhhhccccC------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC
Q 005859 478 LIYDFVPNGNLLQHLDLEAG------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN 545 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~ 545 (673)
+||||+++|+|.++++.... ....+++..++.++.|++.||+|||+. ||+||||||+|||+++++.
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~--gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC--CccccccchheEEecCCCc
Confidence 99999999999999964321 123588999999999999999999987 8999999999999999999
Q ss_pred eeeccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhh
Q 005859 546 PLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDF 624 (673)
Q Consensus 546 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~ 624 (673)
+||+|||+++..... ........+..|+|||++.+..++.++|||||||++|||+| |..||.......... ..
T Consensus 163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-~~--- 236 (303)
T cd05088 163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-KL--- 236 (303)
T ss_pred EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH-HH---
Confidence 999999998643211 11112234567999999988889999999999999999998 999886443221111 11
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 625 IDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
........+...+..+.+++.+||+.+|++||++.++++.|+++++
T Consensus 237 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 237 -PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred -hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111112223345678999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=330.59 Aligned_cols=258 Identities=22% Similarity=0.447 Sum_probs=204.9
Q ss_pred hcCCccccccccCCcceEEEEEEcC-C---cEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-G---SVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
.++|+..+.||+|+||.||+|+.+. + ..||+|.+.........+++.+|++++++++||||+++++++.. .+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK--FKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc--CCCc
Confidence 3467788999999999999999753 3 37999988765433345678999999999999999999999854 4678
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||+++++|.+++... ...+++..+..++.|++.|++|||+. ||+||||||+||++++++.+|++|||++..
T Consensus 82 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~--~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 82 MIITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM--NYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccccchhhEEEcCCCcEEECCCcccee
Confidence 9999999999999998632 24589999999999999999999987 799999999999999999999999999876
Q ss_pred ccCcchhhh--hccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCC
Q 005859 557 LADDIVFSM--LKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 557 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (673)
......... .....+..|+|||++....++.++|||||||++|||+| |+.||........... +.. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~-i~~----~~~~~~ 231 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKA-IND----GFRLPA 231 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH-Hhc----CCCCCC
Confidence 643221111 11223457999999988889999999999999999998 9999865432211111 111 111122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 634 SVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 634 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
....+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus 232 ~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 232 PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 3345678899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=337.84 Aligned_cols=263 Identities=20% Similarity=0.395 Sum_probs=207.2
Q ss_pred hcCCccccccccCCcceEEEEEEc--------CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR--------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSK 471 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 471 (673)
..+|.+.+.||+|+||.||+|+.. ++..||+|.+.........+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456778889999999999999742 24579999887543334456789999999999 899999999998554
Q ss_pred CCCeEEEEEeecCCCChhhhhccccC------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeE
Q 005859 472 GRGECFLIYDFVPNGNLLQHLDLEAG------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVL 539 (673)
Q Consensus 472 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NIL 539 (673)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+. ||+||||||+||+
T Consensus 94 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--givH~dlkp~Nil 169 (304)
T cd05101 94 --GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ--KCIHRDLAARNVL 169 (304)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC--CeeecccccceEE
Confidence 678999999999999999975321 124588999999999999999999987 8999999999999
Q ss_pred ecCCCCeeeccccccccccCcchhh-hhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhh
Q 005859 540 IHRRYNPLLSDSGLHKLLADDIVFS-MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAE 617 (673)
Q Consensus 540 l~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~ 617 (673)
+++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||+| |..||.........
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 9999999999999998765432211 122345678999999988889999999999999999999 77777543222111
Q ss_pred ccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 618 SSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
. .+ ........+..++..+.+++.+||+.+|++||++.|+++.|++++..
T Consensus 250 ~-~~----~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 250 K-LL----KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred H-HH----HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1 11 11111122334567899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=337.92 Aligned_cols=262 Identities=21% Similarity=0.391 Sum_probs=206.6
Q ss_pred cCCccccccccCCcceEEEEEEcC--------CcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCC
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD--------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKG 472 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 472 (673)
++|.+.+.||+|+||.||+++... +..||+|.+..........++.+|+++++++ +||||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~- 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD- 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-
Confidence 568889999999999999998532 3579999987643233446788999999999 799999999998554
Q ss_pred CCeEEEEEeecCCCChhhhhccccC------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEe
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAG------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI 540 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl 540 (673)
+..++||||+++|+|.+++..... ....+++.++++++.|++.||+|||+. |++||||||+||++
T Consensus 97 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~--gi~H~dlkp~Nill 173 (307)
T cd05098 97 -GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK--KCIHRDLAARNVLV 173 (307)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC--CcccccccHHheEE
Confidence 678999999999999999975321 123589999999999999999999987 89999999999999
Q ss_pred cCCCCeeeccccccccccCcchhh-hhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhc
Q 005859 541 HRRYNPLLSDSGLHKLLADDIVFS-MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAES 618 (673)
Q Consensus 541 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~ 618 (673)
++++.+||+|||.++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||..........
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 999999999999987654322111 112234467999999998889999999999999999998 888875432211111
Q ss_pred cchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 619 SKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
.+........+...+.++.+++.+||..+|++||++.+|++.|++++..
T Consensus 254 -----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 254 -----LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred -----HHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1111111223344567899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=359.47 Aligned_cols=251 Identities=16% Similarity=0.252 Sum_probs=201.2
Q ss_pred CccccccccCCcceEEEEEEc-C-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 404 FSEANLLGKSSFSATYKGILR-D-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
|...+.||+|+||.||+|... + ++.||+|.+.... ......+.+|+++++.++|||||++++++... +..++|||
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv~E 145 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSD--DKLLLIME 145 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC--CEEEEEEE
Confidence 788899999999999999854 3 6788888765432 22335678899999999999999999999654 78999999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+++|+|.+++.........+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR--KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999998864333345688999999999999999999987 89999999999999999999999999998765432
Q ss_pred hh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 562 VF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 562 ~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||.......... .+..... ...+...+.+
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~----~~~~~~~-~~~~~~~s~~ 298 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ----QVLYGKY-DPFPCPVSSG 298 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCC-CCCCccCCHH
Confidence 11 1234568999999999999899999999999999999999999986543222111 1111111 1122334578
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.+++.+||+.||++||++.+++.
T Consensus 299 ~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 299 MKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHHHhccChhhCcCHHHHHh
Confidence 999999999999999999999874
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=327.69 Aligned_cols=253 Identities=23% Similarity=0.414 Sum_probs=204.3
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
++|...+.||+|+||.||+|....+..||+|.+.... ...+.+.+|++++++++|||++++++++.. +..++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIYIVTE 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcEEEEE
Confidence 4577888999999999999998877789999886543 345678999999999999999999998732 45789999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+++|+|.+++... ....+++..+..++.|++.||+|||+. ||+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~--~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 81 FMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM--NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC--CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999999743 224589999999999999999999987 89999999999999999999999999998764432
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
........++..|+|||...+..++.++|||||||++|||+| |+.||........... ... ......+...+..
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~ 231 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ-VER----GYRMPCPQGCPES 231 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHc----CCCCCCCcccCHH
Confidence 222222345678999999988889999999999999999999 8888865433222111 111 1111223345678
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
+.+++.+||+.||++||++++|++.|++
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 232 LHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=327.91 Aligned_cols=261 Identities=19% Similarity=0.299 Sum_probs=208.9
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|+..+.||+|+||.||+|... +|+.||+|.++.... ....+.+.+|++++++++|+||+++++++... +..++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEE
Confidence 57888999999999999999987 689999998864321 22356789999999999999999999998654 67899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++.........+++..++.++.|+++||+|||+. ||+||||||+||+++.++.++|+|||+++...
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK--RIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC--CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 9999999999999864333345689999999999999999999987 89999999999999999999999999987654
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCC-HHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS-VSE 637 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 637 (673)
.... ......++..|+|||.+.+..++.++|||||||++|||++|+.||....... ....... ........+ ...
T Consensus 158 ~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~ 233 (267)
T cd08224 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCKKI-EKCDYPPLPADHY 233 (267)
T ss_pred CCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH--HHHHhhh-hcCCCCCCChhhc
Confidence 3321 1223457888999999988889999999999999999999999985422110 0001111 111111122 245
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
+..+.+++.+||+.+|++|||+.+|+++|+++.
T Consensus 234 ~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 234 SEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 678999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=345.94 Aligned_cols=252 Identities=17% Similarity=0.260 Sum_probs=196.9
Q ss_pred CCccccccccCCcceEEEEEEc----CCcEEEEEEecccCC---CCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCC
Q 005859 403 CFSEANLLGKSSFSATYKGILR----DGSVVAVKCIAKTSC---KSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRG 474 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 474 (673)
+|+..+.||+|+||.||+++.. +++.||+|++.+... ....+.+.+|+++++++ +||||+++++++.. .+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CC
Confidence 4778899999999999999853 478999999975321 12235678899999999 59999999998844 47
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLH 554 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla 554 (673)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL--GIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 78999999999999999863 34589999999999999999999987 8999999999999999999999999999
Q ss_pred ccccCcchhhhhccCCCCCccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCC
Q 005859 555 KLLADDIVFSMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (673)
+..............||..|+|||++.+.. ++.++|||||||++|||+||+.||...............+.. .....
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~ 230 (332)
T cd05614 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK--CDPPF 230 (332)
T ss_pred ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--CCCCC
Confidence 865433222233456899999999998654 789999999999999999999998642211111111111111 11122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005859 634 SVSEASNLGQIALHCTHESPSHRP-----SIENVMQ 664 (673)
Q Consensus 634 ~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 664 (673)
+...+..+.+++.+||+.||++|| +++++++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 231 PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 334457789999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=328.31 Aligned_cols=247 Identities=21% Similarity=0.372 Sum_probs=197.8
Q ss_pred ccccCCcceEEEEEEc---CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecC
Q 005859 409 LLGKSSFSATYKGILR---DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVP 484 (673)
Q Consensus 409 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~ 484 (673)
.||+|+||.||+|.++ ++..||+|++...... ...+++.+|+.++++++||||+++++++.. +..++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEecCC
Confidence 5899999999999753 4789999998654321 224678999999999999999999998742 45689999999
Q ss_pred CCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh-
Q 005859 485 NGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF- 563 (673)
Q Consensus 485 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~- 563 (673)
+|+|.+++.. ...+++..+.+++.|++.||+|||++ ||+||||||+||++++++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~--~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 79 LGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET--NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 9999999863 24589999999999999999999987 8999999999999999999999999999876543221
Q ss_pred -hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHH
Q 005859 564 -SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641 (673)
Q Consensus 564 -~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 641 (673)
......++..|+|||.+....++.++|||||||++|||+| |+.||.......... .+........+...+.++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-----~i~~~~~~~~~~~~~~~l 227 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ-----MIESGERMECPQRCPPEM 227 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----HHHCCCCCCCCCCCCHHH
Confidence 1122234578999999988889999999999999999998 999987643322111 111111222334456789
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHh
Q 005859 642 GQIALHCTHESPSHRPSIENVMQELSSI 669 (673)
Q Consensus 642 ~~l~~~Cl~~~p~~RPs~~evl~~L~~i 669 (673)
.+++.+||+.||++||++.+|.+.|++.
T Consensus 228 ~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 228 YDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=309.74 Aligned_cols=254 Identities=20% Similarity=0.335 Sum_probs=208.1
Q ss_pred HHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCc-------HHHHHHHHHHHhcc-CCCCceeEeeEEe
Q 005859 399 RATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSD-------EGEFLKGLKILTSL-KHENLASLRGICC 469 (673)
Q Consensus 399 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l-~H~niv~l~~~~~ 469 (673)
..-+.|...+.||.|..++|-++.++ +|+.+|+|++........ .++-.+|+.||+++ .||+|+.+.++|
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y- 92 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY- 92 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-
Confidence 34567788899999999999999876 488999999876542211 24567899999998 699999999999
Q ss_pred cCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeec
Q 005859 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLS 549 (673)
Q Consensus 470 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~ 549 (673)
+++...++|+|.|+.|.|.++|. +...+++....+|++|+..|++|||.. +||||||||+|||+|++.++||+
T Consensus 93 -es~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~--~IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 93 -ESDAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHAR--NIVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred -cCcchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHh--hhhhcccChhheeeccccceEEe
Confidence 45578999999999999999997 456799999999999999999999987 69999999999999999999999
Q ss_pred cccccccccCcchhhhhccCCCCCccCCccccC------CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhh
Q 005859 550 DSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT------GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVED 623 (673)
Q Consensus 550 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~ 623 (673)
|||+++.+..+. .....+||++|.|||.+.- ..|+..+|+||.||+||-++.|..||...........++..
T Consensus 166 DFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG 243 (411)
T KOG0599|consen 166 DFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG 243 (411)
T ss_pred ccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc
Confidence 999999887764 3456789999999998752 34899999999999999999999999764333222211111
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 624 FIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
. -........+.+....+++.+|++.||.+|.|++|+++
T Consensus 244 k--yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 244 K--YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred c--cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1 11223334566788999999999999999999999875
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=332.07 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=203.9
Q ss_pred cCCccccccccCCcceEEEEEEc-CCc----EEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGS----VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
++|...+.||+|+||+||+|++. +++ .||+|.+..........++.+|+.+++.++||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~ 83 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT---STV 83 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---CCc
Confidence 46788899999999999999854 444 4899998765433445678999999999999999999999854 346
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
+++|||+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 84 ~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~--~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 84 QLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV--RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccccccceEEEcCCCcEEECCCCceee
Confidence 7999999999999998632 24589999999999999999999987 799999999999999999999999999987
Q ss_pred ccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 557 LADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 557 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
....... ......++..|+|||...+..++.++|||||||++|||+| |..||.......... .+..... ...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~----~~~~ 233 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGER----LPQP 233 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCc----CCCC
Confidence 6532211 1112234567999999998889999999999999999998 888886543221111 1111111 1122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
...+.++.+++.+||+.||++||++.++++.|+++..
T Consensus 234 ~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 234 PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 3345788999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=329.63 Aligned_cols=253 Identities=22% Similarity=0.421 Sum_probs=197.6
Q ss_pred cccccCCcceEEEEEEcC-Cc--EEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKSSFSATYKGILRD-GS--VVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
+.||+|+||.||+|+.++ +. .+|+|.+.........+.+.+|++++.++ +||||+++++++... +..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEEEeC
Confidence 368999999999999765 43 57888887543233446789999999999 899999999998553 6689999999
Q ss_pred CCCChhhhhccccC------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccc
Q 005859 484 PNGNLLQHLDLEAG------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDS 551 (673)
Q Consensus 484 ~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~Df 551 (673)
++|+|.+++..... ....+++..+..++.|++.||+|||+. |++||||||+||++++++.+|++||
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~--~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC--CEeecccccceEEEcCCCeEEECCC
Confidence 99999999864321 123588999999999999999999987 8999999999999999999999999
Q ss_pred cccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCC
Q 005859 552 GLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLE 630 (673)
Q Consensus 552 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 630 (673)
|+++..... ........+..|+|||++....++.++|||||||++|||+| |..||.......... .+.....
T Consensus 157 gl~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~-----~~~~~~~ 229 (270)
T cd05047 157 GLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-----KLPQGYR 229 (270)
T ss_pred CCccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHH-----HHhCCCC
Confidence 998633211 11112233567999999988889999999999999999997 999985432221111 1111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 631 GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 631 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
...+...+.++.+++.+||+.+|.+|||+.++++.|+++++
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 230 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 12223345678999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=340.64 Aligned_cols=252 Identities=17% Similarity=0.297 Sum_probs=213.7
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCe-EEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE-CFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~-~~l 478 (673)
++|...+.+|+|+||.++..+++ +++.+++|.+..... ...++...+|+.++++++|||||.+.+.|..+ +. .+|
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~--~~~l~I 81 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED--GQLLCI 81 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC--CceEEE
Confidence 46778899999999999999876 478999999987653 33445788999999999999999999999664 44 899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||+||+||++.+.+...+ +..++++.+.+++.|++.|++|||+. .|+|||||+.||++.++..+||+|||+|+.+.
T Consensus 82 vm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~--~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN--RVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh--hhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 999999999999998553 46799999999999999999999976 69999999999999999999999999999988
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
.+... .....||+.||+||.+.+..|..|+||||+||++|||++-+.+|....-.....++..... ...+...+
T Consensus 158 ~~~~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~-----~Plp~~ys 231 (426)
T KOG0589|consen 158 PEDSL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY-----SPLPSMYS 231 (426)
T ss_pred Cchhh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC-----CCCCcccc
Confidence 76422 3356899999999999999999999999999999999999999877644433333333332 23455667
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
.++..++..|++.+|+.||++.+++.+
T Consensus 232 ~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 232 SELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 889999999999999999999999875
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=334.23 Aligned_cols=257 Identities=23% Similarity=0.393 Sum_probs=202.4
Q ss_pred CCccccccccCCcceEEEEEEcC------CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 403 CFSEANLLGKSSFSATYKGILRD------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
+|...+.||+|+||+||+|...+ ++.||||++.........+.+.+|+.++++++||||+++++++... +..
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE--QPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--Cce
Confidence 35566789999999999998642 5789999997553222346788999999999999999999998554 668
Q ss_pred EEEEeecCCCChhhhhcccc------------CCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC
Q 005859 477 FLIYDFVPNGNLLQHLDLEA------------GSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY 544 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~ 544 (673)
++++||+++++|.+++.... .....+++..+.+++.|++.||+|||+. ||+||||||+||++++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~--gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH--HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc--CccccccchhheEecCCC
Confidence 99999999999999985321 1123588999999999999999999987 899999999999999999
Q ss_pred CeeeccccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchh
Q 005859 545 NPLLSDSGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVE 622 (673)
Q Consensus 545 ~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~ 622 (673)
.+||+|||+++........ ......+++.|+|||++..+.++.++|||||||++|||+| |..||........ ..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~----~~ 237 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV----IE 237 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH----HH
Confidence 9999999998865432211 1122345678999999988889999999999999999998 8778765433221 11
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 623 DFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
.+.+.. ....+..++..+.+++.+||+.+|++||++++|++.|+.
T Consensus 238 ~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 121211 112334566789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=332.69 Aligned_cols=258 Identities=21% Similarity=0.406 Sum_probs=203.1
Q ss_pred hcCCccccccccCCcceEEEEEEcC------CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRG 474 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 474 (673)
+++|...+.||+|+||.||+|.+.+ +..||+|.+...........|.+|+.++++++|+||+++++++.+. +
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER--L 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--C
Confidence 4678888999999999999999753 5689999886543333346799999999999999999999988554 5
Q ss_pred eEEEEEeecCCCChhhhhccccC---CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC---Ceee
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAG---SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY---NPLL 548 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~---~~kl 548 (673)
..++||||+++|+|.++++.... ....++|..+++++.||+.||+|||+. +++||||||+||+++.++ .+||
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN--HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CEeecccchheEEEeccCCCcceEe
Confidence 67899999999999999975421 123589999999999999999999987 799999999999998764 5899
Q ss_pred ccccccccccCcchhh-hhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcC
Q 005859 549 SDSGLHKLLADDIVFS-MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID 626 (673)
Q Consensus 549 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~ 626 (673)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||........ .+.+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~-----~~~~~ 235 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV-----MEFVT 235 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-----HHHHH
Confidence 9999998764322111 112223467999999998889999999999999999997 9988865432211 11111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 005859 627 PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELS 667 (673)
Q Consensus 627 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 667 (673)
.......+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11122233445678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=332.51 Aligned_cols=259 Identities=19% Similarity=0.343 Sum_probs=205.8
Q ss_pred hcCCccccccccCCcceEEEEEEcC------CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRG 474 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 474 (673)
.++|.+.+.||+|+||.||+|...+ +..||+|.+...........+.+|+++++.++||||+++++++... +
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG--Q 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--C
Confidence 4578888999999999999998653 3689999986554333456789999999999999999999998554 6
Q ss_pred eEEEEEeecCCCChhhhhccccCC------ccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeee
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGS------EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLL 548 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl 548 (673)
..++||||+++|+|.+++...... ...++|..++.++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK--KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccccChheEEEcCCCCEEE
Confidence 789999999999999998643221 23478999999999999999999987 7999999999999999999999
Q ss_pred ccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcC
Q 005859 549 SDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID 626 (673)
Q Consensus 549 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~ 626 (673)
+|||+++....... .......++..|+|||.+..+.++.++|||||||++||++| |+.||.......... ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~----~~~~ 236 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK----FVID 236 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH----HHhc
Confidence 99999986644322 11223346778999999988889999999999999999998 888886533222111 1111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 627 PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 627 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
......+...+.++.+++.+||+.+|++|||+.++++.|++
T Consensus 237 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 237 -GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred -CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11112233446789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=334.08 Aligned_cols=264 Identities=23% Similarity=0.371 Sum_probs=204.5
Q ss_pred cCCccccccccCCcceEEEEEEc-----CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-----DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
..|.+.+.||+|+||.||++++. ++..||+|.+...........+.+|++++++++||||+++++++...+....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 35678889999999999999842 4788999998755433344679999999999999999999999876545678
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~--gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR--QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecccchheEEEcCCCCEEECCCccccc
Confidence 9999999999999998632 23589999999999999999999987 899999999999999999999999999987
Q ss_pred ccCcchh--hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhh-------c---cchhhh
Q 005859 557 LADDIVF--SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE-------S---SKVEDF 624 (673)
Q Consensus 557 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~-------~---~~~~~~ 624 (673)
....... ......++..|+|||++.+..++.++|||||||++|||+|++.|.......... . ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6432211 112234566799999998888999999999999999999987654221100000 0 000000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 625 IDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
.........+...+..+.+++.+||+.+|++||+++++++.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 1111111122335678999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=346.75 Aligned_cols=248 Identities=17% Similarity=0.233 Sum_probs=193.6
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|++.+.||+|+||.||+|+.. +++.||+|... ...+.+|++++++++|||||++++++... ...++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYN--KFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEEC--CeeEEE
Confidence 467999999999999999999965 48899999643 23578999999999999999999998654 678999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+. ++|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 162 ~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~--~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 162 LPRYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN--RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred EecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 99994 789888863 24588999999999999999999987 899999999999999999999999999975433
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhh-------hhc--------------
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQA-------AES-------------- 618 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~-------~~~-------------- 618 (673)
..........||+.|+|||++.+..++.++|||||||++|||+||+.|+....... ...
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 22122234568999999999998899999999999999999999998764321000 000
Q ss_pred ----cchhhhc---------CCcCCCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 619 ----SKVEDFI---------DPNLEGKF--SVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 619 ----~~~~~~~---------~~~~~~~~--~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
....... .+.....+ ....+.++.+++.+||+.||++|||++|+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 00000000 0123567899999999999999999999985
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=329.12 Aligned_cols=261 Identities=18% Similarity=0.286 Sum_probs=208.6
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|+..+.||+|+||.||+|+.. +++.||||.+..... .....++.+|+++++.++||||+++++++... +..++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC--CeEEE
Confidence 35777889999999999999964 689999998865332 12335788999999999999999999998654 67899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
+|||+++++|.+++.........+++..++.++.|++.||+|||+. ||+|+||||+||+++.++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 9999999999999864333345689999999999999999999987 89999999999999999999999999987665
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHh-hhhccchhhhcCCcCCCCCCHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQ-AAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
.... ......++..|+|||++.+..++.++||||||+++|||++|..||...... ......+.....+ .......
T Consensus 158 ~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 233 (267)
T cd08229 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP---PLPSDHY 233 (267)
T ss_pred cCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCC---CCCcccc
Confidence 4321 122345788999999998888999999999999999999999998543211 1111111111111 1122345
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
+..+.+++.+||+.||++||||.+|++.++++.
T Consensus 234 ~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 234 SEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred cHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 678999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=343.75 Aligned_cols=255 Identities=20% Similarity=0.302 Sum_probs=195.2
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC---CeEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGR---GECF 477 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---~~~~ 477 (673)
+|...+.||+|+||.||+|+.. +|+.||||++..... ......+.+|++++++++||||+++++++..... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999965 589999999875321 2334578899999999999999999998865432 3579
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||++ ++|.+++.. ...+++..+..++.||++||+|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA--NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 689988862 34589999999999999999999987 8999999999999999999999999999865
Q ss_pred cCcch--hhhhccCCCCCccCCccccC--CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhc---------------
Q 005859 558 ADDIV--FSMLKASAAMGYLAPEYTTT--GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAES--------------- 618 (673)
Q Consensus 558 ~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~--------------- 618 (673)
..... .......++..|+|||++.+ ..++.++|||||||++|||+||+.||..........
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 11233568899999999875 578999999999999999999999985432110000
Q ss_pred ----cc---hhhhcCCcCCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 619 ----SK---VEDFIDPNLEGKFS---VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 619 ----~~---~~~~~~~~~~~~~~---~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.. ....+......... ...+..+.+++.+||+.||++|||++|+++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00 00000000000000 123467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=345.32 Aligned_cols=248 Identities=24% Similarity=0.426 Sum_probs=207.3
Q ss_pred ccccccCCcceEEEEEEcC--Cc--EEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEee
Q 005859 407 ANLLGKSSFSATYKGILRD--GS--VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDF 482 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~ 482 (673)
.++||+|.||.|++|.|.. |+ .||||+++.......-.+|++|+.+|.+|+|||++++||+..+ ....+|||+
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~---qp~mMV~EL 191 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD---QPAMMVFEL 191 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc---chhhHHhhh
Confidence 4679999999999999875 44 6899999887655566899999999999999999999999975 357899999
Q ss_pred cCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcch
Q 005859 483 VPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV 562 (673)
Q Consensus 483 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 562 (673)
++.|+|.+.|+. .....|-......++.|||.||+||.++ ++|||||.++|+||-....+||+|||+.+.+.....
T Consensus 192 aplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk--rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 192 APLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK--RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh--hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999999985 2345688889999999999999999998 699999999999999999999999999998865432
Q ss_pred h-hh-hccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 563 F-SM-LKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 563 ~-~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
. .+ ....-.+.|.|||.+...+++.++|||+|||++|||+| |..||.+.... .+.+.+|..-.-..+..+++
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-----qIL~~iD~~erLpRPk~cse 342 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-----QILKNIDAGERLPRPKYCSE 342 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-----HHHHhccccccCCCCCCChH
Confidence 2 22 22334667999999999999999999999999999999 78888765332 22333444434455778899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHH
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQEL 666 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~~L 666 (673)
+++++|..||..+|++||||..+.+.+
T Consensus 343 dIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 343 DIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHHHHHHhccCCccccccHHHHHHhH
Confidence 999999999999999999999997543
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=334.47 Aligned_cols=260 Identities=23% Similarity=0.378 Sum_probs=205.1
Q ss_pred hcCCccccccccCCcceEEEEEEc------CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGR 473 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 473 (673)
.++|...+.||+|+||.||++... .+..||||+++........+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG-- 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--
Confidence 356888899999999999999742 25589999887654333346789999999999 799999999998554
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL 553 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGl 553 (673)
+..++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+. +|+|+||||+||+++.++.+|++|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC--CeehhhhccceEEEcCCCeEEECCCcc
Confidence 67899999999999999997432 23489999999999999999999987 799999999999999999999999999
Q ss_pred cccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCC
Q 005859 554 HKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEG 631 (673)
Q Consensus 554 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 631 (673)
++........ ......++..|+|||.+.+..++.++|||||||++|||+| |+.||.............. .....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~ 263 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK----EGYRM 263 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH----cCCcC
Confidence 9866433211 1112235678999999998889999999999999999998 9988865332211111111 11111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 632 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
..+...+.++.+++.+||+.+|++|||+.|+++.|++++
T Consensus 264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~ 302 (302)
T cd05055 264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302 (302)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence 122234578999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=328.63 Aligned_cols=260 Identities=22% Similarity=0.354 Sum_probs=203.9
Q ss_pred CccccccccCCcceEEEEEEcC----CcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCC----C
Q 005859 404 FSEANLLGKSSFSATYKGILRD----GSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGR----G 474 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~ 474 (673)
|...+.||+|+||.||+|.... +..||+|.++..... .....+.+|++.+++++||||+++++++..... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999998653 367999998754322 233578999999999999999999998865422 2
Q ss_pred eEEEEEeecCCCChhhhhccccC--CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSG 552 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfG 552 (673)
..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR--NFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC--CeeccccchheEEECCCCeEEECCcc
Confidence 47899999999999999854321 224689999999999999999999987 79999999999999999999999999
Q ss_pred ccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCC
Q 005859 553 LHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLE 630 (673)
Q Consensus 553 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 630 (673)
+++........ .......+..|+|||.+....++.++|||||||++|||++ |..||......... ...... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~----~~~~~~-~~ 233 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY----DYLRHG-NR 233 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHcC-CC
Confidence 99866443221 1112234668999999988889999999999999999999 88888654332211 111111 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 631 GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 631 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
...+...+.++.+++.+||+.||++||++.|+++.|++++
T Consensus 234 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 234 LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 1233445678999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=329.72 Aligned_cols=254 Identities=18% Similarity=0.289 Sum_probs=191.1
Q ss_pred ccccCCcceEEEEEEcC---CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCC
Q 005859 409 LLGKSSFSATYKGILRD---GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPN 485 (673)
Q Consensus 409 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~ 485 (673)
.||+|+||+||+|...+ ...+|+|.+...........|.+|+++++.++||||+++++++.. .+..++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEEEEEeCCC
Confidence 58999999999998543 457888887654333334678999999999999999999999854 4678999999999
Q ss_pred CChhhhhccccCC-ccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh-
Q 005859 486 GNLLQHLDLEAGS-EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF- 563 (673)
Q Consensus 486 gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~- 563 (673)
|+|.+++...... ....++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc--CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999999754322 23456888899999999999999987 7999999999999999999999999998754332211
Q ss_pred hhhccCCCCCccCCccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 564 SMLKASAAMGYLAPEYTTT-------GRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 564 ~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
......++..|+|||++.. ..++.++|||||||++|||++ |..||..................+......+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL 237 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc
Confidence 1122345677999998743 356889999999999999999 77787654332221111111111111122233
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQELS 667 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 667 (673)
..+..+.+++..|| .||++|||+++|++.|.
T Consensus 238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 238 KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 45577788999999 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=332.59 Aligned_cols=247 Identities=22% Similarity=0.282 Sum_probs=193.9
Q ss_pred cccCCcceEEEEEEc-CCcEEEEEEecccCCC--CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCCC
Q 005859 410 LGKSSFSATYKGILR-DGSVVAVKCIAKTSCK--SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNG 486 (673)
Q Consensus 410 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~g 486 (673)
||+|+||.||+++.+ +|+.||+|++...... .....+..|++++++++||||+++++++.. ....++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCCC
Confidence 699999999999976 4899999999754322 223456779999999999999999998854 47899999999999
Q ss_pred ChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhhhh
Q 005859 487 NLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSML 566 (673)
Q Consensus 487 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 566 (673)
+|.+++... ....+++..+..++.|++.||+|||+. ||+||||||+||++++++.+||+|||++....... ...
T Consensus 79 ~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~ 152 (277)
T cd05607 79 DLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM--DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TIT 152 (277)
T ss_pred CHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC--CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eee
Confidence 999888533 224588999999999999999999987 89999999999999999999999999987665432 122
Q ss_pred ccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHH
Q 005859 567 KASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIAL 646 (673)
Q Consensus 567 ~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 646 (673)
...++..|+|||++.+..++.++||||+||++|||++|+.||....................... .....+.++.+++.
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~ 231 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICR 231 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHHHHH
Confidence 34688899999999988899999999999999999999999865432111111111111111110 11234567899999
Q ss_pred HccccCCCCCCCHHHHHHH
Q 005859 647 HCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 647 ~Cl~~~p~~RPs~~evl~~ 665 (673)
+||+.||++||+++|+++.
T Consensus 232 ~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 232 LFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred HHhccCHhhCCCCccchhh
Confidence 9999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=346.43 Aligned_cols=254 Identities=19% Similarity=0.253 Sum_probs=194.4
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|+..+.||+|+||+||+++.. +++.||||++.+... ......+.+|++++.+++||||+++++.+.+ .+..++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEEE
Confidence 46888999999999999999866 488999999975421 1223567889999999999999999999854 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 79 v~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~--givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 79 IMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL--GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred EEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC--CeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 9999999999999963 34689999999999999999999987 89999999999999999999999999987543
Q ss_pred Ccchh----------------------------------hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhC
Q 005859 559 DDIVF----------------------------------SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSG 604 (673)
Q Consensus 559 ~~~~~----------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG 604 (673)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 21100 01234689999999999998999999999999999999999
Q ss_pred CCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccc--cCCCCCCCHHHHHHH
Q 005859 605 KCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTH--ESPSHRPSIENVMQE 665 (673)
Q Consensus 605 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~--~~p~~RPs~~evl~~ 665 (673)
+.||........................ ...+.++.+++.+++. .++..||+++|+++.
T Consensus 233 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 233 YPPFCSETPQETYKKVMNWKETLIFPPE--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCCHHHHHHHHHcCcCcccCCCc--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9999754332221111110001111111 1234566777776433 344467999999763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=325.42 Aligned_cols=253 Identities=23% Similarity=0.396 Sum_probs=195.0
Q ss_pred cccccCCcceEEEEEEcC----CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKSSFSATYKGILRD----GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
+.||+|+||.||+|...+ +..||+|.+.........+.+.+|+.+++.++||||+++++++... .+..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEecC
Confidence 368999999999998542 4579999886543223346788999999999999999999987543 34578999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF 563 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 563 (673)
++|+|.+++... ....++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 80 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 80 KHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK--KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC--CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999998632 23467888899999999999999987 7999999999999999999999999999865432211
Q ss_pred ---hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCC-CCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 564 ---SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKC-SITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 564 ---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
......++..|+|||.+....++.++|||||||++|||++|.. ||........ ...+.... ....+...+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~ 229 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI-TVYLLQGR----RLLQPEYCPD 229 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhcCC----CCCCCCcCCH
Confidence 1112345668999999988889999999999999999999654 4543221111 11111111 1111223456
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.+.+++.+||+.+|++||++.||++.|+++++
T Consensus 230 ~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 230 PLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 79999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=334.48 Aligned_cols=263 Identities=22% Similarity=0.355 Sum_probs=201.5
Q ss_pred hcCCccccccccCCcceEEEEEEcC---------------CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEe
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD---------------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLR 465 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 465 (673)
.++|...+.||+|+||.||+++..+ ...||+|.+...........|.+|++++++++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578888999999999999987642 2358999987653333346799999999999999999999
Q ss_pred eEEecCCCCeEEEEEeecCCCChhhhhccccC--------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCC
Q 005859 466 GICCSKGRGECFLIYDFVPNGNLLQHLDLEAG--------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEK 537 (673)
Q Consensus 466 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~N 537 (673)
+++.. .+..++||||+++++|.+++..... ....+++..+++++.|++.||+|||+. |++||||||+|
T Consensus 84 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--~i~H~dlkp~N 159 (295)
T cd05097 84 GVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL--NFVHRDLATRN 159 (295)
T ss_pred EEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc--CeeccccChhh
Confidence 99954 4678999999999999999864211 112478999999999999999999987 89999999999
Q ss_pred eEecCCCCeeeccccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh--CCCCCChhhHh
Q 005859 538 VLIHRRYNPLLSDSGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS--GKCSITPFTRQ 614 (673)
Q Consensus 538 ILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t--G~~p~~~~~~~ 614 (673)
|++++++.+||+|||+++........ ......++..|+|||++..+.++.++|||||||++|||++ |..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 99999999999999999765432211 1122334678999999988889999999999999999998 55676543322
Q ss_pred hhhccchhhhcC---CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 615 AAESSKVEDFID---PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 615 ~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
..... ..+..+ .......+...+..+.+++.+||+.||++||++++|++.|++
T Consensus 240 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 QVIEN-TGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHH-HHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111 011111 111111222345789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=348.47 Aligned_cols=253 Identities=17% Similarity=0.257 Sum_probs=203.2
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|...+.||+|+||+||+|+.. +++.||||++..... ......+.+|++++..++||||+++++++.+ .+..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD--EEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec--CCeEEE
Confidence 46888999999999999999976 589999999976432 2334678899999999999999999998854 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 79 v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~--giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 79 VMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL--GFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred EEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 99999999999999732 4689999999999999999999987 89999999999999999999999999998665
Q ss_pred Ccc----------------------------hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCh
Q 005859 559 DDI----------------------------VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITP 610 (673)
Q Consensus 559 ~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~ 610 (673)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 432 0112234689999999999999999999999999999999999999976
Q ss_pred hhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 005859 611 FTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPS-IENVMQE 665 (673)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-~~evl~~ 665 (673)
............ .. ...........+.++.+++.+|+. ||.+||+ ++++++.
T Consensus 233 ~~~~~~~~~i~~-~~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 233 DTLQETYNKIIN-WK-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCHHHHHHHHhc-cC-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 543222111111 00 111111111246788999999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=325.91 Aligned_cols=249 Identities=23% Similarity=0.395 Sum_probs=199.3
Q ss_pred cccccCCcceEEEEEEcC----CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKSSFSATYKGILRD----GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
+.||+|+||.||+|.+.. +..||+|.+.........+++.+|++++++++||||+++++++.. +..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEEeC
Confidence 369999999999998543 268999998766533345689999999999999999999998742 4578999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF 563 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 563 (673)
++|+|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 78 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~--~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 78 PLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK--HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc--CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 999999999732 3589999999999999999999987 7999999999999999999999999999876443221
Q ss_pred h--hhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 564 S--MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 564 ~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
. .....++..|+|||.+.+..++.++|||||||++|||++ |+.||.......... .+.. ......+...+..
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~ 226 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA-MLES----GERLPRPEECPQE 226 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHH-HHHc----CCcCCCCCCCCHH
Confidence 1 111223467999999998889999999999999999998 999986543322111 1111 1111223344578
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
+.+++.+||+.+|++||++.++++.|+++.
T Consensus 227 l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 227 IYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=340.95 Aligned_cols=242 Identities=20% Similarity=0.336 Sum_probs=194.0
Q ss_pred cccccCCcceEEEEEEc----CCcEEEEEEecccCC---CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 408 NLLGKSSFSATYKGILR----DGSVVAVKCIAKTSC---KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+.||+|+||.||+++.. +++.||||++.+... ......+.+|+++|++++||||+++++++.. .+..++||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEEE
Confidence 57999999999999853 478999999976421 1233567889999999999999999999855 46899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++|+|.+++.. ...+.+..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 80 EYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ--GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred eCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 99999999999863 34578888999999999999999987 8999999999999999999999999998754322
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
.. ......|++.|+|||++.+..++.++|||||||++|||++|+.||......... ..+..... ..+...+.+
T Consensus 154 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~----~~~~~~~~--~~~~~~~~~ 226 (323)
T cd05584 154 GT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI----DKILKGKL--NLPPYLTPE 226 (323)
T ss_pred CC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH----HHHHcCCC--CCCCCCCHH
Confidence 11 122346899999999999888999999999999999999999999764332211 11111111 223334577
Q ss_pred HHHHHHHccccCCCCCC-----CHHHHHH
Q 005859 641 LGQIALHCTHESPSHRP-----SIENVMQ 664 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RP-----s~~evl~ 664 (673)
+.+++.+||+.||++|| ++.++++
T Consensus 227 ~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 227 ARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 89999999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=333.43 Aligned_cols=252 Identities=21% Similarity=0.305 Sum_probs=201.0
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC--CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK--SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
+|+..+.||+|+||+||++... +++.||+|++...... .....+.+|++++++++||||+++++++.. .+..++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CCeEEEE
Confidence 4777889999999999999965 5899999999754322 223467889999999999999999998854 4689999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++|+|.+++... ....+++..+..++.|++.||+|||+. ||+||||||+||++++++.++|+|||+++....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 79 LTLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE--RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred EeccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC--CcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999999888632 224589999999999999999999987 899999999999999999999999999987543
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
... .....|+..|+|||++.+..++.++|||||||++|||++|+.||.......... .+...+.. ....++...+.
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~ 230 (285)
T cd05605 155 GET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE-EVERRVKE-DQEEYSEKFSE 230 (285)
T ss_pred CCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH-HHHHHhhh-cccccCcccCH
Confidence 321 223468899999999998889999999999999999999999997543221111 11111111 11223344567
Q ss_pred HHHHHHHHccccCCCCCC-----CHHHHHH
Q 005859 640 NLGQIALHCTHESPSHRP-----SIENVMQ 664 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RP-----s~~evl~ 664 (673)
.+.+++.+||+.||++|| +++++++
T Consensus 231 ~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 231 AARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred HHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 889999999999999999 7888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=328.37 Aligned_cols=255 Identities=20% Similarity=0.318 Sum_probs=201.8
Q ss_pred HHhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCC----
Q 005859 399 RATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKG---- 472 (673)
Q Consensus 399 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~---- 472 (673)
.+++.|+..+.||+|+||.||+|...+ ++.||+|++.... .....+.+|+.+++++ +||||+++++++....
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 456778888999999999999999764 8899999986542 3456788999999998 7999999999986532
Q ss_pred CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccc
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSG 552 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfG 552 (673)
....++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~--~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH--KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCCHHHEEECCCCCEEEccCC
Confidence 24689999999999999998743 224689999999999999999999987 79999999999999999999999999
Q ss_pred ccccccCcchhhhhccCCCCCccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCC
Q 005859 553 LHKLLADDIVFSMLKASAAMGYLAPEYTT-----TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDP 627 (673)
Q Consensus 553 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 627 (673)
+++....... ......|+..|+|||++. ...++.++|||||||++|||++|+.||.............. .
T Consensus 157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~----~ 231 (272)
T cd06637 157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR----N 231 (272)
T ss_pred Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc----C
Confidence 9986543221 223346788999999986 33588899999999999999999999865432211111111 1
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 628 NLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 628 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..........+..+.+++.+||..+|.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1111112234567899999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=325.02 Aligned_cols=256 Identities=24% Similarity=0.447 Sum_probs=207.7
Q ss_pred HhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
..++|.+.+.||+|+||.||+|..++++.||||.+.... ...+++.+|++++++++||||+++++++.. ....++|
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 79 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE--EEPIYIV 79 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeec--CCceEEE
Confidence 456788899999999999999998888899999987543 345689999999999999999999999854 3678999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++++|.+++.... ...+++..+..++.|++.|++|||+. +|+|+||||+||++++++.+|++|||+++....
T Consensus 80 ~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~--~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 80 TEYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR--NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EeccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999999997432 24689999999999999999999987 799999999999999999999999999987654
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
...........+..|+|||.+.+..++.++||||||+++||++| |+.||............ .. ......+...+
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~-~~----~~~~~~~~~~~ 230 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV-ER----GYRMPRPPNCP 230 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-Hc----CCCCCCCCCCC
Confidence 33222223334568999999998889999999999999999999 99998654322211111 11 11111222335
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
.++.+++.+||+.+|++||+++++++.|+.
T Consensus 231 ~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 231 EELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=322.12 Aligned_cols=255 Identities=22% Similarity=0.399 Sum_probs=198.2
Q ss_pred ccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhc--cCCCCceeEeeEEecCC--CCeEEEEEee
Q 005859 407 ANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTS--LKHENLASLRGICCSKG--RGECFLIYDF 482 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~--~~~~~lv~E~ 482 (673)
.++||+|.||.||||.+. ++.||||++... +.+.|..|-+|.+- ++|+||++++++-...+ .-+.+||+||
T Consensus 215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred HHHhhcCccceeehhhcc-CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 457999999999999996 599999998643 46788888888776 58999999998754332 3378999999
Q ss_pred cCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcC-------CCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 483 VPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK-------RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 483 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.+.|+|.+||.. ..++|....+|+..+++||+|||+. +|+|+|||||++||||.+|+++.|+|||+|.
T Consensus 290 h~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 290 HPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred ccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999963 4699999999999999999999983 5789999999999999999999999999998
Q ss_pred cccCcchh-hhhccCCCCCccCCccccCCC-CC-----cchhHHHHHHHHHHHHhCCCCCCh---------hhH------
Q 005859 556 LLADDIVF-SMLKASAAMGYLAPEYTTTGR-FT-----EKSDIYAFGMIVFQILSGKCSITP---------FTR------ 613 (673)
Q Consensus 556 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~s-----~ksDVwSfGvvl~el~tG~~p~~~---------~~~------ 613 (673)
.+..+... .....+||.+|||||++.+.. +. .+.||||+|.|||||+++-.-+.+ +..
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 87654322 233478999999999998643 21 469999999999999986532211 100
Q ss_pred --hhhhccchhhhcCCcCCCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 614 --QAAESSKVEDFIDPNLEGKFSV-SEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 614 --~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
...+.-.+.+-.+|.++..+.. ..+.-+.+.+..||+.||+.|-|+.-|-+++.++..
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 0111122333334444332221 345678999999999999999999999999988765
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=328.62 Aligned_cols=257 Identities=23% Similarity=0.440 Sum_probs=204.1
Q ss_pred cCCccccccccCCcceEEEEEEcC----CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD----GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
.+|++.+.||+|+||.||+|+... +..||+|.+.........+.|.+|+.++++++||||+++++++.. .+..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SKPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCccE
Confidence 467788999999999999998642 347999988764433345688999999999999999999999854 46789
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++|+|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++..
T Consensus 82 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~--~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 82 IVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC--CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 999999999999999743 23589999999999999999999987 7999999999999999999999999999876
Q ss_pred cCcchhh--hhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 558 ADDIVFS--MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 558 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||........... +.+.. ....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~-~~~~~----~~~~~ 231 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA-IEEGY----RLPAP 231 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHH-HhCCC----cCCCC
Confidence 5432111 111223467999999998889999999999999999887 9999865432211111 11111 11122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
...+..+.+++.+||+.+|.+||+|.++++.|++++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 267 (267)
T cd05066 232 MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267 (267)
T ss_pred CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence 334578899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.39 Aligned_cols=253 Identities=13% Similarity=0.243 Sum_probs=201.0
Q ss_pred HHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 399 RATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 399 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
...++|+..+.||+|+||.||+++.. +++.||+|++.+... ......+.+|+++++.++||||+++++++.. .+.
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~~~ 117 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--DKY 117 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCE
Confidence 34568899999999999999999976 488999999975321 2233557899999999999999999998854 478
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.++||||+++|+|.+++.. ..++...+..++.|++.||+|||+. ||+||||||+|||+++++.+||+|||+++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEEcCCCCEEEEecccee
Confidence 9999999999999999863 2477888889999999999999987 89999999999999999999999999998
Q ss_pred cccCcchhhhhccCCCCCccCCccccCC----CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCC
Q 005859 556 LLADDIVFSMLKASAAMGYLAPEYTTTG----RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEG 631 (673)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 631 (673)
..............||+.|+|||++... .++.++|||||||++|||++|+.||......... ..+.......
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~----~~i~~~~~~~ 266 (370)
T cd05596 191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY----SKIMDHKNSL 266 (370)
T ss_pred eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH----HHHHcCCCcC
Confidence 7654332222345689999999998653 3789999999999999999999999764332211 1121111111
Q ss_pred CCC--HHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 005859 632 KFS--VSEASNLGQIALHCTHESPSH--RPSIENVMQ 664 (673)
Q Consensus 632 ~~~--~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~ 664 (673)
.++ ...+.++.+++.+|++.+|.+ ||++.|+++
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 267 TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 111 134578899999999999987 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=348.10 Aligned_cols=252 Identities=18% Similarity=0.253 Sum_probs=195.7
Q ss_pred CCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.|+..+.||+|+||+||+|+... ++.||||++..... ......+.+|++++++++||||+++++++.+ .+..++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEE
Confidence 57888999999999999998654 88999999976432 1234578899999999999999999999954 4789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~--givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 80 MDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM--GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC--CeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 999999999999863 24588899999999999999999987 899999999999999999999999999764321
Q ss_pred cch----------------------------------------------hhhhccCCCCCccCCccccCCCCCcchhHHH
Q 005859 560 DIV----------------------------------------------FSMLKASAAMGYLAPEYTTTGRFTEKSDIYA 593 (673)
Q Consensus 560 ~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS 593 (673)
... .......||..|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 000 0011246899999999999888999999999
Q ss_pred HHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHH--ccccCCCCCCCHHHHHH
Q 005859 594 FGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALH--CTHESPSHRPSIENVMQ 664 (673)
Q Consensus 594 fGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--Cl~~~p~~RPs~~evl~ 664 (673)
|||++|||+||+.||............... ............+.++.+++.+ |+..+|..||++.|+++
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVINW--ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHHcc--ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 999999999999999754332211111110 0011111111234677888877 66677777999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=336.36 Aligned_cols=262 Identities=20% Similarity=0.403 Sum_probs=205.6
Q ss_pred hcCCccccccccCCcceEEEEEEc--------CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR--------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSK 471 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 471 (673)
.++|.+.+.||+|+||.||+++.. ....||+|.+...........+.+|+++++++ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ- 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-
Confidence 356778899999999999999742 24579999987654333446788999999999 69999999999854
Q ss_pred CCCeEEEEEeecCCCChhhhhccccC------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeE
Q 005859 472 GRGECFLIYDFVPNGNLLQHLDLEAG------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVL 539 (673)
Q Consensus 472 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NIL 539 (673)
.+..++||||+++|+|.+++..... ....+++.++.+++.|++.||+|||++ ||+||||||+||+
T Consensus 90 -~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~--gi~H~dlkp~Nil 166 (314)
T cd05099 90 -EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR--RCIHRDLAARNVL 166 (314)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC--CeeeccccceeEE
Confidence 3678999999999999999964321 124589999999999999999999987 8999999999999
Q ss_pred ecCCCCeeeccccccccccCcchhh-hhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhh
Q 005859 540 IHRRYNPLLSDSGLHKLLADDIVFS-MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAE 617 (673)
Q Consensus 540 l~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~ 617 (673)
+++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.........
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999998664322111 112234467999999988889999999999999999999 88888654322111
Q ss_pred ccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 618 SSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.. .. .......+...+.++.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 247 ~~-~~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 247 KL-LR----EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HH-HH----cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11 11 111112233455688899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.03 Aligned_cols=250 Identities=17% Similarity=0.297 Sum_probs=188.8
Q ss_pred ccccCCcceEEEEEEcCC---cEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCC
Q 005859 409 LLGKSSFSATYKGILRDG---SVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPN 485 (673)
Q Consensus 409 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~ 485 (673)
.||+|+||+||+|...++ ..+++|.+.........+.|.+|+.+++.++||||+++++.+.. ....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEecCCC
Confidence 599999999999985543 35667776654333345689999999999999999999999864 3678999999999
Q ss_pred CChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc-hhh
Q 005859 486 GNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI-VFS 564 (673)
Q Consensus 486 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~ 564 (673)
|+|.++++.........++.....++.||++||+|||+. +|+||||||+|||++.++.+||+|||++....... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~--~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH--NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC--CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999999975433334567778889999999999999987 79999999999999999999999999986432221 112
Q ss_pred hhccCCCCCccCCccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccch----hhhcCCcCCCC
Q 005859 565 MLKASAAMGYLAPEYTTT-------GRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKV----EDFIDPNLEGK 632 (673)
Q Consensus 565 ~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~----~~~~~~~~~~~ 632 (673)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||............. ....++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 234 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL--- 234 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc---
Confidence 223457788999998753 245789999999999999997 466775443322111111 11122222
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 005859 633 FSVSEASNLGQIALHCTHESPSHRPSIENVMQELS 667 (673)
Q Consensus 633 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 667 (673)
.......+.+++..|| .+|++||++++|++.|.
T Consensus 235 -~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 235 -ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2234567888999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=353.58 Aligned_cols=255 Identities=18% Similarity=0.248 Sum_probs=193.9
Q ss_pred HhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCC------
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKG------ 472 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 472 (673)
...+|...+.||+|+||.||+|... +++.||||++.... ....+|+.+|++++|||||++++++....
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 3567999999999999999999975 48899999885432 23457999999999999999998875321
Q ss_pred CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC-Ceeeccc
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY-NPLLSDS 551 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~-~~kl~Df 551 (673)
....++||||++ ++|.+++.........+++..+..++.||+.||+|||+. ||+||||||+|||++.++ .+||+||
T Consensus 139 ~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~--~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 139 NIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK--FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred ceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCcCHHHEEEcCCCCceeeecc
Confidence 124679999997 478777653323345689999999999999999999987 899999999999999665 7999999
Q ss_pred cccccccCcchhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh--------
Q 005859 552 GLHKLLADDIVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE-------- 622 (673)
Q Consensus 552 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~-------- 622 (673)
|+++.+.... ......+++.|+|||++.+. .++.++|||||||++|||+||..||............+.
T Consensus 216 Gla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 216 GSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9998765432 12234678899999998764 689999999999999999999999865432111111000
Q ss_pred ----------hhcCCc-----CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 623 ----------DFIDPN-----LEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 623 ----------~~~~~~-----~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+.-+. +...++...+.++.+|+.+||+.||.+|||+.|+++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000000 001122234568999999999999999999999984
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=345.26 Aligned_cols=253 Identities=19% Similarity=0.274 Sum_probs=200.4
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|...+.||+|+||+||+++.. +|+.||+|++..... ....+.+.+|+++++.++||||+++++++.. .+..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEEE
Confidence 46888999999999999999976 589999999986532 2234568899999999999999999998854 477999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++.+.
T Consensus 79 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~--~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 79 VMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM--GYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred EECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 99999999999999743 24689999999999999999999987 89999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCcccc------CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCC
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTT------TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGK 632 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (673)
...........|+..|+|||++. ...++.++|||||||++|||+||+.||............. ... ......
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~-~~~-~~~~~~ 231 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM-NFQ-RFLKFP 231 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHH-cCC-CccCCC
Confidence 43322223346899999999986 4567899999999999999999999996543322211111 110 001001
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 633 FSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 633 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.....+..+.+++.+|++ +|++||++.++++
T Consensus 232 ~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 232 EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 112345778899999998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=332.50 Aligned_cols=264 Identities=24% Similarity=0.383 Sum_probs=204.5
Q ss_pred hcCCccccccccCCcceEEEEEEcC-----------------CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCcee
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-----------------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 463 (673)
.++|+..+.||+|+||.||+|...+ +..||+|.+.........+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578888999999999999998653 24689999876543344568899999999999999999
Q ss_pred EeeEEecCCCCeEEEEEeecCCCChhhhhccccC-------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCC
Q 005859 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAG-------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAE 536 (673)
Q Consensus 464 l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~ 536 (673)
+++++... +..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. ||+||||||+
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~--~i~H~dlkp~ 159 (296)
T cd05051 84 LLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL--NFVHRDLATR 159 (296)
T ss_pred EEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc--Cccccccchh
Confidence 99998554 678999999999999999874321 123689999999999999999999987 8999999999
Q ss_pred CeEecCCCCeeeccccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh--CCCCCChhhH
Q 005859 537 KVLIHRRYNPLLSDSGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS--GKCSITPFTR 613 (673)
Q Consensus 537 NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t--G~~p~~~~~~ 613 (673)
||++++++.+||+|||+++........ ......++..|+|||++....++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 999999999999999998765433211 1223345678999999988889999999999999999998 6667754332
Q ss_pred hhhhccchhhhc--CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 614 QAAESSKVEDFI--DPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 614 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
............ ........+...+.++.+++.+||+.||++|||+.||++.|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 221111111000 0111111223345789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=326.54 Aligned_cols=253 Identities=19% Similarity=0.297 Sum_probs=199.0
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
.+|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++... +..++||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~--~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR--EKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--CEEEEEE
Confidence 46888899999999999999964 58899999986543 23445688999999999999999999998654 6789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.++++. ...+++..+..++.|++.||+|||+. ||+||||||+||++++++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 86 EYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK--GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 99999999998863 24588999999999999999999987 8999999999999999999999999999866432
Q ss_pred chhhhhccCCCCCccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhh-hcCCcCCCCCCHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTT---TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVED-FIDPNLEGKFSVS 636 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 636 (673)
.. ......++..|+|||.+. ...++.++|||||||++|||++|+.||............... ...+... ....
T Consensus 160 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 236 (267)
T cd06646 160 IA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLK--DKTK 236 (267)
T ss_pred cc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCc--cccc
Confidence 11 122345788999999874 345788999999999999999999998543221111111111 1111111 1123
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 005859 637 EASNLGQIALHCTHESPSHRPSIENVMQEL 666 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 666 (673)
.+..+.+++.+||+.+|++||+++++++.|
T Consensus 237 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 237 WSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 457899999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=338.47 Aligned_cols=241 Identities=19% Similarity=0.316 Sum_probs=190.9
Q ss_pred cccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
+.||+|+||+||+|+..+ ++.||||+++.... ....+.+..|.+++... +||||+++++++.. .+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999764 88999999976431 22334566777777754 89999999998854 47899999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF 563 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 563 (673)
++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++...... .
T Consensus 79 ~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~--~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~ 151 (316)
T cd05592 79 NGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK--GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-G 151 (316)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-C
Confidence 99999998863 24588999999999999999999987 89999999999999999999999999997643322 1
Q ss_pred hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHH
Q 005859 564 SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQ 643 (673)
Q Consensus 564 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 643 (673)
......||..|+|||++.+..++.++|||||||++|||++|+.||........... +... ....+...+.++.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~----i~~~--~~~~~~~~~~~~~~ 225 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS----ILND--RPHFPRWISKEAKD 225 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH----HHcC--CCCCCCCCCHHHHH
Confidence 22345689999999999988899999999999999999999999975433221111 1111 11223334567889
Q ss_pred HHHHccccCCCCCCCHH-HHH
Q 005859 644 IALHCTHESPSHRPSIE-NVM 663 (673)
Q Consensus 644 l~~~Cl~~~p~~RPs~~-evl 663 (673)
++.+||+.||++||++. +++
T Consensus 226 ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 226 CLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred HHHHHccCCHHHcCCChHHHH
Confidence 99999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=347.87 Aligned_cols=252 Identities=16% Similarity=0.245 Sum_probs=198.0
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|+..+.||+|+||+||+|+.. +|+.||||++..... ......+.+|++++..++||||+++++++.. .+..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEE
Confidence 46888999999999999999976 489999999976421 1223567889999999999999999999854 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++.+.
T Consensus 79 v~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 79 IMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL--GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred EECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 9999999999999863 24589999999999999999999987 79999999999999999999999999987543
Q ss_pred Ccchh-------------------------------------hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHH
Q 005859 559 DDIVF-------------------------------------SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQI 601 (673)
Q Consensus 559 ~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el 601 (673)
..... ......||+.|+|||++....++.++|||||||++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 21100 00123589999999999988999999999999999999
Q ss_pred HhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 005859 602 LSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPS---IENVMQ 664 (673)
Q Consensus 602 ~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~evl~ 664 (673)
++|..||............. .. ............+..+.+++.+|+. +|.+|++ +.|+++
T Consensus 233 ~~G~~Pf~~~~~~~~~~~i~-~~-~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 233 LVGYPPFCSDNPQETYRKII-NW-KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred hcCCCCCCCCCHHHHHHHHH-cC-CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99999997543322111111 10 0111101111235678899999996 9999997 888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=332.45 Aligned_cols=263 Identities=22% Similarity=0.384 Sum_probs=202.0
Q ss_pred hcCCccccccccCCcceEEEEEEc-----------------CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCcee
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-----------------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 463 (673)
.++|+..+.||+|+||.||++... ++..||+|.+..........+|.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888999999999999998643 234699999876533334568999999999999999999
Q ss_pred EeeEEecCCCCeEEEEEeecCCCChhhhhccccC-------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCC
Q 005859 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAG-------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAE 536 (673)
Q Consensus 464 l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~ 536 (673)
+++++... +..++||||+++|+|.+++..... ....+++.++..++.|++.||+|||+. ||+||||||+
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~--~i~H~dlkp~ 159 (296)
T cd05095 84 LLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL--NFVHRDLATR 159 (296)
T ss_pred EEEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC--CeecccCChh
Confidence 99998554 668999999999999999874321 123578899999999999999999988 8999999999
Q ss_pred CeEecCCCCeeeccccccccccCcchhh-hhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh--CCCCCChhhH
Q 005859 537 KVLIHRRYNPLLSDSGLHKLLADDIVFS-MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS--GKCSITPFTR 613 (673)
Q Consensus 537 NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t--G~~p~~~~~~ 613 (673)
||++++++.+||+|||+++.+....... .....++..|+|||....+.++.++|||||||++|||+| |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 9999999999999999998654332111 112234567999999888889999999999999999998 6677754332
Q ss_pred hhhhccchhhhcCC---cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 614 QAAESSKVEDFIDP---NLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 614 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
...... ....... ......+..++..+.+++.+||+.||++||++.||++.|++
T Consensus 240 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQVIEN-TGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHH-HHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 211111 1111100 00111123345789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.54 Aligned_cols=250 Identities=24% Similarity=0.441 Sum_probs=205.0
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
++|+..+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++.. .+..++|||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e 80 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYIVTE 80 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEEEEE
Confidence 46777889999999999999875 78999999976532 45789999999999999999999999865 467899999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+++++|.+++.... ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++.+||+|||.++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~--~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 81 YMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK--NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC--CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 999999999986432 23689999999999999999999987 79999999999999999999999999998764322
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
.....+..|+|||++..+.++.++||||||+++||+++ |+.||............ ........+...+..
T Consensus 157 ----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 227 (256)
T cd05039 157 ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV-----EKGYRMEAPEGCPPE 227 (256)
T ss_pred ----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-----hcCCCCCCccCCCHH
Confidence 12334567999999988889999999999999999997 99888655332211111 111111223345678
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQELSSI 669 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~~L~~i 669 (673)
+.+++.+||+.+|++||+++|++++|+++
T Consensus 228 ~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 228 VYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=343.31 Aligned_cols=243 Identities=19% Similarity=0.298 Sum_probs=194.4
Q ss_pred cccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecC
Q 005859 408 NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVP 484 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~ 484 (673)
+.||+|+||.||+++.. +|+.||+|++.+... ......+.+|+++++.++||||+++++++.. .+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCCC
Confidence 36899999999999965 589999999976432 2233567889999999999999999998854 478999999999
Q ss_pred CCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhh
Q 005859 485 NGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFS 564 (673)
Q Consensus 485 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 564 (673)
+|+|.+++.. ...+++..+..++.||+.||+|||+.. ||+||||||+|||+++++.+||+|||+++....... .
T Consensus 79 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~-~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 79 GGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC-CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 9999988863 346899999999999999999999722 899999999999999999999999999875432211 1
Q ss_pred hhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHH
Q 005859 565 MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQI 644 (673)
Q Consensus 565 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 644 (673)
.....|+..|+|||++.+..++.++|||||||++|||+||+.||............ .... ..++...+.++.++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i----~~~~--~~~p~~~~~~~~~l 226 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI----LMEE--IRFPRTLSPEAKSL 226 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH----hcCC--CCCCCCCCHHHHHH
Confidence 22346899999999999889999999999999999999999998654322111111 1111 11233345788999
Q ss_pred HHHccccCCCCCC-----CHHHHHH
Q 005859 645 ALHCTHESPSHRP-----SIENVMQ 664 (673)
Q Consensus 645 ~~~Cl~~~p~~RP-----s~~evl~ 664 (673)
+.+||+.||++|+ ++.++++
T Consensus 227 i~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 227 LSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 9999999999996 8998874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=338.55 Aligned_cols=245 Identities=18% Similarity=0.293 Sum_probs=193.0
Q ss_pred CccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHH---hccCCCCceeEeeEEecCCCCeEE
Q 005859 404 FSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKIL---TSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
|.+.+.||+|+||.||+|... +++.||||++.+... ....+.+.+|++++ ++++||||+++++++.. .+..|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEE
Confidence 566789999999999999976 489999999975431 12234566676655 56789999999999854 47899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++|+|..++.. ..+++..+..++.|++.||+|||+. ||+||||||+||++++++.+||+|||+++..
T Consensus 79 lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~--~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN--KIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC--CeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 99999999999988752 3589999999999999999999987 8999999999999999999999999998753
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
..... ......|++.|+|||++.+..++.++|||||||++|||++|+.||........... +.... ..++...
T Consensus 152 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~----i~~~~--~~~p~~~ 224 (324)
T cd05589 152 MGFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS----IVNDE--VRYPRFL 224 (324)
T ss_pred CCCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCC--CCCCCCC
Confidence 32211 12335689999999999988999999999999999999999999875433221111 11111 1123344
Q ss_pred HHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRP-----SIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 664 (673)
+..+.+++.+||+.||++|| ++.++++
T Consensus 225 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 225 SREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 57789999999999999999 4666554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=327.26 Aligned_cols=256 Identities=23% Similarity=0.448 Sum_probs=202.4
Q ss_pred CCccccccccCCcceEEEEEEcC-C---cEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILRD-G---SVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
+|+..+.||+|+||.||+|.... + ..||||.+..........+|..|+.++++++||||+++++++.. .+..++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~l 82 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SRPVMI 82 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC--CCceEE
Confidence 46778899999999999999754 3 36999998765323345689999999999999999999999854 467899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++... ...+++.+++.++.|++.||+|||+. |++||||||+||+++.++.+|++|||+++...
T Consensus 83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~--g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 83 ITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM--NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC--CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 99999999999998743 24589999999999999999999987 89999999999999999999999999987654
Q ss_pred Ccchh-hhhc-c--CCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCC
Q 005859 559 DDIVF-SMLK-A--SAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 559 ~~~~~-~~~~-~--~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (673)
..... .... . ..+..|+|||++.+..++.++|||||||++||+++ |..||........... +... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~-i~~~----~~~~~ 232 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINA-IEQD----YRLPP 232 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHH-HHcC----CcCCC
Confidence 32211 1111 1 12357999999998899999999999999999887 9999865432221111 1111 11112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 634 SVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 634 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
+...+..+.+++.+||+.+|++||++.+|+..|++++
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 269 (269)
T cd05065 233 PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269 (269)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 2345577899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=323.71 Aligned_cols=250 Identities=24% Similarity=0.431 Sum_probs=201.2
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
.+|...+.||+|+||.||++... |..||+|.+... ...+.|.+|+.++++++|+|++++++++... .+..++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEEEEE
Confidence 36778889999999999999875 788999988643 2356799999999999999999999986543 356899999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+++|+|.+++.... ...+++..++.++.|++.||+|||++ ||+||||||+||++++++.+|++|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 81 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC--CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 999999999987432 23588999999999999999999987 89999999999999999999999999987654321
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
.....+..|+|||++....++.++|||||||++|||++ |+.||.......... .+. .......+...+..
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~ 227 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-RVE----KGYKMDAPDGCPPV 227 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHh----cCCCCCCCCCCCHH
Confidence 12234567999999988889999999999999999998 998875432211110 111 11112223345678
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQELSSI 669 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~~L~~i 669 (673)
+.+++.+||+.+|++|||+.++++.|+++
T Consensus 228 ~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 228 VYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=328.21 Aligned_cols=248 Identities=17% Similarity=0.279 Sum_probs=196.9
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
+|+..+.||+|+||.||+|+.. +++.||+|.+..........++.+|++++++++||||+++++++... +..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE--NRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC--CEEEEEEe
Confidence 5777889999999999999864 58899999987553233346789999999999999999999999654 67899999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+++++|..+. .+++..+..++.|++.||+|||+. ||+|+||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 80 FMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL--KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred cCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC--CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 99999997543 367888899999999999999987 89999999999999999999999999997654331
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhc---cchhhhcCCcCCCCCCHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAES---SKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 638 (673)
.....++..|+|||++.+..++.++||||||+++|||+||+.||.......... .......+...........+
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFS 226 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCC
Confidence 223468889999999998889999999999999999999999986532211110 01111111111111112244
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
.++.+++.+||+.+|++||+++|+++.
T Consensus 227 ~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 227 EKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 678999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=322.30 Aligned_cols=252 Identities=19% Similarity=0.289 Sum_probs=202.6
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC----cHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS----DEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
++|...+.||+|+||.||+|... +++.||+|.+....... ....+.+|++++++++||||+++++++... +..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD--ETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC--CeE
Confidence 46888999999999999999965 58999999987543211 224688999999999999999999999554 689
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||++++++.+||+|||+++.
T Consensus 80 ~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 999999999999999863 24588899999999999999999987 899999999999999999999999999876
Q ss_pred ccCcchhhh--hccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 557 LADDIVFSM--LKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 557 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
......... ....++..|+|||++.+..++.++||||||+++|||++|+.||......... ............+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~ 229 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI----FKIATQPTNPQLP 229 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH----HHHhccCCCCCCC
Confidence 543211111 2345678899999999888999999999999999999999998654222111 1111111222334
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
...+..+.+++.+||+.+|.+|||+.++++.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 230 SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 4556789999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=346.23 Aligned_cols=258 Identities=14% Similarity=0.244 Sum_probs=202.1
Q ss_pred HHHHHHhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecC
Q 005859 395 EEVERATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSK 471 (673)
Q Consensus 395 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 471 (673)
.++....++|+..+.||+|+||.||+++... ++.||+|++.+... ......+.+|+++++.++||||+++++++..
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~- 114 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD- 114 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-
Confidence 3444456789999999999999999999764 88999999875321 2234568899999999999999999999854
Q ss_pred CCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccc
Q 005859 472 GRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDS 551 (673)
Q Consensus 472 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~Df 551 (673)
.+..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. ||+||||||+|||+++++.+||+||
T Consensus 115 -~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~--~IvHrDLKp~NILl~~~~~~kL~DF 186 (370)
T cd05621 115 -DKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM--GLIHRDVKPDNMLLDKHGHLKLADF 186 (370)
T ss_pred -CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHEEECCCCCEEEEec
Confidence 4789999999999999999862 2478889999999999999999987 8999999999999999999999999
Q ss_pred cccccccCcchhhhhccCCCCCccCCccccCC----CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCC
Q 005859 552 GLHKLLADDIVFSMLKASAAMGYLAPEYTTTG----RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDP 627 (673)
Q Consensus 552 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 627 (673)
|+++..............||+.|+|||++.+. .++.++||||+||++|||+||+.||......... ..+.+.
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~----~~i~~~ 262 (370)
T cd05621 187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY----SKIMDH 262 (370)
T ss_pred ccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH----HHHHhC
Confidence 99987654332223345689999999998754 3789999999999999999999999754332221 122221
Q ss_pred cCCCCCC--HHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 005859 628 NLEGKFS--VSEASNLGQIALHCTHESPSH--RPSIENVMQE 665 (673)
Q Consensus 628 ~~~~~~~--~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~ 665 (673)
.....++ ...+..+.+++.+|+..++.+ ||++.|+++.
T Consensus 263 ~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 263 KNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111111 234567889999999855543 8899998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=339.16 Aligned_cols=237 Identities=20% Similarity=0.308 Sum_probs=190.7
Q ss_pred cccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
+.||+|+||+||+|+.+. ++.||||++.+... ....+.+..|.+++..+ +||||+++++++.. .+..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999764 88999999976421 23345678899999877 69999999999854 47899999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF 563 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 563 (673)
++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~--~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~- 151 (320)
T cd05590 79 NGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK--GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK- 151 (320)
T ss_pred CCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-
Confidence 99999998863 24588999999999999999999987 899999999999999999999999999875432211
Q ss_pred hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHH
Q 005859 564 SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQ 643 (673)
Q Consensus 564 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 643 (673)
......|++.|+|||++.+..++.++|||||||++|||++|+.||........... +..... ..+...+.++.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~----i~~~~~--~~~~~~~~~~~~ 225 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDEV--VYPTWLSQDAVD 225 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH----HhcCCC--CCCCCCCHHHHH
Confidence 22335689999999999988899999999999999999999999976433222111 111111 122234578899
Q ss_pred HHHHccccCCCCCCCH
Q 005859 644 IALHCTHESPSHRPSI 659 (673)
Q Consensus 644 l~~~Cl~~~p~~RPs~ 659 (673)
++.+||+.||++||++
T Consensus 226 li~~~L~~dP~~R~~~ 241 (320)
T cd05590 226 ILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHcccCHHHCCCC
Confidence 9999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=320.68 Aligned_cols=256 Identities=21% Similarity=0.324 Sum_probs=199.1
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccC-CCCcHHHHHHHHHHHhccCCCCceeEeeEEec---CCCCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTS-CKSDEGEFLKGLKILTSLKHENLASLRGICCS---KGRGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---~~~~~~ 476 (673)
..|...+.||+|+||.|..+..+ +|+.||||++.... ...+.++..+|+++|+.++|+||+.+++++.. ..-+.+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 45555788999999999999966 48999999997432 13445778999999999999999999999865 223578
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
|+|+|+| +-||.+.++ ++..++...+..++.|+++||+|+|+. +|+||||||+|+|++.+...||+|||+|+.
T Consensus 102 YiV~elM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA--nViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA--NVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred EEehhHH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc--cccccccchhheeeccCCCEEeccccceee
Confidence 9999999 569999997 334589999999999999999999997 799999999999999999999999999998
Q ss_pred ccCcc-hhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhh-------------------
Q 005859 557 LADDI-VFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQA------------------- 615 (673)
Q Consensus 557 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~------------------- 615 (673)
..... ...++..+.|.+|+|||++.. ..|+.+.||||.|||+.||++|+.-|.+.....
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 85421 113466778999999998875 569999999999999999999986664321100
Q ss_pred hhccchhhhcC--CcCC-CCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 616 AESSKVEDFID--PNLE-GKF---SVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 616 ~~~~~~~~~~~--~~~~-~~~---~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.........+. +..+ ..+ -....+...+|+.+||..||.+|+|++|.++
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00001111111 0111 111 1234567889999999999999999999885
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=337.85 Aligned_cols=242 Identities=18% Similarity=0.266 Sum_probs=193.3
Q ss_pred CCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCC-CceeEeeEEecCCCCeEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHE-NLASLRGICCSKGRGECFL 478 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~~~l 478 (673)
+|+..+.||+|+||.||+|+..+ ++.||||++.+... ..+.+.+..|++++..++|+ +|+++++++.. .+..|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence 47788999999999999999764 78999999976432 23346788899999999765 57888888754 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||+++++.+||+|||+++...
T Consensus 79 v~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 79 VMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK--GIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred EEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 9999999999998863 24588999999999999999999987 89999999999999999999999999987532
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
.... ......|+..|+|||++.+..++.++|||||||++|||+||+.||........... +... ...++...+
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~----i~~~--~~~~~~~~~ 225 (324)
T cd05587 153 FGGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS----IMEH--NVSYPKSLS 225 (324)
T ss_pred CCCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----HHcC--CCCCCCCCC
Confidence 2111 12235689999999999998999999999999999999999999975433222111 1111 112233445
Q ss_pred HHHHHHHHHccccCCCCCCCH
Q 005859 639 SNLGQIALHCTHESPSHRPSI 659 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~ 659 (673)
.++.+++.+||+.||++|++.
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 226 KEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHHHHHHHHHhhcCHHHcCCC
Confidence 788999999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=330.04 Aligned_cols=259 Identities=19% Similarity=0.375 Sum_probs=203.8
Q ss_pred hcCCccccccccCCcceEEEEEEc------CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRG 474 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 474 (673)
.++|+..+.||+|+||.||++... ++..||+|.+..........+|.+|++++++++||||+++++++... +
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~--~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVG--K 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--C
Confidence 467888999999999999999864 36789999987554333346799999999999999999999998543 6
Q ss_pred eEEEEEeecCCCChhhhhccccC------------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCC
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAG------------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAE 536 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~ 536 (673)
..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~--~i~H~dl~p~ 159 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER--KFVHRDLATR 159 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC--CeecccccHh
Confidence 78999999999999999863211 123578999999999999999999987 8999999999
Q ss_pred CeEecCCCCeeeccccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHh
Q 005859 537 KVLIHRRYNPLLSDSGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQ 614 (673)
Q Consensus 537 NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~ 614 (673)
||++++++.+||+|||+++........ .......+..|+|||.+.+..++.++|||||||++|||++ |..||.+....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999998765432211 1112234567999999988899999999999999999998 87787543322
Q ss_pred hhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 615 AAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
.. ...+.+.... ..+...+.++.+++.+||+.||++|||+.|+++.|++
T Consensus 240 ~~----~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 EV----IYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HH----HHHHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11 1111111111 1233456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=324.03 Aligned_cols=254 Identities=22% Similarity=0.402 Sum_probs=204.8
Q ss_pred hcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
.++|...+.||+|+||.||++...++..+|+|.+.... ...+.|.+|++++++++|+||+++++++.. ...+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v~ 79 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYIIT 79 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEEE
Confidence 45788899999999999999998778889999886542 234679999999999999999999998854 5679999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++|+|.+++... ....+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||.++.....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~--~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 80 EFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR--NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC--CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999999643 234588999999999999999999987 8999999999999999999999999999866543
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
.........++..|+|||++....++.++|||||||++||++| |+.||........... ... ......+...+.
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~~~----~~~~~~~~~~~~ 230 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LER----GYRMPRPENCPE 230 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HhC----CCCCCCcccCCH
Confidence 2222222345677999999988889999999999999999999 8888865432221111 111 111112234457
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
++.+++.+||+.+|++||++.++.+.|+.
T Consensus 231 ~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 231 ELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 89999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=339.11 Aligned_cols=242 Identities=19% Similarity=0.299 Sum_probs=193.4
Q ss_pred cccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
++||+|+||+||+|+... ++.||||++.+... ....+.+..|.+++..+ +||||+++++++.. .+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCC
Confidence 369999999999999764 78999999976432 22335678899999876 89999999999854 47799999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF 563 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 563 (673)
++|+|..++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 151 (321)
T cd05591 79 NGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH--GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV- 151 (321)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-
Confidence 99999988863 24588999999999999999999987 899999999999999999999999999875432221
Q ss_pred hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHH
Q 005859 564 SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQ 643 (673)
Q Consensus 564 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 643 (673)
......|+..|+|||++.+..++.++|||||||++|||+||+.||........... +..... ..+...+.++.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~----i~~~~~--~~p~~~~~~~~~ 225 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES----ILHDDV--LYPVWLSKEAVS 225 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH----HHcCCC--CCCCCCCHHHHH
Confidence 12334689999999999988999999999999999999999999976443222211 111111 122234567899
Q ss_pred HHHHccccCCCCCC-------CHHHHHH
Q 005859 644 IALHCTHESPSHRP-------SIENVMQ 664 (673)
Q Consensus 644 l~~~Cl~~~p~~RP-------s~~evl~ 664 (673)
++.+||+.||++|| ++.++++
T Consensus 226 ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 226 ILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 99999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=321.38 Aligned_cols=251 Identities=22% Similarity=0.352 Sum_probs=204.1
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+|+..+.||+|+||.||+|+.+ +++.|++|.+..... .....++.+|++++++++||||+++++++.. .+..++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD--KGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc--CCEEEEEE
Confidence 4677889999999999999976 489999999875432 3345678999999999999999999999854 47889999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++... ....+++..+..++.|++.||.|||+. ||+||||||+||++++++.+||+|||+++.....
T Consensus 79 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~--~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 79 EYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK--KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred EeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 999999999999743 234689999999999999999999987 8999999999999999999999999998876543
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
... .....++..|+|||++.+..++.++|||||||++|||+||+.||............... .....+...+..
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 228 (256)
T cd08529 155 TNF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG-----VFPPVSQMYSQQ 228 (256)
T ss_pred cch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----CCCCCccccCHH
Confidence 221 22345788899999999888999999999999999999999998654322211111111 111222345678
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
+.+++.+||+.+|++||++.++++.
T Consensus 229 ~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 229 LAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHhhC
Confidence 9999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=344.78 Aligned_cols=255 Identities=18% Similarity=0.252 Sum_probs=196.2
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC---CeEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGR---GECF 477 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---~~~~ 477 (673)
+|+..+.||+|+||.||++... +|+.||||++..... ....+.+.+|+++++.++||||+++++++..... ...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999965 589999999865421 1234578899999999999999999999865421 2689
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+. ++|.+++. ....+++..+..++.||+.||+|||+. ||+||||||+|||+++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA--GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 68888775 234689999999999999999999987 8999999999999999999999999999865
Q ss_pred cCcchhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch---------------
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV--------------- 621 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~--------------- 621 (673)
............++..|+|||++.+. .++.++|||||||++|||++|+.||.............
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 44332223344678899999998874 47999999999999999999999986532211100000
Q ss_pred ---hh-hcC-CcCCC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 622 ---ED-FID-PNLEG------KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 622 ---~~-~~~-~~~~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.. +.. +.... ......+.++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00 000 00000 111223567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=325.92 Aligned_cols=257 Identities=23% Similarity=0.403 Sum_probs=205.5
Q ss_pred cCCccccccccCCcceEEEEEEcC----CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD----GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
++|...+.||+|+||.||+|...+ ...||||...........+.+.+|+.++++++||||+++++++.. +..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPVW 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCcE
Confidence 457778899999999999998654 247999988655433345689999999999999999999998853 4568
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||+++..
T Consensus 83 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~--~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 83 IVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK--RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccccChheEEEecCCCeEEccCceeeec
Confidence 999999999999999632 23589999999999999999999987 7999999999999999999999999999876
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (673)
............++..|+|||.+....++.++||||||+++||+++ |..||.......... .+...... ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~-~~~~~~~~----~~~~~ 232 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG-RIENGERL----PMPPN 232 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHcCCcC----CCCCC
Confidence 5543222223334567999999988889999999999999999986 999986654322111 11111111 12334
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 637 EASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.+..+.+++.+||..+|++|||+.++++.|+++..
T Consensus 233 ~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 233 CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 55789999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=329.31 Aligned_cols=262 Identities=21% Similarity=0.378 Sum_probs=206.8
Q ss_pred CCccccccccCCcceEEEEEEc-----CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-----DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
+|...+.||+|+||.||++++. ++..||||.+.........++|.+|++++++++||||+++++++........+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4666788999999999999864 36799999997654222356899999999999999999999998765556789
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||.+...
T Consensus 85 lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ--RYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 999999999999999743 23589999999999999999999987 8999999999999999999999999999876
Q ss_pred cCcchh--hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhh----------ccchhhhc
Q 005859 558 ADDIVF--SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE----------SSKVEDFI 625 (673)
Q Consensus 558 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~----------~~~~~~~~ 625 (673)
...... ......++..|+|||......++.++||||||+++|||+||+.|+......... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 532211 111223456799999998888999999999999999999999887543221100 01111111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 005859 626 DPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSI 669 (673)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i 669 (673)
........+..++.++.+++.+||+.+|++||||.||+++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 12222222334557899999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=318.80 Aligned_cols=249 Identities=20% Similarity=0.321 Sum_probs=207.7
Q ss_pred CCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 403 CFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
-|.+..+||+|+||.|||+.++. |++||||.+... .+.+++.+|+.+|++.+.|++|++||.|... ...++|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~--sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKH--SDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccC--CceEeehh
Confidence 36667899999999999999875 999999988653 5778999999999999999999999988543 56899999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
||..|+..+.++. .++++++.++..+++..++||+|||..+ -||||||+.|||++.+|.+|++|||+|..+.+.-
T Consensus 109 YCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 109 YCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 9999999999974 3567999999999999999999999963 7999999999999999999999999998776543
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 641 (673)
. ......||+.|||||++..-.|+.++||||+|++..||..|+.||.+...... ++.---.|...-.-++.-+.++
T Consensus 184 A-KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---IFMIPT~PPPTF~KPE~WS~~F 259 (502)
T KOG0574|consen 184 A-KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---IFMIPTKPPPTFKKPEEWSSEF 259 (502)
T ss_pred H-hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---eEeccCCCCCCCCChHhhhhHH
Confidence 2 34457799999999999999999999999999999999999999876433211 1111111121122345567889
Q ss_pred HHHHHHccccCCCCCCCHHHHHHH
Q 005859 642 GQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 642 ~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
.+++.+|+-..|++|-|+.++++.
T Consensus 260 ~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 260 NDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HHHHHHHhcCCHHHHHHHHHHhhh
Confidence 999999999999999999988753
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.51 Aligned_cols=261 Identities=20% Similarity=0.385 Sum_probs=205.2
Q ss_pred cCCccccccccCCcceEEEEEEcC--------CcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCC
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD--------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKG 472 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 472 (673)
.+|.+.+.||+|+||.||+++... +..||+|.+.........+++.+|+++++++ +||||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD- 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC-
Confidence 468888999999999999997421 2368999887543233446899999999999 899999999998543
Q ss_pred CCeEEEEEeecCCCChhhhhccccC------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEe
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAG------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI 540 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl 540 (673)
+..+++|||+++|+|.+++..... ....++|.+++.++.|++.||+|||+. ||+||||||+||++
T Consensus 91 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~--givH~dlkp~Nill 167 (334)
T cd05100 91 -GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ--KCIHRDLAARNVLV 167 (334)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC--CeeccccccceEEE
Confidence 678999999999999999874321 234589999999999999999999987 89999999999999
Q ss_pred cCCCCeeeccccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhc
Q 005859 541 HRRYNPLLSDSGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAES 618 (673)
Q Consensus 541 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~ 618 (673)
++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||..........
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999999866442211 1122234567999999998889999999999999999998 888876543221111
Q ss_pred cchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 619 SKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.+ ........+...+.++.+++.+||+.+|++||++.|+++.|+++..
T Consensus 248 ----~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 248 ----LL-KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred ----HH-HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11 1111112233445789999999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=335.34 Aligned_cols=241 Identities=18% Similarity=0.325 Sum_probs=191.4
Q ss_pred cccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
+.||+|+||+||+|+..+ ++.||||++..... ......+..|..++... +||||+++++++.. .+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence 368999999999999765 78999999976431 22345677788888764 99999999999855 47899999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF 563 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 563 (673)
++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~--~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05619 79 NGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK--GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA- 151 (316)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC--CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-
Confidence 99999999863 24588999999999999999999987 899999999999999999999999999875322111
Q ss_pred hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHH
Q 005859 564 SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQ 643 (673)
Q Consensus 564 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 643 (673)
......||..|+|||++.+..++.++|||||||++|||++|+.||............ . ...+ .++...+.++.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i-~-~~~~----~~~~~~~~~~~~ 225 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI-R-MDNP----CYPRWLTREAKD 225 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH-H-hCCC----CCCccCCHHHHH
Confidence 122356899999999999888999999999999999999999998654332211111 0 1111 122234567889
Q ss_pred HHHHccccCCCCCCCHH-HHH
Q 005859 644 IALHCTHESPSHRPSIE-NVM 663 (673)
Q Consensus 644 l~~~Cl~~~p~~RPs~~-evl 663 (673)
++.+||+.||++||++. ++.
T Consensus 226 li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 226 ILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred HHHHHhccCHhhcCCChHHHH
Confidence 99999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=360.33 Aligned_cols=263 Identities=21% Similarity=0.271 Sum_probs=204.9
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCC--CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCK--SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|.+.+.||+|+||.||+|+... |+.||||++...... ...++|.+|++++++++||||+++++++.+ .+..++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEEEE
Confidence 478889999999999999999764 899999999764322 224579999999999999999999999855 478899
Q ss_pred EEeecCCCChhhhhccccC-------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccc
Q 005859 479 IYDFVPNGNLLQHLDLEAG-------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDS 551 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~Df 551 (673)
||||+++|+|.+++..... ....+++..+++++.||++||+|||+. ||+||||||+||+++.++.+||+||
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~--GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK--GVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC--CccccCCchheEEEcCCCCEEEEec
Confidence 9999999999999863211 123467788899999999999999987 8999999999999999999999999
Q ss_pred cccccccCcc-----------------hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHh
Q 005859 552 GLHKLLADDI-----------------VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQ 614 (673)
Q Consensus 552 Gla~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~ 614 (673)
|+++...... ........||+.|||||++.+..++.++|||||||++|||+||+.||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9998662110 00111246899999999999999999999999999999999999998653221
Q ss_pred hhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhhc
Q 005859 615 AAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRP-SIENVMQELSSIIG 671 (673)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~evl~~L~~i~~ 671 (673)
..... .....+. ........+..+.+++.+|++.||++|| +++++++.|+..++
T Consensus 238 ki~~~--~~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 238 KISYR--DVILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhh--hhccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11100 1111111 0011123456788999999999999995 77888888887765
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=337.78 Aligned_cols=242 Identities=19% Similarity=0.284 Sum_probs=194.3
Q ss_pred CCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~l 478 (673)
+|...+.||+|+||.||+|+... ++.||||++.+... ......+..|.+++..+ +|++|+++++++.. .+..++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 47788999999999999999764 78999999976432 22234577788888877 68999999998854 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||+++++.+||+|||+++...
T Consensus 79 v~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 79 VMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred EEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 9999999999998863 24588999999999999999999987 89999999999999999999999999987543
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
.... ......|++.|+|||++.+..++.++|||||||++|||+||+.||.......... .+.... ..++...+
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~----~i~~~~--~~~p~~~s 225 (323)
T cd05616 153 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ----SIMEHN--VAYPKSMS 225 (323)
T ss_pred CCCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHH----HHHhCC--CCCCCcCC
Confidence 2211 2234568999999999999999999999999999999999999997643322211 111111 12333456
Q ss_pred HHHHHHHHHccccCCCCCCCH
Q 005859 639 SNLGQIALHCTHESPSHRPSI 659 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~ 659 (673)
.++.+++.+|++.||++|++.
T Consensus 226 ~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 226 KEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHHHHHHHcccCHHhcCCC
Confidence 788999999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=336.22 Aligned_cols=241 Identities=20% Similarity=0.293 Sum_probs=191.5
Q ss_pred cccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
+.||+|+||.||+|+.+. |+.||+|+++.... ......+..|.+++... +||||+++++++.. .+..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 369999999999999764 88999999976432 22345677788888765 89999999999854 47899999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF 563 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 563 (673)
++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||+++++.+||+|||+++...... .
T Consensus 79 ~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 151 (316)
T cd05620 79 NGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK--GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-N 151 (316)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-C
Confidence 99999998863 24588999999999999999999987 89999999999999999999999999987532211 1
Q ss_pred hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHH
Q 005859 564 SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQ 643 (673)
Q Consensus 564 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 643 (673)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.............. ..+ ..+...+.++.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~--~~~----~~~~~~~~~~~~ 225 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV--DTP----HYPRWITKESKD 225 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCC----CCCCCCCHHHHH
Confidence 22345689999999999998999999999999999999999999975433221111110 111 122234567899
Q ss_pred HHHHccccCCCCCCCHH-HHH
Q 005859 644 IALHCTHESPSHRPSIE-NVM 663 (673)
Q Consensus 644 l~~~Cl~~~p~~RPs~~-evl 663 (673)
++.+||+.||++||++. +++
T Consensus 226 li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 226 ILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHccCCHHHcCCChHHHH
Confidence 99999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=338.84 Aligned_cols=253 Identities=18% Similarity=0.293 Sum_probs=196.0
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC----C
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGR----G 474 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~ 474 (673)
.++|...+.||+|+||.||+++.. +|+.||||++..... ......+.+|+.+++.++||||+++++++..... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 468999999999999999999975 489999999875432 2234578899999999999999999998854321 3
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLH 554 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla 554 (673)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~--~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 57999999964 6766664 2378888999999999999999987 8999999999999999999999999999
Q ss_pred ccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc--------------
Q 005859 555 KLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK-------------- 620 (673)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~-------------- 620 (673)
+...... ......+|..|+|||++.+..++.++|||||||++|||+||+.||............
T Consensus 171 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 171 RTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 7654322 223356789999999999989999999999999999999999999643221110000
Q ss_pred ----hhhhcC--CcCCC----------------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 621 ----VEDFID--PNLEG----------------KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 621 ----~~~~~~--~~~~~----------------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...... +.... ......+.++.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 00000 001112467899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=321.11 Aligned_cols=252 Identities=21% Similarity=0.419 Sum_probs=201.1
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
.+|...+.||+|+||.||++...+++.+|+|.+.... ....+|.+|++++++++||||+++++++.. ....++|||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE--RSPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEcc--CCceEEEEE
Confidence 3567778999999999999998778899999886543 345679999999999999999999999854 367899999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+++++|.+++... ...++++.+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~--~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 80 FMEHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS--NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred cCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC--CccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 99999999998632 23588999999999999999999987 79999999999999999999999999987654432
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
........++..|+|||++.++.++.++||||||+++|||++ |+.||........... ..+.... ..+...+..
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~ 229 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET-INAGFRL----YKPRLASQS 229 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH-HhCCCCC----CCCCCCCHH
Confidence 211222234568999999998889999999999999999998 8988864332211111 1111111 111223578
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQELS 667 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~~L~ 667 (673)
+.+++.+||+.+|++|||+.|+++.|.
T Consensus 230 ~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 230 VYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=326.47 Aligned_cols=258 Identities=17% Similarity=0.301 Sum_probs=204.3
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|+..+.||.|++|.||++... +++.||+|.+..........++.+|++++++++||||++++++|.....+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999976 48899999987654333456799999999999999999999999776666789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++.........+++..+..++.|++.||+|||+. |++|+||+|+||++++++.++|+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~--~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR--KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 99999999998764333345688999999999999999999987 8999999999999999999999999998765432
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHh----hhhccchhhhcCCcCCCCCC--
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQ----AAESSKVEDFIDPNLEGKFS-- 634 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~-- 634 (673)
. .....++..|+|||.+.+..++.++||||+||++|||+||+.||...... ............+.+.....
T Consensus 159 ~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd06621 159 L---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG 235 (287)
T ss_pred c---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCC
Confidence 1 12334678899999999889999999999999999999999998654110 00000011111111111111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...+..+.+++.+||+.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 224568899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=321.56 Aligned_cols=249 Identities=24% Similarity=0.383 Sum_probs=199.4
Q ss_pred cccccCCcceEEEEEEcC--C--cEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKSSFSATYKGILRD--G--SVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
+.||+|+||.||+|.+.+ + ..||||.+.........+.+.+|++++++++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEec
Confidence 368999999999999653 3 36999999876533345689999999999999999999999854 6789999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF 563 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 563 (673)
++|+|.+++..... ..++|..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||+++........
T Consensus 78 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~--~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 78 PLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK--RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC--CccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99999999974321 4689999999999999999999987 8999999999999999999999999999876542211
Q ss_pred --hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 564 --SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 564 --~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
......++..|+|||++.+..++.++|||||||++|||+| |+.||.............. .......+...+..
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 229 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK----EGERLERPEACPQD 229 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh----cCCcCCCCccCCHH
Confidence 1123446778999999998899999999999999999999 9999854322211111110 11111123345678
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQELS 667 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~~L~ 667 (673)
+.+++.+||+.+|++||++.++++.|.
T Consensus 230 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 230 IYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=335.36 Aligned_cols=242 Identities=19% Similarity=0.307 Sum_probs=193.8
Q ss_pred cccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
+.||+|+||+||+|+... ++.||||++.+... ......+.+|.+++..+ +||||+++++++.. .+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 369999999999999764 78999999976421 22345678899999888 79999999999854 47899999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF 563 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 563 (673)
++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||++++++.+||+|||+++.......
T Consensus 79 ~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~--~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 151 (318)
T cd05570 79 NGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER--GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV- 151 (318)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC--CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-
Confidence 99999988863 24689999999999999999999987 899999999999999999999999999875322111
Q ss_pred hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHH
Q 005859 564 SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQ 643 (673)
Q Consensus 564 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 643 (673)
......|+..|+|||++.+..++.++|||||||++|||+||+.||.......... .+.... ...+...+..+.+
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~----~i~~~~--~~~~~~~~~~~~~ 225 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ----SILEDE--VRYPRWLSKEAKS 225 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH----HHHcCC--CCCCCcCCHHHHH
Confidence 1223458899999999999999999999999999999999999996543222111 111111 1123334578899
Q ss_pred HHHHccccCCCCCCCH-----HHHHH
Q 005859 644 IALHCTHESPSHRPSI-----ENVMQ 664 (673)
Q Consensus 644 l~~~Cl~~~p~~RPs~-----~evl~ 664 (673)
++.+||+.||++||++ .++++
T Consensus 226 li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 226 ILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 9999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=330.56 Aligned_cols=254 Identities=19% Similarity=0.301 Sum_probs=198.9
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|+..+.||+|+||.||++... ++..||+|.+..........++.+|++++++++||||+++++++.. .+..++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEEe
Confidence 36888999999999999999976 4888999988754322234568899999999999999999999965 47899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++... ..+++..+..++.|+++||.|||+.. +|+||||||+||++++++.+||+|||++......
T Consensus 79 ey~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 79 EHMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred eccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC-CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999999999632 45889999999999999999999732 7999999999999999999999999998765432
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhc---cchh---------------
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAES---SKVE--------------- 622 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~---~~~~--------------- 622 (673)
. .....++..|+|||.+.+..++.++|||||||++|||+||+.||.......... ....
T Consensus 154 ~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 M---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred c---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 1 123467889999999988889999999999999999999999985432111000 0000
Q ss_pred --------------hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 623 --------------DFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 623 --------------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
...............+.++.+++.+||+.+|++|||+.+|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000011235678999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=315.96 Aligned_cols=260 Identities=18% Similarity=0.290 Sum_probs=198.6
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCC-ceeEeeEEecCCC----C
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHEN-LASLRGICCSKGR----G 474 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~----~ 474 (673)
..|...++||+|+||+||+|+.+ +|+.||+|+++-.... .-.....+|+.++++++|+| ||.+++++...+. .
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34555678999999999999965 5899999999876432 22356789999999999999 9999999976531 3
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLH 554 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla 554 (673)
..++|+||++ -+|..+++........++...++.++.|+++||+|||++ +|+||||||.||||+++|.+||+|||+|
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~--~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH--GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC--CeecccCCcceEEECCCCcEeeeccchH
Confidence 7889999995 599999985432213467788999999999999999998 7999999999999999999999999999
Q ss_pred ccccCcchhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhc--------
Q 005859 555 KLLADDIVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFI-------- 625 (673)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~-------- 625 (673)
+...-.. ...+..++|..|+|||++.+. .|+...||||+||++.||++++.-|.+..+......+..-.-
T Consensus 168 ra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 168 RAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 9665222 124556789999999999876 599999999999999999998866655433211111100000
Q ss_pred ------C-----CcCC--CCCCHHH---HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 626 ------D-----PNLE--GKFSVSE---ASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 626 ------~-----~~~~--~~~~~~~---~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
+ +... ....... .....+++.+|++.+|.+|.|++.++++
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 0000 0001111 2478899999999999999999999875
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.87 Aligned_cols=266 Identities=15% Similarity=0.282 Sum_probs=207.3
Q ss_pred cCHHHHHHHhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEe
Q 005859 392 FNLEEVERATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICC 469 (673)
Q Consensus 392 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 469 (673)
+.++++....++|+..+.||+|+||.||++.... ++.+|+|++.... ....++.+|+++++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 4456677788899999999999999999999754 8899999876432 2345788999999999 7999999999885
Q ss_pred cC---CCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCe
Q 005859 470 SK---GRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNP 546 (673)
Q Consensus 470 ~~---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~ 546 (673)
.. ..+..++||||+++++|.++++........+++..+..++.|++.||.|||+. +|+||||||+||++++++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN--KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC--CccccCCCHHhEEECCCCCE
Confidence 32 23568999999999999998764333345688999999999999999999987 79999999999999999999
Q ss_pred eeccccccccccCcchhhhhccCCCCCccCCccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch
Q 005859 547 LLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT-----GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV 621 (673)
Q Consensus 547 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~ 621 (673)
||+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.||........... .
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~-~ 241 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK-I 241 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh-c
Confidence 9999999986644321 1223468889999998753 4478999999999999999999999865432211111 1
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 622 EDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
.....+.. ..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 242 PRNPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cccCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 11111111 1122234679999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=338.08 Aligned_cols=245 Identities=17% Similarity=0.294 Sum_probs=192.1
Q ss_pred cccccCCcceEEEEEEc-CCcEEEEEEecccCCC--CcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK--SDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
+.||+|+||.||+++.. +++.||+|++++.... .....+.+|..++.++ +||||+++++++.. .+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 36899999999999976 4889999999864321 2235678899999998 79999999999854 47899999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF 563 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 563 (673)
++|+|.+++.. ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~- 151 (329)
T cd05588 79 SGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER--GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD- 151 (329)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHeEECCCCCEEECcCccccccccCCC-
Confidence 99999988863 24689999999999999999999987 899999999999999999999999999875322111
Q ss_pred hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhh-----hhccchhhhcCCcCCCCCCHHHH
Q 005859 564 SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQA-----AESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 564 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
......|+..|+|||++.+..++.++|||||||++|||+||+.||....... ........+..... ..+...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~ 229 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--RIPRSLS 229 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC--CCCCCCC
Confidence 2234568999999999999899999999999999999999999985321110 00001111111111 2233445
Q ss_pred HHHHHHHHHccccCCCCCCC------HHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPS------IENVM 663 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs------~~evl 663 (673)
.++.+++.+||+.||++||+ +.+++
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 77899999999999999997 56665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=362.78 Aligned_cols=259 Identities=16% Similarity=0.285 Sum_probs=203.1
Q ss_pred HHhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 399 RATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 399 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
...++|.+.+.||+|+||+||+|+... +..||+|.+..... ......|..|+.++++++|||||+++++|........
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 345689999999999999999999765 78899999875432 2234678999999999999999999999877666789
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCC-----CCcccCCcCCCCeEecCC--------
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR-----PGLVHPNLSAEKVLIHRR-------- 543 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~ivHrDlk~~NILl~~~-------- 543 (673)
||||||+++|+|.++|.........+++..++.|+.||+.||+|||+.. .+||||||||+||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999999743333356999999999999999999999842 259999999999999642
Q ss_pred ---------CCeeeccccccccccCcchhhhhccCCCCCccCCccccC--CCCCcchhHHHHHHHHHHHHhCCCCCChhh
Q 005859 544 ---------YNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT--GRFTEKSDIYAFGMIVFQILSGKCSITPFT 612 (673)
Q Consensus 544 ---------~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSfGvvl~el~tG~~p~~~~~ 612 (673)
..+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3489999999987644321 223468999999999864 458999999999999999999999986532
Q ss_pred HhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 613 RQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
........+... +.+. ....+.++.+||..||+.+|.+||++.|+++
T Consensus 248 ~~~qli~~lk~~--p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 NFSQLISELKRG--PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cHHHHHHHHhcC--CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 221111111111 1111 1123577899999999999999999999983
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=341.27 Aligned_cols=239 Identities=21% Similarity=0.319 Sum_probs=192.7
Q ss_pred cccccCCcceEEEEEE----cCCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEee
Q 005859 408 NLLGKSSFSATYKGIL----RDGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDF 482 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~ 482 (673)
+.||+|+||.||+++. .+|+.||+|++...... .+...+.+|++++++++||||+++++++.. .+..|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEEcC
Confidence 4699999999999875 24889999999764322 234567889999999999999999999854 4789999999
Q ss_pred cCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcch
Q 005859 483 VPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV 562 (673)
Q Consensus 483 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 562 (673)
+++|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+||++++++.+||+|||+++.......
T Consensus 80 ~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 80 LRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 999999999863 34589999999999999999999987 899999999999999999999999999876543311
Q ss_pred hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHH
Q 005859 563 FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLG 642 (673)
Q Consensus 563 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 642 (673)
......|+..|+|||.+.+..++.++|||||||++|||+||+.||.......... .+.... ...+...+..+.
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~----~i~~~~--~~~p~~~~~~~~ 226 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT----MILKAK--LGMPQFLSPEAQ 226 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH----HHHcCC--CCCCCCCCHHHH
Confidence 1223568899999999998889999999999999999999999987543322111 111111 122334457889
Q ss_pred HHHHHccccCCCCCCCHHH
Q 005859 643 QIALHCTHESPSHRPSIEN 661 (673)
Q Consensus 643 ~l~~~Cl~~~p~~RPs~~e 661 (673)
+++.+||+.||++||++.+
T Consensus 227 ~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 227 SLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHhhcCHhHcCCCCC
Confidence 9999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=337.99 Aligned_cols=241 Identities=17% Similarity=0.278 Sum_probs=189.1
Q ss_pred cccccCCcceEEEEEEcC-CcEEEEEEecccCCC--CcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCK--SDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
+.||+|+||+||+|+... ++.||+|++.+.... .....+.+|+.++.++ +||||+++++++.. .+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence 369999999999999764 889999999865322 2234577899988877 89999999999855 47899999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF 563 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 563 (673)
++|+|..++.. ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~- 151 (329)
T cd05618 79 NGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD- 151 (329)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-
Confidence 99999988863 24589999999999999999999987 899999999999999999999999999875322111
Q ss_pred hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhh----cc-chhhhcCCcCCCCCCHHHH
Q 005859 564 SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE----SS-KVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 564 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~~~ 638 (673)
......||..|+|||++.+..++.++|||||||++|||+||+.||......... .. ....+.... ...+...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~~ 229 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLS 229 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--CCCCCCCC
Confidence 123356899999999999989999999999999999999999998532111000 00 011111111 12334456
Q ss_pred HHHHHHHHHccccCCCCCCCH
Q 005859 639 SNLGQIALHCTHESPSHRPSI 659 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~ 659 (673)
..+.+++.+||+.||++||++
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCC
Confidence 788999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=323.35 Aligned_cols=259 Identities=22% Similarity=0.397 Sum_probs=203.6
Q ss_pred cCCccccccccCCcceEEEEEEcC------CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
++|+....||+|+||+||+|+.+. .+.||+|.+.........+.+.+|++++++++||||+++++++.+ .+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE--AEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC--CCc
Confidence 568888999999999999999642 467999988654322234679999999999999999999999854 467
Q ss_pred EEEEEeecCCCChhhhhccccCC-----ccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGS-----EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSD 550 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~D 550 (673)
.++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~--~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA--RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc--CcccCcCccceEEEeCCCcEEEcc
Confidence 89999999999999999743311 12689999999999999999999987 799999999999999999999999
Q ss_pred ccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcC
Q 005859 551 SGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNL 629 (673)
Q Consensus 551 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 629 (673)
||+++..............++..|+|||.+.+..++.++||||||+++|||++ |..||......... ........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~----~~~~~~~~ 236 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL----NRLQAGKL 236 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHH----HHHHcCCc
Confidence 99987554332222333445677999999988889999999999999999999 77787543222111 11111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 630 EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 630 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
....+...+..+.+++.+||+.+|++||++.|+++.|.+
T Consensus 237 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 237 ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 111223455789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=345.54 Aligned_cols=253 Identities=17% Similarity=0.222 Sum_probs=195.0
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|...+.||+|+||+||+++.. +++.||||++.+... ....+.+.+|++++++++||||+++++++.+ .+..|+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeEE
Confidence 46888899999999999999865 589999999865421 1223568889999999999999999999854 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 79 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~--givHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 79 IMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL--GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 9999999999999863 34588899999999999999999987 89999999999999999999999999986332
Q ss_pred Ccch-------------h---------------------------------hhhccCCCCCccCCccccCCCCCcchhHH
Q 005859 559 DDIV-------------F---------------------------------SMLKASAAMGYLAPEYTTTGRFTEKSDIY 592 (673)
Q Consensus 559 ~~~~-------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVw 592 (673)
.... . ......||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 1000 0 00023589999999999988899999999
Q ss_pred HHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 005859 593 AFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHR---PSIENVMQE 665 (673)
Q Consensus 593 SfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Ps~~evl~~ 665 (673)
||||++|||+||+.||............. ... ..+.-......+.++.+++.+|+. +|.+| +++.|+++.
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~~~~i~-~~~-~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSHETYRKII-NWR-ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHHHHHHHHH-ccC-CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999999999996533221111111 100 011100111235678899999997 67665 599998753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=325.96 Aligned_cols=257 Identities=21% Similarity=0.374 Sum_probs=201.4
Q ss_pred cCCccccccccCCcceEEEEEEc------CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 402 QCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
.+|...++||+|+||.||++... ++..||+|.+.... ......|.+|++++++++|+||+++++++... +.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEG--RP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC--Cc
Confidence 45677889999999999999742 35689999886543 33456899999999999999999999998554 66
Q ss_pred EEEEEeecCCCChhhhhccccC-----------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAG-----------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY 544 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~ 544 (673)
.++||||+++|+|.+++..... ....+++..++.++.|++.|++|||+. ||+||||||+||++++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~--~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL--HFVHRDLATRNCLVGQGL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC--CeecccccHhhEEEcCCC
Confidence 8999999999999999864321 113589999999999999999999987 899999999999999999
Q ss_pred CeeeccccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchh
Q 005859 545 NPLLSDSGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVE 622 (673)
Q Consensus 545 ~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~ 622 (673)
.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||......... .
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~----~ 235 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI----E 235 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH----H
Confidence 9999999998755432211 1112234678999999998889999999999999999999 88888554322111 1
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 623 DFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
.... ......+...+..+.+++.+||+.||++||++.||++.|++
T Consensus 236 ~~~~-~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 CITQ-GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHc-CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111 11112223455778999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=326.67 Aligned_cols=249 Identities=13% Similarity=0.240 Sum_probs=201.4
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
.+|...+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++.+... ...++||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~--~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVG--DELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC-cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC--CEEEEee
Confidence 46888889999999999999964 58899999987654 23456788999999999999999999998654 6899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++.. ..+++.++..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.....
T Consensus 97 e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~--gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 97 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred cccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 99999999999852 3478999999999999999999987 8999999999999999999999999998765432
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
.. ......++..|+|||.+.+..++.++|||||||++|||++|+.||............ ..........+...+..
T Consensus 170 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 245 (296)
T cd06654 170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAI 245 (296)
T ss_pred cc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH---hcCCCCCCCCccccCHH
Confidence 21 122345788999999999888999999999999999999999998654322111111 11111111123345577
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.+++.+||..+|++||++.|+++
T Consensus 246 l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 246 FRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHHHHHHHCcCCcccCcCHHHHhh
Confidence 899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=327.68 Aligned_cols=266 Identities=19% Similarity=0.318 Sum_probs=208.9
Q ss_pred ccCHHHHHHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEE
Q 005859 391 MFNLEEVERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGIC 468 (673)
Q Consensus 391 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~ 468 (673)
.++++++..++++|...+.||+|+||.||++... +++.+|+|++.... ....++.+|+.+++++ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 4566777888999999999999999999999975 58899999986542 2345788899999999 899999999998
Q ss_pred ecCC---CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC
Q 005859 469 CSKG---RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN 545 (673)
Q Consensus 469 ~~~~---~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~ 545 (673)
...+ .+..++||||+++|+|.++++........+++..++.++.|++.||+|||+. ||+||||||+||++++++.
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN--RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHEEEcCCCC
Confidence 6542 2468999999999999998864333345689999999999999999999987 8999999999999999999
Q ss_pred eeeccccccccccCcchhhhhccCCCCCccCCccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc
Q 005859 546 PLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG-----RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK 620 (673)
Q Consensus 546 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~ 620 (673)
+||+|||+++....... ......++..|+|||.+... .++.++|||||||++|||++|+.||...........
T Consensus 167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~- 244 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK- 244 (291)
T ss_pred EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH-
Confidence 99999999886543221 11234578889999998643 268999999999999999999999865432211111
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 621 VEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
......+.+ ..+......+.+++.+||+.+|++||++.|+++
T Consensus 245 ~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 245 IPRNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HhcCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 110001111 112234467999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=342.60 Aligned_cols=261 Identities=13% Similarity=0.208 Sum_probs=202.5
Q ss_pred HHHHHHHhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEec
Q 005859 394 LEEVERATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCS 470 (673)
Q Consensus 394 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 470 (673)
+.++....++|...+.||+|+||.||+++... ++.||+|++.+... ......+.+|+++++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 44555666899999999999999999999764 88999999865321 2233567899999999999999999999854
Q ss_pred CCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecc
Q 005859 471 KGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSD 550 (673)
Q Consensus 471 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~D 550 (673)
.+..++||||+++|+|.+++.. ..++...+..++.||+.||+|||+. ||+||||||+|||+++++.+||+|
T Consensus 115 --~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDLkp~NIll~~~~~ikL~D 185 (371)
T cd05622 115 --DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLAD 185 (371)
T ss_pred --CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC--CEEeCCCCHHHEEECCCCCEEEEe
Confidence 4789999999999999999862 2478888899999999999999987 899999999999999999999999
Q ss_pred ccccccccCcchhhhhccCCCCCccCCccccCC----CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcC
Q 005859 551 SGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG----RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFID 626 (673)
Q Consensus 551 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~ 626 (673)
||+++..............||+.|+|||++... .++.++|||||||++|||++|+.||................
T Consensus 186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-- 263 (371)
T cd05622 186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK-- 263 (371)
T ss_pred CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--
Confidence 999987654332233345689999999998753 37899999999999999999999997543322211111110
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 005859 627 PNLEGKFSVSEASNLGQIALHCTHESPSH--RPSIENVMQE 665 (673)
Q Consensus 627 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~ 665 (673)
....-......+..+.+++.+|+..++.+ ||++.|+++.
T Consensus 264 ~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 264 NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 01111111234577899999999844433 7899988764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.60 Aligned_cols=254 Identities=18% Similarity=0.305 Sum_probs=196.4
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|...+.||+|+||.||+|+.+ +++.||+|++...........+.+|++++++++||||+++++++.. .+..++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT--DKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee--CCeEEEEE
Confidence 46888899999999999999976 4789999999765433444578899999999999999999999855 46789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++ +|.+++... ...+++..+..++.|++.||+|||++ ||+||||||+||++++++.+||+|||+++.....
T Consensus 84 e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~--~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 84 EYLDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR--KVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred eCCCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 99974 888887532 24578999999999999999999987 8999999999999999999999999999765432
Q ss_pred chhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch-----------h------
Q 005859 561 IVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV-----------E------ 622 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~-----------~------ 622 (673)
.. ......++..|+|||.+.+ ..++.++|||||||++|||+||+.||............. .
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 158 TK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred cc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 21 1223457889999998865 458999999999999999999999986532211100000 0
Q ss_pred ---hhcCCcCCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 623 ---DFIDPNLEG----KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 623 ---~~~~~~~~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
....+.... ......+.++.+++.+|++.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 001123467889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.58 Aligned_cols=257 Identities=23% Similarity=0.402 Sum_probs=201.3
Q ss_pred cCCccccccccCCcceEEEEEEc-CCc----EEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGS----VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
++|+..+.||+|+||.||+|... +|. .||+|.+..........++.+|+.++++++||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---~~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS---PTI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---CCc
Confidence 45777889999999999999864 344 5788988654433334578899999999999999999999854 235
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++++||+++|+|.+++... ...+++..+..++.|++.||+|||++ ||+||||||+||++++++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~--~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER--RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc--CeeccccccceeeecCCCceEEcccccccc
Confidence 7899999999999998632 23588999999999999999999987 799999999999999999999999999987
Q ss_pred ccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 557 LADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 557 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
....... ......++..|+|||++.+..++.++|||||||++|||+| |+.||......... +..........+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-----~~~~~~~~~~~~ 233 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-----DLLEKGERLPQP 233 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----HHHHCCCCCCCC
Confidence 6533211 1222335678999999998889999999999999999998 88888654222111 111111111112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
..++..+.+++.+||..+|++||+++++++.|+++.+
T Consensus 234 ~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 234 PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 2345678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=320.30 Aligned_cols=251 Identities=17% Similarity=0.287 Sum_probs=202.4
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
+|+..+.||+|+||.||++... +++.+|+|.++........+.+.+|+.++++++||||+++++.+.. .+..++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEEe
Confidence 4777889999999999999966 4889999998754433445678899999999999999999999854 478999999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+. ||+|+||||+||++++++.++++|||.++......
T Consensus 79 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~--~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 79 YCDGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK--RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC--CcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 999999999886432 24578999999999999999999987 89999999999999999999999999997665432
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 641 (673)
.. .....++..|+|||++.+..++.++||||||+++|+|++|+.||.......... ...... ....+...+..+
T Consensus 155 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~ 228 (255)
T cd08219 155 AY-ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL----KVCQGS-YKPLPSHYSYEL 228 (255)
T ss_pred cc-cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH----HHhcCC-CCCCCcccCHHH
Confidence 21 123457888999999988889999999999999999999999986543221111 111111 111223345678
Q ss_pred HHHHHHccccCCCCCCCHHHHHHH
Q 005859 642 GQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 642 ~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
.+++.+||+.||++||++.+++..
T Consensus 229 ~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 229 RSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=337.94 Aligned_cols=255 Identities=17% Similarity=0.259 Sum_probs=197.2
Q ss_pred HhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCC----C
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKG----R 473 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~ 473 (673)
..++|...+.||+|+||.||++... .++.||||.+...... .....+.+|+.+++.++||||+++++++.... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4468999999999999999999865 4889999998764322 23457889999999999999999999885432 2
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL 553 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGl 553 (673)
...++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~--givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999964 6777664 2478899999999999999999987 899999999999999999999999999
Q ss_pred cccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc-------------
Q 005859 554 HKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK------------- 620 (673)
Q Consensus 554 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~------------- 620 (673)
++...... ......++..|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred cccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98654332 223356889999999999888999999999999999999999998643211110000
Q ss_pred -----hhhhcCC--c--------C--------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 621 -----VEDFIDP--N--------L--------EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 621 -----~~~~~~~--~--------~--------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
...+... . . ..........++.+++.+|++.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 0 0 001111234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=344.02 Aligned_cols=252 Identities=25% Similarity=0.416 Sum_probs=212.0
Q ss_pred ccccccCCcceEEEEEE-cCC----cEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 407 ANLLGKSSFSATYKGIL-RDG----SVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
.++||+|+||+||||.+ .+| .+||||++......+...++++|+-+|.+++|||+++++|+|... ...||++
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~qlvtq 777 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS---TLQLVTQ 777 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hHHHHHH
Confidence 46899999999999984 343 479999998776566678999999999999999999999999653 3789999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
||+.|.|.+|++.++ ..+..+..+.+..|||+||.|||++ ++|||||.++||||.+-..+||.|||+++.+..+.
T Consensus 778 ~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~q--rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQ--RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhc--chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 999999999998654 4577888999999999999999987 69999999999999999999999999999887644
Q ss_pred h-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 562 V-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 562 ~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
. .........+.|||-|.+....|+.++|||||||++||++| |..||...... .+.+.+...-+-..++.++.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-----eI~dlle~geRLsqPpiCti 927 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-----EIPDLLEKGERLSQPPICTI 927 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-----HhhHHHhccccCCCCCCccH
Confidence 2 22233345678999999999999999999999999999999 99998765332 22333333333456777889
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
++..++.+||..|+..||+|+++...+.++..
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 99999999999999999999999999887753
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=323.55 Aligned_cols=257 Identities=24% Similarity=0.376 Sum_probs=204.5
Q ss_pred cCCccccccccCCcceEEEEEEcC-Cc----EEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GS----VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
.+|...+.||+|+||.||+|..++ |. .||+|.+..........++.+|+.++++++||||+++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---Cce
Confidence 457778899999999999999653 33 6899988765433344678999999999999999999999864 568
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||++ ||+||||||+||++++++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~--~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK--RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC--CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 8999999999999999743 23489999999999999999999986 899999999999999999999999999987
Q ss_pred ccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 557 LADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 557 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
....... ......++..|+|||.+....++.++||||||+++||++| |+.||.......... .+. .......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~----~~~~~~~~ 233 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD-LLE----KGERLPQP 233 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-HHh----CCCCCCCC
Confidence 6533211 1111223567999999988889999999999999999999 999987643322111 111 11111122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
..++..+.+++.+||..+|.+||++.++++.|+++..
T Consensus 234 ~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 234 PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 2345678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=345.26 Aligned_cols=251 Identities=16% Similarity=0.249 Sum_probs=195.0
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
+|++.+.||+|+||.||+++.. +++.||||++.+... ......+.+|++++++++||||+++++.+.. .+..++|
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv 79 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEEE
Confidence 6888999999999999999965 489999999875421 2234568899999999999999999999854 4789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++..+..
T Consensus 80 ~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~--~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 80 MDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 999999999999963 24588889999999999999999987 899999999999999999999999999753210
Q ss_pred cc------------------------------------------hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHH
Q 005859 560 DI------------------------------------------VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMI 597 (673)
Q Consensus 560 ~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvv 597 (673)
.. ........||+.|||||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 000112468999999999999899999999999999
Q ss_pred HHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHH
Q 005859 598 VFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRP---SIENVMQ 664 (673)
Q Consensus 598 l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP---s~~evl~ 664 (673)
+|||+||+.||............. .. ............+.++.+++.+|+ .+|.+|+ ++.|+++
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~-~~-~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVI-NW-ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHh-cc-CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 999999999997543322111110 00 011111111234466778888876 5999999 8888874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=322.80 Aligned_cols=251 Identities=24% Similarity=0.437 Sum_probs=198.3
Q ss_pred ccccCCcceEEEEEEcC-------CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 409 LLGKSSFSATYKGILRD-------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 409 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
.||+|+||.||+|+..+ ++.||||.+..........++.+|++++++++||||+++++++... +..++|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN--EPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC--CCeEEEEe
Confidence 68999999999998653 2579999887654334456899999999999999999999998543 67899999
Q ss_pred ecCCCChhhhhccccC---CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC-----Ceeeccccc
Q 005859 482 FVPNGNLLQHLDLEAG---SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY-----NPLLSDSGL 553 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~-----~~kl~DfGl 553 (673)
|+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +++|+||||+||+++.+. .+|++|||+
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM--HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC--CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999974321 123578999999999999999999987 799999999999999877 899999999
Q ss_pred cccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCC
Q 005859 554 HKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEG 631 (673)
Q Consensus 554 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 631 (673)
++........ ......++..|+|||++.++.++.++|||||||++|||+| |+.||.......... .+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~-----~~~~~~~~ 232 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ-----HVTAGGRL 232 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHH-----HHhcCCcc
Confidence 9765433211 1112345678999999998899999999999999999998 998886433221111 11111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 632 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
..+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 233 QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 2234456788999999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=325.96 Aligned_cols=254 Identities=17% Similarity=0.261 Sum_probs=202.5
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|+..+.||+|+||+||++... +|+.||+|++...........+.+|+++++.++||||+++++++... +..++||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEEEEE
Confidence 45677789999999999999966 48899999887654334457899999999999999999999999654 7899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.. +|+||||||+||++++++.++|+|||++......
T Consensus 83 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~-~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 83 EFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH-RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred ecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc-CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 99999999998863 245899999999999999999999732 7999999999999999999999999998754322
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhh-------hccchhhhcCCcCCCCC
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA-------ESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~ 633 (673)
. .....++..|+|||++.+..++.++|||||||++||++||+.||........ .......+.........
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP 234 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC
Confidence 1 1234688899999999888899999999999999999999999875432100 00111222211111111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 634 SVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 634 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
....+..+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 22355789999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=337.39 Aligned_cols=238 Identities=20% Similarity=0.320 Sum_probs=188.1
Q ss_pred cccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHH-HHhccCCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLK-ILTSLKHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
+.||+|+||+||+|+.. +|+.||||++.+... .....++.+|.. +++.++||||+++++++.. .+..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcCC
Confidence 36999999999999976 589999999975432 122344555655 5678999999999998854 47899999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF 563 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 563 (673)
++|+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~--givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 151 (323)
T cd05575 79 NGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL--NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK- 151 (323)
T ss_pred CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-
Confidence 99999998863 34688999999999999999999987 899999999999999999999999999875432211
Q ss_pred hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHH
Q 005859 564 SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQ 643 (673)
Q Consensus 564 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 643 (673)
......|++.|+|||++.+..++.++|||||||++|||++|+.||........... +..... ..+...+..+.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~----i~~~~~--~~~~~~~~~~~~ 225 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDN----ILNKPL--RLKPNISVSARH 225 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHH----HHcCCC--CCCCCCCHHHHH
Confidence 22345689999999999998999999999999999999999999875432221111 111111 112233577899
Q ss_pred HHHHccccCCCCCCCHH
Q 005859 644 IALHCTHESPSHRPSIE 660 (673)
Q Consensus 644 l~~~Cl~~~p~~RPs~~ 660 (673)
++.+||+.||++||++.
T Consensus 226 li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 226 LLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHhhcCHHhCCCCC
Confidence 99999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=343.77 Aligned_cols=251 Identities=16% Similarity=0.243 Sum_probs=193.3
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.|+..+.||+|+||+||+|+.. +++.||+|++.+... ......+.+|++++++++|||||++++.+.+ .+..++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEE
Confidence 5888999999999999999975 488999999875431 1233578899999999999999999999855 4789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~--~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 80 MDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 999999999999863 24578889999999999999999987 899999999999999999999999999753210
Q ss_pred cc----------------------------------------------hhhhhccCCCCCccCCccccCCCCCcchhHHH
Q 005859 560 DI----------------------------------------------VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYA 593 (673)
Q Consensus 560 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwS 593 (673)
.. ........||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 00 00011236899999999999889999999999
Q ss_pred HHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 005859 594 FGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPS---IENVMQ 664 (673)
Q Consensus 594 fGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~evl~ 664 (673)
|||++|||+||+.||............... ............+.++.+++.+++ .+|++|++ +.|+++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINW--QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHcc--CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 999999999999999754332211111110 111111111223466777777765 59999987 877764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=331.18 Aligned_cols=252 Identities=20% Similarity=0.317 Sum_probs=212.2
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCC--cHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCeE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKS--DEGEFLKGLKILTSLK-HENLASLRGICCSKGRGEC 476 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~ 476 (673)
...|+..+.||+|.||.||+++.+. |+.+|+|.+.+..... +...+.+|+++|+++. |||||.++++|.+ ....
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~--~~~~ 111 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED--PDSV 111 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc--CCeE
Confidence 4567778899999999999999776 9999999998765433 3468999999999998 9999999999955 4789
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC----CCeeecccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR----YNPLLSDSG 552 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~----~~~kl~DfG 552 (673)
++|||++.||.|.+.+... .+++..+..++.||+.+++|||+. ||+||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~--gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL--GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999999743 389999999999999999999997 89999999999999643 479999999
Q ss_pred ccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCC
Q 005859 553 LHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGK 632 (673)
Q Consensus 553 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (673)
++...... ......+||+.|+|||++....|+.++||||.||++|.|+.|..||............... +......
T Consensus 185 la~~~~~~--~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~--~~~f~~~ 260 (382)
T KOG0032|consen 185 LAKFIKPG--ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG--DFDFTSE 260 (382)
T ss_pred CceEccCC--ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC--CCCCCCC
Confidence 99988762 2455678999999999999999999999999999999999999999876543332222111 1123344
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 633 FSVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 633 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
.....+..+.+++.+++..||.+|+|+.++++.
T Consensus 261 ~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 261 PWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 555667899999999999999999999999873
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=317.62 Aligned_cols=249 Identities=25% Similarity=0.445 Sum_probs=199.5
Q ss_pred cccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCCCC
Q 005859 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGN 487 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~gs 487 (673)
++||+|+||.||++...+++.||+|.+...........+.+|++++++++||||+++++++... +..++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK--QPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CCeEEEEEcCCCCc
Confidence 3699999999999998779999999887654333456899999999999999999999998544 67899999999999
Q ss_pred hhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhhh-h
Q 005859 488 LLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSM-L 566 (673)
Q Consensus 488 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~-~ 566 (673)
|.+++... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++.......... .
T Consensus 79 l~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~--~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 79 LLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK--NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC--CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 99998642 23578999999999999999999987 799999999999999999999999999986543221111 1
Q ss_pred ccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHH
Q 005859 567 KASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIA 645 (673)
Q Consensus 567 ~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 645 (673)
....+..|+|||.+.++.++.++|||||||++|||+| |..||........... + ........+...+.++.+++
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~li 228 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-I----ESGYRMPAPQLCPEEIYRLM 228 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-H----hcCCCCCCCccCCHHHHHHH
Confidence 1223567999999988889999999999999999999 8888865433221111 1 11111122334567899999
Q ss_pred HHccccCCCCCCCHHHHHHHHHH
Q 005859 646 LHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 646 ~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
.+||+.+|++|||+.|+++.|++
T Consensus 229 ~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 229 LQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HHHhccChhhCcCHHHHHHHhhC
Confidence 99999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=333.45 Aligned_cols=246 Identities=21% Similarity=0.349 Sum_probs=200.8
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCc--HHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSD--EGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
..|...+.||.|+||.||-++.. +.+.||||.+.-...... -.++++|++.|++++|||+|.+.|.|... ...++
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre--~TaWL 103 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE--HTAWL 103 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc--chHHH
Confidence 34667788999999999999954 588999999876532222 36899999999999999999999988654 56899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||| -|+-.+++.-. ++++.+..+..|..+.+.||+|||+. +.||||||+.|||+.+.|.+|++|||.|....
T Consensus 104 VMEYC-lGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~--~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 104 VMEYC-LGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH--NRIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHHHH-hccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh--hHHhhhccccceEecCCCeeeeccccchhhcC
Confidence 99999 56888877643 35688889999999999999999998 69999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTT---TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
+ ....+||++|||||++. .+.|+-|+||||+||++.|+.-+++|+......... ..+....-+.-...
T Consensus 178 P-----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL----YHIAQNesPtLqs~ 248 (948)
T KOG0577|consen 178 P-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----YHIAQNESPTLQSN 248 (948)
T ss_pred c-----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH----HHHHhcCCCCCCCc
Confidence 4 34578999999999986 578999999999999999999999998765443222 22222222222234
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+-+..++.++..|++.-|.+|||..+++.
T Consensus 249 eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 249 EWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred hhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 45678999999999999999999999875
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=324.64 Aligned_cols=251 Identities=20% Similarity=0.298 Sum_probs=198.6
Q ss_pred CccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC--CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 404 FSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK--SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
|...+.||+|+||+||+|... +++.||+|.+...... .....+.+|++++++++|+||+++.+++.. .+..++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEEE
Confidence 666788999999999999975 5889999998764322 223457889999999999999999988854 36789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++|+|.+++... ....+++..+..++.|++.||+|||+. ||+||||||+||++++++.+||+|||++......
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~--~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 80 TIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE--NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 999999999888632 223589999999999999999999987 8999999999999999999999999998765432
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
. ......|+..|+|||++.+..++.++|||||||++|||+||+.||................... ...++...+..
T Consensus 156 ~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 231 (285)
T cd05632 156 E--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--EEVYSAKFSEE 231 (285)
T ss_pred C--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--ccccCccCCHH
Confidence 2 1223468899999999998889999999999999999999999997543322111111111111 11223344567
Q ss_pred HHHHHHHccccCCCCCCC-----HHHHHH
Q 005859 641 LGQIALHCTHESPSHRPS-----IENVMQ 664 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs-----~~evl~ 664 (673)
+.+++.+||+.||++||+ +.++++
T Consensus 232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 232 AKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred HHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 899999999999999999 566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=318.79 Aligned_cols=252 Identities=19% Similarity=0.314 Sum_probs=199.0
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC----CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK----SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
.+|...+.||+|+||.||+|... +++.||+|++...... .....+.+|++++++++||||+++++++.....+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888899999999999999975 4899999988654321 122468889999999999999999998866545678
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
+++|||+++++|.+++.. ...+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~--~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 999999999999999863 23588999999999999999999987 799999999999999999999999999876
Q ss_pred ccCcch--hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 557 LADDIV--FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 557 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
...... .......++..|+|||++.+..++.++|||||||++|||+||+.||........... ..........+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~ 231 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK----IATQPTNPQLP 231 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH----HhcCCCCCCCc
Confidence 532111 111224578899999999988899999999999999999999999875432221111 11111122334
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
......+.+++ +||..+|++||+++||++
T Consensus 232 ~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 232 SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 44556777777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=317.47 Aligned_cols=251 Identities=26% Similarity=0.464 Sum_probs=203.5
Q ss_pred cccccCCcceEEEEEEcC----CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKSSFSATYKGILRD----GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
+.||+|+||.||+|.... +..||+|.+.........+.+.+|++++++++|+||+++++++.. ....++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEec
Confidence 369999999999999764 789999999876533346789999999999999999999999855 47789999999
Q ss_pred CCCChhhhhccccCC-----ccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 484 PNGNLLQHLDLEAGS-----EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
++++|.+++...... ...+++..+..++.|++.||+|||++ ||+||||||+||++++++.+||+|||.++...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~--~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK--KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC--CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 999999999753211 35689999999999999999999987 89999999999999999999999999998765
Q ss_pred Ccch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHH
Q 005859 559 DDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636 (673)
Q Consensus 559 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (673)
.... .......++..|+|||.+....++.++||||+|+++|||++ |..||........... ... ......+..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~ 231 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY----LRK-GYRLPKPEY 231 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHc-CCCCCCCcc
Confidence 4321 12233456788999999988889999999999999999999 6888876533221111 111 111223344
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 005859 637 EASNLGQIALHCTHESPSHRPSIENVMQELS 667 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 667 (673)
.+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 4678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=322.83 Aligned_cols=239 Identities=24% Similarity=0.423 Sum_probs=185.4
Q ss_pred ccccCCcceEEEEEEcC-------------------------CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCcee
Q 005859 409 LLGKSSFSATYKGILRD-------------------------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463 (673)
Q Consensus 409 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 463 (673)
.||+|+||.||+|.+.. ...||+|.+.... ......|.+|++++++++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 59999999999998521 1358899886543 223457889999999999999999
Q ss_pred EeeEEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC
Q 005859 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR 543 (673)
Q Consensus 464 l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~ 543 (673)
+++++... ...++||||+++|+|..++... ...+++..+.+++.||++||+|||+. ||+||||||+|||++++
T Consensus 81 ~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~--~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 81 VHGVCVRG--SENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK--NLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEEeC--CceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC--CccCCCCCcccEEEecc
Confidence 99999654 6789999999999999988632 24588999999999999999999987 89999999999999865
Q ss_pred C-------CeeeccccccccccCcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHH-hCCCCCChhhHh
Q 005859 544 Y-------NPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQIL-SGKCSITPFTRQ 614 (673)
Q Consensus 544 ~-------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~-tG~~p~~~~~~~ 614 (673)
+ .+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||......
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred CcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 4 3799999987644321 12346788999998875 45899999999999999985 688888654222
Q ss_pred hhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 005859 615 AAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELS 667 (673)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 667 (673)
... ....... ..+......+.+++.+||+.+|++||||.+|++.|+
T Consensus 229 ~~~-----~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 EKE-----RFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHH-----HHHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111 1111110 111222357899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=318.82 Aligned_cols=256 Identities=20% Similarity=0.320 Sum_probs=206.6
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+|+..+.||.|+||.||++... +++.||+|.+..... ....+++.+|++++++++||||+++++++........+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4777889999999999999865 588999999875432 22345788999999999999999999988766566789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcC---CCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK---RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
||+++++|.+++.........+++..++.++.|++.||+|||.. ..+|+|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999999975433346789999999999999999999922 237999999999999999999999999999877
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
...... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .+.+........+...
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~ 234 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL-----ASKIKEGKFRRIPYRY 234 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHH-----HHHHhcCCCCCCcccc
Confidence 554321 2234578899999999988899999999999999999999999875432211 1111111222334455
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.++.+++.+|++.+|++||++.+|++
T Consensus 235 ~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 235 SSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=318.85 Aligned_cols=256 Identities=17% Similarity=0.314 Sum_probs=201.8
Q ss_pred CCccccccccCCcceEEEEEEcC--CcEEEEEEecccCC---------CCcHHHHHHHHHHHhc-cCCCCceeEeeEEec
Q 005859 403 CFSEANLLGKSSFSATYKGILRD--GSVVAVKCIAKTSC---------KSDEGEFLKGLKILTS-LKHENLASLRGICCS 470 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~ 470 (673)
+|+..+.||+|+||.||+|.... ++.+|+|.+..... .....++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999765 68899998864321 1122457789988875 799999999999854
Q ss_pred CCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecc
Q 005859 471 KGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSD 550 (673)
Q Consensus 471 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~D 550 (673)
.+..++||||+++++|.+++.........+++..+++++.|++.||.|||+.. +|+||||||+||++++++.+||+|
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK-RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC-ceeecCCCHHHEEECCCCcEEEec
Confidence 47899999999999999988543233456899999999999999999999732 799999999999999999999999
Q ss_pred ccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCC
Q 005859 551 SGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLE 630 (673)
Q Consensus 551 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 630 (673)
||.+....... ......++..|+|||++.+..++.++||||||+++|||++|+.||.......... ........
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~----~~~~~~~~ 231 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT----KIVEAVYE 231 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH----HHhhccCC
Confidence 99998765432 2234557889999999998889999999999999999999999986543221111 11111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 005859 631 GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELS 667 (673)
Q Consensus 631 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 667 (673)
.......+..+.+++.+||+.||++||++.||.++++
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111134578899999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=318.62 Aligned_cols=239 Identities=23% Similarity=0.421 Sum_probs=186.0
Q ss_pred ccccCCcceEEEEEEcC-------------CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 409 LLGKSSFSATYKGILRD-------------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 409 ~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
.||+|+||.||+|++.. ...||+|.+.... ......|.+|+.+++.++||||+++++++... ..
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~--~~ 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRD--VE 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CC
Confidence 58999999999998542 2358899876543 23345788999999999999999999998654 56
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC-------eee
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN-------PLL 548 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~-------~kl 548 (673)
.++||||+++|+|..++... ...+++..+++++.||++||+|||+. +|+||||||+|||++.++. +|+
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK--DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred CEEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC--CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 78999999999999888632 24589999999999999999999987 7999999999999987664 899
Q ss_pred ccccccccccCcchhhhhccCCCCCccCCcccc-CCCCCcchhHHHHHHHHHHHH-hCCCCCChhhHhhhhccchhhhcC
Q 005859 549 SDSGLHKLLADDIVFSMLKASAAMGYLAPEYTT-TGRFTEKSDIYAFGMIVFQIL-SGKCSITPFTRQAAESSKVEDFID 626 (673)
Q Consensus 549 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSfGvvl~el~-tG~~p~~~~~~~~~~~~~~~~~~~ 626 (673)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+........ .....
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-----~~~~~ 223 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-----ERFYE 223 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-----HHHHh
Confidence 999998755322 2235678899999887 456899999999999999997 58877754321111 01111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 005859 627 PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELS 667 (673)
Q Consensus 627 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 667 (673)
.... .......++.+++.+||+.||.+||++.++++.++
T Consensus 224 ~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 GQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1111 11123467899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=316.06 Aligned_cols=260 Identities=21% Similarity=0.384 Sum_probs=205.6
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhc--cCCCCceeEeeEEecCC--CCeEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTS--LKHENLASLRGICCSKG--RGECF 477 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~--~~~~~ 477 (673)
......+.||+|.||+||+|.++ |+.||||++.. .+++.+.+|.+|.+. |+|+||..+++.=...+ ..+.+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 34566788999999999999996 89999999863 467789999999886 49999999987643221 23789
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhc------CCCCcccCCcCCCCeEecCCCCeeeccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHG------KRPGLVHPNLSAEKVLIHRRYNPLLSDS 551 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~------~~~~ivHrDlk~~NILl~~~~~~kl~Df 551 (673)
||++|-+.|||++||.. ..++....++++..+|.||+|||- -+|.|.|||||+.|||+.+++...|+|+
T Consensus 286 LvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 99999999999999962 468999999999999999999996 3788999999999999999999999999
Q ss_pred cccccccCcc---hhhhhccCCCCCccCCccccCCC----C-C-cchhHHHHHHHHHHHHhC----------CCCCChhh
Q 005859 552 GLHKLLADDI---VFSMLKASAAMGYLAPEYTTTGR----F-T-EKSDIYAFGMIVFQILSG----------KCSITPFT 612 (673)
Q Consensus 552 Gla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~-s-~ksDVwSfGvvl~el~tG----------~~p~~~~~ 612 (673)
|+|-....+. .......+||-+|||||++.... + + ..+||||||.|+||++-+ +.||.+..
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 9997665432 23455678999999999987532 2 2 469999999999999853 25665544
Q ss_pred Hhhhhccchhh-----hcCCcCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 613 RQAAESSKVED-----FIDPNLEGKF-SVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 613 ~~~~~~~~~~~-----~~~~~~~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
......+.+.+ -.+|.++..+ +.+....+.++|..||..+|..|-|+-.+-+.|.++.+
T Consensus 441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 33222222222 2344444433 34567889999999999999999999999999988875
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=323.46 Aligned_cols=247 Identities=21% Similarity=0.362 Sum_probs=200.0
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
.|+..+.||+|+||.||+|... +++.||+|.+.........+.+.+|++++++++||||+++++++.. .+..++|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc--CCceEEEEE
Confidence 3566678999999999999865 4789999998755433344678999999999999999999999854 467899999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+++++|.+++.. ..+++..+..++.|++.|++|||+. |++|+||+|+||++++++.+|++|||+++......
T Consensus 83 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~--~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 83 YLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE--RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred ccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC--CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 9999999998852 3588999999999999999999987 89999999999999999999999999998765432
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 641 (673)
. ......++..|+|||++.+..++.++|||||||++|||+||+.|+.......... ..............+.++
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 229 (277)
T cd06642 156 I-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-----LIPKNSPPTLEGQYSKPF 229 (277)
T ss_pred h-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-----hhhcCCCCCCCcccCHHH
Confidence 1 1223457888999999998889999999999999999999999986432211111 111111122233456788
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 005859 642 GQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 642 ~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+++.+||+.+|++||++.++++
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 230 KEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred HHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=335.34 Aligned_cols=241 Identities=19% Similarity=0.299 Sum_probs=188.8
Q ss_pred cccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHH-HHhccCCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLK-ILTSLKHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
+.||+|+||+||+|+... ++.||+|++.+... ......+..|.. +++.++||||+++++++.. .+..++||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeCC
Confidence 369999999999999764 78899999975421 122334555544 5678899999999998854 47899999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF 563 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 563 (673)
++|+|.+++.. ...+++..+..++.||++||+|||+. ||+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~--giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~- 151 (325)
T cd05602 79 NGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG- 151 (325)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-
Confidence 99999999863 24577888889999999999999987 899999999999999999999999999875432211
Q ss_pred hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHH
Q 005859 564 SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQ 643 (673)
Q Consensus 564 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 643 (673)
......|++.|+|||++.+..++.++|||||||++|||++|+.||........... +..... ......+..+.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~----i~~~~~--~~~~~~~~~~~~ 225 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN----ILNKPL--QLKPNITNSARH 225 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHH----HHhCCc--CCCCCCCHHHHH
Confidence 22345689999999999998999999999999999999999999975433222111 111111 122334577899
Q ss_pred HHHHccccCCCCCCCHHHHH
Q 005859 644 IALHCTHESPSHRPSIENVM 663 (673)
Q Consensus 644 l~~~Cl~~~p~~RPs~~evl 663 (673)
++.+|++.||.+||++.+.+
T Consensus 226 li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 226 LLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HHHHHcccCHHHCCCCCCCH
Confidence 99999999999999887544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=332.41 Aligned_cols=242 Identities=18% Similarity=0.284 Sum_probs=192.8
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCeEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLK-HENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~l 478 (673)
+|...+.||+|+||+||+|+.. +|+.||+|++.+... ....+.+..|.+++..+. |++|+++++++.. .+..++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence 3677789999999999999976 488999999976421 223356788999998885 5778888888754 467999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||+++++.+||+|||+++...
T Consensus 79 v~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~--~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 79 VMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR--GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred EEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 9999999999998863 24589999999999999999999987 89999999999999999999999999987543
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
.... ......|+..|+|||++.+..++.++|||||||++|||+||+.||.......... .+.... ..++...+
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~----~i~~~~--~~~p~~~~ 225 (323)
T cd05615 153 VDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQ----SIMEHN--VSYPKSLS 225 (323)
T ss_pred CCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCC--CCCCccCC
Confidence 2221 1223458999999999998889999999999999999999999997643322211 111111 12233445
Q ss_pred HHHHHHHHHccccCCCCCCCH
Q 005859 639 SNLGQIALHCTHESPSHRPSI 659 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~ 659 (673)
.++.+++.+||+.+|.+|++.
T Consensus 226 ~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 226 KEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHHHHHHHcccCHhhCCCC
Confidence 778999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=333.22 Aligned_cols=256 Identities=16% Similarity=0.232 Sum_probs=195.4
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|...+.||+|+||+||+++... ++.||+|++.+... ....+.+.+|+.++..++|+||+++++++.. .+..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD--ENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--CCeEEE
Confidence 468889999999999999999764 89999999975321 2234568899999999999999999998854 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 79 v~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 79 VMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL--GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred EEecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC--CeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 99999999999999632 23588999999999999999999987 79999999999999999999999999987655
Q ss_pred CcchhhhhccCCCCCccCCccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCC
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTT-----GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (673)
...........|++.|+|||++.. ..++.++|||||||++|||++|+.||....................+.. .
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~ 232 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPP-D 232 (331)
T ss_pred CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCC-c
Confidence 433222233468999999999863 4578999999999999999999999865432211111111000001111 1
Q ss_pred CHHHHHHHHHHHHHccccCC--CCCCCHHHHHHH
Q 005859 634 SVSEASNLGQIALHCTHESP--SHRPSIENVMQE 665 (673)
Q Consensus 634 ~~~~~~~l~~l~~~Cl~~~p--~~RPs~~evl~~ 665 (673)
....+..+.+++.+|+..++ ..||+++++++.
T Consensus 233 ~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 233 VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 12245678888888775433 347899988753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=324.18 Aligned_cols=255 Identities=18% Similarity=0.287 Sum_probs=194.2
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC-cHHHHHHHHHHHhcc---CCCCceeEeeEEecC---CCC
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS-DEGEFLKGLKILTSL---KHENLASLRGICCSK---GRG 474 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~---~~~ 474 (673)
+|...+.||+|+||+||+|+.. +++.||+|.+....... ....+.+|+++++++ +||||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778889999999999999976 48999999987643222 234566788777765 799999999988542 234
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLH 554 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla 554 (673)
..++||||++ ++|.+++... ....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN--CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 6899999997 5898888643 224589999999999999999999987 8999999999999999999999999999
Q ss_pred ccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhh----------
Q 005859 555 KLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF---------- 624 (673)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~---------- 624 (673)
+...... ......++..|+|||++.+..++.++|||||||++|||++|+.||................
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 8765332 1223457889999999998889999999999999999999998886432221111100000
Q ss_pred --------cCCcCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 625 --------IDPNLE---GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 625 --------~~~~~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+... .......+..+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 0111233567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=335.95 Aligned_cols=254 Identities=16% Similarity=0.262 Sum_probs=197.0
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCC----CC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKG----RG 474 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~ 474 (673)
.++|...+.||+|+||.||++... .++.||||++..... ......+.+|+.+++.++||||+++++++.... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467999999999999999999965 488999999876432 223457889999999999999999999875432 23
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLH 554 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla 554 (673)
..|+||||++ ++|.+++. ..+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCC-CCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC--CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 5799999996 47777764 2478899999999999999999987 8999999999999999999999999999
Q ss_pred ccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhh-----------
Q 005859 555 KLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVED----------- 623 (673)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~----------- 623 (673)
+...... ......++..|+|||++.+..++.++|||||||++|||+||+.||............+..
T Consensus 174 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 174 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred cccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 8664432 123356889999999999989999999999999999999999998653321111110000
Q ss_pred -------hc--CCcCC----------------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 624 -------FI--DPNLE----------------GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 624 -------~~--~~~~~----------------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
.. .+... .........++.+++.+|++.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 00000 00111124578899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=328.50 Aligned_cols=198 Identities=23% Similarity=0.365 Sum_probs=162.7
Q ss_pred ccccccCCcceEEEEEEc---CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 407 ANLLGKSSFSATYKGILR---DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
...||+|+||+||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++........++||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 457999999999999965 36789999986542 234678999999999999999999998766667789999999
Q ss_pred CCCChhhhhccccC-----CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEe----cCCCCeeecccccc
Q 005859 484 PNGNLLQHLDLEAG-----SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI----HRRYNPLLSDSGLH 554 (673)
Q Consensus 484 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl----~~~~~~kl~DfGla 554 (673)
. ++|.+++..... ....+++..+..++.||+.||+|||+. ||+||||||+|||+ +.++.+||+|||++
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC--CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 588887753221 123588999999999999999999987 89999999999999 45678999999999
Q ss_pred ccccCcch--hhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCh
Q 005859 555 KLLADDIV--FSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITP 610 (673)
Q Consensus 555 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~ 610 (673)
+....... .......+|+.|+|||++.+. .++.++||||+||++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 87654321 122345678999999998764 589999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=324.80 Aligned_cols=251 Identities=21% Similarity=0.334 Sum_probs=199.0
Q ss_pred CccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC--cHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 404 FSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS--DEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
|+..+.||+|+||.||++... +++.||+|.+....... ....+.+|++++++++|+||+++++.+.. .+..++||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~ 79 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVL 79 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEEE
Confidence 667789999999999999976 48899999987643222 23457889999999999999999998854 46899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++|+|.+++... ....+++..+..++.|++.||.|||+. ||+||||||+||++++++.++|+|||++......
T Consensus 80 e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~--~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 80 TLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE--RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC--CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999999988532 223589999999999999999999987 8999999999999999999999999998765433
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||......... ........ ......+...+.+
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~ 231 (285)
T cd05630 156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVK-EVQEEYSEKFSPD 231 (285)
T ss_pred cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HHHHhhhh-hhhhhcCccCCHH
Confidence 21 12346889999999999888999999999999999999999999753221100 01111111 1111223344567
Q ss_pred HHHHHHHccccCCCCCCC-----HHHHHH
Q 005859 641 LGQIALHCTHESPSHRPS-----IENVMQ 664 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs-----~~evl~ 664 (673)
+.+++.+||+.||++||| ++|+++
T Consensus 232 ~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 232 ARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred HHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 899999999999999999 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=321.85 Aligned_cols=249 Identities=18% Similarity=0.261 Sum_probs=196.7
Q ss_pred CccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEee
Q 005859 404 FSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDF 482 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~ 482 (673)
|+..+.||+|+||.||+|.... +..+|+|.+.... ....+.+.+|+++++.++||||+++++++... +..++||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--CEEEEEEEe
Confidence 5566789999999999999765 7889999886543 23446788999999999999999999998654 678999999
Q ss_pred cCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcch
Q 005859 483 VPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV 562 (673)
Q Consensus 483 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 562 (673)
+++++|..++... ...+++..+..++.|+++||+|||+. ||+||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~--~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 84 CAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN--KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred cCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 9999999887632 24689999999999999999999987 899999999999999999999999999876543211
Q ss_pred hhhhccCCCCCccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 563 FSMLKASAAMGYLAPEYTT-----TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 563 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
......++..|+|||++. ...++.++|||||||++|||++|+.||............ .....+.. ..+...
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~-~~~~~~~~--~~~~~~ 234 (282)
T cd06643 159 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI-AKSEPPTL--AQPSRW 234 (282)
T ss_pred -ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH-hhcCCCCC--CCcccc
Confidence 122345788999999984 345788999999999999999999998654322111111 11111111 122334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.++.+++.+||+.||.+||++.++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 235 SSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 578999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.65 Aligned_cols=248 Identities=19% Similarity=0.346 Sum_probs=202.2
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|+..+.||.|+||.||+|+.. +++.||+|.+...........+.+|++++++++||||+++++++... ...++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEEEEE
Confidence 35778889999999999999976 48899999987654334456789999999999999999999998654 7889999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++.....
T Consensus 79 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~--~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 79 EYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE--GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred EeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 99999999999863 2689999999999999999999987 7999999999999999999999999999877543
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHH-HHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS-EAS 639 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 639 (673)
.. ......++..|+|||++.+..++.++|||||||++|||+||+.||.......... .+... ........ .+.
T Consensus 152 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~ 225 (274)
T cd06609 152 MS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF-LIPKN----NPPSLEGNKFSK 225 (274)
T ss_pred cc-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH-Hhhhc----CCCCCcccccCH
Confidence 21 2223457788999999998889999999999999999999999986543221111 11111 11111122 456
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+.+++.+||..+|++|||++++++
T Consensus 226 ~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 226 PFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhh
Confidence 7899999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=333.94 Aligned_cols=238 Identities=21% Similarity=0.319 Sum_probs=187.4
Q ss_pred cccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHH-HHhccCCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLK-ILTSLKHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
+.||+|+||.||+|+.. +++.||+|++.+... ......+.+|.. +++.++||||+++++++.. .+..++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 36999999999999976 488999999875432 122345556654 6788999999999998854 47899999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF 563 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 563 (673)
++|+|..++.. ...+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 151 (321)
T cd05603 79 NGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL--NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE- 151 (321)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-
Confidence 99999988863 24578888999999999999999987 899999999999999999999999999875322211
Q ss_pred hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHH
Q 005859 564 SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQ 643 (673)
Q Consensus 564 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 643 (673)
......|++.|+|||++.+..++.++|||||||++|||++|+.||.......... .+.... ...+...+..+.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~----~i~~~~--~~~~~~~~~~~~~ 225 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD----NILHKP--LQLPGGKTVAACD 225 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH----HHhcCC--CCCCCCCCHHHHH
Confidence 2233568999999999998889999999999999999999999986543222111 111111 1223344567899
Q ss_pred HHHHccccCCCCCCCHH
Q 005859 644 IALHCTHESPSHRPSIE 660 (673)
Q Consensus 644 l~~~Cl~~~p~~RPs~~ 660 (673)
++.+||+.||++||++.
T Consensus 226 li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 226 LLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHccCCHhhcCCCC
Confidence 99999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=319.44 Aligned_cols=256 Identities=23% Similarity=0.301 Sum_probs=200.1
Q ss_pred HHHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 397 VERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 397 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
++.+++++.....||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|++++++++|+||+++++++.. .+.
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 79 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGF 79 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCE
Confidence 4556677777789999999999999965 47889999887553 2345678999999999999999999999855 478
Q ss_pred EEEEEeecCCCChhhhhccccCCcccc--CHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC-CCCeeecccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVL--EWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR-RYNPLLSDSG 552 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~-~~~~kl~DfG 552 (673)
.++||||+++++|.+++.... ..+ ++..+..++.||+.||+|||+. ||+||||||+||+++. ++.+||+|||
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~--~i~h~dl~p~nil~~~~~~~~~l~dfg 154 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN--QIVHRDIKGDNVLVNTYSGVVKISDFG 154 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC--CEeecCCCHHHEEEcCCCCeEEEecch
Confidence 899999999999999987432 234 7888899999999999999987 8999999999999986 6789999999
Q ss_pred ccccccCcchhhhhccCCCCCccCCccccCCC--CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCC
Q 005859 553 LHKLLADDIVFSMLKASAAMGYLAPEYTTTGR--FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLE 630 (673)
Q Consensus 553 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 630 (673)
++........ ......++..|+|||++.... ++.++|||||||++|||++|+.||............ .......
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~ 230 (268)
T cd06624 155 TSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK---VGMFKIH 230 (268)
T ss_pred hheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh---hhhhccC
Confidence 9876543221 122335788999999987643 789999999999999999999998643221111000 0000111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 631 GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 631 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...+.....++.+++.+||+.+|++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 231 PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 2233445678999999999999999999999985
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=315.32 Aligned_cols=249 Identities=20% Similarity=0.366 Sum_probs=202.5
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|+..+.||+|+||.||+|+..+ ++.||+|.+.... ..+++.+|++++++++||||+++++++... ...++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKN--TDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CcEEEEE
Confidence 578888999999999999999875 8899999986542 267899999999999999999999998654 7789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||+|+||++++++.+||+|||++......
T Consensus 78 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~--~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 78 EYCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN--KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred ecCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 999999999998632 34689999999999999999999987 7999999999999999999999999999876543
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
.. ......++..|+|||++.+..++.++|||||||++|||+||+.||........... .... .......+...+..
T Consensus 153 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~ 228 (256)
T cd06612 153 MA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-IPNK--PPPTLSDPEKWSPE 228 (256)
T ss_pred cc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-hccC--CCCCCCchhhcCHH
Confidence 21 12234477889999999988899999999999999999999999865432211110 0000 00111122334568
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.+++.+||+.||++|||+.||++
T Consensus 229 ~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 229 FNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHHHHHHhcChhhCcCHHHHhc
Confidence 999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=318.04 Aligned_cols=248 Identities=20% Similarity=0.352 Sum_probs=203.0
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
.|+..+.||+|+||.||+|... +++.||+|.+...........+.+|++++++++||||+++++++.+. +..++|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG--TKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CEEEEEEe
Confidence 4667788999999999999976 48899999987554333456789999999999999999999998654 78999999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+++|+|.+++.. ..+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~--~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 83 YLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE--KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC--CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 9999999999862 3478889999999999999999987 79999999999999999999999999997665432
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 641 (673)
. ......++..|+|||++.+..++.++|||||||++|||+||+.||......... ...............+..+
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 229 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-----FLIPKNNPPTLTGEFSKPF 229 (277)
T ss_pred c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-----hhhhcCCCCCCchhhhHHH
Confidence 1 122345778899999998888999999999999999999999998654322111 1111122233445677889
Q ss_pred HHHHHHccccCCCCCCCHHHHHHH
Q 005859 642 GQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 642 ~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
.+++.+||+.+|++||++.++++.
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 230 KEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHcccCcccCcCHHHHHhC
Confidence 999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=333.84 Aligned_cols=255 Identities=15% Similarity=0.212 Sum_probs=197.0
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|...+.||+|+||.||+++.. +++.||+|++.+... ......+.+|+.++..++|+||+++++++.. .+..|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 46888999999999999999976 488999999875321 2233458889999999999999999999854 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 79 v~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~--~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 79 VMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL--HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred EEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999999742 24588999999999999999999987 89999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCC
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTT-----GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (673)
...........|++.|+|||++.+ +.++.++|||||||++|||++|+.||...................... ..
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~ 232 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP-SH 232 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCC-Cc
Confidence 443222233568999999999875 468899999999999999999999996543222111111110001111 11
Q ss_pred CHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 005859 634 SVSEASNLGQIALHCTHESPSH--RPSIENVMQ 664 (673)
Q Consensus 634 ~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~ 664 (673)
....+.++.+++.+|+..++++ |++++++++
T Consensus 233 ~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 233 ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred cccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 1234578889999999866544 468888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=318.79 Aligned_cols=252 Identities=18% Similarity=0.294 Sum_probs=196.5
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|...+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.+++.++||||+++++++... +..++||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~--~~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR--DKLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEEEEEE
Confidence 46777788999999999999865 48899999987543 23345688899999999999999999998554 7889999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++.. ...+++.+++.++.|++.||+|||+. ||+|+||||+||+++.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 86 EFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK--GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred eccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 99999999999863 24589999999999999999999987 8999999999999999999999999998765432
Q ss_pred chhhhhccCCCCCccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTT---TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
.. ......|+..|+|||++. ...++.++|||||||++|||++|+.||..................+... ......
T Consensus 160 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 237 (267)
T cd06645 160 IA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKL-KDKMKW 237 (267)
T ss_pred cc-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcc-cccCCC
Confidence 11 223346888999999875 4558899999999999999999999875432111111000010111100 001123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+..+.+++.+||+.+|++||+++++++
T Consensus 238 ~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 238 SNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=334.94 Aligned_cols=241 Identities=20% Similarity=0.292 Sum_probs=189.1
Q ss_pred cccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHH-HHhccCCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLK-ILTSLKHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
+.||+|+||+||+|+.. +|+.||+|++.+... ......+.+|.. +++.++||||+++++++.. .+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcCC
Confidence 36999999999999965 589999999975421 122345566655 4677899999999998854 47899999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF 563 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 563 (673)
++|+|..++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~--givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 151 (325)
T cd05604 79 NGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI--NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD- 151 (325)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-
Confidence 99999988862 34689999999999999999999987 899999999999999999999999999875322111
Q ss_pred hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHH
Q 005859 564 SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQ 643 (673)
Q Consensus 564 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 643 (673)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........... +..... ......+..+.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~----~~~~~~--~~~~~~~~~~~~ 225 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDN----ILHKPL--VLRPGASLTAWS 225 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHH----HHcCCc--cCCCCCCHHHHH
Confidence 22345689999999999998999999999999999999999999875432222111 111111 112234567889
Q ss_pred HHHHccccCCCCCCCHHHHH
Q 005859 644 IALHCTHESPSHRPSIENVM 663 (673)
Q Consensus 644 l~~~Cl~~~p~~RPs~~evl 663 (673)
++.+|++.+|.+||++++.+
T Consensus 226 ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 226 ILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred HHHHHhccCHHhcCCCCCCH
Confidence 99999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=331.89 Aligned_cols=241 Identities=17% Similarity=0.271 Sum_probs=189.3
Q ss_pred cccccCCcceEEEEEEcC-CcEEEEEEecccCCC--CcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCK--SDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
+.||+|+||+||+|+... ++.||+|++.+.... ...+.+.+|+.++.++ +||||+++++++.. .+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCC
Confidence 369999999999999764 789999999865322 2235678899999988 69999999998854 47899999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF 563 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 563 (673)
++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~--~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 151 (327)
T cd05617 79 NGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER--GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD- 151 (327)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-
Confidence 99999988862 24589999999999999999999987 899999999999999999999999999875322111
Q ss_pred hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhh---hccchhhhcCCcCCCCCCHHHHHH
Q 005859 564 SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA---ESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 564 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
......|++.|+|||++.+..++.++|||||||++|||+||+.||........ ............ ...+...+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~ 229 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--IRIPRFLSVK 229 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--CCCCCCCCHH
Confidence 12345689999999999999999999999999999999999999953211100 000111111111 1223334567
Q ss_pred HHHHHHHccccCCCCCCCH
Q 005859 641 LGQIALHCTHESPSHRPSI 659 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~ 659 (673)
+.+++.+||+.||++||++
T Consensus 230 ~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHHHHhccCHHHcCCC
Confidence 8899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=315.97 Aligned_cols=252 Identities=20% Similarity=0.270 Sum_probs=199.5
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCC----CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCK----SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
.+|+..+.||+|+||.||+|...+ ++.||||.+...... ...+.+.+|++++++++||||+++++++.+......
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 468888999999999999999754 899999988643211 112467889999999999999999998865545678
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||+++++|.+++.. ...+++..+.+++.|++.||+|||++ +|+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN--MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999999863 23478888999999999999999987 799999999999999999999999999876
Q ss_pred ccCcch--hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 557 LADDIV--FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 557 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
...... .......++..|+|||.+.+..++.++|||||||++|||++|+.||.......... +..........+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~ 231 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF----KIATQPTNPVLP 231 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH----HHhcCCCCCCCc
Confidence 542111 11223457889999999988889999999999999999999999986543222111 111111122334
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
......+.+++.+|+. +|++||+++||++
T Consensus 232 ~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 232 PHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred hhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 4556778899999995 9999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=332.55 Aligned_cols=256 Identities=16% Similarity=0.227 Sum_probs=196.4
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|...+.||+|+||+||+++.+. ++.||+|++.+... ......+.+|+.++..++|+||+++++++.. .+..++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD--ENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCEEEE
Confidence 468889999999999999999765 78899999865321 1223458889999999999999999998854 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 79 v~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~--~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 79 VMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL--HYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred EEeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 99999999999999732 23588999999999999999999987 79999999999999999999999999987654
Q ss_pred CcchhhhhccCCCCCccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCC
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTT-----TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (673)
...........||+.|+|||++. ...++.++|||||||++|||++|+.||..................... ...
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-p~~ 232 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF-PAQ 232 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccC-CCc
Confidence 33222223356899999999986 345899999999999999999999999654322211111111100111 111
Q ss_pred CHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 005859 634 SVSEASNLGQIALHCTHESPSH--RPSIENVMQE 665 (673)
Q Consensus 634 ~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~ 665 (673)
....+.++.+++.+|+..++.+ |++++|+++.
T Consensus 233 ~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 233 VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 1234577889999988654443 6899988754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.55 Aligned_cols=257 Identities=21% Similarity=0.353 Sum_probs=204.3
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|+..+.||.|+||+||+|... ++..||+|++...........+.+|+++++.++|+||+++++.+.. .+..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEEE
Confidence 46888999999999999999965 4889999998765434455789999999999999999999998855 47889999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++..... ...+++..+..++.|++.||+|||+. ||+||||||+||++++++.+||+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~--~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN--GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 99999999999974321 24589999999999999999999987 8999999999999999999999999998876543
Q ss_pred chh---hhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCC-CH
Q 005859 561 IVF---SMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKF-SV 635 (673)
Q Consensus 561 ~~~---~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 635 (673)
... ......++..|+|||++... .++.++|||||||++|||++|+.||............... ..+...... ..
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN-DPPSLETGADYK 234 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC-CCCCcCCccccc
Confidence 221 11233578899999998877 6899999999999999999999998654332111111111 111111111 12
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+..+.+++.+||+.||++||++.++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 235 KYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 44678899999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=337.84 Aligned_cols=252 Identities=17% Similarity=0.248 Sum_probs=194.7
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|+..+.||+|+||+||+++.. +++.||||++..... ......+.+|++++.+++||||+++++.+.. .+..++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 36888899999999999999976 489999999975321 2234568889999999999999999998854 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 79 v~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~--givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 79 IMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL--GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred EEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 9999999999999863 34588999999999999999999987 89999999999999999999999999987543
Q ss_pred Ccch----------------------------------hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhC
Q 005859 559 DDIV----------------------------------FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSG 604 (673)
Q Consensus 559 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG 604 (673)
.... .......||+.|+|||++.+..++.++|||||||++|||+||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 2100 001134689999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 005859 605 KCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPS---IENVMQ 664 (673)
Q Consensus 605 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~evl~ 664 (673)
+.||........................ ...+.++.+++.+++ .||.+|++ +.|+++
T Consensus 233 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 233 YPPFCSETPQETYRKVMNWKETLVFPPE--VPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCCHHHHHHHHHcCCCceecCCC--CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 9999654332221111110000011111 123467888888876 49999985 566653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.42 Aligned_cols=252 Identities=21% Similarity=0.320 Sum_probs=188.3
Q ss_pred ccccccCCcceEEEEEEcC---CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 407 ANLLGKSSFSATYKGILRD---GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
...||+|+||+||+|+..+ +..||+|.+.... ....+.+|++++++++||||+++++++........++||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 3579999999999999653 5789999886542 234678999999999999999999998766667889999999
Q ss_pred CCCChhhhhccccC-----CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEe----cCCCCeeecccccc
Q 005859 484 PNGNLLQHLDLEAG-----SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI----HRRYNPLLSDSGLH 554 (673)
Q Consensus 484 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl----~~~~~~kl~DfGla 554 (673)
+ ++|.+++..... ....+++..+..++.|++.||+|||+. ||+||||||+|||+ ++++.+||+|||++
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC--CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 6 588877753211 123588999999999999999999987 89999999999999 56678999999999
Q ss_pred ccccCcch--hhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhc-------------
Q 005859 555 KLLADDIV--FSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAES------------- 618 (673)
Q Consensus 555 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~------------- 618 (673)
+....... .......+|..|+|||++.+. .++.++|||||||++|||+||+.||..........
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 87654321 112334678899999998764 58999999999999999999999985321110000
Q ss_pred -------cchhhh-------------cCCcCC--------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 619 -------SKVEDF-------------IDPNLE--------GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 619 -------~~~~~~-------------~~~~~~--------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...... ...... ..........+.+++.+|++.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 000000 0000112346888999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.68 Aligned_cols=254 Identities=20% Similarity=0.309 Sum_probs=197.7
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC---------cHHHHHHHHHHHhccCCCCceeEeeEEecCC
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS---------DEGEFLKGLKILTSLKHENLASLRGICCSKG 472 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 472 (673)
+|...+.||+|+||.||+|... +|+.||+|.++...... ..+.+.+|++++++++||||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 4667789999999999999865 58999999886432111 12357889999999999999999999854
Q ss_pred CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccc
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSG 552 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfG 552 (673)
.+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+|++|||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK--GILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC--CeeecCCChhhEEEcCCCeEEEeecc
Confidence 47789999999999999998632 4689999999999999999999987 79999999999999999999999999
Q ss_pred ccccccCcchh-hhhccCCCCCccCCccccCCC--CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcC
Q 005859 553 LHKLLADDIVF-SMLKASAAMGYLAPEYTTTGR--FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNL 629 (673)
Q Consensus 553 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 629 (673)
+++........ ......++..|+|||.+.... ++.++||||||+++||+++|+.||..................+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI 233 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcC
Confidence 99765432111 122345788999999987654 899999999999999999999998643322111111111111112
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 630 EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 630 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
........+..+.+++.+||+.+|++||++++|++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 234 PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 22222334678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=320.52 Aligned_cols=240 Identities=23% Similarity=0.457 Sum_probs=187.2
Q ss_pred cccccCCcceEEEEEEcC--------CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 408 NLLGKSSFSATYKGILRD--------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+.+++.++||||+++++++... +..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCG--DESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeC--CCcEEE
Confidence 369999999999998643 2348888875432 23346788999999999999999999999654 568899
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC--------eeeccc
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN--------PLLSDS 551 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~--------~kl~Df 551 (673)
|||+++|+|.+++... ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++. +|++||
T Consensus 78 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~--~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 78 QEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK--GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 9999999999999743 23589999999999999999999987 8999999999999988765 589999
Q ss_pred cccccccCcchhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCC-CCCChhhHhhhhccchhhhcCCcC
Q 005859 552 GLHKLLADDIVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGK-CSITPFTRQAAESSKVEDFIDPNL 629 (673)
Q Consensus 552 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~-~p~~~~~~~~~~~~~~~~~~~~~~ 629 (673)
|++...... ....++..|+|||++.+. .++.++|||||||++|||++|. .|+......... . ....
T Consensus 153 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~----~~~~-- 220 (258)
T cd05078 153 GISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-Q----FYED-- 220 (258)
T ss_pred ccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-H----HHHc--
Confidence 988654432 224577889999999874 5899999999999999999985 554432221110 0 1111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 005859 630 EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELS 667 (673)
Q Consensus 630 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 667 (673)
....+.....++.+++.+||+.||++|||++++++.|+
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11122233467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=315.37 Aligned_cols=238 Identities=25% Similarity=0.471 Sum_probs=188.0
Q ss_pred cccccCCcceEEEEEEcCCc-----------EEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 408 NLLGKSSFSATYKGILRDGS-----------VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
+.||+|+||.||+|...+.. .|++|.+..... ....|.+|++++++++||||+++++++.. +..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR--DSLAFFETASLMSQLSHKHLVKLYGVCVR---DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh--hHHHHHHHHHHHHcCCCcchhheeeEEec---CCc
Confidence 36899999999999976532 578887765431 26789999999999999999999999865 456
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC-------Ceeec
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY-------NPLLS 549 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~-------~~kl~ 549 (673)
++||||+++|+|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK--KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC--CeecccCccceEEEecCccccCCceeEEeC
Confidence 89999999999999997432 2689999999999999999999987 899999999999999888 79999
Q ss_pred cccccccccCcchhhhhccCCCCCccCCccccCC--CCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcC
Q 005859 550 DSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG--RFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID 626 (673)
Q Consensus 550 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~ 626 (673)
|||+++..... ....++..|+|||++... .++.++|||||||++|||++ |..|+....... ..... ..
T Consensus 151 Dfg~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-~~~~~---~~ 221 (259)
T cd05037 151 DPGIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-KERFY---QD 221 (259)
T ss_pred CCCcccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-HHHHH---hc
Confidence 99999865431 123456789999999876 78999999999999999999 566665432111 11001 01
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 005859 627 PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELS 667 (673)
Q Consensus 627 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 667 (673)
.. ..+......+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 222 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11 111111278899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=345.43 Aligned_cols=258 Identities=16% Similarity=0.192 Sum_probs=193.8
Q ss_pred HHHHHHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCC------CCceeEee
Q 005859 394 LEEVERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKH------ENLASLRG 466 (673)
Q Consensus 394 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~~ 466 (673)
.+++...+++|.+.+.||+|+||+||+|+.. .++.||||+++... ....++..|++++++++| ++++++++
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 3455566789999999999999999999975 48899999996532 233456667777777654 45888988
Q ss_pred EEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC--
Q 005859 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY-- 544 (673)
Q Consensus 467 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~-- 544 (673)
++... ..+.++|||++ +++|.+++.. ...+++..+..|+.||+.||+|||+.. |||||||||+|||++.++
T Consensus 199 ~~~~~-~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~-gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 199 YFQNE-TGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL-HLMHTDLKPENILMETSDTV 271 (467)
T ss_pred EEEcC-CceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC-CeecCCCCHHHEEEecCCcc
Confidence 88543 45789999998 7889988863 246899999999999999999999732 799999999999998765
Q ss_pred --------------CeeeccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCh
Q 005859 545 --------------NPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITP 610 (673)
Q Consensus 545 --------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~ 610 (673)
.+||+|||.+..... ......||..|+|||++.+..|+.++|||||||++|||+||+.||..
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 489999998764322 22345789999999999999999999999999999999999999965
Q ss_pred hhHhhhhcc-------------------chhhhcCC--cCCCCC---------------CHHHHHHHHHHHHHccccCCC
Q 005859 611 FTRQAAESS-------------------KVEDFIDP--NLEGKF---------------SVSEASNLGQIALHCTHESPS 654 (673)
Q Consensus 611 ~~~~~~~~~-------------------~~~~~~~~--~~~~~~---------------~~~~~~~l~~l~~~Cl~~~p~ 654 (673)
......... ...++.+. .+.... .......+.+|+.+||+.||+
T Consensus 348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence 332110000 00000000 000000 001235678999999999999
Q ss_pred CCCCHHHHHH
Q 005859 655 HRPSIENVMQ 664 (673)
Q Consensus 655 ~RPs~~evl~ 664 (673)
+|||++|+++
T Consensus 428 ~R~ta~e~L~ 437 (467)
T PTZ00284 428 KRLNARQMTT 437 (467)
T ss_pred hCCCHHHHhc
Confidence 9999999986
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=314.28 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=199.4
Q ss_pred CCccccccccCCcceEEEEEEcCCcEEEEEEecccCCC-----CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 403 CFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCK-----SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
+|...+.||+|+||+||+|...+++.+|+|.+...... .....+.+|++++++++|+||+++++++.+. +..+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeEE
Confidence 36778899999999999999888999999988754211 1124688999999999999999999999654 7899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++..
T Consensus 79 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 79 IFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN--CVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 99999999999999963 23578999999999999999999987 7999999999999999999999999998765
Q ss_pred cCcc-----hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCC
Q 005859 558 ADDI-----VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGK 632 (673)
Q Consensus 558 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (673)
.... ........++..|+|||++.+..++.++|||||||++|||+||+.||............ ... ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~-~~~--~~~~~~ 229 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-GAH--RGLMPR 229 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh-hhc--cCCCCC
Confidence 3211 01112345788999999999888999999999999999999999998653322111110 000 011112
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 633 FSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 633 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+...+.++.+++.+||+.+|++||++.|+++
T Consensus 230 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 230 LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 23345578899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.83 Aligned_cols=254 Identities=18% Similarity=0.308 Sum_probs=196.0
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHH-HhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKI-LTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
++|++.+.||+|+||.||+++.. +|+.||+|++..........++..|+.+ ++.++||||+++++++... +..++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE--GDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC--CcEEEE
Confidence 36888899999999999999976 4999999999765433344566677775 5667999999999998654 678999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||++ |+|.+++.........+++..+..++.||+.||+|||+.. +++||||||+||++++++.+||+|||+++....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL-SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC-CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99996 6888887643333457899999999999999999999742 699999999999999999999999999986643
Q ss_pred cchhhhhccCCCCCccCCccccC----CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTT----GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ................
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~ 231 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ---QLKQVVEEPSPQLPAE 231 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH---HHHHHHhcCCCCCCcc
Confidence 22 1223457888999998864 4468999999999999999999999864322111 1111111111111112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+.++.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 232 KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 34578999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=313.80 Aligned_cols=254 Identities=18% Similarity=0.295 Sum_probs=202.8
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|+..+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++... +..+++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-GDDFEIIQQEISMLKECRHPNIVAYFGSYLRR--DKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-hhhHHHHHHHHHHHHhCCCCChhceEEEEEeC--CEEEEE
Confidence 357888899999999999999975 47889999987654 23557899999999999999999999988554 678999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~--~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 79 MEYCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET--GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred EeCCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC--CceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 9999999999988632 24588999999999999999999987 799999999999999999999999999876543
Q ss_pred cchhhhhccCCCCCccCCccccCC---CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTG---RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (673)
... ......++..|+|||.+... .++.++||||||+++|||+||+.||..................+. .......
T Consensus 154 ~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (262)
T cd06613 154 TIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP-KLKDKEK 231 (262)
T ss_pred hhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc-cccchhh
Confidence 211 12234577889999999876 789999999999999999999999865432211111111111111 1112334
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 637 EASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+.++.+++.+||+.+|.+|||+.+|+.
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 232 WSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 5678999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=319.68 Aligned_cols=261 Identities=18% Similarity=0.294 Sum_probs=204.7
Q ss_pred CHHHHHHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEec
Q 005859 393 NLEEVERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCS 470 (673)
Q Consensus 393 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 470 (673)
++.++..+.+.|+..+.||+|+||.||+|+.. +++.||+|.+.... ....++..|+.+++++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 45666667788999999999999999999975 48899999886542 3345788999999998 79999999999854
Q ss_pred C----CCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCe
Q 005859 471 K----GRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNP 546 (673)
Q Consensus 471 ~----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~ 546 (673)
. ..+..+++|||+++|+|.+++.... ...+++..+..++.|++.||+|||+. ||+||||||+||++++++.+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~--~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH--KVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCE
Confidence 2 2357899999999999999986432 23578888999999999999999987 79999999999999999999
Q ss_pred eeccccccccccCcchhhhhccCCCCCccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch
Q 005859 547 LLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTT-----TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV 621 (673)
Q Consensus 547 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~ 621 (673)
+|+|||+++....... ......++..|+|||.+. ...++.++|||||||++|||+||+.||..........
T Consensus 161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~--- 236 (282)
T cd06636 161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF--- 236 (282)
T ss_pred EEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---
Confidence 9999999876542211 122345788999999876 3458889999999999999999999986543221111
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 622 EDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...............+.++.+++.+||+.||.+||++.|+++
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 -LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 111111111112234578999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=315.44 Aligned_cols=248 Identities=22% Similarity=0.395 Sum_probs=198.6
Q ss_pred CccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCc--------HHHHHHHHHHHhccCCCCceeEeeEEecCCCC
Q 005859 404 FSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSD--------EGEFLKGLKILTSLKHENLASLRGICCSKGRG 474 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 474 (673)
|.....||+|+||.||+|... +++.||+|.+........ .+.+.+|++++++++||||+++++++... +
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 79 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA--D 79 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--C
Confidence 566788999999999999865 488999998876532211 14678899999999999999999998654 6
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLH 554 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla 554 (673)
..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. |++||||+|+||++++++.+||+|||.+
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~--~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR--GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred ccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc--CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 78999999999999999963 24588999999999999999999987 8999999999999999999999999999
Q ss_pred ccccCcchh-----hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcC
Q 005859 555 KLLADDIVF-----SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNL 629 (673)
Q Consensus 555 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 629 (673)
+........ ......++..|+|||.+.+..++.++|||||||++|||+||+.||.......... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~--- 229 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-KIGENAS--- 229 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH-HHhccCC---
Confidence 876532111 1112347788999999998889999999999999999999999987543221111 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 630 EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 630 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...+...+..+.+++.+||+.||.+||++.||++
T Consensus 230 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 230 -PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 2233345678899999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=318.34 Aligned_cols=251 Identities=18% Similarity=0.327 Sum_probs=202.3
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
+|+..+.||+|+||.||++..+ +++.||+|.+..........++.+|++++++++||||+++++++... +..++|+|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEEEE
Confidence 5777789999999999999976 48999999987764344456789999999999999999999998654 78999999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhc-CCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHG-KRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
|+++++|.+++.... ..+++..+.+++.|++.||+|||+ . |++||||||+||++++++.+||+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 80 YMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred ecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC--CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 999999999987432 568899999999999999999998 6 8999999999999999999999999998765432
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhh-hccchhhhcCCcCCCCCCHH-HH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA-ESSKVEDFIDPNLEGKFSVS-EA 638 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~ 638 (673)
.. ....++..|+|||++.+..++.++||||||+++|||++|+.||........ .............. ..+.. .+
T Consensus 155 ~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 230 (265)
T cd06605 155 LA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP-RLPSGKFS 230 (265)
T ss_pred Hh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC-CCChhhcC
Confidence 21 125678889999999988999999999999999999999999865421100 00111111111111 11222 56
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.++.+++.+||..||++|||+.+++.
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 231 PDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 78999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=314.94 Aligned_cols=247 Identities=23% Similarity=0.429 Sum_probs=198.9
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
++|...+.||+|+||.||++.. +++.||+|.+... ...+.+.+|+.++++++||||+++++++.. +..++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~v~e 78 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYIVME 78 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc---chHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEEEEE
Confidence 4577888999999999999975 5788999988643 234678999999999999999999999854 34689999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+++|+|.+++... ....+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||+++......
T Consensus 79 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~--~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 79 LMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK--KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154 (254)
T ss_pred CCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence 99999999999743 224588999999999999999999987 89999999999999999999999999987643321
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
.....+..|+|||++.+..++.++|||||||++|||++ |+.||.......... ... .......+...+..
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~ 225 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE-CVE----KGYRMEPPEGCPAD 225 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHH-HHh----CCCCCCCCCcCCHH
Confidence 12234567999999988889999999999999999998 888886543322111 111 11111223345678
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
+.+++.+||+.+|++||+++++++.|++
T Consensus 226 ~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 226 VYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 8999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=321.44 Aligned_cols=249 Identities=14% Similarity=0.246 Sum_probs=201.3
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
.+|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.. .+..++||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEee
Confidence 57888899999999999999964 58999999987644 2345678899999999999999999999855 47899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++.. ..+++..+..++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++......
T Consensus 96 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~--~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 96 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred cccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 99999999999852 3478899999999999999999987 8999999999999999999999999998765433
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
.. ......++..|+|||.+.+..++.++|||||||++||++||+.||............ .. ........+...+..
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~ 244 (297)
T cd06656 169 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-AT--NGTPELQNPERLSAV 244 (297)
T ss_pred cc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-cc--CCCCCCCCccccCHH
Confidence 21 122345788899999999888999999999999999999999998653221111100 00 011111123344567
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.+++.+||+.+|++||+++++++
T Consensus 245 ~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 245 FRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HHHHHHHHccCChhhCcCHHHHhc
Confidence 889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.82 Aligned_cols=252 Identities=17% Similarity=0.313 Sum_probs=190.0
Q ss_pred ccccccC--CcceEEEEEEc-CCcEEEEEEecccCCCCc-HHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEee
Q 005859 407 ANLLGKS--SFSATYKGILR-DGSVVAVKCIAKTSCKSD-EGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDF 482 (673)
Q Consensus 407 ~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~ 482 (673)
.++||+| +|++||+++.+ +|+.||+|++........ .+.+.+|+++++.++||||+++++++..+ +..++||||
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e~ 80 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVVTSF 80 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CEEEEEEec
Confidence 4679999 67899999865 589999999976543222 34567899999999999999999999654 678999999
Q ss_pred cCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcch
Q 005859 483 VPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV 562 (673)
Q Consensus 483 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 562 (673)
+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.++++||+..........
T Consensus 81 ~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~--~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 81 MAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM--GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred cCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999986432 23489999999999999999999987 799999999999999999999999987544321110
Q ss_pred -h-----hhhccCCCCCccCCccccC--CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc----hhhhcC----
Q 005859 563 -F-----SMLKASAAMGYLAPEYTTT--GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK----VEDFID---- 626 (673)
Q Consensus 563 -~-----~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~----~~~~~~---- 626 (673)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||............ .....+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 0 0112245677999999976 45899999999999999999999998643221110000 000000
Q ss_pred ---------------CcC-----------------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 627 ---------------PNL-----------------EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 627 ---------------~~~-----------------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
... ........+..+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 00111223567899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=352.68 Aligned_cols=266 Identities=23% Similarity=0.406 Sum_probs=217.3
Q ss_pred HHHHhcCCccccccccCCcceEEEEEEcC--------CcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeE
Q 005859 397 VERATQCFSEANLLGKSSFSATYKGILRD--------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGI 467 (673)
Q Consensus 397 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~ 467 (673)
++...++....+.||+|.||.|++|.... ...||||.++......+.+.+..|+++|+.+ +||||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 34444445555689999999999998431 3479999998876666778999999999999 69999999999
Q ss_pred EecCCCCeEEEEEeecCCCChhhhhcccc---C---C----c--cccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCC
Q 005859 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEA---G---S----E--KVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSA 535 (673)
Q Consensus 468 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---~---~----~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~ 535 (673)
|.. .+..++|+||++.|+|.++++..+ . . . ..++..+.+.++.|||.||+||++. ++|||||.+
T Consensus 371 ~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~--~~vHRDLAa 446 (609)
T KOG0200|consen 371 CTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV--PCVHRDLAA 446 (609)
T ss_pred ecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC--Cccchhhhh
Confidence 966 577899999999999999998655 0 0 1 2388999999999999999999997 599999999
Q ss_pred CCeEecCCCCeeeccccccccccCcchhhhhccC--CCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhh
Q 005859 536 EKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKAS--AAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFT 612 (673)
Q Consensus 536 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~ 612 (673)
+|||+.++..+||+|||+|+....+......... -...|||||.+....|+.|+|||||||+||||+| |..||....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999976655444333223 3556999999999999999999999999999999 888886532
Q ss_pred HhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 613 RQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
... .+.+.+....+.+.|..+..+++++|..||+.+|++||++.++++.++..+
T Consensus 527 ~~~----~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 527 PTE----ELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred cHH----HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 111 112234444455667778899999999999999999999999999998854
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=320.40 Aligned_cols=249 Identities=16% Similarity=0.268 Sum_probs=201.3
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
.+|...+.||.|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.. .+..++||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLV--GDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEec--CceEEEEE
Confidence 46888899999999999999864 58999999987543 3345678899999999999999999999855 47899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++.. ..+++.++..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++......
T Consensus 96 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~--~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 96 EYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN--QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred EecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 99999999998852 3589999999999999999999987 8999999999999999999999999998865443
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
.. ......++..|+|||.+.+..++.++|||||||++|||+||+.||........... ......+. ...+...+..
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~ 244 (296)
T cd06655 169 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IATNGTPE--LQNPEKLSPI 244 (296)
T ss_pred cc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcCCcc--cCCcccCCHH
Confidence 21 12234578899999999988899999999999999999999999865432211111 11000111 1123345567
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.+++.+||..||++||++.++++
T Consensus 245 ~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 245 FRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHHHHHhhcChhhCCCHHHHhh
Confidence 899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.44 Aligned_cols=254 Identities=18% Similarity=0.304 Sum_probs=196.6
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|...+.||+|+||.||+|+.+ +++.||+|.+...........+.+|++++++++||||+++++++.. .+..++||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTLVF 83 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec--CCeEEEEE
Confidence 46888899999999999999976 4889999998765434445578899999999999999999999854 47899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||++ ++|.+++... ...+++..+..++.|+++||+|||+. ||+||||||+||++++++.+||+|||+++.....
T Consensus 84 e~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 84 EYLD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR--KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred eccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 9996 6998888632 24588999999999999999999987 8999999999999999999999999998765432
Q ss_pred chhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhcc-----------chhhhcC--
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESS-----------KVEDFID-- 626 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~-----------~~~~~~~-- 626 (673)
.. ......++..|+|||.+.+. .++.++|||||||++|||+||+.||........... .......
T Consensus 158 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 158 TK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred CC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 21 11233467889999988754 478999999999999999999999865322111000 0000000
Q ss_pred -------CcCCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 627 -------PNLEG----KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 627 -------~~~~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.... ......+..+.+++.+|++.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 011223567889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.26 Aligned_cols=245 Identities=23% Similarity=0.364 Sum_probs=199.6
Q ss_pred cccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCCC
Q 005859 408 NLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNG 486 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~g 486 (673)
-+||+|.||+||-|+..+ ...+|||.+.... ....+...+|+.+-++++|.|||+++|.+. ..+..-|.||.++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~s--enGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVS--ENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccC--CCCeEEEEeecCCCC
Confidence 379999999999999765 5579999997654 344567889999999999999999999984 347888999999999
Q ss_pred ChhhhhccccCCcccc--CHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC-CCCeeeccccccccccCcchh
Q 005859 487 NLLQHLDLEAGSEKVL--EWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR-RYNPLLSDSGLHKLLADDIVF 563 (673)
Q Consensus 487 sL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~ 563 (673)
+|.++|+.+=+ ++ .+.+.-.+.+||++||.|||+. .|||||||-+|||++. .|.+||+|||.++.+..-...
T Consensus 658 SLSsLLrskWG---PlKDNEstm~fYtkQILeGLkYLHen--~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 658 SLSSLLRSKWG---PLKDNESTMNFYTKQILEGLKYLHEN--KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred cHHHHHHhccC---CCccchhHHHHHHHHHHHHhhhhhhc--ceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 99999974432 34 5667778999999999999998 4999999999999974 678999999999987653322
Q ss_pred hhhccCCCCCccCCccccCCC--CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHH
Q 005859 564 SMLKASAAMGYLAPEYTTTGR--FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641 (673)
Q Consensus 564 ~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 641 (673)
.....||..|||||++..+. |..++|||||||++.||.||++||...........++. --...+..+++.+.+.
T Consensus 733 -TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG---myKvHP~iPeelsaea 808 (1226)
T KOG4279|consen 733 -TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG---MYKVHPPIPEELSAEA 808 (1226)
T ss_pred -ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc---ceecCCCCcHHHHHHH
Confidence 33467999999999998654 99999999999999999999999976543322221111 1122345677888999
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 005859 642 GQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 642 ~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..++.+|+.+||.+||+++++++
T Consensus 809 k~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 809 KNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHcCCCcccCccHHHhcc
Confidence 99999999999999999999875
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=312.28 Aligned_cols=251 Identities=19% Similarity=0.318 Sum_probs=203.1
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+|+..+.||+|+||.||.++.. +++.|++|.+..... .....++.+|++++++++|+||+++++++.+. +..++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD--NTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC--CeEEEEE
Confidence 4788899999999999999855 488999998875432 23346789999999999999999999999654 7889999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++|+|.+++.... ...+++..+..++.|++.||+|||+. |++||||||+||++++++.+||+|||+++.....
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 79 EYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA--GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred EecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 9999999999997432 34689999999999999999999987 7999999999999999999999999999876543
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
.. ......++..|+|||++.+..++.++||||||+++|||++|+.||........ ...+...... ..+...+.+
T Consensus 155 ~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~----~~~~~~~~~~-~~~~~~~~~ 228 (256)
T cd08221 155 YS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL----VVKIVQGNYT-PVVSVYSSE 228 (256)
T ss_pred cc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHcCCCC-CCccccCHH
Confidence 32 22334578899999999888899999999999999999999999865322211 1111111111 122344578
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
+.+++.+||+.+|++||+++++++.
T Consensus 229 ~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 229 LISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHHHHHHcccCcccCCCHHHHhhC
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=318.61 Aligned_cols=255 Identities=19% Similarity=0.273 Sum_probs=195.3
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+|+..+.||+|+||.||+|+.+ +++.||||.+..... ......+.+|+.++++++||||+++++++.. .+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEE
Confidence 4778889999999999999976 589999999865432 2234678899999999999999999999865 47889999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||++ ++|.+++.... ....+++..+..++.|+++||+|||+. ||+||||||+||++++++.+||+|||+++.....
T Consensus 79 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR--RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC--CeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 9997 68988886432 235689999999999999999999987 8999999999999999999999999998765432
Q ss_pred chhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh-----------------
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE----------------- 622 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~----------------- 622 (673)
. .......++..|+|||.+.+. .++.++|||||||++|||+||+.||..............
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 155 V-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred c-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 1 112233567889999988754 478999999999999999999999864322111000000
Q ss_pred h---hcCCcCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 623 D---FIDPNLE---GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 623 ~---~~~~~~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
. ....... .......+.++.+++.+||+.||++|||+.+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 0000000 0001123567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=312.18 Aligned_cols=251 Identities=20% Similarity=0.336 Sum_probs=201.1
Q ss_pred CCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+|+..+.||+|+||.||++..+. ++.||+|.+..... ....+.+.+|++++++++|||++++++.+... ....++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEe
Confidence 47788999999999999999664 78999999875432 23345788999999999999999999877432 34678999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++... ....+++.+++.++.|++.|++|||+. ||+||||||+||++++++.++|+|||+++.....
T Consensus 80 e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~--~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 80 GFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK--HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred cccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999998743 234589999999999999999999987 8999999999999999999999999999866432
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
.. ......++..|+|||++.+..++.++||||||+++|||++|+.||............... .....+...+..
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 229 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG-----KLPPMPKDYSPE 229 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-----CCCCCccccCHH
Confidence 21 122345788999999999888999999999999999999999998654322111111111 111223445678
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 230 LGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHHHHHHHhccCcccCCCHHHHhc
Confidence 999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=315.70 Aligned_cols=259 Identities=22% Similarity=0.336 Sum_probs=200.0
Q ss_pred CccccccccCCcceEEEEEEc----CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC----C
Q 005859 404 FSEANLLGKSSFSATYKGILR----DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGR----G 474 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~ 474 (673)
|...+.||+|+||.||+|.+. .++.||||++..... ....+++.+|++++++++||||+++++++..... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456778999999999999854 368899999876432 2234578899999999999999999998865322 1
Q ss_pred eEEEEEeecCCCChhhhhcccc--CCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEA--GSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSG 552 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfG 552 (673)
..++++||+++|+|.+++.... .....+++..+++++.|++.||+|||+. ||+||||||+||++++++.+|++|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~--~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK--NFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CEeecccchhhEEEcCCCCEEECccc
Confidence 3478999999999998875322 1223578999999999999999999987 89999999999999999999999999
Q ss_pred ccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCC
Q 005859 553 LHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLE 630 (673)
Q Consensus 553 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 630 (673)
+++....... .......++..|++||.+....++.++||||||+++|||++ |+.||........... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~---- 233 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY-LIKGNR---- 233 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHH-HHcCCc----
Confidence 9986643221 11122334567999999988889999999999999999999 8888765432211111 111101
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 005859 631 GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSI 669 (673)
Q Consensus 631 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i 669 (673)
...+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 234 ~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 112233457899999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=312.84 Aligned_cols=251 Identities=26% Similarity=0.485 Sum_probs=200.3
Q ss_pred ccccccccCCcceEEEEEEcC-----CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 405 SEANLLGKSSFSATYKGILRD-----GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 405 ~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
...+.||.|+||.||+++..+ +..||+|.+.........+.+..|++++++++|+||+++++++... +..+++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~i 79 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPLMIV 79 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--CeeEEE
Confidence 456789999999999999764 3889999997654333567899999999999999999999998654 678999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++++|.+++..... ..+++..+..++.|++.||+|||+. |++||||||+||++++++.++|+|||+++....
T Consensus 80 ~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~--~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK--NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC--CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 999999999999874321 1289999999999999999999988 799999999999999999999999999987665
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
..........++..|+|||.+.+..++.++||||+|+++|||++ |..||.......... .... ......+...+
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~ 230 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLE----YLKK-GYRLPKPENCP 230 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHhc-CCCCCCCCcCC
Confidence 43222222346788999999988889999999999999999999 777775432211111 1111 11112223356
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQEL 666 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L 666 (673)
.++.+++.+||+.||++|||+.|+++.|
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 231 PEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 7899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.24 Aligned_cols=256 Identities=18% Similarity=0.322 Sum_probs=195.0
Q ss_pred CCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+|...+.||+|+||.||++.... ++.||+|.+...........+.+|+.++.++. ||||+++++++.. .+..+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEEEE
Confidence 34456789999999999999764 89999999876543344567899999999996 9999999998854 46788999
Q ss_pred eecCCCChhhhhccc-cCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 481 DFVPNGNLLQHLDLE-AGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 481 E~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
||+. +++.++.... ......+++..+.+++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL-KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC-CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9985 4555443211 112246899999999999999999999732 799999999999999999999999999976543
Q ss_pred cchhhhhccCCCCCccCCccccCC---CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTG---RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (673)
... .....++..|+|||++... .++.++|||||||++|||++|+.||..................+.+.......
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence 321 1233578889999998866 68999999999999999999999986543211111111111112222222234
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 637 EASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+.++.+++.+||+.+|++|||+++|++
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 5678999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=320.26 Aligned_cols=253 Identities=18% Similarity=0.336 Sum_probs=200.3
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
+|+..+.||+|+||.||++... +++.||+|.+...........+.+|++++++++||||+++++++.. .+..++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEEEe
Confidence 5777889999999999999976 5899999988754322334678999999999999999999998855 478999999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+++++|.+++.... ....+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 80 YMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH-NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred ecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC-CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 999999999886421 1236899999999999999999999632 79999999999999999999999999987654321
Q ss_pred hhhhhccCCCCCccCCccccCC------CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTG------RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
.....++..|+|||.+.+. .++.++|||||||++|||+||+.||........ ......+... .....+.
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~-~~~~~~~ 232 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-FAQLSAIVDG-DPPTLPS 232 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH-HHHHHHHhhc-CCCCCCc
Confidence 2234577889999998644 358899999999999999999999865322111 1111112111 1122334
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+.++.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 233 GYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 46688999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=339.57 Aligned_cols=250 Identities=18% Similarity=0.237 Sum_probs=192.1
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
..+|.+.+.||+|+||.||+|.... ++.||||... ...+.+|+++|++++|||||++++++... +..++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~--~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVG--GLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEEEE
Confidence 3479999999999999999999775 7899999532 22467899999999999999999998654 678999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+ .++|.+++... ...++|..++.|+.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 239 ~e~~-~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~--gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 239 LPKY-RSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE--GIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred EEcc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC--CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 9999 47999888632 23699999999999999999999987 899999999999999999999999999987643
Q ss_pred cchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHh-------hhhccchhhh------c
Q 005859 560 DIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQ-------AAESSKVEDF------I 625 (673)
Q Consensus 560 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~-------~~~~~~~~~~------~ 625 (673)
.... ......||..|+|||++.+..++.++|||||||++|||++|..|+...... ......+... .
T Consensus 313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 3211 112346899999999999989999999999999999999987664321100 0000000000 0
Q ss_pred --------------------CCcCCC-CCC--HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 626 --------------------DPNLEG-KFS--VSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 626 --------------------~~~~~~-~~~--~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
.+.... .+. ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000 000 0123468899999999999999999999864
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=318.00 Aligned_cols=251 Identities=18% Similarity=0.301 Sum_probs=197.7
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+.|++.+.||+|+||.||+|+... ++.||+|.+.... ....+.+.+|++++++++||||+++++++... +..++||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWD--GKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC--CeEEEEE
Confidence 467788899999999999999765 8899999987543 23346788999999999999999999998654 6789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|..++... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++......
T Consensus 89 e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 89 EFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM--KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred ecCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC--CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 999999998887532 24589999999999999999999987 8999999999999999999999999998754332
Q ss_pred chhhhhccCCCCCccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 561 IVFSMLKASAAMGYLAPEYTT-----TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
.. ......++..|+|||++. ...++.++|||||||++|||++|+.||.......... .......+.. ..+.
T Consensus 164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~--~~~~ 239 (292)
T cd06644 164 LQ-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL-KIAKSEPPTL--SQPS 239 (292)
T ss_pred cc-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHH-HHhcCCCccC--CCCc
Confidence 11 122345778899999985 3447889999999999999999999986543211111 1111111111 1223
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+.++.+++.+||+.+|++||++.++++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 240 KWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 34567899999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=316.29 Aligned_cols=258 Identities=19% Similarity=0.339 Sum_probs=203.6
Q ss_pred HHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCC----
Q 005859 399 RATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKG---- 472 (673)
Q Consensus 399 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~---- 472 (673)
.++++|+..+.||+|+||.||+|... +++.+++|++.... ...+++.+|+++++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 45688999999999999999999976 47899999987653 2446799999999999 7999999999986543
Q ss_pred CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccc
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSG 552 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfG 552 (673)
.+..++||||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~--~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN--KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC--CcccCCCCHHHEEEccCCeEEECCCc
Confidence 3468999999999999999864332345689999999999999999999987 79999999999999999999999999
Q ss_pred ccccccCcchhhhhccCCCCCccCCccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCC
Q 005859 553 LHKLLADDIVFSMLKASAAMGYLAPEYTTT-----GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDP 627 (673)
Q Consensus 553 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 627 (673)
++........ ......++..|+|||++.. ..++.++|||||||++|||+||+.||............ .....+
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~ 236 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI-PRNPPP 236 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh-hccCCC
Confidence 9876543221 2223457889999998753 34788999999999999999999998654222111111 111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 628 NLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 628 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.. ..+...+..+.+++.+||..||++|||+.++++
T Consensus 237 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 237 TL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 112234578999999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=317.85 Aligned_cols=253 Identities=19% Similarity=0.293 Sum_probs=200.2
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|.+.+.||+|+||.||++... ++..||+|++.... ....+.|.+|++++++++||||+++++++.. .+..++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFY--ENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEec--CCeEEEE
Confidence 356888889999999999999975 58899999986542 2334678999999999999999999999864 4678999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++++|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~--~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 81 IEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH--KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred eeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 9999999999998632 24589999999999999999999987 799999999999999999999999999876543
Q ss_pred cchhhhhccCCCCCccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 560 DIVFSMLKASAAMGYLAPEYTT-----TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
... ......++..|+|||.+. ...++.++||||||+++|||++|+.||.......... .+.....+.+ ..+
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~--~~~ 231 (280)
T cd06611 156 TLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL-KILKSEPPTL--DQP 231 (280)
T ss_pred ccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH-HHhcCCCCCc--CCc
Confidence 221 122345788999999875 3447889999999999999999999986543221111 1111111111 122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
...+.++.+++.+||+.+|++||++.++++.
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 232 SKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 3345678999999999999999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=321.43 Aligned_cols=256 Identities=18% Similarity=0.233 Sum_probs=199.5
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|+..+.||+|+||.||++.... ++.||+|.+..... ......+.+|+++++.++||||+++++.+.. .+..++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEE
Confidence 368888999999999999999765 78999999876532 1234578899999999999999999998854 468899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||++++++.+|++|||+++...
T Consensus 79 v~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 79 VMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY--GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred EEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 9999999999999963 24589999999999999999999987 89999999999999999999999999987421
Q ss_pred Ccch--------------hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhh
Q 005859 559 DDIV--------------FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF 624 (673)
Q Consensus 559 ~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~ 624 (673)
.... .......++..|+|||.+....++.++|||||||++|||++|+.||.+..............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~ 232 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 232 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 1000 00112346778999999988889999999999999999999999986543222111111111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 625 IDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
. ... ......+.++.+++.+||+.||++||++.++.+.|+.
T Consensus 233 ~--~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 233 I--EWP-EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred c--CCC-CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0 000 1111345778999999999999999997666666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=317.65 Aligned_cols=251 Identities=25% Similarity=0.450 Sum_probs=197.6
Q ss_pred CccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcH-HHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 404 FSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDE-GEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
|+..+.||+|+||+||+++... ++.||+|++......... ....+|++++++++||||+++++++.. ....++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 5667899999999999999775 678999999876432222 234569999999999999999999966 478899999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+++++|.+++. ....+++..+..++.|+++||+|||+. ||+||||||+||++++++.++|+|||.+......
T Consensus 79 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~--~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~- 151 (260)
T PF00069_consen 79 YCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK--GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN- 151 (260)
T ss_dssp EETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT--TEEESSBSGGGEEESTTSEEEESSGTTTEESTST-
T ss_pred cccccccccccc----ccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccc-
Confidence 999999999997 235689999999999999999999997 8999999999999999999999999998764211
Q ss_pred hhhhhccCCCCCccCCcccc-CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCC--CCCCHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTT-TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLE--GKFSVSEA 638 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 638 (673)
........++..|+|||.+. +..++.++||||+|+++|+|++|+.||......... ............ ........
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 230 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL-EIIEKILKRPLPSSSQQSREKS 230 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH-HHHHHHHHTHHHHHTTSHTTSH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhh-hhhhhcccccccccccccchhH
Confidence 11233456788999999998 778999999999999999999999998765111110 011111110000 00011123
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+.+++.+||+.||++||++.++++
T Consensus 231 ~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 231 EELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 78999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=333.06 Aligned_cols=250 Identities=16% Similarity=0.245 Sum_probs=194.0
Q ss_pred hcCCccccccccCCcceEEEEEEcC---CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD---GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
..+|.+.+.||+|+||.||++...+ +..||+|.+... ..+.+|++++++++|||||++++++.. .+..+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRW--KSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEee--CCEEE
Confidence 3579999999999999999998543 578999987543 245689999999999999999998854 36789
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+. ++|.+++. ....+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 163 lv~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~--givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 163 MVMPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR--GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EEehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 9999995 68988884 235689999999999999999999987 8999999999999999999999999999766
Q ss_pred cCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhh---hccchh-----------
Q 005859 558 ADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA---ESSKVE----------- 622 (673)
Q Consensus 558 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~---~~~~~~----------- 622 (673)
...... ......||..|+|||++....++.++|||||||++|||++|+.||........ ......
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 543211 12245689999999999988999999999999999999999999864321100 000000
Q ss_pred --------hh--cCCcCCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 623 --------DF--IDPNLEGKFS-------VSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 623 --------~~--~~~~~~~~~~-------~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
.+ ........+. ...+.++.+++.+||..||++|||+.|++..
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0000000000 1124568889999999999999999999853
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=309.96 Aligned_cols=248 Identities=21% Similarity=0.332 Sum_probs=199.8
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC----CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK----SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
+|...+.||+|+||+||+|... +++.|++|.+...... ...+.+.+|++++++++||||+++++++.. .+..+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--EDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec--CCeEE
Confidence 3667789999999999999976 6899999998654321 123578899999999999999999999854 46789
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||+. ||+|+||+|+||+++.++.+||+|||++...
T Consensus 79 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 79 IFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR--NTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 99999999999999863 23588999999999999999999987 8999999999999999999999999998866
Q ss_pred cCcchhhhhccCCCCCccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (673)
.... ......++..|+|||.+.... ++.++|||||||++|||++|+.||............ . ........+..
T Consensus 153 ~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~-~---~~~~~~~~~~~ 226 (258)
T cd06632 153 VEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI-G---RSKELPPIPDH 226 (258)
T ss_pred cccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHH-H---hcccCCCcCCC
Confidence 4432 123345788899999988766 899999999999999999999998665422111111 1 10111122334
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 637 EASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+..+.+++.+||+.+|++||++.++++
T Consensus 227 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 227 LSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 4578899999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=317.04 Aligned_cols=254 Identities=20% Similarity=0.317 Sum_probs=193.4
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|+..+.||+|+||.||+|..+ +++.||||.+...........+.+|++++++++||||+++++++.. .+..++||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT--KKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec--CCeEEEEE
Confidence 56888899999999999999976 5899999998765433334567889999999999999999999854 47899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||++ ++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~--~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 83 EYLD-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR--RVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred ecCC-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC--CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 9997 5999988632 23688999999999999999999987 7999999999999999999999999998754321
Q ss_pred chhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcC-------------
Q 005859 561 IVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFID------------- 626 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~------------- 626 (673)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||..............+...
T Consensus 157 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 157 SK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred Cc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 11 1122345778999999875 45899999999999999999999998543211000000000000
Q ss_pred -------------CcCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 627 -------------PNLEGKF-SVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 627 -------------~~~~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+.... ......++.+++.+|++.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000 0011267789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=328.65 Aligned_cols=254 Identities=18% Similarity=0.269 Sum_probs=194.8
Q ss_pred HHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCC----
Q 005859 399 RATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKG---- 472 (673)
Q Consensus 399 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 472 (673)
...++|...+.||+|+||.||+|... +++.||||++...... ...+.+.+|++++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999965 5889999998754321 23356789999999999999999999875322
Q ss_pred CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccc
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSG 552 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfG 552 (673)
....++++|++ +++|.+++. ...+++..+..++.||+.||+|||+. ||+||||||+||++++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA--GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeecccCChhhEEECCCCCEEEcCCc
Confidence 24578999998 789988875 23589999999999999999999987 89999999999999999999999999
Q ss_pred ccccccCcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch----------
Q 005859 553 LHKLLADDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV---------- 621 (673)
Q Consensus 553 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~---------- 621 (673)
+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.............
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99876542 223468899999999876 468999999999999999999999986432111000000
Q ss_pred ---------hhhcC--CcCCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 622 ---------EDFID--PNLEGK----FSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 622 ---------~~~~~--~~~~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..... +..... ......+.+.+++.+|++.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 000000 00012345789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.23 Aligned_cols=254 Identities=18% Similarity=0.261 Sum_probs=196.8
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
++|+..+.||+|+||.||+|+.+ +|+.||+|++..... ....+.+.+|++++++++||||+++++++.. ....++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEEEE
Confidence 36888899999999999999977 489999999875432 2234568899999999999999999999855 4678999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||++++.|..++.. ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 79 FEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH--NCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred EeccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 999999888877652 23589999999999999999999987 899999999999999999999999999987654
Q ss_pred cchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc---h--------------
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK---V-------------- 621 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~---~-------------- 621 (673)
... ......++..|+|||++.+ ..++.++|||||||++|||+||+.||............ .
T Consensus 153 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 153 PGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred Ccc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 321 1122346788999999876 45889999999999999999999998643221110000 0
Q ss_pred ---hhhcCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 622 ---EDFIDPNLEGKFS-----VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 622 ---~~~~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.....+......+ ...+..+.+++.+||+.+|++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000011000000 123567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=311.08 Aligned_cols=252 Identities=21% Similarity=0.368 Sum_probs=199.9
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+|...+.||+|+||.||+|... +++.||+|.+...... ...+.+.+|++++++++|+||+++++++.. .+..++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--REKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec--CCEEEEEE
Confidence 4777889999999999999965 5889999998765432 245688999999999999999999998744 47899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. ||+|+||+|+||++++++.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~--~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 79 EYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH--GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred ecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 99999999999863 23578999999999999999999987 7999999999999999999999999998876543
Q ss_pred chhhh---hccCCCCCccCCccccCCC---CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 561 IVFSM---LKASAAMGYLAPEYTTTGR---FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 561 ~~~~~---~~~~gt~~y~aPE~~~~~~---~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
..... ....++..|+|||++.... ++.++||||||+++||+++|+.||..................+... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~ 230 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIP--DS 230 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCC--cc
Confidence 22111 1245678899999998766 8999999999999999999999986542211111111111111111 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...+..+.+++.+||+.+|++||++.|++.
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 231 LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 123577889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=310.62 Aligned_cols=250 Identities=17% Similarity=0.321 Sum_probs=201.5
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+|+..+.||+|+||.||+++.. +|+.||+|.+..... .....++.+|++++++++||||+++++++.. .+..++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEEEEE
Confidence 4788899999999999999965 588999999875422 2334578999999999999999999999844 47899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++.... ...+++..+++++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 79 DYCEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR--KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred ecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 9999999999886432 23578999999999999999999987 7999999999999999999999999999866543
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
.. ......++..|+|||+..+..++.++|||||||++|||+||+.||......... ....... ....+...+.+
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~ 228 (256)
T cd08218 155 VE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV----LKIIRGS-YPPVSSHYSYD 228 (256)
T ss_pred hh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH----HHHhcCC-CCCCcccCCHH
Confidence 22 122345788899999999888999999999999999999999998653222111 1111111 11223345678
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.+++.+||+.+|++||++++|++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 229 LRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhh
Confidence 999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=297.67 Aligned_cols=246 Identities=18% Similarity=0.334 Sum_probs=194.1
Q ss_pred cccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCeEEEEEeecCC
Q 005859 408 NLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGICCSKGRGECFLIYDFVPN 485 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~lv~E~~~~ 485 (673)
..||.|+.|.|++++++. |..+|||.+.+...+.+-++++..++++.+-+ .|.||+.+|||... ..+++.||.|.
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n--~dV~IcMelMs- 174 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN--TDVFICMELMS- 174 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC--chHHHHHHHHH-
Confidence 469999999999999775 89999999988765555577888888887764 99999999999765 45778899983
Q ss_pred CChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhhh
Q 005859 486 GNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSM 565 (673)
Q Consensus 486 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 565 (673)
.-+..++.. ...++++..+-++...+.+||.||.+++ ||+|||+||+|||+|+.|++|++|||++..+.+.. ..
T Consensus 175 ~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Ah 248 (391)
T KOG0983|consen 175 TCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AH 248 (391)
T ss_pred HHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEEeecccccceeeccc--cc
Confidence 234444442 2346888888899999999999999966 89999999999999999999999999998776654 34
Q ss_pred hccCCCCCccCCccccC---CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHH
Q 005859 566 LKASAAMGYLAPEYTTT---GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLG 642 (673)
Q Consensus 566 ~~~~gt~~y~aPE~~~~---~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 642 (673)
++.+|.+.|||||.+.- .+|+.++|||||||+++||+||+.||............+.+-..|.++.. ...+..+.
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~--~gFSp~F~ 326 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGH--MGFSPDFQ 326 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcc--cCcCHHHH
Confidence 45678999999999873 46999999999999999999999999763222111112222222333222 22578899
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 005859 643 QIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 643 ~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+++..||..|+.+||...++++
T Consensus 327 ~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 327 SFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HHHHHHhhcCcccCcchHHHhc
Confidence 9999999999999999998875
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=326.82 Aligned_cols=192 Identities=18% Similarity=0.295 Sum_probs=162.9
Q ss_pred HhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
...+|.+.+.||+|+||.||+|+... ++.||+|..... ....|+.++++++||||+++++++... +..++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSG--AITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeC--CeeEE
Confidence 34579999999999999999999764 788999975332 245699999999999999999998654 67899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+ .++|.+++... ...+++..++.|+.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 135 v~e~~-~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 135 VLPHY-SSDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ--RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEEcc-CCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 99999 56898888632 34689999999999999999999987 89999999999999999999999999997543
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSI 608 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~ 608 (673)
... ......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 221 122346899999999999999999999999999999999966554
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.40 Aligned_cols=254 Identities=20% Similarity=0.316 Sum_probs=196.5
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCC-cHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKS-DEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
++|+..+.||+|+||.||+|..++ ++.||+|++....... ..+.+.+|++++++++||||+++++++.. .+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEEEE
Confidence 368888999999999999999864 8999999887643222 34578899999999999999999999854 4789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++++|.++... ...+++..++.++.||+.||+|||+. ||+||||+|+||++++++.+||+|||+++....
T Consensus 79 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 79 FEFVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred EecCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 999999999887652 23489999999999999999999987 899999999999999999999999999886644
Q ss_pred cchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc----------hhh-----
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK----------VED----- 623 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~----------~~~----- 623 (673)
... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||............ ...
T Consensus 153 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 153 PGE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred Ccc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 321 2223457788999999875 44789999999999999999999887532211100000 000
Q ss_pred -----hcCCcCCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 624 -----FIDPNLEG-----KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 624 -----~~~~~~~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...+.... ......+..+.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000 001133567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=318.90 Aligned_cols=253 Identities=17% Similarity=0.270 Sum_probs=193.3
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+|+..+.||+|+||.||+|+.. +|+.||+|++...... .....+.+|++++++++||||+++++++.+ .+..++|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS--DKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc--CCceEEEE
Confidence 4777889999999999999976 4899999998754321 223567889999999999999999999854 46789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||++ ++|.+++... ...+++..++.++.||++||+|||+. ||+||||||+||+++.++.+||+|||+++.....
T Consensus 79 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~--~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 79 EYCD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH--NVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred ecCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 9996 5888877532 24589999999999999999999987 7999999999999999999999999999865432
Q ss_pred chhhhhccCCCCCccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch---------------hhh
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV---------------EDF 624 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~---------------~~~ 624 (673)
.. ......++..|+|||++.+.. ++.++|||||||++|||+||+.|+.+..........+ ...
T Consensus 153 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 153 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 21 122345678899999987654 7999999999999999999998864322111100000 000
Q ss_pred cCCc----CCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 625 IDPN----LEG-----KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 625 ~~~~----~~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+.. ... ......+.++.+++.+||+.||++|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 000 001123567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.42 Aligned_cols=248 Identities=21% Similarity=0.366 Sum_probs=200.7
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
-|+..+.||+|+||.||+|... +++.||+|.+...........+.+|++++++++||||+++++++... +..++|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC--CeEEEEEE
Confidence 3667788999999999999865 58899999886544333446788999999999999999999998654 67899999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+++++|.+++.. ..+++..+..++.|++.|++|||+. |++|+||||+||+++.++.++|+|||+++......
T Consensus 83 ~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 83 YLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE--KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred eCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC--CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 9999999999852 3588999999999999999999987 89999999999999999999999999987664432
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 641 (673)
. ......++..|+|||++....++.++|||||||++|||++|..||........... +............+.++
T Consensus 156 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 229 (277)
T cd06641 156 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-----IPKNNPPTLEGNYSKPL 229 (277)
T ss_pred h-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH-----HhcCCCCCCCcccCHHH
Confidence 1 12234578889999999888899999999999999999999999865432211111 11111122333455778
Q ss_pred HHHHHHccccCCCCCCCHHHHHHH
Q 005859 642 GQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 642 ~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
.+++.+||+.+|.+||++.++++.
T Consensus 230 ~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 230 KEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=314.14 Aligned_cols=256 Identities=20% Similarity=0.324 Sum_probs=194.6
Q ss_pred HhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++++|...+.||+|+||.||+|... +|+.||+|++...........+.+|++++++++|+||+++++++.. .+..++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeEEE
Confidence 3467889999999999999999865 5889999998765433334567899999999999999999999854 467899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+. +++.+++... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++...
T Consensus 81 v~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~--~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 81 VFEYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ--HILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred EEeccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 999995 6887776422 23477888899999999999999987 79999999999999999999999999987643
Q ss_pred CcchhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch----------------
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV---------------- 621 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~---------------- 621 (673)
.... ......++..|+|||++.+. .++.++|||||||++|||+||+.||.............
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 155 IPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 3211 11223468889999998754 47899999999999999999999986543211100000
Q ss_pred ------hhhcCCcCCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 622 ------EDFIDPNLEGKF-----SVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 622 ------~~~~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
............ ....+..+.+++.+|++.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000 0012467889999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.32 Aligned_cols=248 Identities=21% Similarity=0.385 Sum_probs=199.0
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccC---CCCceeEeeEEecCCCCeEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK---HENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~~~l 478 (673)
.|+..+.||+|+||.||+|... +++.||+|.+..........++.+|++++++++ |||++++++++.. ....++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEEE
Confidence 4777889999999999999964 589999999876543445567889999999996 9999999999854 367899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+. ||+||||+|+||++++++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~--~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV--GVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 9999999999998852 2589999999999999999999987 89999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
.... ......++..|+|||++.++ .++.++|||||||++|||++|+.||.......... .......+.+. ....
T Consensus 153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~---~~~~ 227 (277)
T cd06917 153 QNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-LIPKSKPPRLE---DNGY 227 (277)
T ss_pred CCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-ccccCCCCCCC---cccC
Confidence 4332 12234578899999998754 46899999999999999999999986543221111 11111111111 1124
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.++.+++.+||+.||++||++.|+++
T Consensus 228 ~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 228 SKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 578999999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=331.01 Aligned_cols=261 Identities=21% Similarity=0.336 Sum_probs=206.9
Q ss_pred cccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCC----CCeEEEEE
Q 005859 406 EANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKG----RGECFLIY 480 (673)
Q Consensus 406 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~~~lv~ 480 (673)
-.+.||+|+||.||+|+.+ .|+.||||.++........+...+|+++|++++|||||+++++-.... .....+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 3467999999999999966 499999999998776677788999999999999999999999865444 45678999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEec--CCC--Ceeecccccccc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIH--RRY--NPLLSDSGLHKL 556 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~--~~~--~~kl~DfGla~~ 556 (673)
|||.+|||+..+..... ..-+++.+.+.+..+++.||.|||++ ||+||||||.||++- ++| .-||+|||.||.
T Consensus 97 EyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn--~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN--GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc--CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 99999999999975432 34599999999999999999999988 899999999999983 334 459999999999
Q ss_pred ccCcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhh-----------
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF----------- 624 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~----------- 624 (673)
++++. .....+||..|.+||++.. +.|+.-+|.|||||++||.+||..||.++.........+...
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 98876 4556789999999999995 779999999999999999999999998764331100000000
Q ss_pred cCCcC------------CCCCCHHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHHhhc
Q 005859 625 IDPNL------------EGKFSVSEASNLGQIALHCTHESPSHRP--SIENVMQELSSIIG 671 (673)
Q Consensus 625 ~~~~~------------~~~~~~~~~~~l~~l~~~Cl~~~p~~RP--s~~evl~~L~~i~~ 671 (673)
.++.. ...........+...+..++..+|++|- .+.+....+..|++
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 00000 0111223345666778888899999998 88888888777765
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.42 Aligned_cols=253 Identities=19% Similarity=0.336 Sum_probs=205.3
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|+..+.||+|++|.||+|+..+ ++.||||++...........+.+|++++.+++|+||+++++++... +..++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEEEE
Confidence 367888999999999999999875 9999999987664333457899999999999999999999998554 7899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhc-CCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHG-KRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
||+++++|.+++... ..+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~--~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 79 EYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC--CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999732 568999999999999999999998 7 899999999999999999999999999987654
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHH-HH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS-EA 638 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 638 (673)
.... .....++..|+|||.+....++.++||||||+++|||+||+.||...... ........+..... ...+.. .+
T Consensus 153 ~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~ 229 (264)
T cd06623 153 TLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGPP-PSLPAEEFS 229 (264)
T ss_pred CCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHhcCCC-CCCCcccCC
Confidence 3221 12345778899999999888999999999999999999999998655310 01111111111111 122223 56
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
..+.+++.+||+.+|++||++.++++.
T Consensus 230 ~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 230 PEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 789999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.46 Aligned_cols=249 Identities=19% Similarity=0.315 Sum_probs=199.8
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+|...+.||+|+||.||++... +++.+|+|.+..... ......+.+|++++++++||||+++++.+.. .+..++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEE
Confidence 4778899999999999999975 488999999876532 2234678999999999999999999998854 47789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC-CeeeccccccccccC
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY-NPLLSDSGLHKLLAD 559 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~-~~kl~DfGla~~~~~ 559 (673)
||+++++|.+++.... ...+++..+..++.|++.||+|||++ ||+||||||+||+++++. .+|++|||+++....
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~--~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 79 EYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK--LILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred ecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999999997432 34589999999999999999999987 899999999999998654 579999999987654
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.||.......... ...... ....+...+.
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~ 227 (256)
T cd08220 155 KSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL----KIMSGT-FAPISDRYSP 227 (256)
T ss_pred Ccc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHH----HHHhcC-CCCCCCCcCH
Confidence 321 223457889999999998889999999999999999999999986543221111 111111 1122233457
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
++.+++.+||+.+|++|||+.|+++
T Consensus 228 ~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 228 DLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhh
Confidence 8999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=328.95 Aligned_cols=241 Identities=20% Similarity=0.262 Sum_probs=185.4
Q ss_pred cccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhcc---CCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 410 LGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSL---KHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 410 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
||+|+||+||+|+.. +++.||||++.+... ......+..|..++.+. +||||+++++++.. .+..++||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence 799999999999976 489999999865421 12223456677777765 69999999998854 47899999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF 563 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 563 (673)
++|+|.+++.. ...+++..+..++.||++||+|||++ ||+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~--~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~- 151 (330)
T cd05586 79 SGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY--DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK- 151 (330)
T ss_pred CCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-
Confidence 99999998863 34589999999999999999999987 899999999999999999999999999875432211
Q ss_pred hhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHH
Q 005859 564 SMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLG 642 (673)
Q Consensus 564 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 642 (673)
......||..|+|||++.+. .++.++|||||||++|||+||+.||............... ...+. ....+.++.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~---~~~~~~~~~ 226 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG--KVRFP---KNVLSDEGR 226 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC--CCCCC---CccCCHHHH
Confidence 12345689999999998765 4899999999999999999999998654322211111100 11111 112356788
Q ss_pred HHHHHccccCCCCCCC----HHHHHH
Q 005859 643 QIALHCTHESPSHRPS----IENVMQ 664 (673)
Q Consensus 643 ~l~~~Cl~~~p~~RPs----~~evl~ 664 (673)
+++.+||+.||.+||+ +.++++
T Consensus 227 ~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 227 QFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 9999999999999984 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=319.26 Aligned_cols=246 Identities=18% Similarity=0.296 Sum_probs=196.4
Q ss_pred cccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecC
Q 005859 406 EANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVP 484 (673)
Q Consensus 406 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~ 484 (673)
....||+|+||.||++... ++..||||.+.... ....+.+.+|+.++++++||||+++++.+... +..++||||++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~lv~e~~~ 102 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVG--DELWVVMEFLE 102 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecC--CeEEEEEeCCC
Confidence 3457999999999999965 48899999986543 23456788999999999999999999988554 78899999999
Q ss_pred CCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhh
Q 005859 485 NGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFS 564 (673)
Q Consensus 485 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 564 (673)
+++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++........ .
T Consensus 103 ~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~--~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~ 174 (292)
T cd06658 103 GGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ--GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-K 174 (292)
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC--CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-c
Confidence 9999998852 3488999999999999999999987 799999999999999999999999999876543221 1
Q ss_pred hhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHH
Q 005859 565 MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQI 644 (673)
Q Consensus 565 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 644 (673)
.....++..|+|||++.+..++.++|||||||++|||++|+.||.......... .+.....+... .....+..+.++
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~l 251 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR-RIRDNLPPRVK--DSHKVSSVLRGF 251 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcCCCccc--cccccCHHHHHH
Confidence 223457889999999988889999999999999999999999986543221111 11111122111 112345678899
Q ss_pred HHHccccCCCCCCCHHHHHHH
Q 005859 645 ALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 645 ~~~Cl~~~p~~RPs~~evl~~ 665 (673)
+.+||..||++|||++|+++.
T Consensus 252 i~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 252 LDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHccCChhHCcCHHHHhhC
Confidence 999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=306.50 Aligned_cols=250 Identities=20% Similarity=0.223 Sum_probs=201.6
Q ss_pred CccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCC--cHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 404 FSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKS--DEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
|+..+.||.|.-|+||+++.++ +..+|+|++.+..... ...+...|-+||+.++||.++.+|+.+ +.....|+||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f--et~~~~cl~m 156 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF--ETDKYSCLVM 156 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee--eccceeEEEE
Confidence 4455789999999999999876 6899999998865432 224567789999999999999999999 4458899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC-
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD- 559 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~- 559 (673)
|||+||+|....+.+ ..+.++...++.++..|+-||+|||-. |||.|||||+||||.++|++.|+||-++.....
T Consensus 157 eyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHml--GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHML--GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhh--ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999999988743 456799999999999999999999987 999999999999999999999999988653210
Q ss_pred -------c--------------------------ch---------------------hhhhccCCCCCccCCccccCCCC
Q 005859 560 -------D--------------------------IV---------------------FSMLKASAAMGYLAPEYTTTGRF 585 (673)
Q Consensus 560 -------~--------------------------~~---------------------~~~~~~~gt~~y~aPE~~~~~~~ 585 (673)
. .. ......+||-.|.|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 00 00112467788999999999999
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC----HHH
Q 005859 586 TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPS----IEN 661 (673)
Q Consensus 586 s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs----~~e 661 (673)
+.++|+|+|||++|||+.|+.||.+..+.+.....+. ..+.-.-....+..+++||++.|.+||.+|-. +.|
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~----~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e 388 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG----QPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE 388 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc----CCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence 9999999999999999999999988766554433332 22211111255678999999999999999987 666
Q ss_pred HH
Q 005859 662 VM 663 (673)
Q Consensus 662 vl 663 (673)
|-
T Consensus 389 IK 390 (459)
T KOG0610|consen 389 IK 390 (459)
T ss_pred hh
Confidence 64
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.08 Aligned_cols=254 Identities=20% Similarity=0.264 Sum_probs=198.4
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+|+..+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.++++++||||+++++++.. .+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence 4778889999999999999975 589999999876542 2234679999999999999999999999855 47889999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+ +++|.+++... ...+++..++.++.||++||+|||+. ||+|+||||+||++++++.++|+|||+++.....
T Consensus 79 e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 79 EYM-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN--GIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred ccc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 999 99999998643 24689999999999999999999987 7999999999999999999999999999876544
Q ss_pred chhhhhccCCCCCccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhh----------------
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVED---------------- 623 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~---------------- 623 (673)
.........++..|+|||++.+.. ++.++||||+|+++|||+||+.||...............
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 322233446788999999987544 689999999999999999997776543221111100000
Q ss_pred ----hcCCcCC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 624 ----FIDPNLE----GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 624 ----~~~~~~~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...+... .......+..+.+++.+|++.+|++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000 0011123478899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.75 Aligned_cols=253 Identities=21% Similarity=0.292 Sum_probs=201.0
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCC--cHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKS--DEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|...+.||+|+||.||+|...+ ++.||+|.+....... ..+.+.+|+++++.++||||+++++.+.. ....++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEE
Confidence 368888999999999999999765 8999999997654322 34578899999999999999999999854 478899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++++|.+++... ....+++..+..++.|+++||+|||+. |++||||||+||+++.++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 79 VMDYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL--GIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EEEecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC--CeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 99999999999998633 234689999999999999999999987 89999999999999999999999999987543
Q ss_pred Ccchh----------------------------hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCh
Q 005859 559 DDIVF----------------------------SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITP 610 (673)
Q Consensus 559 ~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~ 610 (673)
..... ......|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 21100 01123577889999999988899999999999999999999999865
Q ss_pred hhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 005859 611 FTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPS----IENVMQ 664 (673)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs----~~evl~ 664 (673)
....... ..+.............+..+.+++.+||+.||++||| ++|+++
T Consensus 235 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 235 SNRDETF----SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CchHHHH----HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 4332221 1122211111111225678999999999999999999 666664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=309.97 Aligned_cols=253 Identities=17% Similarity=0.321 Sum_probs=199.7
Q ss_pred CCccccccccCCcceEEEEEE-cCCcEEEEEEecccCCCC-----cHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 403 CFSEANLLGKSSFSATYKGIL-RDGSVVAVKCIAKTSCKS-----DEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
+|+..+.||+|+||.||++.. .+++.||+|++....... ..+.+.+|++++++++|+||+++++++.+ .+..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CCeE
Confidence 477788999999999999986 458999999987543211 13578899999999999999999999854 4788
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC-Ceeeccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY-NPLLSDSGLHK 555 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~-~~kl~DfGla~ 555 (673)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||++ |++||||||+||+++.++ .+||+|||.+.
T Consensus 79 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~--~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN--QIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 999999999999999863 24588999999999999999999987 899999999999998776 58999999987
Q ss_pred cccCcchh---hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCC
Q 005859 556 LLADDIVF---SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGK 632 (673)
Q Consensus 556 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (673)
........ ......++..|+|||.+.+..++.++||||+|+++|||++|+.||........ ...............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 231 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALIFKIASATTAPS 231 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHHHHHhccCCCCC
Confidence 76543111 11123577889999999888899999999999999999999999853321110 111111111112233
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 633 FSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 633 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+...+.++.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 232 IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 44556688999999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.65 Aligned_cols=244 Identities=19% Similarity=0.296 Sum_probs=199.4
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|...+.||+|+||.||++... +++.||+|++..... ....+.+.+|++++++++||||+++++++... +..++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD--SNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CeEEE
Confidence 36888899999999999999976 489999999875432 12346788999999999999999999998554 67899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+. ||+||||+|+||+++.++.+||+|||+++...
T Consensus 79 v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~--~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 79 VMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL--DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred EEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 9999999999999863 24689999999999999999999987 89999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
.. .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.......... ...... ...+...+
T Consensus 153 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~--~~~~~~~~ 222 (290)
T cd05580 153 GR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE----KILEGK--VRFPSFFS 222 (290)
T ss_pred CC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHhcCC--ccCCccCC
Confidence 44 223457889999999988888999999999999999999999986543221111 111111 12233345
Q ss_pred HHHHHHHHHccccCCCCCC-----CHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRP-----SIENVM 663 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RP-----s~~evl 663 (673)
..+.+++.+||+.||.+|| +++|++
T Consensus 223 ~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 223 PDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred HHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 7889999999999999998 667765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=315.61 Aligned_cols=255 Identities=20% Similarity=0.309 Sum_probs=198.6
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
++|+..+.||+|+||.||+|..++ ++.||+|++..... ......+.+|++++++++|+||+++++++.. .+..++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEE
Confidence 368888999999999999999764 88999999876432 2234678999999999999999999999965 4678999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||++++.+..+.. ....+++..+..++.||+.||+|||+. +|+||||+|+||++++++.+||+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 79 FEYVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH--NIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred EecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 99999877766554 224489999999999999999999987 799999999999999999999999999987654
Q ss_pred cchhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc----------hhhhc--C
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK----------VEDFI--D 626 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~----------~~~~~--~ 626 (673)
..........++..|+|||++.+. .++.++||||||+++|||++|+.||............ ..... +
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 432122334567889999999887 7899999999999999999999888643221100000 00000 0
Q ss_pred C--------cC------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 627 P--------NL------EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 627 ~--------~~------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+ .. ...++...+.++.+++.+||+.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 00 00112223678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=314.47 Aligned_cols=256 Identities=16% Similarity=0.274 Sum_probs=198.1
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
++|+..+.||+|+||.||+|..+ +++.||+|.++..... .....+.+|++++++++||||+++++++...+.+..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46778889999999999999976 4889999999754322 223467889999999999999999999876655789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||++ ++|.+++... ...+++..+..++.||+.||+|||+. ||+||||||+||++++++.+||+|||+++....
T Consensus 85 ~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~--~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN--WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 5999888632 23589999999999999999999987 799999999999999999999999999987654
Q ss_pred cchhhhhccCCCCCccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh----------------
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE---------------- 622 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~---------------- 622 (673)
... ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||..............
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 159 PLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred Ccc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 321 122344678899999987644 68999999999999999999998864322211110000
Q ss_pred ---------hhcCCcCCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 623 ---------DFIDPNLEGKFSVS-EASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 623 ---------~~~~~~~~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
......+...++.. .+..+.+++.+||+.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000111112222 3567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=316.51 Aligned_cols=245 Identities=17% Similarity=0.291 Sum_probs=195.8
Q ss_pred cccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecC
Q 005859 406 EANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVP 484 (673)
Q Consensus 406 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~ 484 (673)
....||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++... +..++||||++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~iv~e~~~ 101 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG--EELWVLMEFLQ 101 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeC--CeEEEEEecCC
Confidence 3457999999999999965 58999999986543 23456788999999999999999999988554 77899999999
Q ss_pred CCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhh
Q 005859 485 NGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFS 564 (673)
Q Consensus 485 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 564 (673)
+++|.+++.. ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++........ .
T Consensus 102 ~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~--~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~ 173 (297)
T cd06659 102 GGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ--GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K 173 (297)
T ss_pred CCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-c
Confidence 9999987752 3588999999999999999999987 799999999999999999999999999876543321 1
Q ss_pred hhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHH
Q 005859 565 MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQI 644 (673)
Q Consensus 565 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 644 (673)
.....++..|+|||++.+..++.++|||||||++|||++|+.||.......... .+.....+. .......+..+.++
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~l~~~ 250 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRDSPPPK--LKNAHKISPVLRDF 250 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHhccCCCC--ccccCCCCHHHHHH
Confidence 223457889999999998889999999999999999999999986432211111 111110111 11122334678899
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 005859 645 ALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 645 ~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.+||+.+|++||+++++++
T Consensus 251 i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 251 LERMLTREPQERATAQELLD 270 (297)
T ss_pred HHHHhcCCcccCcCHHHHhh
Confidence 99999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=301.53 Aligned_cols=271 Identities=20% Similarity=0.331 Sum_probs=222.4
Q ss_pred ccCHHHHHHHhcCCccccccccCCcceEEEEEEcC------CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeE
Q 005859 391 MFNLEEVERATQCFSEANLLGKSSFSATYKGILRD------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASL 464 (673)
Q Consensus 391 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 464 (673)
....+|+.....++....++-+|.||.||+|.+.+ .+.|-+|.++.....-+...++.|.-.+..+.|||+..+
T Consensus 273 ~~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 273 NRRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred hhhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccce
Confidence 44567787888889999999999999999997653 456888888776655556778999999999999999999
Q ss_pred eeEEecCCCCeEEEEEeecCCCChhhhhccccC----CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEe
Q 005859 465 RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAG----SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI 540 (673)
Q Consensus 465 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl 540 (673)
.+++.+. ....+++|.|+.-|+|..+|...++ ....++-.+...++.|++.||+|||.+ ||||.||.++|++|
T Consensus 353 ~~V~ie~-~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~--~ViHkDiAaRNCvI 429 (563)
T KOG1024|consen 353 LGVSIED-YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH--GVIHKDIAARNCVI 429 (563)
T ss_pred eEEEeec-cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc--Ccccchhhhhccee
Confidence 9999764 4567899999999999999974332 124577778889999999999999988 89999999999999
Q ss_pred cCCCCeeeccccccccccCcchhhh-hccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhc
Q 005859 541 HRRYNPLLSDSGLHKLLADDIVFSM-LKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAES 618 (673)
Q Consensus 541 ~~~~~~kl~DfGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~ 618 (673)
|+...+||+|-.++|.+-+..+... ........||+||.+....|+.++|||||||+||||+| |+.||......
T Consensus 430 dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf---- 505 (563)
T KOG1024|consen 430 DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF---- 505 (563)
T ss_pred hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH----
Confidence 9999999999999997655433322 22335678999999999999999999999999999999 99998654332
Q ss_pred cchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 005859 619 SKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSI 669 (673)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i 669 (673)
.++.++....+-..|..++.++..+|.-||..+|++||++++++..|.+.
T Consensus 506 -Em~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 506 -EMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred -HHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 23333344444456778999999999999999999999999999999875
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=313.46 Aligned_cols=246 Identities=20% Similarity=0.344 Sum_probs=194.8
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC--CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK--SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
+.|+..+.||+|+||.||+|+.. +++.||+|++...... ...+++.+|++++++++||||+++++++... +..++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~--~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE--HTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC--CeEEE
Confidence 45788889999999999999976 5899999998654322 2235688999999999999999999999654 67899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||++ |++.+++... ...+++..+..++.|++.||.|||+. ||+||||+|+||++++++.+||+|||++....
T Consensus 93 v~e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~--~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 93 VMEYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH--ERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred EHHhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 999996 6787777532 23589999999999999999999987 79999999999999999999999999987654
Q ss_pred CcchhhhhccCCCCCccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTT---TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
.. ....++..|+|||++. ...++.++||||||+++|||+||+.||........... ............
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~ 237 (307)
T cd06607 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNDSPTLSSN 237 (307)
T ss_pred CC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH----HhcCCCCCCCch
Confidence 32 2235778899999874 35688999999999999999999999865432211111 111111111123
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+..+.+++.+||+.+|++||++.+|+.
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 238 DWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred hhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 34578999999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=306.75 Aligned_cols=252 Identities=17% Similarity=0.270 Sum_probs=201.0
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC----CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC----KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
.+|...+.||+|+||.||+|+.. +++.||+|.+..... ......+.+|++++++++||||+++++++.+...+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999965 489999998754321 1223578899999999999999999999866555678
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||+++++|.+++.. ...+++....+++.|++.||+|||+. ||+||||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~--~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999999862 23578999999999999999999987 899999999999999999999999999986
Q ss_pred ccCcch--hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 557 LADDIV--FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 557 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
...... .......++..|+|||++.+..++.++|||||||++|||++|+.||........ +............+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~p 231 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA----IFKIATQPTKPMLP 231 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH----HHHHHcCCCCCCCC
Confidence 532110 111234578889999999988899999999999999999999999865432211 11222222223345
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
......+.+++.+||+ +|.+||++.+++.
T Consensus 232 ~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 232 DGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred cccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 5566789999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=323.59 Aligned_cols=249 Identities=16% Similarity=0.266 Sum_probs=198.5
Q ss_pred CccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEee
Q 005859 404 FSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDF 482 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~ 482 (673)
|.+...||.|+||+||++..++ +-..|.|++.... ....++|+-||+||...+||+||++++.|+.. +..+|..||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkLl~ayy~e--nkLwiliEF 110 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKLLSAYYFE--NKLWILIEF 110 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc--CceEEEEee
Confidence 4445679999999999999876 4556778776543 44557899999999999999999999988765 678999999
Q ss_pred cCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcch
Q 005859 483 VPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV 562 (673)
Q Consensus 483 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 562 (673)
|.||-...++-. -...++..++.-+++|++.||.|||++ .|||||||+.|||+.-+|.++++|||++.......
T Consensus 111 C~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~--~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~- 184 (1187)
T KOG0579|consen 111 CGGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ--NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR- 184 (1187)
T ss_pred cCCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc--chhhhhccccceEEEecCcEeeecccccccchhHH-
Confidence 999999887753 235799999999999999999999998 59999999999999999999999999976543321
Q ss_pred hhhhccCCCCCccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 563 FSMLKASAAMGYLAPEYTT-----TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 563 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
.......||++|||||++. ...|+.++||||||++|.||..+.+|..........-+ +..--.|.+ -.+..-
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllK-iaKSePPTL--lqPS~W 261 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK-IAKSEPPTL--LQPSHW 261 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHH-HhhcCCCcc--cCcchh
Confidence 1234578999999999865 45799999999999999999999988766543322211 111111222 223444
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...+.+++.+|+..||..||++.++++
T Consensus 262 s~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 262 SRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 578999999999999999999999875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=342.75 Aligned_cols=255 Identities=20% Similarity=0.339 Sum_probs=196.4
Q ss_pred HHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC---
Q 005859 398 ERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGR--- 473 (673)
Q Consensus 398 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--- 473 (673)
.+...+|++.+.||+||||.|||++.+ ||+.+|||++.............+|++++++|+|||||+++..|.+...
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 456678888999999999999999976 7999999999876533444678899999999999999999876543110
Q ss_pred --------------------------------------------------------------------------------
Q 005859 474 -------------------------------------------------------------------------------- 473 (673)
Q Consensus 474 -------------------------------------------------------------------------------- 473 (673)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeEEEEEeecCCCChhhhhccccCCcccc-CHHHHHHHHHHHHHHH
Q 005859 474 ----------------------------------GECFLIYDFVPNGNLLQHLDLEAGSEKVL-EWATRISVIKGIAKGI 518 (673)
Q Consensus 474 ----------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l-~~~~~~~i~~~ia~gL 518 (673)
...||=||||+.-.+.++++... .. .-...++++++|+.||
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~----~~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH----FNSQRDEAWRLFREILEGL 710 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc----cchhhHHHHHHHHHHHHHH
Confidence 11377889998877877776332 11 3567789999999999
Q ss_pred HHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc----C-------------cchhhhhccCCCCCccCCcccc
Q 005859 519 SYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA----D-------------DIVFSMLKASAAMGYLAPEYTT 581 (673)
Q Consensus 519 ~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~----~-------------~~~~~~~~~~gt~~y~aPE~~~ 581 (673)
+|+|+. |||||||||.||++|++..+||+|||+|+... . ......+..+||.-|+|||++.
T Consensus 711 aYIH~~--giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 711 AYIHDQ--GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHHhC--ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 999998 89999999999999999999999999998721 0 0111345678999999999998
Q ss_pred CC---CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCC--CCHHHHHHHHHHHHHccccCCCCC
Q 005859 582 TG---RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGK--FSVSEASNLGQIALHCTHESPSHR 656 (673)
Q Consensus 582 ~~---~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~Cl~~~p~~R 656 (673)
+. .|+.|+|+||+|||++||+ .||...... ...+....++.++.. +..+....-..+|.++++.||.+|
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMER---a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMER---ASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHh---ccCCchHHH---HHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccC
Confidence 65 4999999999999999998 456543222 223333334443322 333444556689999999999999
Q ss_pred CCHHHHHH
Q 005859 657 PSIENVMQ 664 (673)
Q Consensus 657 Ps~~evl~ 664 (673)
||+.|+++
T Consensus 863 PtA~eLL~ 870 (1351)
T KOG1035|consen 863 PTATELLN 870 (1351)
T ss_pred CCHHHHhh
Confidence 99999985
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.45 Aligned_cols=254 Identities=17% Similarity=0.301 Sum_probs=194.3
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+|+..+.||+|+||.||+|+.. +|+.||||.+...... .....+.+|++++++++||||+++++++.. .+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEEEe
Confidence 4788899999999999999976 5899999988754322 223578899999999999999999999854 46789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+. ++|.+++.... ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||+++.....
T Consensus 79 e~~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~--~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 79 EFLH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred eccc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9995 68998886432 34689999999999999999999987 7999999999999999999999999998765432
Q ss_pred chhhhhccCCCCCccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCC------------
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDP------------ 627 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~------------ 627 (673)
.. ......++..|+|||++.+.. ++.++|||||||++|||+||+.||................-.+
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 154 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred cc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 21 122334678899999887654 6899999999999999999999985432211110000000000
Q ss_pred -------cCCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 628 -------NLEG----KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 628 -------~~~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.... ......+.++.+++.+||+.||++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000 001123466789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=299.84 Aligned_cols=262 Identities=16% Similarity=0.285 Sum_probs=202.2
Q ss_pred cccCHHHHHHHhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeE
Q 005859 390 FMFNLEEVERATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGI 467 (673)
Q Consensus 390 ~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~ 467 (673)
..|+.++++.- ..||.|+||+|+|-.++. |+..|||+++......+..+++.|.++..+- +.||||++||.
T Consensus 59 ~~F~~~~Lqdl-------g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 59 HTFTSDNLQDL-------GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cccccchHHHH-------HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 45555555443 469999999999998765 9999999999876656677899998865554 79999999999
Q ss_pred EecCCCCeEEEEEeecCCCChhhhhccc-cCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCe
Q 005859 468 CCSKGRGECFLIYDFVPNGNLLQHLDLE-AGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNP 546 (673)
Q Consensus 468 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~ 546 (673)
+..+ +.+++.||.|. -+|..+...- .-.+..+++...-+|..-...||.||.... .|||||+||+|||+|..|.+
T Consensus 132 ~F~E--GdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 132 LFSE--GDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhcC--CceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEecCCCE
Confidence 8654 77999999994 4665543211 112346888888888888999999999843 59999999999999999999
Q ss_pred eeccccccccccCcchhhhhccCCCCCccCCccccC--CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhh
Q 005859 547 LLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT--GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF 624 (673)
Q Consensus 547 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~ 624 (673)
|++|||.+..+.+.. ..+..+|...|||||.+.. ..|+.+|||||+|++|||+.||+.||..|.........+...
T Consensus 208 KLCDFGIcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g 285 (361)
T KOG1006|consen 208 KLCDFGICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG 285 (361)
T ss_pred eeecccchHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC
Confidence 999999998876643 3455678889999999874 349999999999999999999999999886643322222221
Q ss_pred cCCcCCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 625 IDPNLEGK-FSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 625 ~~~~~~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
-.|.+... -..+.+..+..++..|+.+|-++||.+.++.+
T Consensus 286 dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 286 DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 11222111 11235678999999999999999999998864
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=306.40 Aligned_cols=250 Identities=17% Similarity=0.330 Sum_probs=199.7
Q ss_pred CCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+|+..+.||+|+||.||+|.... |..||+|.+..... ....+.+.+|++++++++|+||+++++.+.. .+..++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEEEEE
Confidence 47788899999999999999764 88999999876432 2344678899999999999999999998854 47899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC-CeeeccccccccccC
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY-NPLLSDSGLHKLLAD 559 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~-~~kl~DfGla~~~~~ 559 (673)
||+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++ .+||+|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~--~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 79 EYCDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR--KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred ecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC--CcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999999986432 23579999999999999999999987 799999999999999885 469999999987654
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
... ......++..|+|||+.....++.++|||||||++|||++|+.||.......... ....... .......+.
T Consensus 155 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~-~~~~~~~~~ 228 (257)
T cd08225 155 SME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL----KICQGYF-APISPNFSR 228 (257)
T ss_pred Ccc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH----HHhcccC-CCCCCCCCH
Confidence 321 1122357888999999988889999999999999999999999986533221111 1111111 112223456
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
++.+++.+||+.+|++|||+.|+++
T Consensus 229 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 229 DLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhh
Confidence 7999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=306.88 Aligned_cols=243 Identities=18% Similarity=0.284 Sum_probs=195.8
Q ss_pred cccCCcceEEEEEEcC-CcEEEEEEecccCCC--CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCCC
Q 005859 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCK--SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNG 486 (673)
Q Consensus 410 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~g 486 (673)
||.|+||.||+++... ++.||+|++.+.... ...+.+.+|++++++++||||+++++++.+. +..++||||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK--KYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC--CccEEEEecCCCC
Confidence 6999999999999764 889999999765322 2346789999999999999999999988544 6789999999999
Q ss_pred ChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhhhh
Q 005859 487 NLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSML 566 (673)
Q Consensus 487 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 566 (673)
+|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++...... ...
T Consensus 79 ~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~--~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~ 150 (262)
T cd05572 79 ELWTILRD----RGLFDEYTARFYIACVVLAFEYLHNR--GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTW 150 (262)
T ss_pred cHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC--CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccc
Confidence 99999963 23588999999999999999999987 89999999999999999999999999998765432 122
Q ss_pred ccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHH
Q 005859 567 KASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIAL 646 (673)
Q Consensus 567 ~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 646 (673)
...++..|+|||.+....++.++||||||+++|||++|+.||....... ......+.+......++...+.++.+++.
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 228 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEIYNDILKGNGKLEFPNYIDKAAKDLIK 228 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHHHHHhccCCCCCCCcccCHHHHHHHH
Confidence 3457888999999988889999999999999999999999986543110 11111222111122333334678999999
Q ss_pred HccccCCCCCCC-----HHHHHH
Q 005859 647 HCTHESPSHRPS-----IENVMQ 664 (673)
Q Consensus 647 ~Cl~~~p~~RPs-----~~evl~ 664 (673)
+||+.+|++||+ ++|+++
T Consensus 229 ~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 229 QLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHccCChhhCcCCcccCHHHHhc
Confidence 999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=324.34 Aligned_cols=193 Identities=20% Similarity=0.292 Sum_probs=167.4
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccC-C-----CCceeEeeEEecCCCCe
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-H-----ENLASLRGICCSKGRGE 475 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~~~~~~~~~~~ 475 (673)
+|.+.++||+|+||.|.||... +++.||||+++... ....+...|+++|..++ | -|+|+++++|... ++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr--~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR--NH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc--cc
Confidence 7899999999999999999965 59999999998763 34567788999999997 4 4899999999765 89
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC--CCeeeccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR--YNPLLSDSGL 553 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~--~~~kl~DfGl 553 (673)
.|||+|.++ -+|+++++.... ..++...++.|+.||+.||.+||+. +|||+||||+||||.+- ..+||+|||.
T Consensus 263 lciVfELL~-~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l--~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHEL--GIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeeehhhh-hhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCChhheeeccCCcCceeEEeccc
Confidence 999999994 599999986533 4589999999999999999999987 79999999999999754 3799999999
Q ss_pred cccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 005859 554 HKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSI 608 (673)
Q Consensus 554 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~ 608 (673)
|+...+..+ ....+..|+|||++.+.+|+.+.||||||||+.||+||..-|
T Consensus 338 Sc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf 388 (586)
T KOG0667|consen 338 SCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF 388 (586)
T ss_pred ccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence 988766433 345678899999999999999999999999999999996444
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=311.88 Aligned_cols=250 Identities=14% Similarity=0.258 Sum_probs=200.1
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|...+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++... +..++|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVG--DELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeC--CcEEEEE
Confidence 57888899999999999999864 58899999986443 33456789999999999999999999998654 6789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++.. ..+++..+..++.|++.||+|||+. |++||||||+||++++++.+||+|||++......
T Consensus 96 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~--gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 96 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred ecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC--CEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 99999999999862 3478999999999999999999987 8999999999999999999999999998765443
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
.. ......++..|+|||.+....++.++|||||||++||+++|+.||........... .. .........+...+..
T Consensus 169 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~ 244 (293)
T cd06647 169 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IA--TNGTPELQNPEKLSAI 244 (293)
T ss_pred cc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-hh--cCCCCCCCCccccCHH
Confidence 21 12233577889999999888899999999999999999999999865422111110 00 0111111122334567
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
+.+++.+||+.+|++||++.+++..
T Consensus 245 l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 245 FRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 8999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=311.50 Aligned_cols=256 Identities=18% Similarity=0.250 Sum_probs=210.5
Q ss_pred HHHHHHhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCC--CcHHHHHHHHHHHhccCCCCceeEeeEEecC
Q 005859 395 EEVERATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCK--SDEGEFLKGLKILTSLKHENLASLRGICCSK 471 (673)
Q Consensus 395 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 471 (673)
+-.....+.|..-++||+|+||.||-++.++ |+.+|.|++.+...+ ..+...++|-.+|.+++.+.||.+-..| +
T Consensus 178 E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf--e 255 (591)
T KOG0986|consen 178 ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF--E 255 (591)
T ss_pred HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee--c
Confidence 3334456789999999999999999999765 999999998776432 3345678999999999999999997777 5
Q ss_pred CCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccc
Q 005859 472 GRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDS 551 (673)
Q Consensus 472 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~Df 551 (673)
+++..++|+..|.||||.-+|.... ...++++.++.++.+|+.||++||.. +||.||+||+|||+|++|+++|+|.
T Consensus 256 Tkd~LClVLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~--~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 256 TKDALCLVLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR--RIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred CCCceEEEEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc--ceeeccCChhheeeccCCCeEeecc
Confidence 5689999999999999999997543 25699999999999999999999987 6999999999999999999999999
Q ss_pred cccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCC
Q 005859 552 GLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEG 631 (673)
Q Consensus 552 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 631 (673)
|+|..+..+.. ....+||.+|||||++..+.|+...|.||+||++|||+.|+.||..........+ +...+. ....
T Consensus 332 GLAvei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE-vdrr~~-~~~~ 407 (591)
T KOG0986|consen 332 GLAVEIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE-VDRRTL-EDPE 407 (591)
T ss_pred ceEEecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH-HHHHHh-cchh
Confidence 99998877643 3345899999999999999999999999999999999999999976543322211 111111 1123
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 005859 632 KFSVSEASNLGQIALHCTHESPSHRPSIE 660 (673)
Q Consensus 632 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ 660 (673)
++++..+++..+|....|+.||++|-..+
T Consensus 408 ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 408 EYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 56677788999999999999999996543
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=309.60 Aligned_cols=255 Identities=21% Similarity=0.338 Sum_probs=196.5
Q ss_pred CccccccccCCcceEEEEEEcC-CcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 404 FSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
|++.+.||+|+||.||+|+..+ ++.||+|++..... ......+.+|++++++++|||++++++++.....+..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5667889999999999999775 88999999987531 223457889999999999999999999986543468999999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|++ ++|.+++... ...+++..++.++.||++||+|||+. |++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~-~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~--~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMD-HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN--GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 997 4898888632 24689999999999999999999987 79999999999999999999999999998765443
Q ss_pred hhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhh----------------
Q 005859 562 VFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF---------------- 624 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~---------------- 624 (673)
........++..|+|||.+.+ ..++.++||||||+++|||+||+.||................
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 212233456778999998765 457999999999999999999999986543211111000000
Q ss_pred ---cCCcC------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 625 ---IDPNL------EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 625 ---~~~~~------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+.. .......++..+.+++.+||+.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000 00001112567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=309.57 Aligned_cols=252 Identities=20% Similarity=0.265 Sum_probs=192.9
Q ss_pred CccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCeEEEEEe
Q 005859 404 FSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
|+..+.||+|+||.||+|... +++.||+|++.............+|+.++.++. ||||+++++++.+...+..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 556788999999999999965 588999999876533333345568999999995 999999999997654478899999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|++ |+|.+++... ...++|..+..++.|++.||+|||+. ||+||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~--~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN--GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC--CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 996 5888887632 24689999999999999999999987 8999999999999999 999999999998765432
Q ss_pred hhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc----------hhhhcCCc--
Q 005859 562 VFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK----------VEDFIDPN-- 628 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~----------~~~~~~~~-- 628 (673)
. .....++..|+|||++.. +.++.++|||||||++|||++|+.||............ +.......
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 1 122456788999997754 45789999999999999999999998643221100000 00000000
Q ss_pred ----CCC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 629 ----LEG-------KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 629 ----~~~-------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
... ......+..+.+++.+||+.+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000 001234678999999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=312.36 Aligned_cols=259 Identities=15% Similarity=0.234 Sum_probs=195.0
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccC-CCCceeEeeEEecCCC---Ce
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLK-HENLASLRGICCSKGR---GE 475 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~---~~ 475 (673)
++|+..+.||+|+||.||+|... +++.||+|.+...... .....+.+|+.++++++ ||||+++++++..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888999999999999999976 5899999988764322 22357889999999995 6999999998865422 23
Q ss_pred EEEEEeecCCCChhhhhccccCC-ccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC-CCCeeeccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGS-EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR-RYNPLLSDSGL 553 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~-~~~~kl~DfGl 553 (673)
.++||||+++ +|.+++...... ...+++..++.++.||+.||+|||+. ||+||||||+||+++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~--~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH--GVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCChHHEEEecCCCeEEEeeccc
Confidence 7999999975 898888643322 35689999999999999999999987 8999999999999998 88999999999
Q ss_pred cccccCcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcC------
Q 005859 554 HKLLADDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFID------ 626 (673)
Q Consensus 554 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~------ 626 (673)
++....... ......+++.|+|||++.+ ..++.++||||||+++|||+||..||..................
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 158 GRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred ceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 876533211 1122346778999998865 45799999999999999999999988643222111110000000
Q ss_pred ------------CcCC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 627 ------------PNLE----GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 627 ------------~~~~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+... .......+.++.+++.+||+.||++||+++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 0001224577899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=309.65 Aligned_cols=247 Identities=17% Similarity=0.290 Sum_probs=197.0
Q ss_pred CccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEee
Q 005859 404 FSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDF 482 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~ 482 (673)
|...+.||+|++|.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. .+..++|+||
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~e~ 97 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVMEF 97 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEEEec
Confidence 444578999999999999965 58899999886543 2334568899999999999999999998854 4778999999
Q ss_pred cCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcch
Q 005859 483 VPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV 562 (673)
Q Consensus 483 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 562 (673)
+++++|.+++.. ..+++..+..++.|++.||+|||+. ||+||||+|+||+++.++.++|+|||.+........
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 98 LEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ--GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 999999999863 3588999999999999999999987 899999999999999999999999998876543321
Q ss_pred hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHH
Q 005859 563 FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLG 642 (673)
Q Consensus 563 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 642 (673)
......++..|+|||.+.+..++.++|||||||++|||++|+.||.......... .......+... .....+..+.
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~l~ 246 (285)
T cd06648 171 -RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK-RIRDNLPPKLK--NLHKVSPRLR 246 (285)
T ss_pred -ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH-HHHhcCCCCCc--ccccCCHHHH
Confidence 1123457889999999988889999999999999999999999986532211111 11111111111 1122457899
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 005859 643 QIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 643 ~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+++.+||+.+|++||++.++++
T Consensus 247 ~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 247 SFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHcccChhhCcCHHHHcc
Confidence 9999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=309.15 Aligned_cols=243 Identities=18% Similarity=0.285 Sum_probs=187.1
Q ss_pred ccccCCcceEEEEEEc-CCcEEEEEEecccCCCC--cHHHHHHHHHHH---hccCCCCceeEeeEEecCCCCeEEEEEee
Q 005859 409 LLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS--DEGEFLKGLKIL---TSLKHENLASLRGICCSKGRGECFLIYDF 482 (673)
Q Consensus 409 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~~~lv~E~ 482 (673)
.||+|+||.||++... +++.||+|.+.+..... ....+.+|..++ ...+||||+.+++++... +..++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEec
Confidence 4899999999999975 48999999987653221 223344554433 344799999999988543 678999999
Q ss_pred cCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcch
Q 005859 483 VPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV 562 (673)
Q Consensus 483 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 562 (673)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|||++.......
T Consensus 79 ~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~--~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~- 151 (279)
T cd05633 79 MNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (279)
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence 999999998863 24589999999999999999999987 79999999999999999999999999987554321
Q ss_pred hhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHH
Q 005859 563 FSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641 (673)
Q Consensus 563 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 641 (673)
.....++..|+|||.+.. ..++.++|||||||++|||+||+.||......... ..... ........+...+.++
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~ 226 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRM-TLTVNVELPDSFSPEL 226 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH--HHHHH-hhcCCcCCccccCHHH
Confidence 123458899999999874 45899999999999999999999998643211110 11111 1111122344456789
Q ss_pred HHHHHHccccCCCCCC-----CHHHHHHH
Q 005859 642 GQIALHCTHESPSHRP-----SIENVMQE 665 (673)
Q Consensus 642 ~~l~~~Cl~~~p~~RP-----s~~evl~~ 665 (673)
.+++.+||+.||++|| +++|+++.
T Consensus 227 ~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 227 KSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 9999999999999999 59888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=312.77 Aligned_cols=254 Identities=20% Similarity=0.267 Sum_probs=195.3
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC----CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK----SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
+|+..+.||+|+||.||+|... +++.||||.+...... .....+..|++++++++|+||+++++++.. .+..+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 4777889999999999999976 5899999999765422 123457789999999999999999999965 47889
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+ +|+|.+++.... ..+++..+..++.||++||+|||++ ||+||||||+||+++.++.+||+|||+++..
T Consensus 79 lv~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~--~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 79 LVFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN--WILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred EEEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC--CeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 999999 999999996321 3689999999999999999999988 8999999999999999999999999999876
Q ss_pred cCcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh--------------
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE-------------- 622 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~-------------- 622 (673)
..... ......++..|+|||.+.+ ..++.++|||||||++|||++|..||..............
T Consensus 153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 153 GSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred cCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 54321 1222345778999998865 4578999999999999999999766643221111000000
Q ss_pred ---hhcCCcCCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 623 ---DFIDPNLEG-----KFSVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 623 ---~~~~~~~~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
......... ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000 0112235778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.26 Aligned_cols=248 Identities=19% Similarity=0.303 Sum_probs=200.4
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC--CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK--SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
+|...+.||.|+||.||+|... +++.||+|.+.+.... ...+.+.+|++++++++||||+++++++. +.+..++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ--DEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc--CCCeEEEE
Confidence 4778899999999999999976 4899999999764322 23468899999999999999999999884 45789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
+||+++++|.+++... ..+++..+..++.|+++||.|||+. +|+|+||+|+||++++++.++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~--~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 79 VDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK--GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred EeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 9999999999999632 4688999999999999999999987 799999999999999999999999999887654
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
.. ......++..|+|||.+....++.++||||||+++|+|++|+.||....... .. .+...... .....+...+.
T Consensus 153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~-~~~~~~~~-~~~~~~~~~~~ 227 (258)
T cd05578 153 DT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-RD-QIRAKQET-ADVLYPATWST 227 (258)
T ss_pred Cc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-HH-HHHHHhcc-ccccCcccCcH
Confidence 32 1223457788999999988889999999999999999999999987543210 00 11111110 11223344568
Q ss_pred HHHHHHHHccccCCCCCCCH--HHHH
Q 005859 640 NLGQIALHCTHESPSHRPSI--ENVM 663 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~--~evl 663 (673)
.+.+++.+||+.||.+||++ +|++
T Consensus 228 ~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 228 EAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHHHHHHHccCChhHcCCccHHHHh
Confidence 89999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=310.03 Aligned_cols=255 Identities=20% Similarity=0.342 Sum_probs=197.2
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
+|+..+.||+|++|.||+|+.. +|+.||||++...........+.+|++++++++||||+++++++... +..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE--NKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC--CcEEEEEe
Confidence 4788899999999999999976 48899999997654334456788999999999999999999999654 67899999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|++ |+|.+++.... ....+++..+..++.|++.||+|||+. ||+||||||+||++++++.+|++|||+++......
T Consensus 79 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 79 YMD-KDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN--RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred cCC-ccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 997 48988886432 234689999999999999999999987 79999999999999999999999999997654322
Q ss_pred hhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh-----------hhcC-Cc
Q 005859 562 VFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE-----------DFID-PN 628 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~-----------~~~~-~~ 628 (673)
. ......++..|++||++.+. .++.++|||||||++|||++|+.||.............. .+.+ +.
T Consensus 155 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 N-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred c-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1 12234567889999988664 478999999999999999999999864322111110000 0000 00
Q ss_pred CCC-----------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 629 LEG-----------KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 629 ~~~-----------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
... ......+..+.+++.+|++.||++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 011223567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=308.64 Aligned_cols=251 Identities=17% Similarity=0.302 Sum_probs=203.2
Q ss_pred HhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
.++.|+..+.||+|+||.||+|..+ +++.||+|++..... ..+.+.+|++++++++|+||+++++++... +..++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVG--DELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--CEEEE
Confidence 4566888889999999999999987 588999999976532 456789999999999999999999998665 78999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
|+||+++++|.+++.... ..+++..+..++.|++.||+|||+. ||+|+||+|+||+++.++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~--gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ--NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 999999999999997432 3689999999999999999999986 89999999999999999999999999987654
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCC-CCCHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEG-KFSVSE 637 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 637 (673)
.... ......++..|+|||++.+..++.++|||||||++|||+||+.||............. ...... ......
T Consensus 168 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 242 (286)
T cd06614 168 KEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT----TKGIPPLKNPEKW 242 (286)
T ss_pred cchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hcCCCCCcchhhC
Confidence 3321 1223346788999999988889999999999999999999999986543221111111 111111 112224
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+..+.+++.+||+.+|.+||++.++++
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 243 SPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 578999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=313.09 Aligned_cols=257 Identities=19% Similarity=0.281 Sum_probs=196.8
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC-cHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS-DEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
.++|+..+.||+|+||.||+|... +|+.||+|.+....... ....+.+|++++++++|+||+++++++.....+..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357888999999999999999976 48999999987543222 2345678999999999999999999987655567899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||++ ++|.+++... ...+++..+..++.|++.||+|||+. |++||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN--FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 5888888632 24689999999999999999999987 89999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh-----------hhcC
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE-----------DFID 626 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~-----------~~~~ 626 (673)
.... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.............. ....
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 160 LPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred CccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 4321 1222345678999999875 4579999999999999999999999864332211110000 0000
Q ss_pred ------CcCCCC-C------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 627 ------PNLEGK-F------SVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 627 ------~~~~~~-~------~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...... . ....+..+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000 0 0112567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=350.69 Aligned_cols=256 Identities=20% Similarity=0.319 Sum_probs=207.8
Q ss_pred HHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 398 ERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 398 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
...+-++....+||.|.||.||-|... +|...|+|.++-... ......+.+|++++..++|||+|+++|+-.. ++.
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH--Rek 1308 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH--REK 1308 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec--HHH
Confidence 334567788899999999999999954 599999998875432 2334578899999999999999999998755 477
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.+|.||||++|+|.+.+.. .+..++.....+..|++.|++|||++ |||||||||.||+|+.+|.+|++|||.|.
T Consensus 1309 v~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~--gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH--GIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc--CceecCCCccceeeecCCcEEeeccccee
Confidence 8999999999999999973 23456666677899999999999998 89999999999999999999999999999
Q ss_pred cccCcch---hhhhccCCCCCccCCccccCCC---CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcC
Q 005859 556 LLADDIV---FSMLKASAAMGYLAPEYTTTGR---FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNL 629 (673)
Q Consensus 556 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 629 (673)
.+..... .......||+.|||||.+.+.. ...+.||||+|||+.||+||+.||..+.+.....-.+.....
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~--- 1459 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK--- 1459 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC---
Confidence 8765431 1233567999999999998643 567899999999999999999999877655443333333333
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 630 EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 630 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
+..|+..+.+-.+++.+|++.||++|.++.|+++.
T Consensus 1460 -Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 -PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 34455577888999999999999999999887753
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=319.13 Aligned_cols=257 Identities=17% Similarity=0.271 Sum_probs=195.6
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCC---CCeE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKG---RGEC 476 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---~~~~ 476 (673)
+++|++.+.||+|+||.||+|+.. +|+.||||++...........+.+|+.++++++||||+++++++.... ....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467999999999999999999865 589999999865432334467889999999999999999999875432 2467
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++|+||++ ++|.+++.. ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~--~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 99999996 588887752 3589999999999999999999987 899999999999999999999999999876
Q ss_pred ccCcchh--hhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhc-----------cchh
Q 005859 557 LADDIVF--SMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAES-----------SKVE 622 (673)
Q Consensus 557 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~-----------~~~~ 622 (673)
....... ......++..|+|||.+.+ ..++.++|||||||++|||+||+.||.......... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 5432211 1123457889999998765 458999999999999999999999985422110000 0000
Q ss_pred hhcCCc---------CCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 623 DFIDPN---------LEGKF-----SVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 623 ~~~~~~---------~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
.+.+.. ..... ....+.++.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 00000 01234678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=307.32 Aligned_cols=245 Identities=20% Similarity=0.286 Sum_probs=192.3
Q ss_pred cccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCCC
Q 005859 410 LGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNG 486 (673)
Q Consensus 410 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~g 486 (673)
||+|+||+||++... +|+.||+|.+..... ......+.+|++++++++||||+++++++.. .+..++||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCCC
Confidence 689999999999865 489999999875432 2234567889999999999999999998854 47789999999999
Q ss_pred ChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhhhh
Q 005859 487 NLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSML 566 (673)
Q Consensus 487 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 566 (673)
+|.+++.... ...+++..+..++.|++.||.|||+. |++||||+|+||++++++.+||+|||.+....... ...
T Consensus 79 ~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~--~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 152 (277)
T cd05577 79 DLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR--RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIK 152 (277)
T ss_pred cHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccc
Confidence 9999987432 23689999999999999999999987 89999999999999999999999999987654322 122
Q ss_pred ccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHH
Q 005859 567 KASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIAL 646 (673)
Q Consensus 567 ~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 646 (673)
...++..|+|||++.+..++.++|||||||++|||++|+.||................. ......+...+..+.+++.
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~ 230 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL--EMAVEYPDKFSPEAKDLCE 230 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc--cccccCCccCCHHHHHHHH
Confidence 34567889999999888899999999999999999999999865432111111111111 0111233344678899999
Q ss_pred HccccCCCCCC-----CHHHHHH
Q 005859 647 HCTHESPSHRP-----SIENVMQ 664 (673)
Q Consensus 647 ~Cl~~~p~~RP-----s~~evl~ 664 (673)
+||+.||++|| ++.++++
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 231 ALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHccCChhHccCCCcccHHHHHh
Confidence 99999999999 6665653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.41 Aligned_cols=253 Identities=21% Similarity=0.341 Sum_probs=205.5
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+|...+.||+|++|.||+|... +++.|++|++..... ....+.+.+|++++++++||||+++++.+.....+..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999987 589999999876532 13356789999999999999999999998654336789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++... ..+++..+..++.|++.||+|||+. |++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~--~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN--GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998732 3689999999999999999999986 8999999999999999999999999999876654
Q ss_pred chh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 561 IVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 561 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ..............+...+.
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 231 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA---ALYKIGSSGEPPEIPEHLSE 231 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHhccccCCCcCCCcccCH
Confidence 321 12234578889999999888899999999999999999999999876531111 11111111222233444568
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+.+++.+|++.+|++||++.++++
T Consensus 232 ~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 232 EAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHHHHHHhCcCChhhCCCHHHHhh
Confidence 8999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=303.30 Aligned_cols=250 Identities=18% Similarity=0.301 Sum_probs=204.7
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+|++.+.||+|+||.||++... +++.+|+|.+..... .....++.+|++++++++||||+++++++... ...++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEEEe
Confidence 4778889999999999999865 588999999876432 23345788999999999999999999988654 7899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++.........+++..+..++.|++.||+|||+. |++||||+|+||++++++.+|++|||+++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~--~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ--KILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC--CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999999875433345689999999999999999999987 8999999999999999999999999999877654
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
. .....++..|+|||.+.+..++.++|+||||+++|||++|+.||............ ........+...+.+
T Consensus 157 ~---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 228 (256)
T cd08530 157 M---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV-----QRGKYPPIPPIYSQD 228 (256)
T ss_pred C---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----hcCCCCCCchhhCHH
Confidence 1 22345788899999999888999999999999999999999998754332211111 111112233456678
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.+++.+||+.+|++||++.++++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 229 LQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhc
Confidence 999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=310.59 Aligned_cols=259 Identities=20% Similarity=0.326 Sum_probs=197.3
Q ss_pred HHhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCC----
Q 005859 399 RATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKG---- 472 (673)
Q Consensus 399 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 472 (673)
...++|++.+.||+|+||.||+|..+. |+.||+|+++.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 345678889999999999999999864 88999999976432 223356788999999999999999999986542
Q ss_pred ----CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeee
Q 005859 473 ----RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLL 548 (673)
Q Consensus 473 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl 548 (673)
.+..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+. ||+||||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~--~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK--NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCcEEe
Confidence 2378999999975 777776532 24689999999999999999999987 8999999999999999999999
Q ss_pred ccccccccccCcchhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhc-C
Q 005859 549 SDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFI-D 626 (673)
Q Consensus 549 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~-~ 626 (673)
+|||++...............++..|+|||.+.+. .++.++|||||||++|||++|+.||.......... .+.+.. .
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~-~~~~~~~~ 236 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE-LISRLCGS 236 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCC
Confidence 99999987654332222223457789999988653 57899999999999999999998886432211100 000000 0
Q ss_pred ------CcC---------C---------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 627 ------PNL---------E---------GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 627 ------~~~---------~---------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.+ . .......+..+.+++.+||+.||++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 0 0001123578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=317.51 Aligned_cols=254 Identities=17% Similarity=0.273 Sum_probs=196.3
Q ss_pred HhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCC----C
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKG----R 473 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~ 473 (673)
..++|+..+.||+|+||.||+|+.. +++.||||.+..... ......+.+|++++++++||||+++++++.... .
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3467999999999999999999965 589999999865422 223356788999999999999999999885432 2
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL 553 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGl 553 (673)
...++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~--gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35799999995 588887752 288899999999999999999987 899999999999999999999999999
Q ss_pred cccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch------------
Q 005859 554 HKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV------------ 621 (673)
Q Consensus 554 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~------------ 621 (673)
++....... .....++..|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 165 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 165 ARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred ceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 987654321 223457888999999999899999999999999999999999986432111000000
Q ss_pred ------hhhcCC---------------cCC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 622 ------EDFIDP---------------NLE----GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 622 ------~~~~~~---------------~~~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
....+. ... .......+..+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000 000 0001134567899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=309.96 Aligned_cols=252 Identities=16% Similarity=0.293 Sum_probs=193.9
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~lv 479 (673)
++|+..+.||+|+||.||+|...+ ++.||||.+..........++.+|++++.+.. ||||+++++++... ...++|
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v 92 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD--SDVFIC 92 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC--CeEEEE
Confidence 457778899999999999999875 89999999976543334456777888777774 99999999999654 678999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||++ +++.+++... ...+++..+..++.|+++||+|||+.. ||+||||+|+||++++++.+||+|||++.....
T Consensus 93 ~e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~-~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 93 MELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH-GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eeccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC-CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99985 5777766532 236899999999999999999999732 799999999999999999999999999876643
Q ss_pred cchhhhhccCCCCCccCCccccCCC----CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCC-CCCC
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGR----FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLE-GKFS 634 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 634 (673)
... .....++..|+|||++.+.. ++.++||||||+++|||++|+.||........ ........... ....
T Consensus 168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~ 242 (296)
T cd06618 168 SKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE---VLTKILQEEPPSLPPN 242 (296)
T ss_pred CCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH---HHHHHhcCCCCCCCCC
Confidence 321 12334678899999987554 78999999999999999999999865322111 11111111110 0111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
...+.++.+++.+||+.||++||++.++++.
T Consensus 243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1345789999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=317.19 Aligned_cols=258 Identities=19% Similarity=0.294 Sum_probs=197.7
Q ss_pred HhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 476 (673)
..++|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|+.+++++ +||||+++++++...+....
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888899999999999999976 488999998865321 22335677899999999 99999999999866555678
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||++ ++|.+++.. ..++|..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~--~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG--NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999996 599988862 2688999999999999999999987 899999999999999999999999999986
Q ss_pred ccCcchh----hhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc-----------
Q 005859 557 LADDIVF----SMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK----------- 620 (673)
Q Consensus 557 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~----------- 620 (673)
....... ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6443211 2223457889999998765 45789999999999999999999998543211110000
Q ss_pred --------hhhhcC----CcC--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 621 --------VEDFID----PNL--EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 621 --------~~~~~~----~~~--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
...+.+ ... ........+.++.+++.+||+.||++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000 000 000111245788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=308.47 Aligned_cols=246 Identities=20% Similarity=0.350 Sum_probs=194.9
Q ss_pred CccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC--cHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 404 FSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS--DEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
|+..+.||+|+||.||+++.. ++..||+|.+....... ....+.+|++++++++|||++++++++... +..++||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 104 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE--HTAWLVM 104 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--CeEEEEE
Confidence 666788999999999999965 58899999987543222 235788999999999999999999998654 6789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||++ |+|.+.+... ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 105 e~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~--~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 105 EYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH--NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred eCCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 9996 5888777532 34589999999999999999999987 7999999999999999999999999998755432
Q ss_pred chhhhhccCCCCCccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTT---TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
....++..|+|||++. .+.++.++|||||||++|||++|+.||........... ..............
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~ 249 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPTLQSNEW 249 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH----HHhccCCCCCCccc
Confidence 2345788899999974 45689999999999999999999999865432211111 11111111122334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQEL 666 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 666 (673)
+..+.+++.+||+.+|.+||++.++++.+
T Consensus 250 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 250 SDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred cHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 56789999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.79 Aligned_cols=259 Identities=18% Similarity=0.291 Sum_probs=195.7
Q ss_pred CCccccccccCCcceEEEEEEcC---CcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 403 CFSEANLLGKSSFSATYKGILRD---GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
+|...+.||+|+||.||+|.... ++.||+|.+..... ....+.+.+|+.++++++||||+++++++.....+..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47778899999999999999754 78999999986431 22235678899999999999999999999776557899
Q ss_pred EEEeecCCCChhhhhccccCCc-cccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC----CCCeeecccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSE-KVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR----RYNPLLSDSG 552 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~----~~~~kl~DfG 552 (673)
+||||+++ +|.+++....... ..+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC--CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 99999964 7777765332222 3688999999999999999999987 7999999999999999 8999999999
Q ss_pred ccccccCcch--hhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhh--------hccch
Q 005859 553 LHKLLADDIV--FSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA--------ESSKV 621 (673)
Q Consensus 553 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~--------~~~~~ 621 (673)
+++....... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||........ ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9986643221 112234578889999988764 589999999999999999999999864322110 00000
Q ss_pred hhhc---------------------CCcCCCCCC-----------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 622 EDFI---------------------DPNLEGKFS-----------VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 622 ~~~~---------------------~~~~~~~~~-----------~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+.+ +......++ ...+.++.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 000000011 023457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=305.47 Aligned_cols=247 Identities=19% Similarity=0.323 Sum_probs=206.2
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
-|...+.||+|.|++|-.+++- +|..||||++.+.... .....+.+|++.|+-++|||||++|++... ....|||+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT--QTKlyLiL 96 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT--QTKLYLIL 96 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc--cceEEEEE
Confidence 3566678999999999999844 6999999999886532 334678999999999999999999999844 46799999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEe-cCCCCeeeccccccccccC
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI-HRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl-~~~~~~kl~DfGla~~~~~ 559 (673)
|.-++|+|++|+-.. ..-+.+..+.+++.||..|+.|+|.. -+|||||||+||++ .+-|-+|+.|||++-.+..
T Consensus 97 ELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL--HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL--HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh--hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999999643 23488999999999999999999996 39999999999876 4567899999999987766
Q ss_pred cchhhhhccCCCCCccCCccccCCCCC-cchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFT-EKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
+. ..+..+|+..|-|||++.+..|+ +++||||+|||||-|+.|+.||....+. +.+..++|-.. ..+...+
T Consensus 172 G~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS----ETLTmImDCKY--tvPshvS 243 (864)
T KOG4717|consen 172 GK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS----ETLTMIMDCKY--TVPSHVS 243 (864)
T ss_pred cc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch----hhhhhhhcccc--cCchhhh
Confidence 54 35567899999999999999987 7899999999999999999999764332 22333444332 3566778
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+.++||..|+..||.+|.+.+||+.
T Consensus 244 ~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 244 KECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred HHHHHHHHHHHhcCchhhccHHHHhc
Confidence 89999999999999999999999873
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=306.95 Aligned_cols=253 Identities=19% Similarity=0.302 Sum_probs=193.8
Q ss_pred CccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 404 FSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
|+..+.||+|++|.||+|... +|+.||+|++...... ...+.+.+|++++++++||||+++++++.. .+..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS--ENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc--CCeEEEEEe
Confidence 566788999999999999975 5999999998755322 223578899999999999999999999854 478999999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|++ ++|.+++.... ...+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||+++......
T Consensus 79 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~--~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 79 FLD-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH--RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred ccC-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC--CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 995 69999886332 13689999999999999999999987 79999999999999999999999999997654321
Q ss_pred hhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh-----------------h
Q 005859 562 VFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE-----------------D 623 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~-----------------~ 623 (673)
. ......++..|+|||++.+. .++.++||||||+++|||+||+.||.............. +
T Consensus 154 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 154 R-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred c-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 1 11223457889999988764 478999999999999999999999854322111000000 0
Q ss_pred hcC--CcC----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 624 FID--PNL----EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 624 ~~~--~~~----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
... +.. ........+..+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 000 00111223467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.81 Aligned_cols=251 Identities=18% Similarity=0.295 Sum_probs=188.8
Q ss_pred cccccC--CcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKS--SFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
..||+| +||+||+++.. +|+.||+|++...... ...+.+.+|+.+++.++||||+++++++... +..++||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG--SWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC--CceEEEEecc
Confidence 356776 89999999975 5999999998754322 2235788999999999999999999999654 6789999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF 563 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 563 (673)
.+|+|.+++.... ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+|++||+.+.........
T Consensus 82 ~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~--~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 82 AYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN--GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred cCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 9999999987432 23588999999999999999999987 8999999999999999999999999865433221100
Q ss_pred h------hhccCCCCCccCCccccCC--CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh-------------
Q 005859 564 S------MLKASAAMGYLAPEYTTTG--RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE------------- 622 (673)
Q Consensus 564 ~------~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~------------- 622 (673)
. .....++..|+|||++.+. .++.++|||||||++|||++|+.||..............
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence 0 0112345679999999764 478999999999999999999999865432111100000
Q ss_pred ----------------------------hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 623 ----------------------------DFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 623 ----------------------------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...............+..+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000001111122345678999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=297.24 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=201.2
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
+|...+.||+|++|.||++... +++.|++|++..... .....+.+|++++++++||||+++++++... +..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEEe
Confidence 3677789999999999999976 588999999976542 3557899999999999999999999998654 67899999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+++++|.+++... ...+++..+..++.|++.||+|||+. |++||||+|+||++++++.++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~--~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 78 FCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN--GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred cCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC--CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 99999999998632 24689999999999999999999986 89999999999999999999999999988765432
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 641 (673)
. .....++..|+|||++.+..++.++||||||+++|||++|+.||............ .....+... .....+..+
T Consensus 153 ~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~ 227 (253)
T cd05122 153 A--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI-ATNGPPGLR--NPEKWSDEF 227 (253)
T ss_pred c--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-HhcCCCCcC--cccccCHHH
Confidence 1 23345788899999998888999999999999999999999998654221111111 000001111 111125779
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 005859 642 GQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 642 ~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 228 KDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHHHHccCChhhCCCHHHHhc
Confidence 99999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.75 Aligned_cols=256 Identities=11% Similarity=0.120 Sum_probs=184.6
Q ss_pred cCCccccccccCCcceEEEEEEcC----CcEEEEEEecccCCCCcH----------HHHHHHHHHHhccCCCCceeEeeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD----GSVVAVKCIAKTSCKSDE----------GEFLKGLKILTSLKHENLASLRGI 467 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~----------~~~~~E~~~l~~l~H~niv~l~~~ 467 (673)
++|.+.+.||+|+||+||+|...+ +..+|+|........... .....+...+..++|+||+++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578899999999999999999764 346677654332211100 112334455667799999999987
Q ss_pred EecCCC--CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC
Q 005859 468 CCSKGR--GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN 545 (673)
Q Consensus 468 ~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~ 545 (673)
+..... ...++++|++. .++.+.+.. ....++..+..|+.|+++||+|||+. +|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~--~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH--GISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCc
Confidence 644322 24467888773 466666542 12357888899999999999999987 7999999999999999999
Q ss_pred eeeccccccccccCcch------hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhh-hc
Q 005859 546 PLLSDSGLHKLLADDIV------FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA-ES 618 (673)
Q Consensus 546 ~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~-~~ 618 (673)
+||+|||+++....... .......||+.|+|||+..+..++.++|||||||++|||++|+.||........ ..
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999986642211 011234689999999999998999999999999999999999999976522111 00
Q ss_pred ----cchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 005859 619 ----SKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELS 667 (673)
Q Consensus 619 ----~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 667 (673)
.....+..... .....+..+.+++..||+.+|++||++.++++.|+
T Consensus 245 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 245 AAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 00111111111 11233578999999999999999999999998763
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=299.28 Aligned_cols=252 Identities=19% Similarity=0.329 Sum_probs=204.8
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+|+..+.||+|+||.||++... +++.||+|++...... .....+.+|++++++++|||++++++.+... +..++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEEE
Confidence 4778889999999999999976 4889999999765422 3456788999999999999999999988654 7889999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++.........+++..+..++.|++.||+|||+. |++|+||+|+||++++++.++|+|||.+......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR--KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC--CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999999975432246799999999999999999999987 8999999999999999999999999999876544
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
.. ......++..|+|||......++.++||||+|+++|+|++|+.||.......... ...... ....+...+..
T Consensus 157 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~ 230 (258)
T cd08215 157 VD-LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL----KILKGQ-YPPIPSQYSSE 230 (258)
T ss_pred cc-eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHH----HHhcCC-CCCCCCCCCHH
Confidence 31 1223457888999999988889999999999999999999999986543221111 111111 11223345578
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.+++.+||..+|++|||+.|+++
T Consensus 231 ~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 231 LRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhc
Confidence 999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=301.78 Aligned_cols=244 Identities=18% Similarity=0.213 Sum_probs=188.2
Q ss_pred cccccCCcceEEEEEEc-CCcEEEEEEecccCCC--CcHHHHHHHHHHH-hccCCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK--SDEGEFLKGLKIL-TSLKHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
+.||+|+||.||+|... +++.||+|++.+.... .....+..|..++ ...+||||+++++++.. .+..++||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 46899999999999975 4899999998754321 1123345555544 45589999999999854 47899999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF 563 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 563 (673)
++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||+++.....
T Consensus 80 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 150 (260)
T cd05611 80 NGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR--GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN--- 150 (260)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCcEEEeecccceecccc---
Confidence 99999999863 24588999999999999999999987 7999999999999999999999999998764431
Q ss_pred hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHH
Q 005859 564 SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQ 643 (673)
Q Consensus 564 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 643 (673)
....++..|+|||.+.+..++.++||||||+++|||+||..||............... ............+..+.+
T Consensus 151 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 226 (260)
T cd05611 151 --KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR--RINWPEEVKEFCSPEAVD 226 (260)
T ss_pred --ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc--ccCCCCcccccCCHHHHH
Confidence 2235778899999998888999999999999999999999998654332221111111 111111222245678999
Q ss_pred HHHHccccCCCCCCCHHHHHHHH
Q 005859 644 IALHCTHESPSHRPSIENVMQEL 666 (673)
Q Consensus 644 l~~~Cl~~~p~~RPs~~evl~~L 666 (673)
++.+||+.+|++||++.++.+.|
T Consensus 227 ~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 227 LINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HHHHHccCCHHHccCCCcHHHHH
Confidence 99999999999999876555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=300.75 Aligned_cols=249 Identities=16% Similarity=0.230 Sum_probs=190.9
Q ss_pred HHHHHHhcCCcccccc--ccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEec
Q 005859 395 EEVERATQCFSEANLL--GKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCS 470 (673)
Q Consensus 395 ~~l~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 470 (673)
.+.....++|+..+.+ |+|+||.||+++.+ ++..+|+|.+....... . |+.....+ +||||+++++.+..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~--e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----I--EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----h--hHHHHHHhhcCCCEEEEEEEEec
Confidence 4444555667776666 99999999999965 48889999986543211 1 22222222 79999999999965
Q ss_pred CCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC-Ceeec
Q 005859 471 KGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY-NPLLS 549 (673)
Q Consensus 471 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~-~~kl~ 549 (673)
. +..++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. |++||||||+||+++.++ .++|+
T Consensus 81 ~--~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 81 L--KGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH--NIIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred C--CeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHEEEeCCCCeEEEe
Confidence 4 6899999999999999999632 3689999999999999999999987 799999999999999998 99999
Q ss_pred cccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcC
Q 005859 550 DSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNL 629 (673)
Q Consensus 550 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 629 (673)
|||+++...... ...++..|+|||++.+..++.++|||||||++|||+||+.||............+.......
T Consensus 153 dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 226 (267)
T PHA03390 153 DYGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK- 226 (267)
T ss_pred cCccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhccc-
Confidence 999987664322 23578899999999988899999999999999999999999864322111111111111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 005859 630 EGKFSVSEASNLGQIALHCTHESPSHRPS-IENVMQ 664 (673)
Q Consensus 630 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-~~evl~ 664 (673)
.......+..+.+++.+||+.+|.+||+ ++|+++
T Consensus 227 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 -LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1222345678999999999999999996 688874
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=308.75 Aligned_cols=256 Identities=18% Similarity=0.274 Sum_probs=197.6
Q ss_pred CCccccccccCCcceEEEEEEc----CCcEEEEEEecccCC---CCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCC
Q 005859 403 CFSEANLLGKSSFSATYKGILR----DGSVVAVKCIAKTSC---KSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRG 474 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 474 (673)
+|...+.||+|+||.||+++.. +++.||||++++... ....+.+.+|++++.++ +||||+++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence 3677889999999999999843 478899999875421 12335688999999999 69999999988844 46
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLH 554 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla 554 (673)
..++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. |++||||||+||+++.++.++|+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~--~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL--GIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHeEECCCCCEEEEECccc
Confidence 78999999999999999863 24588999999999999999999987 8999999999999999999999999998
Q ss_pred ccccCcchhhhhccCCCCCccCCccccCCC--CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCC
Q 005859 555 KLLADDIVFSMLKASAAMGYLAPEYTTTGR--FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGK 632 (673)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (673)
+..............++..|+|||.+.+.. .+.++||||||+++|||+||..||.................... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~ 230 (288)
T cd05583 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK--PP 230 (288)
T ss_pred cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC--CC
Confidence 865443222222345788999999987665 78999999999999999999999853211110011111111111 12
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 633 FSVSEASNLGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 633 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
.+...+..+.+++.+||+.||++|||+.++.+.|+.
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 231 FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 233345678999999999999999999888776653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=309.25 Aligned_cols=251 Identities=21% Similarity=0.328 Sum_probs=200.9
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCC-CCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~lv 479 (673)
..|++.+.||+||.++||++...+.+.+|+|++..... .....-|.+|++.|.+| .|.+||++++|-.. .+..|+|
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~lYmv 438 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYLYMV 438 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--CceEEEE
Confidence 45777889999999999999998888898887765432 23346799999999999 59999999999865 4889999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||= .-||..+|..... ....| .++.+..|++.++.++|++ ||||.||||.|.|+-+ |.+||+|||+|..+..
T Consensus 439 mE~G-d~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~--gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQH--GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHh--ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 9997 4599999985432 22345 6788999999999999998 8999999999999864 6899999999998876
Q ss_pred cchh-hhhccCCCCCccCCccccCC-----------CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCC
Q 005859 560 DIVF-SMLKASAAMGYLAPEYTTTG-----------RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDP 627 (673)
Q Consensus 560 ~~~~-~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 627 (673)
+... .....+||+.||+||.+... +.+.++||||+|||||+|+-|+.||..+.+... .+..+.+|
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a---Kl~aI~~P 588 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA---KLHAITDP 588 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH---HHHhhcCC
Confidence 5432 23456899999999987532 367899999999999999999999987754433 34555666
Q ss_pred cCCCCCCHHH-HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 628 NLEGKFSVSE-ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 628 ~~~~~~~~~~-~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...-+++.-- ..++.++|..||+.||.+||+..|+++
T Consensus 589 ~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 589 NHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred CccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 5443443221 234999999999999999999999985
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=306.00 Aligned_cols=252 Identities=17% Similarity=0.296 Sum_probs=194.8
Q ss_pred CCccccccccCCcceEEEEEE----cCCcEEEEEEecccCC---CCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCC
Q 005859 403 CFSEANLLGKSSFSATYKGIL----RDGSVVAVKCIAKTSC---KSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRG 474 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 474 (673)
+|+..+.||+|+||.||+++. .+|+.||+|++..... ....+.+.+|+++++++ +|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence 467788999999999999986 3588999999875421 22346788999999999 69999999988844 46
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLH 554 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla 554 (673)
..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~--~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred eEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 78999999999999999863 24588899999999999999999987 8999999999999999999999999999
Q ss_pred ccccCcchhhhhccCCCCCccCCccccCC--CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCC
Q 005859 555 KLLADDIVFSMLKASAAMGYLAPEYTTTG--RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGK 632 (673)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (673)
+..............++..|+|||.+... .++.++||||||+++|||+||+.||................... ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~ 230 (290)
T cd05613 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--EPP 230 (290)
T ss_pred eecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--CCC
Confidence 87654322222334578899999998753 47889999999999999999999985321111111111111111 112
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005859 633 FSVSEASNLGQIALHCTHESPSHRP-----SIENVMQ 664 (673)
Q Consensus 633 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 664 (673)
++...+..+.+++.+||+.||++|| ++++++.
T Consensus 231 ~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 231 YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 3334567889999999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=314.44 Aligned_cols=249 Identities=18% Similarity=0.341 Sum_probs=204.7
Q ss_pred HhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
....|.+...||+|.|++|..|++. ++..||||.+.+.... ...+.+.+|+++|..++|||||+++.+... ....|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t--~~~ly 131 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET--EATLY 131 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee--cceeE
Confidence 4567888999999999999999965 4999999999887543 223568999999999999999999999854 47899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+.+|.+++|+... .......+..++.|+.+|++|+|++ +|||||||++||||+.++++||+|||++..+
T Consensus 132 lV~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k--~ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK--NIVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEEEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc--ceeccccchhhcccccccceeeeccccceee
Confidence 999999999999999743 3345578888999999999999998 6999999999999999999999999999887
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRF-TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (673)
.... .....+|++.|.|||++.+.+| .+++|+||+||++|-|+.|..||++..-.......+.. .. ..+..
T Consensus 206 ~~~~--~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g----k~--rIp~~ 277 (596)
T KOG0586|consen 206 DYGL--MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG----KY--RIPFY 277 (596)
T ss_pred cccc--cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee----ee--cccce
Confidence 7543 2445789999999999999887 58999999999999999999999865332222211111 11 11223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 637 EASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...+..+++++.+..+|.+|++++++.+
T Consensus 278 ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 278 MSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eechhHHHHHHhhccCccccCCHHHhhh
Confidence 3467788999999999999999999864
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=305.54 Aligned_cols=255 Identities=17% Similarity=0.271 Sum_probs=192.6
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
++|+..+.||+|++|.||+|..+ +|+.||+|.+...... ...+.+.+|++++++++||||+++++++.. .+..++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec--CCeEEEE
Confidence 46888899999999999999976 5889999988654322 223578899999999999999999999954 4789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC-CCCeeecccccccccc
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR-RYNPLLSDSGLHKLLA 558 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~-~~~~kl~DfGla~~~~ 558 (673)
|||++ ++|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+||++++ ++.+||+|||+++...
T Consensus 80 ~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~--~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 80 FEYLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH--RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred Eeccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 99995 5888877532 223467888889999999999999987 7999999999999985 4578999999997654
Q ss_pred CcchhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhh-------h------
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVED-------F------ 624 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~-------~------ 624 (673)
.... ......++..|+|||++.+. .++.++|||||||++|||+||+.||............... .
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 155 IPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 3211 12234567889999988764 5789999999999999999999998643221111100000 0
Q ss_pred ----c--CCcCCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 625 ----I--DPNLEGK----FSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 625 ----~--~~~~~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
. .+..... .....+.++.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0000000 01223467889999999999999999999985
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=296.26 Aligned_cols=248 Identities=22% Similarity=0.368 Sum_probs=201.7
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+|+..+.||+|++|.||+++.. +++.||+|.+...... .....+.+|++++++++|||++++++++... +..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEEEE
Confidence 4777889999999999999876 4789999999765421 2346789999999999999999999998654 7789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++... ..+++..+..++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 79 EYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ--GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred ecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC--CcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 999999999998632 4689999999999999999999987 8999999999999999999999999999876543
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
... .....++..|+|||...+..++.++||||+|+++|||++|+.||.............. ......+...+..
T Consensus 153 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 226 (254)
T cd06627 153 SKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-----DDHPPLPEGISPE 226 (254)
T ss_pred ccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-----cCCCCCCCCCCHH
Confidence 221 2234578889999999887789999999999999999999999865432211111110 1111233344678
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.+++.+||..+|++||++.+++.
T Consensus 227 ~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 227 LKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHHHHHhCChhhCcCHHHHhc
Confidence 899999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=302.05 Aligned_cols=242 Identities=18% Similarity=0.293 Sum_probs=186.6
Q ss_pred ccccCCcceEEEEEEc-CCcEEEEEEecccCCCCc--HHHHHHHH---HHHhccCCCCceeEeeEEecCCCCeEEEEEee
Q 005859 409 LLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSD--EGEFLKGL---KILTSLKHENLASLRGICCSKGRGECFLIYDF 482 (673)
Q Consensus 409 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~E~---~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~ 482 (673)
.||+|+||.||++... +++.||+|.+.+...... ...+..|. +.++..+||||+++++++.. .+..++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence 4899999999999865 488999999876532211 22344444 34455689999999998854 4788999999
Q ss_pred cCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcch
Q 005859 483 VPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV 562 (673)
Q Consensus 483 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 562 (673)
+++|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 79 ~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~--~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~- 151 (278)
T cd05606 79 MNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (278)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence 999999998862 34689999999999999999999987 79999999999999999999999999987654322
Q ss_pred hhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHH
Q 005859 563 FSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641 (673)
Q Consensus 563 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 641 (673)
.....|+..|+|||.+.++ .++.++|||||||++|||++|+.||.......... ..... .......+...+.++
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~--~~~~~-~~~~~~~~~~~s~~~ 226 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMT-LTMAVELPDSFSPEL 226 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH--HHHHh-hccCCCCCCcCCHHH
Confidence 1234688999999999754 58999999999999999999999986542111100 00000 011112233346789
Q ss_pred HHHHHHccccCCCCCC-----CHHHHHH
Q 005859 642 GQIALHCTHESPSHRP-----SIENVMQ 664 (673)
Q Consensus 642 ~~l~~~Cl~~~p~~RP-----s~~evl~ 664 (673)
.+++.+|+..+|++|| ++.++++
T Consensus 227 ~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 227 RSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 9999999999999999 9999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=330.87 Aligned_cols=260 Identities=17% Similarity=0.206 Sum_probs=184.6
Q ss_pred HhcCCccccccccCCcceEEEEEEcC--CcEEEEEEe--------------cccC--CCCcHHHHHHHHHHHhccCCCCc
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRD--GSVVAVKCI--------------AKTS--CKSDEGEFLKGLKILTSLKHENL 461 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~--------------~~~~--~~~~~~~~~~E~~~l~~l~H~ni 461 (673)
..++|.+.+.||+|+||+||+|..+. +..+++|.+ .+.. .......+.+|+++|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987643 222222211 1100 01123568899999999999999
Q ss_pred eeEeeEEecCCCCeEEEEEeecCCCChhhhhccccCC-ccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEe
Q 005859 462 ASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGS-EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI 540 (673)
Q Consensus 462 v~l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl 540 (673)
|++++++... +..|+|+|++ .++|.+++...... ........+..|+.|++.||+|||++ |||||||||+|||+
T Consensus 226 v~l~~~~~~~--~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~--gIiHrDLKP~NILl 300 (501)
T PHA03210 226 LKIEEILRSE--ANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK--KLIHRDIKLENIFL 300 (501)
T ss_pred CcEeEEEEEC--CeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEE
Confidence 9999999654 6789999999 46787776532111 12234566778999999999999987 89999999999999
Q ss_pred cCCCCeeeccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCC-CChhhHh--hhh
Q 005859 541 HRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCS-ITPFTRQ--AAE 617 (673)
Q Consensus 541 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p-~~~~~~~--~~~ 617 (673)
+.++.+||+|||+++.+............|+..|+|||++.+..++.++|||||||++|||++|+.+ +...... ...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999987754432223345689999999999998999999999999999999998754 3211100 000
Q ss_pred ccc-----------------hhhhcCCc-CC---CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 618 SSK-----------------VEDFIDPN-LE---GKFS-----VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 618 ~~~-----------------~~~~~~~~-~~---~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
... ..++++.. .. ...+ ...+.++.+++.+|++.||.+|||+.|+++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00000000 00 0000 012345778899999999999999999986
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=306.96 Aligned_cols=250 Identities=19% Similarity=0.254 Sum_probs=186.7
Q ss_pred cccccCCcceEEEEEEcCCcEEEEEEecccC-CCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCCC
Q 005859 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTS-CKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNG 486 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~g 486 (673)
+.+|.|+++.||++.. +++.||||++.... .....+.+.+|++++++++||||+++++++... +..+++|||+++|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~--~~~~~~~e~~~~~ 84 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD--SELYVVSPLMAYG 84 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC--CeEEEEEeccCCC
Confidence 3445555555555544 58999999997652 233446899999999999999999999988554 6789999999999
Q ss_pred ChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcch----
Q 005859 487 NLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV---- 562 (673)
Q Consensus 487 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~---- 562 (673)
+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~--~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK--GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999997432 23588899999999999999999987 799999999999999999999999998875532211
Q ss_pred --hhhhccCCCCCccCCccccCC--CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh----h-----------
Q 005859 563 --FSMLKASAAMGYLAPEYTTTG--RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE----D----------- 623 (673)
Q Consensus 563 --~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~----~----------- 623 (673)
.......++..|+|||++... .++.++|||||||++|||++|+.||.............. .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 011233466789999998763 588999999999999999999999875432211100000 0
Q ss_pred ---------hcCCcC----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 624 ---------FIDPNL----EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 624 ---------~~~~~~----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..++.. ..........++.+++.+||+.||++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000000 00112233567889999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=306.22 Aligned_cols=256 Identities=20% Similarity=0.306 Sum_probs=192.4
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCC------C
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKG------R 473 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~ 473 (673)
++|+..+.||+|+||.||+|... +++.||||.+...... .....+.+|++++++++||||+++++++.... .
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888999999999999999976 4899999988654322 22345678999999999999999999986532 2
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL 553 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGl 553 (673)
...++||||+. ++|.+++... ...+++.+++.++.|++.||+|||+. ||+|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~--~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN--KILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEECCCCcEEECcCCC
Confidence 35699999996 5888877532 23589999999999999999999987 899999999999999999999999999
Q ss_pred cccccCcchh---hhhccCCCCCccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhc---C
Q 005859 554 HKLLADDIVF---SMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFI---D 626 (673)
Q Consensus 554 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~---~ 626 (673)
+......... ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||.......... .+..+. .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~-~~~~~~~~~~ 244 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT-LISQLCGSIT 244 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCC
Confidence 9866432211 112334678899999887644 7899999999999999999998886432211000 000000 0
Q ss_pred ----C-----------cCCCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 627 ----P-----------NLEGKF---------SVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 627 ----~-----------~~~~~~---------~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+ ...... +......+.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 000000 0112356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=301.66 Aligned_cols=244 Identities=18% Similarity=0.283 Sum_probs=193.4
Q ss_pred cccCCcceEEEEEEcC-CcEEEEEEecccCCC--CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCCC
Q 005859 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCK--SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNG 486 (673)
Q Consensus 410 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~g 486 (673)
||+|+||.||+++..+ |+.||+|.+...... ...+.+.+|++++++++||||+++++.+.. .+..++||||++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCCC
Confidence 6899999999999875 999999998764321 334678899999999999999999988854 47789999999999
Q ss_pred ChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcch----
Q 005859 487 NLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV---- 562 (673)
Q Consensus 487 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~---- 562 (673)
+|.+++... ..+++..+..++.||+.||+|||+. |++||||+|+||++++++.+||+|||++........
T Consensus 79 ~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~--~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 79 DLASLLENV----GSLDEDVARIYIAEIVLALEYLHSN--GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc--CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 999999732 3689999999999999999999987 899999999999999999999999999875433211
Q ss_pred ---hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHH--H
Q 005859 563 ---FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS--E 637 (673)
Q Consensus 563 ---~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 637 (673)
.......++..|+|||......++.++||||||+++||++||+.||........... ...... ..+.. .
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~----~~~~~~--~~~~~~~~ 226 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN----ILNGKI--EWPEDVEV 226 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HhcCCc--CCCccccC
Confidence 012234567789999999888899999999999999999999999865433221111 111111 11112 2
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQELS 667 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 667 (673)
+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 227 SDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 678899999999999999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.54 Aligned_cols=256 Identities=18% Similarity=0.286 Sum_probs=196.5
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecC--CCCeEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSK--GRGECF 477 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~~~ 477 (673)
.+|+..+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.++++++||||+++++++... .....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67888899999999999999965 489999999876432 22345678899999999999999999987532 234689
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+. |+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+||++++++.+||+|||+++..
T Consensus 85 lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA--NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999995 689988862 34589999999999999999999987 7999999999999999999999999999765
Q ss_pred cCcchh---hhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhh----------------
Q 005859 558 ADDIVF---SMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE---------------- 617 (673)
Q Consensus 558 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~---------------- 617 (673)
...... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 432211 1123467888999999865 45899999999999999999999998643211000
Q ss_pred ---ccchhhhcCC-cCCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 618 ---SSKVEDFIDP-NLEGKF-----SVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 618 ---~~~~~~~~~~-~~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.....+..+. ...... ....+.++.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000000000 000011 1224578999999999999999999999885
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=304.00 Aligned_cols=243 Identities=17% Similarity=0.297 Sum_probs=193.8
Q ss_pred cccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCCC
Q 005859 408 NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNG 486 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~g 486 (673)
..||+|+||.||++... +++.||||++.... ......+.+|+.++++++|+||+++++++... +..++||||++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~ 102 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVVMEFLEGG 102 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeC--CEEEEEEecCCCC
Confidence 57999999999999875 58999999886433 23456789999999999999999999998654 7899999999999
Q ss_pred ChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhhhh
Q 005859 487 NLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSML 566 (673)
Q Consensus 487 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 566 (673)
+|.+++.. ..+++..+..++.|++.||+|||+. ||+||||||+||++++++.++|+|||++........ ...
T Consensus 103 ~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~--givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~ 174 (292)
T cd06657 103 ALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ--GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRK 174 (292)
T ss_pred cHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccc
Confidence 99998752 3478999999999999999999987 899999999999999999999999999876543321 122
Q ss_pred ccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHH
Q 005859 567 KASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIAL 646 (673)
Q Consensus 567 ~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 646 (673)
...++..|+|||++.+..++.++|||||||++|||++|+.||.......... .......+... .....+..+.+++.
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~l~~li~ 251 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPKLK--NLHKVSPSLKGFLD 251 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhhCCcccC--CcccCCHHHHHHHH
Confidence 3457888999999988889999999999999999999999986432221111 11111111111 11223567889999
Q ss_pred HccccCCCCCCCHHHHHH
Q 005859 647 HCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 647 ~Cl~~~p~~RPs~~evl~ 664 (673)
+||+.+|.+||++.++++
T Consensus 252 ~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 252 RLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHhCCcccCcCHHHHhc
Confidence 999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=312.04 Aligned_cols=251 Identities=16% Similarity=0.285 Sum_probs=192.0
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCC----CC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKG----RG 474 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~ 474 (673)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ......+.+|++++++++||||+++++++.... ..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999965 589999999875432 222356889999999999999999999885432 13
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLH 554 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla 554 (673)
..++|+||+. .+|.++.. ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~--~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA--GIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 5689999996 47776552 2488999999999999999999987 7999999999999999999999999998
Q ss_pred ccccCcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch------------
Q 005859 555 KLLADDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV------------ 621 (673)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~------------ 621 (673)
+..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 165 RHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred cCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 765332 223456788999999876 458999999999999999999999986532111100000
Q ss_pred -------hhhcC--CcC-CCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 622 -------EDFID--PNL-EGKF---SVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 622 -------~~~~~--~~~-~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..... +.. .... ....+..+.+++.+||+.||++||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000 000 0000 0123456889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=305.28 Aligned_cols=246 Identities=21% Similarity=0.348 Sum_probs=193.2
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC--CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK--SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.|+..+.||+|+||.||+|+.. +++.||+|.+...... ....++.+|+++++.++|+|++++++++... +..++|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 93 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLV 93 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CeeEEE
Confidence 3666788999999999999976 4889999988653221 2235688999999999999999999998654 678999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+. |++.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~--~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 94 MEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 99996 6888777532 24588999999999999999999987 799999999999999999999999999876543
Q ss_pred cchhhhhccCCCCCccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTT---TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (673)
. ....++..|+|||.+. ...++.++|||||||++|||++|+.||............ .....+. .....
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~~~~~---~~~~~ 238 (308)
T cd06634 168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-AQNESPA---LQSGH 238 (308)
T ss_pred c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH-hhcCCCC---cCccc
Confidence 2 2345788899999975 356889999999999999999999998654322111111 1111111 11224
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 637 EASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
.+..+.+++.+||+.+|++||++.++++.
T Consensus 239 ~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred ccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 55778999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=303.50 Aligned_cols=252 Identities=20% Similarity=0.310 Sum_probs=193.9
Q ss_pred CccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCeEEEEEe
Q 005859 404 FSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
|.+.+.||+|+||+||+|+..+ ++.||||++.......+.....+|+..+++++ ||||+++++++.. .+..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEe
Confidence 5667889999999999999864 78999999876543334445678999999999 9999999999855 478899999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+ +|+|.+++.... ...+++..+..++.|++.||+|||++ |++|+||+|+||++++++.++|+|||+++......
T Consensus 79 ~~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~--~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 79 YM-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH--GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred cC-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 99 889999887432 24689999999999999999999987 89999999999999999999999999998665432
Q ss_pred hhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhcc-----------------chhh
Q 005859 562 VFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESS-----------------KVED 623 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~-----------------~~~~ 623 (673)
. .....++..|+|||++.+ ..++.++||||||+++|||++|+.||........... ....
T Consensus 154 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 154 P--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred C--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 1 123457788999998854 4579999999999999999999988753321110000 0000
Q ss_pred hcCCcCC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 624 FIDPNLE-------GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 624 ~~~~~~~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+.... .......+..+.+++.+||+.+|++|||++|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000 0001112467999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=298.49 Aligned_cols=251 Identities=16% Similarity=0.257 Sum_probs=196.1
Q ss_pred CCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC----CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 403 CFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC----KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
+|...+.||+|+||.||+++... +..+++|.++.... .....++.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER--DAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC--CceE
Confidence 47778899999999999998654 45566666554221 22334677899999999999999999988544 6689
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++++|.+++.........+++..++.++.|++.||+|||+. |++|+||||+||++++ +.+||+|||+++..
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR--RILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc--CccccCCChhheEeec-CCEeecccCceeec
Confidence 99999999999998865433445799999999999999999999987 8999999999999975 56999999998776
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
..... ......++..|+|||.+....++.++||||||+++|+|++|..||......... ..... ......+...
T Consensus 156 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~ 229 (260)
T cd08222 156 MGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV----LRIVE-GPTPSLPETY 229 (260)
T ss_pred CCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH----HHHHc-CCCCCCcchh
Confidence 44321 122345778899999998888999999999999999999999998653322111 11111 1122234456
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.++.+++.+||+.+|++||++.|+++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 230 SRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred cHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=301.87 Aligned_cols=252 Identities=20% Similarity=0.319 Sum_probs=196.1
Q ss_pred CccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 404 FSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
|+..+.||+|++|.||+|... +++.+|+|++...... .....+.+|++++++++|+||+++++++... +..++|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEEEEe
Confidence 456678999999999999975 5889999998765422 2346788999999999999999999998544 78899999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||.+.......
T Consensus 79 ~~~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 79 FMDT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH--GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred ccCC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC--CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 9975 888888642 24689999999999999999999987 79999999999999999999999999998765432
Q ss_pred hhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCC-------------
Q 005859 562 VFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDP------------- 627 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~------------- 627 (673)
.......++..|+|||.+.+. .++.++||||||+++|+|+||+.||.................++
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 112224567789999998876 68999999999999999999998885432211110000000000
Q ss_pred ----cCC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 628 ----NLE-------GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 628 ----~~~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
... .......+.++.+++.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 0111234678999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=310.59 Aligned_cols=261 Identities=18% Similarity=0.284 Sum_probs=197.9
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC---Ce
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGR---GE 475 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---~~ 475 (673)
.++|...+.||+|+||.||+|+.. +++.||||.+..... ......+.+|+.++++++||||+++++++..... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 356888999999999999999965 589999999875421 2234567889999999999999999998754322 35
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.++||||+. ++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~--~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA--NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999995 789888862 34689999999999999999999987 79999999999999999999999999998
Q ss_pred cccCcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhh-----------------
Q 005859 556 LLADDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE----------------- 617 (673)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~----------------- 617 (673)
....... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||.........
T Consensus 157 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 157 TTSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred ccCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 6644321 1223456788999998865 46899999999999999999999988542110000
Q ss_pred --ccchhhhcC---CcCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHh
Q 005859 618 --SSKVEDFID---PNLEG---KFSVSEASNLGQIALHCTHESPSHRPSIENVMQE--LSSI 669 (673)
Q Consensus 618 --~~~~~~~~~---~~~~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--L~~i 669 (673)
.....+... ..... ......+.++.+++.+||+.+|++|||++|+++. ++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000000 00000 0112345778999999999999999999999865 4443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=301.91 Aligned_cols=249 Identities=20% Similarity=0.315 Sum_probs=200.6
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCeEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLK-HENLASLRGICCSKGRGECF 477 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~ 477 (673)
++|...+.||+|+||.||+|+.. +++.||+|++.+... ....+.+.+|++++++++ ||||+++++++.. .+..+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEE
Confidence 36888899999999999999976 589999999876432 223457889999999998 9999999998854 46789
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++++|||++...
T Consensus 79 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~--~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 79 FVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK--GIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 99999999999999963 23699999999999999999999987 8999999999999999999999999998866
Q ss_pred cCcch-------------------hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhc
Q 005859 558 ADDIV-------------------FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAES 618 (673)
Q Consensus 558 ~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~ 618 (673)
..... .......++..|+|||......++.++||||||++++|+++|+.||.........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~- 231 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF- 231 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH-
Confidence 54321 1112234678899999998888999999999999999999999998754322111
Q ss_pred cchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 005859 619 SKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSI----ENVMQ 664 (673)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~----~evl~ 664 (673)
..... .....+...+..+.+++.+||+.+|++||++ +++++
T Consensus 232 ---~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 ---QKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---HHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11111 1112333446789999999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=298.50 Aligned_cols=254 Identities=17% Similarity=0.270 Sum_probs=193.3
Q ss_pred CccccccccCCcceEEEEEEcC-CcEEEEEEecccCCC-CcHHHHHHHHHHHhcc---CCCCceeEeeEEecCCC---Ce
Q 005859 404 FSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCK-SDEGEFLKGLKILTSL---KHENLASLRGICCSKGR---GE 475 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~---~~ 475 (673)
|++.+.||+|+||.||+|+.+. ++.||+|++...... .....+.+|+.+++++ +||||+++++++..... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999875 899999999754322 1234567788777666 69999999999865422 23
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.+++|||+. ++|.+++.... ...+++..++.++.|+++||+|||+. +++|+||+|+||++++++.+||+|||.+.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~--~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH--RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999996 58998886432 23589999999999999999999987 79999999999999999999999999998
Q ss_pred cccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhh-----------
Q 005859 556 LLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF----------- 624 (673)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~----------- 624 (673)
....... .....++..|+|||.+.+..++.++|||||||++|||+||+.||................
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence 7644321 123346788999999998889999999999999999999988876543221111111100
Q ss_pred -------cCCcCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 625 -------IDPNLE---GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 625 -------~~~~~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...... .......+..+.+++.+||+.||++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000 0111233567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=300.53 Aligned_cols=244 Identities=20% Similarity=0.333 Sum_probs=191.3
Q ss_pred CccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC--CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 404 FSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK--SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
|...+.||+|+||+||+|+.. +++.||+|.+...... .....+.+|++++++++|||++++++++.+. +..++||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE--HTAWLVM 100 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEEEEE
Confidence 555677999999999999965 4889999998754322 1225688999999999999999999998654 6789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+. |++.+++... ...+++..+..++.|++.||+|||+. ||+||||||+||++++++.+||+|||++.....
T Consensus 101 e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~--gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 101 EYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH--NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred ecCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 9995 6888777532 24589999999999999999999987 899999999999999999999999999864332
Q ss_pred chhhhhccCCCCCccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTT---TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
.....++..|+|||++. ...++.++|||||||++|||++|..||.............. ...........
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~ 245 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NDSPTLQSNEW 245 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----cCCCCCCcccc
Confidence 22345788899999985 35688999999999999999999999865432211111111 11111112223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+..+.+++.+||+.+|.+||++.++++
T Consensus 246 ~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 246 TDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 456899999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=287.42 Aligned_cols=203 Identities=22% Similarity=0.362 Sum_probs=168.8
Q ss_pred cCCccccccccCCcceEEEEEEcC-----CcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-----GSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
..|+....||+|.||.||+|.-.+ ...+|||.++..... .-.....+|+.+++.++||||+.+..++... ...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cce
Confidence 457888899999999999996432 237899998765321 1235678999999999999999999998764 467
Q ss_pred EEEEEeecCCCChhhhhccccCC-ccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC----CCeeecc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGS-EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR----YNPLLSD 550 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~----~~~kl~D 550 (673)
+++++||.+. ||.+.++..+.+ .+.++-.....|+.||+.|+.|||++. |+||||||.|||+..+ |.+||+|
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeec
Confidence 8999999976 999998765432 357888899999999999999999974 9999999999999887 8999999
Q ss_pred ccccccccCcch--hhhhccCCCCCccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCC
Q 005859 551 SGLHKLLADDIV--FSMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSI 608 (673)
Q Consensus 551 fGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~el~tG~~p~ 608 (673)
||+++.+.+... ......+.|++|+|||.+.+.+ ||.+.||||.|||..||+|-+.-|
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF 240 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLF 240 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccc
Confidence 999998876432 2334567899999999999865 899999999999999999976544
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=303.60 Aligned_cols=258 Identities=19% Similarity=0.238 Sum_probs=193.6
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC-cHHHHHHHHHHHhccCCCCceeEeeEEecCC------
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS-DEGEFLKGLKILTSLKHENLASLRGICCSKG------ 472 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 472 (673)
.++|...+.||+|+||.||+|+.. +++.||||++....... ....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467899999999999999999976 48899999987653222 2346789999999999999999999876532
Q ss_pred CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccc
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSG 552 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfG 552 (673)
....++||||+++ ++...+.. ....+++..+..++.|+++||+|||+. ||+||||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~--~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN--HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEECcCc
Confidence 2357999999964 77777653 234689999999999999999999987 89999999999999999999999999
Q ss_pred ccccccCcchh----------hhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch
Q 005859 553 LHKLLADDIVF----------SMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV 621 (673)
Q Consensus 553 la~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~ 621 (673)
+++........ ......++..|+|||.+.+. .++.++|||||||++|||++|+.||.............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99865432211 11223457789999988654 58999999999999999999999886432211110000
Q ss_pred -----------------hhhcCCcCCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 622 -----------------EDFIDPNLEGKFS-------VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 622 -----------------~~~~~~~~~~~~~-------~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
....+.......+ ......+.+++.+|++.||++|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000000000 112357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=308.36 Aligned_cols=256 Identities=18% Similarity=0.274 Sum_probs=198.7
Q ss_pred CCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCC---CCeEE
Q 005859 403 CFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKG---RGECF 477 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---~~~~~ 477 (673)
+|.+.+.||+|+||.||+|+..+ ++.||||++..... ....+.+.+|++++++++||||+++++++.... ....+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47788999999999999999765 89999999876532 233467899999999999999999999986542 23689
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||++ ++|.+++.. ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~--gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA--NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 589888863 23689999999999999999999987 8999999999999999999999999999876
Q ss_pred cCcch--hhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch-------------
Q 005859 558 ADDIV--FSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV------------- 621 (673)
Q Consensus 558 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~------------- 621 (673)
..... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||.............
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 55321 112234567889999999887 78999999999999999999999986432211110000
Q ss_pred ------hhhcC---CcCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 622 ------EDFID---PNLE---GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 622 ------~~~~~---~~~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
.+... .... .......+..+.+++.+||+.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000 0000 00011235678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=308.50 Aligned_cols=260 Identities=15% Similarity=0.238 Sum_probs=199.2
Q ss_pred CHHHHHHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEec
Q 005859 393 NLEEVERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCS 470 (673)
Q Consensus 393 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 470 (673)
..+++...+++|...+.||+|+||.||+|... +++.||+|++..... ....+.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 45677778899999999999999999999864 589999999875432 1224568899999999999999999998754
Q ss_pred CC----CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCe
Q 005859 471 KG----RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNP 546 (673)
Q Consensus 471 ~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~ 546 (673)
.. ....++++|++ +++|.+++.. ..+++..+..++.|+++||+|||+. ||+||||||+||++++++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA--DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCChHHEEEcCCCCE
Confidence 32 23467888887 7899888752 3489999999999999999999987 79999999999999999999
Q ss_pred eeccccccccccCcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc-----
Q 005859 547 LLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK----- 620 (673)
Q Consensus 547 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~----- 620 (673)
||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............
T Consensus 160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999998765432 223457888999998866 46889999999999999999999998532211100000
Q ss_pred ------h--------hhh---cCCcCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 621 ------V--------EDF---IDPNLEG---KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 621 ------~--------~~~---~~~~~~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
. ... ....... ......+.++.+++.+|++.||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0 000 0000000 000123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.05 Aligned_cols=256 Identities=22% Similarity=0.288 Sum_probs=196.5
Q ss_pred HHHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCC
Q 005859 397 VERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRG 474 (673)
Q Consensus 397 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 474 (673)
+...+++|...+.||+|+||.||++... +++.||||++.+... ....+.+.+|++++++++||||+++++++... ..
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~ 83 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LE 83 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CC
Confidence 3456788999999999999999999865 589999998865322 22346788999999999999999999988643 34
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLH 554 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla 554 (673)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||.+
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~--~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA--GVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEeECCCCCEEeCccccc
Confidence 688999999 5689888752 3478888889999999999999987 7999999999999999999999999998
Q ss_pred ccccCcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhc---------------
Q 005859 555 KLLADDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAES--------------- 618 (673)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~--------------- 618 (673)
+..... .....++..|+|||.+.+ ..++.++|||||||++|||+||+.||..........
T Consensus 156 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 156 RIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred cccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 754332 122356778999998866 568999999999999999999998885432110000
Q ss_pred ----cchhhhcC-CcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 619 ----SKVEDFID-PNLEGKFS-----VSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 619 ----~~~~~~~~-~~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
....++.. .......+ ...+..+.+++.+||+.+|++|||+.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00000111 1234789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=303.55 Aligned_cols=253 Identities=19% Similarity=0.242 Sum_probs=191.2
Q ss_pred CCc-cccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCc-------------HHHHHHHHHHHhccCCCCceeEeeE
Q 005859 403 CFS-EANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSD-------------EGEFLKGLKILTSLKHENLASLRGI 467 (673)
Q Consensus 403 ~~~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-------------~~~~~~E~~~l~~l~H~niv~l~~~ 467 (673)
+|. ..+.||+|+||+||+|... +++.||||.+........ ...+.+|++++++++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 444 3467999999999999966 589999999875432211 1257899999999999999999999
Q ss_pred EecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCee
Q 005859 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPL 547 (673)
Q Consensus 468 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~k 547 (673)
+... +..++||||++ |+|.+++.. ...+++.....++.|++.||+|||+. ||+||||||+||+++.++.+|
T Consensus 89 ~~~~--~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~--~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 89 YVEG--DFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW--YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EecC--CcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC--CeecccccHHHeEECCCCCEE
Confidence 8654 68899999996 699998862 34588999999999999999999987 899999999999999999999
Q ss_pred eccccccccccCcch-------------hhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhH
Q 005859 548 LSDSGLHKLLADDIV-------------FSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTR 613 (673)
Q Consensus 548 l~DfGla~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~ 613 (673)
|+|||+++....+.. .......++..|+|||++.+. .++.++|||||||++|||+||+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999976652110 111223457789999998764 479999999999999999999998865432
Q ss_pred hhhhccchhhhcCC-------------------cCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 614 QAAESSKVEDFIDP-------------------NLEG---KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 614 ~~~~~~~~~~~~~~-------------------~~~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.............+ .... ......+.++.+++.+||+.+|++||+++|++.
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 21111100000000 0000 001123567889999999999999999999985
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=308.29 Aligned_cols=254 Identities=17% Similarity=0.257 Sum_probs=191.3
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC-------
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGR------- 473 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------- 473 (673)
.+|...+.||+|+||.||+|+.. +|+.||+|.+.... ....+.+.+|++++++++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC-CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 57888999999999999999975 48899999987654 2344678899999999999999999987654321
Q ss_pred -----CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC-CCCee
Q 005859 474 -----GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR-RYNPL 547 (673)
Q Consensus 474 -----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~-~~~~k 547 (673)
...++||||++ ++|.+++.. ..+++..++.++.||+.||+|||+. ||+||||||+||+++. ++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~--givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA--NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEEcCCCceEE
Confidence 35789999996 589888752 3588999999999999999999987 8999999999999974 55789
Q ss_pred eccccccccccCcchh--hhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch---
Q 005859 548 LSDSGLHKLLADDIVF--SMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV--- 621 (673)
Q Consensus 548 l~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~--- 621 (673)
++|||+++........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||.............
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999765432111 1122356788999998754 458899999999999999999999986432211100000
Q ss_pred ---------------hhhcC-CcCCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 622 ---------------EDFID-PNLEGKF-----SVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 622 ---------------~~~~~-~~~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..... ....... ....+.++.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000 0000000 1123467889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=295.77 Aligned_cols=252 Identities=19% Similarity=0.311 Sum_probs=194.8
Q ss_pred CccccccccCCcceEEEEEEcC-CcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 404 FSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
|+..+.||+|+||.||+|+..+ ++.||+|.+..... ....+.+.+|++++++++|+||+++++++... +..++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEEec
Confidence 4556789999999999999765 89999999986531 22346788999999999999999999998544 78899999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|++ ++|.+++.... ..+++..+.+++.|++.||+|||+. ||+||||+|+||++++++.+||+|||.++......
T Consensus 79 ~~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 79 YCD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH--RILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred CcC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 997 59999997421 3589999999999999999999987 79999999999999999999999999998664432
Q ss_pred hhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc-----------hh---hh--
Q 005859 562 VFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK-----------VE---DF-- 624 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~-----------~~---~~-- 624 (673)
. ......++..|+|||.+... .++.++|||||||++|||++|+.||............ .. ..
T Consensus 153 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 153 R-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred c-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 1 12233456789999998776 7899999999999999999999888543211110000 00 00
Q ss_pred cC---CcCCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 625 ID---PNLEG----KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 625 ~~---~~~~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+ +.... ......+..+.+++.+||+.||++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 00000 001112567999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=305.06 Aligned_cols=255 Identities=16% Similarity=0.275 Sum_probs=195.5
Q ss_pred HHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC--
Q 005859 398 ERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGR-- 473 (673)
Q Consensus 398 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-- 473 (673)
....++|+..+.||+|+||.||++... +++.||||++..... ......+.+|++++++++||||+++++++.....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 334678999999999999999999855 589999999865422 1223568899999999999999999998854322
Q ss_pred --CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccc
Q 005859 474 --GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDS 551 (673)
Q Consensus 474 --~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~Df 551 (673)
...++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+. ||+||||||+||++++++.+|++||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~--gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA--GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEeec
Confidence 2468999999 7799888752 3589999999999999999999987 8999999999999999999999999
Q ss_pred cccccccCcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch---------
Q 005859 552 GLHKLLADDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV--------- 621 (673)
Q Consensus 552 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~--------- 621 (673)
|++...... .....++..|+|||.+.+ ..++.++|||||||++|++++|+.||.............
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 163 GLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred ccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 999865432 123356788999999876 458899999999999999999999986432211100000
Q ss_pred ----------hhhcC--CcCC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 622 ----------EDFID--PNLE----GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 622 ----------~~~~~--~~~~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..... +... .......+..+.+++.+|++.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 0000 0011223456889999999999999999999983
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=301.98 Aligned_cols=255 Identities=19% Similarity=0.219 Sum_probs=191.2
Q ss_pred CCccccccccCCcceEEEEEEc-C--CcEEEEEEecccCCC-CcHHHHHHHHHHHhcc-CCCCceeEeeEEecC--CCCe
Q 005859 403 CFSEANLLGKSSFSATYKGILR-D--GSVVAVKCIAKTSCK-SDEGEFLKGLKILTSL-KHENLASLRGICCSK--GRGE 475 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~--~~~~ 475 (673)
+|...+.||+|+||.||+++.. . +..||+|++...... ...+.+.+|+++++++ +||||+++++++... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999965 3 678999998754222 2245788999999999 599999999875432 2345
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.++++||+. ++|.+++.. ...+++..++.++.||+.||+|||+. ||+||||||+||++++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~--givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA--NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788999985 689988862 34689999999999999999999987 89999999999999999999999999998
Q ss_pred cccCcchh---hhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhcc-----------c
Q 005859 556 LLADDIVF---SMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESS-----------K 620 (673)
Q Consensus 556 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~-----------~ 620 (673)
........ ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........... .
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 65432211 1123467889999998765 4589999999999999999999988854321100000 0
Q ss_pred hhhh-----------cCCcCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 621 VEDF-----------IDPNLE---GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 621 ~~~~-----------~~~~~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.... ...... .......+..+.+++.+|++.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 000000 0011123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=288.68 Aligned_cols=237 Identities=22% Similarity=0.328 Sum_probs=191.8
Q ss_pred cccCCcceEEEEEEcC-CcEEEEEEecccCCCC--cHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCCC
Q 005859 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKS--DEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNG 486 (673)
Q Consensus 410 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~g 486 (673)
||+|+||.||++...+ ++.||+|++....... ....+.+|++++++++||||+++++.+.. .+..++||||++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCCC
Confidence 6999999999999764 8999999987654322 34578899999999999999999998843 47899999999999
Q ss_pred ChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhhhh
Q 005859 487 NLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSML 566 (673)
Q Consensus 487 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 566 (673)
+|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 79 ~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~--~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 151 (250)
T cd05123 79 ELFSHLSKE----GRFSEERARFYAAEIVLALEYLHSL--GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTN 151 (250)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCcceEEEcCCCcEEEeecCcceecccCCC-ccc
Confidence 999999632 3589999999999999999999986 799999999999999999999999999876644311 122
Q ss_pred ccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHH
Q 005859 567 KASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIAL 646 (673)
Q Consensus 567 ~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 646 (673)
...++..|+|||...+...+.++|+||||+++||+++|+.||........ ...+... ....+...+..+.+++.
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~----~~~~~~~--~~~~~~~~~~~l~~~i~ 225 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI----YEKILKD--PLRFPEFLSPEARDLIS 225 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHhcC--CCCCCCCCCHHHHHHHH
Confidence 34577889999999888889999999999999999999999865432111 1111111 11233334678899999
Q ss_pred HccccCCCCCCCHHH
Q 005859 647 HCTHESPSHRPSIEN 661 (673)
Q Consensus 647 ~Cl~~~p~~RPs~~e 661 (673)
+||..||++||++.+
T Consensus 226 ~~l~~~p~~R~~~~~ 240 (250)
T cd05123 226 GLLQKDPTKRLGSGG 240 (250)
T ss_pred HHhcCCHhhCCCccc
Confidence 999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=284.32 Aligned_cols=242 Identities=19% Similarity=0.270 Sum_probs=198.8
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
.++|+..++||+|.||+|-.++-+ .|+.+|+|++++... +.+...-+.|-++|+..+||.+..+...| +..++.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF--Qt~drlC 244 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF--QTQDRLC 244 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh--ccCceEE
Confidence 456778889999999999999965 599999999987643 22224567799999999999999887666 5568999
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||..||.|.-+|. ..+.++++....+...|..||.|||+. +||.||||-+|.|+|+||++||+|||+++.-
T Consensus 245 FVMeyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~--~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSR--NIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhC--CeeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999999987 346799999999999999999999997 7999999999999999999999999999853
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
-... ......+||+.|.|||++....|+.++|.|.+||+||||+.|+.||..........-++.+- -.++...
T Consensus 319 I~~g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed------~kFPr~l 391 (516)
T KOG0690|consen 319 IKYG-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED------LKFPRTL 391 (516)
T ss_pred cccc-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh------ccCCccC
Confidence 2221 23456899999999999999999999999999999999999999997654332222222221 1344455
Q ss_pred HHHHHHHHHHccccCCCCCC
Q 005859 638 ASNLGQIALHCTHESPSHRP 657 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RP 657 (673)
+++...++.-.+..||.+|-
T Consensus 392 s~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 392 SPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred CHHHHHHHHHHhhcChHhhc
Confidence 67888999999999999995
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=279.76 Aligned_cols=252 Identities=16% Similarity=0.258 Sum_probs=197.0
Q ss_pred hcCCcc-ccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEec--CCCCe
Q 005859 401 TQCFSE-ANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCS--KGRGE 475 (673)
Q Consensus 401 ~~~~~~-~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~--~~~~~ 475 (673)
+++|++ .++||-|-.|+|..+..+. |+.+|+|++... ...++|++.--+. .|||||.++++|.. .....
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 344443 3579999999999998764 889999988643 3567888876666 69999999999853 23456
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC---CCeeecccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR---YNPLLSDSG 552 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~---~~~kl~DfG 552 (673)
..+|||+|+||.|+..+..+. ...+++.++-.|++||+.|+.|||+. +|.||||||+|+|.... -.+|++|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~--nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM--NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc--chhhccCChhheeeecCCCCcceEecccc
Confidence 789999999999999997542 35699999999999999999999998 69999999999999654 468999999
Q ss_pred ccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCC--cCC
Q 005859 553 LHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDP--NLE 630 (673)
Q Consensus 553 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~--~~~ 630 (673)
+|+...... .....+-|++|.|||++...+|+..+|+||+||+||-|+.|..||......+....-...+... ..+
T Consensus 210 FAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP 287 (400)
T KOG0604|consen 210 FAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP 287 (400)
T ss_pred cccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence 999765422 3445678999999999999999999999999999999999999987543322221111111111 112
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 631 GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 631 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+-+...++...++|+..|..+|.+|-|+.++++
T Consensus 288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 2223455788999999999999999999999874
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=304.99 Aligned_cols=253 Identities=16% Similarity=0.280 Sum_probs=194.7
Q ss_pred HhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC----
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGR---- 473 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 473 (673)
..++|.....||+|+||.||+|+... ++.||||++..... ......+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 35678899999999999999999764 88999998865421 2233567889999999999999999987754322
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL 553 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGl 553 (673)
...++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. ||+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~--gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA--GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCCEEEccccc
Confidence 2489999999 6799998862 3589999999999999999999987 899999999999999999999999999
Q ss_pred cccccCcchhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh----------
Q 005859 554 HKLLADDIVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE---------- 622 (673)
Q Consensus 554 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~---------- 622 (673)
+...... .....++..|+|||.+.+. .++.++|||||||++||++||+.||..............
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 9865432 2234567889999988653 578999999999999999999999864322111000000
Q ss_pred ---------hh---cCCcCCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 623 ---------DF---IDPNLEGKF---SVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 623 ---------~~---~~~~~~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+ +.......+ ....+.++.+++.+||+.||++|||+.||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00 000000000 1123578999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=323.86 Aligned_cols=146 Identities=21% Similarity=0.321 Sum_probs=128.1
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC--CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK--SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|.+.+.||+|+||+||+|+.. +++.||||++...... .....+.+|+++++.++||||+++++++.. .+..|+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~l 81 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNVYL 81 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEEEE
Confidence 57888999999999999999976 5899999999764321 123578899999999999999999988854 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
||||+++++|.+++.. ...+++..++.|+.||+.||+|||.+ +|+||||||+|||++.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~--gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH--GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC--CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999863 23588899999999999999999987 89999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=322.09 Aligned_cols=257 Identities=18% Similarity=0.258 Sum_probs=207.2
Q ss_pred HHHHHHHhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEec
Q 005859 394 LEEVERATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCS 470 (673)
Q Consensus 394 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 470 (673)
..++.-..++|.+.++||+|+||.|..++++. ++++|+|++.+-.. ..+..-|..|-.+|..-+.+.||.++..|
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-- 144 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-- 144 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh--
Confidence 45666667899999999999999999999865 88999999987322 23456788999999999999999998888
Q ss_pred CCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecc
Q 005859 471 KGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSD 550 (673)
Q Consensus 471 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~D 550 (673)
++.++.|+|||||+||||..++... ..+++..++.++..|..||.-||+. |+|||||||+|||||.+|++|++|
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m--gyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM--GYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc--cceeccCCcceeEecccCcEeecc
Confidence 5568999999999999999999732 3689999999999999999999998 899999999999999999999999
Q ss_pred ccccccccCcchhhhhccCCCCCccCCcccc----C-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhc
Q 005859 551 SGLHKLLADDIVFSMLKASAAMGYLAPEYTT----T-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFI 625 (673)
Q Consensus 551 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~ 625 (673)
||.+-.+..+........+|||-|++||++. + +.|++.+|.||+||++|||+-|..||....-.....+++.. .
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h-k 297 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH-K 297 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch-h
Confidence 9999888766555566788999999999986 2 56999999999999999999999999765433333322221 0
Q ss_pred CCcCCCCCC--HHHHHHHHHHHHHccccCCCCCCC---HHHHH
Q 005859 626 DPNLEGKFS--VSEASNLGQIALHCTHESPSHRPS---IENVM 663 (673)
Q Consensus 626 ~~~~~~~~~--~~~~~~l~~l~~~Cl~~~p~~RPs---~~evl 663 (673)
. .+ .+| ...+.+..+||.+.+. +|+.|-. +.++-
T Consensus 298 ~-~l--~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 298 E-SL--SFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred h-hc--CCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 0 11 122 2356778888877654 5677765 66654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=291.90 Aligned_cols=255 Identities=21% Similarity=0.318 Sum_probs=197.2
Q ss_pred cCCccccccccCCcceEEEEE-EcCCcEEEEEEecccCCCCc------HHHHHHHHHHHhccCCCCceeEeeEEecCCCC
Q 005859 402 QCFSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSD------EGEFLKGLKILTSLKHENLASLRGICCSKGRG 474 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 474 (673)
++|-..++||+|+|+.||++. +...+.||||+-.......+ .+...+|.+|-+.|+||.||++|+|+.-+ .+
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD-td 541 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD-TD 541 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-cc
Confidence 456667899999999999998 44588999997543321111 23567899999999999999999999765 35
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC---CCCeeeccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR---RYNPLLSDS 551 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~---~~~~kl~Df 551 (673)
..|-|+|||+|.+|.-||.+ .+.+++.++..|+.||+.||.||.+.+|+|||-||||.|||+.+ .|.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 67899999999999999974 35689999999999999999999999999999999999999954 478999999
Q ss_pred cccccccCcchhh------hhccCCCCCccCCccccCC----CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch
Q 005859 552 GLHKLLADDIVFS------MLKASAAMGYLAPEYTTTG----RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV 621 (673)
Q Consensus 552 Gla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~ 621 (673)
|+++.+.++.+.. .....||.+|.+||.+.-+ +.+.|+||||.|||+|..+-|++||........... .
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq-e 696 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ-E 696 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh-h
Confidence 9999988765432 2356799999999998744 479999999999999999999999975432211100 0
Q ss_pred hhhcCCcCCCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 005859 622 EDFIDPNLEGKF--SVSEASNLGQIALHCTHESPSHRPSIENVM 663 (673)
Q Consensus 622 ~~~~~~~~~~~~--~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl 663 (673)
..++.. ....+ .+....+..++|++|+++.-++|....++.
T Consensus 697 NTIlkA-tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 697 NTILKA-TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hchhcc-eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 000100 00111 123356788999999999999998776654
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.92 Aligned_cols=244 Identities=21% Similarity=0.322 Sum_probs=198.5
Q ss_pred ccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecC
Q 005859 407 ANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVP 484 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~ 484 (673)
.+.||.|.||+||-|+++ +|+.||||++.+... .+.+.+.++|+.||++++||.||.+.-.| ++++.+++|||-+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~--ET~ervFVVMEKl- 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF--ETPERVFVVMEKL- 645 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee--cCCceEEEEehhh-
Confidence 368999999999999976 499999999988654 44567899999999999999999998888 5678999999999
Q ss_pred CCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC---CeeeccccccccccCcc
Q 005859 485 NGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY---NPLLSDSGLHKLLADDI 561 (673)
Q Consensus 485 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~---~~kl~DfGla~~~~~~~ 561 (673)
+||..+.+-.. ....+++.....+..||+.||.|||.+ +|||+||||+|||+.+.. .+||+|||+|+.+.+..
T Consensus 646 ~GDMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~k--nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 646 HGDMLEMILSS--EKGRLPERITKFLVTQILVALRYLHFK--NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred cchHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhc--ceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 56766665422 234688888899999999999999998 799999999999997543 68999999999998765
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 641 (673)
.. ...+||+.|.|||+++.+.|...-|+||.|||+|--++|..||....+....-.... ++- +...+.+.+.+.
T Consensus 722 FR--rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa-FMy---Pp~PW~eis~~A 795 (888)
T KOG4236|consen 722 FR--RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA-FMY---PPNPWSEISPEA 795 (888)
T ss_pred hh--hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc-ccc---CCCchhhcCHHH
Confidence 43 346899999999999999999999999999999999999999976433222111111 111 223345666788
Q ss_pred HHHHHHccccCCCCCCCHHHHH
Q 005859 642 GQIALHCTHESPSHRPSIENVM 663 (673)
Q Consensus 642 ~~l~~~Cl~~~p~~RPs~~evl 663 (673)
.++|...++..-++|-|.+..+
T Consensus 796 idlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 796 IDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred HHHHHHHHHHHHHHhcchHhhc
Confidence 8999999999999999877654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=283.06 Aligned_cols=220 Identities=16% Similarity=0.184 Sum_probs=175.1
Q ss_pred CCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCCCChhhh
Q 005859 413 SSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQH 491 (673)
Q Consensus 413 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~gsL~~~ 491 (673)
|.||+||+++.. +++.||+|++.... .+.+|...+....||||+++++++.. .+..++||||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCCCCHHHH
Confidence 889999999975 48899999986542 23455556666689999999999854 4788999999999999999
Q ss_pred hccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhhhhccCCC
Q 005859 492 LDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAA 571 (673)
Q Consensus 492 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 571 (673)
+... ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.++++|||.+...... .....++
T Consensus 76 l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~ 145 (237)
T cd05576 76 ISKF----LNIPEECVKRWAAEMVVALDALHRE--GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVE 145 (237)
T ss_pred HHHh----cCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcC
Confidence 8632 3489999999999999999999987 8999999999999999999999999987665432 1223456
Q ss_pred CCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHcccc
Q 005859 572 MGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHE 651 (673)
Q Consensus 572 ~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~ 651 (673)
..|+|||.+.+..++.++||||+|+++|||++|+.|+....... ..... ...+...+..+.+++.+|++.
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~----~~~~~~~~~~~~~li~~~l~~ 215 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------NTHTT----LNIPEWVSEEARSLLQQLLQF 215 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------ccccc----cCCcccCCHHHHHHHHHHccC
Confidence 67999999988889999999999999999999997764321110 00000 112233457789999999999
Q ss_pred CCCCCCCHH
Q 005859 652 SPSHRPSIE 660 (673)
Q Consensus 652 ~p~~RPs~~ 660 (673)
||++||++.
T Consensus 216 dp~~R~~~~ 224 (237)
T cd05576 216 NPTERLGAG 224 (237)
T ss_pred CHHHhcCCC
Confidence 999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=301.81 Aligned_cols=239 Identities=19% Similarity=0.300 Sum_probs=193.7
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~l 478 (673)
++.|.....+|.|+|+.|-++... +++..++|++.+.. .+-.+|+.++... +||||+++.+.+.+ ..+.|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYED--GKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecC--Cceeee
Confidence 566777778999999999999865 48899999997652 2334577666666 79999999999954 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEe-cCCCCeeeccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI-HRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl-~~~~~~kl~DfGla~~~ 557 (673)
|||++.+|-+.+.+... +.+. ..+..|+.+|+.|+.|||++ |||||||||+|||+ ++.++++|+|||.++..
T Consensus 394 v~e~l~g~ell~ri~~~----~~~~-~e~~~w~~~lv~Av~~LH~~--gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSK----PEFC-SEASQWAAELVSAVDYLHEQ--GVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred eehhccccHHHHHHHhc----chhH-HHHHHHHHHHHHHHHHHHhc--CeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 99999999888877532 2233 67778999999999999997 89999999999999 58899999999999987
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
..+ ....+-|..|.|||+.....||+++||||||++||||++|+.||...... .++......+.+....
T Consensus 467 ~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~~~s~~v 535 (612)
T KOG0603|consen 467 ERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMPKFSECV 535 (612)
T ss_pred chh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCCcccccc
Confidence 654 22345678899999999889999999999999999999999998655443 1111112223444667
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+...++|+..||+.||.+||+|.++..
T Consensus 536 S~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 536 SDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred CHHHHHHHHHhccCChhhCcChhhhcc
Confidence 789999999999999999999999864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=251.40 Aligned_cols=253 Identities=17% Similarity=0.274 Sum_probs=191.6
Q ss_pred CCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCC-cHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKS-DEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+|...++||+|.||+||+|+.++ ++.||+|+++...... -....++|+-+++.++|.|||+++++... ....-+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs--dkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--CceeEEeH
Confidence 46667889999999999999665 8999999998654322 23578999999999999999999998744 36788999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
|||. .+|..+.+.- +..++.+....++.|+++||.|+|++ ++.|||+||.|.|++.+|+.|++|||+++.+.-.
T Consensus 81 e~cd-qdlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh--nvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 81 EFCD-QDLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH--NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred HHhh-HHHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh--hhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 9994 5888887643 34588999999999999999999998 6999999999999999999999999999977643
Q ss_pred chhhhhccCCCCCccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhcc-c--------------hhhh
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESS-K--------------VEDF 624 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~-~--------------~~~~ 624 (673)
.. .....+.|.+|++|.++.+.+ |+...|+||.||++.|+.....|..+..+....-. + +...
T Consensus 155 vr-cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred eE-eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 32 233456789999999998766 89999999999999999985556444322111111 1 0111
Q ss_pred cCCcCCCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 625 IDPNLEGKFS---------VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 625 ~~~~~~~~~~---------~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
-|-...+.++ +.....=++++.+.+.-+|..|.++++.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1111111111 111223467888888899999999998875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=303.81 Aligned_cols=263 Identities=18% Similarity=0.314 Sum_probs=215.5
Q ss_pred cCHHHHHHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEe
Q 005859 392 FNLEEVERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICC 469 (673)
Q Consensus 392 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 469 (673)
+.++.+...+..|++.+.||+|.+|+||+++.. +++.+|+|++.... ..+++...|.++++.. +|||++.++|++.
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 345556667788999999999999999999954 58999999887653 3456788899999988 7999999999987
Q ss_pred cC---CCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCe
Q 005859 470 SK---GRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNP 546 (673)
Q Consensus 470 ~~---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~ 546 (673)
.. ..++++||||||.+|+.-++++... ...+.|+.+..|++.++.|+.+||.. .++|||||-.|||++.++.+
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n--kviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN--KVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc--ceeeecccCceEEEeccCcE
Confidence 53 3578999999999999999998654 45699999999999999999999987 49999999999999999999
Q ss_pred eeccccccccccCcchhhhhccCCCCCccCCccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch
Q 005859 547 LLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG-----RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV 621 (673)
Q Consensus 547 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~ 621 (673)
|+.|||++..+..... ......||+.|||||++... .|+.++|+||+|++-.||.-|..|+.+........
T Consensus 163 KLvDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF--- 238 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF--- 238 (953)
T ss_pred EEeeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc---
Confidence 9999999988765443 33456799999999998633 37889999999999999999999987654432211
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 622 EDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.-...|......+..-.+++.++|..|+..|-++||++.++++
T Consensus 239 ~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 239 LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111233333445666789999999999999999999998874
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=274.34 Aligned_cols=258 Identities=19% Similarity=0.335 Sum_probs=200.1
Q ss_pred CHHHHHHHhcCCccccccccCCcceEEEEE-EcCCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEec
Q 005859 393 NLEEVERATQCFSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCS 470 (673)
Q Consensus 393 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 470 (673)
+++|+-+-| .+.||+|+|+.|--+. +.+|..+|||++.+.. ...+....+|++++.+. .|+||++++++|.+
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 467776666 3689999999999888 6789999999998763 44567889999999999 69999999999955
Q ss_pred CCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC---Cee
Q 005859 471 KGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY---NPL 547 (673)
Q Consensus 471 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~---~~k 547 (673)
....|||||-|.||.|..+++ ..+.+++.++.++..+||.||.|||.+ ||.|||+||+|||-.+.. -+|
T Consensus 148 --d~~FYLVfEKm~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~k--gIAHRDlKPENiLC~~pn~vsPvK 219 (463)
T KOG0607|consen 148 --DTRFYLVFEKMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHTK--GIAHRDLKPENILCESPNKVSPVK 219 (463)
T ss_pred --cceEEEEEecccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhc--CcccccCCccceeecCCCCcCcee
Confidence 467899999999999999997 346799999999999999999999988 899999999999986544 479
Q ss_pred eccccccccccCcc------hhhhhccCCCCCccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCChhhH---
Q 005859 548 LSDSGLHKLLADDI------VFSMLKASAAMGYLAPEYTT-----TGRFTEKSDIYAFGMIVFQILSGKCSITPFTR--- 613 (673)
Q Consensus 548 l~DfGla~~~~~~~------~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~--- 613 (673)
|+||.++.-..-.. .......+|+..|||||+.. ...|+.++|.||+|||+|-|+.|..||.+.=.
T Consensus 220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC 299 (463)
T KOG0607|consen 220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC 299 (463)
T ss_pred eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence 99998865432111 11233567888999999864 23589999999999999999999999965311
Q ss_pred ----h----hhhccchhhhcCCc--CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 614 ----Q----AAESSKVEDFIDPN--LEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 614 ----~----~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
. .-....++.+.+.. .+.+-+...+.+..+++...+..|+.+|-++.++++
T Consensus 300 GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 300 GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0 01111222222111 111223345678899999999999999999998875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=257.59 Aligned_cols=204 Identities=17% Similarity=0.286 Sum_probs=168.9
Q ss_pred CccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEEEEe
Q 005859 404 FSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
......||+|+||.|-+-++. +|+..|+|+++..-..+..++.++|+++..+- ..|.+|.+||.+... ...++.||
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re--gdvwIcME 125 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE--GDVWICME 125 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc--ccEEEeHH
Confidence 344567999999999888754 59999999998765445556788899876654 899999999987554 67899999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
.|. -+|..+...--.....+++...-+||..|.+||.|||++- .+||||+||+|||++.+|.+|++|||.+..+.+..
T Consensus 126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 994 5887766543345567899999999999999999999953 69999999999999999999999999998887654
Q ss_pred hhhhhccCCCCCccCCccccC----CCCCcchhHHHHHHHHHHHHhCCCCCChhhH
Q 005859 562 VFSMLKASAAMGYLAPEYTTT----GRFTEKSDIYAFGMIVFQILSGKCSITPFTR 613 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~ 613 (673)
. .+...|.-.|||||.+.. ..|+-|+||||+|+++.||.+++.||..+..
T Consensus 204 A--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 204 A--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred H--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 3 333567888999998863 3699999999999999999999999987644
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=282.19 Aligned_cols=240 Identities=20% Similarity=0.284 Sum_probs=196.6
Q ss_pred CCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCC--CcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCK--SDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~l 478 (673)
+|....+||+|+||+|.+|.-+. .+.+|||++++...- .+.+--+.|-++|+-. +-|.+++++..+ ++.+..|+
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF--QTmDRLyF 427 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF--QTMDRLYF 427 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh--hhhhheee
Confidence 67788899999999999998764 678999999876432 2223456677888766 678899998877 55688999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+.||+|..++++- ..+.+..+..+|..||-||-|||++ |||.||||-+||++|.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k--gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC--CeeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999999988743 3477788899999999999999998 89999999999999999999999999998543
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
-+.. .....+||+.|+|||++..+.|+..+|.|||||+||||+.|+.||++.........+.+. . ..++...+
T Consensus 502 ~~~~-TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh----n--vsyPKslS 574 (683)
T KOG0696|consen 502 FDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH----N--VSYPKSLS 574 (683)
T ss_pred cCCc-ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc----c--CcCccccc
Confidence 3222 234578999999999999999999999999999999999999999886554443333322 2 24566677
Q ss_pred HHHHHHHHHccccCCCCCC
Q 005859 639 SNLGQIALHCTHESPSHRP 657 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RP 657 (673)
.+...+....+...|.+|-
T Consensus 575 kEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 575 KEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHHHHHHHhhcCCcccc
Confidence 8888888899999999995
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=298.89 Aligned_cols=262 Identities=16% Similarity=0.233 Sum_probs=183.7
Q ss_pred HhcCCccccccccCCcceEEEEEE-----------------cCCcEEEEEEecccCCCCcH--------------HHHHH
Q 005859 400 ATQCFSEANLLGKSSFSATYKGIL-----------------RDGSVVAVKCIAKTSCKSDE--------------GEFLK 448 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~~ 448 (673)
..++|++.++||+|+||+||+|.. .+++.||||++..... ... +.+..
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~-~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ-GVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch-hhHHHHHhhhhhhhcccchhHH
Confidence 467899999999999999999964 2356899999865421 111 23445
Q ss_pred HHHHHhccCCCCc-----eeEeeEEecC------CCCeEEEEEeecCCCChhhhhccccC--------------------
Q 005859 449 GLKILTSLKHENL-----ASLRGICCSK------GRGECFLIYDFVPNGNLLQHLDLEAG-------------------- 497 (673)
Q Consensus 449 E~~~l~~l~H~ni-----v~l~~~~~~~------~~~~~~lv~E~~~~gsL~~~l~~~~~-------------------- 497 (673)
|+.++.+++|.++ ++++++|... ..+..++||||+++|+|.++++...+
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777888876654 6777877542 13467999999999999999874321
Q ss_pred CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhhhhccCCCCCccCC
Q 005859 498 SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAP 577 (673)
Q Consensus 498 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aP 577 (673)
....++|..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..............+++.|+||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~--~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI--GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 112357888999999999999999987 799999999999999999999999999976544322222223457899999
Q ss_pred ccccCCC--------------------C--CcchhHHHHHHHHHHHHhCCC-CCChhhHh---hhh-ccc---hhhhcCC
Q 005859 578 EYTTTGR--------------------F--TEKSDIYAFGMIVFQILSGKC-SITPFTRQ---AAE-SSK---VEDFIDP 627 (673)
Q Consensus 578 E~~~~~~--------------------~--s~ksDVwSfGvvl~el~tG~~-p~~~~~~~---~~~-~~~---~~~~~~~ 627 (673)
|.+.... | ..+.||||+||++|||++|.. |+...... ... ... +......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9875432 1 235799999999999999875 55432110 000 000 0111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 005859 628 NLEGKFSVSEASNLGQIALHCTHESP---SHRPSIENVMQ 664 (673)
Q Consensus 628 ~~~~~~~~~~~~~l~~l~~~Cl~~~p---~~RPs~~evl~ 664 (673)
...-...........+++.+++..+| .+|+|++|+++
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 11111122345778899999999766 68999999985
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=270.62 Aligned_cols=256 Identities=22% Similarity=0.322 Sum_probs=192.4
Q ss_pred CCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCC------CC
Q 005859 403 CFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKG------RG 474 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~ 474 (673)
.|+...+||+|.||+||+|+.++ |+.||+|++.....+ ......++|+++|..++|+|++.++++|.... +.
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 45556789999999999999765 788999876554322 22356789999999999999999999885432 23
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLH 554 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla 554 (673)
..|+||++|+. +|.-+|.. ....++..++.+++.++..||.|+|.. .|+|||+||.|+||+.++.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~--kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRN--KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHh--hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 58999999976 88888863 234688999999999999999999987 5999999999999999999999999999
Q ss_pred ccccCcc---hhhhhccCCCCCccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCChhhHhhh--------------
Q 005859 555 KLLADDI---VFSMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAA-------------- 616 (673)
Q Consensus 555 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~-------------- 616 (673)
+.+.... ....+..+.|.+|++||.+.+.+ |+++.|||..||||.||.||..-+....+...
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 8765322 11234566799999999998754 99999999999999999999866554322211
Q ss_pred -hcc-----chhhhcCCcCC-CCCC--------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 617 -ESS-----KVEDFIDPNLE-GKFS--------VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 617 -~~~-----~~~~~~~~~~~-~~~~--------~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
|.. .+..+.-+.+. +.+. -...++..+++..++..||.+|+++++++.
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 000 00111001011 0000 011246789999999999999999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=309.28 Aligned_cols=258 Identities=16% Similarity=0.161 Sum_probs=169.8
Q ss_pred HhcCCccccccccCCcceEEEEEEcC-----CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEe----c
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRD-----GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC----S 470 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~----~ 470 (673)
..++|+..+.||+|+||.||+|++.+ +..||||++.... ..+.+..| .+....+.+++.+...+. .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 46789999999999999999999754 6899999876432 11222222 122222333332222111 1
Q ss_pred CCCCeEEEEEeecCCCChhhhhccccCC----------------ccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcC
Q 005859 471 KGRGECFLIYDFVPNGNLLQHLDLEAGS----------------EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLS 534 (673)
Q Consensus 471 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk 534 (673)
....+.++||||+++++|.+++...... ........+..++.|++.||+|||+. +|+|||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~--gIiHRDLK 282 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST--GIVHRDVK 282 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC--CEEeCcCC
Confidence 3346789999999999999988632110 01112344567999999999999987 89999999
Q ss_pred CCCeEecC-CCCeeeccccccccccCcchhhhhccCCCCCccCCccccCC----------------------CCCcchhH
Q 005859 535 AEKVLIHR-RYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG----------------------RFTEKSDI 591 (673)
Q Consensus 535 ~~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksDV 591 (673)
|+|||+++ ++.+||+|||+|+.+............+++.|||||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999987654333333445688999999965422 24557799
Q ss_pred HHHHHHHHHHHhCCCCCChhhHhhhh-----c---cchhhhcCCcCCCC----C--CHHHHHHHHHHHHHccccCCCCCC
Q 005859 592 YAFGMIVFQILSGKCSITPFTRQAAE-----S---SKVEDFIDPNLEGK----F--SVSEASNLGQIALHCTHESPSHRP 657 (673)
Q Consensus 592 wSfGvvl~el~tG~~p~~~~~~~~~~-----~---~~~~~~~~~~~~~~----~--~~~~~~~l~~l~~~Cl~~~p~~RP 657 (673)
|||||++|||+++..++......... . ..+.....+....+ + .........+|+.+|++.||++||
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ 442 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI 442 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence 99999999999987665432111000 0 00111111110000 0 001123455899999999999999
Q ss_pred CHHHHHH
Q 005859 658 SIENVMQ 664 (673)
Q Consensus 658 s~~evl~ 664 (673)
|++|+++
T Consensus 443 ta~e~L~ 449 (566)
T PLN03225 443 SAKAALA 449 (566)
T ss_pred CHHHHhC
Confidence 9999986
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=269.31 Aligned_cols=238 Identities=22% Similarity=0.348 Sum_probs=190.9
Q ss_pred CcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCCCChhhhh
Q 005859 414 SFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHL 492 (673)
Q Consensus 414 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~gsL~~~l 492 (673)
+||.||+|+..+ |+.||+|++.........+.+.+|++.+++++|+||+++++++... ...+++|||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHHHHH
Confidence 589999999875 8999999997664322267899999999999999999999998654 6789999999999999998
Q ss_pred ccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhhhhccCCCC
Q 005859 493 DLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAM 572 (673)
Q Consensus 493 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~ 572 (673)
... ..+++..+..++.+++.+++|||+. +|+|+||+|+||++++++.++++|||.+....... ......++.
T Consensus 79 ~~~----~~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~ 150 (244)
T smart00220 79 KKR----GRLSEDEARFYARQILSALEYLHSN--GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTP 150 (244)
T ss_pred Hhc----cCCCHHHHHHHHHHHHHHHHHHHHc--CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCc
Confidence 632 2288999999999999999999987 79999999999999999999999999998765432 223445778
Q ss_pred CccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCC-CCCHHHHHHHHHHHHHcccc
Q 005859 573 GYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEG-KFSVSEASNLGQIALHCTHE 651 (673)
Q Consensus 573 ~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~Cl~~ 651 (673)
.|++||......++.++||||||+++||+++|..||.......... .......... ......+.++.+++.+||..
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 227 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELF---KKIGKPKPPFPPPEWKISPEAKDLIRKLLVK 227 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHhccCCCCccccccCCHHHHHHHHHHccC
Confidence 8999999988889999999999999999999999986522211111 1111111110 00111457899999999999
Q ss_pred CCCCCCCHHHHHH
Q 005859 652 SPSHRPSIENVMQ 664 (673)
Q Consensus 652 ~p~~RPs~~evl~ 664 (673)
+|++||++.++++
T Consensus 228 ~p~~Rp~~~~~~~ 240 (244)
T smart00220 228 DPEKRLTAEEALQ 240 (244)
T ss_pred CchhccCHHHHhh
Confidence 9999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=273.18 Aligned_cols=251 Identities=16% Similarity=0.226 Sum_probs=194.0
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCC--C----CceeEeeEEecCCC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKH--E----NLASLRGICCSKGR 473 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H--~----niv~l~~~~~~~~~ 473 (673)
+++|.+...+|+|.||+|-++..+. +..||||+++.. ....+..+-|++++.++.+ | -+|.+.+++.. .
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy--r 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY--R 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc--c
Confidence 6789999999999999999999665 789999999765 3455677889999999942 2 36788777743 4
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC-----------
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR----------- 542 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~----------- 542 (673)
++.+||+|.+ |-|+.+++... ...+++...+..|+.|++++++|||+. +++|-||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~--kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL--KLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred CceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc--ceeecCCChheEEEeccceEEEeccCC
Confidence 8899999999 66999999743 446789999999999999999999998 6999999999999842
Q ss_pred ---------CCCeeeccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhH
Q 005859 543 ---------RYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTR 613 (673)
Q Consensus 543 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~ 613 (673)
+..+||.|||.|....+.. ...+.|..|+|||++.+-.++.++||||+||||.|+.||..-|....+
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 2357899999998765543 345678899999999999999999999999999999999876543221
Q ss_pred hh---hhcc------------c-hhhhc--------------------CCcCC----CCCCHHHHHHHHHHHHHccccCC
Q 005859 614 QA---AESS------------K-VEDFI--------------------DPNLE----GKFSVSEASNLGQIALHCTHESP 653 (673)
Q Consensus 614 ~~---~~~~------------~-~~~~~--------------------~~~~~----~~~~~~~~~~l~~l~~~Cl~~~p 653 (673)
.+ ..+. . ..+++ ++..+ -.....+..++.+|+.+++.+||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 10 0000 0 00000 00000 01123345679999999999999
Q ss_pred CCCCCHHHHHH
Q 005859 654 SHRPSIENVMQ 664 (673)
Q Consensus 654 ~~RPs~~evl~ 664 (673)
.+|+|++|+++
T Consensus 395 ~~RiTl~EAL~ 405 (415)
T KOG0671|consen 395 ARRITLREALS 405 (415)
T ss_pred cccccHHHHhc
Confidence 99999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=293.27 Aligned_cols=246 Identities=23% Similarity=0.321 Sum_probs=186.0
Q ss_pred CCccccccccCCcc-eEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFS-ATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
-|...+++|.|+.| .||+|.+. |+.||||++.... ..-..+|+..|+.- +|||||++++ .+.++...||..
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~YIal 582 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYC--SEQDRQFLYIAL 582 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEe--eccCCceEEEEe
Confidence 34555678999988 57999995 7899999986543 33567899999988 6999999965 446678999999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC---C--CCeeeccccccc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR---R--YNPLLSDSGLHK 555 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~---~--~~~kl~DfGla~ 555 (673)
|.|. -+|.++++..........-...+.+..|+++||++||+. +||||||||.||||+. + ..++|+|||+++
T Consensus 583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl--~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL--KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc--ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 9994 599999986311111111134567889999999999997 7999999999999976 3 478999999999
Q ss_pred cccCcch--hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhC-CCCCChhhHhhhhccchhhhcCC-cCCC
Q 005859 556 LLADDIV--FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSG-KCSITPFTRQAAESSKVEDFIDP-NLEG 631 (673)
Q Consensus 556 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG-~~p~~~~~~~~~~~~~~~~~~~~-~~~~ 631 (673)
.+..+.. .......||-+|+|||++....-+.++||||+||++|+.+|| +.||.+...... .++.....- .+..
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~ 737 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEP 737 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeecc
Confidence 8876542 223456799999999999998888999999999999999995 889876433211 111111110 0111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 632 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..++ +..+||.+|++++|..||++.+|+.
T Consensus 738 --~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 738 --LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred --CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1111 7889999999999999999999973
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-33 Score=280.74 Aligned_cols=241 Identities=16% Similarity=0.239 Sum_probs=199.6
Q ss_pred CccccccccCCcceEEEEEEcCCc-EEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 404 FSEANLLGKSSFSATYKGILRDGS-VVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++....||-|+||.|-.+...... .+|+|++++... ..+.+....|-+||.+.+.|.||++|..|.+ ...+|+.|
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd--~kyvYmLm 499 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD--SKYVYMLM 499 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc--chhhhhhH
Confidence 344557999999999998876533 489999987653 3344567889999999999999999998844 47899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
|-|-||.|-..|+. +..++..++..++..+.+|++|||.+ |||.|||||+|.++|.+|-+||.|||+|+.+..+
T Consensus 500 EaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k--~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK--GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc--CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999973 35688888999999999999999988 8999999999999999999999999999998776
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
. .....+||+.|.|||++....++.++|.||+|+++|||+||+.||...........++. .++. -.+|......
T Consensus 574 ~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk-Gid~---i~~Pr~I~k~ 647 (732)
T KOG0614|consen 574 R--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK-GIDK---IEFPRRITKT 647 (732)
T ss_pred C--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh-hhhh---hhcccccchh
Confidence 4 34568999999999999999999999999999999999999999987655433332222 2221 1345555677
Q ss_pred HHHHHHHccccCCCCCCC
Q 005859 641 LGQIALHCTHESPSHRPS 658 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs 658 (673)
..+++.+.+..+|.+|-.
T Consensus 648 a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 648 ATDLIKKLCRDNPTERLG 665 (732)
T ss_pred HHHHHHHHHhcCcHhhhc
Confidence 889999999999999964
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=274.08 Aligned_cols=231 Identities=18% Similarity=0.288 Sum_probs=182.1
Q ss_pred cCCccccccccCCcceEEEEEE-cCCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGIL-RDGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
.-|..++.||-|+||+|.+++- ++...+|+|.+++... .........|-.||...+.+.||++|..| ++.+.+|+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF--QDkdnLYF 706 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF--QDKDNLYF 706 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe--ccCCceEE
Confidence 4577888999999999999884 4477899999987643 22334567799999999999999998877 55688999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||++|||+..+|- ....|++..++.++..+..|+++.|.. |+|||||||+|||||.+|++||.|||++.-+.
T Consensus 707 VMdYIPGGDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkm--GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EEeccCCccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhc--cceecccCccceEEccCCceeeeeccccccce
Confidence 999999999999886 335688999999999999999999987 99999999999999999999999999985321
Q ss_pred ---------Ccch--------------------------------hhhhccCCCCCccCCccccCCCCCcchhHHHHHHH
Q 005859 559 ---------DDIV--------------------------------FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMI 597 (673)
Q Consensus 559 ---------~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvv 597 (673)
.+.. ......+||..|+|||++....|+..+|.||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 1000 00112368999999999999999999999999999
Q ss_pred HHHHHhCCCCCChhhHhhh--hccchhhhcCCcCCCCCCHHHHHH
Q 005859 598 VFQILSGKCSITPFTRQAA--ESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 598 l~el~tG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
||||+.|+.||........ ....+...++-...+..+.++..-
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~l 905 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDL 905 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHH
Confidence 9999999999976443322 223445555544445555444333
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=255.27 Aligned_cols=246 Identities=17% Similarity=0.294 Sum_probs=190.5
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcH--HHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDE--GEFLKGLKILTSL-KHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 476 (673)
-++|....+||+|+|++|..++++. .+.+|+|++++.....++ .=...|-.+..+. +||.+|.++..| ++....
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf--qtesrl 326 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF--QTESRL 326 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh--cccceE
Confidence 3578889999999999999999764 889999999876543222 2234566666666 799999999888 555789
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++|.||++||+|.-++. ..+.++++.+..+...|+.||.|||+. |||.||||-+|||+|..|.+|+.|+|+++.
T Consensus 327 ffvieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~r--giiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHER--GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhc--CeeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999998876 345699999999999999999999998 999999999999999999999999999985
Q ss_pred ccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhh--Hhh--hhccchhhhcCCcCCCC
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFT--RQA--AESSKVEDFIDPNLEGK 632 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~--~~~--~~~~~~~~~~~~~~~~~ 632 (673)
--.+.. .....+||+.|+|||++.+..|...+|.|++||+|+||+.|+.||+-.. +.. ...-.+.-++...+ .
T Consensus 401 ~l~~gd-~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--r 477 (593)
T KOG0695|consen 401 GLGPGD-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--R 477 (593)
T ss_pred CCCCCc-ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--c
Confidence 432221 3446789999999999999999999999999999999999999986321 100 00111111111111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC
Q 005859 633 FSVSEASNLGQIALHCTHESPSHRP 657 (673)
Q Consensus 633 ~~~~~~~~l~~l~~~Cl~~~p~~RP 657 (673)
.+...+.....++..-+++||.+|-
T Consensus 478 iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ccceeehhhHHHHHHhhcCCcHHhc
Confidence 2333345566777788899999985
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=240.58 Aligned_cols=249 Identities=16% Similarity=0.248 Sum_probs=193.5
Q ss_pred hcCCccccccccCCcceEEEEE-EcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCeEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~l 478 (673)
.++|++.+++|+|.|++||.|. ..+.+.++||.++.. ..+.+.+|++||..|. ||||++++++..++......+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 3567888899999999999998 456888999999764 3467899999999996 999999999998877778889
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC-CCeeeccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR-YNPLLSDSGLHKLL 557 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~-~~~kl~DfGla~~~ 557 (673)
|+||+.+.+...+.. .++-.++..++.++++||.|+|+. ||+|||+||.|+++|.. ...+++|+|+|.+.
T Consensus 113 iFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~--GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM--GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc--CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 999999988776553 477778889999999999999998 99999999999999854 57899999999988
Q ss_pred cCcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHh---hhh----------------
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQ---AAE---------------- 617 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~---~~~---------------- 617 (673)
..+.... -.+.+..|.-||.+.. ..|+-.-|+|||||++..|+..+.||...... ...
T Consensus 184 Hp~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 184 HPGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 7654322 3456677889999876 45899999999999999999999998542110 000
Q ss_pred -----ccchhhhcCCcCCCCC--------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 618 -----SSKVEDFIDPNLEGKF--------SVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 618 -----~~~~~~~~~~~~~~~~--------~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
......++....+..+ ..-..+++.+++.+.+..|..+|+|++|.+.
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0011111111101000 0112467889999999999999999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-32 Score=254.30 Aligned_cols=252 Identities=19% Similarity=0.281 Sum_probs=191.6
Q ss_pred ccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC---CeEEEEEe
Q 005859 407 ANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGR---GECFLIYD 481 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---~~~~lv~E 481 (673)
.+.||-|+||.||-.+.. +|+.||.|++..... -...+.+.+|+++|..++|.|+...+++...... .+.|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 467999999999999865 599999998865421 1234678999999999999999998887633322 25788999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
.| ..+|..++- +...++-+...-+..||++||+|||+. +|.||||||.|.|++.+...||+|||+++....+.
T Consensus 138 Lm-QSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA--~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 138 LM-QSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA--NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HH-Hhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc--chhhccCCCccEEeccCceEEecccccccccchhh
Confidence 99 458888875 456788888888999999999999987 79999999999999999999999999999887777
Q ss_pred hhhhhccCCCCCccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCChhhHhh----------------h---hccch
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQA----------------A---ESSKV 621 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~----------------~---~~~~~ 621 (673)
...++..+.|.+|+|||++.+.+ |+.+.||||.||++.|++.++.-|....... . -+...
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 66777778899999999999755 9999999999999999998775553211100 0 00111
Q ss_pred hhhcCCcCCC-C--------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 622 EDFIDPNLEG-K--------FSVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 622 ~~~~~~~~~~-~--------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
..+.+...+. . .+.....+...+...++..||++|.+..+.+..
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 1111111110 0 011223456677888899999999998887653
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=254.48 Aligned_cols=134 Identities=19% Similarity=0.355 Sum_probs=111.9
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccC-----C---CCceeEeeEEecCC
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-----H---ENLASLRGICCSKG 472 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~~~~~~~~ 472 (673)
.+|.+.++||.|.|++||+|... +.+.||+|+.+.. ....+..+.||++|++++ | .+||++++.|...+
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 67899999999999999999954 5789999998754 234567889999999983 3 36999999997644
Q ss_pred C--CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEec
Q 005859 473 R--GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIH 541 (673)
Q Consensus 473 ~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~ 541 (673)
+ .++++|+|+. |-+|..+|... ..+-++.....+|+.||+.||.|||... ||||-||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeeee
Confidence 3 4899999999 77899998744 2345888999999999999999999844 899999999999994
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=239.43 Aligned_cols=211 Identities=28% Similarity=0.512 Sum_probs=181.4
Q ss_pred cccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCCCCh
Q 005859 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNL 488 (673)
Q Consensus 410 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~gsL 488 (673)
||+|++|.||++...+ ++.+++|++.........+.+.+|++.++++.|++|+++++++... ...+++|||+++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCCCcH
Confidence 6899999999999865 8999999997654222346899999999999999999999998553 678999999999999
Q ss_pred hhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC-CCCeeeccccccccccCcchhhhhc
Q 005859 489 LQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR-RYNPLLSDSGLHKLLADDIVFSMLK 567 (673)
Q Consensus 489 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~ 567 (673)
.+++.... ..+++..+..++.+++++++|||+. |++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 79 ~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~--~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (215)
T cd00180 79 KDLLKENE---GKLSEDEILRILLQILEGLEYLHSN--GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKT 152 (215)
T ss_pred HHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhc
Confidence 99986321 3588999999999999999999988 8999999999999999 89999999999987654321 1223
Q ss_pred cCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHH
Q 005859 568 ASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIAL 646 (673)
Q Consensus 568 ~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 646 (673)
..+...|++||..... .++.++|+|++|++++++ ..+.+++.
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~ 195 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PELKDLIR 195 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHHHHHHH
Confidence 4567789999999877 788999999999999999 56789999
Q ss_pred HccccCCCCCCCHHHHHHH
Q 005859 647 HCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 647 ~Cl~~~p~~RPs~~evl~~ 665 (673)
+|++.+|++||++.++++.
T Consensus 196 ~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 196 KMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHhhCCcccCcCHHHHhhC
Confidence 9999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=247.91 Aligned_cols=251 Identities=18% Similarity=0.281 Sum_probs=190.2
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC----Ce
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGR----GE 475 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~~ 475 (673)
.+|.....+|.|.- .|.-+... .++.||+|.+..... ....+...+|...+..+.|+||++++.++..... .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 34556677888877 45545433 388999998865422 2233567789999999999999999999864321 36
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.|+||||| .++|.+.+.. .++..+...|..|++.|++|||+. ||+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m-~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~--~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM------ELDHETISYILYQMLCGIKHLHSA--GIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc--ceeecccCcccceecchhheeeccchhhc
Confidence 79999999 5699988862 377888899999999999999988 89999999999999999999999999998
Q ss_pred cccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhcc----------------
Q 005859 556 LLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESS---------------- 619 (673)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~---------------- 619 (673)
....+ ..++..+.+..|.|||++.+..|.+.+||||.||++.||++|+.-|.+......+.+
T Consensus 167 ~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 167 TEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred ccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 76544 456777889999999999998899999999999999999999876654221111100
Q ss_pred -----------------chhhhcCCc-CC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 620 -----------------KVEDFIDPN-LE--GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 620 -----------------~~~~~~~~~-~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...+.+... .. .+.+......+.+++.+||..||++|.+++++++
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 000000000 00 0111223466889999999999999999999885
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=261.47 Aligned_cols=197 Identities=20% Similarity=0.323 Sum_probs=168.4
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCC-------CcHHHHHHHHHHHhccC---CCCceeEeeEEec
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCK-------SDEGEFLKGLKILTSLK---HENLASLRGICCS 470 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~ 470 (673)
.+|...+.+|+|+||.|+.|.++. ...|+||.+.+...- ......-.|++||..++ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458888999999999999999875 678999999875431 11234567999999997 9999999999954
Q ss_pred CCCCeEEEEEeec-CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeec
Q 005859 471 KGRGECFLIYDFV-PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLS 549 (673)
Q Consensus 471 ~~~~~~~lv~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~ 549 (673)
.+..||+||-- ++-+|++++.. ++.+++..+.-|++||+.|+++||++ ||||||||-+||.+|.+|-+||+
T Consensus 641 --dd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~--~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 641 --DDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ--GIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred --CCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc--CceecccccccEEEecCCeEEEe
Confidence 47899999964 67799999974 35689999999999999999999998 89999999999999999999999
Q ss_pred cccccccccCcchhhhhccCCCCCccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCC
Q 005859 550 DSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRF-TEKSDIYAFGMIVFQILSGKCSIT 609 (673)
Q Consensus 550 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~el~tG~~p~~ 609 (673)
|||.|.....+ .....+||..|.|||++.+.+| ...-|||++|++||-++-...||.
T Consensus 713 dfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999877654 2345679999999999999887 567899999999999998887774
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-30 Score=267.69 Aligned_cols=252 Identities=17% Similarity=0.298 Sum_probs=198.1
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
..+|+....+|.|.||.|||++.. .++.+|+|+++... ..+..-...|+-+++..+|||||.++|-|... +..++.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-~dd~~~iqqei~~~~dc~h~nivay~gsylr~--dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR--DKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC-CccccccccceeeeecCCCcChHHHHhhhhhh--cCcEEE
Confidence 457788889999999999999965 58999999998654 33445567899999999999999999998554 678999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
||||.+|+|.+..+. ..++++.++..+.+...+|++|||+. |-+|||||-.|||+++.+.+|++|||.+..+..
T Consensus 91 MEycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~--gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ--GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EEecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcC--CcccccccccceeecccCceeecccCchhhhhh
Confidence 999999999998763 35688999999999999999999998 789999999999999999999999999876654
Q ss_pred cchhhhhccCCCCCccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCc-CCCCCCH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTT---TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPN-LEGKFSV 635 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 635 (673)
... ......||++|||||+.. .+.|..++|||+.|+...|+---+.|...........---....++. ++. ..
T Consensus 165 ti~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkD--k~ 241 (829)
T KOG0576|consen 165 TIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKD--KT 241 (829)
T ss_pred hhh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccC--Cc
Confidence 322 334567999999999864 56699999999999999999777766544322211111111122222 221 12
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.-.+.+.+++..|+..+|.+||+++.+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 23467889999999999999999987654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=235.79 Aligned_cols=200 Identities=27% Similarity=0.462 Sum_probs=168.9
Q ss_pred CccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEee
Q 005859 404 FSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDF 482 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~ 482 (673)
|...+.||+|++|.||++...+ ++.+|+|.+.........+.+.+|++.+++++|+|++++++++... ...++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEEEec
Confidence 4566789999999999999876 8899999998654222457889999999999999999999998543 678999999
Q ss_pred cCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcch
Q 005859 483 VPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV 562 (673)
Q Consensus 483 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 562 (673)
+++++|.+++.... ..+++..+..++.+++.++.|||+. +++|+|++|+||+++.++.++|+|||.+........
T Consensus 79 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 79 CEGGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL--GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred cCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 99999999987321 1178999999999999999999987 899999999999999999999999999987654321
Q ss_pred hhhhccCCCCCccCCccc-cCCCCCcchhHHHHHHHHHHHHhCCCCCCh
Q 005859 563 FSMLKASAAMGYLAPEYT-TTGRFTEKSDIYAFGMIVFQILSGKCSITP 610 (673)
Q Consensus 563 ~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSfGvvl~el~tG~~p~~~ 610 (673)
.......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 112234567789999998 566788899999999999999999999955
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=233.40 Aligned_cols=246 Identities=15% Similarity=0.326 Sum_probs=197.2
Q ss_pred cccccCCcceEEEEEEcCCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCCC
Q 005859 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNG 486 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~g 486 (673)
.+|.+...|+.|+|+++. ..+++|++...... .-.++|..|.-.|+-+.||||..++|.| +.+....++..||+.|
T Consensus 196 tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac--nsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC--NSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc--cCCCCceEeeeeccch
Confidence 358888999999999974 45556777655432 2346899999999999999999999999 4456788999999999
Q ss_pred ChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeec--cccccccccCcchhh
Q 005859 487 NLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLS--DSGLHKLLADDIVFS 564 (673)
Q Consensus 487 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~--DfGla~~~~~~~~~~ 564 (673)
+|+..|+.. .....+..++.+++.+||+|++|||+..|-|..-.|.+..|++|++.+++|+ |--++. .
T Consensus 273 slynvlhe~--t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--------q 342 (448)
T KOG0195|consen 273 SLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------Q 342 (448)
T ss_pred HHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--------e
Confidence 999999854 4456888899999999999999999977556666899999999999999876 322221 1
Q ss_pred hhccCCCCCccCCccccCCCC---CcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHH
Q 005859 565 MLKASAAMGYLAPEYTTTGRF---TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641 (673)
Q Consensus 565 ~~~~~gt~~y~aPE~~~~~~~---s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 641 (673)
.....-.+.||+||.++...- -.++|+|||.+++||+.|+..||.++...+...+...+..++.+ ++..+..+
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~i----ppgis~hm 418 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHI----PPGISRHM 418 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccC----CCCccHHH
Confidence 222344678999999987653 36799999999999999999999888776655555555544444 44556788
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 642 GQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 642 ~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
.++|.-|+..||.+||.++.|+-.|++++
T Consensus 419 ~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 419 NKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99999999999999999999999999875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-29 Score=253.17 Aligned_cols=207 Identities=19% Similarity=0.225 Sum_probs=170.0
Q ss_pred ccCHHHHHHHhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccC------CCCcee
Q 005859 391 MFNLEEVERATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK------HENLAS 463 (673)
Q Consensus 391 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~ 463 (673)
.+.+.|+. ..+|.+....|+|-|++|.+|..+. |+.||||++.... ...+.=++|++||++|+ --|+++
T Consensus 423 rv~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 423 RVRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred EEehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 34444443 4578899999999999999999765 8899999998753 23345578999999995 357889
Q ss_pred EeeEEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC
Q 005859 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR 543 (673)
Q Consensus 464 l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~ 543 (673)
++..|.. .+++|||+|-+ .-+|.++|... +...-|.......++.|+..||..|-.+ ||+|.||||.|||+++.
T Consensus 499 l~r~F~h--knHLClVFE~L-slNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c--~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 499 LFRHFKH--KNHLCLVFEPL-SLNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKC--GVLHADIKPDNILVNES 572 (752)
T ss_pred HHHHhhh--cceeEEEehhh-hchHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhc--CeeecccCccceEeccC
Confidence 9888854 48999999988 45999999754 3445578888999999999999999998 89999999999999976
Q ss_pred C-CeeeccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCCh
Q 005859 544 Y-NPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITP 610 (673)
Q Consensus 544 ~-~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~ 610 (673)
. .+||||||.|.....+... ....+..|.|||++.+-.|+...|+||.||+|||+.||+.-|.+
T Consensus 573 k~iLKLCDfGSA~~~~eneit---PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEIT---PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred cceeeeccCcccccccccccc---HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 5 5799999999877765432 23345679999999999999999999999999999999977754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=225.31 Aligned_cols=247 Identities=20% Similarity=0.315 Sum_probs=180.4
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~lv 479 (673)
+.|.+.+.+|+|.||++-+++++. .+.+++|.+.... ...++|.+|..---.| .|.||+.-|++-. ++.+..+++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF-qt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAF-QTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHh-hcCceEEEe
Confidence 357888899999999999999876 7789999887653 4567899998766666 6999998887543 445788899
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEec--CCCCeeeccccccccc
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIH--RRYNPLLSDSGLHKLL 557 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~--~~~~~kl~DfGla~~~ 557 (673)
+||++.|||.+-+.. .-+.+....+++.|++.|+.|+|++ ++||||||.+||||- +...+|++|||..+..
T Consensus 101 qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk--nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK--NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc--chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999999988853 2367788899999999999999998 699999999999983 3348999999998765
Q ss_pred cCcchhhhhccCCCCCccCCccccC---C--CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhc---cchhhhcCCcC
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTT---G--RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAES---SKVEDFIDPNL 629 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~---~~~~~~~~~~~ 629 (673)
+... ....-+..|.+||.... + ...+.+|||.||+++|.++||+.||....-..... ........+.+
T Consensus 174 g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 174 GTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred Ccee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 4321 22234556899997653 2 25788999999999999999999986321111111 11111112222
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 005859 630 EGKFSVSEASNLGQIALHCTHESPSHRPSIENVM 663 (673)
Q Consensus 630 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl 663 (673)
+..+ ...++.+..+-.+-+..+|++|-...++.
T Consensus 250 P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 250 PKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred chhh-cccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 2211 22345667777888899999884444443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=220.23 Aligned_cols=167 Identities=15% Similarity=0.200 Sum_probs=127.5
Q ss_pred CChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhhh
Q 005859 486 GNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSM 565 (673)
Q Consensus 486 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 565 (673)
|+|.++++.. ...++|.+++.|+.||++||+|||+. + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~--~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ--A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc--C------CcccEeEcCccceee--ccceEeecccc----
Confidence 7899999732 34699999999999999999999987 4 999999999999999 99998765421
Q ss_pred hccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcC-CC-CCCHHHHH--HH
Q 005859 566 LKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNL-EG-KFSVSEAS--NL 641 (673)
Q Consensus 566 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~--~l 641 (673)
..|++.|||||++.+..++.++|||||||++|||+||+.||............+.....+.. .. ........ ++
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSF 141 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhH
Confidence 25789999999999999999999999999999999999998643221111111111111110 00 11222233 69
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 642 GQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 642 ~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.+++.+||+.+|++||++.|+++.+..+..
T Consensus 142 ~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 142 ADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 999999999999999999999998876643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=277.00 Aligned_cols=197 Identities=20% Similarity=0.237 Sum_probs=140.3
Q ss_pred ccCC-CCceeEeeEEecCC-----CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Q 005859 455 SLKH-ENLASLRGICCSKG-----RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGL 528 (673)
Q Consensus 455 ~l~H-~niv~l~~~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~i 528 (673)
.++| +||++++++|.... ....+.++||+ +++|.++++.. ...+++..++.|+.||++||+|||++ ||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~--gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ--GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC--Ce
Confidence 4455 58888888762211 13456778887 66999999632 34589999999999999999999987 89
Q ss_pred ccCCcCCCCeEecC-------------------CCCeeeccccccccccCcch---------------hhhhccCCCCCc
Q 005859 529 VHPNLSAEKVLIHR-------------------RYNPLLSDSGLHKLLADDIV---------------FSMLKASAAMGY 574 (673)
Q Consensus 529 vHrDlk~~NILl~~-------------------~~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~~y 574 (673)
+||||||+||||+. ++.+|++|||+++....... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 45677788887764321000 001123578889
Q ss_pred cCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCC
Q 005859 575 LAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPS 654 (673)
Q Consensus 575 ~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~ 654 (673)
||||++.+..|+.++|||||||+||||++|..|+....... .........+. ......+..+++.+||+.+|.
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~--~~~~~~~~~~~-----~~~~~~~~~~~~~~~L~~~P~ 254 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTM--SSLRHRVLPPQ-----ILLNWPKEASFCLWLLHPEPS 254 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHH--HHHHHhhcChh-----hhhcCHHHHHHHHHhCCCChh
Confidence 99999999999999999999999999999887764321110 00111111111 111234556888999999999
Q ss_pred CCCCHHHHHH
Q 005859 655 HRPSIENVMQ 664 (673)
Q Consensus 655 ~RPs~~evl~ 664 (673)
+||+|.|+++
T Consensus 255 ~Rps~~eil~ 264 (793)
T PLN00181 255 CRPSMSELLQ 264 (793)
T ss_pred hCcChHHHhh
Confidence 9999999975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=235.31 Aligned_cols=256 Identities=22% Similarity=0.329 Sum_probs=192.8
Q ss_pred HHHHHHhcCCccccccccCCcceEEEEEEc----CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEe
Q 005859 395 EEVERATQCFSEANLLGKSSFSATYKGILR----DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICC 469 (673)
Q Consensus 395 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 469 (673)
+.+....+.|...++||+|.|++||++... ..+.||+|.+.... ......+|+++|..+ .+.||+++.+.+
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts---~p~ri~~El~~L~~~gG~~ni~~~~~~~- 104 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS---SPSRILNELEMLYRLGGSDNIIKLNGCF- 104 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc---CchHHHHHHHHHHHhccchhhhcchhhh-
Confidence 345556678899999999999999999854 36789999987654 445789999999999 599999999988
Q ss_pred cCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC-CCeee
Q 005859 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR-YNPLL 548 (673)
Q Consensus 470 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~-~~~kl 548 (673)
...+...+|+||++.-+..+++. .++...+..+++.+.+||+|+|.+ |||||||||+|+|.+.. +.-.|
T Consensus 105 -rnnd~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~--GIvHRDiKpsNFL~n~~t~rg~L 174 (418)
T KOG1167|consen 105 -RNNDQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN--GIVHRDIKPSNFLYNRRTQRGVL 174 (418)
T ss_pred -ccCCeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc--CccccCCCccccccccccCCceE
Confidence 44588999999999988888875 367888999999999999999988 99999999999999854 56789
Q ss_pred ccccccccccCcc-----------------------------------hh--------hhhccCCCCCccCCccccC-CC
Q 005859 549 SDSGLHKLLADDI-----------------------------------VF--------SMLKASAAMGYLAPEYTTT-GR 584 (673)
Q Consensus 549 ~DfGla~~~~~~~-----------------------------------~~--------~~~~~~gt~~y~aPE~~~~-~~ 584 (673)
.|||+|...+... .. .....+||++|+|||++.. ..
T Consensus 175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~ 254 (418)
T KOG1167|consen 175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR 254 (418)
T ss_pred EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence 9999997211000 00 0112468999999999875 45
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCChhhHh-------------------hhhccc--hhh-------------h--cC-C
Q 005859 585 FTEKSDIYAFGMIVFQILSGKCSITPFTRQ-------------------AAESSK--VED-------------F--ID-P 627 (673)
Q Consensus 585 ~s~ksDVwSfGvvl~el~tG~~p~~~~~~~-------------------~~~~~~--~~~-------------~--~~-~ 627 (673)
.++++||||-|||++-+++++.||....+. +..... +.+ + ++ .
T Consensus 255 QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~ 334 (418)
T KOG1167|consen 255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIE 334 (418)
T ss_pred cCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChh
Confidence 799999999999999999999998432110 000000 000 0 00 0
Q ss_pred cC--------C-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 628 NL--------E-GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 628 ~~--------~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+ . ....+..+..+++++.+|++.||.+|.|++|.++
T Consensus 335 ~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 335 SIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred hcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 00 0 0111223457889999999999999999999874
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=226.63 Aligned_cols=166 Identities=14% Similarity=0.140 Sum_probs=127.8
Q ss_pred HhcCCccccccccCCcceEEEEEEc--CCcEEEEEEecccCC----CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR--DGSVVAVKCIAKTSC----KSDEGEFLKGLKILTSLKHENLASLRGICCSKGR 473 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 473 (673)
..++|...+.||+|+||+||+|+++ +++.||||++..... ....+.|.+|+++|++++|+||+..+..+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----
Confidence 3467899999999999999999875 477889998753311 12245689999999999999998533222
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCc-CCCCeEecCCCCeeecccc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNL-SAEKVLIHRRYNPLLSDSG 552 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDl-k~~NILl~~~~~~kl~DfG 552 (673)
+..++||||++|++|... . ... ...++.|+++||+|||+. ||+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~----~~~------~~~~~~~i~~aL~~lH~~--gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-R----PHG------DPAWFRSAHRALRDLHRA--GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHh-C----ccc------hHHHHHHHHHHHHHHHHC--CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 347999999999999632 1 101 145788999999999987 8999999 9999999999999999999
Q ss_pred ccccccCcch-------hhhhccCCCCCccCCccccCC
Q 005859 553 LHKLLADDIV-------FSMLKASAAMGYLAPEYTTTG 583 (673)
Q Consensus 553 la~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~ 583 (673)
+|+.+..... .......+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9997654321 112345678889999998743
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-22 Score=211.59 Aligned_cols=261 Identities=14% Similarity=0.161 Sum_probs=193.1
Q ss_pred CCccccccccCCcceEEEEEEcCC--cEEEEEEecccCCCCcHHHHHHHHHHHhccCC----CCceeEeeEEecCCCCeE
Q 005859 403 CFSEANLLGKSSFSATYKGILRDG--SVVAVKCIAKTSCKSDEGEFLKGLKILTSLKH----ENLASLRGICCSKGRGEC 476 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~~~~~~~~~ 476 (673)
+|.+.+.||+|+||.||++...+. ..+|+|........... .+..|+.++..+.+ +++..+++... ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCcee
Confidence 789999999999999999997653 47888877665322222 67889999998863 57888877663 234678
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC-----CCeeeccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR-----YNPLLSDS 551 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~-----~~~kl~Df 551 (673)
++||+.+ |.+|.++..... ...++..+..+|+.|++.+|++||+. |++||||||.|+++... ..+.+.||
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~--G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK--GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc--CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 9999998 889999775332 46799999999999999999999998 89999999999999865 46899999
Q ss_pred cccc--cccCcch---h-h---hhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh
Q 005859 552 GLHK--LLADDIV---F-S---MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE 622 (673)
Q Consensus 552 Gla~--~~~~~~~---~-~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~ 622 (673)
|+++ ....... . . .....||..|+++....+...+.+.|+||++-++.|+..|..||.......... .+.
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~-~~~ 250 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS-KFE 250 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH-HHH
Confidence 9998 4322111 1 1 123459999999999999999999999999999999999999986543221111 111
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 623 DFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
...............+.++.++...+-..+..++|....+...|+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 1100011000122234566666666667899999999999998877654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-22 Score=207.78 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=194.8
Q ss_pred CccccccccCCcceEEEEEEcCCcEEEEEEecccCCCC--cHHHHHHHHHHHhccCCC-CceeEeeEEecCCCCeEEEEE
Q 005859 404 FSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKS--DEGEFLKGLKILTSLKHE-NLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~~~lv~ 480 (673)
|.....||.|+||.||++... ..+++|.+....... ....|.+|+.+++.+.|+ +|+++++++.. ....++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEEEEEE
Confidence 556778999999999999987 889999998765443 367899999999999988 79999999843 35579999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC-CeeeccccccccccC
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY-NPLLSDSGLHKLLAD 559 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~-~~kl~DfGla~~~~~ 559 (673)
||+.++++.+++...... ..++......+..|++.+++|+|.. +++|||+||+||+++... .+++.|||.++....
T Consensus 78 ~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~--~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK--GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred ecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 999999999776532110 2588889999999999999999987 799999999999999988 799999999986654
Q ss_pred cchh-----hhhccCCCCCccCCccccC---CCCCcchhHHHHHHHHHHHHhCCCCCChhhH---hhhhccchhhhcCCc
Q 005859 560 DIVF-----SMLKASAAMGYLAPEYTTT---GRFTEKSDIYAFGMIVFQILSGKCSITPFTR---QAAESSKVEDFIDPN 628 (673)
Q Consensus 560 ~~~~-----~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~---~~~~~~~~~~~~~~~ 628 (673)
.... ......++..|+|||.+.. ..++...|+||+|++++++++|..|+..... .......+.....+.
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 3321 2345678999999999987 5788999999999999999999999655432 111111111111110
Q ss_pred CCCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 629 LEGKFS----VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 629 ~~~~~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...... ......+.+++..|+..+|..|.++.+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 111111 122357889999999999999998887664
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6e-23 Score=228.21 Aligned_cols=251 Identities=18% Similarity=0.214 Sum_probs=180.4
Q ss_pred ccccccccCCcceEEEEEEc-CCcEEEEEEecccC-CCCcH----HHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 405 SEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTS-CKSDE----GEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 405 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~----~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
...+++|.|++|.|+..... .....+.|..+... ..... ..+..|+.+-..++|||++..+..+.+. ....-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~--~~~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI--DGILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc--ccchh
Confidence 34578999999977777643 24444444333110 01111 1255678888889999998887776543 33344
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
+||||++ ||...+.. ...++..++..++.|+..|++|+|+. ||.|||+|++|+++..++.+||+|||.+....
T Consensus 399 ~mE~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~--GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM--GLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hhhcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc--CceeccCccccEEEecCCceEEeecCcceeec
Confidence 4999999 99999863 23577888889999999999999998 89999999999999999999999999987664
Q ss_pred Ccch---hhhhccCCCCCccCCccccCCCCCc-chhHHHHHHHHHHHHhCCCCCChhhHhhhh--ccchhhhcC-CcCCC
Q 005859 559 DDIV---FSMLKASAAMGYLAPEYTTTGRFTE-KSDIYAFGMIVFQILSGKCSITPFTRQAAE--SSKVEDFID-PNLEG 631 (673)
Q Consensus 559 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~-ksDVwSfGvvl~el~tG~~p~~~~~~~~~~--~~~~~~~~~-~~~~~ 631 (673)
-+.. ......+|+-.|+|||.+....|++ ..||||.||++..|++|+.||......... ......... ..-..
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN 551 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence 3222 3345677899999999999999986 589999999999999999988543221111 000000000 00001
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 632 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
......+.+.+.++.++++.||.+|.|+++|++
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 122344677889999999999999999999985
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=187.86 Aligned_cols=258 Identities=16% Similarity=0.198 Sum_probs=192.8
Q ss_pred cCCccccccccCCcceEEEEE-EcCCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~lv 479 (673)
-.|.+.++||+|+||+.+.|+ +-+++.||||.-... ++.-++..|.+..+.| ..++|..+|.+- +...+-.||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeec--cccchhhhh
Confidence 368889999999999999998 457999999965443 3445777888888887 468888776443 444567899
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC-----Ceeecccccc
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY-----NPLLSDSGLH 554 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~-----~~kl~DfGla 554 (673)
+|.. |.+|.++.+.. .+.++..+..-||.|++.-++|+|++ .+|.|||||+|.||..-+ .+.|.|||+|
T Consensus 103 idLL-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k--~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK--DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhh-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc--ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 9999 88999988743 45699999999999999999999998 599999999999997543 4689999999
Q ss_pred ccccCcch------hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCc
Q 005859 555 KLLADDIV------FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPN 628 (673)
Q Consensus 555 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 628 (673)
+.+.+... .......||.+||+-....+...+.+.|.=|+|-+++..+-|..||.+....... ...+++-+..
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK-~kYeKIGe~K 255 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK-EKYEKIGETK 255 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH-HHHHHhcccc
Confidence 98765432 1223456999999999989999999999999999999999999999875322111 1222222211
Q ss_pred C---CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 629 L---EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 629 ~---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
. ..+..+..+.++..-+.-.-..+-.+-|..+-+...+.+++.
T Consensus 256 r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 256 RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 1 111122335566666655556677788888887777776654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=190.26 Aligned_cols=174 Identities=12% Similarity=0.102 Sum_probs=134.5
Q ss_pred HhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcH--H------HHHHHHHHHhccCCCCceeEeeEEecC
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDE--G------EFLKGLKILTSLKHENLASLRGICCSK 471 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--~------~~~~E~~~l~~l~H~niv~l~~~~~~~ 471 (673)
-.++|...+.+|.|+||.||.... ++..+|||++......... . .+.+|++.+.++.||+|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 368899999999999999999665 5778999999765422111 1 268999999999999999999886543
Q ss_pred C------CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC
Q 005859 472 G------RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN 545 (673)
Q Consensus 472 ~------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~ 545 (673)
. .+..++||||++|.+|.++.. ++. ....+++.+++.+|+. |++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~--gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH--GMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc--CCccCCCChHHEEEeCCC-
Confidence 2 135789999999999987742 222 2456999999999987 899999999999999988
Q ss_pred eeeccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHH
Q 005859 546 PLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQIL 602 (673)
Q Consensus 546 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~ 602 (673)
++++|||..+....+.... .++....|+.++||||||+++.-..
T Consensus 173 i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence 9999999886553322111 1344455778999999999986553
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-21 Score=181.64 Aligned_cols=259 Identities=14% Similarity=0.190 Sum_probs=191.0
Q ss_pred hcCCccccccccCCcceEEEEE-EcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCC-CCceeEeeEEecCCCCeEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKH-ENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~~~l 478 (673)
.+.|...+.||.|+||.+|.|. ..+|..||||+-... ....+...|.++.+.++| ..|..+.-|. .+...-.+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~---a~hpqL~yEskvY~iL~~g~GiP~i~~y~--~e~~ynvl 88 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK---AKHPQLLYESKVYRILQGGVGIPHIRHYG--TEKDYNVL 88 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc---CCCcchhHHHHHHHHhccCCCCchhhhhc--ccccccee
Confidence 3578999999999999999998 567999999975543 233467889999998864 4555555554 33466789
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC---CCeeeccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR---YNPLLSDSGLHK 555 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~---~~~kl~DfGla~ 555 (673)
|||.. |.+|.++.... .+.++..+.+-++-|++.-++|+|.+ ++|||||||+|.|..-+ ..+.++|||+|+
T Consensus 89 VMdLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r--~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR--NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh--ccccccCCccceeeccccccceEEEEeccchh
Confidence 99999 88999988643 35689999999999999999999987 79999999999998643 357899999999
Q ss_pred cccCcch------hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhh--hccchhhhcCC
Q 005859 556 LLADDIV------FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA--ESSKVEDFIDP 627 (673)
Q Consensus 556 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~--~~~~~~~~~~~ 627 (673)
.+-+... .......||.+|.+-....+...+.+.|+=|.|-+|...-.|..||.+...... ..+.+.+..-.
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS 242 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence 7654321 122345689999988777777788999999999999999999999987543211 11112211111
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 628 NLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 628 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
......-...|.++.-.+.-|-..--++-|...-+-+.+.-++
T Consensus 243 ~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 243 TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 1111112234567778888888888888888877776665544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.2e-21 Score=186.38 Aligned_cols=141 Identities=16% Similarity=0.126 Sum_probs=108.1
Q ss_pred ccccccCCcceEEEEEEcCCcEEEEEEecccCCCC-c-------HHH-----------------HHHHHHHHhccCCCCc
Q 005859 407 ANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKS-D-------EGE-----------------FLKGLKILTSLKHENL 461 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~-------~~~-----------------~~~E~~~l~~l~H~ni 461 (673)
...||+|+||.||+|...+|+.||||+++...... . ... ..+|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999998889999999997643211 1 112 2349999999988876
Q ss_pred eeEeeEEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHH-hcCCCCcccCCcCCCCeEe
Q 005859 462 ASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYL-HGKRPGLVHPNLSAEKVLI 540 (673)
Q Consensus 462 v~l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~ivHrDlk~~NILl 540 (673)
.....+.. ...+|||||++++++..... ....+++....+++.|++.+|+|+ |+. ||+||||||+|||+
T Consensus 82 ~~p~~~~~----~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~--giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL----KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC--RLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe----cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEE
Confidence 44333221 12389999999877765432 123588999999999999999999 566 89999999999999
Q ss_pred cCCCCeeecccccccccc
Q 005859 541 HRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 541 ~~~~~~kl~DfGla~~~~ 558 (673)
+ ++.++|+|||+|....
T Consensus 152 ~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred E-CCcEEEEEccccccCC
Confidence 8 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-20 Score=186.61 Aligned_cols=198 Identities=16% Similarity=0.200 Sum_probs=141.4
Q ss_pred CCCCceeEeeEEecC-------------------------CCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHH
Q 005859 457 KHENLASLRGICCSK-------------------------GRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVI 511 (673)
Q Consensus 457 ~H~niv~l~~~~~~~-------------------------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 511 (673)
+|||||++.++|.+. .+...|+||.-++. +|.+++.. ...+...+.-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence 699999999888653 12357899998854 89999963 234556667799
Q ss_pred HHHHHHHHHHhcCCCCcccCCcCCCCeEe--cCCCC--eeeccccccccccC-----cchhhhhccCCCCCccCCccccC
Q 005859 512 KGIAKGISYLHGKRPGLVHPNLSAEKVLI--HRRYN--PLLSDSGLHKLLAD-----DIVFSMLKASAAMGYLAPEYTTT 582 (673)
Q Consensus 512 ~~ia~gL~yLH~~~~~ivHrDlk~~NILl--~~~~~--~kl~DfGla~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~ 582 (673)
.|+++|+.|||.+ ||.|||+|++|||+ |+|.. ..|+|||.+-.-.. +.........|...-||||+...
T Consensus 348 aQlLEav~hL~~h--gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH--GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHHc--cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999987 89999999999998 45553 46899998642211 11111223345667899998864
Q ss_pred CC------CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCC
Q 005859 583 GR------FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHR 656 (673)
Q Consensus 583 ~~------~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R 656 (673)
.. .-.|+|.|+.|.+-||+++...||....+.........+ ..-+..++.++..+.+++...++.||++|
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe----~qLPalp~~vpp~~rqlV~~lL~r~pskR 501 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE----SQLPALPSRVPPVARQLVFDLLKRDPSKR 501 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh----hhCCCCcccCChHHHHHHHHHhcCCcccc
Confidence 22 236899999999999999999998763322222222222 12234456667889999999999999999
Q ss_pred CCHHHHHHHH
Q 005859 657 PSIENVMQEL 666 (673)
Q Consensus 657 Ps~~evl~~L 666 (673)
++..-....|
T Consensus 502 vsp~iAANvl 511 (598)
T KOG4158|consen 502 VSPNIAANVL 511 (598)
T ss_pred CCccHHHhHH
Confidence 9876655444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-20 Score=179.12 Aligned_cols=141 Identities=19% Similarity=0.208 Sum_probs=110.8
Q ss_pred ccccccCCcceEEEEEEcCCcEEEEEEecccCCCC--------------------c-----HHHHHHHHHHHhccCCCCc
Q 005859 407 ANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKS--------------------D-----EGEFLKGLKILTSLKHENL 461 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~-----~~~~~~E~~~l~~l~H~ni 461 (673)
...||+|+||.||+|+..+|+.||||+++...... . ...+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 35799999999999998789999999998653110 0 1123578999999999988
Q ss_pred eeEeeEEecCCCCeEEEEEeecCCCChhhh-hccccCCccccCHHHHHHHHHHHHHHHHHHhc-CCCCcccCCcCCCCeE
Q 005859 462 ASLRGICCSKGRGECFLIYDFVPNGNLLQH-LDLEAGSEKVLEWATRISVIKGIAKGISYLHG-KRPGLVHPNLSAEKVL 539 (673)
Q Consensus 462 v~l~~~~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~ivHrDlk~~NIL 539 (673)
.....+... ..++||||++++++... +. ...++.....+++.|++.++.|+|+ . ||+||||||+||+
T Consensus 82 ~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~--givHrDlkP~NIl 150 (190)
T cd05145 82 PVPEPILLK----KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEA--GLVHGDLSEYNIL 150 (190)
T ss_pred CCceEEEec----CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCChhhEE
Confidence 544444322 24899999998865433 32 2346778889999999999999998 6 8999999999999
Q ss_pred ecCCCCeeeccccccccccC
Q 005859 540 IHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 540 l~~~~~~kl~DfGla~~~~~ 559 (673)
++ ++.++|+|||+++....
T Consensus 151 l~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EE-CCCEEEEEcccceecCC
Confidence 99 78999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.5e-21 Score=201.33 Aligned_cols=213 Identities=26% Similarity=0.401 Sum_probs=159.8
Q ss_pred HhccCCCCceeEeeEEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCC
Q 005859 453 LTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPN 532 (673)
Q Consensus 453 l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrD 532 (673)
|+.+.|.|+.+++|.+.++ ...++|.+||..|+|.+.+.. ....++|.....+.++|++||+|||+.. ...|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeee
Confidence 4678999999999999876 778999999999999999974 2356899999999999999999999852 339999
Q ss_pred cCCCCeEecCCCCeeeccccccccccCcc-hhhhhccCCCCCccCCccccCCC-------CCcchhHHHHHHHHHHHHhC
Q 005859 533 LSAEKVLIHRRYNPLLSDSGLHKLLADDI-VFSMLKASAAMGYLAPEYTTTGR-------FTEKSDIYAFGMIVFQILSG 604 (673)
Q Consensus 533 lk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-------~s~ksDVwSfGvvl~el~tG 604 (673)
++++|+++|....+|++|||+........ ...........-|.|||.+.... .+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987764210 00011111234599999987531 46789999999999999999
Q ss_pred CCCCChhhHhhhhccchhhhcC---CcCCCCCC-H-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 605 KCSITPFTRQAAESSKVEDFID---PNLEGKFS-V-SEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 605 ~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~-~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
+.||..........+.+..+.+ +...+... . +..+++..++..||..+|++||++++|-..++.+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9998653322221122222111 11222211 1 344578999999999999999999999888876643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-21 Score=205.72 Aligned_cols=226 Identities=21% Similarity=0.305 Sum_probs=179.7
Q ss_pred ccccCCcceEEEEE----EcCCcEEEEEEecccCCCC-cHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCeEEEEEee
Q 005859 409 LLGKSSFSATYKGI----LRDGSVVAVKCIAKTSCKS-DEGEFLKGLKILTSLK-HENLASLRGICCSKGRGECFLIYDF 482 (673)
Q Consensus 409 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~lv~E~ 482 (673)
.+|+|.||.|+.++ ...|+.+|+|++++..... .+.....|..++...+ ||.+|++...+ +.+...+++++|
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf--qt~~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF--QTDGKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee--ccccchhHhhhh
Confidence 37999999999765 3347889999988764322 2224566888888886 99999998877 445778999999
Q ss_pred cCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcch
Q 005859 483 VPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV 562 (673)
Q Consensus 483 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 562 (673)
..+|+|...+.. ...++......+...++-+++++|.. +|+|||+|++||+++.+|.+++.|||+++..-...
T Consensus 79 ~rgg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l--~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~- 151 (612)
T KOG0603|consen 79 LRGGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKL--GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK- 151 (612)
T ss_pred cccchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchh--HHHHhcccccceeecccCccccCCchhhhHhHhhh-
Confidence 999999988863 34567777778888999999999987 89999999999999999999999999998765432
Q ss_pred hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHH
Q 005859 563 FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLG 642 (673)
Q Consensus 563 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 642 (673)
..+||..|||||++. .+...+|.||||++++||+||..||... ....+.. .....+......+.
T Consensus 152 ----~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~--------~~~~Il~--~~~~~p~~l~~~a~ 215 (612)
T KOG0603|consen 152 ----IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD--------TMKRILK--AELEMPRELSAEAR 215 (612)
T ss_pred ----hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH--------HHHHHhh--hccCCchhhhHHHH
Confidence 238999999999997 5788999999999999999999998762 1111111 12245666677888
Q ss_pred HHHHHccccCCCCCCCH
Q 005859 643 QIALHCTHESPSHRPSI 659 (673)
Q Consensus 643 ~l~~~Cl~~~p~~RPs~ 659 (673)
+++..+...+|.+|-..
T Consensus 216 ~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 216 SLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHhhCHHHHhcc
Confidence 88889999999998644
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.1e-20 Score=222.47 Aligned_cols=168 Identities=33% Similarity=0.526 Sum_probs=153.7
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..+..|+|++|.++|.+|..|.++++|+.|+|++|.+++.+|..+..+++|+.|+|++|++.+.+|..+ .+++|+.|+|
T Consensus 404 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~l 482 (968)
T PLN00113 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDL 482 (968)
T ss_pred CCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEEC
Confidence 367889999999999999999999999999999999999999999999999999999999998888866 4589999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
++|++++.+|..|.++++|+.|+|++|++.+.+|..+.++++|+.|+|++|.+++.+|..+.++++|+.|+|++|+++|.
T Consensus 483 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 562 (968)
T PLN00113 483 SRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGE 562 (968)
T ss_pred cCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred Cchhhhhcc
Q 005859 225 VPPALKRLN 233 (673)
Q Consensus 225 ~p~~l~~~~ 233 (673)
+|..+..+.
T Consensus 563 ~p~~l~~l~ 571 (968)
T PLN00113 563 IPKNLGNVE 571 (968)
T ss_pred CChhHhcCc
Confidence 998887654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3e-21 Score=200.55 Aligned_cols=173 Identities=22% Similarity=0.338 Sum_probs=127.4
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
||.|++|+..+|.+|+...+ .....+|...+.++.|++.|++| + +.+|||+||.||....+..+||.|||+...
T Consensus 332 yI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k--~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 332 YIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K--GLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred hhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c--cchhhhccccccccccchhhhhhhhhheee
Confidence 67777888888888886332 23456788889999999999999 4 799999999999999999999999999876
Q ss_pred ccCcc-----hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCC
Q 005859 557 LADDI-----VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEG 631 (673)
Q Consensus 557 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 631 (673)
..... ....+...||..||+||.+.+..|+.|+||||+|++|+|+++ +|.- .........++.+..+++
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T---~~er~~t~~d~r~g~ip~ 479 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFST---QFERIATLTDIRDGIIPP 479 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---Hhcc---HHHHHHhhhhhhcCCCCh
Confidence 65543 334566789999999999999999999999999999999996 1111 111111222232323322
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 005859 632 KFSVSEASNLGQIALHCTHESPSHRPSIENV 662 (673)
Q Consensus 632 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev 662 (673)
.+..+. +.-..++.+++...|.+||++.++
T Consensus 480 ~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 480 EFLQDY-PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HHhhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence 222222 233478899999999999955544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=171.28 Aligned_cols=184 Identities=13% Similarity=0.048 Sum_probs=135.3
Q ss_pred cccccccCCcceEEEEEEcCCcEEEEEEecccCCC---CcHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCeEEEEEe
Q 005859 406 EANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCK---SDEGEFLKGLKILTSLK-HENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 406 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
+...|++|+||+||.+.- .+..++.+.+...... .....|.+|+++|+++. |++|++++++ +..+++||
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvme 78 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDRS 78 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEEe
Confidence 456799999999997665 5777887777554321 11235889999999995 5889999885 23589999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCc-CCCCeEecCCCCeeeccccccccccCc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNL-SAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDl-k~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
|++|.+|.+.+.. ....++.|++.+|+|+|+. ||+|||| ||+|||++.++.++|+|||++......
T Consensus 79 yI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~--GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 79 YLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC--GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred eecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC--cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 9999998754420 1134778999999999988 8999999 799999999999999999999855433
Q ss_pred chh----h--------hhccCCCCCccCCccccCC-CCC-cchhHHHHHHHHHHHHhCCCCCC
Q 005859 561 IVF----S--------MLKASAAMGYLAPEYTTTG-RFT-EKSDIYAFGMIVFQILSGKCSIT 609 (673)
Q Consensus 561 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~s-~ksDVwSfGvvl~el~tG~~p~~ 609 (673)
... . ......++.|++|+.-.-- ..+ ...+.++-|.-+|.++||+.+..
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 210 0 0112245667777643321 233 56799999999999999987754
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-20 Score=208.21 Aligned_cols=244 Identities=21% Similarity=0.274 Sum_probs=175.0
Q ss_pred CCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHH--HhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKI--LTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
.+...+.||++.|=+|.+|+.++|. |+||++.+.......+.|.++++- ..-++|||++++.-+-. .....|||=
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~--t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLV--TDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHH--hhHHHHHHH
Confidence 4555678999999999999998888 889998776544444455444333 44558999998866542 235567888
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc--cc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL--LA 558 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~--~~ 558 (673)
+|..+ +|++.+. .+..+...+.+-|+.|++.||.-+|.. ||.|||||.+||||..-.-+.|+||..-|. +.
T Consensus 101 qyvkh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~--gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKL--GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHHhh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHc--CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 88854 8998886 445677778888999999999999987 899999999999999998999999976542 22
Q ss_pred Ccchhhhh----ccCCCCCccCCccccCC-----------CCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhh-----
Q 005859 559 DDIVFSML----KASAAMGYLAPEYTTTG-----------RFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAE----- 617 (673)
Q Consensus 559 ~~~~~~~~----~~~gt~~y~aPE~~~~~-----------~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~----- 617 (673)
.+.....+ ....-..|.|||.+... ..+++-||||.||++.|+++ |+.+|.-..-..-.
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~ 253 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNAD 253 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCcc
Confidence 22211111 11122359999987541 15788999999999999999 66666432111000
Q ss_pred --ccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 618 --SSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 618 --~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
...++++. ...+++++..|++.||++|-++++.++.-..
T Consensus 254 ~~e~~Le~Ie------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 254 DPEQLLEKIE------------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred CHHHHHHhCc------------CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 00111111 2367899999999999999999999987543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.4e-19 Score=171.25 Aligned_cols=139 Identities=19% Similarity=0.297 Sum_probs=105.5
Q ss_pred CccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-----CCCCceeEeeEEecCCC-CeEE
Q 005859 404 FSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-----KHENLASLRGICCSKGR-GECF 477 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~~-~~~~ 477 (673)
++....||+|+||.||. +++....+||++.... ....+++.+|+++++++ +||||++++|++.+... +..+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 34567899999999996 4432333699887643 23456799999999999 57999999999966431 2333
Q ss_pred -EEEee--cCCCChhhhhccccCCccccCHHHHHHHHHHHHHHH-HHHhcCCCCcccCCcCCCCeEecCC----CCeeec
Q 005859 478 -LIYDF--VPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGI-SYLHGKRPGLVHPNLSAEKVLIHRR----YNPLLS 549 (673)
Q Consensus 478 -lv~E~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~ivHrDlk~~NILl~~~----~~~kl~ 549 (673)
+|+|| +++|+|.+++... .+++. ..++.|++.++ +|||++ +|+||||||+|||++.. ..++|+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~--~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN--RIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC--CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 5579999999631 25554 35678888888 999988 79999999999999743 379999
Q ss_pred ccccc
Q 005859 550 DSGLH 554 (673)
Q Consensus 550 DfGla 554 (673)
||+.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95444
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.5e-19 Score=174.99 Aligned_cols=237 Identities=16% Similarity=0.250 Sum_probs=150.1
Q ss_pred CCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhccCC----------CCceeEeeEEe
Q 005859 403 CFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKH----------ENLASLRGICC 469 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H----------~niv~l~~~~~ 469 (673)
.+.....||.|+++.||.++..+ |+.+|+|+...... ..+.+++.+|.-....+.+ -.++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 34557789999999999999876 89999998865442 2233566666544444322 12221122111
Q ss_pred cC--------C--CC-----eEEEEEeecCCCChhhhhcc---ccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccC
Q 005859 470 SK--------G--RG-----ECFLIYDFVPNGNLLQHLDL---EAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHP 531 (673)
Q Consensus 470 ~~--------~--~~-----~~~lv~E~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHr 531 (673)
.. . .. ..+++|+-+ .+||.+++.. .......+....++.+..|+++-+++||+. |+||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~--GlVHg 169 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY--GLVHG 169 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT--TEEES
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc--ceEec
Confidence 11 0 01 135677777 5688887642 111123455667788889999999999998 89999
Q ss_pred CcCCCCeEecCCCCeeeccccccccccCcchhhhhccCCCCCccCCccccC--------CCCCcchhHHHHHHHHHHHHh
Q 005859 532 NLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT--------GRFTEKSDIYAFGMIVFQILS 603 (673)
Q Consensus 532 Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDVwSfGvvl~el~t 603 (673)
||||+|++++.+|.++|+||+........... ...+..|.+||.... -.++.+.|.|++|+++|.|..
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999876654432221 234467999997643 247999999999999999999
Q ss_pred CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCC
Q 005859 604 GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHR 656 (673)
Q Consensus 604 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R 656 (673)
|+.||........... . ...+. +.++.+..||...|+.||.+|
T Consensus 246 ~~lPf~~~~~~~~~~~--------~-f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW--------D-FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG--------G-GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc--------c-chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999875432221111 1 12334 667899999999999999988
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-20 Score=167.70 Aligned_cols=163 Identities=29% Similarity=0.520 Sum_probs=149.7
Q ss_pred CCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEee
Q 005859 64 NGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143 (673)
Q Consensus 64 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 143 (673)
...++.|.|++|.++ .+|+.+..|.+|+.|++++|+++ .+|.+++.+++|+.|+++-|++. .+|..|+.++.|++||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 357899999999998 68888999999999999999998 68889999999999999999998 8899999999999999
Q ss_pred ccCcccc-ccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCC
Q 005859 144 LCYNKLT-GNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFS 222 (673)
Q Consensus 144 L~~N~l~-~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 222 (673)
|.+|.+. ..+|..|..++.|+.|+|+.|.+. .+|..++.+++|+.|.+..|.+. .+|..++.+..|+.|.+++|+++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 9999996 468999999999999999999998 89999999999999999999987 68999999999999999999998
Q ss_pred cCCchhhhhc
Q 005859 223 GNVPPALKRL 232 (673)
Q Consensus 223 g~~p~~l~~~ 232 (673)
.+|+.+..+
T Consensus 187 -vlppel~~l 195 (264)
T KOG0617|consen 187 -VLPPELANL 195 (264)
T ss_pred -ecChhhhhh
Confidence 567776554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.4e-18 Score=193.73 Aligned_cols=252 Identities=17% Similarity=0.252 Sum_probs=177.5
Q ss_pred HHHHHHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccC---CCCceeEeeEEecC
Q 005859 395 EEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK---HENLASLRGICCSK 471 (673)
Q Consensus 395 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~ 471 (673)
.+.+...+.|.+.+.||+|+||+||+|...+|+.||+|+=+....- +|---.+++.+|+ -+-|+.+...+...
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW----EFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce----eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 4555666889999999999999999999888999999987665421 1111223444444 23344444444333
Q ss_pred CCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC-------CC
Q 005859 472 GRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR-------RY 544 (673)
Q Consensus 472 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~-------~~ 544 (673)
+..++|+||.+.|+|.+++. ..+.++|...+.++.|+++-+++||.+ +|||+||||+|.||.. ..
T Consensus 767 --~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~--~IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 767 --NASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM--GIIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred --CcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc--ceecccCCcceeEeecccCCCCccc
Confidence 56789999999999999997 456799999999999999999999998 7999999999999942 34
Q ss_pred Ceeeccccccccc---cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch
Q 005859 545 NPLLSDSGLHKLL---ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV 621 (673)
Q Consensus 545 ~~kl~DfGla~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~ 621 (673)
.++|+|||.+-.+ .+. ......++|-.+-.+|+..+..++..+|-|-+..+++-|+.|+.- . .+.+..
T Consensus 839 ~l~lIDfG~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-----q--~~~g~~ 909 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-----E--VKNGSS 909 (974)
T ss_pred ceEEEecccceeeeEcCCC--cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-----H--hcCCcc
Confidence 6899999998643 232 234456678889999999999999999999999999999999721 1 111111
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 622 EDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
. .++..++.-+..+... ++....|+.|-..=|...++...+++++.
T Consensus 910 ~-~~~~~~~Ry~~~~~W~---~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 910 W-MVKTNFPRYWKRDMWN---KFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred e-eccccchhhhhHHHHH---HHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 1 1111222222222223 34444455444444777777777777653
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.3e-18 Score=168.52 Aligned_cols=144 Identities=17% Similarity=0.136 Sum_probs=110.8
Q ss_pred CCccccccccCCcceEEEEE--EcCCcEEEEEEecccCCCC------------------c-----HHHHHHHHHHHhccC
Q 005859 403 CFSEANLLGKSSFSATYKGI--LRDGSVVAVKCIAKTSCKS------------------D-----EGEFLKGLKILTSLK 457 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~------------------~-----~~~~~~E~~~l~~l~ 457 (673)
.|.+.+.||+|+||.||+|. ..+|+.||||++....... . ...+.+|++++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788899999999999998 5679999999987543100 0 123568999999997
Q ss_pred CCC--ceeEeeEEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCC-cccCCcC
Q 005859 458 HEN--LASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG-LVHPNLS 534 (673)
Q Consensus 458 H~n--iv~l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-ivHrDlk 534 (673)
+.. +.+++++ ...++||||+++++|...... ...+.......++.|++.+++|||+. | |+|||||
T Consensus 109 ~~~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~--g~iiH~Dik 176 (237)
T smart00090 109 EAGVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE--GELVHGDLS 176 (237)
T ss_pred hcCCCCCeeeEe------cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc--CCEEeCCCC
Confidence 633 3444442 124799999999888765421 12355556788999999999999987 7 9999999
Q ss_pred CCCeEecCCCCeeeccccccccccC
Q 005859 535 AEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 535 ~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|+||+++ ++.++|+|||.+.....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccCC
Confidence 9999999 78999999999875443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=161.68 Aligned_cols=148 Identities=18% Similarity=0.143 Sum_probs=114.5
Q ss_pred HHHHHHHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCC---------------------CcHHHHHHHHHH
Q 005859 394 LEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCK---------------------SDEGEFLKGLKI 452 (673)
Q Consensus 394 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~ 452 (673)
++++......|...+.||+|+||.||++..++|+.||||++...... .....+.+|..+
T Consensus 7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 86 (198)
T cd05144 7 LHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA 86 (198)
T ss_pred HHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence 45555555568888999999999999999888999999987653210 011236778999
Q ss_pred HhccCCCC--ceeEeeEEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCccc
Q 005859 453 LTSLKHEN--LASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVH 530 (673)
Q Consensus 453 l~~l~H~n--iv~l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivH 530 (673)
+.++.|++ +...++. ...++||||+++++|.+.... .....++.+++.++.++|+. ||+|
T Consensus 87 l~~l~~~~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~--gi~H 148 (198)
T cd05144 87 LKALYEEGFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH--GIIH 148 (198)
T ss_pred HHHHHHcCCCCCceeec------CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC--CCCc
Confidence 99998874 4444432 335899999999999765420 23456889999999999986 8999
Q ss_pred CCcCCCCeEecCCCCeeeccccccccccC
Q 005859 531 PNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 531 rDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||||+||++++++.++|+|||++.....
T Consensus 149 ~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 149 GDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.3e-17 Score=160.99 Aligned_cols=135 Identities=13% Similarity=0.256 Sum_probs=110.1
Q ss_pred cccccCCcceEEEEEEcCCcEEEEEEecccCCCCc-------HHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSD-------EGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+.||+|++|.||+|.. +|..|++|+......... ...+.+|++++..+.|++|.....++... +..++||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP--ENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC--CCCEEEE
Confidence 4699999999999987 677899997654332111 23578899999999999987666665443 4578999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
||++|++|.+++... .+ .+..++.+++.+|.++|+. |++|||++|+||+++ ++.++|+|||.++.
T Consensus 79 e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~--~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA--GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC--CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999988521 12 7788999999999999987 899999999999999 78899999998864
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.5e-17 Score=186.16 Aligned_cols=150 Identities=30% Similarity=0.541 Sum_probs=110.1
Q ss_pred CCChhHHHHHHHHHHhcCCCCCCcCCCCCCCCCCCCC--CCceEEeCCC-----CCEEEEEecCCCcccccCccccCCCC
Q 005859 18 LSSTSEVDILMHIKDSLDPENRLLTSWAPNADPCSSD--SFDGVACDEN-----GRVANISLQGKGLSGEIPAAVGGLKS 90 (673)
Q Consensus 18 ~~~~~~~~~ll~~~~~~~~~~~~l~~w~~~~~~C~~~--~w~gv~c~~~-----~~v~~l~l~~~~l~g~~p~~~~~l~~ 90 (673)
...+.|.++|+.+|++++... ..+|. .++|... .|.||.|+.. ..|+.|+|++|+++|.+|..|+.|++
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~--~~~W~--g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~ 443 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPL--RFGWN--GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRH 443 (623)
T ss_pred ccCchHHHHHHHHHHhcCCcc--cCCCC--CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCC
Confidence 345678999999999985322 24795 3677532 6999999532 24788888888888888888888888
Q ss_pred CCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCc-cccCeeccc
Q 005859 91 LTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSL-RKLSVLALQ 169 (673)
Q Consensus 91 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~l~ 169 (673)
|+.|+|++|.|+|.+|..++.+++|+.|+|++|+++|.+|..+++|++|+.|+|++|+++|.+|..+..+ .++..+++.
T Consensus 444 L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~ 523 (623)
T PLN03150 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFT 523 (623)
T ss_pred CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEec
Confidence 8888888888888888878888888888888888887777777777777777777777777777766543 233344444
Q ss_pred cc
Q 005859 170 YN 171 (673)
Q Consensus 170 ~N 171 (673)
+|
T Consensus 524 ~N 525 (623)
T PLN03150 524 DN 525 (623)
T ss_pred CC
Confidence 44
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.1e-18 Score=187.66 Aligned_cols=208 Identities=21% Similarity=0.252 Sum_probs=146.8
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
..+|..++.|..|+||.||..+++. .+.+|+| +.+.. .+.+- ++.....|. .|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~------lilRn--ilt~a~npf-----------------vv 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN------LILRN--ILTFAGNPF-----------------VV 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc------hhhhc--cccccCCcc-----------------ee
Confidence 3578888999999999999999875 6778884 33321 11111 222222222 23
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
||-...+.. ...++. +++.+++|||+. ||+|||+||+|.+|..-|.+|+.|||+.+..-.
T Consensus 136 ------gDc~tllk~----~g~lPv--------dmvla~Eylh~y--givhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ------GDCATLLKN----IGPLPV--------DMVLAVEYLHSY--GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ------chhhhhccc----CCCCcc--------hhhHHhHhhccC--CeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 555555542 123332 237899999988 899999999999999999999999999875321
Q ss_pred c--------c------hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhc
Q 005859 560 D--------I------VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFI 625 (673)
Q Consensus 560 ~--------~------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~ 625 (673)
. . .+.....+||+.|+|||++..+.|...+|+|++|+|+||.+-|+.||.+....+.....+.+.
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~- 274 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD- 274 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh-
Confidence 0 0 112234589999999999999999999999999999999999999998764443332222221
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 005859 626 DPNLEGKFSVSEASNLGQIALHCTHESPSHRP 657 (673)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 657 (673)
....+-++..+.++.+++.+.++.+|..|-
T Consensus 275 --i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 275 --IEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred --ccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 111222445567899999999999999994
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.3e-17 Score=183.25 Aligned_cols=142 Identities=16% Similarity=0.222 Sum_probs=110.1
Q ss_pred HHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCC------cHHHHHHHHHHHhccCCCCceeEeeEEecCC
Q 005859 399 RATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKS------DEGEFLKGLKILTSLKHENLASLRGICCSKG 472 (673)
Q Consensus 399 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 472 (673)
.....|...+.||+|+||+||+|.+.+...++.+.+.+..... ..+.+.+|++++++++|++++....++...
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~- 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP- 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC-
Confidence 3344556678999999999999998654433332232211111 124688999999999999998877766543
Q ss_pred CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccc
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSG 552 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfG 552 (673)
+..++||||+++++|.+++. .+..++.|++++|+|||+. ||+|||+||+|||+ +++.++|+|||
T Consensus 409 -~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~--giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 409 -EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA--GIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred -CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC--CCccCCCChHHEEE-ECCcEEEEeCc
Confidence 45689999999999998874 3467899999999999987 89999999999999 57799999999
Q ss_pred ccccc
Q 005859 553 LHKLL 557 (673)
Q Consensus 553 la~~~ 557 (673)
+++..
T Consensus 473 la~~~ 477 (535)
T PRK09605 473 LGKYS 477 (535)
T ss_pred ccccC
Confidence 98753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.3e-17 Score=158.61 Aligned_cols=131 Identities=16% Similarity=0.253 Sum_probs=103.3
Q ss_pred ccccCCcceEEEEEEcCCcEEEEEEecccCCCCc-------HHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 409 LLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSD-------EGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 409 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
.||+|+||.||+|.+ +|..|++|+......... ...+.+|++++..++|+++.....++... +..++|||
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP--DNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC--CCCEEEEE
Confidence 489999999999985 578899998654322111 24577899999999988755444444333 45689999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
|++|++|.+++... .. .++.+++.+|.+||+. |++|||++|+||+++ ++.+++.|||+++.
T Consensus 78 ~~~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~--gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA--GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC--CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999887521 10 7899999999999987 899999999999999 78999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.9e-19 Score=182.98 Aligned_cols=190 Identities=22% Similarity=0.270 Sum_probs=160.0
Q ss_pred CEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeecc
Q 005859 66 RVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLC 145 (673)
Q Consensus 66 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 145 (673)
....|+|..|+++..-..++.+|+.|+.|+||+|.|....++++...++|++|+|++|+++...+..|..|..|++|+|+
T Consensus 270 kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs 349 (873)
T KOG4194|consen 270 KMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLS 349 (873)
T ss_pred ccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhccc
Confidence 56788888888887777788889999999999999998888888889999999999999997778889899999999999
Q ss_pred CccccccCchhhcCccccCeecccccccCccCCc---cccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCC
Q 005859 146 YNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPA---SLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFS 222 (673)
Q Consensus 146 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~---~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 222 (673)
+|+++..-...|..+++|++|||++|.|+..+-+ .|.+|++|+.|+|.+|+|....-.+|.+++.|+.|||.+|.|.
T Consensus 350 ~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Naia 429 (873)
T KOG4194|consen 350 HNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIA 429 (873)
T ss_pred ccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcce
Confidence 9999877777888999999999999999877665 4788999999999999999766778999999999999999999
Q ss_pred cCCchhhhhccC-CccccCcccccCCCccCCCCC
Q 005859 223 GNVPPALKRLNG-GFQYDNNAALCGTGFTNLKNC 255 (673)
Q Consensus 223 g~~p~~l~~~~~-~~~~~~n~~~~~~~~~~~~~~ 255 (673)
..-|.+|..+.- .+.+.....+|.+.+.++..+
T Consensus 430 SIq~nAFe~m~Lk~Lv~nSssflCDCql~Wl~qW 463 (873)
T KOG4194|consen 430 SIQPNAFEPMELKELVMNSSSFLCDCQLKWLAQW 463 (873)
T ss_pred eecccccccchhhhhhhcccceEEeccHHHHHHH
Confidence 888988877631 233445567888877665544
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.2e-17 Score=146.78 Aligned_cols=144 Identities=29% Similarity=0.518 Sum_probs=131.7
Q ss_pred ccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccC
Q 005859 85 VGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLS 164 (673)
Q Consensus 85 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 164 (673)
+.++++++.|-||+|+++ .+|+.+..|.+|+.|++++|++. .+|..++.|+.|+.|+++-|++. .+|..|++++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 557889999999999999 67888999999999999999998 78999999999999999999999 8999999999999
Q ss_pred eecccccccCc-cCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCchhhhhcc
Q 005859 165 VLALQYNQLTG-AIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233 (673)
Q Consensus 165 ~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~l~~~~ 233 (673)
.|||++|+++. .+|..|..+..|+.|+|++|.+. .+|..++++++|+.|.++.|.+- .+|..++.+.
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt 173 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLT 173 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHH
Confidence 99999999964 68999999999999999999987 68889999999999999999987 4787776543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.2e-15 Score=145.07 Aligned_cols=138 Identities=18% Similarity=0.179 Sum_probs=99.0
Q ss_pred ccccccCCcceEEEEEEcCCcEEEEEEecccCCCC-cHHH----------------------HHHHHHHHhccCCCC--c
Q 005859 407 ANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKS-DEGE----------------------FLKGLKILTSLKHEN--L 461 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~----------------------~~~E~~~l~~l~H~n--i 461 (673)
.+.||+|+||+||+|...+|+.||||++....... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 35799999999999998889999999987543211 1111 135666666665443 4
Q ss_pred eeEeeEEecCCCCeEEEEEeecCCCChhhh-hccccCCccccCHHHHHHHHHHHHHHHHHHhc-CCCCcccCCcCCCCeE
Q 005859 462 ASLRGICCSKGRGECFLIYDFVPNGNLLQH-LDLEAGSEKVLEWATRISVIKGIAKGISYLHG-KRPGLVHPNLSAEKVL 539 (673)
Q Consensus 462 v~l~~~~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~ivHrDlk~~NIL 539 (673)
.+.+++ ...++||||++++.+... +... ... ..+..++.+++.++.++|. . ||+||||||+||+
T Consensus 82 ~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~--~ivH~Dl~p~Nil 147 (187)
T cd05119 82 PKPIDL------NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREA--GLVHGDLSEYNIL 147 (187)
T ss_pred CceEec------CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhcc--CcCcCCCChhhEE
Confidence 444432 234899999998654321 1100 011 5677899999999999998 5 8999999999999
Q ss_pred ecCCCCeeeccccccccccC
Q 005859 540 IHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 540 l~~~~~~kl~DfGla~~~~~ 559 (673)
++ ++.++++|||.+.....
T Consensus 148 i~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred EE-CCcEEEEECcccccccC
Confidence 99 88999999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=9.7e-17 Score=178.78 Aligned_cols=254 Identities=18% Similarity=0.223 Sum_probs=184.8
Q ss_pred cCCccccccccCCcceEEEEEEcC--CcEEEEEEecccC-CCCcHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCeEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD--GSVVAVKCIAKTS-CKSDEGEFLKGLKILTSLK-HENLASLRGICCSKGRGECF 477 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~ 477 (673)
..|...+.||+|+|+.|-...... ...+|+|.+.... ..........|..+-..+. |+|++++++.. ..++..+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~--~~~~~~~ 97 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS--SSPRSYL 97 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc--CCCcccc
Confidence 345566679999999998877543 4456777665443 1112234445777777776 99999999987 4457889
Q ss_pred EEEeecCCCChhhhh-ccccCCccccCHHHHHHHHHHHHHHHHHHh-cCCCCcccCCcCCCCeEecCCC-Ceeecccccc
Q 005859 478 LIYDFVPNGNLLQHL-DLEAGSEKVLEWATRISVIKGIAKGISYLH-GKRPGLVHPNLSAEKVLIHRRY-NPLLSDSGLH 554 (673)
Q Consensus 478 lv~E~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~ivHrDlk~~NILl~~~~-~~kl~DfGla 554 (673)
+++||.++|++.+.+ +.. ....+......+..|+..|+.|+| +. ++.|||+||+|.+++..+ ..|++|||+|
T Consensus 98 ~~~~~s~g~~~f~~i~~~~---~~~~~~~~~~~~~~ql~s~l~~~H~~~--~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPD---STGTSSSSASRYLPQLNSGLSYLHPEN--GVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred cccCcccccccccccccCC---ccCCCCcchhhhhhhhccCccccCccc--ccccCCCCCccchhccCCCcccCCCchhh
Confidence 999999999999888 421 113455567788999999999999 66 899999999999999999 9999999999
Q ss_pred ccccC--cchhhhhccCC-CCCccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCC
Q 005859 555 KLLAD--DIVFSMLKASA-AMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLE 630 (673)
Q Consensus 555 ~~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~~-~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 630 (673)
..+.. +........+| ++.|+|||...+.. ..+..|+||.|+++.-+++|..|+............+.+.-. ...
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~ 251 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKG-RFT 251 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccc-ccc
Confidence 87765 33334445677 99999999998854 467899999999999999999987543322211111111110 111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 005859 631 GKFSVSEASNLGQIALHCTHESPSHRPSIENVM 663 (673)
Q Consensus 631 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl 663 (673)
............++..+++..+|++|.+.+++.
T Consensus 252 ~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 252 QLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cCccccCChhhhhcccccccCCchhcccccccc
Confidence 122334456677888999999999999987764
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.6e-17 Score=161.49 Aligned_cols=200 Identities=23% Similarity=0.256 Sum_probs=149.1
Q ss_pred eEEeCCC----------CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccC-CCCC
Q 005859 58 GVACDEN----------GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNV-NNLS 126 (673)
Q Consensus 58 gv~c~~~----------~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~ 126 (673)
-|.|+.. ...+.|+|..|+|+-..|.+|+.+++|+.||||+|+|+.+-|+.|.+|++|..|-+.+ |+|+
T Consensus 50 ~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~ 129 (498)
T KOG4237|consen 50 IVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT 129 (498)
T ss_pred eEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh
Confidence 4778653 3689999999999987778999999999999999999999999999999988887766 8887
Q ss_pred CCCcccccCCCCCcEe------------------------------------------------eccCcccc--------
Q 005859 127 GKIPSQIGNMTNLQVL------------------------------------------------QLCYNKLT-------- 150 (673)
Q Consensus 127 ~~~p~~~~~l~~L~~L------------------------------------------------~L~~N~l~-------- 150 (673)
...-..|++|.+|+.| ++..|.+.
T Consensus 130 ~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wl 209 (498)
T KOG4237|consen 130 DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWL 209 (498)
T ss_pred hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchh
Confidence 4333334443333333 33322210
Q ss_pred -----------------------------------------------------ccCc-hhhcCccccCeecccccccCcc
Q 005859 151 -----------------------------------------------------GNIP-TQLGSLRKLSVLALQYNQLTGA 176 (673)
Q Consensus 151 -----------------------------------------------------~~~p-~~l~~l~~L~~L~l~~N~l~~~ 176 (673)
+..| ..|..|++|+.|+|++|+++++
T Consensus 210 a~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i 289 (498)
T KOG4237|consen 210 ADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRI 289 (498)
T ss_pred hhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchh
Confidence 0011 1245668888888888888888
Q ss_pred CCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCchhhhhccC--CccccCcccccCCCccCCCC
Q 005859 177 IPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNG--GFQYDNNAALCGTGFTNLKN 254 (673)
Q Consensus 177 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~--~~~~~~n~~~~~~~~~~~~~ 254 (673)
-+.+|..+..++.|+|..|+|...-...|.++..|+.|+|.+|+|+..-|.+|..+.. .+.+..|+..|...+.++..
T Consensus 290 ~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~ 369 (498)
T KOG4237|consen 290 EDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE 369 (498)
T ss_pred hhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH
Confidence 8888888888888888888887666667888889999999999999888888866532 34456788889888776655
Q ss_pred CCC
Q 005859 255 CTA 257 (673)
Q Consensus 255 ~~~ 257 (673)
|..
T Consensus 370 Wlr 372 (498)
T KOG4237|consen 370 WLR 372 (498)
T ss_pred HHh
Confidence 543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.7e-15 Score=136.27 Aligned_cols=135 Identities=15% Similarity=0.094 Sum_probs=111.1
Q ss_pred cccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCC--CCceeEeeEEecCCCCeEEEEEeec
Q 005859 406 EANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKH--ENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 406 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++++++++... .+..+++|||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEEec
Confidence 34679999999999999865 7899998865432 4678999999999976 588898887743 36789999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCC-CCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR-PGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+++.+..+ +......++.+++++++++|... .+++|+|++|+||++++.+.+++.|||.++..
T Consensus 76 ~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 76 EGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred CCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 88777543 45666778999999999999842 47999999999999999899999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.8e-16 Score=160.50 Aligned_cols=166 Identities=22% Similarity=0.208 Sum_probs=143.0
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..+..|+|++|.++..--..|.+|.+|.+|.|+.|+++...+..|.+|++|+.|+|..|+|.-.---.|.+|++|+.|.|
T Consensus 173 ~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlkl 252 (873)
T KOG4194|consen 173 VNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKL 252 (873)
T ss_pred CCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhh
Confidence 46889999999998777778999999999999999999888888888999999999999987433557888999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
..|.+...-...|-.|.++++|+|..|+++..--.++.++++|+.|+||+|.|....++.+.-.++|+.|+|++|+|+.-
T Consensus 253 qrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l 332 (873)
T KOG4194|consen 253 QRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRL 332 (873)
T ss_pred hhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccC
Confidence 99999877778888899999999999999877777888899999999999999888888888888999999999999877
Q ss_pred Cchhhh
Q 005859 225 VPPALK 230 (673)
Q Consensus 225 ~p~~l~ 230 (673)
-+++|.
T Consensus 333 ~~~sf~ 338 (873)
T KOG4194|consen 333 DEGSFR 338 (873)
T ss_pred ChhHHH
Confidence 776664
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.7e-15 Score=145.44 Aligned_cols=139 Identities=15% Similarity=0.155 Sum_probs=105.4
Q ss_pred ccccc-cCCcceEEEEEEcCCcEEEEEEecccCC------------CCcHHHHHHHHHHHhccCCCCc--eeEeeEEecC
Q 005859 407 ANLLG-KSSFSATYKGILRDGSVVAVKCIAKTSC------------KSDEGEFLKGLKILTSLKHENL--ASLRGICCSK 471 (673)
Q Consensus 407 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~ 471 (673)
...|| .|+.|+||++... +..++||.+..... ......+.+|++++.++.|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 7899999999875 67789998854221 1123467889999999998885 6677664332
Q ss_pred CCC--eEEEEEeecCC-CChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeee
Q 005859 472 GRG--ECFLIYDFVPN-GNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLL 548 (673)
Q Consensus 472 ~~~--~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl 548 (673)
... ..++||||+++ .+|.+++.. ..++.. .+.+++.+|.+||+. ||+||||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~--GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA--GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC--CCCCCCCCchhEEEcCCCCEEE
Confidence 211 23599999997 689888752 234433 357899999999988 8999999999999999889999
Q ss_pred ccccccccc
Q 005859 549 SDSGLHKLL 557 (673)
Q Consensus 549 ~DfGla~~~ 557 (673)
+|||.++..
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.5e-15 Score=148.67 Aligned_cols=207 Identities=22% Similarity=0.279 Sum_probs=143.9
Q ss_pred HHHHhccCCCCceeEeeEEecCC---CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCC
Q 005859 450 LKILTSLKHENLASLRGICCSKG---RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526 (673)
Q Consensus 450 ~~~l~~l~H~niv~l~~~~~~~~---~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 526 (673)
..-+-++.|.|||+++.|+.+.. ..+..++.|||+.|++.++|+..+.....+......+++.||..||.|||++.|
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 45566778999999999986643 346789999999999999998665555667777788899999999999999999
Q ss_pred CcccCCcCCCCeEecCCCCeeeccccccccc---cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh
Q 005859 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL---ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS 603 (673)
Q Consensus 527 ~ivHrDlk~~NILl~~~~~~kl~DfGla~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t 603 (673)
.|+|+++..+-|++..++-+||.----.... ............+-++|.|||+-.....+.++|||+||+..+||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999988887532111100 0000011112345678999998887778899999999999999988
Q ss_pred CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 604 GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 604 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+..--................+. .+.. ..=+.++.+|++..|..||+|++++.
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~-~len-------~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVII-GLEN-------GLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCcceeehhhhhhhhee-eccC-------ccccCcCcccccCCCCCCcchhhhhc
Confidence 76321111111000101111000 0000 11135678999999999999998763
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.59 E-value=9.8e-17 Score=167.96 Aligned_cols=163 Identities=30% Similarity=0.406 Sum_probs=113.9
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..++-|||++|.|. +.|..+..-+++-.|+||+|+|..++.+.|.+|+.|-+||||+|++. .+|+.+..|.+|++|+|
T Consensus 103 ~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~L 180 (1255)
T KOG0444|consen 103 KDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKL 180 (1255)
T ss_pred ccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhc
Confidence 45778888888887 67888888888888888888887555556678888888888888887 67777778888888888
Q ss_pred cCcccc-------------------------ccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCC
Q 005859 145 CYNKLT-------------------------GNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFG 199 (673)
Q Consensus 145 ~~N~l~-------------------------~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 199 (673)
++|.+. ..+|.++.++.+|..+|||.|.+. .+|+.+.++.+|+.|+||+|+|+.
T Consensus 181 s~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite 259 (1255)
T KOG0444|consen 181 SNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE 259 (1255)
T ss_pred CCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee
Confidence 887764 235666666667777777777776 666666666666666666666653
Q ss_pred CCcccccCCCCCCEEEccCCCCCcCCchhhhhc
Q 005859 200 PVPVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232 (673)
Q Consensus 200 ~~p~~~~~l~~L~~L~l~~N~l~g~~p~~l~~~ 232 (673)
+........+|+.|+|+.|+++ .+|++++.+
T Consensus 260 -L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL 290 (1255)
T KOG0444|consen 260 -LNMTEGEWENLETLNLSRNQLT-VLPDAVCKL 290 (1255)
T ss_pred -eeccHHHHhhhhhhccccchhc-cchHHHhhh
Confidence 2233334445666666666665 466666544
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.3e-16 Score=163.18 Aligned_cols=155 Identities=34% Similarity=0.413 Sum_probs=134.0
Q ss_pred CEEEEEecCCCccc-ccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 66 RVANISLQGKGLSG-EIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 66 ~v~~l~l~~~~l~g-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
++.++.+..|+|.. -||+.+..|..|+.||||+|++. ..|..+..-+++-.|+||+|+|..+.-+-|-+|+.|-+|||
T Consensus 79 ~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDL 157 (1255)
T KOG0444|consen 79 RLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDL 157 (1255)
T ss_pred hhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhcc
Confidence 45566777777754 48899999999999999999998 68889999999999999999999544456789999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccC-------------------------ccCCccccCCCcccccccccccCCC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLT-------------------------GAIPASLGDLGMLMRLDLSFNNLFG 199 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~-------------------------~~~p~~~~~l~~L~~L~l~~N~l~~ 199 (673)
|+|++. .+|+.+..|..|++|+|++|.+. ..+|.++..+.+|..+|||.|+|.
T Consensus 158 S~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp- 235 (1255)
T KOG0444|consen 158 SNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP- 235 (1255)
T ss_pred ccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-
Confidence 999999 68888999999999999999764 246777888889999999999997
Q ss_pred CCcccccCCCCCCEEEccCCCCCc
Q 005859 200 PVPVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 200 ~~p~~~~~l~~L~~L~l~~N~l~g 223 (673)
.+|..+.++++|+.|+|++|.|+-
T Consensus 236 ~vPecly~l~~LrrLNLS~N~ite 259 (1255)
T KOG0444|consen 236 IVPECLYKLRNLRRLNLSGNKITE 259 (1255)
T ss_pred cchHHHhhhhhhheeccCcCceee
Confidence 789999999999999999999874
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=6.4e-14 Score=158.56 Aligned_cols=110 Identities=38% Similarity=0.643 Sum_probs=99.2
Q ss_pred CCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEcc
Q 005859 138 NLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIR 217 (673)
Q Consensus 138 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 217 (673)
.++.|+|++|.+.|.+|..++.+++|+.|+|++|.|+|.+|..++.+++|+.|+|++|+++|.+|..+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcCCchhhhhcc---CCccccCcccccCC
Q 005859 218 NNSFSGNVPPALKRLN---GGFQYDNNAALCGT 247 (673)
Q Consensus 218 ~N~l~g~~p~~l~~~~---~~~~~~~n~~~~~~ 247 (673)
+|+|+|.+|..+.... ..+.+.+|..+|+.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~ 531 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGI 531 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCC
Confidence 9999999999886532 13456677777763
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.1e-15 Score=148.92 Aligned_cols=157 Identities=30% Similarity=0.469 Sum_probs=138.2
Q ss_pred CEEEEEecCCCcccccCccccCCCCCCeE-eCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 66 RVANISLQGKGLSGEIPAAVGGLKSLTGL-YLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 66 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L-~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
-|+.++++.|.+. ++|..+..++.+.+. .+++|.+ +.+|..++.+++|..|+|++|-+. .+|..++.+..|+.|++
T Consensus 389 ~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~Lnl 465 (565)
T KOG0472|consen 389 IVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNL 465 (565)
T ss_pred ceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecc
Confidence 3999999999987 789888888887655 4555555 588999999999999999999998 78999999999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
+.|+|. .+|..+-.+..|+.+-.++|++....|+.+.+|.+|..|||.+|.+. .+|..+++|.+|++|++.+|+|.
T Consensus 466 S~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr-- 541 (565)
T KOG0472|consen 466 SFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR-- 541 (565)
T ss_pred cccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC--
Confidence 999998 78998888888999999999998666667999999999999999998 68889999999999999999998
Q ss_pred Cchhh
Q 005859 225 VPPAL 229 (673)
Q Consensus 225 ~p~~l 229 (673)
.|...
T Consensus 542 ~Pr~~ 546 (565)
T KOG0472|consen 542 QPRHQ 546 (565)
T ss_pred CCHHH
Confidence 56543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=2e-13 Score=147.71 Aligned_cols=143 Identities=17% Similarity=0.231 Sum_probs=101.9
Q ss_pred cccccCCcceEEEEEEcCCcEEEEEEecccCCCC-------------------------c--------------HHHHHH
Q 005859 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKS-------------------------D--------------EGEFLK 448 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------~--------------~~~~~~ 448 (673)
+.||.|++|.||+|++++|+.||||+.+....+. + +-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999999999999999986542100 0 012555
Q ss_pred HHHHHhccC----CCCceeEeeEEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHH-HHHHHhc
Q 005859 449 GLKILTSLK----HENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAK-GISYLHG 523 (673)
Q Consensus 449 E~~~l~~l~----H~niv~l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~ 523 (673)
|++.+.+++ |.+-+.+-.++.+- ....++||||++|++|.++...... .. .+.+++.+++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHh
Confidence 666666652 33334443444322 2346899999999999887653211 12 23456666666 4678887
Q ss_pred CCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 524 KRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 524 ~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
. |++|+|+||.||++++++.+++.|||++..+..
T Consensus 276 ~--g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D--GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C--CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 6 899999999999999999999999999987764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.4e-15 Score=152.34 Aligned_cols=158 Identities=30% Similarity=0.432 Sum_probs=110.0
Q ss_pred EEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccC
Q 005859 67 VANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCY 146 (673)
Q Consensus 67 v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 146 (673)
...++..+|+++ .+|+.++.+..|..|++.+|+++...|..+. ++.|++||..+|-+. .+|+.++.|.+|..|+|..
T Consensus 139 l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~ 215 (565)
T KOG0472|consen 139 LEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRR 215 (565)
T ss_pred hhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhh
Confidence 344555566665 5666777777777777777777755555444 777777777777766 6777777777777777777
Q ss_pred ccccccCchhhcCccccCeecccccccCccCCcccc-CCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCC
Q 005859 147 NKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLG-DLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNV 225 (673)
Q Consensus 147 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~ 225 (673)
|++. .+| +|.++..|.+|+++.|++. .+|.... ++++|..|||.+|++. ..|..+.-+.+|+.||+++|.+++ +
T Consensus 216 Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-L 290 (565)
T KOG0472|consen 216 NKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-L 290 (565)
T ss_pred cccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-C
Confidence 7777 556 6777777777777777776 5666544 7777777777777776 567777777777777777777775 4
Q ss_pred chhhhhc
Q 005859 226 PPALKRL 232 (673)
Q Consensus 226 p~~l~~~ 232 (673)
|.+++++
T Consensus 291 p~sLgnl 297 (565)
T KOG0472|consen 291 PYSLGNL 297 (565)
T ss_pred Ccccccc
Confidence 5555544
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.6e-12 Score=147.06 Aligned_cols=111 Identities=24% Similarity=0.361 Sum_probs=74.6
Q ss_pred CCCEEEccCCCCCCCCcccccC-----------------CCCCcEeeccCccccccCchhhcCccccCeecccccccCcc
Q 005859 114 ELSDLYLNVNNLSGKIPSQIGN-----------------MTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGA 176 (673)
Q Consensus 114 ~L~~L~l~~N~l~~~~p~~~~~-----------------l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~ 176 (673)
+|++|+|++|+|++ +|....+ ..+|+.|+|++|+|++ +|.. .++|+.|++++|+|++
T Consensus 343 ~Lq~LdLS~N~Ls~-LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss- 416 (788)
T PRK15387 343 GLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS- 416 (788)
T ss_pred ccceEecCCCccCC-CCCCCcccceehhhccccccCcccccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-
Confidence 56677777777763 3432111 1356666666666663 4432 2467777777777763
Q ss_pred CCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCchhhhhccC
Q 005859 177 IPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNG 234 (673)
Q Consensus 177 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~ 234 (673)
+|.. ..+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|+|.+|..+..+..
T Consensus 417 IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l~s 470 (788)
T PRK15387 417 LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITS 470 (788)
T ss_pred CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHHhc
Confidence 5543 246778888888887 57888888888999999999999888888766543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.1e-12 Score=140.04 Aligned_cols=148 Identities=15% Similarity=0.175 Sum_probs=97.9
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCC---------------------C----c--------H---
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCK---------------------S----D--------E--- 443 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---------------------~----~--------~--- 443 (673)
-..|+. +.||.|++|.||+|++++ |+.||||+.++.... . + .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 689999999999999988 999999999754210 0 0 0
Q ss_pred ---HHHHHHHHHHhccC----CCCceeEeeEEecCCCCeEEEEEeecCCCChhhhhcccc-C-CccccCHHHHHHHHHHH
Q 005859 444 ---GEFLKGLKILTSLK----HENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEA-G-SEKVLEWATRISVIKGI 514 (673)
Q Consensus 444 ---~~~~~E~~~l~~l~----H~niv~l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~-~~~~l~~~~~~~i~~~i 514 (673)
-+|.+|+..+.+++ +.+.+.+-.++.+- ....+|||||++|+.+.++-.... + ....+.......++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 12455665555552 44444444444322 234689999999999987432111 1 11123333333444444
Q ss_pred HHHHHHHhcCCCCcccCCcCCCCeEecCCC----CeeeccccccccccC
Q 005859 515 AKGISYLHGKRPGLVHPNLSAEKVLIHRRY----NPLLSDSGLHKLLAD 559 (673)
Q Consensus 515 a~gL~yLH~~~~~ivHrDlk~~NILl~~~~----~~kl~DfGla~~~~~ 559 (673)
. .. |++|+|+||.||+++.++ .+++.|||+...++.
T Consensus 277 f-------~~--GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 F-------RD--GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------hC--CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3 23 899999999999999988 899999999987754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.6e-12 Score=136.97 Aligned_cols=248 Identities=19% Similarity=0.188 Sum_probs=174.7
Q ss_pred CCcccccccc--CCcceEEEEEE--c-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCe
Q 005859 403 CFSEANLLGK--SSFSATYKGIL--R-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGE 475 (673)
Q Consensus 403 ~~~~~~~lg~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 475 (673)
.|.....+|. |.+|.||.+.. . ++..+|+|.-+.... ......=.+|+...+++ .|+|.++.+..+ .+.+.
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~--e~~~~ 192 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW--EGSGI 192 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc--ccCCc
Confidence 3455677899 99999999987 3 478899987443221 12223345666666677 499999987777 44577
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHH----HHHHHhcCCCCcccCCcCCCCeEecCC-CCeeecc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAK----GISYLHGKRPGLVHPNLSAEKVLIHRR-YNPLLSD 550 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~ivHrDlk~~NILl~~~-~~~kl~D 550 (673)
.++-+|++ +.+|.++.+.. ...++....+.+..+..+ |+.++|+. +|+|-|+||.||+..++ ...++.|
T Consensus 193 lfiqtE~~-~~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~--~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN--NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred ceeeeccc-cchhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC--cccccccchhheecccccceeecCC
Confidence 88889998 57888887632 233666677778888888 99999987 79999999999999999 8899999
Q ss_pred ccccccccCcchhhh----hccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcC
Q 005859 551 SGLHKLLADDIVFSM----LKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFID 626 (673)
Q Consensus 551 fGla~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~ 626 (673)
||+...+.+...... ....+...|++||... +.++.+.||||+|.+..|..+|-......... .|. .....
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~-~~r~~-- 341 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS-SWS-QLRQG-- 341 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC-Ccc-ccccc--
Confidence 999988766542211 1224667799999875 46889999999999999999887554322100 011 11111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 627 PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 627 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+..++......++...+..+++.+|-.|++++++..
T Consensus 342 -~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 342 -YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1222232233345556888899999999999887653
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.30 E-value=8.2e-14 Score=145.52 Aligned_cols=137 Identities=34% Similarity=0.559 Sum_probs=97.7
Q ss_pred ccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcC
Q 005859 80 EIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGS 159 (673)
Q Consensus 80 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 159 (673)
.+|..+++|..|++|||+.|+++ .+|..++.|+ |+.|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++.
T Consensus 112 ~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~ 187 (722)
T KOG0532|consen 112 TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGY 187 (722)
T ss_pred ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhh
Confidence 46666777777777777777776 4555566554 667777777766 66777776677777777777777 56777777
Q ss_pred ccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCc
Q 005859 160 LRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 160 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 223 (673)
+.+|+.|++..|++. .+|..+..| .|..||+|+|+++ .+|..|.+|..|++|-|.+|+|..
T Consensus 188 l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 188 LTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred HHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC
Confidence 777777777777776 466666643 4777888888877 577778888888888888888874
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.1e-12 Score=143.91 Aligned_cols=140 Identities=28% Similarity=0.483 Sum_probs=91.4
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..+..|+|++|.|+ .+|..+. .+|+.|+|++|++. .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|
T Consensus 220 ~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~L 290 (754)
T PRK15370 220 GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSV 290 (754)
T ss_pred cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEEC
Confidence 46788889888887 4666553 46888888888887 5666554 47888888888887 4676553 47888888
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFS 222 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 222 (673)
++|+|++ +|..+. ++|+.|++++|.++. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|++++|+|+
T Consensus 291 s~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~ 359 (754)
T PRK15370 291 YDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT 359 (754)
T ss_pred CCCcccc-Ccccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC
Confidence 8888874 454332 356666666666663 444332 456666666666654 443332 45666666666655
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.7e-11 Score=115.80 Aligned_cols=129 Identities=15% Similarity=0.059 Sum_probs=95.1
Q ss_pred cccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCce-eEeeEEecCCCCeEEEEEeecCCC
Q 005859 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLA-SLRGICCSKGRGECFLIYDFVPNG 486 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~~~lv~E~~~~g 486 (673)
+.|+.|.++.||+++.. ++.|++|....... ....+.+|+++++.+.+.+++ +++.+. . ...++||||++|.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~--~~~~lv~e~i~G~ 76 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--P--ETGVLITEFIEGS 76 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--C--CCCeEEEEecCCC
Confidence 46889999999999875 77899998755421 223567899999998665554 444433 2 2347999999998
Q ss_pred ChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCC---CCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 487 NLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR---PGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 487 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++.+.- . ....++.+++++|+.||... .+++|+|++|.||+++ ++.+++.|||.+..
T Consensus 77 ~l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 77 ELLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 876430 0 11235678999999999862 2369999999999999 56899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.2e-11 Score=140.90 Aligned_cols=118 Identities=29% Similarity=0.497 Sum_probs=55.6
Q ss_pred CEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeecc
Q 005859 66 RVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLC 145 (673)
Q Consensus 66 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 145 (673)
..+.|++++++++ .+|..+. ++|+.|+|++|+|+. +|..+. ++|+.|++++|+|+ .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 3455555555555 2444332 345555555555552 333332 35555555555555 3344332 245555555
Q ss_pred CccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCC
Q 005859 146 YNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLF 198 (673)
Q Consensus 146 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 198 (673)
+|++. .+|..+. ++|+.|++++|+|+ .+|..+. ++|+.|+|++|+|+
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt 296 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR 296 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc
Confidence 55554 3444332 24555555555554 3444332 24555555555544
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.25 E-value=6.1e-13 Score=139.13 Aligned_cols=168 Identities=32% Similarity=0.499 Sum_probs=147.4
Q ss_pred CEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeecc
Q 005859 66 RVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLC 145 (673)
Q Consensus 66 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 145 (673)
..+..||+.|.++ ++|.+++.+..|+.|.|.+|.|. .+|..+.+|..|++|||+.|+++ .+|..+..| -|+.|-++
T Consensus 76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~l-pLkvli~s 151 (722)
T KOG0532|consen 76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDL-PLKVLIVS 151 (722)
T ss_pred chhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcC-cceeEEEe
Confidence 3566788888887 89999999999999999999998 78999999999999999999999 778877765 49999999
Q ss_pred CccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCC
Q 005859 146 YNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNV 225 (673)
Q Consensus 146 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~ 225 (673)
+|+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++. .+|..+..++ |..||++.|+++ .+
T Consensus 152 NNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~i 226 (722)
T KOG0532|consen 152 NNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YL 226 (722)
T ss_pred cCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-ec
Confidence 99999 78999999999999999999998 78889999999999999999998 4677777665 899999999998 68
Q ss_pred chhhhhccC--CccccCcc
Q 005859 226 PPALKRLNG--GFQYDNNA 242 (673)
Q Consensus 226 p~~l~~~~~--~~~~~~n~ 242 (673)
|-.|.+|.. .+++++|+
T Consensus 227 Pv~fr~m~~Lq~l~LenNP 245 (722)
T KOG0532|consen 227 PVDFRKMRHLQVLQLENNP 245 (722)
T ss_pred chhhhhhhhheeeeeccCC
Confidence 988887753 34456665
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=8.7e-13 Score=145.18 Aligned_cols=150 Identities=32% Similarity=0.455 Sum_probs=93.6
Q ss_pred CEEEEEecCCCcccccCcc-cc-------------------------CCCCCCeEeCcCCcCCccCCcccCCCCCCCEEE
Q 005859 66 RVANISLQGKGLSGEIPAA-VG-------------------------GLKSLTGLYLHFNALNGVIPKEIASLSELSDLY 119 (673)
Q Consensus 66 ~v~~l~l~~~~l~g~~p~~-~~-------------------------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 119 (673)
.+..|+|+.|+|.. +|+. +. .++.|+.|+|.+|+|+...-+.+.+.++|+.|+
T Consensus 311 sL~tLdL~~N~L~~-lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLh 389 (1081)
T KOG0618|consen 311 SLRTLDLQSNNLPS-LPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLH 389 (1081)
T ss_pred eeeeeeehhccccc-cchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeee
Confidence 47889999998863 3322 11 234455566666666655555566666777777
Q ss_pred ccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCC
Q 005859 120 LNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFG 199 (673)
Q Consensus 120 l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 199 (673)
|++|++.......+.++..|+.|+||+|+|+ .+|..+..++.|++|...+|++. .+| .+..+++|+.+|+|.|+|+.
T Consensus 390 LsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~ 466 (1081)
T KOG0618|consen 390 LSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSE 466 (1081)
T ss_pred ecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhh
Confidence 7777666333334666666777777777776 56666666777777777777766 455 56666777777777776654
Q ss_pred C-CcccccCCCCCCEEEccCCC
Q 005859 200 P-VPVKLANVPKLEVLDIRNNS 220 (673)
Q Consensus 200 ~-~p~~~~~l~~L~~L~l~~N~ 220 (673)
. +|.... .++|++|||++|.
T Consensus 467 ~~l~~~~p-~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 467 VTLPEALP-SPNLKYLDLSGNT 487 (1081)
T ss_pred hhhhhhCC-CcccceeeccCCc
Confidence 3 233222 2667777777765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=8.7e-12 Score=133.06 Aligned_cols=249 Identities=17% Similarity=0.166 Sum_probs=172.2
Q ss_pred HHHhcCCccccccccCCcceEEEEEEc--CCcEEEEEEecccCCCCcHH-HHHHHHHHHhcc-CCCCceeEeeEEecCCC
Q 005859 398 ERATQCFSEANLLGKSSFSATYKGILR--DGSVVAVKCIAKTSCKSDEG-EFLKGLKILTSL-KHENLASLRGICCSKGR 473 (673)
Q Consensus 398 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~-~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 473 (673)
...+.+|.....||.|.|+.|++...+ ++..+++|.+.+.......+ .-..|+-+...+ .|.++++++..+...
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~-- 338 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL-- 338 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc--
Confidence 345567888999999999999998755 47789999887765433322 234566666666 588888877666433
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC-CCeeecccc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR-YNPLLSDSG 552 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~-~~~kl~DfG 552 (673)
+..|+--|||+++++..... ....++...++++..|++.++.++|+. .++|+|+||+||++..+ +.-++.|||
T Consensus 339 r~~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~--~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK--LFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred ccccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch--hhhcccccccceeeccchhhhhccccc
Confidence 45678999999998876552 224577788899999999999999987 69999999999999886 778999999
Q ss_pred ccccccCcchhhhhccCCCCCc-cCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCC
Q 005859 553 LHKLLADDIVFSMLKASAAMGY-LAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEG 631 (673)
Q Consensus 553 la~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 631 (673)
.+..+.-. ..........| .+++......+-.+.|+||||..+.|.++|..--.... ....+....-+..
T Consensus 413 ~~t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~-- 483 (524)
T KOG0601|consen 413 CWTRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNL-- 483 (524)
T ss_pred ccccccee---cccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccccCC--
Confidence 98643211 11111222234 25555556678899999999999999999863221111 1111111111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 005859 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQEL 666 (673)
Q Consensus 632 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 666 (673)
+... .++..+...+...++..||.+.+.....
T Consensus 484 --~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 484 --PGLK-LQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred --CchH-HhhhhhhhhhcCCccccchhhhhhcccc
Confidence 1112 5666777788899999999988876543
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=7.5e-13 Score=145.68 Aligned_cols=140 Identities=37% Similarity=0.565 Sum_probs=116.5
Q ss_pred ccCccccCCCCCCeEeCcCCcCCccCCccc-C-------------------------CCCCCCEEEccCCCCCCCCcccc
Q 005859 80 EIPAAVGGLKSLTGLYLHFNALNGVIPKEI-A-------------------------SLSELSDLYLNVNNLSGKIPSQI 133 (673)
Q Consensus 80 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~-------------------------~l~~L~~L~l~~N~l~~~~p~~~ 133 (673)
.+|+...++++|++|+|..|+|.. +|+.+ . .++.|+.|++.+|.|+...-+.|
T Consensus 301 yip~~le~~~sL~tLdL~~N~L~~-lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l 379 (1081)
T KOG0618|consen 301 YIPPFLEGLKSLRTLDLQSNNLPS-LPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVL 379 (1081)
T ss_pred hCCCcccccceeeeeeehhccccc-cchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhh
Confidence 467777788899999999998874 34321 1 12337788888888887777778
Q ss_pred cCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCE
Q 005859 134 GNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEV 213 (673)
Q Consensus 134 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 213 (673)
.++.+|++|+|++|+|.......+.++..|++|+||+|+|+ .+|..+.+++.|+.|...+|+|. ..| .+..++.|+.
T Consensus 380 ~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~ 456 (1081)
T KOG0618|consen 380 VNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKV 456 (1081)
T ss_pred ccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceE
Confidence 88999999999999999544457889999999999999998 78999999999999999999998 567 7899999999
Q ss_pred EEccCCCCCc
Q 005859 214 LDIRNNSFSG 223 (673)
Q Consensus 214 L~l~~N~l~g 223 (673)
+|++.|+|+-
T Consensus 457 lDlS~N~L~~ 466 (1081)
T KOG0618|consen 457 LDLSCNNLSE 466 (1081)
T ss_pred Eecccchhhh
Confidence 9999999974
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.1e-10 Score=123.52 Aligned_cols=167 Identities=19% Similarity=0.186 Sum_probs=120.8
Q ss_pred EcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCCCChhhhhccccCCcccc
Q 005859 423 LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVL 502 (673)
Q Consensus 423 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l 502 (673)
..++.+|.|...+.... ...+...+.++.|+.++||||++++..+.. .+..|||+|-+. -|..++.. +
T Consensus 34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV~--Pl~~~lk~-------l 101 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERVR--PLETVLKE-------L 101 (690)
T ss_pred eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeeccc--cHHHHHHH-------h
Confidence 34588899888876542 223557788999999999999999998744 468999999983 56666752 2
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhhhhccCCCCCccCCccccC
Q 005859 503 EWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT 582 (673)
Q Consensus 503 ~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 582 (673)
......-.+.||+.||.|||+.. +++|++|.-..|+|++.|.-||++|-++....+-.. .......-..|..|+.+..
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDC-NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccC-CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc
Confidence 23444557899999999999743 799999999999999999999999988764433211 0000011123556665433
Q ss_pred CCCCcchhHHHHHHHHHHHHhCC
Q 005859 583 GRFTEKSDIYAFGMIVFQILSGK 605 (673)
Q Consensus 583 ~~~s~ksDVwSfGvvl~el~tG~ 605 (673)
.. -..|.|-||++++|++.|.
T Consensus 180 s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCcc
Confidence 22 3469999999999999984
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.7e-12 Score=134.51 Aligned_cols=157 Identities=27% Similarity=0.287 Sum_probs=93.8
Q ss_pred EEEEEecCCCcc------cccCccccCCCCCCeEeCcCCcCCccCCcccCCCCC---CCEEEccCCCCCC----CCcccc
Q 005859 67 VANISLQGKGLS------GEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSE---LSDLYLNVNNLSG----KIPSQI 133 (673)
Q Consensus 67 v~~l~l~~~~l~------g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~l~~N~l~~----~~p~~~ 133 (673)
++.++++++.+. ..++..+..+++|+.|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+
T Consensus 53 l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l 132 (319)
T cd00116 53 LKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGL 132 (319)
T ss_pred ceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHH
Confidence 566666666554 223445566667777777777776555555544444 7777777777662 223344
Q ss_pred cCC-CCCcEeeccCcccccc----CchhhcCccccCeecccccccCc----cCCccccCCCcccccccccccCCCC----
Q 005859 134 GNM-TNLQVLQLCYNKLTGN----IPTQLGSLRKLSVLALQYNQLTG----AIPASLGDLGMLMRLDLSFNNLFGP---- 200 (673)
Q Consensus 134 ~~l-~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~---- 200 (673)
..+ ++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++ .++..+..+++|+.|+|++|.+.+.
T Consensus 133 ~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~ 212 (319)
T cd00116 133 KDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASA 212 (319)
T ss_pred HhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHH
Confidence 555 6777777777777632 23345555667777777777663 2333344556777777777766533
Q ss_pred CcccccCCCCCCEEEccCCCCCc
Q 005859 201 VPVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 201 ~p~~~~~l~~L~~L~l~~N~l~g 223 (673)
++..+..+++|+.|++++|++++
T Consensus 213 l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 213 LAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHHhcccCCCCEEecCCCcCch
Confidence 22334556677777777777665
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.18 E-value=7.9e-11 Score=143.07 Aligned_cols=159 Identities=25% Similarity=0.281 Sum_probs=84.2
Q ss_pred CEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeecc
Q 005859 66 RVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLC 145 (673)
Q Consensus 66 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 145 (673)
.+..|+|.++.+. .+|..+..+++|+.|+|++|...+.+|. +..+++|+.|+|++|.....+|..++++++|+.|+++
T Consensus 612 ~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~ 689 (1153)
T PLN03210 612 NLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689 (1153)
T ss_pred CCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence 3445555555543 3444444555555555554433333332 4444555555555444334444444444455555544
Q ss_pred CccccccCchhhcCc---------------------cccCeecccccccCccCCccc-----------------------
Q 005859 146 YNKLTGNIPTQLGSL---------------------RKLSVLALQYNQLTGAIPASL----------------------- 181 (673)
Q Consensus 146 ~N~l~~~~p~~l~~l---------------------~~L~~L~l~~N~l~~~~p~~~----------------------- 181 (673)
+|...+.+|..+ ++ ++|++|+|++|.+. .+|..+
T Consensus 690 ~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~ 767 (1153)
T PLN03210 690 RCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQ 767 (1153)
T ss_pred CCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccCCcCeeecCCCccc-cccccccccccccccccccchhhcccccc
Confidence 433222333322 22 34455555555543 333321
Q ss_pred -------cCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCchh
Q 005859 182 -------GDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPA 228 (673)
Q Consensus 182 -------~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~ 228 (673)
...++|+.|+|++|...+.+|..+.++++|+.|++++|...+.+|..
T Consensus 768 ~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~ 821 (1153)
T PLN03210 768 PLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTG 821 (1153)
T ss_pred ccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCC
Confidence 11246777788888777778888888888888888887665566654
|
syringae 6; Provisional |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.7e-12 Score=133.44 Aligned_cols=159 Identities=26% Similarity=0.313 Sum_probs=124.7
Q ss_pred CCCEEEEEecCCCcccccCccccCCCC---CCeEeCcCCcCCc----cCCcccCCC-CCCCEEEccCCCCCCC----Ccc
Q 005859 64 NGRVANISLQGKGLSGEIPAAVGGLKS---LTGLYLHFNALNG----VIPKEIASL-SELSDLYLNVNNLSGK----IPS 131 (673)
Q Consensus 64 ~~~v~~l~l~~~~l~g~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~l~~N~l~~~----~p~ 131 (673)
..+++.|+++++.+.+..+..+..+.+ |+.|++++|++++ .+...+..+ ++|+.|++++|.+++. ++.
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 358999999999998777777766666 9999999999983 344456677 8999999999999843 344
Q ss_pred cccCCCCCcEeeccCcccccc----CchhhcCccccCeecccccccCcc----CCccccCCCcccccccccccCCCCCcc
Q 005859 132 QIGNMTNLQVLQLCYNKLTGN----IPTQLGSLRKLSVLALQYNQLTGA----IPASLGDLGMLMRLDLSFNNLFGPVPV 203 (673)
Q Consensus 132 ~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~ 203 (673)
.+..+++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++. ++..+..+++|+.|++++|.+++....
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~ 239 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAA 239 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHH
Confidence 567788999999999999852 344566677999999999998743 344567788999999999998863332
Q ss_pred ccc-----CCCCCCEEEccCCCCC
Q 005859 204 KLA-----NVPKLEVLDIRNNSFS 222 (673)
Q Consensus 204 ~~~-----~l~~L~~L~l~~N~l~ 222 (673)
.+. ..++|+.|++++|.++
T Consensus 240 ~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 240 ALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHHHhccCCCceEEEccCCCCC
Confidence 222 2478999999999987
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.9e-10 Score=112.32 Aligned_cols=144 Identities=20% Similarity=0.245 Sum_probs=108.9
Q ss_pred cccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCC--CCceeEeeEEecCC-CCeEEEEEeecC
Q 005859 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKH--ENLASLRGICCSKG-RGECFLIYDFVP 484 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~-~~~~~lv~E~~~ 484 (673)
+.|+.|.++.||++...+|+.+++|............++.+|+++++.+.+ .++.+++.+..... .+..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 468999999999999877789999987654322234578899999999975 34566776653321 125689999999
Q ss_pred CCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 005859 485 NGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK---------------------------------------- 524 (673)
Q Consensus 485 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------- 524 (673)
|.++.+.+.. ..++..++..++.++++.|.+||+.
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888775531 2467777888888888888888852
Q ss_pred --------------CCCcccCCcCCCCeEecC--CCCeeecccccccc
Q 005859 525 --------------RPGLVHPNLSAEKVLIHR--RYNPLLSDSGLHKL 556 (673)
Q Consensus 525 --------------~~~ivHrDlk~~NILl~~--~~~~kl~DfGla~~ 556 (673)
...++|+|+++.||+++. ++.+.|.||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 135799999999999998 56688999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.4e-10 Score=140.80 Aligned_cols=126 Identities=22% Similarity=0.269 Sum_probs=95.8
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..+..|++.++.+. .+|..| .+.+|+.|+|++|++. .+|..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|
T Consensus 589 ~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L 664 (1153)
T PLN03210 589 PKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKL 664 (1153)
T ss_pred cccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEe
Confidence 35778888877764 677766 5788999999999887 4677788889999999988765556764 788889999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccc
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFN 195 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 195 (673)
++|.....+|..+..+++|+.|++++|...+.+|..+ ++++|+.|+|++|
T Consensus 665 ~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc 714 (1153)
T PLN03210 665 SDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGC 714 (1153)
T ss_pred cCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCC
Confidence 8887767888888899999999998875545667654 4555555555544
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.3e-10 Score=131.72 Aligned_cols=134 Identities=25% Similarity=0.324 Sum_probs=73.1
Q ss_pred CEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeecc
Q 005859 66 RVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLC 145 (673)
Q Consensus 66 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 145 (673)
.++.|++.+|+|+. +|. .+++|++|+|++|+|+. +|.. .++|+.|+|++|.++ .+|.. .++|+.|+|+
T Consensus 223 ~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L~-~Lp~l---p~~L~~L~Ls 290 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPLT-HLPAL---PSGLCKLWIF 290 (788)
T ss_pred CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-ccCc---ccccceeeccCCchh-hhhhc---hhhcCEEECc
Confidence 34445555555442 332 13455555555555553 2321 234555555555554 23332 2345666666
Q ss_pred CccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCc
Q 005859 146 YNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 146 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 223 (673)
+|+++ .+|. .+++|+.|+|++|+|++ +|... .+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++
T Consensus 291 ~N~Lt-~LP~---~p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~ 356 (788)
T PRK15387 291 GNQLT-SLPV---LPPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS 356 (788)
T ss_pred CCccc-cccc---cccccceeECCCCcccc-CCCCc---ccccccccccCcccc-cccc---ccccceEecCCCccCC
Confidence 66666 3443 23567777777777774 44422 346667777777764 4431 1368888888888885
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.8e-10 Score=106.85 Aligned_cols=137 Identities=15% Similarity=0.118 Sum_probs=97.0
Q ss_pred cccccCCcceEEEEEEcC-------CcEEEEEEecccCC--C-------Cc------------HHHHH----HHHHHHhc
Q 005859 408 NLLGKSSFSATYKGILRD-------GSVVAVKCIAKTSC--K-------SD------------EGEFL----KGLKILTS 455 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~--~-------~~------------~~~~~----~E~~~l~~ 455 (673)
..||.|.=+.||.|.-.+ +..+|||+.+.... + .+ ...+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 47999998864221 0 00 11223 79999999
Q ss_pred cCC--CCceeEeeEEecCCCCeEEEEEeecCCCChhh-hhccccCCccccCHHHHHHHHHHHHHHHHHH-hcCCCCcccC
Q 005859 456 LKH--ENLASLRGICCSKGRGECFLIYDFVPNGNLLQ-HLDLEAGSEKVLEWATRISVIKGIAKGISYL-HGKRPGLVHP 531 (673)
Q Consensus 456 l~H--~niv~l~~~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~ivHr 531 (673)
+.. -++.+.+++ ...+|||||+.+..+.. .+. ...++..+...+..+++.+|.+| |.. ||||+
T Consensus 83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~--glVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC--NLVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC--CeecC
Confidence 853 466666654 23479999997654422 121 12244456677889999999999 666 89999
Q ss_pred CcCCCCeEecCCCCeeecccccccccc
Q 005859 532 NLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 532 Dlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||++.||++++ +.+.|+|||.+-...
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 99999999974 679999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.11 E-value=6.2e-12 Score=121.81 Aligned_cols=141 Identities=26% Similarity=0.320 Sum_probs=115.6
Q ss_pred cccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhc
Q 005859 79 GEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLG 158 (673)
Q Consensus 79 g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~ 158 (673)
|..-..+.....|++||||+|.|+ .+.++..-++.++.|++|+|.+.. + ..+..|++|+.||||+|.++ .+..+-.
T Consensus 274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~ 349 (490)
T KOG1259|consen 274 GSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHL 349 (490)
T ss_pred CceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHh
Confidence 333344555678999999999998 678888889999999999999983 3 33888999999999999998 5566666
Q ss_pred CccccCeecccccccCccCCccccCCCcccccccccccCCCCC-cccccCCCCCCEEEccCCCCCcCC
Q 005859 159 SLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPV-PVKLANVPKLEVLDIRNNSFSGNV 225 (673)
Q Consensus 159 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~g~~ 225 (673)
.+.+.+.|.|+.|.+.. -..+..+.+|..||+++|+|...- -..++++|-|+.|.|.+|++.+.+
T Consensus 350 KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 350 KLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhcCEeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 78899999999999863 235778889999999999987532 346889999999999999998743
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.4e-11 Score=111.70 Aligned_cols=108 Identities=25% Similarity=0.326 Sum_probs=26.8
Q ss_pred cCCCCCCeEeCcCCcCCccCCcccC-CCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhh-cCcccc
Q 005859 86 GGLKSLTGLYLHFNALNGVIPKEIA-SLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQL-GSLRKL 163 (673)
Q Consensus 86 ~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~l~~L 163 (673)
.+...++.|+|++|.|+. + +.++ .+.+|+.|+|++|.++. ++ .+..++.|+.|++++|+++. +...+ ..+++|
T Consensus 16 ~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L 90 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNL 90 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT-
T ss_pred cccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCCcC
Confidence 344456677777777663 2 2344 45666777777776663 32 35566666666666666663 33333 346666
Q ss_pred CeecccccccCccCC-ccccCCCcccccccccccCC
Q 005859 164 SVLALQYNQLTGAIP-ASLGDLGMLMRLDLSFNNLF 198 (673)
Q Consensus 164 ~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~ 198 (673)
++|+|++|+|...-- ..+..+++|+.|+|.+|.++
T Consensus 91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 666666666653110 12333444444444444443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=5.3e-11 Score=133.27 Aligned_cols=248 Identities=17% Similarity=0.125 Sum_probs=167.0
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccC--CCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTS--CKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
+.|.+.+-+-+|.++.++.+.-.. |...++|+..... ...+.+....+-.++-..+||-++....-+ ......+|
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~rsP~~L 881 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF--PCRSPLPL 881 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC--CCCCCcch
Confidence 455566677889999988776432 4444544433221 122223333444444444567666554332 22356789
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
|++|..+++|...++... ..+.+-.......+..+.+|||.. .+.|||++|.|++...++..+++|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~--~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS--LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc--hhhcccccccchhhcccCCcccCccccccccc
Confidence 999999999999987432 344444555677788999999986 48999999999999999999999998433211
Q ss_pred C------------------------------cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 005859 559 D------------------------------DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSI 608 (673)
Q Consensus 559 ~------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~ 608 (673)
. +.........+|..|.|||...+......+|+|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0001122346888999999999999999999999999999999999998
Q ss_pred ChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 005859 609 TPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIE 660 (673)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ 660 (673)
................ .. ...-+...+.+..+++...+..+|.+|-.|.
T Consensus 1036 na~tpq~~f~ni~~~~--~~-~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRD--IP-WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccCC--CC-CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 7655443332222111 11 1223445567788889999999999997665
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2e-11 Score=122.73 Aligned_cols=162 Identities=25% Similarity=0.327 Sum_probs=120.0
Q ss_pred CceEEeCCCCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccC
Q 005859 56 FDGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGN 135 (673)
Q Consensus 56 w~gv~c~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 135 (673)
..+.+|...+ -..++-++.+|. .+|..+. ..-..|+|..|+|+.+.|.+|..+++|+.|||++|+|+-+-|++|.+
T Consensus 38 P~pC~Cs~~~-g~~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~G 113 (498)
T KOG4237|consen 38 PAPCTCSDVE-GGIVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKG 113 (498)
T ss_pred CCCcccCCCC-CceEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhh
Confidence 4456675433 344566666766 4555432 34567888889998888888888888888888888888888888888
Q ss_pred CCCCcEeeccC-ccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEE
Q 005859 136 MTNLQVLQLCY-NKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVL 214 (673)
Q Consensus 136 l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 214 (673)
+.+|..|-+-+ |+|+...-..|++|.+|+.|.+.-|++.....+.|..+++|..|.+-+|.+...--..|..+..++.+
T Consensus 114 L~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tl 193 (498)
T KOG4237|consen 114 LASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTL 193 (498)
T ss_pred hHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchH
Confidence 88887766655 88885555678888888888888888887777788888888888888888774333367777777777
Q ss_pred EccCCCC
Q 005859 215 DIRNNSF 221 (673)
Q Consensus 215 ~l~~N~l 221 (673)
.+..|++
T Consensus 194 hlA~np~ 200 (498)
T KOG4237|consen 194 HLAQNPF 200 (498)
T ss_pred hhhcCcc
Confidence 7776664
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.8e-10 Score=124.51 Aligned_cols=152 Identities=33% Similarity=0.543 Sum_probs=113.8
Q ss_pred CCEEEEEecCCCcccccCccccCCC-CCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEee
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLK-SLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 143 (673)
..++.+++.+|.++ .+|+....+. +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 35888999888887 5677777774 9999999999998 56677889999999999999998 6777666888999999
Q ss_pred ccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCC
Q 005859 144 LCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFS 222 (673)
Q Consensus 144 L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 222 (673)
+++|+++ .+|.....+..|++|++++|.+. ..+..+.++.++..|.+.+|++.. ++..+..+++++.|++++|.++
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~ 268 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQIS 268 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccchhccccccceecccccccc
Confidence 9999998 67776666666888888888543 345556666666666666666542 2445556666666666666665
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.9e-09 Score=97.89 Aligned_cols=130 Identities=15% Similarity=0.286 Sum_probs=93.4
Q ss_pred cccccCCcceEEEEEEcCCcEEEEEEe-cccCCCCc------HHHHHHHHHHHhccCCCCc--eeEeeEEecCCCCeEEE
Q 005859 408 NLLGKSSFSATYKGILRDGSVVAVKCI-AKTSCKSD------EGEFLKGLKILTSLKHENL--ASLRGICCSKGRGECFL 478 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~~~------~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~~~~~~~l 478 (673)
..+++|+=+.+|.+.+. |..+++|.= .+.-.... .....+|++++.+++--.| ..++++ + ++...|
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D--~~~~~I 76 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--D--PDNGLI 76 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--c--CCCCEE
Confidence 35789999999999775 444666643 32221111 2356789999999864433 334433 2 355679
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
+|||.+|-.|.+.+... +..++..|-.-+.-||.. ||+|+||.++||++..+. +.++|||+++.
T Consensus 77 ~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~--givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 77 VMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA--GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc--CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999998888888622 245677777788889987 899999999999998764 99999999874
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.93 E-value=6.2e-10 Score=120.35 Aligned_cols=149 Identities=32% Similarity=0.483 Sum_probs=111.7
Q ss_pred EEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCC-CCCEEEccCCCCCCCCcccccCCCCCcEeeccCc
Q 005859 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLS-ELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYN 147 (673)
Q Consensus 69 ~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 147 (673)
.+++..+.+...+. .+..++.++.|++.+|.++ .+|.....++ +|+.|++++|.+. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~~~-~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSNIS-ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccCch-hhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 46666666543332 3555678888888888888 4666666674 8888888888887 56677888888888888888
Q ss_pred cccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCc
Q 005859 148 KLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 148 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 223 (673)
+++ .+|...+.+++|+.|++++|++. .+|........|+.|.+++|.+. ..+..+.++.++..|.+.+|++..
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~ 246 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED 246 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee
Confidence 888 56666667888888888888887 67776656667888888888543 356667778888888888887753
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.91 E-value=5.6e-10 Score=104.27 Aligned_cols=110 Identities=31% Similarity=0.433 Sum_probs=43.7
Q ss_pred cCCCCCCCEEEccCCCCCCCCccccc-CCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccc-cCCCc
Q 005859 109 IASLSELSDLYLNVNNLSGKIPSQIG-NMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASL-GDLGM 186 (673)
Q Consensus 109 ~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~ 186 (673)
+.+..++++|+|.+|.|+. + +.++ .+.+|+.|+|++|.++. ++ .+..+++|++|++++|+|+. ++..+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred ccccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 4556689999999999984 3 3466 58899999999999995 43 58889999999999999984 54444 46899
Q ss_pred ccccccccccCCCCC-cccccCCCCCCEEEccCCCCCc
Q 005859 187 LMRLDLSFNNLFGPV-PVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 187 L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~g 223 (673)
|+.|+|++|+|...- -..+..+++|+.|+|.+|+++.
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence 999999999997632 2457789999999999999874
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.1e-08 Score=97.10 Aligned_cols=127 Identities=20% Similarity=0.203 Sum_probs=82.3
Q ss_pred eEEEEEEcCCcEEEEEEecccCCCC--------------------c-----HHHHHHHHHHHhccCCC--CceeEeeEEe
Q 005859 417 ATYKGILRDGSVVAVKCIAKTSCKS--------------------D-----EGEFLKGLKILTSLKHE--NLASLRGICC 469 (673)
Q Consensus 417 ~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~-----~~~~~~E~~~l~~l~H~--niv~l~~~~~ 469 (673)
.||.|...+|..||||..+.....- . .....+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999999999999986532100 0 12356799999999765 566766543
Q ss_pred cCCCCeEEEEEeecC--CCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHH-hcCCCCcccCCcCCCCeEecCCCCe
Q 005859 470 SKGRGECFLIYDFVP--NGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYL-HGKRPGLVHPNLSAEKVLIHRRYNP 546 (673)
Q Consensus 470 ~~~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~ivHrDlk~~NILl~~~~~~ 546 (673)
..+|||||++ |..+..+... .++......++.+++..+..+ |.. ||||+|+.+.||+++++ .+
T Consensus 80 -----~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~--givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 -----RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKA--GIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp -----TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCT--TEEESS-STTSEEEETT-CE
T ss_pred -----CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhc--CceecCCChhhEEeecc-eE
Confidence 2369999998 5445443321 111334556778888877765 566 89999999999999988 99
Q ss_pred eecccccccccc
Q 005859 547 LLSDSGLHKLLA 558 (673)
Q Consensus 547 kl~DfGla~~~~ 558 (673)
.|+|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.3e-10 Score=109.22 Aligned_cols=130 Identities=28% Similarity=0.315 Sum_probs=108.2
Q ss_pred CEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeecc
Q 005859 66 RVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLC 145 (673)
Q Consensus 66 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 145 (673)
.++.+||++|.++ .+.+++.-++.++.|++|+|.|... +.+..|++|+.||||+|.++ .+..+-..|-|.+.|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 3678999999987 6777888899999999999999743 34889999999999999998 555666678899999999
Q ss_pred CccccccCchhhcCccccCeecccccccCcc-CCccccCCCcccccccccccCCCCC
Q 005859 146 YNKLTGNIPTQLGSLRKLSVLALQYNQLTGA-IPASLGDLGMLMRLDLSFNNLFGPV 201 (673)
Q Consensus 146 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~ 201 (673)
.|.+... ..+..+-+|..||+++|+|... --..+++++-|+.|.|-+|.+.+.+
T Consensus 361 ~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 361 QNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 9999732 3577788899999999999732 1236899999999999999998643
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.84 E-value=5.8e-08 Score=101.78 Aligned_cols=169 Identities=19% Similarity=0.314 Sum_probs=125.4
Q ss_pred ceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecC--CCCeEEEEEeecCC-CChhhh
Q 005859 416 SATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSK--GRGECFLIYDFVPN-GNLLQH 491 (673)
Q Consensus 416 g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~~~lv~E~~~~-gsL~~~ 491 (673)
.+.||+... ||..+++|++.... .........-++.++++.|+|||++.+++... .....++||+|+++ ++|.++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r-~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDR-DQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred ceeEeeeeccCCceeeeeeecccc-ccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 467999854 79999999993322 11112233457889999999999999987532 23468899999986 677775
Q ss_pred hcccc-----------CCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 492 LDLEA-----------GSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 492 l~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
.-... ..+...+++..+.++.|+..||.++|+. |+.-+-|.+.+||++.+.+++|+..|....+..+
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss--GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS--GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc--CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 43111 1234577889999999999999999987 8888999999999999999999988877665543
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCC
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGK 605 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~ 605 (673)
.. |-+.. -.+-|.=.||.+++-|.||.
T Consensus 447 ~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 447 PT---------------EPLES---QQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred CC---------------cchhH---HhhhhHHHHHHHHHHHhhcc
Confidence 20 11211 23568889999999999995
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.5e-08 Score=91.19 Aligned_cols=144 Identities=15% Similarity=0.205 Sum_probs=98.0
Q ss_pred cccccccCCcceEEEEEEcCCcEEEEEEe-cccCCC------CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 406 EANLLGKSSFSATYKGILRDGSVVAVKCI-AKTSCK------SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 406 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
...+|-+|+=+.|+++.+. |+...||.= .+.... -..+...+|++.+.+++--.|..-.-++.+. ..-.|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~--~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT--YGGQI 87 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec--CCCeE
Confidence 4567889999999999985 666666643 222111 1134678899999998644443222234333 23368
Q ss_pred EEeecCC-CChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC---Ceeecccccc
Q 005859 479 IYDFVPN-GNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY---NPLLSDSGLH 554 (673)
Q Consensus 479 v~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~---~~kl~DfGla 554 (673)
+|||.+| -++.+++..... ....-+....++.+|-+-+.-||.. +|+|+||..+||++..++ .+.+.|||++
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n--diiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN--DIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC--CeecccccccceEEecCCCcCceEEEeecch
Confidence 9999976 367777753321 1122222367888899999999987 799999999999997665 3579999997
Q ss_pred cc
Q 005859 555 KL 556 (673)
Q Consensus 555 ~~ 556 (673)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 54
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.1e-09 Score=82.48 Aligned_cols=59 Identities=34% Similarity=0.479 Sum_probs=31.2
Q ss_pred CCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCcc
Q 005859 90 SLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNK 148 (673)
Q Consensus 90 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 148 (673)
+|++|+|++|+|+...+..|..+++|++|++++|+++...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 45555555555554444455555555555555555554444455555555555555554
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.76 E-value=4.3e-09 Score=80.76 Aligned_cols=57 Identities=40% Similarity=0.484 Sum_probs=21.1
Q ss_pred CcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccc
Q 005859 139 LQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFN 195 (673)
Q Consensus 139 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 195 (673)
|++|++++|+++...+..|..+++|++|++++|.++...|..|.++++|++|++++|
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 59 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN 59 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence 333333333333332233333333333333333333333333333333333333333
|
... |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.3e-07 Score=95.41 Aligned_cols=143 Identities=13% Similarity=0.038 Sum_probs=97.2
Q ss_pred ccccCCcceEEEEEEcCCcEEEEEEecccCCC----------CcHHHHHHHHHHHhccCCCCc--eeEeeEEecCC---C
Q 005859 409 LLGKSSFSATYKGILRDGSVVAVKCIAKTSCK----------SDEGEFLKGLKILTSLKHENL--ASLRGICCSKG---R 473 (673)
Q Consensus 409 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~~---~ 473 (673)
.+-+-....|++..+ +|+.+.||+....... .....+.+|.+.+.++...+| +..+++..... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333333445777766 5778999977443210 011247789888888743332 33444442211 2
Q ss_pred CeEEEEEeecCCC-ChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC-------CCC
Q 005859 474 GECFLIYDFVPNG-NLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR-------RYN 545 (673)
Q Consensus 474 ~~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~-------~~~ 545 (673)
...++|||++++- +|.+++.... ....+...+..++.+++..+.-||.. ||+|+|++++|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~--Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA--GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC--cCccCCCChhhEEEeccccCCCCCce
Confidence 3578999999876 7988875211 12345567778999999999999988 8999999999999985 467
Q ss_pred eeecccccccc
Q 005859 546 PLLSDSGLHKL 556 (673)
Q Consensus 546 ~kl~DfGla~~ 556 (673)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998753
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.8e-09 Score=110.25 Aligned_cols=156 Identities=29% Similarity=0.300 Sum_probs=83.6
Q ss_pred CEEEEEecCCCcccccC--ccccCCCCCCeEeCcCCcCCccCCcc-cCCCCCCCEEEccCCCCCCC-CcccccCCCCCcE
Q 005859 66 RVANISLQGKGLSGEIP--AAVGGLKSLTGLYLHFNALNGVIPKE-IASLSELSDLYLNVNNLSGK-IPSQIGNMTNLQV 141 (673)
Q Consensus 66 ~v~~l~l~~~~l~g~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~ 141 (673)
+|+.|||+.|-++...| .-...|++|+.|+|+.|++.-..... -..+++|+.|.|+.+.|+-. +-..+..+++|+.
T Consensus 147 ~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~ 226 (505)
T KOG3207|consen 147 NVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEV 226 (505)
T ss_pred cceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHH
Confidence 46666666665554322 12345666666666666665222111 12355666666666666511 1222344566666
Q ss_pred eeccCccccccCchhhcCccccCeecccccccCccCC--ccccCCCcccccccccccCCCC-Cccc-----ccCCCCCCE
Q 005859 142 LQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIP--ASLGDLGMLMRLDLSFNNLFGP-VPVK-----LANVPKLEV 213 (673)
Q Consensus 142 L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~-~p~~-----~~~l~~L~~ 213 (673)
|+|.+|...+.-......+..|++|||++|++. ..+ ...+.|+.|+.|+++.+.+... .|+. ...+++|++
T Consensus 227 L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~ 305 (505)
T KOG3207|consen 227 LYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEY 305 (505)
T ss_pred hhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhccccccee
Confidence 666666432223333444556677777776665 233 2355666677777766666543 2322 245666777
Q ss_pred EEccCCCCC
Q 005859 214 LDIRNNSFS 222 (673)
Q Consensus 214 L~l~~N~l~ 222 (673)
|++..|++.
T Consensus 306 L~i~~N~I~ 314 (505)
T KOG3207|consen 306 LNISENNIR 314 (505)
T ss_pred eecccCccc
Confidence 777777663
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.1e-07 Score=92.69 Aligned_cols=146 Identities=16% Similarity=0.144 Sum_probs=99.0
Q ss_pred HHHHHHHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCC-----C----------------cHHHHHHHHHH
Q 005859 394 LEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCK-----S----------------DEGEFLKGLKI 452 (673)
Q Consensus 394 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~----------------~~~~~~~E~~~ 452 (673)
+..+.....-..+.+.||-|.=+.||.|..++|.++|||.=+..... . .+....+|.++
T Consensus 83 L~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~ 162 (304)
T COG0478 83 LHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA 162 (304)
T ss_pred HHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence 33443333344567889999999999999999999999975432210 0 11245689999
Q ss_pred HhccCCC--CceeEeeEEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCccc
Q 005859 453 LTSLKHE--NLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVH 530 (673)
Q Consensus 453 l~~l~H~--niv~l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivH 530 (673)
|.+|.-. .|.+.+++ +...+||||.+|--|...- ++....-.|+..|+.-+.-.-.. ||||
T Consensus 163 L~~L~~~G~~VP~P~~~------nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~--GiVH 225 (304)
T COG0478 163 LQRLYPEGVKVPKPIAW------NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR--GIVH 225 (304)
T ss_pred HHHhhhcCCCCCCcccc------ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc--Cccc
Confidence 9999644 66666553 4457999999886665322 11222233444444444444334 8999
Q ss_pred CCcCCCCeEecCCCCeeecccccccc
Q 005859 531 PNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 531 rDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
+|+.+-||++++||.+.++||--+..
T Consensus 226 GDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 226 GDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCchheEEEecCCCEEEEeCccccc
Confidence 99999999999999999999975543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=9.4e-09 Score=111.52 Aligned_cols=151 Identities=18% Similarity=0.282 Sum_probs=102.7
Q ss_pred HHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhhhh--------ccCCCCCccCCccccC
Q 005859 511 IKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSML--------KASAAMGYLAPEYTTT 582 (673)
Q Consensus 511 ~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~--------~~~gt~~y~aPE~~~~ 582 (673)
+.+++.|+.|+|.. +++||++|.|++|.++..+..||+.|+++............ -..-..-|.|||++..
T Consensus 105 l~~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hhcccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34566999999973 58999999999999999999999999987654432111100 0112345999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 005859 583 GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENV 662 (673)
Q Consensus 583 ~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev 662 (673)
...+.++|+||+||++|.+..|..+........... ......+..-...++...+.++++=+.+.+..++..||++.++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 888999999999999999995544432211111111 0111111111123345567888888999999999999987776
Q ss_pred H
Q 005859 663 M 663 (673)
Q Consensus 663 l 663 (673)
.
T Consensus 263 ~ 263 (700)
T KOG2137|consen 263 L 263 (700)
T ss_pred h
Confidence 4
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.53 E-value=7.2e-07 Score=86.96 Aligned_cols=109 Identities=17% Similarity=0.233 Sum_probs=81.6
Q ss_pred HHHHHHHHHHHhccCCC--CceeEeeEEecCC--CCeEEEEEeecCCC-ChhhhhccccCCccccCHHHHHHHHHHHHHH
Q 005859 443 EGEFLKGLKILTSLKHE--NLASLRGICCSKG--RGECFLIYDFVPNG-NLLQHLDLEAGSEKVLEWATRISVIKGIAKG 517 (673)
Q Consensus 443 ~~~~~~E~~~l~~l~H~--niv~l~~~~~~~~--~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~g 517 (673)
.....+|.+.+.++... .+.+.+++..... ....++|+|++++. +|.+++... ...+......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHH
Confidence 34677888888777433 3345555544321 13468999999884 799888632 124556678899999999
Q ss_pred HHHHhcCCCCcccCCcCCCCeEecCCC---Ceeeccccccccc
Q 005859 518 ISYLHGKRPGLVHPNLSAEKVLIHRRY---NPLLSDSGLHKLL 557 (673)
Q Consensus 518 L~yLH~~~~~ivHrDlk~~NILl~~~~---~~kl~DfGla~~~ 557 (673)
++-||+. ||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 131 i~~lH~~--gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDA--GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHC--cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999998 899999999999999887 7889999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=5e-09 Score=90.66 Aligned_cols=135 Identities=24% Similarity=0.318 Sum_probs=80.8
Q ss_pred CCeEeCcCCcCCccCCccc---CCCCCCCEEEccCCCCCCCCccccc-CCCCCcEeeccCccccccCchhhcCccccCee
Q 005859 91 LTGLYLHFNALNGVIPKEI---ASLSELSDLYLNVNNLSGKIPSQIG-NMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVL 166 (673)
Q Consensus 91 L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 166 (673)
+..|+|++++|- .+++.. .....|+..+|++|.|. .+|+.|. ..+.++.|+|++|+++ .+|.++..++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 445555555543 334433 33344555577777776 3444443 3456777777777777 567777777777777
Q ss_pred cccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCchhhh
Q 005859 167 ALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALK 230 (673)
Q Consensus 167 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~l~ 230 (673)
++++|.|. ..|..+..+.+|..|+..+|.+. .+|-.+..-...-..++.++++.+.-|.-++
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klq 167 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQ 167 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccc
Confidence 77777776 56666666777777777777765 3444333223333445566666665554443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.47 E-value=8.5e-09 Score=105.50 Aligned_cols=161 Identities=23% Similarity=0.231 Sum_probs=119.2
Q ss_pred eCCCCCEEEEEecCCCcccccCccc-cCCCCCCeEeCcCCcCC-ccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCC
Q 005859 61 CDENGRVANISLQGKGLSGEIPAAV-GGLKSLTGLYLHFNALN-GVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTN 138 (673)
Q Consensus 61 c~~~~~v~~l~l~~~~l~g~~p~~~-~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 138 (673)
|+.-.+++.|+|+.|.+.-...... ..+++|+.|.|+.+.|+ ..+-..+..+++|+.|+|..|...+.-......++.
T Consensus 168 ~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~ 247 (505)
T KOG3207|consen 168 AEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQT 247 (505)
T ss_pred HHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhH
Confidence 3345789999999999876554432 46799999999999998 223334567899999999999643344444566789
Q ss_pred CcEeeccCccccccCc--hhhcCccccCeecccccccCcc-CCcc-----ccCCCcccccccccccCCCC-CcccccCCC
Q 005859 139 LQVLQLCYNKLTGNIP--TQLGSLRKLSVLALQYNQLTGA-IPAS-----LGDLGMLMRLDLSFNNLFGP-VPVKLANVP 209 (673)
Q Consensus 139 L~~L~L~~N~l~~~~p--~~l~~l~~L~~L~l~~N~l~~~-~p~~-----~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~ 209 (673)
|+.|||++|++-. .+ ...+.++.|+.|+++.+.+... .|+. ...+++|++|+++.|++..- .-..+..++
T Consensus 248 L~~LdLs~N~li~-~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~ 326 (505)
T KOG3207|consen 248 LQELDLSNNNLID-FDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLE 326 (505)
T ss_pred HhhccccCCcccc-cccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccc
Confidence 9999999999873 34 4678899999999999998753 3433 46789999999999998531 112344566
Q ss_pred CCCEEEccCCCCC
Q 005859 210 KLEVLDIRNNSFS 222 (673)
Q Consensus 210 ~L~~L~l~~N~l~ 222 (673)
+|+.|.+..|.|+
T Consensus 327 nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 327 NLKHLRITLNYLN 339 (505)
T ss_pred hhhhhhccccccc
Confidence 7777777777775
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=9.6e-07 Score=96.50 Aligned_cols=143 Identities=13% Similarity=0.194 Sum_probs=92.2
Q ss_pred cccccCCcceEEEEEEcCCcEEEEEEecccCCCC--------------------c-------------------HHHHHH
Q 005859 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKS--------------------D-------------------EGEFLK 448 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~-------------------~~~~~~ 448 (673)
+-|+.++-|.||+|++++|+.||||+.+..-... . +-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5789999999999999999999999986543110 0 002345
Q ss_pred HHHHHhccC-----CCCceeEeeEEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHH-HHHHh
Q 005859 449 GLKILTSLK-----HENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKG-ISYLH 522 (673)
Q Consensus 449 E~~~l~~l~-----H~niv~l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~g-L~yLH 522 (673)
|...+.+++ .++ +++=.+|++- .....|+|||++|-.+.+....+. ..++.. .++..++++ +..+-
T Consensus 211 EA~n~~~~~~nf~~~~~-v~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k---~ia~~~~~~f~~q~~ 282 (517)
T COG0661 211 EAANAERFRENFKDDPD-VYVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKS---AGIDRK---ELAELLVRAFLRQLL 282 (517)
T ss_pred HHHHHHHHHHHcCCCCC-eEeceeehhc-cCCcEEEEEeeCCEecccHHHHHh---cCCCHH---HHHHHHHHHHHHHHH
Confidence 655555552 333 2333344322 134579999999988888743221 123322 233322222 11111
Q ss_pred cCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 523 GKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 523 ~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
.. |++|.|..|.||+++.++.+-+-|||+...+.+.
T Consensus 283 ~d--gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 283 RD--GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred hc--CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 12 7999999999999999999999999998776643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.7e-06 Score=87.25 Aligned_cols=254 Identities=15% Similarity=0.153 Sum_probs=151.8
Q ss_pred ccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEe----eEEecCCCCe-EEEEE
Q 005859 407 ANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLR----GICCSKGRGE-CFLIY 480 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~----~~~~~~~~~~-~~lv~ 480 (673)
...||+|+-+.+|-.--- +..|| |++..... ....+ .+..|... .||-+-.=+ ...+..+... .-+.|
T Consensus 16 gr~LgqGgea~ly~l~e~-~d~VA-KIYh~Ppp-a~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV-RDQVA-KIYHAPPP-AAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CccccCCccceeeecchh-hchhh-eeecCCCc-hHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 456999999999953211 22343 65554321 11112 22333333 566443211 1111122222 55677
Q ss_pred eecCCCC-hhhhhcc--ccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 481 DFVPNGN-LLQHLDL--EAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 481 E~~~~gs-L~~~l~~--~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
..+++-. ...++.- .+.+.....|...++.++.+|.+.+-||+. |.+-+|+.++|+|+.+++.+.+.|-..-...
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~--Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH--GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc--CCcccccCccceeeecCceEEEEcccceeec
Confidence 7776532 2222221 122346689999999999999999999988 8999999999999999999988864322222
Q ss_pred cCcchhhhhccCCCCCccCCcccc-----CCCCCcchhHHHHHHHHHHHHhC-CCCCChhhHhhh---------hccchh
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTT-----TGRFTEKSDIYAFGMIVFQILSG-KCSITPFTRQAA---------ESSKVE 622 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~el~tG-~~p~~~~~~~~~---------~~~~~~ 622 (673)
..+. .....+|...|.+||.-. +-.-+...|-|-+||++++++.| +.||.+...... ....+.
T Consensus 168 ~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 168 ANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred cCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 2221 223456888899999755 23356789999999999998886 889865321110 000100
Q ss_pred hh--cCCc---CCCCCC-HHHHHHHHHHHHHcccc--CCCCCCCHHHHHHHHHHhh
Q 005859 623 DF--IDPN---LEGKFS-VSEASNLGQIALHCTHE--SPSHRPSIENVMQELSSII 670 (673)
Q Consensus 623 ~~--~~~~---~~~~~~-~~~~~~l~~l~~~Cl~~--~p~~RPs~~evl~~L~~i~ 670 (673)
.- ..+. ....++ .-.++.+..+-.+|+.. ++.-|||++.-+..|.++-
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 00 0111 111222 22356777788888865 3568999998777776653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.41 E-value=9e-06 Score=77.84 Aligned_cols=157 Identities=9% Similarity=0.068 Sum_probs=108.6
Q ss_pred HHHHHHHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCC-----CCcHHHHHHHHHHHhccCCCC--ceeEee
Q 005859 394 LEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSC-----KSDEGEFLKGLKILTSLKHEN--LASLRG 466 (673)
Q Consensus 394 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~H~n--iv~l~~ 466 (673)
++.+-.....+.+.---|+||.+-|++-.+. |+.+-+|+-..... ...+..|.+|...+.++..-+ +.+..
T Consensus 10 f~~~w~~~~~wve~pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv- 87 (216)
T PRK09902 10 FNHWWATEGDWVEEPNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV- 87 (216)
T ss_pred HHHHHhCCCceecCCCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-
Confidence 3333333333433344678999999997775 44688887753211 234578999999999985332 33333
Q ss_pred EEe---cCCCCeEEEEEeecCC-CChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC
Q 005859 467 ICC---SKGRGECFLIYDFVPN-GNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR 542 (673)
Q Consensus 467 ~~~---~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~ 542 (673)
++. .......+||+|-+++ -+|.+++... .....+...+..+..+|++.++-||+. |+.|+|+-+.||+++.
T Consensus 88 f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~--Gv~Hgdly~khIll~~ 163 (216)
T PRK09902 88 FGEAVKIEGEWRALLVTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV--NRQHGCCYVRHIYVKT 163 (216)
T ss_pred eeeeeccCCceEEEEEEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC--CCcCCCCCHhheeecC
Confidence 221 1222357899998864 5888887532 123456777889999999999999988 8999999999999986
Q ss_pred CCC--eeecccccccc
Q 005859 543 RYN--PLLSDSGLHKL 556 (673)
Q Consensus 543 ~~~--~kl~DfGla~~ 556 (673)
++. +++.||.-++.
T Consensus 164 ~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 164 EGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCeeEEEEEhhccch
Confidence 666 89999976653
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.5e-09 Score=112.64 Aligned_cols=126 Identities=27% Similarity=0.388 Sum_probs=96.9
Q ss_pred CCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCch-hhcCccccCeecc
Q 005859 90 SLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPT-QLGSLRKLSVLAL 168 (673)
Q Consensus 90 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~l 168 (673)
.|.+.+.+.|.+. ....++.-++.|++|||++|+++.. +.+..|+.|++|||++|+|+ .+|. ...++. |+.|+|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 4566678888886 5677788888999999999999843 37888999999999999998 4553 334454 999999
Q ss_pred cccccCccCCccccCCCcccccccccccCCCCCc-ccccCCCCCCEEEccCCCCC
Q 005859 169 QYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVP-VKLANVPKLEVLDIRNNSFS 222 (673)
Q Consensus 169 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~ 222 (673)
++|.++.. ..+.+|.+|+.|||++|-|.+.-- ..+..+..|..|+|.+|++.
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 99998732 347788999999999998876421 12455677889999999986
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.3e-08 Score=109.89 Aligned_cols=126 Identities=29% Similarity=0.324 Sum_probs=96.6
Q ss_pred CEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCccc-ccCCCCCcEeec
Q 005859 66 RVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQ-IGNMTNLQVLQL 144 (673)
Q Consensus 66 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~L~L 144 (673)
.+..++.+.|.|. .+..++.-++.|+.|||++|+++.. +.+..|++|++|||++|++. .+|.. ...+ .|+.|.|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhh-hheeeee
Confidence 3445556666665 4556677789999999999999854 37888999999999999998 55542 2233 4999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCC-ccccCCCcccccccccccCC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIP-ASLGDLGMLMRLDLSFNNLF 198 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~ 198 (673)
++|.++.. ..+.+|.+|+.||+++|-|.+--- ..++.|..|+.|+|.+|.+-
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 99999843 357889999999999999875211 12566788999999999874
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=2.8e-07 Score=100.07 Aligned_cols=104 Identities=24% Similarity=0.316 Sum_probs=72.7
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.....++|.+|.|..... .+..+++|++|+|++|.|+... .+..++.|+.|++++|.++.. ..+..+++|+.|++
T Consensus 95 ~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l 169 (414)
T KOG0531|consen 95 KSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDL 169 (414)
T ss_pred cceeeeeccccchhhccc-chhhhhcchheecccccccccc--chhhccchhhheeccCcchhc--cCCccchhhhcccC
Confidence 456777888887775433 2566788888888888887543 356666788888888888732 34555788888888
Q ss_pred cCccccccCc-hhhcCccccCeecccccccC
Q 005859 145 CYNKLTGNIP-TQLGSLRKLSVLALQYNQLT 174 (673)
Q Consensus 145 ~~N~l~~~~p-~~l~~l~~L~~L~l~~N~l~ 174 (673)
++|++...-+ . +..+.+|+.+++.+|.+.
T Consensus 170 ~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 170 SYNRIVDIENDE-LSELISLEELDLGGNSIR 199 (414)
T ss_pred Ccchhhhhhhhh-hhhccchHHHhccCCchh
Confidence 8888874433 2 567777888888887775
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.28 E-value=1e-06 Score=61.97 Aligned_cols=39 Identities=41% Similarity=0.933 Sum_probs=29.6
Q ss_pred hhHHHHHHHHHHhcC-CCCCCcCCCCCC--CCCCCCCCCceEEeC
Q 005859 21 TSEVDILMHIKDSLD-PENRLLTSWAPN--ADPCSSDSFDGVACD 62 (673)
Q Consensus 21 ~~~~~~ll~~~~~~~-~~~~~l~~w~~~--~~~C~~~~w~gv~c~ 62 (673)
++|+++|++||+++. +....+.+|+.+ .++|+ |.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~---W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCS---WSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCC---STTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCee---eccEEeC
Confidence 579999999999997 455678999886 78997 9999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=3.6e-08 Score=85.41 Aligned_cols=134 Identities=22% Similarity=0.252 Sum_probs=90.9
Q ss_pred CCEEEEEecCCCcccccCc---cccCCCCCCeEeCcCCcCCccCCcccC-CCCCCCEEEccCCCCCCCCcccccCCCCCc
Q 005859 65 GRVANISLQGKGLSGEIPA---AVGGLKSLTGLYLHFNALNGVIPKEIA-SLSELSDLYLNVNNLSGKIPSQIGNMTNLQ 140 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~---~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 140 (673)
.....++|++..|- .++. .+.....|+..+|++|.|.. +|+.|. ..+.++.|+|++|.++ .+|.++..++.|+
T Consensus 27 kE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr 103 (177)
T KOG4579|consen 27 KELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALR 103 (177)
T ss_pred HHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhh
Confidence 33445666665542 2333 34455667777888888874 455554 4558888888888888 6788888888899
Q ss_pred EeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcc
Q 005859 141 VLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPV 203 (673)
Q Consensus 141 ~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 203 (673)
.|+++.|.+. ..|..+..|.+|-.|+..+|.+. .+|-.+-.-..+-..++.++.+.+.-+.
T Consensus 104 ~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 104 SLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKK 164 (177)
T ss_pred hcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence 9999988888 56777777888888888888887 4554433223333445566666665444
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.6e-07 Score=100.86 Aligned_cols=185 Identities=15% Similarity=0.089 Sum_probs=129.8
Q ss_pred CccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCC-ceeEeeEEecCCCCeEEEEEee
Q 005859 404 FSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHEN-LASLRGICCSKGRGECFLIYDF 482 (673)
Q Consensus 404 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~~~lv~E~ 482 (673)
+..-+..++|+++++||.+-...+....+.+... ....-++++|.+++||| .+..++-+ +..+..+++++|
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~~~i~~~i 315 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDY--DGEDYLWIPMRI 315 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccC--Ccccccchhhhh
Confidence 3334457889999999987443333335555332 34566889999999999 55555544 444678899999
Q ss_pred cCCC-ChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 483 VPNG-NLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 483 ~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
+.+| +-..-.. .....+...+...+.+.-.++++|+|+. -=+||| ||+..+ ...|..||+.+..+....
T Consensus 316 ~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~--~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 316 CSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS--YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hcCCccccccCC---hhhHhhhhhhhhhhhhhhcccccccccc--cccCcc----cccccc-cccccccccCCcccCccc
Confidence 9877 2222111 1112233344455667778999999975 248999 777665 678999999988776543
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSI 608 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~ 608 (673)
......++..|+|||......+..+.|+|+.|+--.++.-|-.|-
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 334456889999999999999999999999998777777776654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=3.4e-06 Score=91.88 Aligned_cols=142 Identities=15% Similarity=0.164 Sum_probs=91.4
Q ss_pred cccccCCcceEEEEEEcCCcEEEEEEecccCCCC------------------------------------cHHHHHHHHH
Q 005859 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKS------------------------------------DEGEFLKGLK 451 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------------~~~~~~~E~~ 451 (673)
+.||.-+.|.||+|++++|+.||||+-+..-.+. .+-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5689999999999999999999999876543111 0013455655
Q ss_pred HHhcc----CCCC------ceeEeeEEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHH
Q 005859 452 ILTSL----KHEN------LASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYL 521 (673)
Q Consensus 452 ~l~~l----~H~n------iv~l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL 521 (673)
-..+. .|-+ |.+++-.+ .....|+||||+|..+.+.-... ...++-.....-+.++..-+-+-
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~---~~gi~~~~i~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAID---KRGISPHDILNKLVEAYLEQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHH---HcCCCHHHHHHHHHHHHHHHHHh
Confidence 44443 4555 44443322 13568999999998877654321 12244443333333322222222
Q ss_pred hcCCCCcccCCcCCCCeEecC----CCCeeeccccccccccCc
Q 005859 522 HGKRPGLVHPNLSAEKVLIHR----RYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 522 H~~~~~ivHrDlk~~NILl~~----~~~~kl~DfGla~~~~~~ 560 (673)
| |++|+|=.|.||++.. ++.+.+-|||+...+...
T Consensus 320 ~----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 320 T----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred c----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2 8999999999999984 568889999998876654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.26 E-value=1e-05 Score=79.96 Aligned_cols=137 Identities=9% Similarity=0.105 Sum_probs=81.2
Q ss_pred cccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCc--eeEeeEEecCCCCeEEEEEeecCC
Q 005859 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENL--ASLRGICCSKGRGECFLIYDFVPN 485 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~~~~~~~lv~E~~~~ 485 (673)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-.+ .+.+++... .+...+|||+++|
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeeeecCC
Confidence 56899999999984 24457788776432 33457889999998864333 556666533 3556789999988
Q ss_pred CC-hhhhh---------------------ccccCCccccCHHHHH-HHHH----------HHHH-HHHHHh--cCCCCcc
Q 005859 486 GN-LLQHL---------------------DLEAGSEKVLEWATRI-SVIK----------GIAK-GISYLH--GKRPGLV 529 (673)
Q Consensus 486 gs-L~~~l---------------------~~~~~~~~~l~~~~~~-~i~~----------~ia~-gL~yLH--~~~~~iv 529 (673)
.+ +...+ |...... ....... ++.. .+.. ..++|. ...+.++
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 63 21111 1100000 1111100 0000 0111 122222 2233578
Q ss_pred cCCcCCCCeEecCCCCeeeccccccc
Q 005859 530 HPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 530 HrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
|+|+.|.||++++++ +.|.||+.+.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcC
Confidence 999999999999888 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.18 E-value=2e-05 Score=76.50 Aligned_cols=153 Identities=20% Similarity=0.255 Sum_probs=101.3
Q ss_pred CHHHHHHHhcCCccccccc---cCCcceEEEEEEcCCcEEEEEEecccCCCC------------------cHHH-----H
Q 005859 393 NLEEVERATQCFSEANLLG---KSSFSATYKGILRDGSVVAVKCIAKTSCKS------------------DEGE-----F 446 (673)
Q Consensus 393 ~~~~l~~~~~~~~~~~~lg---~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------~~~~-----~ 446 (673)
+++.+.....+..+....| .|.-+.||+|.-.++..||||+.+.....- +.++ .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 4566666666666655555 566668999998889999999987543211 0111 2
Q ss_pred HHHHHHHhccC--CCCceeEeeEEecCCCCeEEEEEeecCCCCh-hhhhccccCCccccCHHHHHHHHHHHHHHHHHHhc
Q 005859 447 LKGLKILTSLK--HENLASLRGICCSKGRGECFLIYDFVPNGNL-LQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHG 523 (673)
Q Consensus 447 ~~E~~~l~~l~--H~niv~l~~~~~~~~~~~~~lv~E~~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 523 (673)
.+|.+-|.++. +-.+.+-+++. .-.|||||+..... .-.| +...+.......+..++++++.-|-.
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~------~nVLvMEfIg~~g~pAP~L-----kDv~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR------NNVLVMEFIGDDGLPAPRL-----KDVPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec------CCeEEEEeccCCCCCCCCc-----ccCCcCchhHHHHHHHHHHHHHHHHH
Confidence 45778888874 44445555443 23699999954311 1111 11223333566778888888888876
Q ss_pred CCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 524 KRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 524 ~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
. .++||+||..=|||++ ++.+.|+|||-|....
T Consensus 185 ~-a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 E-AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred h-cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 2 2899999999999999 7899999999876544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 673 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-38 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-35 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-34 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-25 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-25 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-25 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-22 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 5e-21 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 5e-21 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-18 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-18 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-18 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-16 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-05 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 1e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-04 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 2e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 3e-76
Identities = 85/293 (29%), Positives = 158/293 (53%), Gaps = 20/293 (6%)
Query: 392 FNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLK 451
F+L E++ A+ FS N+LG+ F YKG L DG++VAVK + + + E +F ++
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 452 ILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVI 511
+++ H NL LRG C E L+Y ++ NG++ L S+ L+W R +
Sbjct: 80 MISMAVHRNLLRLRG-FCMTP-TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 512 KGIAKGISYLHGK-RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI--VFSMLKA 568
G A+G++YLH P ++H ++ A +L+ + ++ D GL KL+ V + ++
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 197
Query: 569 SAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITP-------------FTRQA 615
+ +G++APEY +TG+ +EK+D++ +G+++ ++++G+ + + +
Sbjct: 198 T--IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 616 AESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSS 668
+ K+E +D +L+G + E L Q+AL CT SP RP + V++ L
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 2e-67
Identities = 93/321 (28%), Positives = 161/321 (50%), Gaps = 27/321 (8%)
Query: 366 YSNGWDPLAKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKGILRD 425
YS + + S + ES+ L ++E AT F L+G F YKG+LRD
Sbjct: 5 YSKATNSINDALSSSYLVP--FESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 426 GSVVAVKCIAKTSCKSDEG--EFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFV 483
G+ VA+K + + +S +G EF ++ L+ +H +L SL G C R E LIY ++
Sbjct: 63 GAKVALK---RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE--RNEMILIYKYM 117
Query: 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR 543
NGNL +HL + W R+ + G A+G+ YLH ++H ++ + +L+
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDEN 175
Query: 544 YNPLLSDSGLHKLLADDI---VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQ 600
+ P ++D G+ K + + +++K + +GY+ PEY GR TEKSD+Y+FG+++F+
Sbjct: 176 FVPKITDFGISKKGTELDQTHLSTVVKGT--LGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233
Query: 601 ILSGKCSITP-----------FTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCT 649
+L + +I + ++ + ++E +DPNL K G A+ C
Sbjct: 234 VLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293
Query: 650 HESPSHRPSIENVMQELSSII 670
S RPS+ +V+ +L +
Sbjct: 294 ALSSEDRPSMGDVLWKLEYAL 314
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 3e-62
Identities = 82/319 (25%), Positives = 132/319 (41%), Gaps = 64/319 (20%)
Query: 392 FNLEEVERATQCFSE------ANLLGKSSFSATYKGILRDGSVVAVKCI-AKTSCKSDEG 444
F+ E++ T F E N +G+ F YKG + + + VAVK + A ++E
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 445 --EFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVL 502
+F + +K++ +HENL L G + L+Y ++PNG+LL L L
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSD--GDDLCLVYVYMPNGSLLDRL-SCLDGTPPL 130
Query: 503 EWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR-----------RYNPLLSDS 551
W R + +G A GI++LH E IHR + +SD
Sbjct: 131 SWHMRCKIAQGAANGINFLH-------------ENHHIHRDIKSANILLDEAFTAKISDF 177
Query: 552 GLHKLLADDIVFSMLKASAA-------MGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSG 604
GL + + Y+APE G T KSDIY+FG+++ +I++G
Sbjct: 178 GLARASEKF------AQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG 230
Query: 605 KCSITPFTRQA-----------AESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESP 653
++ R+ E +ED+ID + + + +A C HE
Sbjct: 231 LPAVD-EHREPQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKK 288
Query: 654 SHRPSIENVMQELSSIIGS 672
+ RP I+ V Q L + S
Sbjct: 289 NKRPDIKKVQQLLQEMTAS 307
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 7e-62
Identities = 73/223 (32%), Positives = 107/223 (47%), Gaps = 12/223 (5%)
Query: 18 LSSTSEVDILMHIKDSL-DPENRLLTSWAPNADPCSSDSFDGVACDENG---RVANISLQ 73
L + + L+ IK L +P L+SW P D C+ ++ GV CD + RV N+ L
Sbjct: 2 LCNPQDKQALLQIKKDLGNPTT--LSSWLPTTDCCNR-TWLGVLCDTDTQTYRVNNLDLS 58
Query: 74 GKGLSGE--IPAAVGGLKSLTGLYLH-FNALNGVIPKEIASLSELSDLYLNVNNLSGKIP 130
G L IP+++ L L LY+ N L G IP IA L++L LY+ N+SG IP
Sbjct: 59 GLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP 118
Query: 131 SQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMR- 189
+ + L L YN L+G +P + SL L + N+++GAIP S G L
Sbjct: 119 DFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178
Query: 190 LDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232
+ +S N L G +P AN+ L +D+ N G+
Sbjct: 179 MTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSD 220
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 154 bits (393), Expect = 2e-42
Identities = 49/152 (32%), Positives = 78/152 (51%), Gaps = 4/152 (2%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSL-TGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK 128
I+ G +SG IP + G L T + + N L G IP A+L+ L+ + L+ N L G
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGD 212
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLM 188
G+ N Q + L N L ++ ++G + L+ L L+ N++ G +P L L L
Sbjct: 213 ASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271
Query: 189 RLDLSFNNLFGPVPVKLANVPKLEVLDIRNNS 220
L++SFNNL G +P + N+ + +V NN
Sbjct: 272 SLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 6e-16
Identities = 28/86 (32%), Positives = 40/86 (46%), Gaps = 2/86 (2%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK 128
I L L+ ++ VG K+L GL L N + G +P+ + L L L ++ NNL G+
Sbjct: 225 KIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIP 154
IP GN+ V NK P
Sbjct: 284 IPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 2e-49
Identities = 67/191 (35%), Positives = 103/191 (53%), Gaps = 3/191 (1%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
+ LQ G +G+IP + L L+L FN L+G IP + SLS+L DL L +N L G+I
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458
Query: 130 PSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMR 189
P ++ + L+ L L +N LTG IP+ L + L+ ++L N+LTG IP +G L L
Sbjct: 459 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI 518
Query: 190 LDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAALCGTGF 249
L LS N+ G +P +L + L LD+ N F+G +P A+ + +G + + G +
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANF---IAGKRY 575
Query: 250 TNLKNCTASDH 260
+KN
Sbjct: 576 VYIKNDGMKKE 586
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 4e-46
Identities = 61/158 (38%), Positives = 87/158 (55%), Gaps = 2/158 (1%)
Query: 77 LSGEIPAAVGG--LKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIG 134
SG I + +L LYL N G IP +++ SEL L+L+ N LSG IPS +G
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 135 NMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSF 194
+++ L+ L+L N L G IP +L ++ L L L +N LTG IP+ L + L + LS
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499
Query: 195 NNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232
N L G +P + + L +L + NNSFSGN+P L
Sbjct: 500 NRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 3e-45
Identities = 66/254 (25%), Positives = 103/254 (40%), Gaps = 42/254 (16%)
Query: 12 LSVTYTLSSTSEVDILMHIKDSLDPENRLLTSWAPNADPCSSDSFDGVACDENGRVANIS 71
+ + S E+ L+ KD L +N LL W+ N +PC+ FDGV C + +V +I
Sbjct: 2 FQASPSQSLYREIHQLISFKDVLPDKN-LLPDWSSNKNPCT---FDGVTCR-DDKVTSID 56
Query: 72 LQGKGL---------------------------SGEIPAAVGGLKSLTGLYLHFNALNGV 104
L K L +G + SLT L L N+L+G
Sbjct: 57 LSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGP 115
Query: 105 IP--KEIASLSELSDLYLNVNNLSGKIP-SQIGNMTNLQVLQLCYNKLTGNIPTQL---G 158
+ + S S L L ++ N L S + +L+VL L N ++G
Sbjct: 116 VTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSD 175
Query: 159 SLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRN 218
+L LA+ N+++G + + L LD+S NN +P L + L+ LDI
Sbjct: 176 GCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISG 232
Query: 219 NSFSGNVPPALKRL 232
N SG+ A+
Sbjct: 233 NKLSGDFSRAISTC 246
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 6e-45
Identities = 53/168 (31%), Positives = 77/168 (45%), Gaps = 4/168 (2%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKE-IASLSELSDLYLNVNNLSGK 128
+ L G G +P G L L L N +G +P + + + L L L+ N SG+
Sbjct: 299 LDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGE 358
Query: 129 IPSQIGNMT-NLQVLQLCYNKLTGNIPTQLG--SLRKLSVLALQYNQLTGAIPASLGDLG 185
+P + N++ +L L L N +G I L L L LQ N TG IP +L +
Sbjct: 359 LPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCS 418
Query: 186 MLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233
L+ L LSFN L G +P L ++ KL L + N G +P L +
Sbjct: 419 ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVK 466
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 7e-43
Identities = 63/183 (34%), Positives = 88/183 (48%), Gaps = 7/183 (3%)
Query: 77 LSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNM 136
LSG IP+++G L L L L N L G IP+E+ + L L L+ N+L+G+IPS + N
Sbjct: 430 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489
Query: 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNN 196
TNL + L N+LTG IP +G L L++L L N +G IPA LGD L+ LDL+ N
Sbjct: 490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL 549
Query: 197 LFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYD---NNAALCGTGFTNLK 253
G +P + I N +G +K + N G L
Sbjct: 550 FNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLN 605
Query: 254 NCT 256
+
Sbjct: 606 RLS 608
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-42
Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 13/202 (6%)
Query: 72 LQGKGLSGEIPAAVGGLKSLTGLYLHFNALN--GVIPKEIASLSELSDLYLNVNNLSGKI 129
+ ++G+ + + N L G+ +++ LS + + G
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 130 PSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMR 189
N ++ L + YN L+G IP ++GS+ L +L L +N ++G+IP +GDL L
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI 684
Query: 190 LDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQ------YDNNAA 243
LDLS N L G +P ++ + L +D+ NN+ SG +P G F+ + NN
Sbjct: 685 LDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE-----MGQFETFPPAKFLNNPG 739
Query: 244 LCGTGFTNLKNCTASDHPTPGK 265
LCG A + +
Sbjct: 740 LCGYPLPRCDPSNADGYAHHQR 761
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 9e-42
Identities = 56/168 (33%), Positives = 77/168 (45%), Gaps = 5/168 (2%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK 128
++ + G LSG+ A+ L L + N G IP L L L L N +G+
Sbjct: 227 HLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGE 284
Query: 129 IPSQI-GNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPA-SLGDLGM 186
IP + G L L L N G +P GS L LAL N +G +P +L +
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRG 344
Query: 187 LMRLDLSFNNLFGPVPVKLANV-PKLEVLDIRNNSFSGNVPPALKRLN 233
L LDLSFN G +P L N+ L LD+ +N+FSG + P L +
Sbjct: 345 LKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNP 392
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-40
Identities = 47/167 (28%), Positives = 72/167 (43%), Gaps = 9/167 (5%)
Query: 70 ISLQGKGLSGEIPAAV---GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLS 126
+ L +SG G L L + N ++G + ++ L L ++ NN S
Sbjct: 156 LDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFS 213
Query: 127 GKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGM 186
IP +G+ + LQ L + NKL+G+ + + +L +L + NQ G IP L
Sbjct: 214 TGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKS 270
Query: 187 LMRLDLSFNNLFGPVPVKLA-NVPKLEVLDIRNNSFSGNVPPALKRL 232
L L L+ N G +P L+ L LD+ N F G VPP
Sbjct: 271 LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC 317
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-36
Identities = 41/159 (25%), Positives = 66/159 (41%), Gaps = 6/159 (3%)
Query: 77 LSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNM 136
L+GEIP+ + +L + L N L G IPK I L L+ L L+ N+ SG IP+++G+
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537
Query: 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFN- 195
+L L L N G IP + + N + G + + GM + N
Sbjct: 538 RSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNL 593
Query: 196 -NLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233
G +L + +I + + G+ P
Sbjct: 594 LEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNG 632
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-29
Identities = 38/109 (34%), Positives = 58/109 (53%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
++ + G S+ L + +N L+G IPKEI S+ L L L N++SG I
Sbjct: 613 CNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSI 672
Query: 130 PSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIP 178
P ++G++ L +L L NKL G IP + +L L+ + L N L+G IP
Sbjct: 673 PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-45
Identities = 60/314 (19%), Positives = 112/314 (35%), Gaps = 47/314 (14%)
Query: 392 FNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLK 451
E + + + + F +K L VAVK +S + E+ +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEY--EVY 70
Query: 452 ILTSLKHENLASLRGICCSKGRG---ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRI 508
L +KHEN+ G +G + +LI F G+L L V+ W
Sbjct: 71 SLPGMKHENILQFIG-AEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELC 124
Query: 509 SVIKGIAKGISYLH--------GKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560
+ + +A+G++YLH G +P + H ++ ++ VL+ ++D GL
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 561 IVFSMLKASAAMG---YLAPEY-----TTTGRFTEKSDIYAFGMIVFQILSGKCSIT--- 609
S +G Y+APE + D+YA G++++++ S +
Sbjct: 185 K--SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 610 -----PFTRQAAESSKVEDF--------IDPNLEGKFSVSEA-SNLGQIALHCTHESPSH 655
PF + + +ED P L + + L + C
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 656 RPSIENVMQELSSI 669
R S V + ++ +
Sbjct: 303 RLSAGCVGERITQM 316
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 63/325 (19%), Positives = 121/325 (37%), Gaps = 56/325 (17%)
Query: 392 FNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLK 451
E L+G+ + A YKG L VAVK + + F+
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFA----NRQNFINEKN 57
Query: 452 I--LTSLKHENLASLRGIC---CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWAT 506
I + ++H+N+A + GR E L+ ++ PNG+L ++L S +W +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVS 112
Query: 507 RISVIKGIAKGISYLH-------GKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559
+ + +G++YLH +P + H +L++ VL+ ++SD GL L
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 560 DIVFSMLKASAAM-------GYLAPEY-------TTTGRFTEKSDIYAFGMIVFQILSGK 605
+ + + A Y+APE ++ D+YA G+I ++I
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 606 CSITPFTR----QAAESSKV------EDFID--------PNLEGKFSVSEA--SNLGQIA 645
+ P Q A ++V ED P + + +L +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 646 LHCTHESPSHRPSIENVMQELSSII 670
C + R + + + ++ ++
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELM 317
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 9e-36
Identities = 45/249 (18%), Positives = 85/249 (34%), Gaps = 34/249 (13%)
Query: 17 TLSSTSEVDILMHIKDSLDPEN--------RLLTSWAPNADPCSSDSFDGVACDENGRVA 68
T + L I D+L+ +N + +W N + + GV+ + NGRV
Sbjct: 25 TAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVT 84
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNG----VIPKEIASLSELSDLYLNVNN 124
+SL+G G SG +P A+G L L L L + PK I++ +
Sbjct: 85 GLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMH 144
Query: 125 LSGKIPSQIG--NMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLG 182
+ ++L + + +I K + + N +T + ++
Sbjct: 145 YQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVM 203
Query: 183 DLGMLMRLDLSFNNL-------------------FGPVPVKLANVPKLEVLDIRNNSFSG 223
L L + + + + +K N+ L +++ N
Sbjct: 204 RLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT 263
Query: 224 NVPPALKRL 232
+P LK L
Sbjct: 264 KLPTFLKAL 272
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-32
Identities = 31/189 (16%), Positives = 65/189 (34%), Gaps = 31/189 (16%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNG-------------------VIPKEI 109
I ++ + AV L L Y+ + +
Sbjct: 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKW 245
Query: 110 ASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLT--------GNIPTQLGSLR 161
+L +L+D+ + K+P+ + + +Q++ + N+
Sbjct: 246 DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGE 305
Query: 162 KLSVLALQYNQL-TGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNS 220
K+ ++ + YN L T + SL + L L+ +N L G +P + KL L++ N
Sbjct: 306 KIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQ 364
Query: 221 FSGNVPPAL 229
+ +P
Sbjct: 365 ITE-IPANF 372
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-32
Identities = 34/174 (19%), Positives = 64/174 (36%), Gaps = 11/174 (6%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNAL--------NGVIPKEIASLSELSDLYL 120
++ + ++P + L + + + N + + ++ +Y+
Sbjct: 253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYI 312
Query: 121 NVNNL-SGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPA 179
NNL + + + + M L +L+ YN+L G +P GS KL+ L L YNQ+T
Sbjct: 313 GYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPAN 371
Query: 180 SLGDLGMLMRLDLSFNNLFG-PVPVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232
G + L + N L P +V + +D N L
Sbjct: 372 FCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPL 425
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-30
Identities = 32/168 (19%), Positives = 64/168 (38%), Gaps = 11/168 (6%)
Query: 78 SGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMT 137
+ + ++ +K L L +N L G +P S +L+ L L N ++ + G
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTE 377
Query: 138 NLQVLQLCYNKLTGNIP--TQLGSLRKLSVLALQYNQLTG-------AIPASLGDLGMLM 188
++ L +NKL IP S+ +S + YN++ + + +
Sbjct: 378 QVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436
Query: 189 RLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGF 236
++LS N + + L +++ N + +LK N F
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-30
Identities = 34/174 (19%), Positives = 67/174 (38%), Gaps = 12/174 (6%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNAL-NGVIPKEIASLSELSDLYLNVNNLSGK 128
IS + + A + + +Y+ +N L + + + +L L N L GK
Sbjct: 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGK 345
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASL--GDLGM 186
+P+ G+ L L L YN++T G ++ L+ +N+L IP + +
Sbjct: 346 LPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSV 403
Query: 187 LMRLDLSFNNL-------FGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233
+ +D S+N + F P+ + +++ NN S +
Sbjct: 404 MSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-30
Identities = 32/175 (18%), Positives = 54/175 (30%), Gaps = 16/175 (9%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSG- 127
I + +++ + L N ++ + ++ S LS + L N L+
Sbjct: 413 EIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEI 472
Query: 128 ------KIPSQIGNMTNLQVLQLCYNKLTGNIPT-QLGSLRKLSVLALQYNQLTGAIPAS 180
N L + L +NKLT + +L L + L YN + P
Sbjct: 473 PKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQ 531
Query: 181 LGDLGMLMRL------DLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPAL 229
+ L D N P + P L L I +N V +
Sbjct: 532 PLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI 585
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 37/203 (18%), Positives = 69/203 (33%), Gaps = 24/203 (11%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGV-------IPKEIASLSELSDLYLNV 122
I+L +S L+ + L N L + + + L+ + L
Sbjct: 438 INLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRF 497
Query: 123 NNLSGKIPSQI--GNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQ------YNQLT 174
N L+ + + L + L YN + PTQ + L ++ N+
Sbjct: 498 NKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTL 555
Query: 175 GAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPAL-KRLN 233
P + L +L + N++ V K+ P + VLDI++N + +
Sbjct: 556 REWPEGITLCPSLTQLQIGSNDIRK-VNEKIT--PNISVLDIKDNPNISIDLSYVCPYIE 612
Query: 234 GGFQ---YDNNAALCGTGFTNLK 253
G YD + G ++K
Sbjct: 613 AGMYMLFYDKTQDIRGCDALDIK 635
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-28
Identities = 31/173 (17%), Positives = 59/173 (34%), Gaps = 17/173 (9%)
Query: 77 LSGEIPAAVGGLKSLTGLYLHFNALNGV-IPKEIASLSELSDLYLNVNNLSG-------K 128
++ G + + L N L + + S+S +S + + N +
Sbjct: 365 ITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTG-------AIPASL 181
+ N+ + L N+++ + LS + L N LT +
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484
Query: 182 GDLGMLMRLDLSFNNLFG-PVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233
+ +L +DL FN L + +P L +D+ NSFS P +
Sbjct: 485 KNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSS 536
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-24
Identities = 24/159 (15%), Positives = 52/159 (32%), Gaps = 13/159 (8%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIA--SLSELSDLYLNVNNLS 126
++ K + LT + L FN L + + +L L + L+ N+ S
Sbjct: 468 MLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFS 526
Query: 127 GKIPSQIGNMTNLQVLQLC------YNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPAS 180
P+Q N + L+ + N+ P + L+ L + N + +
Sbjct: 527 K-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEK 584
Query: 181 LGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNN 219
+ + LD+ N + + + + +
Sbjct: 585 I--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-35
Identities = 54/265 (20%), Positives = 115/265 (43%), Gaps = 18/265 (6%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
+G+ +F K R VA+K I +S+ F+ L+ L+ + H N+ L G C
Sbjct: 16 VGRGAFGVVCKAKWR-AKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP-GL 528
+ L+ ++ G+L L A A +S ++G++YLH +P L
Sbjct: 72 NP----VCLVMEYAEGGSLYNVLH-GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 529 VHPNLSAEKVLIHRRYNPL-LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTE 587
+H +L +L+ L + D G + M + ++APE ++E
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 588 KSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALH 647
K D++++G+I++++++ + PF + ++ + + + +
Sbjct: 183 KCDVFSWGIILWEVITRR---KPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTR 239
Query: 648 CTHESPSHRPSIENVMQELSSIIGS 672
C + PS RPS+E +++ ++ ++
Sbjct: 240 CWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 71/275 (25%), Positives = 130/275 (47%), Gaps = 30/275 (10%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSD-EGEFLKGLKILTSLKHENLASLRGIC 468
+G SF ++ GS VAVK + + ++ EFL+ + I+ L+H N+ G
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGL 528
++ +++ G+L + L ++G+ + L+ R+S+ +AKG++YLH + P +
Sbjct: 104 TQPPN--LSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 529 VHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTTTGRF 585
VH NL + +L+ ++Y + D GL +L A + S +A G ++APE
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK----SAAGTPEWMAPEVLRDEPS 216
Query: 586 TEKSDIYAFGMIVFQILSGKCSITPFT----RQAAESSKVEDF---IDPNLEGKFSVSEA 638
EKSD+Y+FG+I++++ + + P+ Q + + I NL + +
Sbjct: 217 NEKSDVYSFGVILWELATLQ---QPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA---- 269
Query: 639 SNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
I C P RPS +M L +I S+
Sbjct: 270 ----AIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 48/274 (17%), Positives = 108/274 (39%), Gaps = 37/274 (13%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSD-EGEFLKGLKILTSLKHENLASLRGIC 468
L ++ +KG + G+ + VK + + +F + L H N+ + G C
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGL 528
S LI ++P G+L L G+ V++ + + +A+G+++LH P +
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLI 134
Query: 529 VHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPE---YTTT 582
L++ V+I +S + + F M ++APE
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKF------SFQS---PGRMYAPAWVAPEALQKKPE 185
Query: 583 GRFTEKSDIYAFGMIVFQILSGKCSITPF----TRQAAESSKVEDF---IDPNLEGKFSV 635
+D+++F ++++++++ + PF + +E I P +
Sbjct: 186 DTNRRSADMWSFAVLLWELVTRE---VPFADLSNMEIGMKVALEGLRPTIPPGIS----- 237
Query: 636 SEASNLGQIALHCTHESPSHRPSIENVMQELSSI 669
++ ++ C +E P+ RP + ++ L +
Sbjct: 238 ---PHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 61/276 (22%), Positives = 112/276 (40%), Gaps = 27/276 (9%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGIC 468
LGK F K R+ G V+ +K + + + + FLK +K++ L+H N+ G+
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGL 528
R I +++ G L + + W+ R+S K IA G++YLH +
Sbjct: 77 YKDKR--LNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHSM--NI 129
Query: 529 VHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG----- 583
+H +L++ L+ N +++D GL +L+ D+ S YT G
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 584 --------RFTEKSDIYAFGMIVFQILSGKCSITPFT-RQAAESSKVEDFIDPNLEGKFS 634
+ EK D+++FG+++ +I+ + + R V F+D
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCP 249
Query: 635 VSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+ I + C P RPS + L ++
Sbjct: 250 ----PSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 35/278 (12%)
Query: 410 LGKSSFSATYKGILR-DGSVVAVKCI------AKTSCKSDEGEFLKGLKILTSLKHENLA 462
+GK F +KG L D SVVA+K + +T EF + + I+++L H N+
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 463 SLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLH 522
L G+ ++ +FVP G+L L ++W+ ++ ++ IA GI Y+
Sbjct: 87 KLYGLM----HNPPRMVMEFVPCGDLYHRL---LDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 523 GKRPGLVH-----PNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAP 577
+ P +VH PN+ + + + ++D GL + S+ ++AP
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH----SVSGLLGNFQWMAP 195
Query: 578 E--YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF----TRQAAESSKVEDFIDPNLEG 631
E +TEK+D Y+F MI++ IL+G+ PF + + + + L
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEG---PFDEYSYGKIKFINMI---REEGLRP 249
Query: 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSI 669
L + C P RP +++ELS +
Sbjct: 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-31
Identities = 37/174 (21%), Positives = 59/174 (33%), Gaps = 4/174 (2%)
Query: 61 CDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYL 120
C E +IP + S L L FN L + S EL L L
Sbjct: 3 CVEVVPNITYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 121 NVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPAS 180
+ + ++++L L L N + L L L L
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 181 LGDLGMLMRLDLSFNNL-FGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233
+G L L L+++ N + +P +N+ LE LD+ +N L+ L+
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH 173
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-31
Identities = 44/194 (22%), Positives = 70/194 (36%), Gaps = 6/194 (3%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
+ L + A L L+ L L N + + + LS L L NL+
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116
Query: 130 PSQIGNMTNLQVLQLCYNKLTG-NIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGML- 187
IG++ L+ L + +N + +P +L L L L N++ L L +
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 188 ---MRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAAL 244
+ LDLS N + P + +L L +RNN S NV + G +
Sbjct: 177 LLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLG 235
Query: 245 CGTGFTNLKNCTAS 258
NL+ S
Sbjct: 236 EFRNEGNLEKFDKS 249
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-31
Identities = 36/154 (23%), Positives = 59/154 (38%), Gaps = 2/154 (1%)
Query: 81 IPAAVGGLKSLTGLYLHFNALNGVIPKEI-ASLSELSDLYLNVNNLSGKIPSQIGNMTNL 139
+ + GL+ L L + L + + SL L L ++ + +++L
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 140 QVLQLCYNKLTGNI-PTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLF 198
+VL++ N N P LR L+ L L QL P + L L L++S NN F
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 507
Query: 199 GPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232
+ L+VLD N + L+
Sbjct: 508 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 541
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 38/159 (23%), Positives = 57/159 (35%), Gaps = 3/159 (1%)
Query: 77 LSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GN 135
G + G SL L L FN + + L +L L +NL + +
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 136 MTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAI-PASLGDLGMLMRLDLSF 194
+ NL L + + L L VL + N P +L L LDLS
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
Query: 195 NNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233
L P ++ L+VL++ +N+F K LN
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 518
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-27
Identities = 35/166 (21%), Positives = 53/166 (31%), Gaps = 5/166 (3%)
Query: 71 SLQGKGLSGEIPAAVGGLKSLTGLYLHFNALN--GVIPKEIASLSELSDLYLNVNNLSGK 128
L G + L SL L L N L+ G + + L L L+ N +
Sbjct: 329 RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT- 387
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQ-LGSLRKLSVLALQYNQLTGAIPASLGDLGML 187
+ S + L+ L ++ L SLR L L + + A L L
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 188 MRLDLSFNNLFGPV-PVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232
L ++ N+ P + L LD+ P A L
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 493
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-25
Identities = 31/165 (18%), Positives = 54/165 (32%), Gaps = 4/165 (2%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEI-ASLSELSDLYLNVNNLSGK 128
+ + GL SL L + N+ +I L L+ L L+ L
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDL-GML 187
P+ ++++LQVL + +N L L VL N + + L L
Sbjct: 486 SPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSL 545
Query: 188 MRLDLSFNNLFGPVPVK--LANVPKLEVLDIRNNSFSGNVPPALK 230
L+L+ N+ + L + L + P +
Sbjct: 546 AFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ 590
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 36/139 (25%), Positives = 53/139 (38%), Gaps = 4/139 (2%)
Query: 94 LYLHFNALNGVIPKEIASLSELSDLYLNVNNLS--GKIPSQIGNMTNLQVLQLCYNKLTG 151
L F + G L L L L+ N LS G T+L+ L L +N +
Sbjct: 328 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387
Query: 152 NIPTQLGSLRKLSVLALQYNQLTGAIPAS-LGDLGMLMRLDLSFNNLFGPVPVKLANVPK 210
+ + L +L L Q++ L S L L+ LD+S + +
Sbjct: 388 -MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 211 LEVLDIRNNSFSGNVPPAL 229
LEVL + NSF N P +
Sbjct: 447 LEVLKMAGNSFQENFLPDI 465
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-19
Identities = 29/141 (20%), Positives = 47/141 (33%), Gaps = 4/141 (2%)
Query: 77 LSGEIPAAV-GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGN 135
+ L++LT L L L + P SLS L L ++ NN
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 516
Query: 136 MTNLQVLQLCYNKLTGNIPTQLGSL-RKLSVLALQYNQLTGAIPAS--LGDLGMLMRLDL 192
+ +LQVL N + + +L L+ L L N L + +L +
Sbjct: 517 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLV 576
Query: 193 SFNNLFGPVPVKLANVPKLEV 213
+ P +P L +
Sbjct: 577 EVERMECATPSDKQGMPVLSL 597
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-17
Identities = 23/127 (18%), Positives = 49/127 (38%), Gaps = 4/127 (3%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
+ L L P A L SL L + N + L+ L L ++N++
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 534
Query: 130 PSQIGNM-TNLQVLQLCYNKLTGNIPTQ--LGSLRKLSVLALQYNQLTGAIPASLGDLGM 186
++ + ++L L L N Q L ++ L ++ ++ A P+ +
Sbjct: 535 KQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM-P 593
Query: 187 LMRLDLS 193
++ L+++
Sbjct: 594 VLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-15
Identities = 35/198 (17%), Positives = 57/198 (28%), Gaps = 34/198 (17%)
Query: 70 ISLQGKGLSGEIPA-AVGGLKSLTGLYLHFNALNGVIPKE---IASLSELSDLYLNVNNL 125
++L+ S + + GL L L E ++L L +L + L
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
Query: 126 S------GKIPSQIGNMTNLQVLQLCYNKLTGNIP-TQLGSLRKLSVL------------ 166
+ I +TN+ L + + + L ++
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKL 324
Query: 167 ----ALQYNQLTGAIPASLGDLGMLMRLDLSFNNL--FGPVPVKLANVPKLEVLDIRNNS 220
L + G S DL L LDLS N L G L+ LD+ N
Sbjct: 325 KSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384
Query: 221 FSGNVP-----PALKRLN 233
L+ L+
Sbjct: 385 VITMSSNFLGLEQLEHLD 402
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 8e-14
Identities = 33/165 (20%), Positives = 54/165 (32%), Gaps = 13/165 (7%)
Query: 80 EIPAAVGGLKSLTGLYLHFNALNGVIPKE-IASLSELSDLYL------NVNNLSGKIPSQ 132
I L L L N + + K I L+ L L N NL S
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 133 IGNMTNLQVLQLCYNKL---TGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMR 189
+ + NL + + L +I L +S +L + S
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQH 308
Query: 190 LDLSFNNLFGPVPVKLANVPKLEVLDIR-NNSFSGNVPPALKRLN 233
L+L +KL ++ +L + N+FS P+L+ L+
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLD 353
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 54/269 (20%), Positives = 110/269 (40%), Gaps = 21/269 (7%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSD-EGEFLKGLKILTSLKHENLASLRGIC 468
+G SF YKG VAVK + T+ F + +L +H N+ G
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-Y 88
Query: 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGL 528
+ + ++ + +L HL SE E I + + A+G+ YLH K +
Sbjct: 89 STAPQ--LAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHAK--SI 141
Query: 529 VHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAA-MGYLAPE---YTTTGR 584
+H +L + + +H + D GL + + + + ++APE +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 585 FTEKSDIYAFGMIVFQILSGKC---SITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641
++ +SD+YAFG++++++++G+ +I + P+L K + +
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMVGRGSLSPDLS-KVRSNCPKRM 258
Query: 642 GQIALHCTHESPSHRPSIENVMQELSSII 670
++ C + RPS ++ E+ +
Sbjct: 259 KRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 61/282 (21%), Positives = 116/282 (41%), Gaps = 47/282 (16%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEG----EFLKGLKILTSLKHENLASLR 465
+G F Y+ G VAVK A+ D + K+ LKH N+ +LR
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVK-AARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 466 GICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
G+C + L+ +F G L + L S K + ++ IA+G++YLH +
Sbjct: 73 GVCLKEPN--LCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 526 PG-LVHPNLSAEKVLIHRRYNPL--------LSDSGLHKLLADDIVFSMLKASAAMG--- 573
++H +L + +LI ++ ++D GL + +A G
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK------MSAAGAYA 179
Query: 574 YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKC---SITPFTRQAAESSKVEDF---IDP 627
++APE F++ SD++++G++++++L+G+ I A + I
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--AVAYGVAMNKLALPIPS 237
Query: 628 NLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSI 669
++ C + P RPS N++ +L++I
Sbjct: 238 TCP--------EPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 58/295 (19%), Positives = 119/295 (40%), Gaps = 41/295 (13%)
Query: 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
+GK + ++G + G VAVK + KS E L L+HEN+
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIAS 70
Query: 468 C--CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK- 524
+ +LI + G+L +L L+ + + ++ IA G+++LH +
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 525 -----RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLA 576
+P + H +L ++ +L+ + ++D GL + + + + +G Y+A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 577 PE------YTTTGRFTEKSDIYAFGMIVFQILSGKCSIT-------PFTRQAAESSKVED 623
PE ++ DI+AFG++++++ S PF ED
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 624 FID--------PNLEGKFSVSEA-SNLGQIALHCTHESPSHRPSIENVMQELSSI 669
PN+ ++ ++L ++ C +++PS R + + + L+ I
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 3e-30
Identities = 61/325 (18%), Positives = 122/325 (37%), Gaps = 51/325 (15%)
Query: 378 SGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKT 437
SG+G V + + E +GK F ++G R G VAVK +
Sbjct: 28 SGSGLPLLVQRTIARTIVLQES----------IGKGRFGEVWRGKWR-GEEVAVKIFSSR 76
Query: 438 SCKSDEGEFLKGLKILTSLKHENLASLRGIC--CSKGRGECFLIYDFVPNGNLLQHLDLE 495
+S E + L+HEN+ + + +L+ D+ +G+L +L
Sbjct: 77 EERSWFRE--AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--- 131
Query: 496 AGSEKVLEWATRISVIKGIAKGISYLHGK------RPGLVHPNLSAEKVLIHRRYNPLLS 549
+ + I + A G+++LH + +P + H +L ++ +L+ + ++
Sbjct: 132 --NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189
Query: 550 DSGLHKLLADDIVFSMLKASAAMG---YLAPE------YTTTGRFTEKSDIYAFGMIVFQ 600
D GL + + +G Y+APE +++DIYA G++ ++
Sbjct: 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 249
Query: 601 ILSGKCSIT-------PFTRQAAESSKVEDFID--------PNLEGKFSVSEA-SNLGQI 644
I P+ VE+ PN+ ++ EA + +I
Sbjct: 250 IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKI 309
Query: 645 ALHCTHESPSHRPSIENVMQELSSI 669
C + + + R + + + LS +
Sbjct: 310 MRECWYANGAARLTALRIKKTLSQL 334
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-30
Identities = 39/173 (22%), Positives = 63/173 (36%), Gaps = 5/173 (2%)
Query: 61 CDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYL 120
C + VA+ S L+ ++P + ++T L L N L + S+L+ L +
Sbjct: 2 CTVSHEVADCS--HLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDV 56
Query: 121 NVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPAS 180
N +S P + L+VL L +N+L+ L+ L L N +
Sbjct: 57 GFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNP 116
Query: 181 LGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233
L+ LDLS N L + L+ L + NN L
Sbjct: 117 FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFA 169
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 39/169 (23%), Positives = 58/169 (34%), Gaps = 5/169 (2%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
++LQ LS +LT L+L N++ + L L L+ N LS
Sbjct: 78 LNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTK 137
Query: 130 PSQIGNMTNLQVLQLCYNKLTGNIPT--QLGSLRKLSVLALQYNQLTGAIPASLGDLGML 187
+ NLQ L L NK+ + + L L L NQ+ P +G L
Sbjct: 138 LGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRL 197
Query: 188 MRLDLSFNNLFGPVPVKLA---NVPKLEVLDIRNNSFSGNVPPALKRLN 233
L L+ L + KL + L + N+ S L
Sbjct: 198 FGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK 246
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-28
Identities = 41/170 (24%), Positives = 67/170 (39%), Gaps = 7/170 (4%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASL--SELSDLYLNVNNLSG 127
+ L GLS L++L L L N + + +E+ S L L L+ N +
Sbjct: 126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE 185
Query: 128 KIPSQIGNMTNLQVLQLCYNKLTGNIPTQLG---SLRKLSVLALQYNQLTGAIPASLGDL 184
P + L L L +L ++ +L + + L+L +QL+ + L
Sbjct: 186 FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGL 245
Query: 185 GM--LMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232
L LDLS+NNL A +P+LE + N+ +L L
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGL 295
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-28
Identities = 42/174 (24%), Positives = 65/174 (37%), Gaps = 11/174 (6%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIP-KEIASLSELSDLYLNVNNLSGK 128
++L +S A L L L L N + + +E L + ++YL+ N
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445
Query: 129 IPSQIGNMTNLQVLQLCYNKLTG--NIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGM 186
+ + +LQ L L L + P+ LR L++L L N + L L
Sbjct: 446 TRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEK 505
Query: 187 LMRLDLSFNNL--------FGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232
L LDL NNL G L + L +L++ +N F K L
Sbjct: 506 LEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL 559
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-26
Identities = 40/173 (23%), Positives = 59/173 (34%), Gaps = 10/173 (5%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGV--IPKEIASLSELSDLYLNVNNLSG 127
I L + + SL L L AL V P L L+ L L+ NN++
Sbjct: 435 IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN 494
Query: 128 KIPSQIGNMTNLQVLQLCYNKLT--------GNIPTQLGSLRKLSVLALQYNQLTGAIPA 179
+ + L++L L +N L G L L L +L L+ N
Sbjct: 495 INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554
Query: 180 SLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232
DL L +DL NNL N L+ L+++ N +
Sbjct: 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPA 607
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-26
Identities = 36/169 (21%), Positives = 60/169 (35%), Gaps = 7/169 (4%)
Query: 71 SLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIP 130
S+ L + LK L L + N + G+ L L L L+ + S +
Sbjct: 311 SISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 370
Query: 131 SQIG----NMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPAS-LGDLG 185
+ + L +L L NK++ L L VL L N++ + L
Sbjct: 371 TNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLE 430
Query: 186 MLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG--NVPPALKRL 232
+ + LS+N A VP L+ L +R + + P + L
Sbjct: 431 NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPL 479
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 35/139 (25%), Positives = 58/139 (41%), Gaps = 3/139 (2%)
Query: 87 GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQ-IGNMTNLQVLQLC 145
L L L N ++ + + L L L L +N + ++ Q + N+ + L
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438
Query: 146 YNKLTGNIPTQLGSLRKLSVLALQYNQLTG--AIPASLGDLGMLMRLDLSFNNLFGPVPV 203
YNK + L L L+ L + P+ L L LDLS NN+
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498
Query: 204 KLANVPKLEVLDIRNNSFS 222
L + KLE+LD+++N+ +
Sbjct: 499 MLEGLEKLEILDLQHNNLA 517
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 32/163 (19%), Positives = 56/163 (34%), Gaps = 7/163 (4%)
Query: 77 LSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPS--QIG 134
+ K+L L L N L+ L L +L L+ N + I
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIF 168
Query: 135 NMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGD---LGMLMRLD 191
++L+ L+L N++ P ++ +L L L QL ++ L + L
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLS 228
Query: 192 LSFNNLFGPVPVKLAN--VPKLEVLDIRNNSFSGNVPPALKRL 232
LS + L L +LD+ N+ + + L
Sbjct: 229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWL 271
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-24
Identities = 43/180 (23%), Positives = 65/180 (36%), Gaps = 15/180 (8%)
Query: 69 NISLQGKGLSGEIPAAVGGLK--SLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLS 126
N+SL LS GLK +LT L L +N LN V A L +L +L NN+
Sbjct: 226 NLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQ 285
Query: 127 GKIPSQIGNMTNLQVLQLCYN---------KLTGNIPTQLGSLRKLSVLALQYNQLTGAI 177
+ + N++ L L + L L+ L L ++ N + G
Sbjct: 286 HLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIK 345
Query: 178 PASLGDLGMLMRLDLSFN--NLFGPVPVKLANVP--KLEVLDIRNNSFSGNVPPALKRLN 233
L L L LS + +L ++ L +L++ N S A L
Sbjct: 346 SNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG 405
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-21
Identities = 31/137 (22%), Positives = 46/137 (33%), Gaps = 9/137 (6%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFN--------ALNGVIPKEIASLSELSDLYLN 121
+ L ++ + GL+ L L L N A G + LS L L L
Sbjct: 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLE 544
Query: 122 VNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASL 181
N ++ L+++ L N L + + L L LQ N +T
Sbjct: 545 SNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVF 604
Query: 182 GD-LGMLMRLDLSFNNL 197
G L LD+ FN
Sbjct: 605 GPAFRNLTELDMRFNPF 621
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 62/330 (18%), Positives = 128/330 (38%), Gaps = 55/330 (16%)
Query: 378 SGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKT 437
SG+G V + ++ V++ +GK + + G R G VAVK T
Sbjct: 23 SGSGLPLLVQRTIAKQIQMVKQ----------IGKGRYGEVWMGKWR-GEKVAVKVFFTT 71
Query: 438 SCKSDEGEFLKGLKI--LTSLKHENLASLRGIC--CSKGRGECFLIYDFVPNGNLLQHLD 493
+E + + +I ++HEN+ + + +LI D+ NG+L +L
Sbjct: 72 ----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL- 126
Query: 494 LEAGSEKVLEWATRISVIKGIAKGISYLHGK------RPGLVHPNLSAEKVLIHRRYNPL 547
L+ + + + G+ +LH + +P + H +L ++ +L+ +
Sbjct: 127 ----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182
Query: 548 LSDSGLHKLLADDIVFSMLKASAAMG---YLAPE------YTTTGRFTEKSDIYAFGMIV 598
++D GL D + + +G Y+ PE + +D+Y+FG+I+
Sbjct: 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLIL 242
Query: 599 FQILSGKCSIT-------PFTRQAAESSKVEDFID--------PNLEGKFSVSEA-SNLG 642
+++ S P+ ED + P+ ++S E +G
Sbjct: 243 WEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG 302
Query: 643 QIALHCTHESPSHRPSIENVMQELSSIIGS 672
++ C +P+ R + V + L+ + S
Sbjct: 303 KLMTECWAHNPASRLTALRVKKTLAKMSES 332
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-27
Identities = 33/203 (16%), Positives = 71/203 (34%), Gaps = 24/203 (11%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNAL-------NGVIPKEIASLSELSDLYLNV 122
++L + ++ + L N + + L+ + L
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRF 737
Query: 123 NNLSGKIPSQI--GNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQY------NQLT 174
N L+ + + L + + YN + PTQ + +L +++ N++
Sbjct: 738 NKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRIL 795
Query: 175 GAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFS----GNVPPALK 230
P + L++L + N++ V KL P+L +LDI +N +V P ++
Sbjct: 796 RQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIE 852
Query: 231 RLNGGFQYDNNAALCGTGFTNLK 253
YD + G ++
Sbjct: 853 AGMYVLLYDKTQDIRGCDALGIE 875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-27
Identities = 41/264 (15%), Positives = 75/264 (28%), Gaps = 45/264 (17%)
Query: 9 TLFLSVTYTLSSTSEVDILMHIKDSLDPEN-----------RLLTSWAPNADPCSSDSFD 57
+ + + T + L I ++LD +N +W N +
Sbjct: 256 NVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQP 315
Query: 58 GVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSD 117
GV D NGRV +SL G G G +P A+G L L L ++
Sbjct: 316 GVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDM 375
Query: 118 LYLNVNNLSGKIPS-QIGNMTNLQVLQLCYNKLTGN------------------------ 152
+ + + L + L + + N
Sbjct: 376 SEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTN 435
Query: 153 ----IPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANV 208
I + L KL ++ + T A + + + + +N+
Sbjct: 436 RITFISKAIQRLTKLQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYENEELSWSNL 490
Query: 209 PKLEVLDIRNNSFSGNVPPALKRL 232
L +++ N +P L L
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDL 514
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-27
Identities = 26/164 (15%), Positives = 46/164 (28%), Gaps = 17/164 (10%)
Query: 79 GEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTN 138
I A+ L L +Y + + D + N+ +
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYENEELSWSNLKD 492
Query: 139 LQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTG---------AIPASLGDLGMLMR 189
L ++L +P L L +L L + N+ + +
Sbjct: 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQI 552
Query: 190 LDLSFNNLFG-PVPVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232
+ +NNL P L + KL +LD +N A
Sbjct: 553 FYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTN 594
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-27
Identities = 31/172 (18%), Positives = 58/172 (33%), Gaps = 15/172 (8%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSG- 127
+ + + LK LT + L+ +P + L EL L + N
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530
Query: 128 --------KIPSQIGNMTNLQVLQLCYNKLTG-NIPTQLGSLRKLSVLALQYNQLTGAIP 178
++ +Q+ + YN L L + KL +L +N++ +
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE 589
Query: 179 ASLGDLGMLMRLDLSFNNLFGPVPVKL-ANVPKLEVLDIRNNSFSGNVPPAL 229
+ G L L L +N + +P A ++E L +N +P
Sbjct: 590 -AFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKY-IPNIF 638
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 33/171 (19%), Positives = 55/171 (32%), Gaps = 20/171 (11%)
Query: 80 EIPAAVG-GLKSLTGLYLHFNALNGVIPK--EIASLSELSDLYLNVNNLSGKIPSQIG-- 134
EIP + GL N L IP S+ + + + N + I
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCS 666
Query: 135 ----NMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLT-------GAIPASLGD 183
N + L YN++ + +S + L N +T + +
Sbjct: 667 MDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKN 726
Query: 184 LGMLMRLDLSFNNLFG-PVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233
+L +DL FN L + +P L +D+ N FS P +
Sbjct: 727 TYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSS 776
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 1e-21
Identities = 29/165 (17%), Positives = 59/165 (35%), Gaps = 12/165 (7%)
Query: 81 IPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIG-NMTNL 139
A++ + L L N + + + +L+DL L+ N + IP +
Sbjct: 565 ASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQV 621
Query: 140 QVLQLCYNKLTGNIP--TQLGSLRKLSVLALQYNQLTGAIPASLGDLGM-----LMRLDL 192
+ L +NKL IP S+ + + YN++ + + L
Sbjct: 622 EGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTL 680
Query: 193 SFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQ 237
S+N + A + + + NN + +LK +G ++
Sbjct: 681 SYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYK 725
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 15/157 (9%), Positives = 39/157 (24%), Gaps = 1/157 (0%)
Query: 98 FNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQL 157
I A + L + + N + + L
Sbjct: 261 LKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKEL-DMWGDQPGVDL 319
Query: 158 GSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIR 217
+ +++ L+L G +P ++G L L L ++ + ++ + R
Sbjct: 320 DNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEER 379
Query: 218 NNSFSGNVPPALKRLNGGFQYDNNAALCGTGFTNLKN 254
+ + + + +K
Sbjct: 380 KHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP 416
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 12/82 (14%), Positives = 28/82 (34%), Gaps = 3/82 (3%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK 128
+G + + P + SL L + N + + +++ +L L + N
Sbjct: 786 QRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISI 842
Query: 129 IPSQIGNMTNLQVLQLCYNKLT 150
+ + + L Y+K
Sbjct: 843 DVTSVCPYIEAGMYVLLYDKTQ 864
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 36/175 (20%), Positives = 62/175 (35%), Gaps = 4/175 (2%)
Query: 61 CDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYL 120
C E + LS ++P + S + L FN L + ++ SEL L L
Sbjct: 7 CIEVVPNITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDL 63
Query: 121 NVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPAS 180
+ + + +L L L N + P L L L +L
Sbjct: 64 SRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFP 123
Query: 181 LGDLGMLMRLDLSFNNLFG-PVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNG 234
+G L L +L+++ N + +P +N+ L +D+ N L+ L
Sbjct: 124 IGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-25
Identities = 33/156 (21%), Positives = 50/156 (32%), Gaps = 2/156 (1%)
Query: 80 EIPAAVGGLKSLTGLYLHFNALNGVIPKE-IASLSELSDLYLNVNNLSGKIPSQIGNMTN 138
+ A GL+ L L + L V SL +L L ++ N +T+
Sbjct: 390 IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTS 449
Query: 139 LQVLQLCYNKLTGNIPTQ-LGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNL 197
L L++ N N + + L+ L L QL L L L++S NNL
Sbjct: 450 LNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509
Query: 198 FGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233
+ L LD N +
Sbjct: 510 LFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPK 545
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-25
Identities = 40/189 (21%), Positives = 66/189 (34%), Gaps = 6/189 (3%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
+ L + A GL L+ L L N + P + L+ L +L L+
Sbjct: 61 LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLE 120
Query: 130 PSQIGNMTNLQVLQLCYNKLTG-NIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGML- 187
IG + L+ L + +N + +P +L L + L YN + L L
Sbjct: 121 SFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENP 180
Query: 188 ---MRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAAL 244
+ LD+S N + + + KL L +R N S N+ + G
Sbjct: 181 QVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILG 239
Query: 245 CGTGFTNLK 253
NL+
Sbjct: 240 EFKDERNLE 248
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 34/155 (21%), Positives = 55/155 (35%), Gaps = 2/155 (1%)
Query: 70 ISLQGKGLSGEIPA-AVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK 128
+ Q L A L+ L L + + L+ L+ L + N+
Sbjct: 404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDN 463
Query: 129 IPSQI-GNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGML 187
S + N TNL L L +L +L +L +L + +N L + L L
Sbjct: 464 TLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSL 523
Query: 188 MRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFS 222
LD SFN + + L ++ NNS +
Sbjct: 524 STLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-21
Identities = 34/159 (21%), Positives = 49/159 (30%), Gaps = 5/159 (3%)
Query: 78 SGEIPAAVGGLKSLTGLYLHFNALNGVIPK--EIASLSELSDLYLNVNNLSGKIPSQIGN 135
G I L SL+ L L NAL+ + L L L+ N + +
Sbjct: 339 KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMG 397
Query: 136 MTNLQVLQLCYNKLTGNIPTQ-LGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSF 194
+ LQ L ++ L SL KL L + Y L L L ++
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAG 457
Query: 195 NNL-FGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232
N+ + AN L LD+ L
Sbjct: 458 NSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTL 496
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 7e-19
Identities = 38/162 (23%), Positives = 57/162 (35%), Gaps = 7/162 (4%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSG- 127
N+ L G + P + GL SL L L + I L L L + N +
Sbjct: 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSC 143
Query: 128 KIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLS----VLALQYNQLTGAIPASLGD 183
K+P+ N+TNL + L YN + L LR+ L + N + +
Sbjct: 144 KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQG 203
Query: 184 LGMLMRLDLSFNNLFGPVPVK-LANVPKLEVLDIRNNSFSGN 224
+ L L L N + L N+ L V + F
Sbjct: 204 IK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDE 244
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-14
Identities = 31/173 (17%), Positives = 54/173 (31%), Gaps = 16/173 (9%)
Query: 70 ISLQGKGLSGEIPA-AVGGLKSLTGLYLHFNALNG------VIPKEIASLSELS--DLYL 120
++L+G S I + L L L P + L +++ + L
Sbjct: 209 LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 268
Query: 121 NVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPAS 180
N + + N+ + L + + K L++ QL P
Sbjct: 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ-FPTL 325
Query: 181 LGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233
DL L L L+ N +P L LD+ N+ S + + L
Sbjct: 326 --DLPFLKSLTLTMNKGSISFK--KVALPSLSYLDLSRNALSFSGCCSYSDLG 374
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 62/278 (22%), Positives = 108/278 (38%), Gaps = 32/278 (11%)
Query: 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDE-GEFLKGLKILTSLKHENLASLRG 466
L+GK F Y G VA++ I D+ F + + +HEN+ G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
C S +I L + ++ VL+ + + I KG+ YLH K
Sbjct: 97 ACMSPPH--LAIITSLCKGRTLYSVV---RDAKIVLDVNKTRQIAQEIVKGMGYLHAK-- 149
Query: 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSML-KASAAMG---YLAPE---- 578
G++H +L ++ V +++D GL + K G +LAPE
Sbjct: 150 GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 579 -----YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAES--SKVEDFIDPNLEG 631
F++ SD++A G I +++ + + PF Q AE+ ++ + PNL
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREW---PFKTQPAEAIIWQMGTGMKPNL-S 264
Query: 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSI 669
+ + + + I L C RP+ +M L +
Sbjct: 265 QIGMGKE--ISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 37/162 (22%), Positives = 64/162 (39%), Gaps = 11/162 (6%)
Query: 80 EIPAAVGGLKSLTGLYL-HFNAL--------NGVIPKEIASLSELSDLYLNVNNLSGKIP 130
+PA++ L L L + L + E L L L L + +P
Sbjct: 141 ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLP 199
Query: 131 SQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRL 190
+ I N+ NL+ L++ + L+ + + L KL L L+ P G L RL
Sbjct: 200 ASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258
Query: 191 DLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232
L + +P+ + + +LE LD+R +P + +L
Sbjct: 259 ILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQL 300
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 34/153 (22%), Positives = 59/153 (38%), Gaps = 5/153 (3%)
Query: 78 SGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMT 137
S + GL +L L L + + +P IA+L L L + + LS + I ++
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLP 229
Query: 138 NLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQ-YNQLTGAIPASLGDLGMLMRLDLSFNN 196
L+ L L N P G L L L+ + L +P + L L +LDL
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCV 288
Query: 197 LFGPVPVKLANVPKLEVLDIRNNSFSGNVPPAL 229
+P +A +P ++ + + +
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPH-LQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 38/173 (21%), Positives = 65/173 (37%), Gaps = 17/173 (9%)
Query: 71 SLQGKGLSGEIPAAVGGLKS--LTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK 128
+ G+ L + L L L P + LS L + ++ L +
Sbjct: 62 TRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-E 118
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGM-- 186
+P + L+ L L N L +P + SL +L L+++ +P L
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 187 -------LMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232
L L L + + +P +AN+ L+ L IRN+ S + PA+ L
Sbjct: 178 EHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSA-LGPAIHHL 228
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 26/149 (17%), Positives = 48/149 (32%), Gaps = 8/149 (5%)
Query: 89 KSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSG--KIPSQIGN--MTNLQVLQL 144
L+ H+NA + ++ + + + L+L
Sbjct: 30 DVLSQWQRHYNADRN-RWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALEL 88
Query: 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVK 204
L P Q L L + + L +P ++ L L L+ N L +P
Sbjct: 89 RSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPL-RALPAS 145
Query: 205 LANVPKLEVLDIRNNSFSGNVPPALKRLN 233
+A++ +L L IR +P L +
Sbjct: 146 IASLNRLRELSIRACPELTELPEPLASTD 174
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 20/93 (21%), Positives = 36/93 (38%), Gaps = 5/93 (5%)
Query: 72 LQGKGLSGEIPAAVGGLKSLTGLYL-HFNALNGVIPKEIASLSELSDLYLNVNNLSGKIP 130
L+G P GG L L L + L +P +I L++L L L ++P
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNL-LTLPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 131 SQIGNMTNLQVLQLCYN---KLTGNIPTQLGSL 160
S I + ++ + + +L + P +
Sbjct: 295 SLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 6e-10
Identities = 21/143 (14%), Positives = 34/143 (23%), Gaps = 26/143 (18%)
Query: 112 LSELSDLYLNVNNLSGKIPSQIGNM--------------------TNLQVLQLCYNKLTG 151
S +LY + + N Q+ L
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK- 69
Query: 152 NIPTQLGSLR--KLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVP 209
L L L+ L P L L + + L +P +
Sbjct: 70 ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFA 127
Query: 210 KLEVLDIRNNSFSGNVPPALKRL 232
LE L + N +P ++ L
Sbjct: 128 GLETLTLARNPLR-ALPASIASL 149
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 10/101 (9%), Positives = 23/101 (22%), Gaps = 6/101 (5%)
Query: 133 IGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDL 192
+ + + L + L ++ +
Sbjct: 8 HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETR 63
Query: 193 SFNNLFG-PVPVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232
+ L ++ A P L++R+ P RL
Sbjct: 64 TGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRL 103
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-25
Identities = 40/183 (21%), Positives = 61/183 (33%), Gaps = 5/183 (2%)
Query: 52 SSDSFDGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIAS 111
++ S E + N + GL+ EIP + S L FN L + +
Sbjct: 1 TTSSDQKCIEKEVNKTYN--CENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSR 55
Query: 112 LSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYN 171
L L+ L L + + L L L N L T L + L L
Sbjct: 56 LINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQT 115
Query: 172 QLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKR 231
++ L + L L L N++ K KL+VLD +NN+ +
Sbjct: 116 GISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSS 175
Query: 232 LNG 234
L
Sbjct: 176 LQQ 178
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-25
Identities = 35/158 (22%), Positives = 65/158 (41%), Gaps = 4/158 (2%)
Query: 80 EIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQ-IGNMTN 138
E+P+ + GL +L L L N + ++ L+ L + N ++ + + N+ N
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351
Query: 139 LQVLQLCYNKLT--GNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNN 196
L+ L L ++ + QL +L L L L YN+ + + L LDL+F
Sbjct: 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411
Query: 197 LFG-PVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233
L N+ L+VL++ ++ + L
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP 449
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-24
Identities = 39/160 (24%), Positives = 58/160 (36%), Gaps = 4/160 (2%)
Query: 78 SGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIP-SQIGNM 136
S + L L L L +N + + +L L L L K S N+
Sbjct: 365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNL 424
Query: 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAI---PASLGDLGMLMRLDLS 193
L+VL L ++ L + L L L LQ N SL LG L L LS
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484
Query: 194 FNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233
F +L ++ + +D+ +N + + AL L
Sbjct: 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK 524
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-23
Identities = 37/168 (22%), Positives = 61/168 (36%), Gaps = 5/168 (2%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEI-ASLSELSDLYLNVNNLSGK 128
++L A L L L F L + +L L L L+ + L
Sbjct: 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS 440
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNI---PTQLGSLRKLSVLALQYNQLTGAIPASLGDLG 185
+ LQ L L N L +L +L +L L + L+ + L
Sbjct: 441 SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLK 500
Query: 186 MLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233
M+ +DLS N L L+++ + L++ +N S +P L L+
Sbjct: 501 MMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILS 547
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 33/182 (18%), Positives = 54/182 (29%), Gaps = 2/182 (1%)
Query: 77 LSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNM 136
L L +LT L L + + S L L L N L + +
Sbjct: 45 LPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGP 104
Query: 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNN 196
L+ L ++ L + + L L L N ++ L LD N
Sbjct: 105 KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164
Query: 197 LFGPVPVKLANVPKLEV--LDIRNNSFSGNVPPALKRLNGGFQYDNNAALCGTGFTNLKN 254
+ ++++ + L++ N +G P A F LKN
Sbjct: 165 IHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKN 224
Query: 255 CT 256
T
Sbjct: 225 ST 226
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 32/146 (21%), Positives = 60/146 (41%), Gaps = 4/146 (2%)
Query: 90 SLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKL 149
S+ + L + + S L +L L +LS ++PS + ++ L+ L L NK
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKF 313
Query: 150 TGNIPTQLGSLRKLSVLALQYNQLTGAI-PASLGDLGMLMRLDLSFNNL--FGPVPVKLA 206
+ L+ L+++ N + L +L L LDLS +++ ++L
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373
Query: 207 NVPKLEVLDIRNNSFSGNVPPALKRL 232
N+ L+ L++ N A K
Sbjct: 374 NLSHLQSLNLSYNEPLSLKTEAFKEC 399
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-22
Identities = 29/148 (19%), Positives = 60/148 (40%), Gaps = 4/148 (2%)
Query: 80 EIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIG---NM 136
+ + L L L L + L+ + L L L L N+ + +
Sbjct: 416 DAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475
Query: 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNN 196
L++L L + L+ SL+ ++ + L +N+LT + +L L + L+L+ N+
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNH 534
Query: 197 LFGPVPVKLANVPKLEVLDIRNNSFSGN 224
+ +P L + + +++R N
Sbjct: 535 ISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-19
Identities = 30/168 (17%), Positives = 58/168 (34%), Gaps = 6/168 (3%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLS-GK 128
+ L +S + L L NA++ + ++++SL + ++L LN+N
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQLG--SLRKLSVLALQYNQLTGAIPASLGDLGM 186
I + Q L + I L +++ L + + PA L
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253
Query: 187 --LMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232
+ ++L + F L+ LD+ S +P L L
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGL 300
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-18
Identities = 29/131 (22%), Positives = 53/131 (40%), Gaps = 4/131 (3%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKE---IASLSELSDLYLNVNNLS 126
++L L GL +L L L N ++ + +L L L L+ +LS
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
Query: 127 GKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGM 186
++ + + L +N+LT + L L+ + L L N ++ +P+ L L
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQ 548
Query: 187 LMRLDLSFNNL 197
++L N L
Sbjct: 549 QRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-17
Identities = 24/168 (14%), Positives = 47/168 (27%), Gaps = 7/168 (4%)
Query: 71 SLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIP 130
G+S + K+L LYL N ++ + + +L L N +
Sbjct: 111 FFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170
Query: 131 SQIGNMTNLQV--LQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLG--DLGM 186
+ ++ L L N + G I L Q I L +
Sbjct: 171 EDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQS 229
Query: 187 LMRLDLSFNNLFGPVPVKLANVPK--LEVLDIRNNSFSGNVPPALKRL 232
L + P + + +E ++++ + F
Sbjct: 230 LWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCF 277
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-15
Identities = 26/150 (17%), Positives = 54/150 (36%), Gaps = 5/150 (3%)
Query: 73 QGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQ 132
+ + ++ L L L L F L+ + SL ++ + L+ N L+
Sbjct: 460 HFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEA 519
Query: 133 IGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDL 192
+ ++ + L L N ++ +P+ L L + + L+ N L + L
Sbjct: 520 LSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN----IYFLEWYKE 574
Query: 193 SFNNLFGPVPVKLANVPKLEVLDIRNNSFS 222
+ L N P L + + + + S
Sbjct: 575 NMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 24/127 (18%), Positives = 43/127 (33%), Gaps = 5/127 (3%)
Query: 71 SLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIP 130
L LS A LK + + L N L + ++ L + L L N++S +P
Sbjct: 482 VLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILP 540
Query: 131 SQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRL 190
S + ++ + + L N L + +L + +L +
Sbjct: 541 SLLPILSQQRTINLRQNPLDCTC--SNIYFLEW--YKENMQKLEDTEDTLCENPPLLRGV 596
Query: 191 DLSFNNL 197
LS L
Sbjct: 597 RLSDVTL 603
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-25
Identities = 64/275 (23%), Positives = 118/275 (42%), Gaps = 37/275 (13%)
Query: 410 LGKSSFSATYKGILRDGSV-VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGIC 468
+G+ +F + G LR + VAVK +T + +FL+ +IL H N+ L G+C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 469 CSKGRGE-CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG 527
+ + +++ + V G+ L L E L T + ++ A G+ YL K
Sbjct: 182 T---QKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESKC-- 233
Query: 528 LVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAA-MGYLAPEYTTTGRFT 586
+H +L+A L+ + +SD G+ + AD + + + + APE GR++
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 587 EKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE-------- 637
+SD+++FG+++++ S G P+ N + + V +
Sbjct: 294 SESDVWSFGILLWETFSLGAS---PYPNL------------SNQQTREFVEKGGRLPCPE 338
Query: 638 --ASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+ ++ C P RPS + QEL SI
Sbjct: 339 LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-25
Identities = 62/269 (23%), Positives = 120/269 (44%), Gaps = 19/269 (7%)
Query: 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
LG+ F + G + VA+K + + FL+ +++ L+HE L L +
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG 527
+ +++ +++ G+LL L E G K L + + IA G++Y+
Sbjct: 248 VSEEPI---YIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN-- 300
Query: 528 LVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTE 587
VH +L A +L+ ++D GL +L+ D+ + A + + APE GRFT
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 588 KSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPN--LEGKFSVSEASNLGQI 644
KSD+++FG+++ ++ + G+ P+ + +V D ++ + E+ L +
Sbjct: 361 KSDVWSFGILLTELTTKGR---VPY--PGMVNREVLDQVERGYRMPCPPECPES--LHDL 413
Query: 645 ALHCTHESPSHRPSIENVMQELSSIIGSS 673
C + P RP+ E + L S+
Sbjct: 414 MCQCWRKEPEERPTFEYLQAFLEDYFTST 442
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 67/270 (24%), Positives = 130/270 (48%), Gaps = 19/270 (7%)
Query: 408 NLLGKSSFSATYKGILRDGSV-VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRG 466
+ LG + Y+G+ + S+ VAVK + + + + EFLK ++ +KH NL L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
+C + ++I +F+ GNLL +L + + + + I+ + YL K
Sbjct: 284 VCTREPP--FYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN- 338
Query: 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFT 586
+H NL+A L+ + ++D GL +L+ D + A + + APE +F+
Sbjct: 339 -FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 587 EKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPN--LEGKFSVSEASNLGQ 643
KSD++AFG+++++I + G +P+ + S+V + ++ + +E E + +
Sbjct: 398 IKSDVWAFGVLLWEIATYGM---SPY--PGIDLSQVYELLEKDYRMERPEGCPEK--VYE 450
Query: 644 IALHCTHESPSHRPSIENVMQELSSIIGSS 673
+ C +PS RPS + Q ++ S
Sbjct: 451 LMRACWQWNPSDRPSFAEIHQAFETMFQES 480
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 62/285 (21%), Positives = 120/285 (42%), Gaps = 36/285 (12%)
Query: 410 LGKSSFSATYKGIL-----RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASL 464
LG+ F G VAVK + S + + K ++IL +L HEN+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK 524
+GIC G LI +F+P+G+L ++L ++ + ++ I KG+ YL +
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 525 RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAM--GYLAPEYTTT 582
+ VH +L+A VL+ + + D GL K + D + +K + APE
Sbjct: 146 Q--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203
Query: 583 GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA---- 638
+F SD+++FG+ + ++L+ + + + + G+ +V+
Sbjct: 204 SKFYIASDVWSFGVTLHELLT-------YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256
Query: 639 -------------SNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+ Q+ C PS+R S +N+++ +++
Sbjct: 257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-24
Identities = 62/269 (23%), Positives = 120/269 (44%), Gaps = 19/269 (7%)
Query: 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
LG+ F + G + VA+K + + FL+ +++ L+HE L L +
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG 527
+ +++ +++ G+LL L E G K L + + IA G++Y+
Sbjct: 331 VSEEPI---YIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN-- 383
Query: 528 LVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTE 587
VH +L A +L+ ++D GL +L+ D+ + A + + APE GRFT
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 588 KSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPN--LEGKFSVSEASNLGQI 644
KSD+++FG+++ ++ + G+ P+ + +V D ++ + E+ L +
Sbjct: 444 KSDVWSFGILLTELTTKGR---VPY--PGMVNREVLDQVERGYRMPCPPECPES--LHDL 496
Query: 645 ALHCTHESPSHRPSIENVMQELSSIIGSS 673
C + P RP+ E + L S+
Sbjct: 497 MCQCWRKEPEERPTFEYLQAFLEDYFTST 525
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 67/286 (23%), Positives = 122/286 (42%), Gaps = 38/286 (13%)
Query: 410 LGKSSFSATYKGILR-----DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASL 464
LGK +F + G VVAVK + + S + +F + ++IL SL+H+N+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHL---DLEAGSEKVLEWATRISVIKGIAKGISYL 521
+G+C S GR LI +++P G+L +L K+L++ + I KG+ YL
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QICKGMEYL 130
Query: 522 HGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAM--GYLAPEY 579
KR +H +L+ +L+ + D GL K+L D F +K + APE
Sbjct: 131 GTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 580 TTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638
T +F+ SD+++FG++++++ + + S +P + + E
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH----LIEL 244
Query: 639 SNLG--------------QIALHCTHESPSHRPSIENVMQELSSII 670
I C + + + RPS ++ + I
Sbjct: 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 63/282 (22%), Positives = 119/282 (42%), Gaps = 48/282 (17%)
Query: 410 LGKSSFSATYKGILRDGS-----VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASL 464
LG +F YKG+ VA+K + + + E L ++ S+ + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHL---DLEAGSEKVLEWATRISVIKGIAKGISYL 521
GIC + LI +P G LL ++ GS+ +L W IAKG++YL
Sbjct: 83 LGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYL 133
Query: 522 HGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL-ADDIVFSMLKASAAMGYLAPEYT 580
+R LVH +L+A VL+ + ++D GL KLL A++ + + ++A E
Sbjct: 134 EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 581 TTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID-----------PN 628
+T +SD++++G+ V+++++ G P+ +S++ ++
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGS---KPY--DGIPASEISSILEKGERLPQPPICT- 245
Query: 629 LEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
++ I C RP ++ E S +
Sbjct: 246 ----------IDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 60/297 (20%), Positives = 126/297 (42%), Gaps = 41/297 (13%)
Query: 396 EVERATQCFSEANLLGKSSFSATYKGILRDGS----VVAVKCIAKTSCKSDEGEFLKGLK 451
+ ++GK F Y G D + A+K +++ + FL+
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74
Query: 452 ILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVI 511
++ L H N+ +L G G ++ ++ +G+LLQ + ++ IS
Sbjct: 75 LMRGLNHPNVLALIG-IMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFG 130
Query: 512 KGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAA 571
+A+G+ YL ++ VH +L+A ++ + ++D GL + + D +S+ + A
Sbjct: 131 LQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA 188
Query: 572 M---GYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID- 626
+ A E T RFT KSD+++FG++++++L+ G P+ + + + F+
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGA---PPY--RHIDPFDLTHFLAQ 243
Query: 627 ----------PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
P+ +L Q+ C P+ RP+ ++ E+ I+ +
Sbjct: 244 GRRLPQPEYCPD-----------SLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 59/286 (20%), Positives = 117/286 (40%), Gaps = 34/286 (11%)
Query: 410 LGKSSFSATYKGILRD-----GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASL 464
LG+ F G +VAVK + + + + + IL +L HE++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK 524
+G C G L+ ++VP G+L +L + A + + I +G++YLH +
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 525 RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAM--GYLAPEYTTT 582
+H +L+A VL+ + D GL K + + + ++ + APE
Sbjct: 154 H--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 583 GRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641
+F SD+++FG+ ++++L+ S +P T+ + + L ++E
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM-TVLR----LTELLER 266
Query: 642 GQ--------------IALHCTHESPSHRPSIENVMQELSSIIGSS 673
G+ + +C S RP+ EN++ L ++
Sbjct: 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 64/283 (22%), Positives = 121/283 (42%), Gaps = 32/283 (11%)
Query: 410 LGKSSFSATYKGIL-----RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASL 464
LGK +F + G VVAVK + + S + +F + ++IL SL+H+N+
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK 524
+G+C S GR LI +++P G+L +L ++ ++ + I KG+ YL K
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 525 RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAM--GYLAPEYTTT 582
R +H +L+ +L+ + D GL K+L D + +K + APE T
Sbjct: 165 R--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 222
Query: 583 GRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641
+F+ SD+++FG++++++ + + S +P + + E
Sbjct: 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH----LIELLKN 278
Query: 642 G--------------QIALHCTHESPSHRPSIENVMQELSSII 670
I C + + + RPS ++ + I
Sbjct: 279 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 58/269 (21%), Positives = 115/269 (42%), Gaps = 19/269 (7%)
Query: 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
LG F + + VAVK + S FL ++ +L+H+ L L +
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG 527
+ ++I +F+ G+LL L + G I IA+G++++ +
Sbjct: 252 VTKEP---IYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRN-- 304
Query: 528 LVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTE 587
+H +L A +L+ ++D GL +++ D+ + A + + APE G FT
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 588 KSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPN--LEGKFSVSEASNLGQI 644
KSD+++FG+++ +I++ G+ P+ + +V ++ + + E L I
Sbjct: 365 KSDVWSFGILLMEIVTYGR---IPY--PGMSNPEVIRALERGYRMPRPENCPEE--LYNI 417
Query: 645 ALHCTHESPSHRPSIENVMQELSSIIGSS 673
+ C P RP+ E + L ++
Sbjct: 418 MMRCWKNRPEERPTFEYIQSVLDDFYTAT 446
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 63/299 (21%), Positives = 127/299 (42%), Gaps = 45/299 (15%)
Query: 396 EVERATQCFSEANLLGKSSFSATYKGILRDGS----VVAVKCIAKTSCKSDEGEFLKGLK 451
+ ++ ++G+ F Y G L D AVK + + + + +FL
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 78
Query: 452 ILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVI 511
I+ H N+ SL G C + G ++ ++ +G+L + E + V + I
Sbjct: 79 IMKDFSHPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFG 134
Query: 512 KGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAA 571
+AKG+ YL K+ VH +L+A ++ ++ ++D GL + + D +S+ + A
Sbjct: 135 LQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 192
Query: 572 MGYL-----APEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFI 625
L A E T +FT KSD+++FG++++++++ G P+ + + ++
Sbjct: 193 K--LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA---PPY--PDVNTFDITVYL 245
Query: 626 D-----------PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
P+ L ++ L C H RPS ++ +S+I +
Sbjct: 246 LQGRRLLQPEYCPD-----------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 5e-23
Identities = 61/264 (23%), Positives = 123/264 (46%), Gaps = 19/264 (7%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
+G F + G + VA+K I + + E +F++ +++ L H L L G+C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVC- 72
Query: 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLV 529
+ L+ +F+ +G L +L + T + + + +G++YL ++
Sbjct: 73 LEQA-PICLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VI 126
Query: 530 HPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKS 589
H +L+A L+ +SD G+ + + DD S + + +PE + R++ KS
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 590 DIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPN--LEGKFSVSEASNLGQIAL 646
D+++FG++++++ S GK P+ + +S+V + I L S + QI
Sbjct: 187 DVWSFGVLMWEVFSEGK---IPY--ENRSNSEVVEDISTGFRLYKPRLASTH--VYQIMN 239
Query: 647 HCTHESPSHRPSIENVMQELSSII 670
HC E P RP+ ++++L+ I
Sbjct: 240 HCWRERPEDRPAFSRLLRQLAEIA 263
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 6e-23
Identities = 59/267 (22%), Positives = 122/267 (45%), Gaps = 19/267 (7%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
LG F + G + VAVK + + S FL ++ L+H+ L L +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLV 529
+ ++I +++ NG+L+ L +G + L + + IA+G++++ + +
Sbjct: 79 QEPI---YIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEERN--YI 131
Query: 530 HPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKS 589
H +L A +L+ + ++D GL +L+ D+ + A + + APE G FT KS
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 590 DIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPN--LEGKFSVSEASNLGQIAL 646
D+++FG+++ +I++ G+ P+ + +V ++ + + E L Q+
Sbjct: 192 DVWSFGILLTEIVTHGRI---PY--PGMTNPEVIQNLERGYRMVRPDNCPEE--LYQLMR 244
Query: 647 HCTHESPSHRPSIENVMQELSSIIGSS 673
C E P RP+ + + L ++
Sbjct: 245 LCWKERPEDRPTFDYLRSVLEDFFTAT 271
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 69/282 (24%), Positives = 136/282 (48%), Gaps = 21/282 (7%)
Query: 396 EVERATQCFSEANLLGKSSFSATYKGILRDGSV-VAVKCIAKTSCKSDEGEFLKGLKILT 454
E+ER + + LG + Y+G+ + S+ VAVK + + + + EFLK ++
Sbjct: 9 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMK 64
Query: 455 SLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGI 514
+KH NL L G C++ ++I +F+ GNLL +L + + + + + I
Sbjct: 65 EIKHPNLVQLLG-VCTRE-PPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQI 120
Query: 515 AKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGY 574
+ + YL K +H +L+A L+ + ++D GL +L+ D + A + +
Sbjct: 121 SSAMEYLEKK--NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 575 LAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPN--LEG 631
APE +F+ KSD++AFG+++++I + G +P+ + S+V + ++ + +E
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGM---SPY--PGIDLSQVYELLEKDYRMER 233
Query: 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
E + ++ C +PS RPS + Q ++ S
Sbjct: 234 PEGCPEK--VYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 37/174 (21%), Positives = 59/174 (33%), Gaps = 4/174 (2%)
Query: 61 CDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYL 120
C E +IP + S L L FN L + S EL L L
Sbjct: 3 CVEVVPNITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 121 NVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPAS 180
+ + ++++L L L N + L L L L
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 181 LGDLGMLMRLDLSFNNL-FGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233
+G L L L+++ N + +P +N+ LE LD+ +N L+ L+
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH 173
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-20
Identities = 31/157 (19%), Positives = 59/157 (37%), Gaps = 3/157 (1%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEI-ASLSELSDLYLNVNNLSGK 128
+ L G+ + + GL+ L L + L + + SL L L ++ +
Sbjct: 378 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQ-LGSLRKLSVLALQYNQLTGAIPASLGDLGML 187
+++L+VL++ N N LR L+ L L QL P + L L
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 496
Query: 188 MRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224
L+++ N L + L+ + + N + +
Sbjct: 497 QVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-18
Identities = 38/159 (23%), Positives = 56/159 (35%), Gaps = 5/159 (3%)
Query: 78 SGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIP-SQIGNM 136
G + G SL L L FN + + L +L L +NL S ++
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 420
Query: 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPA-SLGDLGMLMRLDLSFN 195
NL L + + L L VL + N +L L LDLS
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 196 NLFGPVPVKLANVPKLEVLDIRNNSFSGNVPP-ALKRLN 233
L P ++ L+VL++ +N +VP RL
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLT 518
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 8e-17
Identities = 39/146 (26%), Positives = 56/146 (38%), Gaps = 6/146 (4%)
Query: 87 GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLS--GKIPSQIGNMTNLQVLQL 144
LKSL L N + L L L L+ N LS G T+L+ L L
Sbjct: 323 KLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPAS-LGDLGMLMRLDLSFNNLFGPVPV 203
+N + + + L +L L Q++ L S L L+ LD+S +
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 204 KLANVPKLEVLDIRNNSFSGNVPPAL 229
+ LEVL + NSF N P +
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDI 465
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 32/193 (16%), Positives = 61/193 (31%), Gaps = 16/193 (8%)
Query: 78 SGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELS----DLYLNVNNLSGKIPSQI 133
S ++P L +L L L N + + ++ L ++ L L++N ++ I
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA 196
Query: 134 GNMTNLQVLQLCYNKLTGNIP-TQLGSLRKLSVLALQY------NQLTGAIPASLGDLGM 186
L L L N + N+ T + L L V L L ++L L
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 187 LM--RLDLSFNNLFGPVPVKL-ANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAA 243
L L++ + + + L + + + + + V N
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCK 315
Query: 244 LCGTGFTNLKNCT 256
LK+
Sbjct: 316 FGQFPTLKLKSLK 328
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 32/158 (20%), Positives = 59/158 (37%), Gaps = 23/158 (14%)
Query: 87 GLKSLTGLYLHFNALNGVIPKEIASLSELSDL-YLNVNNLSGKIPSQIGNMTNLQVLQLC 145
GL +LT L+ + I + L+++ ++ +++ + Q L+L
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELV 312
Query: 146 YNKLTGNIPTQLGSLRKLS-------------------VLALQYNQLT--GAIPASLGDL 184
K +L SL++L+ L L N L+ G S
Sbjct: 313 NCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT 372
Query: 185 GMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFS 222
L LDLSFN + + + +LE LD ++++
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK 409
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 37/204 (18%), Positives = 66/204 (32%), Gaps = 30/204 (14%)
Query: 70 ISLQGKGLSGEIPA-AVGGLKSLTGLYL---HFNALNGVIPKEIASLSELSDLYLNVNNL 125
++L+ S + + GL L L F + + ++L L +L + L
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
Query: 126 SG------KIPSQIGNMTNLQVLQLCYNKLTGNIP-TQLGSLRKLSVLALQYNQLTGAIP 178
+ I +TN+ L + + + L ++ ++ Q
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT--- 321
Query: 179 ASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNN--------SFSGNVPPALK 230
L L RL + N ++P LE LD+ N S S +LK
Sbjct: 322 ---LKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 231 RLNGGFQYDNNAALCGTGFTNLKN 254
L+ F N + F L+
Sbjct: 377 YLDLSF---NGVITMSSNFLGLEQ 397
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 21/85 (24%), Positives = 31/85 (36%), Gaps = 1/85 (1%)
Query: 71 SLQGKGLSGEIPAAV-GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
+ G + L++LT L L L + P SLS L L + N L
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVP 510
Query: 130 PSQIGNMTNLQVLQLCYNKLTGNIP 154
+T+LQ + L N + P
Sbjct: 511 DGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 65/263 (24%), Positives = 120/263 (45%), Gaps = 19/263 (7%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
LG F G + VAVK I + S E EF + + + L H L G+C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVC- 72
Query: 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLV 529
SK +++ +++ NG LL +L LE + + + + +G+++L +
Sbjct: 73 SKEY-PIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFLESH--QFI 126
Query: 530 HPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKS 589
H +L+A L+ R +SD G+ + + DD S + + + APE +++ KS
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 590 DIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPN--LEGKFSVSEASNLGQIAL 646
D++AFG++++++ S GK P+ +S+V + L S+ + QI
Sbjct: 187 DVWAFGILMWEVFSLGK---MPY--DLYTNSEVVLKVSQGHRLYRPHLASDT--IYQIMY 239
Query: 647 HCTHESPSHRPSIENVMQELSSI 669
C HE P RP+ + ++ + +
Sbjct: 240 SCWHELPEKRPTFQQLLSSIEPL 262
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 65/371 (17%), Positives = 140/371 (37%), Gaps = 46/371 (12%)
Query: 327 YRRRKQKIGNAFD--NSDSRLSTDQVKEVCRRNSSPLISLEYSNGWDPLAKGQSGNGFSQ 384
+ A + + +C + + + +G +
Sbjct: 9 HHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDL 68
Query: 385 EVLESFMFNL---EEVERATQCFSEANLLGKSSFSATYKGILRDGS----VVAVKCIAKT 437
L + + ++ ++G+ F Y G L D AVK + +
Sbjct: 69 SALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 128
Query: 438 SCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAG 497
+ + +FL I+ H N+ SL G C + G ++ ++ +G+L + E
Sbjct: 129 TDIGEVSQFLTEGIIMKDFSHPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETH 187
Query: 498 SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557
+ V + I +AKG+ +L K+ VH +L+A ++ ++ ++D GL + +
Sbjct: 188 NPTVKD---LIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM 242
Query: 558 ADDIVFSMLKASAAM---GYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTR 613
D S+ + A ++A E T +FT KSD+++FG++++++++ G P+
Sbjct: 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA---PPY-- 297
Query: 614 QAAESSKVEDFID-----------PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENV 662
+ + ++ P L ++ L C H RPS +
Sbjct: 298 PDVNTFDITVYLLQGRRLLQPEYCP-----------DPLYEVMLKCWHPKAEMRPSFSEL 346
Query: 663 MQELSSIIGSS 673
+ +S+I +
Sbjct: 347 VSRISAIFSTF 357
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 34/206 (16%), Positives = 60/206 (29%), Gaps = 17/206 (8%)
Query: 80 EIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSG-KIPSQIGNMTN 138
+ + +YL N + + + S + L L +N + +
Sbjct: 113 RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 139 LQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLF 198
L+ L L YN + ++ Q+ KL L L N+L + + + L N L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL- 226
Query: 199 GPVPVKLANVPKLEVLDIRNNSFSGNVPPALK-RLNGGFQYDNNAALCGTGFTNLKNCTA 257
+ L LE D+R N F + +K T
Sbjct: 227 VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ---------TVKKLTG 277
Query: 258 SDHPTPGKPEPFEPNGLSTKDIPESA 283
+ P +D+P
Sbjct: 278 QNEEECTVPTLGHYGAYCCEDLPAPF 303
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 25/152 (16%), Positives = 58/152 (38%), Gaps = 10/152 (6%)
Query: 71 SLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIP 130
+ L + + ++ L L N L+ + ++A ++L L L+ N L +
Sbjct: 16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL 74
Query: 131 SQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRL 190
+ +++ L+ L L N + +L + L N ++ + S G +
Sbjct: 75 D-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSRGQG--KKNI 125
Query: 191 DLSFNNLFGPVPVKLANVPKLEVLDIRNNSFS 222
L+ N + + +++ LD++ N
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 33/175 (18%), Positives = 60/175 (34%), Gaps = 6/175 (3%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGV-IPKEIASLSELSDLYLNVNNLSG 127
NI L ++ G + L L N ++ V + AS L L L N +
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 128 KIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGML 187
+ Q+ L+ L L NKL + + S ++ ++L+ N+L I +L L
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239
Query: 188 MRLDLSFNNL-FGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNN 241
DL N G + + +++ + + + Y
Sbjct: 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAY 294
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 31/133 (23%), Positives = 50/133 (37%), Gaps = 12/133 (9%)
Query: 105 IPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLS 164
I + + + + ++L + S + N++ L L N L+ L KL
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 165 VLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224
+L L N L L L L LDL+ N + +L P +E L NN+ S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-R 113
Query: 225 VPPA----LKRLN 233
V + K +
Sbjct: 114 VSCSRGQGKKNIY 126
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 24/154 (15%), Positives = 47/154 (30%), Gaps = 7/154 (4%)
Query: 80 EIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNL 139
+L L L +N + + ++ ++L L L+ N L+ + + + +
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGV 216
Query: 140 QVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFG 199
+ L NKL I L + L L+ N R+
Sbjct: 217 TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQRVQTVAKQTVK 273
Query: 200 PVPVKLANVPKLEVLDIRNNSFSGNVP-PALKRL 232
+ + + L ++P P RL
Sbjct: 274 KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRL 307
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 4e-22
Identities = 32/154 (20%), Positives = 67/154 (43%), Gaps = 12/154 (7%)
Query: 84 AVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143
+ L SL + N + + P +A+++ L+ L + N ++ P + N++ L L+
Sbjct: 194 PLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLE 249
Query: 144 LCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPV 203
+ N+++ +I + L KL +L + NQ++ + L +L L L L+ N L
Sbjct: 250 IGTNQIS-DINA-VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDME 305
Query: 204 KLANVPKLEVLDIRNNSFSGNVP----PALKRLN 233
+ + L L + N + P + +
Sbjct: 306 VIGGLTNLTTLFLSQNHITDIRPLASLSKMDSAD 339
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 4e-22
Identities = 40/144 (27%), Positives = 67/144 (46%), Gaps = 9/144 (6%)
Query: 80 EIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNL 139
+A+ L +L LYL+ + ++ + P +A+L+++ L L N+ S + NMT L
Sbjct: 101 TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGL 157
Query: 140 QVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFG 199
L + +K+ P + +L L L+L YNQ+ P L L L N +
Sbjct: 158 NYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD 213
Query: 200 PVPVKLANVPKLEVLDIRNNSFSG 223
P +AN+ +L L I NN +
Sbjct: 214 ITP--VANMTRLNSLKIGNNKITD 235
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 4e-22
Identities = 37/136 (27%), Positives = 68/136 (50%), Gaps = 8/136 (5%)
Query: 84 AVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143
V + L L + N + + P +A+LS+L+ L + N +S + + ++T L++L
Sbjct: 216 PVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLN 271
Query: 144 LCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPV 203
+ N+++ + L +L +L+ L L NQL +G L L L LS N++ P
Sbjct: 272 VGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP- 328
Query: 204 KLANVPKLEVLDIRNN 219
LA++ K++ D N
Sbjct: 329 -LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 38/167 (22%), Positives = 68/167 (40%), Gaps = 15/167 (8%)
Query: 71 SLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIP 130
LQ ++ + L+S+T L + + + + I L+ L L LN N ++ P
Sbjct: 28 VLQKASVTDVVT--QEELESITKLVVAGEKVASI--QGIEYLTNLEYLNLNGNQITDISP 83
Query: 131 SQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRL 190
+ N+ L L + NK+T + L +L L L L + ++ P L +L + L
Sbjct: 84 --LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSL 137
Query: 191 DLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVP----PALKRLN 233
+L N+ L+N+ L L + + P L L+
Sbjct: 138 NLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLS 183
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 34/140 (24%), Positives = 66/140 (47%), Gaps = 9/140 (6%)
Query: 84 AVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143
+ L +L L L+ N + + P +++L +L++LY+ N ++ S + N+TNL+ L
Sbjct: 61 GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELY 116
Query: 144 LCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPV 203
L + ++ P L +L K+ L L N + L ++ L L ++ + + P
Sbjct: 117 LNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP- 172
Query: 204 KLANVPKLEVLDIRNNSFSG 223
+AN+ L L + N
Sbjct: 173 -IANLTDLYSLSLNYNQIED 191
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 29/128 (22%), Positives = 53/128 (41%), Gaps = 8/128 (6%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
+ + ++ P + L LT L + N ++ + + L++L L + N +S
Sbjct: 226 LKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD-- 279
Query: 130 PSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMR 189
S + N++ L L L N+L +G L L+ L L N +T P L L +
Sbjct: 280 ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDS 337
Query: 190 LDLSFNNL 197
D + +
Sbjct: 338 ADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 28/133 (21%), Positives = 50/133 (37%), Gaps = 10/133 (7%)
Query: 91 LTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLT 150
L +N + P A L+E L +++ + + ++ L + K+
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 151 GNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPK 210
+I + L L L L NQ+T P L +L L L + N + L N+
Sbjct: 58 -SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA--LQNLTN 111
Query: 211 LEVLDIRNNSFSG 223
L L + ++ S
Sbjct: 112 LRELYLNEDNISD 124
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 4e-10
Identities = 13/67 (19%), Positives = 30/67 (44%), Gaps = 2/67 (2%)
Query: 84 AVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143
+ L L L+L+ N L + I L+ L+ L+L+ N+++ P + +++ +
Sbjct: 282 VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSAD 339
Query: 144 LCYNKLT 150
+
Sbjct: 340 FANQVIK 346
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 63/282 (22%), Positives = 120/282 (42%), Gaps = 48/282 (17%)
Query: 410 LGKSSFSATYKGILRDGS-----VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASL 464
LG +F YKG+ VA+K + + + E L ++ S+ + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHL---DLEAGSEKVLEWATRISVIKGIAKGISYL 521
GIC + LI +P G LL ++ GS+ +L W IAKG++YL
Sbjct: 83 LGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYL 133
Query: 522 HGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL-ADDIVFSMLKASAAMGYLAPEYT 580
+R LVH +L+A VL+ + ++D GL KLL A++ + + ++A E
Sbjct: 134 EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 581 TTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID-----------PN 628
+T +SD++++G+ V+++++ G P+ +S++ ++
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGS---KPY--DGIPASEISSILEKGERLPQPPICT- 245
Query: 629 LEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
++ I + C RP ++ E S +
Sbjct: 246 ----------IDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 63/289 (21%), Positives = 123/289 (42%), Gaps = 39/289 (13%)
Query: 410 LGKSSFSATYKGILR-----DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASL 464
LGK +F + G++VAVK + + S + +F + ++IL +L + +
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHL---DLEAGSEKVLEWATRISVIKGIAKGISYL 521
RG+ GR L+ +++P+G L L + ++L +++ I KG+ YL
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS------QICKGMEYL 143
Query: 522 HGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAM--GYLAPEY 579
+R VH +L+A +L+ + ++D GL KLL D + +++ + APE
Sbjct: 144 GSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 580 TTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638
+ F+ +SD+++FG++++++ + S +P D + E
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP-ALSR----LLEL 256
Query: 639 SNLG--------------QIALHCTHESPSHRPSIENVMQELSSIIGSS 673
G ++ C SP RPS + +L + S
Sbjct: 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-21
Identities = 78/369 (21%), Positives = 140/369 (37%), Gaps = 55/369 (14%)
Query: 318 VTGLFTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVCRRNSSPLISLEYSNGWDPLAKGQ 377
V G R +K+ G S +L+ ++ + V S + +Y+ + + +
Sbjct: 321 VNGATQSFIIRPQKE--GERALPSIPKLANNEKQGVRSHTVSVSETDDYA---EIIDEED 375
Query: 378 SGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKGILRDGS----VVAVKC 433
+ S E E +E +G+ F ++GI VA+K
Sbjct: 376 TYTMPSTRDYE---IQRERIELG-------RCIGEGQFGDVHQGIYMSPENPAMAVAIKT 425
Query: 434 IAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLD 493
+ S +FL+ + H ++ L G+ ++I + G L L
Sbjct: 426 CKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV---WIIMELCTLGELRSFLQ 482
Query: 494 LEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL 553
+ S L+ A+ I ++ ++YL KR VH +++A VL+ L D GL
Sbjct: 483 VRKFS---LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGL 537
Query: 554 HKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFT 612
+ + D + K + ++APE RFT SD++ FG+ +++IL G PF
Sbjct: 538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV---KPF- 593
Query: 613 RQAAESSKVEDFID-----------PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIEN 661
Q +++ V I+ P L + C PS RP
Sbjct: 594 -QGVKNNDVIGRIENGERLPMPPNCP-----------PTLYSLMTKCWAYDPSRRPRFTE 641
Query: 662 VMQELSSII 670
+ +LS+I+
Sbjct: 642 LKAQLSTIL 650
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 61/280 (21%), Positives = 118/280 (42%), Gaps = 41/280 (14%)
Query: 410 LGKSSFSATYKGILRDGSV---VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRG 466
LG +F + +G+ R VA+K + + + K+D E ++ +I+ L + + L G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
+C ++ L+ + G L + L G + + + ++ ++ G+ YL K
Sbjct: 78 VCQAEAL---MLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYLEEKN- 130
Query: 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA--DDIVFSMLKASAAMGYLAPEYTTTGR 584
VH +L+A VL+ R+ +SD GL K L D + + + APE +
Sbjct: 131 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 585 FTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID-----------PNLEGK 632
F+ +SD++++G+ +++ LS G+ P+ + + +V FI+ P
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQ---KPY--KKMKGPEVMAFIEQGKRMECPPECP----- 239
Query: 633 FSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672
L + C RP V Q + + S
Sbjct: 240 ------PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 69/287 (24%), Positives = 127/287 (44%), Gaps = 39/287 (13%)
Query: 396 EVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTS 455
E++ + + LG F G R VA+K I + S E EF++ K++ +
Sbjct: 20 EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMN 75
Query: 456 LKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIA 515
L HE L L G+C +K R F+I +++ NG LL +L + + + K +
Sbjct: 76 LSHEKLVQLYGVC-TKQR-PIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVC 130
Query: 516 KGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYL 575
+ + YL K +H +L+A L++ + +SD GL + + DD S + + + +
Sbjct: 131 EAMEYLESK--QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 188
Query: 576 APEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID-------- 626
PE +F+ KSDI+AFG+++++I S GK P+ + +S+ + I
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK---MPY--ERFTNSETAEHIAQGLRLYRP 243
Query: 627 ---PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+ I C HE RP+ + ++ + ++
Sbjct: 244 HLAS-----------EKVYTIMYSCWHEKADERPTFKILLSNILDVM 279
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-21
Identities = 62/272 (22%), Positives = 114/272 (41%), Gaps = 39/272 (14%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
+GK F G R G+ VAVKCI + FL ++T L+H NL L G
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG-VI 255
Query: 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLV 529
+ +G +++ +++ G+L+ +L + VL + + + + YL G V
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--NFV 311
Query: 530 HPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKS 589
H +L+A VL+ +SD GL + + + + APE +F+ KS
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGL----TKEASSTQDTGKLPVKWTAPEALREKKFSTKS 367
Query: 590 DIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA---------- 638
D+++FG+++++I S G+ P+ R P + V +
Sbjct: 368 DVWSFGILLWEIYSFGR---VPYPRI------------PLKDVVPRVEKGYKMDAPDGCP 412
Query: 639 SNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+ + +C H + RP+ + ++L I
Sbjct: 413 PAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 60/287 (20%), Positives = 113/287 (39%), Gaps = 52/287 (18%)
Query: 410 LGKSSFSATYKGILRDGS-----VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASL 464
LG F +KG+ V +K I S + + + SL H ++ L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHL---DLEAGSEKVLEWATRISVIKGIAKGISYL 521
G+C L+ ++P G+LL H+ G + +L W IAKG+ YL
Sbjct: 81 LGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIAKGMYYL 131
Query: 522 HGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAM---GYLAPE 578
+VH NL+A VL+ ++D G+ LL D S A ++A E
Sbjct: 132 EEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL--LYSEAKTPIKWMALE 187
Query: 579 YTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID----------- 626
G++T +SD++++G+ V+++++ G P+ ++V D ++
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGA---EPY--AGLRLAEVPDLLEKGERLAQPQIC 242
Query: 627 PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
++ + + C + RP+ + + E + +
Sbjct: 243 T-----------IDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-21
Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 10/150 (6%)
Query: 84 AVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143
+ GL LT L L N ++ + P +A L+ L++L LN N L P I N+ NL L
Sbjct: 260 PLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLT 315
Query: 144 LCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPV 203
L +N ++ P + SL KL L N+++ +SL +L + L N + P
Sbjct: 316 LYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP- 370
Query: 204 KLANVPKLEVLDIRNNSFSGNVPPALKRLN 233
LAN+ ++ L + + +++ ++
Sbjct: 371 -LANLTRITQLGLNDQAWTNAPVNYKANVS 399
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-20
Identities = 45/156 (28%), Positives = 71/156 (45%), Gaps = 14/156 (8%)
Query: 82 PAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQV 141
+ + L +L L N ++ + P + L+ L +L LN N L + ++TNL
Sbjct: 192 ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTD 247
Query: 142 LQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPV 201
L L N+++ P L L KL+ L L NQ++ P L L L L+L+ N L
Sbjct: 248 LDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDIS 303
Query: 202 PVKLANVPKLEVLDIRNNSFSGNVP----PALKRLN 233
P ++N+ L L + N+ S P L+RL
Sbjct: 304 P--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLF 337
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-19
Identities = 47/164 (28%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK 128
+ G+ V L +LT + N L + P + +L++L D+ +N N ++
Sbjct: 50 TLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI 105
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLM 188
P + N+TNL L L N++T P L +L L+ L L N ++ ++L L L
Sbjct: 106 TP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQ 159
Query: 189 RLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232
+L N + P LAN+ LE LDI +N S L +L
Sbjct: 160 QLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKL 198
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-19
Identities = 33/147 (22%), Positives = 55/147 (37%), Gaps = 12/147 (8%)
Query: 87 GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCY 146
L L + + L +++ L + + + + NL +
Sbjct: 22 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSN 77
Query: 147 NKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLA 206
N+LT P L +L KL + + NQ+ P L +L L L L N + P L
Sbjct: 78 NQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LK 131
Query: 207 NVPKLEVLDIRNNSFSGNVPPALKRLN 233
N+ L L++ +N+ S AL L
Sbjct: 132 NLTNLNRLELSSNTISD--ISALSGLT 156
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 7e-19
Identities = 39/149 (26%), Positives = 65/149 (43%), Gaps = 13/149 (8%)
Query: 84 AVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143
+ L +LTGL L N + + P + +L+ L+ L L+ N +S S + +T+LQ L
Sbjct: 107 PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLS 162
Query: 144 LCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPV 203
N++T P L +L L L + N+++ + L L L L + N + P
Sbjct: 163 F-GNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP- 216
Query: 204 KLANVPKLEVLDIRNNSFSGNVPPALKRL 232
L + L+ L + N L L
Sbjct: 217 -LGILTNLDELSLNGNQLKD--IGTLASL 242
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-19
Identities = 35/149 (23%), Positives = 61/149 (40%), Gaps = 12/149 (8%)
Query: 71 SLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIP 130
L ++ + L +T L + + L+ L+ + + N L+ P
Sbjct: 30 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTDITP 85
Query: 131 SQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRL 190
+ N+T L + + N++ P L +L L+ L L NQ+T P L +L L RL
Sbjct: 86 --LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRL 139
Query: 191 DLSFNNLFGPVPVKLANVPKLEVLDIRNN 219
+LS N + L+ + L+ L N
Sbjct: 140 ELSSNTISDISA--LSGLTSLQQLSFGNQ 166
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 9e-19
Identities = 45/154 (29%), Positives = 71/154 (46%), Gaps = 13/154 (8%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
I+ L+ P + L L + ++ N + + P +A+L+ L+ L L N ++
Sbjct: 73 INFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDID 128
Query: 130 PSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMR 189
P + N+TNL L+L N ++ + L L L L+ NQ+T P L +L L R
Sbjct: 129 P--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLER 181
Query: 190 LDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG 223
LD+S N + LA + LE L NN S
Sbjct: 182 LDISSNKVSDISV--LAKLTNLESLIATNNQISD 213
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-18
Identities = 48/154 (31%), Positives = 70/154 (45%), Gaps = 15/154 (9%)
Query: 84 AVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143
A+ GL SL L N + + P +A+L+ L L ++ N +S S + +TNL+ L
Sbjct: 151 ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLI 205
Query: 144 LCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPV 203
N+++ P LG L L L+L NQL +L L L LDL+ N + P
Sbjct: 206 ATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP- 260
Query: 204 KLANVPKLEVLDIRNNSFSGNVP----PALKRLN 233
L+ + KL L + N S P AL L
Sbjct: 261 -LSGLTKLTELKLGANQISNISPLAGLTALTNLE 293
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 7e-16
Identities = 33/162 (20%), Positives = 61/162 (37%), Gaps = 9/162 (5%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK 128
++L +S P V L L L+ + N ++ V +A+L+ ++ L N +S
Sbjct: 313 YLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQISDL 368
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLM 188
P + N+T + L L T ++ + + L PA++ D G
Sbjct: 369 TP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYT 424
Query: 189 RLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALK 230
D+++N + + +FSG V LK
Sbjct: 425 EPDITWNLPSYT-NEVSYTFSQPVTIGKGTTTFSGTVTQPLK 465
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 29/138 (21%), Positives = 52/138 (37%), Gaps = 12/138 (8%)
Query: 86 GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLC 145
G L S +N + +L+E L N++ + ++ + LQ
Sbjct: 1 GPLGSA--TITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQAD 54
Query: 146 YNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKL 205
+ + L L+ + NQLT P L +L L+ + ++ N + P L
Sbjct: 55 RLGIK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--L 108
Query: 206 ANVPKLEVLDIRNNSFSG 223
AN+ L L + NN +
Sbjct: 109 ANLTNLTGLTLFNNQITD 126
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 3e-21
Identities = 62/280 (22%), Positives = 118/280 (42%), Gaps = 41/280 (14%)
Query: 410 LGKSSFSATYKGILRDGSV---VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRG 466
LG +F + +G+ R VA+K + + + K+D E ++ +I+ L + + L G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
+C ++ L+ + G L + L G + + + ++ ++ G+ YL K
Sbjct: 404 VCQAE---ALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYLEEKN- 456
Query: 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA--DDIVFSMLKASAAMGYLAPEYTTTGR 584
VH NL+A VL+ R+ +SD GL K L D + + + APE +
Sbjct: 457 -FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 585 FTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID-----------PNLEGK 632
F+ +SD++++G+ +++ LS G+ P+ + + +V FI+ P
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQ---KPY--KKMKGPEVMAFIEQGKRMECPPECP----- 565
Query: 633 FSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672
L + C RP V Q + + S
Sbjct: 566 ------PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 59/274 (21%), Positives = 114/274 (41%), Gaps = 39/274 (14%)
Query: 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
+GK F G R G+ VAVKCI + FL ++T L+H NL L G
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG- 81
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG 527
+ +G +++ +++ G+L+ +L + VL + + + + YL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYL------ 133
Query: 528 LVHPNLSAEKVLIHR----RYNPLLSDSGLHKL----LADDIVFSMLKASAAMGYLAPEY 579
+HR R N L+S+ + K+ L + + + + APE
Sbjct: 134 -------EGNNFVHRDLAAR-NVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEA 185
Query: 580 TTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPN--LEGKFSVS 636
+F+ KSD+++FG+++++I S G+ P+ V ++ ++
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGR---VPY--PRIPLKDVVPRVEKGYKMDAPDGCP 240
Query: 637 EASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
A + ++ +C H + RPS + ++L I
Sbjct: 241 PA--VYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 3e-21
Identities = 37/198 (18%), Positives = 61/198 (30%), Gaps = 13/198 (6%)
Query: 86 GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSG-KIPSQIGNMTNLQVLQL 144
+ +YL N + + + S + L L +N + + L+ L L
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVK 204
YN + ++ Q+ KL L L N+L + + + L N L +
Sbjct: 177 QYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKA 232
Query: 205 LANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAALCGTGFTNLKNCTASDHPTPG 264
L LE D+R N F N Q + N + CT
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT-------- 284
Query: 265 KPEPFEPNGLSTKDIPES 282
P +D+P
Sbjct: 285 VPTLGHYGAYCCEDLPAP 302
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 6e-20
Identities = 26/159 (16%), Positives = 58/159 (36%), Gaps = 10/159 (6%)
Query: 71 SLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIP 130
+ L + + ++ L L N L+ + ++A ++L L L+ N L
Sbjct: 16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--T 73
Query: 131 SQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRL 190
+ +++ L+ L L N + +L + L N ++ + S G +
Sbjct: 74 LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSRGQG--KKNI 125
Query: 191 DLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPAL 229
L+ N + + +++ LD++ N L
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 3e-18
Identities = 34/179 (18%), Positives = 61/179 (34%), Gaps = 8/179 (4%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGV-IPKEIASLSELSDLYLNVNNLSG 127
NI L ++ G + L L N ++ V + AS L L L N +
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 128 KIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGML 187
+ Q+ L+ L L NKL + + S ++ ++L+ N+L I +L L
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239
Query: 188 MRLDLSFNNL-FGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAALC 245
DL N G + + +++ + + + A C
Sbjct: 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVA--KQTVKKLTGQNEEECTVPTLGHYGAYCC 296
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 9e-17
Identities = 31/133 (23%), Positives = 50/133 (37%), Gaps = 12/133 (9%)
Query: 105 IPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLS 164
I + + + + ++L + S + N++ L L N L+ L KL
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 165 VLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224
+L L N L L L L LDL+ N + +L P +E L NN+ S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-R 113
Query: 225 VPPA----LKRLN 233
V + K +
Sbjct: 114 VSCSRGQGKKNIY 126
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 3e-16
Identities = 23/156 (14%), Positives = 45/156 (28%), Gaps = 6/156 (3%)
Query: 80 EIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNL 139
+L L L +N + + ++ ++L L L+ N L+ + + + +
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGV 216
Query: 140 QVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQL-TGAIPASLGDLGMLMRLDL-SFNNL 197
+ L NKL I L + L L+ N G + + + + L
Sbjct: 217 TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKL 275
Query: 198 FGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233
G + L L
Sbjct: 276 TGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALK 311
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 14/151 (9%), Positives = 36/151 (23%), Gaps = 5/151 (3%)
Query: 49 DPCSSDSFDGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKE 108
+ + D + + A +S QG + + VI +
Sbjct: 297 EDLPAPFADRLIALKRKEHALLSGQGSETE-RLECERENQARQREIDALKEQYRTVIDQV 355
Query: 109 IASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTG--NIPTQLGSLRKLSVL 166
L L ++ + L + + L+ L +
Sbjct: 356 TLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAI 415
Query: 167 ALQYNQLTGAIPASLGDLGMLMRLDLSFNNL 197
+Y ++ + + D+ +
Sbjct: 416 VKRYEEMY--VEQQSVQNNAIRDWDMYQHKE 444
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 3e-21
Identities = 44/179 (24%), Positives = 70/179 (39%), Gaps = 10/179 (5%)
Query: 60 ACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLY 119
+C +GR+A L+ ++P L + L L FN + V L +L L
Sbjct: 1 SCSFDGRIAFYR--FCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLE 54
Query: 120 LNVNNLSGKIPSQI-GNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAI- 177
L I + N+ NL++L L +K+ P L L L L + L+ A+
Sbjct: 55 LGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVL 114
Query: 178 -PASLGDLGMLMRLDLSFNNLFG-PVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNG 234
+L L RLDLS N + + + L+ +D +N L+ L G
Sbjct: 115 KDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 3e-15
Identities = 34/162 (20%), Positives = 63/162 (38%), Gaps = 3/162 (1%)
Query: 75 KGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASL--SELSDLYLNVNNLSGKIPSQ 132
+S ++ + G F+ + A L S + L L+ +
Sbjct: 226 NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRV 285
Query: 133 IGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDL 192
+ +L+VL L YNK+ L L VL L YN L ++ L + +DL
Sbjct: 286 FETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDL 345
Query: 193 SFNNLFGPVPVKLANVPKLEVLDIRNNSFSG-NVPPALKRLN 233
N++ + KL+ LD+R+N+ + + P++ +
Sbjct: 346 QKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIF 387
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 6e-15
Identities = 57/252 (22%), Positives = 82/252 (32%), Gaps = 20/252 (7%)
Query: 90 SLTGLYLHFNALNGV-IPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMTNLQVLQLCYN 147
+ ++L N L + I + + L L LN N S Q +L+ L L N
Sbjct: 402 TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGEN 461
Query: 148 KLTGNIPTQL-----GSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVP 202
L T+L L L VL L +N L P L L L L+ N L
Sbjct: 462 MLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSH 521
Query: 203 VKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAALCG---TGFTNLKNCTASD 259
L LE+LDI N P L+ +N +C + F N N T
Sbjct: 522 NDLP--ANLEILDISRNQLLAPNPDVFVSLS-VLDITHNKFICECELSTFINWLNHTNVT 578
Query: 260 HPT-PGKPEPFEPNGLSTKDIPESAKLPANCGQPGCSSPARRPHTGVFVGVIAVFIILTV 318
P P+ S + + + + S V V + L +
Sbjct: 579 IAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKS------LKFSLFIVCTVTLTLFL 632
Query: 319 TGLFTFTWYRRR 330
+ T T +R
Sbjct: 633 MTILTVTKFRGF 644
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 1e-14
Identities = 31/133 (23%), Positives = 51/133 (38%), Gaps = 5/133 (3%)
Query: 90 SLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKL 149
S+ L L + + + +L +L L L N ++ + NLQVL L YN L
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
Query: 150 TGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVP 209
+ L K++ + LQ N + + L L LDL N L + +P
Sbjct: 327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIP 381
Query: 210 KLEVLDIRNNSFS 222
+ + + N
Sbjct: 382 SIPDIFLSGNKLV 394
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 2e-12
Identities = 41/142 (28%), Positives = 57/142 (40%), Gaps = 11/142 (7%)
Query: 87 GLKSLTGLYLHFNALNGVIPKEIAS-LSELSDLYLNVNNLSGKIPSQI-----GNMTNLQ 140
+ L L L+ N + + S L L+L N L +++ +++LQ
Sbjct: 424 RVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQ 483
Query: 141 VLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGP 200
VL L +N L P L L L+L N+LT L L LD+S N L P
Sbjct: 484 VLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAP 541
Query: 201 VPVKLANVPKLEVLDIRNNSFS 222
P L VLDI +N F
Sbjct: 542 NPDVF---VSLSVLDITHNKFI 560
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 31/165 (18%), Positives = 55/165 (33%), Gaps = 22/165 (13%)
Query: 80 EIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLS--ELSDLYLNVNNLSGKIPSQIGNMT 137
+ + G L SL + N + V E+ L LS L N+L ++ G
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCM 198
Query: 138 N------LQVLQLCYNKLTGNIP------------TQLGSLRKLSVLALQYNQLTGAIPA 179
N L++L + N T +I L + ++ +
Sbjct: 199 NPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN 258
Query: 180 SLGDLGM--LMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFS 222
+ L + LDLS +F + L+VL++ N +
Sbjct: 259 TFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN 303
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 8e-11
Identities = 33/174 (18%), Positives = 59/174 (33%), Gaps = 34/174 (19%)
Query: 87 GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCY 146
GL + + L N + + + L +L L L N L+ I + ++ + L
Sbjct: 336 GLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSG 390
Query: 147 NKLTGNIPTQ----------------------LGSLRKLSVLALQYNQLTG-AIPASLGD 183
NKL +P L + L +L L N+ + + + +
Sbjct: 391 NKLV-TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSE 449
Query: 184 LGMLMRLDLSFNNLFGPVPVKL-----ANVPKLEVLDIRNNSFSGNVPPALKRL 232
L +L L N L +L + L+VL + +N + P L
Sbjct: 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHL 503
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 59/288 (20%), Positives = 116/288 (40%), Gaps = 50/288 (17%)
Query: 410 LGKSSFSATYKGILRDGSV--------VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENL 461
LG+ +F+ +KG+ R+ V +K + + ++ F + +++ L H++L
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL-DKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 462 ASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYL 521
G+ C G E L+ +FV G+L +L + ++ V K +A + +L
Sbjct: 75 VLNYGV-CVCGD-ENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMHFL 129
Query: 522 HGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYL------ 575
L+H N+ A+ +L+ R + + K L+D + L
Sbjct: 130 EENT--LIHGNVCAKNILLIREEDRKTGNPPFIK-LSD---PGISITVLPKDILQERIPW 183
Query: 576 -APEYTTTGR-FTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID------ 626
PE + +D ++FG +++I S G P A +S + F +
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGD---KPL--SALDSQRKLQFYEDRHQLP 238
Query: 627 -PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
P +A+ L + +C P HRPS ++++L+S+
Sbjct: 239 AP---------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 7e-21
Identities = 54/275 (19%), Positives = 111/275 (40%), Gaps = 24/275 (8%)
Query: 409 LLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
+LG+ + + ++G + G + A+K S ++ ++L L H+N+ L I
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG 527
LI +F P G+L L+ E + L + + V++ + G+++L G
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN--G 132
Query: 528 LVHPNLSAEKVLIHRRYNPL----LSDSGLHKLLADDIVFSMLKASAAMGYLAPE----- 578
+VH N+ ++ + L+D G + L DD F L + YL P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGT--EEYLHPDMYERA 190
Query: 579 ---YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635
++ D+++ G+ + +G PF R + ++ + + GK
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGS---LPF-RPFEGPRRNKEVMYKIITGKP-- 244
Query: 636 SEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
S A + Q A + + P ++ + L ++
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLL 279
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 7e-21
Identities = 55/255 (21%), Positives = 102/255 (40%), Gaps = 16/255 (6%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKG-LKILTSLKHENLASLRG 466
+G+ SF YKG+ VA + E + K ++L L+H N+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 467 ICCSKGRGECFL--IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK 524
S +G+ + + + + +G L +L KV++ S + I KG+ +LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 525 RPGLVHPNLSAEKVLIHRRYNPL-LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG 583
P ++H +L + + I + + D GL L +++ M APE
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFM---APEMYEEK 205
Query: 584 RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQ 643
+ E D+YAFGM + ++ + + + A +V + P K ++ E
Sbjct: 206 -YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE--- 261
Query: 644 IALHCTHESPSHRPS 658
I C ++ R S
Sbjct: 262 IIEGCIRQNKDERYS 276
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 8e-21
Identities = 62/276 (22%), Positives = 107/276 (38%), Gaps = 33/276 (11%)
Query: 404 FSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKIL-TSLKHENLA 462
F ++LG + + D VAVK I + E +++L S +H N+
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE----VQLLRESDEHPNVI 81
Query: 463 SLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLH 522
C K R ++ + L ++++ + + LE I++++ G+++LH
Sbjct: 82 RY--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLH 135
Query: 523 GKRPGLVHPNLSAEKVLI-----HRRYNPLLSDSGLHKLLADDIV-FSMLKASAA-MGYL 575
+VH +L +LI H + ++SD GL K LA FS G++
Sbjct: 136 SL--NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 576 APEY---TTTGRFTEKSDIYAFGMIVFQILSGKCSITPF----TRQAAESSKVEDFIDPN 628
APE T DI++ G + + ++S PF RQA +
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS--HPFGKSLQRQANILLGACSLDCLH 251
Query: 629 LEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664
E A L I P RPS ++V++
Sbjct: 252 PEKHED-VIAREL--IE-KMIAMDPQKRPSAKHVLK 283
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 64/277 (23%), Positives = 111/277 (40%), Gaps = 40/277 (14%)
Query: 410 LGKSSFSATYKGILRDGS----VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLR 465
+G+ F ++GI VA+K + S +FL+ + H ++ L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 466 GICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
G+ ++I + G L L + S L+ A+ I ++ ++YL KR
Sbjct: 83 GVITEN---PVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKR 136
Query: 526 PGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRF 585
VH +++A VL+ L D GL + + D + K + ++APE RF
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 586 TEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID-----------PNLEGKF 633
T SD++ FG+ +++IL G PF Q +++ V I+ P
Sbjct: 195 TSASDVWMFGVCMWEILMHGV---KPF--QGVKNNDVIGRIENGERLPMPPNCP------ 243
Query: 634 SVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
L + C PS RP + +LS+I+
Sbjct: 244 -----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 65/277 (23%), Positives = 112/277 (40%), Gaps = 40/277 (14%)
Query: 410 LGKSSFSATYKGILRDGSV----VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLR 465
LG+ F Y+G+ + VAVK K ++ +F+ I+ +L H ++ L
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 466 GICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
GI + ++I + P G L +L+ S KVL T + I K ++YL
Sbjct: 80 GIIEEEPT---WIIMELYPYGELGHYLERNKNSLKVL---TLVLYSLQICKAMAYLESIN 133
Query: 526 PGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRF 585
VH +++ +L+ L D GL + + D+ + + +++PE RF
Sbjct: 134 --CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 586 TEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID-----------PNLEGKF 633
T SD++ F + +++ILS GK PF E+ V ++ P
Sbjct: 192 TTASDVWMFAVCMWEILSFGK---QPF--FWLENKDVIGVLEKGDRLPKPDLCP------ 240
Query: 634 SVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
L + C PS RP ++ LS +
Sbjct: 241 -----PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 28/137 (20%), Positives = 59/137 (43%), Gaps = 5/137 (3%)
Query: 87 GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCY 146
++ L ++ P I+ LS L L + +++ + +T+L +L + +
Sbjct: 64 YAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121
Query: 147 NKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLA 206
+ +I T++ +L K++ + L YN I L L L L++ F+ + +
Sbjct: 122 SAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IE 178
Query: 207 NVPKLEVLDIRNNSFSG 223
+ PKL L + + G
Sbjct: 179 DFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 28/134 (20%), Positives = 61/134 (45%), Gaps = 5/134 (3%)
Query: 86 GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLC 145
+ SLT + L + + I + DL +N + + + I ++NL+ L++
Sbjct: 41 AQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIM 96
Query: 146 YNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKL 205
+T + L L L++L + ++ +I + L + +DLS+N + L
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-L 155
Query: 206 ANVPKLEVLDIRNN 219
+P+L+ L+I+ +
Sbjct: 156 KTLPELKSLNIQFD 169
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-17
Identities = 33/151 (21%), Positives = 62/151 (41%), Gaps = 12/151 (7%)
Query: 88 LKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYN 147
K+ L ++ + ++ SL+ ++ +NV +L+G I N++ L +
Sbjct: 22 FKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINNI 76
Query: 148 KLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLAN 207
T N + L L L + +T +L L L LD+S + + K+
Sbjct: 77 HAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 208 VPKLEVLDIRNNSFSGNVPP-----ALKRLN 233
+PK+ +D+ N ++ P LK LN
Sbjct: 135 LPKVNSIDLSYNGAITDIMPLKTLPELKSLN 165
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 21/114 (18%), Positives = 47/114 (41%), Gaps = 3/114 (2%)
Query: 84 AVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143
+ GL +L L + + ++ L+ L+ L ++ + I ++I + + +
Sbjct: 83 PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142
Query: 144 LCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNL 197
L YN +I L +L +L L +Q++ + + D L +L +
Sbjct: 143 LSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 19/104 (18%), Positives = 37/104 (35%), Gaps = 21/104 (20%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK 128
+ + GK ++ + + GL SLT L + +A + I +I +L +++ + L+ N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151
Query: 129 IP---------------------SQIGNMTNLQVLQLCYNKLTG 151
I I + L L + G
Sbjct: 152 IMPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGG 195
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 63/283 (22%), Positives = 115/283 (40%), Gaps = 49/283 (17%)
Query: 410 LGKSSFSATYKGILRDGS----VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLR 465
+G G LR VA+K + + +FL I+ H N+ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 466 GICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
G+ ++GR ++ +++ NG+L L G + +++G+ G+ YL
Sbjct: 117 GV-VTRGR-LAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLSDL- 170
Query: 526 PGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG------YLAPEY 579
G VH +L+A VL+ +SD GL ++L DD A G + APE
Sbjct: 171 -GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA----AYTTTGGKIPIRWTAPEA 225
Query: 580 TTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID-----------P 627
F+ SD+++FG++++++L+ G+ P+ + V ++ P
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGE---RPY--WNMTNRDVISSVEEGYRLPAPMGCP 280
Query: 628 NLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
L Q+ L C H+ + RP ++ L ++I
Sbjct: 281 -----------HALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 9e-20
Identities = 45/216 (20%), Positives = 89/216 (41%), Gaps = 21/216 (9%)
Query: 409 LLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
+LG+ + + ++G + G + A+K S ++ ++L L H+N+ L I
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG 527
LI +F P G+L L+ + + + E I V++ + G+++L G
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI-VLRDVVGGMNHLREN--G 132
Query: 528 LVHPNLSAEKVLIHRRYNPL----LSDSGLHKLLADDIVFSMLKASAAMGYLAPE----- 578
+VH N+ ++ + L+D G + L DD F L + YL P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGT--EEYLHPDMYERA 190
Query: 579 ---YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
++ D+++ G+ + +G PF
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGS---LPF 223
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 65/284 (22%), Positives = 123/284 (43%), Gaps = 50/284 (17%)
Query: 410 LGKSSFSATYKGILRDGSV-----VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASL 464
+G F YKG+L+ S VA+K + + +FL I+ H N+ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK 524
G+ SK + +I +++ NG L + L + G + +++GIA G+ YL
Sbjct: 112 EGV-ISKYK-PMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYLANM 166
Query: 525 RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG------YLAPE 578
VH +L+A +L++ +SD GL ++L DD G + APE
Sbjct: 167 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA----TYTTSGGKIPIRWTAPE 220
Query: 579 YTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID----------- 626
+ +FT SD+++FG++++++++ G+ P+ + +V I+
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGE---RPY--WELSNHEVMKAINDGFRLPTPMDC 275
Query: 627 PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
P S + Q+ + C + + RP +++ L +I
Sbjct: 276 P-----------SAIYQLMMQCWQQERARRPKFADIVSILDKLI 308
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 39/164 (23%), Positives = 63/164 (38%), Gaps = 11/164 (6%)
Query: 80 EIPAAVGGLKSLTGLYLHFNALNGVIPKEI-ASLSELSDLYLNVNNLSGKIPSQI-GNMT 137
+ + GL+ L L + L + + SL L L ++ + + I ++
Sbjct: 92 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLS 150
Query: 138 NLQVLQLCYNKLTGNIPTQ-LGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNN 196
+L+VL++ N N LR L+ L L QL P + L L L++S NN
Sbjct: 151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 210
Query: 197 LFGPVPVKLANVPKLEVLDIRNNSFS-------GNVPPALKRLN 233
F + L+VLD N + P +L LN
Sbjct: 211 FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN 254
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 44/163 (26%), Positives = 68/163 (41%), Gaps = 7/163 (4%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK- 128
I KGL+ +P + S T L L N L + L++L+ L L+ N LS K
Sbjct: 12 IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 129 -IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASL-GDLGM 186
T+L+ L L +N + + + L +L L Q++ L S+ L
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 127
Query: 187 LMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPAL 229
L+ LD+S + + LEVL + NSF N P +
Sbjct: 128 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 170
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 28/109 (25%), Positives = 49/109 (44%), Gaps = 6/109 (5%)
Query: 116 SDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLT- 174
+++ N L+ +P+ I ++ L+L NKL L +L+ L+L N L+
Sbjct: 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 175 -GAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFS 222
G S L LDLSFN + + + +LE LD ++++
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK 114
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 25/101 (24%), Positives = 35/101 (34%), Gaps = 3/101 (2%)
Query: 75 KGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIG 134
+P L++LT L L L + P SLS L L ++ NN
Sbjct: 161 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 220
Query: 135 NMTNLQVLQLCYNKLTGNIPTQL--GSLRKLSVLALQYNQL 173
+ +LQVL N + Q L+ L L N
Sbjct: 221 CLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 64/275 (23%), Positives = 108/275 (39%), Gaps = 33/275 (12%)
Query: 410 LGKSSFSATYKGILRDGSV----VAVKCI--AKTSCKSDEGEFLKGLKILTSLKHENLAS 463
LG SF +G S VAVKC+ S +F++ + + SL H NL
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKV---LEWATRISVIKGIAKGISY 520
L G+ + ++ + P G+LL L G + +A +A+G+ Y
Sbjct: 86 LYGVVLTPPM---KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV------QVAEGMGY 136
Query: 521 LHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL--ADDIVFSMLKASAAMGYLAPE 578
L KR +H +L+A +L+ R + D GL + L DD + APE
Sbjct: 137 LESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 579 YTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPN---LEGKFS 634
T F+ SD + FG+ ++++ + G+ P+ S++ ID L
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQ---EPW--IGLNGSQILHKIDKEGERLPRPED 249
Query: 635 VSEASNLGQIALHCTHESPSHRPSIENVMQELSSI 669
+ + + + C P RP+ + L
Sbjct: 250 CPQD--IYNVMVQCWAHKPEDRPTFVALRDFLLEA 282
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 58/284 (20%), Positives = 112/284 (39%), Gaps = 49/284 (17%)
Query: 410 LGKSSFSATYKGILRDGSV---VAVKCI-AKTSCKSDEGEFLKGLKILTSLKHENLASLR 465
LG +F KG + V VAVK + + + + + E L ++ L + + +
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 466 GICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
GIC ++ L+ + G L ++L + ++ I ++ ++ G+ YL
Sbjct: 85 GICEAESW---MLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESN 137
Query: 526 PGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYL-----APEYT 580
VH +L+A VL+ ++ +SD GL K L D + G APE
Sbjct: 138 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD---ENYYKAQTHGKWPVKWYAPECI 192
Query: 581 TTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID-----------PN 628
+F+ KSD+++FG+++++ S G+ P+ + + S+V ++ P
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQ---KPY--RGMKGSEVTAMLEKGERMGCPAGCP- 246
Query: 629 LEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672
+ + C +RP V L +
Sbjct: 247 ----------REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 49/214 (22%), Positives = 85/214 (39%), Gaps = 17/214 (7%)
Query: 71 SLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIP 130
SL +S + + + ++ L N++N V+ + EL+ L L NNL+
Sbjct: 187 SLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTA 242
Query: 131 SQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRL 190
+ N L + L YN+L + +++L L + N+L A+ + L L
Sbjct: 243 W-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 300
Query: 191 DLSFNNLFGPVPVKLANVPKLEVLDIRNN---SFSGNVPPALKRLNGG---FQYDNNAAL 244
DLS N+L V +LE L + +N + + LK L + ++ AL
Sbjct: 301 DLSHNHL-LHVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSLRAL 359
Query: 245 CGTGFTNLKNCTASDHPTPGKPEPFEPNGLSTKD 278
F N+ D K + +GL K+
Sbjct: 360 ----FRNVARPAVDDADQHCKIDYQLEHGLCCKE 389
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-18
Identities = 36/155 (23%), Positives = 65/155 (41%), Gaps = 8/155 (5%)
Query: 82 PAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMTNLQ 140
A + + + L L+ + + A + LY+ N + +P + N+ L
Sbjct: 62 AALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLT 120
Query: 141 VLQLCYNKLTGNIPTQL-GSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFG 199
VL L N L+ ++P + + KL+ L++ N L + L L LS N L
Sbjct: 121 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-- 177
Query: 200 PVPVKLANVPKLEVLDIRNNSFSG-NVPPALKRLN 233
V L+ +P L ++ N S +P A++ L+
Sbjct: 178 -THVDLSLIPSLFHANVSYNLLSTLAIPIAVEELD 211
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 24/137 (17%), Positives = 48/137 (35%), Gaps = 10/137 (7%)
Query: 105 IPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLS 164
I + D+++++ + + N +++ + + L S R++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 165 VLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNS---- 220
+L L Q+ + + +L + FN + P NVP L VL + N
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSL 132
Query: 221 ----FSGNVPPALKRLN 233
F P L L+
Sbjct: 133 PRGIFHNT--PKLTTLS 147
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 27/163 (16%), Positives = 59/163 (36%), Gaps = 14/163 (8%)
Query: 81 IPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMTNL 139
I + + +++ + E +L+ + + + K+P+ + + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 140 QVLQLCYNKLTGNIPTQ-LGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLF 198
++L L ++ I T + L + +N + P ++ +L L L N+L
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130
Query: 199 GPVPVKLANVPKLEVLDIRNN--------SFSGNVPPALKRLN 233
N PKL L + NN +F +L+ L
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQAT--TSLQNLQ 171
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 55/290 (18%), Positives = 101/290 (34%), Gaps = 43/290 (14%)
Query: 404 FSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLA 462
F E +LG+ +F K D A+K I T + L + +L SL H+ +
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVV 65
Query: 463 SLRGICCSKGRGEC-----------FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVI 511
+ F+ ++ NG L + + + R+
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQRDEYWRL--F 122
Query: 512 KGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAA 571
+ I + +SY+H + G++H +L + I N + D GL K + + L +
Sbjct: 123 RQILEALSYIHSQ--GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 572 MG-------------YLAPE-YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE 617
G Y+A E TG + EK D+Y+ G+I F+++ T E
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-----FST--GME 233
Query: 618 SSKVEDFI---DPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664
+ + F ++ +I P+ RP ++
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 6e-19
Identities = 49/218 (22%), Positives = 86/218 (39%), Gaps = 17/218 (7%)
Query: 71 SLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIP 130
SL +S + + + ++ L N++N V+ + EL+ L L NNL+
Sbjct: 193 SLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTA 248
Query: 131 SQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRL 190
+ N L + L YN+L + +++L L + N+L A+ + L L
Sbjct: 249 W-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 306
Query: 191 DLSFNNLFGPVPVKLANVPKLEVLDIRNN---SFSGNVPPALKRLNGG---FQYDNNAAL 244
DLS N+L V +LE L + +N + + LK L + ++ AL
Sbjct: 307 DLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSLRAL 365
Query: 245 CGTGFTNLKNCTASDHPTPGKPEPFEPNGLSTKDIPES 282
F N+ D K + +GL K+ +
Sbjct: 366 ----FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKP 399
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 1e-17
Identities = 36/155 (23%), Positives = 65/155 (41%), Gaps = 8/155 (5%)
Query: 82 PAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMTNLQ 140
A + + + L L+ + + A + LY+ N + +P + N+ L
Sbjct: 68 AALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLT 126
Query: 141 VLQLCYNKLTGNIPTQL-GSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFG 199
VL L N L+ ++P + + KL+ L++ N L + L L LS N L
Sbjct: 127 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-- 183
Query: 200 PVPVKLANVPKLEVLDIRNNSFSG-NVPPALKRLN 233
V L+ +P L ++ N S +P A++ L+
Sbjct: 184 -THVDLSLIPSLFHANVSYNLLSTLAIPIAVEELD 217
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 28/165 (16%), Positives = 62/165 (37%), Gaps = 16/165 (9%)
Query: 80 EIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMTN 138
I + + +++ + E +L+ + + + K+P+ + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76
Query: 139 LQVLQLCYNKLTGNIPTQ-LGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNL 197
+++L L ++ I T + L + +N + P ++ +L L L N+L
Sbjct: 77 VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 135
Query: 198 FGPVPVKL-ANVPKLEVLDIRNN--------SFSGNVPPALKRLN 233
+P + N PKL L + NN +F +L+ L
Sbjct: 136 -SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQAT--TSLQNLQ 177
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-19
Identities = 64/283 (22%), Positives = 119/283 (42%), Gaps = 49/283 (17%)
Query: 410 LGKSSFSATYKGILRDGS----VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLR 465
+G F G L+ S VA+K + + +FL I+ H N+ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 466 GICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
G+ +K + ++ +++ NG+L L + +++GIA G+ YL
Sbjct: 113 GV-VTKSK-PVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM- 166
Query: 526 PGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG------YLAPEY 579
G VH +L+A +LI+ +SD GL ++L DD A G + +PE
Sbjct: 167 -GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA----AYTTRGGKIPIRWTSPEA 221
Query: 580 TTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID-----------P 627
+FT SD++++G+++++++S G+ P+ + V +D P
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGE---RPY--WEMSNQDVIKAVDEGYRLPPPMDCP 276
Query: 628 NLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+ L Q+ L C + ++RP E ++ L +I
Sbjct: 277 -----------AALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 8e-19
Identities = 41/166 (24%), Positives = 59/166 (35%), Gaps = 28/166 (16%)
Query: 80 EIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSE-------------LSDLYLNVNNLS 126
E+P +KS T Y ++ P E +L LN LS
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 127 GKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGM 186
+P +L+ L N LT +P SL+ L V L+ P
Sbjct: 85 -SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL------- 132
Query: 187 LMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232
L L +S N L +P L N L+++D+ NNS +P L
Sbjct: 133 LEYLGVSNNQLEK-LPE-LQNSSFLKIIDVDNNSLK-KLPDLPPSL 175
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 7e-17
Identities = 32/148 (21%), Positives = 55/148 (37%), Gaps = 17/148 (11%)
Query: 85 VGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144
+ L + + N+L +P SL + N L ++P + N+ L +
Sbjct: 149 LQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI---AAGNNQLE-ELPE-LQNLPFLTAIYA 202
Query: 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVK 204
N L +P SL + N L L +L L + N L +P
Sbjct: 203 DNNSLK-KLPDLPLSLESIV---AGNNILE--ELPELQNLPFLTTIYADNNLL-KTLPDL 255
Query: 205 LANVPKLEVLDIRNNSFSGNVPPALKRL 232
P LE L++R+N + ++P + L
Sbjct: 256 P---PSLEALNVRDNYLT-DLPELPQSL 279
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 39/156 (25%), Positives = 60/156 (38%), Gaps = 21/156 (13%)
Query: 80 EIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNL 139
E+P + L LT +Y N+L +P SL + N L ++ N+ L
Sbjct: 187 ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLSLESI---VAGNNILE--ELPELQNLPFL 239
Query: 140 QVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFG 199
+ N L +P SL L+V N LT +P L L + F+ L
Sbjct: 240 TTIYADNNLLK-TLPDLPPSLEALNVR---DNYLT-DLPELPQSLTFLDVSENIFSGLS- 293
Query: 200 PVPVKLANVPKLEVLDIRNNSFSG--NVPPALKRLN 233
P L L+ +N ++PP+L+ LN
Sbjct: 294 ------ELPPNLYYLNASSNEIRSLCDLPPSLEELN 323
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 7e-15
Identities = 29/142 (20%), Positives = 57/142 (40%), Gaps = 20/142 (14%)
Query: 105 IPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLS 164
I S + L + + +NL+ ++P + N+ + +++ N P G R+++
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 165 V-------------LALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKL 211
V L L L+ ++P L L S N+L +P ++ L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSL-TELPELPQSLKSL 116
Query: 212 EVLDIRNNSFSGNVPPALKRLN 233
V + + S ++PP L+ L
Sbjct: 117 LVDNNNLKALS-DLPPLLEYLG 137
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 9e-14
Identities = 34/174 (19%), Positives = 59/174 (33%), Gaps = 38/174 (21%)
Query: 87 GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPS---------QI---- 133
SL L + N L +P+ SL+ L + LS P+ +I
Sbjct: 255 LPPSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLC 313
Query: 134 GNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLS 193
+L+ L + NKL +P L +L +N L +P +L +L +
Sbjct: 314 DLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELPQNLK---QLHVE 365
Query: 194 FNNL--FGPVPVKLAN-------------VPKLEVLDIRNNSFSGNVPPALKRL 232
+N L F +P + + L+ L + N P + +
Sbjct: 366 YNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESV 418
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 29/153 (18%), Positives = 48/153 (31%), Gaps = 29/153 (18%)
Query: 86 GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLC 145
SL L + N L +P L L + N+L+ ++P N L+ L +
Sbjct: 314 DLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELPQN---LKQLHVE 365
Query: 146 YNKLTGNIPTQLGSLRKLSV----------------LALQYNQLTGAIPASLGDLGMLMR 189
YN L P S+ L + L ++ N L P +
Sbjct: 366 YNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESV---ED 420
Query: 190 LDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFS 222
L ++ + P KLE ++
Sbjct: 421 LRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 63/280 (22%), Positives = 117/280 (41%), Gaps = 28/280 (10%)
Query: 410 LGKSSFSATYKGILRDGS----VVAVK-CIAKTSCKSDEGEFLKGLKILTSLKHENLASL 464
LGK F + + L+ VAVK A SD EFL+ + H ++A L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 465 RGICCSKG----RGECFLIYDFVPNGNLLQHL--DLEAGSEKVLEWATRISVIKGIAKGI 518
G+ +I F+ +G+L L + L T + + IA G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 519 SYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAM---GYL 575
YL + +H +L+A ++ ++D GL + + + + A+ +L
Sbjct: 151 EYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR--QGCASKLPVKWL 206
Query: 576 APEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPN--LEGK 632
A E +T SD++AFG+ +++I++ G+ TP+ E++++ +++ L+
Sbjct: 207 ALESLADNLYTVHSDVWAFGVTMWEIMTRGQ---TPY--AGIENAEIYNYLIGGNRLKQP 261
Query: 633 FSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672
E + + C P RPS + EL +I+G
Sbjct: 262 PECMEE--VYDLMYQCWSADPKQRPSFTCLRMELENILGH 299
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 73/313 (23%), Positives = 123/313 (39%), Gaps = 84/313 (26%)
Query: 410 LGKSSF----SATYKGILRDGSV--VAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLA 462
LG+ +F A GI + + VAVK + + + S+ + LKIL + H N+
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 463 SLRGICCSKGRGECFLIYDFVPNGNLLQHL------------DLEAGSEKVLEWATRISV 510
+L G C+K G +I +F GNL +L E + L I
Sbjct: 95 NLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 511 IKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR----RYNPLLSDSGLHKL----LADDIV 562
+AKG+ +L A + IHR R N LLS+ + K+ LA DI
Sbjct: 154 SFQVAKGMEFL-------------ASRKCIHRDLAAR-NILLSEKNVVKICDFGLARDIY 199
Query: 563 FS--MLKASAAMGYL-----APEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQ 614
++ A L APE +T +SD+++FG+++++I S G +P+
Sbjct: 200 KDPDYVRKGDAR--LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA---SPY--- 251
Query: 615 AAESSKVEDFIDPNLEGKFSVSEA--------------SNLGQIALHCTHESPSHRPSIE 660
P ++ + Q L C H PS RP+
Sbjct: 252 ------------PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 299
Query: 661 NVMQELSSIIGSS 673
+++ L +++ ++
Sbjct: 300 ELVEHLGNLLQAN 312
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 57/282 (20%), Positives = 106/282 (37%), Gaps = 34/282 (12%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRG- 466
LG+ FS L DG A+K I + D E + + H N+ L
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 467 -ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
+ + E +L+ F G L ++ L + ++ GI +G+ +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--A 152
Query: 526 PGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFS----MLKASAA----MGYLAP 577
G H +L +L+ P+L D G + S L+ AA + Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 578 E------YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF--TRQAAESS--KVEDFIDP 627
E + E++D+++ G +++ ++ G+ P+ Q +S V++ +
Sbjct: 213 ELFSVQSHCVID---ERTDVWSLGCVLYAMMFGE---GPYDMVFQKGDSVALAVQNQLSI 266
Query: 628 NLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSI 669
+ S S L + P RP I ++ +L ++
Sbjct: 267 PQSPRHS-SALWQL--LN-SMMTVDPHQRPHIPLLLSQLEAL 304
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 46/204 (22%), Positives = 68/204 (33%), Gaps = 25/204 (12%)
Query: 51 CSSDSFDGVACDENG----------RVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNA 100
C ++ +C + G I L G +S A+ ++LT L+LH N
Sbjct: 8 CYNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 101 LNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMTNLQVLQLCYNKLTGNIPTQ-LG 158
L + L+ L L L+ N + + L L L L +
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFR 126
Query: 159 SLRKLSVLALQYNQLTGAIPA-SLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIR 217
L L L LQ N L A+P + DLG L L L N + + L+ L +
Sbjct: 127 GLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 218 NN--------SFSGNVPPALKRLN 233
N +F L L
Sbjct: 186 QNRVAHVHPHAFRDL--GRLMTLY 207
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 8e-17
Identities = 43/145 (29%), Positives = 64/145 (44%), Gaps = 5/145 (3%)
Query: 80 EIPAAV-GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMT 137
+ A GL L L+L L + P L+ L LYL N L +P ++
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLG 153
Query: 138 NLQVLQLCYNKLTGNIPTQ-LGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNN 196
NL L L N+++ ++P + L L L L N++ P + DLG LM L L NN
Sbjct: 154 NLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 197 LFGPVPVKLANVPKLEVLDIRNNSF 221
L LA + L+ L + +N +
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPW 237
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-18
Identities = 41/157 (26%), Positives = 65/157 (41%), Gaps = 7/157 (4%)
Query: 80 EIPAAV-GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMT 137
IP V GL +LT L + N + ++ L L L + N+L I + +
Sbjct: 94 LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLN 152
Query: 138 NLQVLQLCYNKLTGNIPTQ-LGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNN 196
+L+ L L LT +IPT+ L L L VL L++ + S L L L++S
Sbjct: 153 SLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWP 211
Query: 197 LFGPVPVKLANVPKLEVLDIRNNSFSGNVPP-ALKRL 232
+ L L I + + + VP A++ L
Sbjct: 212 YLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHL 247
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 8e-18
Identities = 38/154 (24%), Positives = 64/154 (41%), Gaps = 6/154 (3%)
Query: 82 PAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMTNLQ 140
P A L +L L L N L + LS L+ L ++ N + + + ++ NL+
Sbjct: 73 PGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLK 131
Query: 141 VLQLCYNKLTGNIPTQ-LGSLRKLSVLALQYNQLTGAIPA-SLGDLGMLMRLDLSFNNLF 198
L++ N L I + L L L L+ LT +IP +L L L+ L L N+
Sbjct: 132 SLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN 189
Query: 199 GPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232
+ +L+VL+I + + + P
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG 223
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 6e-17
Identities = 42/183 (22%), Positives = 65/183 (35%), Gaps = 2/183 (1%)
Query: 51 CSSDSFDGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIA 110
C F V + L + L L L+ N ++ V P
Sbjct: 18 CHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFN 77
Query: 111 SLSELSDLYLNVNNLSGKIPSQI-GNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQ 169
+L L L L N L IP + ++NL L + NK+ + L L L +
Sbjct: 78 NLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVG 136
Query: 170 YNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPAL 229
N L + L L +L L NL L+++ L VL +R+ + + +
Sbjct: 137 DNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSF 196
Query: 230 KRL 232
KRL
Sbjct: 197 KRL 199
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 35/157 (22%), Positives = 64/157 (40%), Gaps = 14/157 (8%)
Query: 87 GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMTNLQVLQLC 145
GL SL L L L + + ++ L L L L N++ I + L+VL++
Sbjct: 150 GLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEIS 208
Query: 146 YNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPA-SLGDLGMLMRLDLSFNNLFGPVPVK 204
+ + L+ L++ + LT A+P ++ L L L+LS+N +
Sbjct: 209 HWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSM 267
Query: 205 LANVPKLEVLDIRNN--------SFSGNVPPALKRLN 233
L + +L+ + + +F G L+ LN
Sbjct: 268 LHELLRLQEIQLVGGQLAVVEPYAFRGL--NYLRVLN 302
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 32/138 (23%), Positives = 53/138 (38%), Gaps = 4/138 (2%)
Query: 87 GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQ-IGNMTNLQVLQLC 145
L L L + + L+ L + NL+ +P + ++ L+ L L
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLS 256
Query: 146 YNKLTGNIPTQ-LGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVK 204
YN ++ I L L +L + L QL P + L L L++S N L
Sbjct: 257 YNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESV 315
Query: 205 LANVPKLEVLDIRNNSFS 222
+V LE L + +N +
Sbjct: 316 FHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 31/129 (24%), Positives = 46/129 (35%), Gaps = 4/129 (3%)
Query: 71 SLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIP 130
+ + +LT L + L V + L L L L+ N +S I
Sbjct: 206 EISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIE 264
Query: 131 SQI-GNMTNLQVLQLCYNKLTGNIPTQ-LGSLRKLSVLALQYNQLTGAIPASLGDLGMLM 188
+ + LQ +QL +L + L L VL + NQLT + +G L
Sbjct: 265 GSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLE 323
Query: 189 RLDLSFNNL 197
L L N L
Sbjct: 324 TLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 27/129 (20%), Positives = 42/129 (32%), Gaps = 13/129 (10%)
Query: 113 SELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQ 172
++ + + +P I T ++L L N++ + S L L L N
Sbjct: 11 AQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI 67
Query: 173 LTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNN--------SFSGN 224
++ P + +L L L L N L + L LDI N F
Sbjct: 68 VSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDL 127
Query: 225 VPPALKRLN 233
LK L
Sbjct: 128 --YNLKSLE 134
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 6e-18
Identities = 35/291 (12%), Positives = 86/291 (29%), Gaps = 34/291 (11%)
Query: 395 EEVERATQCFSEANLLGKSSFSATYKGILRD------GSVVAVKCIAKTSCKSDEGEFLK 448
E + ++ +LLG+ +F+ Y+ D +K + + +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-ANPWEFYIGTQ 116
Query: 449 GLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDL-EAGSEKVLEWATR 507
++ L + L+ + G LL ++L + EKV+
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQN--GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 508 ISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK--LLAD---DIV 562
IS + I +H ++H ++ + ++ + + L L D I
Sbjct: 175 ISFAMRMLYMIEQVHDC--EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 563 FSMLKASAAM-------GYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQA 615
+ G+ E + + + D + V+ +L G +
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY---MKVKN- 288
Query: 616 AESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQEL 666
E + + + + L + H +++++
Sbjct: 289 ---EGGECKPEGLFRRLPHLDMWNEFFHVML---NIPDCHHLPSLDLLRQK 333
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 61/288 (21%), Positives = 113/288 (39%), Gaps = 49/288 (17%)
Query: 410 LGKSSFSATYKGILRDGS----VVAVK-CIAKTSCKSDEGEFLKGLKILTSLKHENLASL 464
LG+ F + +G L+ VAVK S + + EFL + H N+ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 465 RGICC---SKGRGECFLIYDFVPNGNLLQHL--DLEAGSEKVLEWATRISVIKGIAKGIS 519
G+C S+G + +I F+ G+L +L K + T + + IA G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 520 YLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYL---- 575
YL + +H +L+A ++ ++D GL K + + + A +
Sbjct: 162 YLSNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR--QGRIAK--MPVKW 215
Query: 576 -APEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID------- 626
A E +T KSD++AFG+ +++I + G TP+ ++ ++ D++
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATRGM---TPY--PGVQNHEMYDYLLHGHRLKQ 270
Query: 627 ----PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
L +I C P RP+ + +L ++
Sbjct: 271 PEDCL-----------DELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 56/269 (20%), Positives = 109/269 (40%), Gaps = 27/269 (10%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKG-LKILTSLKHENLASLRG 466
+G S+ K DG ++ K + S E + L + +L LKH N+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
+ +++ ++ G+L + + L+ + V+ + + H +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 527 GL---VHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYT 580
G +H +L V + + N L D GL ++L D F A +G Y++PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF----AKTFVGTPYYMSPEQM 188
Query: 581 TTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAES-----SKVEDFIDPNLEGKFSV 635
+ EKSDI++ G +++++ + PFT A S K+ + + ++S
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALM---PPFT---AFSQKELAGKIREGKFRRIPYRYS- 241
Query: 636 SEASNLGQIALHCTHESPSHRPSIENVMQ 664
L +I + HRPS+E +++
Sbjct: 242 ---DELNEIITRMLNLKDYHRPSVEEILE 267
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 8e-18
Identities = 67/296 (22%), Positives = 123/296 (41%), Gaps = 49/296 (16%)
Query: 408 NLLGKSSF----SATYKGILRDGSV--VAVKCIAKTSCKSDEGEFLKGLKILTSL-KHEN 460
LG +F AT G+ ++ +V VAVK + T+ ++ + LKI++ L +HEN
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 461 LASLRGICCSKGRGECFLIYDFVPNGNLLQHL----------DLEAGSEKVLEWATRISV 510
+ +L G C+ G G +I ++ G+LL L A + +
Sbjct: 112 IVNLLG-ACTHG-GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 511 IKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSM--LKA 568
+A+G+++L K +H +++A VL+ + + D GL A DI+ +
Sbjct: 170 SSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGL----ARDIMNDSNYIVK 223
Query: 569 SAAMGYL-----APEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVE 622
A L APE +T +SD++++G+++++I S G P+ +
Sbjct: 224 GNAR--LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL---NPY--PGILVN--S 274
Query: 623 DFIDPNLEGK-----FSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
F +G + N+ I C P+HRP+ + + L
Sbjct: 275 KFYKLVKDGYQMAQPAFAPK--NIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 9e-18
Identities = 49/215 (22%), Positives = 75/215 (34%), Gaps = 26/215 (12%)
Query: 86 GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMTNLQVLQL 144
G L L L L N L +P +L L+ L ++ N L+ +P + LQ L L
Sbjct: 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYL 131
Query: 145 CYNKLTGNIPTQL-GSLRKLSVLALQYNQLTGAIPASLGD-LGMLMRLDLSFNNLFGPVP 202
N+L +P L KL L+L N LT +PA L + L L L L N+L+ +P
Sbjct: 132 KGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IP 188
Query: 203 VKLANVPKLEVLDIRNNSF----------------SGNVPPALKRLNGGFQYDNNAALCG 246
L + N + + NV + ++ N A++
Sbjct: 189 KGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQDNAENVYVWKQGVDVKAMTSNVASVQC 248
Query: 247 TGFTNLKNCTASDHPTPGKPEPFEPNGLSTKDIPE 281
P + E + PE
Sbjct: 249 DNSDKFPVYKYPGKGCPTLGD--EGDTDLYDYYPE 281
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 8/149 (5%)
Query: 72 LQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPS 131
+ L+ +P + K T L+L N L + + L+ L L+ L+ K+
Sbjct: 17 CDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV 72
Query: 132 QIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGD-LGMLMRL 190
G + L L L +N+L ++P +L L+VL + +N+LT ++P LG L L
Sbjct: 73 -DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQEL 129
Query: 191 DLSFNNLFGPVPVKLANVPKLEVLDIRNN 219
L N L P L PKLE L + NN
Sbjct: 130 YLKGNELKTLPPGLLTPTPKLEKLSLANN 158
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 29/108 (26%), Positives = 48/108 (44%), Gaps = 6/108 (5%)
Query: 112 LSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYN 171
++ ++ + NL+ +P + + +L L N L L +L+ L L
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 172 QLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNN 219
+LT + G L +L LDLS N L +P+ +P L VLD+ N
Sbjct: 66 ELT-KLQVD-GTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFN 110
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 34/147 (23%), Positives = 54/147 (36%), Gaps = 4/147 (2%)
Query: 82 PAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMTNLQ 140
A L L L+L N + + + L L L I ++NL+
Sbjct: 129 NGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLR 188
Query: 141 VLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGP 200
L L L IP L L KL L L N L+ P S L L +L + + +
Sbjct: 189 YLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVI 246
Query: 201 VPVKLANVPKLEVLDIRNNSFSGNVPP 227
N+ L +++ +N+ + +P
Sbjct: 247 ERNAFDNLQSLVEINLAHNNLT-LLPH 272
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 5e-16
Identities = 46/211 (21%), Positives = 78/211 (36%), Gaps = 22/211 (10%)
Query: 40 LLTSWAPNADPCSS-----DSFDGVACDENG----------RVANISLQGKGLSGEIPAA 84
+ +A C S + F V C ++L + +
Sbjct: 24 GCVAETGSAQTCPSVCSCSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNS 83
Query: 85 VGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMTNLQVLQ 143
L+ L L L N + + L+ L+ L L N L+ IP+ ++ L+ L
Sbjct: 84 FKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELW 142
Query: 144 LCYNKLTGNIPTQL-GSLRKLSVLALQ-YNQLTGAIPASLGDLGMLMRLDLSFNNLFGPV 201
L N + +IP+ + L L L +L+ + L L L+L+ NL +
Sbjct: 143 LRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL-REI 200
Query: 202 PVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232
P L + KL+ LD+ N S P + + L
Sbjct: 201 P-NLTPLIKLDELDLSGNHLSAIRPGSFQGL 230
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 8e-16
Identities = 44/163 (26%), Positives = 63/163 (38%), Gaps = 17/163 (10%)
Query: 82 PAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMTNLQ 140
A GL +L L L N L + LS+L +L+L N + IPS + +L+
Sbjct: 105 IGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLR 163
Query: 141 VLQLC-YNKLTGNIPTQ-LGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLF 198
L L +L+ I L L L L L IP L L L LDLS N+L
Sbjct: 164 RLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS 220
Query: 199 GPVPVKLANVPKLEVLDIRNN--------SFSGNVPPALKRLN 233
P + L+ L + + +F +L +N
Sbjct: 221 AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNL--QSLVEIN 261
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 34/142 (23%), Positives = 57/142 (40%), Gaps = 5/142 (3%)
Query: 82 PAAVGGLKSLTGLYL-HFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQ 140
A + SL L L L+ + LS L L L + NL +IP+ + + L
Sbjct: 153 SYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLD 210
Query: 141 VLQLCYNKLTGNIPTQ-LGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFG 199
L L N L+ I L L L + +Q+ + +L L+ ++L+ NNL
Sbjct: 211 ELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL 269
Query: 200 PVPVKLANVPKLEVLDIRNNSF 221
+ LE + + +N +
Sbjct: 270 LPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 30/144 (20%), Positives = 51/144 (35%), Gaps = 4/144 (2%)
Query: 87 GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMTNLQVLQLC 145
L L L+L N + + + L L L I + NL+ L L
Sbjct: 145 YLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG 204
Query: 146 YNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKL 205
+ ++P L L L L + N P S L L +L + + +
Sbjct: 205 MCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAF 262
Query: 206 ANVPKLEVLDIRNNSFSGNVPPAL 229
+ L L++ +N+ S ++P L
Sbjct: 263 DGLASLVELNLAHNNLS-SLPHDL 285
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 30/141 (21%), Positives = 53/141 (37%), Gaps = 3/141 (2%)
Query: 82 PAAVGGLKSLTGLYL-HFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQ 140
A + SL L L L + L L L L + N+ +P+ + + L+
Sbjct: 164 SYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLE 221
Query: 141 VLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGP 200
L++ N P L L L + +Q++ + L L+ L+L+ NNL
Sbjct: 222 ELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSL 281
Query: 201 VPVKLANVPKLEVLDIRNNSF 221
+ L L + +N +
Sbjct: 282 PHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 46/219 (21%), Positives = 79/219 (36%), Gaps = 38/219 (17%)
Query: 40 LLTSWAPNADPCSSDSFDGVACDENGRVANISLQGKGLSGEIPAAV-------------- 85
+ + + C S C + + + + +GLS E+P +
Sbjct: 35 IAAAASAGPQNCPS------VCSCSNQFSKVVCTRRGLS-EVPQGIPSNTRYLNLMENNI 87
Query: 86 --------GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNM 136
L L L L N++ + L+ L+ L L N L+ IPS +
Sbjct: 88 QMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYL 146
Query: 137 TNLQVLQLCYNKLTGNIPTQ-LGSLRKLSVLALQ-YNQLTGAIPASLGDLGMLMRLDLSF 194
+ L+ L L N + +IP+ + L L L +L + L L L+L
Sbjct: 147 SKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGM 205
Query: 195 NNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPP-ALKRL 232
N+ +P L + LE L++ N F + P + L
Sbjct: 206 CNIKD-MP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGL 241
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 62/287 (21%), Positives = 118/287 (41%), Gaps = 45/287 (15%)
Query: 415 FSATYKGILRDGSV--VAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSK 471
AT G+++ + VAVK + ++ ++ + LK+L+ L H N+ +L G C+
Sbjct: 40 VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG-ACTI 98
Query: 472 GRGECFLIYDFVPNGNLLQHL--------------DLEAGSEKVLEWATRISVIKGIAKG 517
G G +I ++ G+LL L + E L+ +S +AKG
Sbjct: 99 G-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKG 157
Query: 518 ISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYL-- 575
+++L K +H +L+A +L+ + D GL + + +D + + A L
Sbjct: 158 MAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY--VVKGNAR--LPV 211
Query: 576 ---APEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEG 631
APE +T +SD++++G+ ++++ S G +P+ F EG
Sbjct: 212 KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS---SPY----PGMPVDSKFYKMIKEG 264
Query: 632 K-----FSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
+ I C P RP+ + ++Q + I S
Sbjct: 265 FRMLSPEHAPA--EMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 57/284 (20%), Positives = 108/284 (38%), Gaps = 35/284 (12%)
Query: 410 LGKSSFSATYKGILRDGS------VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463
LG +F Y+G + VAVK + + + DE +FL I++ H+N+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHL---DLEAGSEKVLEWATRISVIKGIAKGISY 520
G + F++ + + G+L L L + V + IA G Y
Sbjct: 98 CIG-VSLQS-LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 521 LHGKRPGLVHPNLSAEKVLIHRRYNPLL---SDSGLHKLLADDIVFSMLKASAAMGYL-- 575
L +H +++A L+ + D G +A DI + L
Sbjct: 156 LEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGCAMLPV 209
Query: 576 ---APEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPN--L 629
PE G FT K+D ++FG+++++I S G P+ + + +V +F+ +
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY---MPY--PSKSNQEVLEFVTSGGRM 264
Query: 630 EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
+ + + +I C P RP+ +++ +
Sbjct: 265 DPPKNCPGP--VYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 56/284 (19%), Positives = 118/284 (41%), Gaps = 35/284 (12%)
Query: 410 LGKSSF----SATYKGILRDGSV--VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463
LG+ SF KG+++D VA+K + + + + EFL ++ ++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHL------DLEAGSEKVLEWATRISVIKGIAKG 517
L G S+G +I + + G+L +L + I + IA G
Sbjct: 93 LLG-VVSQG-QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 518 ISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYL-- 575
++YL+ + VH +L+A ++ + + D G+ + + + + K + L
Sbjct: 151 MAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR--KGGKGL--LPV 204
Query: 576 ---APEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPN--L 629
+PE G FT SD+++FG+++++I + + P+ Q + +V F+ L
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE---QPY--QGLSNEQVLRFVMEGGLL 259
Query: 630 EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
+ + + L ++ C +P RPS ++ + +
Sbjct: 260 DKPDNCPD--MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 1e-17
Identities = 32/158 (20%), Positives = 60/158 (37%), Gaps = 18/158 (11%)
Query: 88 LKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYN 147
SL L + N L ++P+ A L + + N L+ +P T+L+VL + N
Sbjct: 119 PASLKHLDVDNNQLT-MLPELPALLEYI---NADNNQLT-MLPELP---TSLEVLSVRNN 170
Query: 148 KLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGML----MRLDLSFNNLFGPVPV 203
+LT +P SL L + N L ++PA + N + +P
Sbjct: 171 QLTF-LPELPESLEALD---VSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRI-THIPE 224
Query: 204 KLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNN 241
+ ++ + + +N S + +L + Y
Sbjct: 225 NILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGP 262
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 3e-17
Identities = 36/148 (24%), Positives = 66/148 (44%), Gaps = 21/148 (14%)
Query: 88 LKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYN 147
+ + L L+ L+ +P + +++ L + N L +P + L+ L C N
Sbjct: 58 INQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPAS---LEYLDACDN 110
Query: 148 KLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLAN 207
+L+ +P SL+ L + NQLT +P +L ++ N L +P +
Sbjct: 111 RLS-TLPELPASLKHLD---VDNNQLT-MLPEL---PALLEYINADNNQL-TMLPELPTS 161
Query: 208 VPKLEVLDIRNNSFSG--NVPPALKRLN 233
LEVL +RNN + +P +L+ L+
Sbjct: 162 ---LEVLSVRNNQLTFLPELPESLEALD 186
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 26/177 (14%), Positives = 48/177 (27%), Gaps = 12/177 (6%)
Query: 88 LKSLTGLYLHFNALNGVIPKEIASLSELSD----LYLNVNNLSGKIPSQIGNMTNLQVLQ 143
+SL L + N L +P + N ++ IP I ++ +
Sbjct: 179 PESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTII 236
Query: 144 LCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPV 203
L N L+ I L + + + D
Sbjct: 237 LEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQS 294
Query: 204 KLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAALCGTGFTNLKNCTASDH 260
++ + + N+FS L RL+ N + L+ +AS
Sbjct: 295 DVSQIWHAFEHEEHANTFSAF----LDRLSDTVSARNTSGFREQVAAWLEKLSASAE 347
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 40/147 (27%), Positives = 67/147 (45%), Gaps = 9/147 (6%)
Query: 80 EIPAAV-GGLKSLTGLYLHFNAL-NGVIPKEI-ASLSELSDLYLNVNNLSGKIPSQIGNM 136
++ +V GL + + L N L + I + +LS + + N++ IP G
Sbjct: 135 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLP 191
Query: 137 TNLQVLQLCYNKLTGNIPTQ-LGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFN 195
+L L L NK+T + L L L+ L L +N ++ SL + L L L+ N
Sbjct: 192 PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 250
Query: 196 NLFGPVPVKLANVPKLEVLDIRNNSFS 222
L VP LA+ ++V+ + NN+ S
Sbjct: 251 KL-VKVPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 33/148 (22%), Positives = 56/148 (37%), Gaps = 11/148 (7%)
Query: 80 EIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNL 139
IP G SLT L+L N + V + L+ L+ L L+ N++S + N +L
Sbjct: 185 TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 242
Query: 140 QVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTG------AIPASLGDLGMLMRLDLS 193
+ L L NKL +P L + + V+ L N ++ P + L
Sbjct: 243 RELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLF 301
Query: 194 FNNL-FGPVPVKL-ANVPKLEVLDIRNN 219
N + + + V + + N
Sbjct: 302 SNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 49/210 (23%), Positives = 81/210 (38%), Gaps = 25/210 (11%)
Query: 41 LTSWAPNADPCSSD---SFDGVACDENG----------RVANISLQGKGLSGEIPAAV-G 86
+ P C V C + G A + LQ ++ EI
Sbjct: 15 VPEIEPMGPVCPFRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFK 73
Query: 87 GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCY 146
LK+L L L N ++ + P A L +L LYL+ N L ++P LQ L++
Sbjct: 74 NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHE 130
Query: 147 NKLTGNIPTQLGSLRKLSVLALQYNQLTGAI--PASLGDLGMLMRLDLSFNNLFGPVPVK 204
N++T + L ++ V+ L N L + + + L + ++ N+ +P
Sbjct: 131 NEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQG 189
Query: 205 LANVPKLEVLDIRNNSFSGNVPP-ALKRLN 233
L P L L + N + V +LK LN
Sbjct: 190 L--PPSLTELHLDGNKIT-KVDAASLKGLN 216
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 14/77 (18%), Positives = 28/77 (36%), Gaps = 8/77 (10%)
Query: 80 EIPAAVGGLKSLTGLYLHFNALNGV------IPKEIASLSELSDLYLNVNNLS-GKIPSQ 132
++P + K + +YLH N ++ + P + S + L N + +I
Sbjct: 254 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313
Query: 133 I-GNMTNLQVLQLCYNK 148
+ +QL K
Sbjct: 314 TFRCVYVRAAVQLGNYK 330
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 57/284 (20%), Positives = 108/284 (38%), Gaps = 35/284 (12%)
Query: 410 LGKSSFSATYKGILRDGS------VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463
LG +F Y+G + VAVK + + + DE +FL I++ H+N+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHL---DLEAGSEKVLEWATRISVIKGIAKGISY 520
G + F++ + + G+L L L + V + IA G Y
Sbjct: 139 CIG-VSLQS-LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 521 LHGKRPGLVHPNLSAEKVLIHRRYNPLL---SDSGLHKLLADDIVFSMLKASAAMGYL-- 575
L +H +++A L+ + D G +A DI + L
Sbjct: 197 LEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRAGYYRKGGCAMLPV 250
Query: 576 ---APEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPN--L 629
PE G FT K+D ++FG+++++I S G P+ + + +V +F+ +
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY---MPY--PSKSNQEVLEFVTSGGRM 305
Query: 630 EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
+ + + +I C P RP+ +++ +
Sbjct: 306 DPPKNCPGP--VYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 49/209 (23%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 410 LGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKG-LKILTSLKHENLASLRGI 467
LG ++ + A+K I KTS + L + +L L H N+ L
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYLHGKR 525
+ + +L+ + G L + + +E A I IK + G++YLH
Sbjct: 105 F--EDKRNYYLVMECYKGGELFDEI-IHRMKFNEVD---AAVI--IKQVLSGVTYLHKH- 155
Query: 526 PGLVHPNLSAEKVLIHRR--YNPL-LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT 582
+VH +L E +L+ + + + D GL + + +A Y+APE
Sbjct: 156 -NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTA--YYIAPE-VLR 211
Query: 583 GRFTEKSDIYAFGMIVFQILSGKCSITPF 611
++ EK D+++ G+I+F +L+G PF
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGY---PPF 237
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 53/272 (19%), Positives = 103/272 (37%), Gaps = 28/272 (10%)
Query: 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKG-LKILTSLKHENLASLRG 466
+G S ++ + + A+K + + + + + L L+ + +R
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
+++ + N +L L +K ++ R S K + + + +H
Sbjct: 75 YDYEITDQYIYMVMECG-NIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPE----- 578
G+VH +L LI L D G+ + D + + G Y+ PE
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDM 184
Query: 579 ------YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGK 632
+ + + KSD+++ G I++ + GK TPF + + SK+ IDPN E +
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK---TPFQQIINQISKLHAIIDPNHEIE 241
Query: 633 FSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664
F +L + C P R SI ++
Sbjct: 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 49/267 (18%), Positives = 101/267 (37%), Gaps = 26/267 (9%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDE--GEFLKGLKILTSLKHENLASLR 465
+G+ FS Y+ L DG VA+K + + + +K + +L L H N+
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 466 GICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
E ++ + G+L + + ++++ T + + ++H +R
Sbjct: 99 A--SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR 156
Query: 526 PGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTTT 582
++H ++ V I L D GL + + A + +G Y++PE
Sbjct: 157 --VMHRDIKPANVFITATGVVKLGDLGLGRFFSS----KTTAAHSLVGTPYYMSPERIHE 210
Query: 583 GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK-----VEDFIDPNLEGKFSVSE 637
+ KSDI++ G +++++ + + +PF + P +S
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQ---SPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS--- 264
Query: 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664
L Q+ C + P RP + V
Sbjct: 265 -EELRQLVNMCINPDPEKRPDVTYVYD 290
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 8e-17
Identities = 37/166 (22%), Positives = 62/166 (37%), Gaps = 25/166 (15%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
+++ GL+ +P + +T L + N L +P L L ++ N L+ +
Sbjct: 45 LNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTL---EVSGNQLT-SL 96
Query: 130 PSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMR 189
P + L + L P L KL + NQLT ++P L
Sbjct: 97 PVLPPGLLELSIFSNPLTHL----PALPSGLCKLW---IFGNQLT-SLPVLPPG---LQE 145
Query: 190 LDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG--NVPPALKRLN 233
L +S N L +P + L L NN + +P L+ L+
Sbjct: 146 LSVSDNQL-ASLPALPSE---LCKLWAYNNQLTSLPMLPSGLQELS 187
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 2e-15
Identities = 40/189 (21%), Positives = 65/189 (34%), Gaps = 51/189 (26%)
Query: 80 EIPAAVGGLKSLTGLYLHFNALNGV----------------IPKEIASLSELSDLYLNVN 123
+P GL L+ L + +P L EL ++ N
Sbjct: 95 SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQEL---SVSDN 151
Query: 124 NLSGKIPSQIGNMT-----------------NLQVLQLCYNKLTGNIPTQLGSLRKLSVL 166
L+ +P+ + LQ L + N+L ++PT L KL
Sbjct: 152 QLA-SLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLA-SLPTLPSELYKLWAY 209
Query: 167 ALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG--N 224
N+LT ++PA L L +S N L +PV + L+ L + N +
Sbjct: 210 ---NNRLT-SLPALPSGLK---ELIVSGNRL-TSLPVLPSE---LKELMVSGNRLTSLPM 258
Query: 225 VPPALKRLN 233
+P L L+
Sbjct: 259 LPSGLLSLS 267
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 25/166 (15%), Positives = 51/166 (30%), Gaps = 14/166 (8%)
Query: 80 EIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNL 139
+P LK L + N L +P + L L + N L+ ++P + ++++
Sbjct: 235 SLPVLPSELKEL---MVSGNRLTS-LPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSE 286
Query: 140 QVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFG 199
+ L N L+ Q R+++ + A L L+ +
Sbjct: 287 TTVNLEGNPLS-ERTLQAL--REITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLV 343
Query: 200 PVPVKLANVPKLEVLD-IRNNSFSGNVPPALKRLNGGFQYDNNAAL 244
P + + L RL+ + +A
Sbjct: 344 PAR--EGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFIKDAGF 387
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 65/303 (21%), Positives = 133/303 (43%), Gaps = 64/303 (21%)
Query: 410 LGKSSF----SATYKGILRDGS----VVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHEN 460
LG+ F A GI +D VAVK + + + D + + ++++ + KH+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 461 LASLRGICCSKGRGECFLIYDFVPNGNLLQHL------------DLEAGSEKVLEWATRI 508
+ +L G C++ G ++I ++ GNL ++L D+ E+ + + +
Sbjct: 149 IINLLG-ACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 509 SVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR----RYNPLLSDSGLHKL----LADD 560
S +A+G+ YL A + IHR R N L++++ + K+ LA D
Sbjct: 207 SCTYQLARGMEYL-------------ASQKCIHRDLAAR-NVLVTENNVMKIADFGLARD 252
Query: 561 IVFS--MLKASAAMGYL-----APEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFT 612
I K + L APE +T +SD+++FG+++++I + G +P+
Sbjct: 253 INNIDYYKKTTNGR--LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG---SPY- 306
Query: 613 RQAAESSKVEDFIDPN--LEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
++ + ++ + + L + C H PS RP+ + ++++L I+
Sbjct: 307 -PGIPVEELFKLLKEGHRMDKPANCTNE--LYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363
Query: 671 GSS 673
+
Sbjct: 364 TLT 366
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 39/146 (26%), Positives = 63/146 (43%), Gaps = 8/146 (5%)
Query: 80 EIPAAV-GGLKSLTGLYLHFNAL-NGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMT 137
++P V GL+++ + + N L N +L+ L ++ L+ IP
Sbjct: 137 KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPE 193
Query: 138 NLQVLQLCYNKLTGNIPTQ-LGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNN 196
L L L +NK+ I + L KL L L +NQ+ SL L L L L N
Sbjct: 194 TLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNK 252
Query: 197 LFGPVPVKLANVPKLEVLDIRNNSFS 222
L VP L ++ L+V+ + N+ +
Sbjct: 253 L-SRVPAGLPDLKLLQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 31/150 (20%), Positives = 55/150 (36%), Gaps = 15/150 (10%)
Query: 80 EIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMTN 138
IP ++L L+L N + + +++ S+L L L N + I + +
Sbjct: 186 GIPK--DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPT 242
Query: 139 LQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPAS-------LGDLGMLMRLD 191
L+ L L NKL+ +P L L+ L V+ L N +T + + +
Sbjct: 243 LRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGIS 300
Query: 192 LSFNNL-FGPVPVKL-ANVPKLEVLDIRNN 219
L N + + V V + N
Sbjct: 301 LFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 38/158 (24%), Positives = 68/158 (43%), Gaps = 14/158 (8%)
Query: 80 EIPAAV-GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTN 138
E+ GL+ L L L N ++ + K + L +L LY++ N+L +IP + ++
Sbjct: 68 ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSS 124
Query: 139 LQVLQLCYNKLTGNIPTQ-LGSLRKLSVLALQYNQLTGAI--PASLGDLGMLMRLDLSFN 195
L L++ N++ +P LR ++ + + N L + P + L L L +S
Sbjct: 125 LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEA 182
Query: 196 NLFGPVPVKLANVPKLEVLDIRNNSFSGNVPP-ALKRL 232
L G +P L L L + +N + L R
Sbjct: 183 KLTG-IPKDL--PETLNELHLDHNKIQ-AIELEDLLRY 216
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 25/110 (22%), Positives = 44/110 (40%), Gaps = 8/110 (7%)
Query: 114 ELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQL 173
L + + L +P +I + +L L N ++ L+ L L L N++
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 174 TGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPK-LEVLDIRNNSFS 222
+ + L L +L +S N+L +P N+P L L I +N
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLVE-IP---PNLPSSLVELRIHDNRIR 136
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 53/272 (19%), Positives = 104/272 (38%), Gaps = 28/272 (10%)
Query: 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKG-LKILTSLKHENLASLRG 466
+G S ++ + + A+K + + + + + L L+ + +R
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
+++ + N +L L +K ++ R S K + + + +H
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH-- 146
Query: 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPE----- 578
G+VH +L LI L D G+ + D + + +G Y+ PE
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ--VGTVNYMPPEAIKDM 203
Query: 579 ------YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGK 632
+ + + KSD+++ G I++ + GK TPF + + SK+ IDPN E +
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK---TPFQQIINQISKLHAIIDPNHEIE 260
Query: 633 FSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664
F +L + C P R SI ++
Sbjct: 261 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 65/303 (21%), Positives = 134/303 (44%), Gaps = 64/303 (21%)
Query: 410 LGKSSF----SATYKGILRDGS----VVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHEN 460
LG+ +F A GI +D VAVK + + + D + + ++++ + KH+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 461 LASLRGICCSKGRGECFLIYDFVPNGNLLQHL------------DLEAGSEKVLEWATRI 508
+ +L G C++ G ++I ++ GNL ++L D+ E+ + + +
Sbjct: 103 IINLLG-ACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 509 SVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR----RYNPLLSDSGLHKL----LADD 560
S +A+G+ YL A + IHR R N L++++ + K+ LA D
Sbjct: 161 SCTYQLARGMEYL-------------ASQKCIHRDLAAR-NVLVTENNVMKIADFGLARD 206
Query: 561 IVFS--MLKASAAMGYL-----APEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFT 612
I K + L APE +T +SD+++FG+++++I + G +P+
Sbjct: 207 INNIDYYKKTTNGR--LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG---SPY- 260
Query: 613 RQAAESSKVEDFIDPN--LEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
++ + ++ + + L + C H PS RP+ + ++++L I+
Sbjct: 261 -PGIPVEELFKLLKEGHRMDKPANCTNE--LYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317
Query: 671 GSS 673
+
Sbjct: 318 TLT 320
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 84 AVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143
A+ GL+S+ L L + V P +A LS L LYL++N ++ I + +TNLQ L
Sbjct: 102 AIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLS 157
Query: 144 LCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPV 203
+ +++ ++ L +L KL+ L N+++ I L L L+ + L N + P
Sbjct: 158 IGNAQVS-DLTP-LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDVSP- 212
Query: 204 KLANVPKLEVLDIRNNSFSGNVPPALKRL 232
LAN L ++ + N + + L
Sbjct: 213 -LANTSNLFIVTLTNQTITNQPVFYNNNL 240
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 35/151 (23%), Positives = 60/151 (39%), Gaps = 12/151 (7%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK 128
I+ ++ + L +T L + + + + L+ L L L N ++
Sbjct: 23 KIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT-D 77
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLM 188
+ + N+T + L+L N L N+ + L+ + L L Q+T P L L L
Sbjct: 78 LAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQ 132
Query: 189 RLDLSFNNLFGPVPVKLANVPKLEVLDIRNN 219
L L N + P LA + L+ L I N
Sbjct: 133 VLYLDLNQITNISP--LAGLTNLQYLSIGNA 161
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 27/114 (23%), Positives = 49/114 (42%), Gaps = 6/114 (5%)
Query: 84 AVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143
+ L LT L N ++ + P +ASL L +++L N +S P + N +NL ++
Sbjct: 168 PLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 144 LCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNL 197
L +T +L +V+ PA++ D G +L++N
Sbjct: 224 LTNQTITNQPVFYNNNLVVPNVVKGPSGAPI--APATISDNGTYASPNLTWNLT 275
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 17/85 (20%), Positives = 34/85 (40%), Gaps = 6/85 (7%)
Query: 135 NMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSF 194
+ N + + +T + L ++ L+ +T I + L L+ L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 195 NNLFGPVPVKLANVPKLEVLDIRNN 219
N + P L N+ K+ L++ N
Sbjct: 73 NQITDLAP--LKNLTKITELELSGN 95
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 61/317 (19%), Positives = 117/317 (36%), Gaps = 87/317 (27%)
Query: 410 LGKSSF----SATYKGILRDGSV--VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463
LG+ F AT + VAVK + + + S+ + L +L + H ++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHL--------------------DLEAGSEKVLE 503
L G CS+ G LI ++ G+L L L+ E+ L
Sbjct: 91 LYG-ACSQD-GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 504 WATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR----RYNPLLSDSGLHKL--- 556
IS I++G+ YL AE L+HR R N L+++ K+
Sbjct: 149 MGDLISFAWQISQGMQYL-------------AEMKLVHRDLAAR-NILVAEGRKMKISDF 194
Query: 557 -LADDIVFS--MLKASAAMGYL-----APEYTTTGRFTEKSDIYAFGMIVFQILS-GKCS 607
L+ D+ +K S + A E +T +SD+++FG+++++I++ G
Sbjct: 195 GLSRDVYEEDSYVKRSQGR--IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG-- 250
Query: 608 ITPFTRQAAESSKVEDFID-----------PNLEGKFSVSEASNLGQIALHCTHESPSHR 656
P+ ++ + + + ++ L C + P R
Sbjct: 251 -NPY--PGIPPERLFNLLKTGHRMERPDNCSE-----------EMYRLMLQCWKQEPDKR 296
Query: 657 PSIENVMQELSSIIGSS 673
P ++ ++L ++
Sbjct: 297 PVFADISKDLEKMMVKR 313
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 51/268 (19%), Positives = 117/268 (43%), Gaps = 34/268 (12%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKG-LKILTSLKHENLASLRG 466
+G+ SF DG +K I + S E E + + +L ++KH N+ R
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGS----EKVLEWATRISVIKGIAKGISYLH 522
+ G +++ D+ G+L + ++ + G +++L+W +I + ++H
Sbjct: 91 --SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI------CLALKHVH 142
Query: 523 GKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEY 579
++ ++H ++ ++ + + + L D G+ ++L + A A +G YL+PE
Sbjct: 143 DRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL----ARACIGTPYYLSPEI 196
Query: 580 TTTGRFTEKSDIYAFGMIVFQILSGKCSITPF---TRQAAESSKVEDFIDPNLEGKFSVS 636
+ KSDI+A G +++++ + K F + + + P + +S
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLK---HAFEAGSMKNLVLKIISGSFPP-VSLHYS-- 250
Query: 637 EASNLGQIALHCTHESPSHRPSIENVMQ 664
+L + +P RPS+ ++++
Sbjct: 251 --YDLRSLVSQLFKRNPRDRPSVNSILE 276
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 46/195 (23%), Positives = 70/195 (35%), Gaps = 24/195 (12%)
Query: 48 ADPCSSDSFDGVACDENGRVANISLQGKGLSG--EIPAAVGGLKSLTGLYLHFNALNGVI 105
ADP +S C G A +GL E+PA + + L N++ +
Sbjct: 1 ADPGTS------ECSVIGYNAICI--NRGLHQVPELPA------HVNYVDLSLNSIAELN 46
Query: 106 PKEIASLSELSDLYLNVNNLSGKIPSQI-GNMTNLQVLQLCYNKLTGNIPTQ-LGSLRKL 163
+ L +L L + I + +++L +L+L YN+ + T L L
Sbjct: 47 ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANL 105
Query: 164 SVLALQYNQLTGAI--PASLGDLGMLMRLDLSFNNL--FGPVPVKLANVPKLEVLDIRNN 219
VL L L GA+ L L L L NN+ P N+ + VLD+ N
Sbjct: 106 EVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF-FLNMRRFHVLDLTFN 164
Query: 220 SFSGNVPPALKRLNG 234
L G
Sbjct: 165 KVKSICEEDLLNFQG 179
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 32/135 (23%), Positives = 56/135 (41%), Gaps = 6/135 (4%)
Query: 90 SLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMTNLQVLQLCYNK 148
+ L + + ++ + ++L L L N ++ KI +T+L L L N
Sbjct: 276 GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNF 334
Query: 149 LTGNIPTQL-GSLRKLSVLALQYNQLTGAIPA-SLGDLGMLMRLDLSFNNLFGPVPVKLA 206
L +I +++ +L KL VL L YN + A+ S L L L L N L
Sbjct: 335 LG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFD 392
Query: 207 NVPKLEVLDIRNNSF 221
+ L+ + + N +
Sbjct: 393 RLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 9e-13
Identities = 41/210 (19%), Positives = 71/210 (33%), Gaps = 23/210 (10%)
Query: 70 ISLQGKGLSGEIPAAV-GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNL-SG 127
+ ++ + I GL SL L L +N + L+ L L L NL
Sbjct: 59 LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGA 118
Query: 128 KIPSQI-GNMTNLQVLQLCYNKLTGNIPTQL-GSLRKLSVLALQYNQLTGAIPASLGDLG 185
+ +T+L++L L N + P ++R+ VL L +N++ L +
Sbjct: 119 VLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQ 178
Query: 186 M--LMRLDLSFNNLFGPVPVKLANVP--------KLEVLDIRNNSFSGNVPPA------- 228
L LS L L + LD+ N F ++
Sbjct: 179 GKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAG 238
Query: 229 --LKRLNGGFQYDNNAALCGTGFTNLKNCT 256
++ L Y+ ++ T F + N T
Sbjct: 239 TKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 37/132 (28%), Positives = 55/132 (41%), Gaps = 8/132 (6%)
Query: 70 ISLQGKGLSGEIPAAV-GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK 128
L + + +V L L L N +N + L+ L L L+ N L
Sbjct: 280 CDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-S 337
Query: 129 IPSQI-GNMTNLQVLQLCYNKLTGNIPTQL-GSLRKLSVLALQYNQLTGAIPASLGD-LG 185
I S++ N+ L+VL L YN + + Q L L LAL NQL ++P + D L
Sbjct: 338 IDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLT 395
Query: 186 MLMRLDLSFNNL 197
L ++ L N
Sbjct: 396 SLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 21/162 (12%), Positives = 51/162 (31%), Gaps = 27/162 (16%)
Query: 87 GLKSLTGLYLHFNALNGVIPKEIASL--SELSDLYLNVNNLSGKIPSQIG--------NM 136
++ L L FN + + +++ + + L L+ L +G
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211
Query: 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVL-------------ALQYNQLTGAIPASLGD 183
T++ L L N ++ + + + + + +
Sbjct: 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271
Query: 184 LGM--LMRLDLSFNNLFGPVPVKL-ANVPKLEVLDIRNNSFS 222
L + DLS + +F + + ++ LE L + N +
Sbjct: 272 LEASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEIN 312
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 82.0 bits (202), Expect = 2e-16
Identities = 52/264 (19%), Positives = 104/264 (39%), Gaps = 18/264 (6%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI- 467
LG F + I +D G VA+K + + + ++I+ L H N+ S R +
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 468 ---CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK 524
L ++ G+L ++L+ + E R +++ I+ + YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYLHEN 140
Query: 525 RPGLVHPNLSAEKVLIHRRYNPL---LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTT 581
++H +L E +++ L + D G K L + + + + YLAPE
Sbjct: 141 --RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT--LQYLAPELLE 196
Query: 582 TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641
++T D ++FG + F+ ++G P + KV + + ++ ++
Sbjct: 197 QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT----- 251
Query: 642 GQIALHCTHESPSHRPSIENVMQE 665
G + +P+H I E
Sbjct: 252 GAVKFSSVLPTPNHLSGILAGKLE 275
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 24/210 (11%)
Query: 410 LGKSSFSATYKGILR-DGSVVAVKCIAKT--SCKSDEGEFLKGLKILTSLKHENLASLRG 466
LGK SF + G AVK I+K K+D+ L+ +++L L H N+ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYLHGK 524
+ +G +L+ + G L + + SE A RI I+ + GI+Y+H
Sbjct: 94 FF--EDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVD---AARI--IRQVLSGITYMHKN 145
Query: 525 RPGLVHPNLSAEKVLIHRR--YNPL-LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTT 581
+VH +L E +L+ + + + D GL +A Y+APE
Sbjct: 146 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTA--YYIAPE-VL 200
Query: 582 TGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
G + EK D+++ G+I++ +LSG PF
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSGC---PPF 227
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 59/293 (20%), Positives = 124/293 (42%), Gaps = 48/293 (16%)
Query: 410 LGKSSF----SATYKGILRDGS--VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463
LG+ +F A + +VAVK + K + +F + ++LT+L+HE++
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHL------------DLEAGSEKVLEWATRISVI 511
G C G ++++++ +G+L + L ++ L + + +
Sbjct: 82 FYG-VCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 512 KGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAA 571
IA G+ YL + VH +L+ L+ + D G+ + + +
Sbjct: 140 SQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR--VGGHT 195
Query: 572 MGYL-----APEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFI 625
M L PE +FT +SD+++FG+I+++I + GK P+ + + +V + I
Sbjct: 196 M--LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK---QPWFQLSNT--EVIECI 248
Query: 626 DPNLEGKFSVSEA-----SNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
+G+ V E + + L C P R +I+ + + L ++ ++
Sbjct: 249 T---QGR--VLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKAT 296
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 59/324 (18%), Positives = 119/324 (36%), Gaps = 49/324 (15%)
Query: 374 AKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKGI-LRDGSVVAVK 432
A G+ + F + +E L +L + F+ Y+ + G A+K
Sbjct: 10 ASGRDQSDFVGQTVELGELRLRVRR----------VLAEGGFAFVYEAQDVGSGREYALK 59
Query: 433 CIAKTSCKSDEGEFLKGLKILTSLK-HENL-----ASLRGICCSKGRGECFLIYDFVPNG 486
+ + ++ + + L H N+ A+ G S FL+ + G
Sbjct: 60 RLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKG 118
Query: 487 NLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNP 546
L++ L + S L T + + + + ++H ++P ++H +L E +L+ +
Sbjct: 119 QLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177
Query: 547 LLSDSGLHKLLADDIVFSMLKASAAMG-----------YLAPE-YTTTGRF--TEKSDIY 592
L D G ++ +S A+ Y PE F EK DI+
Sbjct: 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIW 237
Query: 593 AFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV----SEASNLGQIALHC 648
A G I++ + + PF + ++ + GK+S+ ++ + +
Sbjct: 238 ALGCILYLLCFRQ---HPF--EDGAKLRI-------VNGKYSIPPHDTQYTVFHSLIRAM 285
Query: 649 THESPSHRPSIENVMQELSSIIGS 672
+P R SI V+ +L I +
Sbjct: 286 LQVNPEERLSIAEVVHQLQEIAAA 309
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-16
Identities = 54/258 (20%), Positives = 102/258 (39%), Gaps = 34/258 (13%)
Query: 372 PLAKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKGILR-DGSVVA 430
+ G+ F + M+ ++ + + + + LG ++ + S A
Sbjct: 6 HHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKA 65
Query: 431 VKCIAK------------TSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478
+K I K + + E + +L SL H N+ L + K +L
Sbjct: 66 IKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY--FYL 123
Query: 479 IYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAE 536
+ +F G L + + + E A I +K I GI YLH +VH ++ E
Sbjct: 124 VTEFYEGGELFEQI-INRHKFDECD---AANI--MKQILSGICYLHKH--NIVHRDIKPE 175
Query: 537 KVLIHRRYN--PL-LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYA 593
+L+ + + + + D GL + D +A Y+APE ++ EK D+++
Sbjct: 176 NILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA--YYIAPE-VLKKKYNEKCDVWS 232
Query: 594 FGMIVFQILSGKCSITPF 611
G+I++ +L G PF
Sbjct: 233 CGVIMYILLCGY---PPF 247
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 4e-16
Identities = 34/152 (22%), Positives = 59/152 (38%), Gaps = 10/152 (6%)
Query: 86 GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIG---NMTNLQVL 142
+ L N L + + L+EL L L +N L ++ M +LQ L
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQL 379
Query: 143 QLCYNKLTGNIPTQL-GSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPV 201
+ N ++ + + L L + N LT I L + LDL N + +
Sbjct: 380 DISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR--IKVLDLHSNKIKS-I 436
Query: 202 PVKLANVPKLEVLDIRNNSFSGNVPP-ALKRL 232
P ++ + L+ L++ +N +VP RL
Sbjct: 437 PKQVVKLEALQELNVASNQLK-SVPDGIFDRL 467
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 33/153 (21%), Positives = 58/153 (37%), Gaps = 6/153 (3%)
Query: 72 LQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGV--IPKEIASLSELSDLYLNVNNLSGKI 129
L+ + G L L L L N L + I + + L L ++ N++S
Sbjct: 331 FSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDE 390
Query: 130 PSQI-GNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLM 188
+L L + N LT I L ++ VL L N++ +IP + L L
Sbjct: 391 KKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQ 447
Query: 189 RLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSF 221
L+++ N L + L+ + + N +
Sbjct: 448 ELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 38/164 (23%), Positives = 62/164 (37%), Gaps = 8/164 (4%)
Query: 72 LQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPS 131
GL +P + T L + N ++ + +I SLS+L L ++ N + S
Sbjct: 7 RSKNGLI-HVPK--DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63
Query: 132 QIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTG-AIPASLGDLGMLMRL 190
L+ L L +NKL I L L L +N I G++ L L
Sbjct: 64 VFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFL 120
Query: 191 DLSFNNLFGPVPVKLANVPKLEV-LDIRNNSFSGNVPPALKRLN 233
LS +L + +A++ +V L + P L+ N
Sbjct: 121 GLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN 164
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 5e-13
Identities = 32/156 (20%), Positives = 60/156 (38%), Gaps = 12/156 (7%)
Query: 87 GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCY 146
++ + V + +S L + N L+ + G++T L+ L L
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357
Query: 147 NKLTGNIPTQLG---SLRKLSVLALQYNQLTGAIPASLGD-LGMLMRLDLSFNNLFGPVP 202
N+L + ++ L L + N ++ L+ L++S N L +
Sbjct: 358 NQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF 416
Query: 203 VKLANVPKLEVLDIRNN---SFSGNV--PPALKRLN 233
L P+++VLD+ +N S V AL+ LN
Sbjct: 417 RCLP--PRIKVLDLHSNKIKSIPKQVVKLEALQELN 450
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 36/207 (17%), Positives = 57/207 (27%), Gaps = 25/207 (12%)
Query: 77 LSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSG--------- 127
+S + + L L L + N + + EL L L+ N L
Sbjct: 33 ISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVNL 92
Query: 128 -------------KIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLT 174
I + GNM+ L+ L L L + + L VL +
Sbjct: 93 KHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG 152
Query: 175 GAI-PASLGDLGML-MRLDLSFNNLFGPVP-VKLANVPKLEVLDIRNNSFSGNVPPALKR 231
P L D + + N F + V + V LE+ +I+ L
Sbjct: 153 EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSI 212
Query: 232 LNGGFQYDNNAALCGTGFTNLKNCTAS 258
L + L N
Sbjct: 213 LAKLQTNPKLSNLTLNNIETTWNSFIR 239
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 17/140 (12%), Positives = 49/140 (35%), Gaps = 5/140 (3%)
Query: 88 LKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYN 147
L +LT + + + ++ + + ++ L G++ + + + + L +
Sbjct: 222 LSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIH 281
Query: 148 KLTGNIPTQLGS-----LRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVP 202
++ ++ S +++ + + + LD S N L V
Sbjct: 282 QVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVF 341
Query: 203 VKLANVPKLEVLDIRNNSFS 222
++ +LE L ++ N
Sbjct: 342 ENCGHLTELETLILQMNQLK 361
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 50/286 (17%), Positives = 101/286 (35%), Gaps = 38/286 (13%)
Query: 404 FSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENL- 461
F LG+ F ++ D A+K I + + + ++ +K L L+H +
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 462 ---------ASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIK 512
+ + S + ++ NL ++ + + E + + +
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN-GRCTIEERERSVCLHIFL 125
Query: 513 GIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAM 572
IA+ + +LH K GL+H +L + + D GL + D +
Sbjct: 126 QIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 573 G-----------YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQ---AAES 618
Y++PE ++ K DI++ G+I+F++L PF+ Q
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL------YPFSTQMERVRTL 237
Query: 619 SKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664
+ V + P L + + SP RP N+++
Sbjct: 238 TDVRNLKFPPLFTQKY----PCEYVMVQDMLSPSPMERPEAINIIE 279
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 32/295 (10%), Positives = 71/295 (24%), Gaps = 50/295 (16%)
Query: 409 LLGKSSFSATYKGILRD-GSVVAVKCIAKTS--CKSDEGEFLKGLKILTSLKHEN----- 460
L S + + A+K + +S+ + L E+
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 461 -------------LASLRGICCSKGRGECFLIYDFV--------PNGNLLQHLDLEAGSE 499
+ S + + + +++ L LD
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 500 KVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559
+ + + + L K GLVH + + + + I +L D L
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK--GLVHGHFTPDNLFIMPDGRLMLGDVSA--LWKV 244
Query: 560 DIVFSMLKASAAMGYLAPEYTT--TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE 617
Y E+ T FT + + G+ ++++ PF
Sbjct: 245 GTRGPASSVPVT--YAPREFLNASTATFTHALNAWQLGLSIYRVWCLF---LPFGLVTPG 299
Query: 618 SS--------KVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664
+V + + + + + R M+
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDF--VKTLIGRFLNFDRRRRLLPLEAME 352
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 58/289 (20%), Positives = 105/289 (36%), Gaps = 50/289 (17%)
Query: 398 ERATQCFSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL 456
+R F E L+G F +K DG +K + + K+ + +K L L
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA-----EREVKALAKL 61
Query: 457 KHEN--------------LASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGS---- 498
H N + F+ +F G L Q ++ G
Sbjct: 62 DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 499 EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558
LE +I KG+ Y+H K+ L++ +L + + + D GL L
Sbjct: 122 VLALELFEQI------TKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLK 173
Query: 559 DDIVFSMLKASAAMG---YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQA 615
+D K + + G Y++PE ++ + ++ D+YA G+I+ ++L T F
Sbjct: 174 ND-----GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC--DTAFET-- 224
Query: 616 AESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664
S D D + F + L + + P RP+ +++
Sbjct: 225 --SKFFTDLRDGIISDIFD-KKEKTL--LQK-LLSKKPEDRPNTSEILR 267
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 64/295 (21%), Positives = 132/295 (44%), Gaps = 48/295 (16%)
Query: 410 LGKSSF----SATYKGILRDGS----VVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHEN 460
LG+ +F A G+ +D VAVK + + + D + + ++++ + KH+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 461 LASLRGICCSKGRGECFLIYDFVPNGNLLQHL------------DLEAGSEKVLEWATRI 508
+ +L G C++ G ++I ++ GNL ++L + E+ L +
Sbjct: 137 IINLLG-ACTQD-GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 509 SVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFS--ML 566
S +A+G+ YL K+ +H +L+A VL+ ++D GL A DI
Sbjct: 195 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGL----ARDIHHIDYYK 248
Query: 567 KASAAMGYL-----APEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSK 620
K + L APE +T +SD+++FG+++++I + G +P+ +
Sbjct: 249 KTTNGR--LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG---SPY--PGVPVEE 301
Query: 621 VEDFIDPN--LEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
+ + ++ + + L + C H PS RP+ + ++++L I+ +
Sbjct: 302 LFKLLKEGHRMDKPSNCTN--ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 8e-16
Identities = 33/181 (18%), Positives = 53/181 (29%), Gaps = 20/181 (11%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSE-----LSDLYLNVN 123
N+ + G P L L L + +A L + L L +
Sbjct: 104 NLEVTGTAP---PPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQA 159
Query: 124 NLSGKIPSQIGNMTNLQVLQLCYNKLTGNI-------PTQLGSLRKLSVLALQYNQLTGA 176
+ Q+ L L L N G P + +L+ L++ +G
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGV 219
Query: 177 IPASLGDLGMLMRLDLSFNNLFG-PVPVKLANVPKLEVLDIRNNSFS---GNVPPALKRL 232
A L LDLS N+L +L L++ +P L L
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVL 279
Query: 233 N 233
+
Sbjct: 280 D 280
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 38/163 (23%), Positives = 59/163 (36%), Gaps = 15/163 (9%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNG-------VIPKEIASLSELSDLYLNV 122
+S+ V +L+ L L N G + P + +L L+ +
Sbjct: 154 LSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213
Query: 123 NNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGS-LRKLSVLALQYNQLTGAIPASL 181
SG + LQ L L +N L +L+ L L + L +P L
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272
Query: 182 GDLGMLMRLDLSFNNL-FGPVPVKLANVPKLEVLDIRNNSFSG 223
L LDLS+N L P P +L P++ L ++ N F
Sbjct: 273 PA--KLSVLDLSYNRLDRNPSPDEL---PQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 38/161 (23%), Positives = 53/161 (32%), Gaps = 21/161 (13%)
Query: 88 LKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIP----SQIGNMTNLQVLQ 143
L L + +++ LS L L+ N G+ LQVL
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 144 LCYNKLT---GNIPTQLGSLRKLSVLALQYNQLTGAIPASLGD-LGMLMRLDLSFNNL-- 197
L + G + +L L L +N L A A D L L+LSF L
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ 267
Query: 198 -FGPVPVKLANVPKLEVLDIRNNSFSGNVP----PALKRLN 233
+P KL VLD+ N N P + L+
Sbjct: 268 VPKGLP------AKLSVLDLSYNRLDRNPSPDELPQVGNLS 302
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 27/106 (25%), Positives = 41/106 (38%), Gaps = 6/106 (5%)
Query: 72 LQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIAS-LSELSDLYLNVNNLSGKIP 130
+ SG A L GL L N+L S+L+ L L+ L ++P
Sbjct: 211 AGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVP 269
Query: 131 SQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGA 176
+ L VL L YN+L P L ++ L+L+ N +
Sbjct: 270 KGLP--AKLSVLDLSYNRLDR-NP-SPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 38/205 (18%), Positives = 67/205 (32%), Gaps = 21/205 (10%)
Query: 49 DPCSSDSFDGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNA-LNGVIPK 107
+PC D C+ + + S L GG +SL L + +
Sbjct: 4 EPCELDEESCS-CNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFT 62
Query: 108 EIASLSELSDLYLNVNNLSGKIPSQ---IGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLS 164
+I L L + + +I + ++ LQ L L ++TG P L
Sbjct: 63 DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPD 122
Query: 165 VLALQYNQLTGA-IPASLGDLGMLM-----RLDLSFNNLFGPVPVKLANVPKLEVLDIRN 218
+ L ++ A A L +L + L ++ + ++ P L LD+ +
Sbjct: 123 LNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSD 182
Query: 219 NSFSGNVP----------PALKRLN 233
N G P L+ L
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLA 207
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 57/310 (18%), Positives = 105/310 (33%), Gaps = 35/310 (11%)
Query: 366 YSNGWDPL-AKGQSGNGFSQEVLESFMFNLEEVE-RATQCFSEANLLGKSSFSATYKGI- 422
Y L + S G + E L+S ++ E Q F + LG S+ +K
Sbjct: 19 YFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRS 78
Query: 423 LRDGSVVAVKCIAKTSCKS-DEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLIY 480
DG + AVK D L + + +H L + G +L
Sbjct: 79 KEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ--AWEEGGILYLQT 136
Query: 481 DFVPNGNLLQHLDLEAGS---EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEK 537
+ +L QH + S +V + +++LH + GLVH ++
Sbjct: 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDT------LLALAHLHSQ--GLVHLDVKPAN 187
Query: 538 VLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTTTGRFTEKSDIYAF 594
+ + R L D GL L + G Y+APE G + +D+++
Sbjct: 188 IFLGPRGRCKLGDFGLLVELG-----TAGAGEVQEGDPRYMAPE-LLQGSYGTAADVFSL 241
Query: 595 GMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPS 654
G+ + ++ + ++ P S SE ++ + + P
Sbjct: 242 GLTILEVACNM---ELPHGGEGWQQLRQGYLPPEFTAGLS-SELRSV--LVM-MLEPDPK 294
Query: 655 HRPSIENVMQ 664
R + E ++
Sbjct: 295 LRATAEALLA 304
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 44/153 (28%), Positives = 69/153 (45%), Gaps = 8/153 (5%)
Query: 71 SLQGKGLSGEIPAAV-GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
L L +PA + LK+L L++ N L + L L++L L+ N L +
Sbjct: 67 YLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SL 124
Query: 130 PSQI-GNMTNLQVLQLCYNKLTGNIPTQL-GSLRKLSVLALQYNQLTGAIPASLGD-LGM 186
P ++ ++T L L L YN+L ++P + L L L L NQL +P D L
Sbjct: 125 PPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTE 182
Query: 187 LMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNN 219
L L L N L ++ KL++L ++ N
Sbjct: 183 LKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 42/166 (25%), Positives = 64/166 (38%), Gaps = 33/166 (19%)
Query: 57 DGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELS 116
DG C N ++ K L+ IP+ IP ++
Sbjct: 8 DGGVCSCNNNKNSVDCSSKKLT-AIPSN--------------------IP------ADTK 40
Query: 117 DLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQL-GSLRKLSVLALQYNQLTG 175
L L N LS +T L++L L NKL +P + L+ L L + N+L
Sbjct: 41 KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ- 98
Query: 176 AIPASLGD-LGMLMRLDLSFNNLFGPVPVKL-ANVPKLEVLDIRNN 219
A+P + D L L L L N L +P ++ ++ KL L + N
Sbjct: 99 ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYN 143
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 30/112 (26%), Positives = 43/112 (38%), Gaps = 24/112 (21%)
Query: 124 NLSGK----IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPA 179
+ S K IPS I + + L L NKL+ L KL +L L N+L +PA
Sbjct: 22 DCSSKKLTAIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPA 78
Query: 180 SL-GDLGMLMRLDLSFNNLFGPVPVKLANVP--------KLEVLDIRNNSFS 222
+ +L L L ++ N KL +P L L + N
Sbjct: 79 GIFKELKNLETLWVTDN--------KLQALPIGVFDQLVNLAELRLDRNQLK 122
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 63/289 (21%), Positives = 108/289 (37%), Gaps = 46/289 (15%)
Query: 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILT-SLKHENLASLRG 466
+LG S G VAVK + C E +K+LT S H N+
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALME----IKLLTESDDHPNVIRY-- 74
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHL---DLEAGSEKVLEWATRISVIKGIAKGISYLHG 523
C ++ + N NL + ++ + K+ + IS+++ IA G+++LH
Sbjct: 75 YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 524 KRPGLVHPNLSAEKVLI-------------HRRYNPLLSDSGLHKLLADDIVFSMLKASA 570
++H +L + +L+ L+SD GL K L +
Sbjct: 134 L--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 571 AMG---YLAPE-------YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF----TRQAA 616
G + APE T R T DI++ G + + ILS PF +R++
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK--HPFGDKYSRESN 249
Query: 617 ESSKVEDFIDPNLEGKFSVS-EASNLGQIALHCTHESPSHRPSIENVMQ 664
+ + S+ EA++L I+ P RP+ V++
Sbjct: 250 IIRGIFSLDEMKCLHDRSLIAEATDL--IS-QMIDHDPLKRPTAMKVLR 295
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 58/288 (20%), Positives = 123/288 (42%), Gaps = 38/288 (13%)
Query: 408 NLLGKSSFSATYKGILRDGSV---VAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLAS 463
+++G+ +F K ++ + A+K + + + K D +F L++L L H N+ +
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHL------------DLEAGSEKVLEWATRISVI 511
L G C G +L ++ P+GNLL L + + L +
Sbjct: 91 LLG-ACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 512 KGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAA 571
+A+G+ YL K+ +H +L+A +L+ Y ++D GL + ++
Sbjct: 149 ADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLP 204
Query: 572 MGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLE 630
+ ++A E +T SD++++G+++++I+S G TP+ ++ + + +
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG---TPYCGMTCA--ELYEKLP---Q 256
Query: 631 GKFSVSEA-----SNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
G E + + C E P RPS ++ L+ ++
Sbjct: 257 GY--RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 73/302 (24%), Positives = 125/302 (41%), Gaps = 70/302 (23%)
Query: 415 FSATYKGILRDGSV--VAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSK 471
+AT GI + G VAVK + + + S+ + LK++T L HEN+ +L G C+
Sbjct: 62 MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG-ACTL 120
Query: 472 GRGECFLIYDFVPNGNLLQHL----------DLEAGSEKVLEWATRISVIKG-------- 513
G +LI+++ G+LL +L ++E ++K LE ++V+
Sbjct: 121 S-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 179
Query: 514 -IAKGISYLHGKRPGLVHPNLSAEKVLIHR----RYNPLLSDSGLHKL----LADDIVFS 564
+AKG+ +L K +HR R N L++ + K+ LA DI+
Sbjct: 180 QVAKGMEFL-------------EFKSCVHRDLAAR-NVLVTHGKVVKICDFGLARDIMSD 225
Query: 565 M--LKASAAMGYL-----APEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAA 616
+ A L APE G +T KSD++++G+++++I S G P+
Sbjct: 226 SNYVVRGNAR--LPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV---NPY----P 276
Query: 617 ESSKVEDFIDPNLEGK-----FSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671
+F G F +E + I C RPS N+ L +
Sbjct: 277 GIPVDANFYKLIQNGFKMDQPFYATE--EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334
Query: 672 SS 673
+
Sbjct: 335 DA 336
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 35/154 (22%), Positives = 53/154 (34%), Gaps = 12/154 (7%)
Query: 82 PAAVGGLKSLTGLYLHFNALN--GVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNL 139
A G SL L L N L + + +L L+ L ++ N +P +
Sbjct: 354 SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM 412
Query: 140 QVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFG 199
+ L L + + T + L VL + N L + L L L +S N L
Sbjct: 413 RFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFSLFLPRL---QELYISRNKLKT 465
Query: 200 PVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233
+P + P L V+ I N RL
Sbjct: 466 -LP-DASLFPVLLVMKISRNQLKSVPDGIFDRLT 497
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 41/189 (21%), Positives = 69/189 (36%), Gaps = 10/189 (5%)
Query: 49 DPCSSDSFDGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKE 108
+P SD + E + + + L ++ L+ + + + + + V
Sbjct: 270 NPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSF 329
Query: 109 IASLSELSDLYLNVNNLSGKIPSQ---IGNMTNLQVLQLCYNKLT--GNIPTQLGSLRKL 163
L L L L+ N + + G +LQ L L N L L +L+ L
Sbjct: 330 SQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNL 389
Query: 164 SVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG 223
+ L + N +P S + L+LS + VK LEVLD+ NN+
Sbjct: 390 TSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI---RVVKTCIPQTLEVLDVSNNNLD- 444
Query: 224 NVPPALKRL 232
+ L RL
Sbjct: 445 SFSLFLPRL 453
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 4e-15
Identities = 30/178 (16%), Positives = 55/178 (30%), Gaps = 5/178 (2%)
Query: 82 PAAVGGLKSLTGLYLHFNALNGV-IPKEIASLSELSDLYLNVNNLSGKIPSQ-IGNMTNL 139
+ G L SL L L N + + +L+ L L + +I +T+L
Sbjct: 91 SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSL 150
Query: 140 QVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNL-- 197
L++ L L S+R + L L ++ + L + L+L NL
Sbjct: 151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210
Query: 198 -FGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAALCGTGFTNLKN 254
++ L R + + L +L + L +
Sbjct: 211 FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGD 268
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 6e-15
Identities = 29/154 (18%), Positives = 56/154 (36%), Gaps = 2/154 (1%)
Query: 82 PAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQV 141
+ +L L L + +N + SL L L L+ N+LS S G +++L+
Sbjct: 43 HGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKY 102
Query: 142 LQLCYNKLTG-NIPTQLGSLRKLSVLALQYNQLTGAIPA-SLGDLGMLMRLDLSFNNLFG 199
L L N + + +L L L + + I L L L++ +L
Sbjct: 103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN 162
Query: 200 PVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233
L ++ + L + + + + L+
Sbjct: 163 YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILS 196
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 26/135 (19%), Positives = 54/135 (40%), Gaps = 10/135 (7%)
Query: 87 GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCY 146
LK+LT L + N + +P ++ L L+ + + + L+VL +
Sbjct: 385 TLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSN 440
Query: 147 NKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLA 206
N L + L L++L + N+L +P + +L+ + +S N L
Sbjct: 441 NNLD-SFSLFLPRLQELY---ISRNKLK-TLPDASL-FPVLLVMKISRNQLKSVPDGIFD 494
Query: 207 NVPKLEVLDIRNNSF 221
+ L+ + + N +
Sbjct: 495 RLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 30/116 (25%), Positives = 45/116 (38%), Gaps = 3/116 (2%)
Query: 105 IPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLS 164
IP + + + L L+ N ++ + NLQVL L +++ SL L
Sbjct: 20 IPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLE 77
Query: 165 VLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFG-PVPVKLANVPKLEVLDIRNN 219
L L N L+ + G L L L+L N V N+ L+ L I N
Sbjct: 78 HLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNV 133
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 26/118 (22%), Positives = 41/118 (34%), Gaps = 9/118 (7%)
Query: 80 EIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNL 139
+P + + + L L + V+ I L L ++ NNL + L
Sbjct: 401 PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSL---FLPRL 453
Query: 140 QVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNL 197
Q L + NKL +P L V+ + NQL L L ++ L N
Sbjct: 454 QELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 26/156 (16%), Positives = 57/156 (36%), Gaps = 13/156 (8%)
Query: 82 PAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQV 141
GL SL L + +L + + S+ ++ L L+++ + + +++++
Sbjct: 141 RIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRY 200
Query: 142 LQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMR----------LD 191
L+L L + L S + + + S +L L+R D
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD 260
Query: 192 LSFNNLFGPVPVK---LANVPKLEVLDIRNNSFSGN 224
+ N L P + ++ + K+E + IR
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF 296
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 26/192 (13%), Positives = 51/192 (26%), Gaps = 27/192 (14%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK 128
+++L + + L S+ L L L + S + S
Sbjct: 176 HLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVL 235
Query: 129 IPSQIGNMTNLQ--VLQLCYNKLTGNIPTQLGSLRK----------------LSVLALQY 170
+ L +L+L + LG + L +
Sbjct: 236 TDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQ 295
Query: 171 NQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVP---- 226
L + L + R+ + + +F ++ LE LD+ N
Sbjct: 296 FYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSA 355
Query: 227 -----PALKRLN 233
P+L+ L
Sbjct: 356 CKGAWPSLQTLV 367
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 53/272 (19%), Positives = 103/272 (37%), Gaps = 28/272 (10%)
Query: 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKG-LKILTSLKHENLASLRG 466
+G S ++ + + A+K + + + + + L L+ + +R
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
+++ + N +L L +K ++ R S K + + + +H
Sbjct: 122 YDYEITDQYIYMVMECG-NIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH-- 174
Query: 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPE----- 578
G+VH +L LI L D G+ + D + + G Y+ PE
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV--GAVNYMPPEAIKDM 231
Query: 579 ------YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGK 632
+ + + KSD+++ G I++ + GK TPF + + SK+ IDPN E +
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK---TPFQQIINQISKLHAIIDPNHEIE 288
Query: 633 FSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664
F +L + C P R SI ++
Sbjct: 289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 410 LGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKG-LKILTSLKHENLASLRGI 467
LGK SF K R AVK I K S K+ + + +++L L H N+ L I
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYLHGKR 525
+ +++ + G L + ++ SE A RI IK + GI+Y+H
Sbjct: 90 L--EDSSSFYIVGELYTGGELFDEI-IKRKRFSEHD---AARI--IKQVFSGITYMHKH- 140
Query: 526 PGLVHPNLSAEKVLIHRR--YNPL-LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT 582
+VH +L E +L+ + + + D GL + +A Y+APE
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTA--YYIAPE-VLR 196
Query: 583 GRFTEKSDIYAFGMIVFQILSGKCSITPF 611
G + EK D+++ G+I++ +LSG PF
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGT---PPF 222
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 61/292 (20%), Positives = 125/292 (42%), Gaps = 47/292 (16%)
Query: 410 LGKSSFSATYKGILRDGS------VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463
LG+ +F + + +VAVK + K + +S +F + ++LT L+H+++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQHIVR 107
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHL-----------DLEAGSEKVLEWATRISVIK 512
G C++GR ++++++ +G+L + L E + L ++V
Sbjct: 108 FFG-VCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 513 GIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAM 572
+A G+ YL G VH +L+ L+ + + D G+ + + + M
Sbjct: 166 QVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR--VGGRTM 221
Query: 573 GYL-----APEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID 626
L PE +FT +SD+++FG+++++I + GK P+ + + + D I
Sbjct: 222 --LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK---QPWYQLSNT--EAIDCIT 274
Query: 627 PNLEGKFSVSEA-----SNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
+G+ E + I C P R SI++V L ++ +
Sbjct: 275 ---QGR--ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 40/298 (13%), Positives = 81/298 (27%), Gaps = 60/298 (20%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGE---------------------- 445
+LG+ A + G V T
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 446 -----FLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFV--PNGNLLQHLDLEAGS 498
F+ ++ + + + +R F +Y + + L + +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 499 EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558
K L R+ + + + ++ LH GLVH L +++ +R L+
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 559 DDIVFSMLKASAAMGYLAPEYTTT-----------GRFTEKSDIYAFGMIVFQILSGKCS 607
+V S+ + G+ PE T D +A G++++ I
Sbjct: 258 ARVVSSV-----SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD-- 310
Query: 608 ITPFTRQAAESSKVEDFIDPNLEGKFSVS-EASNLGQIALHCTHESPSHRPSIENVMQ 664
P T+ AA + ++ L + R M+
Sbjct: 311 -LPITKDAALGG-----SEWIFRSCKNIPQPVRAL--LE-GFLRYPKEDRLLPLQAME 359
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 67/271 (24%), Positives = 116/271 (42%), Gaps = 40/271 (14%)
Query: 409 LLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
+LG +FS + R G + A+KCI K+ D + +L +KHEN+ +L I
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS-SLENEIAVLKKIKHENIVTLEDI 74
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYLHGKR 525
S +L+ V G L + LE G +EK A+ + I+ + + YLH
Sbjct: 75 YESTT--HYYLVMQLVSGGELFDRI-LERGVYTEKD---ASLV--IQQVLSAVKYLHEN- 125
Query: 526 PGLVHPNLSAEKVLIHRRYN--PL-LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT 582
G+VH +L E +L + ++D GL K+ + I+ + + GY+APE
Sbjct: 126 -GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC-GTP--GYVAPEVLAQ 181
Query: 583 GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKF--------S 634
+++ D ++ G+I + +L G PF E+ + EG +
Sbjct: 182 KPYSKAVDCWSIGVITYILLCG---YPPFY---EET--ESKLFEKIKEGYYEFESPFWDD 233
Query: 635 VS-EASNLGQIALHCTHESPSHRPSIENVMQ 664
+S A + I H + P+ R + E +
Sbjct: 234 ISESAKDF--I-CHLLEKDPNERYTCEKALS 261
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 78.2 bits (192), Expect = 3e-15
Identities = 39/151 (25%), Positives = 72/151 (47%), Gaps = 12/151 (7%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK 128
+L+ K ++ + L S+ + + + + V + I L ++ L+LN N L+
Sbjct: 25 KDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLT-D 79
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLM 188
I + N+ NL L L NK+ ++ + L L+KL L+L++N ++ I L L L
Sbjct: 80 I-KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQLE 134
Query: 189 RLDLSFNNLFGPVPVKLANVPKLEVLDIRNN 219
L L N + L+ + KL+ L + +N
Sbjct: 135 SLYLGNNKITDITV--LSRLTKLDTLSLEDN 163
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 70.1 bits (171), Expect = 9e-13
Identities = 39/215 (18%), Positives = 68/215 (31%), Gaps = 21/215 (9%)
Query: 87 GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCY 146
LK L L L N ++ + + L +L LYL N ++ I + +T L L L
Sbjct: 107 DLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLED 162
Query: 147 NKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLA 206
N+++ +I L L KL L L N ++ +L L L L+L +
Sbjct: 163 NQIS-DIV-PLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQS 218
Query: 207 NVPKLEVLDIRNNSF-------------SGNVPPALKRLNGGFQYDNNAALCGTGFTNLK 253
N+ + + S NV L + +
Sbjct: 219 NLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARF 278
Query: 254 NCTASDHPTPGKPEPFEPNGLSTKDIPESAKLPAN 288
+ + ++ +G K E+
Sbjct: 279 HGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITA 313
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 15/108 (13%), Positives = 32/108 (29%), Gaps = 14/108 (12%)
Query: 115 LSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLT 174
+ + + +I L +T + L + + + +
Sbjct: 1 MGETITVSTPIK-QI-FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 175 GAIPASLGDLGM---LMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNN 219
S+ + + +L L+ N L P L N+ L L + N
Sbjct: 57 -----SVQGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDEN 97
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 53/284 (18%), Positives = 97/284 (34%), Gaps = 30/284 (10%)
Query: 399 RATQCFSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKS-DEGEFLKGLKILTSL 456
R T F E +G F + +K + DG + A+K K S DE L+ + L
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 457 -KHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIA 515
+H ++ + ++ G+L + + A ++ +
Sbjct: 68 GQHSHVVRYFS--AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 516 KGISYLHGKRPGLVH-----PN--LSAEKVLIHRRYNPLLSDSGLHKL---LAD-DIVFS 564
+G+ Y+H LVH N +S + D +K+ + D V
Sbjct: 126 RGLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 565 MLKASAAMG---YLAPE-YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK 620
+ G +LA E K+DI+A + V + P R + +
Sbjct: 184 ISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE----PLPRNGDQWHE 239
Query: 621 VEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664
+ P + S E + L + + H P RPS +++
Sbjct: 240 IRQGRLPRIPQVLS-QEFTEL--LKV-MIHPDPERRPSAMALVK 279
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 26/150 (17%), Positives = 53/150 (35%), Gaps = 13/150 (8%)
Query: 82 PAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMTNLQ 140
GL L L + + L PK + S+ +S L L++ + ++++
Sbjct: 167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVE 225
Query: 141 VLQLCYNKLTGNIPTQLGS--------LRKLSVLALQYNQLTGAIPASLGDLGMLMRLDL 192
L+L L ++L + + + L + L + L+ L+
Sbjct: 226 CLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEF 284
Query: 193 SFNNLFGPVPVK-LANVPKLEVLDIRNNSF 221
S N L VP + L+ + + N +
Sbjct: 285 SRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 32/170 (18%), Positives = 58/170 (34%), Gaps = 18/170 (10%)
Query: 81 IPAAV-GGLKSLTGLYLHFNALNGVIPKEI-ASLSELSDLYLNVNNLSGKIPSQI-GNMT 137
+ ++ L SLT L L N + + + L++L L + + KI + +T
Sbjct: 115 LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLT 174
Query: 138 NLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGD-LGMLMRLDLSFNN 196
L+ L++ + L P L S++ +S L L Q + D + L+L +
Sbjct: 175 FLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTD 233
Query: 197 LFGP--------VPVKLANVPKLEVLDIRNNSFSGNVP-----PALKRLN 233
L L + I + S + L L
Sbjct: 234 LDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELE 283
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 9e-10
Identities = 32/127 (25%), Positives = 51/127 (40%), Gaps = 9/127 (7%)
Query: 105 IPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQL-GSLRKL 163
IP + + L L+ N ++ S + NLQ L L N + I SL L
Sbjct: 46 IPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSL 102
Query: 164 SVLALQYNQLTGAIPASL-GDLGMLMRLDLSFNNL--FGPVPVKLANVPKLEVLDIRNNS 220
L L YN L+ + +S L L L+L N G + +++ KL++L + N
Sbjct: 103 EHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSL-FSHLTKLQILRVGNMD 160
Query: 221 FSGNVPP 227
+
Sbjct: 161 TFTKIQR 167
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 30/137 (21%), Positives = 48/137 (35%), Gaps = 14/137 (10%)
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPA-SLGDLGML 187
IPS + ++ L L N++T + L L L L N + I S LG L
Sbjct: 46 IPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSL 102
Query: 188 MRLDLSFNNLFGPVPVKL-ANVPKLEVLDIRNNSFSGNVPPA-----LKRLNGGFQYDNN 241
LDLS+N L + + L L++ N + + L +L + +
Sbjct: 103 EHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD 160
Query: 242 A--ALCGTGFTNLKNCT 256
+ F L
Sbjct: 161 TFTKIQRKDFAGLTFLE 177
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 15/101 (14%), Positives = 35/101 (34%), Gaps = 12/101 (11%)
Query: 81 IPAAV-GGLKSLTGLYLHFNALNGVIPKEIAS--------LSELSDLYLNVNNLSGKIPS 131
+ S+ L L L+ E+++ ++ + +L ++
Sbjct: 213 LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMK 271
Query: 132 QIGNMTNLQVLQLCYNKLTGNIPTQ-LGSLRKLSVLALQYN 171
+ ++ L L+ N+L ++P L L + L N
Sbjct: 272 LLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 4e-15
Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 20/207 (9%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGIC 468
LG +F ++ R G+ A K + E K ++ ++ L+H L +L
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYLHGKRP 526
E +IY+F+ G L + + E SE + ++ + KG+ ++H
Sbjct: 224 EDDN--EMVMIYEFMSGGELFEKVADEHNKMSEDEA-----VEYMRQVCKGLCHMHEN-- 274
Query: 527 GLVHPNLSAEKVLI-HRRYNPL-LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGR 584
VH +L E ++ +R N L L D GL L + +A + APE
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA--EFAAPEVAEGKP 332
Query: 585 FTEKSDIYAFGMIVFQILSGKCSITPF 611
+D+++ G++ + +LSG ++PF
Sbjct: 333 VGYYTDMWSVGVLSYILLSG---LSPF 356
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 6e-15
Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKG-LKILTSLKHENLASLRGI 467
LGK +FS + + + G A K I + + + L+ +I L+H N+ L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYLHGKR 525
+ +L++D V G L + + + SE A+ I+ I + I+Y H
Sbjct: 74 I--QEESFHYLVFDLVTGGELFEDI-VAREFYSEAD---ASHC--IQQILESIAYCHSN- 124
Query: 526 PGLVHPNLSAEKVLIHRRYN--PL-LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT 582
G+VH NL E +L+ + + L+D GL + D + + GYL+PE
Sbjct: 125 -GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP--GYLSPEVLKK 181
Query: 583 GRFTEKSDIYAFGMIVFQILSGKCSITPF 611
+++ DI+A G+I++ +L G PF
Sbjct: 182 DPYSKPVDIWACGVILYILLVG---YPPF 207
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 7e-15
Identities = 55/280 (19%), Positives = 105/280 (37%), Gaps = 48/280 (17%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGL-------KILTSLKHENL 461
LG + R VA++ I+K +IL L H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 462 ASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYL 521
++ ++ + +++ + + G L + G++++ E + + + YL
Sbjct: 203 IKIKNFFDAE---DYYIVLELMEGGELFDKV---VGNKRLKEATCK-LYFYQMLLAVQYL 255
Query: 522 HGKRPGLVHPNLSAEKVLIHRRYNPL---LSDSGLHKLLADDIVFSMLKASAAMGYLAPE 578
H G++H +L E VL+ + ++D G K+L + + L + YLAPE
Sbjct: 256 HEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP--TYLAPE 311
Query: 579 ---YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF--IDPNLEGKF 633
T + D ++ G+I+F LSG PF+ ++V I GK+
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSG---YPPFS---EHRTQVSLKDQI---TSGKY 362
Query: 634 --------SVS-EASNLGQIALHCTHESPSHRPSIENVMQ 664
VS +A +L + P R + E ++
Sbjct: 363 NFIPEVWAEVSEKALDL--VK-KLLVVDPKARFTTEEALR 399
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 67/310 (21%), Positives = 128/310 (41%), Gaps = 61/310 (19%)
Query: 394 LEEVERATQCFSEANLLGKSSFSATYKGILRDGS------VVAVKCIAKTSCKSDEGEFL 447
L+E+ + F E LG+ F YKG L + VA+K + + EF
Sbjct: 3 LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 60
Query: 448 KGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHL------------DLE 495
+ L+H N+ L G +K + +I+ + +G+L + L D +
Sbjct: 61 HEAMLRARLQHPNVVCLLG-VVTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 496 AGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555
+ LE + ++ IA G+ YL +VH +L+ VL++ + N +SD GL +
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFR 176
Query: 556 LLADDIVFSMLKASAAMGYL-----APEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSIT 609
+ + ++ L APE G+F+ SDI+++G++++++ S G
Sbjct: 177 EVYAADYYK--LLGNSL--LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL---Q 229
Query: 610 PFTRQAAESSKVEDFID-----------PNLEGKFSVSEASNLGQIALHCTHESPSHRPS 658
P+ + + V + I P + + + + C +E PS RP
Sbjct: 230 PYCGYSNQ--DVVEMIRNRQVLPCPDDCP-----------AWVYALMIECWNEFPSRRPR 276
Query: 659 IENVMQELSS 668
+++ L +
Sbjct: 277 FKDIHSRLRA 286
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKG-LKILTSLKHENLASLRGI 467
LGK SF K R AVK I K S K+ + + +++L L H N+ L I
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYLHGKR 525
+ +++ + G L + ++ SE A RI IK + GI+Y+H
Sbjct: 90 L--EDSSSFYIVGELYTGGELFDEI-IKRKRFSEHD---AARI--IKQVFSGITYMHKH- 140
Query: 526 PGLVHPNLSAEKVLIHRR---YNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT 582
+VH +L E +L+ + + + D GL + +A Y+APE
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTA--YYIAPE-VLR 196
Query: 583 GRFTEKSDIYAFGMIVFQILSGKCSITPF 611
G + EK D+++ G+I++ +LSG PF
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG---TPPF 222
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 37/188 (19%), Positives = 69/188 (36%), Gaps = 23/188 (12%)
Query: 51 CSSDSFDGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIA 110
+ D ++ ++ + ++ ++ ++ + L LT L N + + +++
Sbjct: 28 FEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITTL---DLS 82
Query: 111 SLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQY 170
+ L+ L + N L+ + + +T L L NKLT + + L+ L
Sbjct: 83 QNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCAR 136
Query: 171 NQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNN-----SFSGNV 225
N LT I + L LD N + + +L LD N S N
Sbjct: 137 NTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITELDVSQN- 190
Query: 226 PPALKRLN 233
L RLN
Sbjct: 191 -KLLNRLN 197
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 32/152 (21%), Positives = 58/152 (38%), Gaps = 17/152 (11%)
Query: 85 VGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144
V LT L N L + +++ ++L++L ++N K+ + T L L
Sbjct: 123 VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDC 177
Query: 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVK 204
+NK+T + + + L+ L N +T + L L LD S N L +
Sbjct: 178 SFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKL---TEID 228
Query: 205 LANVPKLEVLDIRNN---SFSGNVPPALKRLN 233
+ + +L D N + L L+
Sbjct: 229 VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLH 260
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 33/156 (21%), Positives = 55/156 (35%), Gaps = 23/156 (14%)
Query: 84 AVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143
V LT L FN + + +++ L+ L + NN++ K+ + L L
Sbjct: 165 DVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLD 218
Query: 144 LCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPV 203
NKLT I + L +L+ N LT + S L L L +L + +
Sbjct: 219 CSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDL---LEI 269
Query: 204 KLANVPKLEVLDIRNNS------FSGNVPPALKRLN 233
L + +L + N L L+
Sbjct: 270 DLTHNTQLIYFQAEGCRKIKELDVTHN--TQLYLLD 303
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 32/154 (20%), Positives = 57/154 (37%), Gaps = 21/154 (13%)
Query: 85 VGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144
+ +LT L N L + ++ L++L+ L + N L+ K+ + L L
Sbjct: 81 LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNC 134
Query: 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVK 204
N LT I + +L+ L N+ + + L LD SFN + +
Sbjct: 135 ARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI---TELD 186
Query: 205 LANVPKLEVLDIRNN-----SFSGNVPPALKRLN 233
++ L L+ N + N L L+
Sbjct: 187 VSQNKLLNRLNCDTNNITKLDLNQN--IQLTFLD 218
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 34/180 (18%), Positives = 62/180 (34%), Gaps = 23/180 (12%)
Query: 85 VGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144
V L LT L N L + +++ L+ L N L+ +I + + T L L
Sbjct: 102 VTPLTKLTYLNCDTNKLTKL---DVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDC 155
Query: 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVK 204
NK + + +L+ L +N++T + +L RL+ NN+ +
Sbjct: 156 HLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITK---LD 207
Query: 205 LANVPKLEVLDIRNN-----SFSGNVPPALKRLNGGFQYDNNAALCGTGFTNLKNCTASD 259
L +L LD +N + L + + L + + L
Sbjct: 208 LNQNIQLTFLDCSSNKLTEIDVTPL--TQLTYFD--CSVNPLTELDVSTLSKLTTLHCIQ 263
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 31/154 (20%), Positives = 53/154 (34%), Gaps = 21/154 (13%)
Query: 85 VGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144
V K L L N + + ++ +L+ L + N L+ +I + +T L
Sbjct: 187 VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDC 240
Query: 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVK 204
N LT + + +L KL+ L L I L L+ +
Sbjct: 241 SVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD-- 292
Query: 205 LANVPKLEVLDIRNN-----SFSGNVPPALKRLN 233
+ + +L +LD + S N P L L
Sbjct: 293 VTHNTQLYLLDCQAAGITELDLSQN--PKLVYLY 324
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 29/167 (17%), Positives = 53/167 (31%), Gaps = 18/167 (10%)
Query: 91 LTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLT 150
+ L+ L+ L + ++++ + I +T L L N +T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT 77
Query: 151 GNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPK 210
+ L L+ LA N+LT + + L L L+ N L + ++ P
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKL---TKLDVSQNPL 128
Query: 211 LEVLDIRNN---SFSGNVPPALKRLNGGFQYDNNAALCGTGFTNLKN 254
L L+ N + L L+ N + T
Sbjct: 129 LTYLNCARNTLTEIDVSHNTQLTELD----CHLNKKITKLDVTPQTQ 171
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 18/115 (15%), Positives = 42/115 (36%), Gaps = 8/115 (6%)
Query: 85 VGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144
V L L + + +++ +L LYLN L+ ++ + + T L+ L
Sbjct: 293 VTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSC 346
Query: 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFG 199
+ + + +G + L+ Q +L + + + + + FG
Sbjct: 347 VNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFG 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 17/101 (16%), Positives = 31/101 (30%), Gaps = 12/101 (11%)
Query: 138 NLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNL 197
N ++ L L+ L + +T + + L L +L + NN+
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNI 76
Query: 198 FGPVPVKLANVPKLEVLDIRNN-----SFSGNVPPALKRLN 233
+ L+ L L +N + L LN
Sbjct: 77 TT---LDLSQNTNLTYLACDSNKLTNLDVTPL--TKLTYLN 112
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 50/154 (32%), Positives = 69/154 (44%), Gaps = 6/154 (3%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK 128
+ LQ GL+ A GL LT L L +N L + L+EL L L N L+
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 129 IPSQI-GNMTNLQVLQLCYNKLTGNIPTQL-GSLRKLSVLALQYNQLTGAIPASLGD-LG 185
+P + ++T L L L N+L +P+ + L KL L L NQL +IPA D L
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT 155
Query: 186 MLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNN 219
L L LS N L + KL+ + + N
Sbjct: 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 46/183 (25%), Positives = 76/183 (41%), Gaps = 35/183 (19%)
Query: 51 CSSDSFDGVACDENGRVANISLQGKGLS---GEIPAAVGGLKSLTGLYLHFNALNGVIPK 107
C + + G C+E + + QGK L IPA L L L +
Sbjct: 4 CETVT--GCTCNEGKK--EVDCQGKSLDSVPSGIPA------DTEKLDLQSTGLATLSDA 53
Query: 108 EIASLSELSDLYLNVNNLSGKIPSQI-GNMTNLQVLQLCYNKLTGNIPTQL-GSLRKLSV 165
L++L+ L L+ N L + + + ++T L L L N+L ++P + L +L
Sbjct: 54 TFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDK 111
Query: 166 LALQYNQLTGAIPASLGD-LGMLMRLDLSFNNLFGPVPVKLANVP--------KLEVLDI 216
L L NQL ++P+ + D L L L L+ N +L ++P L+ L +
Sbjct: 112 LYLGGNQLK-SLPSGVFDRLTKLKELRLNTN--------QLQSIPAGAFDKLTNLQTLSL 162
Query: 217 RNN 219
N
Sbjct: 163 STN 165
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 58/315 (18%), Positives = 123/315 (39%), Gaps = 83/315 (26%)
Query: 410 LGKSSF----SATYKGILRDGSV--VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463
+G+ +F A G+L VAVK + + + + +F + ++ + N+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHL--------------------DLEAGSEKVLE 503
L G C+ G L+++++ G+L + L + + L
Sbjct: 115 LLG-VCAVG-KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 504 WATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR----RYNPLLSDSGLHKLLAD 559
A ++ + + +A G++YL +E+ +HR R N L+ ++ + K +AD
Sbjct: 173 CAEQLCIARQVAAGMAYL-------------SERKFVHRDLATR-NCLVGENMVVK-IAD 217
Query: 560 DIVFSM----------LKASAAMGYL-----APEYTTTGRFTEKSDIYAFGMIVFQILS- 603
F + + PE R+T +SD++A+G+++++I S
Sbjct: 218 ---FGLSRNIYSADYYKADGNDA--IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272
Query: 604 GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA-----SNLGQIALHCTHESPSHRPS 658
G P+ A E +V ++ +G + L + C + P+ RPS
Sbjct: 273 GL---QPYYGMAHE--EVIYYVR---DGN--ILACPENCPLELYNLMRLCWSKLPADRPS 322
Query: 659 IENVMQELSSIIGSS 673
++ + L + +
Sbjct: 323 FCSIHRILQRMCERA 337
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 45/206 (21%), Positives = 84/206 (40%), Gaps = 14/206 (6%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGIC 468
LG +F + R G +K I K + + +++L SL H N+ + +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGL 528
+++ + G LL+ + K L ++K + ++Y H + +
Sbjct: 90 EDY--HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ--HV 145
Query: 529 VHPNLSAEKVLIHRR---YNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRF 585
VH +L E +L + D GL +L D + +A Y+APE
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTA--LYMAPE-VFKRDV 202
Query: 586 TEKSDIYAFGMIVFQILSGKCSITPF 611
T K DI++ G++++ +L+G PF
Sbjct: 203 TFKCDIWSAGVVMYFLLTGC---LPF 225
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 46/207 (22%), Positives = 88/207 (42%), Gaps = 20/207 (9%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGIC 468
LG +F ++ + + G V K I + I+ L H L +L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAF 117
Query: 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYLHGKRP 526
K E LI +F+ G L + E SE + I+ ++ +G+ ++H
Sbjct: 118 EDK--YEMVLILEFLSGGELFDRIAAEDYKMSEAEV-----INYMRQACEGLKHMHEH-- 168
Query: 527 GLVHPNLSAEKVLI-HRRYNPL-LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGR 584
+VH ++ E ++ ++ + + + D GL L D + + A+A + APE
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA--EFAAPEIVDREP 226
Query: 585 FTEKSDIYAFGMIVFQILSGKCSITPF 611
+D++A G++ + +LSG ++PF
Sbjct: 227 VGFYTDMWAIGVLGYVLLSG---LSPF 250
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 36/143 (25%), Positives = 55/143 (38%), Gaps = 11/143 (7%)
Query: 87 GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMTNLQVLQLC 145
L +L L L N LN + + + L L L+ N+L + + ++ L+VL L
Sbjct: 62 RLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLY 120
Query: 146 YNKLTGNIPT-QLGSLRKLSVLALQYNQLTGAIPA----SLGDLGMLMRLDLSFNNLFGP 200
N + + + +L L L NQ++ P L LM LDLS N L
Sbjct: 121 NNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKL 178
Query: 201 VPVKLANVPKLEVLDIR--NNSF 221
L +P + NN
Sbjct: 179 PLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 9e-10
Identities = 31/118 (26%), Positives = 49/118 (41%), Gaps = 6/118 (5%)
Query: 113 SELSDLYLNVNNLSGKIPSQI--GNMTNLQVLQLCYNKLTGNIPTQ-LGSLRKLSVLALQ 169
S + L L+ NNLS ++ ++ +TNL L L +N L I ++ + L L L
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96
Query: 170 YNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPP 227
N L DL L L L N++ ++ +L+ L + N S P
Sbjct: 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPV 153
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKG-LKILTSLKHENLASLRGI 467
LGK +FS + + + G A K I + + + L+ +I L+H N+ L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYLHGKR 525
+ +L++D V G L + + + SE A+ I+ I + I+Y H
Sbjct: 97 IQEE--SFHYLVFDLVTGGELFEDI-VAREFYSEAD---ASHC--IQQILESIAYCHSN- 147
Query: 526 PGLVHPNLSAEKVLIHRRYN--PL-LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT 582
G+VH NL E +L+ + + L+D GL + D + + GYL+PE
Sbjct: 148 -GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP--GYLSPEVLKK 204
Query: 583 GRFTEKSDIYAFGMIVFQILSGKCSITPF 611
+++ DI+A G+I++ +L G PF
Sbjct: 205 DPYSKPVDIWACGVILYILLVG---YPPF 230
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 7e-14
Identities = 34/173 (19%), Positives = 69/173 (39%), Gaps = 9/173 (5%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK 128
N+++ + E + LKSL ++ + +E++ L++++
Sbjct: 285 NLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFI 344
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPA---SLGDLG 185
+ ++ L N T ++ +L++L L LQ N L ++
Sbjct: 345 HMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMS 403
Query: 186 MLMRLDLSFNNL-FGPVPVKLANVPKLEVLDIRNNSFSGNV----PPALKRLN 233
L LD+S N+L A + VL++ +N +G+V PP +K L+
Sbjct: 404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLD 456
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 40/201 (19%), Positives = 75/201 (37%), Gaps = 29/201 (14%)
Query: 40 LLTSWAPNADPCSSDSFDGVACDENGRVANISLQGKGLS---GEIPAAVGGLKSLTGLYL 96
L + P S++ V + L+ ++P L L
Sbjct: 17 ALALIVGSMTPFSNELESMVDY-----------SNRNLTHVPKDLPP------RTKALSL 59
Query: 97 HFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMTNLQVLQLCYNKLTGNIPT 155
N+++ + +I+ LSEL L L+ N + + + +L+ L + +N+L NI
Sbjct: 60 SQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISC 117
Query: 156 QLGSLRKLSVLALQYNQLTGAIP--ASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEV 213
+ L L L +N +P G+L L L LS + +A++ +
Sbjct: 118 --CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCI 174
Query: 214 -LDIRNNSFSGNVPPALKRLN 233
LD+ + G +L+ N
Sbjct: 175 LLDLVSYHIKGGETESLQIPN 195
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 33/142 (23%), Positives = 56/142 (39%), Gaps = 10/142 (7%)
Query: 60 ACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALN----GVIPKEIASLSEL 115
C R+ + LQ GL K+++ L +LN + A +
Sbjct: 372 GCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430
Query: 116 SDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTG 175
L L+ N L+G + + ++VL L N++ +IP + L+ L L + NQL
Sbjct: 431 LVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK- 486
Query: 176 AIP-ASLGDLGMLMRLDLSFNN 196
++P L L + L N
Sbjct: 487 SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 31/148 (20%), Positives = 55/148 (37%), Gaps = 8/148 (5%)
Query: 80 EIPAAV-GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNL-SGKIPSQIGNMT 137
+ V + L L + N L I ++ L L L+ N+ + + GN+T
Sbjct: 90 SLDFHVFLFNQDLEYLDVSHNRL-QNIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLT 146
Query: 138 NLQVLQLCYNKLTGNIPTQLGSLRKLSV-LALQYNQLTGAIPASLGDLGM-LMRLDLSFN 195
L L L K + L + L L + G SL ++ L N
Sbjct: 147 KLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPN 206
Query: 196 NLFG-PVPVKLANVPKLEVLDIRNNSFS 222
+LF V + + + L++ +I+ N +
Sbjct: 207 SLFSVQVNMSVNALGHLQLSNIKLNDEN 234
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 25/156 (16%), Positives = 48/156 (30%), Gaps = 10/156 (6%)
Query: 81 IPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQ 140
+ G L LT L L + +A L L V+ ++ + N
Sbjct: 138 VCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTT 197
Query: 141 VLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGM-----LMRLDLSFN 195
VL L ++ + S+ L L L +L L L+++
Sbjct: 198 VLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQ 257
Query: 196 NLFGPVP-----VKLANVPKLEVLDIRNNSFSGNVP 226
++ + +E L+I N + + +
Sbjct: 258 HIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERID 293
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 39/208 (18%), Positives = 86/208 (41%), Gaps = 23/208 (11%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGIC 468
LG+ F ++ + K + +D+ K + IL +H N+ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAG---SEKVLEWATRISVIKGIAKGISYLHGKR 525
S E +I++F+ ++ + + + +E+ + +S + + + + +LH
Sbjct: 71 ESM--EELVMIFEFISGLDIFERI-NTSAFELNEREI-----VSYVHQVCEALQFLHSH- 121
Query: 526 PGLVHPNLSAEKVLIHRRYNPLL--SDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG 583
+ H ++ E ++ R + + + G + L F +L + Y APE
Sbjct: 122 -NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP--EYYAPEVHQHD 178
Query: 584 RFTEKSDIYAFGMIVFQILSGKCSITPF 611
+ +D+++ G +V+ +LSG I PF
Sbjct: 179 VVSTATDMWSLGTLVYVLLSG---INPF 203
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 25/213 (11%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKG-----LKILTSLKHENLAS 463
LG F+ K + G A K I K ++ + + IL + H N+ +
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHL-DLEAGSEKVLEWATRISVIKGIAKGISYLH 522
L + ++ + LI + V G L L E+ SE+ S IK I G++YLH
Sbjct: 80 LHDVYENRT--DVVLILELVSGGELFDFLAQKESLSEEEA-----TSFIKQILDGVNYLH 132
Query: 523 GKRPGLVHPNLSAEKVLIHRRYNPL----LSDSGLHKLLADDIVFSMLKASAAMGYLAPE 578
K + H +L E +++ + P+ L D GL + D + F + + ++APE
Sbjct: 133 TK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP--EFVAPE 188
Query: 579 YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
++D+++ G+I + +LSG +PF
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSG---ASPF 218
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 25/213 (11%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKG-----LKILTSLKHENLAS 463
LG F+ K + G A K I K ++ + + IL + H N+ +
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHL-DLEAGSEKVLEWATRISVIKGIAKGISYLH 522
L + ++ + LI + V G L L E+ SE+ S IK I G++YLH
Sbjct: 80 LHDVYENR--TDVVLILELVSGGELFDFLAQKESLSEEEA-----TSFIKQILDGVNYLH 132
Query: 523 GKRPGLVHPNLSAEKVLIHRRYNPL----LSDSGLHKLLADDIVFSMLKASAAMGYLAPE 578
K + H +L E +++ + P+ L D GL + D + F + + ++APE
Sbjct: 133 TK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP--EFVAPE 188
Query: 579 YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
++D+++ G+I + +LSG +PF
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSG---ASPF 218
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 33/220 (15%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLK--------ILTSLK-HE 459
LG+ S + I + AVK I T S E ++ L+ IL + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 460 NLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKG 517
N+ L+ + FL++D + G L +L E SEK TR +++ + +
Sbjct: 85 NIIQLKDTYETN--TFFFLVFDLMKKGELFDYL-TEKVTLSEK----ETR-KIMRALLEV 136
Query: 518 ISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAP 577
I LH +VH +L E +L+ N L+D G L + + YLAP
Sbjct: 137 ICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP--SYLAP 192
Query: 578 E------YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
E + ++ D+++ G+I++ +L+G PF
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG---SPPF 229
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 33/148 (22%), Positives = 50/148 (33%), Gaps = 13/148 (8%)
Query: 81 IPAAV-GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIG---NM 136
+ GL SL L L + I L L +L + N + N+
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLP-EYFSNL 148
Query: 137 TNLQVLQLCYNKLTGNIP----TQLGSLRKLSV-LALQYNQLTGAIPASLGDLGMLMRLD 191
TNL+ L L NK+ +I L + L++ L L N + I L L
Sbjct: 149 TNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELA 206
Query: 192 LSFNNLFGPVPVKLANVPKLEVLDIRNN 219
L N L + L+ + + N
Sbjct: 207 LDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 25/104 (24%), Positives = 40/104 (38%), Gaps = 4/104 (3%)
Query: 118 LYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQL-GSLRKLSVLALQYNQLTGA 176
L L+ N L + LQVL L ++ I SL LS L L N + +
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-S 90
Query: 177 IPASL-GDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNN 219
+ L L +L NL + ++ L+ L++ +N
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN 134
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 21/106 (19%), Positives = 32/106 (30%), Gaps = 12/106 (11%)
Query: 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGD-LGMLMRLDLSFN 195
+ + L L +N L S +L VL L ++ I L L L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 196 NLFGPVPVKLANVPKLEVLDIRNN--------SFSGNVPPALKRLN 233
+ + + L+ L LK LN
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH--LKTLKELN 130
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 37/153 (24%), Positives = 66/153 (43%), Gaps = 11/153 (7%)
Query: 73 QGKGLSGEIPAAVGGL-KSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPS 131
+GKGL+ EIP L +++T + L N + + P + +L + L+ N +S ++
Sbjct: 19 RGKGLT-EIPT---NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAP 73
Query: 132 QI-GNMTNLQVLQLCYNKLTGNIPTQL-GSLRKLSVLALQYNQLTGAIPASLGD-LGMLM 188
+ +L L L NK+T +P L L L +L L N++ + L L
Sbjct: 74 DAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLN 131
Query: 189 RLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSF 221
L L N L + + ++ + + N F
Sbjct: 132 LLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-12
Identities = 31/132 (23%), Positives = 55/132 (41%), Gaps = 5/132 (3%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK 128
I L+ + P A K L + L N ++ + P L L+ L L N ++ +
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-E 94
Query: 129 IPSQI-GNMTNLQVLQLCYNKLTGNIPTQL-GSLRKLSVLALQYNQLTGAIPASLGDLGM 186
+P + + +LQ+L L NK+ + L L++L+L N+L + L
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153
Query: 187 LMRLDLSFNNLF 198
+ + L N F
Sbjct: 154 IQTMHL-AQNPF 164
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 30/175 (17%), Positives = 62/175 (35%), Gaps = 19/175 (10%)
Query: 61 CDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYL 120
C + + K + IP S L L L + ++L +S +Y+
Sbjct: 10 CHQEEDF---RVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYV 62
Query: 121 NVNNLSGKIPSQI-GNMTNLQVLQLCYNKLTGNIPTQ-LGSLRKLSVLALQYNQLTGAIP 178
+++ ++ S N++ + +++ + I L L L L + L P
Sbjct: 63 SIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFP 121
Query: 179 A--SLGDLGMLMRLDLSFNNLFGPVP----VKLANVPKLEVLDIRNNSFSGNVPP 227
+ + L+++ N +P L N + L + NN F+ +V
Sbjct: 122 DLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCN--ETLTLKLYNNGFT-SVQG 173
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 26/122 (21%), Positives = 40/122 (32%), Gaps = 8/122 (6%)
Query: 82 PAAVGGLKSLTGLYLHFNALNGVIPKEIA--SLSELSDLYLNVNNLSGKIPSQI-GNMTN 138
P A+ L L L + L + P S L + N IP + N
Sbjct: 98 PDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCN 156
Query: 139 -LQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASL--GDLGMLMRLDLSFN 195
L+L N T ++ + KL + L N+ I G LD+S
Sbjct: 157 ETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQT 215
Query: 196 NL 197
++
Sbjct: 216 SV 217
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 27/120 (22%), Positives = 39/120 (32%), Gaps = 9/120 (7%)
Query: 80 EIPA--AVGGLKSLTGLYLHFNALNGVIPKEI-ASL-SELSDLYLNVNNLSGKIPSQIGN 135
P V L + N IP L +E L L N + + N
Sbjct: 119 MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFN 177
Query: 136 MTNLQVLQLCYNKLTGNIPTQL--GSLRKLSVLALQYNQLTGAIPA-SLGDLGMLMRLDL 192
T L + L NK I G S+L + +T A+P+ L L L+ +
Sbjct: 178 GTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 49/207 (23%), Positives = 86/207 (41%), Gaps = 17/207 (8%)
Query: 408 NLLGKSSFSATYKGI-LRDGSVVAVKCIAKTS-CKSDEGEFLKG-LKILTSLKHENLASL 464
LGK F Y + ++A+K + K K+ L+ ++I + L+H N+ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK 524
G R +LI ++ P G + + L K E T + I +A +SY H K
Sbjct: 75 YGYFHDATR--VYLILEYAPLGTVYREL---QKLSKFDEQRTA-TYITELANALSYCHSK 128
Query: 525 RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGR 584
++H ++ E +L+ ++D G + + YL PE
Sbjct: 129 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL---CGTLDYLPPEMIEGRM 183
Query: 585 FTEKSDIYAFGMIVFQILSGKCSITPF 611
EK D+++ G++ ++ L GK PF
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGK---PPF 207
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 24/234 (10%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLK----ILTSLKHENLASL 464
+GK FS + I R+ G AVK + S G + LK I LKH ++ L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK 524
S G +++++F+ +L + A + V A ++ I + + Y H
Sbjct: 92 LETYSSD--GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 525 RPGLVHPNLSAEKVLIHRRYN--PL-LSDSGL-HKLLADDIVFSMLKASAAMGYLAPEYT 580
++H ++ VL+ + N P+ L G+ +L +V + ++APE
Sbjct: 150 --NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP--HFMAPEVV 205
Query: 581 TTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634
+ + D++ G+I+F +LSG PF ++ + I ++GK+
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSG---CLPFY---GTKERLFEGI---IKGKYK 250
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 27/214 (12%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGL-----KILTSLKHENLAS 463
LG F+ K + G A K I K S + IL ++H N+ +
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYL 521
L I +K + LI + V G L L E +E AT+ +K I G+ YL
Sbjct: 73 LHDIFENK--TDVVLILELVSGGELFDFL-AEKESLTEDE---ATQF--LKQILDGVHYL 124
Query: 522 HGKRPGLVHPNLSAEKVLIHRRYNPL----LSDSGLHKLLADDIVFSMLKASAAMGYLAP 577
H K + H +L E +++ + P L D G+ + F + + ++AP
Sbjct: 125 HSK--RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTP--EFVAP 180
Query: 578 EYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
E ++D+++ G+I + +LSG +PF
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSG---ASPF 211
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 39/151 (25%), Positives = 72/151 (47%), Gaps = 12/151 (7%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK 128
+L+ K ++ + L S+ + + + + V + I L ++ L+LN N L+
Sbjct: 28 KDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLT-D 82
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLM 188
I + N+ NL L L NK+ ++ + L L+KL L+L++N ++ I L L L
Sbjct: 83 I-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQLE 137
Query: 189 RLDLSFNNLFGPVPVKLANVPKLEVLDIRNN 219
L L N + L+ + KL+ L + +N
Sbjct: 138 SLYLGNNKITDITV--LSRLTKLDTLSLEDN 166
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 33/135 (24%), Positives = 53/135 (39%), Gaps = 8/135 (5%)
Query: 87 GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCY 146
LK L L L N ++ + + L +L LYL N ++ I + +T L L L
Sbjct: 110 DLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLED 165
Query: 147 NKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLA 206
N+++ +I L L KL L L N ++ L L L L+L +
Sbjct: 166 NQIS-DIV-PLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQS 221
Query: 207 NVPKLEVLDIRNNSF 221
N+ + + S
Sbjct: 222 NLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 21/129 (16%), Positives = 48/129 (37%), Gaps = 10/129 (7%)
Query: 94 LYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNI 153
+ + + +E L +++ + + ++ + + + ++
Sbjct: 7 TITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV 61
Query: 154 PTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEV 213
+ L ++ L L N+LT P L +L L L L N + L ++ KL+
Sbjct: 62 -QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS--LKDLKKLKS 116
Query: 214 LDIRNNSFS 222
L + +N S
Sbjct: 117 LSLEHNGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 24/111 (21%), Positives = 49/111 (44%), Gaps = 6/111 (5%)
Query: 87 GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCY 146
L L L L N ++ ++P +A L++L +LYL+ N++S + + + NL VL+L
Sbjct: 154 RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFS 209
Query: 147 NKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNL 197
+ +L + + L P + D G + ++ ++
Sbjct: 210 QECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLP 258
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 4e-13
Identities = 34/296 (11%), Positives = 70/296 (23%), Gaps = 57/296 (19%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDE---------------------GEF 446
+LG+ A + G V T +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 447 LKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFV--------PNGNLLQHLDLEAGS 498
L+ + + + + + + L + +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 499 EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558
K L R+ + + + ++ LH GLVH L +++ +R L+
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 559 DDIVFSMLKASAAMGYLAPEY----------TTTGRFTEKSDIYAFGMIVFQILSGKCSI 608
V G+ PE T D + G+ ++ I
Sbjct: 263 ASAVSP-----IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD--- 314
Query: 609 TPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664
P T AA + ++ + + + R M+
Sbjct: 315 LPNTDDAALGG-----SEWIFRSCKNIPQP--VRALLEGFLRYPKEDRLLPLQAME 363
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 409 LLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
LG+ + S Y+ + A+K + K D+ + +L L H N+ L+ I
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKK---TVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYLHGKR 525
+ E L+ + V G L + +E G SE+ A +K I + ++YLH
Sbjct: 117 FETPT--EISLVLELVTGGELFDRI-VEKGYYSERD---AADA--VKQILEAVAYLHEN- 167
Query: 526 PGLVHPNLSAEKVLIHRRYN--PL-LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT 582
G+VH +L E +L PL ++D GL K++ ++ + + GY APE
Sbjct: 168 -GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTP--GYCAPEILRG 224
Query: 583 GRFTEKSDIYAFGMIVFQILSGKCSITPF 611
+ + D+++ G+I + +L G PF
Sbjct: 225 CAYGPEVDMWSVGIITYILLCG---FEPF 250
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 53/214 (24%), Positives = 89/214 (41%), Gaps = 27/214 (12%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKG-----LKILTSLKHENLAS 463
LG F+ K + G A K I K KS + + IL ++H N+ +
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYL 521
L + +K + LI + V G L L E +E+ AT +K I G+ YL
Sbjct: 79 LHEVYENKT--DVILILELVAGGELFDFL-AEKESLTEEE---ATEF--LKQILNGVYYL 130
Query: 522 HGKRPGLVHPNLSAEKVLIHRRYNPL----LSDSGLHKLLADDIVFSMLKASAAMGYLAP 577
H + H +L E +++ R P + D GL + F + + ++AP
Sbjct: 131 HSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP--EFVAP 186
Query: 578 EYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
E ++D+++ G+I + +LSG +PF
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSG---ASPF 217
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 7e-13
Identities = 40/208 (19%), Positives = 80/208 (38%), Gaps = 23/208 (11%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGIC 468
+G+ S+ + + A K I K + + F + ++I+ SL H N+ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEIMKSLDHPNIIRLYETF 75
Query: 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYLHGKRP 526
+ + +L+ + G L + + + E A RI +K + ++Y H
Sbjct: 76 --EDNTDIYLVMELCTGGELFERV-VHKRVFRESD---AARI--MKDVLSAVAYCHKL-- 125
Query: 527 GLVHPNLSAEKVLIHRR---YNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG 583
+ H +L E L L D GL + + Y++P+ G
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTP--YYVSPQ-VLEG 182
Query: 584 RFTEKSDIYAFGMIVFQILSGKCSITPF 611
+ + D ++ G++++ +L G PF
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGY---PPF 207
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.6 bits (172), Expect = 7e-13
Identities = 27/115 (23%), Positives = 50/115 (43%), Gaps = 6/115 (5%)
Query: 106 PKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSV 165
+++ L+L +L+ + + + + L L +N+L +P L +LR L V
Sbjct: 434 SVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEV 490
Query: 166 LALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFG-PVPVKLANVPKLEVLDIRNN 219
L N L + + +L L L L N L L + P+L +L+++ N
Sbjct: 491 LQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 67.9 bits (165), Expect = 6e-12
Identities = 30/126 (23%), Positives = 53/126 (42%), Gaps = 9/126 (7%)
Query: 94 LYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNI 153
L+L L + + L ++ L L+ N L +P + + L+VLQ N L N+
Sbjct: 446 LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NV 501
Query: 154 PTQLGSLRKLSVLALQYNQLTG-AIPASLGDLGMLMRLDLSFNNLFGPVPVK---LANVP 209
+ +L +L L L N+L A L L+ L+L N+L ++ +P
Sbjct: 502 DG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 560
Query: 210 KLEVLD 215
+ +
Sbjct: 561 SVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 5e-10
Identities = 41/160 (25%), Positives = 63/160 (39%), Gaps = 20/160 (12%)
Query: 82 PAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQV 141
A+ L +F+ L V P A L +L +L + +++V
Sbjct: 392 MRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLL------ENSVLKMEYADVRV 445
Query: 142 LQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPV 201
L L + LT + L L ++ L L +N+L A+P +L L L L S N L
Sbjct: 446 LHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD 502
Query: 202 PVKLANVPKLEVLDIRNNSFSGNVP--------PALKRLN 233
+AN+P+L+ L + NN P L LN
Sbjct: 503 G--VANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLN 539
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 3e-07
Identities = 31/159 (19%), Positives = 49/159 (30%), Gaps = 25/159 (15%)
Query: 82 PAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVN-------------NLSGK 128
+ L L V+ E+ S EL +L +
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 129 IPSQIGNMTNLQVL--------QLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPAS 180
+ + L+ + +K + VL L + LT +
Sbjct: 401 EKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCH 458
Query: 181 LGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNN 219
L L ++ LDLS N L +P LA + LEVL +N
Sbjct: 459 LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDN 496
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 16/211 (7%)
Query: 404 FSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLA 462
S+ +LG F +K G +A K I K E E + ++ L H NL
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANLI 149
Query: 463 SLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLH 522
L SK + L+ ++V G L + E S + E T I +K I +GI ++H
Sbjct: 150 QLYDAFESK--NDIVLVMEYVDGGELFDRIIDE--SYNLTELDT-ILFMKQICEGIRHMH 204
Query: 523 GKRPGLVHPNLSAEKVL-IHRRYNPL-LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYT 580
++H +L E +L ++R + + D GL + + + +LAPE
Sbjct: 205 QM--YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTP--EFLAPEVV 260
Query: 581 TTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
+ +D+++ G+I + +LSG ++PF
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLSG---LSPF 288
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 46/271 (16%), Positives = 97/271 (35%), Gaps = 34/271 (12%)
Query: 409 LLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
+LG + R G A+K + + E + ++ + +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQA-----SGGPHIVCILDV 90
Query: 468 C--CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
G+ +I + + G L + E G + E +++ I I +LH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRI-QERGDQAFTEREAA-EIMRDIGTAIQFLHSH- 147
Query: 526 PGLVHPNLSAEKVL-IHRRYNPLL--SDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT 582
+ H ++ E +L + + +L +D G K + + + + Y+APE
Sbjct: 148 -NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC-YTP--YYVAPEVLGP 203
Query: 583 GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKF--------S 634
++ + D+++ G+I++ +L G PF + G++
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGF---PPFYSN-TGQAISPGMKRRIRLGQYGFPNPEWSE 259
Query: 635 VS-EASNLGQIALHCTHESPSHRPSIENVMQ 664
VS +A L ++ L P+ R +I M
Sbjct: 260 VSEDAKQLIRLLLKT---DPTERLTITQFMN 287
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 49/278 (17%), Positives = 109/278 (39%), Gaps = 54/278 (19%)
Query: 419 YKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKI----LTSLKHENLASL--RGICCSK 471
+ LRD VAVK + + D F + +L H + ++ G +
Sbjct: 29 HLARDLRDHRDVAVK-VLRADLARDP-SFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 86
Query: 472 GRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHP 531
+++ ++V L + +E + I VI + +++ H + G++H
Sbjct: 87 AGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSH--QNGIIHR 140
Query: 532 NLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTTTGRFTEK 588
++ ++I + D G+ + +AD S+ + +A +G YL+PE +
Sbjct: 141 DVKPANIMISATNAVKVMDFGIARAIADSGN-SVTQTAAVIGTAQYLSPEQARGDSVDAR 199
Query: 589 SDIYAFGMIVFQILSGKCSITPFTRQAAES----------------SKVEDFIDPNLEGK 632
SD+Y+ G +++++L+G+ PFT +S S + + +L+
Sbjct: 200 SDVYSLGCVLYEVLTGE---PPFT---GDSPVSVAYQHVREDPIPPSARHEGLSADLD-- 251
Query: 633 FSVSEASNLGQIALHCTHESPSHRP-SIENVMQELSSI 669
+ L ++P +R + + +L +
Sbjct: 252 ----------AVVLKALAKNPENRYQTAAEMRADLVRV 279
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKG-LKILTSLKHENLASLRGI 467
LGK +FS + + G A I + + + L+ +I LKH N+ L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYLHGKR 525
+ G +LI+D V G L + + + SE A+ I+ I + + + H
Sbjct: 79 ISEE--GHHYLIFDLVTGGELFEDI-VAREYYSEAD---ASHC--IQQILEAVLHCHQM- 129
Query: 526 PGLVHPNLSAEKVLIHRRYN--PL-LSDSGL-HKLLADDIVFSMLKASAAMGYLAPEYTT 581
G+VH NL E +L+ + + L+D GL ++ + + + GYL+PE
Sbjct: 130 -GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP--GYLSPEVLR 186
Query: 582 TGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
+ + D++A G+I++ +L G PF
Sbjct: 187 KDPYGKPVDLWACGVILYILLVG---YPPF 213
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 46/328 (14%), Positives = 99/328 (30%), Gaps = 77/328 (23%)
Query: 404 FSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL------ 456
F +G+ F ++ D A+K I + + + ++ +K L L
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 457 ----------------------------------------------KHENLASLRGICCS 470
+ + ++ +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 471 KGRGECFLIY---DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG 527
+ +Y NL ++ S + E + + IA+ + +LH K G
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMN-RRCSLEDREHGVCLHIFIQIAEAVEFLHSK--G 184
Query: 528 LVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG-----------YLA 576
L+H +L + + D GL + D + Y++
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 577 PEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636
PE ++ K DI++ G+I+F++L F+ Q + D + F+
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFELL------YSFSTQMERVRIITDVRNLKFPLLFT-Q 297
Query: 637 EASNLGQIALHCTHESPSHRPSIENVMQ 664
+ + SP+ RP ++++
Sbjct: 298 KYPQEHMMVQDMLSPSPTERPEATDIIE 325
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 56/287 (19%), Positives = 105/287 (36%), Gaps = 77/287 (26%)
Query: 419 YKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGL----KILTSLKHENLASLRGICCSKGR 473
Y VA+K + E E LK + L H+N+ S
Sbjct: 28 YLAEDTILNIKVAIK-AIFIPPREKE-ETLKRFEREVHNSSQLSHQNIVS---------- 75
Query: 474 GECFLIYD-------------FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISY 520
+ D ++ L ++++ S L T I+ I GI +
Sbjct: 76 -----MIDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKH 126
Query: 521 LHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAP 577
H +VH ++ + +LI + D G+ K L++ S+ + + +G Y +P
Sbjct: 127 AH--DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET---SLTQTNHVLGTVQYFSP 181
Query: 578 EYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAES--------------SKVED 623
E E +DIY+ G++++++L G+ PF + A S + V
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGE---PPFNGETAVSIAIKHIQDSVPNVTTDVRK 238
Query: 624 FIDPNLEGKFSVSEASNLGQIALHCTHESPSHRP-SIENVMQELSSI 669
I +L + L T + ++R +I+ + +LSS+
Sbjct: 239 DIPQSLS------------NVILRATEKDKANRYKTIQEMKDDLSSV 273
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 41/228 (17%), Positives = 88/228 (38%), Gaps = 40/228 (17%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKT------------SCKSDEGEFLKGLK----IL 453
L + F+ +D A+K K+ + K K I+
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 454 TSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLD-----LEAGSEKVLEWATRI 508
T +K+E + GI + ++IY+++ N ++L+ + + + + +
Sbjct: 98 TDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK- 154
Query: 509 SVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKA 568
+IK + SY+H ++ + H ++ +L+ + LSD G + + D +K
Sbjct: 155 CIIKSVLNSFSYIHNEK-NICHRDVKPSNILMDKNGRVKLSDFGESEYMVD----KKIKG 209
Query: 569 SAAMG---YLAPE--YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
S G ++ PE + K DI++ G+ ++ + PF
Sbjct: 210 S--RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV---VPF 252
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 34/148 (22%), Positives = 61/148 (41%), Gaps = 11/148 (7%)
Query: 85 VGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144
+ +L L+L N ++ + P + L++L +L +N N L + L L L
Sbjct: 59 MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFL 113
Query: 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVK 204
N+L + + L L+ L +L+++ N+L + LG L L LDL N +
Sbjct: 114 DNNELR-DTDS-LIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITNTGG-- 167
Query: 205 LANVPKLEVLDIRNNSFSGNVPPALKRL 232
L + K+ +D+ L
Sbjct: 168 LTRLKKVNWIDLTGQKCVNEPVKYQPEL 195
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 24/127 (18%), Positives = 45/127 (35%), Gaps = 11/127 (8%)
Query: 96 LHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPT 155
+N V P L+ L +++ + S ++ +Q + + ++
Sbjct: 4 QRPTPINQVFP--DPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SLAG 58
Query: 156 QLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLD 215
+ L L L +NQ++ P L DL L L ++ N L + L L
Sbjct: 59 -MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPS---ACLSRLF 112
Query: 216 IRNNSFS 222
+ NN
Sbjct: 113 LDNNELR 119
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 22/139 (15%), Positives = 44/139 (31%), Gaps = 7/139 (5%)
Query: 87 GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCY 146
LK+L L + N L ++ + LS+L L L+ N ++ + + + + L
Sbjct: 126 HLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTG 181
Query: 147 NKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLA 206
K L + + + P + + G + + + V
Sbjct: 182 QKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPVYTDEVSYK 239
Query: 207 NVPKLEVLDIRNNSFSGNV 225
+ V F G V
Sbjct: 240 FSEYINV-GETEAIFDGTV 257
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 32/219 (14%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGL-------KILTSLK-HEN 460
+G+ S + + R G AVK + T+ + + + IL + H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 461 LASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGI 518
+ +L S FL++D + G L +L E SEK TR S+++ + + +
Sbjct: 162 IITLIDSYESS--SFMFLVFDLMRKGELFDYL-TEKVALSEK----ETR-SIMRSLLEAV 213
Query: 519 SYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPE 578
S+LH +VH +L E +L+ LSD G L L + GYLAPE
Sbjct: 214 SFLHAN--NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTP--GYLAPE 269
Query: 579 ------YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
T + ++ D++A G+I+F +L+G PF
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAG---SPPF 305
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 66/277 (23%), Positives = 112/277 (40%), Gaps = 47/277 (16%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGI 467
LG+ SFS K + + AVK I+K + + E + L + H N+ L +
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKE----ITALKLCEGHPNIVKLHEV 74
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYLHGKR 525
+ FL+ + + G L + + + SE A+ I ++ + +S++H
Sbjct: 75 FHDQLH--TFLVMELLNGGELFERI-KKKKHFSETE---ASYI--MRKLVSAVSHMHDV- 125
Query: 526 PGLVHPNLSAEKVL-IHRRYNPLL--SDSGLHKLL-ADDIVFSMLKASAAMGYLAPEYTT 581
G+VH +L E +L N + D G +L D+ + Y APE
Sbjct: 126 -GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTL--HYAAPELLN 182
Query: 582 TGRFTEKSDIYAFGMIVFQILSGKCSITPF---TRQAAESSKVEDF--IDPNLEGKFS-- 634
+ E D+++ G+I++ +LSG+ PF R +S VE I +G FS
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQ---VPFQSHDRSLTCTSAVEIMKKI---KKGDFSFE 236
Query: 635 ------VS-EASNLGQIALHCTHESPSHRPSIENVMQ 664
VS EA +L I P+ R + +
Sbjct: 237 GEAWKNVSQEAKDL--IQ-GLLTVDPNKRLKMSGLRY 270
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 44/218 (20%), Positives = 80/218 (36%), Gaps = 32/218 (14%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGL-------KILTSLKHENL 461
LG + R VA+K I+K +IL L H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 462 ASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGIS 519
++ ++ + +++ + + G L + + E + + +
Sbjct: 78 IKIKNFFDAE---DYYIVLELMEGGELFDKV-VGNKRLKEA----TCK-LYFYQMLLAVQ 128
Query: 520 YLHGKRPGLVHPNLSAEKVLIHRRYNPL---LSDSGLHKLLADDIVFSMLKASAAMGYLA 576
YLH G++H +L E VL+ + ++D G K+L + + L + YLA
Sbjct: 129 YLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP--TYLA 184
Query: 577 PE---YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
PE T + D ++ G+I+F LSG PF
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSG---YPPF 219
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 32/205 (15%), Positives = 69/205 (33%), Gaps = 19/205 (9%)
Query: 61 CDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYL 120
C + RV Q ++ EIP+ + ++ L L + + +L + +
Sbjct: 7 CHCSNRV--FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEI 61
Query: 121 NVNNLSGKIPSQI-GNMTNLQVLQLC-YNKLTGNIPTQ-LGSLRKLSVLALQYNQLTGAI 177
+ N++ I + + N+ L +++ N L I + +L L L + + +
Sbjct: 62 SQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HL 119
Query: 178 PA-SLGDLGMLMRLDLSFNNLFGPVPVK-LANVP-KLEVLDIRNNSFSGNVPPA---LKR 231
P + LD+ N + + + +L + N + + +
Sbjct: 120 PDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQ 178
Query: 232 LNGGFQYDNN--AALCGTGFTNLKN 254
L+ DNN L F
Sbjct: 179 LDELNLSDNNNLEELPNDVFHGASG 203
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 22/145 (15%), Positives = 36/145 (24%), Gaps = 5/145 (3%)
Query: 80 EIPAAV-GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI--GNM 136
I L +L L + + + + L + N I G
Sbjct: 94 YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS 153
Query: 137 TNLQVLQLCYNKLTGNIPTQ-LGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFN 195
+L L N + I + + N L + LD+S
Sbjct: 154 FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT 212
Query: 196 NLFGPVPVKLANVPKLEVLDIRNNS 220
+ L N+ KL N
Sbjct: 213 RIHSLPSYGLENLKKLRARSTYNLK 237
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 6e-12
Identities = 42/254 (16%), Positives = 81/254 (31%), Gaps = 66/254 (25%)
Query: 425 DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFV- 483
+G V +K + + + + + L + H ++ I++FV
Sbjct: 105 NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ---------------IFNFVE 149
Query: 484 ---PNGNLLQHL--------DLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVH-- 530
+G+ + ++ L+ + L A I+ + I +SYLH GLV+
Sbjct: 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLH--SIGLVYND 207
Query: 531 --PNLSAEKVLIHRRYNPLLSDSGLHKLLADD--IVFSMLKASAAMG---YLAPEYTTTG 583
P N +L++ L KL+ D V + G + APE
Sbjct: 208 LKPE------------NIMLTEEQL-KLI--DLGAVSRINSFGYLYGTPGFQAPE-IVRT 251
Query: 584 RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQ 643
T +DIY G + + + + P + ++ G+
Sbjct: 252 GPTVATDIYTVGRTLAALTLDL---PTRNGRYVDG-------LPEDDPVLKTYDS--YGR 299
Query: 644 IALHCTHESPSHRP 657
+ P R
Sbjct: 300 LLRRAIDPDPRQRF 313
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 37/113 (32%), Positives = 51/113 (45%), Gaps = 4/113 (3%)
Query: 87 GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGN-MTNLQVLQLC 145
L +LT L L N L + L+ L +L L N L +P + + +TNL L L
Sbjct: 83 ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLA 141
Query: 146 YNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGD-LGMLMRLDLSFNNL 197
+N+L L L+ L L YNQL ++P + D L L L L N L
Sbjct: 142 HNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 35/110 (31%), Positives = 48/110 (43%), Gaps = 10/110 (9%)
Query: 69 NISLQGKGLSGEIPAAV-GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSG 127
+ L G L +P V L +L L L N L + L+ L+ L L N L
Sbjct: 89 YLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ- 146
Query: 128 KIPSQI-GNMTNLQVLQLCYNKLTGNIPTQLG---SLRKLSVLALQYNQL 173
+P + +TNL L L YN+L ++P G L +L L L NQL
Sbjct: 147 SLPKGVFDKLTNLTELDLSYNQLQ-SLPE--GVFDKLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 30/162 (18%), Positives = 56/162 (34%), Gaps = 39/162 (24%)
Query: 73 QGKGLSG---EIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
+ A L ++ + + L+ + + N +++ +
Sbjct: 6 STPIKQIFPDDAFA------ETIKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV 56
Query: 130 PSQIGNMTNLQVLQLCYNKLTGNIPTQLG---SLRKLSVLALQYNQLTGAIPASLGD-LG 185
I + N++ L L NKL + L L+ L L NQL ++P + D L
Sbjct: 57 QG-IQYLPNVRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLT 109
Query: 186 MLMRLDLSFNNLFGPVPVKLANVP--------KLEVLDIRNN 219
L L L N +L ++P L L++ +N
Sbjct: 110 NLKELVLVEN--------QLQSLPDGVFDKLTNLTYLNLAHN 143
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 8e-12
Identities = 43/206 (20%), Positives = 86/206 (41%), Gaps = 17/206 (8%)
Query: 409 LLGKSSFSATYKGILRD-GSVVAVKCIAKTS-CKSDEGEFLKG-LKILTSLKHENLASLR 465
LGK F Y + ++A+K + K+ K L+ ++I + L+H N+ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 466 GICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
+ R +L+ +F P G L + L + E + + ++ +A + Y H +
Sbjct: 81 NYFHDRKR--IYLMLEFAPRGELYKEL---QKHGRFDEQRSA-TFMEELADALHYCHER- 133
Query: 526 PGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRF 585
++H ++ E +L+ + ++D G +M + YL PE
Sbjct: 134 -KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM---CGTLDYLPPEMIEGKTH 189
Query: 586 TEKSDIYAFGMIVFQILSGKCSITPF 611
EK D++ G++ ++ L G PF
Sbjct: 190 DEKVDLWCAGVLCYEFLVGM---PPF 212
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 53/267 (19%), Positives = 104/267 (38%), Gaps = 34/267 (12%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSD--EGEFLKGLKILTSLKHENLASLR 465
LGK F+ ++ V A K + K+ + + I SL H+++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 466 GICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
G F++ + +LL+ + + E R ++ I G YLH
Sbjct: 108 GFFEDNDF--VFVVLELCRRRSLLELH---KRRKALTEPEAR-YYLRQIVLGCQYLHRN- 160
Query: 526 PGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTTT 582
++H +L + ++ + D GL + D K G Y+APE +
Sbjct: 161 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKVLC--GTPNYIAPEVLSK 215
Query: 583 GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV-----SE 637
+ + D+++ G I++ +L GK PF E+S +++ + ++S+
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGK---PPF-----ETSCLKETYLRIKKNEYSIPKHINPV 267
Query: 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664
A++L I P+ RP+I ++
Sbjct: 268 AASL--IQ-KMLQTDPTARPTINELLN 291
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 45/208 (21%), Positives = 84/208 (40%), Gaps = 17/208 (8%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKG-LKILTSLKH-ENLASLRG 466
LG+ F+ + I + G A K + K D + + +L K + +L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
+ + E LI ++ G + L +E V E +IK I +G+ YLH
Sbjct: 97 VYENT--SEIILILEYAAGGEIFSLC-LPELAEMVSENDVI-RLIKQILEGVYYLHQN-- 150
Query: 527 GLVHPNLSAEKVLIHRR--YNPL-LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG 583
+VH +L + +L+ + + D G+ + + + + YLAPE
Sbjct: 151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP--EYLAPEILNYD 208
Query: 584 RFTEKSDIYAFGMIVFQILSGKCSITPF 611
T +D++ G+I + +L+ +PF
Sbjct: 209 PITTATDMWNIGIIAYMLLTH---TSPF 233
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 41/151 (27%), Positives = 58/151 (38%), Gaps = 12/151 (7%)
Query: 73 QGKGLS---GEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
+ K + IP + LYLH N + + P SL L +LYL N L +
Sbjct: 27 RSKRHASVPAGIPT------NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-AL 79
Query: 130 PSQI-GNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLM 188
P + ++T L VL L N+LT L L L + N+LT +P + L L
Sbjct: 80 PVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLT 138
Query: 189 RLDLSFNNLFGPVPVKLANVPKLEVLDIRNN 219
L L N L + L + N
Sbjct: 139 HLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-10
Identities = 42/147 (28%), Positives = 61/147 (41%), Gaps = 4/147 (2%)
Query: 51 CSSDSFDGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIA 110
C S V + L ++ P L +L LYL N L +
Sbjct: 26 CRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD 85
Query: 111 SLSELSDLYLNVNNLSGKIPSQI-GNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQ 169
SL++L+ L L N L+ +PS + + +L+ L +C NKLT +P + L L+ LAL
Sbjct: 86 SLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALD 143
Query: 170 YNQLTGAIPASLGDLGMLMRLDLSFNN 196
NQL + L L L F N
Sbjct: 144 QNQLKSIPHGAFDRLSSLTHAYL-FGN 169
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 21/206 (10%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
+LGK ++ Y G L + +A+K I + + + + + + LKH+N+ G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLGS 87
Query: 468 CCSKGRGECFLIY-DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
I+ + VP G+L L + G K E K I +G+ YLH
Sbjct: 88 FSE---NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-YTKQILEGLKYLHDN-- 141
Query: 527 GLVHPNLSAEKVLIHRRYNPL-LSDSGLHKLLADDIVFSMLKASAAMG---YLAPE---Y 579
+VH ++ + VLI+ L +SD G K LA G Y+APE
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG----INPCTETFTGTLQYMAPEIIDK 197
Query: 580 TTTGRFTEKSDIYAFGMIVFQILSGK 605
G + +DI++ G + ++ +GK
Sbjct: 198 GPRGY-GKAADIWSLGCTIIEMATGK 222
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 3e-11
Identities = 53/267 (19%), Positives = 104/267 (38%), Gaps = 34/267 (12%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSD--EGEFLKGLKILTSLKHENLASLR 465
LGK F+ ++ V A K + K+ + + I SL H+++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 466 GICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
G F++ + +LL+ + + E R ++ I G YLH
Sbjct: 82 GFFEDNDF--VFVVLELCRRRSLLELH---KRRKALTEPEAR-YYLRQIVLGCQYLHRN- 134
Query: 526 PGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPEYTTT 582
++H +L + ++ + D GL + D K G Y+APE +
Sbjct: 135 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKVLC--GTPNYIAPEVLSK 189
Query: 583 GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV-----SE 637
+ + D+++ G I++ +L GK PF E+S +++ + ++S+
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGK---PPF-----ETSCLKETYLRIKKNEYSIPKHINPV 241
Query: 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664
A++L I P+ RP+I ++
Sbjct: 242 AASL--IQ-KMLQTDPTARPTINELLN 265
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 3e-11
Identities = 60/266 (22%), Positives = 110/266 (41%), Gaps = 31/266 (11%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSD--EGEFLKGLKILTSLKHENLASLR 465
LLGK SF+ Y+ + G VA+K I K + +KI LKH ++ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 466 GICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
+L+ + NG + ++L E R + I G+ YLH
Sbjct: 78 NYFEDSNY--VYLVLEMCHNGEMNRYLKNRVK--PFSENEAR-HFMHQIITGMLYLHSH- 131
Query: 526 PGLVHPNLSAEKVLIHRRYNPLLSDSGL-HKLLADDIVFSMLKAS-AAMGYLAPEYTTTG 583
G++H +L+ +L+ R N ++D GL +L Y++PE T
Sbjct: 132 -GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH---EKHYTLCGTPNYISPEIATRS 187
Query: 584 RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV-----SEA 638
+SD+++ G + + +L G+ PF ++ V++ ++ + + + EA
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGR---PPF-----DTDTVKNTLNKVVLADYEMPSFLSIEA 239
Query: 639 SNLGQIALHCTHESPSHRPSIENVMQ 664
+L L +P+ R S+ +V+
Sbjct: 240 KDLIHQLL---RRNPADRLSLSSVLD 262
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 40/130 (30%), Positives = 56/130 (43%), Gaps = 13/130 (10%)
Query: 73 QGKGLS---GEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
+G + IPA T L L N+L + L+ L+ LYL N L +
Sbjct: 15 YSQGRTSVPTGIPA------QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SL 67
Query: 130 PSQIGN-MTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGD-LGML 187
P+ + N +T+L L L N+L L +L LAL NQL ++P + D L L
Sbjct: 68 PNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQL 126
Query: 188 MRLDLSFNNL 197
L L N L
Sbjct: 127 KDLRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 7e-10
Identities = 36/127 (28%), Positives = 52/127 (40%), Gaps = 8/127 (6%)
Query: 51 CSSDSFDGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIA 110
C S V + + L+ L L SLT LYL N L +
Sbjct: 14 CYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFN 73
Query: 111 SLSELSDLYLNVNNLSGKIPSQI-GNMTNLQVLQLCYNKLTGNIPTQLG---SLRKLSVL 166
L+ L+ L L+ N L +P+ + +T L+ L L N+L ++P G L +L L
Sbjct: 74 KLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPD--GVFDKLTQLKDL 129
Query: 167 ALQYNQL 173
L NQL
Sbjct: 130 RLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 32/107 (29%), Positives = 43/107 (40%), Gaps = 10/107 (9%)
Query: 118 LYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAI 177
L L N+L +T+L L L NKL L L+ L L NQL ++
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SL 91
Query: 178 PASLGD-LGMLMRLDLSFNNLFGPVPV----KLANVPKLEVLDIRNN 219
P + D L L L L+ N L +P KL L+ L + N
Sbjct: 92 PNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQ---LKDLRLYQN 134
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 65/272 (23%), Positives = 117/272 (43%), Gaps = 41/272 (15%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGI 467
+G S+S + I + AVK I K+ ++E E L L +H N+ +L+ +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEIL-----LRYGQHPNIITLKDV 84
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYLHGKR 525
+++ + + G LL + L SE+ A+ + + I K + YLH +
Sbjct: 85 YDDGKY--VYVVTELMKGGELLDKI-LRQKFFSERE---ASAV--LFTITKTVEYLHAQ- 135
Query: 526 PGLVHPNLSAEKVL-IHRRYNPL---LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTT 581
G+VH +L +L + NP + D G K L + M A ++APE
Sbjct: 136 -GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTA-NFVAPEVLE 193
Query: 582 TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS------- 634
+ DI++ G++++ +L+G TPF ++ E+ + GKFS
Sbjct: 194 RQGYDAACDIWSLGVLLYTMLTG---YTPFANGPDDTP--EEILARIGSGKFSLSGGYWN 248
Query: 635 -VSE-ASNLGQIALHCTHESPSHRPSIENVMQ 664
VS+ A +L ++ H P R + V++
Sbjct: 249 SVSDTAKDL--VS-KMLHVDPHQRLTAALVLR 277
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 67/275 (24%), Positives = 115/275 (41%), Gaps = 54/275 (19%)
Query: 404 FSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLA 462
F++ +GK SF +KGI R VVA+K I + + + + + +L+ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 463 SLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVI-KGIAKGISYL 521
G K + ++I +++ G+ L L+ E I+ I + I KG+ YL
Sbjct: 84 KYYG-SYLKD-TKLWIIMEYLGGGSALDLLEPGPLDETQ------IATILREILKGLDYL 135
Query: 522 HGKRPGLVHPNLSAEKVLIHR---RYNPLLSDSGLHKLLAD-----DIVFSMLKASAAMG 573
H ++ IHR N LLS+ G K LAD + + +K + +G
Sbjct: 136 HSEK-------------KIHRDIKAANVLLSEHGEVK-LADFGVAGQLTDTQIKRNTFVG 181
Query: 574 ---YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGK---CSITPFTRQAAESSKVEDFID- 626
++APE + K+DI++ G+ ++ G+ + P KV I
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--------KVLFLIPK 233
Query: 627 ---PNLEGKFSVSEASNLGQIALHCTHESPSHRPS 658
P LEG +S L + C ++ PS RP+
Sbjct: 234 NNPPTLEGNYS----KPLKEFVEACLNKEPSFRPT 264
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 5e-11
Identities = 26/133 (19%), Positives = 51/133 (38%), Gaps = 6/133 (4%)
Query: 69 NISLQGKGLSGEIPAAV-GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSG 127
+ L + + L L + N + + S ++++ L N L
Sbjct: 36 ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN 95
Query: 128 KIPSQI-GNMTNLQVLQLCYNKLTGNIPTQL-GSLRKLSVLALQYNQLTGAIPASLGDLG 185
+ ++ + +L+ L L N++T + L + +L+L NQ+T P + L
Sbjct: 96 -VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLH 153
Query: 186 MLMRLDLSFNNLF 198
L L+L N F
Sbjct: 154 SLSTLNL-LANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 21/93 (22%), Positives = 36/93 (38%), Gaps = 5/93 (5%)
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIPT-QLGSLRKLSVLALQYNQLTGAIPASLGDLGML 187
IP I L+L N+ T T L +L + N++T + +
Sbjct: 26 IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 188 MRLDLSFNNLFGPVPVKL-ANVPKLEVLDIRNN 219
+ L+ N L V K+ + L+ L +R+N
Sbjct: 84 NEILLTSNRLEN-VQHKMFKGLESLKTLMLRSN 115
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 43/250 (17%), Positives = 83/250 (33%), Gaps = 55/250 (22%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKT----SCKSDEGEFLKGLKILTSLKHENLASL 464
+G+ S+ I ++ A+K + K D ++++ L H N+A L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRI---------------- 508
+ + L+ + G+LL L++ +
Sbjct: 94 YEVYEDEQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 509 --------------------SVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR--YNP 546
++++ I + YLH + G+ H ++ E L +
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ--GICHRDIKPENFLFSTNKSFEI 209
Query: 547 LLSDSGLHKLLADDIVFSMLKASAAMG---YLAPE--YTTTGRFTEKSDIYAFGMIVFQI 601
L D GL K + G ++APE TT + K D ++ G+++ +
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 602 LSGKCSITPF 611
L G PF
Sbjct: 270 LMGA---VPF 276
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 49/272 (18%), Positives = 94/272 (34%), Gaps = 37/272 (13%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGIC 468
LG + + A+K + E E + ++ + +
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA-----SQCPHIVRIVDVY 124
Query: 469 --CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
GR ++ + + G L + + G + E ++K I + I YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREAS-EIMKSIGEAIQYLHSI-- 180
Query: 527 GLVHPNLSAEKVL-IHRRYNPLL--SDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG 583
+ H ++ E +L +R N +L +D G K + + Y+APE
Sbjct: 181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP--YYVAPEVLGPE 238
Query: 584 RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF--IDPNLEGKFS------- 634
++ + D+++ G+I++ +L G PF + I G++
Sbjct: 239 KYDKSCDMWSLGVIMYILLCGY---PPFYSNHGLAISPGMKTRI---RMGQYEFPNPEWS 292
Query: 635 -VS-EASNLGQIALHCTHESPSHRPSIENVMQ 664
VS E L I + P+ R +I M
Sbjct: 293 EVSEEVKML--IR-NLLKTEPTQRMTITEFMN 321
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 23/108 (21%), Positives = 48/108 (44%), Gaps = 11/108 (10%)
Query: 508 ISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLK 567
+++++ I + H G H ++ E +L+ L D G+ D+ + +
Sbjct: 137 VAIVRQIGSALDAAH--AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE---KLTQ 191
Query: 568 ASAAMG---YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFT 612
+G Y+APE + T ++DIYA ++++ L+G P+
Sbjct: 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS---PPYQ 236
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 24/126 (19%), Positives = 50/126 (39%), Gaps = 14/126 (11%)
Query: 99 NALNGVIPKEIASLSELS--DLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQ 156
+A+ ++ +E +L+ + + K+ + + + + L L N + I +
Sbjct: 9 DAIRIFEERKSVVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SS 65
Query: 157 LGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANV---PKLEV 213
L + L +L+L N + I L L +S+N + L+ + L V
Sbjct: 66 LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQI-----ASLSGIEKLVNLRV 119
Query: 214 LDIRNN 219
L + NN
Sbjct: 120 LYMSNN 125
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 34/136 (25%), Positives = 60/136 (44%), Gaps = 28/136 (20%)
Query: 86 GGLKSLTGLYLHFNALNGVIPKEIASLSELSD----LYLNVNNLSGKIPSQIGNMTNLQV 141
G+++L L L N + K+I +L ++D L+++ N ++ + S I + NL+V
Sbjct: 67 SGMENLRILSLGRNLI-----KKIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRV 119
Query: 142 LQLCYNKLT--GNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFG 199
L + NK+T G I +L +L KL L L N L + + +
Sbjct: 120 LYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV--------- 169
Query: 200 PVPVKLANVPKLEVLD 215
+ +P L+ LD
Sbjct: 170 -----VKRLPNLKKLD 180
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 57/293 (19%), Positives = 111/293 (37%), Gaps = 54/293 (18%)
Query: 409 LLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRG 466
+LG+ + + I AVK I K + +++L + H N+ L
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-RVFREVEMLYQCQGHRNVLELIE 78
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYLHGK 524
+ R +L+++ + G++L H+ + +E E + V++ +A + +LH K
Sbjct: 79 FFEEEDR--FYLVFEKMRGGSILSHI-HKRRHFNEL--EAS---VVVQDVASALDFLHNK 130
Query: 525 RPGLVHPNLSAEKVL-IHRRYN-PL-LSDSGLHKLLADDIVFSMLKASAAM------GYL 575
G+ H +L E +L H P+ + D L + + S + + Y+
Sbjct: 131 --GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 576 APE-----YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPN-- 628
APE + ++ D+++ G+I++ +LSG PF + +
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY---PPFVGRCGSDCGWDRGEACPAC 245
Query: 629 --------LEGKFS--------VSE-ASNLGQIALHCTHESPSHRPSIENVMQ 664
EGK+ +S A +L I+ R S V+Q
Sbjct: 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDL--IS-KLLVRDAKQRLSAAQVLQ 295
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.6 bits (151), Expect = 3e-10
Identities = 66/434 (15%), Positives = 124/434 (28%), Gaps = 134/434 (30%)
Query: 318 VTGLFTFTWYRRRKQK-IGNAF----DNSDSRLSTDQVKEVCRRNSSPLISLEYSNGWDP 372
V+G W KQ+ + F + + +K R+ S +++ Y D
Sbjct: 61 VSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPS--MMTRMYIEQRDR 118
Query: 373 LAKGQSGNGFSQEVLESFMFNLEEVERATQCFSEA----NLL-------GKSSFSATYKG 421
L + N Q + + L+ + Q E N+L GK+ +
Sbjct: 119 L---YNDN---QVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALD--- 169
Query: 422 ILRDGSVVAVKC-----IAKTSCKSDEGEFLKGLKILTSLKHE---NLAS---------- 463
+ V + +C S E L++L L ++ N S
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETV----LEMLQKLLYQIDPNWTSRSDHSSNIKL 225
Query: 464 --------LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIA 515
LR + SK C L+ V N +L K+L TR K +
Sbjct: 226 RIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC---KIL-LTTR---FKQVT 278
Query: 516 KGISYLHGKRPGLVHPN----------------------LSAEKVLIHRRYNPLLSDSGL 553
+S L H + L E + + P S +
Sbjct: 279 DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN----PRRL-SII 333
Query: 554 HKLLADDI-------------VFSMLKASAAMGYLAPE-----YTTTGRFTEKSDIYAFG 595
+ + D + + +++++S + L P + F + I
Sbjct: 334 AESIRDGLATWDNWKHVNCDKLTTIIESS--LNVLEPAEYRKMFDRLSVFPPSAHI---P 388
Query: 596 MIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALH-------- 647
I+ ++ S V ++ L V + I++
Sbjct: 389 TILLSLIWFD----------VIKSDVMVVVN-KLHKYSLVEKQPKESTISIPSIYLELKV 437
Query: 648 -CTHESPSHRPSIE 660
+E HR ++
Sbjct: 438 KLENEYALHRSIVD 451
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 6e-07
Identities = 108/714 (15%), Positives = 180/714 (25%), Gaps = 263/714 (36%)
Query: 20 STSEVDILMHIKDSLDPENRLLTSWAPNADPCSSDSFDGVACDENGRVANISLQGKGLSG 79
S E+D ++ KD++ RL W +L K
Sbjct: 47 SKEEIDHIIMSKDAVSGTLRLF--W--------------------------TLLSKQEEM 78
Query: 80 EIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLN-VNNLSGKIPSQIGNMTN 138
+ V + L +++ L I E S ++ +Y+ + L
Sbjct: 79 -VQKFVEEV-----LRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV----FAK 128
Query: 139 LQVLQL-CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNL 197
V +L Y KL L LR + + G LG
Sbjct: 129 YNVSRLQPYLKLR----QALLELRPAKNVLID------------GVLG------------ 160
Query: 198 FGPVPVK--LANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDNNAALCGTGFTNLKNC 255
G K +A L+V + + F + NLKNC
Sbjct: 161 SG----KTWVA----LDVC--LSYKVQCKMD------FKIF------------WLNLKNC 192
Query: 256 TASDHPTPGKPEP-------FEPNGLSTKDIPESAKLPANCGQPGCSS-PARRPHTGVFV 307
+ + E +PN S D + KL + Q +P+
Sbjct: 193 NSPE----TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE---- 244
Query: 308 GVIAVFIIL-TVTGLFTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVCR-----RNSSPL 361
++L V K NAF+ S C+ R
Sbjct: 245 ---NCLLVLLNV-------QNA----KAWNAFNLS------------CKILLTTRFKQ-- 276
Query: 362 ISLEYSNGWDPLAKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKG 421
+ S + L+ L E + L
Sbjct: 277 -----------VTDFLSAATTTHISLDHHSMTLTPDEVKSLL---LKYLDCRPQD----- 317
Query: 422 ILR----DGSVVAVKCIAKTSCKSDEG--EFLKGLK-------ILTSLKHENLASLRGIC 468
L + + IA+ S + + K + I +SL A R
Sbjct: 318 -LPREVLTTNPRRLSIIAE-SIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR--- 372
Query: 469 CSKGRGECFL---IYDFVPNGNLLQHLDLEAGSEKVLE--WATRIS-------------- 509
+ F + F P+ ++ +L W I
Sbjct: 373 ------KMFDRLSV--FPPSAHI---------PTILLSLIWFDVIKSDVMVVVNKLHKYS 415
Query: 510 -VIKGIAKGISYLHGKRPGL---VHPNLSAEKVLIHRR----YNPL--LSDSGLHKLLAD 559
V K + + + + L E L HR YN L D
Sbjct: 416 LVEKQPKESTISIP----SIYLELKVKLENEYAL-HRSIVDHYNIPKTFDSDDLIPPYLD 470
Query: 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYA-FGMIVFQI------LSGKCSITP-- 610
+S + G+ R T ++ F + +I + SI
Sbjct: 471 QYFYSHI------GHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTL 524
Query: 611 ---------FTRQAAE-SSKVEDFID--PNLEGKFSVSEASNLGQIALHCTHES 652
+ V +D P +E S+ ++L +IAL E+
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEA 578
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-10
Identities = 28/113 (24%), Positives = 49/113 (43%), Gaps = 8/113 (7%)
Query: 111 SLSELSDLYLNVN-NLSGKIPSQIGNMTNLQVLQLCYNKLT--GNIPTQLGSLRKLSVLA 167
+ S++ +L L+ + + GK+ L+ L LT N+P L KL L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLE 70
Query: 168 LQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVK-LANVPKLEVLDIRNN 219
L N+++G + L L+LS N + ++ L + L+ LD+ N
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-09
Identities = 29/139 (20%), Positives = 48/139 (34%), Gaps = 19/139 (13%)
Query: 88 LKSLTGLYLHFNALN-GVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCY 146
+ L L + N G + EL L L+ I + + + L+ L+L
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73
Query: 147 NKLTGNIPTQLGSLRKLSVLALQYNQLTG-AIPASLGDLGMLMRLDLSFNNLFGPVPVK- 204
N+++G + L+ L L N++ + L L L LDL V
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC------EVTN 127
Query: 205 --------LANVPKLEVLD 215
+P+L LD
Sbjct: 128 LNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 22/89 (24%), Positives = 39/89 (43%), Gaps = 3/89 (3%)
Query: 135 NMTNLQVLQLCYNKLT-GNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLS 193
++++ L L ++ G + +L L+ LT +I A+L L L +L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 194 FNNLFGPVPVKLANVPKLEVLDIRNNSFS 222
N + G + V P L L++ N
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 14/106 (13%)
Query: 73 QGKGLS---GEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
KGL IP V T LYL N ++PKE+++ L+ + L+ N +S +
Sbjct: 18 SNKGLKVLPKGIPRDV------TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TL 69
Query: 130 PSQI-GNMTNLQVLQLCYNKLTGNIPTQL-GSLRKLSVLALQYNQL 173
+Q NMT L L L YN+L IP + L+ L +L+L N +
Sbjct: 70 SNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDI 114
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 22/95 (23%), Positives = 43/95 (45%), Gaps = 11/95 (11%)
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGD-LGML 187
+P I ++ L L N+ T +P +L + + L+++ L N+++ + + L
Sbjct: 25 LPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80
Query: 188 MRLDLSFNNLFG-PVPV--KLANVPKLEVLDIRNN 219
+ L LS+N L P L + L +L + N
Sbjct: 81 LTLILSYNRLRCIPPRTFDGLKS---LRLLSLHGN 112
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 42/205 (20%), Positives = 78/205 (38%), Gaps = 22/205 (10%)
Query: 408 NLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRG 466
+G+ SF ++ + G AVK + + +E L L + L G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE------LVACAGLSSPRIVPLYG 117
Query: 467 ICCSKGRGECFLIY-DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
G I+ + + G+L Q + + G E + +G+ YLH +
Sbjct: 118 AVRE---GPWVNIFMELLEGGSLGQLIK-QMGCLP--EDRALY-YLGQALEGLEYLHTR- 169
Query: 526 PGLVHPNLSAEKVLIHRRYNPL-LSDSGLHKLLADDIVFSMLKASAAM-G---YLAPEYT 580
++H ++ A+ VL+ + L D G L D + L + G ++APE
Sbjct: 170 -RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 581 TTGRFTEKSDIYAFGMIVFQILSGK 605
K DI++ ++ +L+G
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-09
Identities = 32/113 (28%), Positives = 48/113 (42%), Gaps = 8/113 (7%)
Query: 111 SLSELSDLYL-NVNNLSGKIPSQIGNMTNLQVLQLCYNKLT--GNIPTQLGSLRKLSVLA 167
+ + + +L L N + GKI NL+ L L L N+P L KL L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKLE 77
Query: 168 LQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVK-LANVPKLEVLDIRNN 219
L N++ G + L L L+LS N L ++ L + L+ LD+ N
Sbjct: 78 LSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 5e-07
Identities = 26/97 (26%), Positives = 37/97 (38%), Gaps = 3/97 (3%)
Query: 79 GEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTN 138
G+I +L L L L V + L +L L L+ N + G + + N
Sbjct: 39 GKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPN 96
Query: 139 LQVLQLCYNKLTG-NIPTQLGSLRKLSVLALQYNQLT 174
L L L NKL + L L L L L ++T
Sbjct: 97 LTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 6e-06
Identities = 25/98 (25%), Positives = 40/98 (40%), Gaps = 7/98 (7%)
Query: 125 LSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDL 184
L + P+ + L VL C + G I L L+L L ++L L
Sbjct: 18 LRNRTPAAV---REL-VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLISV--SNLPKL 70
Query: 185 GMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFS 222
L +L+LS N +FG + + +P L L++ N
Sbjct: 71 PKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 62/278 (22%), Positives = 109/278 (39%), Gaps = 59/278 (21%)
Query: 410 LGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKG-LKILTSLKHENLASLRGI 467
+GK +F+ + G VA+K I KT + L ++I+ L H N+ L +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYLHGKR 525
++ +LI ++ G + +L + G EK A + I + Y H K
Sbjct: 83 IETEKT--LYLIMEYASGGEVFDYL-VAHGRMKEKE---ARSK--FRQIVSAVQYCHQK- 133
Query: 526 PGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPE---- 578
+VH +L AE +L+ N ++D G L A G Y APE
Sbjct: 134 -RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFC--GAPPYAAPELFQG 187
Query: 579 --YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNL-----EG 631
Y G + D+++ G+I++ ++SG PF + L G
Sbjct: 188 KKYD--GP---EVDVWSLGVILYTLVSGSL---PF----------DGQNLKELRERVLRG 229
Query: 632 KFSV-----SEASNLGQIALHCTHESPSHRPSIENVMQ 664
K+ + ++ NL + +P R ++E +M+
Sbjct: 230 KYRIPFYMSTDCENL--LK-RFLVLNPIKRGTLEQIMK 264
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 49/269 (18%), Positives = 92/269 (34%), Gaps = 52/269 (19%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGIC 468
LG + + A+K + E E + ++ + +
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA-----SQCPHIVRIVDVY 80
Query: 469 --CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
GR ++ + + G L + + G + E ++K I + I YLH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREAS-EIMKSIGEAIQYLHSI-- 136
Query: 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFT 586
+ H ++ E N L + + ++LK G A E TT ++
Sbjct: 137 NIAHRDVKPE--------NLLYTSK------RPN---AILKL-TDFG-FAKE-TTGEKYD 176
Query: 587 EKSDIYAFGMIVFQILSGKCSITPF--TRQAAESSKVEDFIDPNLEGKF--------SVS 636
+ D+++ G+I++ +L G PF A S ++ I G++ VS
Sbjct: 177 KSCDMWSLGVIMYILLCGY---PPFYSNHGLAISPGMKTRI---RMGQYEFPNPEWSEVS 230
Query: 637 -EASNLGQIALHCTHESPSHRPSIENVMQ 664
E L I + P+ R +I M
Sbjct: 231 EEVKML--IR-NLLKTEPTQRMTITEFMN 256
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 4e-09
Identities = 51/219 (23%), Positives = 99/219 (45%), Gaps = 25/219 (11%)
Query: 402 QCFSEANLLGKSSFS----ATYKGILRDGSVVAVKCIAKTS-CKSDEGEFLKGLK-ILTS 455
+ F +LG+ SFS A A+K + K K ++ ++ + +++
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 456 LKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIA 515
L H L + + + NG LL+++ E TR + I
Sbjct: 87 LDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAE-IV 140
Query: 516 KGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG-- 573
+ YLHGK G++H +L E +L++ + ++D G K+L+ + + +A++ +G
Sbjct: 141 SALEYLHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA--RANSFVGTA 196
Query: 574 -YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
Y++PE T + SD++A G I++Q+++G PF
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGL---PPF 232
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 50/208 (24%), Positives = 86/208 (41%), Gaps = 36/208 (17%)
Query: 401 TQCFSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHE 459
+ F LG+ S+ + YK I G +VA+K + +SD E +K + I+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVESDLQEIIKEISIMQQCDSP 84
Query: 460 NLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVI-KGIAKGI 518
++ G K + +++ ++ G++ D+ K L I+ I + KG+
Sbjct: 85 HVVKYYG-SYFKN-TDLWIVMEYCGAGSVS---DIIRLRNKTLT-EDEIATILQSTLKGL 138
Query: 519 SYLHGKRPGLVHPNLSAEKVLIHR---RYNPLLSDSGLHKLLAD-----DIVFSMLKASA 570
YLH R IHR N LL+ G K LAD + +M K +
Sbjct: 139 EYLHFMR-------------KIHRDIKAGNILLNTEGHAK-LADFGVAGQLTDTMAKRNT 184
Query: 571 AMG---YLAPEYTTTGRFTEKSDIYAFG 595
+G ++APE + +DI++ G
Sbjct: 185 VIGTPFWMAPEVIQEIGYNCVADIWSLG 212
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 51/281 (18%), Positives = 104/281 (37%), Gaps = 38/281 (13%)
Query: 381 GFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC 439
F + + ++ E+ + LG + +K + G V+A K I
Sbjct: 19 AFLTQKQKVGELKDDDFEKI-------SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK 71
Query: 440 KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNL---LQHLDLEA 496
+ + ++ L++L + G F +G + ++H+D
Sbjct: 72 PAIRNQIIRELQVLHECNSPYIVGFYGA--------------FYSDGEISICMEHMD--G 115
Query: 497 GS-EKVLEWATRIS------VIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLS 549
GS ++VL+ A RI V + KG++YL K ++H ++ +L++ R L
Sbjct: 116 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLC 174
Query: 550 DSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSIT 609
D G+ L D + S + + Y++PE ++ +SDI++ G+ + ++ G+ I
Sbjct: 175 DFGVSGQLIDSMANSFVGTRS---YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 231
Query: 610 PFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTH 650
P + E E +
Sbjct: 232 PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSR 272
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 35/207 (16%), Positives = 67/207 (32%), Gaps = 40/207 (19%)
Query: 411 GKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKG-LKILTSLKHENLASLRGIC 468
G G V V+ I +C ++ FL+G L + H N+ +
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI--VPYRA 93
Query: 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGL 528
E +++ F+ G+ L + + +++G+ K + Y+H
Sbjct: 94 TFIADNELWVVTSFMAYGSAK-DL-ICTHFMDGMNELAIAYILQGVLKALDYIHHMG--- 148
Query: 529 VHPNLSAEKVLIHRRY---NPLLSDSGLHKLLAD-----DIVFSMLKASAAMGY------ 574
+HR + L+S G L+ ++ + +
Sbjct: 149 ----------YVHRSVKASHILISVDGKVY-LSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 575 ----LAPEYTTTGR--FTEKSDIYAFG 595
L+PE + KSDIY+ G
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVG 224
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 64/339 (18%), Positives = 116/339 (34%), Gaps = 86/339 (25%)
Query: 410 LGKSSF----SATYKGILRDGSV--VAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLA 462
LG+ +F A GI + + VAVK + + + S+ + LKIL + H N+
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 463 SLRGICCSKGRGECFLIYDFVPNGNLLQHL--------DLEAGSEKVLEWATRISVIKGI 514
+L G C+K G +I +F GNL +L + + + + I
Sbjct: 90 NLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148
Query: 515 AKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGY 574
K EK L D L + ++ + + M +
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208
Query: 575 LA------------------------------------PEYTTTG--------------- 583
LA P+Y G
Sbjct: 209 LASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 268
Query: 584 --RFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEG------KFS 634
+T +SD+++FG+++++I S G +P+ E+F EG ++
Sbjct: 269 DRVYTIQSDVWSFGVLLWEIFSLGA---SPY----PGVKIDEEFCRRLKEGTRMRAPDYT 321
Query: 635 VSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
E + Q L C H PS RP+ +++ L +++ ++
Sbjct: 322 TPE---MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 22/115 (19%), Positives = 39/115 (33%), Gaps = 8/115 (6%)
Query: 108 EIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLT--GNIPTQLGSLRKLSV 165
+ + +L L I + + + N++ P LR+L
Sbjct: 14 QYTNAVRDRELDLR-GYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRLKT 68
Query: 166 LALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVK-LANVPKLEVLDIRNN 219
L + N++ L L L L+ N+L + LA++ L L I N
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-07
Identities = 19/95 (20%), Positives = 33/95 (34%), Gaps = 9/95 (9%)
Query: 131 SQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRL 190
+Q N + L L K+ I +L + + N++ L +L RL
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-----KLDGFPLLRRL 66
Query: 191 ---DLSFNNLFGPVPVKLANVPKLEVLDIRNNSFS 222
++ N + +P L L + NNS
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 20/89 (22%), Positives = 33/89 (37%), Gaps = 5/89 (5%)
Query: 88 LKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYN 147
L + N + + L L L +N N + + +L L L N
Sbjct: 41 LDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN 98
Query: 148 KLT--GNIPTQLGSLRKLSVLALQYNQLT 174
L G++ L SL+ L+ L + N +T
Sbjct: 99 SLVELGDL-DPLASLKSLTYLCILRNPVT 126
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 30/108 (27%), Positives = 45/108 (41%), Gaps = 14/108 (12%)
Query: 73 QGKGLS---GEIPAAVGGLKSLTGLYLHFNALNGVIPKEI-ASLSELSDLYLNVNNLSGK 128
G+GL +IP T L L+ N L + + L L L L N L+
Sbjct: 16 TGRGLKEIPRDIPL------HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-G 68
Query: 129 IPSQI-GNMTNLQVLQLCYNKLTGNIPTQL-GSLRKLSVLALQYNQLT 174
I +++Q LQL NK+ I ++ L +L L L NQ++
Sbjct: 69 IEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS 115
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 25/83 (30%), Positives = 36/83 (43%), Gaps = 5/83 (6%)
Query: 118 LYLNVNNLSGKIPSQ--IGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTG 175
L LN N L +I S G + +L L+L N+LTG P + L L N++
Sbjct: 34 LLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91
Query: 176 AIPASLGD-LGMLMRLDLSFNNL 197
I + L L L+L N +
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQI 114
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 26/108 (24%), Positives = 43/108 (39%), Gaps = 9/108 (8%)
Query: 69 NISLQGKGLSGEIPAAV-GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSG 127
+ L L + G L L L L N L G+ P S + +L L N +
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91
Query: 128 KIPSQI-GNMTNLQVLQLCYNKLTGNIPTQLG---SLRKLSVLALQYN 171
+I +++ + L+ L L N+++ + G L L+ L L N
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQIS-CVMP--GSFEHLNSLTSLNLASN 136
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 44/210 (20%), Positives = 89/210 (42%), Gaps = 39/210 (18%)
Query: 404 FSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLA 462
+ LG +F YK G++ A K I S + + +++ ++IL + H +
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIV 79
Query: 463 SLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVI-KGIAKGISYL 521
L G G+ +++ +F P G + + ++ L +I V+ + + + +++L
Sbjct: 80 KLLG-AYYHD-GKLWIMIEFCPGGAVD---AIMLELDRGLT-EPQIQVVCRQMLEALNFL 133
Query: 522 HGKRPGLVHPNLSAEKVLIHR---RYNPLLSDSGLHKLLAD-----DIVFSMLKASAAMG 573
H KR +IHR N L++ G + LAD + ++ K + +G
Sbjct: 134 HSKR-------------IIHRDLKAGNVLMTLEGDIR-LADFGVSAKNLKTLQKRDSFIG 179
Query: 574 ---YLAPE-----YTTTGRFTEKSDIYAFG 595
++APE + K+DI++ G
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLG 209
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-08
Identities = 40/132 (30%), Positives = 60/132 (45%), Gaps = 20/132 (15%)
Query: 73 QGKGLS---GEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
KGL+ IP+ S T L L N L + L++L+ L L+ N + +
Sbjct: 15 NSKGLTSVPTGIPS------SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SL 67
Query: 130 PSQI-GNMTNLQVLQLCYNKLTGNIPTQLG---SLRKLSVLALQYNQLTGAIPASLGD-L 184
P + +T L +L L NKL ++P G L +L LAL NQL ++P + D L
Sbjct: 68 PDGVFDKLTKLTILYLHENKLQ-SLPN--GVFDKLTQLKELALDTNQLK-SVPDGIFDRL 123
Query: 185 GMLMRLDLSFNN 196
L ++ L N
Sbjct: 124 TSLQKIWL-HTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 26/100 (26%), Positives = 43/100 (43%), Gaps = 20/100 (20%)
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGD-LGML 187
+P+ I ++ L+L NKL L +L+ L+L NQ+ ++P + D L L
Sbjct: 22 VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKL 78
Query: 188 MRLDLSFNNLFGPVPVKLANVP--------KLEVLDIRNN 219
L L N KL ++P +L+ L + N
Sbjct: 79 TILYLHEN--------KLQSLPNGVFDKLTQLKELALDTN 110
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 59/250 (23%), Positives = 101/250 (40%), Gaps = 45/250 (18%)
Query: 363 SLEYSNGWDPLAKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKGI 422
+L + DP+ G + F + + FS+ +G SF A Y
Sbjct: 19 NLYFQGAMDPMPAGGRAGSLKDPDVAELFFK----DDPEKLFSDLREIGHGSFGAVYFAR 74
Query: 423 -LRDGSVVAVKCI--AKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479
+R+ VVA+K + + + +K ++ L L+H N RG C + +L+
Sbjct: 75 DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG-CYLRE-HTAWLV 132
Query: 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVI-KGIAKGISYLHGKRPGLVHPNLSAEKV 538
++ DL +K L+ I+ + G +G++YLH
Sbjct: 133 MEYCLGSAS----DLLEVHKKPLQ-EVEIAAVTHGALQGLAYLHSHN------------- 174
Query: 539 LIHR---RYNPLLSDSGLHKLLADDIVF----SMLKASAAMG---YLAPE---YTTTGRF 585
+IHR N LLS+ GL K L D F M A++ +G ++APE G++
Sbjct: 175 MIHRDVKAGNILLSEPGLVK-LGD---FGSASIMAPANSFVGTPYWMAPEVILAMDEGQY 230
Query: 586 TEKSDIYAFG 595
K D+++ G
Sbjct: 231 DGKVDVWSLG 240
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 48/295 (16%), Positives = 120/295 (40%), Gaps = 33/295 (11%)
Query: 327 YRRRKQKIGNAFDNSDSRLSTDQVKEVCRRNSSPLISLEYSNGWDPLAKGQSGNGFSQEV 386
+ R +K+ N + S +++D + + L +L Y + L K ++ + F
Sbjct: 2 FETRFEKMDNLLRDPKSEVNSDCLLDG-------LDALVYDLDFPALRKNKNIDNFLSRY 54
Query: 387 LESFMFNLEEVERATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC-KSDEG 444
+ + + ++ + + ++G+ +F + V A+K ++K K +
Sbjct: 55 -KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDS 113
Query: 445 EFLKGLK-ILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLE 503
F + I+ + L + +++ +++P G+L+ + + V E
Sbjct: 114 AFFWEERDIMAFANSPWVVQLF--YAFQDDRYLYMVMEYMPGGDLVNLMS----NYDVPE 167
Query: 504 WATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF 563
R + + +H G +H ++ + +L+ + + L+D G + +
Sbjct: 168 KWARF-YTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE--- 221
Query: 564 SMLKASAAMG---YLAPE----YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
M++ A+G Y++PE G + + D ++ G+ ++++L G TPF
Sbjct: 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD---TPF 273
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 5e-07
Identities = 21/100 (21%), Positives = 37/100 (37%), Gaps = 2/100 (2%)
Query: 123 NNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQ-LGSLRKLSVLALQYNQLTGAIPASL 181
+ + + NL L + + ++ + L L +L L + + L P +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 182 GDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSF 221
L RL+LSFN L + K L+ L + N
Sbjct: 77 HFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 7e-07
Identities = 19/103 (18%), Positives = 33/103 (32%), Gaps = 2/103 (1%)
Query: 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPA-SLGDLGMLMRLDLSFNNLFGPVPV 203
C + L L+ L ++ Q + L LG L L + + L P
Sbjct: 15 CTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74
Query: 204 KLANVPKLEVLDIRNNSFSGNVPPALKRLN-GGFQYDNNAALC 245
P+L L++ N+ ++ L+ N C
Sbjct: 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 24/115 (20%), Positives = 40/115 (34%), Gaps = 14/115 (12%)
Query: 49 DPCSSDSFDGVACDENGRVANIS------------LQGKGLSGEIPA-AVGGLKSLTGLY 95
D C G+ C +G + ++ ++ + + + GL L L
Sbjct: 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 96 LHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLT 150
+ + L V P LS L L+ N L + + +LQ L L N L
Sbjct: 63 IVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 37/208 (17%), Positives = 80/208 (38%), Gaps = 36/208 (17%)
Query: 401 TQCFSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHE 459
+ ++ +G+ + Y + + G VA++ + + + + + ++ K+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNP 77
Query: 460 NLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVI-KGIAKGI 518
N+ + G E +++ +++ G+L + E +I+ + + + +
Sbjct: 78 NIVNYLD-SYLVG-DELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQAL 129
Query: 519 SYLHGKRPGLVHPNLSAEKVLIHR---RYNPLLSDSGLHKLLAD-----DIVFSMLKASA 570
+LH + +IHR N LL G K L D I K S
Sbjct: 130 EFLHSNQ-------------VIHRDIKSDNILLGMDGSVK-LTDFGFCAQITPEQSKRST 175
Query: 571 AMG---YLAPEYTTTGRFTEKSDIYAFG 595
+G ++APE T + K DI++ G
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLG 203
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 42/209 (20%), Positives = 84/209 (40%), Gaps = 38/209 (18%)
Query: 410 LGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGIC 468
+G + + VA+K I C++ E LK ++ ++ H N+ +
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI--VSYYT 80
Query: 469 CSKGRGECFLIYDFVPNG---NLLQHLDLEAGSE-KVLEWATRISVIKGIAKGISYLHGK 524
+ E +L+ + G ++++H+ + + VL+ +T ++++ + +G+ YLH
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140
Query: 525 RPGLVHPNLSAEKVLIHR---RYNPLLSDSGLHKLLADDIVFSMLKASAAMGYL------ 575
IHR N LL + G + +AD V + L +
Sbjct: 141 G-------------QIHRDVKAGNILLGEDGSVQ-IADFGVSAFLATGGDITRNKVRKTF 186
Query: 576 -------APEYTTTGR-FTEKSDIYAFGM 596
APE R + K+DI++FG+
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGI 215
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.3 bits (119), Expect = 1e-06
Identities = 23/151 (15%), Positives = 48/151 (31%), Gaps = 22/151 (14%)
Query: 68 ANISLQGKGLSGEIPAAVGGLKS--LTGLYLHFNALNGVIPKEIAS-----LSELSDLYL 120
A L + G ++G L L + L + ++I L +L LY+
Sbjct: 170 AMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKL-VLYV 228
Query: 121 NVNNLSGKIPSQI-------GNMTNLQVLQLCYNKLTGNIPTQLGS---LRKLSVLALQY 170
V + + NL+ L + + + L +L + +
Sbjct: 229 GVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISA 288
Query: 171 NQLTG----AIPASLGDLGMLMRLDLSFNNL 197
LT + + + L +++ +N L
Sbjct: 289 GVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.5 bits (109), Expect = 2e-05
Identities = 21/169 (12%), Positives = 48/169 (28%), Gaps = 21/169 (12%)
Query: 79 GEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIG--NM 136
++ + + L L + + L L + L + I ++
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGK---KPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 137 TNLQVLQLCY---NKLTGNIPTQL------GSLRKLSVLALQYNQLTGAIPASLGD---L 184
NL+ L L + L L + + + + L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 185 GMLMRLDLSFNNL----FGPVPVKLANVPKLEVLDIRNNSFSGNVPPAL 229
L +D+S L + + + L+ ++++ N S + L
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKEL 327
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 49/310 (15%), Positives = 107/310 (34%), Gaps = 24/310 (7%)
Query: 328 RRRKQKIGNAFDNSDSRLSTDQVKEV----CRRNSSPLISLEYSNGWDPLAKGQSGNGFS 383
++ Q + A+ ++L + R + + F
Sbjct: 104 PQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFL 163
Query: 384 QEVLESFMFNLEEVERAT---QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC 439
+ + +E F + +LG+ F + ++ G + A K + K
Sbjct: 164 DSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL 223
Query: 440 KSDEGEF--LKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAG 497
K +G + KIL + + SL + + + L+ + G++ H+
Sbjct: 224 KKRKGYQGAMVEKKILAKVHSRFIVSLA--YAFETKTDLCLVMTIMNGGDIRYHIYNVDE 281
Query: 498 SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557
+ I I G+ +LH + +++ +L E VL+ N +SD GL
Sbjct: 282 DNPGFQEPRAIFYTAQIVSGLEHLHQR--NIIYRDLKPENVLLDDDGNVRISDLGLAV-- 337
Query: 558 ADDIVFSMLKASAAMG---YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQ 614
++ K G ++APE + D +A G+ ++++++ + PF +
Sbjct: 338 --ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR---GPFRAR 392
Query: 615 AAESSKVEDF 624
+ E
Sbjct: 393 GEKVENKELK 402
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 48/220 (21%), Positives = 81/220 (36%), Gaps = 42/220 (19%)
Query: 409 LLGKSSFS----ATYKGILRDGSVVAVKCIAKTSCKS-DEGEFLKGLK-ILTSLKHENLA 462
LLGK +F K G A+K + K + DE +L + +H L
Sbjct: 155 LLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 463 SLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLH 522
+L+ + + ++ G L HL E E R + I + YLH
Sbjct: 212 ALK--YSFQTHDRLCFVMEYANGGELFFHLSRE---RVFSEDRARFYGAE-IVSALDYLH 265
Query: 523 GKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG--------- 573
++ +V+ +L E N +L G H + D F + K G
Sbjct: 266 SEK-NVVYRDLKLE--------NLMLDKDG-HIKITD---FGLCKEGIKDGATMKTFCGT 312
Query: 574 --YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
YLAPE + D + G+++++++ G+ PF
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL---PF 349
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 2e-06
Identities = 33/195 (16%), Positives = 55/195 (28%), Gaps = 41/195 (21%)
Query: 400 ATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEF------------- 446
T+ +G+ F ++ I VA+K IA G
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 447 ---LKGLKILTSLKHENLASLRGICCSKG----------------RGECFLIYDFVPNGN 487
L L + E L + C +G +G DF +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 488 L-------LQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI 540
L +DLE K+ AT S++ + ++ H +L VL+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE-ASLRFEHRDLHWGNVLL 195
Query: 541 HRRYNPLLSDSGLHK 555
+ L + K
Sbjct: 196 KKTSLKKLHYTLNGK 210
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 43/212 (20%), Positives = 78/212 (36%), Gaps = 37/212 (17%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
LG+ ++ + VAVK + K + I L HEN+ G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATR------ISVIKGIAKGISYL 521
+L ++ G L + + E + ++ G+ YL
Sbjct: 74 RREG--NIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMA-------GVVYL 121
Query: 522 HGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPE 578
HG G+ H ++ E +L+ R N +SD GL + + +L G Y+APE
Sbjct: 122 HGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPE 177
Query: 579 ------YTTTGRFTEKSDIYAFGMIVFQILSG 604
+ E D+++ G+++ +L+G
Sbjct: 178 LLKRREF--HA---EPVDVWSCGIVLTAMLAG 204
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 38/208 (18%), Positives = 78/208 (37%), Gaps = 36/208 (17%)
Query: 401 TQCFSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHE 459
+G+ S G VAVK + + + I+ +H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM-DLRKQQRRELLFNEVVIMRDYQHF 102
Query: 460 NLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVI-KGIAKGI 518
N+ + G E +++ +F+ G L + +E+ +I+ + + + + +
Sbjct: 103 NVVEMYK-SYLVG-EELWVLMEFLQGGALTDIVSQVRLNEE------QIATVCEAVLQAL 154
Query: 519 SYLHGKRPGLVHPNLSAEKVLIHR---RYNPLLSDSGLHKLLAD-----DIVFSMLKASA 570
+YLH + +IHR + LL+ G K L+D I + K +
Sbjct: 155 AYLHAQG-------------VIHRDIKSDSILLTLDGRVK-LSDFGFCAQISKDVPKRKS 200
Query: 571 AMG---YLAPEYTTTGRFTEKSDIYAFG 595
+G ++APE + + + DI++ G
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLG 228
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 52/217 (23%), Positives = 90/217 (41%), Gaps = 37/217 (17%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLK----ILTSLKHENLAS 463
LG +F G G VAVK + + K + + +K L +H ++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQ--KIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHG 523
L + + + F++ ++V G L ++ +V E R + + I + Y H
Sbjct: 76 LYQVISTPT--DFFMVMEYVSGGELFDYI---CKHGRVEEMEAR-RLFQQILSAVDYCHR 129
Query: 524 KRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPE-- 578
+VH +L E VL+ N ++D GL +++D L+ S G Y APE
Sbjct: 130 H--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSC--GSPNYAAPEVI 182
Query: 579 ----YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
Y G + DI++ G+I++ +L G PF
Sbjct: 183 SGRLY--AGP---EVDIWSCGVILYALLCGT---LPF 211
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 55/288 (19%), Positives = 97/288 (33%), Gaps = 76/288 (26%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGL-------KILTSLKHE- 459
LLG F + Y GI + D VA+K + K + + L +L +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKD--RISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 460 -NLASLRGICCSK-----------GRGECFLIYDF-VPNGNLLQHLDLEAGSEKVLEWAT 506
+ L + F DF G L E++ A
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPVQDLF---DFITERGAL---------QEEL---AR 152
Query: 507 RISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI-HRRYNPLLSDSGLHKLLADDIVFSM 565
+ + + + H G++H ++ E +LI R L D G LL D ++
Sbjct: 153 SF--FWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TV 204
Query: 566 LKASAAMG---YLAPEYTTTGRFT-EKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV 621
G Y PE+ R+ + +++ G++++ ++ G PF ++
Sbjct: 205 YTDFD--GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD---IPFEHD----EEI 255
Query: 622 EDFIDPNLEGKFSV-----SEASNLGQIALHCTHESPSHRPSIENVMQ 664
+ G+ SE +L I C PS RP+ E +
Sbjct: 256 -------IRGQVFFRQRVSSECQHL--IR-WCLALRPSDRPTFEEIQN 293
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 58/265 (21%), Positives = 107/265 (40%), Gaps = 27/265 (10%)
Query: 361 LISLEYSNGWDPLAKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYK 420
L+ + G LA+ + F Q E + L+EV F ++G+ +FS
Sbjct: 21 LLGVHQELGASELAQDKYVADFLQWA-EPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAV 79
Query: 421 GILRD-GSVVAVKCIAKTS-CKSDEGEFLKGLK-ILTSLKHENLASLRGICCSKGRGECF 477
++ G V A+K + K K E + + +L + + L + +
Sbjct: 80 VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH--FAFQDENYLY 137
Query: 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEK 537
L+ ++ G+LL L E++ R + I I +H G VH ++ +
Sbjct: 138 LVMEYYVGGDLLTLLSKFG--ERIPAEMARF-YLAEIVMAIDSVHRL--GYVHRDIKPDN 192
Query: 538 VLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPE-------YTTTGRFTE 587
+L+ R + L+D G L D +++ A+G YL+PE TG +
Sbjct: 193 ILLDRCGHIRLADFGSCLKLRAD---GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGP 249
Query: 588 KSDIYAFGMIVFQILSGKCSITPFT 612
+ D +A G+ +++ G+ TPF
Sbjct: 250 ECDWWALGVFAYEMFYGQ---TPFY 271
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 44/172 (25%), Positives = 75/172 (43%), Gaps = 37/172 (21%)
Query: 399 RATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEG-------EFLKGL 450
++ + + L+G+ S+ K +D G +VA+K ++ D+ E +
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMRE----I 75
Query: 451 KILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISV 510
K+L L+HENL +L +C K R +L+++FV + +L L+L L++
Sbjct: 76 KLLKQLRHENLVNLLEVCKKKKR--WYLVFEFVDH-TILDDLEL---FPNGLDYQVVQKY 129
Query: 511 IKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR---RYNPLLSDSGLHKLLAD 559
+ I GI + H IHR N L+S SG+ K L D
Sbjct: 130 LFQIINGIGFCHSHNI-------------IHRDIKPENILVSQSGVVK-LCD 167
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 73/392 (18%), Positives = 133/392 (33%), Gaps = 62/392 (15%)
Query: 245 CGTGFTNLKNCTASDHPTPGKPEPFEPNGLSTKDIPESAKLPANCGQPGCSSPAR----- 299
G +K D + K + + E+ +
Sbjct: 190 NGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWD 249
Query: 300 RPHTGVFVGVIAVFIILTVTGLFTFTWYRRRKQKIGNAFDNSDSRLSTDQVKEVCRRNSS 359
F+G ++ F I + W++ Q+ G F+ ++ +E+ ++
Sbjct: 250 LTSRNDFMGSLS-FGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFER 308
Query: 360 PLISLEYSNGWDPLAKGQSGNGFSQEVLESFMFNLEEVERAT-QCFSEANLLGKSSFS-- 416
I +G S N +R F+ +LGK SF
Sbjct: 309 AKIG-----------QGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKV 357
Query: 417 --ATYKGILRDGSVVAVKCIAKTSCKS-DEGEFLKGLK-IL-TSLKHENLASLRGICCSK 471
+ KG + AVK + K D+ E K +L K L L C +
Sbjct: 358 MLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH--SCFQ 412
Query: 472 GRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHP 531
+ + ++V G+L+ H+ + E IA G+ +L K G+++
Sbjct: 413 TMDRLYFVMEYVNGGDLMYHIQQV---GRFKEPHAVF-YAAEIAIGLFFLQSK--GIIYR 466
Query: 532 NLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG-----------YLAPEYT 580
+L + N +L G H +AD F M K + G Y+APE
Sbjct: 467 DLKLD--------NVMLDSEG-HIKIAD---FGMCKENIWDGVTTKTFCGTPDYIAPEII 514
Query: 581 TTGRFTEKSDIYAFGMIVFQILSGKCSITPFT 612
+ + D +AFG++++++L+G+ PF
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQA---PFE 543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 35/201 (17%), Positives = 65/201 (32%), Gaps = 42/201 (20%)
Query: 63 ENGRVANISLQGKGLSGE----IPAAVGGLKSLTGLYLHFNALNGV---IPKEIASLSE- 114
E+ V I L G + E + + K L V IP+ + L +
Sbjct: 30 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQA 89
Query: 115 ------LSDLYLNVNNLSGKIPSQIG----NMTNLQVLQLCYNKLT-------------G 151
L + L+ N + T L+ L L N L
Sbjct: 90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 149
Query: 152 NIPTQLGSLRKLSVLALQYNQLTG----AIPASLGDLGMLMRLDLSFNNLFGPVPVK--- 204
+ + + L + N+L + +L + + N + P ++
Sbjct: 150 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGI-RPEGIEHLL 208
Query: 205 ---LANVPKLEVLDIRNNSFS 222
LA +L+VLD+++N+F+
Sbjct: 209 LEGLAYCQELKVLDLQDNTFT 229
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 32/160 (20%), Positives = 50/160 (31%), Gaps = 24/160 (15%)
Query: 87 GLKSLTGLYLHFNAL--NGV--IPKEIASLSELSDLYLNVNNLSGK-----IPSQIGNMT 137
L + N L + K S L + + N + + + +
Sbjct: 157 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ 216
Query: 138 NLQVLQLCYNKLTGN----IPTQLGSLRKLSVLALQYNQLTG----AIPASLGDLGM--L 187
L+VL L N T + L S L L L L+ A+ + L L
Sbjct: 217 ELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGL 276
Query: 188 MRLDLSFNNLFGPVPVKLA-----NVPKLEVLDIRNNSFS 222
L L +N + L +P L L++ N FS
Sbjct: 277 QTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 56/289 (19%), Positives = 97/289 (33%), Gaps = 76/289 (26%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASL-RG 466
LLGK F + G L D VA+K I + ++L + +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRN-------------RVLGWSPLSDSVTCPLE 84
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEK---VLEWATR-------ISVIKG--- 513
+ + + +++ LD E VLE I KG
Sbjct: 85 VALLW------KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-TEKGPLG 137
Query: 514 ----------IAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPL-LSDSGLHKLLADDIV 562
+ I + H + G+VH ++ E +LI R L D G LL D
Sbjct: 138 EGPSRCFFGQVVAAIQHCHSR--GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--- 192
Query: 563 FSMLKASA-AMGYLAPEYTTTGRFT-EKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK 620
Y PE+ + ++ + +++ G++++ ++ G PF R +
Sbjct: 193 -EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD---IPFERD----QE 244
Query: 621 VEDFIDPNLEGKFSV-----SEASNLGQIALHCTHESPSHRPSIENVMQ 664
+ LE + + L I C PS RPS+E ++
Sbjct: 245 I-------LEAELHFPAHVSPDCCAL--IR-RCLAPKPSSRPSLEEILL 283
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 43/212 (20%), Positives = 78/212 (36%), Gaps = 37/212 (17%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
LG+ ++ + VAVK + K + I L HEN+ G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATR------ISVIKGIAKGISYL 521
+L ++ G L + + E + ++ G+ YL
Sbjct: 74 RREGN--IQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMA-------GVVYL 121
Query: 522 HGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPE 578
HG G+ H ++ E +L+ R N +SD GL + + +L G Y+APE
Sbjct: 122 HGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLPYVAPE 177
Query: 579 ------YTTTGRFTEKSDIYAFGMIVFQILSG 604
+ E D+++ G+++ +L+G
Sbjct: 178 LLKRREF--HA---EPVDVWSCGIVLTAMLAG 204
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 51/263 (19%), Positives = 111/263 (42%), Gaps = 25/263 (9%)
Query: 361 LISLEYSNGWDPLAKGQSGNGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYK 420
LI L PL + ++ + + + F ++++ + F ++G+ +F
Sbjct: 34 LICLYDECNNSPLRREKNILEYLEWA-KPFTSKVKQMRLHREDFEILKVIGRGAFGEVAV 92
Query: 421 GILRD-GSVVAVKCIAKTSC-KSDEGEFLKGLK-ILTSLKHENLASLRGICCSKGRGECF 477
L++ V A+K + K K E + + +L + + + +L + +
Sbjct: 93 VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH--YAFQDDNNLY 150
Query: 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEK 537
L+ D+ G+LL L ++ E R + + I +H VH ++ +
Sbjct: 151 LVMDYYVGGDLLTLLSKFED--RLPEEMARF-YLAEMVIAIDSVHQL--HYVHRDIKPDN 205
Query: 538 VLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPE-----YTTTGRFTEKS 589
+L+ + L+D G L +D +++S A+G Y++PE GR+ +
Sbjct: 206 ILMDMNGHIRLADFGSCLKLMED---GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPEC 262
Query: 590 DIYAFGMIVFQILSGKCSITPFT 612
D ++ G+ ++++L G+ TPF
Sbjct: 263 DWWSLGVCMYEMLYGE---TPFY 282
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 48/287 (16%), Positives = 93/287 (32%), Gaps = 76/287 (26%)
Query: 410 LGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGL-------KILTSLKHENL 461
LG +F + + V VK I K D L IL+ ++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 462 ASLRGICCSKGR-----------GECFLIYDF-VPNGNLLQHLDLEAGSEKVLEWATRIS 509
+ I ++G + F F + L E + A+ I
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLF---AFIDRHPRL---------DEPL---ASYI- 135
Query: 510 VIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKAS 569
+ + + YL K ++H ++ E ++I + L D G L +
Sbjct: 136 -FRQLVSAVGYLRLK--DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG---KLFYTF 189
Query: 570 AA-MGYLAPE------YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE 622
+ Y APE Y G + ++++ G+ ++ ++ + PF
Sbjct: 190 CGTIEYCAPEVLMGNPY--RGP---ELEMWSLGVTLYTLVFEE---NPF----------- 230
Query: 623 DFIDPNLEGKFSV-----SEASNLGQIALHCTHESPSHRPSIENVMQ 664
++ +E E +L L P R ++E ++
Sbjct: 231 CELEETVEAAIHPPYLVSKELMSLVSGLL---QPVPERRTTLEKLVT 274
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 61/338 (18%), Positives = 119/338 (35%), Gaps = 39/338 (11%)
Query: 328 RRRKQKIGNAFDNSDSR-----LSTDQVKEVCRR----NSSPLISLEYSNGWDPLAKGQS 378
++I + + + S ++ V P + Y +G
Sbjct: 102 LVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDV 161
Query: 379 GNGFSQEVLESFMFNLEEVERATQC----FSEANLLGKSSFSATYKGILRD-GSVVAVKC 433
F + + + VE FS ++G+ F Y D G + A+KC
Sbjct: 162 FQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC 221
Query: 434 IAKTSCKSDEGEFL-----KGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNL 488
+ K K +GE L L ++++ + + + I D + G+L
Sbjct: 222 LDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS--YAFHTPDKLSFILDLMNGGDL 279
Query: 489 LQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLL 548
HL E R I G+ ++H + +V+ +L +L+ + +
Sbjct: 280 HYHLSQH---GVFSEADMRF-YAAEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRI 333
Query: 549 SDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCS 607
SD GL + + + GY+APE G + +D ++ G ++F++L G
Sbjct: 334 SDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH-- 388
Query: 608 ITPFT-RQAAESSKVEDFI---DPNLEGKFSVSEASNL 641
+PF + + +++ L FS E +L
Sbjct: 389 -SPFRQHKTKDKHEIDRMTLTMAVELPDSFS-PELRSL 424
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 40/225 (17%), Positives = 86/225 (38%), Gaps = 45/225 (20%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLK---GLKILTSLKHENLASL 464
LLG+ S+ + + AVK + K + +++L L+H+N+ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 465 RGICCSKGRGECFLIYDFVPNGN--LLQHLDLEAGSEKVLEWATR------ISVIKGIAK 516
+ ++ + + +++ ++ G +L + ++ I
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP----EKRFPVCQAHGYFCQLID------- 120
Query: 517 GISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG--- 573
G+ YLH + G+VH ++ +L+ +S G+ + L + S G
Sbjct: 121 GLEYLHSQ--GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPA 176
Query: 574 YLAPE-------YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
+ PE + +G K DI++ G+ ++ I +G PF
Sbjct: 177 FQPPEIANGLDTF--SGF---KVDIWSAGVTLYNITTGL---YPF 213
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 60/307 (19%), Positives = 112/307 (36%), Gaps = 72/307 (23%)
Query: 389 SFMFNLEEVERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFL 447
S +++E LG+ ++ K G ++AVK I T ++ L
Sbjct: 1 SMEVKADDLE-------PIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLL 53
Query: 448 KGLKI-LTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNL---LQHLD--LEAGSEKV 501
L I + ++ + G G++ ++ +D L+ ++V
Sbjct: 54 MDLDISMRTVDCPFTVTFYGA--------------LFREGDVWICMELMDTSLDKFYKQV 99
Query: 502 LEWATRIS--VIKGIA----KGISYLHGKRPGLVHPNLSAEKVLIHR---RYNPLLSDSG 552
++ I ++ IA K + +LH K V IHR N L++ G
Sbjct: 100 IDKGQTIPEDILGKIAVSIVKALEHLHSKL-----------SV-IHRDVKPSNVLINALG 147
Query: 553 LHKLLADDIVFSMLKASAAMG-------YLAPE----YTTTGRFTEKSDIYAFGMIVFQI 601
K + D + L A Y+APE ++ KSDI++ G+ + ++
Sbjct: 148 QVK-MCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206
Query: 602 LSGK---CSITPFTRQAAESSKVEDFIDPNL-EGKFSVSEASNLGQIALHCTHESPSHRP 657
+ S +Q +V + P L KFS +E + + C ++ RP
Sbjct: 207 AILRFPYDSWGTPFQQ---LKQVVEEPSPQLPADKFS-AEFVDF--TSQ-CLKKNSKERP 259
Query: 658 SIENVMQ 664
+ +MQ
Sbjct: 260 TYPELMQ 266
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 27/70 (38%), Positives = 37/70 (52%), Gaps = 4/70 (5%)
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGD-LGML 187
+P+ I T QVL L N++T P L +L+ L L NQLT +PA + D L L
Sbjct: 24 VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQL 80
Query: 188 MRLDLSFNNL 197
+L L+ N L
Sbjct: 81 TQLSLNDNQL 90
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 55/303 (18%), Positives = 106/303 (34%), Gaps = 33/303 (10%)
Query: 328 RRRKQKIGNAFDNSDSRLSTDQVKEVCRRNSSPLISLEYSNGWDPLAKGQSGNGFSQEVL 387
+ + + F + +V N + + + S
Sbjct: 99 KACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPF 158
Query: 388 ESFM----------FNLEEVERAT-QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIA 435
++ + E + T F + +LGK F +R G + A K +
Sbjct: 159 ADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE 218
Query: 436 KTSCKSDEGEF--LKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLD 493
K K +GE L +IL + + SL + + L+ + G+L H+
Sbjct: 219 KKRIKKRKGEAMALNEKQILEKVNSRFVVSLA--YAYETKDALCLVLTLMNGGDLKFHIY 276
Query: 494 LEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL 553
G E I G+ LH + +V+ +L E +L+ + +SD GL
Sbjct: 277 -HMGQAGFPEARAVF-YAAEICCGLEDLHRE--RIVYRDLKPENILLDDHGHIRISDLGL 332
Query: 554 HKLLADDIVFSMLKASAAM----GYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSIT 609
+ + + GY+APE R+T D +A G +++++++G+ +
Sbjct: 333 AVHVPEG------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ---S 383
Query: 610 PFT 612
PF
Sbjct: 384 PFQ 386
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 2e-05
Identities = 34/157 (21%), Positives = 66/157 (42%), Gaps = 29/157 (18%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGE---FLKGLKILTSLKHENLASLR 465
+G+ S+ +K RD G +VA+K ++ + D L+ +++L LKH NL +L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLES--EDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 466 GICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
+ K R L++++ + +L LD ++ + S+ + +++ H
Sbjct: 69 EVFRRKRR--LHLVFEYCDH-TVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 526 PGLVHPNLSAEKVLIHRRYNP---LLSDSGLHKLLAD 559
IHR P L++ + K L D
Sbjct: 123 -------------CIHRDVKPENILITKHSVIK-LCD 145
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 47/230 (20%), Positives = 94/230 (40%), Gaps = 48/230 (20%)
Query: 392 FNLEEVERATQCFSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGL 450
+L + F L+G ++ YKG ++ G + A+K + T +E E + +
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEI 71
Query: 451 KILTSL-KHENLASLRG----ICCSKGRGECFLIYDFVPNG---NLLQHLDLEAGSEKVL 502
+L H N+A+ G + +L+ +F G +L+++ E+
Sbjct: 72 NMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW- 130
Query: 503 EWATRISVI-KGIAKGISYLHGKRPGLVHPNLSAEKVLIHR---RYNPLLSDSGLHKLLA 558
I+ I + I +G+S+LH + +IHR N LL+++ K L
Sbjct: 131 -----IAYICREILRGLSHLHQHK-------------VIHRDIKGQNVLLTENAEVK-LV 171
Query: 559 D-----DIVFSMLKASAAMG---YLAPE-----YTTTGRFTEKSDIYAFG 595
D + ++ + + +G ++APE + KSD+++ G
Sbjct: 172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 221
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 37/217 (17%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLK----ILTSLKHENLAS 463
LG +F G G VAVK + + K + + ++ L +H ++
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQ--KIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHG 523
L + + + F++ ++V G L ++ + ++ E +R + + I G+ Y H
Sbjct: 81 LYQVISTPS--DIFMVMEYVSGGELFDYI---CKNGRLDEKESR-RLFQQILSGVDYCHR 134
Query: 524 KRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPE-- 578
+VH +L E VL+ N ++D GL +++D L+ S G Y APE
Sbjct: 135 H--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSC--GSPNYAAPEVI 187
Query: 579 ----YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
Y G + DI++ G+I++ +L G PF
Sbjct: 188 SGRLY--AGP---EVDIWSSGVILYALLCGT---LPF 216
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 3e-05
Identities = 26/70 (37%), Positives = 36/70 (51%), Gaps = 4/70 (5%)
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGD-LGML 187
+P+ I T+ Q L L N++T P L L L N+LT AIP + D L L
Sbjct: 27 VPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQL 83
Query: 188 MRLDLSFNNL 197
+LDL+ N+L
Sbjct: 84 TQLDLNDNHL 93
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 47/221 (21%), Positives = 81/221 (36%), Gaps = 43/221 (19%)
Query: 409 LLGKSSFS----ATYKGILRDGSVVAVKCIAKTSCKS-DEGEFLKGLK-ILTSLKHENLA 462
LLGK +F K G A+K + K + DE +L + +H L
Sbjct: 12 LLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 463 SLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLH 522
+L+ + + ++ G L HL E E R + I + YLH
Sbjct: 69 ALK--YAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAE-IVSALEYLH 122
Query: 523 GKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG--------- 573
+ +V+ ++ E N +L G H + D F + K + G
Sbjct: 123 SR--DVVYRDIKLE--------NLMLDKDG-HIKITD---FGLCKEGISDGATMKTFCGT 168
Query: 574 --YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFT 612
YLAPE + D + G+++++++ G+ PF
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL---PFY 206
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 5e-05
Identities = 35/190 (18%), Positives = 65/190 (34%), Gaps = 29/190 (15%)
Query: 61 CDENGRVANISLQGKGLSGE----IPAAVGGLKSLTGLYLHFNALNGVIPKEIASL---- 112
+ R+ + + G++ + + + +SL L L N L + +
Sbjct: 252 LHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEP 311
Query: 113 -SELSDLYLNVNNLSGK----IPSQIGNMTNLQVLQLCYNKLTGNIPTQLG-----SLRK 162
+L L++ + + S + L LQ+ N+L +L
Sbjct: 312 GCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSV 371
Query: 163 LSVLALQYNQLT----GAIPASLGDLGMLMRLDLSFNNLFGPVPVKL------ANVPKLE 212
L VL L ++ ++ A+L L LDLS N L G + LE
Sbjct: 372 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL-GDAGILQLVESVRQPGCLLE 430
Query: 213 VLDIRNNSFS 222
L + + +S
Sbjct: 431 QLVLYDIYWS 440
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 43/235 (18%), Positives = 88/235 (37%), Gaps = 46/235 (19%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLK---------------- 451
+GK S+ D + A+K ++K G +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 452 ---------ILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVL 502
IL L H N+ L + +++++ V G +++ L+ SE
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ- 138
Query: 503 EWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV 562
A + + KGI YLH + ++H ++ +L+ + ++D G+
Sbjct: 139 --ARFY--FQDLIKGIEYLHYQ--KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS-- 190
Query: 563 FSMLKASAAMG---YLAPEYTTTGRFT---EKSDIYAFGMIVFQILSGKCSITPF 611
++L + G ++APE + R + D++A G+ ++ + G+C PF
Sbjct: 191 DALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC---PF 240
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 46/217 (21%), Positives = 90/217 (41%), Gaps = 38/217 (17%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLK----ILTSLKHENLAS 463
LG+ SF + VA+K I++ + + ++ L L+H ++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQ--LLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHG 523
L + + + ++ ++ G L ++ +++ E R + I I Y H
Sbjct: 74 LYDVITTPT--DIVMVIEYA-GGELFDYI---VEKKRMTEDEGR-RFFQQIICAIEYCHR 126
Query: 524 KRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPE-- 578
+VH +L E +L+ N ++D GL ++ D + LK S G Y APE
Sbjct: 127 H--KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---NFLKTSC--GSPNYAAPEVI 179
Query: 579 ----YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
Y G + D+++ G++++ +L G+ PF
Sbjct: 180 NGKLY--AGP---EVDVWSCGIVLYVMLVGR---LPF 208
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 41/230 (17%), Positives = 88/230 (38%), Gaps = 33/230 (14%)
Query: 388 ESFMFNLEEVERATQCFSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEF 446
+ + + ++E +G + +K + G V+AVK + ++ K +
Sbjct: 18 QRYQAEINDLE-------NLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRI 70
Query: 447 LKGLKILTSL-KHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAG--SEKVLE 503
L L ++ + G + F+ + + + G E++L
Sbjct: 71 LMDLDVVLKSHDCPYIVQCFG-TFITN-TDVFIAMELM-GTCAEKLKKRMQGPIPERILG 127
Query: 504 WATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF 563
+ I K + YL K G++H ++ +L+ R L D G+ L D
Sbjct: 128 -----KMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD---- 177
Query: 564 SMLKASAAMG---YLAPE-----YTTTGRFTEKSDIYAFGMIVFQILSGK 605
K +A G Y+APE T + ++D+++ G+ + ++ +G+
Sbjct: 178 DKAKDRSA-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 40/238 (16%), Positives = 82/238 (34%), Gaps = 62/238 (26%)
Query: 410 LGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGI 467
+G+ ++ + K + G ++AVK I T + ++ + L L ++ + G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 468 CCSKGRGECFLIYDFVPNGNL---LQHLDLEAGSEKVLEWATR----------ISVI-KG 513
G+ ++ + +K ++ + I
Sbjct: 90 --------------LFREGDCWICMELMS--TSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 514 IAKGISYLHGKRPGLVHPNLSAEKVLIHR---RYNPLLSDSGLHKLLADDIVFSMLKASA 570
K +++L K+ IHR N LL SG K L D + L S
Sbjct: 134 TVKALNHLKENL-----------KI-IHRDIKPSNILLDRSGNIK-LCDFGISGQLVDSI 180
Query: 571 AM-------GYLAPE----YTTTGRFTEKSDIYAFGMIVFQILSGK---CSITPFTRQ 614
A Y+APE + + +SD+++ G+ ++++ +G+ Q
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ 238
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 27/118 (22%), Positives = 45/118 (38%), Gaps = 18/118 (15%)
Query: 419 YKGILRD---GSVVAVKCIAKTSCKSDEGEFLKGL---KILTSLKHENLASLRGICCSKG 472
YK +D A+K I G + +L LKH N+ SL+ + S
Sbjct: 38 YKAKRKDGKDDKDYALKQI------EGTGISMSACREIALLRELKHPNVISLQKVFLSHA 91
Query: 473 RGECFLIYDFVPNGNLLQHLDLEAGSEK-----VLEWATRISVIKGIAKGISYLHGKR 525
+ +L++D+ + +L + S+ L S++ I GI YLH
Sbjct: 92 DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 148
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 42/218 (19%), Positives = 96/218 (44%), Gaps = 19/218 (8%)
Query: 409 LLGKSSFSATYKGILRD-GSVVAVKCIAKTSC-KSDEGEFLKG-LKILTSLKHENLASLR 465
+GK SF D + A+K + K C + +E + L+I+ L+H L +L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 466 GICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
+ + F++ D + G+L HL E ++ + + + + YL +
Sbjct: 82 --YSFQDEEDMFMVVDLLLGGDLRYHLQQN---VHFKEETVKLFICE-LVMALDYLQNQ- 134
Query: 526 PGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPE--YTTTG 583
++H ++ + +L+ + ++D + +L + + + + Y+APE + G
Sbjct: 135 -RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM--AGTKPYMAPEMFSSRKG 191
Query: 584 RFTEKS-DIYAFGMIVFQILSGKCSITPFTRQAAESSK 620
+ D ++ G+ +++L G+ P+ +++ SSK
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGR---RPYHIRSSTSSK 226
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 33/157 (21%), Positives = 69/157 (43%), Gaps = 21/157 (13%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
+G SF ++ L + VA+K + D+ + L+I+ +KH N+ L+
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKV-----LQDKRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 470 SKGRGECF----LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKG----IAKGISYL 521
S G + L+ ++VP + + A ++ + + +IK + + ++Y+
Sbjct: 103 SNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP----MLLIKLYMYQLLRSLAYI 157
Query: 522 HGKRPGLVHPNLSAEKVLIHRRYNPL-LSDSGLHKLL 557
H G+ H ++ + +L+ L L D G K+L
Sbjct: 158 HSI--GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 30/160 (18%), Positives = 58/160 (36%), Gaps = 30/160 (18%)
Query: 89 KSLTGLYLHFNAL--NGVIPKEIASL-----SELSDLYLNVNNLSGKIPSQIG-----NM 136
++ L L N L E+A + ++ L L+ N L K +++
Sbjct: 167 ANVNSLNLRGNNLASKNC--AELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIP 224
Query: 137 TNLQVLQLCYNKLTG----NIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLG------- 185
++ L LC N L G N+ SL+ L + L Y+ + LG
Sbjct: 225 NHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQ 284
Query: 186 MLMRLDLSFNNLFGPVPVKLANV-----PKLEVLDIRNNS 220
++ +D + + + ++N+ K +V + N
Sbjct: 285 KIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQC 324
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 32/160 (20%), Positives = 60/160 (37%), Gaps = 27/160 (16%)
Query: 89 KSLTGLYLHFNALNGVIPKEIASL-----SELSDLYLNVNNLSGKIPSQIGNM-----TN 138
+T L L N L + E+ + ++ L L+ N+L K ++ + N
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81
Query: 139 LQVLQLCYNKLTGNIPTQLGSL-----RKLSVLALQYNQLTGAIPASLGDLGM-----LM 188
+ L L N L+ +L ++VL L +N + + +
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141
Query: 189 RLDLSFNNLFGPVPVK-----LANVP-KLEVLDIRNNSFS 222
L+L N+L G LA +P + L++R N+ +
Sbjct: 142 SLNLRGNDL-GIKSSDELIQILAAIPANVNSLNLRGNNLA 180
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 2e-04
Identities = 41/179 (22%), Positives = 71/179 (39%), Gaps = 50/179 (27%)
Query: 398 ERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEG-------EFLKGL 450
+ + + + +G+ ++ YK G +VA+K I + DEG E +
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI-RLD-AEDEGIPSTAIRE----I 70
Query: 451 KILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRI-- 508
+L L H N+ SL + S+ L+++F+ DL +KVL+
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERC--LTLVFEFM-------EKDL----KKVLDENKTGLQ 117
Query: 509 -SVIKGIA----KGISYLHGKRPGLVHPNLSAEKVLIHRRYNP---LLSDSGLHKLLAD 559
S IK +G+++ H R ++HR P L++ G K LAD
Sbjct: 118 DSQIKIYLYQLLRGVAHCHQHR-------------ILHRDLKPQNLLINSDGALK-LAD 162
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 30/153 (19%), Positives = 54/153 (35%), Gaps = 20/153 (13%)
Query: 89 KSLTGLYLHFNALNGVIPKEIAS-LSELSDLYLNVNNLSGKIPSQIG-----NMTNLQVL 142
+L + L L+ + + L L +N+L + + + + L
Sbjct: 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTL 160
Query: 143 QLCYNKLTGN----IPTQLGSLRKLSVLALQYNQLT----GAIPASLGDLGMLMRLDLSF 194
+L N LT + L ++ L+L + L + A L L L++++
Sbjct: 161 RLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAY 220
Query: 195 NNLFGPVPVK-LANV----PKLEVLDIRNNSFS 222
N G LA P LE+L + N S
Sbjct: 221 NGA-GDTAALALARAAREHPSLELLHLYFNELS 252
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 7e-04
Identities = 35/172 (20%), Positives = 78/172 (45%), Gaps = 44/172 (25%)
Query: 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGE---FLKGLKILTSLK 457
+ + + + LG+ +++ YKG + ++VA+K + + +EG ++ + +L LK
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALK---EIRLEHEEGAPCTAIREVSLLKDLK 58
Query: 458 HENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRI---SVIKG- 513
H N+ +L I ++ L+++++ DL ++ L+ I +K
Sbjct: 59 HANIVTLHDIIHTEKS--LTLVFEYL-------DKDL----KQYLDDCGNIINMHNVKLF 105
Query: 514 ---IAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNP---LLSDSGLHKLLAD 559
+ +G++Y H ++ ++HR P L+++ G K LAD
Sbjct: 106 LFQLLRGLAYCHRQK-------------VLHRDLKPQNLLINERGELK-LAD 143
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 8e-04
Identities = 40/175 (22%), Positives = 66/175 (37%), Gaps = 50/175 (28%)
Query: 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEG-------EFLKGLKILT 454
+ + +G+ ++ YK G A+K I + K DEG E + IL
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI-RLE-KEDEGIPSTTIRE----ISILK 55
Query: 455 SLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATR---ISVI 511
LKH N+ L + +K R L+++ + DL +K+L+
Sbjct: 56 ELKHSNIVKLYDVIHTKKR--LVLVFEHL-------DQDL----KKLLDVCEGGLESVTA 102
Query: 512 KGIA----KGISYLHGKRPGLVHPNLSAEKVLIHRRYNP---LLSDSGLHKLLAD 559
K GI+Y H +R ++HR P L++ G K +AD
Sbjct: 103 KSFLLQLLNGIAYCHDRR-------------VLHRDLKPQNLLINREGELK-IAD 143
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 8e-04
Identities = 27/243 (11%), Positives = 59/243 (24%), Gaps = 59/243 (24%)
Query: 428 VVAVKCIAKTSCKSDEG---EFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVP 484
VA+ + E L L+ + +A + + R ++ +++
Sbjct: 58 QVALT-FVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDV--VHTRAGGLVVAEWIR 114
Query: 485 NGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY 544
G+L + + I ++ +A H R G+
Sbjct: 115 GGSLQEVA------DTSPSPVGAIRAMQSLAAAADAAH--RAGVAL-----------SID 155
Query: 545 NP---LLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQI 601
+P +S G L A + + DI G ++ +
Sbjct: 156 HPSRVRVSIDGDVVL-------------AYPATMPDA-------NPQDDIRGIGASLYAL 195
Query: 602 LSGKCSITPFTRQAAESS------KVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSH 655
L + P S + + + +A
Sbjct: 196 LVNR---WPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ--ISAVAARSVQGDGGI 250
Query: 656 RPS 658
R +
Sbjct: 251 RSA 253
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 8e-04
Identities = 49/222 (22%), Positives = 86/222 (38%), Gaps = 41/222 (18%)
Query: 409 LLGKSSFS----ATYKGILRDGSVVAVKCIAKTSC--KSDEGEFLKGLK-ILTSLKHENL 461
+LGK + G + A+K + K + + K + IL +KH +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 462 ASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYL 521
L + G+ +LI +++ G L L+ E +E + I+ + +L
Sbjct: 84 VDLI--YAFQTGGKLYLILEYLSGGELFMQLERE---GIFMEDTACF-YLAEISMALGHL 137
Query: 522 HGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG-------- 573
H K G+++ +L E N +L+ G H L D F + K S G
Sbjct: 138 HQK--GIIYRDLKPE--------NIMLNHQG-HVKLTD---FGLCKESIHDGTVTHTFCG 183
Query: 574 ---YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFT 612
Y+APE D ++ G +++ +L+G PFT
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA---PPFT 222
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 673 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.95 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.94 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.93 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.87 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.86 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.86 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.86 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.86 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.86 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.86 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.84 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.84 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.83 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.83 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.83 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.82 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.82 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.82 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.81 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.81 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.81 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.8 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.8 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.8 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.79 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.79 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.79 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.79 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.79 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.78 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.78 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.78 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.78 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.78 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.78 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.78 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.77 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.77 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.77 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.76 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.76 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.76 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.76 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.76 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.75 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.75 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.75 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.75 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.74 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.74 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.74 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.74 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.74 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.74 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.74 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.73 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.73 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.73 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.72 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.72 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.72 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.71 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.7 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.7 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.7 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.7 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.68 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.68 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.68 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.68 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.68 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.68 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.67 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.66 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.65 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.65 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.65 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.65 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.64 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.64 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.63 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.63 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.62 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.62 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.6 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.6 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.6 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.59 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.59 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.58 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.57 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.57 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.56 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.55 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.55 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.55 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.55 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.53 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.52 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.52 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.51 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.49 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.47 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.41 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.4 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.38 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.33 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.26 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.25 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.13 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.11 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.02 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.02 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.9 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.89 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.82 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.72 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.7 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.68 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.65 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.64 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.6 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.55 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.51 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.47 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.47 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.43 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.34 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.23 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.22 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.15 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.9 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.84 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.65 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.64 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.64 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.56 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.5 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.46 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.44 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.44 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.38 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.29 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.17 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.15 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.99 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.98 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.96 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.93 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.86 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.73 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.7 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.56 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.52 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.35 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.18 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.05 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.84 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.01 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 93.83 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.25 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 92.82 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 91.67 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.19 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.31 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.58 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.62 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-57 Score=468.84 Aligned_cols=261 Identities=22% Similarity=0.359 Sum_probs=214.3
Q ss_pred CCccccccccCCcceEEEEEEc------CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 403 CFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
+++..+.||+|+||+||+|++. +++.||||+++........++|.+|+++|++++|||||+++|+|... +..
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~--~~~ 104 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD--QPL 104 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSC
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC--CEE
Confidence 3455678999999999999963 46799999998765455568899999999999999999999999654 678
Q ss_pred EEEEeecCCCChhhhhccccC------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC
Q 005859 477 FLIYDFVPNGNLLQHLDLEAG------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY 544 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~ 544 (673)
+||||||++|+|.++|..... ....++|.++++|+.|||+||+|||++ +||||||||+||||++++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~--~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH--HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC--CCCCCCccccceEECCCC
Confidence 999999999999999964321 124699999999999999999999997 799999999999999999
Q ss_pred CeeeccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchh
Q 005859 545 NPLLSDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVE 622 (673)
Q Consensus 545 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~ 622 (673)
.+||+|||+|+....... .......||+.|||||++.++.|+.++|||||||+||||+| |+.||...........
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~--- 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM--- 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH---
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH---
Confidence 999999999987654322 22345678999999999999999999999999999999999 8999977544332221
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 623 DFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
+........+..++.++.+|+.+||+.||++||||+||++.|+++.+-
T Consensus 260 --i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~nl 307 (308)
T 4gt4_A 260 --IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNL 307 (308)
T ss_dssp --HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC-
T ss_pred --HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccCC
Confidence 111222234556678899999999999999999999999999987554
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-57 Score=467.69 Aligned_cols=261 Identities=18% Similarity=0.360 Sum_probs=214.2
Q ss_pred cCCccccccccCCcceEEEEEEc------CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 402 QCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
++|...+.||+|+||+||+|++. +++.||||+++... ....++|.+|+++|++++|||||+++|+|.+ .+.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~~~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVE--GDP 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEee--CCE
Confidence 56788899999999999999864 37789999997643 3345789999999999999999999999965 467
Q ss_pred EEEEEeecCCCChhhhhcccc---------CCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCe
Q 005859 476 CFLIYDFVPNGNLLQHLDLEA---------GSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNP 546 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~ 546 (673)
.+||||||++|+|.++|+... .....++|.++++|+.|||+||+|||++ +||||||||+||||++++.+
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~--~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ--HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCccCHhhEEECCCCcE
Confidence 999999999999999997432 1235699999999999999999999987 79999999999999999999
Q ss_pred eeccccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhh
Q 005859 547 LLSDSGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDF 624 (673)
Q Consensus 547 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~ 624 (673)
||+|||+|+........ ......||+.|||||++.++.|+.|+|||||||++|||+| |+.||............ ..
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i-~~- 245 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI-TQ- 245 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HH-
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-Hc-
Confidence 99999999876543322 2233468999999999999999999999999999999999 89999765443322211 11
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 625 IDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
......+..++.++.+|+.+||+.||++||||+||++.|+++..+
T Consensus 246 ---~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 246 ---GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 111233455678899999999999999999999999999988654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-57 Score=462.39 Aligned_cols=261 Identities=18% Similarity=0.368 Sum_probs=207.4
Q ss_pred hcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.+++...+.||+|+||+||+|++++ .||||+++..... ...++|.+|+++|++++|||||+++|++.. +..+||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEEEE
Confidence 3567778899999999999998753 5999998754322 234679999999999999999999999843 457999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
||||++|+|.++|+.. ...++|.++++|+.|||+||+|||++ +||||||||+||||++++.+||+|||+|+....
T Consensus 110 mEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~--~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK--NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT--TCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC--CccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999999743 34699999999999999999999987 799999999999999999999999999987654
Q ss_pred cc-hhhhhccCCCCCccCCccccC---CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhh-cCCcCCCCCC
Q 005859 560 DI-VFSMLKASAAMGYLAPEYTTT---GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF-IDPNLEGKFS 634 (673)
Q Consensus 560 ~~-~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 634 (673)
.. .......+||+.|||||++.+ +.|+.|+|||||||+||||+||+.||............+... ..|.+ ...+
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~-~~~~ 263 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL-SKLY 263 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS-TTSC
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc-cccc
Confidence 32 223345689999999999864 459999999999999999999999997643322222222222 22222 2344
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
..++.++.+|+.+||+.||++||||.||++.|+.+-++
T Consensus 264 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 264 KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 56678899999999999999999999999999877543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-57 Score=468.45 Aligned_cols=261 Identities=21% Similarity=0.362 Sum_probs=208.8
Q ss_pred cCCccccccccCCcceEEEEEEc------CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 402 QCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
++|...+.||+|+||+||+|+++ +++.||||+++... ....++|.+|+++|++++|||||+++|+|.+ .+.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTE--GRP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCE
Confidence 46777889999999999999865 37899999997643 3445789999999999999999999999955 467
Q ss_pred EEEEEeecCCCChhhhhccccC-----------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAG-----------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY 544 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~ 544 (673)
.+||||||++|+|.++++.... ....++|.++++|+.|||+||+|||++ +||||||||+||||++++
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~--~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL--HFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEETTT
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC--CeecccccHhhEEECCCC
Confidence 9999999999999999975321 124699999999999999999999987 799999999999999999
Q ss_pred CeeeccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchh
Q 005859 545 NPLLSDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVE 622 (673)
Q Consensus 545 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~ 622 (673)
.+||+|||+|+....... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||........... +.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~-i~ 274 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC-IT 274 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH-HH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH-HH
Confidence 999999999997654332 22345679999999999999999999999999999999999 8999976544332221 11
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 623 DFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
... ....+..+++++.+|+.+||+.||++||||+||++.|+++.++
T Consensus 275 ~g~----~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 275 QGR----ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HTC----CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cCC----CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 111 2234455678899999999999999999999999999998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-56 Score=464.28 Aligned_cols=275 Identities=22% Similarity=0.358 Sum_probs=225.2
Q ss_pred ccCHHHHHHHhcCCccccccccCCcceEEEEEEcC------CcEEEEEEecccCCCCcHHHHHHHHHHHhccCC-CCcee
Q 005859 391 MFNLEEVERATQCFSEANLLGKSSFSATYKGILRD------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKH-ENLAS 463 (673)
Q Consensus 391 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~ 463 (673)
.+...+++...++|+..+.||+|+||+||+|++.. ++.||||++.......+.++|.+|+++|++++| ||||+
T Consensus 53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 34556777788899999999999999999998653 368999999876544456789999999999965 99999
Q ss_pred EeeEEecCCCCeEEEEEeecCCCChhhhhccccC------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccC
Q 005859 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAG------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHP 531 (673)
Q Consensus 464 l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHr 531 (673)
++|+|... .+..+||||||++|+|.++|+.... ....++|..++.|+.|||+||+|||++ +||||
T Consensus 133 l~g~~~~~-~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~--~iiHR 209 (353)
T 4ase_A 133 LLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHR 209 (353)
T ss_dssp EEEEECCT-TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT--TCCCS
T ss_pred EEEEEEec-CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC--CeecC
Confidence 99998643 3568999999999999999974321 134589999999999999999999998 79999
Q ss_pred CcCCCCeEecCCCCeeeccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 005859 532 NLSAEKVLIHRRYNPLLSDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSIT 609 (673)
Q Consensus 532 Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~ 609 (673)
||||+|||+++++.+||+|||+|+.+..+.. .......||+.|||||++.++.|+.++|||||||+||||+| |+.||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999997654332 22334578999999999999999999999999999999998 899997
Q ss_pred hhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 610 PFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
...........+.+.. ....+..+++++.+++.+||+.||++||||.||++.|++++++
T Consensus 290 ~~~~~~~~~~~i~~g~----~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 290 GVKIDEEFCRRLKEGT----RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp TCCCSHHHHHHHHHTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCC----CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 6432221112222222 2233445667899999999999999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-54 Score=439.66 Aligned_cols=249 Identities=22% Similarity=0.360 Sum_probs=200.9
Q ss_pred ccccccccCCcceEEEEEEcC-CcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecC--CCCeEEEEE
Q 005859 405 SEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSK--GRGECFLIY 480 (673)
Q Consensus 405 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~~~lv~ 480 (673)
...+.||+|+||+||+|+... ++.||||++..... ....+.|.+|+++|++++|||||+++++|... ..+..||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 455679999999999999764 88999999976542 23346799999999999999999999998642 235689999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC-CCCeeeccccccccccC
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR-RYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~-~~~~kl~DfGla~~~~~ 559 (673)
|||++|+|.+++.. ...+++..+..|+.||+.||+|||++.++||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999973 34699999999999999999999998556999999999999984 78999999999986544
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
. .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||............+..... ...++...++
T Consensus 185 ~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~---~~~~~~~~~~ 257 (290)
T 3fpq_A 185 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK---PASFDKVAIP 257 (290)
T ss_dssp T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC---CGGGGGCCCH
T ss_pred C---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC---CCCCCccCCH
Confidence 3 2335689999999998864 6999999999999999999999999654322221111111111 1122333456
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
++.+|+.+||+.||++|||++|+++
T Consensus 258 ~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 258 EVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhc
Confidence 7999999999999999999999985
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-54 Score=449.88 Aligned_cols=251 Identities=16% Similarity=0.334 Sum_probs=204.2
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.... ...+.|.+|+++|++++|||||++++++.+. +..|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~--~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN--GSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEEEE
Confidence 57999999999999999999976 5999999999765432 2346799999999999999999999999654 789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
||||+||+|.+++... ....+++..++.|+.||+.||+|||++ |||||||||+||||++++.+||+|||+|+.+..
T Consensus 102 mEy~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~--~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR--KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp EECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT--TCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred EeCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 9999999999999643 234578999999999999999999998 899999999999999999999999999997754
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||............... .. ...+...+.
T Consensus 178 ~~~-~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~----~~-~~~~~~~s~ 251 (350)
T 4b9d_A 178 TVE-LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG----SF-PPVSLHYSY 251 (350)
T ss_dssp HHH-HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT----CC-CCCCTTSCH
T ss_pred Ccc-cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC----CC-CCCCccCCH
Confidence 322 233457999999999999999999999999999999999999999765433322222221 11 122334567
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
++.+|+.+||+.||++|||++|+++
T Consensus 252 ~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 252 DLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhc
Confidence 8999999999999999999999985
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-54 Score=446.07 Aligned_cols=249 Identities=17% Similarity=0.293 Sum_probs=209.6
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
..|+..+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+. +..||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEE
Confidence 56889999999999999999976 59999999997654 34456789999999999999999999999664 7899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
|||++|+|.+++.. ..+++..+..|+.||+.||+|||++ |||||||||+||||+.++.+||+|||+|+.+..+
T Consensus 151 Ey~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~--~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 151 EFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ--GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp CCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred eCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC--CcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 99999999999863 3589999999999999999999998 8999999999999999999999999999977554
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
.. .....+||+.|||||++.+..|+.++||||+||++|||+||+.||........... +.....+.+ ......+.+
T Consensus 224 ~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~-i~~~~~~~~--~~~~~~s~~ 299 (346)
T 4fih_A 224 VP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-IRDNLPPRL--KNLHKVSPS 299 (346)
T ss_dssp SC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-HHHSSCCCC--SCGGGSCHH
T ss_pred CC-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-HHcCCCCCC--CccccCCHH
Confidence 32 23456899999999999999999999999999999999999999976433322211 111111111 223445678
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.+|+.+||+.||++|||++|+++
T Consensus 300 ~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 300 LKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHcCCChhHCcCHHHHhc
Confidence 999999999999999999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-54 Score=444.62 Aligned_cols=261 Identities=19% Similarity=0.272 Sum_probs=200.4
Q ss_pred CCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC--CeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGR--GECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~~~lv~ 480 (673)
+|...+.||+|+||+||+|++ +|+.||||++.... .....+..|+..+.+++|||||+++|+|...+. ...+|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 567788999999999999998 58999999986532 112233456666778999999999999976532 3689999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcC------CCCcccCCcCCCCeEecCCCCeeecccccc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK------RPGLVHPNLSAEKVLIHRRYNPLLSDSGLH 554 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~ivHrDlk~~NILl~~~~~~kl~DfGla 554 (673)
|||++|+|.++++. ..++|..+.+++.|+|+||+|||++ .++||||||||+||||++++.+||+|||+|
T Consensus 81 Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999999999963 3589999999999999999999975 458999999999999999999999999999
Q ss_pred ccccCcchh---hhhccCCCCCccCCccccCC------CCCcchhHHHHHHHHHHHHhCCCCCChhhH-------h----
Q 005859 555 KLLADDIVF---SMLKASAAMGYLAPEYTTTG------RFTEKSDIYAFGMIVFQILSGKCSITPFTR-------Q---- 614 (673)
Q Consensus 555 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSfGvvl~el~tG~~p~~~~~~-------~---- 614 (673)
+........ .....+||+.|||||++.+. .|+.|+|||||||++|||+||+.|+..... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 876543221 22345799999999999754 378899999999999999999876532110 0
Q ss_pred ----hhhccchhhhcCCcCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 615 ----AAESSKVEDFIDPNLEGKF-SVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 615 ----~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
........+..+|.++... +.+.+..+.+|+.+||+.||++||||.||++.|+++.+
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0000011122233332211 23456789999999999999999999999999999865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-54 Score=445.24 Aligned_cols=253 Identities=18% Similarity=0.198 Sum_probs=206.3
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+.|...++||+|+||+||+|+.+. |+.||||+++.... +.+|+++|++++|||||++++++.+. +..||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~--~~~~ivm 129 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREG--PWVNIFM 129 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEE
Confidence 467888899999999999999764 99999999976431 24799999999999999999999654 7899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC-CeeeccccccccccC
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY-NPLLSDSGLHKLLAD 559 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~-~~kl~DfGla~~~~~ 559 (673)
|||+||+|.++++. ...+++..+..|+.||+.||+|||++ |||||||||+||||+.++ .+||+|||+|+.+..
T Consensus 130 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~--~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR--RILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp CCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT--TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred eccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 99999999999973 34699999999999999999999987 799999999999999988 699999999998764
Q ss_pred cchh----hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 560 DIVF----SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 560 ~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
+... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||............... +......+.
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~ 280 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE---PPPIREIPP 280 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS---CCGGGGSCT
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC---CCCchhcCc
Confidence 3221 122357999999999999999999999999999999999999999754322111111111 111113344
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
..+..+.+++.+||+.||++|||+.|+++.|.+.+.
T Consensus 281 ~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 281 SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 566889999999999999999999999999887654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=437.05 Aligned_cols=248 Identities=18% Similarity=0.247 Sum_probs=208.6
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|+..+.||+|+||+||+|+.. +|+.||||++.+... ....+.+.+|+++|++++|||||++++++.+ .+..||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~yi 109 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLYF 109 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 46999999999999999999976 499999999976431 3345689999999999999999999999954 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
|||||+||+|.+++.. ...+++..+..|+.||+.||+|||++ |||||||||+|||+++++.+||+|||+|+.+.
T Consensus 110 vmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~--~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp EECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 9999999999999973 34699999999999999999999998 89999999999999999999999999999875
Q ss_pred Ccch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 559 DDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 559 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
.+.. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||............... . ..++...
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~----~--~~~p~~~ 257 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL----E--YDFPEKF 257 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----C--CCCCTTC
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC----C--CCCCccc
Confidence 4322 2234568999999999999999999999999999999999999999765433222222111 1 1233445
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVM 663 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl 663 (673)
++++.+|+.+||+.||++|||++|++
T Consensus 258 s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 258 FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 67899999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=447.14 Aligned_cols=250 Identities=17% Similarity=0.292 Sum_probs=210.0
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.+.|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+. +..|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT-CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC--CEEEEE
Confidence 457999999999999999999976 49999999997654 34456799999999999999999999999664 789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
||||+||+|.+++.. ..+++..+..|+.||+.||+|||++ |||||||||+||||+.++.+||+|||+|+.+..
T Consensus 227 mEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~--~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ--GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp EECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred EeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC--CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 999999999999863 3489999999999999999999998 899999999999999999999999999987755
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||........... +.....+.+ ......+.
T Consensus 300 ~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~-i~~~~~~~~--~~~~~~s~ 375 (423)
T 4fie_A 300 EVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-IRDNLPPRL--KNLHKVSP 375 (423)
T ss_dssp SCC-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-HHHSCCCCC--SCTTSSCH
T ss_pred CCc-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-HHcCCCCCC--cccccCCH
Confidence 432 23456799999999999999999999999999999999999999976543322221 111111221 22234567
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
++.+|+.+||+.||++|||+.|+++
T Consensus 376 ~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 376 SLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhc
Confidence 8999999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=423.68 Aligned_cols=246 Identities=18% Similarity=0.290 Sum_probs=191.8
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|+..+.||+|+||+||+|+.. +|+.||||++.+... ....+.+.+|+++|++++|||||++++++.+ .+..|+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~i 90 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS--KDEIIM 90 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEE
Confidence 57999999999999999999975 599999999976542 2234679999999999999999999999954 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||| +|+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+|+...
T Consensus 91 vmEy~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH--KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EEECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred EEeCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 99999 6899999873 34699999999999999999999998 89999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRF-TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
+.. .....+||+.|||||++.+..| +.++||||+||++|||+||+.||............. ... ..++...
T Consensus 164 ~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~----~~~--~~~p~~~ 235 (275)
T 3hyh_A 164 DGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS----NGV--YTLPKFL 235 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HTC--CCCCTTS
T ss_pred CCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH----cCC--CCCCCCC
Confidence 432 2334679999999999998876 589999999999999999999997643322211111 111 1223345
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
++++.+++.+||+.||++|||++|+++
T Consensus 236 s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 236 SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 678899999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=430.88 Aligned_cols=248 Identities=20% Similarity=0.299 Sum_probs=198.1
Q ss_pred cCCccccccccCCcceEEEEEEc----CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR----DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
++|++.+.||+|+||+||+|+.. .++.||||++.+... ..+...+.+|+++|++++|||||++++++.+. +..
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE--GKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET--TEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEE
Confidence 46999999999999999999863 378999999976532 22345788999999999999999999999654 789
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
|+|||||+||+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+|+.
T Consensus 102 ~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~--~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 999999999999999973 34699999999999999999999998 899999999999999999999999999986
Q ss_pred ccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHH
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (673)
...... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.............. .. ..++..
T Consensus 176 ~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~----~~--~~~p~~ 248 (304)
T 3ubd_A 176 SIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK----AK--LGMPQF 248 (304)
T ss_dssp -----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CC--CCCCTT
T ss_pred ccCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc----CC--CCCCCc
Confidence 544321 23346799999999999999999999999999999999999999976543332222211 11 123344
Q ss_pred HHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 005859 637 EASNLGQIALHCTHESPSHRPSI-----ENVMQ 664 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RPs~-----~evl~ 664 (673)
.++++.+|+.+||+.||++|||+ +|+++
T Consensus 249 ~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 249 LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 56789999999999999999984 56653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=423.28 Aligned_cols=253 Identities=18% Similarity=0.288 Sum_probs=192.9
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC-------
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGR------- 473 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------- 473 (673)
++|+..+.||+|+||+||+|+.+ +|+.||||++.........+.+.+|+++|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999976 5899999999765433445679999999999999999999999865432
Q ss_pred ---CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecc
Q 005859 474 ---GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSD 550 (673)
Q Consensus 474 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~D 550 (673)
...|+|||||++|+|.+++.... .....++..++.|+.||+.||+|||++ |||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~--~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC--cCccccCcHHHeEECCCCcEEEcc
Confidence 24789999999999999997432 234567788899999999999999998 899999999999999999999999
Q ss_pred ccccccccCcchh-----------hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhcc
Q 005859 551 SGLHKLLADDIVF-----------SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESS 619 (673)
Q Consensus 551 fGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~ 619 (673)
||+|+.+..+... ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||........
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~--- 235 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR--- 235 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH---
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH---
Confidence 9999977543211 1234579999999999999999999999999999999996 7754332211
Q ss_pred chhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 620 KVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+..+.....+ .......+.+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 TLTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHhcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111111111 112233456788999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=415.48 Aligned_cols=256 Identities=18% Similarity=0.262 Sum_probs=200.9
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecC----CCCe
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSK----GRGE 475 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----~~~~ 475 (673)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.... ...+.+.+|+++|++++|||||++++++... +.+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999976 5999999999765422 2346788999999999999999999987543 2367
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.|||||||+ |+|.+++.. ...+++..+..|+.||+.||+|||++ |||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~--~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA--QVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--cCcCCCcCccccccCCCCCEEEeecceee
Confidence 899999995 789999963 35699999999999999999999998 89999999999999999999999999998
Q ss_pred cccCcch---hhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCc---
Q 005859 556 LLADDIV---FSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPN--- 628 (673)
Q Consensus 556 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~--- 628 (673)
.+..... ......+||+.|||||++.+. .|+.++||||+||++|||+||+.||.+................+.
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 7644221 123456899999999998875 469999999999999999999999975432221111111000000
Q ss_pred ---------------CCC--CCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 629 ---------------LEG--KFS-----VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 629 ---------------~~~--~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
... ..+ ...+.++.+|+.+||+.||++|||+.|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 001 123467899999999999999999999975
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=405.99 Aligned_cols=256 Identities=20% Similarity=0.287 Sum_probs=198.8
Q ss_pred HHHHHHhcCCccccccccCCcceEEEEEEc----CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEe
Q 005859 395 EEVERATQCFSEANLLGKSSFSATYKGILR----DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICC 469 (673)
Q Consensus 395 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 469 (673)
+.+....++|++.+.||+|+||+||+|+.+ .++.||||++.+. ....++.+|+++|+++ +|||||++++++.
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 344455688999999999999999999853 3678999998654 3456788999999998 6999999999996
Q ss_pred cCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC-CCeee
Q 005859 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR-YNPLL 548 (673)
Q Consensus 470 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~-~~~kl 548 (673)
+ .+..|+|||||++|+|.+++. .+++.++..++.|++.||+|||++ ||+||||||+|||++.+ +.+||
T Consensus 91 ~--~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~--gIiHRDiKPeNiLl~~~~~~~kl 159 (361)
T 4f9c_A 91 K--NDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF--GIVHRDVKPSNFLYNRRLKKYAL 159 (361)
T ss_dssp E--TTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEETTTTEEEE
T ss_pred E--CCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC--CeEeCcCCHHHeEEeCCCCeEEE
Confidence 5 478999999999999999984 388999999999999999999998 89999999999999877 79999
Q ss_pred ccccccccccCcch---------------------------hhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHH
Q 005859 549 SDSGLHKLLADDIV---------------------------FSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQ 600 (673)
Q Consensus 549 ~DfGla~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~e 600 (673)
+|||+|+...+... ......+||+.|||||++.+. .|+.++||||+||++||
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~e 239 (361)
T 4f9c_A 160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS 239 (361)
T ss_dssp CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHH
Confidence 99999986543211 012335799999999999875 48999999999999999
Q ss_pred HHhCCCCCChhhHhhhhccch-----------------------------------hhh--cC---CcCC---------C
Q 005859 601 ILSGKCSITPFTRQAAESSKV-----------------------------------EDF--ID---PNLE---------G 631 (673)
Q Consensus 601 l~tG~~p~~~~~~~~~~~~~~-----------------------------------~~~--~~---~~~~---------~ 631 (673)
|+||+.||.+..+.......+ ... .+ +... .
T Consensus 240 ll~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 319 (361)
T 4f9c_A 240 LLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNL 319 (361)
T ss_dssp HHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC--------------------
T ss_pred HHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccc
Confidence 999999995432110000000 000 00 0000 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 632 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
......++++.+|+.+||+.||++|||++|+++
T Consensus 320 ~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 320 EGWNEVPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp --CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 111223567899999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=398.11 Aligned_cols=278 Identities=30% Similarity=0.597 Sum_probs=233.4
Q ss_pred cccCHHHHHHHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEe
Q 005859 390 FMFNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469 (673)
Q Consensus 390 ~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 469 (673)
..++++++...+++|...+.||+|+||.||+|+..+|+.||||++...........+.+|++++++++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 46788999999999999999999999999999988899999999987654444457999999999999999999999995
Q ss_pred cCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcC-CCCcccCCcCCCCeEecCCCCeee
Q 005859 470 SKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK-RPGLVHPNLSAEKVLIHRRYNPLL 548 (673)
Q Consensus 470 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~ivHrDlk~~NILl~~~~~~kl 548 (673)
. .+..++||||+++|+|.+++.........++|..+..++.|++.||+|||+. .+||+||||||+|||+++++.+||
T Consensus 98 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 98 T--PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp C--SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred c--CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 4 4678999999999999999986554556699999999999999999999985 447999999999999999999999
Q ss_pred ccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhh-------------
Q 005859 549 SDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQA------------- 615 (673)
Q Consensus 549 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~------------- 615 (673)
+|||+++..............||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999998775443333444568999999999988889999999999999999999999986432111
Q ss_pred hhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 005859 616 AESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSI 669 (673)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i 669 (673)
..........+.......+...+..+.+++.+||+.||++|||+.||++.|++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 111233344455555667788899999999999999999999999999999853
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=392.69 Aligned_cols=276 Identities=31% Similarity=0.574 Sum_probs=229.0
Q ss_pred ccCHHHHHHHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEec
Q 005859 391 MFNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCS 470 (673)
Q Consensus 391 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 470 (673)
.+++.++...+++|...+.||+|+||.||+|+.++++.||||++.... ....+.+.+|++++++++||||+++++++..
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 345566677889999999999999999999998889999999887653 3445789999999999999999999999854
Q ss_pred CCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecc
Q 005859 471 KGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSD 550 (673)
Q Consensus 471 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~D 550 (673)
.+..++||||+++|+|.+++.........++|..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|
T Consensus 107 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 107 --RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR--AIIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp --TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCSTTEEECTTCCEEECC
T ss_pred --CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC--CeecCCCCHHHEEECCCCCEEEee
Confidence 4678999999999999999975443345699999999999999999999997 899999999999999999999999
Q ss_pred ccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhh-----------hhc
Q 005859 551 SGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQA-----------AES 618 (673)
Q Consensus 551 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~-----------~~~ 618 (673)
||+++....... .......||..|+|||++.+..++.++|||||||++|||+||+.||....... ...
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 262 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence 999986543211 11223457899999999998899999999999999999999999986432110 111
Q ss_pred cchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 619 SKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
..+...+++..........+..+.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 22334455555566778889999999999999999999999999999998865
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=422.55 Aligned_cols=251 Identities=18% Similarity=0.301 Sum_probs=208.2
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|++.+.||+|+||+||+|+.+ +|+.||||++.... ..+.+.+.+|+++|++++|||||++++++.+ .+..||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~iv~ 233 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVMIY 233 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC--SSEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEE
Confidence 57999999999999999999976 49999999997653 3345678999999999999999999999954 48899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC--CCeeecccccccccc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR--YNPLLSDSGLHKLLA 558 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~--~~~kl~DfGla~~~~ 558 (673)
|||+||+|.+++... ...+++..+..|+.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 234 E~~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~--~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 234 EFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp ECCCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred eecCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 999999999998632 24689999999999999999999998 79999999999999854 799999999999876
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
.... ....+||+.|||||++.+..|+.++||||+||++|||++|+.||............... +...........+
T Consensus 309 ~~~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s 384 (573)
T 3uto_A 309 PKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC--DWNMDDSAFSGIS 384 (573)
T ss_dssp TTSE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT--CCCCCSGGGTTSC
T ss_pred CCCc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC--CCCCCcccccCCC
Confidence 5432 33457999999999999999999999999999999999999999765433222211111 1111112223345
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.++.+|+.+||+.||++|||+.|+++
T Consensus 385 ~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 385 EDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 78899999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=420.00 Aligned_cols=249 Identities=19% Similarity=0.267 Sum_probs=200.9
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHH---HHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLK---GLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
++|++.+.||+|+||+||+|+.+. |+.||||++.+... ......+.+ ++++++.++|||||++++++.+ .+.
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~--~~~ 266 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDK 266 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--SSE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE--CCE
Confidence 689999999999999999999764 99999999976421 122333333 4677788899999999999954 588
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.|+|||||+||+|.++|.. ...+++..+..|+.||+.||+|||++ |||||||||+||||+.+|.+||+|||+|+
T Consensus 267 lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~--gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCchHHeEEeCCCCEEecccceee
Confidence 9999999999999999973 34699999999999999999999998 89999999999999999999999999998
Q ss_pred cccCcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 556 LLADDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
.+.... ....+||+.|||||++.. ..|+.++||||+||++|||+||+.||........ ......+... ...++
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-~~i~~~i~~~--~~~~p 414 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTM--AVELP 414 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-HHHHHHHHHC--CCCCC
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhhcCC--CCCCC
Confidence 876543 234689999999999975 5799999999999999999999999975422111 0111111111 11234
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 005859 635 VSEASNLGQIALHCTHESPSHRPS-----IENVMQ 664 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 664 (673)
...+.++.+|+.+||+.||++|++ ++||++
T Consensus 415 ~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 455678999999999999999998 677753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=390.09 Aligned_cols=262 Identities=20% Similarity=0.391 Sum_probs=213.5
Q ss_pred hcCCccccccccCCcceEEEEEEc--------CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR--------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSK 471 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 471 (673)
.++|...+.||+|+||.||+|+.. ++..||||++.........+++.+|+++++++ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-
Confidence 467889999999999999999863 35679999997654333456799999999999 89999999999954
Q ss_pred CCCeEEEEEeecCCCChhhhhccccC------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeE
Q 005859 472 GRGECFLIYDFVPNGNLLQHLDLEAG------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVL 539 (673)
Q Consensus 472 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NIL 539 (673)
.+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ ||+||||||+|||
T Consensus 159 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 -DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ--KCIHRDLAARNVL 235 (370)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEE
T ss_pred -CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC--CeeccccchhhEE
Confidence 4678999999999999999975421 124589999999999999999999998 8999999999999
Q ss_pred ecCCCCeeeccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhh
Q 005859 540 IHRRYNPLLSDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAE 617 (673)
Q Consensus 540 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~ 617 (673)
++.++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||+| |+.||.........
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999987654322 12334457788999999999999999999999999999999 99998654322111
Q ss_pred ccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 618 SSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
. .+........+..++.++.+++.+||+.||++|||+.|+++.|++++.
T Consensus 316 ~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 316 K-----LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp H-----HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-----HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 111111223344556789999999999999999999999999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=378.07 Aligned_cols=269 Identities=24% Similarity=0.404 Sum_probs=207.3
Q ss_pred HHHHHHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCC
Q 005859 395 EEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGR 473 (673)
Q Consensus 395 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 473 (673)
+++....++|++.+.||+|+||+||+|+. +|+.||||++...... ...+++.+|++++++++||||+++++++.. .
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 106 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ--P 106 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--T
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--C
Confidence 33444567899999999999999999987 5889999999765422 223578999999999999999999999954 4
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL 553 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGl 553 (673)
+..++||||+++|+|.+++... .....+++..++.++.|++.||+|||+..++|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHST-THHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CceEEEEecCCCCcHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 6789999999999999999742 122358999999999999999999999832399999999999999999999999999
Q ss_pred cccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCC
Q 005859 554 HKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 554 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (673)
++....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||............... ......
T Consensus 186 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~----~~~~~~ 260 (309)
T 3p86_A 186 SRLKASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK----CKRLEI 260 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS----CCCCCC
T ss_pred Ccccccccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----CCCCCC
Confidence 986544321 233456899999999999999999999999999999999999999765433221111111 111233
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 634 SVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 634 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
+...+.++.+++.+||+.||++|||+.++++.|++++.+
T Consensus 261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 444567899999999999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=369.79 Aligned_cols=257 Identities=22% Similarity=0.406 Sum_probs=215.6
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
++|...+.||+|+||.||+|+..+++.||+|++.... ...+++.+|++++++++||||+++++++.+ .+..++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 85 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLVFE 85 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEEEEEE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCceEEEEE
Confidence 5688899999999999999999889999999997653 345789999999999999999999999954 467899999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+++|+|.+++... ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred eCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC--CeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 99999999999632 34589999999999999999999987 89999999999999999999999999998776554
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
........++..|+|||.+.+..++.++||||+|+++|||+| |+.||............ .. ......+...+..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~ 235 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-ST----GFRLYKPRLASTH 235 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HT----TCCCCCCTTSCHH
T ss_pred cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-hc----CccCCCCCcCCHH
Confidence 434444567778999999998899999999999999999999 99998764333221111 11 1111223334578
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
+.+++.+||+.||++|||++|+++.|+++.++
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 236 VYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 99999999999999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=381.06 Aligned_cols=260 Identities=23% Similarity=0.414 Sum_probs=211.2
Q ss_pred hcCCccccccccCCcceEEEEEEc----CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR----DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
.++|...+.||+|+||.||+|+.. .+..||||++.........+.|.+|++++++++||||+++++++.. .+..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--GRLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG--GGCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCcc
Confidence 357888999999999999999975 3456999999865434445789999999999999999999999954 4678
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 126 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL--GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC--CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 9999999999999999632 24689999999999999999999998 899999999999999999999999999987
Q ss_pred ccCcchh--hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCC
Q 005859 557 LADDIVF--SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 557 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (673)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||............ .. ......
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-~~----~~~~~~ 275 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV-EE----GYRLPA 275 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-HT----TCCCCC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-Hc----CCCCCC
Confidence 6543211 1223345778999999998899999999999999999999 99998765433222111 11 111223
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 634 SVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 634 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
+...+..+.+++.+||+.||++|||+.||++.|++++.+
T Consensus 276 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 344567899999999999999999999999999999764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=388.50 Aligned_cols=259 Identities=23% Similarity=0.425 Sum_probs=200.7
Q ss_pred hcCCccccccccCCcceEEEEEEc----CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR----DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
.++|...+.||+|+||.||+|+.. ++..||||++.........++|.+|++++++++||||+++++++.. .+..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCce
Confidence 357899999999999999999975 4778999999765433445689999999999999999999999954 4678
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||+++|+|.++++.. ...+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC--CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 9999999999999999732 34689999999999999999999987 899999999999999999999999999987
Q ss_pred ccCcchh--hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCC
Q 005859 557 LADDIVF--SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 557 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (673)
....... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||........... +........
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~-----i~~~~~~~~ 271 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA-----VDEGYRLPP 271 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH-----HHTTEECCC
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCCCCCC
Confidence 6543221 1122345678999999998999999999999999999998 9999876543322111 111111122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 634 SVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 634 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
+...+..+.+++.+||+.||++||++.+|++.|++++.
T Consensus 272 ~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 33456789999999999999999999999999999865
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=397.94 Aligned_cols=261 Identities=21% Similarity=0.389 Sum_probs=216.9
Q ss_pred HHHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 398 ERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 398 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
+...++|...+.||+|+||+||+|.++++..||||+++... ...++|.+|+++|++++|||||++++++. .+..+
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~~~~ 258 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPIY 258 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe---CCccE
Confidence 33456788899999999999999999888999999997653 45678999999999999999999999984 25679
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 259 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR--NYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 9999999999999997431 23588999999999999999999998 7999999999999999999999999999887
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (673)
............++..|+|||++....++.++|||||||++|||+| |+.||........... +... .....+..
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~----~~~~~~~~ 409 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LERG----YRMPRPEN 409 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHHT----CCCCCCTT
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcC----CCCCCCCC
Confidence 6543333334456778999999998899999999999999999999 9999976543322211 1111 11122344
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 637 EASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
++.++.+++.+||+.||++|||+++|++.|++++.+
T Consensus 410 ~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 410 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 567899999999999999999999999999998753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=376.50 Aligned_cols=258 Identities=22% Similarity=0.434 Sum_probs=209.0
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|...+.||+|+||+||+|+.. +++.||+|++.... ....+.|.+|++++++++||||+++++++.+. +..++||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~ 86 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD--KRLNFIT 86 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecC--CeeEEEE
Confidence 56888899999999999999976 48999999886532 34457899999999999999999999999654 7799999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.....
T Consensus 87 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 87 EYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM--NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp ECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred EecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 999999999999742 34589999999999999999999998 8999999999999999999999999999876543
Q ss_pred chhh-------------hhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhh-ccchhhhcC
Q 005859 561 IVFS-------------MLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE-SSKVEDFID 626 (673)
Q Consensus 561 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~-~~~~~~~~~ 626 (673)
.... .....||+.|+|||++.+..++.++||||||+++|||++|..|+......... ........+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 2211 11356899999999999999999999999999999999999887654222111 111111111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 627 PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 627 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.. .+...+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 242 ~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 242 RY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp HT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11 122334678999999999999999999999999998753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=368.17 Aligned_cols=257 Identities=26% Similarity=0.427 Sum_probs=212.6
Q ss_pred hcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
.++|...+.||+|+||.||+|...++..||||++.... ...+++.+|++++++++||||+++++++.. .+..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 98 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFIIT 98 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEec--CCCeEEEE
Confidence 45788899999999999999999988899999997653 345789999999999999999999999954 47789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.....
T Consensus 99 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 99 EYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK--QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC--CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 999999999999742 34589999999999999999999987 8999999999999999999999999999877654
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
.........+++.|+|||.+.+..++.++||||||+++|||+| |+.||........... +... .....+...+.
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~~~~----~~~~~~~~~~~ 248 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQG----LRLYRPHLASE 248 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHTT----CCCCCCTTCCH
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH-Hhcc----cCCCCCCcCCH
Confidence 4333444556788999999998899999999999999999999 9999876543322221 1111 11122333457
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.+.+++.+||+.||++|||++|+++.|++++.
T Consensus 249 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 249 KVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 89999999999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=391.82 Aligned_cols=259 Identities=25% Similarity=0.439 Sum_probs=211.4
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|...+.||+|+||.||+|++. +++.||||++.........++|.+|+++|++++||||+++++++.. .+..++|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS--SSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec--CCCcEEE
Confidence 457888899999999999999987 5899999998765322334578899999999999999999999954 3678999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++|+|.+++... ...+++..+..++.||+.||+|||+. ||+||||||+|||+++++.+||+|||+++....
T Consensus 191 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK--CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC--CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 9999999999999742 24589999999999999999999998 899999999999999999999999999986554
Q ss_pred cchhhh-hccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 560 DIVFSM-LKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 560 ~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
...... ....++..|+|||.+..+.++.++|||||||++|||+| |+.||.......... .+........+..+
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~ 340 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE-----FVEKGGRLPCPELC 340 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH-----HHHTTCCCCCCTTC
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----HHHcCCCCCCCCCC
Confidence 322111 11234667999999998899999999999999999999 999987654332211 11111122233445
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
+.++.+++.+||+.||++|||+.++++.|+++..
T Consensus 341 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 341 PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 6789999999999999999999999999998864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=375.50 Aligned_cols=266 Identities=23% Similarity=0.392 Sum_probs=209.5
Q ss_pred hcCCccccccccCCcceEEEEEEc-----CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-----DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
.++|+..+.||+|+||+||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++...+...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 357888999999999999999852 48899999987543 333467999999999999999999999987654456
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK--RYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC--CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 89999999999999999743 23589999999999999999999987 89999999999999999999999999998
Q ss_pred cccCcchh--hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhh-----------ccchh
Q 005859 556 LLADDIVF--SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE-----------SSKVE 622 (673)
Q Consensus 556 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~-----------~~~~~ 622 (673)
........ ......++..|+|||.+.+..++.++||||||+++|||+||..|+......... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 76543221 122344677899999999899999999999999999999999887643221100 00111
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 623 DFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
+..........+...+.++.+++.+||+.||++|||+.|+++.|+++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 11112222233445668899999999999999999999999999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=379.63 Aligned_cols=263 Identities=19% Similarity=0.273 Sum_probs=207.5
Q ss_pred hcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCC--CCeEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKG--RGECFL 478 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~~~l 478 (673)
.++|...+.||+|+||+||+|+.. ++.||||++.... .....+.+|+.++++++||||+++++++.... ....++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 467899999999999999999876 7999999996542 33456677999999999999999999997643 235799
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcC--------CCCcccCCcCCCCeEecCCCCeeecc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK--------RPGLVHPNLSAEKVLIHRRYNPLLSD 550 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------~~~ivHrDlk~~NILl~~~~~~kl~D 550 (673)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. .+||+||||||+|||++.++.+||+|
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 9999999999999963 3489999999999999999999986 34799999999999999999999999
Q ss_pred ccccccccCcchh-hhhccCCCCCccCCccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhh--------
Q 005859 551 SGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTG-----RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA-------- 616 (673)
Q Consensus 551 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~-------- 616 (673)
||+++........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||........
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9999876543221 22335689999999999863 467789999999999999999999864211100
Q ss_pred ----hccc----hhhhcCCcCCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 617 ----ESSK----VEDFIDPNLEGK-FSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 617 ----~~~~----~~~~~~~~~~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.... ......+.+... .....+.++.+++.+||+.||++|||+.||++.|+++.+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0000 011111111111 123456779999999999999999999999999998864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=370.22 Aligned_cols=250 Identities=14% Similarity=0.252 Sum_probs=207.7
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|...+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++... +..++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVG--DELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC--CEEEEE
Confidence 467999999999999999999964 58999999997654 34567899999999999999999999999654 679999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++|+|.+++.. ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp EECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC--CceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 999999999999963 3589999999999999999999998 899999999999999999999999999987654
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||............... ..+ ....+...+.
T Consensus 169 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~ 244 (297)
T 3fxz_A 169 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTP--ELQNPEKLSA 244 (297)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH-CSC--CCSCGGGSCH
T ss_pred ccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCC--CCCCccccCH
Confidence 332 233457899999999999999999999999999999999999999654332221111111 111 1122345567
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 245 IFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhh
Confidence 8999999999999999999999985
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=386.00 Aligned_cols=275 Identities=22% Similarity=0.362 Sum_probs=220.2
Q ss_pred ccCHHHHHHHhcCCccccccccCCcceEEEEEEc------CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCcee
Q 005859 391 MFNLEEVERATQCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLAS 463 (673)
Q Consensus 391 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~ 463 (673)
.+...+++...++|...+.||+|+||.||+|++. +++.||||++.........+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 4556777788899999999999999999999842 36799999997654334456799999999999 8999999
Q ss_pred EeeEEecCCCCeEEEEEeecCCCChhhhhccccCC---------------------------------------------
Q 005859 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGS--------------------------------------------- 498 (673)
Q Consensus 464 l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~--------------------------------------------- 498 (673)
+++++... ....++||||+++|+|.+++......
T Consensus 91 ~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 91 LLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp EEEEECST-TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeecC-CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 99998653 34589999999999999999754221
Q ss_pred -----------------ccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 499 -----------------EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 499 -----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
...+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~--~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 12289999999999999999999998 89999999999999999999999999998664332
Q ss_pred h-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 562 V-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 562 ~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
. .......+|..|+|||++.+..++.++|||||||++|||+| |+.||............+... .....+...+.
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 323 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG----TRMRAPDYTTP 323 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT----CCCCCCTTCCH
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC----CCCCCCCCCCH
Confidence 1 12334567889999999999899999999999999999999 999986543221111111111 11222334457
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
++.+++.+||+.||++|||+.|+++.|++++++
T Consensus 324 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 324 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 899999999999999999999999999998763
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=371.62 Aligned_cols=264 Identities=19% Similarity=0.316 Sum_probs=215.1
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|...+.||+|+||+||+|+... ++.||||++.........+.+.+|++++++++||||+++++++........++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 578899999999999999999875 8999999998655445567889999999999999999999999776666889999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEe----cCCCCeeecccccccc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI----HRRYNPLLSDSGLHKL 556 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl----~~~~~~kl~DfGla~~ 556 (673)
||+++|+|.+++.... ....+++..++.++.|++.||+|||+. ||+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999997432 123489999999999999999999998 89999999999999 7888899999999987
Q ss_pred ccCcchhhhhccCCCCCccCCcccc--------CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhc---
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTT--------TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFI--- 625 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~--- 625 (673)
...... .....||..|+|||++. +..++.++|||||||++|||+||+.||.+..........+..+.
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 655432 23456899999999886 56789999999999999999999999864322111111111111
Q ss_pred --------------------CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 626 --------------------DPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 626 --------------------~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
........+...+..+.+++.+||+.||++|||++|+++...+..
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 001112445677889999999999999999999999999887653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=371.49 Aligned_cols=261 Identities=20% Similarity=0.323 Sum_probs=207.2
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC--cHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS--DEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|...+.||+|+||.||+|+.. +++.||+|.+....... ..+.+.+|++++++++||||+++++++.. .+..++
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~l 88 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE--DDCYYL 88 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC--SSEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee--CCeEEE
Confidence 57889999999999999999976 48999999986543222 23578999999999999999999999854 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++...
T Consensus 89 v~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM--RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999999999999973 24689999999999999999999988 89999999999999999999999999998776
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
...........||+.|+|||.+.+..++.++||||||+++|||+||+.||................. +..........+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 241 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-PNVTTDVRKDIP 241 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC-CCHHHHSCTTSC
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC-CCcchhcccCCC
Confidence 5433334445689999999999999999999999999999999999999976543222111111111 111111223345
Q ss_pred HHHHHHHHHccccCCCCCC-CHHHHHHHHHHhhc
Q 005859 639 SNLGQIALHCTHESPSHRP-SIENVMQELSSIIG 671 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RP-s~~evl~~L~~i~~ 671 (673)
..+.+++.+||+.||++|| +++++.+.|++++.
T Consensus 242 ~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 242 QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred HHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 7899999999999999998 99999999998765
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=365.55 Aligned_cols=257 Identities=23% Similarity=0.399 Sum_probs=213.7
Q ss_pred hcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
.++|...+.||+|+||.||+|..+++..||+|++.... ...+++.+|++++++++||||+++++++.. .+..++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 82 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK--EYPIYIVT 82 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCceEEEE
Confidence 46788999999999999999999888899999997653 345789999999999999999999999944 46789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 83 EYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH--QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp ECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT--TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999999999743 24589999999999999999999998 8999999999999999999999999999877654
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
.........+++.|+|||.+.+..++.++||||||+++|||+| |+.||............ ... .....+...+.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-~~~----~~~~~~~~~~~ 232 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV-SQG----HRLYRPHLASD 232 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTT----CCCCCCTTSCH
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH-HcC----CCCCCCCcChH
Confidence 4333334456778999999998889999999999999999999 99998765433221111 111 11112233456
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 233 TIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 79999999999999999999999999998864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=370.67 Aligned_cols=261 Identities=18% Similarity=0.286 Sum_probs=214.4
Q ss_pred cccCHHHHHHHhcC----------CccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCC
Q 005859 390 FMFNLEEVERATQC----------FSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKH 458 (673)
Q Consensus 390 ~~~~~~~l~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 458 (673)
..+++++++.+++. |+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCC
Confidence 35788888888764 677789999999999999987 59999999997654 3456789999999999999
Q ss_pred CCceeEeeEEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCe
Q 005859 459 ENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKV 538 (673)
Q Consensus 459 ~niv~l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NI 538 (673)
|||+++++++... +..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. ||+||||||+||
T Consensus 102 ~niv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NI 172 (321)
T 2c30_A 102 FNVVEMYKSYLVG--EELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ--GVIHRDIKSDSI 172 (321)
T ss_dssp TTBCCEEEEEEET--TEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGE
T ss_pred CCcceEEEEEEEC--CEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHE
Confidence 9999999999664 679999999999999999862 3589999999999999999999997 899999999999
Q ss_pred EecCCCCeeeccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhc
Q 005859 539 LIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAES 618 (673)
Q Consensus 539 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~ 618 (673)
+++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..........
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~ 251 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 251 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred EECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999999987654322 2234578999999999999999999999999999999999999986543322111
Q ss_pred cchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 619 SKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+.....+.. ......+..+.+++.+||+.||++|||+.|+++
T Consensus 252 -~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 252 -RLRDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp -HHHHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHhcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111111 122334578999999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=366.67 Aligned_cols=275 Identities=28% Similarity=0.508 Sum_probs=224.0
Q ss_pred cccCHHHHHHHhcCCccc------cccccCCcceEEEEEEcCCcEEEEEEecccCC---CCcHHHHHHHHHHHhccCCCC
Q 005859 390 FMFNLEEVERATQCFSEA------NLLGKSSFSATYKGILRDGSVVAVKCIAKTSC---KSDEGEFLKGLKILTSLKHEN 460 (673)
Q Consensus 390 ~~~~~~~l~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~H~n 460 (673)
..|+++++..++++|... +.||+|+||.||+|+. +++.||||++..... ....+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 468999999999999988 8899999999999987 588999999875431 223467999999999999999
Q ss_pred ceeEeeEEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEe
Q 005859 461 LASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI 540 (673)
Q Consensus 461 iv~l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl 540 (673)
|+++++++.. .+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. ||+||||||+||++
T Consensus 92 i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~--~i~H~dlkp~Nili 166 (307)
T 2nru_A 92 LVELLGFSSD--GDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN--HHIHRDIKSANILL 166 (307)
T ss_dssp BCCEEEEECS--SSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEE
T ss_pred eEEEEEEEec--CCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEE
Confidence 9999999954 467899999999999999987432 234689999999999999999999987 89999999999999
Q ss_pred cCCCCeeeccccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhh--
Q 005859 541 HRRYNPLLSDSGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE-- 617 (673)
Q Consensus 541 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~-- 617 (673)
++++.+||+|||+++........ ......|+..|+|||.+.+ .++.++||||||+++|||+||+.||.........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 99999999999999876542211 1223568999999998864 5899999999999999999999998654321110
Q ss_pred --------ccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 618 --------SSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 618 --------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
...+...+++.. ...+...+..+.+++.+||+.||.+|||+++|++.|+++..|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 111223333332 245667788999999999999999999999999999998654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=374.35 Aligned_cols=248 Identities=19% Similarity=0.322 Sum_probs=206.0
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
.++|...+.||+|+||.||+|+.. +|+.||||++...... ...+.+.+|+++|++++||||+++++++.. .+..++
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 91 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET--EKTLYL 91 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEE
Confidence 457999999999999999999974 6999999999765422 234678899999999999999999999954 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK--RIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC--CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999999632 4589999999999999999999987 89999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCC-cchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFT-EKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
... .....+||+.|+|||++.+..++ .++||||+||++|||+||+.||............... .. ..+...
T Consensus 166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----~~--~~p~~~ 237 (328)
T 3fe3_A 166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG----KY--RIPFYM 237 (328)
T ss_dssp SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CC--CCCTTS
T ss_pred CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----CC--CCCCCC
Confidence 443 23456799999999999988765 8999999999999999999999765433222211111 11 123334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.++.+++.+||+.||++|||++|+++
T Consensus 238 s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 238 STDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 578899999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=398.61 Aligned_cols=260 Identities=23% Similarity=0.418 Sum_probs=216.6
Q ss_pred HhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
...+|...+.||+|+||.||+|++.. +..||||++.... ...++|.+|+++|++++|||||+++++|... +..++
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 293 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYI 293 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecC--CcEEE
Confidence 34568889999999999999999875 8899999997653 3567899999999999999999999999543 67899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++... ....+++..++.++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+++...
T Consensus 294 v~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 294 ITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK--NFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999999999743 234589999999999999999999998 89999999999999999999999999998776
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
...........+++.|+|||.+....++.++|||||||++|||+| |+.||........ .+.+........+..+
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~ 444 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----YELLEKDYRMERPEGC 444 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-----HHHHHTTCCCCCCTTC
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH-----HHHHHcCCCCCCCCCC
Confidence 544333334456788999999998899999999999999999999 9989865432211 1112222222344556
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
+.++.+|+.+||+.||++|||+.+|++.|+.+++.
T Consensus 445 ~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 445 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 68899999999999999999999999999988653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=379.23 Aligned_cols=269 Identities=18% Similarity=0.326 Sum_probs=216.2
Q ss_pred HHHHHHhcCCccccccccCCcceEEEEEEcC------CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEE
Q 005859 395 EEVERATQCFSEANLLGKSSFSATYKGILRD------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGIC 468 (673)
Q Consensus 395 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 468 (673)
.++....++|...+.||+|+||.||+|+..+ ++.||||++.........+.+.+|++++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3444567899999999999999999999753 4889999997654333456799999999999999999999999
Q ss_pred ecCCCCeEEEEEeecCCCChhhhhccccCC--------------------ccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Q 005859 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAGS--------------------EKVLEWATRISVIKGIAKGISYLHGKRPGL 528 (673)
Q Consensus 469 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~i 528 (673)
.. .+..++||||+++|+|.+++...... ...+++..++.++.||++||+|||++ ||
T Consensus 120 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--~i 195 (343)
T 1luf_A 120 AV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--KF 195 (343)
T ss_dssp CS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT--TC
T ss_pred cc--CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC--Ce
Confidence 54 46789999999999999999753211 15689999999999999999999998 89
Q ss_pred ccCCcCCCCeEecCCCCeeeccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCC
Q 005859 529 VHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKC 606 (673)
Q Consensus 529 vHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~ 606 (673)
+||||||+||+++.++.+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||+| |+.
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999987643321 12234567889999999998899999999999999999999 999
Q ss_pred CCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 607 SITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 607 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
||........... +.+.. ....+...+.++.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 276 p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 276 PYYGMAHEEVIYY----VRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTTTSCHHHHHHH----HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred cCCCCChHHHHHH----HhCCC-cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 9876433222111 11111 1123344567899999999999999999999999999998753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=368.87 Aligned_cols=257 Identities=21% Similarity=0.367 Sum_probs=202.4
Q ss_pred hcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhc--cCCCCceeEeeEEecC--CCCeE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTS--LKHENLASLRGICCSK--GRGEC 476 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~--~~~~~ 476 (673)
.++|...+.||+|+||+||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++... .....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46799999999999999999998 6899999998643 34566777777766 7999999999987543 23568
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHh--------cCCCCcccCCcCCCCeEecCCCCeee
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLH--------GKRPGLVHPNLSAEKVLIHRRYNPLL 548 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~ivHrDlk~~NILl~~~~~~kl 548 (673)
++||||+++|+|.++++. ..+++..+++++.|++.||+||| +. ||+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~--~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP--AIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC--EEECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC--CeecCCCChHhEEEcCCCCEEE
Confidence 999999999999999952 35899999999999999999999 55 8999999999999999999999
Q ss_pred ccccccccccCcchh---hhhccCCCCCccCCccccCC------CCCcchhHHHHHHHHHHHHhC----------CCCCC
Q 005859 549 SDSGLHKLLADDIVF---SMLKASAAMGYLAPEYTTTG------RFTEKSDIYAFGMIVFQILSG----------KCSIT 609 (673)
Q Consensus 549 ~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSfGvvl~el~tG----------~~p~~ 609 (673)
+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||+|| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999999876543221 12234789999999999876 456799999999999999999 77775
Q ss_pred hhhHhhhhccchhh-----hcCCcCCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 005859 610 PFTRQAAESSKVED-----FIDPNLEG-KFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSI 669 (673)
Q Consensus 610 ~~~~~~~~~~~~~~-----~~~~~~~~-~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i 669 (673)
.............. ...+.... ..+...+.++.+++.+||+.||++|||+.||++.|++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 43211111111111 11111111 12345678899999999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=392.78 Aligned_cols=259 Identities=23% Similarity=0.408 Sum_probs=208.9
Q ss_pred HhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
..++|...+.||+|+||.||+|.+.++..||||++.... ...++|.+|+++|++++||||+++++++.. +..++|
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~iv 256 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV 256 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEEE
Confidence 346788889999999999999999888889999997653 346789999999999999999999999853 567999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++|+|.+++.... ...+++..+..++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+++....
T Consensus 257 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp ECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred ehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 99999999999997431 24589999999999999999999998 799999999999999999999999999987765
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
..........++..|+|||.+....++.++|||||||++|||+| |+.||........... +.. ......+..++
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~----~~~~~~~~~~~ 407 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VER----GYRMPCPPECP 407 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHT----TCCCCCCTTSC
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHc----CCCCCCCCCCC
Confidence 43333334456788999999998899999999999999999999 9999876543322111 111 11122334556
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
..+.+++.+||+.||++|||++++++.|++++.+
T Consensus 408 ~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 408 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 7899999999999999999999999999998764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=367.55 Aligned_cols=258 Identities=22% Similarity=0.370 Sum_probs=199.6
Q ss_pred hcCCccccccccCCcceEEEEEEcC----CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD----GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
.++|...+.||+|+||.||+|+... +..||+|.+.........+.+.+|+.++++++||||+++++++.. +..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 90 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPV 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---Ccc
Confidence 4678899999999999999999753 457999998765433445679999999999999999999999832 467
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK--RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC--CeecccccHHHEEECCCCCEEECccccccc
Confidence 8999999999999999743 23589999999999999999999997 899999999999999999999999999987
Q ss_pred ccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
.............+++.|+|||.+....++.++||||||+++|||++ |+.||......... ..+.. ......+.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~----~~i~~-~~~~~~~~ 240 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI----GRIEN-GERLPMPP 240 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----HHHHT-TCCCCCCT
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH----HHHHc-CCCCCCCC
Confidence 76544333344456788999999998899999999999999999997 99898654322111 11111 11112334
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
..+..+.+++.+||+.||++|||+.|+++.|+++++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 456789999999999999999999999999999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=381.78 Aligned_cols=262 Identities=20% Similarity=0.312 Sum_probs=210.8
Q ss_pred hcCCccccccccCCcceEEEEEEc------CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRG 474 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 474 (673)
.++|...+.||+|+||+||+|++. +++.||||++..........++.+|+.++++++||||+++++++.. .+
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--SL 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec--CC
Confidence 457888999999999999999953 3678999999765434445679999999999999999999999954 46
Q ss_pred eEEEEEeecCCCChhhhhccccC---CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC---Ceee
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAG---SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY---NPLL 548 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~---~~kl 548 (673)
..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChhhEEEecCCCCceEEE
Confidence 67999999999999999975432 224589999999999999999999998 899999999999999555 5999
Q ss_pred ccccccccccCcc-hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcC
Q 005859 549 SDSGLHKLLADDI-VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID 626 (673)
Q Consensus 549 ~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~ 626 (673)
+|||+++...... ........+|+.|+|||++.+..++.++|||||||++|||+| |+.||........... +.
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~-i~---- 300 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-VT---- 300 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HH----
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HH----
Confidence 9999998653321 112233457889999999998899999999999999999998 9999876433222111 11
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 627 PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 627 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.......+...+..+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 301 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 301 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 111122334455789999999999999999999999999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=375.04 Aligned_cols=257 Identities=22% Similarity=0.384 Sum_probs=203.8
Q ss_pred cCCccccccccCCcceEEEEEEcC-Cc----EEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GS----VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
++|+..+.||+|+||+||+|++.. ++ .||+|.+.........++|.+|++++++++||||++++++|... ..
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~ 91 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---TV 91 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---SE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---Ce
Confidence 568889999999999999999653 44 46888886554445567899999999999999999999999653 47
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++|+||+++|+|.+++... ...+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 92 ~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC--CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 8999999999999999743 24589999999999999999999998 899999999999999999999999999987
Q ss_pred ccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 557 LADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 557 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
...... .......+|..|+|||++.+..++.++|||||||++|||+| |+.||........ ...+........+
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-----~~~~~~~~~~~~~ 241 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-----SSILEKGERLPQP 241 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-----HHHHHTTCCCCCC
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH-----HHHHHcCCCCCCC
Confidence 654322 12233456788999999999999999999999999999999 9999875433221 1111112222234
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
...+.++.+++.+||+.||++||++.|+++.|+++..
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 242 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 4456789999999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=380.90 Aligned_cols=263 Identities=21% Similarity=0.372 Sum_probs=213.9
Q ss_pred HhcCCccccccccCCcceEEEEEEc--------CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEec
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR--------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCS 470 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 470 (673)
..++|...+.||+|+||+||+|+.. ++..||||++.........+++.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3467889999999999999999853 24579999997664334457899999999999 99999999999954
Q ss_pred CCCCeEEEEEeecCCCChhhhhccccC------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCe
Q 005859 471 KGRGECFLIYDFVPNGNLLQHLDLEAG------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKV 538 (673)
Q Consensus 471 ~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NI 538 (673)
.+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+. ||+||||||+||
T Consensus 147 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NI 222 (382)
T 3tt0_A 147 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--KCIHRDLAARNV 222 (382)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGE
T ss_pred --CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCcceE
Confidence 4678999999999999999975431 124599999999999999999999988 899999999999
Q ss_pred EecCCCCeeeccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhh
Q 005859 539 LIHRRYNPLLSDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAA 616 (673)
Q Consensus 539 Ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~ 616 (673)
|+++++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||+| |+.||........
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987654322 12334456788999999999999999999999999999999 9999865433221
Q ss_pred hccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 617 ESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.. .+.. ......+...+.++.+++.+||+.||++|||++||++.|++++.
T Consensus 303 ~~-~~~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 303 FK-LLKE----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp HH-HHHT----TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH-HHHc----CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 1111 11222334456789999999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=370.82 Aligned_cols=263 Identities=21% Similarity=0.364 Sum_probs=213.1
Q ss_pred HhcCCccccccccCCcceEEEEEEc------CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGR 473 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 473 (673)
..++|...+.||+|+||.||+|+.. +++.||||++.........+.+.+|++++++++||||+++++++.. .
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 98 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ--D 98 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec--C
Confidence 3567889999999999999999862 3578999999765433445688999999999999999999999854 4
Q ss_pred CeEEEEEeecCCCChhhhhccccC--------------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAG--------------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNL 533 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDl 533 (673)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ ||+||||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~di 176 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM--KLVHRDL 176 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT--TEECCCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC--CCccccc
Confidence 678999999999999999975322 123589999999999999999999998 8999999
Q ss_pred CCCCeEecCCCCeeeccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChh
Q 005859 534 SAEKVLIHRRYNPLLSDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPF 611 (673)
Q Consensus 534 k~~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~ 611 (673)
||+||++++++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987644321 12233456788999999998889999999999999999999 99998654
Q ss_pred hHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 612 TRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
...... ..+........+...+.++.+++.+||+.||++|||+.|+++.|++++.
T Consensus 257 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 257 PPERLF-----NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp CGGGHH-----HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHH-----HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 322111 1111111222334456789999999999999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=358.23 Aligned_cols=257 Identities=16% Similarity=0.286 Sum_probs=210.4
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|...+.||+|+||.||+|+.+ ++.||||++...... ...+.|.+|++++++++||||+++++++.....+..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56888999999999999999985 889999999765422 2346799999999999999999999999766557889999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++|+|.+++... ....+++..++.++.|++.||+|||+..++|+||||||+||+++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp ECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred cccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 999999999999743 22358999999999999999999999733499999999999999999999999888764332
Q ss_pred chhhhhccCCCCCccCCccccCCCCCc---chhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTE---KSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~---ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
....+|+.|+|||.+.+..++. ++||||||+++|||+||+.||.................. ...+...
T Consensus 166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~ 236 (271)
T 3kmu_A 166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR----PTIPPGI 236 (271)
T ss_dssp -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC----CCCCTTC
T ss_pred -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC----CCCCCCC
Confidence 2346789999999998765544 899999999999999999999765443322222222222 2333445
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
+.++.+++.+||+.||++|||++|+++.|+++.+
T Consensus 237 ~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 237 SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 6789999999999999999999999999998864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=386.70 Aligned_cols=254 Identities=24% Similarity=0.430 Sum_probs=209.8
Q ss_pred HhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
..++|...+.||+|+||.||+|.+. |+.||||+++... ..+.|.+|+++|++++||||+++++++... .+..++|
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~iv 265 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIV 265 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TSCEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CCceEEE
Confidence 3467888999999999999999985 7899999997643 456899999999999999999999998654 3468999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+++....
T Consensus 266 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 99999999999997432 23479999999999999999999998 799999999999999999999999999985543
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
. .....++..|+|||.+.+..++.++|||||||++|||+| |+.||.......... .+. .......+..++
T Consensus 342 ~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~-~i~----~~~~~~~p~~~~ 412 (450)
T 1k9a_A 342 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-RVE----KGYKMDAPDGCP 412 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH-HHH----TTCCCCCCTTCC
T ss_pred c----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHH----cCCCCCCCCcCC
Confidence 2 122356889999999999999999999999999999999 999987543222111 111 112223344566
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.++.++|.+||+.||++|||+.++++.|+++..
T Consensus 413 ~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 413 PAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 889999999999999999999999999999865
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=359.53 Aligned_cols=258 Identities=22% Similarity=0.395 Sum_probs=214.3
Q ss_pred hcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
.++|...+.||+|+||.||+|+..+++.||+|++.... ...+++.+|++++++++||||+++++++.. .+..++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 82 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLVT 82 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT--BCHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSCEEEE
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCeEEEE
Confidence 35788899999999999999999888999999997653 345789999999999999999999999954 46789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 999999999999743 24589999999999999999999998 8999999999999999999999999999876554
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
.........++..|+|||.+.+..++.++||||||+++|||+| |+.||........... +... .....+...+.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-i~~~----~~~~~~~~~~~ 232 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-ISTG----FRLYKPRLAST 232 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTT----CCCCCCTTSCH
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH-HhcC----CcCCCCccCcH
Confidence 3333344556788999999998889999999999999999999 8989865433222111 1111 11122333457
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
.+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 233 HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 899999999999999999999999999999765
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=363.25 Aligned_cols=251 Identities=17% Similarity=0.280 Sum_probs=199.0
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC-------------------------cHHHHHHHHHHHhc
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS-------------------------DEGEFLKGLKILTS 455 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------------------------~~~~~~~E~~~l~~ 455 (673)
++|...+.||+|+||.||+|+.. +++.||||++....... ..+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57889999999999999999975 48899999997643211 12568999999999
Q ss_pred cCCCCceeEeeEEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCC
Q 005859 456 LKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSA 535 (673)
Q Consensus 456 l~H~niv~l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~ 535 (673)
++||||+++++++.....+..++||||+++|+|.+++. ...+++..+..++.||+.||+|||+. ||+||||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp 165 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ--KIIHRDIKP 165 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCH
Confidence 99999999999997655678999999999999988764 24689999999999999999999998 899999999
Q ss_pred CCeEecCCCCeeeccccccccccCcchhhhhccCCCCCccCCccccCCC---CCcchhHHHHHHHHHHHHhCCCCCChhh
Q 005859 536 EKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGR---FTEKSDIYAFGMIVFQILSGKCSITPFT 612 (673)
Q Consensus 536 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSfGvvl~el~tG~~p~~~~~ 612 (673)
+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||....
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999999987654321 123457899999999998655 4789999999999999999999997543
Q ss_pred HhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 613 RQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
........... ..........+.++.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 IMCLHSKIKSQ----ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHHHHHC----CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHhcc----cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 22211111111 1111111234578999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=368.02 Aligned_cols=265 Identities=23% Similarity=0.350 Sum_probs=209.9
Q ss_pred cCCccccccccCCcceEEEEEE-----cCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGIL-----RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
..|+..+.||+|+||.||+|++ .+++.||||++.........+.+.+|++++++++||||+++++++.....+..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588889999999999999984 35889999999866545556789999999999999999999999977655778
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR--QYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC--CcccCCCchheEEEcCCCCEEECccccccc
Confidence 9999999999999999643 24589999999999999999999997 899999999999999999999999999987
Q ss_pred ccCcch--hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhh----------hccchhhh
Q 005859 557 LADDIV--FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA----------ESSKVEDF 624 (673)
Q Consensus 557 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~----------~~~~~~~~ 624 (673)
...... .......+|..|+|||.+.+..++.++||||||+++|||+||+.|+........ ........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 654321 122344578889999999988999999999999999999999987643211100 00111111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 625 IDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.........+...+..+.+++.+||+.||++|||+.|+++.|+++++
T Consensus 256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 11222223344556789999999999999999999999999999874
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=370.73 Aligned_cols=248 Identities=19% Similarity=0.296 Sum_probs=205.4
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccC--CCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTS--CKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|+..+.||+|+||+||+|+.. +|+.||||++.+.. .......+.+|++++++++||||+++++++.. .+..++
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~~l 82 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCF 82 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe--CCEEEE
Confidence 57899999999999999999976 48999999997642 13345678999999999999999999999954 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 83 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 83 VMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 9999999999999873 34689999999999999999999998 89999999999999999999999999998643
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||............... . ..++...+
T Consensus 157 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----~--~~~p~~~s 229 (337)
T 1o6l_A 157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME----E--IRFPRTLS 229 (337)
T ss_dssp CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----C--CCCCTTSC
T ss_pred cCCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC----C--CCCCCCCC
Confidence 3211 233457899999999999999999999999999999999999999754332222111111 1 12333455
Q ss_pred HHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRP-----SIENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 664 (673)
.++.+++.+||+.||++|| +++|+++
T Consensus 230 ~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 7899999999999999999 8999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=374.31 Aligned_cols=252 Identities=21% Similarity=0.335 Sum_probs=205.9
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC-----cHHHHHHHHHHHhccCCCCceeEeeEEecCCCC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS-----DEGEFLKGLKILTSLKHENLASLRGICCSKGRG 474 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 474 (673)
.++|...+.||+|+||+||+|+.. +|+.||+|++.+..... ..+.+.+|+++|++++||||+++++++.. .+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~ 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--RT 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe--CC
Confidence 457899999999999999999976 48999999998754321 34689999999999999999999999954 47
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC----Ceeecc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY----NPLLSD 550 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~----~~kl~D 550 (673)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||+++++ .+||+|
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~--givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 89999999999999999963 34689999999999999999999998 899999999999998877 799999
Q ss_pred ccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCC
Q 005859 551 SGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLE 630 (673)
Q Consensus 551 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 630 (673)
||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||................. ...
T Consensus 163 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--~~~ 238 (361)
T 2yab_A 163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY--DFD 238 (361)
T ss_dssp CSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC--CCC
T ss_pred cCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--CCC
Confidence 99998765532 22345799999999999988999999999999999999999999976433322211111100 011
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 631 GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 631 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.......+..+.+++.+||..||++|||+.|+++
T Consensus 239 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 239 EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0111223567899999999999999999999984
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=358.95 Aligned_cols=255 Identities=24% Similarity=0.457 Sum_probs=204.9
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcH------HHHHHHHHHHhccCCCCceeEeeEEecCCCC
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDE------GEFLKGLKILTSLKHENLASLRGICCSKGRG 474 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~------~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 474 (673)
++|...+.||+|+||+||+|+.. +++.||||++......... +.+.+|++++++++||||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 95 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--- 95 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT---
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC---
Confidence 57888999999999999999975 5899999998765432222 6789999999999999999999998432
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC-----eeec
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN-----PLLS 549 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~-----~kl~ 549 (673)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+..++|+||||||+||+++.++. +||+
T Consensus 96 -~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 96 -PRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -TEEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -CeEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 26999999999999888632 34699999999999999999999998223999999999999988776 9999
Q ss_pred cccccccccCcchhhhhccCCCCCccCCcccc--CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCC
Q 005859 550 DSGLHKLLADDIVFSMLKASAAMGYLAPEYTT--TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDP 627 (673)
Q Consensus 550 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 627 (673)
|||+++..... .....|++.|+|||.+. ...++.++|||||||++|||++|+.||......... ........
T Consensus 172 Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~ 245 (287)
T 4f0f_A 172 DFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK--FINMIREE 245 (287)
T ss_dssp CCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH--HHHHHHHS
T ss_pred CCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH--HHHHHhcc
Confidence 99999855432 23456899999999984 455899999999999999999999998654321110 01111112
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 005859 628 NLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSI 669 (673)
Q Consensus 628 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i 669 (673)
......+...+.++.+++.+||+.||++|||++|+++.|+++
T Consensus 246 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 222334445568899999999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=379.90 Aligned_cols=265 Identities=18% Similarity=0.307 Sum_probs=216.3
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|...+.||+|+||+||+|+... |+.||||++.........+.+.+|++++++++||||+++++++........++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 578899999999999999999875 8999999998655445567889999999999999999999999776556789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEe----cCCCCeeecccccccc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI----HRRYNPLLSDSGLHKL 556 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl----~~~~~~kl~DfGla~~ 556 (673)
||+++|+|.+++.... ....+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC--CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999997432 123389999999999999999999998 89999999999999 7778899999999987
Q ss_pred ccCcchhhhhccCCCCCccCCccccC--------CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcC--
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTTT--------GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFID-- 626 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~-- 626 (673)
...... .....||..|+|||++.+ ..++.++|||||||++|||+||+.||.+..........+..+..
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp CCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred ccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 755432 234568999999999864 46789999999999999999999998653221111111111100
Q ss_pred ---------------------CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 627 ---------------------PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 627 ---------------------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.......+...+..+.+++.+||+.||++||+++|+++.++++++
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 011123456778899999999999999999999999999999876
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=368.42 Aligned_cols=262 Identities=21% Similarity=0.338 Sum_probs=213.0
Q ss_pred CCccccccccCCcceEEEEEEc-----CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-----DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
.|...+.||+|+||+||++.++ +++.||||++.........+.+.+|++++++++||||+++++++...+....+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 3488899999999999998753 48899999998654334456799999999999999999999999876667899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++..
T Consensus 112 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~--~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999963 2489999999999999999999998 8999999999999999999999999999877
Q ss_pred cCcch--hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhh----------hccchhhhc
Q 005859 558 ADDIV--FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA----------ESSKVEDFI 625 (673)
Q Consensus 558 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~----------~~~~~~~~~ 625 (673)
..... .......++..|+|||.+.+..++.++||||||+++|||+||+.||........ ....+.+.+
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 54321 122344577889999999988899999999999999999999998865322110 001112222
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 626 DPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
........+...+.++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 2222333445566889999999999999999999999999998864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=396.67 Aligned_cols=259 Identities=23% Similarity=0.408 Sum_probs=215.4
Q ss_pred HhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
..++|...+.||+|+||+||+|++.++..||||+++... ...++|.+|+++|++++||||+++++++.. +..++|
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~lv 339 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV 339 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEE
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee---ccceEe
Confidence 456788899999999999999999888899999997653 346789999999999999999999999853 567999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++|+|.+++.... ...+++..++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 340 ~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp ECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 99999999999997431 24589999999999999999999998 799999999999999999999999999987765
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
..........++..|+|||.+....++.++|||||||++|||+| |+.||........... +.. ......+..++
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~-i~~----~~~~~~~~~~~ 490 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VER----GYRMPCPPECP 490 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH-HHT----TCCCCCCTTCC
T ss_pred CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHc----CCCCCCCCCCC
Confidence 43333334456788999999998899999999999999999999 9999876543322111 111 11122334556
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
..+.+||.+||+.||++|||+++|++.|++++.+
T Consensus 491 ~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 491 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 7899999999999999999999999999998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=366.92 Aligned_cols=265 Identities=21% Similarity=0.368 Sum_probs=213.4
Q ss_pred HhcCCccccccccCCcceEEEEEE------cCCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCC
Q 005859 400 ATQCFSEANLLGKSSFSATYKGIL------RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKG 472 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 472 (673)
..++|...+.||+|+||.||+|+. .+++.||||++.........+.+.+|+++++++ +||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence 346788999999999999999985 236799999997654334457899999999999 99999999999954
Q ss_pred CCeEEEEEeecCCCChhhhhccccC--------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCe
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAG--------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKV 538 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NI 538 (673)
.+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ ||+||||||+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Ni 176 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNI 176 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCccceE
Confidence 4678999999999999999975421 123589999999999999999999998 899999999999
Q ss_pred EecCCCCeeeccccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhh
Q 005859 539 LIHRRYNPLLSDSGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAA 616 (673)
Q Consensus 539 Ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~ 616 (673)
+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||........
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 9999999999999999876544321 1223346778999999998899999999999999999999 9999865432211
Q ss_pred hccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 617 ESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
......... ....+...+.++.+++.+||+.||.+|||+.|+++.|++++..
T Consensus 257 ~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 257 FYKMIKEGF----RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp HHHHHHHTC----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhccCC----CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 111122211 1222334557899999999999999999999999999998753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=365.99 Aligned_cols=259 Identities=23% Similarity=0.415 Sum_probs=215.2
Q ss_pred HhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
..++|...+.||+|+||.||+|.... +..||+|.+... ....+.+.+|++++++++||||+++++++.. .+..++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 86 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYI 86 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCEEE
Confidence 45678899999999999999999875 889999999754 3355789999999999999999999999854 467899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++... ....+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++...
T Consensus 87 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH--TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC--CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999999743 234689999999999999999999987 79999999999999999999999999998776
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
...........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......... +.+........+...
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~ 237 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-----ELLEKDYRMERPEGC 237 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-----HHHHTTCCCCCCTTC
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----HHHhccCCCCCCCCC
Confidence 544333334456788999999998899999999999999999999 98888654322111 111112222333445
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
+..+.+++.+||+.||++|||+.|+++.|++++.
T Consensus 238 ~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 238 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 6789999999999999999999999999998865
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=362.55 Aligned_cols=261 Identities=20% Similarity=0.361 Sum_probs=198.5
Q ss_pred hcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|...+.||+|+||+||+|+.. ..||||++...... ...+.|.+|++++++++||||+++++++. .+..++|
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---~~~~~lv 97 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQLAIV 97 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc---CCccEEE
Confidence 457899999999999999999864 35999999765422 23467899999999999999999999763 2457899
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++++|.+++... ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++....
T Consensus 98 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~--~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 98 TQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK--SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC--CcccccCccceEEECCCCCEEEccceecccccc
Confidence 9999999999999632 35689999999999999999999997 899999999999999999999999999986543
Q ss_pred cc-hhhhhccCCCCCccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 560 DI-VFSMLKASAAMGYLAPEYTT---TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 560 ~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
.. ........|+..|+|||.+. ...++.++||||||+++|||+||+.||............+..............
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS 252 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCT
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccc
Confidence 21 11223456899999999987 566899999999999999999999999764332221111111111111122334
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.++.++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 253 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 253 NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 556889999999999999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=369.20 Aligned_cols=252 Identities=20% Similarity=0.305 Sum_probs=201.6
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|...+.||+|+||+||+|+.. +++.||||++.........+.+.+|++++++++||||+++++++.. .+..++||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~ 84 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLFL 84 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEEEEE
Confidence 57899999999999999999976 5899999999765433444678999999999999999999999954 47889999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++.....
T Consensus 85 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~--givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 85 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99999999999962 34589999999999999999999987 8999999999999999999999999999865432
Q ss_pred c-hhhhhccCCCCCccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 561 I-VFSMLKASAAMGYLAPEYTTTGRF-TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 561 ~-~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
. ........||+.|+|||++.+..+ +.++|||||||++|||+||+.||......... .................+
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 235 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---YSDWKEKKTYLNPWKKID 235 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH---HHHHHTTCTTSTTGGGSC
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH---HHHHhcccccCCccccCC
Confidence 2 112234578999999999987775 78999999999999999999999654322111 111111111111123455
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 236 SAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhh
Confidence 78899999999999999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=367.77 Aligned_cols=254 Identities=17% Similarity=0.279 Sum_probs=202.5
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC------
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGR------ 473 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------ 473 (673)
.++|+..+.||+|+||.||+|+.. +|+.||||++.........+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457899999999999999999987 6999999999865544456789999999999999999999999865432
Q ss_pred -------------------------------------------------CeEEEEEeecCCCChhhhhccccCCccccCH
Q 005859 474 -------------------------------------------------GECFLIYDFVPNGNLLQHLDLEAGSEKVLEW 504 (673)
Q Consensus 474 -------------------------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~ 504 (673)
...++||||+++|+|.+++.... .....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence 13799999999999999997542 3355678
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcch-----------hhhhccCCCCC
Q 005859 505 ATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV-----------FSMLKASAAMG 573 (673)
Q Consensus 505 ~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~~ 573 (673)
..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHHhC--CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 88999999999999999987 899999999999999999999999999987765321 11233468999
Q ss_pred ccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCC
Q 005859 574 YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESP 653 (673)
Q Consensus 574 y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p 653 (673)
|+|||++.+..++.++|||||||++|||++|..|+...... ........ ........+.++.+++.+||+.||
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~------~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p 314 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI------ITDVRNLK-FPLLFTQKYPQEHMMVQDMLSPSP 314 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHH------HHHHHTTC-CCHHHHHHCHHHHHHHHHHHCSSG
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHH------HHHhhccC-CCcccccCChhHHHHHHHHccCCC
Confidence 99999999999999999999999999999987654322111 11111111 111123345678999999999999
Q ss_pred CCCCCHHHHHH
Q 005859 654 SHRPSIENVMQ 664 (673)
Q Consensus 654 ~~RPs~~evl~ 664 (673)
++|||+.|+++
T Consensus 315 ~~Rps~~~~l~ 325 (332)
T 3qd2_B 315 TERPEATDIIE 325 (332)
T ss_dssp GGSCCHHHHHH
T ss_pred CcCCCHHHHhh
Confidence 99999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=360.22 Aligned_cols=257 Identities=22% Similarity=0.390 Sum_probs=212.8
Q ss_pred hcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
.++|...+.||+|+||.||+|...+++.||||.+.... ...+.+.+|++++++++||||+++++++.. +..++||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~ 86 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYIIT 86 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEcC---CCcEEEE
Confidence 46788899999999999999999888899999997653 356789999999999999999999999843 4578999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++++|.+++.... ...+++..+..++.|++.||+|||+. ||+||||||+||++++++.+||+|||+++.....
T Consensus 87 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER--NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp ECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred ecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 9999999999996321 23589999999999999999999988 8999999999999999999999999999877654
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
.........++..|+|||.+.+..++.++||||||+++|||+| |+.||........... +... .....+...+.
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~----~~~~~~~~~~~ 237 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERG----YRMVRPDNCPE 237 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTT----CCCCCCTTCCH
T ss_pred ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH-Hhcc----cCCCCcccccH
Confidence 3333334456788999999988889999999999999999999 8989865433221111 1111 11122334557
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
++.+++.+||+.||++|||++++++.|++++.
T Consensus 238 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 89999999999999999999999999998864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=367.09 Aligned_cols=251 Identities=20% Similarity=0.326 Sum_probs=204.6
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-----CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-----SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
++|...+.||+|+||.||+|+.. +|+.||+|++...... ...+.+.+|++++++++||||+++++++.. .+.
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 88 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 88 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence 46889999999999999999976 4899999999765422 135789999999999999999999999954 478
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC----Ceeeccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY----NPLLSDS 551 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~----~~kl~Df 551 (673)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++ .+||+||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC--CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 9999999999999999963 34689999999999999999999987 899999999999999887 7999999
Q ss_pred cccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCC
Q 005859 552 GLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEG 631 (673)
Q Consensus 552 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 631 (673)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||............... ......
T Consensus 163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~--~~~~~~ 238 (326)
T 2y0a_A 163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV--NYEFED 238 (326)
T ss_dssp TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHT--CCCCCH
T ss_pred CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhc--CCCcCc
Confidence 9998765432 223456899999999999889999999999999999999999999654332211111100 111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 632 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 239 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111223567899999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=371.25 Aligned_cols=266 Identities=24% Similarity=0.369 Sum_probs=210.3
Q ss_pred HHhcCCccccccccCCcceEEEEEEc------CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecC
Q 005859 399 RATQCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSK 471 (673)
Q Consensus 399 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 471 (673)
...++|...+.||+|+||.||+|+.. +++.||||++.........+.+.+|+++++++ +||||+++++++..
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 120 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL- 120 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee-
Confidence 34578999999999999999999962 35689999998654444557899999999999 99999999999955
Q ss_pred CCCeEEEEEeecCCCChhhhhccccCC-------------------ccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCC
Q 005859 472 GRGECFLIYDFVPNGNLLQHLDLEAGS-------------------EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPN 532 (673)
Q Consensus 472 ~~~~~~lv~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrD 532 (673)
.+..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||+. ||+|||
T Consensus 121 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~D 197 (344)
T 1rjb_A 121 -SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRD 197 (344)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT--TEEETT
T ss_pred -CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC--CcccCC
Confidence 46789999999999999999743211 13489999999999999999999997 899999
Q ss_pred cCCCCeEecCCCCeeeccccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCh
Q 005859 533 LSAEKVLIHRRYNPLLSDSGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITP 610 (673)
Q Consensus 533 lk~~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~ 610 (673)
|||+||+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 9999999999999999999999876543221 1223456788999999998899999999999999999998 9999865
Q ss_pred hhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 611 FTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
..........+. .......+...+.++.+++.+||+.||++|||+.|+++.|+.++..
T Consensus 278 ~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 278 IPVDANFYKLIQ----NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CCCSHHHHHHHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCcHHHHHHHHh----cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 432211111111 1222223344567899999999999999999999999999988653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=368.47 Aligned_cols=251 Identities=16% Similarity=0.214 Sum_probs=205.0
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|...+.||+|+||.||+|+... ++.||+|.+... ..+...+.+|+++++.++||||+++++++.+. +..++|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESM--EELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC--CEEEEE
Confidence 4678999999999999999999764 889999998754 23456788999999999999999999999654 789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC--CCCeeeccccccccc
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR--RYNPLLSDSGLHKLL 557 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~--~~~~kl~DfGla~~~ 557 (673)
|||+++|+|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+|||++. ++.+||+|||+++..
T Consensus 80 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~--givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 80 FEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC--CCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 9999999999999632 24689999999999999999999998 8999999999999987 789999999999877
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.................. .........
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~ 230 (321)
T 1tki_A 155 KPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT--FDEEAFKEI 230 (321)
T ss_dssp CTTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--CCHHHHTTS
T ss_pred CCCCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCC--CChhhhccC
Confidence 54332 23456899999999999888999999999999999999999999764433222111111110 000001123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.++.+++.+||+.||++|||+.|+++
T Consensus 231 s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 231 SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 578899999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=361.44 Aligned_cols=258 Identities=22% Similarity=0.337 Sum_probs=206.4
Q ss_pred hcCCccccccccCCcceEEEEEEcC----CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD----GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
.++|...+.||+|+||.||+|+..+ +..||+|.+.........+.+.+|++++++++||||+++++++.. +..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 87 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---EPT 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---SSC
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCC
Confidence 4578889999999999999998653 346999999765433445789999999999999999999999843 346
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||+++++|.+++... ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++.
T Consensus 88 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI--NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 8999999999999999743 24589999999999999999999987 899999999999999999999999999987
Q ss_pred ccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
.............++..|+|||.+.+..++.++||||||+++|||+| |+.||.......... .+..... ...+.
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~-~~~~~~~----~~~~~ 237 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG-VLEKGDR----LPKPD 237 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH-HHHHTCC----CCCCT
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH-HHhcCCC----CCCCC
Confidence 66543333344557788999999988899999999999999999999 999986433221111 1111111 11223
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
..+..+.+++.+||+.||++|||+.|+++.|+++++
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 345789999999999999999999999999999865
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=385.35 Aligned_cols=265 Identities=16% Similarity=0.222 Sum_probs=212.9
Q ss_pred cCHHHHHHHhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEE
Q 005859 392 FNLEEVERATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGIC 468 (673)
Q Consensus 392 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 468 (673)
+.+.++...+++|+..+.||+|+||+||+|+.++ ++.||||++.+... ......+.+|++++..++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3456677778999999999999999999999875 88999999975321 12234588999999999999999999999
Q ss_pred ecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeee
Q 005859 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLL 548 (673)
Q Consensus 469 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl 548 (673)
.+ .+..++|||||++|+|.+++... ...+++..+..++.||+.||+|||+. |||||||||+|||++.++.+||
T Consensus 144 ~~--~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~--giiHrDLKp~NILl~~~g~vkL 216 (437)
T 4aw2_A 144 QD--DNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL--HYVHRDIKPDNILMDMNGHIRL 216 (437)
T ss_dssp EC--SSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEE
T ss_pred ee--CCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC--CeEecccCHHHeeEcCCCCEEE
Confidence 55 47899999999999999999742 34699999999999999999999987 8999999999999999999999
Q ss_pred ccccccccccCcchhhhhccCCCCCccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhh
Q 005859 549 SDSGLHKLLADDIVFSMLKASAAMGYLAPEYTT-----TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVED 623 (673)
Q Consensus 549 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~ 623 (673)
+|||+++.............+||+.|+|||++. ...|+.++|||||||++|||+||+.||............+..
T Consensus 217 ~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 296 (437)
T 4aw2_A 217 ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 296 (437)
T ss_dssp CCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred cchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhc
Confidence 999999876554333334467999999999987 567999999999999999999999999765433322222211
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 005859 624 FIDPNLEGKFSVSEASNLGQIALHCTHESPSH--RPSIENVMQ 664 (673)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~ 664 (673)
....... ......+.++.+++.+||..+|++ ||+++|+++
T Consensus 297 ~~~~~~p-~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 297 KERFQFP-TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHCCCC-SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cccccCC-cccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1111111 111234578899999999888888 999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=375.63 Aligned_cols=260 Identities=22% Similarity=0.365 Sum_probs=197.8
Q ss_pred cCCccccccccCCcceEEEEEEcC----CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD----GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
..|...+.||+|+||+||+|+..+ +..||||.+.........++|.+|++++++++||||+++++++... .+..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC-SSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CCCeE
Confidence 346677899999999999998642 2468999987654344457899999999999999999999987543 35678
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++|+|.+++... ...+++..++.++.||++||+|||+. ||+||||||+|||+++++.+||+|||+++..
T Consensus 168 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEEECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC--CEecCccchheEEECCCCCEEEeeccccccc
Confidence 999999999999999732 34588999999999999999999998 8999999999999999999999999999876
Q ss_pred cCcchh---hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCC
Q 005859 558 ADDIVF---SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 558 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (673)
...... ......+++.|+|||.+.+..++.++|||||||++|||+| |..||.......... .+... .....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~-~~~~~----~~~~~ 317 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-YLLQG----RRLLQ 317 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH-HHHTT----CCCCC
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH-HHHcC----CCCCC
Confidence 443211 1233456788999999999999999999999999999999 566665432211111 11111 11122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 634 SVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 634 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
+...+..+.+++.+||+.||++|||+.|+++.|++++.+
T Consensus 318 p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 318 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 334567899999999999999999999999999998764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=369.08 Aligned_cols=257 Identities=22% Similarity=0.373 Sum_probs=205.1
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcE----EEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSV----VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
++|...+.||+|+||+||+|++.. ++. ||+|.+...........+.+|+.++++++||||+++++++.. +..
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 89 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG---SSL 89 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB---SSE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---Ccc
Confidence 468888999999999999999654 443 888887655433444678899999999999999999999843 568
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH--GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT--TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC--CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 8999999999999999742 34689999999999999999999998 899999999999999999999999999987
Q ss_pred ccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 557 LADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 557 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
....... ......++..|+|||++.+..++.++|||||||++|||+| |+.||......... ..+........+
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~ 239 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-----DLLEKGERLAQP 239 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-----HHHHTTCBCCCC
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH-----HHHHcCCCCCCC
Confidence 7543221 2234557789999999998899999999999999999999 99998754322111 111111111222
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
...+.++.+++.+||+.||++|||+.|+++.|+++..
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 240 QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 3344578899999999999999999999999998864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=355.12 Aligned_cols=253 Identities=23% Similarity=0.417 Sum_probs=196.3
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCC---CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSC---KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|...+.||+|+||.||+|+.. ++.||||++..... ....+.+.+|++++++++||||+++++++.. .+..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 83 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK--EPNLCL 83 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC--C--CEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--CCceEE
Confidence 57888999999999999999975 88999999876432 1234678999999999999999999999954 467899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCC-CCcccCCcCCCCeEecC--------CCCeeec
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR-PGLVHPNLSAEKVLIHR--------RYNPLLS 549 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~ivHrDlk~~NILl~~--------~~~~kl~ 549 (673)
||||+++++|.+++. ...+++..+..++.|++.||+|||+.. .+|+||||||+||+++. ++.+||+
T Consensus 84 v~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999985 246899999999999999999999972 12999999999999986 6789999
Q ss_pred cccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcC
Q 005859 550 DSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNL 629 (673)
Q Consensus 550 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 629 (673)
|||+++...... .....|++.|+|||.+.+..++.++||||||+++|||+||+.||............. ....
T Consensus 159 Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~ 231 (271)
T 3dtc_A 159 DFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA----MNKL 231 (271)
T ss_dssp CCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH----TSCC
T ss_pred cCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh----cCCC
Confidence 999998665432 223468999999999998889999999999999999999999997654332222111 1122
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 005859 630 EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSI 669 (673)
Q Consensus 630 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i 669 (673)
....+...+..+.+++.+||+.||++|||+.|+++.|++|
T Consensus 232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 232 ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 2233444567899999999999999999999999999865
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=371.30 Aligned_cols=252 Identities=15% Similarity=0.227 Sum_probs=194.7
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|...+.||+|+||+||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv 94 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAII 94 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEee--CCEEEEE
Confidence 357899999999999999999987 58999999997653 334678999999999999999999999965 4789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC--eeeccccccccc
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN--PLLSDSGLHKLL 557 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~--~kl~DfGla~~~ 557 (673)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||++ ||+||||||+|||++.++. +||+|||+++..
T Consensus 95 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~--~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 95 MEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT--TCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 999999999999863 24589999999999999999999987 8999999999999987765 999999999754
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcc-hhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEK-SDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-sDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (673)
.... ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||............+..+............
T Consensus 169 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (361)
T 3uc3_A 169 VLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR 246 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSC
T ss_pred cccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCC
Confidence 3221 2234568999999999988887655 899999999999999999997643322222222222222221111223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 637 EASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+.++.+++.+||+.||++|||+.|+++
T Consensus 247 ~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 247 ISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 4578899999999999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=370.33 Aligned_cols=253 Identities=21% Similarity=0.305 Sum_probs=205.6
Q ss_pred HhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
..++|...+.||+|+||.||+|... +|+.||+|++...... ...+.+.+|++++++++||||+++++++.+ .+..+
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 104 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHY 104 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEE
Confidence 3567999999999999999999976 4899999999765422 234678899999999999999999999955 47889
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC---Ceeecccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY---NPLLSDSGLH 554 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~---~~kl~DfGla 554 (673)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++ .+||+|||++
T Consensus 105 lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 99999999999999863 34689999999999999999999998 899999999999998654 5999999999
Q ss_pred ccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 555 KLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||................. .......
T Consensus 179 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~ 254 (362)
T 2bdw_A 179 IEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY--DYPSPEW 254 (362)
T ss_dssp BCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCCTTGG
T ss_pred eEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC--CCCcccc
Confidence 8765432 22345789999999999998999999999999999999999999976433222211111111 1111112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...+.++.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 255 DTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp GGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 344678999999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=366.49 Aligned_cols=274 Identities=22% Similarity=0.365 Sum_probs=218.4
Q ss_pred ccCHHHHHHHhcCCccccccccCCcceEEEEEE------cCCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCcee
Q 005859 391 MFNLEEVERATQCFSEANLLGKSSFSATYKGIL------RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLAS 463 (673)
Q Consensus 391 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~ 463 (673)
.+...++....++|...+.||+|+||+||+|+. .+++.||||++.........+.+.+|+++++++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 345566666778999999999999999999984 246899999997654333456799999999999 7999999
Q ss_pred EeeEEecCCCCeEEEEEeecCCCChhhhhccccCC------------ccccCHHHHHHHHHHHHHHHHHHhcCCCCcccC
Q 005859 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGS------------EKVLEWATRISVIKGIAKGISYLHGKRPGLVHP 531 (673)
Q Consensus 464 l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHr 531 (673)
+++++... ....++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. ||+||
T Consensus 96 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~i~H~ 172 (316)
T 2xir_A 96 LLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHR 172 (316)
T ss_dssp EEEEECCT-TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT--TCCCS
T ss_pred EEEEEecC-CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC--Ccccc
Confidence 99998643 34589999999999999999754321 12389999999999999999999998 89999
Q ss_pred CcCCCCeEecCCCCeeeccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 005859 532 NLSAEKVLIHRRYNPLLSDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSIT 609 (673)
Q Consensus 532 Dlk~~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~ 609 (673)
||||+||+++.++.+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||+| |+.||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999986644321 12223457788999999998899999999999999999999 999986
Q ss_pred hhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 610 PFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
...........+..... ...+...+.++.+++.+||+.||++|||+.|+++.|+++++
T Consensus 253 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 253 GVKIDEEFCRRLKEGTR----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp TCCCSHHHHHHHHHTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccchhHHHHHHhccCcc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 54221111111111111 12223345789999999999999999999999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=378.19 Aligned_cols=254 Identities=21% Similarity=0.288 Sum_probs=205.4
Q ss_pred HhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
..++|...+.||+|+||+||+|... +|+.||+|++...... .+.+.+.+|++++++++|||||++++++.+ .+..+
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~ 86 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE--EGHHY 86 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC--SSEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE--CCEEE
Confidence 3567999999999999999999975 5899999999765432 234678999999999999999999999954 47899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEec---CCCCeeecccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIH---RRYNPLLSDSGLH 554 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~---~~~~~kl~DfGla 554 (673)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++ +++.+||+|||++
T Consensus 87 lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~--givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM--GVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 99999999999999873 34589999999999999999999998 899999999999998 4678999999999
Q ss_pred ccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 555 KLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
+....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.................+ ......
T Consensus 161 ~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~ 237 (444)
T 3soa_A 161 IEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD--FPSPEW 237 (444)
T ss_dssp BCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--CCTTTT
T ss_pred EEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC--CCcccc
Confidence 87654322 223457999999999999989999999999999999999999999765433222221111111 111122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...+.++.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 238 DTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 344578999999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=361.39 Aligned_cols=255 Identities=19% Similarity=0.274 Sum_probs=198.5
Q ss_pred hcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCC-cHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKS-DEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|...+.||+|+||+||+|+..+|+.||+|++....... ....+.+|++++++++||||+++++++.. .+..++|
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 97 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS--ERCLTLV 97 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC--SSCEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc--CCEEEEE
Confidence 36789999999999999999999889999999997653222 24678999999999999999999999954 4788999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||++ |+|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 98 FEFME-KDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH--RILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EECCS-EEHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EcCCC-CCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99997 5888888632 34589999999999999999999988 899999999999999999999999999987653
Q ss_pred cchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCc----------
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPN---------- 628 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~---------- 628 (673)
... ......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||..................+.
T Consensus 172 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 172 PVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred Ccc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 321 2334568999999999876 5689999999999999999999999865432211111100000000
Q ss_pred -------C--CCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 629 -------L--EGK-----FSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 629 -------~--~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
. ... .....+.++.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 000 01123467899999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=395.35 Aligned_cols=250 Identities=23% Similarity=0.379 Sum_probs=203.4
Q ss_pred ccccCCcceEEEEEEc---CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeecCC
Q 005859 409 LLGKSSFSATYKGILR---DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPN 485 (673)
Q Consensus 409 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~ 485 (673)
.||+|+||.||+|.++ ++..||||+++........++|.+|+++|++++|||||++++++.. +..++||||+++
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~lv~E~~~~ 419 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALMLVMEMAGG 419 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SSEEEEEECCTT
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CCeEEEEEeCCC
Confidence 7999999999999875 4668999999876545567889999999999999999999999854 458999999999
Q ss_pred CChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchh--
Q 005859 486 GNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVF-- 563 (673)
Q Consensus 486 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-- 563 (673)
|+|.+++... ...+++..+..++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+++........
T Consensus 420 g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~--~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 420 GPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK--NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp CBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred CcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC--CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 9999999632 34689999999999999999999998 7999999999999999999999999999876543211
Q ss_pred hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHH
Q 005859 564 SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLG 642 (673)
Q Consensus 564 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 642 (673)
......+++.|+|||++....++.++|||||||++|||+| |+.||.......... .+........+..++.++.
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~-----~i~~~~~~~~p~~~~~~l~ 569 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-----FIEQGKRMECPPECPPELY 569 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH-----HHHTTCCCCCCTTCCHHHH
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-----HHHcCCCCCCCCcCCHHHH
Confidence 1222345688999999998899999999999999999998 999997643322111 1111122234445668899
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 643 QIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 643 ~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
++|.+||+.||++||++.+|++.|+.++.
T Consensus 570 ~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 570 ALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999998754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=369.39 Aligned_cols=269 Identities=22% Similarity=0.346 Sum_probs=199.6
Q ss_pred HHHHHhcCCccccccccCCcceEEEEEEcC-Cc---EEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEec
Q 005859 396 EVERATQCFSEANLLGKSSFSATYKGILRD-GS---VVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCS 470 (673)
Q Consensus 396 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~---~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 470 (673)
++....++|...+.||+|+||.||+|+... +. .||||++..... ....+.+.+|++++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 333445789999999999999999999664 32 799999976532 2345789999999999999999999999865
Q ss_pred CCCC----eEEEEEeecCCCChhhhhccccC--CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC
Q 005859 471 KGRG----ECFLIYDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY 544 (673)
Q Consensus 471 ~~~~----~~~lv~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~ 544 (673)
.... ..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. ||+||||||+|||+++++
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR--NFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTS
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC--CcccCCCCcceEEEcCCC
Confidence 4221 23899999999999999964332 123589999999999999999999998 899999999999999999
Q ss_pred CeeeccccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchh
Q 005859 545 NPLLSDSGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVE 622 (673)
Q Consensus 545 ~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~ 622 (673)
.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||+| |+.||.............
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~- 253 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI- 253 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh-
Confidence 9999999999876543221 2223456778999999999899999999999999999999 899987643322211111
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 623 DFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
. ......+...+.++.+++.+||+.||++|||+.++++.|+++++
T Consensus 254 ---~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 254 ---G-GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp ---T-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---c-CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1 11112233455789999999999999999999999999999976
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=364.10 Aligned_cols=264 Identities=19% Similarity=0.350 Sum_probs=204.9
Q ss_pred HHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhcc--CCCCceeEeeEEecCCC--C
Q 005859 399 RATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL--KHENLASLRGICCSKGR--G 474 (673)
Q Consensus 399 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~~~--~ 474 (673)
...++|...+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++... +||||+++++++..... .
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 34568999999999999999999986 899999998643 344566666666665 99999999999876533 5
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcC------CCCcccCCcCCCCeEecCCCCeee
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK------RPGLVHPNLSAEKVLIHRRYNPLL 548 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~ivHrDlk~~NILl~~~~~~kl 548 (673)
..++||||+++|+|.++++. ..+++..++.++.|++.||+|||+. ++||+||||||+|||++.++.+||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred ceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 78999999999999999963 3589999999999999999999986 457999999999999999999999
Q ss_pred ccccccccccCcchh---hhhccCCCCCccCCccccCCCCCcc------hhHHHHHHHHHHHHhC----------CCCCC
Q 005859 549 SDSGLHKLLADDIVF---SMLKASAAMGYLAPEYTTTGRFTEK------SDIYAFGMIVFQILSG----------KCSIT 609 (673)
Q Consensus 549 ~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~k------sDVwSfGvvl~el~tG----------~~p~~ 609 (673)
+|||+++........ ......||+.|+|||++.+..++.+ +|||||||++|||+|| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 999999766543221 1124568999999999987766654 9999999999999999 55654
Q ss_pred hhhHhhhhccchhhh-cCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 610 PFTRQAAESSKVEDF-IDPNLEGKFS-----VSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 610 ~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
............... .........+ ..++.++.+++.+||+.||++|||+.||++.|+++.++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 332111111111111 1111222222 36778899999999999999999999999999999765
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=361.85 Aligned_cols=253 Identities=20% Similarity=0.377 Sum_probs=199.1
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
++|+..+.||+|+||+||+|+.. ++.||||++... ...+.|.+|++++++++||||+++++++. +..++|||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----~~~~lv~e 79 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL----NPVCLVME 79 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT----TTTEEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc----CCcEEEEE
Confidence 56888899999999999999985 788999998643 34578999999999999999999999884 34789999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCC-CCcccCCcCCCCeEecCCCC-eeeccccccccccC
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR-PGLVHPNLSAEKVLIHRRYN-PLLSDSGLHKLLAD 559 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~ivHrDlk~~NILl~~~~~-~kl~DfGla~~~~~ 559 (673)
|+++|+|.+++.... ....+++..++.++.|+++||+|||+.. .||+||||||+||+++.++. +||+|||+++....
T Consensus 80 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 80 YAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp CCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred cCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 999999999997432 2245789999999999999999999832 28999999999999998886 79999999976543
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhh-ccchhhhcCCcCCCCCCHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE-SSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 638 (673)
. .....|+..|+|||++.+..++.++||||||+++|||+||+.||......... ......... .......+
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 230 (307)
T 2eva_A 159 H----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR----PPLIKNLP 230 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC----CCCBTTCC
T ss_pred c----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC----CCcccccC
Confidence 2 22346899999999999989999999999999999999999998653211100 001111111 12223445
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
..+.+++.+||+.||++|||++|+++.|+++..
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 788999999999999999999999999998864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=369.36 Aligned_cols=264 Identities=21% Similarity=0.364 Sum_probs=214.1
Q ss_pred cCCccccccccCCcceEEEEEE-----cCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGIL-----RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
++|+..+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++...+.+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 5788899999999999999984 358899999997653 3344679999999999999999999999987666789
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR--RCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999999743 23589999999999999999999987 899999999999999999999999999987
Q ss_pred ccCcch--hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhc----------cchhhh
Q 005859 557 LADDIV--FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAES----------SKVEDF 624 (673)
Q Consensus 557 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~----------~~~~~~ 624 (673)
...... .......++..|+|||++.+..++.++||||||+++|||+||+.||.......... ....+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 654321 12233457888999999998889999999999999999999999876543221100 111122
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 625 IDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.........+...+..+.+++.+||+.||++|||++|+++.|+++..
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 22222233445566889999999999999999999999999998865
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=370.01 Aligned_cols=254 Identities=18% Similarity=0.283 Sum_probs=204.5
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccC----CCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTS----CKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
.+.|...+.||+|+||+||+|+.. +|+.||||++.... .....+.+.+|++++++++||||+++++++... +.
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~ 100 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD--GM 100 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CE
Confidence 356899999999999999999976 48999999986432 122457899999999999999999999999654 78
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC---eeecccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN---PLLSDSG 552 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~---~kl~DfG 552 (673)
.++||||+++|+|.+++.........+++..+..++.||+.||+|||++ ||+||||||+|||++.++. +||+|||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN--NIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999999988864433334689999999999999999999998 8999999999999987654 9999999
Q ss_pred ccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCC-
Q 005859 553 LHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEG- 631 (673)
Q Consensus 553 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~- 631 (673)
+++....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ...+.......
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~i~~~~~~~~ 252 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL-----FEGIIKGKYKMN 252 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHH-----HHHHHHTCCCCC
T ss_pred ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHH-----HHHHHcCCCCCC
Confidence 9987654322 2234578999999999999899999999999999999999999997643211 11111111100
Q ss_pred -CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 632 -KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 632 -~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
......+.++.+++.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 253 PRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001123578899999999999999999999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=367.55 Aligned_cols=262 Identities=20% Similarity=0.384 Sum_probs=211.0
Q ss_pred hcCCccccccccCCcceEEEEEEc--------CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR--------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSK 471 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 471 (673)
.++|...+.||+|+||.||+|+.. ++..||||++.........+.+.+|+++++++ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc-
Confidence 467889999999999999999863 46789999997654334456789999999999 89999999999954
Q ss_pred CCCeEEEEEeecCCCChhhhhccccC------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeE
Q 005859 472 GRGECFLIYDFVPNGNLLQHLDLEAG------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVL 539 (673)
Q Consensus 472 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NIL 539 (673)
.+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+. ||+||||||+||+
T Consensus 113 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 -DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ--KCIHRDLAARNVL 189 (334)
T ss_dssp -SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEE
T ss_pred -CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCccceEE
Confidence 4678999999999999999975421 123489999999999999999999998 8999999999999
Q ss_pred ecCCCCeeeccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhh
Q 005859 540 IHRRYNPLLSDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAE 617 (673)
Q Consensus 540 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~ 617 (673)
++.++.+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||+| |+.||.........
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 99999999999999987654322 12233456788999999988889999999999999999999 99998654332211
Q ss_pred ccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 618 SSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
. .+.... ....+...+.++.+++.+||+.||++|||+.|+++.|++++.
T Consensus 270 ~-~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 270 K-LLKEGH----RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp H-HHHHTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-HHhcCC----CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1 111111 112233455789999999999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=362.63 Aligned_cols=258 Identities=19% Similarity=0.338 Sum_probs=190.2
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|+..+.||+|+||.||+|+.. +|+.||||++.........+.+.+|++++++++||||+++++++.. .+..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT--ENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC--TTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE--CCeEEEE
Confidence 457888999999999999999976 4899999999766544455789999999999999999999999854 4789999
Q ss_pred EeecCCCChhhhhccccC--CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 480 YDFVPNGNLLQHLDLEAG--SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
|||++ |+|.+++..... ....+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN--KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 99997 699999864321 124589999999999999999999987 8999999999999999999999999999876
Q ss_pred cCcchhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhh------------
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF------------ 624 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~------------ 624 (673)
..... ......+|+.|+|||++.+. .++.++|||||||++|||+||+.||................
T Consensus 159 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 159 GIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 53221 22345689999999999764 58999999999999999999999996543321111100000
Q ss_pred ----cCCcCCC------------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 625 ----IDPNLEG------------KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 625 ----~~~~~~~------------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+.... ......+.++.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000000 011123468999999999999999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=372.48 Aligned_cols=249 Identities=20% Similarity=0.293 Sum_probs=201.0
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 476 (673)
.++|+..+.||+|+||+||+|+.+. |+.||||++.+... ....+.+.+|.++++.+ +||||+++++++.. .+..
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~ 99 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDRL 99 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCEE
Confidence 4689999999999999999999764 89999999976421 23446788999999998 79999999999954 4789
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK--GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CCcccCCCHHHEEECCCCCEEEccccceee
Confidence 999999999999999973 24589999999999999999999998 899999999999999999999999999986
Q ss_pred ccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHH
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (673)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.............. .. ..++..
T Consensus 174 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~----~~--~~~p~~ 246 (353)
T 3txo_A 174 GICNGV-TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN----DE--VVYPTW 246 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CC--CCCCTT
T ss_pred cccCCc-cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc----CC--CCCCCC
Confidence 433221 23345799999999999988899999999999999999999999976543322222211 11 122333
Q ss_pred HHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 005859 637 EASNLGQIALHCTHESPSHRPSI------ENVMQ 664 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RPs~------~evl~ 664 (673)
.+..+.+++.+||+.||++||++ .|+++
T Consensus 247 ~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 247 LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 55778999999999999999998 66654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=356.82 Aligned_cols=254 Identities=20% Similarity=0.318 Sum_probs=198.6
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|...+.||+|+||+||+|+..+|+.||||++..... ....+.+.+|++++++++||||+++++++... +..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC--CeEEEEE
Confidence 46888999999999999999998899999999976532 22346789999999999999999999999654 6789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++ +|.+++... ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++.....
T Consensus 80 e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR--RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp ECCSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EecCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 99975 999988642 24589999999999999999999998 8999999999999999999999999999876432
Q ss_pred chhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhh---------------
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF--------------- 624 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~--------------- 624 (673)
.. ......+|+.|+|||++.+. .++.++|||||||++|||+||+.||................
T Consensus 154 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence 21 22345689999999999764 58999999999999999999999997543221111110000
Q ss_pred -cCCcCC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 625 -IDPNLE-------GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 625 -~~~~~~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.++... .......+.++.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 0111234578899999999999999999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=357.19 Aligned_cols=254 Identities=17% Similarity=0.274 Sum_probs=199.1
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC-cHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS-DEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
++|+..+.||+|+||+||+|+.. +++.||||++....... ....+.+|++++++++||||+++++++... +..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC--CEEEEE
Confidence 47889999999999999999976 48999999997654322 246789999999999999999999999654 789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++ ++.+++... ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~e~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~--~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EECCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred EecCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 999975 666666432 34699999999999999999999998 899999999999999999999999999987653
Q ss_pred cchhhhhccCCCCCccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCC-----------
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDP----------- 627 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~----------- 627 (673)
... ......+|..|+|||++.+.. ++.++|||||||++|||+||..|+............+.+....
T Consensus 154 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 154 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 321 233456899999999998766 8999999999999999999988864322111110000000000
Q ss_pred -------------cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 628 -------------NLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 628 -------------~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..........+.++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000112234578899999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=364.88 Aligned_cols=258 Identities=22% Similarity=0.459 Sum_probs=203.3
Q ss_pred cCCccccccccCCcceEEEEEEcC-----CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-----GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
.+|...+.||+|+||.||+|+... +..||||.+...........+.+|++++++++||||+++++++.. .+..
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 121 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--YKPM 121 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec--CCCc
Confidence 467778999999999999998653 236999999765433345679999999999999999999999854 4778
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. ||+||||||+||++++++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM--NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999999742 24689999999999999999999998 899999999999999999999999999987
Q ss_pred ccCcchh--hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCC
Q 005859 557 LADDIVF--SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 557 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (673)
....... ......++..|+|||.+.+..++.++|||||||++|||+| |+.||........... +.. ......
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~-~~~----~~~~~~ 271 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-IND----GFRLPT 271 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHT----TCCCCC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHC----CCcCCC
Confidence 6543211 1223345778999999998899999999999999999999 9999865433222111 111 111122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 634 SVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 634 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
+...+..+.+++.+||+.||++||++.++++.|++++.
T Consensus 272 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 33456789999999999999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=361.67 Aligned_cols=245 Identities=19% Similarity=0.301 Sum_probs=204.9
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|...+.||+|+||+||+|+.. +|+.||+|++.+... ....+.+.+|+.+++.++||||+++++++.+ .+..++
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~l 83 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIFM 83 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe--CCEEEE
Confidence 57889999999999999999976 589999999976421 2345678899999999999999999999954 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 84 v~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 84 IMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK--DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp EECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 9999999999999973 24589999999999999999999987 89999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.............. ... .++...+
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~----~~~--~~p~~~~ 227 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----AEL--RFPPFFN 227 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----CCC--CCCTTSC
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCC--CCCCCCC
Confidence 43 2245789999999999999999999999999999999999999976433322221111 111 2233445
Q ss_pred HHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRP-----SIENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 664 (673)
.++.+++.+||+.||++|| +++|+++
T Consensus 228 ~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 228 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 7899999999999999999 8888874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=380.10 Aligned_cols=260 Identities=12% Similarity=0.209 Sum_probs=210.4
Q ss_pred HHHHHHHhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEec
Q 005859 394 LEEVERATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCS 470 (673)
Q Consensus 394 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 470 (673)
+.++....++|...+.||+|+||+||+|+.+. ++.||+|++.+... ....+.+.+|+++++.++|||||++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 45566667899999999999999999999875 88999999975321 2233568899999999999999999999954
Q ss_pred CCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecc
Q 005859 471 KGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSD 550 (673)
Q Consensus 471 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~D 550 (673)
.+..|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|
T Consensus 141 --~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~--givHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 141 --DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp --SSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECC
T ss_pred --CCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCCHHHeeECCCCCEEEec
Confidence 4789999999999999999863 2488999999999999999999998 899999999999999999999999
Q ss_pred ccccccccCcchhhhhccCCCCCccCCccccCCC----CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcC
Q 005859 551 SGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGR----FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFID 626 (673)
Q Consensus 551 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~ 626 (673)
||+++.............+||+.|+|||++.+.. ++.++|||||||++|||+||+.||..................
T Consensus 212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 291 (410)
T 3v8s_A 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 291 (410)
T ss_dssp CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred cceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc
Confidence 9999877654333334567999999999998655 889999999999999999999999765433222222211111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 005859 627 PNLEGKFSVSEASNLGQIALHCTHESPSH--RPSIENVMQ 664 (673)
Q Consensus 627 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~ 664 (673)
.... .....+.++.+++.+||+.+|.+ ||+++||++
T Consensus 292 ~~~p--~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 292 LTFP--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp CCCC--TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ccCC--CcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 1111 11234578899999999999988 999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=375.53 Aligned_cols=263 Identities=14% Similarity=0.176 Sum_probs=204.7
Q ss_pred HhcCCccccccccCCcceEEEEEEcC------CcEEEEEEecccCCCC----------cHHHHHHHHHHHhccCCCCcee
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRD------GSVVAVKCIAKTSCKS----------DEGEFLKGLKILTSLKHENLAS 463 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~H~niv~ 463 (673)
..++|.+.+.||+|+||.||+|.+.. ++.||||++....... ....+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34679999999999999999999765 4789999986543100 1123445666778889999999
Q ss_pred EeeEEecCCC--CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEec
Q 005859 464 LRGICCSKGR--GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIH 541 (673)
Q Consensus 464 l~~~~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~ 541 (673)
+++++..... ...++||||+ +++|.+++... ...+++..++.|+.||+.||+|||+. ||+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~--~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH--EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEEecCCHHHEEEe
Confidence 9999866422 4589999999 99999999742 24699999999999999999999998 899999999999999
Q ss_pred --CCCCeeeccccccccccCcchh------hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhH
Q 005859 542 --RRYNPLLSDSGLHKLLADDIVF------SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTR 613 (673)
Q Consensus 542 --~~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~ 613 (673)
.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999876543211 11234589999999999998999999999999999999999999975321
Q ss_pred hhhh--------ccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 614 QAAE--------SSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 614 ~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.... ...+....++.+. ....+.++.+++..||+.||++||++.+|++.|++++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 1111 0112222222211 12235789999999999999999999999999998875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=359.21 Aligned_cols=258 Identities=22% Similarity=0.348 Sum_probs=209.6
Q ss_pred cCCcccc-ccccCCcceEEEEEEc---CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 402 QCFSEAN-LLGKSSFSATYKGILR---DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 402 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
++|.+.+ .||+|+||.||+|.+. ++..||||++.........+.+.+|++++++++||||+++++++.. +..+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~ 85 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALM 85 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---CCcE
Confidence 4555555 8999999999999864 4788999999875434445789999999999999999999999832 4589
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++..
T Consensus 86 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK--NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC--CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 999999999999999632 34589999999999999999999998 8999999999999999999999999999876
Q ss_pred cCcch--hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 558 ADDIV--FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 558 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
..... .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||.......... .+.. ......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-~i~~----~~~~~~~ 235 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-FIEQ----GKRMECP 235 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH-HHHT----TCCCCCC
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH-HHhc----CCcCCCC
Confidence 54321 11223346788999999988889999999999999999999 999986543322111 1111 1112234
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
...+.++.+++.+||+.||++||++.++++.|++++.+
T Consensus 236 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 236 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 45567899999999999999999999999999998753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=357.75 Aligned_cols=261 Identities=22% Similarity=0.374 Sum_probs=205.7
Q ss_pred hcCCccccccccCCcceEEEEEEcC----CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD----GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
..+|...+.||+|+||.||+|+..+ ...||+|.+.........+.+.+|++++++++||||+++++++... .+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC-CCce
Confidence 3468888999999999999999653 2368999987654334456799999999999999999999997543 4567
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. ||+||||||+||++++++.+||+|||+++.
T Consensus 103 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK--KFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCchheEEECCCCCEEECccccccc
Confidence 8999999999999999632 34589999999999999999999988 899999999999999999999999999987
Q ss_pred ccCcchh---hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCC-CCChhhHhhhhccchhhhcCCcCCCC
Q 005859 557 LADDIVF---SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKC-SITPFTRQAAESSKVEDFIDPNLEGK 632 (673)
Q Consensus 557 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (673)
....... ......+++.|+|||.+.+..++.++||||||+++|||+||.. ||......... ...... ....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~-~~~~~~----~~~~ 252 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT-VYLLQG----RRLL 252 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH-HHHHTT----CCCC
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH-HHHhcC----CCCC
Confidence 6543321 2233456788999999998899999999999999999999554 44332211111 111111 1112
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 633 FSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 633 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
.+...+..+.+++.+||+.||++|||+.|+++.|++++..
T Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 253 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 2333457899999999999999999999999999998763
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=366.87 Aligned_cols=258 Identities=14% Similarity=0.158 Sum_probs=205.8
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~lv 479 (673)
++|...+.||+|+||+||+|+.. +|+.||||++.... ..+.+.+|+++++++ +||||+++++++... +..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~~lv 83 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG--KYNAMV 83 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC---SSCCHHHHHHHHHHHCSCTTSCCEEEEEEET--TEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHhhCCCCCCEEEEEEecC--CccEEE
Confidence 57889999999999999999964 58999999987543 234688999999999 999999999998654 788999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC-----eeecccccc
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN-----PLLSDSGLH 554 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~-----~kl~DfGla 554 (673)
|||+ +++|.+++... ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++. +||+|||++
T Consensus 84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~--~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 84 LELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK--NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 9999 99999999743 34699999999999999999999998 8999999999999999887 999999999
Q ss_pred ccccCcchh------hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhh--ccchhhhcC
Q 005859 555 KLLADDIVF------SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE--SSKVEDFID 626 (673)
Q Consensus 555 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~--~~~~~~~~~ 626 (673)
+........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||......... ...+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 876543211 123457899999999999999999999999999999999999999753211100 001100000
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 627 PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 627 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
+..........+ ++.+++..||+.||.+||++++|++.|++++.
T Consensus 238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 000000011123 89999999999999999999999999998864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=372.80 Aligned_cols=248 Identities=17% Similarity=0.273 Sum_probs=199.2
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCC--CcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCK--SDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 476 (673)
.++|+..+.||+|+||+||+|+.+. ++.||||++++.... ...+.+.+|..++.++ +|||||++++++.. .+..
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~ 128 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRL 128 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCEE
Confidence 4579999999999999999999775 889999999865422 2235688999999887 89999999999854 4789
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 129 ~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~--givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 999999999999999973 24699999999999999999999998 899999999999999999999999999986
Q ss_pred ccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhh-----hccchhhhcCCcCCC
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA-----ESSKVEDFIDPNLEG 631 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~-----~~~~~~~~~~~~~~~ 631 (673)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......+.... .
T Consensus 203 ~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~ 279 (396)
T 4dc2_A 203 GLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--I 279 (396)
T ss_dssp CCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--C
T ss_pred cccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--c
Confidence 33221 123446799999999999999999999999999999999999999953211100 000111111111 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCH
Q 005859 632 KFSVSEASNLGQIALHCTHESPSHRPSI 659 (673)
Q Consensus 632 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 659 (673)
.++...+.++.+++.+||+.||++||++
T Consensus 280 ~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 2334456789999999999999999996
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=365.25 Aligned_cols=258 Identities=22% Similarity=0.377 Sum_probs=203.6
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcE----EEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSV----VAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
.++|+..+.||+|+||+||+|+... ++. ||+|.+.........+.+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS---S
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC---C
Confidence 3578899999999999999999653 443 5778776655455678899999999999999999999999653 4
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.++|+||+++|+|.+++... ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC--CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 78999999999999999743 24589999999999999999999998 89999999999999999999999999998
Q ss_pred cccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCC
Q 005859 556 LLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 556 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (673)
....... .......+++.|+|||.+.+..++.++|||||||++|||+| |+.||......... ..+........
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-----~~~~~~~~~~~ 240 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----SILEKGERLPQ 240 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-----HHHHTTCCCCC
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-----HHHHcCCCCCC
Confidence 7654321 12233456778999999999999999999999999999999 99998764332211 11111112223
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 634 SVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 634 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
+...+.++.+++.+||+.||++|||+.|+++.|+++..
T Consensus 241 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 241 PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 34456789999999999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=361.38 Aligned_cols=253 Identities=23% Similarity=0.416 Sum_probs=201.8
Q ss_pred hcCCccccccccCCcceEEEEEEcC-C-------cEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-G-------SVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKG 472 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 472 (673)
.++|...+.||+|+||+||+|+... + ..||+|++.... ....+.+.+|++++++++||||+++++++..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVC-- 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC--
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe--
Confidence 3578889999999999999998654 3 479999987643 3455789999999999999999999999954
Q ss_pred CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC-------
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN------- 545 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~------- 545 (673)
.+..++||||+++|+|.+++... ...+++..+..++.|++.||+|||++ ||+||||||+|||++.++.
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN--TLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC--CeECCCcCcceEEEecCCcccccccc
Confidence 46789999999999999999742 23489999999999999999999998 7999999999999998887
Q ss_pred -eeeccccccccccCcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhh
Q 005859 546 -PLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVED 623 (673)
Q Consensus 546 -~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~ 623 (673)
+||+|||+++...... ...++..|+|||++.+ ..++.++|||||||++|||+||..|+...............
T Consensus 159 ~~kl~Dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~ 233 (289)
T 4fvq_A 159 FIKLSDPGISITVLPKD-----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233 (289)
T ss_dssp EEEECCCCSCTTTSCHH-----HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred eeeeccCcccccccCcc-----ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc
Confidence 9999999997654322 2346888999999987 66999999999999999999965544332111111111111
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 624 FIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
... .+...+.++.+++.+||+.||++|||+.|+++.|++++.+
T Consensus 234 --~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 234 --RHQ----LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp --TCC----CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred --cCC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 111 1122245688999999999999999999999999999865
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=366.13 Aligned_cols=246 Identities=16% Similarity=0.251 Sum_probs=202.2
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|...+.||+|+||+||+|+.. +++.||||++..... ......+.+|+++++.++||||+++++++.. .+..++
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 86 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT--PTDIVM 86 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 57899999999999999999974 589999999875421 2234578999999999999999999999965 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+ +|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||+++++.+||+|||+++...
T Consensus 87 v~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~--givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH--KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EEECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 99999 7899998863 24589999999999999999999997 89999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRF-TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
.... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... ..+.. .....+...
T Consensus 160 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----~~i~~--~~~~~p~~~ 231 (336)
T 3h4j_B 160 DGNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----KKVNS--CVYVMPDFL 231 (336)
T ss_dssp TSBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----CCCCS--SCCCCCTTS
T ss_pred CCcc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----HHHHc--CCCCCcccC
Confidence 5432 234578999999999988776 78999999999999999999999653221111 11111 011233445
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.++.+++.+||+.||.+|||++|+++
T Consensus 232 s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 232 SPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 678899999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=366.62 Aligned_cols=251 Identities=20% Similarity=0.300 Sum_probs=189.4
Q ss_pred HhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
..++|...+.||+|+||.||+|+... ++.||||++.... ..+.+.+|++++++++||||+++++++.. .+..++
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFET--PTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEec--CCeEEE
Confidence 35679999999999999999999874 8899999997643 34578899999999999999999999955 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC---CCCeeeccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR---RYNPLLSDSGLHK 555 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~---~~~~kl~DfGla~ 555 (673)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||++. ++.+||+|||+++
T Consensus 126 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 126 VLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN--GIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp EECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 9999999999999863 34589999999999999999999998 8999999999999975 8899999999998
Q ss_pred cccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 556 LLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||............+... ..........
T Consensus 200 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~-~~~~~~~~~~ 276 (349)
T 2w4o_A 200 IVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC-EYYFISPWWD 276 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTT-CCCCCTTTTT
T ss_pred ccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhC-CCccCCchhh
Confidence 765432 1234568999999999999899999999999999999999999986543221111111111 0111112223
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+.++.+++.+||+.||++|||+.|+++
T Consensus 277 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 45678999999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=354.87 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=200.1
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|...+.||+|+||+||+|+.. ++..||+|++.........+.+.+|++++++++||||+++++++.. .+..++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED--YHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec--CCeEEEEE
Confidence 46888999999999999999976 4889999999876545566889999999999999999999999954 47899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEe---cCCCCeeeccccccccc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI---HRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl---~~~~~~kl~DfGla~~~ 557 (673)
||+++|+|.+++.........+++..+..++.|++.||+|||+. ||+||||||+||++ +.++.+||+|||+++..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ--HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC--CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999999864432335699999999999999999999987 89999999999999 45678999999999876
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
.... ......++..|+|||.+. +.++.++||||||+++|||++|+.||.............. ..+..... ....
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~--~~~~~~~~-~~~~ 251 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY--KEPNYAVE-CRPL 251 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCC---CCC
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc--CCcccccc-cCcC
Confidence 5432 223456899999999885 5689999999999999999999999976433222111111 11111110 1113
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.++.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 252 TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 467889999999999999999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=359.60 Aligned_cols=259 Identities=15% Similarity=0.176 Sum_probs=207.3
Q ss_pred hcCCccccccccCCcceEEEEEE-cCCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGIL-RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~l 478 (673)
.++|...+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+++++++ +|+||+++++++.. ....++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~l 83 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVL 83 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeEE
Confidence 35788999999999999999996 458999999986543 334688999999999 89999999999854 478899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC-----eeeccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN-----PLLSDSGL 553 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~-----~kl~DfGl 553 (673)
||||+ +++|.+++... ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++. +||+|||+
T Consensus 84 v~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 99999 99999999743 24589999999999999999999987 8999999999999988776 99999999
Q ss_pred cccccCcchh------hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHh---hhhccchhhh
Q 005859 554 HKLLADDIVF------SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQ---AAESSKVEDF 624 (673)
Q Consensus 554 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~---~~~~~~~~~~ 624 (673)
++........ ......||+.|+|||.+.+..++.++|||||||++|||+||+.||...... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 9876543221 123456899999999999989999999999999999999999999763211 0000000000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 625 IDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.... ........+.++.+++.+||+.||++||++++|++.|++++.
T Consensus 238 ~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 238 QSTP-LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HHSC-HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred cCcc-HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 0000 001112345789999999999999999999999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=379.79 Aligned_cols=265 Identities=18% Similarity=0.239 Sum_probs=210.6
Q ss_pred ccCHHHHHHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeE
Q 005859 391 MFNLEEVERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGI 467 (673)
Q Consensus 391 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~ 467 (673)
.+.++++....++|+..+.||+|+||+||+|+.+ +|+.||||++.+... ....+.+.+|.+++.+++||||++++++
T Consensus 50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 3456677777899999999999999999999986 599999999975321 1223458899999999999999999999
Q ss_pred EecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCee
Q 005859 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPL 547 (673)
Q Consensus 468 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~k 547 (673)
+.+ .+..|+||||+++|+|.+++... ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+|
T Consensus 130 ~~~--~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~--giiHrDLKp~NILld~~g~vk 202 (412)
T 2vd5_A 130 FQD--ENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL--GYVHRDIKPDNILLDRCGHIR 202 (412)
T ss_dssp EEC--SSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEE
T ss_pred Eee--CCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecccCHHHeeecCCCCEE
Confidence 954 47899999999999999999742 23689999999999999999999987 899999999999999999999
Q ss_pred eccccccccccCcchhhhhccCCCCCccCCcccc-------CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc
Q 005859 548 LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTT-------TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK 620 (673)
Q Consensus 548 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~ 620 (673)
|+|||+++.............+||+.|+|||++. ...|+.++|||||||++|||+||+.||............
T Consensus 203 L~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i 282 (412)
T 2vd5_A 203 LADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI 282 (412)
T ss_dssp ECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred EeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999877654332333457999999999987 356899999999999999999999999765433222222
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHH
Q 005859 621 VEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHR---PSIENVMQ 664 (673)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Ps~~evl~ 664 (673)
......... .......+.++.+++.+||. +|++| |+++|+++
T Consensus 283 ~~~~~~~~~-p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 283 VHYKEHLSL-PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HTHHHHCCC-C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HhcccCcCC-CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 211100111 11123345789999999999 99998 58988864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=367.20 Aligned_cols=268 Identities=19% Similarity=0.339 Sum_probs=215.1
Q ss_pred HHHHHHhcCCccccccccCCcceEEEEEEc------CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEE
Q 005859 395 EEVERATQCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGIC 468 (673)
Q Consensus 395 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 468 (673)
++++...++|...+.||+|+||.||+|+.. +++.||||.+...........+.+|++++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 444556778999999999999999999865 36789999997654333456799999999999999999999999
Q ss_pred ecCCCCeEEEEEeecCCCChhhhhccccC------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC
Q 005859 469 CSKGRGECFLIYDFVPNGNLLQHLDLEAG------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR 542 (673)
Q Consensus 469 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~ 542 (673)
.. .+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ ||+||||||+||+++.
T Consensus 98 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 98 SQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAE 173 (322)
T ss_dssp CS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT--TCBCSCCSGGGEEECT
T ss_pred cc--CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC--CCccCCCccceEEEcC
Confidence 54 4678999999999999999974321 113578999999999999999999998 8999999999999999
Q ss_pred CCCeeeccccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccc
Q 005859 543 RYNPLLSDSGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSK 620 (673)
Q Consensus 543 ~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~ 620 (673)
++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||............
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 999999999999866443221 2223456788999999998889999999999999999999 88888664332221111
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 621 VEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
. .... ...+...+..+.+++.+||+.||++|||+.|+++.|++++.
T Consensus 254 ~----~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 M----EGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp H----TTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred H----cCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1 1111 12233455789999999999999999999999999998765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=368.30 Aligned_cols=251 Identities=17% Similarity=0.306 Sum_probs=204.3
Q ss_pred HHHhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCC
Q 005859 398 ERATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSL-KHENLASLRGICCSKGR 473 (673)
Q Consensus 398 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 473 (673)
....++|...+.||+|+||+||+|+.+. |+.||||++.+... ....+.+..|.+++..+ +||||+++++++.+ .
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~ 90 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--K 90 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--S
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--C
Confidence 3456789999999999999999999864 89999999976421 23456788999999987 99999999999954 4
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL 553 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGl 553 (673)
+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGM 164 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEeCCCChhhEEECCCCCEEEeEChh
Confidence 789999999999999999973 24589999999999999999999998 899999999999999999999999999
Q ss_pred cccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCC
Q 005859 554 HKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 554 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (673)
++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||............... .+ .+
T Consensus 165 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~----~~ 237 (345)
T 1xjd_A 165 CKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP----FY 237 (345)
T ss_dssp CBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC----CC
T ss_pred hhhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CC----CC
Confidence 986432211 233467999999999999999999999999999999999999999764333222111111 11 22
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 005859 634 SVSEASNLGQIALHCTHESPSHRPSIE-NVM 663 (673)
Q Consensus 634 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~-evl 663 (673)
+...+.++.+++.+||+.||++||++. +++
T Consensus 238 p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 238 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 333557899999999999999999987 554
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=369.57 Aligned_cols=252 Identities=18% Similarity=0.291 Sum_probs=205.3
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... ..+...+.+|+++|++++||||+++++++.. .+..++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe--CCEEEEE
Confidence 357999999999999999999976 48999999987543 2344678999999999999999999999955 4789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC--CCCeeeccccccccc
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR--RYNPLLSDSGLHKLL 557 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~--~~~~kl~DfGla~~~ 557 (673)
|||+++|+|.+++... ...+++..+..++.||+.||+|||+. ||+||||||+|||++. ++.+||+|||+++..
T Consensus 127 ~E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~--givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 127 LEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EECCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC--CeeecccchHHeEEecCCCCceEEEecccceec
Confidence 9999999999998632 23589999999999999999999998 8999999999999974 467999999999877
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||............... ............
T Consensus 202 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~ 277 (387)
T 1kob_A 202 NPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC--DWEFDEDAFSSV 277 (387)
T ss_dssp CTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC--CCCCCSSTTTTS
T ss_pred CCCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccccccC
Confidence 54322 23346899999999999989999999999999999999999999764332211111110 111111222344
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.++.+++.+||+.||++|||+.|+++
T Consensus 278 s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 278 SPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 578999999999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=365.46 Aligned_cols=245 Identities=18% Similarity=0.240 Sum_probs=204.9
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|...+.||+|+||.||+|+.. +|+.||||++.+... ....+.+.+|++++++++||||+++++++.+ .+..++
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 118 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEEEE
Confidence 57889999999999999999976 589999999975421 2345678999999999999999999999854 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 119 v~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC--CcccccCccceEEECCCCCEEEcccccceecc
Confidence 99999999999999732 4589999999999999999999987 89999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.............. .. ..++...+
T Consensus 193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~----~~--~~~p~~~~ 262 (350)
T 1rdq_E 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GK--VRFPSHFS 262 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CC--CCCCTTCC
T ss_pred CC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc----CC--CCCCCCCC
Confidence 43 2245689999999999999999999999999999999999999976433222211111 11 12333456
Q ss_pred HHHHHHHHHccccCCCCCCC-----HHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPS-----IENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 664 (673)
.++.+++.+||+.||++||+ ++|+++
T Consensus 263 ~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 78999999999999999998 888764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=361.81 Aligned_cols=272 Identities=22% Similarity=0.328 Sum_probs=205.4
Q ss_pred CHHHHHHHhcCCccccccccCCcceEEEEEEcC----CcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeE
Q 005859 393 NLEEVERATQCFSEANLLGKSSFSATYKGILRD----GSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGI 467 (673)
Q Consensus 393 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~ 467 (673)
.++++....++|...+.||+|+||.||+|+... ++.||||++...... ...+.+.+|++++++++||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 344555567789999999999999999998653 458999998765322 233678999999999999999999999
Q ss_pred EecCCCC---eEEEEEeecCCCChhhhhcccc--CCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC
Q 005859 468 CCSKGRG---ECFLIYDFVPNGNLLQHLDLEA--GSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR 542 (673)
Q Consensus 468 ~~~~~~~---~~~lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~ 542 (673)
+...... ..++||||+++|+|.+++.... .....+++..++.++.|++.||+|||++ ||+||||||+||+++.
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR--NFLHRDLAARNCMLRD 182 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT--TCCCCCCSGGGEEECT
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCcceEEEcC
Confidence 8764332 4599999999999999985322 2335699999999999999999999987 8999999999999999
Q ss_pred CCCeeeccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccc
Q 005859 543 RYNPLLSDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSK 620 (673)
Q Consensus 543 ~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~ 620 (673)
++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||............
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 262 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence 99999999999987654322 12233456788999999999899999999999999999999 88888654332211111
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 621 VEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.. ......+...+.++.+++.+||+.||++|||+.++++.|+++++
T Consensus 263 -~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 263 -LH----GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp -HT----TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -Hc----CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 11122334455789999999999999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=362.63 Aligned_cols=260 Identities=22% Similarity=0.422 Sum_probs=206.9
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcE--EEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSV--VAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~ 477 (673)
++|...+.||+|+||.||+|+.. ++.. ||||.+.........+.+.+|+++++++ +||||+++++++... +..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--CceE
Confidence 57888999999999999999965 4654 4999987654444556899999999999 999999999999654 7899
Q ss_pred EEEeecCCCChhhhhcccc------------CCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC
Q 005859 478 LIYDFVPNGNLLQHLDLEA------------GSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN 545 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~ 545 (673)
+||||+++|+|.+++.... .....+++..++.++.|++.||+|||+. ||+||||||+||+++.++.
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCccceEEEcCCCe
Confidence 9999999999999997432 1234689999999999999999999987 8999999999999999999
Q ss_pred eeeccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhh
Q 005859 546 PLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDF 624 (673)
Q Consensus 546 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~ 624 (673)
+||+|||+++...... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||........... +..
T Consensus 181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~-~~~- 256 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQ- 256 (327)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-GGG-
T ss_pred EEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH-hhc-
Confidence 9999999987543221 2223456788999999988889999999999999999998 9999876433222111 111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 625 IDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
......+...+.++.+++.+||+.||++|||+.|+++.|+++++.
T Consensus 257 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 257 ---GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp ---TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111223334567899999999999999999999999999998763
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=358.36 Aligned_cols=260 Identities=14% Similarity=0.231 Sum_probs=201.0
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC--cHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS--DEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
-++|...+.||+|+||.||+|+.. +++.||||++....... ..+.+.+|++++++++||||+++++++... +..+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~ 110 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID--GQLY 110 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC--CeEE
Confidence 468999999999999999999976 58899999997653222 236789999999999999999999999654 7899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++..
T Consensus 111 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA--GATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC--cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 999999999999999732 4589999999999999999999998 8999999999999999999999999999876
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
............++..|+|||.+.+..++.++||||||+++|||+||+.||.......... .+.... ......+...
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~--~~~~~~~~~~ 261 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGA-HINQAI--PRPSTVRPGI 261 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHH-HHHSCC--CCGGGTSTTC
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHH-HhccCC--CCccccCCCC
Confidence 5543333344568999999999999899999999999999999999999997644321111 111110 0011223344
Q ss_pred HHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhhc
Q 005859 638 ASNLGQIALHCTHESPSHRP-SIENVMQELSSIIG 671 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RP-s~~evl~~L~~i~~ 671 (673)
+.++.+++.+||+.||++|| +++++++.|++++.
T Consensus 262 ~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 262 PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 56899999999999999999 99999999998765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=354.86 Aligned_cols=259 Identities=22% Similarity=0.347 Sum_probs=205.7
Q ss_pred CCccccccccCCcceEEEEEEcC----CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILRD----GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
.|...+.||+|+||+||+|++.+ +..||+|.+.........+.+.+|++++++++||||+++++++... ....++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP-EGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC-CCCcEE
Confidence 45667899999999999998643 2379999997654334457899999999999999999999998654 234589
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+.+|+|.+++.. ....+++..+..++.|++.||+|||+. ||+||||||+||++++++.+||+|||+++...
T Consensus 101 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ--KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999974 235689999999999999999999998 89999999999999999999999999998665
Q ss_pred Ccchh---hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 559 DDIVF---SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 559 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
..... ......++..|+|||.+.+..++.++||||||+++|||+||..|+............+.. ......+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 251 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ----GRRLPQPE 251 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT----TCCCCCCT
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc----CCCCCCCc
Confidence 43211 122345778899999999999999999999999999999966665432221111111111 11122233
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
..+..+.+++.+||+.||++|||++++++.|++++.
T Consensus 252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 252 YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 445789999999999999999999999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=356.35 Aligned_cols=259 Identities=17% Similarity=0.308 Sum_probs=208.6
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
.++|...+.||+|+||.||+|+.. +++.||+|++...... ...+.+.+|++++++++||||+++++++.....+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357889999999999999999976 5899999999765422 23467899999999999999999999987655678999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCC-----cccCCcCCCCeEecCCCCeeeccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG-----LVHPNLSAEKVLIHRRYNPLLSDSGL 553 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-----ivHrDlk~~NILl~~~~~~kl~DfGl 553 (673)
||||+++|+|.+++.........+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR--SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc--cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999999975433345599999999999999999999987 5 99999999999999999999999999
Q ss_pred cccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCC
Q 005859 554 HKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 554 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (673)
++....... ......++..|+|||.+.+..++.++||||||+++|||+||+.||........... +..... ...
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-i~~~~~----~~~ 236 (279)
T 2w5a_A 163 ARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK-IREGKF----RRI 236 (279)
T ss_dssp HHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHTCC----CCC
T ss_pred heeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH-Hhhccc----ccC
Confidence 987654322 12234688999999999988999999999999999999999999876543222111 111111 122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 005859 634 SVSEASNLGQIALHCTHESPSHRPSIENVMQELS 667 (673)
Q Consensus 634 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 667 (673)
+...+.++.+++.+||+.||++|||+.|+++.+.
T Consensus 237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 3345578999999999999999999999997643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=364.84 Aligned_cols=262 Identities=17% Similarity=0.254 Sum_probs=202.5
Q ss_pred HHHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccC----CCCcHHHHHHHHHHHhccCCCCceeEeeEEecC
Q 005859 397 VERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTS----CKSDEGEFLKGLKILTSLKHENLASLRGICCSK 471 (673)
Q Consensus 397 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 471 (673)
+....++|...+.||+|+||+||+|+.. +++.||+|++.... .....+.+.+|++++++++||||+++++++.+
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 99 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED- 99 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc-
Confidence 4455678999999999999999999975 48899999987542 12345789999999999999999999999955
Q ss_pred CCCeEEEEEeecCCCChhhhhccccC------------------------------------CccccCHHHHHHHHHHHH
Q 005859 472 GRGECFLIYDFVPNGNLLQHLDLEAG------------------------------------SEKVLEWATRISVIKGIA 515 (673)
Q Consensus 472 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------~~~~l~~~~~~~i~~~ia 515 (673)
.+..++||||+++|+|.+++..... ....+++..+..++.||+
T Consensus 100 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 100 -EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp -SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred -CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 4789999999999999999852110 022346778889999999
Q ss_pred HHHHHHhcCCCCcccCCcCCCCeEecCCC--CeeeccccccccccC---cchhhhhccCCCCCccCCccccC--CCCCcc
Q 005859 516 KGISYLHGKRPGLVHPNLSAEKVLIHRRY--NPLLSDSGLHKLLAD---DIVFSMLKASAAMGYLAPEYTTT--GRFTEK 588 (673)
Q Consensus 516 ~gL~yLH~~~~~ivHrDlk~~NILl~~~~--~~kl~DfGla~~~~~---~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k 588 (673)
.||+|||+. ||+||||||+||+++.++ .+||+|||+++.... ..........||+.|+|||.+.+ ..++.+
T Consensus 179 ~~l~~LH~~--~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 179 SALHYLHNQ--GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHHT--TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHHC--CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999998 799999999999998776 899999999986543 11122345678999999999875 678999
Q ss_pred hhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 589 SDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 589 sDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+|||||||++|||++|+.||................. ..........+..+.+++.+||+.||++|||+.|+++
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL--CFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccc--ccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 9999999999999999999976543322222111111 1111112234578999999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=360.88 Aligned_cols=249 Identities=19% Similarity=0.308 Sum_probs=194.3
Q ss_pred hcCCccccccccCCcceEEEEEE----cCCcEEEEEEecccCC---CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC
Q 005859 401 TQCFSEANLLGKSSFSATYKGIL----RDGSVVAVKCIAKTSC---KSDEGEFLKGLKILTSLKHENLASLRGICCSKGR 473 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 473 (673)
.++|+..+.||+|+||.||+++. .+|+.||+|++.+... ......+.+|++++++++||||+++++++.. .
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 93 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--G 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--C
Confidence 35789999999999999999997 4689999999976532 1234568899999999999999999999955 4
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL 553 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGl 553 (673)
+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK--GIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred CEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC--CEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 779999999999999999963 24588999999999999999999998 899999999999999999999999999
Q ss_pred cccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCC
Q 005859 554 HKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 554 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (673)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............... . ...
T Consensus 168 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~----~--~~~ 240 (327)
T 3a62_A 168 CKESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC----K--LNL 240 (327)
T ss_dssp C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT----C--CCC
T ss_pred ccccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC----C--CCC
Confidence 976443221 223456899999999999889999999999999999999999999764333222111111 1 122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005859 634 SVSEASNLGQIALHCTHESPSHRP-----SIENVMQ 664 (673)
Q Consensus 634 ~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 664 (673)
+...+.++.+++.+||+.||++|| ++.|+++
T Consensus 241 p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 241 PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 334457899999999999999999 7778764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=364.18 Aligned_cols=262 Identities=22% Similarity=0.408 Sum_probs=199.5
Q ss_pred hcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHH--HhccCCCCceeEeeEEec---CCCCe
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKI--LTSLKHENLASLRGICCS---KGRGE 475 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~---~~~~~ 475 (673)
.++|...+.||+|+||.||+|+. +++.||||++... ....+..|.++ +..++||||+++++.+.. .+...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 35788999999999999999987 5899999998643 23445555555 445899999999985532 33346
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcC-------CCCcccCCcCCCCeEecCCCCeee
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK-------RPGLVHPNLSAEKVLIHRRYNPLL 548 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~ivHrDlk~~NILl~~~~~~kl 548 (673)
.++||||+++|+|.+++.. ...++..+.+++.||+.||+|||+. ++||+||||||+|||++.++.+||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 7899999999999999963 2358999999999999999999986 447999999999999999999999
Q ss_pred ccccccccccCcch-------hhhhccCCCCCccCCccccC-------CCCCcchhHHHHHHHHHHHHhCCCCCChhhHh
Q 005859 549 SDSGLHKLLADDIV-------FSMLKASAAMGYLAPEYTTT-------GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQ 614 (673)
Q Consensus 549 ~DfGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~ 614 (673)
+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||+||..|+.+....
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987654221 11224468999999999986 35678999999999999999998776443211
Q ss_pred hhhcc------------------chhhhcCCcCCCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 615 AAESS------------------KVEDFIDPNLEGKF--SVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 615 ~~~~~------------------~~~~~~~~~~~~~~--~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
..... .......+.+...+ ....+.++.+++.+||+.||++|||++|+++.|++++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 00000 00011111111111 234667899999999999999999999999999998763
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=367.69 Aligned_cols=250 Identities=18% Similarity=0.330 Sum_probs=202.4
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|...+.||+|+||.||+|+... ++.||+|++.+... ....+.+.+|+++|++++|||||++++++.. .+..++
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~l 92 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD--EEDMFM 92 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEEE
Confidence 578899999999999999999765 88999999975421 2345688999999999999999999999954 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ--RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 9999999999999973 34699999999999999999999998 89999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCccccC---CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTT---GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
... ......||+.|+|||++.. ..|+.++|||||||++|||+||+.||........ ......+... ...++.
T Consensus 167 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~~~~~--~~~~p~ 241 (384)
T 4fr4_A 167 RET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFETT--VVTYPS 241 (384)
T ss_dssp TTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-HHHHHHHHHC--CCCCCT
T ss_pred CCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-HHHHHHHhhc--ccCCCC
Confidence 432 2345679999999999874 4589999999999999999999999964321110 0011111111 112334
Q ss_pred HHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 005859 636 SEASNLGQIALHCTHESPSHRPS-IENVMQ 664 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs-~~evl~ 664 (673)
..+..+.+++.+||+.||++||+ ++++.+
T Consensus 242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 45578999999999999999998 666653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=365.34 Aligned_cols=265 Identities=22% Similarity=0.358 Sum_probs=211.1
Q ss_pred HHhcCCccccccccCCcceEEEEEEcC-C-----cEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecC
Q 005859 399 RATQCFSEANLLGKSSFSATYKGILRD-G-----SVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSK 471 (673)
Q Consensus 399 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 471 (673)
...++|...+.||+|+||.||+|.... + ..||+|.+.........+.+.+|+++++++ +||||+++++++..
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 121 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH- 121 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-
Confidence 345789999999999999999999653 2 479999997654334456799999999999 89999999999954
Q ss_pred CCCeEEEEEeecCCCChhhhhccccC----------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEec
Q 005859 472 GRGECFLIYDFVPNGNLLQHLDLEAG----------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIH 541 (673)
Q Consensus 472 ~~~~~~lv~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~ 541 (673)
.+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. ||+||||||+|||++
T Consensus 122 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 -GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK--NCIHRDVAARNVLLT 198 (333)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGCEEE
T ss_pred -CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC--CcccCCcccceEEEC
Confidence 4678999999999999999974321 123579999999999999999999998 899999999999999
Q ss_pred CCCCeeeccccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhcc
Q 005859 542 RRYNPLLSDSGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESS 619 (673)
Q Consensus 542 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~ 619 (673)
.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||+| |..||...........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 9999999999999866443221 1223446778999999998899999999999999999999 8888865422211111
Q ss_pred chhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 620 KVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
..... .....+...+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 279 ~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 279 LVKDG----YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcC----CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 11111 1112233345789999999999999999999999999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=368.14 Aligned_cols=248 Identities=21% Similarity=0.254 Sum_probs=196.5
Q ss_pred ccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 405 SEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 405 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
...+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.. .+..++||||+
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~E~~ 168 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFES--KNDIVLVMEYV 168 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEECC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEEeCC
Confidence 34678999999999999975 58999999997653 2345689999999999999999999999965 47899999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEe--cCCCCeeeccccccccccCcc
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI--HRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl--~~~~~~kl~DfGla~~~~~~~ 561 (673)
++|+|.+++... ...+++..+..++.||+.||+|||+. ||+||||||+|||+ ++++.+||+|||+++......
T Consensus 169 ~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 169 DGGELFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM--YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp TTCEEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC--CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 999999988632 24589999999999999999999997 89999999999999 567899999999998765432
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 641 (673)
. .....||+.|+|||++....++.++|||||||++|||+||+.||................. ..........+.++
T Consensus 244 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 244 K--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW--DLEDEEFQDISEEA 319 (373)
T ss_dssp B--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--CSCSGGGTTSCHHH
T ss_pred c--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--CCChhhhccCCHHH
Confidence 2 2334689999999999988999999999999999999999999976543322221111111 11111112345789
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 005859 642 GQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 642 ~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+++.+||+.||++|||+.|+++
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHhc
Confidence 99999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=364.71 Aligned_cols=250 Identities=20% Similarity=0.276 Sum_probs=204.5
Q ss_pred HhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCe
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGE 475 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 475 (673)
..++|...+.||+|+||+||+|+.+. |+.||||++.+... ....+.+.+|.+++..+ +||||+++++++.. .+.
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~ 95 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR 95 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SSE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CCE
Confidence 34679999999999999999999875 88999999976421 23456788999999998 89999999999854 478
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.|+||||+++|+|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC--CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 99999999999999999732 4589999999999999999999998 89999999999999999999999999998
Q ss_pred cccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 556 LLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.............. .. ..++.
T Consensus 170 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~----~~--~~~p~ 242 (353)
T 2i0e_A 170 ENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----HN--VAYPK 242 (353)
T ss_dssp CCCCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CC--CCCCT
T ss_pred ccccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh----CC--CCCCC
Confidence 6432211 23345799999999999999999999999999999999999999976443322221111 11 12334
Q ss_pred HHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 005859 636 SEASNLGQIALHCTHESPSHRPS-----IENVMQ 664 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 664 (673)
..+.++.+++.+||+.||++||+ ++|+++
T Consensus 243 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 243 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 45678999999999999999995 466653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=361.57 Aligned_cols=247 Identities=17% Similarity=0.278 Sum_probs=198.9
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCC--cHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKS--DEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~ 477 (673)
++|...+.||+|+||+||+|+.+. ++.||||++.+..... ..+.+.+|.++++++ +||||+++++++.. .+..+
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~~ 86 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLF 86 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCEEE
Confidence 568889999999999999999864 8999999998654322 235688999999988 89999999999954 47899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 87 lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 99999999999999973 24589999999999999999999998 8999999999999999999999999999864
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhh-----hhccchhhhcCCcCCCC
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQA-----AESSKVEDFIDPNLEGK 632 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~ 632 (673)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........+.... ..
T Consensus 161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~ 237 (345)
T 3a8x_A 161 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IR 237 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--CC
T ss_pred cCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--CC
Confidence 3221 12334579999999999999999999999999999999999999996421100 0000111111111 12
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH
Q 005859 633 FSVSEASNLGQIALHCTHESPSHRPSI 659 (673)
Q Consensus 633 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 659 (673)
++...+.++.+++.+||+.||++||++
T Consensus 238 ~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 334456789999999999999999996
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=355.62 Aligned_cols=263 Identities=17% Similarity=0.269 Sum_probs=199.1
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|...+.||+|+||.||+|... +|+.||||++..... ......+.+|++++++++||||+++++++... +..++
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l 109 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELNI 109 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CcEEE
Confidence 46899999999999999999975 589999999976432 22346789999999999999999999999664 68999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++.........+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC--CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999999975333345689999999999999999999998 89999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ .....+.............+
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 264 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SLCKKIEQCDYPPLPSDHYS 264 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH--HHHHHHHTTCSCCCCTTTSC
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH--HHHHHhhcccCCCCcccccC
Confidence 4321 12234688999999999998999999999999999999999999864321100 00111111111111123345
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.++.+++.+||+.||++|||+.+|++.|+++..
T Consensus 265 ~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 265 EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 789999999999999999999999999998854
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=359.48 Aligned_cols=265 Identities=20% Similarity=0.314 Sum_probs=208.7
Q ss_pred hcCCccccccccCCcceEEEEEE-cCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecC--CCCeEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGIL-RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSK--GRGECF 477 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~~~ 477 (673)
.++|...+.||+|+||.||+++. .+++.||||++.... ....+.+.+|++++++++||||+++++++... .....+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 46799999999999999999997 458999999986543 33456789999999999999999999998632 235789
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++|+|.+++.........+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK--GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999999975443456799999999999999999999998 8999999999999999999999999998765
Q ss_pred cCcch--------hhhhccCCCCCccCCccccCCC---CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcC
Q 005859 558 ADDIV--------FSMLKASAAMGYLAPEYTTTGR---FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFID 626 (673)
Q Consensus 558 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~ 626 (673)
..... .......|+..|+|||.+.... ++.++||||||+++|||++|+.||........ .......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~ 261 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---SVALAVQ 261 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS---CHHHHHH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc---hhhHHhh
Confidence 32110 0112345789999999987654 78999999999999999999999865322111 1111111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 627 PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 627 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
...........+.++.+++.+||+.||.+|||+.++++.|+++..
T Consensus 262 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 111111223345789999999999999999999999999998754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=363.34 Aligned_cols=265 Identities=22% Similarity=0.391 Sum_probs=210.1
Q ss_pred hcCCccccccccCCcceEEEEEE-----cCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 401 TQCFSEANLLGKSSFSATYKGIL-----RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
.++|...+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++...+...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 35688899999999999999984 358899999997643 334568999999999999999999999987655557
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK--RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC--CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 89999999999999999743 23589999999999999999999987 89999999999999999999999999998
Q ss_pred cccCcchh--hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhh-----------ccchh
Q 005859 556 LLADDIVF--SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE-----------SSKVE 622 (673)
Q Consensus 556 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~-----------~~~~~ 622 (673)
........ ......++..|+|||.+.+..++.++||||||+++|||+||+.|+......... ...+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 76543221 122345677899999999888999999999999999999999887543211100 00111
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 623 DFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
+.+........+...+.++.+++.+||+.||++|||+.|+++.|+++..
T Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1122221222344556789999999999999999999999999998864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=362.46 Aligned_cols=261 Identities=16% Similarity=0.249 Sum_probs=197.7
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC--cHHHHHHHHHHHhccCCCCceeEeeEEecCCCC--e
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS--DEGEFLKGLKILTSLKHENLASLRGICCSKGRG--E 475 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~--~ 475 (673)
.++|...+.||+|+||.||+|+.. +++.||||++....... ....+.+|++++++++||||+++++++...... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 357889999999999999999974 58999999997654222 235788999999999999999999998654322 4
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.++||||+++|+|.+++.. ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 5899999999999999973 24589999999999999999999998 89999999999999999999999999998
Q ss_pred cccCcch--hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCC
Q 005859 556 LLADDIV--FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 556 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (673)
....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.................. .....
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~ 242 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI--PPSAR 242 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC--CHHHH
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC--Ccccc
Confidence 7654321 1223356899999999999999999999999999999999999999764332221111111100 00011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHH-HHHHHh
Q 005859 634 SVSEASNLGQIALHCTHESPSHRPSIENVM-QELSSI 669 (673)
Q Consensus 634 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl-~~L~~i 669 (673)
....+.++.+++.+||+.||++||++.+++ +.+.++
T Consensus 243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 122457899999999999999999665544 555554
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=364.39 Aligned_cols=252 Identities=20% Similarity=0.326 Sum_probs=199.3
Q ss_pred hcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCC--CCceeEeeEEecCCCCeEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKH--ENLASLRGICCSKGRGECF 477 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~~~ 477 (673)
.++|.+.+.||+|+||.||++...+++.||||++...... ...+.+.+|++++++++| |||+++++++.. .+..+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~~ 85 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIY 85 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee--CCEEE
Confidence 4568999999999999999999988999999999765322 223678999999999976 999999999965 47899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+|||| .+|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++ ++.+||+|||+++..
T Consensus 86 lv~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~--~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH--GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 99995 58899999973 34689999999999999999999998 899999999999997 578999999999876
Q ss_pred cCcchh-hhhccCCCCCccCCccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhc
Q 005859 558 ADDIVF-SMLKASAAMGYLAPEYTTT-----------GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFI 625 (673)
Q Consensus 558 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~ 625 (673)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .......
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~ 234 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAII 234 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---HHHHHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH---HHHHHHh
Confidence 543321 2234579999999999864 678999999999999999999999996532221 1222333
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 626 DPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
++.....++...+.++.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 3333334444455788999999999999999999999853
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=368.35 Aligned_cols=262 Identities=13% Similarity=0.163 Sum_probs=199.1
Q ss_pred hcCCccccccccCCcceEEEEEEc----CCcEEEEEEecccCCCC----------cHHHHHHHHHHHhccCCCCceeEee
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR----DGSVVAVKCIAKTSCKS----------DEGEFLKGLKILTSLKHENLASLRG 466 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~H~niv~l~~ 466 (673)
.++|...+.||+|+||.||+|+.. ++..||||++....... ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357899999999999999999976 47789999987653110 1234678889999999999999999
Q ss_pred EEecC--CCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC
Q 005859 467 ICCSK--GRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY 544 (673)
Q Consensus 467 ~~~~~--~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~ 544 (673)
++... +....++||||+ +++|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN--EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCcCHHHEEEccCC
Confidence 98762 246789999999 99999999732 3699999999999999999999988 899999999999999887
Q ss_pred --CeeeccccccccccCcchh------hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhh
Q 005859 545 --NPLLSDSGLHKLLADDIVF------SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA 616 (673)
Q Consensus 545 --~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~ 616 (673)
.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876433211 12345789999999999998999999999999999999999999954221111
Q ss_pred hccchhhhcCCcCCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 005859 617 ESSKVEDFIDPNLEGK-----FSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSI 669 (673)
Q Consensus 617 ~~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i 669 (673)
............+... .....+.++.+++.+||+.||++||++.+|++.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 1101111111111000 0013456899999999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=358.23 Aligned_cols=258 Identities=21% Similarity=0.332 Sum_probs=206.2
Q ss_pred HhcCCcccc-ccccCCcceEEEEEEc---CCcEEEEEEecccCCCC-cHHHHHHHHHHHhccCCCCceeEeeEEecCCCC
Q 005859 400 ATQCFSEAN-LLGKSSFSATYKGILR---DGSVVAVKCIAKTSCKS-DEGEFLKGLKILTSLKHENLASLRGICCSKGRG 474 (673)
Q Consensus 400 ~~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 474 (673)
..++|...+ .||+|+||.||+|.+. +++.||||++....... ..+++.+|++++++++||||+++++++. .+
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~ 90 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---AE 90 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE---SS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC---CC
Confidence 345677777 9999999999999653 36889999997653222 2467999999999999999999999983 25
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLH 554 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla 554 (673)
..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC--CeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 68899999999999999973 24589999999999999999999998 8999999999999999999999999999
Q ss_pred ccccCcchh--hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCC
Q 005859 555 KLLADDIVF--SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEG 631 (673)
Q Consensus 555 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 631 (673)
+........ ......++..|+|||.+.+..++.++||||||+++|||+| |+.||.......... .+.. ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~~~~----~~~~ 239 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEK----GERM 239 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-HHHT----TCCC
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHHc----CCCC
Confidence 876543221 1223346788999999988889999999999999999999 999987643322111 1111 1112
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 632 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
..+...+..+.+++.+||+.||++||++.++++.|++++.
T Consensus 240 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 240 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 2334456789999999999999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=352.12 Aligned_cols=253 Identities=24% Similarity=0.431 Sum_probs=200.8
Q ss_pred hcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
.++|...+.||+|+||.||+|... |+.||||++... ...+.+.+|++++++++||||+++++++... .+..++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CCceEEEE
Confidence 457889999999999999999875 889999998754 2456899999999999999999999987543 34689999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+++|+|.+++... ....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.....
T Consensus 95 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 95 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 999999999999743 123488999999999999999999997 8999999999999999999999999998765432
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
.....++..|+|||.+.+..++.++||||||+++|||+| |+.||.......... .+ ........+...+.
T Consensus 171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~-~~----~~~~~~~~~~~~~~ 241 (278)
T 1byg_A 171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-RV----EKGYKMDAPDGCPP 241 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH-HH----TTTCCCCCCTTCCH
T ss_pred ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HH----hcCCCCCCcccCCH
Confidence 123356888999999998899999999999999999998 999986543221111 11 11112223344567
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 242 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 89999999999999999999999999998753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=367.21 Aligned_cols=248 Identities=19% Similarity=0.284 Sum_probs=194.3
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHH-HhccCCCCceeEeeEEecCCCCeE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKI-LTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
.++|+..+.||+|+||+||+|+.+. ++.||||++.+... ......+.+|..+ ++.++||||+++++++.. .+..
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--~~~~ 114 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKL 114 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC--SSEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe--CCEE
Confidence 3578999999999999999999875 88999999976542 2233456777776 577899999999999955 4789
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 115 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 999999999999999973 24588999999999999999999988 899999999999999999999999999986
Q ss_pred ccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHH
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (673)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.............. ... .++..
T Consensus 189 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~----~~~--~~~~~ 261 (373)
T 2r5t_A 189 NIEHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN----KPL--QLKPN 261 (373)
T ss_dssp GBCCCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH----SCC--CCCSS
T ss_pred cccCCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh----ccc--CCCCC
Confidence 433221 23346799999999999999999999999999999999999999976443322222211 111 12233
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHH
Q 005859 637 EASNLGQIALHCTHESPSHRPSIENVM 663 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RPs~~evl 663 (673)
.+..+.+++.+||+.||++||++.+.+
T Consensus 262 ~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 262 ITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred CCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 457889999999999999999986433
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=378.00 Aligned_cols=249 Identities=20% Similarity=0.296 Sum_probs=196.3
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccC--CCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTS--CKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... .......+.+|++++++++||||+++++++... +..+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~ 224 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLC 224 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET--TEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC--CEEE
Confidence 467999999999999999999976 48999999997642 123345788999999999999999999999654 7899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhc-CCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHG-KRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ . ||+||||||+|||++.++.+||+|||+++.
T Consensus 225 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~--giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 99999999999999963 3468999999999999999999997 6 899999999999999999999999999986
Q ss_pred ccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHH
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (673)
...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||............... . ..++..
T Consensus 299 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----~--~~~p~~ 371 (446)
T 4ejn_A 299 GIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME----E--IRFPRT 371 (446)
T ss_dssp TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----C--CCCCTT
T ss_pred ccCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC----C--CCCCcc
Confidence 443221 234467999999999999999999999999999999999999999764333222211111 1 112334
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005859 637 EASNLGQIALHCTHESPSHRP-----SIENVMQ 664 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 664 (673)
.+.++.+++.+||+.||++|| +++|+++
T Consensus 372 ~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 372 LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 457899999999999999999 9999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=353.07 Aligned_cols=258 Identities=19% Similarity=0.293 Sum_probs=200.3
Q ss_pred HhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC----CCcHHHHHHHHHHHhccC---CCCceeEeeEEecC
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC----KSDEGEFLKGLKILTSLK---HENLASLRGICCSK 471 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~ 471 (673)
..++|+..+.||+|+||+||+|+.. +++.||||++..... ......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3568999999999999999999964 589999999975431 112356778888887775 99999999999764
Q ss_pred CCC---eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeee
Q 005859 472 GRG---ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLL 548 (673)
Q Consensus 472 ~~~---~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl 548 (673)
..+ ..++||||++ |+|.+++.... ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN--CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEcCCCCEEE
Confidence 322 5789999996 69999997432 23489999999999999999999998 7999999999999999999999
Q ss_pred ccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCc
Q 005859 549 SDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPN 628 (673)
Q Consensus 549 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 628 (673)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..................+.
T Consensus 162 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 162 ADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp CSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999998765432 23345689999999999999999999999999999999999999965433222111111100000
Q ss_pred --------------CC--C-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 629 --------------LE--G-----KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 629 --------------~~--~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.. . ......+..+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00 0 001123578899999999999999999999985
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=357.83 Aligned_cols=245 Identities=19% Similarity=0.239 Sum_probs=193.8
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|+..+.||+|+||+||+|+.. +|+.||||++...... .....+..|+..+.++ +||||++++++|.. .+..++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEE
Confidence 57999999999999999999987 5999999998654321 2234566677666666 89999999999965 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+ +|+|.+++... ...++|..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 135 v~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ--GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999 77999988643 24599999999999999999999987 79999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+........ +.........+...+
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-------~~~~~~~~~~~~~~~ 278 (311)
T 3p1a_A 209 TAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ-------LRQGYLPPEFTAGLS 278 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH-------HTTTCCCHHHHTTSC
T ss_pred cCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-------HhccCCCcccccCCC
Confidence 432 2334568999999998875 799999999999999999999766544322111 111111111122345
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.++.+++.+||+.||++|||++|+++
T Consensus 279 ~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 279 SELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 78999999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=368.33 Aligned_cols=250 Identities=21% Similarity=0.332 Sum_probs=198.7
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCC-CcHHHHHHHHHHHhccC--CCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLK--HENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~~~l 478 (673)
.+|.+.+.||+|+||+||+|...+++.||||++...... ...+.+.+|+++|++++ ||||+++++++... +..++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~--~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC--CEEEE
Confidence 468999999999999999999888999999999765322 23467899999999996 59999999998654 67999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||| +.+++|.+++... ..+++..+..++.||+.||+|||+. ||+||||||+|||++ ++.+||+|||+++...
T Consensus 134 v~E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~--~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH--GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEE-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT--TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred EEe-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 999 5688999999742 3688999999999999999999987 899999999999996 5789999999998765
Q ss_pred Ccchh-hhhccCCCCCccCCccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcC
Q 005859 559 DDIVF-SMLKASAAMGYLAPEYTTT-----------GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFID 626 (673)
Q Consensus 559 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~ 626 (673)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+..+++
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~~~~~ 282 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIID 282 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHC
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH---HHHHHHhC
Confidence 43221 2234579999999999865 368999999999999999999999996542211 12223333
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 627 PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 627 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.....++...+.++.+++.+||+.||++|||+.|+++
T Consensus 283 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 33333333334578899999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=391.16 Aligned_cols=250 Identities=21% Similarity=0.333 Sum_probs=202.1
Q ss_pred cccccCCcceEEEEEEc---CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKSSFSATYKGILR---DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
+.||+|+||+||+|.+. .++.||||+++.... ....++|.+|+++|++++|||||++++++.. +..++|||||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEEEEEEcc
Confidence 47999999999999764 367899999976532 2235789999999999999999999999853 4578999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcch-
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV- 562 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 562 (673)
++|+|.+++.. ...+++..++.|+.||+.||+|||++ ||+||||||+|||+++++.+||+|||+++.+..+..
T Consensus 452 ~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~--~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 452 ELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp TTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC--CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 99999999963 34689999999999999999999998 899999999999999999999999999987754322
Q ss_pred -hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 563 -FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 563 -~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
.......+++.|+|||++....++.++|||||||++|||+| |+.||.......... .+........+..++.+
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~-----~i~~~~~~~~p~~~~~~ 600 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-----MLEKGERMGCPAGCPRE 600 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-----HHHTTCCCCCCTTCCHH
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----HHHcCCCCCCCCCCCHH
Confidence 12233456788999999999899999999999999999999 999997654332211 11111122334456688
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
+.+++.+||+.||++||++.+|++.|++++.
T Consensus 601 l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 601 MYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999998864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=357.15 Aligned_cols=252 Identities=21% Similarity=0.341 Sum_probs=205.1
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC-----cHHHHHHHHHHHhccCCCCceeEeeEEecCCCC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS-----DEGEFLKGLKILTSLKHENLASLRGICCSKGRG 474 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 474 (673)
.++|...+.||+|+||.||+|+.. +|+.||||++....... ..+.+.+|++++++++||||+++++++.. .+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN--RT 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 356889999999999999999976 48999999997654322 35689999999999999999999999954 47
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC----Ceeecc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY----NPLLSD 550 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~----~~kl~D 550 (673)
..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++ .+||+|
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~--~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 89999999999999999973 34689999999999999999999998 899999999999999888 799999
Q ss_pred ccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCC
Q 005859 551 SGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLE 630 (673)
Q Consensus 551 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 630 (673)
||+++...... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||............... .....
T Consensus 163 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~ 238 (321)
T 2a2a_A 163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV--SYDFD 238 (321)
T ss_dssp CTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT--CCCCC
T ss_pred CccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc--ccccC
Confidence 99998765432 223456899999999999889999999999999999999999999654332221111110 00111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 631 GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 631 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.......+..+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0111223467899999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=367.33 Aligned_cols=258 Identities=17% Similarity=0.295 Sum_probs=201.1
Q ss_pred hcCCccccccccC--CcceEEEEEEc-CCcEEEEEEecccCCCC-cHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 401 TQCFSEANLLGKS--SFSATYKGILR-DGSVVAVKCIAKTSCKS-DEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 401 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
.++|++.+.||+| +||.||+|+.. +|+.||||++....... ..+.+.+|++++++++|||||++++++... +..
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 101 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NEL 101 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC--CEE
Confidence 3578999999999 99999999987 59999999997654322 235688899999999999999999999654 789
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++|||||++|+|.+++.... ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||.+..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM--GYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999999997432 24589999999999999999999998 899999999999999999999999999865
Q ss_pred ccCcch------hhhhccCCCCCccCCccccC--CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhc---
Q 005859 557 LADDIV------FSMLKASAAMGYLAPEYTTT--GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFI--- 625 (673)
Q Consensus 557 ~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~--- 625 (673)
...... .......||..|+|||++.+ ..++.++|||||||++|||+||+.||.................
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 432211 11123468889999999987 5799999999999999999999999965322111111000000
Q ss_pred -CCc------------------------------------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 626 -DPN------------------------------------LEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 626 -~~~------------------------------------~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.. .....+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000 000122334567999999999999999999999985
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=360.74 Aligned_cols=247 Identities=22% Similarity=0.360 Sum_probs=200.3
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC--cHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS--DEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
.+.|...+.||+|+||+||+|+.. +|+.||||++....... ..+++.+|++++++++||||+++++++... +..+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 130 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAW 130 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CeEE
Confidence 355888999999999999999964 68999999997653221 235789999999999999999999999654 7899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||++ |+|.+++... ...+++..+..++.|+++||+|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 131 lv~e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp EEEECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEEecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 9999997 6888887532 24689999999999999999999998 8999999999999999999999999999876
Q ss_pred cCcchhhhhccCCCCCccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTT---TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
... ....||+.|+|||++. .+.++.++|||||||++|||+||+.||............. ....+.. ..
T Consensus 205 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~-~~~~~~~---~~ 275 (348)
T 1u5q_A 205 APA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPAL---QS 275 (348)
T ss_dssp SSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCCCC---CC
T ss_pred CCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-hcCCCCC---CC
Confidence 532 2356899999999984 5679999999999999999999999986643322211111 1111111 12
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...+..+.+++.+||+.||++|||++++++
T Consensus 276 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 276 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 234567899999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=357.40 Aligned_cols=263 Identities=19% Similarity=0.316 Sum_probs=207.9
Q ss_pred HHHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhc--cCCCCceeEeeEEecCCC--
Q 005859 398 ERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTS--LKHENLASLRGICCSKGR-- 473 (673)
Q Consensus 398 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~~-- 473 (673)
....++|...+.||+|+||.||+|+. +|+.||||++... ....+.+|++++.. ++||||+++++++.....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 34456899999999999999999998 4899999998643 35678889999887 799999999999876532
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHh--------cCCCCcccCCcCCCCeEecCCCC
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLH--------GKRPGLVHPNLSAEKVLIHRRYN 545 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~ivHrDlk~~NILl~~~~~ 545 (673)
...++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +. ||+||||||+||+++.++.
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~--~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP--AIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC--EEECSCCSGGGEEECTTSC
T ss_pred ceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC--CeeeCCCCHHHEEECCCCC
Confidence 278999999999999999963 35899999999999999999999 55 8999999999999999999
Q ss_pred eeeccccccccccCcchh---hhhccCCCCCccCCccccCC------CCCcchhHHHHHHHHHHHHhC----------CC
Q 005859 546 PLLSDSGLHKLLADDIVF---SMLKASAAMGYLAPEYTTTG------RFTEKSDIYAFGMIVFQILSG----------KC 606 (673)
Q Consensus 546 ~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSfGvvl~el~tG----------~~ 606 (673)
+||+|||+++........ ......||..|+|||++.+. .++.++|||||||++|||+|| +.
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 999999999876543211 12345689999999999865 234789999999999999999 67
Q ss_pred CCChhhHhhhhcc-----chhhhcCCcCCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 607 SITPFTRQAAESS-----KVEDFIDPNLEGK-FSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 607 p~~~~~~~~~~~~-----~~~~~~~~~~~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
||........... .......+.+... .....+..+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 7754321110001 1111112222211 1235678899999999999999999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=348.12 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=204.6
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
.++|...+.||+|+||.||+|.... ++.||+|++...... ...+.+.+|++++++++||||+++++++.. .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc--CCEEEE
Confidence 4679999999999999999999764 899999999765422 234678899999999999999999999954 477899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC---eeeccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN---PLLSDSGLHK 555 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~---~kl~DfGla~ 555 (673)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++. +||+|||++.
T Consensus 83 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 9999999999998863 24589999999999999999999998 8999999999999987655 9999999998
Q ss_pred cccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 556 LLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
....... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||.................. .......
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~ 232 (284)
T 3kk8_A 157 EVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD--YPSPEWD 232 (284)
T ss_dssp ECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--CCTTTTT
T ss_pred EcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc--CCchhhc
Confidence 7654322 23456899999999999999999999999999999999999998664333222211111111 1111122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+.++.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 233 TVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 34578999999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=367.54 Aligned_cols=251 Identities=14% Similarity=0.227 Sum_probs=191.2
Q ss_pred CCccc-cccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhc-cCCCCceeEeeEEec--CCCCeEE
Q 005859 403 CFSEA-NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTS-LKHENLASLRGICCS--KGRGECF 477 (673)
Q Consensus 403 ~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~--~~~~~~~ 477 (673)
+|... +.||+|+||+||+|+.. +|+.||||++.. ...+.+|++++.+ .+||||+++++++.. .+.+..+
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 45554 68999999999999976 489999999853 2467789988755 489999999998854 2245789
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC---CCCeeecccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR---RYNPLLSDSGLH 554 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~---~~~~kl~DfGla 554 (673)
+||||+++|+|.+++... ....+++..+..|+.||+.||+|||+. ||+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999999743 224689999999999999999999997 8999999999999998 789999999999
Q ss_pred ccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCC--cCCCC
Q 005859 555 KLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDP--NLEGK 632 (673)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~--~~~~~ 632 (673)
+...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...............+... .....
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 289 (400)
T 1nxk_A 212 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred cccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence 8765432 2334578999999999999999999999999999999999999996543221111111111111 11111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 633 FSVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 633 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
.....+.++.+++.+||+.||++|||+.|+++.
T Consensus 290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 123455789999999999999999999999863
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=357.79 Aligned_cols=244 Identities=18% Similarity=0.318 Sum_probs=202.6
Q ss_pred HhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC-------cHHHHHHHHHHHhccCCCCceeEeeEEecC
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS-------DEGEFLKGLKILTSLKHENLASLRGICCSK 471 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 471 (673)
..++|...+.||+|+||.||+|+.. +++.||||++....... ..+.+.+|++++++++||||+++++++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~- 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN- 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 4568999999999999999999965 58999999998654211 23467889999999999999999999954
Q ss_pred CCCeEEEEEeecCCC-ChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecc
Q 005859 472 GRGECFLIYDFVPNG-NLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSD 550 (673)
Q Consensus 472 ~~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~D 550 (673)
.+..++||||+.+| +|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|
T Consensus 101 -~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 101 -QGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK--DIIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp -SSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECC
T ss_pred -CCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC--CeEEeccCHHHEEEcCCCcEEEee
Confidence 47899999999777 99999873 34599999999999999999999998 899999999999999999999999
Q ss_pred ccccccccCcchhhhhccCCCCCccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcC
Q 005859 551 SGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRF-TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNL 629 (673)
Q Consensus 551 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 629 (673)
||+++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .....
T Consensus 174 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~---- 241 (335)
T 3dls_A 174 FGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VEAAI---- 241 (335)
T ss_dssp CTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TTTCC----
T ss_pred cccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hhhcc----
Confidence 999987655432 234568999999999988776 88999999999999999999999753221 11111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 630 EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 630 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
..+...+.++.+++.+||+.||++|||+.|+++.
T Consensus 242 --~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 242 --HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112245678999999999999999999999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=349.39 Aligned_cols=248 Identities=21% Similarity=0.354 Sum_probs=201.4
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
.++|...+.||+|+||.||+|+... ++.||||++..... ......+.+|++++++++||||+++++++.. .+..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 85 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVY 85 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec--CCEEE
Confidence 4678999999999999999999765 77999999865421 2234678999999999999999999999955 47899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~--~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT--TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC--CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 999999999999998632 4589999999999999999999987 8999999999999999999999999998655
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.||........... +.. .....+...
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~-----~~~~~~~~~ 230 (279)
T 3fdn_A 160 PSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-ISR-----VEFTFPDFV 230 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-HHH-----TCCCCCTTS
T ss_pred Cccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH-HHh-----CCCCCCCcC
Confidence 4332 2345689999999999998999999999999999999999999875433222111 111 111223334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
+..+.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 231 TEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 5788999999999999999999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=373.05 Aligned_cols=247 Identities=19% Similarity=0.336 Sum_probs=204.3
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|...+.||+|+||+||+|+.. +|+.||||++..... ....+.+.+|+++++.++||||+++++++.. .+..++
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~l 93 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST--PSDIFM 93 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 46888999999999999999976 599999999975421 1234678999999999999999999999955 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~--givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 94 VMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT--TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 9999999999999963 34699999999999999999999987 89999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRF-TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
.... ....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......... .+.+... ..+...
T Consensus 168 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~----~i~~~~~--~~p~~~ 239 (476)
T 2y94_A 168 DGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK----KICDGIF--YTPQYL 239 (476)
T ss_dssp TTCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH----HHHTTCC--CCCTTC
T ss_pred cccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH----HHhcCCc--CCCccC
Confidence 4322 234579999999999988775 789999999999999999999997543222111 1111111 122334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.++.+++.+||+.||++|||+.|+++
T Consensus 240 s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 240 NPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 567899999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=358.20 Aligned_cols=262 Identities=20% Similarity=0.318 Sum_probs=205.8
Q ss_pred hcCCccccccccCCcceEEEEEEc------CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRG 474 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 474 (673)
.++|...+.||+|+||.||+|++. +++.||||++..........++.+|+.++++++||||+++++++.. .+
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--SL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC--CC
Confidence 467899999999999999999842 3778999999755434445689999999999999999999999954 46
Q ss_pred eEEEEEeecCCCChhhhhccccC---CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC---CCCeee
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAG---SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR---RYNPLL 548 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~---~~~~kl 548 (673)
..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. ||+||||||+||+++. +..+||
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC--CeecCcCCHhHEEEecCCCcceEEE
Confidence 78999999999999999975432 124589999999999999999999988 8999999999999994 446999
Q ss_pred ccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcC
Q 005859 549 SDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFID 626 (673)
Q Consensus 549 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~ 626 (673)
+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||........... +..
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~--- 260 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-VTS--- 260 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHT---
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH-Hhc---
Confidence 99999986543321 12223457889999999998899999999999999999998 9888865433221111 111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 627 PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 627 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
......+...+..+.+++.+||+.||++||++.++++.|+.+..
T Consensus 261 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 261 -GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 11112233455789999999999999999999999999998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=346.33 Aligned_cols=253 Identities=20% Similarity=0.303 Sum_probs=204.7
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|+..+.||+|+||.||+|+.. +++.||||++.........+.+.+|++++++++||||+++++++... +..++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC--CEEEEE
Confidence 357889999999999999999976 58999999997654444557899999999999999999999998654 778999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||.++....
T Consensus 84 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 84 LEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp EECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 999999999999862 34689999999999999999999987 899999999999999999999999999986543
Q ss_pred cc-hhhhhccCCCCCccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 560 DI-VFSMLKASAAMGYLAPEYTTTGRF-TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 560 ~~-~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
.. ........|+..|+|||.+.+..+ +.++||||||+++|||+||+.||.......... ................
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 234 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY---SDWKEKKTYLNPWKKI 234 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH---HHHHTTCTTSTTGGGS
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH---HHhhhcccccCchhhc
Confidence 21 112234568899999999987765 789999999999999999999996543211111 1111111111112344
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 235 DSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 578899999999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=367.97 Aligned_cols=258 Identities=23% Similarity=0.329 Sum_probs=193.1
Q ss_pred HhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCeE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLK-HENLASLRGICCSKGRGEC 476 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~ 476 (673)
..++|...+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+++++. ||||+++++++...+....
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4568999999999999999999975 589999999865432 233467889999999997 9999999999976655679
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
|+|||||+ |+|.+++.. ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG--GLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC--CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 699998863 3589999999999999999999988 899999999999999999999999999986
Q ss_pred ccCc--------------------chhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhh
Q 005859 557 LADD--------------------IVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQA 615 (673)
Q Consensus 557 ~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~ 615 (673)
.... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5321 0112234578999999999986 579999999999999999999999996543222
Q ss_pred hhccchhhhcCC-----------------------------cCCCCC------------CHHHHHHHHHHHHHccccCCC
Q 005859 616 AESSKVEDFIDP-----------------------------NLEGKF------------SVSEASNLGQIALHCTHESPS 654 (673)
Q Consensus 616 ~~~~~~~~~~~~-----------------------------~~~~~~------------~~~~~~~l~~l~~~Cl~~~p~ 654 (673)
.....+...-.| .....+ ....+.++.+|+.+||+.||+
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 111111000000 000000 012346789999999999999
Q ss_pred CCCCHHHHHHH
Q 005859 655 HRPSIENVMQE 665 (673)
Q Consensus 655 ~RPs~~evl~~ 665 (673)
+|||++|+++.
T Consensus 319 ~R~t~~e~l~H 329 (388)
T 3oz6_A 319 KRISANDALKH 329 (388)
T ss_dssp GSCCHHHHTTS
T ss_pred cCCCHHHHhCC
Confidence 99999999753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=364.07 Aligned_cols=254 Identities=19% Similarity=0.286 Sum_probs=202.8
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|...+.||+|+||.||+|+.. +++.||+|++.........+.+.+|++++++++||||+++++++... +..++|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET--TEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC--CEEEEE
Confidence 357899999999999999999976 58999999997654333456899999999999999999999999654 789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.. ||+||||||+||+++.++.+||+|||+++....
T Consensus 110 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp ECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH-CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC-CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999999732 45899999999999999999999832 799999999999999999999999999976543
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhcc--------------------
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESS-------------------- 619 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~-------------------- 619 (673)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||...........
T Consensus 185 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 185 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp H---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred c---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 2 12345689999999999999999999999999999999999999865322111000
Q ss_pred ------------------chhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 620 ------------------KVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 620 ------------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..................+.++.+++.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000011111111224567999999999999999999999985
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=348.25 Aligned_cols=252 Identities=17% Similarity=0.274 Sum_probs=205.7
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|...+.||+|+||.||+|+... +..||+|++.... ....+.+.+|++++++++||||+++++++.. .+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-VEDVDRFKQEIEIMKSLDHPNIIRLYETFED--NTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeEEEE
Confidence 4578999999999999999999765 7799999997654 3456789999999999999999999999954 4789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEe---cCCCCeeecccccccc
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI---HRRYNPLLSDSGLHKL 556 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl---~~~~~~kl~DfGla~~ 556 (673)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||++ +.++.+||+|||+++.
T Consensus 85 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 85 MELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL--NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 999999999998863 34589999999999999999999988 89999999999999 7889999999999987
Q ss_pred ccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCH-
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV- 635 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 635 (673)
..... ......+|+.|+|||.+.+ .++.++||||||+++|||+||+.||............... .. ..+.
T Consensus 159 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~--~~~~~ 229 (277)
T 3f3z_A 159 FKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG----TF--TFPEK 229 (277)
T ss_dssp CCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CC--CCCHH
T ss_pred ccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC----CC--CCCch
Confidence 65432 2234568999999998865 4999999999999999999999999764333222111111 11 1111
Q ss_pred ---HHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhh
Q 005859 636 ---SEASNLGQIALHCTHESPSHRPSIENVMQ--ELSSII 670 (673)
Q Consensus 636 ---~~~~~l~~l~~~Cl~~~p~~RPs~~evl~--~L~~i~ 670 (673)
..+..+.+++.+||+.||++|||+.|+++ .+++..
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 230 DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 23578999999999999999999999985 344443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=378.91 Aligned_cols=252 Identities=16% Similarity=0.254 Sum_probs=204.7
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
.++|...+.||+|+||+||+|+.. +|+.||||++.+... ......+.+|++++++++||||+++++++.. .+..|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l~ 261 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET--KTDLC 261 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee--CCEEE
Confidence 367888999999999999999986 499999999976432 2345678999999999999999999999854 47899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++|+|.+++.........+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~--gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR--NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc--CCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999999875433345699999999999999999999998 8999999999999999999999999999876
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
..... .....+||+.|+|||++.+..|+.++|||||||++|||+||+.||...............+.... ..++...
T Consensus 340 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~--~~~p~~~ 416 (543)
T 3c4z_A 340 KAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA--VTYPDKF 416 (543)
T ss_dssp CTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC--CCCCTTS
T ss_pred cCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc--cCCCccc
Confidence 54322 12335799999999999999999999999999999999999999975421111111111111111 1234445
Q ss_pred HHHHHHHHHHccccCCCCCCCH
Q 005859 638 ASNLGQIALHCTHESPSHRPSI 659 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~ 659 (673)
+..+.+++.+||+.||++||++
T Consensus 417 s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 417 SPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCC
T ss_pred CHHHHHHHHHhccCCHhHCCCC
Confidence 6789999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=364.86 Aligned_cols=255 Identities=16% Similarity=0.292 Sum_probs=203.1
Q ss_pred hcCCccccccccCCcceEEEEEE----cCCcEEEEEEecccCC---CCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCC
Q 005859 401 TQCFSEANLLGKSSFSATYKGIL----RDGSVVAVKCIAKTSC---KSDEGEFLKGLKILTSL-KHENLASLRGICCSKG 472 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 472 (673)
.++|...+.||+|+||.||+|+. .+++.||||++..... ....+.+.+|+++++++ +||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 131 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 131 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence 36799999999999999999997 3689999999875431 23345678899999999 699999999998654
Q ss_pred CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccc
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSG 552 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfG 552 (673)
+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||
T Consensus 132 -~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 132 -TKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp -TEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred -ceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCcEEEeeCC
Confidence 6789999999999999999732 4589999999999999999999987 89999999999999999999999999
Q ss_pred ccccccCcchhhhhccCCCCCccCCccccCC--CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCC
Q 005859 553 LHKLLADDIVFSMLKASAAMGYLAPEYTTTG--RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLE 630 (673)
Q Consensus 553 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 630 (673)
+++..............||+.|+|||++.+. .++.++|||||||++|||+||+.||................... .
T Consensus 205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~ 282 (355)
T 1vzo_A 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--E 282 (355)
T ss_dssp EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC--C
T ss_pred CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc--C
Confidence 9987654433334445799999999999863 47899999999999999999999986432111111111111111 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 005859 631 GKFSVSEASNLGQIALHCTHESPSHRP-----SIENVMQE 665 (673)
Q Consensus 631 ~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 665 (673)
..++...+..+.+++.+||+.||++|| +++|+++.
T Consensus 283 ~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 283 PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 123344557889999999999999999 99998753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=361.48 Aligned_cols=254 Identities=15% Similarity=0.205 Sum_probs=205.1
Q ss_pred HhcCCccccccccCCcceEEEEE------EcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccC---CCCceeEeeEEec
Q 005859 400 ATQCFSEANLLGKSSFSATYKGI------LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK---HENLASLRGICCS 470 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~ 470 (673)
..++|.+.+.||+|+||+||+|+ ..+++.||||++... ...++.+|++++++++ |+||+++++++..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 45779999999999999999994 445889999998643 4567888888888886 9999999999965
Q ss_pred CCCCeEEEEEeecCCCChhhhhccccC-CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC-------
Q 005859 471 KGRGECFLIYDFVPNGNLLQHLDLEAG-SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR------- 542 (673)
Q Consensus 471 ~~~~~~~lv~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~------- 542 (673)
. +..++||||+++|+|.+++..... ....+++..++.|+.||+.||+|||++ |||||||||+|||++.
T Consensus 139 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~--~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 139 Q--NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC--EIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp S--SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCSGGGEEECGGGTCC--
T ss_pred C--CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC--CeecCCCCHHHEEecccccCccc
Confidence 4 678999999999999999974322 235699999999999999999999997 8999999999999998
Q ss_pred ----CCCeeeccccccccccCc-chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhh
Q 005859 543 ----RYNPLLSDSGLHKLLADD-IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE 617 (673)
Q Consensus 543 ----~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~ 617 (673)
++.+||+|||+++.+... .........||..|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-- 292 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-- 292 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence 899999999999765321 1122345679999999999999999999999999999999999999986532211
Q ss_pred ccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHhhc
Q 005859 618 SSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHR-PSIENVMQELSSIIG 671 (673)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R-Ps~~evl~~L~~i~~ 671 (673)
... ...... . .....+.+++..|++.+|.+| |+++++.+.|++++.
T Consensus 293 -~~~----~~~~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 293 -CKP----EGLFRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp -EEE----CSCCTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred -eee----chhccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 111 111111 1 124567889999999999999 689999999888764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=353.74 Aligned_cols=260 Identities=13% Similarity=0.185 Sum_probs=206.3
Q ss_pred hcCCccccccccCCcceEEEEEE-cCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGIL-RDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ..+++.+|++++++++|++++..++++... .+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS---SCCHHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc---chhHHHHHHHHHHHhhcCCCCCccccccCC-CCceEEE
Confidence 46799999999999999999997 469999999987543 334689999999999999888777766443 4678999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEe---cCCCCeeecccccccc
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI---HRRYNPLLSDSGLHKL 556 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl---~~~~~~kl~DfGla~~ 556 (673)
|||+ +++|.+++... ...+++..+..++.|++.||+|||++ ||+||||||+||++ ++++.+||+|||+++.
T Consensus 84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 9999 99999999632 24589999999999999999999998 89999999999999 4888999999999987
Q ss_pred ccCcchh------hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhh---ccchhhhcCC
Q 005859 557 LADDIVF------SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE---SSKVEDFIDP 627 (673)
Q Consensus 557 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~---~~~~~~~~~~ 627 (673)
....... ......|+..|+|||.+.+..++.++|||||||++|||+||+.||......... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 6553221 123456899999999999999999999999999999999999999753211100 0000000000
Q ss_pred cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 628 NLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 628 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
. ........+.++.+++.+||+.||++|||+.+|++.|++++.
T Consensus 238 ~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 238 P-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp C-HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred c-hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 0 000112234779999999999999999999999999999865
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=372.25 Aligned_cols=253 Identities=17% Similarity=0.255 Sum_probs=194.8
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCC----CC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKG----RG 474 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~ 474 (673)
.++|...+.||+|+||+||+|+.. +++.||||++..... ....+.+.+|+++|+.++|||||++++++.... ..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999976 489999999976431 223467889999999999999999999986532 24
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLH 554 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla 554 (673)
..|+||||+++ +|.+.+. ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~--~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 68999999975 5776664 2388999999999999999999998 8999999999999999999999999999
Q ss_pred ccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh------------
Q 005859 555 KLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE------------ 622 (673)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~------------ 622 (673)
+...... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+..........+.
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 212 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp -----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred eecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 8765432 23446789999999999999999999999999999999999999975432211111100
Q ss_pred ------hhcCCc--CC-------------C---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 623 ------DFIDPN--LE-------------G---KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 623 ------~~~~~~--~~-------------~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+... .. . ......+.++.+|+.+||+.||++|||++|+++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 00 0 001112577999999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=354.06 Aligned_cols=261 Identities=13% Similarity=0.195 Sum_probs=203.5
Q ss_pred HhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
..++|...+.||+|+||+||+|+.. +++.||||++.... ...++.+|++++++++|++++..++++... .+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecCC-CCceEE
Confidence 3468999999999999999999974 58999999876543 224588999999999999888887776543 467899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEe---cCCCCeeeccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI---HRRYNPLLSDSGLHK 555 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl---~~~~~~kl~DfGla~ 555 (673)
||||+ +|+|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+|||+ ++++.+||+|||+++
T Consensus 83 v~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEcc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 99999 99999998732 24589999999999999999999998 89999999999999 788999999999998
Q ss_pred cccCcch------hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcC
Q 005859 556 LLADDIV------FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNL 629 (673)
Q Consensus 556 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 629 (673)
....... .......||..|+|||.+.+..++.++|||||||++|||+||+.||......... ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~ 235 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKKM 235 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-SHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh-hhhhhhhcccc
Confidence 7654322 1123456899999999999999999999999999999999999999753221110 00111000000
Q ss_pred C---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 630 E---GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 630 ~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
. .......+.++.+++.+||+.||++|||++++++.|+++++
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 0 00111234789999999999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=348.48 Aligned_cols=251 Identities=20% Similarity=0.347 Sum_probs=206.7
Q ss_pred HhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEec--------
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCS-------- 470 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-------- 470 (673)
..++|+..+.||+|+||.||+|+.. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 3457899999999999999999986 69999999986542 357789999999999999999998753
Q ss_pred ------CCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC
Q 005859 471 ------KGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY 544 (673)
Q Consensus 471 ------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~ 544 (673)
......++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. ||+||||||+||++++++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK--KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETT
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCCHHHEEEcCCC
Confidence 11345799999999999999997432 24689999999999999999999988 899999999999999999
Q ss_pred CeeeccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhh
Q 005859 545 NPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF 624 (673)
Q Consensus 545 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~ 624 (673)
.+||+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||+||..|+...... ....
T Consensus 160 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~------~~~~ 231 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF------FTDL 231 (284)
T ss_dssp EEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH------HHHH
T ss_pred CEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHH------HHHh
Confidence 99999999998765432 223456899999999999888999999999999999999999876432211 1111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 625 IDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
....+ +...+..+.+++.+||+.||++|||+.|+++.|..+..
T Consensus 232 ~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 232 RDGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HTTCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred hcccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 11112 22234678899999999999999999999999998754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=349.60 Aligned_cols=250 Identities=24% Similarity=0.415 Sum_probs=202.4
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|...+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.. .+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIYES--TTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-ccchHHHHHHHHHHHhCCCCCeeehhhhccc--CCEEEEE
Confidence 457889999999999999999976 58999999997643 2334578999999999999999999999854 4789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEe---cCCCCeeecccccccc
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI---HRRYNPLLSDSGLHKL 556 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl---~~~~~~kl~DfGla~~ 556 (673)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||++ ++++.+||+|||+++.
T Consensus 85 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 85 MQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN--GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp ECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 999999999999863 24589999999999999999999998 89999999999999 7888999999999976
Q ss_pred ccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHH
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (673)
..... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||................. .........
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~ 233 (304)
T 2jam_A 159 EQNGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY--EFESPFWDD 233 (304)
T ss_dssp CCCBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCC--CCCTTTTTT
T ss_pred cCCCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC--CCCcccccc
Confidence 54432 2234589999999999999999999999999999999999999876433222111111111 111122334
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 637 EASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+..+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 234 ISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp SCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 5678999999999999999999999985
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=358.64 Aligned_cols=245 Identities=20% Similarity=0.349 Sum_probs=178.5
Q ss_pred ccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCeEEEEEeecC
Q 005859 407 ANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGICCSKGRGECFLIYDFVP 484 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~lv~E~~~ 484 (673)
.+.||+|+||+||+|+.. +++.||||++... ....+.+|+++++++. ||||+++++++.+ .+..++||||++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~~~lv~e~~~ 89 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHD--QLHTFLVMELLN 89 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEECCCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCEEEEEEEccC
Confidence 478999999999999986 4899999998643 3567889999999997 9999999999954 478999999999
Q ss_pred CCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC---CeeeccccccccccCcc
Q 005859 485 NGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY---NPLLSDSGLHKLLADDI 561 (673)
Q Consensus 485 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~---~~kl~DfGla~~~~~~~ 561 (673)
+|+|.+++.. ...+++..+..++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||+++......
T Consensus 90 ~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 90 GGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV--GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp SCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 9999999973 34699999999999999999999987 899999999999998765 79999999998665432
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhh---ccchhhhcCCcC--CCCCCHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE---SSKVEDFIDPNL--EGKFSVS 636 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~---~~~~~~~~~~~~--~~~~~~~ 636 (673)
. ......+|+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+..... .......
T Consensus 164 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (325)
T 3kn6_A 164 Q-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN 242 (325)
T ss_dssp ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHT
T ss_pred C-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccC
Confidence 2 233456899999999999999999999999999999999999999754321110 111111211111 1111123
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 637 EASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+.++.+++.+||+.||++|||++|+++
T Consensus 243 ~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 243 VSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp SCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 4678999999999999999999999873
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=369.23 Aligned_cols=254 Identities=19% Similarity=0.280 Sum_probs=192.6
Q ss_pred HHhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCC-------CcHHHHHHHHHHHhccCCCCceeEeeEEec
Q 005859 399 RATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCK-------SDEGEFLKGLKILTSLKHENLASLRGICCS 470 (673)
Q Consensus 399 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 470 (673)
...++|...+.||+|+||+||+|.... ++.||||++...... .....+.+|+++|++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 346789999999999999999999764 899999999764311 112358899999999999999999999843
Q ss_pred CCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC---CCee
Q 005859 471 KGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR---YNPL 547 (673)
Q Consensus 471 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~---~~~k 547 (673)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ ||+||||||+|||++.+ ..+|
T Consensus 212 ---~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~--~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 212 ---EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp ---SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESSSSSSCCEE
T ss_pred ---CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChHhEEEecCCCcceEE
Confidence 457999999999999998863 35689999999999999999999987 89999999999999754 4599
Q ss_pred eccccccccccCcchhhhhccCCCCCccCCccccC---CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhh
Q 005859 548 LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT---GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF 624 (673)
Q Consensus 548 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~ 624 (673)
|+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||............+...
T Consensus 283 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~ 360 (419)
T 3i6u_A 283 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360 (419)
T ss_dssp ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTT
T ss_pred EeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcC
Confidence 99999998775432 2234578999999999863 568899999999999999999999986532211111111110
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 625 IDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.. ..........+..+.+++.+||+.||++|||+.|+++
T Consensus 361 ~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 361 KY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CC-CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00 0000011123578999999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=363.96 Aligned_cols=259 Identities=14% Similarity=0.190 Sum_probs=204.6
Q ss_pred hcCCccccccccCCcceEEEEEEcC---------CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCcee--------
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD---------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS-------- 463 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-------- 463 (673)
.++|...+.||+|+||.||+|+... ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 3578999999999999999999764 789999998653 36889999999999999988
Q ss_pred -------EeeEEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCC
Q 005859 464 -------LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAE 536 (673)
Q Consensus 464 -------l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~ 536 (673)
+++++... .+..++||||+ +|+|.+++... ....+++..++.++.||+.||+|||++ ||+||||||+
T Consensus 115 ~~~~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dikp~ 188 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN--EYVHGNVTAE 188 (352)
T ss_dssp TTCSCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT--TCBCSCCCGG
T ss_pred CccCccchhhccccC-CcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCCHH
Confidence 56666542 46889999999 99999999743 235699999999999999999999998 8999999999
Q ss_pred CeEecCCC--CeeeccccccccccCcchh------hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 005859 537 KVLIHRRY--NPLLSDSGLHKLLADDIVF------SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSI 608 (673)
Q Consensus 537 NILl~~~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~ 608 (673)
|||++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 8999999999876543211 112346899999999999989999999999999999999999999
Q ss_pred ChhhHh-hhhccchhhhcC--CcCCCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 609 TPFTRQ-AAESSKVEDFID--PNLEGK--FSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 609 ~~~~~~-~~~~~~~~~~~~--~~~~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
...... ............ +.+... .....+.++.+++.+||+.||++|||+++|++.|++++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 764311 111111111111 011000 011235789999999999999999999999999999875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=350.06 Aligned_cols=250 Identities=20% Similarity=0.369 Sum_probs=207.5
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.+.|...+.||+|+||.||+|+.. +++.||||++.........+.+.+|++++++++||||+++++++... +..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEE
Confidence 346888999999999999999975 58999999998765455567899999999999999999999999654 678999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++++|.+++.. ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++....
T Consensus 99 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE--KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp EECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 999999999999862 4589999999999999999999998 899999999999999999999999999987654
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||.......... .+.....+ ..+...+.
T Consensus 172 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~----~~~~~~~~ 245 (303)
T 3a7i_A 172 TQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-LIPKNNPP----TLEGNYSK 245 (303)
T ss_dssp TBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHSCCC----CCCSSCCH
T ss_pred ccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH-HhhcCCCC----CCccccCH
Confidence 321 2234568899999999999999999999999999999999999986543322111 11111111 22233456
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
.+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 246 PLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 79999999999999999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=346.63 Aligned_cols=251 Identities=22% Similarity=0.360 Sum_probs=200.2
Q ss_pred CCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecC--CCCeEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSK--GRGECFL 478 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~~~l 478 (673)
.|...+.||+|+||.||+|.... +..||+|.+..... ....+.+.+|++++++++||||+++++++... .....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 46777889999999999999764 88999999876542 23346789999999999999999999988642 2356899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEec-CCCCeeeccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIH-RRYNPLLSDSGLHKLL 557 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~-~~~~~kl~DfGla~~~ 557 (673)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+..++|+||||||+||+++ +++.+||+|||+++..
T Consensus 107 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 9999999999999973 2458999999999999999999999733499999999999998 7889999999999765
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
.... .....|++.|+|||.+. +.++.++||||||+++|||+||+.||................. .....+...
T Consensus 183 ~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~ 255 (290)
T 1t4h_A 183 RASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV---KPASFDKVA 255 (290)
T ss_dssp CTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC---CCGGGGGCC
T ss_pred cccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC---CccccCCCC
Confidence 4432 23456899999999886 4699999999999999999999999865432222111111111 111222233
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.++.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 256 IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 467999999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=355.71 Aligned_cols=255 Identities=18% Similarity=0.270 Sum_probs=192.2
Q ss_pred HhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
..++|...+.||+|+||+||+|+.. +++.||||++...... ...+.+.+|++++++++||||+++++++... +..+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 109 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN--HRLH 109 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET--TEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC--CEEE
Confidence 4568999999999999999999965 5899999999765422 2245678999999999999999999999654 7899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEec-----CCCCeeecccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIH-----RRYNPLLSDSG 552 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~-----~~~~~kl~DfG 552 (673)
+||||++ |+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||++ +++.+||+|||
T Consensus 110 lv~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR--RCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC--CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999997 599999873 24589999999999999999999998 899999999999994 45569999999
Q ss_pred ccccccCcchhhhhccCCCCCccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCC----
Q 005859 553 LHKLLADDIVFSMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDP---- 627 (673)
Q Consensus 553 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~---- 627 (673)
+++....... ......+|..|+|||++.+.. ++.++|||||||++|||++|+.||..................+
T Consensus 183 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 183 LARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 9987653321 233456799999999998754 8999999999999999999999986543322111111110000
Q ss_pred ---------------cCCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 628 ---------------NLEGK-----FSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 628 ---------------~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..... .....+.++.+++.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 01113477899999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=363.99 Aligned_cols=260 Identities=16% Similarity=0.206 Sum_probs=204.6
Q ss_pred ccCHHHHHHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccC-----CCCceeE
Q 005859 391 MFNLEEVERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-----HENLASL 464 (673)
Q Consensus 391 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l 464 (673)
.+++++.....++|.+.+.||+|+||+||+|+.. +++.||||++... ....+.+..|+++++++. ||||+++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 4445555556788999999999999999999975 5899999999643 234467788999999986 9999999
Q ss_pred eeEEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC--
Q 005859 465 RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR-- 542 (673)
Q Consensus 465 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~-- 542 (673)
++++... +..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ ||+||||||+|||++.
T Consensus 102 ~~~~~~~--~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 102 HGKFMYY--DHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM--SLTHTDLKPENILLDDPY 174 (360)
T ss_dssp EEEEEET--TEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCTT
T ss_pred cceeeEC--CeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCcccEEEcccc
Confidence 9999664 7899999999 999999997432 23589999999999999999999987 8999999999999975
Q ss_pred -----------------------CCCeeeccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHH
Q 005859 543 -----------------------RYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVF 599 (673)
Q Consensus 543 -----------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ 599 (673)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 789999999999865442 23456899999999999999999999999999999
Q ss_pred HHHhCCCCCChhhHhhhhccchhhh--------------------cCC-c----CCCCC----------------CHHHH
Q 005859 600 QILSGKCSITPFTRQAAESSKVEDF--------------------IDP-N----LEGKF----------------SVSEA 638 (673)
Q Consensus 600 el~tG~~p~~~~~~~~~~~~~~~~~--------------------~~~-~----~~~~~----------------~~~~~ 638 (673)
||+||+.||.......... .+... ... . ..... .....
T Consensus 251 ell~g~~pf~~~~~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 329 (360)
T 3llt_A 251 ELYTGSLLFRTHEHMEHLA-MMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH 329 (360)
T ss_dssp HHHHSSCSCCCSSHHHHHH-HHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred HHHHCCCCCCCCcHHHHHH-HHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence 9999999996532211100 00000 000 0 00000 00112
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+.+++.+||+.||++|||++|+++
T Consensus 330 ~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 330 ELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 56789999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=346.74 Aligned_cols=251 Identities=20% Similarity=0.331 Sum_probs=201.3
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-----CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-----SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
++|...+.||+|+||.||+|+.. +++.||+|++...... ...+.+.+|++++++++||||+++++++.. .+.
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN--KTD 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC--CCe
Confidence 46889999999999999999987 5899999999765322 135789999999999999999999999965 478
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC----Ceeeccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY----NPLLSDS 551 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~----~~kl~Df 551 (673)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++ .+||+||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK--RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 9999999999999999963 34689999999999999999999988 899999999999999877 7999999
Q ss_pred cccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCC
Q 005859 552 GLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEG 631 (673)
Q Consensus 552 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 631 (673)
|+++...... ......+++.|+|||.+.+..++.++||||||+++|||+||+.||............... ......
T Consensus 157 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~ 232 (283)
T 3bhy_A 157 GIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV--NYDFDE 232 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCH
T ss_pred ccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhc--ccCCcc
Confidence 9998765432 123446889999999999889999999999999999999999998764332211111100 001110
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 632 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 233 EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 111223467899999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=379.25 Aligned_cols=254 Identities=19% Similarity=0.299 Sum_probs=206.8
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
.++|...+.||+|+||.||+|+.. +|+.||||++.+... ......+.+|+++|++++|||||++++++.+ .+..+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l~ 260 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALC 260 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee--CCEEE
Confidence 467999999999999999999986 599999999976421 2345678999999999999999999999854 47899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++|+|.+++... ....+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 261 lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~--gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE--RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC--CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999998743 223589999999999999999999998 8999999999999999999999999999877
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
..... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...............+.. ....++...
T Consensus 337 ~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~--~~~~~p~~~ 412 (576)
T 2acx_A 337 PEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYSERF 412 (576)
T ss_dssp CTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--CCCCCCTTS
T ss_pred ccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc--ccccCCccC
Confidence 54321 23457999999999999989999999999999999999999999754211111111111111 112234445
Q ss_pred HHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRP-----SIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 664 (673)
+.++.+++.+||+.||++|| +++||++
T Consensus 413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 67899999999999999999 7788864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=358.50 Aligned_cols=254 Identities=18% Similarity=0.296 Sum_probs=192.7
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|...+.||+|+||+||+|+.. +++.||||++...........+.+|++++++++||||+++++++.. .+..++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC--SSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee--CCEEEEEe
Confidence 47889999999999999999976 5899999999765433233356689999999999999999999965 46789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||++ |+|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ--KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp ECCS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT--TEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred cccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC--CccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 9997 5999988643 34589999999999999999999988 8999999999999999999999999999865433
Q ss_pred chhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcC-------------
Q 005859 561 IVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFID------------- 626 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~------------- 626 (673)
.. ......+|..|+|||++.+ ..++.++|||||||++|||+||+.||..................
T Consensus 154 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 154 TK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred cc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 21 2234467999999999876 56899999999999999999999999764332211111110000
Q ss_pred -------CcCCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 627 -------PNLEGK----FSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 627 -------~~~~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+..... .....+.++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 01123467899999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=369.53 Aligned_cols=196 Identities=19% Similarity=0.333 Sum_probs=154.8
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCC---CCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKG---RGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---~~~~ 476 (673)
++|...+.||+|+||+||+|+.. +++.||||++...... ...+.+.+|+++|++++|||||++++++.... ....
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 57999999999999999999976 5899999999764322 23467899999999999999999999985432 2578
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
|+||||+ +|+|.+++.. ...+++..+..++.||+.||+|||+. |||||||||+|||++.++.+||+|||+++.
T Consensus 133 ~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~--~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA--GILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC--CcCCCCCChhhEEECCCCCEeecccccchh
Confidence 9999998 5799999862 35699999999999999999999998 899999999999999999999999999987
Q ss_pred ccCcch--------------------------hhhhccCCCCCccCCcccc-CCCCCcchhHHHHHHHHHHHHhC
Q 005859 557 LADDIV--------------------------FSMLKASAAMGYLAPEYTT-TGRFTEKSDIYAFGMIVFQILSG 604 (673)
Q Consensus 557 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSfGvvl~el~tG 604 (673)
...... ......+||+.|+|||++. ...|+.++|||||||++|||+||
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 643211 1233457899999999864 56699999999999999999994
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=346.29 Aligned_cols=250 Identities=22% Similarity=0.338 Sum_probs=183.4
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
.++|.+.+.||+|+||.||+|+.. +|+.||||++..... ....+.+.+|++++++++||||+++++++.. .+..+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 87 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED--SNYVY 87 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC--SSEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc--CCeEE
Confidence 357889999999999999999974 689999999975421 2234678999999999999999999999955 47899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++..
T Consensus 88 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH--GILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EEEECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT--TEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 999999999999999732 24689999999999999999999998 8999999999999999999999999999876
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
..... ......+++.|+|||.+.+..++.++||||||+++|||+||+.||........ ........ ...+...
T Consensus 163 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~--~~~~~~~ 235 (278)
T 3cok_A 163 KMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----LNKVVLAD--YEMPSFL 235 (278)
T ss_dssp C-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSC--CCCCTTS
T ss_pred cCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----HHHHhhcc--cCCcccc
Confidence 53221 12235688999999999988899999999999999999999999865321111 11111111 1123334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.++.+++.+||+.||++|||++++++
T Consensus 236 ~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 236 SIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 578899999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=347.81 Aligned_cols=248 Identities=18% Similarity=0.264 Sum_probs=200.2
Q ss_pred HhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 476 (673)
..++|...+.||+|+||+||+|+.. +++.||||++..... .....++.+|+..+.++ +||||+++++++... +..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~~ 86 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DHM 86 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeE
Confidence 3467999999999999999999986 599999999986532 23456789999999999 999999999999654 789
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC-------------
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR------------- 543 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~------------- 543 (673)
++||||+++|+|.+++.........+++..++.++.||+.||+|||++ ||+||||||+||+++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEC---------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC--CEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999999999975432235689999999999999999999998 89999999999999844
Q ss_pred ------CCeeeccccccccccCcchhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhh
Q 005859 544 ------YNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA 616 (673)
Q Consensus 544 ------~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~ 616 (673)
..+||+|||.++...... ...|+..|+|||.+.+. .++.++|||||||++|||++|..++.......
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~- 238 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH- 238 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH-
T ss_pred cccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH-
Confidence 478999999998765432 24589999999999876 56789999999999999999987654332111
Q ss_pred hccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 617 ESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+.....+ ..+...+.++.+++.+||+.||++|||+.|+++
T Consensus 239 ---~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 239 ---EIRQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ---HHHTTCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHcCCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11111111 223344578999999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=361.53 Aligned_cols=266 Identities=18% Similarity=0.253 Sum_probs=203.1
Q ss_pred ccCHHHHHHHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCc----------HHHHHHHHHHHhccCCCC
Q 005859 391 MFNLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSD----------EGEFLKGLKILTSLKHEN 460 (673)
Q Consensus 391 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~E~~~l~~l~H~n 460 (673)
....+++....++|...+.||+|+||.||+|...+|+.||||++........ .+.+.+|++++++++|||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 3456888899999999999999999999999988899999999976432211 267899999999999999
Q ss_pred ceeEeeEEecC---CCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCC
Q 005859 461 LASLRGICCSK---GRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEK 537 (673)
Q Consensus 461 iv~l~~~~~~~---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~N 537 (673)
|+++++++... .....++||||++ |+|.+++.. ....+++..+..++.||+.||+|||+. ||+||||||+|
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~N 164 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA--GVVHRDLHPGN 164 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGG
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC--cCEecCCChHH
Confidence 99999998653 2346899999997 688888863 234689999999999999999999998 89999999999
Q ss_pred eEecCCCCeeeccccccccccCcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhh
Q 005859 538 VLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA 616 (673)
Q Consensus 538 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~ 616 (673)
|+++.++.+||+|||+++...... ......++..|+|||++.+ ..++.++|||||||++|||+||+.||........
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999998654432 2234568889999999887 6789999999999999999999999975432111
Q ss_pred hccch-------------------hhhcCCcCC---C----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 617 ESSKV-------------------EDFIDPNLE---G----KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 617 ~~~~~-------------------~~~~~~~~~---~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..... .+....... . ......+..+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11100 001101100 0 011223567899999999999999999999985
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=348.70 Aligned_cols=254 Identities=19% Similarity=0.250 Sum_probs=196.0
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCC-cHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKS-DEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
++|...+.||+|+||+||+|+... |+.||||++....... ..+.+.+|++++++++||||+++++++... +..++|
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK--RRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC--CeEEEE
Confidence 578899999999999999999865 8999999987653221 245688999999999999999999999654 788999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 81 FEYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH--NCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp EECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC--CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 999999999988763 34589999999999999999999988 899999999999999999999999999987654
Q ss_pred cchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch-----------------
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV----------------- 621 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~----------------- 621 (673)
... ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||.............
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 155 PSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred ccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 322 2234568899999999876 568999999999999999999999986543221111000
Q ss_pred ---hhhcCCcCCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 622 ---EDFIDPNLEGKF-----SVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 622 ---~~~~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.....+...... ....+.++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000000000 0124567899999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=363.54 Aligned_cols=257 Identities=19% Similarity=0.228 Sum_probs=197.8
Q ss_pred HHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCC----
Q 005859 398 ERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKG---- 472 (673)
Q Consensus 398 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 472 (673)
+...++|...+.||+|+||+||+|+.. +|+.||||++..... ...+|+++|++++|||||++++++....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 455678999999999999999999975 589999999865432 2347999999999999999999986532
Q ss_pred --------------------------------CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHH
Q 005859 473 --------------------------------RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISY 520 (673)
Q Consensus 473 --------------------------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~y 520 (673)
....++||||++ |+|.+.+.........+++..+..++.||++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 234789999997 58888776433334579999999999999999999
Q ss_pred HhcCCCCcccCCcCCCCeEec-CCCCeeeccccccccccCcchhhhhccCCCCCccCCccccCCC-CCcchhHHHHHHHH
Q 005859 521 LHGKRPGLVHPNLSAEKVLIH-RRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIV 598 (673)
Q Consensus 521 LH~~~~~ivHrDlk~~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl 598 (673)
||+. ||+||||||+|||++ .++.+||+|||+++...... ......+|..|+|||.+.+.. ++.++||||+||++
T Consensus 157 LH~~--gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 157 IHSL--GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHTT--TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHC--cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9987 899999999999998 68899999999998765432 223456789999999988754 89999999999999
Q ss_pred HHHHhCCCCCChhhHhhhhccchh------------------hhcCCcCCC-----CCCHHHHHHHHHHHHHccccCCCC
Q 005859 599 FQILSGKCSITPFTRQAAESSKVE------------------DFIDPNLEG-----KFSVSEASNLGQIALHCTHESPSH 655 (673)
Q Consensus 599 ~el~tG~~p~~~~~~~~~~~~~~~------------------~~~~~~~~~-----~~~~~~~~~l~~l~~~Cl~~~p~~ 655 (673)
|||++|+.||............+. +..-+.... ..+...+.++.+++.+||+.||++
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 999999999975433221111110 000011110 122334577999999999999999
Q ss_pred CCCHHHHHH
Q 005859 656 RPSIENVMQ 664 (673)
Q Consensus 656 RPs~~evl~ 664 (673)
|||+.|+++
T Consensus 313 R~t~~e~l~ 321 (383)
T 3eb0_A 313 RINPYEAMA 321 (383)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999984
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=387.01 Aligned_cols=261 Identities=22% Similarity=0.371 Sum_probs=209.1
Q ss_pred HHHhcCCccccccccCCcceEEEEEEcC----CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC
Q 005859 398 ERATQCFSEANLLGKSSFSATYKGILRD----GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGR 473 (673)
Q Consensus 398 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 473 (673)
+...++|...+.||+|+||+||+|++.. +..||||.+.........+.|.+|+.++++++||||+++++++.+
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--- 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--- 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---
Confidence 3345778999999999999999999753 567999998765433344789999999999999999999999843
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL 553 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGl 553 (673)
+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~--givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK--RFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC--CccccccchHhEEEeCCCCEEEEecCC
Confidence 4579999999999999999742 23589999999999999999999998 899999999999999999999999999
Q ss_pred cccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCC
Q 005859 554 HKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGK 632 (673)
Q Consensus 554 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (673)
++..............+++.|+|||.+.+..++.++|||||||++|||++ |..||........... +..... ..
T Consensus 538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~-i~~~~~----~~ 612 (656)
T 2j0j_A 538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-IENGER----LP 612 (656)
T ss_dssp CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHHTCC----CC
T ss_pred CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHcCCC----CC
Confidence 98776544333344557789999999998899999999999999999997 9999876433222111 111111 12
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 633 FSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 633 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.+...+..+.+++.+||+.||++|||+.|+++.|+++++
T Consensus 613 ~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 613 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 334456789999999999999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=359.56 Aligned_cols=249 Identities=20% Similarity=0.327 Sum_probs=198.5
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~l 478 (673)
.++|...+.||+|+||+||+|+.+ +|+.||||++.+... .+.+|++++.++ +||||+++++++.+ .+..++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDD--GKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEEE
Confidence 467999999999999999999976 489999999976531 245788889888 79999999999954 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC-C---Ceeecccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR-Y---NPLLSDSGLH 554 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~-~---~~kl~DfGla 554 (673)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||+.++ + .+||+|||++
T Consensus 94 v~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~--givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 94 VTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ--GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp EECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 9999999999999863 34689999999999999999999998 89999999999998543 2 4999999999
Q ss_pred ccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcC--CcCCCC
Q 005859 555 KLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFID--PNLEGK 632 (673)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~--~~~~~~ 632 (673)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+.. ......
T Consensus 168 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~i~~~~~~~~~~ 245 (342)
T 2qr7_A 168 KQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT-PEEILARIGSGKFSLSGG 245 (342)
T ss_dssp EECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC-HHHHHHHHHHCCCCCCST
T ss_pred ccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC-HHHHHHHHccCCcccCcc
Confidence 87654322 2234578999999999988789999999999999999999999996431110 0011111111 112222
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 633 FSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 633 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.....+.++.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 33445678999999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=352.64 Aligned_cols=252 Identities=18% Similarity=0.305 Sum_probs=194.3
Q ss_pred cCCccc-cccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEA-NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~l 478 (673)
+.|.+. +.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.++ +||||+++++++... +..++
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--~~~~l 88 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE--DRFYL 88 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CEEEE
Confidence 456663 78999999999999965 58999999997653 34567899999999995 799999999999654 78999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC---eeeccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN---PLLSDSGLHK 555 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~---~kl~DfGla~ 555 (673)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++. +||+|||+++
T Consensus 89 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK--GIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp EEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC--CceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 99999999999999732 4589999999999999999999998 8999999999999998776 9999999987
Q ss_pred cccCcch------hhhhccCCCCCccCCccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhh--------
Q 005859 556 LLADDIV------FSMLKASAAMGYLAPEYTTT-----GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA-------- 616 (673)
Q Consensus 556 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~-------- 616 (673)
....... .......||..|+|||++.. ..++.++|||||||++|||+||+.||........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 6542211 11223458999999999875 4589999999999999999999999865321100
Q ss_pred ---hccchhhhcCCcCCCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 617 ---ESSKVEDFIDPNLEGKFSV----SEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 617 ---~~~~~~~~~~~~~~~~~~~----~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.......+..... .++. ..+..+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 243 PACQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0000111111111 1121 23568999999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=353.41 Aligned_cols=257 Identities=22% Similarity=0.296 Sum_probs=198.7
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCC------C
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKG------R 473 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~ 473 (673)
++|...+.||+|+||+||+|+.. +|+.||||++...... .....+.+|++++++++||||+++++++.... .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57899999999999999999985 5899999998765432 23467889999999999999999999987643 3
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL 553 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGl 553 (673)
+..++||||+++ +|.+.+... ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN--KILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 568999999974 787777532 24589999999999999999999998 899999999999999999999999999
Q ss_pred cccccCcc---hhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh--hhcCC
Q 005859 554 HKLLADDI---VFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE--DFIDP 627 (673)
Q Consensus 554 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~--~~~~~ 627 (673)
++...... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.............. ....+
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 98764321 112234568999999999876 4589999999999999999999999875432211110000 00000
Q ss_pred cCC-----------------CCCCH-H------HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 628 NLE-----------------GKFSV-S------EASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 628 ~~~-----------------~~~~~-~------~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
... ..... . .+..+.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 000 00000 0 1356889999999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=344.86 Aligned_cols=246 Identities=18% Similarity=0.335 Sum_probs=203.8
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|...+.||+|+||.||+|+... ++.||||++..... ....+.+.+|++++++++||||+++++++.. .+..++
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 91 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD--RKRIYL 91 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc--CCEEEE
Confidence 578899999999999999999764 78999999865421 2234678999999999999999999999965 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++....
T Consensus 92 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER--KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999999732 4589999999999999999999987 89999999999999999999999999987654
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||........... +.... ..++...+
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~--~~~~~~~~ 236 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR----IVNVD--LKFPPFLS 236 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHTTC--CCCCTTSC
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH----Hhccc--cCCCCcCC
Confidence 321 2335688999999999998999999999999999999999999875433222111 11111 12233445
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 237 DGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 78899999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=354.02 Aligned_cols=260 Identities=17% Similarity=0.270 Sum_probs=190.2
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccC-CCCceeEeeEEec------CC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGICCS------KG 472 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~------~~ 472 (673)
..+|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++++. ||||+++++++.. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 457899999999999999999975 58999999986543 334567899999999996 9999999999853 22
Q ss_pred CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccc
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSG 552 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfG 552 (673)
....++||||+. |+|.+++.... ....+++..++.++.||+.||+|||+..++|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 346899999995 79999886432 2346999999999999999999999983349999999999999999999999999
Q ss_pred ccccccCcchh-----------hhhccCCCCCccCCccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhc
Q 005859 553 LHKLLADDIVF-----------SMLKASAAMGYLAPEYT---TTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAES 618 (673)
Q Consensus 553 la~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~ 618 (673)
+++........ ......+++.|+|||++ .+..++.++|||||||++|||+||+.||........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-- 261 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI-- 261 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh--
Confidence 99876543211 11134588999999998 466789999999999999999999999865432211
Q ss_pred cchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 619 SKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
...... .......+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 262 --~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 262 --VNGKYS----IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ------CC----CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --hcCccc----CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111111 11112223558899999999999999999999999998864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=355.27 Aligned_cols=258 Identities=19% Similarity=0.236 Sum_probs=195.0
Q ss_pred HHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC----cHHHHHHHHHHHhccCCCCceeEeeEEecCC
Q 005859 398 ERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS----DEGEFLKGLKILTSLKHENLASLRGICCSKG 472 (673)
Q Consensus 398 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 472 (673)
....++|...+.||+|+||.||+|+.. +|+.||||++....... ..+.+.+|++++++++||||+++++++..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 83 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-- 83 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee--
Confidence 344578999999999999999999976 48999999997543211 12478899999999999999999999954
Q ss_pred CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccc
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSG 552 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfG 552 (673)
.+..++||||+++ +|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH--WILHRDLKPNNLLLDENGVLKLADFG 157 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred CCceEEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC--CEECCCCCHHHEEEcCCCCEEEEecc
Confidence 4678999999975 898888632 34588899999999999999999998 89999999999999999999999999
Q ss_pred ccccccCcchhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcC--
Q 005859 553 LHKLLADDIVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNL-- 629 (673)
Q Consensus 553 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~-- 629 (673)
+++....... ......+|+.|+|||.+.+. .++.++|||||||++|||++|..||............+.....+..
T Consensus 158 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 158 LAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 236 (346)
T ss_dssp GGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence 9987654321 23345689999999999764 4899999999999999999999888654332221111111100000
Q ss_pred ---------------CCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 630 ---------------EGKFS-----VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 630 ---------------~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
....+ ...+.++.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00001 233578999999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=352.73 Aligned_cols=260 Identities=20% Similarity=0.334 Sum_probs=201.9
Q ss_pred HHHHHHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecC
Q 005859 394 LEEVERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSK 471 (673)
Q Consensus 394 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 471 (673)
+.++....++|...+.||+|+||.||+|+.. +|+.||||++.... .....+.+|+++++++ +||||+++++++...
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3344456778999999999999999999975 58999999987543 3456899999999999 899999999999764
Q ss_pred C----CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCee
Q 005859 472 G----RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPL 547 (673)
Q Consensus 472 ~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~k 547 (673)
. .+..++||||+++|+|.+++... ....+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH--KVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEECTTCCEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCcHHHEEEcCCCCEE
Confidence 3 46789999999999999999743 234689999999999999999999998 899999999999999999999
Q ss_pred eccccccccccCcchhhhhccCCCCCccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh
Q 005859 548 LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTT-----TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE 622 (673)
Q Consensus 548 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~ 622 (673)
|+|||+++....... ......|+..|+|||++. +..++.++|||||||++|||+||+.||........... +.
T Consensus 170 l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~ 247 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-IP 247 (326)
T ss_dssp ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-HH
T ss_pred EeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-hh
Confidence 999999987653221 123346899999999987 55689999999999999999999999865433221111 11
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 623 DFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
....+. ......+..+.+++.+||+.||++||++.++++
T Consensus 248 ~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 248 RNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HSCCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCcccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111111 112234578999999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=346.36 Aligned_cols=249 Identities=18% Similarity=0.277 Sum_probs=204.6
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCC--CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCK--SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
.++|...+.||+|+||.||+|+..+ ++.||+|++...... ...+.+.+|++++++++||||+++++++.. .+..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 91 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVF 91 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc--CCEEE
Confidence 3578889999999999999999875 889999998765322 234678899999999999999999999955 47899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 92 VVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 99999999999998863 24689999999999999999999998 8999999999999999999999999999876
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
..... ......++..|+|||.+.+..++.++||||||+++|||+||+.||.......... .+.... ...+...
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~--~~~~~~~ 238 (294)
T 2rku_A 166 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL----RIKKNE--YSIPKHI 238 (294)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHTTC--CCCCTTS
T ss_pred ccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHhhcc--CCCcccc
Confidence 53221 2233568999999999998889999999999999999999999987643322111 111111 1122334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+..+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 239 NPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 567899999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=369.29 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=202.7
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
.++|.+.+.||+|+||+||+|+.. +++.||||++..... ......+.+|++++++++||||+++++++.. .+..++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 98 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYI 98 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc--CCEEEE
Confidence 356899999999999999999976 589999999965432 3456789999999999999999999999954 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEec---CCCCeeeccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIH---RRYNPLLSDSGLHK 555 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~---~~~~~kl~DfGla~ 555 (673)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++ .++.+||+|||+++
T Consensus 99 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 9999999999998863 24689999999999999999999998 899999999999995 45679999999998
Q ss_pred cccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 556 LLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
...... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||................. ........
T Consensus 173 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~ 247 (486)
T 3mwu_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY--AFDLPQWR 247 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CSCSGGGG
T ss_pred ECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCcccC
Confidence 765442 2334578999999999875 599999999999999999999999976433222111111111 11111123
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+.++.+++.+||+.||++|||+.|+++
T Consensus 248 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 248 TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 44678999999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=347.45 Aligned_cols=255 Identities=16% Similarity=0.245 Sum_probs=187.6
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHH-HHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGE-FLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~-~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
.++|+..+.||+|+||+||+|+.. +|+.||||++..........+ +.++...++.++||||+++++++... +..++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--~~~~l 83 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE--GDVWI 83 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SSEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc--CCEEE
Confidence 467899999999999999999975 589999999976543222333 44455568888999999999999654 67899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||++ |+|.+++.........+++..+..++.|++.||+|||++. ||+||||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL-SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS-CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC-CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999997 5888887643333457999999999999999999999842 79999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCccc----cCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 559 DDIVFSMLKASAAMGYLAPEYT----TTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
.... .....|++.|+|||++ .+..++.++||||||+++|||+||+.||.......... .............
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~ 236 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL---KQVVEEPSPQLPA 236 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH---HHHHHSCCCCCCT
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH---HHHhccCCCCccc
Confidence 4322 2234689999999996 45668999999999999999999999997532221111 1111111111122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...+.++.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 334578999999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=371.08 Aligned_cols=251 Identities=22% Similarity=0.336 Sum_probs=205.3
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ....+.+.+|++++++++||||+++++++.. .+..+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 102 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYFY 102 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEE
Confidence 357889999999999999999976 589999999976532 3456789999999999999999999999955 47899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEe---cCCCCeeecccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI---HRRYNPLLSDSGLH 554 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl---~~~~~~kl~DfGla 554 (673)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++
T Consensus 103 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 99999999999998863 34689999999999999999999998 89999999999999 56789999999999
Q ss_pred ccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 555 KLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
+...... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||.................. ......
T Consensus 177 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~ 251 (484)
T 3nyv_A 177 THFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT--FELPQW 251 (484)
T ss_dssp HHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--CCSGGG
T ss_pred EEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--CCCccc
Confidence 8765543 2334568999999999875 6999999999999999999999999765433222111111111 111122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...+.++.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 252 KKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 345678999999999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=369.08 Aligned_cols=246 Identities=15% Similarity=0.197 Sum_probs=190.6
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHH---HHHhccCCCCceeEe-------eE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGL---KILTSLKHENLASLR-------GI 467 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~---~~l~~l~H~niv~l~-------~~ 467 (673)
.++|...+.||+|+||+||+|+.. +|+.||||++..... ....+.+.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467888999999999999999964 599999999975432 23347789999 566666899999998 55
Q ss_pred EecCCC----------C-----eEEEEEeecCCCChhhhhccccC---CccccCHHHHHHHHHHHHHHHHHHhcCCCCcc
Q 005859 468 CCSKGR----------G-----ECFLIYDFVPNGNLLQHLDLEAG---SEKVLEWATRISVIKGIAKGISYLHGKRPGLV 529 (673)
Q Consensus 468 ~~~~~~----------~-----~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~iv 529 (673)
+...+. + ..++||||+ +|+|.+++..... ....+++..++.|+.||+.||+|||++ ||+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~iv 228 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLV 228 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT--TEE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC--Cee
Confidence 533211 1 278999999 6899999974311 123456788999999999999999998 899
Q ss_pred cCCcCCCCeEecCCCCeeeccccccccccCcchhhhhccCCCCCccCCccccCC-----------CCCcchhHHHHHHHH
Q 005859 530 HPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG-----------RFTEKSDIYAFGMIV 598 (673)
Q Consensus 530 HrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVwSfGvvl 598 (673)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++.+. .++.++|||||||++
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTCE----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCCc----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 9999999999999999999999999864432 233456 899999999877 799999999999999
Q ss_pred HHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 599 FQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 599 ~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
|||+||+.||........ ...+.. . ....+.++.+++.+||+.||++|||+.|+++
T Consensus 304 ~elltg~~Pf~~~~~~~~----~~~~~~-~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 304 YWIWCADLPITKDAALGG----SEWIFR-S-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHSSCCC------CC----SGGGGS-S-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHCCCCCcccccccc----hhhhhh-h-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999865432211 111111 1 1123467899999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=346.76 Aligned_cols=259 Identities=21% Similarity=0.333 Sum_probs=198.7
Q ss_pred hcCCccccccccCCcceEEEEEEcC--Cc--EEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD--GS--VVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRG 474 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 474 (673)
.++|+..+.||+|+||.||+|++.. ++ .||||++..... ....+.+.+|++++++++||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 3578899999999999999998642 33 699999876532 22346789999999999999999999998643
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLH 554 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla 554 (673)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 94 PMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK--RFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp SCEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC--CcccCCCchheEEEcCCCCEEEcccccc
Confidence 378999999999999999743 24589999999999999999999998 8999999999999999999999999999
Q ss_pred ccccCcch--hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCC
Q 005859 555 KLLADDIV--FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEG 631 (673)
Q Consensus 555 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 631 (673)
+....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......... .+.......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~~~~~~~~~ 244 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH----KIDKEGERL 244 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHTSCCCC
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH----HHHccCCCC
Confidence 87654321 11223456778999999988889999999999999999999 999987653322211 111111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 632 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
..+...+.++.+++.+||+.||++|||+.++++.|+++..
T Consensus 245 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 245 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 2233456789999999999999999999999999998754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=352.19 Aligned_cols=257 Identities=19% Similarity=0.290 Sum_probs=203.3
Q ss_pred HHHhcCCccc-cccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCC
Q 005859 398 ERATQCFSEA-NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSL-KHENLASLRGICCSKGR 473 (673)
Q Consensus 398 ~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 473 (673)
+...++|.+. +.||+|+||.||+|+.. +++.||||++..... ......+.+|+++++++ +||||+++++++.. .
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~ 101 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--T 101 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--S
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--C
Confidence 3445567666 78999999999999976 489999999976532 23357899999999999 56999999999954 4
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC---CCCeeecc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR---RYNPLLSD 550 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~---~~~~kl~D 550 (673)
+..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+. ||+||||||+||+++. ++.+||+|
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~--givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN--NIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred CeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC--CeecCcCChHHEEEecCCCCCcEEEee
Confidence 7899999999999999998632 235689999999999999999999998 8999999999999998 78999999
Q ss_pred ccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCC
Q 005859 551 SGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLE 630 (673)
Q Consensus 551 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 630 (673)
||+++...... ......|++.|+|||++.+..++.++|||||||++|||+||+.||............... .....
T Consensus 178 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~ 253 (327)
T 3lm5_A 178 FGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV--NVDYS 253 (327)
T ss_dssp GGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCC
T ss_pred CccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc--ccccC
Confidence 99998765432 223456899999999999999999999999999999999999999764433222111111 11112
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 631 GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 631 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.......+..+.+++.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 254 EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 2223345678999999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=353.25 Aligned_cols=249 Identities=18% Similarity=0.282 Sum_probs=204.8
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCC--CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCK--SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
.++|...+.||+|+||.||+++..+ ++.||+|++...... ...+.+.+|++++++++||||+++++++.+ .+..+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 117 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVF 117 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEE
Confidence 4678899999999999999999765 889999998765322 234678999999999999999999999965 47899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++..
T Consensus 118 lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 118 VVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp EEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC--CCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 99999999999998863 24689999999999999999999998 8999999999999999999999999999876
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
..... ......|+..|+|||++.+..++.++||||||+++|||+||+.||............... .. ..+...
T Consensus 192 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~----~~~~~~ 264 (335)
T 2owb_A 192 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EY----SIPKHI 264 (335)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CC----CCCTTS
T ss_pred ccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--CC----CCCccC
Confidence 53221 223456899999999999888999999999999999999999998754322211111111 11 122334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+..+.+++.+||+.||++|||+.|+++
T Consensus 265 ~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 265 NPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 567899999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=369.44 Aligned_cols=251 Identities=20% Similarity=0.315 Sum_probs=198.6
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
.++|...+.||+|+||+||+|+.. ++..||||++..... ......+.+|++++++++|||||++++++.. .+..++
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED--KRNYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 346899999999999999999976 588999999976542 2345689999999999999999999999954 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC---CCeeeccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR---YNPLLSDSGLHK 555 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~---~~~kl~DfGla~ 555 (673)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++.. +.+||+|||+++
T Consensus 114 v~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 114 VMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH--NIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 9999999999998863 24589999999999999999999988 89999999999999764 459999999998
Q ss_pred cccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 556 LLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
...... ......||+.|+|||++. +.++.++||||+||++|||++|+.||................. ........
T Consensus 188 ~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~ 262 (494)
T 3lij_A 188 VFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY--TFDSPEWK 262 (494)
T ss_dssp ECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCCSGGGT
T ss_pred ECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCchhcc
Confidence 765432 233457999999999886 5699999999999999999999999976543322211111111 11111112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+..+.+++.+||+.||++|||+.|+++
T Consensus 263 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 263 NVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 34578999999999999999999999984
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.62 Aligned_cols=248 Identities=16% Similarity=0.201 Sum_probs=199.3
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~lv 479 (673)
++|...+.||+|+||+||+|+.. +++.||||++.. ...+.+.+|++++++++ ||||+++++++........++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 57899999999999999999864 589999999864 34578999999999997 9999999999977556788999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC-Ceeecccccccccc
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY-NPLLSDSGLHKLLA 558 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~-~~kl~DfGla~~~~ 558 (673)
|||+++++|.+++. .+++..+..++.|++.||+|||+. ||+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999884 388999999999999999999988 899999999999999776 89999999998765
Q ss_pred CcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhcc---------ch-------
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESS---------KV------- 621 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~---------~~------- 621 (673)
.... .....++..|+|||.+.+ ..++.++|||||||++|||+||+.||........... ..
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence 4322 234568889999999987 6689999999999999999999999843211100000 00
Q ss_pred --------hhhcCC--------cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 622 --------EDFIDP--------NLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 622 --------~~~~~~--------~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+.... ..........+.++.+++.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 0011112224678999999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=356.53 Aligned_cols=252 Identities=17% Similarity=0.298 Sum_probs=194.8
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCC----C
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGR----G 474 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~ 474 (673)
.++|...+.||+|+||.||+|+.. +|+.||||++...... ...+.+.+|++++++++||||+++++++..... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 457899999999999999999975 5999999999654322 224678899999999999999999999865421 3
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLH 554 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla 554 (673)
..|+||||+ +++|.+++.. ..+++..+..++.||++||+|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC--CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 569999999 8899999863 3589999999999999999999998 8999999999999999999999999999
Q ss_pred ccccCcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh-----------
Q 005859 555 KLLADDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE----------- 622 (673)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~----------- 622 (673)
+..... .....+|..|+|||++.+ ..++.++||||+||++|||++|+.||..............
T Consensus 176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 876542 234578999999999887 6799999999999999999999999975432211110000
Q ss_pred --------hhcC--CcCC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 623 --------DFID--PNLE----GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 623 --------~~~~--~~~~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.++. +... .......+..+.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000 0000 0112234578999999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=354.61 Aligned_cols=258 Identities=21% Similarity=0.313 Sum_probs=205.0
Q ss_pred HHHHHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCc-------HHHHHHHHHHHhcc-CCCCceeEe
Q 005859 395 EEVERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSD-------EGEFLKGLKILTSL-KHENLASLR 465 (673)
Q Consensus 395 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l-~H~niv~l~ 465 (673)
+......++|...+.||+|+||.||+|+.. +|+.||||++........ .+.+.+|+++++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334555678999999999999999999986 599999999876542111 34678999999999 899999999
Q ss_pred eEEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC
Q 005859 466 GICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN 545 (673)
Q Consensus 466 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~ 545 (673)
+++.. .+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+||+++.++.
T Consensus 167 ~~~~~--~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~--gi~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 167 DSYES--SSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN--NIVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEB--SSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCC
T ss_pred EEEee--CCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCC
Confidence 99855 4789999999999999999973 24689999999999999999999987 8999999999999999999
Q ss_pred eeeccccccccccCcchhhhhccCCCCCccCCccccC------CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhcc
Q 005859 546 PLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT------GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESS 619 (673)
Q Consensus 546 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~ 619 (673)
+||+|||+++.+.... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...........
T Consensus 239 ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 316 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM 316 (365)
T ss_dssp EEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9999999998765432 2234578999999999863 3589999999999999999999999865432221111
Q ss_pred chhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 620 KVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
....... .........+..+.+++.+||+.||++|||+.|+++
T Consensus 317 i~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 IMEGQYQ--FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHTCCC--CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhCCCC--CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111000 000000123467899999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=342.66 Aligned_cols=252 Identities=22% Similarity=0.303 Sum_probs=198.2
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
.|.....||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++... +..++|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC--CcEEEEEE
Confidence 3555668999999999999975 48899999997653 34457899999999999999999999999654 68899999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC-CCCeeeccccccccccCc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR-RYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~-~~~~kl~DfGla~~~~~~ 560 (673)
|+++++|.+++.... ....+++..+..++.|++.||+|||+. ||+||||||+||+++. ++.+||+|||+++.....
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 100 QVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN--QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred eCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC--CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999999999997432 223567899999999999999999987 8999999999999987 899999999999876542
Q ss_pred chhhhhccCCCCCccCCccccCCC--CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGR--FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
.. ......|+..|+|||.+.+.. ++.++||||||+++|||+||+.||............... .......+...+
T Consensus 177 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 252 (295)
T 2clq_A 177 NP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM---FKVHPEIPESMS 252 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH---HCCCCCCCTTSC
T ss_pred CC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc---ccccccccccCC
Confidence 21 123456889999999987643 899999999999999999999998654222111100000 011122334456
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.++.+++.+||+.||++|||+.|+++
T Consensus 253 ~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 253 AEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 78999999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=340.50 Aligned_cols=248 Identities=19% Similarity=0.319 Sum_probs=195.7
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|.+.+.||+|+||.||+|+.. +|+.||||++..... ....+.+.+|++++++++||||+++++++.. .+..++
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 88 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST--PTDFFM 88 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCeEEE
Confidence 57888999999999999999986 589999999875421 2335678999999999999999999999855 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++++|.+++... ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++...
T Consensus 89 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH--CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999999632 4589999999999999999999987 79999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRF-TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
.... .....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||............ ... . ...+...
T Consensus 163 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~---~--~~~~~~~ 234 (276)
T 2h6d_A 163 DGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI-RGG---V--FYIPEYL 234 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHC---C--CCCCTTS
T ss_pred CCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh-hcC---c--ccCchhc
Confidence 4322 223468899999999987765 68999999999999999999998654322211111 110 0 1122334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
+..+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 235 NRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 5778999999999999999999999863
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=353.77 Aligned_cols=254 Identities=21% Similarity=0.336 Sum_probs=196.8
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCC-cHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKS-DEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
++|...+.||+|+||.||+|+... |+.||||++....... ..+.+.+|++++++++||||+++++++... +..++|
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 102 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK--KRWYLV 102 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC--CEEEEE
Confidence 578889999999999999999865 8999999987654222 235678999999999999999999999654 788999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++....
T Consensus 103 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 103 FEFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHC--CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999999999887652 24589999999999999999999998 899999999999999999999999999987654
Q ss_pred cchhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc------------------
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK------------------ 620 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~------------------ 620 (673)
... ......++..|+|||++.+. .++.++|||||||++|||+||+.||............
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 321 22345689999999999875 6899999999999999999999998654322111100
Q ss_pred --hhhhcCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 621 --VEDFIDPNLEGKFS-----VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 621 --~~~~~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
......+......+ ...+..+.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00111111111111 124578999999999999999999999875
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=382.47 Aligned_cols=249 Identities=19% Similarity=0.275 Sum_probs=205.6
Q ss_pred HhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccC--CCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCe
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTS--CKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGE 475 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 475 (673)
..++|...+.||+|+||+||+|+... ++.||||++.+.. .....+.+..|.+++..+ +||||+++++++. +.+.
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~--~~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB--CSSE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE--eCCE
Confidence 45689999999999999999999764 8899999997642 123456788999999998 7999999999884 4578
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.|+||||+++|+|.+++... ..+++..++.|+.||+.||+|||+. |||||||||+||||+.++.+||+|||+++
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~--gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT--SEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC--CeEeccCChhhEEEcCCCcEEEeecceee
Confidence 99999999999999999732 4589999999999999999999998 89999999999999999999999999998
Q ss_pred cccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 556 LLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
....... .....+||+.|+|||++.+..|+.++|||||||++|||+||+.||........... +.... ..++.
T Consensus 491 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~----i~~~~--~~~p~ 563 (674)
T 3pfq_A 491 ENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHN--VAYPK 563 (674)
T ss_dssp ECCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHSSC--CCCCT
T ss_pred ccccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHH----HHhCC--CCCCc
Confidence 6433221 23446799999999999999999999999999999999999999976543322222 22211 12344
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH-----HHHH
Q 005859 636 SEASNLGQIALHCTHESPSHRPSI-----ENVM 663 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~-----~evl 663 (673)
..+.++.+|+.+||+.||++||++ +||+
T Consensus 564 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 564 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 556789999999999999999997 6665
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=350.76 Aligned_cols=261 Identities=18% Similarity=0.341 Sum_probs=186.0
Q ss_pred HHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 399 RATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 399 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
...++|...+.||+|+||.||+|+.. +++.||||++.........+++.+|++++++++||||+++++++... +..+
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 89 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK--DELW 89 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS--SCEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec--CCcE
Confidence 34568999999999999999999965 58999999987654344456789999999999999999999999654 6789
Q ss_pred EEEeecCCCChhhhhcccc----CCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEA----GSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL 553 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGl 553 (673)
+||||+++|+|.+++.... .....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN--GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC--CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999986321 1234589999999999999999999987 899999999999999999999999999
Q ss_pred cccccCcch----hhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCc
Q 005859 554 HKLLADDIV----FSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPN 628 (673)
Q Consensus 554 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 628 (673)
++....... .......|++.|+|||.+.+ ..++.++||||||+++|||+||+.||................ .+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~ 246 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND-PPS 246 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS-CCC
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC-CCc
Confidence 986643221 11223468899999999875 568999999999999999999999987643321111111100 000
Q ss_pred C-----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 629 L-----EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 629 ~-----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
. ........+.++.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 01112234567899999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=362.55 Aligned_cols=254 Identities=13% Similarity=0.061 Sum_probs=182.8
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC--CcHHHHHHHHHHHhcc--CCCCceeEe-------eEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK--SDEGEFLKGLKILTSL--KHENLASLR-------GIC 468 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l--~H~niv~l~-------~~~ 468 (673)
..+|...+.||+|+||.||+|+.. +|+.||||++...... ...+.+.+|+++++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888999999999999999976 5899999999875421 2235677785444444 699988755 444
Q ss_pred ecCCC---------------CeEEEEEeecCCCChhhhhccccCCccccCHHHH------HHHHHHHHHHHHHHhcCCCC
Q 005859 469 CSKGR---------------GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATR------ISVIKGIAKGISYLHGKRPG 527 (673)
Q Consensus 469 ~~~~~---------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~ 527 (673)
..... ...++||||++ |+|.+++... ...+++..+ ..++.||+.||+|||++ |
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--~ 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK--G 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT--T
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC--C
Confidence 32221 34799999998 8999999743 223455556 78889999999999988 8
Q ss_pred cccCCcCCCCeEecCCCCeeeccccccccccCcchhhhhccCCCCCccCCccccC--CCCCcchhHHHHHHHHHHHHhCC
Q 005859 528 LVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT--GRFTEKSDIYAFGMIVFQILSGK 605 (673)
Q Consensus 528 ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSfGvvl~el~tG~ 605 (673)
|+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||+||+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999998765432 13446699999999987 67999999999999999999999
Q ss_pred CCCChhhHhhhhccc---hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 606 CSITPFTRQAAESSK---VEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 606 ~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.||............ .................+..+.+++.+||+.||++|||+.|+++
T Consensus 291 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999764322111000 00001111111112245678999999999999999999999974
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=343.73 Aligned_cols=253 Identities=20% Similarity=0.348 Sum_probs=196.9
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecC--------
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSK-------- 471 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-------- 471 (673)
.++|+..+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 457899999999999999999975 5899999999653 23446789999999999999999999988653
Q ss_pred ---CCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeee
Q 005859 472 ---GRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLL 548 (673)
Q Consensus 472 ---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl 548 (673)
..+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ--GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC--CeecccCCHHhEEEcCCCCEEE
Confidence 235789999999999999999742 24578899999999999999999998 8999999999999999999999
Q ss_pred ccccccccccCcc-------------hhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHh
Q 005859 549 SDSGLHKLLADDI-------------VFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQ 614 (673)
Q Consensus 549 ~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~ 614 (673)
+|||+++...... ........|+..|+|||.+.+. .++.++|||||||++|||++ ||......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~ 234 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence 9999998664321 1112344688999999999864 68999999999999999998 55433222
Q ss_pred hhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 615 AAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
......+.. ........++...+..+.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 VNILKKLRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHS-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccc-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111111111 1122333445556678899999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=354.43 Aligned_cols=253 Identities=16% Similarity=0.255 Sum_probs=191.6
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCC----CC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKG----RG 474 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~ 474 (673)
.++|...+.||+|+||.||+|+.. +++.||||++...... ...+.+.+|+++++.++||||+++++++.... ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 357899999999999999999976 4899999999764322 23457889999999999999999999986542 13
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLH 554 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla 554 (673)
..++||||++ |+|.+++. ..+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC--CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 7899999996 57888875 2488999999999999999999998 8999999999999999999999999999
Q ss_pred ccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhh----------
Q 005859 555 KLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF---------- 624 (673)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~---------- 624 (673)
+...... ......||..|+|||++.+..++.++|||||||++|||+||+.||............+...
T Consensus 175 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 175 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred ccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 8765432 2234568999999999999899999999999999999999999997543321111110000
Q ss_pred --------c--CCcCC-------------C---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 625 --------I--DPNLE-------------G---KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 625 --------~--~~~~~-------------~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
. .+... + ......+.++.+++.+||+.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 00000 0 001223678999999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=345.88 Aligned_cols=252 Identities=17% Similarity=0.282 Sum_probs=198.9
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|++.+.||+|+||.||+|+... ++.||+|++.... ....+.+.+|++++++++||||+++++++... +..++|
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 94 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHD--GKLWIM 94 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC---CEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC--CeEEEE
Confidence 4678999999999999999999874 8999999987653 34567899999999999999999999999654 678999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++++|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++.....
T Consensus 95 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK--RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp EECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC--CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999988642 24589999999999999999999998 899999999999999999999999999764332
Q ss_pred cchhhhhccCCCCCccCCccc-----cCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 560 DIVFSMLKASAAMGYLAPEYT-----TTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
.. .......|+..|+|||++ ....++.++||||||+++|||+||+.||.............. ...+ ....+
T Consensus 170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~--~~~~~ 245 (302)
T 2j7t_A 170 TL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-SDPP--TLLTP 245 (302)
T ss_dssp HH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SCCC--CCSSG
T ss_pred cc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc-cCCc--ccCCc
Confidence 11 112234688999999998 356789999999999999999999999876433222111111 1111 11123
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...+..+.+++.+||+.||++|||+.++++
T Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 246 SKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp GGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 344578999999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=370.39 Aligned_cols=251 Identities=19% Similarity=0.307 Sum_probs=199.8
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCC------------CcHHHHHHHHHHHhccCCCCceeEeeE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCK------------SDEGEFLKGLKILTSLKHENLASLRGI 467 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~H~niv~l~~~ 467 (673)
.++|.+.+.||+|+||+||+|+... ++.||||++...... ...+.+.+|++++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 5679999999999999999999764 889999999765322 234678999999999999999999999
Q ss_pred EecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC---
Q 005859 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY--- 544 (673)
Q Consensus 468 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~--- 544 (673)
+.. .+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++
T Consensus 115 ~~~--~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 115 FED--KKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH--NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEC--SSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESSTTCCS
T ss_pred EEc--CCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEeCCCcHHHEEEecCCCCc
Confidence 954 4789999999999999999863 24589999999999999999999998 899999999999998776
Q ss_pred CeeeccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhh
Q 005859 545 NPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF 624 (673)
Q Consensus 545 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~ 624 (673)
.+||+|||+++...... ......||+.|+|||++. +.++.++||||+||++|||++|+.||................
T Consensus 187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 263 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK 263 (504)
T ss_dssp SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 69999999998765432 233457899999999986 469999999999999999999999997654332211111110
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 625 IDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.. .........+.++.+++.+||+.||.+|||+.|+++
T Consensus 264 ~~--~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 264 YY--FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CC--CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC--CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 000001123578999999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=364.41 Aligned_cols=201 Identities=18% Similarity=0.304 Sum_probs=166.3
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC---Ce
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGR---GE 475 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---~~ 475 (673)
.++|...+.||+|+||.||+|+... ++.||||++..... ....+.+.+|+++|++++||||+++++++..... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 3579999999999999999999764 88999999976432 2234678999999999999999999999865432 56
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.|+||||++ |+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~--givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES--GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC--CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999996 699999963 34699999999999999999999998 89999999999999999999999999998
Q ss_pred cccCcchh---------------------hhhccCCCCCccCCcccc-CCCCCcchhHHHHHHHHHHHHhCCCCC
Q 005859 556 LLADDIVF---------------------SMLKASAAMGYLAPEYTT-TGRFTEKSDIYAFGMIVFQILSGKCSI 608 (673)
Q Consensus 556 ~~~~~~~~---------------------~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSfGvvl~el~tG~~p~ 608 (673)
........ .....+||..|+|||++. ...++.++||||+||++|||++|..||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76543211 134567899999999864 556999999999999999999865544
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=344.44 Aligned_cols=251 Identities=20% Similarity=0.346 Sum_probs=200.5
Q ss_pred HhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
..++|+..+.||+|+||.||+|+... |+.||||.+... ...+.+.+|++++++++||||+++++++... +..++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPHVVKYYGSYFKN--TDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT---SCCHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch---HHHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEEE
Confidence 45679999999999999999999764 899999999764 2456799999999999999999999999654 67899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++...
T Consensus 102 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM--RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred EeecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC--CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 99999999999998632 24689999999999999999999987 89999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.||.......... .......+. ...+...+
T Consensus 177 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~ 252 (314)
T 3com_A 177 DTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIPTNPPPT--FRKPELWS 252 (314)
T ss_dssp TTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHSCCCC--CSSGGGSC
T ss_pred hhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHhcCCCcc--cCCcccCC
Confidence 4321 2234568899999999999899999999999999999999999987543221111 111111111 11233345
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+.+++.+||+.||++|||+.++++
T Consensus 253 ~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 253 DNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 78999999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=351.90 Aligned_cols=265 Identities=17% Similarity=0.199 Sum_probs=192.9
Q ss_pred HHHHHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC
Q 005859 395 EEVERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGR 473 (673)
Q Consensus 395 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 473 (673)
++.....++|...+.||+|+||.||+|+.. +|+.||||++.... .....+.+|++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 556677889999999999999999999986 58999999986543 234467788999999999999999999865322
Q ss_pred -----CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC-CCCee
Q 005859 474 -----GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR-RYNPL 547 (673)
Q Consensus 474 -----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~-~~~~k 547 (673)
...++||||+++ +|.+.+.........+++..+..++.|++.||+|||.+..||+||||||+|||++. ++.+|
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEE
Confidence 237899999975 56555443223445689999999999999999999932338999999999999997 89999
Q ss_pred eccccccccccCcchhhhhccCCCCCccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhh--
Q 005859 548 LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF-- 624 (673)
Q Consensus 548 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~-- 624 (673)
|+|||+++....... .....||..|+|||++.+.. ++.++|||||||++|||+||+.||................
T Consensus 173 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp ECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 999999987654322 23456899999999987654 8999999999999999999999997643321111111000
Q ss_pred --------cCCc----------------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 625 --------IDPN----------------LEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 625 --------~~~~----------------~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.++. .........+.++.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000 001112235678999999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=362.65 Aligned_cols=253 Identities=19% Similarity=0.282 Sum_probs=194.2
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCC----CCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKG----RGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~~ 476 (673)
.+|...+.||+|+||+||+|+.. +|+.||||++.... ..+.+|+++|++++|||||++++++.... ....
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 46888999999999999999986 48999999986542 22347999999999999999999886421 2246
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC-CCeeeccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR-YNPLLSDSGLHK 555 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~-~~~kl~DfGla~ 555 (673)
++||||+++ +|.+.+.........+++..+..++.||++||+|||+. ||+||||||+|||++.+ +.+||+|||+++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 799999975 67666653222345699999999999999999999987 89999999999999965 568999999998
Q ss_pred cccCcchhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh------------
Q 005859 556 LLADDIVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE------------ 622 (673)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~------------ 622 (673)
...... ......+|..|+|||++.+. .++.++|||||||++|||++|+.||............+.
T Consensus 206 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 206 QLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp ECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 765432 12345689999999998765 699999999999999999999999975432211111110
Q ss_pred ------hhcCCcCCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 623 ------DFIDPNLEGK-----FSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 623 ------~~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
++..+.+... +....+.++.+|+.+||+.||++|||+.|+++
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0000111100 12234578999999999999999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=355.94 Aligned_cols=256 Identities=18% Similarity=0.262 Sum_probs=200.1
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCC---CCeE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKG---RGEC 476 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---~~~~ 476 (673)
.++|...+.||+|+||.||+|+.. +++.||||++.........+.+.+|++++++++||||+++++++.... ....
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 357999999999999999999976 588999999976443333467899999999999999999999986532 2468
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999996 599998862 3589999999999999999999998 899999999999999999999999999987
Q ss_pred ccCcchh--hhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhh----------
Q 005859 557 LADDIVF--SMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVED---------- 623 (673)
Q Consensus 557 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~---------- 623 (673)
....... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...............
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 6543221 1234578999999998765 45899999999999999999999998654222111110000
Q ss_pred ---------hc-CCcCCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 624 ---------FI-DPNLEGKF-----SVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 624 ---------~~-~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.. ........ ....+.++.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 00000011 1223467899999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=351.67 Aligned_cols=251 Identities=18% Similarity=0.305 Sum_probs=202.1
Q ss_pred hcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCc----------------HHHHHHHHHHHhccCCCCceeE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSD----------------EGEFLKGLKILTSLKHENLASL 464 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------~~~~~~E~~~l~~l~H~niv~l 464 (673)
.++|...+.||+|+||.||+|+. +|+.||||++........ .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35799999999999999999999 899999999976432111 1789999999999999999999
Q ss_pred eeEEecCCCCeEEEEEeecCCCChhhh------hccccCCccccCHHHHHHHHHHHHHHHHHHhc-CCCCcccCCcCCCC
Q 005859 465 RGICCSKGRGECFLIYDFVPNGNLLQH------LDLEAGSEKVLEWATRISVIKGIAKGISYLHG-KRPGLVHPNLSAEK 537 (673)
Q Consensus 465 ~~~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~ivHrDlk~~N 537 (673)
++++... +..++||||+++|+|.++ +... ....+++..+..++.|++.||+|||+ . ||+||||||+|
T Consensus 109 ~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dl~p~N 182 (348)
T 2pml_X 109 EGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSN 182 (348)
T ss_dssp SEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS--CEECCCCCGGG
T ss_pred EEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC--CEeecCCChHh
Confidence 9999654 789999999999999998 5421 24579999999999999999999998 6 89999999999
Q ss_pred eEecCCCCeeeccccccccccCcchhhhhccCCCCCccCCccccCC-CCCc-chhHHHHHHHHHHHHhCCCCCChhhHhh
Q 005859 538 VLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG-RFTE-KSDIYAFGMIVFQILSGKCSITPFTRQA 615 (673)
Q Consensus 538 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDVwSfGvvl~el~tG~~p~~~~~~~~ 615 (673)
|+++.++.+||+|||+++..... ......++..|+|||.+.+. .++. ++||||||+++|||+||+.||.......
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred EEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 99999999999999999876543 23345689999999999877 6766 9999999999999999999987543211
Q ss_pred hhccchhhhcCCcC--C---------------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 616 AESSKVEDFIDPNL--E---------------GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 616 ~~~~~~~~~~~~~~--~---------------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.. ...+..... . .......+.++.+++.+||+.||++|||+.|+++
T Consensus 260 ~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 EL---FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HH---HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HH---HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 011111000 0 0001334678999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=342.36 Aligned_cols=254 Identities=18% Similarity=0.243 Sum_probs=200.9
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC---CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC---KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
.++|...+.||+|+||.||+|... +++.||+|++..... ....+.+.+|++++++++||||+++++++...+.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 367999999999999999999975 488999999976421 2345689999999999999999999999876656788
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||++++ |.+++... ....+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~--~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ--GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999876 77777643 234689999999999999999999998 899999999999999999999999999987
Q ss_pred ccCcc-hhhhhccCCCCCccCCccccCCC--CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCC
Q 005859 557 LADDI-VFSMLKASAAMGYLAPEYTTTGR--FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 557 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (673)
..... ........|+..|+|||++.+.. ++.++||||||+++|||++|+.||........... +.. .. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-i~~---~~--~~~ 232 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN-IGK---GS--YAI 232 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHH---CC--CCC
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH-Hhc---CC--CCC
Confidence 64321 11223456899999999987644 47899999999999999999999975432221111 111 11 112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 634 SVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 634 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 233 PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 23345788999999999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=349.19 Aligned_cols=252 Identities=20% Similarity=0.297 Sum_probs=195.7
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCC-------CcHHHHHHHHHHHhccCCCCceeEeeEEecCC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCK-------SDEGEFLKGLKILTSLKHENLASLRGICCSKG 472 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 472 (673)
.++|...+.||+|+||.||+|+... ++.||||++...... .....+.+|++++++++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 4579999999999999999999764 889999998754311 1224588999999999999999999998543
Q ss_pred CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC---eeec
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN---PLLS 549 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~---~kl~ 549 (673)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++. +||+
T Consensus 88 --~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 --DYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp --SEEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred --ceEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 37999999999999998863 34689999999999999999999988 8999999999999987664 9999
Q ss_pred cccccccccCcchhhhhccCCCCCccCCcccc---CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcC
Q 005859 550 DSGLHKLLADDIVFSMLKASAAMGYLAPEYTT---TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFID 626 (673)
Q Consensus 550 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~ 626 (673)
|||+++....... .....|+..|+|||++. ...++.++|||||||++|||+||+.||............+.....
T Consensus 160 Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (322)
T 2ycf_A 160 DFGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237 (322)
T ss_dssp CCTTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred cCccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence 9999987754422 22346899999999974 466899999999999999999999998653221111111111000
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 627 PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 627 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..........+..+.+++.+||+.||++|||+.|+++
T Consensus 238 -~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 238 -NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0000011123578899999999999999999999984
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=360.18 Aligned_cols=257 Identities=22% Similarity=0.322 Sum_probs=183.4
Q ss_pred cCCcc-ccccccCCcceEEEEEEc---CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 402 QCFSE-ANLLGKSSFSATYKGILR---DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 402 ~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
+.|.. .++||+|+||+||+|+.+ +++.||||++.... ....+.+|+++|++++|||||++++++........+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 34554 457999999999999976 47899999997542 345788999999999999999999999776678899
Q ss_pred EEEeecCCCChhhhhccccC-----CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEe----cCCCCeee
Q 005859 478 LIYDFVPNGNLLQHLDLEAG-----SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI----HRRYNPLL 548 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl----~~~~~~kl 548 (673)
+||||++ |+|.+++..... ....+++..++.|+.||+.||+|||+. ||+||||||+|||+ +.++.+||
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC--CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999996 588888753221 123489999999999999999999998 89999999999999 77889999
Q ss_pred ccccccccccCcch--hhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhh--------
Q 005859 549 SDSGLHKLLADDIV--FSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE-------- 617 (673)
Q Consensus 549 ~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~-------- 617 (673)
+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||.........
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987654221 123345789999999999874 5899999999999999999999998532211000
Q ss_pred ccchhhhcC-C-----------------------cCCCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 618 SSKVEDFID-P-----------------------NLEGKFS---------VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 618 ~~~~~~~~~-~-----------------------~~~~~~~---------~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...+.+.+. + ....... ...+..+.+|+.+||+.||++|||++|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 0 0000000 011457889999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.48 Aligned_cols=258 Identities=16% Similarity=0.326 Sum_probs=180.8
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHH-HHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLK-ILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
.++|...+.||+|+||.||+|... +|+.||||++..........++.+|+. +++.++||||+++++++... +..++
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~--~~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE--GDCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS--SEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC--CceEE
Confidence 357888899999999999999986 589999999976543333456666666 77788999999999999654 78899
Q ss_pred EEeecCCCChhhhhcccc-CCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEA-GSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
||||+++ +|.+++.... .....+++..+..++.|++.||+|||+.. ||+||||||+||+++.++.+||+|||+++..
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL-KIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH-SCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC-CEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9999975 8887775311 12356899999999999999999999841 6999999999999999999999999999876
Q ss_pred cCcchhhhhccCCCCCccCCccc----cCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCC
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYT----TTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (673)
..... .....|+..|+|||++ .+..++.++|||||||++|||+||+.||..................+.+....
T Consensus 177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3aln_A 177 VDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE 254 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCS
T ss_pred ccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcc
Confidence 54321 2234689999999998 45668999999999999999999999997643221111111111112222222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 634 SVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 634 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
....+..+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 255 EREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 2345678999999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.03 Aligned_cols=263 Identities=21% Similarity=0.334 Sum_probs=202.2
Q ss_pred HHHHHHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC
Q 005859 395 EEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGR 473 (673)
Q Consensus 395 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 473 (673)
+++....++|...+.||+|+||.||+|+..+ .||+|++..... ....+.+.+|++++++++||||+++++++...
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 101 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-- 101 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS--
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--
Confidence 3344456788999999999999999999854 599999876532 22335688999999999999999999999654
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL 553 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGl 553 (673)
+..++||||+++++|.+++... ...+++..+..++.||+.||+|||+. ||+||||||+||+++ ++.+||+|||+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~--~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK--GILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred CceEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCChhhEEEe-CCCEEEeecCC
Confidence 6789999999999999999732 24689999999999999999999998 899999999999998 67999999999
Q ss_pred cccccCcc----hhhhhccCCCCCccCCccccC---------CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc
Q 005859 554 HKLLADDI----VFSMLKASAAMGYLAPEYTTT---------GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK 620 (673)
Q Consensus 554 a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~ 620 (673)
++...... ........|+..|+|||.+.. ..++.++||||||+++|||+||+.||...........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~- 254 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ- 254 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH-
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-
Confidence 87653211 111223458889999999874 3579999999999999999999999976433222111
Q ss_pred hhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 621 VEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
+.....+... ....+.++.+++.+||+.||++|||+.++++.|+++..
T Consensus 255 ~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 255 MGTGMKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp HHTTCCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred hccCCCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1111112111 11234678999999999999999999999999998864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=361.21 Aligned_cols=251 Identities=15% Similarity=0.217 Sum_probs=197.6
Q ss_pred hcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhcc------CCCCceeEeeEEecCCC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSL------KHENLASLRGICCSKGR 473 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~~~ 473 (673)
..+|++.+.||+|+||+||+|+... ++.||||++... ....+++.+|+++++.+ +|+||+++++++...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~-- 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR-- 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET--
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC--
Confidence 3568999999999999999998765 899999999753 22345778888888887 577999999999654
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC--eeeccc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN--PLLSDS 551 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~--~kl~Df 551 (673)
+..++||||++ ++|.+++.... ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++. +||+||
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN--RIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH--TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred CeEEEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEEccCCCcceEEeec
Confidence 78999999995 69999987432 23589999999999999999999987 7999999999999999887 999999
Q ss_pred cccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhcc------------
Q 005859 552 GLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESS------------ 619 (673)
Q Consensus 552 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~------------ 619 (673)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...........
T Consensus 247 G~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~ 322 (429)
T 3kvw_A 247 GSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322 (429)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 999765433 2235689999999999999999999999999999999999999865332111100
Q ss_pred -----chhhhcCCc--------------------------------CCCC----CCHHHHHHHHHHHHHccccCCCCCCC
Q 005859 620 -----KVEDFIDPN--------------------------------LEGK----FSVSEASNLGQIALHCTHESPSHRPS 658 (673)
Q Consensus 620 -----~~~~~~~~~--------------------------------~~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs 658 (673)
....+++.. .... .....+..+.+|+.+||+.||++|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 000000000 0000 01112467899999999999999999
Q ss_pred HHHHHH
Q 005859 659 IENVMQ 664 (673)
Q Consensus 659 ~~evl~ 664 (673)
++|+++
T Consensus 403 a~e~L~ 408 (429)
T 3kvw_A 403 PGQALR 408 (429)
T ss_dssp HHHHHT
T ss_pred HHHHhC
Confidence 999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=339.03 Aligned_cols=252 Identities=19% Similarity=0.273 Sum_probs=203.0
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC--------CcHHHHHHHHHHHhccC-CCCceeEeeEEec
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK--------SDEGEFLKGLKILTSLK-HENLASLRGICCS 470 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~ 470 (673)
.++|...+.||+|+||.||+|+.. +|+.||||++...... ...+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467899999999999999999986 4899999999754311 11356889999999995 9999999999954
Q ss_pred CCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecc
Q 005859 471 KGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSD 550 (673)
Q Consensus 471 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~D 550 (673)
.+..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|
T Consensus 96 --~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 96 --NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECC
T ss_pred --CCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCcceEEEcCCCcEEEec
Confidence 4789999999999999999973 24689999999999999999999988 899999999999999999999999
Q ss_pred ccccccccCcchhhhhccCCCCCccCCcccc------CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhh
Q 005859 551 SGLHKLLADDIVFSMLKASAAMGYLAPEYTT------TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF 624 (673)
Q Consensus 551 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~ 624 (673)
||+++...... ......++..|+|||.+. ...++.++||||||+++|||++|+.||................
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (298)
T 1phk_A 168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245 (298)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC
Confidence 99998765432 223456889999999885 4568999999999999999999999986543322211111111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 625 IDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
. ..........+..+.+++.+||+.||++|||+.|+++
T Consensus 246 ~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 246 Y--QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp C--CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred c--ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1 1111112345678999999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=365.10 Aligned_cols=259 Identities=14% Similarity=0.206 Sum_probs=202.1
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCce-eEeeEEecCCCCeEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLA-SLRGICCSKGRGECFL 478 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~~~l 478 (673)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ...++.+|+++++.++|++.+ .+..++.. .+..++
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKIYRILQGGTGIPNVRWFGVE--GDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC---SSCCHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc---ccHHHHHHHHHHHHhcCCCCCCeEEEEEee--CCEEEE
Confidence 367999999999999999999974 58999999886543 234588999999999875544 44444433 467899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEe---cCCCCeeeccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI---HRRYNPLLSDSGLHK 555 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl---~~~~~~kl~DfGla~ 555 (673)
||||+ +++|.+++... ...+++..++.|+.||+.||+|||++ |||||||||+|||| +.++.+||+|||+++
T Consensus 81 vme~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~--gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp EEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC--CEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 99999 99999999742 24699999999999999999999998 89999999999999 688999999999998
Q ss_pred cccCcchh------hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhh---hhccchhhhcC
Q 005859 556 LLADDIVF------SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQA---AESSKVEDFID 626 (673)
Q Consensus 556 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~---~~~~~~~~~~~ 626 (673)
........ ......||..|+|||++.+..++.++|||||||++|||++|+.||....... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence 76543221 1224578999999999999999999999999999999999999997532210 00000011000
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 627 PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 627 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
..+ .......+.++.+++..||+.||++||++.+|++.|++++.
T Consensus 235 ~~~-~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 235 TSI-EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp SCH-HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccH-HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 000 00111234689999999999999999999999999998864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.95 Aligned_cols=253 Identities=17% Similarity=0.280 Sum_probs=193.6
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC----CeEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGR----GECF 477 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~~~~ 477 (673)
.+|...+.||+|+||+||+|+..++..||+|++..... ...+|+++++.++||||+++++++..... ...+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 46889999999999999999998777799998865431 22369999999999999999999865422 2378
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEec-CCCCeeecccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIH-RRYNPLLSDSGLHKL 556 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~-~~~~~kl~DfGla~~ 556 (673)
+||||++++ +.+.+.........+++..+..++.||++||+|||+. ||+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 999999764 4443332212235689999999999999999999998 899999999999999 789999999999987
Q ss_pred ccCcchhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh-------------
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE------------- 622 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~------------- 622 (673)
..... ......+|..|+|||++.+. .++.++|||||||++|||++|+.||............+.
T Consensus 192 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 192 LIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 65432 22345689999999998765 589999999999999999999999975432211111100
Q ss_pred --hhcC---CcCCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 623 --DFID---PNLEG-----KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 623 --~~~~---~~~~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.... +.... .++...+.++.+++.+||+.||++|||+.|+++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0000 11110 112224578999999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=349.37 Aligned_cols=256 Identities=19% Similarity=0.283 Sum_probs=198.4
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCC---CCeE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKG---RGEC 476 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---~~~~ 476 (673)
.++|...+.||+|+||.||+|+.. +|+.||||++...........+.+|++++++++||||+++++++.... ....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 357889999999999999999976 589999999975433333467889999999999999999999875431 3578
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~--~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS--NVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999996 699998863 3589999999999999999999988 899999999999999999999999999987
Q ss_pred ccCcchh---------hhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch-----
Q 005859 557 LADDIVF---------SMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV----- 621 (673)
Q Consensus 557 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~----- 621 (673)
....... ......||..|+|||++.. ..++.++|||||||++|||++|+.||.............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 6532211 1123467899999998765 678999999999999999999999997543221110000
Q ss_pred ---------------hhhcC--CcCCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 622 ---------------EDFID--PNLEG----KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 622 ---------------~~~~~--~~~~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+... +.... ......+.++.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 00000 001234577899999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=343.70 Aligned_cols=258 Identities=18% Similarity=0.278 Sum_probs=202.1
Q ss_pred HhcCCccccccccCCcceEEEEEEc--CCcEEEEEEecccCCC-CcHHHHHHHHHHHhcc---CCCCceeEeeEEec---
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR--DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSL---KHENLASLRGICCS--- 470 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~--- 470 (673)
..++|...+.||+|+||.||+|+.. +|+.||||++...... .....+.+|+++++.+ +||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999973 5889999999764322 2234677888877776 89999999999862
Q ss_pred CCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecc
Q 005859 471 KGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSD 550 (673)
Q Consensus 471 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~D 550 (673)
......++||||++ |+|.+++.... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~--gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCHHHeEEcCCCCEEEec
Confidence 13467899999997 69999987432 23589999999999999999999998 899999999999999999999999
Q ss_pred ccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhc-----
Q 005859 551 SGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFI----- 625 (673)
Q Consensus 551 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~----- 625 (673)
||+++...... ......++..|+|||++.+..++.++|||||||++|||+||+.||.................
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 99998765432 23345689999999999998999999999999999999999999975433221111110000
Q ss_pred -------------C---CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 626 -------------D---PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 626 -------------~---~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
. ...........+..+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 00001122334578899999999999999999999984
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=353.92 Aligned_cols=252 Identities=17% Similarity=0.280 Sum_probs=182.5
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCC----CC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKG----RG 474 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~ 474 (673)
.++|...+.||+|+||.||+|... +|+.||||++..... ....+.+.+|++++++++||||+++++++.... ..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 367999999999999999999965 589999999976432 223467889999999999999999999985431 24
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLH 554 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla 554 (673)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~--givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA--DIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 7899988862 3589999999999999999999987 8999999999999999999999999999
Q ss_pred ccccCcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh-----------
Q 005859 555 KLLADDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE----------- 622 (673)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~----------- 622 (673)
+..... .....+|..|+|||++.+ ..++.++|||||||++|||+||+.||..............
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 875532 234578999999999887 6789999999999999999999999965432211111000
Q ss_pred --------hhcC--CcCCC-CC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 623 --------DFID--PNLEG-KF---SVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 623 --------~~~~--~~~~~-~~---~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.+.. +.... .+ ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000 00000 00 0123467899999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=341.66 Aligned_cols=255 Identities=20% Similarity=0.319 Sum_probs=199.0
Q ss_pred HHHHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCC-CcHHHHHHHHHHHhccC--CCCceeEeeEEecCCC
Q 005859 397 VERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLK--HENLASLRGICCSKGR 473 (673)
Q Consensus 397 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~ 473 (673)
+....++|...+.||+|+||.||++...+++.||||++...... ...+.+.+|++++++++ ||||+++++++...
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-- 100 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-- 100 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS--
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC--
Confidence 33445679999999999999999999988999999999765322 23467899999999997 59999999998654
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL 553 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGl 553 (673)
+..++||| +.+++|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||++++ +.+||+|||+
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH--GIVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred CEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCcccEEEEC-CeEEEeeccc
Confidence 67999999 558899999973 24689999999999999999999998 8999999999999975 8999999999
Q ss_pred cccccCcchh-hhhccCCCCCccCCccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch
Q 005859 554 HKLLADDIVF-SMLKASAAMGYLAPEYTTT-----------GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV 621 (673)
Q Consensus 554 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~ 621 (673)
++........ ......|+..|+|||.+.+ ..++.++||||||+++|||+||+.||........ ..
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~ 249 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KL 249 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HH
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH---HH
Confidence 9876543221 1234468999999999875 4688999999999999999999999865422211 12
Q ss_pred hhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 622 EDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
....++.....++...+.++.+++.+||+.||++||++.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 250 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 2233333333333344578999999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=348.28 Aligned_cols=201 Identities=17% Similarity=0.253 Sum_probs=169.7
Q ss_pred HhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccC-CC-----CceeEeeEEecCC
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HE-----NLASLRGICCSKG 472 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~~ 472 (673)
..++|...+.||+|+||+||+|+.. +++.||||++... .....++.+|+++++.++ |+ +|+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~- 128 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR- 128 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-
Confidence 3568999999999999999999976 4889999999743 223456788999988884 55 499999998654
Q ss_pred CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEec--CCCCeeecc
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIH--RRYNPLLSD 550 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~--~~~~~kl~D 550 (673)
+..++||||++ |+|.+++.... ...+++..+..++.|++.||+|||++..||+||||||+|||++ .++.+||+|
T Consensus 129 -~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 129 -NHLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp -TEEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred -CceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 78999999995 59999997432 2458999999999999999999997444899999999999994 577899999
Q ss_pred ccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChh
Q 005859 551 SGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611 (673)
Q Consensus 551 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~ 611 (673)
||+++..... .....+|+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 205 FG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 205 FGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999876543 23456899999999999999999999999999999999999999753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=343.03 Aligned_cols=254 Identities=17% Similarity=0.265 Sum_probs=191.6
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecC---------
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSK--------- 471 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------- 471 (673)
++|...+.||+|+||.||+|+... ++.||||++.... ....+++.+|++++++++||||+++++++...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 578889999999999999999875 8999999987543 23456789999999999999999999987432
Q ss_pred ---CCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEec-CCCCee
Q 005859 472 ---GRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIH-RRYNPL 547 (673)
Q Consensus 472 ---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~-~~~~~k 547 (673)
..+..++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+. ||+||||||+||+++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA--NVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEcCCCCeEE
Confidence 2367899999997 699999852 3588999999999999999999988 899999999999997 567999
Q ss_pred eccccccccccCcch--hhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhh-
Q 005859 548 LSDSGLHKLLADDIV--FSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVED- 623 (673)
Q Consensus 548 l~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~- 623 (673)
|+|||+++....... .......++..|+|||.+.. ..++.++|||||||++|||+||+.||...............
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999987643211 11223456889999998875 67899999999999999999999999754322111110000
Q ss_pred ----------h-------cCCcCC-C-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 624 ----------F-------IDPNLE-G-----KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 624 ----------~-------~~~~~~-~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
. ...... . ......+.++.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0 000000 0 011224578999999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.34 Aligned_cols=252 Identities=22% Similarity=0.320 Sum_probs=201.7
Q ss_pred HhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
..++|.+.+.||+|+||.||+|+.. +++.||||++..... ....+.+.+|++++++++||||+++++++.. .+..+
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 97 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFY 97 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC--CCeEE
Confidence 3467999999999999999999976 589999999976532 3456789999999999999999999999855 47899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC---CCeeecccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR---YNPLLSDSGLH 554 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~---~~~kl~DfGla 554 (673)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999998863 24589999999999999999999998 89999999999999764 46999999999
Q ss_pred ccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 555 KLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
+....... .....++..|+|||.+.+ .++.++||||||+++|||++|+.||..................... ...
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 246 (287)
T 2wei_A 172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL--PQW 246 (287)
T ss_dssp GTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS--GGG
T ss_pred eeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--hhh
Confidence 87654321 122347888999998875 5899999999999999999999998764332221111111110000 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...+.++.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 247 RTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 234578999999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=352.98 Aligned_cols=254 Identities=16% Similarity=0.272 Sum_probs=199.5
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccC--------CCCceeEeeEEecC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK--------HENLASLRGICCSK 471 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~~~ 471 (673)
.++|.+.+.||+|+||+||+|+.. +++.||||++... ....+.+.+|++++++++ ||||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 367999999999999999999965 4889999999643 233467889999999985 78899999988632
Q ss_pred --CCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC-----
Q 005859 472 --GRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY----- 544 (673)
Q Consensus 472 --~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~----- 544 (673)
.....++||||+ +++|.+++... ....+++..++.|+.||+.||+|||++. ||+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~-givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC-RIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT-CEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHeeEeccchhhhh
Confidence 345789999999 66777776532 2245899999999999999999999852 699999999999999775
Q ss_pred --------------------------------------------CeeeccccccccccCcchhhhhccCCCCCccCCccc
Q 005859 545 --------------------------------------------NPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYT 580 (673)
Q Consensus 545 --------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~ 580 (673)
.+||+|||+++..... .....||..|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 7999999999876543 2345689999999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhh-----hhccchh------------------hhcCCc-----C---
Q 005859 581 TTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQA-----AESSKVE------------------DFIDPN-----L--- 629 (673)
Q Consensus 581 ~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~-----~~~~~~~------------------~~~~~~-----~--- 629 (673)
.+..++.++|||||||++|||+||+.||.+..... .....+. .+.... +
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 99899999999999999999999999996432100 0000000 000000 0
Q ss_pred -----------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 630 -----------EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 630 -----------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
....+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 01235667788999999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.26 Aligned_cols=251 Identities=16% Similarity=0.257 Sum_probs=194.2
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCC----
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRG---- 474 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~---- 474 (673)
.++|...+.||+|+||.||+|+.. +|+.||||++...... ...+.+.+|++++++++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 357889999999999999999976 4899999999765322 2246788999999999999999999999654221
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLH 554 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla 554 (673)
..++||||++ |+|.+++. ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC--CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 2489999996 68988874 2489999999999999999999998 8999999999999999999999999999
Q ss_pred ccccCcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh-----------
Q 005859 555 KLLADDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE----------- 622 (673)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~----------- 622 (673)
+..... .....+|+.|+|||++.+ ..++.++|||||||++|||+||+.||..............
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 192 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred cccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 866442 234568999999999987 6789999999999999999999999975432211111000
Q ss_pred -----------hhcCCcCCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 623 -----------DFIDPNLEGK---FSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 623 -----------~~~~~~~~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.......... .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000000000 01223578999999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=342.03 Aligned_cols=249 Identities=15% Similarity=0.212 Sum_probs=198.8
Q ss_pred cCCccccccccCCcceEEEEEE-c-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCC------ceeEeeEEecCCC
Q 005859 402 QCFSEANLLGKSSFSATYKGIL-R-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHEN------LASLRGICCSKGR 473 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~ 473 (673)
++|.+.+.||+|+||+||+|.. . +++.||||++... ....+.+.+|++++++++|++ |+++++++...
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~-- 89 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH-- 89 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET--
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC--
Confidence 5789999999999999999987 3 5889999998653 233467889999999987665 99999998654
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC-----------
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR----------- 542 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~----------- 542 (673)
+..++||||+ +++|.+++... ....+++..+..++.|++.||+|||++ ||+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN--KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred CcEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC--CCcCCCCCHHHEEEeccccccccCCcc
Confidence 7899999999 89999999743 224689999999999999999999998 8999999999999987
Q ss_pred --------CCCeeeccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHh
Q 005859 543 --------RYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQ 614 (673)
Q Consensus 543 --------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~ 614 (673)
++.+||+|||+++..... .....||..|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999999865432 23456899999999999989999999999999999999999998654322
Q ss_pred hhhccchhhhcC--------------------------------------Cc-CCCCCCHHHHHHHHHHHHHccccCCCC
Q 005859 615 AAESSKVEDFID--------------------------------------PN-LEGKFSVSEASNLGQIALHCTHESPSH 655 (673)
Q Consensus 615 ~~~~~~~~~~~~--------------------------------------~~-~~~~~~~~~~~~l~~l~~~Cl~~~p~~ 655 (673)
.... .+..... +. .........+.++.+++.+||+.||++
T Consensus 241 ~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 241 EHLA-MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHH-HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHH-HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 1100 0000000 00 001123345688999999999999999
Q ss_pred CCCHHHHHH
Q 005859 656 RPSIENVMQ 664 (673)
Q Consensus 656 RPs~~evl~ 664 (673)
|||+.|+++
T Consensus 320 Rpt~~ell~ 328 (339)
T 1z57_A 320 RITLREALK 328 (339)
T ss_dssp SCCHHHHTT
T ss_pred ccCHHHHhc
Confidence 999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=342.69 Aligned_cols=250 Identities=16% Similarity=0.260 Sum_probs=194.7
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCC----Ce
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGR----GE 475 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~~ 475 (673)
++|...+.||+|+||.||+|+.. +|+.||||++...... ...+.+.+|++++++++||||+++++++..... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57888999999999999999976 4899999999764322 224678899999999999999999999865422 23
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.++||||++ |+|.+++. ..+++..+..++.||+.||+|||++ ||+||||||+||++++++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~--~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 599999997 68888774 2489999999999999999999998 89999999999999999999999999998
Q ss_pred cccCcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh------------
Q 005859 556 LLADDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE------------ 622 (673)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~------------ 622 (673)
..... .....+|..|+|||.+.+ ..++.++|||||||++|||+||+.||..............
T Consensus 175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 65432 234568999999999887 6789999999999999999999999975432111100000
Q ss_pred ----------hhcCCcCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 623 ----------DFIDPNLE---GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 623 ----------~~~~~~~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
........ .......+.++.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 1122345678999999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.14 Aligned_cols=252 Identities=15% Similarity=0.230 Sum_probs=173.4
Q ss_pred hcCCccc-cccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCC--CCeE
Q 005859 401 TQCFSEA-NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKG--RGEC 476 (673)
Q Consensus 401 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~~ 476 (673)
.++|.+. ++||+|+||+||+|+.. +|+.||||++... .....+....++.++||||+++++++.... ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 4567774 46999999999999987 5899999998643 222222333456679999999999986522 3458
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC---CCCeeeccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR---RYNPLLSDSGL 553 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~---~~~~kl~DfGl 553 (673)
++||||+++|+|.+++... ....+++..++.++.|++.||+|||+. ||+||||||+||+++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~--~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH--NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999999743 224699999999999999999999998 8999999999999986 45599999999
Q ss_pred cccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhc--CCcCCC
Q 005859 554 HKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFI--DPNLEG 631 (673)
Q Consensus 554 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~--~~~~~~ 631 (673)
++...... .....+|+.|+|||++.+..++.++|||||||++|||+||+.||...............+. ......
T Consensus 178 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (336)
T 3fhr_A 178 AKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCT
T ss_pred ceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc
Confidence 98665432 2345679999999999888899999999999999999999999965433221111111111 111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 632 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
......+.++.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 122345678999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=353.23 Aligned_cols=251 Identities=22% Similarity=0.275 Sum_probs=186.7
Q ss_pred CCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEEEEe
Q 005859 403 CFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +|||||++++++.. .+..++|||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~lv~E 89 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLYIALE 89 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEEC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEEEEEe
Confidence 34556889999999998777677999999998653 245678999999987 89999999998854 478999999
Q ss_pred ecCCCChhhhhccccCCccc---cCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC-------------CC
Q 005859 482 FVPNGNLLQHLDLEAGSEKV---LEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR-------------YN 545 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~-------------~~ 545 (673)
|++ |+|.+++......... .++..++.++.||+.||+|||++ ||+||||||+|||++.+ +.
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC--CccccCCChHhEEEecCcccccccccCCCceE
Confidence 995 6999999743221111 23345678999999999999988 89999999999999754 48
Q ss_pred eeeccccccccccCcchh---hhhccCCCCCccCCccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCChhhHh
Q 005859 546 PLLSDSGLHKLLADDIVF---SMLKASAAMGYLAPEYTTT-------GRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQ 614 (673)
Q Consensus 546 ~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~ 614 (673)
+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999999877653221 1234578999999999875 568999999999999999999 99998653222
Q ss_pred hhhccchhhhcC-CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 615 AAESSKVEDFID-PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 615 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
. ......... +..........+.++.+++.+||+.||++|||+.||++
T Consensus 247 ~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 E--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 111111111 11122234566789999999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=341.70 Aligned_cols=247 Identities=19% Similarity=0.304 Sum_probs=200.0
Q ss_pred HHHHHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC-----cHHHHHHHHHHHhccC--CCCceeEee
Q 005859 395 EEVERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS-----DEGEFLKGLKILTSLK--HENLASLRG 466 (673)
Q Consensus 395 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~--H~niv~l~~ 466 (673)
++.....++|...+.||+|+||.||+|+.. +++.||||++....... ..+.+.+|++++++++ ||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 334445678999999999999999999965 58999999997654221 2246778999999996 599999999
Q ss_pred EEecCCCCeEEEEEeecCC-CChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEec-CCC
Q 005859 467 ICCSKGRGECFLIYDFVPN-GNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIH-RRY 544 (673)
Q Consensus 467 ~~~~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~-~~~ 544 (673)
++.. .+..++||||+.+ ++|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++ +++
T Consensus 116 ~~~~--~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 116 WFER--PDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRG 187 (320)
T ss_dssp EEEC--SSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTT
T ss_pred EEec--CCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC--CcEeCCCCHHHEEEeCCCC
Confidence 9955 4788999999976 899999873 34689999999999999999999987 899999999999999 788
Q ss_pred CeeeccccccccccCcchhhhhccCCCCCccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhh
Q 005859 545 NPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRF-TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVED 623 (673)
Q Consensus 545 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~ 623 (673)
.+||+|||+++...... .....||..|+|||++.+..+ +.++||||||+++|||+||+.||..........
T Consensus 188 ~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~----- 259 (320)
T 3a99_A 188 ELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ----- 259 (320)
T ss_dssp EEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCC-----
T ss_pred CEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhccc-----
Confidence 99999999998776432 233568999999999987665 788999999999999999999987543211100
Q ss_pred hcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 624 FIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
. ..+...+.++.+++.+||+.||++|||++|+++
T Consensus 260 ---~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 ---V----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ---C----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---c----cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 111223467899999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=336.93 Aligned_cols=246 Identities=20% Similarity=0.332 Sum_probs=193.2
Q ss_pred HHHHHhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-----CcHHHHHHHHHHHhcc----CCCCceeEe
Q 005859 396 EVERATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-----SDEGEFLKGLKILTSL----KHENLASLR 465 (673)
Q Consensus 396 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l----~H~niv~l~ 465 (673)
+.+...++|...+.||+|+||.||+|+.. +++.||||++...... .....+.+|++++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34445678999999999999999999865 5889999999765321 1223466799999998 899999999
Q ss_pred eEEecCCCCeEEEEEee-cCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEec-CC
Q 005859 466 GICCSKGRGECFLIYDF-VPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIH-RR 543 (673)
Q Consensus 466 ~~~~~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~-~~ 543 (673)
+++... +..++|||| +++++|.+++.. ...+++..++.++.||+.||+|||+. ||+||||||+||+++ ++
T Consensus 105 ~~~~~~--~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 105 DWFETQ--EGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR--GVVHRDIKDENILIDLRR 176 (312)
T ss_dssp EEC-------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH--TEECCCCSGGGEEEETTT
T ss_pred EEEecC--CeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCChhhEEEeCCC
Confidence 998543 678999999 789999999973 24589999999999999999999987 799999999999999 88
Q ss_pred CCeeeccccccccccCcchhhhhccCCCCCccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh
Q 005859 544 YNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRF-TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE 622 (673)
Q Consensus 544 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~ 622 (673)
+.+||+|||+++...... .....++..|+|||++.+..+ +.++||||||+++|||++|+.||.........
T Consensus 177 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----- 248 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEA----- 248 (312)
T ss_dssp TEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHT-----
T ss_pred CeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhh-----
Confidence 999999999998776542 234568999999999887666 45999999999999999999998754321110
Q ss_pred hhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 623 DFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
. ...+...+.++.+++.+||+.||++|||+.|+++
T Consensus 249 -----~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 249 -----E--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -----C--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----c--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 1122334577899999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=343.42 Aligned_cols=253 Identities=17% Similarity=0.284 Sum_probs=197.8
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccC-----------CCCceeEeeEEe
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-----------HENLASLRGICC 469 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~ 469 (673)
++|...+.||+|+||+||+|+.. +++.||||++... ....+.+.+|++++++++ ||||+++++++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 57899999999999999999975 5899999998743 234467889999999886 899999999987
Q ss_pred cCCC--CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEec------
Q 005859 470 SKGR--GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIH------ 541 (673)
Q Consensus 470 ~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~------ 541 (673)
.... ...++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.. ||+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~-~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT-CEECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC-CEEecCCChHHeEEeccCCCc
Confidence 5422 2789999999 899999997432 245899999999999999999999842 699999999999994
Q ss_pred CCCCeeeccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhh-----
Q 005859 542 RRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA----- 616 (673)
Q Consensus 542 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~----- 616 (673)
..+.+||+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 4457999999999876543 2345689999999999999999999999999999999999999975321100
Q ss_pred hccchhh------------------hcCC-------------------cCCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 005859 617 ESSKVED------------------FIDP-------------------NLEGKFSVSEASNLGQIALHCTHESPSHRPSI 659 (673)
Q Consensus 617 ~~~~~~~------------------~~~~-------------------~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 659 (673)
....+.+ .... .....++...+.++.+|+.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 0000000 0000 00112456678899999999999999999999
Q ss_pred HHHHH
Q 005859 660 ENVMQ 664 (673)
Q Consensus 660 ~evl~ 664 (673)
+|+++
T Consensus 329 ~ell~ 333 (373)
T 1q8y_A 329 GGLVN 333 (373)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=338.61 Aligned_cols=250 Identities=15% Similarity=0.225 Sum_probs=196.9
Q ss_pred hcCCccccccccCCcceEEEEEEcC-C-cEEEEEEecccCCCCcHHHHHHHHHHHhccCCCC------ceeEeeEEecCC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD-G-SVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHEN------LASLRGICCSKG 472 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~ 472 (673)
.++|.+.+.||+|+||+||+|+... + +.||||++... ....+.+.+|++++++++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~- 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH- 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET-
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC-
Confidence 3578999999999999999999753 4 78999999653 234567889999999998766 89999988554
Q ss_pred CCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEe------------
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLI------------ 540 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl------------ 540 (673)
+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ ||+||||||+|||+
T Consensus 95 -~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~--~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 95 -GHMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN--QLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp -TEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred -CeEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEeccccccccccc
Confidence 7899999999 67887777643 224689999999999999999999987 89999999999999
Q ss_pred -------cCCCCeeeccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhH
Q 005859 541 -------HRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTR 613 (673)
Q Consensus 541 -------~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~ 613 (673)
+.++.+||+|||+++..... .....||..|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 56789999999999865432 2345689999999999999999999999999999999999999975432
Q ss_pred hhhhccchhhhcCC-------------------------------------c--CCCCCCHHHHHHHHHHHHHccccCCC
Q 005859 614 QAAESSKVEDFIDP-------------------------------------N--LEGKFSVSEASNLGQIALHCTHESPS 654 (673)
Q Consensus 614 ~~~~~~~~~~~~~~-------------------------------------~--~~~~~~~~~~~~l~~l~~~Cl~~~p~ 654 (673)
...... +.....+ . .........+.++.+++.+||+.||+
T Consensus 245 ~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 245 REHLVM-MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp HHHHHH-HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHHHH-HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 211000 0000000 0 00011233466899999999999999
Q ss_pred CCCCHHHHHH
Q 005859 655 HRPSIENVMQ 664 (673)
Q Consensus 655 ~RPs~~evl~ 664 (673)
+|||+.|+++
T Consensus 324 ~Rpt~~e~l~ 333 (355)
T 2eu9_A 324 QRITLAEALL 333 (355)
T ss_dssp TSCCHHHHTT
T ss_pred hCcCHHHHhc
Confidence 9999999974
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=333.28 Aligned_cols=253 Identities=17% Similarity=0.276 Sum_probs=178.9
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHH-HHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEG-EFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~-~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
.++|+..+.||+|+||.||+|+.. +|+.||||++.......... .+.++..+++.++||||+++++++... +..++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~l 101 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN--TDVFI 101 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcEEE
Confidence 457888999999999999999986 58999999997654322223 344455678888999999999999654 78999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+ ++.+..+.... ...+++..+..++.|++.||+|||+.. ||+||||||+||+++.++.+||+|||+++...
T Consensus 102 v~e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EECCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH-CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred EEecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC-CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 99999 45555544321 245899999999999999999999832 79999999999999999999999999997665
Q ss_pred CcchhhhhccCCCCCccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCC
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTT-----TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (673)
... ......++..|+|||++. ...++.++|||||||++|||+||+.||..................+... .
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~ 252 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP--G 252 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC--S
T ss_pred CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC--c
Confidence 432 123346899999999985 4568999999999999999999999987532211111111111111111 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 634 SVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 634 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
....+.++.+++.+||+.||.+||++.|+++
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1234578999999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=361.79 Aligned_cols=265 Identities=20% Similarity=0.265 Sum_probs=205.2
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEec----CCCCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCS----KGRGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~~ 476 (673)
++|...+.||+|+||.||+|... +|+.||||++.........+.+.+|++++++++||||+++++++.. ...+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 57999999999999999999975 4899999998765433445679999999999999999999998744 124677
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC---eeeccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN---PLLSDSGL 553 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~---~kl~DfGl 553 (673)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. ||+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~--gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN--RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT--TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997432 223588999999999999999999997 8999999999999997765 89999999
Q ss_pred cccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc----------hhh
Q 005859 554 HKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK----------VED 623 (673)
Q Consensus 554 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~----------~~~ 623 (673)
++....... .....|+..|+|||.+.+..++.++|||||||++|||+||+.||.+......+... ..+
T Consensus 171 a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 171 AKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 987655432 23457899999999999999999999999999999999999999653222111100 000
Q ss_pred hcC--------CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH-----HHHHHHHhhc
Q 005859 624 FID--------PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIEN-----VMQELSSIIG 671 (673)
Q Consensus 624 ~~~--------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e-----vl~~L~~i~~ 671 (673)
... ...........+..+.+++.+||+.||++|||+.| ..+.++.++.
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 000 01112344567889999999999999999999988 4566666654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=346.27 Aligned_cols=249 Identities=19% Similarity=0.219 Sum_probs=185.4
Q ss_pred hcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~lv 479 (673)
..+|...+.||+|+||+||.....+|+.||||++.... ...+.+|+++|+++ +|||||++++++.+ .+..++|
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~lv 96 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC----FSFADREVQLLRESDEHPNVIRYFCTEKD--RQFQYIA 96 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT----EEECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEec--CCEEEEE
Confidence 45688889999999999765556679999999996543 22356899999999 89999999999855 4788999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC-----CCCeeecccccc
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR-----RYNPLLSDSGLH 554 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~-----~~~~kl~DfGla 554 (673)
|||++ |+|.+++.... ..+.+..+..++.||+.||+|||+. ||+||||||+|||++. ...+||+|||++
T Consensus 97 ~E~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL--NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EECCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT--TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EECCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC--cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 99996 69999997432 2344455678999999999999998 8999999999999953 335789999999
Q ss_pred ccccCcch--hhhhccCCCCCccCCcccc---CCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCc
Q 005859 555 KLLADDIV--FSMLKASAAMGYLAPEYTT---TGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPN 628 (673)
Q Consensus 555 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 628 (673)
+....... .......||+.|+|||++. ...++.++|||||||++|||+| |+.||.......... ........
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~--~~~~~~~~ 248 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--LLGACSLD 248 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH--HTTCCCCT
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH--HhccCCcc
Confidence 87654321 1233467999999999997 4567889999999999999999 888885432211110 11000000
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 629 LEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 629 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
........+..+.+++.+||+.||++|||+.||++
T Consensus 249 -~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 -CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 01122345567889999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=323.54 Aligned_cols=230 Identities=10% Similarity=0.110 Sum_probs=183.1
Q ss_pred cCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCC--cHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKS--DEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|.+.+.||+|+||.||+|+... ++.||||++....... ..+.+.+|++++++++||||+++++++... +..|+
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~l 108 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR--AGGLV 108 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC--CcEEE
Confidence 468889999999999999999865 8999999998654322 236799999999999999999999999654 78999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+++++|.+++.. . ....++.+|+.|++.||+|||++ ||+||||||+|||+++++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~--givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA--GVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC--CCccCCCCcccEEEcCCCCEEEEecc------
Confidence 9999999999999952 1 34556888999999999999998 89999999999999999999998543
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCC--CCCCHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLE--GKFSVS 636 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 636 (673)
|++| ++.++|||||||++|||+||+.||............. ........ ......
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 231 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-RDTAGQPIEPADIDRD 231 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC-BCTTSCBCCHHHHCTT
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH-HHhccCCCChhhcccC
Confidence 3433 6899999999999999999999997543211110000 00011000 011223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 637 EASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.+.++.+++.+||+.||++| |+.|+++.|+++..
T Consensus 232 ~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 232 IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 45789999999999999999 99999999998764
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=363.28 Aligned_cols=242 Identities=18% Similarity=0.258 Sum_probs=193.7
Q ss_pred cCCccccccccCCcceEEEEEEc--CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCC---eE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR--DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRG---EC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~---~~ 476 (673)
++|.+.+.||+|+||+||+|+.. +|+.||||++...........+.+|++++++++||||+++++++...+.. ..
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67999999999999999999976 58999999987543233346789999999999999999999999764321 26
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
|+||||+++++|.+++. ..+++..++.|+.||+.||+|||++ ||+||||||+|||++.+ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~--giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI--GLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC--CCeecccChHHeEEeCC-cEEEEecccchh
Confidence 99999999999998775 2589999999999999999999998 89999999999999986 899999999987
Q ss_pred ccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHH
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (673)
.... ....||+.|+|||++.++ ++.++|||||||++|||++|..|+..... ... ........
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~--------~~~----~~~~~~~~ 292 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV--------DGL----PEDDPVLK 292 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC--------SSC----CTTCHHHH
T ss_pred cccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc--------ccc----cccccccc
Confidence 6543 345689999999998765 48999999999999999999877653210 000 01111122
Q ss_pred HHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhh
Q 005859 637 EASNLGQIALHCTHESPSHRP-SIENVMQELSSII 670 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RP-s~~evl~~L~~i~ 670 (673)
.+..+.+++.+||+.||++|| +++++.+.|..++
T Consensus 293 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 293 TYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp HCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 346789999999999999999 5667777776654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=340.49 Aligned_cols=246 Identities=15% Similarity=0.140 Sum_probs=183.2
Q ss_pred HhcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC--CcHHHHHHHHHHHhccCC-CCcee------------
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK--SDEGEFLKGLKILTSLKH-ENLAS------------ 463 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H-~niv~------------ 463 (673)
.+..|...+.||+|+||+||+|+.. +|+.||||++...... ...+.|.+|+.+++.++| +|...
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3456778889999999999999965 5999999998744322 235689999999999987 32111
Q ss_pred ---------EeeEEecCC---CCeEEEEEeecCCCChhhhhccc---cCCccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Q 005859 464 ---------LRGICCSKG---RGECFLIYDFVPNGNLLQHLDLE---AGSEKVLEWATRISVIKGIAKGISYLHGKRPGL 528 (673)
Q Consensus 464 ---------l~~~~~~~~---~~~~~lv~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~i 528 (673)
+..++.... ....+++|+++ +++|.++++.. ......+++..++.++.||++||+|||++ ||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~i 232 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GL 232 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT--TE
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC--Cc
Confidence 111111111 12356777766 68999988421 12345688999999999999999999987 89
Q ss_pred ccCCcCCCCeEecCCCCeeeccccccccccCcchhhhhccCCCCCccCCccc----------cCCCCCcchhHHHHHHHH
Q 005859 529 VHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYT----------TTGRFTEKSDIYAFGMIV 598 (673)
Q Consensus 529 vHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDVwSfGvvl 598 (673)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999999876543 234467 899999999 555689999999999999
Q ss_pred HHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 005859 599 FQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVM 663 (673)
Q Consensus 599 ~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl 663 (673)
|||+||+.||........ ....+... . ..+.++.+++.+||+.||++||++.+++
T Consensus 308 ~elltg~~Pf~~~~~~~~----~~~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGG----SEWIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHSSCCCCTTGGGSC----SGGGGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHCCCCCCCcchhhh----HHHHHhhc--c----cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999976433221 11111110 1 2347799999999999999999987775
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=319.15 Aligned_cols=228 Identities=14% Similarity=0.250 Sum_probs=178.2
Q ss_pred cCCccc-cccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHH-hccCCCCceeEeeEEec--CCCCeE
Q 005859 402 QCFSEA-NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKIL-TSLKHENLASLRGICCS--KGRGEC 476 (673)
Q Consensus 402 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~--~~~~~~ 476 (673)
++|... +.||+|+||.||+|... +++.||||++.. ...+.+|++++ +..+||||+++++++.. .+....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 346655 78999999999999975 589999999853 24678899988 55699999999999854 224678
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC---CCCeeeccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR---RYNPLLSDSGL 553 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~---~~~~kl~DfGl 553 (673)
++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. ||+||||||+||+++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999999743 224689999999999999999999998 8999999999999998 78899999999
Q ss_pred cccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCC
Q 005859 554 HKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKF 633 (673)
Q Consensus 554 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (673)
++... +..++.++|||||||++|||+||+.||.................... ...
T Consensus 167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~--~~~ 221 (299)
T 3m2w_A 167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ--YEF 221 (299)
T ss_dssp CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTC--CSS
T ss_pred ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcc--ccC
Confidence 86432 23578899999999999999999999965433221111111111111 111
Q ss_pred C----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 634 S----VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 634 ~----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+ ...+.++.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 2 224578999999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=321.34 Aligned_cols=243 Identities=16% Similarity=0.178 Sum_probs=186.8
Q ss_pred hcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCC-------CCcHHHHHHHHHHHhccC---------CCCceeE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSC-------KSDEGEFLKGLKILTSLK---------HENLASL 464 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~---------H~niv~l 464 (673)
.++|...+.||+|+||+||+|+. +|+.||||++..... ....+.+.+|++++++++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688889999999999999998 689999999986532 223378899999999886 7777777
Q ss_pred eeEEecC----------------------------CCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHH
Q 005859 465 RGICCSK----------------------------GRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAK 516 (673)
Q Consensus 465 ~~~~~~~----------------------------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~ 516 (673)
.+++... +.+..++||||+++|++.+.+.. ..+++..++.|+.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 7765311 24689999999999987776642 45899999999999999
Q ss_pred HHHHHh-cCCCCcccCCcCCCCeEecCCC--------------------CeeeccccccccccCcchhhhhccCCCCCcc
Q 005859 517 GISYLH-GKRPGLVHPNLSAEKVLIHRRY--------------------NPLLSDSGLHKLLADDIVFSMLKASAAMGYL 575 (673)
Q Consensus 517 gL~yLH-~~~~~ivHrDlk~~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~ 575 (673)
||+||| ++ ||+||||||+|||++.++ .+||+|||+|+..... ...||+.|+
T Consensus 173 aL~~lH~~~--~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~ 244 (336)
T 2vuw_A 173 SLAVAEASL--RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHHH--CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred HHHHHHHhC--CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence 999999 77 799999999999999887 8999999999876543 246899999
Q ss_pred CCccccCCCCCcchhHHHHHHH-HHHHHhCCCCCChhhHhhhhccchh-hhc-CCcCCCCCCHHHHHHHHHHHHHccccC
Q 005859 576 APEYTTTGRFTEKSDIYAFGMI-VFQILSGKCSITPFTRQAAESSKVE-DFI-DPNLEGKFSVSEASNLGQIALHCTHES 652 (673)
Q Consensus 576 aPE~~~~~~~s~ksDVwSfGvv-l~el~tG~~p~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~l~~l~~~Cl~~~ 652 (673)
|||++.+.. +.++||||+|++ .+++++|..||............+. ... ............+.++.+|+.+||+.|
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d 323 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS 323 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence 999998766 899999998777 7788899988754211010111111 111 111111223457789999999999976
Q ss_pred CCCCCCHHHHH
Q 005859 653 PSHRPSIENVM 663 (673)
Q Consensus 653 p~~RPs~~evl 663 (673)
|++|++
T Consensus 324 -----sa~e~l 329 (336)
T 2vuw_A 324 -----SATDLL 329 (336)
T ss_dssp -----SHHHHH
T ss_pred -----CHHHHH
Confidence 899887
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=275.55 Aligned_cols=213 Identities=33% Similarity=0.597 Sum_probs=197.2
Q ss_pred CCChhHHHHHHHHHHhcCCCCCCcCCCCCCCCCCCCCCCceEEeCCC---CCEEEEEecCCCccc--ccCccccCCCCCC
Q 005859 18 LSSTSEVDILMHIKDSLDPENRLLTSWAPNADPCSSDSFDGVACDEN---GRVANISLQGKGLSG--EIPAAVGGLKSLT 92 (673)
Q Consensus 18 ~~~~~~~~~ll~~~~~~~~~~~~l~~w~~~~~~C~~~~w~gv~c~~~---~~v~~l~l~~~~l~g--~~p~~~~~l~~L~ 92 (673)
.|.++|++||++||+++.... .+.+|..+.++|. +.|.||.|+.. ++|+.|+|++++++| .+|..|.++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~~~~C~-~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCN-RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTT-TCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCCCCCCc-CCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence 467889999999999995333 5899987778885 35999999864 799999999999999 9999999999999
Q ss_pred eEeCcC-CcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeeccccc
Q 005859 93 GLYLHF-NALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYN 171 (673)
Q Consensus 93 ~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N 171 (673)
+|+|++ |.+.+.+|..|.++++|++|+|++|++++.+|..|.++++|++|+|++|.+++.+|..|..+++|++|+|++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 999995 9999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCccCCccccCCC-cccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCchhhhhcc
Q 005859 172 QLTGAIPASLGDLG-MLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233 (673)
Q Consensus 172 ~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~l~~~~ 233 (673)
++++.+|..+..++ +|+.|+|++|++++.+|..+..+. |+.|++++|.+++.+|..+..+.
T Consensus 160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~ 221 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDK 221 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTS
T ss_pred cccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCC
Confidence 99999999999998 999999999999999999999887 99999999999999888776554
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.1e-31 Score=293.86 Aligned_cols=185 Identities=12% Similarity=0.043 Sum_probs=127.9
Q ss_pred ccccCCcceEEEEE-EcCCcEEEEEEecccCCC---------CcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEE
Q 005859 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCK---------SDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 409 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---------~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~ 477 (673)
..+.|++|.++.++ .-.|+.+|+|++.+.... ...++|.+|+++|+++ .|+||+++++++.+ .+..|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~y 318 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSGW 318 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEEE
Confidence 35566666666554 234899999999764311 1235799999999999 79999999999954 47899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
|||||++||+|.++|.. ...++.. +|+.||+.||+|+|++ |||||||||+|||+++++.+||+|||+|+..
T Consensus 319 LVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~--GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ--GFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT--TCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC--CceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 99999999999999973 2346654 5899999999999998 8999999999999999999999999999877
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKC 606 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~ 606 (673)
..+.. .....+||+.|||||++.+ .+..++|+||+|++++++.++..
T Consensus 390 ~~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 390 PQDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp C---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CCCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 65432 2334579999999999875 56788999999999888876643
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-28 Score=277.30 Aligned_cols=207 Identities=25% Similarity=0.409 Sum_probs=187.0
Q ss_pred ChhHHHHHHHHHHhcCCC-CC-------CcCCCCCCCCCCCCCCC---ceEEeCCCCCEEEEEecCCCcccccCccccCC
Q 005859 20 STSEVDILMHIKDSLDPE-NR-------LLTSWAPNADPCSSDSF---DGVACDENGRVANISLQGKGLSGEIPAAVGGL 88 (673)
Q Consensus 20 ~~~~~~~ll~~~~~~~~~-~~-------~l~~w~~~~~~C~~~~w---~gv~c~~~~~v~~l~l~~~~l~g~~p~~~~~l 88 (673)
...|++||.+|+++++.. .. ...+|+.+.++|. | .||+|+..++|+.|+|++++++|.+|++|++|
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~---w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L 104 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDM---WGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQL 104 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGG---TTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGC
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCccc---ccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcC
Confidence 356899999999998532 11 1237988888887 8 99999988999999999999999999999999
Q ss_pred CCCCeEeCcCCc--------------------------------------------------------------------
Q 005859 89 KSLTGLYLHFNA-------------------------------------------------------------------- 100 (673)
Q Consensus 89 ~~L~~L~L~~N~-------------------------------------------------------------------- 100 (673)
++|++|+|++|.
T Consensus 105 ~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~ 184 (636)
T 4eco_A 105 TELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184 (636)
T ss_dssp TTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCC
T ss_pred ccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchh
Confidence 999999999984
Q ss_pred ----------CCccCCcccCCCCCCCEEEccCCCCCCC-----------------Cccccc--CCCCCcEeeccCccccc
Q 005859 101 ----------LNGVIPKEIASLSELSDLYLNVNNLSGK-----------------IPSQIG--NMTNLQVLQLCYNKLTG 151 (673)
Q Consensus 101 ----------l~~~~p~~~~~l~~L~~L~l~~N~l~~~-----------------~p~~~~--~l~~L~~L~L~~N~l~~ 151 (673)
|+| +|..|+++++|++|+|++|++++. +|..++ ++++|++|+|++|++.+
T Consensus 185 ~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~ 263 (636)
T 4eco_A 185 DTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT 263 (636)
T ss_dssp TTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCS
T ss_pred hhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCc
Confidence 445 889999999999999999999986 999999 99999999999999999
Q ss_pred cCchhhcCccccCeecccccc-cCc-cCCccccCC------CcccccccccccCCCCCcc--cccCCCCCCEEEccCCCC
Q 005859 152 NIPTQLGSLRKLSVLALQYNQ-LTG-AIPASLGDL------GMLMRLDLSFNNLFGPVPV--KLANVPKLEVLDIRNNSF 221 (673)
Q Consensus 152 ~~p~~l~~l~~L~~L~l~~N~-l~~-~~p~~~~~l------~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l 221 (673)
.+|..|+++++|++|+|++|+ ++| .+|..++.+ ++|+.|+|++|+++ .+|. .+.++++|+.|++++|++
T Consensus 264 ~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l 342 (636)
T 4eco_A 264 KLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQL 342 (636)
T ss_dssp SCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCC
T ss_pred cChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcC
Confidence 999999999999999999998 998 899988877 99999999999999 7888 899999999999999999
Q ss_pred CcCCchhhhhc
Q 005859 222 SGNVPPALKRL 232 (673)
Q Consensus 222 ~g~~p~~l~~~ 232 (673)
+|.+| .+..+
T Consensus 343 ~g~ip-~~~~l 352 (636)
T 4eco_A 343 EGKLP-AFGSE 352 (636)
T ss_dssp EEECC-CCEEE
T ss_pred ccchh-hhCCC
Confidence 99999 66554
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=277.07 Aligned_cols=212 Identities=30% Similarity=0.423 Sum_probs=168.6
Q ss_pred HhhcCCChhHHHHHHHHHHhcCCCCCCcCCCCCCCCCCCCCCCceEEeCCCCCEEEEEecCCCcccc---cC--------
Q 005859 14 VTYTLSSTSEVDILMHIKDSLDPENRLLTSWAPNADPCSSDSFDGVACDENGRVANISLQGKGLSGE---IP-------- 82 (673)
Q Consensus 14 ~~~~~~~~~~~~~ll~~~~~~~~~~~~l~~w~~~~~~C~~~~w~gv~c~~~~~v~~l~l~~~~l~g~---~p-------- 82 (673)
++++++.++|++||++||+++.+.. .+++|..++++|. |.||+|+ .++|+.|+|++++++|. +|
T Consensus 4 ~~~~~~~~~~~~all~~k~~~~~~~-~l~~W~~~~~~C~---w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~ 78 (768)
T 3rgz_A 4 ASPSQSLYREIHQLISFKDVLPDKN-LLPDWSSNKNPCT---FDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTG 78 (768)
T ss_dssp ----CCHHHHHHHHHHHHTTCSCTT-SSTTCCTTSCGGG---STTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTT
T ss_pred CccccCCHHHHHHHHHHHhhCCCcc-cccCCCCCCCCcC---CcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCc
Confidence 3445556889999999999995333 6899987788887 9999998 79999999999999987 44
Q ss_pred ---------------ccccCCCCCCeEeCcCCcCCccCCc--ccCCCCCCCEEEccCCCCCCCCcccc-cCCCCCcEeec
Q 005859 83 ---------------AAVGGLKSLTGLYLHFNALNGVIPK--EIASLSELSDLYLNVNNLSGKIPSQI-GNMTNLQVLQL 144 (673)
Q Consensus 83 ---------------~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~L 144 (673)
..|+.+++|++|+|++|.++|.+|. .++++++|++|+|++|.+++.+|..+ .++++|++|+|
T Consensus 79 L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L 158 (768)
T 3rgz_A 79 LESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158 (768)
T ss_dssp CCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEEC
T ss_pred ccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEEC
Confidence 4677788888888888888888887 88888888888888888887777765 77888888888
Q ss_pred cCccccccCchh---hcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCC
Q 005859 145 CYNKLTGNIPTQ---LGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSF 221 (673)
Q Consensus 145 ~~N~l~~~~p~~---l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 221 (673)
++|++++..|.. +.++++|++|++++|.+++.+|. ..+++|++|+|++|++++.+|. +.++++|++|++++|.+
T Consensus 159 s~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l 235 (768)
T 3rgz_A 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKL 235 (768)
T ss_dssp CSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCC
T ss_pred CCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcC
Confidence 888888777766 67777788888877777765553 6777888888888888877776 77888888888888888
Q ss_pred CcCCchhhhhcc
Q 005859 222 SGNVPPALKRLN 233 (673)
Q Consensus 222 ~g~~p~~l~~~~ 233 (673)
++.+|..+..+.
T Consensus 236 ~~~~~~~l~~l~ 247 (768)
T 3rgz_A 236 SGDFSRAISTCT 247 (768)
T ss_dssp CSCHHHHTTTCS
T ss_pred CCcccHHHhcCC
Confidence 887777776554
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=278.26 Aligned_cols=203 Identities=25% Similarity=0.377 Sum_probs=180.4
Q ss_pred CChhHHHHHHHHHHhcCCCCCCcCCCCCCC-----CC--CCCCCC------------ceEEeCCCCCEEEEEecCCCccc
Q 005859 19 SSTSEVDILMHIKDSLDPENRLLTSWAPNA-----DP--CSSDSF------------DGVACDENGRVANISLQGKGLSG 79 (673)
Q Consensus 19 ~~~~~~~~ll~~~~~~~~~~~~l~~w~~~~-----~~--C~~~~w------------~gv~c~~~~~v~~l~l~~~~l~g 79 (673)
....|++||++||++++.. +|+.++ +| |. | .||.|+..++|+.|+|++++|+|
T Consensus 266 ~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~---W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G 337 (876)
T 4ecn_A 266 EYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLN---WNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKG 337 (876)
T ss_dssp HHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCS---CCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEE
T ss_pred cchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccc---cccccccccccCcCceEecCCCCEEEEECccCCCCC
Confidence 3467999999999999532 786544 56 54 9 99999988999999999999999
Q ss_pred ccCccccCCCCCCeEeC-cCCcCCcc------------------------------------------------------
Q 005859 80 EIPAAVGGLKSLTGLYL-HFNALNGV------------------------------------------------------ 104 (673)
Q Consensus 80 ~~p~~~~~l~~L~~L~L-~~N~l~~~------------------------------------------------------ 104 (673)
.+|++|++|++|++|+| ++|.++|.
T Consensus 338 ~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i 417 (876)
T 4ecn_A 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI 417 (876)
T ss_dssp EECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCC
T ss_pred cCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccc
Confidence 99999999999999999 77866554
Q ss_pred ----------------------CCcccCCCCCCCEEEccCCCCCC-----------------CCccccc--CCCCCcEee
Q 005859 105 ----------------------IPKEIASLSELSDLYLNVNNLSG-----------------KIPSQIG--NMTNLQVLQ 143 (673)
Q Consensus 105 ----------------------~p~~~~~l~~L~~L~l~~N~l~~-----------------~~p~~~~--~l~~L~~L~ 143 (673)
+|..|++|++|++|+|++|+|++ .+|..++ ++++|++|+
T Consensus 418 ~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~ 497 (876)
T 4ecn_A 418 KKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE 497 (876)
T ss_dssp CCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEE
T ss_pred ccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEE
Confidence 78899999999999999999998 3899988 999999999
Q ss_pred ccCccccccCchhhcCccccCeecccccc-cCc-cCCccccCCC-------cccccccccccCCCCCcc--cccCCCCCC
Q 005859 144 LCYNKLTGNIPTQLGSLRKLSVLALQYNQ-LTG-AIPASLGDLG-------MLMRLDLSFNNLFGPVPV--KLANVPKLE 212 (673)
Q Consensus 144 L~~N~l~~~~p~~l~~l~~L~~L~l~~N~-l~~-~~p~~~~~l~-------~L~~L~l~~N~l~~~~p~--~~~~l~~L~ 212 (673)
|++|.+.+.+|..|+++++|+.|+|++|+ +++ .+|..++.++ +|+.|+|++|+++ .+|. .+.++++|+
T Consensus 498 Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~ 576 (876)
T 4ecn_A 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLG 576 (876)
T ss_dssp EESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCC
T ss_pred CcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCC
Confidence 99999999999999999999999999998 998 8898777665 9999999999999 7888 899999999
Q ss_pred EEEccCCCCCcCCchhhhhc
Q 005859 213 VLDIRNNSFSGNVPPALKRL 232 (673)
Q Consensus 213 ~L~l~~N~l~g~~p~~l~~~ 232 (673)
.|+|++|+++ .+| .+..+
T Consensus 577 ~L~Ls~N~l~-~lp-~~~~L 594 (876)
T 4ecn_A 577 LLDCVHNKVR-HLE-AFGTN 594 (876)
T ss_dssp EEECTTSCCC-BCC-CCCTT
T ss_pred EEECCCCCcc-cch-hhcCC
Confidence 9999999999 788 55544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=264.67 Aligned_cols=185 Identities=11% Similarity=0.103 Sum_probs=143.4
Q ss_pred ccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCc-------HHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 405 SEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSD-------EGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 405 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
...+.||+|+||+||+|.. .++.+|+|+......... .+.+.+|++++++++||||+++..++... +..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL--DNKR 415 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET--TTTE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC--CccE
Confidence 3356899999999999954 478899998755432111 24589999999999999999555555433 4569
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+||||+++|+|.+++.. +..++.|+++||+|||++ ||+||||||+|||+++ .+||+|||+++..
T Consensus 416 lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~--gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN--DVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT--TEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC--cCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 99999999999999962 457999999999999987 8999999999999998 9999999999987
Q ss_pred cCcchhh------hhccCCCCCccCCccccC--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 005859 558 ADDIVFS------MLKASAAMGYLAPEYTTT--GRFTEKSDIYAFGMIVFQILSGKCSI 608 (673)
Q Consensus 558 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSfGvvl~el~tG~~p~ 608 (673)
....... .....||+.|||||++.. ..|+.++|+||..+-..+.+.++.+|
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 6543211 234578999999999986 56888999999999999988877665
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-26 Score=239.25 Aligned_cols=207 Identities=23% Similarity=0.345 Sum_probs=183.3
Q ss_pred CChhHHHHHHHHHHhcC-CCCCCcCCCC----CCCCCCCCCCCceEEeCC---------CCCEEEEEecCCCcccccCcc
Q 005859 19 SSTSEVDILMHIKDSLD-PENRLLTSWA----PNADPCSSDSFDGVACDE---------NGRVANISLQGKGLSGEIPAA 84 (673)
Q Consensus 19 ~~~~~~~~ll~~~~~~~-~~~~~l~~w~----~~~~~C~~~~w~gv~c~~---------~~~v~~l~l~~~~l~g~~p~~ 84 (673)
...+|.++|++||.++. +....+.+|. .+.++|+ |.|+.|+. ..+|+.|+|++|+++ .+|..
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~---~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~ 99 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIET---RTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQ 99 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCC---SHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSC
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccc---cCCcchhhhHHHHhcccccceeEEEccCCCch-hcChh
Confidence 34578999999999872 3344567893 4567776 99999952 378999999999998 88999
Q ss_pred ccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcC-----
Q 005859 85 VGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGS----- 159 (673)
Q Consensus 85 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~----- 159 (673)
++.+++|++|+|++|.|+ .+|..++.+++|++|+|++|+++ .+|..|+++++|++|+|++|++.+.+|..+..
T Consensus 100 l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~ 177 (328)
T 4fcg_A 100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177 (328)
T ss_dssp GGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CC
T ss_pred hhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchh
Confidence 999999999999999999 89999999999999999999999 78999999999999999999999999987765
Q ss_pred ----ccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCchhhhhcc
Q 005859 160 ----LRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233 (673)
Q Consensus 160 ----l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~l~~~~ 233 (673)
+++|++|+|++|+++ .+|..++.+++|+.|+|++|++++ +|..+..+++|+.|+|++|++.+.+|..+..+.
T Consensus 178 ~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~ 253 (328)
T 4fcg_A 178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA 253 (328)
T ss_dssp CEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCC
T ss_pred hhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCC
Confidence 999999999999998 889999999999999999999996 566789999999999999999999998876654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=253.27 Aligned_cols=112 Identities=36% Similarity=0.628 Sum_probs=66.9
Q ss_pred CCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEc
Q 005859 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDI 216 (673)
Q Consensus 137 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 216 (673)
++|+.|+|++|+++|.+|..|+++++|+.|+|++|+++|.+|..|+++++|+.|+|++|+++|.+|..+.++++|++||+
T Consensus 632 ~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~l 711 (768)
T 3rgz_A 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDL 711 (768)
T ss_dssp BCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEEC
T ss_pred ccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEEC
Confidence 44555555555555566666666666666666666666666666666666666666666666666666666666666666
Q ss_pred cCCCCCcCCchh--hhhccCCccccCcccccCCCc
Q 005859 217 RNNSFSGNVPPA--LKRLNGGFQYDNNAALCGTGF 249 (673)
Q Consensus 217 ~~N~l~g~~p~~--l~~~~~~~~~~~n~~~~~~~~ 249 (673)
++|+|+|.+|.. +..+. ...|.+|+.+||.++
T Consensus 712 s~N~l~g~iP~~~~~~~~~-~~~~~gN~~Lcg~~l 745 (768)
T 3rgz_A 712 SNNNLSGPIPEMGQFETFP-PAKFLNNPGLCGYPL 745 (768)
T ss_dssp CSSEEEEECCSSSSGGGSC-GGGGCSCTEEESTTS
T ss_pred cCCcccccCCCchhhccCC-HHHhcCCchhcCCCC
Confidence 666666666643 22221 234667888888654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-24 Score=220.16 Aligned_cols=155 Identities=14% Similarity=0.109 Sum_probs=122.4
Q ss_pred CHHHHHHHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCC-----------------CcHHHHHHHHHHHhc
Q 005859 393 NLEEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCK-----------------SDEGEFLKGLKILTS 455 (673)
Q Consensus 393 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~ 455 (673)
.+..+......|...+.||+|+||.||+|+..+|+.||||++...... .....+.+|+++|++
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 345556666778888999999999999999977999999999653211 123568999999999
Q ss_pred cCCCCceeEeeEEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCC
Q 005859 456 LKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSA 535 (673)
Q Consensus 456 l~H~niv~l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~ 535 (673)
++| +++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||+|||+. ||+||||||
T Consensus 161 l~~---~~v~~~~~~---~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~--giiHrDlkp 221 (282)
T 1zar_A 161 LQG---LAVPKVYAW---EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR--GIVHGDLSQ 221 (282)
T ss_dssp TTT---SSSCCEEEE---ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT--TEECSCCST
T ss_pred ccC---CCcCeEEec---cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC--CCEeCCCCH
Confidence 994 555555432 34689999999999998 531 12346999999999999987 899999999
Q ss_pred CCeEecCCCCeeeccccccccccCcchhhhhccCCCCCccCCcccc
Q 005859 536 EKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTT 581 (673)
Q Consensus 536 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 581 (673)
+|||++ ++.+||+|||+++.. ..|+|||++.
T Consensus 222 ~NILl~-~~~vkl~DFG~a~~~--------------~~~~a~e~l~ 252 (282)
T 1zar_A 222 YNVLVS-EEGIWIIDFPQSVEV--------------GEEGWREILE 252 (282)
T ss_dssp TSEEEE-TTEEEECCCTTCEET--------------TSTTHHHHHH
T ss_pred HHEEEE-CCcEEEEECCCCeEC--------------CCCCHHHHHH
Confidence 999999 999999999998632 3468888875
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.89 E-value=8.5e-24 Score=219.64 Aligned_cols=167 Identities=29% Similarity=0.485 Sum_probs=144.1
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCC-CCcEee
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMT-NLQVLQ 143 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~L~ 143 (673)
.+++.|+|++|.++|.+|..|.++++|++|+|++|.+++.+|..|..+++|++|+|++|++++.+|..+.+++ +|+.|+
T Consensus 101 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~ 180 (313)
T 1ogq_A 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180 (313)
T ss_dssp TTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEE
T ss_pred CCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEE
Confidence 4678999999999999999999999999999999999999999999999999999999999999999999998 999999
Q ss_pred ccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCc
Q 005859 144 LCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 144 L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 223 (673)
|++|++++.+|..+..++ |++|++++|.+++.+|..|..+++|+.|+|++|.+++.+|. +..+++|+.|++++|+|+|
T Consensus 181 L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~ 258 (313)
T 1ogq_A 181 ISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYG 258 (313)
T ss_dssp CCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEE
T ss_pred CcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccC
Confidence 999999988888888887 88888888888888888888888888888888887766555 6667777777777777777
Q ss_pred CCchhhhhcc
Q 005859 224 NVPPALKRLN 233 (673)
Q Consensus 224 ~~p~~l~~~~ 233 (673)
.+|..+..+.
T Consensus 259 ~~p~~l~~l~ 268 (313)
T 1ogq_A 259 TLPQGLTQLK 268 (313)
T ss_dssp CCCGGGGGCT
T ss_pred cCChHHhcCc
Confidence 7777766543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-22 Score=202.51 Aligned_cols=160 Identities=28% Similarity=0.302 Sum_probs=137.2
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..++.|+|++|++++..+..|.++++|++|+|++|.|++..|..|..+++|++|+|++|++++..+..|..+++|++|+|
T Consensus 35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 35788888888888888888888899999999999988888888888899999999999988777778888889999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++.+.
T Consensus 115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 99988877677788888899999999988876666788888899999999998887777888888899999999988876
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-22 Score=203.94 Aligned_cols=193 Identities=26% Similarity=0.295 Sum_probs=158.7
Q ss_pred CCceEEeCC----------CCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCC
Q 005859 55 SFDGVACDE----------NGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNN 124 (673)
Q Consensus 55 ~w~gv~c~~----------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 124 (673)
.|..|.|.. ...++.|+|++|++++..+..|.++++|++|+|++|.++...+..|..+++|++|+|++|+
T Consensus 17 ~~~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~ 96 (270)
T 2o6q_A 17 NKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96 (270)
T ss_dssp TTTEEECTTSCCSSCCSCCCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSC
T ss_pred CCCEEEccCCCCCccCCCCCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCc
Confidence 466777753 1357889999999987777789999999999999999987777778889999999999999
Q ss_pred CCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCccc
Q 005859 125 LSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVK 204 (673)
Q Consensus 125 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 204 (673)
+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|++++..+..
T Consensus 97 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 176 (270)
T 2o6q_A 97 LQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGA 176 (270)
T ss_dssp CCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred CCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhH
Confidence 99777778889999999999999999888888899999999999999998766667889999999999999999877778
Q ss_pred ccCCCCCCEEEccCCCCCcCCchhhhhccC--CccccCcccccCC
Q 005859 205 LANVPKLEVLDIRNNSFSGNVPPALKRLNG--GFQYDNNAALCGT 247 (673)
Q Consensus 205 ~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~--~~~~~~n~~~~~~ 247 (673)
|..+++|+.|+|++|++++..+..+..+.. .+.+.+|+..|..
T Consensus 177 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 177 FDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred hccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence 888999999999999998766655655432 2445566666653
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-22 Score=201.38 Aligned_cols=187 Identities=24% Similarity=0.295 Sum_probs=162.7
Q ss_pred CCceEEeCCCCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCccccc
Q 005859 55 SFDGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIG 134 (673)
Q Consensus 55 ~w~gv~c~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 134 (673)
.|.|+.|... ...+++++++++ .+|..+. ++|+.|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.
T Consensus 6 ~~~gC~C~~~--~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 80 (251)
T 3m19_A 6 TVTGCTCNEG--KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFD 80 (251)
T ss_dssp HHHSSEEEGG--GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTT
T ss_pred CCCceEcCCC--CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhc
Confidence 3899999532 346889999988 5776665 6899999999999999999999999999999999999998888899
Q ss_pred CCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEE
Q 005859 135 NMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVL 214 (673)
Q Consensus 135 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 214 (673)
++++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|
T Consensus 81 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 160 (251)
T 3m19_A 81 DLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTL 160 (251)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEE
Confidence 99999999999999998888889999999999999999997777778999999999999999998888789999999999
Q ss_pred EccCCCCCcCCchhhhhccC--CccccCcccccC
Q 005859 215 DIRNNSFSGNVPPALKRLNG--GFQYDNNAALCG 246 (673)
Q Consensus 215 ~l~~N~l~g~~p~~l~~~~~--~~~~~~n~~~~~ 246 (673)
+|++|+|++..|..+..+.. .+.+.+|...|.
T Consensus 161 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 161 SLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred ECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 99999999887777765543 233455555443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-22 Score=195.98 Aligned_cols=171 Identities=25% Similarity=0.223 Sum_probs=116.2
Q ss_pred CCceEEeCCC----------CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCC
Q 005859 55 SFDGVACDEN----------GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNN 124 (673)
Q Consensus 55 ~w~gv~c~~~----------~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 124 (673)
.|.+|.|+.. .+++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus 8 ~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 87 (208)
T 2o6s_A 8 SGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87 (208)
T ss_dssp ETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCc
Confidence 4999999743 246677777777776555556677777777777777776555566677777777777777
Q ss_pred CCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCccc
Q 005859 125 LSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVK 204 (673)
Q Consensus 125 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 204 (673)
+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+.+
T Consensus 88 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~----- 162 (208)
T 2o6s_A 88 LQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC----- 162 (208)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-----
T ss_pred CCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-----
Confidence 775555556777777777777777776555566677777777777777775555556667777777777776553
Q ss_pred ccCCCCCCEEEccCCCCCcCCchhhhhc
Q 005859 205 LANVPKLEVLDIRNNSFSGNVPPALKRL 232 (673)
Q Consensus 205 ~~~l~~L~~L~l~~N~l~g~~p~~l~~~ 232 (673)
.+++|+.|+++.|+++|.+|..+..+
T Consensus 163 --~~~~l~~L~~~~n~~~g~ip~~~~~l 188 (208)
T 2o6s_A 163 --TCPGIRYLSEWINKHSGVVRNSAGSV 188 (208)
T ss_dssp --CTTTTHHHHHHHHHCTTTBBCTTSSB
T ss_pred --CCCCHHHHHHHHHhCCceeeccCccc
Confidence 34566777777777777777665443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=198.72 Aligned_cols=180 Identities=27% Similarity=0.323 Sum_probs=160.4
Q ss_pred CCCCCCCCCceEEeCCCCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCC
Q 005859 48 ADPCSSDSFDGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSG 127 (673)
Q Consensus 48 ~~~C~~~~w~gv~c~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 127 (673)
.+.|. |.|+.|+..+.++.+++++++++ .+|..+. ++|+.|+|++|++++..+..|..+++|++|+|++|+++.
T Consensus 2 ~~~C~---~~~~~C~c~~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 75 (270)
T 2o6q_A 2 EALCK---KDGGVCSCNNNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT 75 (270)
T ss_dssp CCCBG---GGTCSBEEETTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSC
T ss_pred CccCC---CCCCCCEeCCCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCe
Confidence 46776 99999976666789999999998 4777664 789999999999998888899999999999999999997
Q ss_pred CCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccC
Q 005859 128 KIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLAN 207 (673)
Q Consensus 128 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 207 (673)
..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|..+++|+.|+|++|.+++..+..+..
T Consensus 76 i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 155 (270)
T 2o6q_A 76 LPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDK 155 (270)
T ss_dssp CCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred eChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccC
Confidence 76777899999999999999999877788899999999999999999888888999999999999999999877777999
Q ss_pred CCCCCEEEccCCCCCcCCchhhhhcc
Q 005859 208 VPKLEVLDIRNNSFSGNVPPALKRLN 233 (673)
Q Consensus 208 l~~L~~L~l~~N~l~g~~p~~l~~~~ 233 (673)
+++|+.|++++|.+++..+..+..+.
T Consensus 156 l~~L~~L~L~~n~l~~~~~~~~~~l~ 181 (270)
T 2o6q_A 156 LTSLKELRLYNNQLKRVPEGAFDKLT 181 (270)
T ss_dssp CTTCCEEECCSSCCSCCCTTTTTTCT
T ss_pred CcccceeEecCCcCcEeChhHhccCC
Confidence 99999999999999987766665443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.86 E-value=7.7e-22 Score=206.18 Aligned_cols=166 Identities=23% Similarity=0.390 Sum_probs=137.9
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccC---------
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGN--------- 135 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~--------- 135 (673)
.+++.|+|++|.++ .+|..++++++|++|+|++|.|+ .+|..+..+++|++|+|++|++.+.+|..+..
T Consensus 104 ~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~ 181 (328)
T 4fcg_A 104 SHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181 (328)
T ss_dssp TTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEE
T ss_pred CCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhcc
Confidence 46788888888888 88888888889999999998888 67888888888888888888888888877654
Q ss_pred CCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEE
Q 005859 136 MTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLD 215 (673)
Q Consensus 136 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 215 (673)
+++|++|+|++|+++ .+|..++.+++|++|+|++|.+++ +|..++.+++|+.|+|++|++.+.+|..+.++++|+.|+
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~ 259 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLI 259 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEE
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEE
Confidence 888888888888888 778888888888888888888884 666788888888888888888888888888888888888
Q ss_pred ccCCCCCcCCchhhhhccC
Q 005859 216 IRNNSFSGNVPPALKRLNG 234 (673)
Q Consensus 216 l~~N~l~g~~p~~l~~~~~ 234 (673)
|++|++.+.+|..+..+..
T Consensus 260 L~~n~~~~~~p~~~~~l~~ 278 (328)
T 4fcg_A 260 LKDCSNLLTLPLDIHRLTQ 278 (328)
T ss_dssp CTTCTTCCBCCTTGGGCTT
T ss_pred CCCCCchhhcchhhhcCCC
Confidence 8888888888877766543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.1e-21 Score=198.72 Aligned_cols=169 Identities=26% Similarity=0.263 Sum_probs=153.1
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCC-CCCCCcccccCCCCCcEee
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNN-LSGKIPSQIGNMTNLQVLQ 143 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~ 143 (673)
..++.|+|++|.+++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|. +....|..|..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 468999999999998888889999999999999999998889999999999999999997 8776688899999999999
Q ss_pred ccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCc
Q 005859 144 LCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 144 L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 223 (673)
|++|.+++..|..|..+++|++|++++|++++..+..|..+++|+.|+|++|++++..+..+..+++|+.|++++|.+++
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 191 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence 99999998888899999999999999999997777779999999999999999997777779999999999999999998
Q ss_pred CCchhhhhcc
Q 005859 224 NVPPALKRLN 233 (673)
Q Consensus 224 ~~p~~l~~~~ 233 (673)
..|..+..+.
T Consensus 192 ~~~~~~~~l~ 201 (285)
T 1ozn_A 192 VHPHAFRDLG 201 (285)
T ss_dssp ECTTTTTTCT
T ss_pred cCHhHccCcc
Confidence 8888776553
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2e-21 Score=198.80 Aligned_cols=184 Identities=26% Similarity=0.242 Sum_probs=166.0
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCc-CCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEee
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNA-LNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 143 (673)
.+++.|+|++|.+++..|..|.++++|++|+|++|. ++...|..|..+++|++|+|++|.+++..|..|.++++|++|+
T Consensus 56 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 135 (285)
T 1ozn_A 56 RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135 (285)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEE
Confidence 578999999999999889999999999999999997 8877789999999999999999999988899999999999999
Q ss_pred ccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCc
Q 005859 144 LCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 144 L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 223 (673)
|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+++..|..+..+++|+.|++++|++++
T Consensus 136 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 215 (285)
T 1ozn_A 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215 (285)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCc
Confidence 99999998777789999999999999999997777779999999999999999999889999999999999999999998
Q ss_pred CCchhhhhccC--CccccCcccccCCC
Q 005859 224 NVPPALKRLNG--GFQYDNNAALCGTG 248 (673)
Q Consensus 224 ~~p~~l~~~~~--~~~~~~n~~~~~~~ 248 (673)
..+..+..+.. .+.+.+|+..|...
T Consensus 216 ~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 216 LPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp CCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred CCHHHcccCcccCEEeccCCCccCCCC
Confidence 77777766543 34556777777654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.7e-21 Score=191.17 Aligned_cols=166 Identities=27% Similarity=0.333 Sum_probs=147.6
Q ss_pred CCCCCCCCCCCCCCceEEeCCCCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccC
Q 005859 43 SWAPNADPCSSDSFDGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNV 122 (673)
Q Consensus 43 ~w~~~~~~C~~~~w~gv~c~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 122 (673)
-|..+.+.|+ |.+|.|+. +++. .+|..+. ++|++|+|++|.|++..|..|..+++|++|+|++
T Consensus 11 ~~~~~~~~Cs---~~~v~c~~-----------~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 73 (229)
T 3e6j_A 11 AACPSQCSCS---GTTVDCRS-----------KRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGS 73 (229)
T ss_dssp CCCCTTCEEE---TTEEECTT-----------SCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred ccCCCCCEEe---CCEeEccC-----------CCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCC
Confidence 4555678887 99999963 3333 5666553 8999999999999999999999999999999999
Q ss_pred CCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCc
Q 005859 123 NNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVP 202 (673)
Q Consensus 123 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 202 (673)
|+|+...+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+
T Consensus 74 N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~ 152 (229)
T 3e6j_A 74 NQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPH 152 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCT
T ss_pred CCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCH
Confidence 9998776777899999999999999999877788999999999999999999 789999999999999999999998777
Q ss_pred ccccCCCCCCEEEccCCCCCcCCc
Q 005859 203 VKLANVPKLEVLDIRNNSFSGNVP 226 (673)
Q Consensus 203 ~~~~~l~~L~~L~l~~N~l~g~~p 226 (673)
..+..+++|+.|+|++|++.+..+
T Consensus 153 ~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 153 GAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp TTTTTCTTCCEEECTTSCBCTTBG
T ss_pred HHHhCCCCCCEEEeeCCCccCCcc
Confidence 889999999999999999998765
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.86 E-value=3e-21 Score=197.96 Aligned_cols=181 Identities=25% Similarity=0.221 Sum_probs=159.1
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..++.|+|++|.+++..|..|.++++|++|+|++|.|++..+. ..+++|++|+|++|+++ .+|..+..+++|++|+|
T Consensus 31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l 107 (290)
T 1p9a_G 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (290)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEEC
Confidence 5789999999999999999999999999999999999975443 78999999999999998 78889999999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
++|++++..|..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|+ .
T Consensus 108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ 186 (290)
T 1p9a_G 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (290)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred CCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-c
Confidence 999999888889999999999999999999877778899999999999999999877777889999999999999999 5
Q ss_pred CchhhhhccC--CccccCcccccCCCc
Q 005859 225 VPPALKRLNG--GFQYDNNAALCGTGF 249 (673)
Q Consensus 225 ~p~~l~~~~~--~~~~~~n~~~~~~~~ 249 (673)
+|..+..... .+.+.+|+..|...+
T Consensus 187 ip~~~~~~~~L~~l~L~~Np~~C~c~~ 213 (290)
T 1p9a_G 187 IPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (290)
T ss_dssp CCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred cChhhcccccCCeEEeCCCCccCcCcc
Confidence 6766554332 234567888886543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=7.4e-21 Score=186.79 Aligned_cols=155 Identities=19% Similarity=0.219 Sum_probs=141.5
Q ss_pred EEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCC-cccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCc
Q 005859 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIP-KEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYN 147 (673)
Q Consensus 69 ~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 147 (673)
.+++++|+++. +|..+. ..+++|+|++|+|++..| ..|..+++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 67777888874 777663 457899999999998865 46899999999999999999888889999999999999999
Q ss_pred cccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCc
Q 005859 148 KLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVP 226 (673)
Q Consensus 148 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p 226 (673)
++++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++.+..+
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 9998888889999999999999999999889999999999999999999999889999999999999999999998765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-20 Score=191.57 Aligned_cols=160 Identities=26% Similarity=0.287 Sum_probs=138.1
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..++.|+|++|.+++. +.+..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..|+.+++|++|+|
T Consensus 63 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 140 (272)
T 3rfs_A 63 PNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNL 140 (272)
T ss_dssp TTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEEC
Confidence 4688899999988873 47888999999999999998888888888999999999999998777777888999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
++|++++..+..|..+++|++|++++|++++..+..|..+++|+.|+|++|++++..|..+..+++|+.|++++|++.+.
T Consensus 141 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 220 (272)
T 3rfs_A 141 AHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 220 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc
Confidence 99999877777788899999999999999877777788889999999999999888777788889999999999998887
Q ss_pred Cc
Q 005859 225 VP 226 (673)
Q Consensus 225 ~p 226 (673)
.|
T Consensus 221 ~~ 222 (272)
T 3rfs_A 221 CP 222 (272)
T ss_dssp TT
T ss_pred Cc
Confidence 76
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-20 Score=184.39 Aligned_cols=152 Identities=24% Similarity=0.323 Sum_probs=137.5
Q ss_pred EEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccc
Q 005859 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKL 149 (673)
Q Consensus 70 l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 149 (673)
+++++++++ .+|..+. ++|+.|+|++|.|++..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|++
T Consensus 16 v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 92 (220)
T 2v9t_B 16 VDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92 (220)
T ss_dssp EECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCC
T ss_pred EEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcC
Confidence 444566665 4666554 7899999999999988888999999999999999999988899999999999999999999
Q ss_pred cccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 150 TGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 150 ~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
+...+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++...
T Consensus 93 ~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 93 TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 976667789999999999999999998899999999999999999999998888899999999999999999753
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.6e-20 Score=205.37 Aligned_cols=173 Identities=21% Similarity=0.183 Sum_probs=120.3
Q ss_pred CCceEEeCCC----------CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCC
Q 005859 55 SFDGVACDEN----------GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNN 124 (673)
Q Consensus 55 ~w~gv~c~~~----------~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 124 (673)
.|..|.|... ..++.|+|++|++++..|..|.++++|++|+|++|.|++..|..|.++++|++|+|++|+
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 4778888642 368999999999999889999999999999999999998888999999999999999999
Q ss_pred CCCCCcccccCCCCCcEeeccCccccccCchh-------------------------hcCccccCeecccccccCccCCc
Q 005859 125 LSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQ-------------------------LGSLRKLSVLALQYNQLTGAIPA 179 (673)
Q Consensus 125 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-------------------------l~~l~~L~~L~l~~N~l~~~~p~ 179 (673)
+++..+..|..+++|++|+|++|+++...+.. |..+++|++|+|++|++++ +|
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~- 212 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP- 212 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-
T ss_pred CCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-
Confidence 99777777888999999999988887544433 3344444444444444442 22
Q ss_pred cccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCchhh
Q 005859 180 SLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPAL 229 (673)
Q Consensus 180 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~l 229 (673)
.+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..+
T Consensus 213 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 262 (452)
T 3zyi_A 213 NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAF 262 (452)
T ss_dssp CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTT
T ss_pred cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHh
Confidence 23344444445555555544444445555555555555555544444433
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.83 E-value=5.7e-20 Score=186.74 Aligned_cols=178 Identities=23% Similarity=0.260 Sum_probs=155.2
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.+++.|+++++++.. + +.+..+++|++|+|++|.+++. +.+..+++|++|+|++|.+++..+..|.++++|++|+|
T Consensus 41 ~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 116 (272)
T 3rfs_A 41 NSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVL 116 (272)
T ss_dssp TTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEEC
Confidence 568899999999874 3 3588999999999999999973 47999999999999999999888888999999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
++|++++..+..|..+++|++|++++|.+++..+..|..+++|+.|++++|++++..+..+..+++|+.|++++|++++.
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 196 (272)
T 3rfs_A 117 VENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSV 196 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCcc
Confidence 99999988888899999999999999999987777889999999999999999988888889999999999999999998
Q ss_pred CchhhhhccC--CccccCcccccC
Q 005859 225 VPPALKRLNG--GFQYDNNAALCG 246 (673)
Q Consensus 225 ~p~~l~~~~~--~~~~~~n~~~~~ 246 (673)
.|..+..+.. .+.+.+|...|.
T Consensus 197 ~~~~~~~l~~L~~L~l~~N~~~~~ 220 (272)
T 3rfs_A 197 PDGVFDRLTSLQYIWLHDNPWDCT 220 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CHHHHhCCcCCCEEEccCCCcccc
Confidence 8776665543 233445554443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.4e-20 Score=191.72 Aligned_cols=165 Identities=22% Similarity=0.189 Sum_probs=138.1
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..++.|+|++|++++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..|.++++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 45889999999998877778899999999999999998887888899999999999999998877788899999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCcc-CCccccCCCcccccccccccCCCCCcccccCCCCCC----EEEccCC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGA-IPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLE----VLDIRNN 219 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~----~L~l~~N 219 (673)
++|.+++..+..+..+++|++|++++|.+++. +|..|..+++|+.|+|++|++++..+..+..+++|+ .|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 99999877776788899999999999998863 688888899999999999998877776666666665 7788888
Q ss_pred CCCcCCchhh
Q 005859 220 SFSGNVPPAL 229 (673)
Q Consensus 220 ~l~g~~p~~l 229 (673)
++++..+..+
T Consensus 188 ~l~~~~~~~~ 197 (276)
T 2z62_A 188 PMNFIQPGAF 197 (276)
T ss_dssp CCCEECTTSS
T ss_pred cccccCcccc
Confidence 8776555443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=4.3e-20 Score=201.14 Aligned_cols=195 Identities=18% Similarity=0.165 Sum_probs=125.0
Q ss_pred CCceEEeCCC----------CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCC
Q 005859 55 SFDGVACDEN----------GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNN 124 (673)
Q Consensus 55 ~w~gv~c~~~----------~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 124 (673)
.|..|.|... ..++.|+|++|++++..+..|.++++|++|+|++|.|++..+..|.++++|++|+|++|+
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 4778888642 357889999999988888888889999999999998888878888888888888888888
Q ss_pred CCCCCcccccCCCCCcEeeccCccccccCchh-------------------------hcCccccCeeccccccc------
Q 005859 125 LSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQ-------------------------LGSLRKLSVLALQYNQL------ 173 (673)
Q Consensus 125 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-------------------------l~~l~~L~~L~l~~N~l------ 173 (673)
++...+..|..+++|+.|+|++|+++...+.. |.++++|++|+|++|++
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~ 203 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNL 203 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCCCC
T ss_pred CCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccccc
Confidence 88666667888888888888888776544333 33344444444444433
Q ss_pred ----------------CccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCchhhhhccC--C
Q 005859 174 ----------------TGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNG--G 235 (673)
Q Consensus 174 ----------------~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~--~ 235 (673)
++..|..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|+|++..+..+..+.. .
T Consensus 204 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 283 (440)
T 3zyj_A 204 TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLER 283 (440)
T ss_dssp TTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCE
T ss_pred CCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCE
Confidence 3333444444444444444444444444444555555555555555555444443333321 2
Q ss_pred ccccCcccccCCCc
Q 005859 236 FQYDNNAALCGTGF 249 (673)
Q Consensus 236 ~~~~~n~~~~~~~~ 249 (673)
+.+.+|+..|.+..
T Consensus 284 L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 284 IHLHHNPWNCNCDI 297 (440)
T ss_dssp EECCSSCEECSSTT
T ss_pred EEcCCCCccCCCCc
Confidence 33456666666543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.9e-20 Score=193.72 Aligned_cols=180 Identities=22% Similarity=0.291 Sum_probs=121.6
Q ss_pred CEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCC-cccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 66 RVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIP-KEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 66 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.+..|+|++|.+. .+|..+.++++|++|+|++|.+++..+ ..+..+++|++|++++|.+.+..|..|..+++|++|+|
T Consensus 79 ~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 157 (306)
T 2z66_A 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 157 (306)
T ss_dssp CCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEEC
T ss_pred ccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEEC
Confidence 4556666666665 355556677777777777777765544 46677777777777777777666667777777777777
Q ss_pred cCccccc-cCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCc
Q 005859 145 CYNKLTG-NIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 145 ~~N~l~~-~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 223 (673)
++|.+++ .+|..+..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|++++|++++
T Consensus 158 ~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 237 (306)
T 2z66_A 158 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 237 (306)
T ss_dssp TTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCB
T ss_pred CCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcc
Confidence 7777765 466677777777777777777776666777777777777777777776666667777777777777777777
Q ss_pred CCchhhhhccC---CccccCcccccC
Q 005859 224 NVPPALKRLNG---GFQYDNNAALCG 246 (673)
Q Consensus 224 ~~p~~l~~~~~---~~~~~~n~~~~~ 246 (673)
..|..+..+.. .+.+.+|...|.
T Consensus 238 ~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 238 SKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp CSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred cCHHHHHhhhccCCEEEccCCCeecc
Confidence 76666554421 223445554444
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.8e-20 Score=192.37 Aligned_cols=178 Identities=20% Similarity=0.223 Sum_probs=150.1
Q ss_pred CCceEEeCCC----------CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCc--cCCcccCCCCCCCEEEccC
Q 005859 55 SFDGVACDEN----------GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNG--VIPKEIASLSELSDLYLNV 122 (673)
Q Consensus 55 ~w~gv~c~~~----------~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~ 122 (673)
.|.+|.|+.. ..++.|+|++|+++...+..|.++++|++|+|++|.++. ..|..+..+++|++|+|++
T Consensus 8 ~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~ 87 (306)
T 2z66_A 8 SGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87 (306)
T ss_dssp ETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred CCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence 4999999753 378999999999995444568999999999999999983 3467777889999999999
Q ss_pred CCCCCCCcccccCCCCCcEeeccCccccccCc-hhhcCccccCeecccccccCccCCccccCCCcccccccccccCCC-C
Q 005859 123 NNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIP-TQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFG-P 200 (673)
Q Consensus 123 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~ 200 (673)
|.+. .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+.+..|..+..+++|+.|++++|.+.+ .
T Consensus 88 n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 166 (306)
T 2z66_A 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 166 (306)
T ss_dssp CSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGE
T ss_pred Cccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccccc
Confidence 9988 577778899999999999999986655 578889999999999999988888888889999999999999886 5
Q ss_pred CcccccCCCCCCEEEccCCCCCcCCchhhhhcc
Q 005859 201 VPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233 (673)
Q Consensus 201 ~p~~~~~l~~L~~L~l~~N~l~g~~p~~l~~~~ 233 (673)
+|..+..+++|+.|++++|.+++..|..+..+.
T Consensus 167 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 199 (306)
T 2z66_A 167 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 199 (306)
T ss_dssp ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred chhHHhhCcCCCEEECCCCCcCCcCHHHhcCCC
Confidence 778888899999999999999887777776544
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.1e-20 Score=197.51 Aligned_cols=181 Identities=20% Similarity=0.226 Sum_probs=154.1
Q ss_pred CCCCCCCCCCCCCCceEEeCC------------CCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccC
Q 005859 43 SWAPNADPCSSDSFDGVACDE------------NGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIA 110 (673)
Q Consensus 43 ~w~~~~~~C~~~~w~gv~c~~------------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 110 (673)
.|......|. |.|+ |+. ..+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.
T Consensus 22 ~~~~~~~~C~---~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 97 (353)
T 2z80_A 22 SSNQASLSCD---RNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFS 97 (353)
T ss_dssp -----CCEEC---TTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred CCCccCCCCC---CCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcC
Confidence 3444455665 8777 542 13789999999999987777899999999999999999998899999
Q ss_pred CCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCc-hhhcCccccCeeccccc-ccCccCCccccCCCccc
Q 005859 111 SLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIP-TQLGSLRKLSVLALQYN-QLTGAIPASLGDLGMLM 188 (673)
Q Consensus 111 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~ 188 (673)
++++|++|+|++|++++..+..|.++++|++|+|++|++++..+ ..|..+++|++|++++| .+.+..|..|.++++|+
T Consensus 98 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~ 177 (353)
T 2z80_A 98 SLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLE 177 (353)
T ss_dssp TCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEE
T ss_pred CCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCC
Confidence 99999999999999997666669999999999999999995444 47899999999999999 47766678899999999
Q ss_pred ccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCchh
Q 005859 189 RLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPA 228 (673)
Q Consensus 189 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~ 228 (673)
.|++++|.+++..|..+..+++|+.|++++|.+.. +|..
T Consensus 178 ~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~-~~~~ 216 (353)
T 2z80_A 178 ELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL-LLEI 216 (353)
T ss_dssp EEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTT-HHHH
T ss_pred EEECCCCCcCccCHHHHhccccCCeecCCCCcccc-chhh
Confidence 99999999999889999999999999999999864 4543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=4.9e-20 Score=202.90 Aligned_cols=178 Identities=22% Similarity=0.195 Sum_probs=162.9
Q ss_pred CCceEEeCC----------CCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCC
Q 005859 55 SFDGVACDE----------NGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNN 124 (673)
Q Consensus 55 ~w~gv~c~~----------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 124 (673)
.|..|.|.. ...++.|+|++|.+++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 477888864 2368899999999999989999999999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCccc
Q 005859 125 LSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVK 204 (673)
Q Consensus 125 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 204 (673)
++...+..|.++++|++|+|++|++++..|..|..+++|++|+|++|.+++..|..|.++++|+.|+|++|++++..+..
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 171 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEA 171 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHH
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhH
Confidence 99776777999999999999999999999999999999999999999999888889999999999999999999877778
Q ss_pred ccCCCCCCEEEccCCCCCcCCchhhhhc
Q 005859 205 LANVPKLEVLDIRNNSFSGNVPPALKRL 232 (673)
Q Consensus 205 ~~~l~~L~~L~l~~N~l~g~~p~~l~~~ 232 (673)
+.++++|+.|++++|.+.+..+..+..+
T Consensus 172 l~~l~~L~~L~l~~n~i~~~~~~~~~~l 199 (477)
T 2id5_A 172 LSHLHGLIVLRLRHLNINAIRDYSFKRL 199 (477)
T ss_dssp HTTCTTCCEEEEESCCCCEECTTCSCSC
T ss_pred hcccCCCcEEeCCCCcCcEeChhhcccC
Confidence 9999999999999999998776665544
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.5e-19 Score=191.45 Aligned_cols=177 Identities=24% Similarity=0.265 Sum_probs=144.8
Q ss_pred EEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccC-CCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCc
Q 005859 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIA-SLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYN 147 (673)
Q Consensus 69 ~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 147 (673)
.+++++++|+. +|..+. +.|+.|+|++|+|++..+..|. .+++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 46677777774 666553 4588999999999988888887 8999999999999999877788999999999999999
Q ss_pred cccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccc---cCCCCCCEEEccCCCCCcC
Q 005859 148 KLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKL---ANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 148 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~---~~l~~L~~L~l~~N~l~g~ 224 (673)
+|++..+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+ ..+++|+.|+|++|+|++.
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 178 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence 9998777789999999999999999998888889999999999999999987555555 5688999999999999976
Q ss_pred Cchhhhhcc----CCccccCcccccCCC
Q 005859 225 VPPALKRLN----GGFQYDNNAALCGTG 248 (673)
Q Consensus 225 ~p~~l~~~~----~~~~~~~n~~~~~~~ 248 (673)
.+..+..+. ..+.+.+|+..|...
T Consensus 179 ~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 179 PLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp CHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred CHHHhhhccHhhcceEEecCCCccCCcC
Confidence 666666654 345677888777654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=2.9e-20 Score=203.32 Aligned_cols=152 Identities=24% Similarity=0.276 Sum_probs=136.2
Q ss_pred ceEEeCCC---------CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccC-CcccCCCCCCCEEEccCCCCC
Q 005859 57 DGVACDEN---------GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVI-PKEIASLSELSDLYLNVNNLS 126 (673)
Q Consensus 57 ~gv~c~~~---------~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~ 126 (673)
..|.|+.. .+++.|+|++|.+++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|+++
T Consensus 13 ~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~ 92 (455)
T 3v47_A 13 YNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL 92 (455)
T ss_dssp TEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTC
T ss_pred cccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccC
Confidence 34788642 46899999999999999999999999999999999998655 567999999999999999999
Q ss_pred CCCcccccCCCCCcEeeccCccccccCchh--hcCccccCeecccccccCccCCcc-ccCCCcccccccccccCCCCCcc
Q 005859 127 GKIPSQIGNMTNLQVLQLCYNKLTGNIPTQ--LGSLRKLSVLALQYNQLTGAIPAS-LGDLGMLMRLDLSFNNLFGPVPV 203 (673)
Q Consensus 127 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--l~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~ 203 (673)
+..|..|+++++|++|+|++|++++.+|.. |..+++|++|+|++|++++..|.. +.++++|+.|++++|++.+..|.
T Consensus 93 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 172 (455)
T 3v47_A 93 QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEE 172 (455)
T ss_dssp EECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTT
T ss_pred ccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChh
Confidence 888999999999999999999999866655 999999999999999999887876 89999999999999999998887
Q ss_pred cccCC
Q 005859 204 KLANV 208 (673)
Q Consensus 204 ~~~~l 208 (673)
.+..+
T Consensus 173 ~l~~l 177 (455)
T 3v47_A 173 DLLNF 177 (455)
T ss_dssp TSGGG
T ss_pred hhhcc
Confidence 77654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.7e-19 Score=173.05 Aligned_cols=162 Identities=23% Similarity=0.297 Sum_probs=143.3
Q ss_pred eEEeCCCCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCC
Q 005859 58 GVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMT 137 (673)
Q Consensus 58 gv~c~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 137 (673)
+..|.. +.+++++++++ .+|..+ .++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..++
T Consensus 4 ~C~C~~----~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 76 (208)
T 2o6s_A 4 RCSCSG----TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLT 76 (208)
T ss_dssp TCEEET----TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCT
T ss_pred CCEECC----CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCC
Confidence 456743 37888888887 455544 46899999999999988888899999999999999999977777789999
Q ss_pred CCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEcc
Q 005859 138 NLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIR 217 (673)
Q Consensus 138 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 217 (673)
+|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+++
T Consensus 77 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 156 (208)
T 2o6s_A 77 SLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLH 156 (208)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred CcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEec
Confidence 99999999999998777778999999999999999998777779999999999999999998777778999999999999
Q ss_pred CCCCCcCCc
Q 005859 218 NNSFSGNVP 226 (673)
Q Consensus 218 ~N~l~g~~p 226 (673)
+|++.+..|
T Consensus 157 ~N~~~~~~~ 165 (208)
T 2o6s_A 157 DNPWDCTCP 165 (208)
T ss_dssp SCCBCCCTT
T ss_pred CCCeecCCC
Confidence 999998776
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.8e-19 Score=212.17 Aligned_cols=163 Identities=21% Similarity=0.203 Sum_probs=104.5
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.+++.|+|++|.+++..|..|.++++|++|+|++|.+++..|..|..+++|+.|+|++|++++..+..|.++++|+.|+|
T Consensus 290 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 369 (844)
T 3j0a_A 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDL 369 (844)
T ss_dssp CCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEE
T ss_pred CCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEEC
Confidence 35667777777777777777777777777777777777766777777777777777777777666666777777777777
Q ss_pred cCccccccC------------------c----------------------hhhcCccccCeecccccccCc---------
Q 005859 145 CYNKLTGNI------------------P----------------------TQLGSLRKLSVLALQYNQLTG--------- 175 (673)
Q Consensus 145 ~~N~l~~~~------------------p----------------------~~l~~l~~L~~L~l~~N~l~~--------- 175 (673)
++|.+++.. | ..+..+++|++|+|++|++++
T Consensus 370 s~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 449 (844)
T 3j0a_A 370 RDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSE 449 (844)
T ss_dssp ETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCS
T ss_pred CCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCccccccccccccc
Confidence 666655310 0 012234444444444444432
Q ss_pred ---------------------cCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCch
Q 005859 176 ---------------------AIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPP 227 (673)
Q Consensus 176 ---------------------~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~ 227 (673)
..|..|.++++|+.|+|++|++++.+|..|.++++|+.|+|++|+|++..|.
T Consensus 450 ~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~ 522 (844)
T 3j0a_A 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHN 522 (844)
T ss_dssp CTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCC
T ss_pred CCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChh
Confidence 1223355667777777777777777777777777777777777777654443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.80 E-value=2e-19 Score=203.62 Aligned_cols=161 Identities=19% Similarity=0.171 Sum_probs=118.8
Q ss_pred CcCCCCCCCCCCCC-CCCceEEeCCC-----------------CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcC
Q 005859 40 LLTSWAPNADPCSS-DSFDGVACDEN-----------------GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNAL 101 (673)
Q Consensus 40 ~l~~w~~~~~~C~~-~~w~gv~c~~~-----------------~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l 101 (673)
.+.+|.++.++|.. ..|.++.|+.. ..+..++++++.+....+..|.++++|++|+|++|.|
T Consensus 8 ~l~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l 87 (597)
T 3oja_B 8 NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI 87 (597)
T ss_dssp ---CCCSEECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCC
T ss_pred cccCCCCCCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCC
Confidence 36788766555532 24777666520 2356677777777665555677788888888888888
Q ss_pred CccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccc
Q 005859 102 NGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASL 181 (673)
Q Consensus 102 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~ 181 (673)
++..|..|..+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|+.+++|++|+|++|.+++..|..|
T Consensus 88 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 167 (597)
T 3oja_B 88 EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTF 167 (597)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTT
T ss_pred CCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhh
Confidence 87777788888888888888888887777778888888888888888886555567888888888888888887777778
Q ss_pred cCCCcccccccccccCCCC
Q 005859 182 GDLGMLMRLDLSFNNLFGP 200 (673)
Q Consensus 182 ~~l~~L~~L~l~~N~l~~~ 200 (673)
+.+++|+.|+|++|.+++.
T Consensus 168 ~~l~~L~~L~L~~N~l~~~ 186 (597)
T 3oja_B 168 QATTSLQNLQLSSNRLTHV 186 (597)
T ss_dssp TTCTTCCEEECTTSCCSBC
T ss_pred hcCCcCcEEECcCCCCCCc
Confidence 8888888888888887764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1e-19 Score=183.15 Aligned_cols=147 Identities=14% Similarity=0.091 Sum_probs=109.6
Q ss_pred HHHHHHhcCCccccccccCCcceEEEEEE-cCCcE--EEEEEecccCCCC-----------------------cHHHHHH
Q 005859 395 EEVERATQCFSEANLLGKSSFSATYKGIL-RDGSV--VAVKCIAKTSCKS-----------------------DEGEFLK 448 (673)
Q Consensus 395 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~-----------------------~~~~~~~ 448 (673)
..+......|+..+.||+|+||.||+|.. .+|+. ||||+++...... ....+.+
T Consensus 40 ~~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (258)
T 1zth_A 40 YKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK 119 (258)
T ss_dssp HHHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred HHHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence 34433344467788999999999999998 67888 9999875432110 0136789
Q ss_pred HHHHHhccCCCCc--eeEeeEEecCCCCeEEEEEeecCC-C----ChhhhhccccCCccccCHHHHHHHHHHHHHHHHHH
Q 005859 449 GLKILTSLKHENL--ASLRGICCSKGRGECFLIYDFVPN-G----NLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYL 521 (673)
Q Consensus 449 E~~~l~~l~H~ni--v~l~~~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL 521 (673)
|+++|.++.|+++ ...+++ +..++||||+.+ | +|.++... .++..+..++.|++.||+||
T Consensus 120 E~~~l~~l~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~l 186 (258)
T 1zth_A 120 EFRNLERAKEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRL 186 (258)
T ss_dssp HHHHHHHHHHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHH
Confidence 9999999988864 334332 235899999942 4 56555421 23445678999999999999
Q ss_pred h-cCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 522 H-GKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 522 H-~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
| ++ ||+||||||+|||+++ .++|+|||+|....
T Consensus 187 H~~~--givHrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 187 YQEA--ELVHADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp HHTS--CEECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred HHHC--CEEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 9 77 8999999999999998 99999999997653
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=8.8e-20 Score=207.07 Aligned_cols=183 Identities=21% Similarity=0.222 Sum_probs=130.0
Q ss_pred CEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCC-cccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 66 RVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIP-KEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 66 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
++..|+|++|.+++ +|..+..+++|+.|+|++|.+++..| ..+..+++|++|++++|.+++..|..|.++++|++|+|
T Consensus 377 ~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 455 (606)
T 3vq2_A 377 SLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKM 455 (606)
T ss_dssp CCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEEC
T ss_pred cccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEEC
Confidence 34555555555554 44666677777777777777776666 56777777777777777777777777777777777777
Q ss_pred cCccccc-cCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCc
Q 005859 145 CYNKLTG-NIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 145 ~~N~l~~-~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 223 (673)
++|++++ .+|..|..+++|++|+|++|++++..|..|..+++|+.|+|++|++++.+|..+.++++|+.|++++|+|+
T Consensus 456 ~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~- 534 (606)
T 3vq2_A 456 AGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE- 534 (606)
T ss_dssp TTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-
T ss_pred CCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-
Confidence 7777776 36777777778888888888877777777777788888888888887777777777788888888888877
Q ss_pred CCchhhhhccC---CccccCcccccCCCcc
Q 005859 224 NVPPALKRLNG---GFQYDNNAALCGTGFT 250 (673)
Q Consensus 224 ~~p~~l~~~~~---~~~~~~n~~~~~~~~~ 250 (673)
.+|..+..+.. .+.+.+|+..|.....
T Consensus 535 ~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~ 564 (606)
T 3vq2_A 535 TSKGILQHFPKSLAFFNLTNNSVACICEHQ 564 (606)
T ss_dssp CEESCGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred ccCHhHhhhcccCcEEEccCCCcccCCccH
Confidence 46665655432 2345667777765543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.1e-19 Score=204.75 Aligned_cols=157 Identities=22% Similarity=0.232 Sum_probs=97.1
Q ss_pred cCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCcccccc
Q 005859 73 QGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGN 152 (673)
Q Consensus 73 ~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 152 (673)
++.+|+ .+|..+. +++++|||++|+|++..|..|.++++|++|+|++|+|++..|.+|.+|++|++|+|++|+|++.
T Consensus 39 ~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l 115 (635)
T 4g8a_A 39 MELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 115 (635)
T ss_dssp TTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEE
T ss_pred CCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCC
Confidence 344444 3454332 3566666666666666566666666666666666666655555666666666666666666655
Q ss_pred CchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCC-CcccccCCCCCCEEEccCCCCCcCCchhhhh
Q 005859 153 IPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGP-VPVKLANVPKLEVLDIRNNSFSGNVPPALKR 231 (673)
Q Consensus 153 ~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~l~~ 231 (673)
.+..|.++++|++|+|++|++++..+..|+++++|+.|+|++|.+++. +|..+..+++|+.|++++|+|++..|..+..
T Consensus 116 ~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~ 195 (635)
T 4g8a_A 116 ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 195 (635)
T ss_dssp CGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHH
T ss_pred CHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccc
Confidence 555666666666666666666655555566666666666666666542 4555666666666666666666666655544
Q ss_pred c
Q 005859 232 L 232 (673)
Q Consensus 232 ~ 232 (673)
+
T Consensus 196 L 196 (635)
T 4g8a_A 196 L 196 (635)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.2e-19 Score=198.46 Aligned_cols=162 Identities=20% Similarity=0.232 Sum_probs=145.0
Q ss_pred CCEEEEEecCCCcccccCccccC---------------------------------------CCCCCeEeCcCCcCCccC
Q 005859 65 GRVANISLQGKGLSGEIPAAVGG---------------------------------------LKSLTGLYLHFNALNGVI 105 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~---------------------------------------l~~L~~L~L~~N~l~~~~ 105 (673)
..++.|+|++|.+++.+|..+.. .++|++|+|++|.+++.+
T Consensus 212 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 291 (455)
T 3v47_A 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALL 291 (455)
T ss_dssp CEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEEC
T ss_pred ceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccc
Confidence 36888999999888766654432 268999999999999999
Q ss_pred CcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCC
Q 005859 106 PKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLG 185 (673)
Q Consensus 106 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 185 (673)
|..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|..++
T Consensus 292 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 371 (455)
T 3v47_A 292 KSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLP 371 (455)
T ss_dssp TTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred hhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccc
Confidence 99999999999999999999988888999999999999999999988889999999999999999999988899999999
Q ss_pred cccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCc
Q 005859 186 MLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVP 226 (673)
Q Consensus 186 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p 226 (673)
+|+.|+|++|++++..+..+..+++|+.|++++|++++..|
T Consensus 372 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 372 NLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred cccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 99999999999998777778899999999999999999888
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.79 E-value=1e-19 Score=181.08 Aligned_cols=172 Identities=17% Similarity=0.221 Sum_probs=146.9
Q ss_pred eEEeCC-------CCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCc-CCccCCcccCCCCCCCEEEccC-CCCCCC
Q 005859 58 GVACDE-------NGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNA-LNGVIPKEIASLSELSDLYLNV-NNLSGK 128 (673)
Q Consensus 58 gv~c~~-------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~l~~-N~l~~~ 128 (673)
.|.|.. ...++.|+|++|++++..+..|.++++|++|+|++|. +++..+..|.++++|++|+|++ |++++.
T Consensus 17 ~v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i 96 (239)
T 2xwt_C 17 RVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYI 96 (239)
T ss_dssp EEEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEE
T ss_pred eeEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEc
Confidence 455853 3478999999999998888899999999999999997 8887777899999999999998 999977
Q ss_pred CcccccCCCCCcEeeccCccccccCchhhcCccccC---eeccccc-ccCccCCccccCCCccc-ccccccccCCCCCcc
Q 005859 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLS---VLALQYN-QLTGAIPASLGDLGMLM-RLDLSFNNLFGPVPV 203 (673)
Q Consensus 129 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~---~L~l~~N-~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~ 203 (673)
.+..|.++++|++|+|++|++++ +|. |..+++|+ +|++++| .+++..+..|..+++|+ .|++++|+++...+.
T Consensus 97 ~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~ 174 (239)
T 2xwt_C 97 DPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGY 174 (239)
T ss_dssp CTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTT
T ss_pred CHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHh
Confidence 77889999999999999999996 676 88888898 9999999 99877777899999999 999999999843333
Q ss_pred cccCCCCCCEEEccCCC-CCcCCchhhhhc
Q 005859 204 KLANVPKLEVLDIRNNS-FSGNVPPALKRL 232 (673)
Q Consensus 204 ~~~~l~~L~~L~l~~N~-l~g~~p~~l~~~ 232 (673)
.+.. ++|+.|++++|+ +++..+..+..+
T Consensus 175 ~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l 203 (239)
T 2xwt_C 175 AFNG-TKLDAVYLNKNKYLTVIDKDAFGGV 203 (239)
T ss_dssp TTTT-CEEEEEECTTCTTCCEECTTTTTTC
T ss_pred hcCC-CCCCEEEcCCCCCcccCCHHHhhcc
Confidence 4444 899999999995 886656666554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=8.1e-20 Score=193.53 Aligned_cols=170 Identities=24% Similarity=0.238 Sum_probs=150.3
Q ss_pred CCceEEeCCC----------CCEEEEEecCCCcccccCcccc-CCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCC
Q 005859 55 SFDGVACDEN----------GRVANISLQGKGLSGEIPAAVG-GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVN 123 (673)
Q Consensus 55 ~w~gv~c~~~----------~~v~~l~l~~~~l~g~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 123 (673)
.+..|.|... ..++.|+|++|.|++..+..+. ++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 19 ~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 19 ASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp ETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 3778888642 3578999999999998888887 9999999999999999988899999999999999999
Q ss_pred CCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccc---cCCCcccccccccccCCCC
Q 005859 124 NLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASL---GDLGMLMRLDLSFNNLFGP 200 (673)
Q Consensus 124 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~---~~l~~L~~L~l~~N~l~~~ 200 (673)
+|++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++.
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 178 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence 9998878889999999999999999999889999999999999999999996444445 6799999999999999987
Q ss_pred CcccccCCCC--CCEEEccCCCCCcC
Q 005859 201 VPVKLANVPK--LEVLDIRNNSFSGN 224 (673)
Q Consensus 201 ~p~~~~~l~~--L~~L~l~~N~l~g~ 224 (673)
.+..+..++. |+.|+|++|++...
T Consensus 179 ~~~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 179 PLTDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp CHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred CHHHhhhccHhhcceEEecCCCccCC
Confidence 7777888887 48899999999853
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3.4e-19 Score=174.87 Aligned_cols=145 Identities=23% Similarity=0.279 Sum_probs=134.5
Q ss_pred CCceEEeCCC----------CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCC
Q 005859 55 SFDGVACDEN----------GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNN 124 (673)
Q Consensus 55 ~w~gv~c~~~----------~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 124 (673)
.|..|.|... ..++.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 12 SNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp ETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred CCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 4889999642 368999999999998888899999999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCC
Q 005859 125 LSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFG 199 (673)
Q Consensus 125 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 199 (673)
|+...+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 997766778999999999999999999989999999999999999999998888889999999999999999864
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.79 E-value=6.6e-19 Score=184.32 Aligned_cols=169 Identities=24% Similarity=0.350 Sum_probs=129.0
Q ss_pred CCceEEeCCC----------CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCC
Q 005859 55 SFDGVACDEN----------GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNN 124 (673)
Q Consensus 55 ~w~gv~c~~~----------~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 124 (673)
.|..+.|... ..++.|+|++|.+++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus 34 ~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 113 (332)
T 2ft3_A 34 HLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113 (332)
T ss_dssp ETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSC
T ss_pred cCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCc
Confidence 4999999642 368999999999998888899999999999999999999989999999999999999999
Q ss_pred CCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccC--ccCCccccCCCcccccccccccCCCCCc
Q 005859 125 LSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLT--GAIPASLGDLGMLMRLDLSFNNLFGPVP 202 (673)
Q Consensus 125 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~--~~~p~~~~~l~~L~~L~l~~N~l~~~~p 202 (673)
++ .+|..+. ++|++|++++|++++..+..|..+++|+.|++++|.++ +..|..+..+ +|+.|++++|++++ +|
T Consensus 114 l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~ 188 (332)
T 2ft3_A 114 LV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IP 188 (332)
T ss_dssp CC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CC
T ss_pred CC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cC
Confidence 98 5666554 78888888888888766667888888888888888885 3566666665 56666666555553 33
Q ss_pred ccccCCCCCCEEEccCCCCCcCCchhhh
Q 005859 203 VKLANVPKLEVLDIRNNSFSGNVPPALK 230 (673)
Q Consensus 203 ~~~~~l~~L~~L~l~~N~l~g~~p~~l~ 230 (673)
..+. ++|+.|++++|.+++..|..+.
T Consensus 189 ~~~~--~~L~~L~l~~n~i~~~~~~~l~ 214 (332)
T 2ft3_A 189 KDLP--ETLNELHLDHNKIQAIELEDLL 214 (332)
T ss_dssp SSSC--SSCSCCBCCSSCCCCCCTTSST
T ss_pred cccc--CCCCEEECCCCcCCccCHHHhc
Confidence 3222 4455555555555554444443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.3e-19 Score=213.31 Aligned_cols=180 Identities=19% Similarity=0.168 Sum_probs=157.3
Q ss_pred CCCCCCCceEEeCCCCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccC-CcccCCCCCCCEEEccCCCCCCC
Q 005859 50 PCSSDSFDGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVI-PKEIASLSELSDLYLNVNNLSGK 128 (673)
Q Consensus 50 ~C~~~~w~gv~c~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~ 128 (673)
.|+..+|..|++ ...+++.|+|++|.+++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|.+++.
T Consensus 10 dcs~~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~ 88 (844)
T 3j0a_A 10 FYRFCNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFL 88 (844)
T ss_dssp EESCCCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEE
T ss_pred EccCCCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCccc
Confidence 466667999998 7789999999999999999999999999999999999766666 78899999999999999999988
Q ss_pred CcccccCCCCCcEeeccCccccccCchh--hcCccccCeecccccccCccCC-ccccCCCcccccccccccCCCCCcccc
Q 005859 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQ--LGSLRKLSVLALQYNQLTGAIP-ASLGDLGMLMRLDLSFNNLFGPVPVKL 205 (673)
Q Consensus 129 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~--l~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~ 205 (673)
.|..|+++++|++|+|++|.+++.+|.. |.++++|++|+|++|.+++..+ ..|+++++|+.|+|++|.+++..|..+
T Consensus 89 ~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l 168 (844)
T 3j0a_A 89 HPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHEL 168 (844)
T ss_dssp CTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGG
T ss_pred CHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHc
Confidence 8999999999999999999999877765 8999999999999999987655 579999999999999999998888887
Q ss_pred cCC--CCCCEEEccCCCCCcCCchhhh
Q 005859 206 ANV--PKLEVLDIRNNSFSGNVPPALK 230 (673)
Q Consensus 206 ~~l--~~L~~L~l~~N~l~g~~p~~l~ 230 (673)
..+ ++|+.|++++|.+.+..|..+.
T Consensus 169 ~~l~~~~L~~L~L~~n~l~~~~~~~~~ 195 (844)
T 3j0a_A 169 EPLQGKTLSFFSLAANSLYSRVSVDWG 195 (844)
T ss_dssp HHHHHCSSCCCEECCSBSCCCCCCCCC
T ss_pred ccccCCccceEECCCCccccccccchh
Confidence 766 7788888888888777665543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.5e-19 Score=174.84 Aligned_cols=148 Identities=19% Similarity=0.206 Sum_probs=135.8
Q ss_pred CCceEEeCCC----------CCEEEEEecCCCcccccC-ccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCC
Q 005859 55 SFDGVACDEN----------GRVANISLQGKGLSGEIP-AAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVN 123 (673)
Q Consensus 55 ~w~gv~c~~~----------~~v~~l~l~~~~l~g~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 123 (673)
.|..+.|+.. ..++.|+|++|.+++..| ..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 12 ~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 12 EGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp ETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 4888888642 257899999999998866 45899999999999999999988889999999999999999
Q ss_pred CCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCc
Q 005859 124 NLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVP 202 (673)
Q Consensus 124 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 202 (673)
++++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|.+....+
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 9998888889999999999999999999999999999999999999999999889999999999999999999986543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.8e-19 Score=205.27 Aligned_cols=166 Identities=23% Similarity=0.194 Sum_probs=149.3
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..++.|+|++|.|++..|.+|.++++|++|+|++|+|++..|+.|.+|++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 47899999999999888889999999999999999999988899999999999999999999877788999999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCc-cCCccccCCCcccccccccccCCCCCcccccCCCCC----CEEEccCC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTG-AIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKL----EVLDIRNN 219 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L----~~L~l~~N 219 (673)
++|++++..+..|+++++|++|+|++|.+++ .+|..++.+++|+.|+|++|++++..|..+..+.++ ..++++.|
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n 211 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 211 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence 9999998777789999999999999999976 468889999999999999999999888877655543 47899999
Q ss_pred CCCcCCchhhh
Q 005859 220 SFSGNVPPALK 230 (673)
Q Consensus 220 ~l~g~~p~~l~ 230 (673)
.+....|..+.
T Consensus 212 ~l~~i~~~~~~ 222 (635)
T 4g8a_A 212 PMNFIQPGAFK 222 (635)
T ss_dssp CCCEECTTTTT
T ss_pred cccccCccccc
Confidence 99876665543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.9e-19 Score=204.26 Aligned_cols=166 Identities=23% Similarity=0.219 Sum_probs=148.8
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.+++.|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 57899999999999988889999999999999999999988999999999999999999999888999999999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCc-cCCccccCCCcccccccccccCCCCCcccccCCCCCC----EEEccCC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTG-AIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLE----VLDIRNN 219 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~----~L~l~~N 219 (673)
++|++++..|..++.+++|++|++++|.+++ .+|..|+++++|+.|++++|++++..|..+..+.+|+ .|++++|
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n 191 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence 9999998777889999999999999999986 5799999999999999999999988887777666554 7999999
Q ss_pred CCCcCCchhhh
Q 005859 220 SFSGNVPPALK 230 (673)
Q Consensus 220 ~l~g~~p~~l~ 230 (673)
++++..+..+.
T Consensus 192 ~l~~~~~~~~~ 202 (606)
T 3vq2_A 192 PIDFIQDQAFQ 202 (606)
T ss_dssp CCCEECTTTTT
T ss_pred CcceeCccccc
Confidence 98876555443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=7.1e-20 Score=189.92 Aligned_cols=163 Identities=21% Similarity=0.200 Sum_probs=120.1
Q ss_pred CCEEEEEecCCCcccccCccc--cCCCCCCeEeCcCCcCCccCCcccCCC-----CCCCEEEccCCCCCCCCcccccCCC
Q 005859 65 GRVANISLQGKGLSGEIPAAV--GGLKSLTGLYLHFNALNGVIPKEIASL-----SELSDLYLNVNNLSGKIPSQIGNMT 137 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~p~~~~~l~ 137 (673)
.+++.|+|++|.++|.+|..+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..|++++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 357778888888888887765 7788888888888888876 6666666 7888888888888877777888888
Q ss_pred CCcEeeccCcccccc--Cchhh--cCccccCeecccccccCc--cCC-ccccCCCcccccccccccCCCCCc-ccccCCC
Q 005859 138 NLQVLQLCYNKLTGN--IPTQL--GSLRKLSVLALQYNQLTG--AIP-ASLGDLGMLMRLDLSFNNLFGPVP-VKLANVP 209 (673)
Q Consensus 138 ~L~~L~L~~N~l~~~--~p~~l--~~l~~L~~L~l~~N~l~~--~~p-~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~ 209 (673)
+|++|+|++|++.+. +|..+ ..+++|++|+|++|++++ .++ ..+..+++|+.|+|++|++++.+| ..+..++
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~ 253 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCT
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcC
Confidence 888888888887664 23344 777888888888888873 222 234567788888888888877664 3455677
Q ss_pred CCCEEEccCCCCCcCCchhh
Q 005859 210 KLEVLDIRNNSFSGNVPPAL 229 (673)
Q Consensus 210 ~L~~L~l~~N~l~g~~p~~l 229 (673)
+|+.|+|++|+|+ .+|..+
T Consensus 254 ~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 254 QLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp TCCEEECTTSCCS-SCCSSC
T ss_pred CCCEEECCCCccC-hhhhhc
Confidence 8888888888887 566544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=4.9e-19 Score=200.92 Aligned_cols=181 Identities=22% Similarity=0.222 Sum_probs=113.1
Q ss_pred CEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcc-cCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 66 RVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKE-IASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 66 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
+++.|++++|.+.+..|..|..+++|++|+|++|.+++..|.. +..+++|+.|++++|.+++..|..|..+++|+.|+|
T Consensus 377 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 456 (606)
T 3t6q_A 377 HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNL 456 (606)
T ss_dssp TCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEEC
Confidence 4556666666666666666666666666666666666554433 566666666666666666666666666666666666
Q ss_pred cCcccccc---CchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCC
Q 005859 145 CYNKLTGN---IPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSF 221 (673)
Q Consensus 145 ~~N~l~~~---~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 221 (673)
++|++++. .+..+..+++|++|++++|++++..|..|..+++|+.|+|++|++++..|..+.++++| .|++++|++
T Consensus 457 ~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l 535 (606)
T 3t6q_A 457 QGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHI 535 (606)
T ss_dssp TTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCC
T ss_pred CCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcc
Confidence 66666552 22456666666666666666666666666666666666666666666666666666666 666666666
Q ss_pred CcCCchhhhhccC--CccccCcccccCC
Q 005859 222 SGNVPPALKRLNG--GFQYDNNAALCGT 247 (673)
Q Consensus 222 ~g~~p~~l~~~~~--~~~~~~n~~~~~~ 247 (673)
++.+|..+..+.. .+.+.+|+..|..
T Consensus 536 ~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 536 SIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp CCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred cccCHhhcccCCCCCEEeCCCCCccccC
Confidence 6666655554432 2334555555543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.6e-19 Score=202.46 Aligned_cols=163 Identities=18% Similarity=0.169 Sum_probs=145.1
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.+++.|+|++|.+++..|..|.++++|++|+|++|++++..|+.|..+++|++|+|++|++++..|..|+++++|++|+|
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 105 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence 36899999999999988999999999999999999999988899999999999999999999888888999999999999
Q ss_pred cCccccc-cCchhhcCccccCeecccccccCccCC-ccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCC
Q 005859 145 CYNKLTG-NIPTQLGSLRKLSVLALQYNQLTGAIP-ASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFS 222 (673)
Q Consensus 145 ~~N~l~~-~~p~~l~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 222 (673)
++|++++ ..|..++++++|++|++++|.+.+.+| ..|.++++|+.|++++|.+++.+|..+..+++|+.|++++|.+.
T Consensus 106 s~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~ 185 (549)
T 2z81_A 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185 (549)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST
T ss_pred CCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCccc
Confidence 9999986 467789999999999999998555555 57999999999999999999989999999999999999998875
Q ss_pred cCCchh
Q 005859 223 GNVPPA 228 (673)
Q Consensus 223 g~~p~~ 228 (673)
.+|..
T Consensus 186 -~~~~~ 190 (549)
T 2z81_A 186 -FLLEI 190 (549)
T ss_dssp -THHHH
T ss_pred -ccchh
Confidence 34443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=3.1e-19 Score=202.50 Aligned_cols=175 Identities=17% Similarity=0.111 Sum_probs=159.4
Q ss_pred CceEEeCC----------CCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCC
Q 005859 56 FDGVACDE----------NGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNL 125 (673)
Q Consensus 56 w~gv~c~~----------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 125 (673)
+..|.|.. +..++.|+|++|.+++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 55677853 24789999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccc
Q 005859 126 SGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKL 205 (673)
Q Consensus 126 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 205 (673)
++..|..|+++++|++|+|++|++++..|..|+.+++|++|++++|.+++..+..+..+++|+.|++++|.+++..|..+
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 173 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHH
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhh
Confidence 99889999999999999999999998778889999999999999999997544455569999999999999998888899
Q ss_pred cCCCCCC--EEEccCCCCCcCCchhhh
Q 005859 206 ANVPKLE--VLDIRNNSFSGNVPPALK 230 (673)
Q Consensus 206 ~~l~~L~--~L~l~~N~l~g~~p~~l~ 230 (673)
..+++|+ .|++++|.+++..|..+.
T Consensus 174 ~~l~~L~~l~L~l~~n~l~~~~~~~~~ 200 (606)
T 3t6q_A 174 SSLQQATNLSLNLNGNDIAGIEPGAFD 200 (606)
T ss_dssp HTTTTCCSEEEECTTCCCCEECTTTTT
T ss_pred hhhcccceeEEecCCCccCccChhHhh
Confidence 9999999 999999999998887664
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.78 E-value=6.3e-19 Score=188.75 Aligned_cols=160 Identities=19% Similarity=0.170 Sum_probs=118.4
Q ss_pred cCCCCCCCCCCCC-CCCceEEeCC-----------------CCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCC
Q 005859 41 LTSWAPNADPCSS-DSFDGVACDE-----------------NGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALN 102 (673)
Q Consensus 41 l~~w~~~~~~C~~-~~w~gv~c~~-----------------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~ 102 (673)
+++|..+.++|.. ..|.++.|+. -..++.++++++.+....+..|..+++|++|+|++|.++
T Consensus 3 ~~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~ 82 (390)
T 3o6n_A 3 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE 82 (390)
T ss_dssp ----CCEECBCC------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCC
T ss_pred cCCCCCccceehhhhhhccceeeeeeecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECCCCccc
Confidence 5678766565542 2355555541 135677888888877544445788888888888888888
Q ss_pred ccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCcccc
Q 005859 103 GVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLG 182 (673)
Q Consensus 103 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~ 182 (673)
+..+..|..+++|++|+|++|++++..|..|+++++|++|+|++|+++...+..|..+++|++|++++|.+++..|..|.
T Consensus 83 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 162 (390)
T 3o6n_A 83 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ 162 (390)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTS
T ss_pred ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhcc
Confidence 87777888888888888888888887778888888888888888888854445568888888888888888877777788
Q ss_pred CCCcccccccccccCCCC
Q 005859 183 DLGMLMRLDLSFNNLFGP 200 (673)
Q Consensus 183 ~l~~L~~L~l~~N~l~~~ 200 (673)
.+++|+.|++++|++++.
T Consensus 163 ~l~~L~~L~l~~n~l~~~ 180 (390)
T 3o6n_A 163 ATTSLQNLQLSSNRLTHV 180 (390)
T ss_dssp SCTTCCEEECCSSCCSBC
T ss_pred CCCCCCEEECCCCcCCcc
Confidence 888888888888888754
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.78 E-value=9e-19 Score=179.47 Aligned_cols=164 Identities=27% Similarity=0.323 Sum_probs=145.3
Q ss_pred CCCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEe
Q 005859 63 ENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVL 142 (673)
Q Consensus 63 ~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 142 (673)
....++.+++++++++ .+|..+. ++|+.|+|++|.|++..|..|..+++|++|+|++|.+++. |.. +.+++|++|
T Consensus 8 ~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L~~L 82 (290)
T 1p9a_G 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD-GTLPVLGTL 82 (290)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECC-SCCTTCCEE
T ss_pred ccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cCC-CCCCcCCEE
Confidence 3456888999999998 5676664 7899999999999999999999999999999999999954 443 889999999
Q ss_pred eccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCC
Q 005859 143 QLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFS 222 (673)
Q Consensus 143 ~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 222 (673)
+|++|+++ .+|..+..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+|+
T Consensus 83 ~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 161 (290)
T 1p9a_G 83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (290)
T ss_dssp ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred ECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC
Confidence 99999999 68889999999999999999999877788999999999999999999888888899999999999999999
Q ss_pred cCCchhhhhc
Q 005859 223 GNVPPALKRL 232 (673)
Q Consensus 223 g~~p~~l~~~ 232 (673)
+..+..+..+
T Consensus 162 ~l~~~~~~~l 171 (290)
T 1p9a_G 162 ELPAGLLNGL 171 (290)
T ss_dssp CCCTTTTTTC
T ss_pred ccCHHHhcCc
Confidence 7655555444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=4.5e-19 Score=204.10 Aligned_cols=169 Identities=22% Similarity=0.207 Sum_probs=155.3
Q ss_pred CCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEee
Q 005859 64 NGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143 (673)
Q Consensus 64 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 143 (673)
..+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|+++++|++|+
T Consensus 24 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103 (680)
T ss_dssp CTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence 35799999999999998888899999999999999999999999999999999999999999976666899999999999
Q ss_pred ccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCccccc--CCCCCCEEEccCCCC
Q 005859 144 LCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLA--NVPKLEVLDIRNNSF 221 (673)
Q Consensus 144 L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~l~~L~~L~l~~N~l 221 (673)
|++|++++..|..|+.+++|++|+|++|.+++..|..++++++|+.|++++|.+++..+..+. .+++|+.|++++|++
T Consensus 104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l 183 (680)
T 1ziw_A 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183 (680)
T ss_dssp CCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred CCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcc
Confidence 999999988888999999999999999999999899999999999999999999988777654 568999999999999
Q ss_pred CcCCchhhhhc
Q 005859 222 SGNVPPALKRL 232 (673)
Q Consensus 222 ~g~~p~~l~~~ 232 (673)
++..|..+..+
T Consensus 184 ~~~~~~~~~~l 194 (680)
T 1ziw_A 184 KEFSPGCFHAI 194 (680)
T ss_dssp CCBCTTGGGGS
T ss_pred cccChhhhhhh
Confidence 99888877654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.78 E-value=8.2e-20 Score=208.14 Aligned_cols=163 Identities=22% Similarity=0.418 Sum_probs=153.8
Q ss_pred CCEEEEEecCCCcccc-----------------cCcccc--CCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCC-
Q 005859 65 GRVANISLQGKGLSGE-----------------IPAAVG--GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNN- 124 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~-----------------~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~- 124 (673)
.+++.|+|++|.++|. +|..++ ++++|++|+|++|.+.+.+|..|+++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~ 285 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCC
Confidence 5789999999999997 999999 99999999999999999999999999999999999998
Q ss_pred CCC-CCcccccCC------CCCcEeeccCccccccCch--hhcCccccCeecccccccCccCCccccCCCcccccccccc
Q 005859 125 LSG-KIPSQIGNM------TNLQVLQLCYNKLTGNIPT--QLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFN 195 (673)
Q Consensus 125 l~~-~~p~~~~~l------~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 195 (673)
++| .+|..++++ ++|++|+|++|+++ .+|. .++.+++|++|++++|+++|.+| .|+.+++|+.|+|++|
T Consensus 286 l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N 363 (636)
T 4eco_A 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYN 363 (636)
T ss_dssp SCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSS
T ss_pred CccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCC
Confidence 998 899999887 99999999999999 8998 99999999999999999999999 8999999999999999
Q ss_pred cCCCCCcccccCCCC-CCEEEccCCCCCcCCchhhhh
Q 005859 196 NLFGPVPVKLANVPK-LEVLDIRNNSFSGNVPPALKR 231 (673)
Q Consensus 196 ~l~~~~p~~~~~l~~-L~~L~l~~N~l~g~~p~~l~~ 231 (673)
+++ .+|..+..+++ |+.|++++|.++ .+|..+..
T Consensus 364 ~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~ 398 (636)
T 4eco_A 364 QIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDA 398 (636)
T ss_dssp EEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCT
T ss_pred ccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhh
Confidence 999 78888999999 999999999999 78876543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-18 Score=176.83 Aligned_cols=182 Identities=21% Similarity=0.230 Sum_probs=152.6
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.+++.|+|++|.+++..+..|.++++|++|+|++|.+++..+..|.++++|++|++++|++++..+..++++++|++|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 131 (276)
T 2z62_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (276)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence 57889999999999888888999999999999999999888899999999999999999999877778999999999999
Q ss_pred cCcccccc-CchhhcCccccCeecccccccCccCCccccCCCccc----ccccccccCCCCCcccccCCCCCCEEEccCC
Q 005859 145 CYNKLTGN-IPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLM----RLDLSFNNLFGPVPVKLANVPKLEVLDIRNN 219 (673)
Q Consensus 145 ~~N~l~~~-~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~----~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 219 (673)
++|++++. +|..|..+++|++|+|++|++++..+..+..+.+|+ .|++++|.+++..+..+. ..+|+.|++++|
T Consensus 132 ~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n 210 (276)
T 2z62_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTN 210 (276)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSS
T ss_pred cCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCC
Confidence 99999874 689999999999999999999987777787777777 788999999866555554 458999999999
Q ss_pred CCCcCCchhhhhccC--CccccCcccccCC
Q 005859 220 SFSGNVPPALKRLNG--GFQYDNNAALCGT 247 (673)
Q Consensus 220 ~l~g~~p~~l~~~~~--~~~~~~n~~~~~~ 247 (673)
++++..+..+..+.. .+.+.+|+..|..
T Consensus 211 ~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 240 (276)
T 2z62_A 211 QLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 240 (276)
T ss_dssp CCSCCCTTTTTTCCSCCEEECCSSCBCCCT
T ss_pred ceeecCHhHhcccccccEEEccCCcccccC
Confidence 998766655555543 3445677766654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2e-18 Score=180.41 Aligned_cols=172 Identities=24% Similarity=0.346 Sum_probs=138.3
Q ss_pred CCceEEeCCC----------CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCC
Q 005859 55 SFDGVACDEN----------GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNN 124 (673)
Q Consensus 55 ~w~gv~c~~~----------~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 124 (673)
.|+.+.|... ..++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|+
T Consensus 32 ~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 111 (330)
T 1xku_A 32 HLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111 (330)
T ss_dssp ETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC
T ss_pred CCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCc
Confidence 4899999642 368899999999998888899999999999999999999889999999999999999999
Q ss_pred CCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCc--cCCccccCCCcccccccccccCCCCCc
Q 005859 125 LSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTG--AIPASLGDLGMLMRLDLSFNNLFGPVP 202 (673)
Q Consensus 125 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p 202 (673)
++ .+|..+. ++|+.|++++|++++..+..|..+++|++|++++|.+.. ..+..+..+++|+.|++++|.++. +|
T Consensus 112 l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~ 187 (330)
T 1xku_A 112 LK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IP 187 (330)
T ss_dssp CS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CC
T ss_pred CC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CC
Confidence 98 5666554 688888888888887777778888888888888888853 566777778888888887777764 44
Q ss_pred ccccCCCCCCEEEccCCCCCcCCchhhhhc
Q 005859 203 VKLANVPKLEVLDIRNNSFSGNVPPALKRL 232 (673)
Q Consensus 203 ~~~~~l~~L~~L~l~~N~l~g~~p~~l~~~ 232 (673)
..+. ++|+.|++++|.+++..|..+..+
T Consensus 188 ~~~~--~~L~~L~l~~n~l~~~~~~~~~~l 215 (330)
T 1xku_A 188 QGLP--PSLTELHLDGNKITKVDAASLKGL 215 (330)
T ss_dssp SSCC--TTCSEEECTTSCCCEECTGGGTTC
T ss_pred cccc--ccCCEEECCCCcCCccCHHHhcCC
Confidence 4332 667777777777777666666544
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=9.3e-19 Score=168.68 Aligned_cols=152 Identities=19% Similarity=0.302 Sum_probs=133.4
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.+++.|++++|+++ .+| .+..+++|++|+|++|.++ .++.+..+++|++|++++|++++..|..|+.+++|++|+|
T Consensus 44 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 44 NSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp HTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 46889999999998 666 6999999999999999776 3457999999999999999999888999999999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCc
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 223 (673)
++|++++..|..+..+++|++|++++|.+.+.+| .+..+++|+.|++++|.+++. + .+..+++|+.|++++|++.+
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC----
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCcccCC
Confidence 9999998889999999999999999998333566 689999999999999999874 3 68899999999999999864
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=7.2e-19 Score=197.92 Aligned_cols=168 Identities=23% Similarity=0.190 Sum_probs=153.9
Q ss_pred CCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEee
Q 005859 64 NGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143 (673)
Q Consensus 64 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 143 (673)
..+++.|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+
T Consensus 27 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (570)
T 2z63_A 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (570)
T ss_dssp CSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred cccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence 45789999999999998888999999999999999999998889999999999999999999988889999999999999
Q ss_pred ccCccccccCchhhcCccccCeecccccccCc-cCCccccCCCcccccccccccCCCCCcccccCCCCC----CEEEccC
Q 005859 144 LCYNKLTGNIPTQLGSLRKLSVLALQYNQLTG-AIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKL----EVLDIRN 218 (673)
Q Consensus 144 L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L----~~L~l~~ 218 (673)
+++|++++..+..++.+++|++|++++|.+++ .+|..|+++++|+.|++++|++++..|..+..+++| ..|++++
T Consensus 107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~ 186 (570)
T 2z63_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (570)
T ss_dssp CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence 99999997666679999999999999999987 479999999999999999999998888888888888 8999999
Q ss_pred CCCCcCCchhhhh
Q 005859 219 NSFSGNVPPALKR 231 (673)
Q Consensus 219 N~l~g~~p~~l~~ 231 (673)
|.+.+..|..+..
T Consensus 187 n~l~~~~~~~~~~ 199 (570)
T 2z63_A 187 NPMNFIQPGAFKE 199 (570)
T ss_dssp CCCCEECTTTTTT
T ss_pred CCceecCHHHhcc
Confidence 9999888776654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.3e-19 Score=196.36 Aligned_cols=159 Identities=25% Similarity=0.255 Sum_probs=112.2
Q ss_pred CEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCC-------------------C
Q 005859 66 RVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNL-------------------S 126 (673)
Q Consensus 66 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l-------------------~ 126 (673)
+++.|+|++|++++..|..|.++++|++|+|++|.+++.+| |..+++|++|+|++|.+ +
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~ 112 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS 112 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCC
Confidence 45666666666666555566666666666666666665444 55555555555555544 3
Q ss_pred CCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCcccc-CCCcccccccccccCCCCCcccc
Q 005859 127 GKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLG-DLGMLMRLDLSFNNLFGPVPVKL 205 (673)
Q Consensus 127 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~ 205 (673)
+..+ ..+++|+.|+|++|.+++..|..|+.+++|++|+|++|.+++.+|..+. .+++|+.|+|++|.+++..+ +
T Consensus 113 ~~~~---~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~ 187 (487)
T 3oja_A 113 RVSC---SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--Q 187 (487)
T ss_dssp CEEE---CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--C
T ss_pred CCCc---cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--c
Confidence 3222 2357788888888888888888888888999999999999888887775 78889999999998886532 3
Q ss_pred cCCCCCCEEEccCCCCCcCCchhhhhc
Q 005859 206 ANVPKLEVLDIRNNSFSGNVPPALKRL 232 (673)
Q Consensus 206 ~~l~~L~~L~l~~N~l~g~~p~~l~~~ 232 (673)
..+++|+.|+|++|.|++..|. +..+
T Consensus 188 ~~l~~L~~L~Ls~N~l~~~~~~-~~~l 213 (487)
T 3oja_A 188 VVFAKLKTLDLSSNKLAFMGPE-FQSA 213 (487)
T ss_dssp CCCTTCCEEECCSSCCCEECGG-GGGG
T ss_pred ccCCCCCEEECCCCCCCCCCHh-HcCC
Confidence 4588889999999988875443 5544
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.6e-19 Score=207.07 Aligned_cols=162 Identities=20% Similarity=0.329 Sum_probs=151.3
Q ss_pred CCEEEEEecCCCccc-----------------ccCcccc--CCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCC-
Q 005859 65 GRVANISLQGKGLSG-----------------EIPAAVG--GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNN- 124 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g-----------------~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~- 124 (673)
.+++.|+|++|.|+| .+|..++ +|++|++|+|++|.+.+.+|..|+++++|+.|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~ 527 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCC
Confidence 578999999999999 4999988 99999999999999999999999999999999999998
Q ss_pred CCC-CCcccccCCC-------CCcEeeccCccccccCch--hhcCccccCeecccccccCccCCccccCCCccccccccc
Q 005859 125 LSG-KIPSQIGNMT-------NLQVLQLCYNKLTGNIPT--QLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSF 194 (673)
Q Consensus 125 l~~-~~p~~~~~l~-------~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 194 (673)
++| .+|..|++++ +|+.|+|++|+++ .+|. .|+.+++|+.|+|++|.++ .+| .|+.+++|+.|+|++
T Consensus 528 lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~ 604 (876)
T 4ecn_A 528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDY 604 (876)
T ss_dssp SCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCS
T ss_pred cccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcC
Confidence 998 8998877766 9999999999999 8898 9999999999999999999 888 899999999999999
Q ss_pred ccCCCCCcccccCCCC-CCEEEccCCCCCcCCchhhhh
Q 005859 195 NNLFGPVPVKLANVPK-LEVLDIRNNSFSGNVPPALKR 231 (673)
Q Consensus 195 N~l~~~~p~~~~~l~~-L~~L~l~~N~l~g~~p~~l~~ 231 (673)
|+++ .+|..+.++++ |+.|+|++|+|+ .+|..+..
T Consensus 605 N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~ 640 (876)
T 4ecn_A 605 NQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNA 640 (876)
T ss_dssp SCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCT
T ss_pred Cccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhc
Confidence 9999 78988999999 999999999999 78876544
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.3e-18 Score=191.61 Aligned_cols=165 Identities=22% Similarity=0.232 Sum_probs=152.0
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.+++.|+|++|.+++..|..|.++++|++|+|++|.+++..+..|.++++|++|+|++|++.+..|..|.++++|+.|+|
T Consensus 56 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 135 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV 135 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEE
T ss_pred CCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEEC
Confidence 57899999999999999999999999999999999999877778999999999999999999888999999999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
++|.+++..|..|.++++|+.|+|++|.+++..+..|..+++|+.|+|++|.+.+..+..+..+++|+.|++++|++.+.
T Consensus 136 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~ 215 (477)
T 2id5_A 136 GDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDT 215 (477)
T ss_dssp CCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCE
T ss_pred CCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccc
Confidence 99999998899999999999999999999977667799999999999999999988888899999999999999888877
Q ss_pred Cchhh
Q 005859 225 VPPAL 229 (673)
Q Consensus 225 ~p~~l 229 (673)
+|...
T Consensus 216 ~~~~~ 220 (477)
T 2id5_A 216 MTPNC 220 (477)
T ss_dssp ECTTT
T ss_pred cCccc
Confidence 77654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=7.4e-19 Score=182.09 Aligned_cols=162 Identities=19% Similarity=0.152 Sum_probs=138.6
Q ss_pred CEEEEEecCCCcccccCccc--cCCCCCCeEeCcCCcCCccCC----cccCCCCCCCEEEccCCCCCCCCcccccCCCCC
Q 005859 66 RVANISLQGKGLSGEIPAAV--GGLKSLTGLYLHFNALNGVIP----KEIASLSELSDLYLNVNNLSGKIPSQIGNMTNL 139 (673)
Q Consensus 66 ~v~~l~l~~~~l~g~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 139 (673)
+++.|+|++|.+++.+|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|+|++|++++..|..|+.+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 48899999999999999988 999999999999999998666 455689999999999999998888999999999
Q ss_pred cEeeccCcccccc--C--chhhcCccccCeecccccccCccCCc----cccCCCcccccccccccCCCCCcccccCC---
Q 005859 140 QVLQLCYNKLTGN--I--PTQLGSLRKLSVLALQYNQLTGAIPA----SLGDLGMLMRLDLSFNNLFGPVPVKLANV--- 208 (673)
Q Consensus 140 ~~L~L~~N~l~~~--~--p~~l~~l~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~~~~p~~~~~l--- 208 (673)
++|+|++|++.+. + +..+..+++|++|+|++|+++. +|. .+..+++|++|+|++|++.+..|..+..+
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 250 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS 250 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence 9999999998753 2 2334789999999999999973 333 25788999999999999998888777776
Q ss_pred CCCCEEEccCCCCCcCCchhh
Q 005859 209 PKLEVLDIRNNSFSGNVPPAL 229 (673)
Q Consensus 209 ~~L~~L~l~~N~l~g~~p~~l 229 (673)
++|+.|+|++|+|+ .+|..+
T Consensus 251 ~~L~~L~Ls~N~l~-~lp~~~ 270 (310)
T 4glp_A 251 SALNSLNLSFAGLE-QVPKGL 270 (310)
T ss_dssp TTCCCEECCSSCCC-SCCSCC
T ss_pred CcCCEEECCCCCCC-chhhhh
Confidence 69999999999999 667654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=4.4e-18 Score=195.75 Aligned_cols=184 Identities=22% Similarity=0.268 Sum_probs=136.9
Q ss_pred CCEEEEEecCCCcccccC-ccccCCCCCCeEeCcCCcCCc--------------------------cCCcccCCCCCCCE
Q 005859 65 GRVANISLQGKGLSGEIP-AAVGGLKSLTGLYLHFNALNG--------------------------VIPKEIASLSELSD 117 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p-~~~~~l~~L~~L~L~~N~l~~--------------------------~~p~~~~~l~~L~~ 117 (673)
.++..|+|++|.+++.+| ..|.++++|++|+|++|++++ .+|..|..+++|+.
T Consensus 405 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~ 484 (680)
T 1ziw_A 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI 484 (680)
T ss_dssp TTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCE
T ss_pred CCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCE
Confidence 357778888888777666 466777777777777776543 45666777778888
Q ss_pred EEccCCCCCCCCcccccCCCCCcEeeccCccccccCc--------hhhcCccccCeecccccccCccCCccccCCCcccc
Q 005859 118 LYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIP--------TQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMR 189 (673)
Q Consensus 118 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--------~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 189 (673)
|+|++|++++..|..|.++++|++|+|++|++++..+ ..|.++++|++|+|++|+++...+..|.++++|+.
T Consensus 485 L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~ 564 (680)
T 1ziw_A 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564 (680)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred EECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcce
Confidence 8888888887667777888888888888888775321 23677888888888888888444446888889999
Q ss_pred cccccccCCCCCcccccCCCCCCEEEccCCCCCcCCchhhh-hccC--CccccCcccccCCC
Q 005859 190 LDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALK-RLNG--GFQYDNNAALCGTG 248 (673)
Q Consensus 190 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~l~-~~~~--~~~~~~n~~~~~~~ 248 (673)
|+|++|++++..+..|.++++|+.|+|++|+|++..|..+. .+.. .+.+.+|+..|.+.
T Consensus 565 L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 565 IDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred eECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 99999999877777788888999999999999887777665 3332 34567888888765
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.4e-18 Score=194.73 Aligned_cols=167 Identities=23% Similarity=0.235 Sum_probs=140.0
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..++.|+|++|.+++..|..|+++++|++|+|++|.|++..|..|+++++|++|+|++|.+++..+..|+++++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 46889999999999988889999999999999999999988889999999999999999999766666899999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCC-------------------------------------Ccc
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDL-------------------------------------GML 187 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l-------------------------------------~~L 187 (673)
++|.+++..|..|..+++|++|+|++|.+++..+..+..+ ++|
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L 234 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVEL 234 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSCC
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCCC
Confidence 9999999888899999999999999999986533333222 235
Q ss_pred cccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCchhhhhcc
Q 005859 188 MRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233 (673)
Q Consensus 188 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~l~~~~ 233 (673)
+.|+|++|.+++ +..+..+++|+.|+|++|.+++.+|..+..+.
T Consensus 235 ~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 278 (597)
T 3oja_B 235 TILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ 278 (597)
T ss_dssp CEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCS
T ss_pred CEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCcc
Confidence 566666666665 35677888888999999988888888776654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=2.8e-18 Score=164.55 Aligned_cols=113 Identities=25% Similarity=0.308 Sum_probs=59.6
Q ss_pred CCCEEEccCCCCCCCCcc-cccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCccccccc
Q 005859 114 ELSDLYLNVNNLSGKIPS-QIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDL 192 (673)
Q Consensus 114 ~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 192 (673)
+|++|+|++|++++..+. .|..+++|++|+|++|++++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 344444444444433322 2444444444444444444444444555555555555555555444444555555555555
Q ss_pred ccccCCCCCcccccCCCCCCEEEccCCCCCcCCc
Q 005859 193 SFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVP 226 (673)
Q Consensus 193 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p 226 (673)
++|++++.+|..+..+++|+.|+|++|+|.+..+
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 5555555555566666667777777777766554
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.3e-18 Score=173.05 Aligned_cols=163 Identities=17% Similarity=0.120 Sum_probs=142.8
Q ss_pred CCEEEEEecCCC-cccccCccccCCCCCCeEeCcC-CcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCc--
Q 005859 65 GRVANISLQGKG-LSGEIPAAVGGLKSLTGLYLHF-NALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQ-- 140 (673)
Q Consensus 65 ~~v~~l~l~~~~-l~g~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~-- 140 (673)
.+++.|+|++|. +++..+..|.++++|++|+|++ |.+++..+..|.++++|++|++++|++++ +|. |..+++|+
T Consensus 55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L 132 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIF 132 (239)
T ss_dssp TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSE
T ss_pred CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccc
Confidence 578999999997 8877777899999999999999 99998888899999999999999999996 676 88999998
Q ss_pred -EeeccCc-cccccCchhhcCccccC-eecccccccCccCCccccCCCccccccccccc-CCCCCcccccCC-CCCCEEE
Q 005859 141 -VLQLCYN-KLTGNIPTQLGSLRKLS-VLALQYNQLTGAIPASLGDLGMLMRLDLSFNN-LFGPVPVKLANV-PKLEVLD 215 (673)
Q Consensus 141 -~L~L~~N-~l~~~~p~~l~~l~~L~-~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l-~~L~~L~ 215 (673)
+|++++| ++++..+..|..+++|+ .|++++|+++ .+|......++|+.|+|++|+ +++..+..|.++ ++|+.|+
T Consensus 133 ~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~ 211 (239)
T 2xwt_C 133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLD 211 (239)
T ss_dssp EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEE
T ss_pred cEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEE
Confidence 9999999 99987778899999999 9999999999 555543344899999999995 987777889999 9999999
Q ss_pred ccCCCCCcCCchhhh
Q 005859 216 IRNNSFSGNVPPALK 230 (673)
Q Consensus 216 l~~N~l~g~~p~~l~ 230 (673)
+++|++++..+..+.
T Consensus 212 l~~N~l~~l~~~~~~ 226 (239)
T 2xwt_C 212 VSQTSVTALPSKGLE 226 (239)
T ss_dssp CTTCCCCCCCCTTCT
T ss_pred CCCCccccCChhHhc
Confidence 999999865444333
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.75 E-value=5.3e-19 Score=183.32 Aligned_cols=163 Identities=26% Similarity=0.248 Sum_probs=139.8
Q ss_pred CCCEEEEEecCCCcccccCccccCC-----CCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCC--Ccccc--c
Q 005859 64 NGRVANISLQGKGLSGEIPAAVGGL-----KSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK--IPSQI--G 134 (673)
Q Consensus 64 ~~~v~~l~l~~~~l~g~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~~~--~ 134 (673)
...++.|+|++|.+++. |..++.+ ++|++|+|++|++++..|..|+.+++|++|+|++|++.+. +|..+ .
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 35789999999999988 8888887 9999999999999999889999999999999999998875 34455 8
Q ss_pred CCCCCcEeeccCccccc--cCc-hhhcCccccCeecccccccCccCC-ccccCCCcccccccccccCCCCCcccccCCCC
Q 005859 135 NMTNLQVLQLCYNKLTG--NIP-TQLGSLRKLSVLALQYNQLTGAIP-ASLGDLGMLMRLDLSFNNLFGPVPVKLANVPK 210 (673)
Q Consensus 135 ~l~~L~~L~L~~N~l~~--~~p-~~l~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 210 (673)
.+++|++|+|++|++++ .++ ..+..+++|++|+|++|++++.+| ..+..+++|+.|+|++|+|+ .+|..+. ++
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~ 275 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AK 275 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SE
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CC
Confidence 99999999999999983 223 345688999999999999998775 45777899999999999998 6777766 89
Q ss_pred CCEEEccCCCCCcCCchhhhhc
Q 005859 211 LEVLDIRNNSFSGNVPPALKRL 232 (673)
Q Consensus 211 L~~L~l~~N~l~g~~p~~l~~~ 232 (673)
|+.|+|++|+|++. |. +..+
T Consensus 276 L~~L~Ls~N~l~~~-p~-~~~l 295 (312)
T 1wwl_A 276 LSVLDLSYNRLDRN-PS-PDEL 295 (312)
T ss_dssp EEEEECCSSCCCSC-CC-TTTS
T ss_pred ceEEECCCCCCCCC-hh-HhhC
Confidence 99999999999986 54 5443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.75 E-value=8.5e-18 Score=175.85 Aligned_cols=161 Identities=25% Similarity=0.300 Sum_probs=125.3
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.+++.|+|++|.+++..|..|.++++|++|+|++|.++ .+|..+. ++|++|++++|++++..+..|.++++|+.|++
T Consensus 78 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l 154 (332)
T 2ft3_A 78 QHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEM 154 (332)
T ss_dssp TTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEEC
T ss_pred CCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEEC
Confidence 47899999999999999999999999999999999998 5666555 89999999999999777778999999999999
Q ss_pred cCcccc--ccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCC
Q 005859 145 CYNKLT--GNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFS 222 (673)
Q Consensus 145 ~~N~l~--~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 222 (673)
++|.++ +..|..+..+ +|++|++++|.+++ +|..+. ++|+.|++++|.+++..|..+..+++|+.|++++|+++
T Consensus 155 ~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~ 230 (332)
T 2ft3_A 155 GGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR 230 (332)
T ss_dssp CSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCC
T ss_pred CCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCC
Confidence 999996 4677777777 77777777777764 454433 56666666666666666666666666666666666666
Q ss_pred cCCchhhhhc
Q 005859 223 GNVPPALKRL 232 (673)
Q Consensus 223 g~~p~~l~~~ 232 (673)
+..|..+..+
T Consensus 231 ~~~~~~~~~l 240 (332)
T 2ft3_A 231 MIENGSLSFL 240 (332)
T ss_dssp CCCTTGGGGC
T ss_pred cCChhHhhCC
Confidence 6555555443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.75 E-value=5.7e-18 Score=167.22 Aligned_cols=152 Identities=26% Similarity=0.291 Sum_probs=135.7
Q ss_pred CCCCCCCCceEEeCCCCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCC
Q 005859 49 DPCSSDSFDGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK 128 (673)
Q Consensus 49 ~~C~~~~w~gv~c~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 128 (673)
-.|+......+.-.....++.|+|++|.+++..|..|.++++|++|+|++|+|+...+..|..+++|++|+|++|+|++.
T Consensus 24 v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l 103 (229)
T 3e6j_A 24 VDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVL 103 (229)
T ss_dssp EECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred eEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCcc
Confidence 34654445555555557899999999999999999999999999999999999887778889999999999999999987
Q ss_pred CcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCC
Q 005859 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPV 201 (673)
Q Consensus 129 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 201 (673)
.+..|..+++|++|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+....
T Consensus 104 ~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 104 PSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp CTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred ChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 7788999999999999999999 78999999999999999999999777778999999999999999988644
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.74 E-value=6e-18 Score=184.82 Aligned_cols=184 Identities=21% Similarity=0.216 Sum_probs=155.4
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcc-------------
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPS------------- 131 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~------------- 131 (673)
.+++.|+|++|.+++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+++...+.
T Consensus 99 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 178 (452)
T 3zyi_A 99 HHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDL 178 (452)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeC
Confidence 4688899999999988888899999999999999999887777788888899998888888743332
Q ss_pred ------------cccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCC
Q 005859 132 ------------QIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFG 199 (673)
Q Consensus 132 ------------~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 199 (673)
.|.++++|+.|+|++|++++ +| .+..+++|++|+|++|.+++..|..|.++++|+.|+|++|++++
T Consensus 179 ~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 256 (452)
T 3zyi_A 179 GELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL 256 (452)
T ss_dssp CCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCE
T ss_pred CCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCce
Confidence 36677788888888888885 44 58899999999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCEEEccCCCCCcCCchhhhhccC--CccccCcccccCCCcc
Q 005859 200 PVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNG--GFQYDNNAALCGTGFT 250 (673)
Q Consensus 200 ~~p~~~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~--~~~~~~n~~~~~~~~~ 250 (673)
..|..|.++++|+.|+|++|+|++..+..+..+.. .+.+.+|+..|.+...
T Consensus 257 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~~ 309 (452)
T 3zyi_A 257 IERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDIL 309 (452)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTTH
T ss_pred ECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCch
Confidence 88999999999999999999999877766665543 3456788888877643
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.74 E-value=6.3e-18 Score=190.00 Aligned_cols=158 Identities=24% Similarity=0.322 Sum_probs=113.1
Q ss_pred cCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCC--CcccccCCCCCcEeeccCccccccCch-hhcCccc
Q 005859 86 GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK--IPSQIGNMTNLQVLQLCYNKLTGNIPT-QLGSLRK 162 (673)
Q Consensus 86 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~ 162 (673)
..+++|++|+|++|++++.+|..+..+++|+.|+|++|++++. +|..|.++++|+.|+|++|++++.+|. .+..+++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 5677788888888888877778888888888888888888753 345677888888888888888874554 4677788
Q ss_pred cCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCchh-hhhccC--Ccccc
Q 005859 163 LSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPA-LKRLNG--GFQYD 239 (673)
Q Consensus 163 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-l~~~~~--~~~~~ 239 (673)
|++|++++|++++.+|..+. ++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|++ +|.. +..+.. .+.+.
T Consensus 430 L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~ 505 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLH 505 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECC
T ss_pred CCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEec
Confidence 88888888888776666554 57888888888877 466666678888888888888874 5554 544432 23455
Q ss_pred CcccccCC
Q 005859 240 NNAALCGT 247 (673)
Q Consensus 240 ~n~~~~~~ 247 (673)
+|+..|..
T Consensus 506 ~N~~~c~c 513 (562)
T 3a79_B 506 DNPWDCTC 513 (562)
T ss_dssp SCCBCCCH
T ss_pred CCCcCCCc
Confidence 66666554
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.5e-18 Score=192.28 Aligned_cols=182 Identities=23% Similarity=0.247 Sum_probs=137.1
Q ss_pred CCEEEEEecCCCccccc--CccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCc-ccccCCCCCcE
Q 005859 65 GRVANISLQGKGLSGEI--PAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIP-SQIGNMTNLQV 141 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~ 141 (673)
..+..|++++|.+++.. |..+.++++|++|+|++|.+++..+. +..+++|+.|++++|.+.+..| ..+.++++|++
T Consensus 347 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 425 (570)
T 2z63_A 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425 (570)
T ss_dssp TTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCE
T ss_pred CCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCE
Confidence 46778888888887654 66777888888888888888765444 7788888888888888876655 46778888888
Q ss_pred eeccCccccccCchhhcCccccCeecccccccC-ccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCC
Q 005859 142 LQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLT-GAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNS 220 (673)
Q Consensus 142 L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 220 (673)
|++++|.+++..|..|..+++|++|++++|.++ +.+|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|+
T Consensus 426 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 505 (570)
T 2z63_A 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQ 505 (570)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCc
Confidence 888888888777778888888888888888876 5677778888888888888888887777778888888888888888
Q ss_pred CCcCCchhhhhccC--CccccCcccccCC
Q 005859 221 FSGNVPPALKRLNG--GFQYDNNAALCGT 247 (673)
Q Consensus 221 l~g~~p~~l~~~~~--~~~~~~n~~~~~~ 247 (673)
+++..|..+..+.. .+.+.+|+..|..
T Consensus 506 l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 534 (570)
T 2z63_A 506 LKSVPDGIFDRLTSLQKIWLHTNPWDCSC 534 (570)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CCCCCHHHhhcccCCcEEEecCCcccCCC
Confidence 88777666655442 2344556555543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=4e-18 Score=189.68 Aligned_cols=138 Identities=25% Similarity=0.326 Sum_probs=84.8
Q ss_pred cCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCC--CCcccccCCCCCcEeeccCccccccCch-hhcCccc
Q 005859 86 GGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSG--KIPSQIGNMTNLQVLQLCYNKLTGNIPT-QLGSLRK 162 (673)
Q Consensus 86 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~ 162 (673)
..+++|++|+|++|++++.+|..+..+++|++|+|++|++++ .+|..+..+++|++|+|++|++++.+|. .+..+++
T Consensus 321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~ 400 (520)
T 2z7x_B 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS 400 (520)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence 455666666666666666666666666666666666666664 3445566666666666666666654444 3555666
Q ss_pred cCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCch
Q 005859 163 LSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPP 227 (673)
Q Consensus 163 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~ 227 (673)
|++|++++|++++.+|..+. ++|+.|+|++|+++ .+|..+..+++|+.|++++|+|+. +|.
T Consensus 401 L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~ 461 (520)
T 2z7x_B 401 LLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPD 461 (520)
T ss_dssp CCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCT
T ss_pred CCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCH
Confidence 66666666666655555443 56666666666666 455555566666666666666663 444
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=7.3e-18 Score=183.52 Aligned_cols=158 Identities=22% Similarity=0.245 Sum_probs=120.2
Q ss_pred CEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcc--------------
Q 005859 66 RVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPS-------------- 131 (673)
Q Consensus 66 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-------------- 131 (673)
+++.|+|++|.+++..+..|.++++|++|+|++|+|+...+..|..+++|++|+|++|+++...+.
T Consensus 89 ~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~ 168 (440)
T 3zyj_A 89 HLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLG 168 (440)
T ss_dssp SCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCC
Confidence 566666766666665556666666666666666666655555555566666666555555422221
Q ss_pred -----------c----------------------ccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCC
Q 005859 132 -----------Q----------------------IGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIP 178 (673)
Q Consensus 132 -----------~----------------------~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 178 (673)
. +..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|
T Consensus 169 ~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 248 (440)
T 3zyj_A 169 ELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIER 248 (440)
T ss_dssp CCTTCCEECTTTTTTCSSCCEEECTTSCCSSCCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECT
T ss_pred CCCCcceeCcchhhcccccCeecCCCCcCccccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEECh
Confidence 1 3344566677777777887778899999999999999999999999
Q ss_pred ccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCc
Q 005859 179 ASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 179 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 223 (673)
..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|++.-
T Consensus 249 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 249 NAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp TSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred hhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence 999999999999999999998888889999999999999999874
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.6e-18 Score=183.06 Aligned_cols=165 Identities=21% Similarity=0.205 Sum_probs=145.7
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCc-ccccCCCCCcEee
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIP-SQIGNMTNLQVLQ 143 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~ 143 (673)
.+++.|+|++|.+++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+ ..|.++++|++|+
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~ 155 (353)
T 2z80_A 76 VNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR 155 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred CCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEE
Confidence 578999999999999888999999999999999999997666669999999999999999995444 4799999999999
Q ss_pred ccCc-cccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCC
Q 005859 144 LCYN-KLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFS 222 (673)
Q Consensus 144 L~~N-~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 222 (673)
+++| .+.+..|..|..+++|++|++++|.+++..|..+..+++|+.|++++|.+....+..+..+++|+.|++++|.++
T Consensus 156 l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~ 235 (353)
T 2z80_A 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLD 235 (353)
T ss_dssp EEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCT
T ss_pred CCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccc
Confidence 9999 577777889999999999999999999988999999999999999999997544444556899999999999999
Q ss_pred cCCchhh
Q 005859 223 GNVPPAL 229 (673)
Q Consensus 223 g~~p~~l 229 (673)
+..+..+
T Consensus 236 ~~~~~~l 242 (353)
T 2z80_A 236 TFHFSEL 242 (353)
T ss_dssp TCCCC--
T ss_pred ccccccc
Confidence 8665544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.3e-18 Score=200.49 Aligned_cols=202 Identities=22% Similarity=0.201 Sum_probs=118.3
Q ss_pred hhHHHHHHHHHHhcC-CCCCCcCCCCCCCCCCCCCCCceEEeCCCCCEEEEEecCCCcccccCccccCCCCCCe-----E
Q 005859 21 TSEVDILMHIKDSLD-PENRLLTSWAPNADPCSSDSFDGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTG-----L 94 (673)
Q Consensus 21 ~~~~~~ll~~~~~~~-~~~~~l~~w~~~~~~C~~~~w~gv~c~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~-----L 94 (673)
..++++|+.+..++. .....-..|.....++. .|.++.++. ++++.|+|.++++.. ++..+.....|.. +
T Consensus 131 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~-~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~ 206 (727)
T 4b8c_D 131 DCTKQALMEMADTLTDSKTAKKQQPTGDSTPSG--TATNSAVST-PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDED 206 (727)
T ss_dssp -CCCHHHHHHHHHHHHHHTTC-----------------------------------------------------------
T ss_pred ccchhhhhhhhhhcccccCcccCCCcCCCCccc--cCCCceecC-CccceEEeeCCCCCc-chhhHhhcCccCcccccCc
Confidence 456788999888763 11122345644333333 498888864 689999999998876 3433322222222 2
Q ss_pred eCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccC
Q 005859 95 YLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLT 174 (673)
Q Consensus 95 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 174 (673)
+++.|.+. ..|+.+..+++|+.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|+.+++|++|+|++|.|+
T Consensus 207 ~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~ 283 (727)
T 4b8c_D 207 DDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT 283 (727)
T ss_dssp ----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred ccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence 23334443 45778899999999999999998 77887889999999999999999 88999999999999999999998
Q ss_pred ccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCchhhhh
Q 005859 175 GAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKR 231 (673)
Q Consensus 175 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~l~~ 231 (673)
.+|..|++|++|+.|+|++|.|+ .+|..|.++++|+.|+|++|+|+|.+|..+..
T Consensus 284 -~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 338 (727)
T 4b8c_D 284 -SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTE 338 (727)
T ss_dssp -SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHH
T ss_pred -ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhh
Confidence 78999999999999999999987 67888999999999999999999999888754
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.3e-17 Score=178.51 Aligned_cols=167 Identities=23% Similarity=0.235 Sum_probs=134.7
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.+++.|+|++|.+++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|+++...+..|.++++|++|+|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 46888999999998888888999999999999999999888888999999999999999998555555789999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCC-------------------------------------Ccc
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDL-------------------------------------GML 187 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l-------------------------------------~~L 187 (673)
++|++++..|..|..+++|++|++++|++++.....+..+ ++|
T Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L 228 (390)
T 3o6n_A 149 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVEL 228 (390)
T ss_dssp CSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCSSC
T ss_pred CCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccccccCCCCcceEEECCCCeeeeccccccccc
Confidence 9999998888889999999999999998875432222222 246
Q ss_pred cccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCchhhhhcc
Q 005859 188 MRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233 (673)
Q Consensus 188 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~l~~~~ 233 (673)
+.|++++|.+++. ..+..+++|+.|++++|.+++..|..+..+.
T Consensus 229 ~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 272 (390)
T 3o6n_A 229 TILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ 272 (390)
T ss_dssp CEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCS
T ss_pred cEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccc
Confidence 6666666666653 4577888999999999999888888776654
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=7.1e-18 Score=187.68 Aligned_cols=160 Identities=21% Similarity=0.267 Sum_probs=144.8
Q ss_pred CCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCc--cCCcccCCCCCCCEEEccCCCCCCCCccc-ccCCCCCc
Q 005859 64 NGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNG--VIPKEIASLSELSDLYLNVNNLSGKIPSQ-IGNMTNLQ 140 (673)
Q Consensus 64 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~ 140 (673)
...++.|+|++|.+++.+|..++++++|++|+|++|++++ .+|..+..+++|++|+|++|++++.+|.. +..+++|+
T Consensus 323 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 4578999999999999999999999999999999999997 56788999999999999999999867764 88999999
Q ss_pred EeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCC
Q 005859 141 VLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNS 220 (673)
Q Consensus 141 ~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 220 (673)
.|+|++|++++.+|..+. ++|++|++++|+++ .+|..+..+++|+.|+|++|+++...+..+..+++|+.|++++|+
T Consensus 403 ~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~ 479 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNP 479 (520)
T ss_dssp EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCC
Confidence 999999999988887664 79999999999999 789888899999999999999995444448999999999999999
Q ss_pred CCcCCc
Q 005859 221 FSGNVP 226 (673)
Q Consensus 221 l~g~~p 226 (673)
+++..+
T Consensus 480 ~~c~c~ 485 (520)
T 2z7x_B 480 WDCSCP 485 (520)
T ss_dssp BCCCHH
T ss_pred CcccCC
Confidence 998765
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.2e-18 Score=178.56 Aligned_cols=155 Identities=20% Similarity=0.161 Sum_probs=133.2
Q ss_pred CCEEEEEecCCCcccccC----ccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCC--C--cccccCC
Q 005859 65 GRVANISLQGKGLSGEIP----AAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK--I--PSQIGNM 136 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~--p~~~~~l 136 (673)
..+..|+|++|.+++..+ ..+..+++|++|+|++|.+++..|..|..+++|++|+|++|++.+. + +..++.+
T Consensus 117 ~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l 196 (310)
T 4glp_A 117 LALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKF 196 (310)
T ss_dssp BCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSS
T ss_pred CCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcC
Confidence 468899999999998766 4566899999999999999999999999999999999999998752 2 2334789
Q ss_pred CCCcEeeccCccccccCch----hhcCccccCeecccccccCccCCccccCC---CcccccccccccCCCCCcccccCCC
Q 005859 137 TNLQVLQLCYNKLTGNIPT----QLGSLRKLSVLALQYNQLTGAIPASLGDL---GMLMRLDLSFNNLFGPVPVKLANVP 209 (673)
Q Consensus 137 ~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L~l~~N~l~~~~p~~~~~l---~~L~~L~l~~N~l~~~~p~~~~~l~ 209 (673)
++|++|+|++|+++. ++. .+..+++|++|+|++|++++..|..+..+ ++|+.|+|++|+|+ .+|..+. +
T Consensus 197 ~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~ 272 (310)
T 4glp_A 197 PAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--A 272 (310)
T ss_dssp CCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--S
T ss_pred CCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--C
Confidence 999999999999973 333 35788999999999999998888888777 69999999999999 5677664 7
Q ss_pred CCCEEEccCCCCCc
Q 005859 210 KLEVLDIRNNSFSG 223 (673)
Q Consensus 210 ~L~~L~l~~N~l~g 223 (673)
+|+.|+|++|+|++
T Consensus 273 ~L~~L~Ls~N~l~~ 286 (310)
T 4glp_A 273 KLRVLDLSSNRLNR 286 (310)
T ss_dssp CCSCEECCSCCCCS
T ss_pred CCCEEECCCCcCCC
Confidence 99999999999997
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.1e-17 Score=174.82 Aligned_cols=161 Identities=29% Similarity=0.367 Sum_probs=121.9
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCC--CCcccccCCCCCcEe
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSG--KIPSQIGNMTNLQVL 142 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L 142 (673)
.++..|+|++|.++ .+|..+. ++|++|+|++|.+++..+..|..+++|+.|++++|.+.. ..+..|.++++|+.|
T Consensus 100 ~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L 176 (330)
T 1xku_A 100 VKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYI 176 (330)
T ss_dssp TTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEE
T ss_pred CCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEE
Confidence 36788888888887 5665554 788888888888887777778888888888888888853 567778888888888
Q ss_pred eccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCC
Q 005859 143 QLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFS 222 (673)
Q Consensus 143 ~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 222 (673)
++++|.++. +|..+. ++|++|++++|.+++..|..|..+++|+.|+|++|.+++..+..+..+++|+.|++++|+++
T Consensus 177 ~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (330)
T 1xku_A 177 RIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 253 (330)
T ss_dssp ECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS
T ss_pred ECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc
Confidence 888888874 555443 67888888888887777777888888888888888887766667777788888888888877
Q ss_pred cCCchhhhhc
Q 005859 223 GNVPPALKRL 232 (673)
Q Consensus 223 g~~p~~l~~~ 232 (673)
.+|..+..+
T Consensus 254 -~lp~~l~~l 262 (330)
T 1xku_A 254 -KVPGGLADH 262 (330)
T ss_dssp -SCCTTTTTC
T ss_pred -cCChhhccC
Confidence 566666544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=1.1e-17 Score=160.34 Aligned_cols=131 Identities=29% Similarity=0.358 Sum_probs=118.8
Q ss_pred EEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCc-ccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCc
Q 005859 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPK-EIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYN 147 (673)
Q Consensus 69 ~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 147 (673)
.++++++++ +.+|..+.. +|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 12 ~l~~s~~~l-~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 12 TVDCTGRGL-KEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCC-SSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCc-CcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 566677888 467876654 999999999999987775 4899999999999999999999999999999999999999
Q ss_pred cccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCc
Q 005859 148 KLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVP 202 (673)
Q Consensus 148 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 202 (673)
++++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|.+.+..+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 9999989899999999999999999999999999999999999999999987654
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=7.4e-18 Score=188.80 Aligned_cols=165 Identities=21% Similarity=0.329 Sum_probs=147.6
Q ss_pred CceEEeCCCCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccC
Q 005859 56 FDGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGN 135 (673)
Q Consensus 56 w~gv~c~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 135 (673)
|.|+ |+ +++++++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.+
T Consensus 6 ~~~~-c~---------~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~ 72 (549)
T 2z81_A 6 ASGV-CD---------GRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYS 72 (549)
T ss_dssp TTSE-EE---------CTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTT
T ss_pred CCce-EE---------CCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccc
Confidence 8888 74 3466776 5777664 89999999999999999999999999999999999999988899999
Q ss_pred CCCCcEeeccCccccccCchhhcCccccCeecccccccCc-cCCccccCCCcccccccccccCCCCCc-ccccCCCCCCE
Q 005859 136 MTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTG-AIPASLGDLGMLMRLDLSFNNLFGPVP-VKLANVPKLEV 213 (673)
Q Consensus 136 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~ 213 (673)
+++|++|+|++|++++..|..|+.+++|++|++++|.+++ ..|..++++++|+.|++++|.+.+.+| ..+.++++|+.
T Consensus 73 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~ 152 (549)
T 2z81_A 73 LGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNE 152 (549)
T ss_dssp CTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEE
T ss_pred cccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCe
Confidence 9999999999999998888889999999999999999986 467789999999999999999655555 68999999999
Q ss_pred EEccCCCCCcCCchhhhhcc
Q 005859 214 LDIRNNSFSGNVPPALKRLN 233 (673)
Q Consensus 214 L~l~~N~l~g~~p~~l~~~~ 233 (673)
|++++|.+++.+|..+..+.
T Consensus 153 L~L~~n~l~~~~~~~l~~l~ 172 (549)
T 2z81_A 153 LEIKALSLRNYQSQSLKSIR 172 (549)
T ss_dssp EEEEETTCCEECTTTTTTCS
T ss_pred eeccCCcccccChhhhhccc
Confidence 99999999999998887654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.72 E-value=3.8e-18 Score=189.80 Aligned_cols=162 Identities=27% Similarity=0.339 Sum_probs=135.1
Q ss_pred cCCCCCCCCCCCCC--CCceE-EeCCCCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCE
Q 005859 41 LTSWAPNADPCSSD--SFDGV-ACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSD 117 (673)
Q Consensus 41 l~~w~~~~~~C~~~--~w~gv-~c~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 117 (673)
+.+|..+.++|... .|.|+ .|. .++++.|+|++|+|++ +|..+ +++|++|+|++|+|+ .+| ..+++|++
T Consensus 33 l~~W~~~~~~~~~~~~~~~~l~~C~-~~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~ 104 (571)
T 3cvr_A 33 WDKWEKQALPGENRNEAVSLLKECL-INQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEY 104 (571)
T ss_dssp HHHHHTTCCTTCCHHHHHHHHHHHH-HTTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCE
T ss_pred HHHHhccCCccccccchhhhccccc-cCCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCE
Confidence 45676667788421 49999 685 3589999999999998 88766 389999999999999 566 55799999
Q ss_pred EEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccC
Q 005859 118 LYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNL 197 (673)
Q Consensus 118 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 197 (673)
|+|++|+|++ +|. |.+ +|+.|+|++|+|++ +|. .+++|+.|+|++|.|++ +|. .+++|+.|+|++|+|
T Consensus 105 L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L 172 (571)
T 3cvr_A 105 LDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQL 172 (571)
T ss_dssp EECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCC
T ss_pred EEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCC
Confidence 9999999997 777 665 99999999999997 666 68899999999999986 666 578999999999999
Q ss_pred CCCCcccccCCCCCCEEEccCCCCCcCCch
Q 005859 198 FGPVPVKLANVPKLEVLDIRNNSFSGNVPP 227 (673)
Q Consensus 198 ~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~ 227 (673)
++ +|. +. ++|+.|+|++|+|+ .+|.
T Consensus 173 ~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~ 197 (571)
T 3cvr_A 173 TF-LPE-LP--ESLEALDVSTNLLE-SLPA 197 (571)
T ss_dssp SC-CCC-CC--TTCCEEECCSSCCS-SCCC
T ss_pred CC-cch-hh--CCCCEEECcCCCCC-chhh
Confidence 87 666 65 89999999999998 5665
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.4e-17 Score=187.16 Aligned_cols=162 Identities=22% Similarity=0.291 Sum_probs=144.1
Q ss_pred CCCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCcc--CCcccCCCCCCCEEEccCCCCCCCCcc-cccCCCCC
Q 005859 63 ENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGV--IPKEIASLSELSDLYLNVNNLSGKIPS-QIGNMTNL 139 (673)
Q Consensus 63 ~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L 139 (673)
....++.|+|++|.+++.+|..+.++++|++|+|++|++++. +|..+..+++|++|+|++|++++.+|. .+..+++|
T Consensus 351 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L 430 (562)
T 3a79_B 351 SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430 (562)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTC
T ss_pred CCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccC
Confidence 345789999999999999999999999999999999999973 457799999999999999999985665 58899999
Q ss_pred cEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCC
Q 005859 140 QVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNN 219 (673)
Q Consensus 140 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 219 (673)
+.|+|++|++++.+|..+. ++|++|+|++|+++ .+|..+..+++|+.|+|++|++++..+..+..+++|+.|++++|
T Consensus 431 ~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N 507 (562)
T 3a79_B 431 LVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507 (562)
T ss_dssp CEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSC
T ss_pred CEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCC
Confidence 9999999999987776554 79999999999998 78888889999999999999999544444899999999999999
Q ss_pred CCCcCCch
Q 005859 220 SFSGNVPP 227 (673)
Q Consensus 220 ~l~g~~p~ 227 (673)
++.+..|.
T Consensus 508 ~~~c~c~~ 515 (562)
T 3a79_B 508 PWDCTCPG 515 (562)
T ss_dssp CBCCCHHH
T ss_pred CcCCCcch
Confidence 99987764
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.1e-18 Score=179.30 Aligned_cols=148 Identities=21% Similarity=0.211 Sum_probs=91.9
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.+++.|+|++|.+++..| +..+++|++|+|++|.+++.. ..++|++|++++|++++..+. .+++|+.|+|
T Consensus 58 ~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l 127 (317)
T 3o53_A 58 TKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYL 127 (317)
T ss_dssp TTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEEC
T ss_pred CcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEEC
Confidence 356667777776666544 666677777777777666432 124555555555555433222 2456777777
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccc-cCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCc
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASL-GDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 223 (673)
++|++++..|..+..+++|++|+|++|.+++..|..+ ..+++|+.|+|++|.+++. |. ...+++|+.|+|++|++++
T Consensus 128 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~ 205 (317)
T 3o53_A 128 ANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF 205 (317)
T ss_dssp CSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE
T ss_pred CCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc
Confidence 7777776666667777777777777777776655555 3567777777777777654 22 2346677777777777765
Q ss_pred C
Q 005859 224 N 224 (673)
Q Consensus 224 ~ 224 (673)
.
T Consensus 206 l 206 (317)
T 3o53_A 206 M 206 (317)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.9e-17 Score=155.01 Aligned_cols=133 Identities=24% Similarity=0.198 Sum_probs=88.7
Q ss_pred CCCCCeEeCcCCcCC-ccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCee
Q 005859 88 LKSLTGLYLHFNALN-GVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVL 166 (673)
Q Consensus 88 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 166 (673)
.++|+.|+|++|.++ +.+|..+..+++|+.|+|++|.+++. ..|..+++|++|+|++|++++.+|..+..+++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 356667777777766 56666666667777777777776654 556667777777777777766666666667777777
Q ss_pred cccccccCccC-CccccCCCcccccccccccCCCCCc---ccccCCCCCCEEEccCCCCC
Q 005859 167 ALQYNQLTGAI-PASLGDLGMLMRLDLSFNNLFGPVP---VKLANVPKLEVLDIRNNSFS 222 (673)
Q Consensus 167 ~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p---~~~~~l~~L~~L~l~~N~l~ 222 (673)
+|++|.+++.. +..+..+++|+.|++++|.+++..+ ..+..+++|+.|++++|.+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 77777776432 1566677777777777777765544 35667777777777777665
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.70 E-value=5.9e-17 Score=167.50 Aligned_cols=148 Identities=28% Similarity=0.420 Sum_probs=86.1
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.+++.|+|++|.+++..+ +..+++|++|+|++|.+++. +.+..+++|++|+|++|++++ +|. +..+++|+.|+|
T Consensus 63 ~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 136 (308)
T 1h6u_A 63 NNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYL 136 (308)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEEC
Confidence 345666666666654333 66666666666666666542 245666666666666666654 232 566666666666
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
++|++++..+ +..+++|+.|++++|.+++. +. +..+++|+.|++++|++++..+ +..+++|+.|++++|++++.
T Consensus 137 ~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~ 210 (308)
T 1h6u_A 137 DLNQITNISP--LAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDV 210 (308)
T ss_dssp CSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBC
T ss_pred CCCccCcCcc--ccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcc
Confidence 6666664322 55666666666666666542 22 5566666666666666654333 55566666666666666543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.70 E-value=7.8e-18 Score=185.37 Aligned_cols=172 Identities=23% Similarity=0.217 Sum_probs=133.0
Q ss_pred CCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEee
Q 005859 64 NGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143 (673)
Q Consensus 64 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 143 (673)
...+..|+|++|.+++..+ .++|++|+|++|.|++..+. .+++|+.|+|++|.+++..|..|+++++|+.|+
T Consensus 79 l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 150 (487)
T 3oja_A 79 LSTLRTLDLNNNYVQELLV-----GPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150 (487)
T ss_dssp CTTCCEEECCSSEEEEEEE-----CTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEE
T ss_pred CCCCCEEEecCCcCCCCCC-----CCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEE
Confidence 3578889999998886433 38889999999998876654 357888999999999888888888889999999
Q ss_pred ccCccccccCchhhc-CccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCC
Q 005859 144 LCYNKLTGNIPTQLG-SLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFS 222 (673)
Q Consensus 144 L~~N~l~~~~p~~l~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 222 (673)
|++|.+++..|..+. .+++|+.|+|++|.|++. |. +..+++|+.|+|++|.+++.+| .+..+++|+.|+|++|.|+
T Consensus 151 Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~ 227 (487)
T 3oja_A 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLV 227 (487)
T ss_dssp CTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCC
T ss_pred CCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCc
Confidence 999999888887776 788899999999998865 32 3458889999999999887544 4788888999999999988
Q ss_pred cCCchhhhhccC--CccccCcccccCC
Q 005859 223 GNVPPALKRLNG--GFQYDNNAALCGT 247 (673)
Q Consensus 223 g~~p~~l~~~~~--~~~~~~n~~~~~~ 247 (673)
+ +|..+..+.. .+.+.+|...|+.
T Consensus 228 ~-lp~~l~~l~~L~~L~l~~N~l~c~~ 253 (487)
T 3oja_A 228 L-IEKALRFSQNLEHFDLRGNGFHCGT 253 (487)
T ss_dssp E-ECTTCCCCTTCCEEECTTCCBCHHH
T ss_pred c-cchhhccCCCCCEEEcCCCCCcCcc
Confidence 6 6666554432 2345566666553
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.70 E-value=8.9e-17 Score=164.72 Aligned_cols=147 Identities=27% Similarity=0.372 Sum_probs=119.0
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.+++.|+++++++... + .+..+++|++|+|++|++++..+ +..+++|++|+|++|++++ +| .+..+++|+.|+|
T Consensus 46 ~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L 119 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (291)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred CcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEEC
Confidence 4578888888888754 3 47888888899998888887554 8888888999998888875 33 4888888899999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCc
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 223 (673)
++|++++. ..+..+++|+.|++++|++++. ..+..+++|+.|+|++|++++..| +..+++|+.|++++|.+++
T Consensus 120 ~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~ 192 (291)
T 1h6t_A 120 EHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 192 (291)
T ss_dssp TTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred CCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC
Confidence 88888863 4688888888899988888864 568888888888888888887655 7888888889998888876
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.7e-17 Score=152.01 Aligned_cols=129 Identities=21% Similarity=0.199 Sum_probs=93.6
Q ss_pred CCCCCeEeCcCCcCC-ccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCee
Q 005859 88 LKSLTGLYLHFNALN-GVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVL 166 (673)
Q Consensus 88 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 166 (673)
.++|+.|++++|.++ +.+|..+..+++|++|++++|.+++. ..++.+++|++|+|++|++++.+|..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 366777777777777 66777777777777777777777754 667777777777777777776677777777777777
Q ss_pred cccccccCcc-CCccccCCCcccccccccccCCCCCc---ccccCCCCCCEEEccC
Q 005859 167 ALQYNQLTGA-IPASLGDLGMLMRLDLSFNNLFGPVP---VKLANVPKLEVLDIRN 218 (673)
Q Consensus 167 ~l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p---~~~~~l~~L~~L~l~~ 218 (673)
++++|.+++. .|..+..+++|+.|++++|.+++..+ ..+..+++|+.|++++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 7777777753 33667777777777777777776555 4567777788777753
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.3e-16 Score=152.97 Aligned_cols=110 Identities=23% Similarity=0.376 Sum_probs=67.3
Q ss_pred CCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccc
Q 005859 114 ELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLS 193 (673)
Q Consensus 114 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 193 (673)
+|++|+|++|+|+ .+|..|.++++|+.|+|++|++++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|+
T Consensus 32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~ 110 (193)
T 2wfh_A 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH 110 (193)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence 4555555555554 444555555555555555555555555555556666666666666665555556666666666666
Q ss_pred cccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 194 FNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 194 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
+|+|+...+..|..+++|+.|+|++|++...
T Consensus 111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 111 GNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 6666655555667777788888888887653
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.69 E-value=4.8e-17 Score=152.32 Aligned_cols=136 Identities=24% Similarity=0.178 Sum_probs=122.8
Q ss_pred CCEEEEEecCCCcc-cccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEee
Q 005859 65 GRVANISLQGKGLS-GEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143 (673)
Q Consensus 65 ~~v~~l~l~~~~l~-g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 143 (673)
.+++.|+|++|+++ |.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 57899999999998 89999999999999999999999976 7899999999999999999988899898999999999
Q ss_pred ccCccccccC-chhhcCccccCeecccccccCccCC---ccccCCCcccccccccccCCCCCcc
Q 005859 144 LCYNKLTGNI-PTQLGSLRKLSVLALQYNQLTGAIP---ASLGDLGMLMRLDLSFNNLFGPVPV 203 (673)
Q Consensus 144 L~~N~l~~~~-p~~l~~l~~L~~L~l~~N~l~~~~p---~~~~~l~~L~~L~l~~N~l~~~~p~ 203 (673)
|++|++++.. +..+..+++|++|++++|.+++..+ ..+..+++|+.|++++|.+.. +|.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~-~~~ 164 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE-APD 164 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB-CCS
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh-ccc
Confidence 9999999642 2789999999999999999996655 479999999999999999874 443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.68 E-value=8.7e-17 Score=164.80 Aligned_cols=148 Identities=30% Similarity=0.415 Sum_probs=132.5
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.+++.|+|++|.+++..+ +.++++|++|+|++|.+++ +| .+..+++|++|+|++|++++. +.+..+++|+.|+|
T Consensus 68 ~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l 141 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYL 141 (291)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEEC
T ss_pred CCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEc
Confidence 578999999999998655 9999999999999999986 33 499999999999999999964 56899999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|+|++|.+++. | .+..+++|+.|++++|+++..
T Consensus 142 ~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 142 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEECC
T ss_pred cCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccCC
Confidence 99999965 679999999999999999997554 99999999999999999864 4 488999999999999999863
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.68 E-value=1.6e-16 Score=164.14 Aligned_cols=150 Identities=30% Similarity=0.465 Sum_probs=132.5
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.+++.|+++++++.. +| .+..+++|++|+|++|.+++..+ +..+++|++|+|++|++++ +| .+..+++|+.|+|
T Consensus 41 ~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l 114 (308)
T 1h6u_A 41 DGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDL 114 (308)
T ss_dssp HTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEEC
T ss_pred CCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEEC
Confidence 478999999999885 45 68999999999999999997555 9999999999999999986 34 6999999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
++|++++ ++. +..+++|++|++++|.+++..+ +..+++|+.|+|++|++++..+ +..+++|+.|++++|++++.
T Consensus 115 ~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~ 188 (308)
T 1h6u_A 115 TSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDI 188 (308)
T ss_dssp TTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC
T ss_pred CCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcC
Confidence 9999996 443 9999999999999999986543 8899999999999999997544 88999999999999999875
Q ss_pred Cc
Q 005859 225 VP 226 (673)
Q Consensus 225 ~p 226 (673)
.+
T Consensus 189 ~~ 190 (308)
T 1h6u_A 189 SP 190 (308)
T ss_dssp GG
T ss_pred hh
Confidence 44
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.68 E-value=2.1e-17 Score=171.70 Aligned_cols=139 Identities=21% Similarity=0.231 Sum_probs=78.5
Q ss_pred CCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccc-cCCCCCcEeeccCccccccCchhhcCccccCee
Q 005859 88 LKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVL 166 (673)
Q Consensus 88 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 166 (673)
+++|++|+|++|++++..|..+..+++|++|+|++|.+++..|..+ ..+++|++|+|++|++++. |. ...+++|++|
T Consensus 119 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L 196 (317)
T 3o53_A 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTL 196 (317)
T ss_dssp CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEE
T ss_pred cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEE
Confidence 4555566666666655555555556666666666666665444444 2456666666666666543 21 2235566666
Q ss_pred cccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCC-cCCchhhh
Q 005859 167 ALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFS-GNVPPALK 230 (673)
Q Consensus 167 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-g~~p~~l~ 230 (673)
+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|++. +.+|..+.
T Consensus 197 ~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~ 259 (317)
T 3o53_A 197 DLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259 (317)
T ss_dssp ECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHH
T ss_pred ECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHh
Confidence 666666653 3334556666666666666665 34555556666666666666665 44444443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.9e-16 Score=149.59 Aligned_cols=114 Identities=24% Similarity=0.266 Sum_probs=67.2
Q ss_pred CCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecc
Q 005859 89 KSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLAL 168 (673)
Q Consensus 89 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l 168 (673)
++|+.|+|++|++++..+..|..+++|++|+|++|++++..+. .|..+++|++|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~------------------------~~~~l~~L~~L~l 83 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDG------------------------VFDKLTKLTILYL 83 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT------------------------TTTTCTTCCEEEC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChh------------------------HccCCCccCEEEC
Confidence 4556666666666554444455555555555555555543333 3444555555555
Q ss_pred cccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCc
Q 005859 169 QYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVP 226 (673)
Q Consensus 169 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p 226 (673)
++|.+++..+..|..+++|+.|+|++|++++..+..+..+++|+.|++++|++.+..|
T Consensus 84 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 84 HENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 5555554444445556666666666666665555556677888888888888887665
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.1e-16 Score=178.21 Aligned_cols=147 Identities=22% Similarity=0.292 Sum_probs=82.6
Q ss_pred CEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeecc
Q 005859 66 RVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLC 145 (673)
Q Consensus 66 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 145 (673)
.+..|+|++|.|++ +|. +.+ +|++|+|++|.|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|+
T Consensus 101 ~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 168 (571)
T 3cvr_A 101 SLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVR 168 (571)
T ss_dssp TCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred CCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECC
Confidence 34445555555544 444 333 55555555555554 333 34555555555555554 343 34566666666
Q ss_pred CccccccCchhhcCccccCeecccccccCccCCccccCCCcc-------cccccccccCCCCCcccccCCCCCCEEEccC
Q 005859 146 YNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGML-------MRLDLSFNNLFGPVPVKLANVPKLEVLDIRN 218 (673)
Q Consensus 146 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L-------~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 218 (673)
+|+|++ +|. |. ++|+.|+|++|+|+ .+|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++
T Consensus 169 ~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~ 239 (571)
T 3cvr_A 169 NNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILED 239 (571)
T ss_dssp SSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCS
T ss_pred CCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeC
Confidence 666664 444 44 56666666666666 4554 443 55 66777777766 3555555677777777777
Q ss_pred CCCCcCCchhhhhcc
Q 005859 219 NSFSGNVPPALKRLN 233 (673)
Q Consensus 219 N~l~g~~p~~l~~~~ 233 (673)
|+|++.+|..+..+.
T Consensus 240 N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 240 NPLSSRIRESLSQQT 254 (571)
T ss_dssp SSCCHHHHHHHHHHH
T ss_pred CcCCCcCHHHHHHhh
Confidence 777777776666543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.68 E-value=4.4e-18 Score=196.04 Aligned_cols=164 Identities=25% Similarity=0.270 Sum_probs=126.4
Q ss_pred CEEEEEecCCCccc---------ccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCC
Q 005859 66 RVANISLQGKGLSG---------EIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNM 136 (673)
Q Consensus 66 ~v~~l~l~~~~l~g---------~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 136 (673)
.+..++|+.+.|.+ ..|..+..++.|+.|+|++|.|. .+|..+..+++|++|+|++|.|+ .+|..|++|
T Consensus 192 ~l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l 269 (727)
T 4b8c_D 192 LLQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNL 269 (727)
T ss_dssp ------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGG
T ss_pred HhhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCC
Confidence 34455555555444 34778999999999999999998 67888889999999999999999 889999999
Q ss_pred CCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCC-CCEEE
Q 005859 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPK-LEVLD 215 (673)
Q Consensus 137 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~-L~~L~ 215 (673)
++|++|+|++|+|+ .+|..|+.|++|++|+|++|.|+ .+|..|+.+++|+.|+|++|.|++.+|..+..+.. +..|+
T Consensus 270 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~ 347 (727)
T 4b8c_D 270 SNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFY 347 (727)
T ss_dssp TTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHH
T ss_pred CCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHh
Confidence 99999999999999 78999999999999999999997 78888999999999999999999998887765422 23478
Q ss_pred ccCCCCCcCCchhhhhcc
Q 005859 216 IRNNSFSGNVPPALKRLN 233 (673)
Q Consensus 216 l~~N~l~g~~p~~l~~~~ 233 (673)
|++|.++|.+|..+..+.
T Consensus 348 l~~N~l~~~~p~~l~~l~ 365 (727)
T 4b8c_D 348 LRDNRPEIPLPHERRFIE 365 (727)
T ss_dssp HHHCCCCCCCCCC-----
T ss_pred hccCcccCcCccccceeE
Confidence 999999999999876553
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=2.2e-16 Score=149.16 Aligned_cols=124 Identities=23% Similarity=0.267 Sum_probs=109.5
Q ss_pred CCceEEeCCC----------CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCC
Q 005859 55 SFDGVACDEN----------GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNN 124 (673)
Q Consensus 55 ~w~gv~c~~~----------~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 124 (673)
.|.+|.|+.. ..++.|++++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus 8 ~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 87 (177)
T 2o6r_A 8 SGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87 (177)
T ss_dssp ETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence 4999999742 368999999999998777788999999999999999998888889999999999999999
Q ss_pred CCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCC
Q 005859 125 LSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIP 178 (673)
Q Consensus 125 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 178 (673)
+++..+..|..+++|+.|+|++|++++..+..|..+++|++|+|++|.+.+..|
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 88 LQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 998777788999999999999999997666667889999999999998886544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.6e-17 Score=173.80 Aligned_cols=147 Identities=14% Similarity=0.160 Sum_probs=104.0
Q ss_pred HHHHHHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCC-------------CcHHHH--------HHHHHHH
Q 005859 395 EEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCK-------------SDEGEF--------LKGLKIL 453 (673)
Q Consensus 395 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------~~~~~~--------~~E~~~l 453 (673)
..+.....-|++...||+|+||.||+|...+|+.||||+++..... ...... .+|...|
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 4444444558999999999999999999989999999987643110 011122 3456666
Q ss_pred hccCCCCceeEeeEEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCc
Q 005859 454 TSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNL 533 (673)
Q Consensus 454 ~~l~H~niv~l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDl 533 (673)
.++.+.++.-..-+.. ...+|||||++|+.|.++... .....++.|++.+|.|||.+ |||||||
T Consensus 168 ~rL~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~--gIVHrDL 231 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH--GLIHGDF 231 (397)
T ss_dssp HHHHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT--TEECSCC
T ss_pred HHHHhcCCCCCeeeec----cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC--CCcCCCC
Confidence 6665444321111111 123699999999888765531 12346789999999999987 8999999
Q ss_pred CCCCeEecCCCC----------eeeccccccccc
Q 005859 534 SAEKVLIHRRYN----------PLLSDSGLHKLL 557 (673)
Q Consensus 534 k~~NILl~~~~~----------~kl~DfGla~~~ 557 (673)
||.|||+++++. +.|+||+-+-..
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999999988763 789999977544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=5.5e-17 Score=148.63 Aligned_cols=128 Identities=23% Similarity=0.201 Sum_probs=117.3
Q ss_pred CCEEEEEecCCCcc-cccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEee
Q 005859 65 GRVANISLQGKGLS-GEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143 (673)
Q Consensus 65 ~~v~~l~l~~~~l~-g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 143 (673)
.+++.|++++|+++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 46889999999999 89999999999999999999999976 7899999999999999999988999999999999999
Q ss_pred ccCcccccc-CchhhcCccccCeecccccccCccCC---ccccCCCccccccccc
Q 005859 144 LCYNKLTGN-IPTQLGSLRKLSVLALQYNQLTGAIP---ASLGDLGMLMRLDLSF 194 (673)
Q Consensus 144 L~~N~l~~~-~p~~l~~l~~L~~L~l~~N~l~~~~p---~~~~~l~~L~~L~l~~ 194 (673)
+++|++++. .+..+..+++|++|++++|.+++..+ ..+..+++|+.|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999974 45889999999999999999997665 5789999999999874
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.8e-16 Score=159.89 Aligned_cols=147 Identities=24% Similarity=0.323 Sum_probs=128.2
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.+++.|++++|+++. +| .+..+++|++|+|++|+|++..+ +..+++|++|+|++|++++ +|.. .. ++|+.|+|
T Consensus 41 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L 113 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFL 113 (263)
T ss_dssp TTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEEC
T ss_pred CcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEc
Confidence 468899999999884 55 68999999999999999997655 9999999999999999996 4443 33 99999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
++|++++. + .+..+++|++|+|++|++++. | .+..+++|+.|+|++|++++. ..+..+++|+.|++++|++++.
T Consensus 114 ~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 114 DNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred cCCccCCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 99999963 4 699999999999999999864 4 688999999999999999876 6788999999999999999875
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.1e-16 Score=177.70 Aligned_cols=148 Identities=31% Similarity=0.428 Sum_probs=119.1
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..+..|+|++|.|++..| +..|++|+.|+|++|.|++ +| .+..+++|+.|+|++|++++ + +.+..|++|+.|+|
T Consensus 65 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~L 138 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 138 (605)
T ss_dssp TTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEEC
T ss_pred CCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEEC
Confidence 467888888888887555 8888888888888888875 33 68888888888888888885 3 45788888888888
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
++|++++. ..|..+++|+.|+|++|.|++..| +..+++|+.|+|++|+|++. | .+..+++|+.|+|++|++++.
T Consensus 139 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 139 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEECC
T ss_pred CCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCcCcCC
Confidence 88888864 568888888888888888886655 88888888888888888764 3 577888888888888888764
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.65 E-value=2.3e-16 Score=166.12 Aligned_cols=171 Identities=21% Similarity=0.134 Sum_probs=122.7
Q ss_pred CCceEEeCCC----------CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCC-cccCCCCCCCE-EEccC
Q 005859 55 SFDGVACDEN----------GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIP-KEIASLSELSD-LYLNV 122 (673)
Q Consensus 55 ~w~gv~c~~~----------~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~l~~ 122 (673)
.|..|.|+.. ..++.|+|++|.|+...+..|.+|++|++|+|++|++.+.+| ..|.++++|.. +.++.
T Consensus 10 ~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 10 SNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp ETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred eCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 4888999632 368999999999996656689999999999999999977665 46889988875 66778
Q ss_pred CCCCCCCcccccCCCCCcEeeccCccccccCchhhcCcc--------------------------ccCeecccccccCcc
Q 005859 123 NNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLR--------------------------KLSVLALQYNQLTGA 176 (673)
Q Consensus 123 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~--------------------------~L~~L~l~~N~l~~~ 176 (673)
|+++...|..|..+++|++|++++|++++..+..+.... .|+.|+|++|+|+.
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~- 168 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE- 168 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-
T ss_pred CcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC-
Confidence 999988888999999999999999998855443333322 35556666666663
Q ss_pred CCccccCCCccccccccc-ccCCCCCcccccCCCCCCEEEccCCCCCcCCc
Q 005859 177 IPASLGDLGMLMRLDLSF-NNLFGPVPVKLANVPKLEVLDIRNNSFSGNVP 226 (673)
Q Consensus 177 ~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p 226 (673)
+|.......+|+.|++++ |.++...+..|.++++|+.|||++|+|+...+
T Consensus 169 i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~ 219 (350)
T 4ay9_X 169 IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 219 (350)
T ss_dssp ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCS
T ss_pred CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccCh
Confidence 344333445666666654 44443333456667777777777777764333
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=5e-16 Score=148.87 Aligned_cols=127 Identities=29% Similarity=0.456 Sum_probs=114.4
Q ss_pred EEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCcc
Q 005859 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNK 148 (673)
Q Consensus 69 ~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 148 (673)
.+++++++++ .+|..+. ++|++|+|++|+|+ .+|..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 4667778877 5776553 68999999999998 678999999999999999999998888899999999999999999
Q ss_pred ccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCC
Q 005859 149 LTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFG 199 (673)
Q Consensus 149 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 199 (673)
+++..|..|..+++|++|+|++|.|++..+..|..+++|+.|+|++|.+..
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 999888899999999999999999997666679999999999999999864
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.65 E-value=3.1e-16 Score=150.95 Aligned_cols=136 Identities=21% Similarity=0.285 Sum_probs=121.9
Q ss_pred cccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCcccc
Q 005859 84 AVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKL 163 (673)
Q Consensus 84 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 163 (673)
....+++|+.|+|++|.++ .+| .+..+++|++|++++|.++ .++.+..+++|++|++++|++++..|..|+.+++|
T Consensus 39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 114 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114 (197)
T ss_dssp BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence 3467899999999999998 556 6999999999999999775 34579999999999999999998889999999999
Q ss_pred CeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 164 SVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 164 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
++|++++|++++..|..+..+++|+.|++++|.+.+.+| .+..+++|+.|++++|++++.
T Consensus 115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~ 174 (197)
T 4ezg_A 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY 174 (197)
T ss_dssp CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCC
T ss_pred CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcCh
Confidence 999999999998889999999999999999998334556 688999999999999999873
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.9e-16 Score=172.21 Aligned_cols=154 Identities=29% Similarity=0.452 Sum_probs=133.3
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..+..|++++|.+++. +.+..+++|+.|+|++|.+++..| +..+++|+.|++++|.+++..| +..+++|+.|+|
T Consensus 221 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L 294 (466)
T 1o6v_A 221 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLEL 294 (466)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred CCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEc
Confidence 4688999999998864 468899999999999999997655 8899999999999999996544 889999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
++|++++..| +..+++|+.|++++|++++..| +..+++|+.|++++|.+++. ..+.++++|+.|++++|++++.
T Consensus 295 ~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~ 368 (466)
T 1o6v_A 295 NENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDL 368 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBC
T ss_pred CCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCcc
Confidence 9999997544 8899999999999999997665 78899999999999999875 4688999999999999999988
Q ss_pred Cchhhhhc
Q 005859 225 VPPALKRL 232 (673)
Q Consensus 225 ~p~~l~~~ 232 (673)
.| +..+
T Consensus 369 ~~--~~~l 374 (466)
T 1o6v_A 369 TP--LANL 374 (466)
T ss_dssp GG--GTTC
T ss_pred ch--hhcC
Confidence 77 4444
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.65 E-value=4.7e-16 Score=174.82 Aligned_cols=154 Identities=28% Similarity=0.390 Sum_probs=135.6
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.+++.|+|+++.+.. +| .|..|++|+.|+|++|.|++..| +..+++|+.|+|++|++++ +| .|..+++|+.|+|
T Consensus 43 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~L 116 (605)
T 1m9s_A 43 NSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSL 116 (605)
T ss_dssp TTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEe
Confidence 467889999999875 34 58999999999999999998665 9999999999999999985 34 7999999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
++|++++ + ..+..+++|+.|+|++|.|++. ..+..+++|+.|+|++|.|++..| +..+++|+.|+|++|+|++.
T Consensus 117 s~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l 190 (605)
T 1m9s_A 117 EHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL 190 (605)
T ss_dssp TTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC
T ss_pred cCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC
Confidence 9999996 3 4699999999999999999965 679999999999999999998777 89999999999999999974
Q ss_pred Cchhhhhc
Q 005859 225 VPPALKRL 232 (673)
Q Consensus 225 ~p~~l~~~ 232 (673)
| .+..+
T Consensus 191 -~-~l~~l 196 (605)
T 1m9s_A 191 -R-ALAGL 196 (605)
T ss_dssp -G-GGTTC
T ss_pred -h-HHccC
Confidence 3 45444
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.64 E-value=4.3e-16 Score=163.78 Aligned_cols=152 Identities=22% Similarity=0.312 Sum_probs=135.3
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..+..|++++|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++. |. +..+++|++|++
T Consensus 177 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l 250 (347)
T 4fmz_A 177 TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL-SP-LANLSQLTWLEI 250 (347)
T ss_dssp TTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEEC
T ss_pred CCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCC-cc-hhcCCCCCEEEC
Confidence 468899999999986544 8899999999999999987655 88999999999999999964 44 899999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
++|.+++. ..+..+++|++|++++|.+++. +.+..+++|+.|++++|.+++..|..+..+++|+.|++++|++++.
T Consensus 251 ~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 326 (347)
T 4fmz_A 251 GTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326 (347)
T ss_dssp CSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCC
T ss_pred CCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccc
Confidence 99999963 5689999999999999999864 4588999999999999999988888999999999999999999987
Q ss_pred Cc
Q 005859 225 VP 226 (673)
Q Consensus 225 ~p 226 (673)
.|
T Consensus 327 ~~ 328 (347)
T 4fmz_A 327 RP 328 (347)
T ss_dssp GG
T ss_pred cC
Confidence 66
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=5.4e-18 Score=189.46 Aligned_cols=154 Identities=21% Similarity=0.227 Sum_probs=128.8
Q ss_pred EEEEEecCCCcccccCccccCCCCCCeEeCcCCc-------------CCccCCcccCCC---------------------
Q 005859 67 VANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNA-------------LNGVIPKEIASL--------------------- 112 (673)
Q Consensus 67 v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l--------------------- 112 (673)
+..|+|++|.|+ .+|..+++|++|+.|++++|. +.+.+|..++.+
T Consensus 351 L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~L~~l~ 429 (567)
T 1dce_A 351 LFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKF 429 (567)
T ss_dssp SSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHHHHHHH
T ss_pred ceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccchhhhhh
Confidence 335667777775 788899999999999987775 445555433221
Q ss_pred -----------CCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccc
Q 005859 113 -----------SELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASL 181 (673)
Q Consensus 113 -----------~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~ 181 (673)
..|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|++ +| .+
T Consensus 430 l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l 504 (567)
T 1dce_A 430 LLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GV 504 (567)
T ss_dssp HHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GG
T ss_pred hhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-cc
Confidence 257789999999996 676 999999999999999999 789999999999999999999996 67 89
Q ss_pred cCCCcccccccccccCCCCC-cccccCCCCCCEEEccCCCCCcCCc
Q 005859 182 GDLGMLMRLDLSFNNLFGPV-PVKLANVPKLEVLDIRNNSFSGNVP 226 (673)
Q Consensus 182 ~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~g~~p 226 (673)
+.+++|+.|+|++|+|++.. |..+..+++|+.|+|++|+|++.+|
T Consensus 505 ~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 505 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp TTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 99999999999999999887 8899999999999999999998765
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.3e-15 Score=166.99 Aligned_cols=154 Identities=32% Similarity=0.437 Sum_probs=135.5
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..+..|++++|.+++..| ++.+++|+.|+|++|.+++. +.+..+++|+.|++++|.+++..| +..+++|+.|++
T Consensus 199 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l 272 (466)
T 1o6v_A 199 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 272 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred CCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEEC
Confidence 578999999999998766 78899999999999999864 468899999999999999997655 899999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
++|.+++..+ +..+++|+.|++++|++++..| +..+++|+.|+|++|++++..| +..+++|+.|++++|++++.
T Consensus 273 ~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 273 GANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp CSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred CCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc
Confidence 9999997544 8999999999999999997544 8899999999999999998776 77899999999999999985
Q ss_pred Cchhhhhc
Q 005859 225 VPPALKRL 232 (673)
Q Consensus 225 ~p~~l~~~ 232 (673)
+.+..+
T Consensus 347 --~~l~~l 352 (466)
T 1o6v_A 347 --SSLANL 352 (466)
T ss_dssp --GGGTTC
T ss_pred --hhhccC
Confidence 344443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.63 E-value=9.5e-16 Score=161.13 Aligned_cols=158 Identities=26% Similarity=0.395 Sum_probs=138.9
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..+..|+++++.+.+..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|.+.+..+ +..+++|+.|++
T Consensus 155 ~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l 228 (347)
T 4fmz_A 155 TGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKI 228 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEEC
T ss_pred CCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEc
Confidence 478899999999886554 8899999999999999986544 8899999999999999996544 899999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
++|++++..+ +..+++|++|++++|.+++. ..+..+++|+.|++++|.+++. ..+..+++|+.|++++|++++.
T Consensus 229 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~ 302 (347)
T 4fmz_A 229 GNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNE 302 (347)
T ss_dssp CSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGG
T ss_pred cCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCc
Confidence 9999996443 89999999999999999863 4689999999999999999875 3588899999999999999999
Q ss_pred CchhhhhccC
Q 005859 225 VPPALKRLNG 234 (673)
Q Consensus 225 ~p~~l~~~~~ 234 (673)
.|..+..+..
T Consensus 303 ~~~~l~~l~~ 312 (347)
T 4fmz_A 303 DMEVIGGLTN 312 (347)
T ss_dssp GHHHHHTCTT
T ss_pred ChhHhhcccc
Confidence 8888876653
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.62 E-value=4.7e-17 Score=170.32 Aligned_cols=167 Identities=18% Similarity=0.198 Sum_probs=124.5
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCcc-CCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEee
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGV-IPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 143 (673)
..++.+++++|.+.+..+. +..+++|++|+|++|.+++. +|..+..+++|++|+|++|.+++..|..++.+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 4567777777777776555 55688888888888887765 777778888888888888888777777788888888888
Q ss_pred ccCc-cccc-cCchhhcCccccCeeccccc-ccCcc-CCccccCCC-cccccccccc--cCC-CCCcccccCCCCCCEEE
Q 005859 144 LCYN-KLTG-NIPTQLGSLRKLSVLALQYN-QLTGA-IPASLGDLG-MLMRLDLSFN--NLF-GPVPVKLANVPKLEVLD 215 (673)
Q Consensus 144 L~~N-~l~~-~~p~~l~~l~~L~~L~l~~N-~l~~~-~p~~~~~l~-~L~~L~l~~N--~l~-~~~p~~~~~l~~L~~L~ 215 (673)
|++| .+++ .++..+..+++|++|++++| .+++. ++..+..++ +|+.|+|++| .++ +.+|..+..+++|+.|+
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~ 228 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEE
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEe
Confidence 8888 5665 25666777888888888888 77754 566677788 8888888888 444 34566667788888888
Q ss_pred ccCCC-CCcCCchhhhhc
Q 005859 216 IRNNS-FSGNVPPALKRL 232 (673)
Q Consensus 216 l~~N~-l~g~~p~~l~~~ 232 (673)
+++|. +++..+..+..+
T Consensus 229 l~~~~~l~~~~~~~l~~l 246 (336)
T 2ast_B 229 LSDSVMLKNDCFQEFFQL 246 (336)
T ss_dssp CTTCTTCCGGGGGGGGGC
T ss_pred CCCCCcCCHHHHHHHhCC
Confidence 88887 666666666544
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.62 E-value=4e-15 Score=162.26 Aligned_cols=150 Identities=21% Similarity=0.251 Sum_probs=113.3
Q ss_pred ceEEeCCCCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCC
Q 005859 57 DGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNM 136 (673)
Q Consensus 57 ~gv~c~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 136 (673)
.++......+++.|+|++|.+++. | ++++++|++|+|++|++++. | ++.+++|++|++++|++++. | ++++
T Consensus 77 ~~~~~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l 147 (457)
T 3bz5_A 77 TTLDLSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHN 147 (457)
T ss_dssp SCCCCTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTC
T ss_pred CeEccccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccC
Confidence 333333345788999999999884 3 88999999999999999874 4 88899999999999999874 3 7778
Q ss_pred CCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEc
Q 005859 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDI 216 (673)
Q Consensus 137 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 216 (673)
++|++|++++|+..+.+ .+..+++|++|++++|++++ +| ++.+++|+.|++++|++++. .+..+++|+.|++
T Consensus 148 ~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~L 219 (457)
T 3bz5_A 148 TQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDC 219 (457)
T ss_dssp TTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEEC
T ss_pred CcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEEC
Confidence 88888888888655555 36677777888888877775 44 66777777777777777764 3666777777777
Q ss_pred cCCCCCc
Q 005859 217 RNNSFSG 223 (673)
Q Consensus 217 ~~N~l~g 223 (673)
++|++++
T Consensus 220 s~N~l~~ 226 (457)
T 3bz5_A 220 SSNKLTE 226 (457)
T ss_dssp CSSCCSC
T ss_pred cCCcccc
Confidence 7777776
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2.5e-18 Score=165.81 Aligned_cols=131 Identities=26% Similarity=0.310 Sum_probs=68.2
Q ss_pred EEEEEecCCCcccccCc------cccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCc
Q 005859 67 VANISLQGKGLSGEIPA------AVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQ 140 (673)
Q Consensus 67 v~~l~l~~~~l~g~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 140 (673)
++.++++.+.++|.+|. .+..+++|++|+|++|.+++ +| .+..+++|++|++++|+++ .+|..+..+++|+
T Consensus 20 l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~ 96 (198)
T 1ds9_A 20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96 (198)
T ss_dssp CCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCS
T ss_pred ccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCC
Confidence 33344444444444444 55555555555555555554 34 5555555555555555555 4455555555555
Q ss_pred EeeccCccccccCchhhcCccccCeecccccccCccCC-ccccCCCcccccccccccCCCCCc
Q 005859 141 VLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIP-ASLGDLGMLMRLDLSFNNLFGPVP 202 (673)
Q Consensus 141 ~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p 202 (673)
+|+|++|++++ +| .+..+++|++|++++|++++..+ ..+..+++|+.|++++|.+.+.+|
T Consensus 97 ~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 157 (198)
T 1ds9_A 97 ELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp EEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred EEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccc
Confidence 55555555553 23 45555555555555555553211 245555555555555555544433
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.60 E-value=4.4e-15 Score=161.97 Aligned_cols=143 Identities=20% Similarity=0.244 Sum_probs=110.7
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.+++.|+|++|++++. | .++.+++|++|+|++|+|++. | ++.+++|++|++++|++++. | ++++++|++|+|
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNC 113 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEEC
Confidence 4677888888888864 4 688888888888888888874 3 78888888888888888864 3 778888888888
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCc
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 223 (673)
++|++++ +| ++.+++|++|++++|++++. + ++.+++|+.|++++|+..+.+ .+..+++|+.|++++|++++
T Consensus 114 ~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~ 184 (457)
T 3bz5_A 114 DTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE 184 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC
T ss_pred CCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce
Confidence 8888886 44 77888888888888888763 3 777788888888888655555 36677788888888888776
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.60 E-value=8.6e-17 Score=168.28 Aligned_cols=156 Identities=19% Similarity=0.188 Sum_probs=140.2
Q ss_pred CCEEEEEecCCCcccc-cCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCC-CCCCC-CcccccCCCCCcE
Q 005859 65 GRVANISLQGKGLSGE-IPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVN-NLSGK-IPSQIGNMTNLQV 141 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~l~~L~~ 141 (673)
.+++.|+|++|.+++. +|..+..+++|++|+|++|.+++..|..+..+++|++|+|++| .+++. +|..+.++++|+.
T Consensus 93 ~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~ 172 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 172 (336)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCE
Confidence 5789999999999877 8888999999999999999999888999999999999999999 78753 6777899999999
Q ss_pred eeccCc-ccccc-CchhhcCcc-ccCeeccccc--ccC-ccCCccccCCCccccccccccc-CCCCCcccccCCCCCCEE
Q 005859 142 LQLCYN-KLTGN-IPTQLGSLR-KLSVLALQYN--QLT-GAIPASLGDLGMLMRLDLSFNN-LFGPVPVKLANVPKLEVL 214 (673)
Q Consensus 142 L~L~~N-~l~~~-~p~~l~~l~-~L~~L~l~~N--~l~-~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L 214 (673)
|+|++| .+++. ++..+..++ +|++|++++| .++ +.+|..+..+++|+.|++++|. +++..+..+..+++|+.|
T Consensus 173 L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L 252 (336)
T 2ast_B 173 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 252 (336)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred EcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEe
Confidence 999999 99864 677889999 9999999999 555 5677788899999999999999 777778889999999999
Q ss_pred EccCCC
Q 005859 215 DIRNNS 220 (673)
Q Consensus 215 ~l~~N~ 220 (673)
++++|.
T Consensus 253 ~l~~~~ 258 (336)
T 2ast_B 253 SLSRCY 258 (336)
T ss_dssp ECTTCT
T ss_pred eCCCCC
Confidence 999996
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.9e-15 Score=152.30 Aligned_cols=145 Identities=24% Similarity=0.291 Sum_probs=123.9
Q ss_pred EEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccC
Q 005859 67 VANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCY 146 (673)
Q Consensus 67 v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 146 (673)
++.+++.++.+++.. .+..+++|++|++++|.++. +| .+..+++|++|+|++|++++..| +.++++|+.|+|++
T Consensus 21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~ 94 (263)
T 1xeu_A 21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNR 94 (263)
T ss_dssp HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCS
T ss_pred HHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCC
Confidence 445567777777544 57889999999999999985 45 68999999999999999996544 99999999999999
Q ss_pred ccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 147 NKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 147 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
|++++ +|.. .. ++|++|+|++|++++ ++ .+..+++|+.|+|++|++++. + .+..+++|+.|++++|++++.
T Consensus 95 N~l~~-l~~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 95 NRLKN-LNGI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp SCCSC-CTTC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred CccCC-cCcc-cc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence 99996 4443 33 899999999999996 44 699999999999999999875 4 688999999999999999976
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.59 E-value=6.8e-16 Score=145.65 Aligned_cols=133 Identities=17% Similarity=0.143 Sum_probs=104.4
Q ss_pred cccCCCCCCeEeCcCCcCCccCCcccCCCC-CCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccc
Q 005859 84 AVGGLKSLTGLYLHFNALNGVIPKEIASLS-ELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRK 162 (673)
Q Consensus 84 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 162 (673)
.+.++++|+.|+|++|.++. +|. +..+. +|++|+|++|.+++. ..|..+++|++|+|++|++++..+..|..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 45677888888888888884 454 44444 888888888888864 57888888888888888888665566688888
Q ss_pred cCeecccccccCccCCc--cccCCCcccccccccccCCCCCcc----cccCCCCCCEEEccCCCCC
Q 005859 163 LSVLALQYNQLTGAIPA--SLGDLGMLMRLDLSFNNLFGPVPV----KLANVPKLEVLDIRNNSFS 222 (673)
Q Consensus 163 L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~ 222 (673)
|++|+|++|.++ .+|. .+..+++|+.|++++|.++. +|. .+..+++|+.||+++|.+.
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 888888888886 4565 78888888999999998874 454 3778899999999988765
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.58 E-value=7.2e-16 Score=168.03 Aligned_cols=146 Identities=24% Similarity=0.319 Sum_probs=70.3
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCC-------------------------------
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLS------------------------------- 113 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~------------------------------- 113 (673)
.++..|++++|++ |.+|.+|++|++|++|+|++|.++|.+|..++++.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~ 89 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPEL 89 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSC
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCC
Confidence 3455666666666 66666666666666666666666666666655544
Q ss_pred --CCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccc
Q 005859 114 --ELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLD 191 (673)
Q Consensus 114 --~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 191 (673)
+|++|++++|.+++ +|.. +++|+.|++++|++++ +|.. .++|++|++++|++++ +| .|+++++|++|+
T Consensus 90 ~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~ 159 (454)
T 1jl5_A 90 PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIID 159 (454)
T ss_dssp CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEE
T ss_pred cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEE
Confidence 34444444444443 3322 2344445555554443 1211 1467777777777764 55 477777777777
Q ss_pred cccccCCCCCcccccCCCCCCEEEccCCCCCcCCc
Q 005859 192 LSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVP 226 (673)
Q Consensus 192 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p 226 (673)
+++|++++ +|..+ ++|+.|++++|++++ +|
T Consensus 160 l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~ 189 (454)
T 1jl5_A 160 VDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP 189 (454)
T ss_dssp CCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC
T ss_pred CCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc
Confidence 77777765 44322 466777777777765 44
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=6.6e-17 Score=172.76 Aligned_cols=159 Identities=22% Similarity=0.281 Sum_probs=81.6
Q ss_pred CEEEEEecCC---CcccccCccc-------cCCCCCCeEeCcCCcCCc----cCCcccCCCCCCCEEEccCCCCCCCCcc
Q 005859 66 RVANISLQGK---GLSGEIPAAV-------GGLKSLTGLYLHFNALNG----VIPKEIASLSELSDLYLNVNNLSGKIPS 131 (673)
Q Consensus 66 ~v~~l~l~~~---~l~g~~p~~~-------~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 131 (673)
+++.|+|++| .++|.+|..+ ..+++|++|+|++|.|++ .+|..+..+++|++|+|++|.++...+.
T Consensus 61 ~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~ 140 (386)
T 2ca6_A 61 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGA 140 (386)
T ss_dssp TCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHH
T ss_pred CccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHH
Confidence 4555555553 3444444433 455566666666666554 3455555555666666666655432222
Q ss_pred ccc----CC---------CCCcEeeccCcccc-ccCc---hhhcCccccCeecccccccC--c---cCCccccCCCcccc
Q 005859 132 QIG----NM---------TNLQVLQLCYNKLT-GNIP---TQLGSLRKLSVLALQYNQLT--G---AIPASLGDLGMLMR 189 (673)
Q Consensus 132 ~~~----~l---------~~L~~L~L~~N~l~-~~~p---~~l~~l~~L~~L~l~~N~l~--~---~~p~~~~~l~~L~~ 189 (673)
.+. .+ ++|++|+|++|+++ +.+| ..+..+++|++|+|++|+++ | .+|..+..+++|+.
T Consensus 141 ~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~ 220 (386)
T 2ca6_A 141 KIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKV 220 (386)
T ss_dssp HHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCE
T ss_pred HHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccE
Confidence 222 22 55555555555554 2333 24445555555555555554 1 22324555555555
Q ss_pred cccccccCC----CCCcccccCCCCCCEEEccCCCCCcC
Q 005859 190 LDLSFNNLF----GPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 190 L~l~~N~l~----~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
|+|++|.++ +.+|..+..+++|+.|+|++|.|++.
T Consensus 221 L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~ 259 (386)
T 2ca6_A 221 LDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259 (386)
T ss_dssp EECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred EECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchh
Confidence 555555553 33455555555555555555555543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2e-16 Score=169.03 Aligned_cols=169 Identities=22% Similarity=0.282 Sum_probs=139.3
Q ss_pred CCEEEEEecCCCccccc----CccccCCCCCCeEeCcCC---cCCccCCccc-------CCCCCCCEEEccCCCCCC---
Q 005859 65 GRVANISLQGKGLSGEI----PAAVGGLKSLTGLYLHFN---ALNGVIPKEI-------ASLSELSDLYLNVNNLSG--- 127 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~----p~~~~~l~~L~~L~L~~N---~l~~~~p~~~-------~~l~~L~~L~l~~N~l~~--- 127 (673)
.+++.|+|++|.+++.. +..+..+++|++|+|++| ++++.+|..+ ..+++|++|+|++|.+++
T Consensus 32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~ 111 (386)
T 2ca6_A 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111 (386)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHH
Confidence 46899999999998764 445779999999999995 5556677665 789999999999999997
Q ss_pred -CCcccccCCCCCcEeeccCccccccCchhh----cCc---------cccCeecccccccC-ccCC---ccccCCCcccc
Q 005859 128 -KIPSQIGNMTNLQVLQLCYNKLTGNIPTQL----GSL---------RKLSVLALQYNQLT-GAIP---ASLGDLGMLMR 189 (673)
Q Consensus 128 -~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l----~~l---------~~L~~L~l~~N~l~-~~~p---~~~~~l~~L~~ 189 (673)
.+|..+..+++|++|+|++|.++...+..+ ..+ ++|++|+|++|+++ +.+| ..+..+++|+.
T Consensus 112 ~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~ 191 (386)
T 2ca6_A 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 191 (386)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCE
T ss_pred HHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCE
Confidence 478889999999999999999975544444 444 89999999999997 4555 46778899999
Q ss_pred cccccccCC--C---CCcccccCCCCCCEEEccCCCCC----cCCchhhhhcc
Q 005859 190 LDLSFNNLF--G---PVPVKLANVPKLEVLDIRNNSFS----GNVPPALKRLN 233 (673)
Q Consensus 190 L~l~~N~l~--~---~~p~~~~~l~~L~~L~l~~N~l~----g~~p~~l~~~~ 233 (673)
|+|++|+++ | ..|..+..+++|+.|+|++|.++ +.+|..+..+.
T Consensus 192 L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~ 244 (386)
T 2ca6_A 192 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 244 (386)
T ss_dssp EECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCT
T ss_pred EECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCC
Confidence 999999997 3 34547889999999999999997 66777665543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.56 E-value=7.6e-15 Score=165.25 Aligned_cols=67 Identities=24% Similarity=0.338 Sum_probs=35.5
Q ss_pred cccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCchhhhhc
Q 005859 161 RKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRL 232 (673)
Q Consensus 161 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~l~~~ 232 (673)
++|+.|+|++|.|+ .+|. .+++|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++.+|..+..+
T Consensus 241 ~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L 307 (622)
T 3g06_A 241 SELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 307 (622)
T ss_dssp TTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred CcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence 44445555555544 2333 3445555555555555 445555555566666666666655555555444
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.55 E-value=6e-16 Score=163.81 Aligned_cols=157 Identities=21% Similarity=0.246 Sum_probs=67.0
Q ss_pred EecCCCcccccCccccCCCCCCeEeCcCCcCCccCC----cccCCCC-CCCEEEccCCCCCCCCcccccCC-----CCCc
Q 005859 71 SLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIP----KEIASLS-ELSDLYLNVNNLSGKIPSQIGNM-----TNLQ 140 (673)
Q Consensus 71 ~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l-----~~L~ 140 (673)
+|+.|+++|.+|..+...++|++|+|++|.|++..+ ..|..++ +|++|+|++|++++..+..|..+ ++|+
T Consensus 4 ~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~ 83 (362)
T 3goz_A 4 KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT 83 (362)
T ss_dssp ECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCC
T ss_pred ccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCcc
Confidence 344444444444444444444444444444444333 3344444 44444444444444444444332 4444
Q ss_pred EeeccCccccccCchhhcC----c-cccCeecccccccCccCCccc----cC-CCcccccccccccCCCCCc----cccc
Q 005859 141 VLQLCYNKLTGNIPTQLGS----L-RKLSVLALQYNQLTGAIPASL----GD-LGMLMRLDLSFNNLFGPVP----VKLA 206 (673)
Q Consensus 141 ~L~L~~N~l~~~~p~~l~~----l-~~L~~L~l~~N~l~~~~p~~~----~~-l~~L~~L~l~~N~l~~~~p----~~~~ 206 (673)
+|+|++|++++..+..+.. + ++|++|+|++|.+++..+..+ .. .++|++|+|++|.+++..+ ..+.
T Consensus 84 ~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~ 163 (362)
T 3goz_A 84 SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILA 163 (362)
T ss_dssp EEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred EEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHh
Confidence 4444444444443332222 2 444444444444443333222 11 1344444444444443221 1222
Q ss_pred CCC-CCCEEEccCCCCCcCCch
Q 005859 207 NVP-KLEVLDIRNNSFSGNVPP 227 (673)
Q Consensus 207 ~l~-~L~~L~l~~N~l~g~~p~ 227 (673)
.++ +|+.|+|++|++++..+.
T Consensus 164 ~~~~~L~~L~Ls~n~l~~~~~~ 185 (362)
T 3goz_A 164 AIPANVNSLNLRGNNLASKNCA 185 (362)
T ss_dssp TSCTTCCEEECTTSCGGGSCHH
T ss_pred cCCccccEeeecCCCCchhhHH
Confidence 232 444444444444444433
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.55 E-value=2.1e-14 Score=156.47 Aligned_cols=141 Identities=23% Similarity=0.275 Sum_probs=104.1
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..++.|++++|.+++ +|.. .++|++|+|++|++++ +| .|+++++|++|++++|++++ +|..+ .+|++|++
T Consensus 111 ~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L 180 (454)
T 1jl5_A 111 QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAA 180 (454)
T ss_dssp TTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEEC
T ss_pred CCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEEC
Confidence 356666666666654 2211 1678888888888886 66 58888888888888888885 56543 58888888
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCc
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 223 (673)
++|++++ +| .++.+++|++|++++|++++ +|... ++|+.|++++|.++ .+| .+..+++|+.|++++|++++
T Consensus 181 ~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~ 251 (454)
T 1jl5_A 181 GNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT 251 (454)
T ss_dssp CSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS
T ss_pred cCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc
Confidence 8888886 56 58888888888888888875 45432 47888888888887 566 37788888888888888876
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.55 E-value=5.5e-17 Score=156.33 Aligned_cols=138 Identities=27% Similarity=0.304 Sum_probs=124.2
Q ss_pred ccCCCCCCeEeCcCCcCCccCCc------ccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhc
Q 005859 85 VGGLKSLTGLYLHFNALNGVIPK------EIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLG 158 (673)
Q Consensus 85 ~~~l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~ 158 (673)
+.....++.++|+.|.++|.+|. .+..+++|++|+|++|++++ +| .+..+++|++|+|++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 56678899999999999999887 89999999999999999996 67 8999999999999999999 6888888
Q ss_pred CccccCeecccccccCccCCccccCCCcccccccccccCCCCCc-ccccCCCCCCEEEccCCCCCcCCch
Q 005859 159 SLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVP-VKLANVPKLEVLDIRNNSFSGNVPP 227 (673)
Q Consensus 159 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~g~~p~ 227 (673)
.+++|++|++++|++++ +| .+..+++|+.|++++|++++..+ ..+..+++|+.|++++|++++.+|.
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 89999999999999996 55 68899999999999999986433 4788999999999999999987765
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.55 E-value=4.2e-16 Score=165.00 Aligned_cols=160 Identities=23% Similarity=0.230 Sum_probs=125.1
Q ss_pred CCEEEEEecCCCcccccC----ccccCCC-CCCeEeCcCCcCCccCCcccCCC-----CCCCEEEccCCCCCCCCccccc
Q 005859 65 GRVANISLQGKGLSGEIP----AAVGGLK-SLTGLYLHFNALNGVIPKEIASL-----SELSDLYLNVNNLSGKIPSQIG 134 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~p~~~~ 134 (673)
..++.|+|++|.+++..+ ..|..++ +|++|+|++|.|++..+..+..+ ++|++|+|++|++++..+..+.
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 458899999999887766 6778888 89999999999988777777765 8999999999999877776544
Q ss_pred C----C-CCCcEeeccCccccccCchhhc----C-ccccCeecccccccCccC----CccccCCC-cccccccccccCCC
Q 005859 135 N----M-TNLQVLQLCYNKLTGNIPTQLG----S-LRKLSVLALQYNQLTGAI----PASLGDLG-MLMRLDLSFNNLFG 199 (673)
Q Consensus 135 ~----l-~~L~~L~L~~N~l~~~~p~~l~----~-l~~L~~L~l~~N~l~~~~----p~~~~~l~-~L~~L~l~~N~l~~ 199 (673)
. + ++|+.|+|++|++++..+..+. . .++|++|+|++|.++... +..+..++ +|+.|+|++|++++
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~ 181 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCch
Confidence 4 4 8899999999999877665544 3 258999999999988533 34445565 89999999999987
Q ss_pred CCcccc----cCC-CCCCEEEccCCCCCcC
Q 005859 200 PVPVKL----ANV-PKLEVLDIRNNSFSGN 224 (673)
Q Consensus 200 ~~p~~~----~~l-~~L~~L~l~~N~l~g~ 224 (673)
..+..+ ..+ ++|+.|+|++|.|+..
T Consensus 182 ~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~ 211 (362)
T 3goz_A 182 KNCAELAKFLASIPASVTSLDLSANLLGLK 211 (362)
T ss_dssp SCHHHHHHHHHTSCTTCCEEECTTSCGGGS
T ss_pred hhHHHHHHHHHhCCCCCCEEECCCCCCChh
Confidence 766544 344 5899999999998864
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=8.4e-15 Score=163.61 Aligned_cols=122 Identities=23% Similarity=0.266 Sum_probs=109.9
Q ss_pred CCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeeccc
Q 005859 90 SLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQ 169 (673)
Q Consensus 90 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~ 169 (673)
.|+.|+|++|.|++ +|. |+.+++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .|+.+++|++|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 47789999999997 566 999999999999999999 889999999999999999999997 67 89999999999999
Q ss_pred ccccCccC-CccccCCCcccccccccccCCCCCccc---ccCCCCCCEEEc
Q 005859 170 YNQLTGAI-PASLGDLGMLMRLDLSFNNLFGPVPVK---LANVPKLEVLDI 216 (673)
Q Consensus 170 ~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~---~~~l~~L~~L~l 216 (673)
+|+|++.. |..|+.+++|+.|+|++|.+++.+|.. +..+++|+.|++
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 99999876 999999999999999999999876532 334899999975
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.53 E-value=8.7e-15 Score=138.01 Aligned_cols=129 Identities=20% Similarity=0.214 Sum_probs=112.3
Q ss_pred CCEEEEEecCCCcccccCccccCCC-CCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEee
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLK-SLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 143 (673)
..++.|+|++|+++. +|. +..+. +|++|+|++|.|++. +.|..+++|++|+|++|++++..|..|..+++|++|+
T Consensus 19 ~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 19 VRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred CCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 468999999999995 454 55555 999999999999976 6899999999999999999976556669999999999
Q ss_pred ccCccccccCch--hhcCccccCeecccccccCccCCcc----ccCCCcccccccccccCCC
Q 005859 144 LCYNKLTGNIPT--QLGSLRKLSVLALQYNQLTGAIPAS----LGDLGMLMRLDLSFNNLFG 199 (673)
Q Consensus 144 L~~N~l~~~~p~--~l~~l~~L~~L~l~~N~l~~~~p~~----~~~l~~L~~L~l~~N~l~~ 199 (673)
|++|+++ .+|. .+..+++|+.|++++|.++ .+|.. +..+++|+.|+++.|.+..
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 9999997 5666 8999999999999999998 56664 8899999999999998753
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.52 E-value=6.3e-15 Score=165.91 Aligned_cols=160 Identities=27% Similarity=0.328 Sum_probs=97.1
Q ss_pred CcCCCCCCCCCCCCCCCceEE--------eCCCCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCC
Q 005859 40 LLTSWAPNADPCSSDSFDGVA--------CDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIAS 111 (673)
Q Consensus 40 ~l~~w~~~~~~C~~~~w~gv~--------c~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 111 (673)
.+..|....++|. |.|.. |. ...++.|++++|+|+ .+|..+. ++|++|+|++|.|+. +|. .
T Consensus 11 ~w~~W~~~~~~~~---~~~r~~~~~~~~~c~-~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~ 79 (622)
T 3g06_A 11 VWSAWRRAAPAEE---SRGRAAVVQKMRACL-NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---L 79 (622)
T ss_dssp HHHHHHHTCCGGG---HHHHHHHHHHHHHHH-HHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---C
T ss_pred HHHHHHhcCCcch---hccccccCccccccc-CCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---c
Confidence 3556765556664 75432 22 134677888888877 6676654 677888888887774 444 4
Q ss_pred CCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccc
Q 005859 112 LSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLD 191 (673)
Q Consensus 112 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 191 (673)
+++|++|+|++|+|+ .+|. .+++|++|+|++|++++ +|. .+++|+.|++++|++++ +|.. +++|+.|+
T Consensus 80 l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~ 147 (622)
T 3g06_A 80 PPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELS 147 (622)
T ss_dssp CTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEE
T ss_pred CCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEE
Confidence 677777777777777 3554 56777777777777774 343 44566666666666653 4432 25566666
Q ss_pred cccccCCCCCcccc-----------------cCCCCCCEEEccCCCCCc
Q 005859 192 LSFNNLFGPVPVKL-----------------ANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 192 l~~N~l~~~~p~~~-----------------~~l~~L~~L~l~~N~l~g 223 (673)
|++|++++. |..+ ..+++|+.|++++|.|++
T Consensus 148 Ls~N~l~~l-~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~ 195 (622)
T 3g06_A 148 VSDNQLASL-PALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS 195 (622)
T ss_dssp CCSSCCSCC-CCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC
T ss_pred CcCCcCCCc-CCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC
Confidence 666655542 2211 122566666666666664
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.52 E-value=4.8e-14 Score=132.57 Aligned_cols=105 Identities=24% Similarity=0.320 Sum_probs=82.5
Q ss_pred EEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCc
Q 005859 68 ANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYN 147 (673)
Q Consensus 68 ~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 147 (673)
+.+++++|+|+ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 46788888884 6777664 78888888888888888888888888888888888888765666788888888888888
Q ss_pred cccccCchhhcCccccCeecccccccCc
Q 005859 148 KLTGNIPTQLGSLRKLSVLALQYNQLTG 175 (673)
Q Consensus 148 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 175 (673)
+|++..+..|..+++|++|+|++|.+..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccc
Confidence 8886555567778888888888887763
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.51 E-value=4.6e-14 Score=132.23 Aligned_cols=90 Identities=29% Similarity=0.265 Sum_probs=50.4
Q ss_pred CCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEc
Q 005859 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDI 216 (673)
Q Consensus 137 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 216 (673)
++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 34444444444444444444555555555555555555444444555556666666666666555555666777777777
Q ss_pred cCCCCCcCCc
Q 005859 217 RNNSFSGNVP 226 (673)
Q Consensus 217 ~~N~l~g~~p 226 (673)
++|++....+
T Consensus 110 ~~N~~~c~c~ 119 (170)
T 3g39_A 110 LNNPWDCACS 119 (170)
T ss_dssp CSSCBCTTBG
T ss_pred CCCCCCCCch
Confidence 7777766543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.51 E-value=5.1e-14 Score=131.86 Aligned_cols=104 Identities=24% Similarity=0.311 Sum_probs=71.3
Q ss_pred EEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCcc
Q 005859 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNK 148 (673)
Q Consensus 69 ~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 148 (673)
.+++++|+|+. +|..+ .++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+
T Consensus 13 ~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 45666666664 56554 2677777777777777777777777777777777777776655566777777777777777
Q ss_pred ccccCchhhcCccccCeecccccccCc
Q 005859 149 LTGNIPTQLGSLRKLSVLALQYNQLTG 175 (673)
Q Consensus 149 l~~~~p~~l~~l~~L~~L~l~~N~l~~ 175 (673)
|++..+..|..+++|++|+|++|.+..
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 776555566667777777777776653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.49 E-value=8.3e-14 Score=130.93 Aligned_cols=106 Identities=26% Similarity=0.292 Sum_probs=57.1
Q ss_pred CeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeeccccc
Q 005859 92 TGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYN 171 (673)
Q Consensus 92 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N 171 (673)
+.+++++|.++ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++.
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i------------------- 72 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAI------------------- 72 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC-------------------
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCcc-------------------
Confidence 45666666664 3444332 4555555555555554455555555555555555555543
Q ss_pred ccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 172 QLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 172 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
.+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|...
T Consensus 73 -----~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 73 -----PTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp -----CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred -----ChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 333344555555555555555544444456666666666666666643
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.47 E-value=7.8e-14 Score=146.75 Aligned_cols=164 Identities=15% Similarity=0.145 Sum_probs=131.5
Q ss_pred EEeCCCCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCc-ccccCCC
Q 005859 59 VACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIP-SQIGNMT 137 (673)
Q Consensus 59 v~c~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~ 137 (673)
..|+. + .++.++++|+ .+|..+ .++|++|+|++|+|+...+..|.++++|++|+|++|++.+.+| ..|.+++
T Consensus 7 C~C~~--~--~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~ 79 (350)
T 4ay9_X 7 CHCSN--R--VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 79 (350)
T ss_dssp SEEET--T--EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCT
T ss_pred cEeeC--C--EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcch
Confidence 46743 3 4677889988 678766 4789999999999997777789999999999999999977665 4689999
Q ss_pred CCcE-eeccCccccccCchhhcCccccCeecccccccCccCCccccCCCccccccccc-ccCCCCCcccccCCC-CCCEE
Q 005859 138 NLQV-LQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSF-NNLFGPVPVKLANVP-KLEVL 214 (673)
Q Consensus 138 ~L~~-L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~-~L~~L 214 (673)
+|+. +.+++|+++...|..|..+++|++|++++|++++..+..+....++..|++.+ |++....+..|..+. .++.|
T Consensus 80 ~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L 159 (350)
T 4ay9_X 80 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVIL 159 (350)
T ss_dssp TCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEE
T ss_pred hhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhh
Confidence 8775 67788999988899999999999999999999977666777777788888865 566655555666664 58889
Q ss_pred EccCCCCCcCCchhh
Q 005859 215 DIRNNSFSGNVPPAL 229 (673)
Q Consensus 215 ~l~~N~l~g~~p~~l 229 (673)
+|++|+|+...+..+
T Consensus 160 ~L~~N~i~~i~~~~f 174 (350)
T 4ay9_X 160 WLNKNGIQEIHNSAF 174 (350)
T ss_dssp ECCSSCCCEECTTSS
T ss_pred ccccccccCCChhhc
Confidence 999999985444333
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.41 E-value=4.9e-13 Score=140.43 Aligned_cols=107 Identities=24% Similarity=0.326 Sum_probs=94.0
Q ss_pred CCceEEeCCCCCEEEEEecCC-CcccccCccccCCCCCCeEeCcC-CcCCccCCcccCCCCCCCEEEccCCCCCCCCccc
Q 005859 55 SFDGVACDENGRVANISLQGK-GLSGEIPAAVGGLKSLTGLYLHF-NALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQ 132 (673)
Q Consensus 55 ~w~gv~c~~~~~v~~l~l~~~-~l~g~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 132 (673)
.|..|.|+ ++ +|++ +|. |..+++|+.|+|++ |.|++..|..|.+|++|+.|+|++|+|++..|..
T Consensus 9 ~~~~v~~~-----------~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 75 (347)
T 2ifg_A 9 GSSGLRCT-----------RDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75 (347)
T ss_dssp SSSCEECC-----------SSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTG
T ss_pred cCCEEEcC-----------CCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHH
Confidence 37667664 44 6774 788 99999999999996 9999988899999999999999999999999999
Q ss_pred ccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCc
Q 005859 133 IGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTG 175 (673)
Q Consensus 133 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 175 (673)
|.+|++|+.|+|++|+|++..+..|..++ |+.|+|.+|.|..
T Consensus 76 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp GGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred hcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 99999999999999999977666777776 9999999999974
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.40 E-value=7.5e-15 Score=160.49 Aligned_cols=165 Identities=19% Similarity=0.120 Sum_probs=91.3
Q ss_pred CCEEEEEecCCCcccccCcccc-----CCCCCCeEeCcCCcCCcc----CCcccCCCCCCCEEEccCCCCCCCC-----c
Q 005859 65 GRVANISLQGKGLSGEIPAAVG-----GLKSLTGLYLHFNALNGV----IPKEIASLSELSDLYLNVNNLSGKI-----P 130 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~-----~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~-----p 130 (673)
..++.|+|++|.+++..+..+. .+++|++|+|++|.+++. ++..+..+++|++|+|++|.+++.. +
T Consensus 170 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~ 249 (461)
T 1z7x_W 170 PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCP 249 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHH
T ss_pred CCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHH
Confidence 3566677777666654333332 245666666666666642 4555556666666666666665321 2
Q ss_pred ccccCCCCCcEeeccCcccccc----CchhhcCccccCeecccccccCccCCccccC-----CCcccccccccccCCCC-
Q 005859 131 SQIGNMTNLQVLQLCYNKLTGN----IPTQLGSLRKLSVLALQYNQLTGAIPASLGD-----LGMLMRLDLSFNNLFGP- 200 (673)
Q Consensus 131 ~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~~- 200 (673)
..+..+++|+.|+|++|.++.. ++..+..+++|++|++++|.+.+..+..+.. .++|+.|+|++|.+++.
T Consensus 250 ~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 329 (461)
T 1z7x_W 250 GLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAAC 329 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG
T ss_pred HHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHH
Confidence 2223456666666666666643 4555555666666666666665433322221 24666666666666543
Q ss_pred ---CcccccCCCCCCEEEccCCCCCcCCchhh
Q 005859 201 ---VPVKLANVPKLEVLDIRNNSFSGNVPPAL 229 (673)
Q Consensus 201 ---~p~~~~~l~~L~~L~l~~N~l~g~~p~~l 229 (673)
++..+..+++|+.|++++|.+++..+..+
T Consensus 330 ~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l 361 (461)
T 1z7x_W 330 CSHFSSVLAQNRFLLELQISNNRLEDAGVREL 361 (461)
T ss_dssp HHHHHHHHHHCSSCCEEECCSSBCHHHHHHHH
T ss_pred HHHHHHHHhhCCCccEEEccCCccccccHHHH
Confidence 34444555666666666666655444333
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.38 E-value=9.6e-15 Score=159.62 Aligned_cols=169 Identities=22% Similarity=0.222 Sum_probs=134.7
Q ss_pred CCEEEEEecCCCcccc----cCccccCCCCCCeEeCcCCcCCccC-----CcccCCCCCCCEEEccCCCCCCC----Ccc
Q 005859 65 GRVANISLQGKGLSGE----IPAAVGGLKSLTGLYLHFNALNGVI-----PKEIASLSELSDLYLNVNNLSGK----IPS 131 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~----~p~~~~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~l~~N~l~~~----~p~ 131 (673)
.+++.|+|++|.+++. ++..+..+++|++|+|++|.++... +..+..+++|++|++++|.++.. ++.
T Consensus 199 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~ 278 (461)
T 1z7x_W 199 CQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCR 278 (461)
T ss_dssp CCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred CCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHH
Confidence 3788999999999874 6778888999999999999987532 33344689999999999999854 677
Q ss_pred cccCCCCCcEeeccCccccccCchhhcCc-----cccCeecccccccCcc----CCccccCCCcccccccccccCCCCCc
Q 005859 132 QIGNMTNLQVLQLCYNKLTGNIPTQLGSL-----RKLSVLALQYNQLTGA----IPASLGDLGMLMRLDLSFNNLFGPVP 202 (673)
Q Consensus 132 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l-----~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p 202 (673)
.+..+++|+.|+|++|.+++..+..+... ++|+.|++++|.+++. ++..+..+++|+.|+|++|.+++..+
T Consensus 279 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~ 358 (461)
T 1z7x_W 279 VLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGV 358 (461)
T ss_dssp HHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHH
T ss_pred HHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccH
Confidence 78889999999999999986555444432 6899999999999865 56667788999999999999876555
Q ss_pred ccccC-----CCCCCEEEccCCCCCc----CCchhhhhcc
Q 005859 203 VKLAN-----VPKLEVLDIRNNSFSG----NVPPALKRLN 233 (673)
Q Consensus 203 ~~~~~-----l~~L~~L~l~~N~l~g----~~p~~l~~~~ 233 (673)
..+.. .++|+.|++++|.+++ .+|..+..+.
T Consensus 359 ~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~ 398 (461)
T 1z7x_W 359 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANH 398 (461)
T ss_dssp HHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCC
T ss_pred HHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCC
Confidence 44432 6789999999999986 6777776554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.33 E-value=2.3e-12 Score=135.21 Aligned_cols=90 Identities=23% Similarity=0.193 Sum_probs=44.4
Q ss_pred ccCCCCCcEeeccC-ccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCC
Q 005859 133 IGNMTNLQVLQLCY-NKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKL 211 (673)
Q Consensus 133 ~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 211 (673)
|..+++|+.|+|++ |+|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+..++ |
T Consensus 27 l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L 105 (347)
T 2ifg_A 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-L 105 (347)
T ss_dssp SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-C
T ss_pred CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-c
Confidence 44444444444443 444444444444444444444444444444444444555555555555555544333444333 6
Q ss_pred CEEEccCCCCCc
Q 005859 212 EVLDIRNNSFSG 223 (673)
Q Consensus 212 ~~L~l~~N~l~g 223 (673)
+.|+|++|+|..
T Consensus 106 ~~l~l~~N~~~c 117 (347)
T 2ifg_A 106 QELVLSGNPLHC 117 (347)
T ss_dssp CEEECCSSCCCC
T ss_pred eEEEeeCCCccC
Confidence 666676666664
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=5.6e-14 Score=148.70 Aligned_cols=167 Identities=19% Similarity=0.229 Sum_probs=127.6
Q ss_pred CCEEEEEecCCCcccccCccccCC-----CCCCeEeCcCCcCCccCCccc-CCCCCCCEEEccCCCCCCCCcccc-----
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGL-----KSLTGLYLHFNALNGVIPKEI-ASLSELSDLYLNVNNLSGKIPSQI----- 133 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~p~~~----- 133 (673)
..+..|+|++|.++......+..+ ++|+.|+|++|.|+......+ ..+++|+.|+|++|+++......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 468899999999986544444333 799999999999975433333 346789999999999985444444
Q ss_pred cCCCCCcEeeccCccccc----cCchhhcCccccCeecccccccCcc----CCccccCCCcccccccccccCCCC----C
Q 005859 134 GNMTNLQVLQLCYNKLTG----NIPTQLGSLRKLSVLALQYNQLTGA----IPASLGDLGMLMRLDLSFNNLFGP----V 201 (673)
Q Consensus 134 ~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~ 201 (673)
...++|+.|+|++|.++. .++..+..+++|++|+|++|.|... ++..+...++|+.|+|++|.|+.. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 346899999999999974 3455667889999999999999753 355677788999999999999753 3
Q ss_pred cccccCCCCCCEEEccCCCCCcCCchhhhh
Q 005859 202 PVKLANVPKLEVLDIRNNSFSGNVPPALKR 231 (673)
Q Consensus 202 p~~~~~l~~L~~L~l~~N~l~g~~p~~l~~ 231 (673)
+..+...++|+.|+|++|.|+..-...+..
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~ 261 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSSEGRQVLRD 261 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred HHHHHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence 344556789999999999998655555544
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.25 E-value=7.5e-12 Score=130.34 Aligned_cols=134 Identities=13% Similarity=0.120 Sum_probs=78.5
Q ss_pred CCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccC--------------------------------
Q 005859 88 LKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGN-------------------------------- 135 (673)
Q Consensus 88 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-------------------------------- 135 (673)
+++|+.|+|++ .++..-+..|.++++|+.|++++|.+....+..|.+
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 77777777777 666666667777777777777777664333333333
Q ss_pred ----------------------------------------------CCCCcEeeccCccccccCchhhcCccccCeeccc
Q 005859 136 ----------------------------------------------MTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQ 169 (673)
Q Consensus 136 ----------------------------------------------l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~ 169 (673)
+++|+.|+|++|+++...+..|.++++|+.|+|.
T Consensus 179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~ 258 (329)
T 3sb4_A 179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLP 258 (329)
T ss_dssp EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECC
T ss_pred ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECC
Confidence 4455566666655554444455566666666665
Q ss_pred ccccCccCCccccCCCccc-ccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 170 YNQLTGAIPASLGDLGMLM-RLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 170 ~N~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
+| ++..-+..|.++.+|+ .|++.+ .++...+.+|.++++|+.|++++|++...
T Consensus 259 ~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I 312 (329)
T 3sb4_A 259 HN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTL 312 (329)
T ss_dssp TT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEE
T ss_pred cc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCcc
Confidence 55 4444444555666665 666655 44444445556666666666655555543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=2.2e-11 Score=122.41 Aligned_cols=146 Identities=11% Similarity=0.047 Sum_probs=111.5
Q ss_pred HHHHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCe
Q 005859 397 VERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGICCSKGRGE 475 (673)
Q Consensus 397 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 475 (673)
+...-..|.....++.|+.+.||++... ++.+++|+..... ......+.+|+++++.+. |..+.++++++.. .+.
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~-~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~ 84 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGW 84 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCccc-CCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCc
Confidence 3444567888888888999999999754 6889999987532 122346889999999984 6778889988754 367
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCC------------------------------
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR------------------------------ 525 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------ 525 (673)
.|+||||++|.+|.+.+. +......++.+++++|+.||+..
T Consensus 85 ~~lv~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred eEEEEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 899999999999887642 11123467889999999999810
Q ss_pred ---------------------------CCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 526 ---------------------------PGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 526 ---------------------------~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
+.++|+|++|.||+++++..+.|.||+.+.
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 358999999999999876566799998764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.13 E-value=1e-10 Score=121.62 Aligned_cols=149 Identities=13% Similarity=0.060 Sum_probs=124.6
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccC----------------------------------
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIA---------------------------------- 110 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~---------------------------------- 110 (673)
..++.|+|++ +++..-+.+|.++++|+.|+|++|.+....+..|.
T Consensus 101 ~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~ 179 (329)
T 3sb4_A 101 QTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLE 179 (329)
T ss_dssp TTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCE
T ss_pred CCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccc
Confidence 4678888988 88766667899999999999999986322221111
Q ss_pred --------------------------------------------CCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccC
Q 005859 111 --------------------------------------------SLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCY 146 (673)
Q Consensus 111 --------------------------------------------~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 146 (673)
.+++|+.|+|++|+++...+..|.++++|+.|+|.+
T Consensus 180 ~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~ 259 (329)
T 3sb4_A 180 TTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPH 259 (329)
T ss_dssp EEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCT
T ss_pred eeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCc
Confidence 267999999999999977777899999999999999
Q ss_pred ccccccCchhhcCccccC-eecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEc
Q 005859 147 NKLTGNIPTQLGSLRKLS-VLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDI 216 (673)
Q Consensus 147 N~l~~~~p~~l~~l~~L~-~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 216 (673)
| ++..-+..|.++++|+ .|++.+ .++..-+..|.++++|+.|+++.|++....+.+|.++++|+.+..
T Consensus 260 n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 260 N-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp T-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred c-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 8 8767778999999999 999998 787677789999999999999999999877889999999999864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.11 E-value=1.1e-10 Score=116.86 Aligned_cols=136 Identities=17% Similarity=0.137 Sum_probs=98.0
Q ss_pred CCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCC--ceeEeeEEecCCCCeEEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHEN--LASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~~~lv~ 480 (673)
.+....+.+.|..+.||++...+|+.+++|..... ....+.+|+++++.+.+.+ +.+++++... .+..++||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~~~v~ 94 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLL 94 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccC--CCCCEEEE
Confidence 34443333456669999998777888999987543 2245788999999986545 4567777643 35689999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR----------------------------------- 525 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------- 525 (673)
||++|.+|. ... .+ ...++.++++.|+.||+..
T Consensus 95 e~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 95 GEVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp ECCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 999998884 220 11 1256778888888888642
Q ss_pred ---------------------CCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 526 ---------------------PGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 526 ---------------------~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++++|+|++|.||+++++..+.|.|||.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 1399999999999998876677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.11 E-value=2.3e-10 Score=120.60 Aligned_cols=145 Identities=15% Similarity=0.231 Sum_probs=106.0
Q ss_pred cccccccCCcceEEEEEEcCCcEEEEEEec--ccCCCCcHHHHHHHHHHHhccC--CCCceeEeeEEecCCC-CeEEEEE
Q 005859 406 EANLLGKSSFSATYKGILRDGSVVAVKCIA--KTSCKSDEGEFLKGLKILTSLK--HENLASLRGICCSKGR-GECFLIY 480 (673)
Q Consensus 406 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~-~~~~lv~ 480 (673)
..+.|+.|.++.||+....+ ..+++|+.. ..........+.+|+++++.+. +..+.++++++.+.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999998764 577888775 3322223456888999999996 4567888888754321 4578999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK------------------------------------ 524 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------ 524 (673)
||++|..+.+... ..++...+..++.++++.|+.||..
T Consensus 121 e~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999987754221 2367888889999999999999972
Q ss_pred --------------------CCCcccCCcCCCCeEecCCCC--eeeccccccccc
Q 005859 525 --------------------RPGLVHPNLSAEKVLIHRRYN--PLLSDSGLHKLL 557 (673)
Q Consensus 525 --------------------~~~ivHrDlk~~NILl~~~~~--~kl~DfGla~~~ 557 (673)
.+.++|+|+++.||+++.++. +.|.||+.+..-
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 246999999999999997753 589999998753
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.02 E-value=6.6e-12 Score=132.77 Aligned_cols=158 Identities=20% Similarity=0.202 Sum_probs=116.8
Q ss_pred CCEEEEEecCCCcccccCccc-cCCCCCCeEeCcCCcCCccCCccc-----CCCCCCCEEEccCCCCCC----CCccccc
Q 005859 65 GRVANISLQGKGLSGEIPAAV-GGLKSLTGLYLHFNALNGVIPKEI-----ASLSELSDLYLNVNNLSG----KIPSQIG 134 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~l~~N~l~~----~~p~~~~ 134 (673)
..++.|+|++|.++..-...+ ..+++|+.|+|++|.|+......+ ...++|++|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 479999999999976543333 357889999999999985444444 356899999999999974 2455667
Q ss_pred CCCCCcEeeccCcccccc----CchhhcCccccCeecccccccCcc----CCccccCCCcccccccccccCCCCCccccc
Q 005859 135 NMTNLQVLQLCYNKLTGN----IPTQLGSLRKLSVLALQYNQLTGA----IPASLGDLGMLMRLDLSFNNLFGPVPVKLA 206 (673)
Q Consensus 135 ~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 206 (673)
.+++|++|+|++|.++.. ++..+...++|++|+|++|.|+.. ++..+...++|+.|+|++|.|+..-...+.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~ 260 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLR 260 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence 899999999999999853 356677888999999999999753 444566678999999999999865444443
Q ss_pred CCC---C--CCEEE--ccCCCCC
Q 005859 207 NVP---K--LEVLD--IRNNSFS 222 (673)
Q Consensus 207 ~l~---~--L~~L~--l~~N~l~ 222 (673)
.+. . |+.+. +..|.++
T Consensus 261 ~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 261 DLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp HCC------CEEECCCC----CH
T ss_pred HHhcCCCccchhhHhhhcCCccC
Confidence 332 1 66666 6666654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.02 E-value=1.3e-11 Score=139.16 Aligned_cols=157 Identities=17% Similarity=0.163 Sum_probs=79.9
Q ss_pred CEEEEEecCCCcc-cccCccccCCCCCCeEeCc-----------CCcCCcc-CCcccCCCCCCCEEEccCCCCCCCCccc
Q 005859 66 RVANISLQGKGLS-GEIPAAVGGLKSLTGLYLH-----------FNALNGV-IPKEIASLSELSDLYLNVNNLSGKIPSQ 132 (673)
Q Consensus 66 ~v~~l~l~~~~l~-g~~p~~~~~l~~L~~L~L~-----------~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 132 (673)
++..|+|. +.+. +.++..+..+++|++|+|+ .|.+++. ++..+..+++|++|+++.|++++..+..
T Consensus 319 ~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~ 397 (592)
T 3ogk_B 319 NLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLES 397 (592)
T ss_dssp TCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHH
T ss_pred CCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHH
Confidence 55666666 3333 2233334556666666666 2455432 1222334566666666666666554545
Q ss_pred ccC-CCCCcEeecc----Ccccccc-----CchhhcCccccCeeccccc--ccCccCCcccc-CCCcccccccccccCCC
Q 005859 133 IGN-MTNLQVLQLC----YNKLTGN-----IPTQLGSLRKLSVLALQYN--QLTGAIPASLG-DLGMLMRLDLSFNNLFG 199 (673)
Q Consensus 133 ~~~-l~~L~~L~L~----~N~l~~~-----~p~~l~~l~~L~~L~l~~N--~l~~~~p~~~~-~l~~L~~L~l~~N~l~~ 199 (673)
+.. +++|+.|+|+ .|.+++. ++..+.++++|+.|++++| .+++..+..+. .+++|+.|+|++|++++
T Consensus 398 l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~ 477 (592)
T 3ogk_B 398 IGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESD 477 (592)
T ss_dssp HHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSH
T ss_pred HHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCH
Confidence 444 5666666664 4555542 2233445566666666532 24433333332 25556666666665554
Q ss_pred C-CcccccCCCCCCEEEccCCCCCc
Q 005859 200 P-VPVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 200 ~-~p~~~~~l~~L~~L~l~~N~l~g 223 (673)
. ++..+.++++|+.|++++|+|++
T Consensus 478 ~~~~~~~~~~~~L~~L~l~~n~l~~ 502 (592)
T 3ogk_B 478 EGLMEFSRGCPNLQKLEMRGCCFSE 502 (592)
T ss_dssp HHHHHHHTCCTTCCEEEEESCCCBH
T ss_pred HHHHHHHhcCcccCeeeccCCCCcH
Confidence 2 23334455566666666666543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.90 E-value=1.1e-10 Score=131.42 Aligned_cols=158 Identities=11% Similarity=0.088 Sum_probs=118.6
Q ss_pred CEEEEEecCCC-ccc-ccCccccCCCCCCeEeCcCCcCCcc----CCcccCCCCCCCEEEccCCCCCC----CCcccccC
Q 005859 66 RVANISLQGKG-LSG-EIPAAVGGLKSLTGLYLHFNALNGV----IPKEIASLSELSDLYLNVNNLSG----KIPSQIGN 135 (673)
Q Consensus 66 ~v~~l~l~~~~-l~g-~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~ 135 (673)
+++.|+|+++. ++. .++..+.++++|++|+|++|.+++. ++..+..+++|++|++++|.+++ .++..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 48999998876 221 1333345789999999999998765 44456678999999999999983 34556678
Q ss_pred CCCCcEeeccCccccccCchhhcCccccCeecccccccC---ccCCccccCCCcccccccccccCCCCCcccccCCCCCC
Q 005859 136 MTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLT---GAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLE 212 (673)
Q Consensus 136 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~---~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 212 (673)
+++|+.|+|++|.+.+ +|..+..+++|+.|+++.+... +..+..+..+++|+.|+++++. .+.+|..+..+++|+
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~ 296 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIR 296 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGGCC
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHhhcCCCc
Confidence 9999999999999986 7788999999999999864332 2344556777788888887753 335666777778888
Q ss_pred EEEccCCCCCcCC
Q 005859 213 VLDIRNNSFSGNV 225 (673)
Q Consensus 213 ~L~l~~N~l~g~~ 225 (673)
.|+|++|.+++..
T Consensus 297 ~L~Ls~~~l~~~~ 309 (592)
T 3ogk_B 297 KLDLLYALLETED 309 (592)
T ss_dssp EEEETTCCCCHHH
T ss_pred EEecCCCcCCHHH
Confidence 8888888876543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.89 E-value=6e-12 Score=125.44 Aligned_cols=117 Identities=19% Similarity=0.220 Sum_probs=50.3
Q ss_pred CCceEEeCCCC-CEEEEEecC---CCcccccCc-cccCCCCCCeEeCcCCcCCccCCc-ccCCCCCCCE--EEccCCCCC
Q 005859 55 SFDGVACDENG-RVANISLQG---KGLSGEIPA-AVGGLKSLTGLYLHFNALNGVIPK-EIASLSELSD--LYLNVNNLS 126 (673)
Q Consensus 55 ~w~gv~c~~~~-~v~~l~l~~---~~l~g~~p~-~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~--L~l~~N~l~ 126 (673)
.|.|+.|+..+ +|..+-..+ ..+.|.+++ .+..|+. .|...+|..++.++- .|...+.|.. ++++.|+..
T Consensus 79 ~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~ 156 (267)
T 3rw6_A 79 AVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS 156 (267)
T ss_dssp HTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH
T ss_pred hcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCHHH
Confidence 39999998654 665555544 233344432 2222222 233333333322221 1222333333 344444322
Q ss_pred CCCcc----cccCCCCCcEeeccCccccc--cCchhhcCccccCeecccccccC
Q 005859 127 GKIPS----QIGNMTNLQVLQLCYNKLTG--NIPTQLGSLRKLSVLALQYNQLT 174 (673)
Q Consensus 127 ~~~p~----~~~~l~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~l~~N~l~ 174 (673)
.++. ...++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|+
T Consensus 157 -~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~ 209 (267)
T 3rw6_A 157 -CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 209 (267)
T ss_dssp -HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCC
T ss_pred -HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccC
Confidence 1111 11334455555555555554 23344444555555555555554
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.82 E-value=1.5e-09 Score=111.49 Aligned_cols=187 Identities=16% Similarity=0.151 Sum_probs=117.9
Q ss_pred ccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCC--ceeEeeEEecCC-CCeEEEEEee
Q 005859 407 ANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHEN--LASLRGICCSKG-RGECFLIYDF 482 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~n--iv~l~~~~~~~~-~~~~~lv~E~ 482 (673)
.+.++.|.+..||+.. ..+++|+.... .....+.+|+++|+.+ .+.. +.+++....... ....|+||||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 3458899999999863 46888876432 2346788999999888 3333 334444332111 1235789999
Q ss_pred cCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 005859 483 VPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK-------------------------------------- 524 (673)
Q Consensus 483 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------- 524 (673)
++|.++.+... ..++..++..++.++++.++.||..
T Consensus 98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99988764322 2356677777888888888888751
Q ss_pred ------------------CCCcccCCcCCCCeEecC--CCCeeeccccccccccCcchhhhhccC----C---------C
Q 005859 525 ------------------RPGLVHPNLSAEKVLIHR--RYNPLLSDSGLHKLLADDIVFSMLKAS----A---------A 571 (673)
Q Consensus 525 ------------------~~~ivHrDlk~~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~~~~----g---------t 571 (673)
.+.++|+|++|.||++++ ...+.|.||+.+..-............ + .
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 135799999999999998 456789999998754321111000000 0 0
Q ss_pred CCccC-CccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 005859 572 MGYLA-PEYTTTGRFTEKSDIYAFGMIVFQILSGKCSI 608 (673)
Q Consensus 572 ~~y~a-PE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~ 608 (673)
.++.. |+... +.....+.|++|.++|++.+|+.+|
T Consensus 252 Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00111 12111 1122368999999999999998654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.72 E-value=1.3e-09 Score=122.75 Aligned_cols=129 Identities=15% Similarity=0.127 Sum_probs=84.2
Q ss_pred CCEEEEEecCCCcccccCcccc-CCCCCCeEeCcCC-cCCcc-CCcccCCCCCCCEEEccCCCCCCCCccccc----CCC
Q 005859 65 GRVANISLQGKGLSGEIPAAVG-GLKSLTGLYLHFN-ALNGV-IPKEIASLSELSDLYLNVNNLSGKIPSQIG----NMT 137 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~l~ 137 (673)
.+++.|+|+++.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4678888888888777666665 6788888888887 45432 444445778888888888887765544443 566
Q ss_pred CCcEeeccCcc--ccc-cCchhhcCccccCeeccccc-ccCccCCccccCCCccccccccc
Q 005859 138 NLQVLQLCYNK--LTG-NIPTQLGSLRKLSVLALQYN-QLTGAIPASLGDLGMLMRLDLSF 194 (673)
Q Consensus 138 ~L~~L~L~~N~--l~~-~~p~~l~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~ 194 (673)
+|+.|+|++|. ++. .++..+..+++|+.|++++| .+. .+|..+..+++|+.|+++.
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~ 244 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGG 244 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSB
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEccccc
Confidence 88888888876 221 11122344578888888877 333 3555566666666666443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.70 E-value=3.2e-10 Score=127.79 Aligned_cols=156 Identities=17% Similarity=0.183 Sum_probs=75.8
Q ss_pred CCEEEEEecCCCcccc-cCccccCCCCCCeEeC---------cCCcCCccCCcccC-CCCCCCEEEccCCCCCCCCcccc
Q 005859 65 GRVANISLQGKGLSGE-IPAAVGGLKSLTGLYL---------HFNALNGVIPKEIA-SLSELSDLYLNVNNLSGKIPSQI 133 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~-~p~~~~~l~~L~~L~L---------~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~ 133 (673)
.++..|+++++ +... ++.....+++|++|+| ..|.+++.....+. .+++|+.|+++.|.+++..+..+
T Consensus 314 ~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l 392 (594)
T 2p1m_B 314 PKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITI 392 (594)
T ss_dssp TTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHH
T ss_pred CCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHH
Confidence 35667777766 3322 2222234666777766 23444432222222 25666666666666654444444
Q ss_pred c-CCCCCcEeecc--C----cccccc-----CchhhcCccccCeecccccccCccCCccccC-CCcccccccccccCCCC
Q 005859 134 G-NMTNLQVLQLC--Y----NKLTGN-----IPTQLGSLRKLSVLALQYNQLTGAIPASLGD-LGMLMRLDLSFNNLFGP 200 (673)
Q Consensus 134 ~-~l~~L~~L~L~--~----N~l~~~-----~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~ 200 (673)
. .+++|+.|+|+ + |.++.. ++..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++.
T Consensus 393 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~ 471 (594)
T 2p1m_B 393 ARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDL 471 (594)
T ss_dssp HHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHH
T ss_pred HhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHH
Confidence 3 35666666666 2 344311 111244455566666644 444333333333 55555666665555443
Q ss_pred Ccccc-cCCCCCCEEEccCCCCC
Q 005859 201 VPVKL-ANVPKLEVLDIRNNSFS 222 (673)
Q Consensus 201 ~p~~~-~~l~~L~~L~l~~N~l~ 222 (673)
.+..+ .++++|+.|+|++|+++
T Consensus 472 ~~~~l~~~~~~L~~L~L~~n~~~ 494 (594)
T 2p1m_B 472 GMHHVLSGCDSLRKLEIRDCPFG 494 (594)
T ss_dssp HHHHHHHHCTTCCEEEEESCSCC
T ss_pred HHHHHHhcCCCcCEEECcCCCCc
Confidence 33222 34555566666665553
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.68 E-value=5.3e-08 Score=103.77 Aligned_cols=149 Identities=13% Similarity=0.094 Sum_probs=93.4
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..+..++|++|+++-.-...|. ..+|+.+.|..| ++..-...|.++++|+.+++..| ++..-..+|.+ ++|+.+.|
T Consensus 180 ~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l 255 (401)
T 4fdw_A 180 YNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL 255 (401)
T ss_dssp TTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE
T ss_pred ccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe
Confidence 3577888888877754445555 578888888744 66566667778888888888764 44344455555 56666666
Q ss_pred cCccccccCchhhcCccccCeecccccccC-----ccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLT-----GAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNN 219 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~-----~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 219 (673)
.|.++..-+..|.++++|+.+++.+|.+. ...+..|.++++|+.++|. |.+......+|.++++|+.++|.+|
T Consensus 256 -p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~ 333 (401)
T 4fdw_A 256 -PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN 333 (401)
T ss_dssp -ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT
T ss_pred -CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc
Confidence 34455444556666666776666666553 2334456666666666666 3355444556666666666666443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.65 E-value=5.5e-09 Score=109.49 Aligned_cols=162 Identities=14% Similarity=0.168 Sum_probs=101.4
Q ss_pred CEEEEEecCCCc---------ccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCccccc--
Q 005859 66 RVANISLQGKGL---------SGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIG-- 134 (673)
Q Consensus 66 ~v~~l~l~~~~l---------~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-- 134 (673)
++..|.+.++.. .+.++..+..+++|+.|+|++|.-. .++. +. +++|+.|+|..|.++......+.
T Consensus 140 ~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~ 216 (362)
T 2ra8_A 140 HFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGS 216 (362)
T ss_dssp TCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHS
T ss_pred hhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHc
Confidence 567777755432 1234455667788888888887311 2333 33 78888888888877643333343
Q ss_pred CCCCCcEeeccC--cccccc-----Cchhh--cCccccCeecccccccCccCCccc---cCCCcccccccccccCCCC--
Q 005859 135 NMTNLQVLQLCY--NKLTGN-----IPTQL--GSLRKLSVLALQYNQLTGAIPASL---GDLGMLMRLDLSFNNLFGP-- 200 (673)
Q Consensus 135 ~l~~L~~L~L~~--N~l~~~-----~p~~l--~~l~~L~~L~l~~N~l~~~~p~~~---~~l~~L~~L~l~~N~l~~~-- 200 (673)
.+++|+.|+|+. |...+. +...+ ..+++|++|+|.+|.+....+..+ ..+++|+.|+|+.|.+.+.
T Consensus 217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~ 296 (362)
T 2ra8_A 217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGA 296 (362)
T ss_dssp BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHH
T ss_pred cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHH
Confidence 688888888853 222211 11222 247888899998888865433333 2577888999988888763
Q ss_pred --CcccccCCCCCCEEEccCCCCCcCCchhhh
Q 005859 201 --VPVKLANVPKLEVLDIRNNSFSGNVPPALK 230 (673)
Q Consensus 201 --~p~~~~~l~~L~~L~l~~N~l~g~~p~~l~ 230 (673)
++..+..+++|+.|+|++|.++...-..+.
T Consensus 297 ~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~ 328 (362)
T 2ra8_A 297 RLLLDHVDKIKHLKFINMKYNYLSDEMKKELQ 328 (362)
T ss_dssp HHHHTTHHHHTTCSEEECCSBBCCHHHHHHHH
T ss_pred HHHHhhcccCCcceEEECCCCcCCHHHHHHHH
Confidence 233344568888999988887754333343
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.64 E-value=1.2e-07 Score=101.07 Aligned_cols=145 Identities=14% Similarity=0.081 Sum_probs=81.8
Q ss_pred EEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccC
Q 005859 67 VANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCY 146 (673)
Q Consensus 67 v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 146 (673)
++.+.|.+ .+...-+.+|.++++|+.++|++|.++......|. ..+|+.+.|.+| +...-..+|.++++|+.++|..
T Consensus 159 L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~ 235 (401)
T 4fdw_A 159 VQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPE 235 (401)
T ss_dssp CCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCT
T ss_pred ceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCC
Confidence 44555543 44433344566666666666666666644444444 456666666533 4444455566666666666665
Q ss_pred ccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCC-----CCCcccccCCCCCCEEEcc
Q 005859 147 NKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLF-----GPVPVKLANVPKLEVLDIR 217 (673)
Q Consensus 147 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-----~~~p~~~~~l~~L~~L~l~ 217 (673)
| ++..-...|.+ .+|+.+.| .|.++..-+..|.++++|+.+++.+|.+. ...+.+|.++++|+.++|.
T Consensus 236 ~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~ 308 (401)
T 4fdw_A 236 N-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP 308 (401)
T ss_dssp T-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC
T ss_pred C-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC
Confidence 4 34333445555 55666666 34454444556666777777777666554 2334556666777777666
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.60 E-value=4e-09 Score=105.05 Aligned_cols=105 Identities=25% Similarity=0.301 Sum_probs=73.8
Q ss_pred ccCCCCCCe--EeCcCCcCC---ccCCcccCCCCCCCEEEccCCCCCC--CCcccccCCCCCcEeeccCccccccCchhh
Q 005859 85 VGGLKSLTG--LYLHFNALN---GVIPKEIASLSELSDLYLNVNNLSG--KIPSQIGNMTNLQVLQLCYNKLTGNIPTQL 157 (673)
Q Consensus 85 ~~~l~~L~~--L~L~~N~l~---~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l 157 (673)
|...+.|.. ++++.|... +.++-...++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 455556665 778888533 3333333568899999999999997 4567788899999999999999965 334
Q ss_pred cCcc--ccCeecccccccCccCCc-------cccCCCcccccc
Q 005859 158 GSLR--KLSVLALQYNQLTGAIPA-------SLGDLGMLMRLD 191 (673)
Q Consensus 158 ~~l~--~L~~L~l~~N~l~~~~p~-------~~~~l~~L~~L~ 191 (673)
..+. +|++|+|++|.+.+.+|. .+..+++|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 4444 788888888888876652 244555555554
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.51 E-value=7.3e-09 Score=97.96 Aligned_cols=122 Identities=11% Similarity=0.051 Sum_probs=61.2
Q ss_pred cCccccCCCCCCeEeCcCC-cCCc----cCCcccCCCCCCCEEEccCCCCCCC----CcccccCCCCCcEeeccCccccc
Q 005859 81 IPAAVGGLKSLTGLYLHFN-ALNG----VIPKEIASLSELSDLYLNVNNLSGK----IPSQIGNMTNLQVLQLCYNKLTG 151 (673)
Q Consensus 81 ~p~~~~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~ 151 (673)
+...+...+.|++|+|++| .|.. .+...+...++|++|+|++|.+... +...+...++|++|+|++|.+..
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 3344555666777777766 6652 1233444555666666666665421 12233334455555555555542
Q ss_pred cCchhhcCccccCeecccccccCccCCccccCCCccccccc--ccccCCCC----CcccccCCCCCCEEEccCCCCC
Q 005859 152 NIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDL--SFNNLFGP----VPVKLANVPKLEVLDIRNNSFS 222 (673)
Q Consensus 152 ~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l--~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 222 (673)
.--. .+...+...++|+.|+| ++|.+... +...+...++|+.|+|++|.+.
T Consensus 108 ~g~~--------------------~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 108 SGIL--------------------ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHH--------------------HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHH--------------------HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 1000 12223333444555555 44544432 2233444567888888888764
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.47 E-value=2.9e-08 Score=104.01 Aligned_cols=159 Identities=16% Similarity=0.166 Sum_probs=109.9
Q ss_pred CCCEEEEEecCCCccc-c-------cCccccCCCCCCeEeCcCCcCC---------ccCCcccCCCCCCCEEEccCCCCC
Q 005859 64 NGRVANISLQGKGLSG-E-------IPAAVGGLKSLTGLYLHFNALN---------GVIPKEIASLSELSDLYLNVNNLS 126 (673)
Q Consensus 64 ~~~v~~l~l~~~~l~g-~-------~p~~~~~l~~L~~L~L~~N~l~---------~~~p~~~~~l~~L~~L~l~~N~l~ 126 (673)
..+|+.|.+...+..| . +..++..+++|+.|.+..+.+. +.++..+..+++|+.|+|++|.-.
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l 185 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL 185 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence 3568888888776553 2 2334667899999999766432 234455677899999999988411
Q ss_pred CCCcccccCCCCCcEeeccCccccccCchhhc--CccccCeecccc--cccCcc-----CCccc--cCCCcccccccccc
Q 005859 127 GKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLG--SLRKLSVLALQY--NQLTGA-----IPASL--GDLGMLMRLDLSFN 195 (673)
Q Consensus 127 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~--~l~~L~~L~l~~--N~l~~~-----~p~~~--~~l~~L~~L~l~~N 195 (673)
.++. +. +++|+.|+|..|.+.......+. .+++|+.|+|+. |...+. +...+ ..+++|+.|+|.+|
T Consensus 186 -~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~ 262 (362)
T 2ra8_A 186 -SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDA 262 (362)
T ss_dssp -BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESC
T ss_pred -eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCC
Confidence 3444 43 89999999999988754444454 789999999863 322111 11222 35789999999999
Q ss_pred cCCCCCccccc---CCCCCCEEEccCCCCCcCC
Q 005859 196 NLFGPVPVKLA---NVPKLEVLDIRNNSFSGNV 225 (673)
Q Consensus 196 ~l~~~~p~~~~---~l~~L~~L~l~~N~l~g~~ 225 (673)
.+....+..+. .+++|+.|+|+.|.+.+.-
T Consensus 263 ~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G 295 (362)
T 2ra8_A 263 EEQNVVVEMFLESDILPQLETMDISAGVLTDEG 295 (362)
T ss_dssp TTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHH
T ss_pred CCchHHHHHHHhCccCCCCCEEECCCCCCChHH
Confidence 98754333333 5789999999999998643
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.43 E-value=2.3e-08 Score=94.46 Aligned_cols=99 Identities=17% Similarity=0.181 Sum_probs=53.8
Q ss_pred cccCCCCCCCEEEccCC-CCCCC----CcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccc
Q 005859 107 KEIASLSELSDLYLNVN-NLSGK----IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASL 181 (673)
Q Consensus 107 ~~~~~l~~L~~L~l~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~ 181 (673)
..+...++|++|+|++| .+... +...+...++|++|+|++|.+...-.. .+...+
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~--------------------~l~~~L 89 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAF--------------------ALAEML 89 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHH--------------------HHHHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHH--------------------HHHHHH
Confidence 34455566666666666 55421 223334445555555555555421110 112223
Q ss_pred cCCCcccccccccccCCCC----CcccccCCCCCCEEEc--cCCCCCcCC
Q 005859 182 GDLGMLMRLDLSFNNLFGP----VPVKLANVPKLEVLDI--RNNSFSGNV 225 (673)
Q Consensus 182 ~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l--~~N~l~g~~ 225 (673)
...++|+.|+|++|.|... +...+...++|+.|+| ++|.|...-
T Consensus 90 ~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g 139 (185)
T 1io0_A 90 KVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNV 139 (185)
T ss_dssp HHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHH
T ss_pred HhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHH
Confidence 3334555566666655432 3445666788999999 889998643
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=2.1e-06 Score=87.90 Aligned_cols=137 Identities=18% Similarity=0.126 Sum_probs=89.0
Q ss_pred ccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCC---CceeEeeEEecCCCCeEEEEEeec
Q 005859 407 ANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHE---NLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
.+.++.|....||+. |..+++|+... ......+.+|.++|+.+.+. .+.+++.+.. ...+..++||||+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEEEecc
Confidence 345788888899987 56688887532 12345788999999999652 2456666653 2235678999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHG---------------------------------------- 523 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~---------------------------------------- 523 (673)
+|..+.+..- ..++...+..++.++++.|+.||+
T Consensus 96 ~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 96 QGQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CSEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred CCeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9987765211 012333333344444444444332
Q ss_pred ------------------CCCCcccCCcCCCCeEecC---CCC-eeeccccccccc
Q 005859 524 ------------------KRPGLVHPNLSAEKVLIHR---RYN-PLLSDSGLHKLL 557 (673)
Q Consensus 524 ------------------~~~~ivHrDlk~~NILl~~---~~~-~kl~DfGla~~~ 557 (673)
..+.++|+|+++.||+++. ++. ..|.||+.+..-
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2235799999999999987 455 479999987653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=5.3e-06 Score=83.10 Aligned_cols=134 Identities=12% Similarity=0.101 Sum_probs=90.5
Q ss_pred ccccCCcc-eEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCeEEEEEeecCC
Q 005859 409 LLGKSSFS-ATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGICCSKGRGECFLIYDFVPN 485 (673)
Q Consensus 409 ~lg~G~~g-~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~lv~E~~~~ 485 (673)
.+..|..+ .||+..... +..+.+|+-... ...++.+|.++|+.+. +--+.++++++.+. +..++|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEeeCC
Confidence 34556555 689887654 667888976532 3456888999998884 33466778777544 678999999999
Q ss_pred CChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 005859 486 GNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK----------------------------------------- 524 (673)
Q Consensus 486 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------- 524 (673)
.++.+..... ......++.+++..|+-||..
T Consensus 105 ~~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 105 KTAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp EEHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred ccccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 8776654211 112223445555555555532
Q ss_pred ---------------CCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 525 ---------------RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 525 ---------------~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
.+.++|+|+.+.||++++++.+-|.||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11378999999999999877677999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=4.3e-06 Score=87.54 Aligned_cols=84 Identities=11% Similarity=0.019 Sum_probs=55.6
Q ss_pred cccc-ccCCcceEEEEEEc-------CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccC-C--CCceeEeeEEecCC-
Q 005859 407 ANLL-GKSSFSATYKGILR-------DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLK-H--ENLASLRGICCSKG- 472 (673)
Q Consensus 407 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~- 472 (673)
.+.| +.|....+|+.... +++.+++|....... ......+.+|+++++.+. + ..+.++++++.+.+
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78888999998764 266788887654320 001245778888888884 3 35667777764321
Q ss_pred CCeEEEEEeecCCCChhh
Q 005859 473 RGECFLIYDFVPNGNLLQ 490 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~ 490 (673)
.+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 134689999999877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.90 E-value=3.1e-05 Score=80.21 Aligned_cols=143 Identities=17% Similarity=0.208 Sum_probs=79.5
Q ss_pred cccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCC--CCceeEeeE----EecCCCCeEEEEEe
Q 005859 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKH--ENLASLRGI----CCSKGRGECFLIYD 481 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~----~~~~~~~~~~lv~E 481 (673)
+.|+.|..+.||+....+| .+++|+.... ...+..|.++++.+.. -.+.+++.. ......+..++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 4566677889999987655 4888988642 2344455666655531 123333321 00011356789999
Q ss_pred ecCCCChh--------------hhhccccC----C------ccccCHHHH------------------------------
Q 005859 482 FVPNGNLL--------------QHLDLEAG----S------EKVLEWATR------------------------------ 507 (673)
Q Consensus 482 ~~~~gsL~--------------~~l~~~~~----~------~~~l~~~~~------------------------------ 507 (673)
|++|..+. ..+|.... . ...-.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 11121100 0 011233221
Q ss_pred -HHHHHHHHHHHHHHhc-----------CCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 508 -ISVIKGIAKGISYLHG-----------KRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 508 -~~i~~~ia~gL~yLH~-----------~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
..+..++..++++|+. ..+.++|+|+++.||+++.++.+.|.||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111224456667763 234799999999999998888899999997753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=5.3e-05 Score=80.43 Aligned_cols=76 Identities=4% Similarity=-0.070 Sum_probs=49.5
Q ss_pred ccccccCCcceEEEEEEc-CCcEEEEEEecccCC------CCcHHHHHHHHHHHhccCC--CC-ceeEeeEEecCCCCeE
Q 005859 407 ANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC------KSDEGEFLKGLKILTSLKH--EN-LASLRGICCSKGRGEC 476 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~H--~n-iv~l~~~~~~~~~~~~ 476 (673)
.+.||.|.++.||++... +++.|+||....... ......+..|.++++.+.. |. +.+++.+. . +..
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~--~~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EMA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C--Ccc
Confidence 457999999999999764 468899998654211 1123467789999888742 33 44555432 2 335
Q ss_pred EEEEeecCCC
Q 005859 477 FLIYDFVPNG 486 (673)
Q Consensus 477 ~lv~E~~~~g 486 (673)
++||||+++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 7999999764
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.65 E-value=9.4e-05 Score=78.42 Aligned_cols=109 Identities=12% Similarity=0.131 Sum_probs=53.2
Q ss_pred cccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCc
Q 005859 107 KEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGM 186 (673)
Q Consensus 107 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 186 (673)
..|.++..|+.+.+..+..+ .-...|.++++|+.+.+. +.++..-...|.++.+|+.++|..+ ++..-..+|.++.+
T Consensus 259 ~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~ 335 (394)
T 4gt6_A 259 HAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQ 335 (394)
T ss_dssp TTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred ceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCC
Confidence 34555555555555444322 333445555555555554 2333333345555555555555433 33233344555555
Q ss_pred ccccccccccCCCCCcccccCCCCCCEEEccCC
Q 005859 187 LMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNN 219 (673)
Q Consensus 187 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 219 (673)
|+.+.|..+ ++..-..+|.++.+|+.+++.+|
T Consensus 336 L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~ 367 (394)
T 4gt6_A 336 LERIAIPSS-VTKIPESAFSNCTALNNIEYSGS 367 (394)
T ss_dssp CCEEEECTT-CCBCCGGGGTTCTTCCEEEESSC
T ss_pred CCEEEECcc-cCEEhHhHhhCCCCCCEEEECCc
Confidence 555555433 33333445555555555555554
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00011 Score=74.20 Aligned_cols=79 Identities=19% Similarity=0.163 Sum_probs=56.7
Q ss_pred CCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCC---CCceeEeeEEecCCCCeEEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKH---ENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~~~~~~~~lv 479 (673)
.....+.+|.|..+.||+.+..+|+.|.+|+..... ......|..|++.|+.+.- --+.+++++. ..++|
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~------~~~lv 88 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD------DRTLA 88 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE------TTEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEecc------CceEE
Confidence 344566789999999999999999999999765443 2334568899999988842 2344555432 23789
Q ss_pred EeecCCCCh
Q 005859 480 YDFVPNGNL 488 (673)
Q Consensus 480 ~E~~~~gsL 488 (673)
|||++++..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.64 E-value=6.6e-05 Score=80.38 Aligned_cols=80 Identities=13% Similarity=0.128 Sum_probs=49.4
Q ss_pred CCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhhhhccCCCCCccCCccccCC---CCCcchhHHHHHHHHHHH
Q 005859 525 RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG---RFTEKSDIYAFGMIVFQI 601 (673)
Q Consensus 525 ~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSfGvvl~el 601 (673)
.+.++|+|+++.||+++.++ ++|.||+.+..-.........-..-...|.+|+..... .-....++.+....+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 34799999999999998876 99999998875432211110000011235666554311 122345667888888888
Q ss_pred HhCC
Q 005859 602 LSGK 605 (673)
Q Consensus 602 ~tG~ 605 (673)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.0004 Score=70.82 Aligned_cols=139 Identities=19% Similarity=0.201 Sum_probs=90.6
Q ss_pred cccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccC---CCCceeEeeEEecCCCCeEEEEEee
Q 005859 406 EANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK---HENLASLRGICCSKGRGECFLIYDF 482 (673)
Q Consensus 406 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~~~lv~E~ 482 (673)
..+.|+.|....+|+... +++.+++|+.... ....+..|.+.|+.+. ...+.+++++... .+..++||||
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lvme~ 112 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLLLEA 112 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEEEEC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEEEEe
Confidence 345789999999999886 4667888976542 3567889999998883 3567788877644 3678999999
Q ss_pred cCCCChhh-----------hhccccC-C-----------------ccccCHHHHH---HHHH----------------HH
Q 005859 483 VPNGNLLQ-----------HLDLEAG-S-----------------EKVLEWATRI---SVIK----------------GI 514 (673)
Q Consensus 483 ~~~gsL~~-----------~l~~~~~-~-----------------~~~l~~~~~~---~i~~----------------~i 514 (673)
+++..+.. .||.... . ...-+|.... ++.. .+
T Consensus 113 l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l 192 (312)
T 3jr1_A 113 LNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLI 192 (312)
T ss_dssp CCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHH
T ss_pred ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHH
Confidence 99876521 1222111 0 0012565321 1111 11
Q ss_pred HHH-HHHH--hcCCCCcccCCcCCCCeEecCCCCeeecccc
Q 005859 515 AKG-ISYL--HGKRPGLVHPNLSAEKVLIHRRYNPLLSDSG 552 (673)
Q Consensus 515 a~g-L~yL--H~~~~~ivHrDlk~~NILl~~~~~~kl~DfG 552 (673)
... ...| |...|.++|+|+.+.|++++.++ +.|.||.
T Consensus 193 ~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 193 VQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 111 2234 33456899999999999999887 8899974
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00029 Score=74.14 Aligned_cols=131 Identities=12% Similarity=0.076 Sum_probs=82.5
Q ss_pred cccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCcccc
Q 005859 84 AVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKL 163 (673)
Q Consensus 84 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 163 (673)
.+....+|+.+.+..+ +.......|.++..|+.+.+..+ ++..-...|.++.+|+.+.+..+ +...-...|.++++|
T Consensus 212 ~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L 288 (379)
T 4h09_A 212 GFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNL 288 (379)
T ss_dssp TTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTC
T ss_pred ccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccc
Confidence 4555666666666544 33344456667777777777665 44344556777777777777543 443444567777777
Q ss_pred CeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccC
Q 005859 164 SVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRN 218 (673)
Q Consensus 164 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 218 (673)
+.+.+.++.++..-...|.++.+|+.+.|..+ ++..-..+|.++.+|+.+.+..
T Consensus 289 ~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 289 TKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp CEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred ccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 77777777776555556777777777777644 4433445677777777666543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.46 E-value=3.1e-05 Score=71.41 Aligned_cols=33 Identities=6% Similarity=0.128 Sum_probs=13.9
Q ss_pred CCEEEccCCCCCCCCcccccCCCCCcEeeccCc
Q 005859 115 LSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYN 147 (673)
Q Consensus 115 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 147 (673)
|++|||+++.++..--..+.++++|+.|+|++|
T Consensus 63 L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 63 IQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp EEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred EeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 444444444433222223344444555555444
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.44 E-value=3.8e-05 Score=70.84 Aligned_cols=84 Identities=10% Similarity=0.082 Sum_probs=48.6
Q ss_pred CCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCC-CCCCCcccccCC----CCCcEeeccCcc-ccccCchhhcCccc
Q 005859 89 KSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNN-LSGKIPSQIGNM----TNLQVLQLCYNK-LTGNIPTQLGSLRK 162 (673)
Q Consensus 89 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~~l~~l~~ 162 (673)
-.|+.|||+++.++..--..+.++++|++|+|+++. ++..--..+..+ ++|+.|+|++|. ++..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 356666666666653333445677777777777764 543222334443 357777777764 55332334556666
Q ss_pred cCeecccccc
Q 005859 163 LSVLALQYNQ 172 (673)
Q Consensus 163 L~~L~l~~N~ 172 (673)
|+.|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 7777766654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.0004 Score=73.52 Aligned_cols=128 Identities=13% Similarity=0.071 Sum_probs=81.5
Q ss_pred cccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCcccc
Q 005859 84 AVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKL 163 (673)
Q Consensus 84 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 163 (673)
.+.++..|+.+.+..+... .....|..+..|+.+.+..+.+ ....|..+.+|+.+.+..+ ++..-..+|.++++|
T Consensus 248 ~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L 322 (394)
T 4fs7_A 248 VFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSL 322 (394)
T ss_dssp TTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTC
T ss_pred cccccccceeEEcCCCcce-eeccccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCC
Confidence 4555666666666555432 3444566666666666655432 2345667777777777654 554445677778888
Q ss_pred CeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccC
Q 005859 164 SVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRN 218 (673)
Q Consensus 164 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 218 (673)
+.++|.++ ++..-..+|.++.+|+.+.+..| ++..-..+|.++++|+.+++..
T Consensus 323 ~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~ 375 (394)
T 4fs7_A 323 VSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPK 375 (394)
T ss_dssp CEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEG
T ss_pred CEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECC
Confidence 88887644 55444557778888888888766 5544456777888888877654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00053 Score=72.05 Aligned_cols=125 Identities=13% Similarity=0.047 Sum_probs=98.9
Q ss_pred cCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCc
Q 005859 81 IPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSL 160 (673)
Q Consensus 81 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 160 (673)
-...+.++..|+.+.+..+ ++..-...|.++.+|+.+.+..+ +.......|.++++|+.+.+.+|.++..-...|.++
T Consensus 232 ~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c 309 (379)
T 4h09_A 232 GDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDC 309 (379)
T ss_dssp CTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTC
T ss_pred ccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCC
Confidence 3456788999999999876 66566678899999999999765 554556679999999999999999986667899999
Q ss_pred cccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCC
Q 005859 161 RKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVP 209 (673)
Q Consensus 161 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 209 (673)
.+|+.+.|..+ ++..-..+|.++.+|+.+.+..+ ++..-..+|.++.
T Consensus 310 ~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 310 VKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp TTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred CCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 99999999765 66455568999999999998755 4433345666554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00036 Score=73.89 Aligned_cols=63 Identities=13% Similarity=0.061 Sum_probs=40.0
Q ss_pred ccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCc
Q 005859 83 AAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYN 147 (673)
Q Consensus 83 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 147 (673)
.+|.++++|+.+.|..+ ++..-...|.++++|+.++|.+| ++..-...|.++++|+.+.+..+
T Consensus 65 ~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~ 127 (394)
T 4fs7_A 65 AAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM 127 (394)
T ss_dssp TTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred HHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc
Confidence 45677777777777643 55455566777777777777654 44344456667777776665543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00083 Score=71.05 Aligned_cols=87 Identities=10% Similarity=0.083 Sum_probs=53.6
Q ss_pred cccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCC
Q 005859 130 PSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVP 209 (673)
Q Consensus 130 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 209 (673)
..+|.++++|+.+.+..+..+ .-...|.++++|+.+.+. +.++..-...|.++.+|+.++|..+ ++..-..+|.++.
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~ 334 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE 334 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred cceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC
Confidence 445667777777777655443 444566677777777775 3444344446777777777777654 4433445677777
Q ss_pred CCCEEEccCC
Q 005859 210 KLEVLDIRNN 219 (673)
Q Consensus 210 ~L~~L~l~~N 219 (673)
+|+.+.+..+
T Consensus 335 ~L~~i~ip~s 344 (394)
T 4gt6_A 335 QLERIAIPSS 344 (394)
T ss_dssp TCCEEEECTT
T ss_pred CCCEEEECcc
Confidence 7777777543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0011 Score=67.98 Aligned_cols=161 Identities=13% Similarity=0.099 Sum_probs=87.3
Q ss_pred cCHHHHHHHhcCCcc-----ccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCC--ceeE
Q 005859 392 FNLEEVERATQCFSE-----ANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHEN--LASL 464 (673)
Q Consensus 392 ~~~~~l~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l 464 (673)
++.+++...-..|.. .+.|+.|....+|+....+| .+++|...... ....+..|++++..+.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 445566555555543 34466788889999987666 57789876521 2235667888777764222 2333
Q ss_pred eeEE----ecCCCCeEEEEEeecCCCChhh--------------hhcccc-C---C----ccccCHHHHHH---------
Q 005859 465 RGIC----CSKGRGECFLIYDFVPNGNLLQ--------------HLDLEA-G---S----EKVLEWATRIS--------- 509 (673)
Q Consensus 465 ~~~~----~~~~~~~~~lv~E~~~~gsL~~--------------~l~~~~-~---~----~~~l~~~~~~~--------- 509 (673)
+... .....+..+++|||++|..+.. .+|... . . .....|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 3210 0001245689999998865421 011110 0 0 01112332111
Q ss_pred ---HHHHHHHHHHHHhc-----CCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 510 ---VIKGIAKGISYLHG-----KRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 510 ---i~~~ia~gL~yLH~-----~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
+...+...+++++. ..++++|+|+.+.|||++++..+.|.||+.+..
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 01123445555542 123699999999999999876568999987753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0018 Score=65.62 Aligned_cols=71 Identities=1% Similarity=-0.053 Sum_probs=42.8
Q ss_pred ccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCc-eeEeeEEecCCCCeEEEEEeec-C
Q 005859 407 ANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENL-ASLRGICCSKGRGECFLIYDFV-P 484 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~~~lv~E~~-~ 484 (673)
.+.|+.|....+|+. +.+++|+....... .....+|+++++.+....+ .+++++. . +.-++|+||+ +
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~~--~--~~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHVD--P--ATGVMVTRYIAG 91 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEEC--T--TTCCEEEECCTT
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEEE--C--CCCEEEEeecCC
Confidence 467888999999998 45888877653211 1123467777777642222 4555543 2 2246899999 5
Q ss_pred CCCh
Q 005859 485 NGNL 488 (673)
Q Consensus 485 ~gsL 488 (673)
+.++
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 5444
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.98 E-value=0.00015 Score=68.04 Aligned_cols=19 Identities=16% Similarity=0.111 Sum_probs=12.4
Q ss_pred cccCCCCCCEEEccCCCCC
Q 005859 204 KLANVPKLEVLDIRNNSFS 222 (673)
Q Consensus 204 ~~~~l~~L~~L~l~~N~l~ 222 (673)
.+..-+.|+.|+++.|.+.
T Consensus 152 aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 152 AIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHCSSCCEEECCCCCHH
T ss_pred HHHhCCCcCeEeccCCCcc
Confidence 3444567888888776643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0024 Score=65.68 Aligned_cols=33 Identities=21% Similarity=0.056 Sum_probs=27.8
Q ss_pred CCcccCCcCCCCeEecCC----CCeeecccccccccc
Q 005859 526 PGLVHPNLSAEKVLIHRR----YNPLLSDSGLHKLLA 558 (673)
Q Consensus 526 ~~ivHrDlk~~NILl~~~----~~~kl~DfGla~~~~ 558 (673)
+.++|+|+.+.||+++.+ ..+.|.||+.+..-.
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 479999999999999875 678999999886543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0059 Score=62.46 Aligned_cols=143 Identities=12% Similarity=0.095 Sum_probs=81.0
Q ss_pred cccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCC--CceeEeeEEec----CCCCeEEEEEe
Q 005859 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHE--NLASLRGICCS----KGRGECFLIYD 481 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~----~~~~~~~lv~E 481 (673)
..++ |....||+....+|+.+++|...... .....+..|..+++.+... .+++++.. .. ...+..++|||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEE
Confidence 3466 77789999887778789999886432 2345677788888877422 23444432 00 01245678999
Q ss_pred ecCCCChhh-----h---------hccccC-----CccccCHHHH----------------------HHHHHHHHHHHHH
Q 005859 482 FVPNGNLLQ-----H---------LDLEAG-----SEKVLEWATR----------------------ISVIKGIAKGISY 520 (673)
Q Consensus 482 ~~~~gsL~~-----~---------l~~~~~-----~~~~l~~~~~----------------------~~i~~~ia~gL~y 520 (673)
|++|..+.. + +|.... ....+++... ...+.+++..++-
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 998754321 0 111000 0112222211 0111122222221
Q ss_pred Hhc--CCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 521 LHG--KRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 521 LH~--~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
+-. ..+.++|+|+++.||+++ + .+.|.||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 111 233589999999999999 4 889999988754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.86 E-value=0.00018 Score=67.59 Aligned_cols=87 Identities=11% Similarity=0.077 Sum_probs=43.9
Q ss_pred ccCCCCCCeEeCcCC-cCCc----cCCcccCCCCCCCEEEccCCCCCC----CCcccccCCCCCcEeeccCcccccc---
Q 005859 85 VGGLKSLTGLYLHFN-ALNG----VIPKEIASLSELSDLYLNVNNLSG----KIPSQIGNMTNLQVLQLCYNKLTGN--- 152 (673)
Q Consensus 85 ~~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~--- 152 (673)
+.+-+.|+.|+|++| .|.. .+-+.+..-+.|+.|+|++|.|.. .+-..+..-+.|+.|+|++|.|...
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 334456677777664 5541 123334445566666666666652 1222333345566666666666521
Q ss_pred -CchhhcCccccCeeccccc
Q 005859 153 -IPTQLGSLRKLSVLALQYN 171 (673)
Q Consensus 153 -~p~~l~~l~~L~~L~l~~N 171 (673)
+-..+..-+.|++|+|++|
T Consensus 117 ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHhhCCceeEEECCCC
Confidence 1223334445666666543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0064 Score=57.41 Aligned_cols=99 Identities=16% Similarity=0.129 Sum_probs=64.1
Q ss_pred CChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcchhhh
Q 005859 486 GNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSM 565 (673)
Q Consensus 486 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 565 (673)
-+|.++|... +.++++++++.++.|.+++|.-+-..+ .-..+=+.|..|++..+|.+...+ ..+.
T Consensus 33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRR-QPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcc-cCCceecCCcceEEecCCceeccc-cccc----------
Confidence 3788888743 457999999999999999987762111 011223346899999999887764 1110
Q ss_pred hccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh
Q 005859 566 LKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS 603 (673)
Q Consensus 566 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t 603 (673)
.....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0122356888764 345788899999999998875
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0027 Score=55.52 Aligned_cols=35 Identities=26% Similarity=0.338 Sum_probs=15.3
Q ss_pred CCEEEccCCCCCCCCcccccCCCCCcEeeccCccc
Q 005859 115 LSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKL 149 (673)
Q Consensus 115 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 149 (673)
|+.|+|++|+|+...+..|..+++|+.|+|++|.+
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 44444444444433333344444444444444444
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0032 Score=55.07 Aligned_cols=56 Identities=25% Similarity=0.307 Sum_probs=47.1
Q ss_pred EEEecCCCcc-cccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCC
Q 005859 69 NISLQGKGLS-GEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLS 126 (673)
Q Consensus 69 ~l~l~~~~l~-g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 126 (673)
.++.++++|+ ..+|..+. ++|+.|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 6777888886 46775442 47999999999999888888999999999999999875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0055 Score=65.44 Aligned_cols=73 Identities=18% Similarity=0.249 Sum_probs=49.7
Q ss_pred ccccccCCcceEEEEEEcC--------CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCc-eeEeeEEecCCCCeEE
Q 005859 407 ANLLGKSSFSATYKGILRD--------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENL-ASLRGICCSKGRGECF 477 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~~~ 477 (673)
.+.|+.|....||+....+ ++.+++|+.... .....+.+|..+++.+...++ .++++.+ . + .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~--~--~--g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIF--S--G--G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEE--T--T--E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEe--C--C--C
Confidence 3467888888999998753 478899987432 122466789999988843333 5677665 2 2 3
Q ss_pred EEEeecCCCCh
Q 005859 478 LIYDFVPNGNL 488 (673)
Q Consensus 478 lv~E~~~~gsL 488 (673)
+||||++|.++
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999986444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.0094 Score=62.30 Aligned_cols=141 Identities=12% Similarity=0.092 Sum_probs=82.0
Q ss_pred cccccCCcceEEEEEEcC--------CcEEEEEEecccCCCCcHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCeEEE
Q 005859 408 NLLGKSSFSATYKGILRD--------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~l 478 (673)
+.|..|-...+|+....+ ++.+++|+.... ......+.+|.++++.+. +.-..++++++ . + .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~--~--g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVF--P--E--GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--T--T--EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEc--C--C--cc
Confidence 356667788899998752 478899986332 234556778999998884 32235666665 3 2 28
Q ss_pred EEeecCCCChhhh-----------------hccccC-Ccccc--CHHHHHHHHHHHHH-------------------HHH
Q 005859 479 IYDFVPNGNLLQH-----------------LDLEAG-SEKVL--EWATRISVIKGIAK-------------------GIS 519 (673)
Q Consensus 479 v~E~~~~gsL~~~-----------------l~~~~~-~~~~l--~~~~~~~i~~~ia~-------------------gL~ 519 (673)
||||++|..|..- +|.... -.+.. -|.+..++..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999998555311 111100 01112 24455445444322 223
Q ss_pred HHh----c--CCCCcccCCcCCCCeEecCC----CCeeecccccccc
Q 005859 520 YLH----G--KRPGLVHPNLSAEKVLIHRR----YNPLLSDSGLHKL 556 (673)
Q Consensus 520 yLH----~--~~~~ivHrDlk~~NILl~~~----~~~kl~DfGla~~ 556 (673)
.|. . ....++|+|+.+.||+++.+ +.+.+.||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 2 22358999999999999876 6889999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.18 E-value=0.028 Score=60.34 Aligned_cols=73 Identities=11% Similarity=0.007 Sum_probs=47.1
Q ss_pred cccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCc-eeEeeEEecCCCCeEEEEEeecCC
Q 005859 408 NLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENL-ASLRGICCSKGRGECFLIYDFVPN 485 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~~~lv~E~~~~ 485 (673)
+.|+.|-...+|+....+ +..+++|+..... ...-+..+|..+++.+...++ .++++++ . + ..||||++|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~--~--G~v~e~I~G 185 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DEIINREREKKISCILYNKNIAKKIYVFF--T--N--GRIEEFMDG 185 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C--CSCSCHHHHHHHHHHHTTSSSBCCEEEEE--T--T--EEEEECCCS
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hhhcCHHHHHHHHHHHHhcCCCCCEEEEe--C--C--eEEEEeeCC
Confidence 467788888999998875 5788899875432 111112578888888865445 4677765 2 2 259999987
Q ss_pred CCh
Q 005859 486 GNL 488 (673)
Q Consensus 486 gsL 488 (673)
..|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.05 E-value=0.01 Score=61.95 Aligned_cols=73 Identities=10% Similarity=0.085 Sum_probs=43.3
Q ss_pred cccccCCcceEEEEEEcC---------CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCC-ceeEeeEEecCCCCeEE
Q 005859 408 NLLGKSSFSATYKGILRD---------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHEN-LASLRGICCSKGRGECF 477 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~~~ 477 (673)
..|+.|....+|+....+ ++.+++|+...... ...+...|.++++.+...+ +.++++.. . + +
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~--~ 110 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G--G 110 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T--E
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEec--C--C--c
Confidence 457778888999998754 26788887654321 1112357888888774333 44666543 2 2 6
Q ss_pred EEEeecCCCCh
Q 005859 478 LIYDFVPNGNL 488 (673)
Q Consensus 478 lv~E~~~~gsL 488 (673)
+||||++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.84 E-value=0.026 Score=58.05 Aligned_cols=32 Identities=22% Similarity=0.175 Sum_probs=27.9
Q ss_pred CCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 526 PGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 526 ~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
..++|+|+.+.||++++++.+.|.||+.+..-
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 36999999999999998888999999887653
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.83 E-value=0.11 Score=35.25 Aligned_cols=29 Identities=24% Similarity=0.406 Sum_probs=16.6
Q ss_pred ceehhHHHHHHHHHHHHHHhhhHhhhhcc
Q 005859 304 GVFVGVIAVFIILTVTGLFTFTWYRRRKQ 332 (673)
Q Consensus 304 ~~iv~vi~~~i~l~~~~l~~~~~~rr~~~ 332 (673)
+++.|+++++++++++++..++++|||++
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 45566666565555555555555555543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.25 E-value=0.22 Score=52.70 Aligned_cols=73 Identities=8% Similarity=-0.018 Sum_probs=47.0
Q ss_pred cccccCCcceEEEEEEcC--------CcEEEEEEecccCCCCcHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCeEEE
Q 005859 408 NLLGKSSFSATYKGILRD--------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~l 478 (673)
+.+..|-...+|+....+ ++.+++|+..... ...-+..+|.++++.+. +.-..++++.+ . + +.
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~--~~ 147 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADF--P--E--GR 147 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--T--EE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--C--CE
Confidence 456677788999998763 5788898865432 11112357888888774 32244666543 2 2 68
Q ss_pred EEeecCCCCh
Q 005859 479 IYDFVPNGNL 488 (673)
Q Consensus 479 v~E~~~~gsL 488 (673)
||||++|..|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998654
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=92.82 E-value=0.14 Score=34.48 Aligned_cols=21 Identities=29% Similarity=0.463 Sum_probs=11.3
Q ss_pred HHHHHHHHHHhhhHhhhhccc
Q 005859 313 FIILTVTGLFTFTWYRRRKQK 333 (673)
Q Consensus 313 ~i~l~~~~l~~~~~~rr~~~~ 333 (673)
+++++++++..++|.|||+++
T Consensus 21 vll~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 21 ILLVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHCSC
T ss_pred HHHHHHHHHHHHhheehhhhh
Confidence 444445555555666666543
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.67 E-value=0.16 Score=34.33 Aligned_cols=29 Identities=31% Similarity=0.449 Sum_probs=16.2
Q ss_pred ceehhHHHHHHHHHHHHHHhhhHhhhhcc
Q 005859 304 GVFVGVIAVFIILTVTGLFTFTWYRRRKQ 332 (673)
Q Consensus 304 ~~iv~vi~~~i~l~~~~l~~~~~~rr~~~ 332 (673)
+++.|+++++++++++++..++++|||++
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred eEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 45556666555555555555555555543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.19 E-value=1.1 Score=46.92 Aligned_cols=30 Identities=13% Similarity=0.231 Sum_probs=24.9
Q ss_pred cccCCcCCCCeEe------cCCCCeeeccccccccc
Q 005859 528 LVHPNLSAEKVLI------HRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 528 ivHrDlk~~NILl------~~~~~~kl~DfGla~~~ 557 (673)
++|+|+.+.|||+ +++..+++.||-.|..-
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 5699999999999 44567899999988643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.31 E-value=4.6 Score=37.90 Aligned_cols=119 Identities=13% Similarity=0.159 Sum_probs=78.7
Q ss_pred CCCCceeEeeEEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCC
Q 005859 457 KHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAE 536 (673)
Q Consensus 457 ~H~niv~l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~ 536 (673)
.||+.+.. .+- .+.+...+.|+.-+ +...+-. -+.++...+++++.+|+.-.++++.. +|--+.|+
T Consensus 43 ~~~~Fl~~-~I~--e~eD~v~~~y~~~~--~~~~f~~-----ik~~~~~eKlr~l~ni~~l~~~~~~r----~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELT--ELRDSFQIHYDIND--NHTPFDN-----IKSFTKNEKLRYLLNIKNLEEVNRTR----YTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEE--ECSSEEEEEECCCT--TSEEGGG-----GGGSCHHHHHHHHHHGGGGGGGGGSS----EECCCSGG
T ss_pred cCCcccce-EEE--EcccEEEEEEEcCc--ccCCHHH-----HHhcCHHHHHHHHHHHHHHHHHhcCc----eEEEEecc
Confidence 68888755 233 22355555555443 2222221 13478889999999999888777643 78889999
Q ss_pred CeEecCCCCeeeccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhh
Q 005859 537 KVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFT 612 (673)
Q Consensus 537 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~ 612 (673)
||+++.++.+++.-.|+...+ +|. ..++..=.-.+=+++..+++++..|....
T Consensus 109 NL~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~ 161 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDALV 161 (215)
T ss_dssp GEEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHH
T ss_pred eEEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHH
Confidence 999999999999988864322 222 11222224467778888999998876543
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.58 E-value=0.097 Score=56.20 Aligned_cols=60 Identities=3% Similarity=0.035 Sum_probs=16.9
Q ss_pred ccccccCCcceEEEEEEcC-CcEEEE------EEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEe
Q 005859 407 ANLLGKSSFSATYKGILRD-GSVVAV------KCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICC 469 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 469 (673)
.+.|| ||.||+|.+.. ...||| |..+..... .....|.+|..+++.++|||+++.+++..
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 34565 99999999864 467888 766543322 22356889999999999999999988764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.62 E-value=3.5 Score=38.80 Aligned_cols=118 Identities=11% Similarity=0.168 Sum_probs=77.3
Q ss_pred CCCCceeEeeEEecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHH-HHhcCCCCcccCCcCC
Q 005859 457 KHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGIS-YLHGKRPGLVHPNLSA 535 (673)
Q Consensus 457 ~H~niv~l~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~ivHrDlk~ 535 (673)
.||+. . ..+- .+.+...+.|+.-+++.=...+ +.++...+++++.+|+.-.. +++. -+|--+.|
T Consensus 48 ~~~~f-~-~~I~--~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI-V-RDID--VSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCP 112 (219)
T ss_dssp SCSSS-E-EEEE--ECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCG
T ss_pred cCCCC-C-eEEE--EeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeC
Confidence 67877 2 2222 3346666666655443322333 24778899999999988877 6664 47888999
Q ss_pred CCeEecCCCCeeeccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhh
Q 005859 536 EKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFT 612 (673)
Q Consensus 536 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~ 612 (673)
+||++|.++.++|.-.|+-.. ++|.- .++.-=.-.+=+++..++.++..|....
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe~l~ 166 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKES------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFDEYL 166 (219)
T ss_dssp GGEEECTTCCEEESCCEETTT------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHHHH
T ss_pred ceEEEeCCCcEEEEEcCCccc------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHHHH
Confidence 999999999999998886432 23321 1222223466777888888887776543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 673 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-50 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-47 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-45 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-43 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-42 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-42 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-41 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-41 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-40 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-40 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-40 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-38 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-36 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-36 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-36 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-35 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-35 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-35 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-35 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-34 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-33 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-33 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-33 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-28 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-27 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-27 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-26 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-26 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-25 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-24 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-23 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-23 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-22 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-21 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-20 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-19 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-16 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-15 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-08 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 8e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 6e-50
Identities = 60/279 (21%), Positives = 116/279 (41%), Gaps = 13/279 (4%)
Query: 395 EEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILT 454
+E E + LG F + G + VAVK + + S D FL ++
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMK 63
Query: 455 SLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGI 514
L+H+ L L + ++I +++ NG+L+ L +G + L + + I
Sbjct: 64 QLQHQRLVRLYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQI 118
Query: 515 AKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGY 574
A+G++++ +H +L A +L+ + ++D GL +L+ D+ + A + +
Sbjct: 119 AEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
Query: 575 LAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634
APE G FT KSD+++FG+++ +I++ P +E
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP 236
Query: 635 VSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
L Q+ C E P RP+ + + L ++
Sbjct: 237 ----EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-47
Identities = 56/265 (21%), Positives = 119/265 (44%), Gaps = 13/265 (4%)
Query: 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
+G F + G + VA+K I + E +F++ +++ L H L L G+
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG 527
C + L+++F+ +G L + + T + + + +G++YL
Sbjct: 69 CLEQA--PICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLE--EAC 121
Query: 528 LVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTE 587
++H +L+A L+ +SD G+ + + DD S + + +PE + R++
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 588 KSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALH 647
KSD+++FG++++++ S +S+V + I ++++ QI H
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENR----SNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237
Query: 648 CTHESPSHRPSIENVMQELSSIIGS 672
C E P RP+ ++++L+ I S
Sbjct: 238 CWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (420), Expect = 6e-47
Identities = 67/296 (22%), Positives = 123/296 (41%), Gaps = 28/296 (9%)
Query: 392 FNLEEVERATQCFSEA---------NLLGKSSFSATYKGILR----DGSVVAVKCIAKTS 438
F E+ A + F++ ++G F G L+ VA+K +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 439 CKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGS 498
+ +FL I+ H N+ L G+ +I +F+ NG+L L G
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS--TPVMIITEFMENGSLDSFLRQNDGQ 124
Query: 499 EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558
+ +++GIA G+ YL VH +L+A +L++ +SD GL + L
Sbjct: 125 F---TVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 559 DD----IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQ 614
DD S L + + APE +FT SD++++G+++++++S P+
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS--YGERPY--W 235
Query: 615 AAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+ V + I+ + + S L Q+ L C + +HRP ++ L +I
Sbjct: 236 DMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 6e-47
Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 13/266 (4%)
Query: 404 FSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLAS 463
+ LG F G R VA+K I + S DE F++ K++ +L HE L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE--FIEEAKVMMNLSHEKLVQ 63
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHG 523
L G+C + F+I +++ NG LL +L + + + K + + + YL
Sbjct: 64 LYGVCTKQR--PIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLES 118
Query: 524 KRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG 583
K +H +L+A L++ + +SD GL + + DD S + + + + PE
Sbjct: 119 K--QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 584 RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQ 643
+F+ KSDI+AFG+++++I S P+ R +S+ + I L + +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK--MPYERF--TNSETAEHIAQGLRLYRPHLASEKVYT 232
Query: 644 IALHCTHESPSHRPSIENVMQELSSI 669
I C HE RP+ + ++ + +
Sbjct: 233 IMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 165 bits (418), Expect = 8e-47
Identities = 63/282 (22%), Positives = 132/282 (46%), Gaps = 13/282 (4%)
Query: 393 NLEEVERATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLK 451
N ++ E + + LG + Y+G+ + VAVK + + + + +E FLK
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 65
Query: 452 ILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVI 511
++ +KH NL L G+C + ++I +F+ GNLL +L + + + + +
Sbjct: 66 VMKEIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMA 121
Query: 512 KGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAA 571
I+ + YL + +H +L+A L+ + ++D GL +L+ D + A
Sbjct: 122 TQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 572 MGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEG 631
+ + APE +F+ KSD++AFG+++++I + +P+ + S+V + ++ +
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM--SPY--PGIDLSQVYELLEKDYRM 235
Query: 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
+ + ++ C +PS RPS + Q ++ S
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-46
Identities = 53/274 (19%), Positives = 113/274 (41%), Gaps = 23/274 (8%)
Query: 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGE-FLKGLKILTSLKHENLASLRG 466
+G SF YKG VAVK + T+ + + F + +L +H N+ G
Sbjct: 14 QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
+ + ++ + +L HL E E I + + A+G+ YLH K
Sbjct: 72 YSTA---PQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAK-- 123
Query: 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASA-AMGYLAPEYTTT--- 582
++H +L + + +H + D GL + + + + ++ ++APE
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 583 GRFTEKSDIYAFGMIVFQILSGKCSITPF----TRQAAESSKVEDFIDPNLEGKFSVSEA 638
++ +SD+YAFG++++++++G+ P+ R ++ P+L K +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQ---LPYSNINNRDQIIFMVGRGYLSPDLS-KVRSNCP 239
Query: 639 SNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672
+ ++ C + RP ++ + + S
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 5e-46
Identities = 57/276 (20%), Positives = 117/276 (42%), Gaps = 18/276 (6%)
Query: 402 QCFSEANLLGKSSFSATYKGILRDGS-----VVAVKCIAKTSCKSDEGEFLKGLKILTSL 456
C + ++G F YKG+L+ S VA+K + + +FL I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 457 KHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAK 516
H N+ L G+ +I +++ NG + + +++GIA
Sbjct: 67 SHHNIIRLEGVISKYK--PMMIITEYMENGA---LDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 517 GISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI--VFSMLKASAAMGY 574
G+ YL VH +L+A +L++ +SD GL ++L DD ++ + +
Sbjct: 122 GMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 575 LAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634
APE + +FT SD+++FG++++++++ + +V I+
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----SNHEVMKAINDGFRLPTP 235
Query: 635 VSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+ S + Q+ + C + + RP +++ L +I
Sbjct: 236 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 6e-46
Identities = 63/278 (22%), Positives = 121/278 (43%), Gaps = 15/278 (5%)
Query: 396 EVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTS 455
E+ R + LG+ F + G + VA+K + + + FL+ +++
Sbjct: 13 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKK 68
Query: 456 LKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIA 515
L+HE L L + +++ +++ G+LL L E G K L + + IA
Sbjct: 69 LRHEKLVQLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIA 123
Query: 516 KGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYL 575
G++Y+ R VH +L A +L+ ++D GL +L+ D+ + A + +
Sbjct: 124 SGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 181
Query: 576 APEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635
APE GRFT KSD+++FG+++ ++ + P+ + +V D ++
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGR--VPY--PGMVNREVLDQVERGYRMPCPP 237
Query: 636 SEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
+L + C + P RP+ E + L S+
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-45
Identities = 58/265 (21%), Positives = 118/265 (44%), Gaps = 17/265 (6%)
Query: 410 LGKSSFSATYKGILR---DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRG 466
LG +F + +G+ R VA+K + + + K+D E ++ +I+ L + + L G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
+C ++ L+ + G L + L G + + + ++ ++ G+ YL K
Sbjct: 77 VCQAEAL---MLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYLEEK-- 128
Query: 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAA--MGYLAPEYTTTGR 584
VH +L+A VL+ R+ +SD GL K L D + +++ + + APE +
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188
Query: 585 FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQI 644
F+ +SD++++G+ +++ LS P+ + + +V FI+ + L +
Sbjct: 189 FSSRSDVWSYGVTMWEALS--YGQKPY--KKMKGPEVMAFIEQGKRMECPPECPPELYAL 244
Query: 645 ALHCTHESPSHRPSIENVMQELSSI 669
C RP V Q + +
Sbjct: 245 MSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 2e-44
Identities = 61/262 (23%), Positives = 110/262 (41%), Gaps = 17/262 (6%)
Query: 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
+GK F G R G+ VAVKCI + FL ++T L+H NL L G
Sbjct: 13 QTIGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLG- 67
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG 527
+ +G +++ +++ G+L+ +L + VL + + + + YL
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNN 123
Query: 528 LVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTE 587
VH +L+A VL+ +SD GL K + + + APE +F+
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFST 179
Query: 588 KSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALH 647
KSD+++FG+++++I S P +VE + + ++ +
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP----PAVYEVMKN 235
Query: 648 CTHESPSHRPSIENVMQELSSI 669
C H + RPS + ++L I
Sbjct: 236 CWHLDAAMRPSFLQLREQLEHI 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 4e-43
Identities = 60/300 (20%), Positives = 125/300 (41%), Gaps = 19/300 (6%)
Query: 380 NGFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKGILRDGS----VVAVKCIA 435
+ + E++++ + F+E ++G+ F Y G L D AVK +
Sbjct: 7 SALNPELVQAVQHVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64
Query: 436 KTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLE 495
+ + + +FL I+ H N+ SL G C + G ++ ++ +G+L + E
Sbjct: 65 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNE 123
Query: 496 AGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555
+ I +AKG+ +L VH +L+A ++ ++ ++D GL +
Sbjct: 124 THN---PTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 556 LLADDIVFSMLKASAAMG---YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFT 612
+ D S+ + A ++A E T +FT KSD+++FG++++++++ P
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
Query: 613 RQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672
+ + L ++ L C H RPS ++ +S+I +
Sbjct: 239 NTFDITVYLLQGRRLLQPEYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 8e-43
Identities = 55/270 (20%), Positives = 106/270 (39%), Gaps = 19/270 (7%)
Query: 406 EANLLGKSSFSATYKGILRD---GSVVAVKCIAKTSCKSD-EGEFLKGLKILTSLKHENL 461
E LG +F KG + VAVK + + + E L ++ L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 462 ASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYL 521
+ GIC L+ + G L ++L + ++ I ++ ++ G+ YL
Sbjct: 71 VRMIGICE---AESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYL 123
Query: 522 HGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAA--MGYLAPEY 579
VH +L+A VL+ ++ +SD GL K L D + + + + APE
Sbjct: 124 EES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 580 TTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639
+F+ KSD+++FG+++++ S P+ + S+V ++
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQ--KPYRGM--KGSEVTAMLEKGERMGCPAGCPR 237
Query: 640 NLGQIALHCTHESPSHRPSIENVMQELSSI 669
+ + C +RP V L +
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 1e-42
Identities = 50/268 (18%), Positives = 109/268 (40%), Gaps = 15/268 (5%)
Query: 404 FSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGE-FLKGLKILTSLKHENL 461
+ +G S+ K + DG ++ K + S E + + + +L LKH N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 462 ASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYL 521
+ +++ ++ G+L + + L+ + V+ + +
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 522 HGK---RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPE 578
H + ++H +L V + + N L D GL ++L D F+ Y++PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK-AFVGTPYYMSPE 184
Query: 579 YTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAES--SKVEDFIDPNLEGKFSVS 636
+ EKSDI++ G +++++ + PFT + + K+ + + ++S
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALM---PPFTAFSQKELAGKIREGKFRRIPYRYS-- 239
Query: 637 EASNLGQIALHCTHESPSHRPSIENVMQ 664
L +I + HRPS+E +++
Sbjct: 240 --DELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 7e-42
Identities = 57/288 (19%), Positives = 114/288 (39%), Gaps = 29/288 (10%)
Query: 408 NLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HEN 460
LG +F + VAVK + ++ ++ + LK+L+ L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 461 LASLRGICCSKGRGECFLIYDFVPNGNLLQHL--------------DLEAGSEKVLEWAT 506
+ +L G C G +I ++ G+LL L + E L+
Sbjct: 89 IVNLLGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 507 RISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSML 566
+S +AKG+++L K +H +L+A +L+ + D GL + + +D + +
Sbjct: 147 LLSFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 567 KASA-AMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFI 625
+ + ++APE +T +SD++++G+ ++++ S + SK I
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG---SSPYPGMPVDSKFYKMI 261
Query: 626 DPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
+ + I C P RP+ + ++Q + I S
Sbjct: 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 3e-41
Identities = 71/332 (21%), Positives = 129/332 (38%), Gaps = 38/332 (11%)
Query: 366 YSNGWDPL-AKGQSGNGFSQEVLESFMFNLE-EVERATQCFSEANLLGKSSFSATYKGIL 423
Y + + G S N + + ++L+ E R + +LG +F
Sbjct: 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPR--ENLEFGKVLGSGAFGKVMNATA 58
Query: 424 RDGS------VVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGEC 476
S VAVK + + + S+ + LK++T L HEN+ +L G C G
Sbjct: 59 YGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG--PI 116
Query: 477 FLIYDFVPNGNLLQHL-------------------DLEAGSEKVLEWATRISVIKGIAKG 517
+LI+++ G+LL +L E VL + + +AKG
Sbjct: 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKG 176
Query: 518 ISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASA-AMGYLA 576
+ +L K VH +L+A VL+ + D GL + + D + + + + ++A
Sbjct: 177 MEFLEFK--SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMA 234
Query: 577 PEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636
PE G +T KSD++++G+++++I S P+ + + I +
Sbjct: 235 PESLFEGIYTIKSDVWSYGILLWEIFSLGV--NPYPGIPVD-ANFYKLIQNGFKMDQPFY 291
Query: 637 EASNLGQIALHCTHESPSHRPSIENVMQELSS 668
+ I C RPS N+ L
Sbjct: 292 ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 8e-41
Identities = 56/283 (19%), Positives = 125/283 (44%), Gaps = 26/283 (9%)
Query: 404 FSEANLLGKSSFSATYKGILRDGS---VVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHE 459
+++G+ +F K ++ A+K + + + K D +F L++L L H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 460 NLASLRGICCSKGRGECFLIYDFVPNGNLLQHL------------DLEAGSEKVLEWATR 507
N+ +L G C + RG +L ++ P+GNLL L + + L
Sbjct: 72 NIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 508 ISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLK 567
+ +A+G+ YL + +H +L+A +L+ Y ++D GL + + +M +
Sbjct: 130 LHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 187
Query: 568 ASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDP 627
+ ++A E +T SD++++G+++++I+S TP+ +++ + +
Sbjct: 188 LP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG--TPYCGM--TCAELYEKLPQ 241
Query: 628 NLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+ ++ + + C E P RPS ++ L+ ++
Sbjct: 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 9e-41
Identities = 54/293 (18%), Positives = 112/293 (38%), Gaps = 41/293 (13%)
Query: 410 LGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICC 469
+GK F ++G R G VAVK + +S E + L+HEN+
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADN 67
Query: 470 SKGRG--ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLH----- 522
+ +L+ D+ +G+L +L+ + I + A G+++LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 523 -GKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLAPE 578
+P + H +L ++ +L+ + ++D GL + + +G Y+APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 579 Y------TTTGRFTEKSDIYAFGMIVFQILSGK---------------CSITPFTRQAAE 617
+++DIYA G++ ++I + + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 618 SSKVEDFIDPNLEGKFSVSEASN-LGQIALHCTHESPSHRPSIENVMQELSSI 669
E + PN+ ++ EA + +I C + + + R + + + LS +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-40
Identities = 42/209 (20%), Positives = 87/209 (41%), Gaps = 14/209 (6%)
Query: 404 FSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLA 462
F + + LG + +K + G V+A K I + + ++ L++L +
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 463 SLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLH 522
G S G E + + + G+L Q L + V + KG++YL
Sbjct: 68 GFYGAFYSDG--EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 523 GKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT 582
++ ++H ++ +L++ R L D G+ L D + S + Y++PE
Sbjct: 122 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQG 177
Query: 583 GRFTEKSDIYAFGMIVFQILSGKCSITPF 611
++ +SDI++ G+ + ++ G+ P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGR---YPI 203
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-40
Identities = 53/260 (20%), Positives = 107/260 (41%), Gaps = 16/260 (6%)
Query: 410 LGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGE-FLKGLKILTSLKHENLASLRGI 467
+G+ SF YKG+ + VA + E + F + ++L L+H N+
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 468 C--CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
KG+ L+ + + +G L +L KV++ S + I KG+ +LH +
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 526 PGLVHPNLSAEKVLIHRRYNPL-LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGR 584
P ++H +L + + I + + D GL L +++ ++APE +
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI---GTPEFMAPEMYE-EK 188
Query: 585 FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQI 644
+ E D+YAFGM + ++ + + P++ + F + +I
Sbjct: 189 YDESVDVYAFGMCMLEMATSE---YPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 245
Query: 645 ALHCTHESPSHRPSIENVMQ 664
C ++ R SI++++
Sbjct: 246 IEGCIRQNKDERYSIKDLLN 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 6e-40
Identities = 56/266 (21%), Positives = 104/266 (39%), Gaps = 16/266 (6%)
Query: 409 LLGKSSFSATYKGILRD----GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASL 464
+G+ F ++GI VA+K + S +FL+ + H ++ L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK 524
G+ ++I + G L L + S L+ A+ I ++ ++YL
Sbjct: 74 IGVIT---ENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLE-- 125
Query: 525 RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGR 584
VH +++A VL+ L D GL + + D + K + ++APE R
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 585 FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQI 644
FT SD++ FG+ +++IL + ++E+ + L +
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP----PTLYSL 241
Query: 645 ALHCTHESPSHRPSIENVMQELSSII 670
C PS RP + +LS+I+
Sbjct: 242 MTKCWAYDPSRRPRFTELKAQLSTIL 267
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (369), Expect = 6e-40
Identities = 49/303 (16%), Positives = 119/303 (39%), Gaps = 35/303 (11%)
Query: 394 LEEVERATQCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFL 447
L +E +G+ +F ++ ++VAVK + + + + +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 448 KGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHL--------------- 492
+ ++ + N ++ + L+++++ G+L + L
Sbjct: 65 REAALMAEFDNPN--IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 493 -----DLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPL 547
+ + L A ++ + + +A G++YL VH +L+ L+
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVK 180
Query: 548 LSDSGLHKLLADDIVFSMLKASA-AMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKC 606
++D GL + + + A + ++ PE R+T +SD++A+G+++++I S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG- 239
Query: 607 SITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQEL 666
+ P+ A E +V ++ + L + C + P+ RPS ++ + L
Sbjct: 240 -LQPYYGMAHE--EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
Query: 667 SSI 669
+
Sbjct: 297 QRM 299
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (363), Expect = 5e-39
Identities = 54/270 (20%), Positives = 109/270 (40%), Gaps = 23/270 (8%)
Query: 401 TQCFSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEG--EFLKGLKILTSLK 457
+ FS+ +G SF A Y +R+ VVA+K ++ + +S+E + +K ++ L L+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 458 HENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKG 517
H N RG + +L+ ++ +K L+ +V G +G
Sbjct: 74 HPNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQG 127
Query: 518 ISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAP 577
++YLH ++H ++ A +L+ L D G ++A F ++AP
Sbjct: 128 LAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAP 180
Query: 578 EY---TTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634
E G++ K D+++ G+ ++ K + +A ++ G +S
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240
Query: 635 VSEASNLGQIALHCTHESPSHRPSIENVMQ 664
C + P RP+ E +++
Sbjct: 241 ----EYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 4e-38
Identities = 58/273 (21%), Positives = 118/273 (43%), Gaps = 18/273 (6%)
Query: 404 FSEANLLGKSSFSATYKGILRD-----GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKH 458
F + +LG +F YKG+ VA+K + + + E L ++ S+ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 459 ENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGI 518
++ L GIC + LI +P G LL + + + ++ IAKG+
Sbjct: 71 PHVCRLLGICLT---STVQLITQLMPFGCLLDY---VREHKDNIGSQYLLNWCVQIAKGM 124
Query: 519 SYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL-ADDIVFSMLKASAAMGYLAP 577
+YL + LVH +L+A VL+ + ++D GL KLL A++ + + ++A
Sbjct: 125 NYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 578 EYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637
E +T +SD++++G+ V+++++ P+ +S++ ++
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGS--KPY--DGIPASEISSILEKGERLPQPPIC 238
Query: 638 ASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
++ I + C RP ++ E S +
Sbjct: 239 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-36
Identities = 52/262 (19%), Positives = 103/262 (39%), Gaps = 24/262 (9%)
Query: 408 NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGE--FLKGLKILTSLKHENLASL 464
LGK F Y + ++A+K + K + E + ++I + L+H N+ L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK 524
G R +LI ++ P G + + L + + I +A +SY H K
Sbjct: 72 YGYFHDATR--VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK 125
Query: 525 RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGR 584
++H ++ E +L+ ++D G ++ + YL PE
Sbjct: 126 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---GTLDYLPPEMIEGRM 180
Query: 585 FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE--ASNLG 642
EK D+++ G++ ++ L GK PF E++ ++ +F+ +
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGK---PPF-----EANTYQETYKRISRVEFTFPDFVTEGAR 232
Query: 643 QIALHCTHESPSHRPSIENVMQ 664
+ +PS RP + V++
Sbjct: 233 DLISRLLKHNPSQRPMLREVLE 254
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 55/293 (18%), Positives = 121/293 (41%), Gaps = 21/293 (7%)
Query: 391 MFNLEEVERATQCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEG 444
++ +E E A + + + LG+ SF Y+G+ + + VA+K + + + +
Sbjct: 9 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 68
Query: 445 EFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLD------LEAGS 498
EFL ++ ++ L G+ +I + + G+L +L
Sbjct: 69 EFLNEASVMKEFNCHHVVRLLGVVSQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPV 126
Query: 499 EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558
+ I + IA G++YL+ VH +L+A ++ + + D G+ + +
Sbjct: 127 LAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 184
Query: 559 D-DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE 617
+ D K + +++PE G FT SD+++FG+++++I + P+ Q
Sbjct: 185 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA--EQPY--QGLS 240
Query: 618 SSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+ +V F+ + L ++ C +P RPS ++ + +
Sbjct: 241 NEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 7e-36
Identities = 56/285 (19%), Positives = 121/285 (42%), Gaps = 30/285 (10%)
Query: 408 NLLGKSSFSATYKGILR--------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KH 458
LG+ +F + VAVK + + + D + + ++++ + KH
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 459 ENLASLRGICCSKGRGECFLIYDFVPNGNLLQHL------------DLEAGSEKVLEWAT 506
+N+ +L G C G ++I ++ GNL ++L + E+ L
Sbjct: 79 KNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 507 RISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA-DDIVFSM 565
+S +A+G+ YL +H +L+A VL+ ++D GL + + D
Sbjct: 137 LVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 566 LKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFI 625
+ ++APE +T +SD+++FG+++++I + +P+ E ++ +
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVE--ELFKLL 250
Query: 626 DPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+ + L + C H PS RP+ + ++++L I+
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-35
Identities = 54/265 (20%), Positives = 98/265 (36%), Gaps = 19/265 (7%)
Query: 410 LGKSSFSATYKGILR----DGSVVAVKCIAKTSCKSDEG--EFLKGLKILTSLKHENLAS 463
LG SF +G VAVKC+ E +F++ + + SL H NL
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHG 523
L G+ + ++ + P G+LL L G T +A+G+ YL
Sbjct: 76 LYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLE- 128
Query: 524 KRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAA--MGYLAPEYTT 581
+H +L+A +L+ R + D GL + L + +++ + APE
Sbjct: 129 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 582 TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641
T F+ SD + FG+ ++++ + P+ + ++
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQ--EPWIGLNGSQI-LHKIDKEGERLPRPEDCPQDI 244
Query: 642 GQIALHCTHESPSHRPSIENVMQEL 666
+ + C P RP+ + L
Sbjct: 245 YNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-35
Identities = 59/285 (20%), Positives = 113/285 (39%), Gaps = 24/285 (8%)
Query: 408 NLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENL 461
LG+ +F + VAVK + + + S+ + LKIL + H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 462 ASLRGICCSKGRGECFLIYDFVPNGNLLQHL------------DLEAGSEKVLEWATRIS 509
C+K G +I +F GNL +L E + L I
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 510 VIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKAS 569
+AKG+ +L +H +L+A +L+ + + D GL + + D + +
Sbjct: 139 YSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 570 A-AMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPN 628
+ ++APE +T +SD+++FG+++++I S S P + E +
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEG 253
Query: 629 LEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673
+ + Q L C H PS RP+ +++ L +++ ++
Sbjct: 254 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 3e-35
Identities = 53/260 (20%), Positives = 97/260 (37%), Gaps = 14/260 (5%)
Query: 408 NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRG 466
LG+ ++ + R VAVK + K + I L HEN+ G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
+L ++ G L ++ + + + G+ YLHG
Sbjct: 71 HRREGNI--QYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI-- 122
Query: 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAA-MGYLAPEYTTTGRF 585
G+ H ++ E +L+ R N +SD GL + + +L + Y+APE F
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 586 -TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQI 644
E D+++ G+++ +L+G+ + E S ++ K S L
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL--- 239
Query: 645 ALHCTHESPSHRPSIENVMQ 664
E+PS R +I ++ +
Sbjct: 240 LHKILVENPSARITIPDIKK 259
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 3e-35
Identities = 48/265 (18%), Positives = 95/265 (35%), Gaps = 22/265 (8%)
Query: 408 NLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRG 466
LG +F YK ++ + A K I S + E +++ + IL S H N+ L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLD 76
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
+ +++ +F G + + E+ L + V K ++YLH
Sbjct: 77 AFYYENN--LWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLHDN-- 129
Query: 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEY-----TT 581
++H +L A +L + L+D G+ I ++APE +
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDSFIGTPYWMAPEVVMCETSK 188
Query: 582 TGRFTEKSDIYAFGMIVFQILSGKCSITPFTR--QAAESSKVEDFIDPNLEGKFSVSEAS 639
+ K+D+++ G+ + ++ + P K+ P L S
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIE---PPHHELNPMRVLLKIAKSEPPTLAQPSRWSS-- 243
Query: 640 NLGQIALHCTHESPSHRPSIENVMQ 664
N C ++ R + ++Q
Sbjct: 244 NFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 7e-35
Identities = 37/260 (14%), Positives = 97/260 (37%), Gaps = 19/260 (7%)
Query: 408 NLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRG 466
+G+ + Y + + G VA++ + E + + ++ K+ N+ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNPNIVNYLD 84
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
E +++ +++ G+L + E ++ +V + + + +LH
Sbjct: 85 SYLVGD--ELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFT 586
++H ++ ++ +L+ + L+D G + + ++APE T +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 587 EKSDIYAFGMIVFQILSGKCSITPF--TRQAAESSKVEDFIDPNLEGKFSVSEASNLGQI 644
K DI++ G++ +++ G+ P+ + P L+ +S
Sbjct: 195 PKVDIWSLGIMAIEMIEGE---PPYLNENPLRALYLIATNGTPELQNPEKLSAI--FRDF 249
Query: 645 ALHCTHESPSHRPSIENVMQ 664
C R S + ++Q
Sbjct: 250 LNRCLDMDVEKRGSAKELLQ 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 130 bits (329), Expect = 5e-34
Identities = 46/259 (17%), Positives = 97/259 (37%), Gaps = 15/259 (5%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
LG +F ++ G+ A K + +SD+ K ++ ++ L+H L +L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG 527
E +IY+F+ G L + + E + + ++ + KG+ ++H
Sbjct: 92 FEDDN--EMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMHEN--N 144
Query: 528 LVHPNLSAEKVLIHRRYNPL--LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRF 585
VH +L E ++ + + L D GL L + +A + APE
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA--EFAAPEVAEGKPV 202
Query: 586 TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIA 645
+D+++ G++ + +LSG + + + +SE +
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE--DGKDFI 260
Query: 646 LHCTHESPSHRPSIENVMQ 664
P+ R +I ++
Sbjct: 261 RKLLLADPNTRMTIHQALE 279
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (321), Expect = 3e-33
Identities = 60/261 (22%), Positives = 104/261 (39%), Gaps = 16/261 (6%)
Query: 408 NLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRG 466
++LG +FS R +VA+KCIAK + + EG + +L +KH N+ +L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
I S G +LI V G L + + +I + + YLH
Sbjct: 75 IYESGGH--LYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLH--DL 126
Query: 527 GLVHPNLSAEKVLI---HRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG 583
G+VH +L E +L ++SD GL K+ V S + GY+APE
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTP--GYVAPEVLAQK 184
Query: 584 RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQ 643
+++ D ++ G+I + +L G ++ + + +S++
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS--AKD 242
Query: 644 IALHCTHESPSHRPSIENVMQ 664
H + P R + E +Q
Sbjct: 243 FIRHLMEKDPEKRFTCEQALQ 263
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 6e-33
Identities = 45/263 (17%), Positives = 94/263 (35%), Gaps = 22/263 (8%)
Query: 408 NLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEG--EFLKGLKILTSLKHENLASL 464
+LG+ SFS L A+K + K + + +++ L H L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK 524
+ + + NG LL+++ + I + YLH
Sbjct: 74 YFTFQDDEK--LYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLH-- 125
Query: 525 RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAM-GYLAPEYTTTG 583
G++H +L E +L++ + ++D G K+L+ + + + Y++PE T
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 584 RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA--SNL 641
+ SD++A G I++Q+++G PF + ++ ++ E
Sbjct: 186 SACKSSDLWALGCIIYQLVAGL---PPF-----RAGNEYLIFQKIIKLEYDFPEKFFPKA 237
Query: 642 GQIALHCTHESPSHRPSIENVMQ 664
+ + R E +
Sbjct: 238 RDLVEKLLVLDATKRLGCEEMEG 260
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 127 bits (320), Expect = 8e-33
Identities = 48/259 (18%), Positives = 97/259 (37%), Gaps = 15/259 (5%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
LG +F ++ + G V K I D+ + I+ L H L +L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG 527
K LI +F+ G L + A + + A I+ ++ +G+ ++H
Sbjct: 95 FEDKYE--MVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMH--EHS 147
Query: 528 LVHPNLSAEKVLIHRRYNPL--LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRF 585
+VH ++ E ++ + + D GL L D + + A+A + APE
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA--EFAAPEIVDREPV 205
Query: 586 TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIA 645
+D++A G++ + +LSG + + + + SVS
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP--EAKDFI 263
Query: 646 LHCTHESPSHRPSIENVMQ 664
+ + P R ++ + ++
Sbjct: 264 KNLLQKEPRKRLTVHDALE 282
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 125 bits (314), Expect = 1e-32
Identities = 46/266 (17%), Positives = 104/266 (39%), Gaps = 16/266 (6%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEG--EFLKGLKILTSLKHENLASLR 465
+LG S + LR VAVK + + F + + +L H + ++
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 466 GICCSKGR--GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHG 523
++ +++ ++V L + +E + I VI + +++ H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSH- 128
Query: 524 KRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAA--MGYLAPEYTT 581
+ G++H ++ ++I + D G+ + +AD A+ YL+PE
Sbjct: 129 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187
Query: 582 TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641
+SD+Y+ G +++++L+G+ T + + V + P +S L
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD--L 245
Query: 642 GQIALHCTHESPSHRP-SIENVMQEL 666
+ L ++P +R + + +L
Sbjct: 246 DAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-31
Identities = 43/259 (16%), Positives = 94/259 (36%), Gaps = 16/259 (6%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
LG+ F ++ + K + +D+ K + IL +H N+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHES 69
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG 527
S E +I++F+ ++ + ++ A L +S + + + + +LH
Sbjct: 70 FESME--ELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLH--SHN 122
Query: 528 LVHPNLSAEKVLIHRRYNPL--LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRF 585
+ H ++ E ++ R + + + G + L F +L + Y APE
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA--PEYYAPEVHQHDVV 180
Query: 586 TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIA 645
+ +D+++ G +V+ +LSG T Q + + + E +S
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE--AMDFV 238
Query: 646 LHCTHESPSHRPSIENVMQ 664
+ R + +Q
Sbjct: 239 DRLLVKERKSRMTASEALQ 257
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 112 bits (282), Expect = 2e-28
Identities = 47/275 (17%), Positives = 92/275 (33%), Gaps = 24/275 (8%)
Query: 404 FSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGE--------FLKGLKILT 454
+ +LG+ S + I AVK I T S E LK + IL
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 455 SLK-HENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKG 513
+ H N+ L+ + FL++D + G L +L + L +++
Sbjct: 65 KVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRA 118
Query: 514 IAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG 573
+ + I LH +VH +L E +L+ N L+D G L + + +
Sbjct: 119 LLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 176
Query: 574 ----YLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNL 629
+ ++ D+++ G+I++ +L+G + +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236
Query: 630 EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664
S+ + + P R + E +
Sbjct: 237 PEWDDYSDT--VKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 114 bits (287), Expect = 2e-28
Identities = 50/263 (19%), Positives = 96/263 (36%), Gaps = 21/263 (7%)
Query: 404 FSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGE-----FLKGLKILTSLK 457
FS ++G+ F Y D G + A+KC+ K K +GE L ++++
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 458 HENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKG 517
+ + + + I D + G+L HL V A I G
Sbjct: 66 CPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILG 119
Query: 518 ISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAP 577
+ ++H +V+ +L +L+ + +SD GL + + GY+AP
Sbjct: 120 LEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAP 174
Query: 578 EYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636
E G + +D ++ G ++F++L G PF + + D + + + S
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHS---PFRQHKTKDKHEIDRMTLTMAVELPDS 231
Query: 637 EASNLGQIALHCTHESPSHRPSI 659
+ L + + R
Sbjct: 232 FSPELRSLLEGLLQRDVNRRLGC 254
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 6e-28
Identities = 42/267 (15%), Positives = 89/267 (33%), Gaps = 25/267 (9%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
+LG + R A+K + E E + + ++ + +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELH-----WRASQCPHIVRIVDV 73
Query: 468 C--CSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
GR ++ + + G L + + ++ ++K I + I YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHSI- 130
Query: 526 PGLVHPNLSAEKVLIHRRYNPL---LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT 582
+ H ++ E +L + L+D G K + + Y+APE
Sbjct: 131 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT--PYYVAPEVLGP 187
Query: 583 GRFTEKSDIYAFGMIVFQILSGK-----CSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637
++ + D+++ G+I++ +L G + ++ + PN E E
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247
Query: 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664
L + P+ R +I M
Sbjct: 248 VKML---IRNLLKTEPTQRMTITEFMN 271
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (278), Expect = 1e-27
Identities = 38/278 (13%), Positives = 77/278 (27%), Gaps = 30/278 (10%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
+G SF Y G + G VA+K K+ + KI ++
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECV---KTKHPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG 527
C ++G ++ + + + T + + + I Y+H K
Sbjct: 71 CGAEG-DYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSK--N 123
Query: 528 LVHPNLSAEKVLIHRR---YNPLLSDSGLHKLLADDIVFSMLKASAA------MGYLAPE 578
+H ++ + L+ + D GL K D + Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 579 YTTTGRFTEKSDIYAFGMIVFQILSGK------CSITPFTRQAAESSKVEDFIDPNLEGK 632
+ + D+ + G ++ G + T + S K L
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243
Query: 633 FSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+ S C +P + Q ++
Sbjct: 244 YP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 4e-27
Identities = 60/293 (20%), Positives = 109/293 (37%), Gaps = 35/293 (11%)
Query: 382 FSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCK 440
F QE ++ + ++ E LG F+ K G A K I K K
Sbjct: 3 FRQENVDDY-YDTGEE------------LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTK 49
Query: 441 SDEG-----EFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLE 495
S + + + IL ++H N+ +L + +K LI + V G L L
Sbjct: 50 SSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLA-- 105
Query: 496 AGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPL----LSDS 551
++ L +K I G+ YLH + H +L E +++ R P + D
Sbjct: 106 --EKESLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161
Query: 552 GLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
GL + F + + ++APE ++D+++ G+I + +LSG
Sbjct: 162 GLAHKIDFGNEFKNIFGT--PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 219
Query: 612 TRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664
T+Q ++ + E + S + P R +I++ +Q
Sbjct: 220 TKQETLANVSAVNYEFEDEYFSNTSAL--AKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 109 bits (272), Expect = 5e-27
Identities = 46/281 (16%), Positives = 98/281 (34%), Gaps = 32/281 (11%)
Query: 408 NLLGKSSFSATYKGILRDGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRG 466
+G+ ++ YK G A+K I + ++ + IL LKH N+ L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 467 ICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRP 526
+ +K R ++ + +L + LD+ E LE T S + + GI+Y H
Sbjct: 68 VIHTKKR---LVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH--DR 119
Query: 527 GLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFT 586
++H +L + +LI+R ++D GL + + + + +++
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 587 EKSDIYAFGMIVFQILSGKC-----------------------SITPFTRQAAESSKVED 623
DI++ G I ++++G P + +
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 624 FIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664
+P F + + P+ R + + ++
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 9e-27
Identities = 44/215 (20%), Positives = 85/215 (39%), Gaps = 20/215 (9%)
Query: 404 FSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLA 462
+++ ++G SF Y+ L D G +VA+K + D+ + L+I+ L H N+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIV 76
Query: 463 SLRGICCSKGRGE----CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGI 518
LR S G + L+ D+VP ++ L + + + +
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA-KQTLPVIYVKLYMYQLFRSL 135
Query: 519 SYLHGKRPGLVHPNLSAEKV-LIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAP 577
+Y+H G+ H ++ + + L L D G K L + + Y AP
Sbjct: 136 AYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAP 191
Query: 578 -EYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
+T D+++ G ++ ++L G+ F
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ---PIF 223
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 6e-26
Identities = 43/264 (16%), Positives = 99/264 (37%), Gaps = 23/264 (8%)
Query: 408 NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEG--EFLKGLKILT-SLKHENLAS 463
+LGK SF + + A+K + K D+ + ++L+ + +H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 464 LRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHG 523
+ +K F + +++ G+L+ H+ S + + I G+ +LH
Sbjct: 68 MFCTFQTKEN--LFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLH- 120
Query: 524 KRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTG 583
G+V+ +L + +L+ + + ++D G+ K Y+APE
Sbjct: 121 -SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNTFCGTPDYIAPEILLGQ 178
Query: 584 RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE--ASNL 641
++ D ++FG++++++L G+ +PF E+
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQ---SPF-----HGQDEEELFHSIRMDNPFYPRWLEKEA 230
Query: 642 GQIALHCTHESPSHRPSIENVMQE 665
+ + P R + +++
Sbjct: 231 KDLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 105 bits (263), Expect = 8e-26
Identities = 37/276 (13%), Positives = 82/276 (29%), Gaps = 24/276 (8%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
+G+ SF ++G L + VA+K + +SD + + L
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPR---RSDAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPG 527
+G L+ D + DL + T K + + +H
Sbjct: 69 FGQEG-LHNVLVIDLLGPS----LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH--EKS 121
Query: 528 LVHPNLSAEKVLIHRRYNPL-----LSDSGLHKLLADDI---VFSMLKASAAMG---YLA 576
LV+ ++ + LI R + + D G+ K D + + G Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 577 PEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFT--RQAAESSKVEDFIDPNLEGKFS 634
+ + D+ A G + L G + ++ + +
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 635 VSEASNLGQIALHCTHESPSHRPSIENVMQELSSII 670
+ + + + P + + S ++
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 8e-26
Identities = 42/293 (14%), Positives = 101/293 (34%), Gaps = 31/293 (10%)
Query: 399 RATQCFSEANLLGKSSFSATYKGILR--DGSVVAVKCIAKTSCKSDEGE----FLKGLKI 452
RA Q + +G+ ++ +K G VA+K + + + + L+
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 453 LTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIK 512
L + +H N+ L +C + + + L+ E + T ++
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 513 GIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAM 572
+ +G+ +LH +VH +L + +L+ L+D GL ++ + + + + + +
Sbjct: 124 QLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT--L 179
Query: 573 GYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGK-----------------CSITPFTRQA 615
Y APE + D+++ G I ++ K P
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 616 AESSKVEDFIDPNLEGKFSVSEASNLGQIAL----HCTHESPSHRPSIENVMQ 664
+ + + +++ ++ C +P+ R S + +
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 6e-25
Identities = 52/266 (19%), Positives = 91/266 (34%), Gaps = 32/266 (12%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEG-----EFLKGLKILTSLK--HEN 460
LLG F + Y GI + D VA+K + K + +L +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 461 LASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISY 520
+ L LI + L E G+ L+ S + + + +
Sbjct: 71 VIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRH 125
Query: 521 LHGKRPGLVHPNLSAEKVLIHR-RYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEY 579
H G++H ++ E +LI R L D G LL D + Y PE+
Sbjct: 126 CHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPEW 180
Query: 580 TTTGRF-TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638
R+ + +++ G++++ ++ G PF E+ I + + VS
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGD---IPFEHD-------EEIIRGQVFFRQRVSS- 229
Query: 639 SNLGQIALHCTHESPSHRPSIENVMQ 664
+ C PS RP+ E +
Sbjct: 230 -ECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 8e-25
Identities = 42/286 (14%), Positives = 99/286 (34%), Gaps = 32/286 (11%)
Query: 404 FSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGE-FLKGLKILTSLKHENL 461
F + +G+ ++ YK + G VVA+K I + ++ + +L L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 462 ASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYL 521
L + ++ + + + +L + +D A + + S + + +G+++
Sbjct: 64 VKLLDVIHTENK---LYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFC 118
Query: 522 HGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTT 581
H ++H +L + +LI+ L+D GL + + +
Sbjct: 119 H--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 582 TGRFTEKSDIYAFGMIVFQILSGK-----------------CSITPFTRQAAESSKVEDF 624
++ DI++ G I ++++ + TP + + D+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 625 ID--PNLEGKFSVSEASNLGQIALH----CTHESPSHRPSIENVMQ 664
P + L + H P+ R S + +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 1e-24
Identities = 42/269 (15%), Positives = 97/269 (36%), Gaps = 13/269 (4%)
Query: 408 NLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRG 466
+ +G+ ++ + VA+K I+ ++ L+ +KIL +HEN+ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 467 ICCSKG--RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK 524
I + + + + + +L + L + L + I +G+ Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA 128
Query: 525 RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKAS--AAMGYLAPEYTTT 582
++H +L +L++ + + D GL ++ D + A Y APE
Sbjct: 129 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 583 GR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641
+ +T+ DI++ G I+ ++LS + + + P+ E +
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 642 GQIALHCTHESPSHRPSIENVMQELSSII 670
+ N + ++
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLL 275
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 101 bits (253), Expect = 3e-24
Identities = 46/256 (17%), Positives = 94/256 (36%), Gaps = 25/256 (9%)
Query: 408 NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEG--EFLKGLKILTSLKHENLASL 464
LG SF + R +G A+K + K + +L+ + H + +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 465 RGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK 524
G + F+I D++ G L L S++ + + + YLH
Sbjct: 70 WGTFQDAQQ--IFMIMDYIEGGELF---SLLRKSQRFPNPVAKF-YAAEVCLALEYLH-- 121
Query: 525 RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGR 584
+++ +L E +L+ + + ++D G K + D Y+APE +T
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKP 177
Query: 585 FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA--SNLG 642
+ + D ++FG++++++L+G TPF S + L + ++
Sbjct: 178 YNKSIDWWSFGILIYEMLAGY---TPF-----YDSNTMKTYEKILNAELRFPPFFNEDVK 229
Query: 643 QIALHCTHESPSHRPS 658
+ S R
Sbjct: 230 DLLSRLITRDLSQRLG 245
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 2e-23
Identities = 52/312 (16%), Positives = 115/312 (36%), Gaps = 42/312 (13%)
Query: 381 GFSQEVLESFMFNLEEVERATQCFSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSC 439
GF ++ + + + V + + +G ++ A + R G+ VA+K + +
Sbjct: 3 GFYRQEVTKTAWEVRAV------YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ 56
Query: 440 KSDEGE-FLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGS 498
+ + L++L ++HEN+ L + + DF + +
Sbjct: 57 SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD--DFTDFYLVMPFMGTDLGKLMK 114
Query: 499 EKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558
+ L ++ + KG+ Y+H G++H +L + ++ + D GL +
Sbjct: 115 HEKLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172
Query: 559 DDIVFSMLKASAAMGYLAPE-YTTTGRFTEKSDIYAFGMIVFQILSGK------------ 605
+ M Y APE R+T+ DI++ G I+ ++++GK
Sbjct: 173 SE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL 228
Query: 606 -------CSITPFTRQAAESSKVEDFID--PNLEGKFSVSEASNLGQIALH----CTHES 652
+ Q +S + ++++ P LE K S +N +A++
Sbjct: 229 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLD 288
Query: 653 PSHRPSIENVMQ 664
R + +
Sbjct: 289 AEQRVTAGEALA 300
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 4e-23
Identities = 49/284 (17%), Positives = 96/284 (33%), Gaps = 35/284 (12%)
Query: 408 NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGE----FLKGLKILTSLKHENLA 462
+ LG+ F+ YK + +VA+K I + L+ +K+L L H N+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 463 SLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLH 522
L K L++DF+ + D + VL + + + +G+ YLH
Sbjct: 64 GLLDAFGHKS--NISLVFDFMETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 523 GKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT 582
+ ++H +L +L+ L+D GL K +
Sbjct: 118 --QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 583 GRFTEKSDIYAFGMIVFQILSG-----------------KCSITPFTRQAAESSKVEDFI 625
+ D++A G I+ ++L + TP Q + + D++
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 626 D----PNLEGKFSVSEASNLG-QIALHCTHESPSHRPSIENVMQ 664
P + S A + + +P R + ++
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 95.6 bits (237), Expect = 5e-22
Identities = 52/292 (17%), Positives = 98/292 (33%), Gaps = 25/292 (8%)
Query: 382 FSQEVLESFMFNLEEVERATQC---FSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKT 437
F + E F+ E + T F LG SF G+ A+K + K
Sbjct: 18 FLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ 77
Query: 438 SCKSDEG--EFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLE 495
+ L +IL ++ L L +++ ++V G + HL
Sbjct: 78 KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLR-- 133
Query: 496 AGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555
I YLH L++ +L E +LI ++ ++D G
Sbjct: 134 --RIGRFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGF-- 187
Query: 556 LLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFT-RQ 614
A + LAPE + + + D +A G++++++ +G PF Q
Sbjct: 188 --AKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY---PPFFADQ 242
Query: 615 AAESSKVEDFIDPNLEGKFSVSEASNLGQIALHC--THESPSHRPSIENVMQ 664
+ + FS S+ +L + L T + + + ++
Sbjct: 243 PIQIYEKIVSGKVRFPSHFS-SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.6 bits (234), Expect = 9e-22
Identities = 59/295 (20%), Positives = 112/295 (37%), Gaps = 44/295 (14%)
Query: 408 NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSD-EGEFLKGLKILTSLKHENLASLR 465
+G+ +F +K R G VA+K + + K L+ +KIL LKHEN+ +L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 466 GICCSKG------RGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGIS 519
IC +K +G +L++DF + + + V++ + G+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLY 131
Query: 520 YLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMG---YLA 576
Y+H R ++H ++ A VLI R L+D GL + + + + + Y
Sbjct: 132 YIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 577 PEYTTTGR-FTEKSDIYAFGMIVFQILSGKC-------------------SITPFTRQAA 616
PE R + D++ G I+ ++ + SITP
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 617 ESSKVEDFIDPNLEGKFSVSE---ASNLGQIALH----CTHESPSHRPSIENVMQ 664
++ ++ + ++ K V + A AL P+ R ++ +
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.1 bits (230), Expect = 2e-21
Identities = 42/283 (14%), Positives = 86/283 (30%), Gaps = 34/283 (12%)
Query: 408 NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGE-FLKGLKILTSLKHENLASLR 465
+G+ ++ +K R +VA+K + L+ + +L LKH+N
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN----- 62
Query: 466 GICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
I V L+ S + + KG+ + H +
Sbjct: 63 -IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 526 PGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRF 585
++H +L + +LI+R L++ GL + + + +
Sbjct: 121 -NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 586 TEKSDIYAFGMIVFQILSGK------------------CSITPFTRQAAESSKVEDFIDP 627
+ D+++ G I ++ + TP Q +K+ D+
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 628 NL--EGKFSVSEASNLGQIALH----CTHESPSHRPSIENVMQ 664
+ V+ L +P R S E +Q
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 92.1 bits (227), Expect = 6e-21
Identities = 81/318 (25%), Positives = 121/318 (38%), Gaps = 85/318 (26%)
Query: 18 LSSTSEVDILMHIKDSLDPENRLLTSWAPNADPCSSDSFDGVACDENG---RVANISLQG 74
L + + L+ IK L L +SW P D C+ ++ GV CD + RV N+ L G
Sbjct: 2 LCNPQDKQALLQIKKDLGNPTTL-SSWLPTTDCCNR-TWLGVLCDTDTQTYRVNNLDLSG 59
Query: 75 KGLSG--EIPAAVGGLKSLTGLYLHFNA-LNGVIPKEIASLSELSDLYLNVN-------- 123
L IP+++ L L LY+ L G IP IA L++L LY+
Sbjct: 60 LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119
Query: 124 ----------------NLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSV-L 166
LSG +P I ++ NL + N+++G IP GS KL +
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179
Query: 167 ALQYNQLTGAIPASLGDLGMLMRL------------------------------------ 190
+ N+LTG IP + +L +
Sbjct: 180 TISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
Query: 191 ----------DLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPP--ALKRLNGGFQY 238
DL N ++G +P L + L L++ N+ G +P L+R + Y
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFD-VSAY 298
Query: 239 DNNAALCGTGFTNLKNCT 256
NN LCG+ L CT
Sbjct: 299 ANNKCLCGSP---LPACT 313
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (221), Expect = 6e-20
Identities = 46/260 (17%), Positives = 90/260 (34%), Gaps = 22/260 (8%)
Query: 404 FSEANLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEG--EFLKGLKILTSLKHEN 460
F LLGK +F G A+K + K + + + ++L + +H
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 461 LASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISY 520
L +L+ + R + ++ G L HL E+V I + Y
Sbjct: 67 LTALKYAFQTHDR--LCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEY 120
Query: 521 LHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYT 580
LH +V+ ++ E +++ + + ++D GL K D YLAPE
Sbjct: 121 LH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT-PEYLAPEVL 177
Query: 581 TTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA-- 638
+ D + G+++++++ G+ PF + E + L +
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGR---LPF-----YNQDHERLFELILMEEIRFPRTLS 229
Query: 639 SNLGQIALHCTHESPSHRPS 658
+ + P R
Sbjct: 230 PEAKSLLAGLLKKDPKQRLG 249
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.0 bits (212), Expect = 6e-19
Identities = 44/262 (16%), Positives = 99/262 (37%), Gaps = 22/262 (8%)
Query: 408 NLLGKSSFSATYKGIL----RDGSVVAVKCIAKTSCKSDEG---EFLKGLKILTSLKHE- 459
+LG ++ + G + A+K + K + ++L ++
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 460 NLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGIS 519
L +L ++ + LI D++ G L HL + + I +
Sbjct: 90 FLVTLHYAFQTETK--LHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALE 143
Query: 520 YLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEY 579
+LH + G+++ ++ E +L+ + +L+D GL K D + Y+AP+
Sbjct: 144 HLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 580 TTTGR--FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF-IDPNLEGKFSVS 636
G + D ++ G++++++L+G +PFT ++S+ E E +
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGA---SPFTVDGEKNSQAEISRRILKSEPPYPQE 258
Query: 637 EASNLGQIALHCTHESPSHRPS 658
++ + + P R
Sbjct: 259 MSALAKDLIQRLLMKDPKKRLG 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 85.7 bits (211), Expect = 8e-19
Identities = 40/207 (19%), Positives = 79/207 (38%), Gaps = 20/207 (9%)
Query: 408 NLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLR 465
LG+ +S ++ I + + V VK + K + + +KIL +L+ N+ +L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK----KIKREIKILENLRGGPNIITLA 96
Query: 466 GICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR 525
I L+++ V N + Q + L + I K + Y H
Sbjct: 97 DIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM- 148
Query: 526 PGLVHPNLSAEKVLIHRRYNPL-LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGR 584
G++H ++ V+I + L L D GL + +++ AS
Sbjct: 149 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RYFKGPELLVDYQM 206
Query: 585 FTEKSDIYAFGMIVFQILSGKCSITPF 611
+ D+++ G ++ ++ K PF
Sbjct: 207 YDYSLDMWSLGCMLASMIFRK---EPF 230
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.1 bits (204), Expect = 1e-17
Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 30/170 (17%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
+SL G L + L +LT L L N ++ + P ++ L++L++L L N +S
Sbjct: 224 LSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS 279
Query: 130 P--------------------SQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQ 169
P S I N+ NL L L +N ++ P + SL KL L
Sbjct: 280 PLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFA 337
Query: 170 YNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNN 219
N+++ +SL +L + L N + P LAN+ ++ L + +
Sbjct: 338 NNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 82.0 bits (201), Expect = 3e-17
Identities = 43/190 (22%), Positives = 75/190 (39%), Gaps = 38/190 (20%)
Query: 77 LSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNM 136
+S P + +L L L+ N L +ASL+ L+DL L N +S P + +
Sbjct: 209 ISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGL 262
Query: 137 TNLQVLQLCYNKLTGNIP--------------------TQLGSLRKLSVLALQYNQLTGA 176
T L L+L N+++ P + + +L+ L+ L L +N ++
Sbjct: 263 TKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDI 322
Query: 177 IPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVP----PALKRL 232
P + L L RL + N + LAN+ + L +N S P + +L
Sbjct: 323 SP--VSSLTKLQRLFFANNKVSDVSS--LANLTNINWLSAGHNQISDLTPLANLTRITQL 378
Query: 233 NGGFQYDNNA 242
++ A
Sbjct: 379 G----LNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 73.9 bits (180), Expect = 1e-14
Identities = 36/147 (24%), Positives = 64/147 (43%), Gaps = 28/147 (19%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIP--------------------KE 108
++ L +S P + GL LT L L N ++ + P
Sbjct: 245 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP 302
Query: 109 IASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLAL 168
I++L L+ L L NN+S P + ++T LQ L NK++ + L +L ++ L+
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 169 QYNQLTGAIPASLGDLGMLMRLDLSFN 195
+NQ++ P L +L + +L L+
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 3e-06
Identities = 15/81 (18%), Positives = 31/81 (38%), Gaps = 8/81 (9%)
Query: 87 GLKSLTGLYLHFNALNGVIPK-EIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLC 145
L L + + + ++ ++ L L + ++ G + + NL +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 146 YNKLTGNIPTQLGSLRKLSVL 166
N+LT P L +L KL +
Sbjct: 75 NNQLTDITP--LKNLTKLVDI 93
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 2e-04
Identities = 20/88 (22%), Positives = 38/88 (43%), Gaps = 8/88 (9%)
Query: 110 ASLSELSDLYLNVNNLSGKIP-SQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLAL 168
+L+E L N++ + + + +T LQ +L + G + L L+ +
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINF 73
Query: 169 QYNQLTGAIPASLGDLGMLMRLDLSFNN 196
NQLT P L +L L+ + ++ N
Sbjct: 74 SNNQLTDITP--LKNLTKLVDILMNNNQ 99
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.6 bits (195), Expect = 1e-16
Identities = 40/210 (19%), Positives = 80/210 (38%), Gaps = 20/210 (9%)
Query: 408 NLLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGE-FLKGLKILTSLKHENLASLR 465
+ +G ++ + + G VAVK +++ + + L++L +KHEN+ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 466 GICCSKGR---GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLH 522
+ + + +L + L +I I +G+ Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNI-----VKCQKLTDDHVQFLIYQILRGLKYIH 138
Query: 523 GKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPE-YTT 581
++H +L + ++ + D G LA M A Y APE
Sbjct: 139 --SADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIMLN 192
Query: 582 TGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
+ + DI++ G I+ ++L+G+ T F
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGR---TLF 219
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.1 bits (186), Expect = 2e-15
Identities = 33/209 (15%), Positives = 76/209 (36%), Gaps = 20/209 (9%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGE-FLKGLKILTSLKHENLASLRG 466
+G + VA+K +++ + + L ++ + H+N+ SL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 467 ICCSKGRGE----CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLH 522
+ + E +L+ + + + L+ ++ + GI +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQMLCGIKHLH 136
Query: 523 GKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTT 582
G++H +L +++ + D GL + + + + Y APE
Sbjct: 137 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT--RYYRAPEVILG 192
Query: 583 GRFTEKSDIYAFGMIVFQILSGKCSITPF 611
+ E DI++ G I+ +++ K F
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHK---ILF 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 75.8 bits (185), Expect = 2e-15
Identities = 35/216 (16%), Positives = 74/216 (34%), Gaps = 19/216 (8%)
Query: 409 LLGKSSFSATYKGI-LRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467
LG FS + + + + VA+K + K +K+L + + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAG----------SEKVLEWATRISVIKGIAKG 517
+ PNG + + G + + + K + G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 518 ISYLHGKRPGLVHPNLSAEKVLIHRR-YNPLLSDSGLHKL-LADDIVFSMLKASAAMGYL 575
+ Y+H +R G++H ++ E VL+ L + L A + Y
Sbjct: 138 LDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 576 APEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPF 611
+PE + +DI++ ++F++++G F
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD---FLF 229
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 73.9 bits (180), Expect = 5e-15
Identities = 38/183 (20%), Positives = 68/183 (37%), Gaps = 4/183 (2%)
Query: 51 CSSDSFDGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIA 110
CS + V D A + LQ ++ LK+L L L N ++ + P A
Sbjct: 17 CSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA 76
Query: 111 SLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQY 170
L +L LYL+ N L + L+V + K+ ++ L + + L
Sbjct: 77 PLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNP 135
Query: 171 NQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALK 230
+ +G + + L + ++ N+ + P L L + N + +LK
Sbjct: 136 LKSSGIENGAFQGMKKLSYIRIADTNI---TTIPQGLPPSLTELHLDGNKITKVDAASLK 192
Query: 231 RLN 233
LN
Sbjct: 193 GLN 195
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 60.8 bits (146), Expect = 1e-10
Identities = 37/187 (19%), Positives = 58/187 (31%), Gaps = 8/187 (4%)
Query: 90 SLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKL 149
L + L +PK++ + + L L N ++ N+ NL L L NK+
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 150 TGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVP 209
+ P L KL L L NQL L L + + V L +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 210 KLEVLDIRNNSFSGNVPPA---LKRLNGGFQYDNN-AALCGTGFTNLKNCTASDHPTPGK 265
+E L SG A +K+L+ D N + +L +
Sbjct: 128 VVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKV 186
Query: 266 PEPFEPN 272
Sbjct: 187 DAASLKG 193
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 56.6 bits (135), Expect = 3e-09
Identities = 33/150 (22%), Positives = 61/150 (40%), Gaps = 12/150 (8%)
Query: 77 LSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNM 136
SG A G+K L+ + + + IP+ + L++L+L+ N ++ + + +
Sbjct: 138 SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGL 194
Query: 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNN 196
NL L L +N ++ L + L L L N+L +P L D + + L NN
Sbjct: 195 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNN 253
Query: 197 L-------FGPVPVKLANVPKLEVLDIRNN 219
+ F P P + + +N
Sbjct: 254 ISAIGSNDFCP-PGYNTKKASYSGVSLFSN 282
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.9 bits (128), Expect = 2e-08
Identities = 35/130 (26%), Positives = 58/130 (44%), Gaps = 4/130 (3%)
Query: 94 LYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNI 153
L + +G+ + +LS + + N++ IP G +L L L NK+T
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVD 187
Query: 154 PTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEV 213
L L L+ L L +N ++ SL + L L L+ N L VP LA+ ++V
Sbjct: 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV 246
Query: 214 LDIRNNSFSG 223
+ + NN+ S
Sbjct: 247 VYLHNNNISA 256
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 64.8 bits (157), Expect = 1e-12
Identities = 27/169 (15%), Positives = 56/169 (33%), Gaps = 21/169 (12%)
Query: 408 NLLGKSSFSATYKGILRDGSVVAVKCI---------AKTSCKSDEGEFLKGLKILTSLKH 458
L+G+ SA + VK K + F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 459 ENLASLRGICCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGI 518
L L+G+ K +Y + N L++ +D + +E + + I + +
Sbjct: 66 RALQKLQGLAVPK-------VYAWEGNAVLMELIDAKELYRVRVENPDEV--LDMILEEV 116
Query: 519 SYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIVFSMLK 567
+ + G+VH +LS VL+ + D + ++ +L+
Sbjct: 117 AKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILE 162
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.4 bits (155), Expect = 7e-12
Identities = 43/148 (29%), Positives = 60/148 (40%)
Query: 77 LSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNM 136
L PA GL L L+L L + P L+ L LYL N L ++
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152
Query: 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNN 196
NL L L N+++ L L L L N++ P + DLG LM L L NN
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 197 LFGPVPVKLANVPKLEVLDIRNNSFSGN 224
L LA + L+ L + +N + +
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCD 240
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.4 bits (142), Expect = 3e-10
Identities = 43/216 (19%), Positives = 65/216 (30%), Gaps = 33/216 (15%)
Query: 50 PCSSDSFDGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEI 109
PC C +V S +GL +P + + ++LH N ++ V
Sbjct: 1 PCPG----ACVCYNEPKV-TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASF 52
Query: 110 ASLSELSDLYLNVNN-------------------------LSGKIPSQIGNMTNLQVLQL 144
+ L+ L+L+ N L P+ + L L L
Sbjct: 53 RACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112
Query: 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVK 204
L P L L L LQ N L + DLG L L L N +
Sbjct: 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172
Query: 205 LANVPKLEVLDIRNNSFSGNVPPALKRLNGGFQYDN 240
+ L+ L + N + P A + L
Sbjct: 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.1 bits (141), Expect = 4e-10
Identities = 35/131 (26%), Positives = 51/131 (38%), Gaps = 4/131 (3%)
Query: 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGK 128
++ L G +S A GL SL L LH N + V P L L LYL NNLS
Sbjct: 157 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 216
Query: 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLM 188
+ + LQ L+L N + L +++ ++P L +
Sbjct: 217 PTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGRDL-- 273
Query: 189 RLDLSFNNLFG 199
L+ N+L G
Sbjct: 274 -KRLAANDLQG 283
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 54.3 bits (130), Expect = 1e-09
Identities = 29/118 (24%), Positives = 49/118 (41%), Gaps = 8/118 (6%)
Query: 118 LYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAI 177
L+L +L+ + + + + L L +N+L P L +LR L VL N L
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALE--N 57
Query: 178 PASLGDLGMLMRLDLSFNNLFG-PVPVKLANVPKLEVLDIRNNSFSG--NVPPALKRL 232
+ +L L L L N L L + P+L +L+++ NS + L +
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 8e-07
Identities = 27/125 (21%), Positives = 47/125 (37%), Gaps = 9/125 (7%)
Query: 94 LYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNI 153
L+L L + + L ++ L L+ N L P+ + + L+VLQ N L
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59
Query: 154 PTQLGSLRKLSVLALQYNQLTG-AIPASLGDLGMLMRLDLSFNNLFGPVPVK---LANVP 209
+ L L N+L A L L+ L+L N+L ++ +P
Sbjct: 60 GVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 210 KLEVL 214
+ +
Sbjct: 118 SVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 4e-06
Identities = 30/107 (28%), Positives = 47/107 (43%), Gaps = 6/107 (5%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
+ L K L+ + + L +T L L N L + P +A+L L L ++ + +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNALEN 57
Query: 130 PSQIGNMTNLQVLQLCYNKLTG-NIPTQLGSLRKLSVLALQYNQLTG 175
+ N+ LQ L LC N+L L S +L +L LQ N L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.4 bits (134), Expect = 4e-09
Identities = 23/92 (25%), Positives = 40/92 (43%), Gaps = 10/92 (10%)
Query: 95 YLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIP 154
+ NA + I L +L ++ N L ++P+ L+ L +N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVP 320
Query: 155 TQLGSLRKLSVLALQYNQLTG--AIPASLGDL 184
+L++L ++YN L IP S+ DL
Sbjct: 321 ELPQNLKQLH---VEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 5e-08
Identities = 21/91 (23%), Positives = 37/91 (40%), Gaps = 10/91 (10%)
Query: 119 YLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIP 178
+N S +I S +L+ L + NKL +P L +L +N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVP 320
Query: 179 ASLGDLGMLMRLDLSFNNL--FGPVPVKLAN 207
+ L +L + +N L F +P + +
Sbjct: 321 ELPQN---LKQLHVEYNPLREFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 2e-07
Identities = 20/78 (25%), Positives = 31/78 (39%), Gaps = 9/78 (11%)
Query: 88 LKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYN 147
SL L + N L +P L L + N+L+ ++P NL+ L + YN
Sbjct: 283 PPSLEELNVSNNKLIE-LPALPPRLERL---IASFNHLA-EVPELPQ---NLKQLHVEYN 334
Query: 148 KLTGNIPTQLGSLRKLSV 165
L P S+ L +
Sbjct: 335 PLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.1 bits (115), Expect = 9e-07
Identities = 23/93 (24%), Positives = 36/93 (38%), Gaps = 10/93 (10%)
Query: 143 QLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVP 202
N + I + L L + N+L +PA L RL SFN+L VP
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHL-AEVP 320
Query: 203 VKLANVPKLEVLDIRNNSFSG--NVPPALKRLN 233
N L+ L + N ++P +++ L
Sbjct: 321 ELPQN---LKQLHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.7 bits (96), Expect = 2e-04
Identities = 16/72 (22%), Positives = 32/72 (44%), Gaps = 9/72 (12%)
Query: 70 ISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI 129
+++ L E+PA L L FN L +P+ +L + L++ N L +
Sbjct: 289 LNVSNNKLI-ELPA---LPPRLERLIASFNHLAE-VPELPQNLKQ---LHVEYNPLR-EF 339
Query: 130 PSQIGNMTNLQV 141
P ++ +L++
Sbjct: 340 PDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.001
Identities = 15/63 (23%), Positives = 21/63 (33%), Gaps = 8/63 (12%)
Query: 137 TNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNN 196
L+L L+ ++P L L N LT +P L L + NN
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQS---LKSLLVDNNN 89
Query: 197 LFG 199
L
Sbjct: 90 LKA 92
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 38/206 (18%), Positives = 60/206 (29%), Gaps = 49/206 (23%)
Query: 61 CDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYL 120
+ ++ + L+ +P + K T L+L N L + + L+ L L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 121 N---------------------------------------------VNNLSGKIPSQIGN 135
+ N L+ +
Sbjct: 63 DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122
Query: 136 MTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFN 195
+ LQ L L N+L P L KL L+L N LT L L L L L N
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182
Query: 196 NLFGPVPVKLANVPKLEVLDIRNNSF 221
+L+ +P L + N +
Sbjct: 183 SLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 1e-04
Identities = 12/65 (18%), Positives = 27/65 (41%), Gaps = 3/65 (4%)
Query: 108 EIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLA 167
E++ ++ ++ + NL+ +P + + +L L N L L +L+ L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 168 LQYNQ 172
L +
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.003
Identities = 13/65 (20%), Positives = 24/65 (36%), Gaps = 3/65 (4%)
Query: 132 QIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLD 191
++ + + + LT +P L ++L L N L A+L L +L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 192 LSFNN 196
L
Sbjct: 62 LDRAE 66
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 5e-08
Identities = 19/92 (20%), Positives = 36/92 (39%), Gaps = 10/92 (10%)
Query: 138 NLQVLQLCYNKLTGNIPTQL-GSLRKLSVLALQYNQLTG----AIPASLGDLGMLMRLDL 192
++Q L + +L+ +L L++ V+ L LT I ++L L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 193 SFNNLFGPVPVKLA-----NVPKLEVLDIRNN 219
N L + K++ L ++N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 3e-07
Identities = 20/80 (25%), Positives = 32/80 (40%), Gaps = 9/80 (11%)
Query: 162 KLSVLALQYNQLTG----AIPASLGDLGMLMRLDLSFNNLFGPVPVKLA-----NVPKLE 212
L VL L ++ ++ A+L L LDLS N L ++L LE
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 213 VLDIRNNSFSGNVPPALKRL 232
L + + +S + L+ L
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 2e-06
Identities = 15/91 (16%), Positives = 28/91 (30%), Gaps = 5/91 (5%)
Query: 90 SLTGLYLHFNALNGVIPKEIAS-LSELSDLYLNVNNLSGK----IPSQIGNMTNLQVLQL 144
+ L + L+ E+ L + + L+ L+ I S + L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTG 175
N+L + + +Q L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 5e-06
Identities = 17/99 (17%), Positives = 32/99 (32%), Gaps = 9/99 (9%)
Query: 73 QGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIAS----LSELSDLYLNVNNLSGK 128
+ G+ L L+L ++ +A+ L +L L+ N L
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412
Query: 129 IPSQIG-----NMTNLQVLQLCYNKLTGNIPTQLGSLRK 162
Q+ L+ L L + + +L +L K
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 1e-05
Identities = 17/81 (20%), Positives = 27/81 (33%), Gaps = 9/81 (11%)
Query: 113 SELSDLYLNVNNLSGK----IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGS-----LRKL 163
S L L+L ++S + + + +L+ L L N L QL L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 164 SVLALQYNQLTGAIPASLGDL 184
L L + + L L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 4e-04
Identities = 17/88 (19%), Positives = 29/88 (32%), Gaps = 10/88 (11%)
Query: 70 ISLQGKGLSGE-IPAAVGGLKSLTGLYLHFNALNGVIPKEIAS----LSELSDLYLNVNN 124
+ +Q + LS + L+ + L L K+I+S L++L L N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 125 LSGKIPSQIG-----NMTNLQVLQLCYN 147
L + +Q L L
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 1e-06
Identities = 17/64 (26%), Positives = 31/64 (48%), Gaps = 4/64 (6%)
Query: 130 PSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMR 189
+ + N++ L L+ NK++ P L SL L + L+ NQ++ P L + L
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 190 LDLS 193
+ L+
Sbjct: 222 VTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 18/63 (28%), Positives = 29/63 (46%), Gaps = 4/63 (6%)
Query: 156 QLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLD 215
L +L KL+ L N+++ P L L L+ + L N + P LAN L ++
Sbjct: 168 PLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 216 IRN 218
+ N
Sbjct: 224 LTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 18/64 (28%), Positives = 34/64 (53%), Gaps = 5/64 (7%)
Query: 109 IASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLAL 168
+A+LS+L+ L + N +S P + ++ NL + L N+++ P L + L ++ L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 169 QYNQ 172
NQ
Sbjct: 225 T-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 17/55 (30%), Positives = 29/55 (52%), Gaps = 4/55 (7%)
Query: 90 SLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144
LT L N ++ + P +ASL L +++L N +S P + N +NL ++ L
Sbjct: 174 KLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (104), Expect = 8e-06
Identities = 28/146 (19%), Positives = 50/146 (34%), Gaps = 18/146 (12%)
Query: 104 VIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKL 163
+ ++ + S L++ L + + VL + + + ++ +L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPEL 67
Query: 164 SVLALQYNQLTG--AIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSF 221
L L N+L + + + L L+LS N L + KLE L + NS
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 222 SGNVP-------------PALKRLNG 234
S P L RL+G
Sbjct: 128 SDTFRDQSTYISAIRERFPKLLRLDG 153
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 2e-04
Identities = 11/66 (16%), Positives = 23/66 (34%), Gaps = 4/66 (6%)
Query: 87 GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCY 146
L ++ + + L+ + + N +++ I + N+ L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 147 NKLTGN 152
NKLT
Sbjct: 78 NKLTDI 83
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 7/66 (10%), Positives = 26/66 (39%), Gaps = 4/66 (6%)
Query: 159 SLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRN 218
+ + L+ +T A+ + +L + ++ + +++ + +P + L +
Sbjct: 22 AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 219 NSFSGN 224
N +
Sbjct: 78 NKLTDI 83
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.9 bits (84), Expect = 0.004
Identities = 10/77 (12%), Positives = 27/77 (35%), Gaps = 10/77 (12%)
Query: 105 IPKEI------ASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLG 158
+P I + +E L +++ + + ++ + + + +
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQ 65
Query: 159 SLRKLSVLALQYNQLTG 175
L ++ L L N+LT
Sbjct: 66 YLPNVTKLFLNGNKLTD 82
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 5e-04
Identities = 15/79 (18%), Positives = 31/79 (39%), Gaps = 13/79 (16%)
Query: 119 YLNVNNLSGKIPSQIGNM------TNLQVLQLCYNKLTGNIPTQLGS-----LRKLSVLA 167
LN LS + + + + LQ L+L YN++ + L + + L L
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 168 LQYNQLT--GAIPASLGDL 184
L N+ + + + ++
Sbjct: 309 LNGNRFSEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 7e-04
Identities = 16/78 (20%), Positives = 28/78 (35%), Gaps = 13/78 (16%)
Query: 168 LQYNQLTGAIPASLGD------LGMLMRLDLSFNNLFGPVPVKLA-----NVPKLEVLDI 216
L L+ A++ D L L L +N + L +P L L++
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 217 RNNSFS--GNVPPALKRL 232
N FS +V ++ +
Sbjct: 310 NGNRFSEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.001
Identities = 9/92 (9%), Positives = 30/92 (32%), Gaps = 8/92 (8%)
Query: 115 LSDLYLNVNNLSGK----IPSQIGNMTNLQVLQLCYNKLTGN----IPTQLGSLRKLSVL 166
+ L ++ ++ + + + + +++ + L N + + + S + L +
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 167 ALQYNQLTGAIPASLGDLGMLMRLDLSFNNLF 198
L +L++ L L
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLH 96
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.001
Identities = 12/80 (15%), Positives = 24/80 (30%), Gaps = 12/80 (15%)
Query: 95 YLHFNALNGVIPKEIA------SLSELSDLYLNVNNLSGKIPSQI-----GNMTNLQVLQ 143
L+ L+ + L L L N + + M +L L+
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 144 LCYNKLTGNIPTQLGSLRKL 163
L N+ + +R++
Sbjct: 309 LNGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.6 bits (85), Expect = 0.004
Identities = 12/85 (14%), Positives = 32/85 (37%), Gaps = 11/85 (12%)
Query: 90 SLTGLYLHFNALNGV----IPKEIASLSELSDLYLNVNNLSGK----IPSQIGNMTNLQV 141
S+ G L +A+ + + + ++ L+ N + + + I + +L++
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 142 LQLCYN---KLTGNIPTQLGSLRKL 163
+ ++ IP L L +
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQA 88
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.001
Identities = 15/90 (16%), Positives = 31/90 (34%), Gaps = 3/90 (3%)
Query: 108 EIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLA 167
+ + +L L + I + + + N++ + LR+L L
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGF-PLLRRLKTLL 69
Query: 168 LQYNQLTGAIPASLGDLGMLMRLDLSFNNL 197
+ N++ L L L L+ N+L
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSL 99
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.5 bits (83), Expect = 0.004
Identities = 15/83 (18%), Positives = 26/83 (31%), Gaps = 6/83 (7%)
Query: 148 KLTGNIPTQLGS---LRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVK 204
KLT + Q + L L+ ++ I L +D S N +
Sbjct: 2 KLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF- 59
Query: 205 LANVPKLEVLDIRNNSFSGNVPP 227
+ +L+ L + NN
Sbjct: 60 -PLLRRLKTLLVNNNRICRIGEG 81
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (83), Expect = 0.003
Identities = 23/146 (15%), Positives = 46/146 (31%), Gaps = 4/146 (2%)
Query: 90 SLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQI-GNMTNLQVLQLCYNK 148
+GL + + L++LY+ + + + L+ L + +
Sbjct: 9 GSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 149 LTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVK-LAN 207
L P +LS L L +N L ++ L L LS N L ++ L
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126
Query: 208 VPKLEVLDIRNNSFSGNVPPALKRLN 233
+ + + + L +
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGPLAHMP 152
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (84), Expect = 0.004
Identities = 12/81 (14%), Positives = 25/81 (30%), Gaps = 2/81 (2%)
Query: 94 LYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNI 153
L+L+ N + + + NNL + +L + ++
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217
Query: 154 PTQLGSLRKLSVLALQYNQLT 174
L +L+KL + L
Sbjct: 218 SYGLENLKKLRARST--YNLK 236
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 673 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.84 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.81 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.8 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.72 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.71 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.63 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.58 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.57 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.54 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.54 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.52 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.5 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.5 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.47 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.47 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.45 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.44 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.43 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.41 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.36 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.29 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.26 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.25 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.03 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.87 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.78 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.73 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.67 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.64 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.62 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.48 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.43 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.27 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.16 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.75 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.61 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.58 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.49 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.84 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.84 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.75 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.41 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.3 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-55 Score=439.67 Aligned_cols=257 Identities=21% Similarity=0.389 Sum_probs=203.2
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
++|+..+.||+|+||+||+|++.+++.||||++... ....++|.+|++++++++|||||+++|+|... +..++|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC--cCcHHHHHHHHHHHHhcCCCCcccccceeccC--CceEEEEE
Confidence 467888999999999999999998999999999764 34567899999999999999999999999654 67899999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
||++|+|.+++.. ....++|..+++|+.|||+||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~--~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 81 FMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred ecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc--ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999999999863 235689999999999999999999987 79999999999999999999999999998876554
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCC-CChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCS-ITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
........||+.|+|||++.+..|+.|+|||||||++|||+|+..| +......... ..+.. ......+..++.+
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~-~~i~~----~~~~~~p~~~~~~ 230 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-EDIST----GFRLYKPRLASTH 230 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHH-HHHHH----TCCCCCCTTSCHH
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHH-HHHHh----cCCCCCccccCHH
Confidence 4444456789999999999999999999999999999999995444 4332221111 11222 1222234445678
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
+.+++.+||+.||++||||+||++.|++|.+|
T Consensus 231 l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 231 VYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 99999999999999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-55 Score=446.23 Aligned_cols=261 Identities=22% Similarity=0.361 Sum_probs=216.7
Q ss_pred HhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
..++|+..+.||+|+||+||+|++++++.||||++.... ...++|.+|+++|++++|||||+++|++.+ +..++|
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~iv 85 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYII 85 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc---CCeEEE
Confidence 346788899999999999999999888999999997643 456789999999999999999999998843 457899
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+++|+|.+++... ....++|..+++|+.||++||+|||++ +|+||||||+||||++++.+||+|||+|+....
T Consensus 86 ~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~--~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER--NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp EECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCccchhheeeecccceeeccccceEEccC
Confidence 9999999999988643 224599999999999999999999987 799999999999999999999999999998876
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
..........||+.|||||++.++.++.++|||||||++|||+||..|+............+..... ...+...+.
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~----~~~p~~~~~ 237 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR----MVRPDNCPE 237 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----CCCCTTCCH
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC----CCCcccChH
Confidence 5444445567899999999999889999999999999999999976665443222111112222222 223344567
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHhhcCC
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQELSSIIGSS 673 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~~ 673 (673)
++.+|+.+||+.||++||||+||++.|++++.+|
T Consensus 238 ~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 8999999999999999999999999999988764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-55 Score=446.39 Aligned_cols=263 Identities=19% Similarity=0.349 Sum_probs=208.5
Q ss_pred HhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
..++|...+.||+|+||+||+|+++ ..||||+++.... ....+.|.+|+++|++++|||||+++|++.. +..++
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~l 80 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAI 80 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEEEE
Confidence 3467888999999999999999865 3599999976543 3345789999999999999999999998743 45799
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
|||||++|+|.+++... ...+++..+++|+.|||+||+|||++ |||||||||+|||+++++.+||+|||+|+...
T Consensus 81 v~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~--~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC--CEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 99999999999999632 34699999999999999999999987 79999999999999999999999999998765
Q ss_pred Ccch-hhhhccCCCCCccCCccccC---CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 559 DDIV-FSMLKASAAMGYLAPEYTTT---GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 559 ~~~~-~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
.... .......||+.|||||++.. ..|+.++|||||||++|||+||+.||............+.....+......+
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 235 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSC
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcc
Confidence 4322 23345679999999999864 3589999999999999999999999976433222222222221111112334
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
..+++++.+++.+||+.||++||||+||++.|+.+.++
T Consensus 236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 45568899999999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-54 Score=443.43 Aligned_cols=263 Identities=23% Similarity=0.396 Sum_probs=219.3
Q ss_pred HHHhcCCccccccccCCcceEEEEEEcC-CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 398 ERATQCFSEANLLGKSSFSATYKGILRD-GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 398 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
+...++|+..+.||+|+||+||+|++++ |+.||||+++.. ....++|.+|+++|++++|||||+++|+|.+ .+..
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~ 88 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPF 88 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT--CSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSC
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc--cchHHHHHHHHHHHHhCCCCCEecCCccEee--CCee
Confidence 3345678889999999999999999864 889999998765 3456789999999999999999999999954 4778
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++|||||++|+|.+++... ....+++..++.|+.|||+||+|||++ ||+||||||+||||++++.+||+|||+|+.
T Consensus 89 ~iv~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~--~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EEEeecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC--CcccCccccCeEEECCCCcEEEccccceee
Confidence 9999999999999998643 235689999999999999999999987 899999999999999999999999999998
Q ss_pred ccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHH
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (673)
...+.........|++.|||||++.++.|+.|+|||||||++|||+||..|+......... .+.+........+..
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~----~~~i~~~~~~~~~~~ 240 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----YELLEKDYRMERPEG 240 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH----HHHHHTTCCCCCCTT
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHH----HHHHhcCCCCCCCcc
Confidence 7665444444456888999999999999999999999999999999987776543322211 122222233344455
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 637 EASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
.+.++.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 668899999999999999999999999999998753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-54 Score=443.90 Aligned_cols=259 Identities=25% Similarity=0.464 Sum_probs=202.5
Q ss_pred cCCccccccccCCcceEEEEEEcC-C---cEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-G---SVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
++|+..+.||+|+||+||+|+++. + ..||||.+.........++|.+|+++|++++|||||+++|+|.. .+..+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK--STPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSSCE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee--CCEEE
Confidence 345667899999999999999753 3 36899988765544455789999999999999999999999954 46789
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+|||||++|+|.+++... ...++|.++++|+.|||+||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 104 iv~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~--~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM--NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC--CCccCccccceEEECCCCcEEECCcccceEc
Confidence 999999999999988732 34699999999999999999999997 7999999999999999999999999999977
Q ss_pred cCcchh----hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCC
Q 005859 558 ADDIVF----SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGK 632 (673)
Q Consensus 558 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (673)
...... ......+|+.|||||.+.++.++.++|||||||++|||+| |+.||........... + .......
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~-i----~~~~~~~ 253 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA-I----EQDYRLP 253 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-H----HTTCCCC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHH-H----HcCCCCC
Confidence 543321 1223457889999999999999999999999999999998 8999876543322211 1 1122223
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 633 FSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 633 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
.+...+.++.+|+.+||+.||++||||+||++.|++++++
T Consensus 254 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 3445668899999999999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-53 Score=425.79 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=216.3
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
++|+..+.||+|+||+||+|++++++.||||++++.. ...++|.+|++++++++|||||+++|+|.+ .+..++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~--~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECC--SSSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEee--CCceEEEEE
Confidence 5788899999999999999999889999999998653 456789999999999999999999999954 477999999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+++|+|.+++.. ....+++..+++++.|||+||+|||++ ||+||||||+|||+++++.+||+|||+++......
T Consensus 80 y~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~--~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 80 YMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK--QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT--TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred ccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc--CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 9999999999763 235689999999999999999999997 89999999999999999999999999998776654
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
........+|+.|+|||.+.+..++.|+|||||||++|||+| |+.||........... +.+. .....+...+.+
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~-i~~~----~~~~~p~~~~~~ 229 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQG----LRLYRPHLASEK 229 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-HHTT----CCCCCCTTCCHH
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH-HHhC----CCCCCcccccHH
Confidence 444445678999999999999999999999999999999998 8989876544332221 2221 222334455678
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQELSSI 669 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~~L~~i 669 (673)
+.+++.+||+.||++||||+|+++.|.+|
T Consensus 230 l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 230 VYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 99999999999999999999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=431.61 Aligned_cols=257 Identities=18% Similarity=0.303 Sum_probs=199.3
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
++|+..+.||+|+||+||+|+.+ +|+.||||++...... ...+.+.+|+++|++++|||||++++++.+...+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999976 5899999999776432 234678999999999999999999999977656778999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCC---CCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKR---PGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
||||++|+|.+++.........+++..++.++.||+.||+|||+.. .+||||||||+|||+++++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999754333457999999999999999999999852 2499999999999999999999999999998
Q ss_pred ccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHH
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (673)
...+.. ......||+.|||||++.+..|+.++|||||||++|||+||+.||............ .....+ ..+..
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i-~~~~~~----~~~~~ 237 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFR----RIPYR 237 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHTCCC----CCCTT
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHH-HcCCCC----CCCcc
Confidence 765432 233467899999999999999999999999999999999999999765433222211 111111 23334
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 637 EASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.++++.+++.+||+.||++|||++|+++
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 5678999999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=432.04 Aligned_cols=257 Identities=22% Similarity=0.348 Sum_probs=210.3
Q ss_pred cCCccccc-cccCCcceEEEEEEcC---CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEE
Q 005859 402 QCFSEANL-LGKSSFSATYKGILRD---GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 402 ~~~~~~~~-lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
++|...+. ||+|+||+||+|.++. +..||||+++........++|.+|+++|++++|||||+++|++.. +..+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---CeEE
Confidence 45666664 9999999999998653 557999999876544455789999999999999999999999853 4579
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+|||||++|+|.+++.. ....+++..+.+|+.|||+||+|||++ ||+||||||+|||++.++.+||+|||+++.+
T Consensus 85 lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~--~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK--NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCcCchhheeeccCCceeeccchhhhcc
Confidence 99999999999998853 234699999999999999999999997 7999999999999999999999999999977
Q ss_pred cCcch--hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 558 ADDIV--FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 558 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
..... .......||+.|||||++..+.++.++|||||||++|||+| |+.||.......... .+.. ......+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~-~i~~----~~~~~~p 234 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-FIEQ----GKRMECP 234 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH-HHHT----TCCCCCC
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHH-HHHc----CCCCCCC
Confidence 54322 12234568899999999999999999999999999999998 899997653322111 1111 2222344
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
...+.++.+|+.+||+.||++||||.+|++.|+.+..
T Consensus 235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 5566889999999999999999999999999987754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-53 Score=427.11 Aligned_cols=252 Identities=20% Similarity=0.308 Sum_probs=203.8
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|+..+.||+|+||+||+|+.+ +|+.||||++.........+.+.+|+++|++++|||||++++++.+. +..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~--~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--ceeEEEE
Confidence 57899999999999999999976 58999999997654444456799999999999999999999999664 7899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
|||++|+|.+++. ....+++..+..++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+|+.....
T Consensus 83 Ey~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~--~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 83 EYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp ECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred eccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc--CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 9999999999996 235699999999999999999999998 8999999999999999999999999999876543
Q ss_pred c-hhhhhccCCCCCccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 561 I-VFSMLKASAAMGYLAPEYTTTGRF-TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 561 ~-~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
. .......+||+.|||||++.+..+ +.++||||+||++|||+||+.||.......... ................+
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~s 233 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY---SDWKEKKTYLNPWKKID 233 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH---HHHHTTCTTSTTGGGSC
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH---HHHhcCCCCCCccccCC
Confidence 2 222345679999999999988776 578999999999999999999996543221111 11111111112223446
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 234 SAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 78899999999999999999999975
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=427.22 Aligned_cols=260 Identities=22% Similarity=0.420 Sum_probs=205.0
Q ss_pred cCCccccccccCCcceEEEEEEcCC-----cEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDG-----SVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
..|+..++||+|+||+||+|.+++. ..||||++..........+|.+|+++|++++|||||+++|++.. .+..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~--~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--YKPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec--CCce
Confidence 4578889999999999999997642 47999999765544445679999999999999999999999954 4678
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++|||||++|++.+++... ...++|..+++++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 85 ~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~--~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM--NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc--ccccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999999887632 34699999999999999999999997 799999999999999999999999999987
Q ss_pred ccCcch--hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 557 LADDIV--FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 557 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
...... .......||+.|||||++.++.++.++|||||||++|||+||..|+.......... +.+........+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~----~~i~~~~~~~~~ 235 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM----KAINDGFRLPTP 235 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHHTTCCCCCC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHH----HHHhccCCCCCc
Confidence 754322 12234568899999999999999999999999999999999766654332221111 112222233344
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
...+.++.+|+.+||+.||++||||.||++.|++++++
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 236 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 55668899999999999999999999999999998763
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=426.10 Aligned_cols=258 Identities=23% Similarity=0.381 Sum_probs=207.5
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
++|++.+.||+|+||+||+|++++++.||||++... ....+.|.+|+.+|++++|||||+++|+|.+ +..++|||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~lv~E 91 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTE 91 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc--cCCHHHHHHHHHHHHhcccCCEeEEEEEEec---CCeEEEEE
Confidence 578999999999999999999998889999999755 3456789999999999999999999999843 45789999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
||++|+|..++.... ...++|..++.|+.|||.||+|||++ ||+||||||+|||||+++.+||+|||+++......
T Consensus 92 y~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~--~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 92 YMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred ecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh--heecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 999999999887432 24599999999999999999999987 79999999999999999999999999999876554
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNL 641 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 641 (673)
........||+.|+|||++..+.++.++|||||||++|||+||..|+............+.. ......+...+.++
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~----~~~~~~~~~~~~~l 243 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----GYRMPCPPECPESL 243 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT----TCCCCCCTTSCHHH
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh----cCCCCCCcccCHHH
Confidence 44455567899999999999999999999999999999999977666543222211111221 12223344556789
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 642 GQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 642 ~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
.+++.+||+.||++||||++|+++|++++.+
T Consensus 244 ~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 9999999999999999999999999988754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=420.55 Aligned_cols=246 Identities=21% Similarity=0.343 Sum_probs=207.4
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|++.+.||+|+||+||+|+.+ +++.||||++.+... ....+.+.+|++++++++|||||++++++.+ .+..++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~i 83 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVYL 83 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE--CCEEEE
Confidence 46889999999999999999986 489999999875421 2345678999999999999999999999965 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
|||||++|+|.+++.. ...+++..+..++.||+.||+|||++ |||||||||+|||+++++.+||+|||+|+...
T Consensus 84 vmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~--~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 84 ILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred EEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeeeeccccceecCCCCEeecccceeeecC
Confidence 9999999999999973 34699999999999999999999997 89999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
... .....||+.|||||++.+..|+.++|||||||++|||+||+.||.......... .+.... ..++...+
T Consensus 158 ~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~----~i~~~~--~~~p~~~s 228 (263)
T d2j4za1 158 SSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK----RISRVE--FTFPDFVT 228 (263)
T ss_dssp CCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHTTC--CCCCTTSC
T ss_pred CCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHH----HHHcCC--CCCCccCC
Confidence 542 234579999999999999999999999999999999999999997643322221 111111 12334456
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+++.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 229 EGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 78999999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-52 Score=422.88 Aligned_cols=249 Identities=14% Similarity=0.252 Sum_probs=208.8
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+. +..|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVG--DELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc-ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC--CEEEEEE
Confidence 47999999999999999999965 59999999997654 34567899999999999999999999999664 7899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
|||++|+|.+++.. ..+++..+..++.||+.||+|||++ |||||||||+|||++.++.+||+|||+|+.+..+
T Consensus 97 Ey~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~--~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp ECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC--CCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence 99999999998752 3589999999999999999999998 8999999999999999999999999999877543
Q ss_pred chhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
.. ......||+.|||||++.+..|+.++|||||||++|||+||+.||................ .+ ....+...+.+
T Consensus 170 ~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~--~~~~~~~~s~~ 245 (293)
T d1yhwa1 170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TP--ELQNPEKLSAI 245 (293)
T ss_dssp TC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SC--CCSSGGGSCHH
T ss_pred cc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CC--CCCCcccCCHH
Confidence 32 2345579999999999999999999999999999999999999997644332221111111 11 11233455688
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.+++.+||+.||++|||++|+++
T Consensus 246 ~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 246 FRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=424.15 Aligned_cols=249 Identities=21% Similarity=0.341 Sum_probs=201.5
Q ss_pred cccccCCcceEEEEEEcC---CcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEeec
Q 005859 408 NLLGKSSFSATYKGILRD---GSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDFV 483 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~~ 483 (673)
+.||+|+||+||+|.+++ ++.||||+++..... ...++|.+|+++|++++|||||+++|+|.. +..++|||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEEEEEEcC
Confidence 469999999999998754 568999999764322 234679999999999999999999999843 3468999999
Q ss_pred CCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcch-
Q 005859 484 PNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV- 562 (673)
Q Consensus 484 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 562 (673)
++|+|.+++.. ...++|..+++|+.|||+||+|||++ +||||||||+|||++.++.+||+|||+++.......
T Consensus 90 ~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~--~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 90 ELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp TTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC--CcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 99999999873 34699999999999999999999987 799999999999999999999999999987654322
Q ss_pred -hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 563 -FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 563 -~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
.......||+.|||||.+.+..++.++|||||||++|||+| |+.||.......... .+........+..++.+
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~-----~i~~~~~~~~p~~~~~~ 238 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-----MLEKGERMGCPAGCPRE 238 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-----HHHTTCCCCCCTTCCHH
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHH-----HHHcCCCCCCCcccCHH
Confidence 12234568899999999999999999999999999999998 899997654332211 11112222344556688
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
+.+|+.+||+.||++||||++|++.|+..+
T Consensus 239 ~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 239 MYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 999999999999999999999999988764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-52 Score=417.87 Aligned_cols=249 Identities=22% Similarity=0.362 Sum_probs=200.5
Q ss_pred ccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecC--CCCeEEEEE
Q 005859 405 SEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSK--GRGECFLIY 480 (673)
Q Consensus 405 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~~~lv~ 480 (673)
+..+.||+|+||+||+|+.. +++.||+|++..... ....+.|.+|+++|++++|||||++++++... +....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45567999999999999976 488999999976542 23346799999999999999999999998642 245689999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEec-CCCCeeeccccccccccC
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIH-RRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~-~~~~~kl~DfGla~~~~~ 559 (673)
||+++|+|.+++.. ...+++..+..++.||++||+|||++.++|+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999973 3468999999999999999999999855599999999999996 578999999999986554
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
.. .....||+.|||||++.+ .|+.++|||||||++|||+||+.||............+..... ...++...++
T Consensus 168 ~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~---~~~~~~~~~~ 240 (270)
T d1t4ha_ 168 SF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK---PASFDKVAIP 240 (270)
T ss_dssp TS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC---CGGGGGCCCH
T ss_pred Cc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC---CcccCccCCH
Confidence 32 234679999999998865 6999999999999999999999999654322221112211111 1122333456
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
++.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 241 EVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhC
Confidence 7899999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-52 Score=430.97 Aligned_cols=254 Identities=19% Similarity=0.291 Sum_probs=204.5
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|++.+.||+|+||+||+|+.. +|+.||||+++........+++.+|+++|++++|||||+++++|.+. ++.++|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS--SEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEE
Confidence 568999999999999999999975 58999999998664444567899999999999999999999999654 789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
||||++|+|.+++.. ...+++..+..++.|++.||+|||+.. ||+||||||+|||+++++.+||+|||+|+...+
T Consensus 83 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~-~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH-CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC-CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999999999999973 245899999999999999999999732 799999999999999999999999999987654
Q ss_pred cchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhcc--------------------
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESS-------------------- 619 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~-------------------- 619 (673)
.. ....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.........
T Consensus 158 ~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp HT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred Cc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 32 2346899999999999999999999999999999999999999965321100000
Q ss_pred ------------------chhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 620 ------------------KVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 620 ------------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..................+.++.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000000000000001123467899999999999999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-52 Score=421.63 Aligned_cols=251 Identities=18% Similarity=0.246 Sum_probs=206.4
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
+.|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.|.+|+++|++++|||||++++++.+. +..++||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CeEEEEE
Confidence 46888999999999999999976 48999999997653 34557899999999999999999999999654 7899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
|||++|+|.+++... ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.....
T Consensus 89 Ey~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~--~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 89 EFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN--KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp ECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred ecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC--CEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 999999999987632 24599999999999999999999998 8999999999999999999999999999866443
Q ss_pred chhhhhccCCCCCccCCcccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 561 IVFSMLKASAAMGYLAPEYTT-----TGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
. .......||+.|||||++. ...|+.++|||||||++|||+||+.||............... ..+ ....+.
T Consensus 164 ~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~-~~~--~~~~~~ 239 (288)
T d2jfla1 164 I-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-EPP--TLAQPS 239 (288)
T ss_dssp H-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS-CCC--CCSSGG
T ss_pred c-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCC--CCCccc
Confidence 2 1233567999999999984 455899999999999999999999999765332221111111 111 112334
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+.++.+++.+||+.||++|||++|+++
T Consensus 240 ~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 55688999999999999999999999976
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=429.46 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=209.0
Q ss_pred HhcCCccccccccCCcceEEEEEEcC-C-----cEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCC
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILRD-G-----SVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKG 472 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 472 (673)
..++|+..+.||+|+||+||+|++.. + ..||||.+...........|.+|+++|.++ +|||||++++++.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-- 112 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 112 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--
Confidence 34678899999999999999999653 2 369999997665455567899999999998 89999999999954
Q ss_pred CCeEEEEEeecCCCChhhhhccccC-------------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCc
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAG-------------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNL 533 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDl 533 (673)
.+..++|||||++|+|.++++.... ....++|..++.|+.||++||+|||++ +||||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~--~IiHRDl 190 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRDL 190 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT--TEEETTC
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeccC
Confidence 4778999999999999999975421 123589999999999999999999997 7999999
Q ss_pred CCCCeEecCCCCeeeccccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChh
Q 005859 534 SAEKVLIHRRYNPLLSDSGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPF 611 (673)
Q Consensus 534 k~~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~ 611 (673)
||+|||++.++.+||+|||+|+........ ......||+.|||||++.++.|+.++|||||||++|||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876543321 2234567999999999999999999999999999999998 89998754
Q ss_pred hHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 005859 612 TRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSS 668 (673)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 668 (673)
...... .+++........+...+.++.+|+.+||+.||++||||+||++.|..
T Consensus 271 ~~~~~~----~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 271 PVDANF----YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CCSHHH----HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHHH----HHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 322221 22222222333445566889999999999999999999999999863
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-51 Score=422.34 Aligned_cols=252 Identities=23% Similarity=0.376 Sum_probs=192.0
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.+.|+..+.||+|+||+||+|+.+ +|+.||||++.+.........+.+|+++|++++|||||++++++.+ .+..|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES--GGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 456899999999999999999976 4899999999876544445678899999999999999999999954 4789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEec---CCCCeeecccccccc
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIH---RRYNPLLSDSGLHKL 556 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~---~~~~~kl~DfGla~~ 556 (673)
||||++|+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||+. +++.+||+|||+|+.
T Consensus 86 mE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~--~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp ECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred EeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc--eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 999999999999963 34699999999999999999999987 899999999999994 578999999999987
Q ss_pred ccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHH
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVS 636 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (673)
...... ....+||+.|||||++.+..|+.++|||||||++|||+||+.||................ ..........
T Consensus 160 ~~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~ 235 (307)
T d1a06a_ 160 EDPGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE--YEFDSPYWDD 235 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTC--CCCCTTTTTT
T ss_pred ccCCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccC--CCCCCccccC
Confidence 654432 234679999999999999999999999999999999999999997654332222211111 1112222344
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 637 EASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 637 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.++++.+++.+||+.||++|||++|+++
T Consensus 236 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 5678999999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-52 Score=422.29 Aligned_cols=258 Identities=22% Similarity=0.375 Sum_probs=201.7
Q ss_pred hcCCccccccccCCcceEEEEEEcC----CcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD----GSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
.++|+..+.||+|+||+||+|++.. +..||||.++........+.|.+|+++|++++|||||+++|++.+ +..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CeE
Confidence 4678899999999999999998753 457899998765434445689999999999999999999999843 567
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
++||||+++|+|.+++... ...+++..++.++.||++||+|||++ +|+||||||+||++++++.+||+|||+|+.
T Consensus 83 ~iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~--~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK--RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc--CeeccccchhheeecCCCcEEEccchhhee
Confidence 9999999999999987632 34689999999999999999999998 799999999999999999999999999998
Q ss_pred ccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
.............||+.|+|||.+.+..|+.++|||||||++|||+| |..||........... +.... ....+.
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~-i~~~~----~~~~~~ 232 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-IENGE----RLPMPP 232 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-HHTTC----CCCCCT
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCC----CCCCCC
Confidence 76554444455678999999999999999999999999999999998 8888866433322111 11111 123344
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
..+.++.+|+.+||+.||++|||+.||++.|++|++
T Consensus 233 ~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 566889999999999999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-51 Score=423.84 Aligned_cols=269 Identities=19% Similarity=0.326 Sum_probs=216.8
Q ss_pred HHHHHHHhcCCccccccccCCcceEEEEEEc------CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeE
Q 005859 394 LEEVERATQCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGI 467 (673)
Q Consensus 394 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 467 (673)
+.+++..+++|+..+.||+|+||+||+|+++ +++.||||++.........++|.+|+++|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3455567789999999999999999999964 3578999999765433345689999999999999999999999
Q ss_pred EecCCCCeEEEEEeecCCCChhhhhccccC--------------------CccccCHHHHHHHHHHHHHHHHHHhcCCCC
Q 005859 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAG--------------------SEKVLEWATRISVIKGIAKGISYLHGKRPG 527 (673)
Q Consensus 468 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 527 (673)
|.. .+..++||||+++|+|.+++..... ....+++..++.|+.|++.||+|||++ +
T Consensus 85 ~~~--~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~--~ 160 (301)
T d1lufa_ 85 CAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--K 160 (301)
T ss_dssp ECS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT--T
T ss_pred ecc--CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC--C
Confidence 954 4678999999999999999863211 123589999999999999999999987 7
Q ss_pred cccCCcCCCCeEecCCCCeeeccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCC-
Q 005859 528 LVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGK- 605 (673)
Q Consensus 528 ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~- 605 (673)
||||||||+|||+|.++.+||+|||+|+...+... .......+++.|+|||.+.+..|+.|+|||||||++|||++|.
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence 99999999999999999999999999987654322 2233456889999999999999999999999999999999986
Q ss_pred CCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 606 CSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 606 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.||........... +. +.. ....+...+.++.+|+.+||+.||++||||.||+++|++|.+
T Consensus 241 ~p~~~~~~~e~~~~-v~---~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 241 QPYYGMAHEEVIYY-VR---DGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp CTTTTSCHHHHHHH-HH---TTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCCCCHHHHHHH-HH---cCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 46655433322211 11 111 223344566789999999999999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-51 Score=418.50 Aligned_cols=246 Identities=21% Similarity=0.332 Sum_probs=202.2
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC--cHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS--DEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
..|+..+.||+|+||+||+|+.. +|+.||||++....... ..+.+.+|+++|++++|||||++++++.+. +..|+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC--CEEEE
Confidence 45899999999999999999975 58899999997654322 235689999999999999999999999654 78999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
|||||++|+|..++.. ...+++..+..++.||+.||+|||++ |||||||||+|||+++++.+||+|||+|+...
T Consensus 93 v~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~--~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp EEECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EEEecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC--CEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 9999999999776642 34699999999999999999999998 89999999999999999999999999998765
Q ss_pred CcchhhhhccCCCCCccCCccccC---CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTT---GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSV 635 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (673)
.. ....||+.|||||++.+ +.|+.++|||||||++|||++|+.||............... ..+.. .+.
T Consensus 167 ~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~-~~~~~---~~~ 237 (309)
T d1u5ra_ 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPAL---QSG 237 (309)
T ss_dssp SB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-CCCCC---SCT
T ss_pred CC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-CCCCC---CCC
Confidence 43 24579999999999864 45899999999999999999999999765433222211111 11111 223
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 636 SEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 636 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..++++.+|+.+||+.||++|||++|+++
T Consensus 238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 34578999999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-51 Score=410.38 Aligned_cols=251 Identities=24% Similarity=0.427 Sum_probs=200.5
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEe
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYD 481 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E 481 (673)
++|+..+.||+|+||.||+|+++ |+.||||+++.. ...++|.+|++++++++|||||+++|+|.+. .+..++|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEEC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCcEEEEEe
Confidence 45777889999999999999985 788999999653 3457899999999999999999999998653 345799999
Q ss_pred ecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcc
Q 005859 482 FVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDI 561 (673)
Q Consensus 482 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~ 561 (673)
|+++|+|.+++... ....++|..+++|+.||+.||+|||+. +|+||||||+|||++.++.+|++|||+++.....
T Consensus 82 y~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~--~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp CCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC--ceeccccchHhheecCCCCEeecccccceecCCC-
Confidence 99999999999743 224589999999999999999999987 7999999999999999999999999999876543
Q ss_pred hhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHHH
Q 005859 562 VFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEASN 640 (673)
Q Consensus 562 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (673)
.....++..|+|||++.++.++.++|||||||++|||+| |+.||........ ...+........+...+++
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~-----~~~i~~~~~~~~~~~~~~~ 228 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----VPRVEKGYKMDAPDGCPPA 228 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-----HHHHTTTCCCCCCTTCCHH
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH-----HHHHHcCCCCCCCccCCHH
Confidence 223457889999999999999999999999999999999 6776654322211 1111222233445556688
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 005859 641 LGQIALHCTHESPSHRPSIENVMQELSSII 670 (673)
Q Consensus 641 l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~ 670 (673)
+.+++.+||+.||++||||.|++++|++|.
T Consensus 229 ~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 229 VYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 999999999999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=420.90 Aligned_cols=271 Identities=22% Similarity=0.346 Sum_probs=207.7
Q ss_pred HHHHHHhcCCccccccccCCcceEEEEEEcC------CcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeE
Q 005859 395 EEVERATQCFSEANLLGKSSFSATYKGILRD------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGI 467 (673)
Q Consensus 395 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~ 467 (673)
.+++...++|+..+.||+|+||+||+|++.. ++.||||++.........+.+.+|++++.++ +|+|||.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 4444455789999999999999999999642 4689999997655444557788999988887 78999999998
Q ss_pred EecCCCCeEEEEEeecCCCChhhhhccccC------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCC
Q 005859 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAG------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSA 535 (673)
Q Consensus 468 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~ 535 (673)
+... .+..++|||||++|+|.++++.... ....+++..++.++.||++||+|||++ +||||||||
T Consensus 86 ~~~~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~--~ivHrDlKp 162 (299)
T d1ywna1 86 CTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAA 162 (299)
T ss_dssp ECST-TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCG
T ss_pred eccC-CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC--CCcCCcCCc
Confidence 8654 3568999999999999999974321 124589999999999999999999997 799999999
Q ss_pred CCeEecCCCCeeeccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCC-CCCChhhH
Q 005859 536 EKVLIHRRYNPLLSDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGK-CSITPFTR 613 (673)
Q Consensus 536 ~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~-~p~~~~~~ 613 (673)
+||||++++.+||+|||+|+....... .......||+.|||||++.++.++.++|||||||++|||+||. .||.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654332 2233457899999999999999999999999999999999975 46654322
Q ss_pred hhhhccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 614 QAAESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
.......+.+... ...+...++++.+++.+||+.||++||||+||++.|++++++
T Consensus 243 ~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 243 DEEFCRRLKEGTR----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp SHHHHHHHHHTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCC----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1111112222222 233444567899999999999999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=417.18 Aligned_cols=249 Identities=18% Similarity=0.250 Sum_probs=204.8
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|+..+.||+|+||+||+|+.. +|+.||||++.+... ....+.+.+|+++|++++|||||++++++.+ .+..|+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLYF 85 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--SSEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE--CCEEEE
Confidence 46999999999999999999975 589999999975421 2345679999999999999999999999955 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
|||||++|+|.+++.. ...+++..+..++.|++.||+|||++ |||||||||+|||+++++.+||+|||+|+.+.
T Consensus 86 vmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~--~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp EECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccc--cEEcCcCCccccccCCCceEEecccccceecc
Confidence 9999999999999873 34699999999999999999999998 89999999999999999999999999999875
Q ss_pred Ccch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 559 DDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 559 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
.... .......||+.|||||++.+..|+.++||||+||++|||+||+.||........... +.... ..++...
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~----i~~~~--~~~p~~~ 233 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLE--YDFPEKF 233 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHTTC--CCCCTTC
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHH----HHcCC--CCCCccC
Confidence 4322 223346799999999999999999999999999999999999999976433322221 11111 1233445
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
++++.+|+.+||+.||++|||++|+++
T Consensus 234 s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 234 FPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 678999999999999999999998743
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=420.12 Aligned_cols=257 Identities=22% Similarity=0.373 Sum_probs=206.2
Q ss_pred cCCccccccccCCcceEEEEEEcC-Cc----EEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GS----VVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 476 (673)
.+|++.+.||+|+||+||+|++.. |+ .||||++.........++|.+|+++|++++|||||+++|+|.+ +..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~---~~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCe
Confidence 368999999999999999999753 44 6899988765545567789999999999999999999999965 346
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
+++|||+.+|+|.+++... ...+++..+++++.|||+||+|||++ +||||||||+|||++.++.+||+|||+|+.
T Consensus 86 ~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~--~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEEEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred eEEEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc--CcccCcchhhcceeCCCCCeEeecccccee
Confidence 7899999999999988643 35699999999999999999999997 799999999999999999999999999997
Q ss_pred ccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 557 LADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 557 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
....... ......||+.|||||++.++.|+.++|||||||++|||+| |+.||........ ...+........+
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~-----~~~i~~~~~~~~p 235 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-----SSILEKGERLPQP 235 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-----HHHHHHTCCCCCC
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-----HHHHHcCCCCCCC
Confidence 7543322 2334568999999999999999999999999999999999 7888865433221 1111112222334
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 635 VSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
..++.++.+++.+||+.||++||||.||++.|+++..
T Consensus 236 ~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 4566889999999999999999999999999988753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-50 Score=412.97 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=206.3
Q ss_pred ccccccCCcceEEEEEEcCC----cEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEEee
Q 005859 407 ANLLGKSSFSATYKGILRDG----SVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIYDF 482 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~E~ 482 (673)
.++||+|+||+||+|++.++ ..||||++.+.......++|.+|+++|++++|||||+++|++... .+..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEEEEE
Confidence 36799999999999997542 368999997654344457899999999999999999999998654 3578999999
Q ss_pred cCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCcch
Q 005859 483 VPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADDIV 562 (673)
Q Consensus 483 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 562 (673)
|++|+|.+++... ...+++..+++++.|+|+||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 111 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~--~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 111 MKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred eecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc--CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999998743 34578899999999999999999987 799999999999999999999999999987654322
Q ss_pred h---hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHHH
Q 005859 563 F---SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEAS 639 (673)
Q Consensus 563 ~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (673)
. ......||..|+|||.+..+.++.++||||||+++|||+||+.||............+.... ....+...+.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~----~~~~p~~~~~ 261 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR----RLLQPEYCPD 261 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC----CCCCCTTCCH
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----CCCCcccCcH
Confidence 1 22335688999999999999999999999999999999998888765432221111111111 2223344567
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 640 NLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 640 ~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
++.+++.+||+.||++||+|.||++.|++++++
T Consensus 262 ~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 262 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 899999999999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=413.94 Aligned_cols=259 Identities=22% Similarity=0.405 Sum_probs=207.7
Q ss_pred cCCccccccccCCcceEEEEEEcC-Cc--EEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCCCCeEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD-GS--VVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~ 477 (673)
++|+..+.||+|+||+||+|++++ |. .||||++.........++|.+|+++|+++ +|||||+++|+|... +..+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--CeeE
Confidence 568888999999999999999764 44 57888887655445567899999999999 799999999999764 7899
Q ss_pred EEEeecCCCChhhhhcccc------------CCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC
Q 005859 478 LIYDFVPNGNLLQHLDLEA------------GSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN 545 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~ 545 (673)
+||||+++|+|.++++... .....++|..+.+++.|||+||+|||++ +|+||||||+|||++.++.
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~--~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECGGGC
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC--CccccccccceEEEcCCCc
Confidence 9999999999999996431 2235699999999999999999999997 7999999999999999999
Q ss_pred eeeccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCC-CCChhhHhhhhccchhhh
Q 005859 546 PLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKC-SITPFTRQAAESSKVEDF 624 (673)
Q Consensus 546 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~-p~~~~~~~~~~~~~~~~~ 624 (673)
+||+|||+++...... ......||..|+|||.+.++.|+.++|||||||++|||++|.. ||.......... .+.+
T Consensus 166 ~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~-~i~~- 241 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-KLPQ- 241 (309)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-HGGG-
T ss_pred eEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH-HHHh-
Confidence 9999999998655432 2234468899999999999999999999999999999999765 565433222211 1111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 625 IDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
......+...+.++.+|+.+||+.||++||||+||++.|+++++
T Consensus 242 ---~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 242 ---GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp ---TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 12223344566889999999999999999999999999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=410.78 Aligned_cols=251 Identities=20% Similarity=0.326 Sum_probs=205.8
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-----CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-----SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
++|+..+.||+|+||+||+|+.+ +|+.||||++.+.... ...+.+.+|+++|++++|||||++++++.+ .+.
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCE
Confidence 57999999999999999999975 5999999999765322 235789999999999999999999999955 478
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC----Ceeeccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY----NPLLSDS 551 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~----~~kl~Df 551 (673)
.|+|||||++|+|.+++.. ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++ .+|++||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~--~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc--ceeecccccceEEEecCCCcccceEecch
Confidence 9999999999999999973 24699999999999999999999988 799999999999998876 4899999
Q ss_pred cccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCC
Q 005859 552 GLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEG 631 (673)
Q Consensus 552 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 631 (673)
|+|+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||............... ......
T Consensus 162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--~~~~~~ 237 (293)
T d1jksa_ 162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV--NYEFED 237 (293)
T ss_dssp TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--CCCCCH
T ss_pred hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhc--CCCCCc
Confidence 9998775432 233457899999999999999999999999999999999999999764433222111111 011111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 632 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+...+.++.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111234568899999999999999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.9e-50 Score=418.86 Aligned_cols=251 Identities=19% Similarity=0.309 Sum_probs=207.2
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ..+.+.+.+|+++|++++|||||++++++.+. +..|+||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ivm 102 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEMVMIY 102 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET--TEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEE
Confidence 47999999999999999999975 59999999997653 33456789999999999999999999999654 7899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEec--CCCCeeecccccccccc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIH--RRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~--~~~~~kl~DfGla~~~~ 558 (673)
|||++|+|.+++... ...+++..+..|+.||+.||+|||++ |||||||||+|||++ .++.+||+|||+++.+.
T Consensus 103 E~~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~--~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 103 EFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCCCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EcCCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 999999999998632 34599999999999999999999998 899999999999996 45789999999998776
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
... ......||+.|||||++.+..|+.++||||+||++|||+||+.||............... ............+
T Consensus 178 ~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s 253 (350)
T d1koaa2 178 PKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC--DWNMDDSAFSGIS 253 (350)
T ss_dssp TTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCSCCGGGGGCC
T ss_pred ccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCcccccCCC
Confidence 543 233467899999999999999999999999999999999999999754333222111111 1111122223445
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.++.+|+.+||+.||++|||++|+++
T Consensus 254 ~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 254 EDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 78999999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-49 Score=416.79 Aligned_cols=251 Identities=18% Similarity=0.294 Sum_probs=208.1
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ..+...+.+|+++|++++|||||++++++.+ .+..|+||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEE
Confidence 46999999999999999999975 59999999987653 2345678899999999999999999999964 47899999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEec--CCCCeeecccccccccc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIH--RRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~--~~~~~kl~DfGla~~~~ 558 (673)
|||++|+|.+++.. ....+++..++.|+.||+.||+|||++ |||||||||+||||+ +++.+||+|||+|+.+.
T Consensus 106 E~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~--~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 106 EFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp ECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EcCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecccccccccccccCCCeEEEeecccceecC
Confidence 99999999988753 234699999999999999999999987 899999999999998 67899999999999876
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
.+.. .....||+.|||||++.+..|+.++||||+||++|||+||+.||............... ............+
T Consensus 181 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s 256 (352)
T d1koba_ 181 PDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC--DWEFDEDAFSSVS 256 (352)
T ss_dssp TTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC--CCCCCSSTTTTSC
T ss_pred CCCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCcccccCCC
Confidence 5432 33457899999999999999999999999999999999999999765443322211111 1112222334456
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.++.+|+.+||+.||.+|||+.|+++
T Consensus 257 ~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 257 PEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 78999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-50 Score=405.48 Aligned_cols=256 Identities=21% Similarity=0.339 Sum_probs=198.6
Q ss_pred cCCccccccccCCcceEEEEEEcC--C--cEEEEEEecccCCCCc--HHHHHHHHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 402 QCFSEANLLGKSSFSATYKGILRD--G--SVVAVKCIAKTSCKSD--EGEFLKGLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
++|+..+.||+|+||+||+|++.. + ..||||++.+...... .++|.+|+++|++++|||||+++|++.+ +.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~~ 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---PP 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee---cc
Confidence 568889999999999999998643 2 3789999876543222 3689999999999999999999999954 34
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.++|||||++|++.+++... ...+++..+++++.|||.||+|||++ ||+||||||+||+++.++.+||+|||+++
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~--~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK--RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred hheeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC--CEeeeeecHHHhccccccceeeccchhhh
Confidence 68999999999999988643 34699999999999999999999997 79999999999999999999999999999
Q ss_pred cccCcch--hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhhccchhhhcCCcCCCC
Q 005859 556 LLADDIV--FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAESSKVEDFIDPNLEGK 632 (673)
Q Consensus 556 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (673)
....... .......++..|+|||.+.+..++.++|||||||++|||+| |+.||.......... .+........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~----~i~~~~~~~~ 235 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH----KIDKEGERLP 235 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHTSCCCCC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH----HHHhCCCCCC
Confidence 8754322 12233457889999999999999999999999999999998 899987654433222 2222222223
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 005859 633 FSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSI 669 (673)
Q Consensus 633 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i 669 (673)
.+...+.++.+++.+||+.||++||||.||++.|++.
T Consensus 236 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 3445567899999999999999999999999998864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-49 Score=404.10 Aligned_cols=262 Identities=16% Similarity=0.244 Sum_probs=206.3
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC--cHHHHHHHHHHHhccCCCCceeEeeEEecCCC--CeE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS--DEGEFLKGLKILTSLKHENLASLRGICCSKGR--GEC 476 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~~ 476 (673)
++|++.+.||+|+||+||+|+.. +|+.||||++....... ..+.|.+|+++|++++|||||++++++...+. ...
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 57999999999999999999975 59999999997654322 23578999999999999999999999876433 357
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
|+||||+++|+|.+++.. ...+++.+++.++.||+.||+|||++ ||+||||||+|||++.++..+++|||.++.
T Consensus 87 ~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~--~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC--CccCccccCcccccCccccceeehhhhhhh
Confidence 899999999999998863 34699999999999999999999987 899999999999999999999999999876
Q ss_pred ccCcch--hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 557 LADDIV--FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 557 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
...... .......||+.|||||++.+..++.++|||||||++|||+||+.||............+... +.......
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~ 238 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED--PIPPSARH 238 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--CCCGGGTS
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcC--CCCCchhc
Confidence 543221 22344579999999999999999999999999999999999999997654332222222111 11111222
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhhc
Q 005859 635 VSEASNLGQIALHCTHESPSHRP-SIENVMQELSSIIG 671 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RP-s~~evl~~L~~i~~ 671 (673)
...+.++.+++.+||+.||++|| |++++++.|.++.+
T Consensus 239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 34457899999999999999999 89999999998753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=409.40 Aligned_cols=263 Identities=21% Similarity=0.376 Sum_probs=210.0
Q ss_pred hcCCccccccccCCcceEEEEEEcC--------CcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILRD--------GSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSK 471 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 471 (673)
.++|...+.||+|+||.||+|+... +..||||++..........++.+|+..+.++ +|||||+++++|.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~- 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence 4578888999999999999998532 3479999997765444557899999999998 89999999999965
Q ss_pred CCCeEEEEEeecCCCChhhhhccccC------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeE
Q 005859 472 GRGECFLIYDFVPNGNLLQHLDLEAG------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVL 539 (673)
Q Consensus 472 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NIL 539 (673)
.+..++|||||++|+|.+++..... ....+++.++++++.||+.||+|||++ +||||||||+|||
T Consensus 91 -~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~--~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 -DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--KCIHRDLAARNVL 167 (299)
T ss_dssp -SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEE
T ss_pred -CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC--CEEeeeeccccee
Confidence 4678999999999999999975421 234689999999999999999999998 7999999999999
Q ss_pred ecCCCCeeeccccccccccCcchh-hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHh-CCCCCChhhHhhhh
Q 005859 540 IHRRYNPLLSDSGLHKLLADDIVF-SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILS-GKCSITPFTRQAAE 617 (673)
Q Consensus 540 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~t-G~~p~~~~~~~~~~ 617 (673)
++.++.+||+|||+++........ ......+++.|+|||.+.++.|+.|+|||||||++|||+| |..||.........
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 999999999999999977654322 2334568889999999999999999999999999999998 67777654332221
Q ss_pred ccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 618 SSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
..+. .......+...+.++.+|+.+||+.||++||||.||++.|++|+..
T Consensus 248 -~~i~----~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 248 -KLLK----EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp -HHHH----TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHH----cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 1122 2222233445567899999999999999999999999999999764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=409.75 Aligned_cols=265 Identities=22% Similarity=0.360 Sum_probs=213.9
Q ss_pred HhcCCccccccccCCcceEEEEEEc------CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEecCC
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCSKG 472 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 472 (673)
..++|+..+.||+|+||+||+|++. +++.||||+++.........+|.+|+.+++++ +|||||+++|+|..
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-- 98 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence 4467888999999999999999852 36789999998765444556899999999999 69999999999954
Q ss_pred CCeEEEEEeecCCCChhhhhccccC--------------CccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCe
Q 005859 473 RGECFLIYDFVPNGNLLQHLDLEAG--------------SEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKV 538 (673)
Q Consensus 473 ~~~~~lv~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NI 538 (673)
.+..++|||||++|+|.++++.... ....+++..+.+++.||++||+|||++ +||||||||+||
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~--~ivHrDLKp~NI 176 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNI 176 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC--Ceeecccccccc
Confidence 4678999999999999999974321 123589999999999999999999998 799999999999
Q ss_pred EecCCCCeeeccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCC-CChhhHhhh
Q 005859 539 LIHRRYNPLLSDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCS-ITPFTRQAA 616 (673)
Q Consensus 539 Ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p-~~~~~~~~~ 616 (673)
+++.++.+|++|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||+|+..| +........
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999997765332 223345789999999999999999999999999999999995545 433221111
Q ss_pred hccchhhhcCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 617 ESSKVEDFIDPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
+.+++........+...+.++.+|+.+||+.||++||||+||+++|++++..
T Consensus 257 ----~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 257 ----FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp ----HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 1222222233333445567899999999999999999999999999987653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=409.74 Aligned_cols=264 Identities=18% Similarity=0.312 Sum_probs=213.6
Q ss_pred HhcCCccccccccCCcceEEEEEEc------CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC
Q 005859 400 ATQCFSEANLLGKSSFSATYKGILR------DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGR 473 (673)
Q Consensus 400 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 473 (673)
..++|...+.||+|+||+||+|.+. +++.||||+++......+...|.+|++++++++|||||+++|+|.. .
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~ 95 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--G 95 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--S
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec--C
Confidence 3467888899999999999999864 2578999999765434444679999999999999999999999954 4
Q ss_pred CeEEEEEeecCCCChhhhhcccc------CCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCee
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEA------GSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPL 547 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~k 547 (673)
+..++|||||++|+|.+++.... .....+++..+.+++.|+|+||+|||++ +|+||||||+|||+++++.+|
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~--~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT--TCBCSCCSGGGEEECTTCCEE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC--CeeeceEcCCceeecCCceEE
Confidence 67899999999999999986432 1224579999999999999999999997 799999999999999999999
Q ss_pred eccccccccccCcch-hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCC-CCCChhhHhhhhccchhhhc
Q 005859 548 LSDSGLHKLLADDIV-FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGK-CSITPFTRQAAESSKVEDFI 625 (673)
Q Consensus 548 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~-~p~~~~~~~~~~~~~~~~~~ 625 (673)
|+|||+|+....... .......+|+.|+|||.+.+..++.++|||||||++|||+||. .||.......... .+.
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~----~i~ 249 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR----FVM 249 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH----HHH
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH----HHH
Confidence 999999987654332 2233446889999999999999999999999999999999985 5665443322221 111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhcC
Q 005859 626 DPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIGS 672 (673)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~~ 672 (673)
+.. ....+...+..+.+++.+||+.||++||||++|++.|++.+++
T Consensus 250 ~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 250 EGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp TTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred hCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 211 1223344567899999999999999999999999999988764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=405.93 Aligned_cols=259 Identities=19% Similarity=0.310 Sum_probs=198.9
Q ss_pred CCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHH--HHHHHhccCCCCceeEeeEEecCCC--CeEEE
Q 005859 403 CFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLK--GLKILTSLKHENLASLRGICCSKGR--GECFL 478 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~--E~~~l~~l~H~niv~l~~~~~~~~~--~~~~l 478 (673)
.|...+.||+|+||+||+|++ +|+.||||++... ..+++.+ |+..+.+++|||||+++|+|..... ...++
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 466778899999999999997 5899999998643 2334444 4555567899999999999986543 36899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcC------CCCcccCCcCCCCeEecCCCCeeecccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK------RPGLVHPNLSAEKVLIHRRYNPLLSDSG 552 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~ivHrDlk~~NILl~~~~~~kl~DfG 552 (673)
|||||++|+|.++++. ..++|..+++++.|+|.||+|||+. .+|||||||||+||||++++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 9999999999999973 3589999999999999999999973 3489999999999999999999999999
Q ss_pred ccccccCcch---hhhhccCCCCCccCCccccCCC------CCcchhHHHHHHHHHHHHhCCCCCChhhHh---------
Q 005859 553 LHKLLADDIV---FSMLKASAAMGYLAPEYTTTGR------FTEKSDIYAFGMIVFQILSGKCSITPFTRQ--------- 614 (673)
Q Consensus 553 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~------~s~ksDVwSfGvvl~el~tG~~p~~~~~~~--------- 614 (673)
+++....... .......||+.|||||++.+.. ++.|+|||||||+||||+||..|+......
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 9987754321 1233467999999999987542 678999999999999999998775321100
Q ss_pred ------hhhccchhhhcCCcCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 615 ------AAESSKVEDFIDPNLEGKF-SVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 615 ------~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
........+..+|.+.... +.+....+.+++.+||+.||++||||.||++.|+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0000011112222222221 23455679999999999999999999999999998864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=408.96 Aligned_cols=248 Identities=19% Similarity=0.290 Sum_probs=207.3
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|++.+.||+|+||+||+|+.+ +|+.||||++.+... ....+.+.+|+++|++++|||||++++++.+ .+..|+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~i 82 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCF 82 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc--cccccc
Confidence 57999999999999999999975 599999999976421 3345778999999999999999999999955 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
|||||++|+|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+|+...
T Consensus 83 v~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~--~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 83 VMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred ceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc--CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 9999999999999873 34689999999999999999999998 89999999999999999999999999998764
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
.... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.............. .. ..++...+
T Consensus 157 ~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~----~~--~~~p~~~s 229 (337)
T d1o6la_ 157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----EE--IRFPRTLS 229 (337)
T ss_dssp CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CC--CCCCTTSC
T ss_pred cCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc----CC--CCCCccCC
Confidence 4321 23346799999999999999999999999999999999999999976543322221111 11 12344456
Q ss_pred HHHHHHHHHccccCCCCCCC-----HHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRPS-----IENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 664 (673)
.++.+|+.+||+.||++||+ +.|+++
T Consensus 230 ~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 78899999999999999995 778765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.9e-49 Score=404.97 Aligned_cols=245 Identities=19% Similarity=0.289 Sum_probs=205.6
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|++.+.||+|+||+||+|+.+ +|+.||||++.+... ....+.+.+|+++|++++|||||++++++.+ .+..|+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~i 81 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIFM 81 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee--CCeeee
Confidence 46899999999999999999975 599999999975421 2345789999999999999999999999965 478999
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
|||||+||+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 vmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~--~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 82 IMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK--DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp EECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC--cEEccccCchheeEcCCCCEEEecCccceEec
Confidence 9999999999998873 34578899999999999999999987 89999999999999999999999999998876
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
.. ....+||+.|||||++.+..|+.++||||+||++|||+||+.||.............. .. ..++...+
T Consensus 156 ~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~----~~--~~~p~~~s 225 (316)
T d1fota_ 156 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----AE--LRFPPFFN 225 (316)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----CC--CCCCTTSC
T ss_pred cc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc----CC--CCCCCCCC
Confidence 53 2346799999999999999999999999999999999999999976543322221111 11 12233445
Q ss_pred HHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRP-----SIENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 664 (673)
.++.+++.+||+.||++|| |++|+++
T Consensus 226 ~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 226 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 7899999999999999996 8999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-48 Score=395.59 Aligned_cols=251 Identities=20% Similarity=0.276 Sum_probs=206.9
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCc--------HHHHHHHHHHHhccC-CCCceeEeeEEecC
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSD--------EGEFLKGLKILTSLK-HENLASLRGICCSK 471 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--------~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 471 (673)
++|+..+.||+|+||+||+|+.. +|+.||||++.+...... .+.+.+|+++|++++ |||||++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET- 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence 57899999999999999999975 589999999976543211 236889999999997 9999999999954
Q ss_pred CCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccc
Q 005859 472 GRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDS 551 (673)
Q Consensus 472 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~Df 551 (673)
.+..|+|||||++|+|.+++.. ...+++.++..++.||++||+|||++ ||+||||||+|||++.++.+||+||
T Consensus 82 -~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~--~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 -NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCC
T ss_pred -CcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc--CCcccccccceEEEcCCCCeEEccc
Confidence 4889999999999999999973 34699999999999999999999987 8999999999999999999999999
Q ss_pred cccccccCcchhhhhccCCCCCccCCccccC------CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhc
Q 005859 552 GLHKLLADDIVFSMLKASAAMGYLAPEYTTT------GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFI 625 (673)
Q Consensus 552 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~ 625 (673)
|+++...... ......||..|+|||++.+ ..++.++||||+||++|||+||+.||...............-
T Consensus 155 G~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~- 231 (277)
T d1phka_ 155 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN- 231 (277)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-
T ss_pred hheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC-
Confidence 9999876543 2334679999999999862 347899999999999999999999997654433222222211
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 626 DPNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...........++++.+++.+||+.||++|||++||++
T Consensus 232 -~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 232 -YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp -CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11222233456688999999999999999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=401.61 Aligned_cols=251 Identities=14% Similarity=0.226 Sum_probs=198.9
Q ss_pred cCCccc-cccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhcc-CCCCceeEeeEEec--CCCCeE
Q 005859 402 QCFSEA-NLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSL-KHENLASLRGICCS--KGRGEC 476 (673)
Q Consensus 402 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~--~~~~~~ 476 (673)
++|.+. +.||+|+||+||+|+.. +++.||||++.. ...+.+|++++.++ +|||||++++++.+ ......
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 468776 46999999999999975 589999999854 24678899997665 89999999999854 234578
Q ss_pred EEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC---CCCeeeccccc
Q 005859 477 FLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR---RYNPLLSDSGL 553 (673)
Q Consensus 477 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~---~~~~kl~DfGl 553 (673)
|+|||||+||+|.+++... ....+++..+..|+.||+.||+|||++ ||+||||||+|||+++ ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~--~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc--CCccccccccccccccccccccccccccce
Confidence 9999999999999999743 224699999999999999999999988 8999999999999986 45799999999
Q ss_pred cccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcC--CC
Q 005859 554 HKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNL--EG 631 (673)
Q Consensus 554 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 631 (673)
|+...... ......||+.|||||++.+..|+.++|||||||++|||+||+.||...............+..... ..
T Consensus 161 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~ 238 (335)
T d2ozaa1 161 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238 (335)
T ss_dssp CEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred eeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 98776543 234467999999999999989999999999999999999999999654322111111111111111 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 632 KFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 632 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
......++++.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 112345678999999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4e-48 Score=405.23 Aligned_cols=245 Identities=18% Similarity=0.242 Sum_probs=205.4
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~l 478 (673)
++|++.+.||+|+||+||+|+.+ +|+.||||++.+... ....+.+.+|+++|++++|||||++++++.. .+..++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~~ 118 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc--cccccc
Confidence 47999999999999999999976 599999999875321 2345679999999999999999999999955 478899
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
||||+.+|+|.+++.. ...+++..+..|+.||+.||+|||++ |||||||||+|||++.++.+||+|||+|+...
T Consensus 119 v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~--~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC--CEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 9999999999999863 24689999999999999999999988 79999999999999999999999999999876
Q ss_pred CcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHHH
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSEA 638 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (673)
.. .....||+.|||||++.+..|+.++|||||||++|||+||+.||............... . ...+...+
T Consensus 193 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~----~--~~~p~~~s 262 (350)
T d1rdqe_ 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----K--VRFPSHFS 262 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----C--CCCCTTCC
T ss_pred cc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC----C--CCCCccCC
Confidence 43 23457999999999999999999999999999999999999999764333222211111 1 12233455
Q ss_pred HHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005859 639 SNLGQIALHCTHESPSHRP-----SIENVMQ 664 (673)
Q Consensus 639 ~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 664 (673)
.++.+++.+||+.||.+|+ |++|+++
T Consensus 263 ~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 7899999999999999994 8999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=401.66 Aligned_cols=251 Identities=16% Similarity=0.223 Sum_probs=204.7
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
.++|.+.+.||+|+||+||+|+.. +|+.||||+++... .+...+.+|+++|++++|||||++++++.+. +..|+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESM--EELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEEE
Confidence 357899999999999999999976 58899999997653 3455788999999999999999999999654 789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC--CCeeeccccccccc
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR--YNPLLSDSGLHKLL 557 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~--~~~kl~DfGla~~~ 557 (673)
||||++|+|.+++... ...+++.++..|+.||+.||+|||++ ||+||||||+|||++.+ ..+||+|||+++..
T Consensus 80 mE~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~--~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 80 FEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc--CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 9999999999999632 23589999999999999999999987 89999999999999854 47999999999876
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
..... .....+++.|+|||.+.+..|+.++||||+||++|||++|+.||................. ..........
T Consensus 155 ~~~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~ 230 (321)
T d1tkia_ 155 KPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY--TFDEEAFKEI 230 (321)
T ss_dssp CTTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--CCCHHHHTTS
T ss_pred ccCCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCChhhccCC
Confidence 54322 2335688999999999999999999999999999999999999976544322222111110 1110111123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
+.++.+|+.+||+.||++|||++|+++
T Consensus 231 s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 231 SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 567899999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.1e-48 Score=406.57 Aligned_cols=249 Identities=18% Similarity=0.268 Sum_probs=199.3
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHH---HHHHHhccCCCCceeEeeEEecCCCCe
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLK---GLKILTSLKHENLASLRGICCSKGRGE 475 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (673)
++|++.+.||+|+||+||+|+.. +|+.||||++.+... ......+.+ |+++++.++|||||++++++.+ .+.
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~--~~~ 81 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDK 81 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--SSE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE--CCE
Confidence 57999999999999999999976 599999999865321 122333444 4777888899999999999955 478
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.|+|||||++|+|.+++.. ...+++..+..++.||+.||+|||++ |||||||||+|||+++++.+||+|||+|+
T Consensus 82 ~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~--~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC--CccceeeccceeEEcCCCcEEEeeeceee
Confidence 9999999999999999973 34688999999999999999999998 89999999999999999999999999998
Q ss_pred cccCcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCC
Q 005859 556 LLADDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFS 634 (673)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (673)
...... .....||+.|||||++.. ..|+.++|||||||++|||+||+.||......... ........ .....+
T Consensus 156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~~~~~~~--~~~~~~ 229 (364)
T d1omwa3 156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLT--MAVELP 229 (364)
T ss_dssp ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-HHHHHSSS--CCCCCC
T ss_pred ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhccc--CCCCCC
Confidence 776542 334579999999999975 45899999999999999999999999653221110 01111111 112233
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 005859 635 VSEASNLGQIALHCTHESPSHRPS-----IENVMQ 664 (673)
Q Consensus 635 ~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 664 (673)
...++++.+|+.+||+.||++||| ++|+++
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 230 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 345678999999999999999999 678764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=400.75 Aligned_cols=247 Identities=17% Similarity=0.317 Sum_probs=203.5
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC--CCcHHHHHHHHHHHh-ccCCCCceeEeeEEecCCCCeEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC--KSDEGEFLKGLKILT-SLKHENLASLRGICCSKGRGECF 477 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~~~ 477 (673)
++|...+.||+|+||+||+|+.. +|+.||||++.+... ....+.+.+|..++. .++|||||++++++.+ .+..|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--CCcee
Confidence 47889999999999999999976 499999999975421 334566778888766 6899999999999965 47899
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLL 557 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~ 557 (673)
+|||||++|+|.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+++..
T Consensus 80 ivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~--~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCcccceeecCCCceeccccchhhhc
Confidence 99999999999999973 34588999999999999999999998 7999999999999999999999999999866
Q ss_pred cCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCCCCCHHH
Q 005859 558 ADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEGKFSVSE 637 (673)
Q Consensus 558 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (673)
..... ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+............. .+ .++...
T Consensus 154 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~----~~p~~~ 226 (320)
T d1xjda_ 154 MLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP----FYPRWL 226 (320)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC----CCCTTS
T ss_pred ccccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC----CCCccC
Confidence 54322 234467999999999999999999999999999999999999999764433222221111 11 233345
Q ss_pred HHHHHHHHHHccccCCCCCCCHH-HHH
Q 005859 638 ASNLGQIALHCTHESPSHRPSIE-NVM 663 (673)
Q Consensus 638 ~~~l~~l~~~Cl~~~p~~RPs~~-evl 663 (673)
+.++.+|+.+||+.||++|||+. |++
T Consensus 227 s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 227 EKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 67899999999999999999985 665
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=394.60 Aligned_cols=250 Identities=19% Similarity=0.236 Sum_probs=192.7
Q ss_pred cccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCc----HHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 406 EANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSD----EGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 406 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
..++||+|+||+||+|+.+ +|+.||||+++....... .+.+.+|+++|++++|||||++++++.. .+..++||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCCEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCceeehh
Confidence 3578999999999999975 489999999976532211 2468999999999999999999999954 47799999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||++++++..+.. ....+++..+..++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+++.....
T Consensus 80 E~~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~--~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 80 DFMETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH--WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp ECCSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred hhhcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc--ceecccCCcceEEecCCCccccccCccccccCCC
Confidence 9999887776654 235688899999999999999999997 8999999999999999999999999999876554
Q ss_pred chhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCC------------
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDP------------ 627 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~------------ 627 (673)
.. .....+||+.|+|||++... .|+.++|||||||++|||+||+.||..................+
T Consensus 154 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 154 NR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred cc-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 32 22345789999999998755 57999999999999999999999986543322111110000000
Q ss_pred -----cCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 628 -----NLEGKFS-----VSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 628 -----~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
......+ ...++++.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000011 123568999999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=386.90 Aligned_cols=256 Identities=17% Similarity=0.313 Sum_probs=198.0
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ....+++.+|+++|++++|||||++++++.+. +..|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~--~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc--cceeEE
Confidence 57999999999999999999975 599999999975432 22356899999999999999999999999654 789999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
|||+.+ ++.+++... ....+++..+..++.||+.||+|||++ |||||||||+|||++.++.+||+|||+|+....
T Consensus 80 ~e~~~~-~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~--~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp EECCSE-EHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred EeecCC-chhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC--CEEccccCchheeecccCcceeccCCcceeccC
Confidence 999965 555554322 234699999999999999999999987 899999999999999999999999999987754
Q ss_pred cchhhhhccCCCCCccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhh-----------hc-C
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVED-----------FI-D 626 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~-----------~~-~ 626 (673)
... ......||+.|+|||.+.... ++.++||||+||++|||++|+.||............... .. .
T Consensus 155 ~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 155 PVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp CSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred Ccc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 332 234457899999999887665 589999999999999999999999654322111110000 00 0
Q ss_pred CcCCCCC-----------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 627 PNLEGKF-----------SVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 627 ~~~~~~~-----------~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
+...... ....+.++.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000000 11234678999999999999999999999863
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-46 Score=384.45 Aligned_cols=254 Identities=18% Similarity=0.268 Sum_probs=198.8
Q ss_pred cCCccccccccCCcceEEEEEEcCCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|...+.||+|+||+||+|+.++|+.||||++..... ....+.+.+|+++|++++|||||++++++... +..+++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC--CceeEEE
Confidence 57899999999999999999999999999999976542 23357899999999999999999999999654 7789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccCc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLADD 560 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~~ 560 (673)
||+.++.+..+.. ....+++..+..|+.||+.||+|||+. |||||||||+|||++.++.+|++|||.+......
T Consensus 80 e~~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~--~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 80 EHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR--RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp ECCSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EeehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccC--cEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9998776666654 335699999999999999999999987 7999999999999999999999999999876543
Q ss_pred chhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch--------------hhh-
Q 005859 561 IVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV--------------EDF- 624 (673)
Q Consensus 561 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~--------------~~~- 624 (673)
.. ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+........... ...
T Consensus 154 ~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence 32 23344688899999998765 46999999999999999999999996542221111000 000
Q ss_pred -cC-------CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 625 -ID-------PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 625 -~~-------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.. +..........+..+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00001112233578899999999999999999999984
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=384.89 Aligned_cols=240 Identities=19% Similarity=0.298 Sum_probs=196.9
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCC-----cHHHHHHHHHHHhccC--CCCceeEeeEEecCCC
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKS-----DEGEFLKGLKILTSLK--HENLASLRGICCSKGR 473 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~ 473 (673)
++|.+.+.||+|+||+||+|+.. +|+.||||++.+..... ...++.+|+++|++++ |||||++++++.+ .
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~--~ 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER--P 81 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--S
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--C
Confidence 57899999999999999999975 58999999997643221 1234778999999996 9999999999955 4
Q ss_pred CeEEEEEeecCC-CChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCC-CCeeeccc
Q 005859 474 GECFLIYDFVPN-GNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRR-YNPLLSDS 551 (673)
Q Consensus 474 ~~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~-~~~kl~Df 551 (673)
+..++||||+.+ +++.+++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||++.+ +.+||+||
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~--~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC--CCccccCcccceEEecCCCeEEECcc
Confidence 789999999976 678888763 34699999999999999999999987 89999999999999854 78999999
Q ss_pred cccccccCcchhhhhccCCCCCccCCccccCCCC-CcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCC
Q 005859 552 GLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRF-TEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLE 630 (673)
Q Consensus 552 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 630 (673)
|+|+...... .....||+.|+|||++.+..+ +.++||||+||++|||+||+.||......... ..
T Consensus 156 G~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~--------~~--- 221 (273)
T d1xwsa_ 156 GSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG--------QV--- 221 (273)
T ss_dssp TTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHC--------CC---
T ss_pred ccceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhc--------cc---
Confidence 9998765432 334679999999999987765 67799999999999999999999764321110 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 631 GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 631 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.++...+.++.+++.+||+.||++|||++|+++
T Consensus 222 -~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 -FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 122234578899999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=385.31 Aligned_cols=257 Identities=17% Similarity=0.260 Sum_probs=199.5
Q ss_pred hcCCccccccccCCcceEEEEEEc-C-CcEEEEEEecccCCC-CcHHHHHHHHHHHhcc---CCCCceeEeeEEecC---
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-D-GSVVAVKCIAKTSCK-SDEGEFLKGLKILTSL---KHENLASLRGICCSK--- 471 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~--- 471 (673)
.++|++.+.||+|+||+||+|+.. + ++.||||++...... .....+.+|+++|+.+ +||||++++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 4 678999999764322 2334577888877766 799999999998542
Q ss_pred CCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccc
Q 005859 472 GRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDS 551 (673)
Q Consensus 472 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~Df 551 (673)
.....+++|||++++++...... ....+++..+..++.|++.||+|||++ |||||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~--~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC--CEEecCCCccEEEEcCCCCeeecch
Confidence 23578999999988776544432 235689999999999999999999988 7999999999999999999999999
Q ss_pred cccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhh--------
Q 005859 552 GLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVED-------- 623 (673)
Q Consensus 552 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~-------- 623 (673)
|+++...... ......||+.|||||++.+..|+.++||||+||++|||+||+.||...............
T Consensus 161 g~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 161 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 9998665432 334567999999999999999999999999999999999999999754322111110000
Q ss_pred ----------hcC---CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 624 ----------FID---PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 624 ----------~~~---~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
... ......+....++.+.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 00001122234577899999999999999999999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=375.45 Aligned_cols=257 Identities=20% Similarity=0.255 Sum_probs=194.5
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCC-CCcHHHHHHHHHHHhccCCCCceeEeeEEecCC------C
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSC-KSDEGEFLKGLKILTSLKHENLASLRGICCSKG------R 473 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~ 473 (673)
++|++.+.||+|+||+||+|+.. +|+.||||++..... .....++.+|+++|++++||||+++++++.... .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 68999999999999999999975 699999999866533 334578999999999999999999999985532 3
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL 553 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGl 553 (673)
+..++||||++++.+..+.. ....++...+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~--~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN--KILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccC--CEEecCcCchheeecCCCcEEeeecce
Confidence 46899999998877665543 334688899999999999999999987 899999999999999999999999999
Q ss_pred cccccCcchh---hhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhc--CC
Q 005859 554 HKLLADDIVF---SMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFI--DP 627 (673)
Q Consensus 554 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~--~~ 627 (673)
++........ ......||+.|+|||.+.+. .|+.++||||+||++|||+||+.||................. .+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9876543221 12234689999999998765 589999999999999999999999975332211111000000 00
Q ss_pred -----------------cCCCCCCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 628 -----------------NLEGKFSV-------SEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 628 -----------------~~~~~~~~-------~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
........ .....+.+|+.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00000011 11356789999999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-45 Score=375.80 Aligned_cols=260 Identities=13% Similarity=0.172 Sum_probs=198.8
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLIY 480 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv~ 480 (673)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ...++.+|++++++++|+|+|..++.+... .+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT---TSCCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc---cCHHHHHHHHHHHHccCCCcccEEEEEEec-CCEEEEEE
Confidence 46999999999999999999975 58999999887643 234588999999999888776666555433 46789999
Q ss_pred eecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC---CCCeeeccccccccc
Q 005859 481 DFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR---RYNPLLSDSGLHKLL 557 (673)
Q Consensus 481 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~---~~~~kl~DfGla~~~ 557 (673)
||+ +|++.+.+.. ....+++..+..++.|++.||+|||++ |||||||||+|||++. +..+||+|||+|+..
T Consensus 83 e~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~--~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 83 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp ECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEc-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC--CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 999 5677766643 234699999999999999999999998 8999999999999864 457999999999987
Q ss_pred cCcchh------hhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc--hhhhcCCcC
Q 005859 558 ADDIVF------SMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK--VEDFIDPNL 629 (673)
Q Consensus 558 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~--~~~~~~~~~ 629 (673)
...... ......||+.|||||.+.+..++.++|||||||++|||+||+.||............ .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 543211 223457999999999999989999999999999999999999999764322111110 000000000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 630 EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 630 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
........++++.+++.+||+.||++||+++++.+.|+.++.
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 001122345789999999999999999999999999988753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-45 Score=381.00 Aligned_cols=252 Identities=18% Similarity=0.263 Sum_probs=192.9
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecC----CCCeEE
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSK----GRGECF 477 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----~~~~~~ 477 (673)
+|...++||+|+||+||+|+.. +|+.||||++..... .+.+|+++|++++|||||++++++... +..+.+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 5788899999999999999976 499999999976432 234799999999999999999998643 234578
Q ss_pred EEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC-Ceeecccccccc
Q 005859 478 LIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY-NPLLSDSGLHKL 556 (673)
Q Consensus 478 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~-~~kl~DfGla~~ 556 (673)
+|||||+++.+ +.+.........+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus 96 lv~Ey~~~~~~-~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~--~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHH-HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEeccCCccH-HHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc--CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999976543 33332222345699999999999999999999987 899999999999999775 899999999987
Q ss_pred ccCcchhhhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccch-----------h--
Q 005859 557 LADDIVFSMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKV-----------E-- 622 (673)
Q Consensus 557 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~-----------~-- 622 (673)
...... .....|+..|+|||.+.+ ..|+.++||||+||++|||++|+.||............. .
T Consensus 173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 654332 234578999999998875 468999999999999999999999986543221111000 0
Q ss_pred --hhcC---CcC-----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 623 --DFID---PNL-----EGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 623 --~~~~---~~~-----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
...+ +.. ........++++.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000 00112234577899999999999999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-45 Score=380.61 Aligned_cols=257 Identities=17% Similarity=0.243 Sum_probs=195.1
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCceeEeeEEecCCC--CeEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLASLRGICCSKGR--GECFL 478 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~~~l 478 (673)
.+|.+.+.||+|+||+||+|+.. +|+.||||++.+.......+.+.+|+++|++++||||+++++++..... ...++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 46899999999999999999964 6999999999765433445688999999999999999999999865321 12344
Q ss_pred EEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccccccc
Q 005859 479 IYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLA 558 (673)
Q Consensus 479 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~ 558 (673)
++||+.+|+|.+++.. ..+++..++.++.|++.||+|||++ |||||||||+|||+++++.+||+|||+++...
T Consensus 88 l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~--~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC--CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 5566779999999962 3589999999999999999999988 89999999999999999999999999998765
Q ss_pred Ccchh--hhhccCCCCCccCCccccC-CCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchh-------------
Q 005859 559 DDIVF--SMLKASAAMGYLAPEYTTT-GRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVE------------- 622 (673)
Q Consensus 559 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~------------- 622 (673)
..... ......||+.|+|||.+.. ..++.++||||+||++|||++|+.||..............
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 43221 2344668999999999854 4578999999999999999999999865322111100000
Q ss_pred ------h-hcCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 623 ------D-FIDPNLEGKFS-----VSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 623 ------~-~~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
. ..........+ ...+.++.+|+.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00000000111 1223578999999999999999999999863
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-45 Score=377.30 Aligned_cols=253 Identities=16% Similarity=0.292 Sum_probs=202.7
Q ss_pred cCCccccccccCCcceEEEEEEc----CCcEEEEEEecccCC---CCcHHHHHHHHHHHhccCC-CCceeEeeEEecCCC
Q 005859 402 QCFSEANLLGKSSFSATYKGILR----DGSVVAVKCIAKTSC---KSDEGEFLKGLKILTSLKH-ENLASLRGICCSKGR 473 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~ 473 (673)
++|+..+.||+|+||+||+|+.. +|+.||||++++... ....+.+.+|+++|++++| |||+++++++.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-- 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-- 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC--
Confidence 56999999999999999999852 378999999876432 2234678899999999976 8999999998654
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccc
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGL 553 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGl 553 (673)
+..++||||+.+|+|.+++... ..++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~--~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred CceeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC--CEEeccCCccceeecCCCCEEEeeccc
Confidence 7899999999999999999733 4577888999999999999999997 799999999999999999999999999
Q ss_pred cccccCcchhhhhccCCCCCccCCccccCC--CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhhcCCcCCC
Q 005859 554 HKLLADDIVFSMLKASAAMGYLAPEYTTTG--RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDFIDPNLEG 631 (673)
Q Consensus 554 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 631 (673)
++.+............|++.|+|||.+... .++.++||||+||+||||+||+.||.................... .
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~--~ 253 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--P 253 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--C
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC--C
Confidence 987765444444456789999999999764 478899999999999999999999965432222111112111111 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005859 632 KFSVSEASNLGQIALHCTHESPSHRP-----SIENVMQ 664 (673)
Q Consensus 632 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 664 (673)
..+...+.++.+++.+||+.||++|| |++|+++
T Consensus 254 ~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 23345668899999999999999999 4788875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=366.98 Aligned_cols=254 Identities=17% Similarity=0.249 Sum_probs=201.2
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~lv 479 (673)
++|++.+.||+|+||+||+|+.. +|+.||||+++..... ....++.+|+++|++++|||||++++++.. .+..++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc--ccceeEE
Confidence 57999999999999999999975 5899999999765432 335789999999999999999999999965 4788999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccccccC
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKLLAD 559 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~~~~ 559 (673)
+||+.+++|..++. ....+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||.++....
T Consensus 80 ~~~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~--~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 80 FEFCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EECCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eeeccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC--CEeeecccCcccccccCCceeeeecchhhcccC
Confidence 99999999988776 235688999999999999999999997 899999999999999999999999999987755
Q ss_pred cchhhhhccCCCCCccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhh---------------
Q 005859 560 DIVFSMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVED--------------- 623 (673)
Q Consensus 560 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~--------------- 623 (673)
... ......++..|+|||.+.... ++.++||||+||++|||++|+.||............+..
T Consensus 154 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 154 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred CCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 432 223345678899999988765 699999999999999999999997432211110000000
Q ss_pred hcC---------CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 624 FID---------PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 624 ~~~---------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..+ ...........+..+.+|+.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00001122334567899999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=377.77 Aligned_cols=252 Identities=17% Similarity=0.274 Sum_probs=194.0
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCC----CC
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKG----RG 474 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~ 474 (673)
.++|++.+.||+|+||+||+|+.. +|+.||||++...... ...+.+.+|+++|++++|||||+++++|...+ ..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 467999999999999999999975 5999999999764322 22457899999999999999999999996542 23
Q ss_pred eEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeecccccc
Q 005859 475 ECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLH 554 (673)
Q Consensus 475 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla 554 (673)
+.++||||+ +.+|..+.+ ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|++|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~--~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC--CCcccccCcchhhcccccccccccccce
Confidence 579999999 667877764 23599999999999999999999998 8999999999999999999999999999
Q ss_pred ccccCcchhhhhccCCCCCccCCccccCC-CCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccc-------------
Q 005859 555 KLLADDIVFSMLKASAAMGYLAPEYTTTG-RFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSK------------- 620 (673)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~------------- 620 (673)
+..... .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||.+..........
T Consensus 169 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 876543 3346789999999998764 4789999999999999999999999654322111000
Q ss_pred ---------hhhhcCCcCC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005859 621 ---------VEDFIDPNLE----GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQE 665 (673)
Q Consensus 621 ---------~~~~~~~~~~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 665 (673)
..... +... .......++.+.+|+.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGL-PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp TCSCHHHHHHHHHS-CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhcchhhhhhhccC-CcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 0000 01122335678899999999999999999999863
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.9e-44 Score=373.37 Aligned_cols=248 Identities=16% Similarity=0.214 Sum_probs=197.9
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~lv 479 (673)
++|++.+.||+|+||+||+|+.. +|+.||||+++.. ..+++.+|+++|+++. ||||+++++++........++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 57999999999999999999975 5899999998643 4567899999999995 9999999999976666779999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCC-Ceeecccccccccc
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRY-NPLLSDSGLHKLLA 558 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~-~~kl~DfGla~~~~ 558 (673)
||||++|+|.++.+ .+++..+..++.||+.||+|||++ |||||||||+|||++.++ .+||+|||+|+...
T Consensus 111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~--gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc--ccccccccccceEEcCCCCeeeecccccceecc
Confidence 99999999987642 489999999999999999999998 899999999999998655 68999999998776
Q ss_pred CcchhhhhccCCCCCccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhc-------------------
Q 005859 559 DDIVFSMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAES------------------- 618 (673)
Q Consensus 559 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~------------------- 618 (673)
... ......+|..|+|||.+.+.. ++.++||||+||++|||++|+.||..........
T Consensus 182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 182 PGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 543 233456899999999988654 7999999999999999999999985432110000
Q ss_pred -----cchhhhcCCc--------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 619 -----SKVEDFIDPN--------LEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 619 -----~~~~~~~~~~--------~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.......... .........+.++.+|+.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000 001111234578899999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.4e-44 Score=368.21 Aligned_cols=259 Identities=15% Similarity=0.190 Sum_probs=203.6
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccCC-CCceeEeeEEecCCCCeEEEE
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKH-ENLASLRGICCSKGRGECFLI 479 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~~~lv 479 (673)
++|++.+.||+|+||+||+|+.. +|+.||||++.... +...+.+|+++++.+.| +||+.+++++... ...++|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG--LHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET--TEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc---CcHHHHHHHHHHHHhcCCCCCCEEEEEeecC--CccEEE
Confidence 57999999999999999999976 58999999886543 33457889999999965 8999999988554 788999
Q ss_pred EeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecC-----CCCeeecccccc
Q 005859 480 YDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHR-----RYNPLLSDSGLH 554 (673)
Q Consensus 480 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~-----~~~~kl~DfGla 554 (673)
|||+ +|+|.+++... ...+++.++..++.|++.||+|||++ ||+||||||+|||++. ++.+||+|||+|
T Consensus 80 me~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~--giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC--CceeccCCccceeecCcccccCCceEEccccee
Confidence 9999 78999988643 34689999999999999999999988 8999999999999974 567999999999
Q ss_pred ccccCcch------hhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhh--hccchhhhcC
Q 005859 555 KLLADDIV------FSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAA--ESSKVEDFID 626 (673)
Q Consensus 555 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~--~~~~~~~~~~ 626 (673)
+....... .......||+.|||||++.+..++.++|||||||++|||+||+.||........ ....+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 87654321 112345699999999999999999999999999999999999999964321111 0001111100
Q ss_pred CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhc
Q 005859 627 PNLEGKFSVSEASNLGQIALHCTHESPSHRPSIENVMQELSSIIG 671 (673)
Q Consensus 627 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~i~~ 671 (673)
.....+.....++++.+++..|++.+|++||+++.+.+.|+++++
T Consensus 234 ~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 000011112234679999999999999999999999999998865
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=370.18 Aligned_cols=252 Identities=17% Similarity=0.247 Sum_probs=189.1
Q ss_pred cCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCC----CCe
Q 005859 402 QCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKG----RGE 475 (673)
Q Consensus 402 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~ 475 (673)
++|++.+.||+|+||+||+|+.. +|+.||||++...... .....+.+|++++++++|||||++++++...+ ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999976 5999999999765432 22356889999999999999999999986542 368
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.|+|||||.++ +.+.+. ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~--giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc--ccccccCCccccccccccceeeechhhhh
Confidence 89999999654 544443 3488999999999999999999998 89999999999999999999999999988
Q ss_pred cccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhcc----------------
Q 005859 556 LLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESS---------------- 619 (673)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~---------------- 619 (673)
...... ......+|+.|+|||++.+..++.++||||+||++|||++|+.||...........
T Consensus 168 ~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 168 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred cccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 765432 23445689999999999999999999999999999999999999854321111000
Q ss_pred --chhhh---------------cCCcCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 620 --KVEDF---------------IDPNLE---GKFSVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 620 --~~~~~---------------~~~~~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
..... ...... .......+.++.+|+.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 000000 0112334678999999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-43 Score=367.79 Aligned_cols=253 Identities=16% Similarity=0.217 Sum_probs=193.8
Q ss_pred hcCCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCC-CcHHHHHHHHHHHhccCCCCceeEeeEEecCC---CCe
Q 005859 401 TQCFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCK-SDEGEFLKGLKILTSLKHENLASLRGICCSKG---RGE 475 (673)
Q Consensus 401 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---~~~ 475 (673)
.++|++.+.||+|+||+||+|+.. +|+.||||++.+.... ...+.+.+|+++|++++|||||++++++.... ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 457999999999999999999965 5999999999765422 23357889999999999999999999985431 223
Q ss_pred EEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 476 CFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 476 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.+++|||+.+|+|.+++.. ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~--giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA--DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC--CCcccccCCccccccccccccccccchhc
Confidence 4566788889999999852 3599999999999999999999998 89999999999999999999999999997
Q ss_pred cccCcchhhhhccCCCCCccCCccccCCC-CCcchhHHHHHHHHHHHHhCCCCCChhhHhhhhccchhhh----------
Q 005859 556 LLADDIVFSMLKASAAMGYLAPEYTTTGR-FTEKSDIYAFGMIVFQILSGKCSITPFTRQAAESSKVEDF---------- 624 (673)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~~~~~~~~---------- 624 (673)
..... .....|+..|+|||.+.+.. ++.++||||+||++|||++|+.||................
T Consensus 170 ~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 170 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 65432 23456888999999877654 6899999999999999999999986532221111100000
Q ss_pred ---------cCCc-CCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005859 625 ---------IDPN-LEGKF-----SVSEASNLGQIALHCTHESPSHRPSIENVMQ 664 (673)
Q Consensus 625 ---------~~~~-~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 664 (673)
.... ..... ....+.++.+|+.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000 00000 1123467899999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.7e-39 Score=338.45 Aligned_cols=254 Identities=17% Similarity=0.247 Sum_probs=192.7
Q ss_pred CCccccccccCCcceEEEEEEc-CCcEEEEEEecccCCCCcHHHHHHHHHHHhccC-----------CCCceeEeeEEec
Q 005859 403 CFSEANLLGKSSFSATYKGILR-DGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-----------HENLASLRGICCS 470 (673)
Q Consensus 403 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~ 470 (673)
+|++.++||+|+||+||+|+.. +|+.||||++++.. ...+.+.+|++++++++ |+|||++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 5899999999999999999975 59999999997542 23457788999988875 5789999999876
Q ss_pred CCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCC-----
Q 005859 471 KGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYN----- 545 (673)
Q Consensus 471 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~----- 545 (673)
......+++|+++..+......... .....+++..+..++.||+.||+|||+.. ||+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~-~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT-CEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc-CcccccCChhHeeeeccCcccccc
Confidence 6666778888887665543333221 23456889999999999999999999833 8999999999999986653
Q ss_pred -eeeccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHHHHHHhCCCCCChhhHhhhh-------
Q 005859 546 -PLLSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIVFQILSGKCSITPFTRQAAE------- 617 (673)
Q Consensus 546 -~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~el~tG~~p~~~~~~~~~~------- 617 (673)
+|++|||.++..... .....||+.|+|||++....++.++||||+||+++||++|+.||.+.......
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 899999999865432 23457899999999999999999999999999999999999998643211000
Q ss_pred ----------------ccchhhhcCC-----c--------------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 005859 618 ----------------SSKVEDFIDP-----N--------------LEGKFSVSEASNLGQIALHCTHESPSHRPSIENV 662 (673)
Q Consensus 618 ----------------~~~~~~~~~~-----~--------------~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev 662 (673)
........+. . .........+.++.+|+.+||+.||.+|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 0000000000 0 0112345667889999999999999999999999
Q ss_pred HH
Q 005859 663 MQ 664 (673)
Q Consensus 663 l~ 664 (673)
++
T Consensus 326 L~ 327 (362)
T d1q8ya_ 326 VN 327 (362)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=6.6e-34 Score=293.67 Aligned_cols=229 Identities=35% Similarity=0.629 Sum_probs=174.2
Q ss_pred CCChhHHHHHHHHHHhcCCCCCCcCCCCCCCCCCCCCCCceEEeCCCC---CEEEEEecCCCccc--ccCccccCCCCCC
Q 005859 18 LSSTSEVDILMHIKDSLDPENRLLTSWAPNADPCSSDSFDGVACDENG---RVANISLQGKGLSG--EIPAAVGGLKSLT 92 (673)
Q Consensus 18 ~~~~~~~~~ll~~~~~~~~~~~~l~~w~~~~~~C~~~~w~gv~c~~~~---~v~~l~l~~~~l~g--~~p~~~~~l~~L~ 92 (673)
.|.++|++||++||+++.+.. .+++|..++|+|. ..|.||+|+..+ ||+.|+|++++++| .+|++|++|++|+
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~~~d~C~-~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~ 79 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCN-RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTT-TCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHHCCCCC-cCCCCCCCCCCCC-CcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence 478999999999999996433 5899988889985 349999998643 79999999999998 5899999999999
Q ss_pred eEeCcC-CcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeeccccc
Q 005859 93 GLYLHF-NALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYN 171 (673)
Q Consensus 93 ~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N 171 (673)
+|+|++ |+++|.+|..|++|++|++|+|++|++.+..|..+..+.+|+.|++++|.+.+.+|..+.++++|+.+++++|
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n 159 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence 999997 8999999999999999999999999988766666666666666666666666666666666666666665555
Q ss_pred ccCccCCc-----------------------------------------------------------------------c
Q 005859 172 QLTGAIPA-----------------------------------------------------------------------S 180 (673)
Q Consensus 172 ~l~~~~p~-----------------------------------------------------------------------~ 180 (673)
.+.+.+|. .
T Consensus 160 ~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~ 239 (313)
T d1ogqa_ 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 55443332 2
Q ss_pred ccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCchh--hhhccCCccccCcccccCCCc
Q 005859 181 LGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPA--LKRLNGGFQYDNNAALCGTGF 249 (673)
Q Consensus 181 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--l~~~~~~~~~~~n~~~~~~~~ 249 (673)
++.+++|+.|+|++|+++|.+|..+.++++|+.|+|++|+|+|.+|.. +.++. .+.+.+|..+||.++
T Consensus 240 ~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~-~l~l~~N~~l~g~pl 309 (313)
T d1ogqa_ 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFD-VSAYANNKCLCGSPL 309 (313)
T ss_dssp CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSC-GGGTCSSSEEESTTS
T ss_pred cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCC-HHHhCCCccccCCCC
Confidence 334566777788888888778888888888888888888888877752 22221 244567777787654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=4.4e-24 Score=202.69 Aligned_cols=170 Identities=14% Similarity=0.128 Sum_probs=120.3
Q ss_pred ccccccccCCcceEEEEEEcCCcEEEEEEecccCCC-----C------------cHHHHHHHHHHHhccCCCCceeEeeE
Q 005859 405 SEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCK-----S------------DEGEFLKGLKILTSLKHENLASLRGI 467 (673)
Q Consensus 405 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~------------~~~~~~~E~~~l~~l~H~niv~l~~~ 467 (673)
.+.+.||+|+||+||+|+..+|+.||||+++..... . ....+.+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 457889999999999999989999999987643210 0 01234568899999999999998765
Q ss_pred EecCCCCeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcCCCCcccCCcCCCCeEecCCCCee
Q 005859 468 CCSKGRGECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGKRPGLVHPNLSAEKVLIHRRYNPL 547 (673)
Q Consensus 468 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ivHrDlk~~NILl~~~~~~k 547 (673)
. . .+++|||+++..+.+ ++......++.|+++|++|||++ ||+||||||+|||++++ .++
T Consensus 83 ~--~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~--giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 83 E--G----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR--GIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp E--T----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT--TEECSCCSTTSEEEETT-EEE
T ss_pred c--C----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC--CEEEccCChhheeeeCC-CEE
Confidence 4 2 269999998755433 23344567899999999999988 89999999999999965 589
Q ss_pred eccccccccccCcchhhhhccCCCCCccCCccccCCCCCcchhHHHHHHHH
Q 005859 548 LSDSGLHKLLADDIVFSMLKASAAMGYLAPEYTTTGRFTEKSDIYAFGMIV 598 (673)
Q Consensus 548 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl 598 (673)
|+|||.|+............. .... -.|.+ ...|+.++||||..--+
T Consensus 143 liDFG~a~~~~~~~~~~~l~r--d~~~-~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWREILER--DVRN-IITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHHHHHHH--HHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcHHHHHH--HHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence 999999976653321110000 0000 00111 35688899999975433
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=1.3e-20 Score=188.48 Aligned_cols=181 Identities=25% Similarity=0.218 Sum_probs=160.6
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..++.|+|++|.|++..+..|.++++|++|+|++|+|+. +| .++.+++|+.|+|++|+++ ..|..+.++++|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccccccccccc-ccccccccccccccccc
Confidence 468999999999998777889999999999999999985 33 4688999999999999998 45778999999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
++|.+.+..+..+..+.+|++|++++|.++...+..+..+++|+.|++++|++++..+..|..+++|+.|+|++|+|+ .
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~ 186 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-c
Confidence 999999888889999999999999999999777778889999999999999999988888999999999999999999 7
Q ss_pred CchhhhhccC--CccccCcccccCCCc
Q 005859 225 VPPALKRLNG--GFQYDNNAALCGTGF 249 (673)
Q Consensus 225 ~p~~l~~~~~--~~~~~~n~~~~~~~~ 249 (673)
+|..+..+.. .+.+.+|+..|....
T Consensus 187 lp~~~~~~~~L~~L~L~~Np~~CdC~~ 213 (266)
T d1p9ag_ 187 IPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (266)
T ss_dssp CCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred cChhHCCCCCCCEEEecCCCCCCCcch
Confidence 8877655432 355778998887654
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=1e-19 Score=183.55 Aligned_cols=194 Identities=24% Similarity=0.267 Sum_probs=159.8
Q ss_pred CCceEEeCCC----------CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccC-------------------
Q 005859 55 SFDGVACDEN----------GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVI------------------- 105 (673)
Q Consensus 55 ~w~gv~c~~~----------~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~------------------- 105 (673)
.|.-|.|+.. ..++.|+|++|.|+...+..|.++++|++|++++|++....
T Consensus 12 ~~~~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 12 PKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp SSCEEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred CCeEEEcCCCCCCccCCCCCCCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 4556777642 35689999999999776678999999999999999876432
Q ss_pred ------CcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCc
Q 005859 106 ------PKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPA 179 (673)
Q Consensus 106 ------p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~ 179 (673)
|..|.++++|++|++++|.+....+..+..+++|+.+++++|++++..+..|..+++|+.|++++|++++..+.
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 44567778899999999998877777888888999999999999877777888899999999999999887788
Q ss_pred cccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCchhhhhccC--CccccCcccccCCC
Q 005859 180 SLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNG--GFQYDNNAALCGTG 248 (673)
Q Consensus 180 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~--~~~~~~n~~~~~~~ 248 (673)
.|.++++|+.|++++|++++..|..|.++++|+.|++++|.+.+..|..+..+.. .+.+.+|+..|...
T Consensus 172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred hhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 8899999999999999999888889999999999999999999888888766543 34456777777643
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.80 E-value=5.9e-21 Score=195.71 Aligned_cols=159 Identities=31% Similarity=0.559 Sum_probs=128.7
Q ss_pred CCEEEEEecC-CCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEee
Q 005859 65 GRVANISLQG-KGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQ 143 (673)
Q Consensus 65 ~~v~~l~l~~-~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 143 (673)
..++.|+|++ |+++|.+|+.|++|++|++|+|++|+|.+..|..+..+.+|+.+++++|.+.+.+|..|+++++|+.++
T Consensus 76 ~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~ 155 (313)
T d1ogqa_ 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceee
Confidence 3678899987 899999999999999999999999999888777777777777777777666666666666666666666
Q ss_pred ccCccccccCchh-------------------------------------------------------------------
Q 005859 144 LCYNKLTGNIPTQ------------------------------------------------------------------- 156 (673)
Q Consensus 144 L~~N~l~~~~p~~------------------------------------------------------------------- 156 (673)
+++|.++|.+|..
T Consensus 156 l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~ 235 (313)
T d1ogqa_ 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp CCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 6666555444332
Q ss_pred ----hcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCC-CCcC
Q 005859 157 ----LGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNS-FSGN 224 (673)
Q Consensus 157 ----l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~g~ 224 (673)
+..+++|+.|+|++|+++|.+|..|+++++|++|+|++|+|+|.+|. +.++++|+.+++++|+ +.|.
T Consensus 236 ~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp BGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred cccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence 23347788899999999999999999999999999999999999985 6788999999999998 5664
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=6e-19 Score=166.95 Aligned_cols=159 Identities=25% Similarity=0.315 Sum_probs=116.6
Q ss_pred EEEecCCCcccccCccccCCCCCCeEeCcCCcCCccC-CcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCc
Q 005859 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVI-PKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYN 147 (673)
Q Consensus 69 ~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 147 (673)
.++.++++|+ .+|..+. +++++|+|++|+|++.+ +..|..+++|+.|+|++|++.+..+..|..+++|+.|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 3455677777 6776653 67888999999887644 556788888888888888888888888888888888888888
Q ss_pred cccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCch
Q 005859 148 KLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPP 227 (673)
Q Consensus 148 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~ 227 (673)
+|+...|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+.......+. ...++.+.+..|.+....|.
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~-~~~l~~~~l~~~~~~c~~p~ 167 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF-AEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHH-HHHHHHHCCSGGGCBBCSST
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHH-hhhhhhhcccCCCeEeCCCh
Confidence 88877777888888888888888888877777788888888888888877654322111 11244455666666666666
Q ss_pred hhhh
Q 005859 228 ALKR 231 (673)
Q Consensus 228 ~l~~ 231 (673)
.+..
T Consensus 168 ~l~~ 171 (192)
T d1w8aa_ 168 KVRD 171 (192)
T ss_dssp TTTT
T ss_pred hhcC
Confidence 5543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=5.4e-18 Score=169.03 Aligned_cols=167 Identities=28% Similarity=0.327 Sum_probs=145.3
Q ss_pred eCCCCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCc
Q 005859 61 CDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQ 140 (673)
Q Consensus 61 c~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 140 (673)
|........++.++++|+ .+|+.+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|+
T Consensus 6 ~~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~ 80 (266)
T d1p9ag_ 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLG 80 (266)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCC
T ss_pred EcccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccc
Confidence 334444556788889998 5787764 68999999999999888889999999999999999998 455 368899999
Q ss_pred EeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCC
Q 005859 141 VLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNS 220 (673)
Q Consensus 141 ~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 220 (673)
+|+|++|++++ .+..+..+++|++|++++|.+.+..+..+..+.+++.|++++|.+....+..+..+++|+.|++++|+
T Consensus 81 ~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~ 159 (266)
T d1p9ag_ 81 TLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (266)
T ss_dssp EEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred ccccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccc
Confidence 99999999994 57789999999999999999998888889999999999999999998888888999999999999999
Q ss_pred CCcCCchhhhhcc
Q 005859 221 FSGNVPPALKRLN 233 (673)
Q Consensus 221 l~g~~p~~l~~~~ 233 (673)
|++..+..+..+.
T Consensus 160 l~~~~~~~~~~l~ 172 (266)
T d1p9ag_ 160 LTELPAGLLNGLE 172 (266)
T ss_dssp CSCCCTTTTTTCT
T ss_pred ccccCcccccccc
Confidence 9988777776554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=2.5e-18 Score=162.62 Aligned_cols=164 Identities=20% Similarity=0.251 Sum_probs=138.6
Q ss_pred CCceEEeCCC----------CCEEEEEecCCCccccc-CccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCC
Q 005859 55 SFDGVACDEN----------GRVANISLQGKGLSGEI-PAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVN 123 (673)
Q Consensus 55 ~w~gv~c~~~----------~~v~~l~l~~~~l~g~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 123 (673)
.|..|.|+.. ..++.|+|++|.|++.+ +..|.++++|+.|+|++|.+.+..+..|..+++|++|+|++|
T Consensus 9 ~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 9 EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred cCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 3788888642 36899999999999866 457899999999999999999999999999999999999999
Q ss_pred CCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcc
Q 005859 124 NLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPV 203 (673)
Q Consensus 124 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 203 (673)
+|+...|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....+..+ -...++.+.+..|.+....|.
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~~p~ 167 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSST
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEeCCCh
Confidence 9998888899999999999999999999889999999999999999999985433221 123577788888888876675
Q ss_pred cccCCCCCCEEEccCCCCC
Q 005859 204 KLANVPKLEVLDIRNNSFS 222 (673)
Q Consensus 204 ~~~~l~~L~~L~l~~N~l~ 222 (673)
.+ ..++.++|+.|.|.
T Consensus 168 ~l---~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 168 KV---RDVQIKDLPHSEFK 183 (192)
T ss_dssp TT---TTSBGGGSCTTTCC
T ss_pred hh---cCCEeeecCHhhCc
Confidence 44 45667788888875
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=1.9e-17 Score=166.71 Aligned_cols=153 Identities=28% Similarity=0.314 Sum_probs=141.6
Q ss_pred CCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccC
Q 005859 74 GKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNI 153 (673)
Q Consensus 74 ~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 153 (673)
.+.++...|..|.++++|++|+|++|.+....+..+..+.+|+.+++++|++++..+..|..+++|+.|+|++|++++..
T Consensus 90 ~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~ 169 (284)
T d1ozna_ 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (284)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred ccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccc
Confidence 44455555778999999999999999999888888999999999999999999877888999999999999999999888
Q ss_pred chhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCc
Q 005859 154 PTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVP 226 (673)
Q Consensus 154 p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p 226 (673)
+..|.++++|+.|++++|++++..|..|.++++|+.|++++|.+.+..|..|.++++|+.|++++|++.+.-+
T Consensus 170 ~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred hhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 8999999999999999999999999999999999999999999999889999999999999999999997654
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.70 E-value=6.1e-17 Score=164.69 Aligned_cols=175 Identities=30% Similarity=0.385 Sum_probs=132.7
Q ss_pred CCceEEeCC----------CCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCC
Q 005859 55 SFDGVACDE----------NGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNN 124 (673)
Q Consensus 55 ~w~gv~c~~----------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 124 (673)
.|.+|.|+. ...++.|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|+.|++++|+
T Consensus 11 ~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~ 90 (305)
T d1xkua_ 11 HLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90 (305)
T ss_dssp ETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC
T ss_pred cCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCc
Confidence 499999974 2468899999999987666789999999999999999998889999999999999999998
Q ss_pred CCCC-----------------------------------------------CcccccCCCCCcEeeccCccccccCchhh
Q 005859 125 LSGK-----------------------------------------------IPSQIGNMTNLQVLQLCYNKLTGNIPTQL 157 (673)
Q Consensus 125 l~~~-----------------------------------------------~p~~~~~l~~L~~L~L~~N~l~~~~p~~l 157 (673)
++.. .+..|..+++|+.+++++|.++ .+|..+
T Consensus 91 l~~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~ 169 (305)
T d1xkua_ 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL 169 (305)
T ss_dssp CSBCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC
T ss_pred cCcCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc
Confidence 7511 1123344566777777777766 344332
Q ss_pred cCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCchhhhhcc
Q 005859 158 GSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLN 233 (673)
Q Consensus 158 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~l~~~~ 233 (673)
+++|+.|++++|.+++..+..|..++.++.|++++|.+.+..+..+.++++|+.|+|++|+|+ .+|.++..+.
T Consensus 170 --~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~ 242 (305)
T d1xkua_ 170 --PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 242 (305)
T ss_dssp --CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCS
T ss_pred --CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cccccccccc
Confidence 456777777777777777777777777888888888877776777777778888888888776 4566665543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.63 E-value=1.4e-15 Score=144.21 Aligned_cols=147 Identities=32% Similarity=0.459 Sum_probs=127.3
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.+++.|+++++++.. ++ .+..+++|++|+|++|+|++..| +.++++|++|++++|.+.. ++ .+.++++|+.|++
T Consensus 40 ~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEEC
T ss_pred cCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccccc
Confidence 468899999999874 33 48889999999999999997543 9999999999999999884 44 4899999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCc
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 223 (673)
++|.+... ..+..+++|+.|++++|++.. ++ .+..+++|+.|++++|++++.. .+.++++|+.|++++|+++.
T Consensus 114 ~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 114 FNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp CSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred cccccccc--cccchhhhhHHhhhhhhhhcc-cc-cccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCC
Confidence 99999853 358899999999999999974 44 5889999999999999998743 38899999999999999986
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.58 E-value=5.2e-15 Score=150.13 Aligned_cols=169 Identities=22% Similarity=0.239 Sum_probs=136.9
Q ss_pred CceEEeCCCCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccC
Q 005859 56 FDGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGN 135 (673)
Q Consensus 56 w~gv~c~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 135 (673)
..+..|.. +.++-++++|+ .+|..+. ++|++|+|++|+|+...+..|.++++|++|++++|.+....|..|.+
T Consensus 5 p~~c~c~~----~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~ 77 (305)
T d1xkua_ 5 PFRCQCHL----RVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAP 77 (305)
T ss_dssp CTTCEEET----TEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTT
T ss_pred CCCCEecC----CEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhC
Confidence 45667842 34788888888 6787764 78999999999999877778999999999999999999888899999
Q ss_pred CCCCcEeeccCccccccC-----------------------------------------------chhhcCccccCeecc
Q 005859 136 MTNLQVLQLCYNKLTGNI-----------------------------------------------PTQLGSLRKLSVLAL 168 (673)
Q Consensus 136 l~~L~~L~L~~N~l~~~~-----------------------------------------------p~~l~~l~~L~~L~l 168 (673)
+++|+.|++++|+++... +..+..+++|+.+++
T Consensus 78 l~~L~~L~l~~n~l~~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l 157 (305)
T d1xkua_ 78 LVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 157 (305)
T ss_dssp CTTCCEEECCSSCCSBCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEEC
T ss_pred CCccCEecccCCccCcCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCcccc
Confidence 999999999999876211 112344566777778
Q ss_pred cccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCchhhhhccC
Q 005859 169 QYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKRLNG 234 (673)
Q Consensus 169 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~l~~~~~ 234 (673)
++|.++ .+|..+ +++|+.|++++|.+++..+..+.+++.++.|++++|.+.+..|..+..+..
T Consensus 158 ~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~ 220 (305)
T d1xkua_ 158 ADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH 220 (305)
T ss_dssp CSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTT
T ss_pred ccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccccccccc
Confidence 777776 455443 578999999999999888999999999999999999999988877765543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.57 E-value=7.7e-15 Score=140.29 Aligned_cols=153 Identities=27% Similarity=0.342 Sum_probs=125.6
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..++.|+++++.+.... .+..+++|++|+|++|+|++.. .++.+++|++|++++|++++ +| .+.++++|+.|++
T Consensus 46 ~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (210)
T ss_dssp HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred cCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccccc
Confidence 35788999999887543 3788999999999999998743 37889999999999999984 45 5889999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
++|.+.. + ..+..+++|+.+++++|.+++ +..+..+++|+.+++++|++++.. .+.++++|+.|+|++|+++.
T Consensus 120 ~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~- 192 (210)
T d1h6ta2 120 EHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD- 192 (210)
T ss_dssp TTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB-
T ss_pred ccccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC-
Confidence 9999873 3 468889999999999999974 345778899999999999998643 37889999999999999974
Q ss_pred Cchhhhh
Q 005859 225 VPPALKR 231 (673)
Q Consensus 225 ~p~~l~~ 231 (673)
+| .+..
T Consensus 193 l~-~l~~ 198 (210)
T d1h6ta2 193 LR-ALAG 198 (210)
T ss_dssp CG-GGTT
T ss_pred Ch-hhcC
Confidence 44 3443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=1.9e-15 Score=138.01 Aligned_cols=128 Identities=20% Similarity=0.156 Sum_probs=99.2
Q ss_pred cccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCcccc
Q 005859 84 AVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKL 163 (673)
Q Consensus 84 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 163 (673)
.+.++..|++|+|++|+|+. +|..+..+++|+.|+|++|+++ .++ .|..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 36677788899999999885 4666677888999999999888 343 47888889999999999887666667778889
Q ss_pred CeecccccccCccCC--ccccCCCcccccccccccCCCCC---cccccCCCCCCEEE
Q 005859 164 SVLALQYNQLTGAIP--ASLGDLGMLMRLDLSFNNLFGPV---PVKLANVPKLEVLD 215 (673)
Q Consensus 164 ~~L~l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~---p~~~~~l~~L~~L~ 215 (673)
+.|++++|+++. ++ ..+..+++|+.|++++|.++... +..+..+|+|+.||
T Consensus 90 ~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccc-cccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 999999998874 33 35778888888888888886432 22467788888877
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=7.4e-15 Score=127.50 Aligned_cols=102 Identities=26% Similarity=0.294 Sum_probs=56.4
Q ss_pred CeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeeccccc
Q 005859 92 TGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYN 171 (673)
Q Consensus 92 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N 171 (673)
|.|+|++|+|+. ++ .+..+++|++|++++|+|+ .+|+.|+.+++|+.|++++|++++ +| .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 356666666652 23 2556666666666666665 345556666666666666666653 33 3555666666666666
Q ss_pred ccCccC-CccccCCCcccccccccccCC
Q 005859 172 QLTGAI-PASLGDLGMLMRLDLSFNNLF 198 (673)
Q Consensus 172 ~l~~~~-p~~~~~l~~L~~L~l~~N~l~ 198 (673)
+++... ...+..+++|+.|++++|.++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 655321 123455555555555555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.52 E-value=3.2e-14 Score=135.89 Aligned_cols=142 Identities=32% Similarity=0.425 Sum_probs=123.3
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.+++.|+|++|.+++.. .++.+++|++|++++|+|++ +| .+..+++|+.|++++|.+.. + +.+..+++|+.+++
T Consensus 68 ~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~ 141 (210)
T d1h6ta2 68 PNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 141 (210)
T ss_dssp TTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred CCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccccccccccccc-c-cccccccccccccc
Confidence 47899999999998743 37899999999999999986 44 58999999999999999873 3 46889999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRN 218 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 218 (673)
++|.+++ +..+..+++|+++++++|++++ ++ .+.++++|+.|+|++|+++. +| .+.++++|++|+|++
T Consensus 142 ~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 142 GNNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred ccccccc--cccccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 9999985 3467889999999999999985 44 38899999999999999985 55 589999999999975
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=3.2e-14 Score=138.97 Aligned_cols=176 Identities=19% Similarity=0.141 Sum_probs=124.7
Q ss_pred CCceEEeCCC----------CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccC-CcccCCCCCCCEEEcc-C
Q 005859 55 SFDGVACDEN----------GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVI-PKEIASLSELSDLYLN-V 122 (673)
Q Consensus 55 ~w~gv~c~~~----------~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~-~ 122 (673)
....|.|... ..++.|+|++|.++...+..|.++++|++|+|++|.+...+ +..|..++++++|++. .
T Consensus 9 ~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 9 SNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp CSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred cCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 3678888531 36889999999998666668999999999999999987654 4568889999999876 4
Q ss_pred CCCCCCCcccccCCCCCcEeeccCccccccCch-------------------------hhcCcc-ccCeecccccccCcc
Q 005859 123 NNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPT-------------------------QLGSLR-KLSVLALQYNQLTGA 176 (673)
Q Consensus 123 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-------------------------~l~~l~-~L~~L~l~~N~l~~~ 176 (673)
|++....+..|.++++|+.|++++|.+....+. .|..++ .++.|++++|+++..
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i 168 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI 168 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccc
Confidence 678777778899999999999999988633221 122222 455566667777643
Q ss_pred CCccccCCCccc-ccccccccCCCCCcccccCCCCCCEEEccCCCCCcCCchhhhh
Q 005859 177 IPASLGDLGMLM-RLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGNVPPALKR 231 (673)
Q Consensus 177 ~p~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~l~~ 231 (673)
.+..+ ...++. .+++++|+++...+..|.++++|+.|+|++|+|+...+..+.+
T Consensus 169 ~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~ 223 (242)
T d1xwdc1 169 HNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 223 (242)
T ss_dssp CTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTT
T ss_pred ccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcC
Confidence 33333 334443 3456777787655566788888888888888887433333433
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.50 E-value=6.9e-14 Score=135.28 Aligned_cols=149 Identities=26% Similarity=0.429 Sum_probs=96.4
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..++.|++.+++++. ++ .+..|++|++|+|++|++++..| +..+++|++|++++|.++ .++ .+..+++|+.|++
T Consensus 41 ~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l 114 (227)
T d1h6ua2 41 DGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDL 114 (227)
T ss_dssp HTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEEC
T ss_pred CCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-ccccccccccccc
Confidence 356777787777774 33 47778888888888888775443 777778888888877776 333 4667777777777
Q ss_pred cCccccccCc--------------------hhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCccc
Q 005859 145 CYNKLTGNIP--------------------TQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVK 204 (673)
Q Consensus 145 ~~N~l~~~~p--------------------~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 204 (673)
++|...+..+ ..+..+++|+.|++++|.+.... .++++++|+.|+|++|++++. + .
T Consensus 115 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~ 190 (227)
T d1h6ua2 115 TSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI-S-P 190 (227)
T ss_dssp TTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-G
T ss_pred ccccccccchhccccchhhhhchhhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCCC-h-h
Confidence 7777653211 12445566666666666665322 256666666677766666643 2 2
Q ss_pred ccCCCCCCEEEccCCCCCc
Q 005859 205 LANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 205 ~~~l~~L~~L~l~~N~l~g 223 (673)
+.++++|+.|+|++|+++.
T Consensus 191 l~~l~~L~~L~Ls~N~lt~ 209 (227)
T d1h6ua2 191 LASLPNLIEVHLKNNQISD 209 (227)
T ss_dssp GGGCTTCCEEECTTSCCCB
T ss_pred hcCCCCCCEEECcCCcCCC
Confidence 5566666677777666664
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=2.7e-14 Score=123.82 Aligned_cols=103 Identities=27% Similarity=0.367 Sum_probs=91.6
Q ss_pred CEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccc
Q 005859 116 SDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFN 195 (673)
Q Consensus 116 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 195 (673)
+.|+|++|+++ .++ .+..+++|++|++++|+++ .+|..|+.+++|++|++++|.|++ +| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 57999999998 555 4899999999999999999 578889999999999999999985 55 5899999999999999
Q ss_pred cCCCCC-cccccCCCCCCEEEccCCCCCc
Q 005859 196 NLFGPV-PVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 196 ~l~~~~-p~~~~~l~~L~~L~l~~N~l~g 223 (673)
+++... ...+..+++|+.|++++|+++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 998654 3568899999999999999974
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.47 E-value=1e-13 Score=131.08 Aligned_cols=138 Identities=29% Similarity=0.446 Sum_probs=118.6
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.+++.|+|++|.+++..| ++++++|++|++++|.+... + .+.++++|+.|++++|.+... ..+..+++|+.|++
T Consensus 62 ~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l 135 (199)
T d2omxa2 62 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLEL 135 (199)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEEC
T ss_pred CCcCcCccccccccCccc--ccCCcccccccccccccccc-c-ccccccccccccccccccccc--cccchhhhhHHhhh
Confidence 578999999999987543 89999999999999999753 3 489999999999999998753 34889999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEE
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVL 214 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 214 (673)
++|++.. ++ .+..+++|+.|++.+|++++. + .++++++|+.|++++|+++. ++ .+.++++|+.|
T Consensus 136 ~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 136 SSNTISD-IS-ALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp CSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred hhhhhcc-cc-cccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 9999984 43 689999999999999999864 3 48999999999999999986 33 47888988876
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.47 E-value=6.3e-14 Score=146.44 Aligned_cols=154 Identities=28% Similarity=0.436 Sum_probs=130.3
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
..+..|++++|.++. .+.+..+++|+.|++++|.+++..+ +..+++|+.|++++|++++. + .+..++.++.+++
T Consensus 219 ~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~-~-~~~~~~~l~~l~~ 292 (384)
T d2omza2 219 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI-S-PLAGLTALTNLEL 292 (384)
T ss_dssp TTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC-G-GGTTCTTCSEEEC
T ss_pred CCCCEEECCCCCCCC--cchhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCC-C-ccccccccccccc
Confidence 467889999999875 3468899999999999999997544 88899999999999999854 3 3788999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
+.|.+++ ...+..+++++.|++++|++++.. .+..+++|+.|++++|+|++ ++ .+.++++|+.|++++|+|++.
T Consensus 293 ~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l 366 (384)
T d2omza2 293 NENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDL 366 (384)
T ss_dssp CSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBC
T ss_pred ccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCC
Confidence 9999985 345888999999999999998653 38889999999999999985 44 588999999999999999976
Q ss_pred Cchhhhhc
Q 005859 225 VPPALKRL 232 (673)
Q Consensus 225 ~p~~l~~~ 232 (673)
.| +.++
T Consensus 367 ~~--l~~l 372 (384)
T d2omza2 367 TP--LANL 372 (384)
T ss_dssp GG--GTTC
T ss_pred hh--hccC
Confidence 54 5444
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.45 E-value=2.1e-13 Score=142.30 Aligned_cols=155 Identities=32% Similarity=0.420 Sum_probs=129.5
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
.....+++++|.+++..| +...++|++|++++|.++.. +.+..+++|+.|++++|.+++..+ +..+++|+.|++
T Consensus 197 ~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l 270 (384)
T d2omza2 197 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 270 (384)
T ss_dssp TTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred cccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeec
Confidence 356788999999988655 56788999999999999853 468899999999999999996443 788999999999
Q ss_pred cCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCcC
Q 005859 145 CYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSGN 224 (673)
Q Consensus 145 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ 224 (673)
++|++++.. .+..++.++.+++..|.+++ ...+..+++++.|++++|++++..+ +..+++|+.|++++|+|++
T Consensus 271 ~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~- 343 (384)
T d2omza2 271 GANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD- 343 (384)
T ss_dssp CSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-
T ss_pred cCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-
Confidence 999998643 37889999999999999985 3357888999999999999997643 7889999999999999986
Q ss_pred Cchhhhhcc
Q 005859 225 VPPALKRLN 233 (673)
Q Consensus 225 ~p~~l~~~~ 233 (673)
+| .+..+.
T Consensus 344 l~-~l~~l~ 351 (384)
T d2omza2 344 VS-SLANLT 351 (384)
T ss_dssp CG-GGGGCT
T ss_pred Ch-hHcCCC
Confidence 44 465554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=6.3e-14 Score=127.64 Aligned_cols=124 Identities=20% Similarity=0.194 Sum_probs=104.9
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeec
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQL 144 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 144 (673)
-++..|+|++|+|+. +|..+..+++|+.|+|++|.|+.. +.|..+++|++|++++|+++...+..+..+++|+.|+|
T Consensus 18 ~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 18 VRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 367899999999985 566678899999999999999854 35899999999999999999766666788999999999
Q ss_pred cCccccccCc-hhhcCccccCeecccccccCccCCc----cccCCCccccccc
Q 005859 145 CYNKLTGNIP-TQLGSLRKLSVLALQYNQLTGAIPA----SLGDLGMLMRLDL 192 (673)
Q Consensus 145 ~~N~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~L~l 192 (673)
++|+++.... ..+..+++|++|++++|.++. .|. .+..+++|+.||-
T Consensus 95 ~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 95 TNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp CSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETT
T ss_pred ccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeCC
Confidence 9999985322 468899999999999999974 443 4778899998873
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=2.2e-13 Score=123.10 Aligned_cols=147 Identities=22% Similarity=0.226 Sum_probs=102.9
Q ss_pred CCCCCCCceEEeCCCCCEEEEEecCCCcccccCccccCCCCCCeEeCcCC-cCCccCCcccCCCCCCCEEEccCCCCCCC
Q 005859 50 PCSSDSFDGVACDENGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFN-ALNGVIPKEIASLSELSDLYLNVNNLSGK 128 (673)
Q Consensus 50 ~C~~~~w~gv~c~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 128 (673)
.|++..+.+|+|. ++++. .+|..+.++++|++|+|++| .|+...++.|.++++|+.|+|++|+|+..
T Consensus 4 ~C~c~~~~~l~c~-----------~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i 71 (156)
T d2ifga3 4 ACCPHGSSGLRCT-----------RDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71 (156)
T ss_dssp SSCCSSSSCEECC-----------SSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEE
T ss_pred CCCcCCCCeEEec-----------CCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCc
Confidence 3544456777774 34443 45777888999999999876 58877778899999999999999999988
Q ss_pred CcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccC-CccccCCCcccccccccccCCCCCcccccC
Q 005859 129 IPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAI-PASLGDLGMLMRLDLSFNNLFGPVPVKLAN 207 (673)
Q Consensus 129 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 207 (673)
.|..|..+++|++|+|++|+|+...+..|..+ +|+.|+|++|.+.-.- -.+|..+.......+..+++.-..|..+.+
T Consensus 72 ~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~l~~ 150 (156)
T d2ifga3 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAH 150 (156)
T ss_dssp CTTGGGSCSCCCEEECCSSCCSCCCSTTTCSC-CCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSCSSC
T ss_pred ccccccccccccceeccCCCCcccChhhhccc-cccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcChHHCc
Confidence 78889999999999999999995444455444 7999999999885211 111212112223333445555555555555
Q ss_pred CC
Q 005859 208 VP 209 (673)
Q Consensus 208 l~ 209 (673)
+|
T Consensus 151 ~p 152 (156)
T d2ifga3 151 MP 152 (156)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.41 E-value=4.2e-13 Score=129.63 Aligned_cols=145 Identities=26% Similarity=0.383 Sum_probs=118.3
Q ss_pred CCCEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCC--------------
Q 005859 64 NGRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI-------------- 129 (673)
Q Consensus 64 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-------------- 129 (673)
-.++..|++++|.+++..| +.++++|++|++++|.++. + +.+..+++|+.|++++|...+..
T Consensus 62 l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~ 137 (227)
T d1h6ua2 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-V-SAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD 137 (227)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECC
T ss_pred CCCCcEeecCCceeecccc--ccccccccccccccccccc-c-ccccccccccccccccccccccchhccccchhhhhch
Confidence 3578999999999987544 8899999999999998874 3 35788888888888888765321
Q ss_pred ------cccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcc
Q 005859 130 ------PSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPV 203 (673)
Q Consensus 130 ------p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 203 (673)
...+.++++|+.|++++|.+++. ..++++++|+.|+|++|++++ ++ .+.++++|++|+|++|++++..|
T Consensus 138 ~~~~~~~~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~- 212 (227)
T d1h6ua2 138 LNQITNISPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSP- 212 (227)
T ss_dssp SSCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGG-
T ss_pred hhhhchhhhhccccccccccccccccccc--hhhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcc-
Confidence 23456778899999999999853 348999999999999999985 44 38899999999999999986543
Q ss_pred cccCCCCCCEEEccC
Q 005859 204 KLANVPKLEVLDIRN 218 (673)
Q Consensus 204 ~~~~l~~L~~L~l~~ 218 (673)
+.++++|+.|++++
T Consensus 213 -l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 213 -LANTSNLFIVTLTN 226 (227)
T ss_dssp -GTTCTTCCEEEEEE
T ss_pred -cccCCCCCEEEeeC
Confidence 88999999999974
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.36 E-value=3.4e-15 Score=141.08 Aligned_cols=130 Identities=26% Similarity=0.334 Sum_probs=91.2
Q ss_pred cCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCc
Q 005859 81 IPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSL 160 (673)
Q Consensus 81 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 160 (673)
+|..+..|++|++|+|++|+|+. ++ .+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|+++. + ..+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred hhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccc
Confidence 44567788888888888888874 33 4777888888888888887 456655566678888888888874 2 347777
Q ss_pred cccCeecccccccCccCC-ccccCCCcccccccccccCCCCCccc----------ccCCCCCCEEE
Q 005859 161 RKLSVLALQYNQLTGAIP-ASLGDLGMLMRLDLSFNNLFGPVPVK----------LANVPKLEVLD 215 (673)
Q Consensus 161 ~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~----------~~~l~~L~~L~ 215 (673)
++|+.|++++|+++.... ..+..+++|+.|+|++|.+....+.. +..+|+|+.||
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 888888888888864321 35677778888888887765433221 44567777765
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=4.9e-12 Score=114.06 Aligned_cols=103 Identities=21% Similarity=0.148 Sum_probs=53.1
Q ss_pred EEccCCCCCCCCcccccCCCCCcEeeccCc-cccccCchhhcCccccCeecccccccCccCCccccCCCccccccccccc
Q 005859 118 LYLNVNNLSGKIPSQIGNMTNLQVLQLCYN-KLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNN 196 (673)
Q Consensus 118 L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 196 (673)
++.+++.+. ..|..+..+++|+.|++++| .++...+..|.++++|+.|+|++|+|+...|..|..+++|+.|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 444444433 23344444445555555433 2443334445555555555555555554444555555555555555565
Q ss_pred CCCCCcccccCCCCCCEEEccCCCCC
Q 005859 197 LFGPVPVKLANVPKLEVLDIRNNSFS 222 (673)
Q Consensus 197 l~~~~p~~~~~l~~L~~L~l~~N~l~ 222 (673)
|+...+..+.. .+|+.|+|++|+|.
T Consensus 92 l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 92 LESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp CSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred CcccChhhhcc-ccccccccCCCccc
Confidence 55333333333 35777888888775
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=6.8e-12 Score=122.06 Aligned_cols=157 Identities=14% Similarity=0.143 Sum_probs=124.6
Q ss_pred EEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCC-cccccCCCCCcEeecc-C
Q 005859 69 NISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI-PSQIGNMTNLQVLQLC-Y 146 (673)
Q Consensus 69 ~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~L~-~ 146 (673)
.++.++.+++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|++++|.+...+ +..|.++++++.|.+. .
T Consensus 12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 4667788887 7887663 68999999999999777778999999999999999998655 4578999999999986 5
Q ss_pred ccccccCchhhcCccccCeecccccccCccCCc-cccCCCcccccccccccCCCCCcccccCCC-CCCEEEccCCCCCcC
Q 005859 147 NKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPA-SLGDLGMLMRLDLSFNNLFGPVPVKLANVP-KLEVLDIRNNSFSGN 224 (673)
Q Consensus 147 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~g~ 224 (673)
|.+....+..|.++++|++|++++|.+....+. .+..+..+..+..+++.+....+..+.+++ .++.|++++|+++..
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i 168 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI 168 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccc
Confidence 788888888999999999999999999743332 244455666666777777766666676665 788999999999864
Q ss_pred Cchh
Q 005859 225 VPPA 228 (673)
Q Consensus 225 ~p~~ 228 (673)
.+..
T Consensus 169 ~~~~ 172 (242)
T d1xwdc1 169 HNCA 172 (242)
T ss_dssp CTTT
T ss_pred cccc
Confidence 4433
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.25 E-value=8.1e-14 Score=131.48 Aligned_cols=118 Identities=27% Similarity=0.318 Sum_probs=99.9
Q ss_pred cCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecccccccCccCCccccC
Q 005859 104 VIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGD 183 (673)
Q Consensus 104 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~ 183 (673)
.+|.++..|++|++|+|++|+|+ .++ .|..+++|+.|+|++|+++ .+|..+..+++|++|++++|+++. + +.+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccc
Confidence 34567889999999999999998 455 5899999999999999998 567767777899999999999985 3 35888
Q ss_pred CCcccccccccccCCCCCc-ccccCCCCCCEEEccCCCCCcCCc
Q 005859 184 LGMLMRLDLSFNNLFGPVP-VKLANVPKLEVLDIRNNSFSGNVP 226 (673)
Q Consensus 184 l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~g~~p 226 (673)
+++|+.|+|++|+++.... ..+..+++|+.|+|++|++....+
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred cccccccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence 9999999999999986432 468899999999999999875433
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.03 E-value=2.5e-11 Score=121.03 Aligned_cols=167 Identities=18% Similarity=0.166 Sum_probs=113.6
Q ss_pred CCEEEEEecCCCcccc-cCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCC-CCCCC-CcccccCCCCCcE
Q 005859 65 GRVANISLQGKGLSGE-IPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVN-NLSGK-IPSQIGNMTNLQV 141 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~l~~L~~ 141 (673)
.++..|||+++.++.. ++..+..+++|++|+|+++.++...+..++.+++|++|+++++ .++.. +...+.++++|++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 4688899998877654 3445788899999999999988877888889999999999985 55521 2233457889999
Q ss_pred eeccCc-cccc-cCchhhcC-ccccCeeccccc--ccCc-cCCccccCCCcccccccccc-cCCCCCcccccCCCCCCEE
Q 005859 142 LQLCYN-KLTG-NIPTQLGS-LRKLSVLALQYN--QLTG-AIPASLGDLGMLMRLDLSFN-NLFGPVPVKLANVPKLEVL 214 (673)
Q Consensus 142 L~L~~N-~l~~-~~p~~l~~-l~~L~~L~l~~N--~l~~-~~p~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L 214 (673)
|+++++ .++. .+...+.. .++|+.|+++++ .++. .+...+.++++|++|++++| .+++.....+..+++|++|
T Consensus 126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L 205 (284)
T d2astb2 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 205 (284)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence 999885 4442 12222333 467888888754 3332 12223456778888888775 4665666677778888888
Q ss_pred EccCC-CCCcCCchhhhh
Q 005859 215 DIRNN-SFSGNVPPALKR 231 (673)
Q Consensus 215 ~l~~N-~l~g~~p~~l~~ 231 (673)
+++++ .++......+.+
T Consensus 206 ~L~~C~~i~~~~l~~L~~ 223 (284)
T d2astb2 206 SLSRCYDIIPETLLELGE 223 (284)
T ss_dssp ECTTCTTCCGGGGGGGGG
T ss_pred ECCCCCCCChHHHHHHhc
Confidence 88884 566544444443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.87 E-value=7.6e-09 Score=105.36 Aligned_cols=138 Identities=25% Similarity=0.332 Sum_probs=103.0
Q ss_pred CEEEEEecCCCcccccCccccCCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeecc
Q 005859 66 RVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLC 145 (673)
Q Consensus 66 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 145 (673)
+++.|+|++++|+ .+|+. +++|++|+|++|+|+ .+|+. +.+|+.|++++|+++ .++.. .++|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 5678999999997 57753 578999999999998 56765 468999999999988 44431 2469999999
Q ss_pred CccccccCchhhcCccccCeecccccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCc
Q 005859 146 YNKLTGNIPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 146 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 223 (673)
+|.+. .+|. ++.+++|+.|++++|.+.. .|.. ...+..|.+..+... .+..+..++.++.|++++|.+..
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~ 176 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKK 176 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSS
T ss_pred ccccc-cccc-hhhhccceeeccccccccc-cccc---cccccchhhcccccc--ccccccccccceecccccccccc
Confidence 99998 5664 6789999999999999874 3333 334555555555443 33456667778888888887664
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.78 E-value=4.7e-10 Score=111.63 Aligned_cols=155 Identities=21% Similarity=0.268 Sum_probs=120.1
Q ss_pred CCEEEEEecCCCcccccCccccCCCCCCeEeCcCC-cCCcc-CCcccCCCCCCCEEEccCC-CCCCC-CcccccC-CCCC
Q 005859 65 GRVANISLQGKGLSGEIPAAVGGLKSLTGLYLHFN-ALNGV-IPKEIASLSELSDLYLNVN-NLSGK-IPSQIGN-MTNL 139 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~-l~~L 139 (673)
.+++.|+|+++.+++..+..++.+++|++|+|+++ .++.. +...+.++++|++|+++++ .++.. +...+.. .++|
T Consensus 71 ~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L 150 (284)
T d2astb2 71 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI 150 (284)
T ss_dssp CCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC
T ss_pred CCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhccccccc
Confidence 47899999999999888889999999999999994 66521 2233457899999999985 44421 2233333 4789
Q ss_pred cEeeccCc--ccccc-CchhhcCccccCeeccccc-ccCccCCccccCCCccccccccc-ccCCCCCcccccCCCCCCEE
Q 005859 140 QVLQLCYN--KLTGN-IPTQLGSLRKLSVLALQYN-QLTGAIPASLGDLGMLMRLDLSF-NNLFGPVPVKLANVPKLEVL 214 (673)
Q Consensus 140 ~~L~L~~N--~l~~~-~p~~l~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L 214 (673)
+.|+++++ .++.. +...+..+++|++|++++| .+++.....+..+++|++|+|++ +.+++.....++++++|+.|
T Consensus 151 ~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L 230 (284)
T d2astb2 151 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTL 230 (284)
T ss_dssp CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred chhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEE
Confidence 99999975 34422 3334567899999999986 57777778899999999999999 46776666778899999999
Q ss_pred EccCC
Q 005859 215 DIRNN 219 (673)
Q Consensus 215 ~l~~N 219 (673)
+++++
T Consensus 231 ~l~~~ 235 (284)
T d2astb2 231 QVFGI 235 (284)
T ss_dssp ECTTS
T ss_pred eeeCC
Confidence 99987
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.73 E-value=3.1e-08 Score=100.69 Aligned_cols=117 Identities=25% Similarity=0.313 Sum_probs=92.1
Q ss_pred CCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCccccccCchhhcCccccCeecc
Q 005859 89 KSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLSVLAL 168 (673)
Q Consensus 89 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l 168 (673)
.+|+.|||++|.++. +|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .++|++|++
T Consensus 38 ~~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 468999999999984 6753 578999999999999 778654 68999999999998 34431 246999999
Q ss_pred cccccCccCCccccCCCcccccccccccCCCCCcccccCCCCCCEEEccCCCCCc
Q 005859 169 QYNQLTGAIPASLGDLGMLMRLDLSFNNLFGPVPVKLANVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 169 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g 223 (673)
++|.+. .+|. ++.+++|+.|++++|.+....+ ....+..+++.++....
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~~ 154 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLEE 154 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSS
T ss_pred cccccc-cccc-hhhhccceeecccccccccccc----ccccccchhhccccccc
Confidence 999998 5664 6789999999999999875332 24567788887776543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.67 E-value=7.7e-10 Score=113.23 Aligned_cols=139 Identities=21% Similarity=0.216 Sum_probs=68.6
Q ss_pred ccCCCCCCeEeCcCCcCCcc----CCcccCCCCCCCEEEccCCCCCCCCcc-------------cccCCCCCcEeeccCc
Q 005859 85 VGGLKSLTGLYLHFNALNGV----IPKEIASLSELSDLYLNVNNLSGKIPS-------------QIGNMTNLQVLQLCYN 147 (673)
Q Consensus 85 ~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~-------------~~~~l~~L~~L~L~~N 147 (673)
+...++|+.|+|++|.++.. +...+...++|++|++++|.+...-.. .....+.|+.|++++|
T Consensus 89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n 168 (344)
T d2ca6a1 89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 168 (344)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred HhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccc
Confidence 44456666666666666532 222334456666666666655311000 0123445666666666
Q ss_pred ccccc----CchhhcCccccCeecccccccCcc-----CCccccCCCcccccccccccCCCC----CcccccCCCCCCEE
Q 005859 148 KLTGN----IPTQLGSLRKLSVLALQYNQLTGA-----IPASLGDLGMLMRLDLSFNNLFGP----VPVKLANVPKLEVL 214 (673)
Q Consensus 148 ~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~-----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L 214 (673)
+++.. +...+...++|+.|+|++|.+... +...+..+++|+.|+|++|.++.. +...+..+++|+.|
T Consensus 169 ~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L 248 (344)
T d2ca6a1 169 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248 (344)
T ss_dssp CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEE
T ss_pred cccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhh
Confidence 55421 222334455566666666655421 222344455566666666655321 22334455566666
Q ss_pred EccCCCCCc
Q 005859 215 DIRNNSFSG 223 (673)
Q Consensus 215 ~l~~N~l~g 223 (673)
+|++|.|++
T Consensus 249 ~Ls~n~i~~ 257 (344)
T d2ca6a1 249 GLNDCLLSA 257 (344)
T ss_dssp ECTTCCCCH
T ss_pred hhhcCccCc
Confidence 666666554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.64 E-value=1e-09 Score=112.25 Aligned_cols=159 Identities=18% Similarity=0.191 Sum_probs=101.4
Q ss_pred CCEEEEEecCCCcccc----cCccccCCCCCCeEeCcCCcCCccCCc-------------ccCCCCCCCEEEccCCCCCC
Q 005859 65 GRVANISLQGKGLSGE----IPAAVGGLKSLTGLYLHFNALNGVIPK-------------EIASLSELSDLYLNVNNLSG 127 (673)
Q Consensus 65 ~~v~~l~l~~~~l~g~----~p~~~~~l~~L~~L~L~~N~l~~~~p~-------------~~~~l~~L~~L~l~~N~l~~ 127 (673)
.+++.|+|++|.+... +...+...++|+.|+|++|.+...-.. .....+.|+.|++++|+++.
T Consensus 93 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~ 172 (344)
T d2ca6a1 93 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 172 (344)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccc
Confidence 4678888888887653 445566778888888888877421100 11345677888888877752
Q ss_pred C----CcccccCCCCCcEeeccCcccccc-----CchhhcCccccCeecccccccCcc----CCccccCCCccccccccc
Q 005859 128 K----IPSQIGNMTNLQVLQLCYNKLTGN-----IPTQLGSLRKLSVLALQYNQLTGA----IPASLGDLGMLMRLDLSF 194 (673)
Q Consensus 128 ~----~p~~~~~l~~L~~L~L~~N~l~~~-----~p~~l~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~ 194 (673)
. +...+...+.|+.|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+++|+.|+|++
T Consensus 173 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~ 252 (344)
T d2ca6a1 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 252 (344)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred cccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhc
Confidence 2 233445667788888888877531 233456677788888888876532 334566677788888888
Q ss_pred ccCCCCCccc----cc--CCCCCCEEEccCCCCCc
Q 005859 195 NNLFGPVPVK----LA--NVPKLEVLDIRNNSFSG 223 (673)
Q Consensus 195 N~l~~~~p~~----~~--~l~~L~~L~l~~N~l~g 223 (673)
|.|++.-... +. ..++|+.|++++|+++.
T Consensus 253 n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~ 287 (344)
T d2ca6a1 253 CLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 287 (344)
T ss_dssp CCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred CccCchhhHHHHHHhhhccCCCCCEEECCCCcCCh
Confidence 8776432222 22 23567788888887764
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.62 E-value=1.5e-09 Score=98.11 Aligned_cols=106 Identities=21% Similarity=0.089 Sum_probs=58.3
Q ss_pred cCCCCCCCEEEccCCCCCCCCcccccCCCCCcEeeccCcccccc--CchhhcCccccCeecccccccCccCCccccCCCc
Q 005859 109 IASLSELSDLYLNVNNLSGKIPSQIGNMTNLQVLQLCYNKLTGN--IPTQLGSLRKLSVLALQYNQLTGAIPASLGDLGM 186 (673)
Q Consensus 109 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 186 (673)
+..+..+..|+..+|... .++..+..+++|++|+|++|+++.. ++..+..+++|+.|+|++|.++...+-.+.....
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~ 116 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence 333444444444443332 3344445566777777777777643 2344556677777777777776432223333445
Q ss_pred ccccccccccCCCCCcc-------cccCCCCCCEEE
Q 005859 187 LMRLDLSFNNLFGPVPV-------KLANVPKLEVLD 215 (673)
Q Consensus 187 L~~L~l~~N~l~~~~p~-------~~~~l~~L~~L~ 215 (673)
|+.|++++|.+...... .+..+|+|+.||
T Consensus 117 L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 117 LEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 67777777776654332 245667777665
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.48 E-value=3.6e-09 Score=111.86 Aligned_cols=136 Identities=21% Similarity=0.190 Sum_probs=55.7
Q ss_pred CCCCCCeEeCcCCcCCcc----CCcccCCCCCCCEEEccCCCCCCCCcccc-----cCCCCCcEeeccCccccccCchh-
Q 005859 87 GLKSLTGLYLHFNALNGV----IPKEIASLSELSDLYLNVNNLSGKIPSQI-----GNMTNLQVLQLCYNKLTGNIPTQ- 156 (673)
Q Consensus 87 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~p~~- 156 (673)
....|+.|++++|.+... ....+...+.++.+++++|.++......+ ...+.|+.+++++|.++......
T Consensus 253 ~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l 332 (460)
T d1z7xw1 253 PSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHF 332 (460)
T ss_dssp TTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhc
Confidence 344555555555554421 11223334455555555555432111111 12234555555555544322221
Q ss_pred ---hcCccccCeecccccccCcc----CCcccc-CCCcccccccccccCCCC----CcccccCCCCCCEEEccCCCCC
Q 005859 157 ---LGSLRKLSVLALQYNQLTGA----IPASLG-DLGMLMRLDLSFNNLFGP----VPVKLANVPKLEVLDIRNNSFS 222 (673)
Q Consensus 157 ---l~~l~~L~~L~l~~N~l~~~----~p~~~~-~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 222 (673)
+...++|++|+|++|+++.. ++..+. ..+.|+.|+|++|+|+.. ++..+..+++|++|+|++|+|+
T Consensus 333 ~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~ 410 (460)
T d1z7xw1 333 SSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410 (460)
T ss_dssp HHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred ccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCC
Confidence 22233455555555554321 122221 233455555555554421 2222333445555555555554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.43 E-value=6.3e-09 Score=93.87 Aligned_cols=104 Identities=23% Similarity=0.142 Sum_probs=61.8
Q ss_pred CCCCCCeEeCcCCcCCccCCcccCCCCCCCEEEccCCCCCCCC--cccccCCCCCcEeeccCccccccCchhhcCccccC
Q 005859 87 GLKSLTGLYLHFNALNGVIPKEIASLSELSDLYLNVNNLSGKI--PSQIGNMTNLQVLQLCYNKLTGNIPTQLGSLRKLS 164 (673)
Q Consensus 87 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 164 (673)
.+..+..|++.+|... .++..+..+++|++|+|++|+++..- +..+..+++|+.|+|++|+++...+-.+....+|+
T Consensus 40 ~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~ 118 (162)
T d1koha1 40 AQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118 (162)
T ss_dssp TTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCS
T ss_pred hccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccc
Confidence 3334444444444332 33444455677777777777776432 34466677777777777777743332333445677
Q ss_pred eecccccccCccCCcc-------ccCCCcccccc
Q 005859 165 VLALQYNQLTGAIPAS-------LGDLGMLMRLD 191 (673)
Q Consensus 165 ~L~l~~N~l~~~~p~~-------~~~l~~L~~L~ 191 (673)
.|++++|.+....... +..+++|+.||
T Consensus 119 ~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 119 ELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp SCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred eeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 8888888776544422 55677787775
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.27 E-value=2.4e-06 Score=82.80 Aligned_cols=149 Identities=12% Similarity=0.046 Sum_probs=94.9
Q ss_pred HHHHHHhcCCccccccccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccC-CCCceeEeeEEecCCC
Q 005859 395 EEVERATQCFSEANLLGKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGICCSKGR 473 (673)
Q Consensus 395 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 473 (673)
.|+...-+.|...+..+.++.+.||+.... ++.+.+|+..... ......+.+|...+..+. +--+.+++.+... .
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~-~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~ 82 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--D 82 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--T
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCc-ccchhhHHHHHHHHHHHhccCCCCcEEEEEec--C
Confidence 456665666766655444455789998754 5566788775543 222335678888877763 4335566666543 3
Q ss_pred CeEEEEEeecCCCChhhhhccccCCccccCHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 005859 474 GECFLIYDFVPNGNLLQHLDLEAGSEKVLEWATRISVIKGIAKGISYLHGK----------------------------- 524 (673)
Q Consensus 474 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------- 524 (673)
+..++|||+++|..+.+..... .. ...++.++++.++.||+.
T Consensus 83 ~~~~lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T d1j7la_ 83 GWSNLLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp TEEEEEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred CceEEEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence 6789999999998876543210 11 122344455555555531
Q ss_pred ----------------------------CCCcccCCcCCCCeEecCCCCeeecccccccc
Q 005859 525 ----------------------------RPGLVHPNLSAEKVLIHRRYNPLLSDSGLHKL 556 (673)
Q Consensus 525 ----------------------------~~~ivHrDlk~~NILl~~~~~~kl~DfGla~~ 556 (673)
.+.++|+|+.|.||++++++..-|.||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11378999999999999876667999987753
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.16 E-value=8.1e-08 Score=101.10 Aligned_cols=165 Identities=22% Similarity=0.193 Sum_probs=103.3
Q ss_pred CEEEEEecCCCcccc----cCccccCCCCCCeEeCcCCcCCccCCc----cc-CCCCCCCEEEccCCCCCCCCcc----c
Q 005859 66 RVANISLQGKGLSGE----IPAAVGGLKSLTGLYLHFNALNGVIPK----EI-ASLSELSDLYLNVNNLSGKIPS----Q 132 (673)
Q Consensus 66 ~v~~l~l~~~~l~g~----~p~~~~~l~~L~~L~L~~N~l~~~~p~----~~-~~l~~L~~L~l~~N~l~~~~p~----~ 132 (673)
.+..+++++|.+... ....+...+.++.+++++|.++..... .+ .....|+.+++++|.++..... .
T Consensus 256 ~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~ 335 (460)
T d1z7xw1 256 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV 335 (460)
T ss_dssp CCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccc
Confidence 567777777776543 233455677788888888877532111 11 2345788888888877644322 2
Q ss_pred ccCCCCCcEeeccCcccccc----Cchhhc-CccccCeecccccccCc----cCCccccCCCcccccccccccCCCCCcc
Q 005859 133 IGNMTNLQVLQLCYNKLTGN----IPTQLG-SLRKLSVLALQYNQLTG----AIPASLGDLGMLMRLDLSFNNLFGPVPV 203 (673)
Q Consensus 133 ~~~l~~L~~L~L~~N~l~~~----~p~~l~-~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 203 (673)
+...++|+.|+|++|+++.. ++..+. ..+.|++|+|++|.|+. .++..+..+++|++|+|++|+|+.....
T Consensus 336 ~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~ 415 (460)
T d1z7xw1 336 LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL 415 (460)
T ss_dssp HHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHH
T ss_pred cccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHH
Confidence 34456788888888887642 333333 35668888888888864 2444566667888888888887643222
Q ss_pred c----cc-CCCCCCEEEccCCCCCcCCchhhh
Q 005859 204 K----LA-NVPKLEVLDIRNNSFSGNVPPALK 230 (673)
Q Consensus 204 ~----~~-~l~~L~~L~l~~N~l~g~~p~~l~ 230 (673)
. +. +..+|+.|++.+|.+.......+.
T Consensus 416 ~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l~ 447 (460)
T d1z7xw1 416 QLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQ 447 (460)
T ss_dssp HHHHHHTSTTCCCCEEECTTCCCCHHHHHHHH
T ss_pred HHHHHHHhCCCccCEEECCCCCCCHHHHHHHH
Confidence 2 22 334688888888888765555543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.75 E-value=2.2e-05 Score=75.26 Aligned_cols=74 Identities=19% Similarity=0.168 Sum_probs=50.5
Q ss_pred cccCCc-ceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCC--CCceeEeeEEecCCCCeEEEEEeecCCC
Q 005859 410 LGKSSF-SATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKH--ENLASLRGICCSKGRGECFLIYDFVPNG 486 (673)
Q Consensus 410 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~~~lv~E~~~~g 486 (673)
+..|.. +.||+...+++..+.+|...... ...+..|++.++.+.. -.+.+++++..+ .+..++||||++|-
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEVPGQ 91 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECCSSE
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeeccc--ccceEEEEEeeecc
Confidence 444543 67999998888888899765432 2346778888877743 334566766543 46789999999886
Q ss_pred Chh
Q 005859 487 NLL 489 (673)
Q Consensus 487 sL~ 489 (673)
++.
T Consensus 92 ~~~ 94 (255)
T d1nd4a_ 92 DLL 94 (255)
T ss_dssp ETT
T ss_pred ccc
Confidence 654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.61 E-value=8.1e-06 Score=73.15 Aligned_cols=39 Identities=8% Similarity=-0.094 Sum_probs=19.5
Q ss_pred cCCCcccccccccccCCCC-------CcccccCCCCCCEEEccCCC
Q 005859 182 GDLGMLMRLDLSFNNLFGP-------VPVKLANVPKLEVLDIRNNS 220 (673)
Q Consensus 182 ~~l~~L~~L~l~~N~l~~~-------~p~~~~~l~~L~~L~l~~N~ 220 (673)
...++|++|+|++|.+... +...+...++|+.|+++.+.
T Consensus 97 ~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 97 LVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp TTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 3344455555555443321 22333445677777776654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.58 E-value=1e-05 Score=72.52 Aligned_cols=110 Identities=13% Similarity=0.136 Sum_probs=66.9
Q ss_pred CCCCCCeEeCcCC-cCCcc----CCcccCCCCCCCEEEccCCCCCC----CCcccccCCCCCcEeeccCcccccc----C
Q 005859 87 GLKSLTGLYLHFN-ALNGV----IPKEIASLSELSDLYLNVNNLSG----KIPSQIGNMTNLQVLQLCYNKLTGN----I 153 (673)
Q Consensus 87 ~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~ 153 (673)
+.++|+.|+|+++ .++.. +-..+...+.|+.|+|++|.+.. .+...+...+.|+.|+|++|.++.. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4567777777763 45421 22345566777788887777752 2233445567788888888877632 2
Q ss_pred chhhcCccccCeecccccccCcc-------CCccccCCCccccccccccc
Q 005859 154 PTQLGSLRKLSVLALQYNQLTGA-------IPASLGDLGMLMRLDLSFNN 196 (673)
Q Consensus 154 p~~l~~l~~L~~L~l~~N~l~~~-------~p~~~~~l~~L~~L~l~~N~ 196 (673)
-..+...++|++|+|++|.+... +...+...++|+.|+++.+.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 23455667788888887765421 23334455777777776654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.49 E-value=0.0002 Score=73.19 Aligned_cols=77 Identities=5% Similarity=-0.038 Sum_probs=48.6
Q ss_pred ccccccCCcceEEEEEEcC-CcEEEEEEecccC------CCCcHHHHHHHHHHHhccC-C--CCceeEeeEEecCCCCeE
Q 005859 407 ANLLGKSSFSATYKGILRD-GSVVAVKCIAKTS------CKSDEGEFLKGLKILTSLK-H--ENLASLRGICCSKGRGEC 476 (673)
Q Consensus 407 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~------~~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~~ 476 (673)
.+.||.|....||+....+ ++.|+||.-.... ......+...|.+.|+.+. + ..+.+++.+. . +..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~--~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--C--CCC
Confidence 3468999999999998765 6789999764311 1112234566888887662 2 3456666543 3 345
Q ss_pred EEEEeecCCCC
Q 005859 477 FLIYDFVPNGN 487 (673)
Q Consensus 477 ~lv~E~~~~gs 487 (673)
++|||++++..
T Consensus 107 ~lvmE~L~~~~ 117 (392)
T d2pula1 107 VTVMEDLSHLK 117 (392)
T ss_dssp EEEECCCTTSE
T ss_pred EEEEeccCCcc
Confidence 78999997644
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.84 E-value=8.6e-05 Score=66.09 Aligned_cols=18 Identities=11% Similarity=-0.036 Sum_probs=11.6
Q ss_pred cccCCCCCCEEEccCCCC
Q 005859 204 KLANVPKLEVLDIRNNSF 221 (673)
Q Consensus 204 ~~~~l~~L~~L~l~~N~l 221 (673)
.+...++|+.|+++.|..
T Consensus 127 ~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 127 MLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHCSSCCEEECCCSSH
T ss_pred HHHhCCCcCEEeCcCCCC
Confidence 344566777777776654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.84 E-value=8.8e-05 Score=65.99 Aligned_cols=113 Identities=14% Similarity=0.140 Sum_probs=75.6
Q ss_pred ccCCCCCCeEeCcC-CcCCcc----CCcccCCCCCCCEEEccCCCCCCCC----cccccCCCCCcEeeccCcccccc---
Q 005859 85 VGGLKSLTGLYLHF-NALNGV----IPKEIASLSELSDLYLNVNNLSGKI----PSQIGNMTNLQVLQLCYNKLTGN--- 152 (673)
Q Consensus 85 ~~~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~--- 152 (673)
..+.+.|++|+|++ |.++.. +-..+...++|++|+|++|.++... -..+...++|+.|++++|.+...
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~ 92 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 92 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence 34668899999987 556521 2344567888999999999886432 23455668889999988888632
Q ss_pred -CchhhcCccccCeecc--cccccCc----cCCccccCCCcccccccccccC
Q 005859 153 -IPTQLGSLRKLSVLAL--QYNQLTG----AIPASLGDLGMLMRLDLSFNNL 197 (673)
Q Consensus 153 -~p~~l~~l~~L~~L~l--~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l 197 (673)
+-..+...++|+.++| ++|.+.. .+...+...++|+.|+++.+..
T Consensus 93 ~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 93 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 2345666777876444 5666643 2444556678888888876653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.75 E-value=0.0016 Score=64.42 Aligned_cols=69 Identities=13% Similarity=0.120 Sum_probs=44.8
Q ss_pred eEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCce--eEeeE---EecCCCCeEEEEEeecCCCC
Q 005859 417 ATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENLA--SLRGI---CCSKGRGECFLIYDFVPNGN 487 (673)
Q Consensus 417 ~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv--~l~~~---~~~~~~~~~~lv~E~~~~gs 487 (673)
.||+.+..+|+.|++|+.+... ...+++..|.+.+..|....|. ..... ......+..+.++++++|..
T Consensus 37 ~vy~v~~~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 37 RVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp EEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred eeEEEEcCCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 7999999999999999987652 3456788898888887433221 11110 00011246788999997633
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.41 E-value=0.023 Score=57.33 Aligned_cols=72 Identities=17% Similarity=0.191 Sum_probs=47.8
Q ss_pred cccccCCcceEEEEEEcCC--------cEEEEEEecccCCCCcHHHHHHHHHHHhccC-CCCceeEeeEEecCCCCeEEE
Q 005859 408 NLLGKSSFSATYKGILRDG--------SVVAVKCIAKTSCKSDEGEFLKGLKILTSLK-HENLASLRGICCSKGRGECFL 478 (673)
Q Consensus 408 ~~lg~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~l 478 (673)
+.|+.|-.=.+|+...+++ +.|.+++.... .......+|.++++.+. +.-..++++++ . + .+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~---~~~idr~~E~~i~~~ls~~gl~Pkll~~~--~--~--g~ 118 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIF--S--G--GR 118 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEE--T--T--EE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc---chhhHHHHHHHHHHHHHhCCCCCeEEEEc--C--C--ce
Confidence 4577777779999987543 45777665422 23345668999998884 43334777776 2 2 57
Q ss_pred EEeecCCCCh
Q 005859 479 IYDFVPNGNL 488 (673)
Q Consensus 479 v~E~~~~gsL 488 (673)
||||++|..+
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.30 E-value=0.019 Score=55.89 Aligned_cols=160 Identities=11% Similarity=0.042 Sum_probs=82.1
Q ss_pred cCHHHHHHHhcCCcccccc-----ccCCcceEEEEEEcCCcEEEEEEecccCCCCcHHHHHHHHHHHhccCCCCc-----
Q 005859 392 FNLEEVERATQCFSEANLL-----GKSSFSATYKGILRDGSVVAVKCIAKTSCKSDEGEFLKGLKILTSLKHENL----- 461 (673)
Q Consensus 392 ~~~~~l~~~~~~~~~~~~l-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~ni----- 461 (673)
++.+|++....+|...+.. ..|---+.|+.+..+|+ +++|+..... ..++...|+++|..+...++
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~---~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC---CHHHHHHHHHHHHhhhhcccccccc
Confidence 4567788777788764443 34444678998877665 7889876432 22345556777777643222
Q ss_pred eeEe-eEEecCCCCeEEEEEeecCCCChhhhh--------------ccc----cC--Cccc-----------------cC
Q 005859 462 ASLR-GICCSKGRGECFLIYDFVPNGNLLQHL--------------DLE----AG--SEKV-----------------LE 503 (673)
Q Consensus 462 v~l~-~~~~~~~~~~~~lv~E~~~~gsL~~~l--------------~~~----~~--~~~~-----------------l~ 503 (673)
+... |.....-......++.+..+......- +.. .. .... ..
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 1110 000000123456677777664332110 000 00 0000 00
Q ss_pred HHHHHHHHHHHHHHHHHHhc--CCCCcccCCcCCCCeEecCCCCeeeccccccc
Q 005859 504 WATRISVIKGIAKGISYLHG--KRPGLVHPNLSAEKVLIHRRYNPLLSDSGLHK 555 (673)
Q Consensus 504 ~~~~~~i~~~ia~gL~yLH~--~~~~ivHrDlk~~NILl~~~~~~kl~DfGla~ 555 (673)
.......+..+...+.-.+. ..-|+||+|+.++||+++++...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 00111222222233333322 12379999999999999988777899999875
|